Psyllid ID: psy6203
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | 2.2.26 [Sep-21-2011] | |||||||
| Q91821 | 651 | Maternal embryonic leucin | N/A | N/A | 0.572 | 0.499 | 0.570 | 1e-109 | |
| F1QGZ6 | 676 | Maternal embryonic leucin | yes | N/A | 0.568 | 0.477 | 0.583 | 1e-108 | |
| Q28GW8 | 652 | Maternal embryonic leucin | yes | N/A | 0.572 | 0.498 | 0.570 | 1e-108 | |
| Q61846 | 643 | Maternal embryonic leucin | yes | N/A | 0.572 | 0.505 | 0.576 | 1e-102 | |
| Q14680 | 651 | Maternal embryonic leucin | yes | N/A | 0.572 | 0.499 | 0.561 | 1e-101 | |
| Q5RDH5 | 554 | 5'-AMP-activated protein | yes | N/A | 0.508 | 0.521 | 0.468 | 5e-69 | |
| Q5EG47 | 559 | 5'-AMP-activated protein | no | N/A | 0.554 | 0.563 | 0.441 | 5e-69 | |
| P54645 | 559 | 5'-AMP-activated protein | no | N/A | 0.554 | 0.563 | 0.441 | 5e-69 | |
| Q13131 | 559 | 5'-AMP-activated protein | no | N/A | 0.508 | 0.516 | 0.468 | 5e-69 | |
| Q38997 | 535 | SNF1-related protein kina | yes | N/A | 0.568 | 0.603 | 0.444 | 2e-68 |
| >sp|Q91821|MELK_XENLA Maternal embryonic leucine zipper kinase OS=Xenopus laevis GN=melk PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 395 bits (1014), Expect = e-109, Method: Compositional matrix adjust.
Identities = 186/326 (57%), Positives = 246/326 (75%), Gaps = 1/326 (0%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
Y +L Y L TVG+GGFAKVKLA+H++TGEKVAIKIM K +LG+DLPRVK EI+A+K+
Sbjct: 6 YEELLKYYELHETVGTGGFAKVKLASHLITGEKVAIKIMDKESLGDDLPRVKTEIDAMKN 65
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+SHQH+C+L+ VIET IFMV+EYCPGGEL D+I+ + RL E+E+R FFRQI+SAVAY+
Sbjct: 66 LSHQHVCRLYHVIETPKKIFMVLEYCPGGELFDYIIAKDRLTEEEARVFFRQIVSAVAYI 125
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H GYAHRDLKPEN+L+D +QNLKLIDFGLCAKP+GGL+ L T CGSP YAAPE+I+GK
Sbjct: 126 HSQGYAHRDLKPENLLIDEDQNLKLIDFGLCAKPKGGLDYHLMTCCGSPAYAAPELIQGK 185
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
Y GSE D+WSMGV++YAL+CG+LPFD D++ LY KI+ GKY P W+SP S ++ M
Sbjct: 186 AYIGSEADIWSMGVLMYALMCGYLPFDDDNVMVLYKKIMRGKYEIPKWLSPGSVLLLSQM 245
Query: 243 LQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMW 302
+QV+P KRI ++ LL H W+ G PV ++ + L D+D + ++ + S
Sbjct: 246 MQVDPKKRITVKHLLNHPWLMHG-YSCPVEWQSKYPLGYIDEDCVTELSVFYKYSRTSTT 304
Query: 303 SQLNEWTYNYDTCTYLLLLSRKKQGK 328
++EW+Y++ T +YLLL S+K GK
Sbjct: 305 RLISEWSYDHITASYLLLHSKKSHGK 330
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Also plays a role in primitive hematopoiesis, possibly by affecting the expression of genes critical for hematopoiesis (By similarity). Plays a role in cytokinesis during early development. Xenopus laevis (taxid: 8355) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F1QGZ6|MELK_DANRE Maternal embryonic leucine zipper kinase OS=Danio rerio GN=melk PE=2 SV=1 | Back alignment and function description |
|---|
Score = 394 bits (1011), Expect = e-108, Method: Compositional matrix adjust.
Identities = 189/324 (58%), Positives = 243/324 (75%), Gaps = 1/324 (0%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+L Y + T+GSGGFAKVKL H LTGEKVAIKIM+K LG+DLPRVK+EI A+K++S
Sbjct: 8 ELLKHYEVYETIGSGGFAKVKLGRHKLTGEKVAIKIMEKKDLGDDLPRVKIEIEAMKNLS 67
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
HQH+C+L+ VIET+S I+MV+EYCPGGEL D+I+ + RL E+E+R FFRQI+SA+AY+H
Sbjct: 68 HQHVCRLYHVIETTSKIYMVLEYCPGGELFDYIIAKDRLSEEETRVFFRQIISALAYVHS 127
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
GYAHRDLKPEN+L+D + NLKLIDFGLCAKP+GGL +L T CGSP YAAPE+I+GK Y
Sbjct: 128 QGYAHRDLKPENLLIDEDHNLKLIDFGLCAKPKGGLGFELLTCCGSPAYAAPELIQGKAY 187
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244
GSE DVWSMGV+LYALLCGFLPFD D+ LY KI GKY+ P W+SP+S ++ M+Q
Sbjct: 188 IGSEADVWSMGVLLYALLCGFLPFDDDNCMVLYRKITRGKYSNPHWLSPSSILLLNQMMQ 247
Query: 245 VEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQ 304
V+P +R+ ++ LL H WV G PV + + L D+D I MA + S
Sbjct: 248 VDPKRRLTVKHLLDHPWVMRG-YSTPVEWHSKYPLGHIDEDCITEMAVTFKQSKQRTIQL 306
Query: 305 LNEWTYNYDTCTYLLLLSRKKQGK 328
++EW Y+ T TYLLLL++K+QG+
Sbjct: 307 VSEWKYDQITATYLLLLAKKRQGR 330
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation (By similarity). Also plays a role in primitive hematopoiesis, possibly by affecting the expression of genes critical for hematopoiesis. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q28GW8|MELK_XENTR Maternal embryonic leucine zipper kinase OS=Xenopus tropicalis GN=melk PE=2 SV=1 | Back alignment and function description |
|---|
Score = 393 bits (1010), Expect = e-108, Method: Compositional matrix adjust.
Identities = 186/326 (57%), Positives = 244/326 (74%), Gaps = 1/326 (0%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
Y +L Y L T+G+GGFAKVKLA+H+ TGEKVAIKIM K +LG+DLPRVK EI+A+K+
Sbjct: 6 YEELLKYYELHETIGTGGFAKVKLASHLTTGEKVAIKIMDKESLGDDLPRVKTEIDAMKN 65
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+SHQH+C+L+ VIET + IFMV+EYCPGGEL D+I+ + RL E E+R FFRQI+SAVAY+
Sbjct: 66 LSHQHVCRLYHVIETPNKIFMVLEYCPGGELFDYIIAKDRLTEDEARVFFRQIVSAVAYI 125
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H GYAHRDLKPEN+L+D +QNLKLIDFGLCAKP+GGL+ L T CGSP YAAPE+I+GK
Sbjct: 126 HSQGYAHRDLKPENLLIDEDQNLKLIDFGLCAKPKGGLDYHLMTCCGSPAYAAPELIQGK 185
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
Y GSE D+WSMGV++YAL+CG+LPFD D++ LY KI+ GKY P W+SP S ++ M
Sbjct: 186 AYIGSEADIWSMGVLMYALMCGYLPFDDDNVMVLYKKIMRGKYEIPKWLSPGSVLLLSQM 245
Query: 243 LQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMW 302
LQV+P KRI ++ LL H W+ G PV ++ + L D+D + ++ + S
Sbjct: 246 LQVDPKKRISVKHLLSHPWLMQG-YSCPVEWQSKYPLGYVDEDCVTELSVFYKCSRTSTS 304
Query: 303 SQLNEWTYNYDTCTYLLLLSRKKQGK 328
++EW Y++ T +YLLL S+K GK
Sbjct: 305 RLISEWNYDHITASYLLLHSKKSHGK 330
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Also plays a role in primitive hematopoiesis, possibly by affecting the expression of genes critical for hematopoiesis. Plays a role in cytokinesis during early development. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q61846|MELK_MOUSE Maternal embryonic leucine zipper kinase OS=Mus musculus GN=Melk PE=1 SV=2 | Back alignment and function description |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 188/326 (57%), Positives = 238/326 (73%), Gaps = 1/326 (0%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
Y +L Y L T+G+GGFAKVKLA HVLTGE VAIKIM K LG DLPRVK EI+ALK
Sbjct: 4 YDELLKYYELYETIGTGGFAKVKLACHVLTGEMVAIKIMDKNALGSDLPRVKTEIDALKS 63
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+ HQHIC+L+ V+ET + IFMV+EYCPGGEL D+I+ + RL E+E+R FRQILSAVAY+
Sbjct: 64 LRHQHICQLYHVLETKNKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQILSAVAYV 123
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H GYAHRDLKPEN+L D N LKLIDFGLCAKP+G + LQT CGS YAAPE+I+GK
Sbjct: 124 HSQGYAHRDLKPENLLFDENHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGK 183
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
Y GSE DVWSMG++LY L+CGFLPFD D++ LY KI+ GKY P W+SP+S +++ M
Sbjct: 184 SYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYEVPKWLSPSSILLLQQM 243
Query: 243 LQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMW 302
LQV+P KRI +++LL H WV M PV ++ L D+D + ++ H + S M
Sbjct: 244 LQVDPKKRISMRNLLNHPWV-MQDYSCPVEWQSKTPLTHLDEDCVTELSVHHRSSRQTME 302
Query: 303 SQLNEWTYNYDTCTYLLLLSRKKQGK 328
++ W Y++ T TYLLLL++K +GK
Sbjct: 303 DLISSWQYDHLTATYLLLLAKKARGK 328
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. Plays a key role in cell proliferation. Required for proliferation of embryonic and postnatal multipotent neural progenitors. Phosphorylates and inhibits BCL2L14. Also involved in the inhibition of spliceosome assembly during mitosis by phosphorylating ZNF622, thereby contributing to its redirection to the nucleus. May also play a role in primitive hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q14680|MELK_HUMAN Maternal embryonic leucine zipper kinase OS=Homo sapiens GN=MELK PE=1 SV=3 | Back alignment and function description |
|---|
Score = 368 bits (944), Expect = e-101, Method: Compositional matrix adjust.
Identities = 183/326 (56%), Positives = 240/326 (73%), Gaps = 1/326 (0%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
Y +L Y L T+G+GGFAKVKLA H+LTGE VAIKIM K TLG DLPR+K EI ALK+
Sbjct: 4 YDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKN 63
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+ HQHIC+L+ V+ET++ IFMV+EYCPGGEL D+I+ + RL E+E+R FRQI+SAVAY+
Sbjct: 64 LRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYV 123
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H GYAHRDLKPEN+L D LKLIDFGLCAKP+G + LQT CGS YAAPE+I+GK
Sbjct: 124 HSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGK 183
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
Y GSE DVWSMG++LY L+CGFLPFD D++ LY KI+ GKY P W+SP+S +++ M
Sbjct: 184 SYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQM 243
Query: 243 LQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMW 302
LQV+P KRI +++LL H W+ M + PV ++ + DDD + ++ H + + M
Sbjct: 244 LQVDPKKRISMKNLLNHPWI-MQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTME 302
Query: 303 SQLNEWTYNYDTCTYLLLLSRKKQGK 328
++ W Y++ T TYLLLL++K +GK
Sbjct: 303 DLISLWQYDHLTATYLLLLAKKARGK 328
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. Plays a key role in cell proliferation and carcinogenesis. Required for proliferation of embryonic and postnatal multipotent neural progenitors. Phosphorylates and inhibits BCL2L14, possibly leading to affect mammary carcinogenesis by mediating inhibition of the pro-apoptotic function of BCL2L14. Also involved in the inhibition of spliceosome assembly during mitosis by phosphorylating ZNF622, thereby contributing to its redirection to the nucleus. May also play a role in primitive hematopoiesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q5RDH5|AAPK1_PONAB 5'-AMP-activated protein kinase catalytic subunit alpha-1 (Fragment) OS=Pongo abelii GN=PRKAA1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 143/305 (46%), Positives = 189/305 (61%), Gaps = 16/305 (5%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQ 66
YIL T+G G F KVK+ H LTG KVA+KI+ + + + + +++ EI LK H
Sbjct: 21 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 80
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
HI KL+QVI T S IFMV+EY GGEL D+I + RL EKESR F+QILS V Y H
Sbjct: 81 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 140
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPENVLLD + N K+ DFGL G L+TSCGSPNYAAPEVI G+ Y G
Sbjct: 141 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAG 198
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E D+WS GV+LYALLCG LPFD D + L+ KI +G + P +++P+ +++ MLQV+
Sbjct: 199 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 258
Query: 247 PGKRIKIQDLLGHNWVK------MGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
P KR I+D+ H W K + PED P + DD+ +K + + + S ++
Sbjct: 259 PMKRATIKDIREHEWFKQDLPKYLFPED------PSYSSTMIDDEALKEVCEKFECSEEE 312
Query: 301 MWSQL 305
+ S L
Sbjct: 313 VLSCL 317
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q5EG47|AAPK1_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Mus musculus GN=Prkaa1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 148/335 (44%), Positives = 201/335 (60%), Gaps = 20/335 (5%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQ 66
YIL T+G G F KVK+ H LTG KVA+KI+ + + + + +++ EI LK H
Sbjct: 26 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 85
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
HI KL+QVI T S IFMV+EY GGEL D+I + RL EKESR F+QILS V Y H
Sbjct: 86 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 145
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPENVLLD + N K+ DFGL G L+TSCGSPNYAAPEVI G+ Y G
Sbjct: 146 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAG 203
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E D+WS GV+LYALLCG LPFD D + L+ KI +G + P +++P+ +++ MLQV+
Sbjct: 204 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 263
Query: 247 PGKRIKIQDLLGHNWVK------MGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
P KR I+D+ H W K + PED P + DD+ +K + + + S ++
Sbjct: 264 PMKRAAIKDIREHEWFKQDLPKYLFPED------PSYSSTMIDDEALKEVCEKFECSEEE 317
Query: 301 MWSQL-NEWTYNYDTCTYLLLLSRKK---QGKQYY 331
+ S L N + Y L++ ++ + K +Y
Sbjct: 318 VLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFY 352
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P54645|AAPK1_RAT 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Rattus norvegicus GN=Prkaa1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 148/335 (44%), Positives = 201/335 (60%), Gaps = 20/335 (5%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQ 66
YIL T+G G F KVK+ H LTG KVA+KI+ + + + + +++ EI LK H
Sbjct: 26 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 85
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
HI KL+QVI T S IFMV+EY GGEL D+I + RL EKESR F+QILS V Y H
Sbjct: 86 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 145
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPENVLLD + N K+ DFGL G L+TSCGSPNYAAPEVI G+ Y G
Sbjct: 146 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAG 203
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E D+WS GV+LYALLCG LPFD D + L+ KI +G + P +++P+ +++ MLQV+
Sbjct: 204 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 263
Query: 247 PGKRIKIQDLLGHNWVK------MGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
P KR I+D+ H W K + PED P + DD+ +K + + + S ++
Sbjct: 264 PMKRATIKDIREHEWFKQDLPKYLFPED------PSYSSTMIDDEALKEVCEKFECSEEE 317
Query: 301 MWSQL-NEWTYNYDTCTYLLLLSRKK---QGKQYY 331
+ S L N + Y L++ ++ + K +Y
Sbjct: 318 VLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFY 352
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q13131|AAPK1_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens GN=PRKAA1 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 143/305 (46%), Positives = 189/305 (61%), Gaps = 16/305 (5%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQ 66
YIL T+G G F KVK+ H LTG KVA+KI+ + + + + +++ EI LK H
Sbjct: 26 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 85
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
HI KL+QVI T S IFMV+EY GGEL D+I + RL EKESR F+QILS V Y H
Sbjct: 86 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 145
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPENVLLD + N K+ DFGL G L+TSCGSPNYAAPEVI G+ Y G
Sbjct: 146 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAG 203
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E D+WS GV+LYALLCG LPFD D + L+ KI +G + P +++P+ +++ MLQV+
Sbjct: 204 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 263
Query: 247 PGKRIKIQDLLGHNWVK------MGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
P KR I+D+ H W K + PED P + DD+ +K + + + S ++
Sbjct: 264 PMKRATIKDIREHEWFKQDLPKYLFPED------PSYSSTMIDDEALKEVCEKFECSEEE 317
Query: 301 MWSQL 305
+ S L
Sbjct: 318 VLSCL 322
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q38997|KIN10_ARATH SNF1-related protein kinase catalytic subunit alpha KIN10 OS=Arabidopsis thaliana GN=KIN10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 260 bits (665), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 147/331 (44%), Positives = 201/331 (60%), Gaps = 8/331 (2%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQ 66
Y L RT+G G F +VK+A H LTG KVAIKI+ + + E +V+ EI L+ H
Sbjct: 41 NYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 100
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
HI +L++VIET + I++V+EY GEL D+IVE+ RL E E+R FF+QI+S V Y H
Sbjct: 101 HIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 160
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPEN+LLD N+K+ DFGL G L+TSCGSPNYAAPEVI GK Y G
Sbjct: 161 VVHRDLKPENLLLDSKCNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAG 218
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E DVWS GV+LYALLCG LPFD ++I L+ KI G YT P +SP +R ++ ML V+
Sbjct: 219 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLVVD 278
Query: 247 PGKRIKIQDLLGHNWVKMGPEDNPVSFRPD--HELREKDDDVIKVMADHKQLSPDDMWSQ 304
P KR+ I ++ H W + PD + ++ D+++++ + + + +
Sbjct: 279 PMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKIDEEILQEVIN-MGFDRNHLIES 337
Query: 305 LNEWTYNYDTCTYLLLL-SRKKQGKQYYGSE 334
L T N T TY L+L +R + Y G+E
Sbjct: 338 LRNRTQNDGTVTYYLILDNRFRASSGYLGAE 368
|
Catalytic subunit of the probable trimeric SNF1-related protein kinase (SnRK) complex, which may play a role in a signal transduction cascade regulating gene expression and carbohydrate metabolism in higher plants. The SnRK complex may also be involved in the regulation of fatty acid synthesis by phosphorylation of acetyl-CoA carboxylase and in assimilation of nitrogen by phosphorylating nitrate reductase. In vitro, KIN10 exhibits kinase activity on sucrose phosphate synthase and the kinase activity is inhibited by PRL1. May be a subunit of a SCF ubiquitin ligase complex and thus be involved in proteasomal ubiquitination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | ||||||
| 340713176 | 606 | PREDICTED: maternal embryonic leucine zi | 0.600 | 0.562 | 0.628 | 1e-122 | |
| 270004242 | 439 | hypothetical protein TcasGA2_TC003567 [T | 0.572 | 0.740 | 0.642 | 1e-122 | |
| 380015447 | 623 | PREDICTED: LOW QUALITY PROTEIN: maternal | 0.573 | 0.523 | 0.631 | 1e-118 | |
| 197245398 | 582 | maternal embryonic leucine zipper kinase | 0.572 | 0.558 | 0.631 | 1e-118 | |
| 350417105 | 578 | PREDICTED: maternal embryonic leucine zi | 0.508 | 0.5 | 0.694 | 1e-116 | |
| 383850409 | 578 | PREDICTED: maternal embryonic leucine zi | 0.508 | 0.5 | 0.690 | 1e-116 | |
| 307199875 | 616 | Maternal embryonic leucine zipper kinase | 0.572 | 0.527 | 0.625 | 1e-115 | |
| 193598885 | 548 | PREDICTED: maternal embryonic leucine zi | 0.558 | 0.578 | 0.628 | 1e-115 | |
| 332019871 | 614 | Maternal embryonic leucine zipper kinase | 0.572 | 0.529 | 0.618 | 1e-114 | |
| 307175640 | 613 | Maternal embryonic leucine zipper kinase | 0.570 | 0.528 | 0.629 | 1e-114 |
| >gi|340713176|ref|XP_003395123.1| PREDICTED: maternal embryonic leucine zipper kinase-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1144), Expect = e-122, Method: Compositional matrix adjust.
Identities = 222/353 (62%), Positives = 266/353 (75%), Gaps = 12/353 (3%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
++Y L+ Y LE+T+GSGGFAKVKLATH+ TGEKVAIKIM K +LG+DLPRVKLE+ AL
Sbjct: 2 VRYAALKGLYDLEKTIGSGGFAKVKLATHIATGEKVAIKIMDKTSLGDDLPRVKLEVQAL 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K + HQHIC+L+QVIET SH FM+IEYC GGEL DHIVE+ RL E ESR FFRQI+SAVA
Sbjct: 62 KTLLHQHICRLYQVIETESHYFMIIEYCSGGELFDHIVEKNRLSETESRKFFRQIVSAVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
YLH LGYAHRDLKPENVLLDR +NLKLIDFGLCAKP+ G++S LQTSCGSP YAAPE+I
Sbjct: 122 YLHSLGYAHRDLKPENVLLDREENLKLIDFGLCAKPKNGIDSHLQTSCGSPTYAAPELIL 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
GK+Y GSE D+WSMGV+LYALLCGFLPFD +SI+ LY KIL+GKY EP W+S +SR+++R
Sbjct: 182 GKKYLGSEVDIWSMGVLLYALLCGFLPFDDNSIENLYRKILSGKYDEPCWLSNSSRRLIR 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
+MLQ +P KRI IQ+L H WV G NPVSF EKDDDV+ M+ P D
Sbjct: 242 AMLQTDPKKRITIQELCNHPWVTAGFL-NPVSFVHKTNF-EKDDDVLSTMSAICGEHPSD 299
Query: 301 MWSQLNEW-TYNYDTCTYLLLLSRKKQG---------KQYYGSETDVWSMGVM 343
+W +L + +Y T TYLLLL RK +G K + SE D G++
Sbjct: 300 IWRKLMKSDRTDYKTATYLLLLDRKLRGLSLRISSSAKSHLKSECDEEGNGII 352
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270004242|gb|EFA00690.1| hypothetical protein TcasGA2_TC003567 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1142), Expect = e-122, Method: Compositional matrix adjust.
Identities = 210/327 (64%), Positives = 259/327 (79%), Gaps = 2/327 (0%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
++Y +L+ Y +E+T+G GGFAKVKLATHV TGEKVA+KIM K LG+DLPRVKLE+ AL
Sbjct: 2 VRYAELKGLYEIEKTIGCGGFAKVKLATHVATGEKVAVKIMNKTGLGDDLPRVKLELKAL 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K SHQHICKL+QVIE+ +H F+VIEYC GGEL DHIVE+ RL E ESR FFRQI+S VA
Sbjct: 62 KSFSHQHICKLYQVIESETHFFIVIEYCSGGELFDHIVEKNRLSESESRTFFRQIVSGVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
YLH LGYAHRDLKPENVLLD++QNLKLIDFGLCA+PEGG+ S L TSCGSP YAAPE++
Sbjct: 122 YLHSLGYAHRDLKPENVLLDKDQNLKLIDFGLCARPEGGMGSPLYTSCGSPTYAAPELVL 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
GK+Y G E DVW+MGV+LYALL G LPFD +ID LY KIL+GKY EPP++S S++++
Sbjct: 182 GKKYLGPEVDVWAMGVLLYALLVGALPFDDINIDSLYKKILSGKYAEPPFLSAESKRLIA 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
SMLQV+P KRI +Q+LL H W+ +G D PV + +LR+ D D + VMA + ++P+
Sbjct: 242 SMLQVDPKKRITVQELLSHPWLTLGILD-PVDYT-SIDLRKYDKDCVDVMASYYNVNPER 299
Query: 301 MWSQLNEWTYNYDTCTYLLLLSRKKQG 327
MW L +W Y+Y T TY LLLSRKK+G
Sbjct: 300 MWRHLKKWKYDYHTATYFLLLSRKKRG 326
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380015447|ref|XP_003691713.1| PREDICTED: LOW QUALITY PROTEIN: maternal embryonic leucine zipper kinase-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 433 bits (1114), Expect = e-118, Method: Compositional matrix adjust.
Identities = 211/334 (63%), Positives = 259/334 (77%), Gaps = 8/334 (2%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
++Y L+ Y LE+T+GSGGFAKVKLATH+ TGEKVAIKIM K +LG+DLPRVKLE+ AL
Sbjct: 2 VRYGALKGLYDLEKTIGSGGFAKVKLATHIATGEKVAIKIMDKTSLGDDLPRVKLEVQAL 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K + HQHIC+L+QVIET SH FMVIEYC GGEL DHIVE+ +L E ESR FFRQI+SAVA
Sbjct: 62 KTLLHQHICRLYQVIETESHYFMVIEYCSGGELFDHIVEKNKLSEAESRKFFRQIVSAVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
YLH LGYAHRDLKPENVLLD+ +NLKLIDFGLCAKP+ G++S LQTSCGSP YAAPE+I
Sbjct: 122 YLHSLGYAHRDLKPENVLLDKEENLKLIDFGLCAKPKNGIDSHLQTSCGSPTYAAPELIL 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
GK+Y GSE D+WSMGV+LYALLCGFLPFD +SI+ LY KIL+GKY EP W+S +S+++++
Sbjct: 182 GKKYLGSEVDIWSMGVLLYALLCGFLPFDDNSIENLYRKILSGKYDEPSWLSSSSKRLIQ 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPD------HELREKDDDVIKVMADHK 294
+MLQ++P KRI IQ+L H W+ G NPVSF + +KDDDV+ M+
Sbjct: 242 AMLQIDPKKRITIQELCNHPWITAGFL-NPVSFVHKTMXIFLYFFFQKDDDVLSTMSAIC 300
Query: 295 QLSPDDMWSQL-NEWTYNYDTCTYLLLLSRKKQG 327
+ D+W +L +Y T TYLLLL RK +G
Sbjct: 301 GENTSDIWKKLIKSDRTDYKTATYLLLLDRKLRG 334
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|197245398|ref|NP_001127794.1| maternal embryonic leucine zipper kinase [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 433 bits (1113), Expect = e-118, Method: Compositional matrix adjust.
Identities = 207/328 (63%), Positives = 261/328 (79%), Gaps = 3/328 (0%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
++Y L+ Y LE+TVG GGFAKVKLATHV TGEKVAIKIM+KA LGEDLPRV LEI+A+
Sbjct: 2 VRYSALKGLYELEKTVGCGGFAKVKLATHVATGEKVAIKIMEKAALGEDLPRVGLEISAM 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K++ HQHICKL+QVIET H FMV+EYC GGEL DHIVE+ +L E ESR FFRQI+SAVA
Sbjct: 62 KNLLHQHICKLYQVIETEDHYFMVLEYCSGGELFDHIVEKSKLSESESRRFFRQIVSAVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
YLH LGY HRDLKPENVLLD++QNLKLIDFGLCAKP+GG++S L TSCGSP YAAPE+I
Sbjct: 122 YLHSLGYVHRDLKPENVLLDKDQNLKLIDFGLCAKPKGGIQSPLYTSCGSPAYAAPELIL 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
G +Y GSE D+WS+GV+LYALLCGFLPFD ++I+ LY KILNG+Y EP WMS +SR+++R
Sbjct: 182 GNKYLGSEIDIWSLGVLLYALLCGFLPFDDNNIENLYKKILNGQYDEPSWMSQSSRRLIR 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
+MLQ++P KRI I++L H W+ G NP++F + + E+D++++K + D+
Sbjct: 242 AMLQIDPRKRITIKELCSHPWITAGFL-NPITFMKNTTV-ERDEEILKALKAVCTKCYDE 299
Query: 301 MWSQLNEW-TYNYDTCTYLLLLSRKKQG 327
+W Q+ E +Y T TYLLLL RK++G
Sbjct: 300 IWKQIIENDRSDYVTATYLLLLDRKRRG 327
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350417105|ref|XP_003491259.1| PREDICTED: maternal embryonic leucine zipper kinase-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1091), Expect = e-116, Method: Compositional matrix adjust.
Identities = 202/291 (69%), Positives = 238/291 (81%), Gaps = 2/291 (0%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
++Y L+ Y LE+T+GSGGFAKVKLATH+ TGEKVAIKIM K +LG+DLPRVKLE+ AL
Sbjct: 2 VRYAALKGLYDLEKTIGSGGFAKVKLATHIATGEKVAIKIMDKTSLGDDLPRVKLEVQAL 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K + HQHIC+L+QVIET SH FM+IEYC GGEL DHIVE+ RL E ESR FFRQI+SAVA
Sbjct: 62 KTLLHQHICRLYQVIETESHYFMIIEYCSGGELFDHIVEKNRLSETESRKFFRQIVSAVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
YLH LGYAHRDLKPENVLLDR +NLKLIDFGLCAKP+ G++S LQTSCGSP YAAPE+I
Sbjct: 122 YLHSLGYAHRDLKPENVLLDREENLKLIDFGLCAKPKNGIDSHLQTSCGSPTYAAPELIL 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
GK+Y GSE D+WSMGV+LYALLCGFLPFD +SI+ LY KIL+GKY EP W+S +SR+++R
Sbjct: 182 GKKYLGSEVDIWSMGVLLYALLCGFLPFDDNSIENLYRKILSGKYDEPCWLSNSSRRLIR 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMA 291
+MLQ +P KRI IQ+L H WV G NPVSF EKDDDV+ M+
Sbjct: 242 AMLQTDPKKRITIQELCNHPWVTAGFL-NPVSFVHKTNF-EKDDDVLSTMS 290
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383850409|ref|XP_003700788.1| PREDICTED: maternal embryonic leucine zipper kinase-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1089), Expect = e-116, Method: Compositional matrix adjust.
Identities = 201/291 (69%), Positives = 237/291 (81%), Gaps = 2/291 (0%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
++Y L+ Y LE+T+GSGGFAKVKLATH+ TGEKVAIKIM K LG+DLPRVKLE+ AL
Sbjct: 2 VRYAALKGLYDLEKTIGSGGFAKVKLATHIATGEKVAIKIMDKTALGDDLPRVKLEVEAL 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K + HQHIC+L+QVIET SH FMVIEYC GGEL DHIVE+ RL E ESR FFRQI+SAVA
Sbjct: 62 KTLLHQHICRLYQVIETDSHYFMVIEYCSGGELFDHIVEKNRLSETESRKFFRQIVSAVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
YLH LGYAHRDLKPENVLLDR +NLKLIDFGLCAKP+ G+ES LQTSCGSP YAAPE+I
Sbjct: 122 YLHSLGYAHRDLKPENVLLDREENLKLIDFGLCAKPKNGIESHLQTSCGSPTYAAPELIL 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
G++Y GSE D+WSMGV+LYALLCGFLPFD +SI+ LY KIL+GKY EP W+S +S++++R
Sbjct: 182 GRKYLGSEVDIWSMGVLLYALLCGFLPFDDNSIESLYRKILSGKYDEPGWLSSSSKRLIR 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMA 291
+MLQ +P KRI IQ+L H W+ G NPVSF EKDDDV+ M+
Sbjct: 242 AMLQTDPKKRITIQELCNHPWITAGFL-NPVSFAHKTNF-EKDDDVLSTMS 290
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307199875|gb|EFN80272.1| Maternal embryonic leucine zipper kinase [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1085), Expect = e-115, Method: Compositional matrix adjust.
Identities = 205/328 (62%), Positives = 248/328 (75%), Gaps = 3/328 (0%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
+++ L+ Y +E+T+GSGGFAKVKLATHV TGEKVAIKIM K LG+DLPRVKLE+ AL
Sbjct: 2 VRHAALKGLYDVEKTIGSGGFAKVKLATHVATGEKVAIKIMDKTALGDDLPRVKLEVEAL 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K + HQHIC+L+QVIET SH FMVIEYC GGEL DHIVE+ RL E +SR FFRQI+SAVA
Sbjct: 62 KTLLHQHICRLYQVIETESHYFMVIEYCSGGELFDHIVEKNRLSETDSRKFFRQIVSAVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
Y+H LGYAHRDLKPENVLLD+ +NLKLIDFGLCAKP+ G++S L TSCGSP YAAPE+I
Sbjct: 122 YMHSLGYAHRDLKPENVLLDKEENLKLIDFGLCAKPKTGMQSHLYTSCGSPTYAAPELIM 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
GK+Y GSE D+WSMGV+LYALLCGFLPFD ++++ LY KILNGKY EP W+S NS+ ++R
Sbjct: 182 GKRYLGSEVDIWSMGVLLYALLCGFLPFDDNNLETLYKKILNGKYEEPYWLSNNSKMLIR 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
MLQ+ P RI I +L H W+ PVSF EKDD+V+ M+ D
Sbjct: 242 KMLQINPANRITIHELCNHPWITSNSL-KPVSFVHRTNF-EKDDEVLSTMSAICGEHSID 299
Query: 301 MWSQL-NEWTYNYDTCTYLLLLSRKKQG 327
+W +L +Y T TYLLLL RK +G
Sbjct: 300 IWKRLVKSDRTDYKTATYLLLLDRKLRG 327
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|193598885|ref|XP_001952136.1| PREDICTED: maternal embryonic leucine zipper kinase-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1084), Expect = e-115, Method: Compositional matrix adjust.
Identities = 200/318 (62%), Positives = 257/318 (80%), Gaps = 1/318 (0%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
Y L+RT+G+GGF KVKLATH LTGEKVAIKIM K LG+DLPRVKLEI+ALK++SH +IC
Sbjct: 12 YELDRTIGTGGFGKVKLATHTLTGEKVAIKIMDKTKLGKDLPRVKLEISALKNLSHPNIC 71
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
KL+QVIET SH ++V+EYC GGEL DHIVE+ RL E ESR FFRQI+SAV+YLH GYAH
Sbjct: 72 KLYQVIETESHCYVVMEYCSGGELFDHIVEKSRLSEMESRMFFRQIISAVSYLHDSGYAH 131
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RDLKPENVLLDR QNLK+IDFGLCAKP+GG++S L TSCGSP YAAPE+I+G +Y+GSE
Sbjct: 132 RDLKPENVLLDREQNLKIIDFGLCAKPQGGMDSLLLTSCGSPTYAAPELIQGVKYHGSEV 191
Query: 190 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 249
D+WSMGV+LYALLCG LPF+SD+ID+L+ KIL GKY EP W+S S++++R ML V+P K
Sbjct: 192 DIWSMGVILYALLCGCLPFESDNIDELFKKILRGKYIEPGWLSSGSKRLLRRMLCVDPLK 251
Query: 250 RIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEWT 309
RI+I +L+ WV++G P + D + R KD + ++ ++ H + + +WS+L++W
Sbjct: 252 RIRISELINDPWVRLGFGCPPSTKTHDID-RCKDMECLEAISQHFDIDKEIIWSRLSKWK 310
Query: 310 YNYDTCTYLLLLSRKKQG 327
Y+ +T TYLLLL++KK G
Sbjct: 311 YDCETATYLLLLNKKKNG 328
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332019871|gb|EGI60332.1| Maternal embryonic leucine zipper kinase [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1077), Expect = e-114, Method: Compositional matrix adjust.
Identities = 203/328 (61%), Positives = 255/328 (77%), Gaps = 3/328 (0%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
++Y L+ Y LE+T+GSGGFAKVKLATHV TGEKVAIKIM+K LGEDLPRVK+E+ AL
Sbjct: 2 VRYAALKGLYDLEKTIGSGGFAKVKLATHVATGEKVAIKIMEKTALGEDLPRVKVEVEAL 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K + HQHIC+L+QVIET SH FMV+EYC GGEL DHIVE+ +L E +SR FF QI+SAVA
Sbjct: 62 KTLLHQHICRLYQVIETESHYFMVMEYCSGGELFDHIVEKNKLSESDSRRFFYQIVSAVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
Y+H LGYAHRDLKPENVLLD+++NLKLIDFGLCAKP+ G+++ L TSCGSP YAAPE+I
Sbjct: 122 YMHSLGYAHRDLKPENVLLDKDENLKLIDFGLCAKPKMGIQAHLYTSCGSPTYAAPELIM 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
GK+Y GSE D+WSMGV+LYALLCGFLPFD ++++ LY KIL+GKY EP W+S NS+ +++
Sbjct: 182 GKKYLGSEVDIWSMGVLLYALLCGFLPFDDNNLENLYKKILSGKYEEPYWLSNNSKMLIK 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
SMLQ++P KRI I +L H W+ PVSF E EKD++V+ M+ + D
Sbjct: 242 SMLQIDPAKRITIHELCRHPWITRSSL-KPVSFIHRTEF-EKDNEVLNTMSAICGGNSID 299
Query: 301 MWSQLNEW-TYNYDTCTYLLLLSRKKQG 327
+W +L + +Y T TYLLLL RK +G
Sbjct: 300 IWKKLLQSDRTDYRTATYLLLLDRKLRG 327
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307175640|gb|EFN65549.1| Maternal embryonic leucine zipper kinase [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1073), Expect = e-114, Method: Compositional matrix adjust.
Identities = 207/329 (62%), Positives = 256/329 (77%), Gaps = 5/329 (1%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
++Y L+ Y LE+T+GSGGFAKVKLATHV TGEKVAIKIM+K TLGEDLPRVKLE+ AL
Sbjct: 2 VRYTALKGLYDLEKTIGSGGFAKVKLATHVATGEKVAIKIMEKTTLGEDLPRVKLEVEAL 61
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K + HQHIC+L+QVIET +H FMV+EYC GGEL DHIVE+ RL E E+R FF QI+SAVA
Sbjct: 62 KTLLHQHICRLYQVIETENHYFMVLEYCSGGELFDHIVEKNRLPEIEARRFFCQIISAVA 121
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
Y+H+LGYAHRDLKPENVLLD+ +NLKLIDFGLCAKP+ G+++ L TSCGSP YAAPE+I
Sbjct: 122 YMHNLGYAHRDLKPENVLLDKEENLKLIDFGLCAKPKMGMQAHLYTSCGSPTYAAPELIM 181
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
GK+Y GSE D+WSMGV+LYALLCGFLPFD +S++ LY KIL+GKY EP W+S +S+ +++
Sbjct: 182 GKKYLGSEVDIWSMGVLLYALLCGFLPFDDNSLENLYKKILSGKYEEPYWLSHDSKALIK 241
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELR-EKDDDVIKVMADHKQLSPD 299
SMLQV+P KRI I +L H W+ PV F H+ + EKDD+V+ M+ S
Sbjct: 242 SMLQVDPVKRITIHELCHHPWITSN-SLKPVVF--IHKTKFEKDDEVLSTMSAICGESNT 298
Query: 300 DMWSQL-NEWTYNYDTCTYLLLLSRKKQG 327
D+W +L +Y T TYLLLL RK +G
Sbjct: 299 DIWKKLMRSDRTDYRTATYLLLLDRKLRG 327
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | ||||||
| ZFIN|ZDB-GENE-990603-5 | 676 | melk "maternal embryonic leuci | 0.568 | 0.477 | 0.583 | 5.1e-104 | |
| UNIPROTKB|F1NKU2 | 657 | LOC100857167 "Uncharacterized | 0.577 | 0.499 | 0.562 | 2.6e-102 | |
| UNIPROTKB|Q91821 | 651 | melk "Maternal embryonic leuci | 0.572 | 0.499 | 0.570 | 8.8e-102 | |
| UNIPROTKB|Q28GW8 | 652 | melk "Maternal embryonic leuci | 0.572 | 0.498 | 0.570 | 1.1e-101 | |
| MGI|MGI:106924 | 643 | Melk "maternal embryonic leuci | 0.575 | 0.508 | 0.577 | 3.4e-100 | |
| RGD|1308974 | 643 | Melk "maternal embryonic leuci | 0.575 | 0.508 | 0.565 | 1.2e-99 | |
| UNIPROTKB|F5H689 | 610 | MELK "Maternal embryonic leuci | 0.575 | 0.536 | 0.562 | 3.1e-99 | |
| UNIPROTKB|Q14680 | 651 | MELK "Maternal embryonic leuci | 0.575 | 0.502 | 0.562 | 3.1e-99 | |
| UNIPROTKB|E2RNL1 | 651 | MELK "Uncharacterized protein" | 0.575 | 0.502 | 0.559 | 7.4e-98 | |
| UNIPROTKB|A9Q1J5 | 650 | MELK "Maternal embryonic leuci | 0.575 | 0.503 | 0.559 | 1.2e-97 |
| ZFIN|ZDB-GENE-990603-5 melk "maternal embryonic leucine zipper kinase" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 5.1e-104, Sum P(2) = 5.1e-104
Identities = 189/324 (58%), Positives = 243/324 (75%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+L Y + T+GSGGFAKVKL H LTGEKVAIKIM+K LG+DLPRVK+EI A+K++S
Sbjct: 8 ELLKHYEVYETIGSGGFAKVKLGRHKLTGEKVAIKIMEKKDLGDDLPRVKIEIEAMKNLS 67
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
HQH+C+L+ VIET+S I+MV+EYCPGGEL D+I+ + RL E+E+R FFRQI+SA+AY+H
Sbjct: 68 HQHVCRLYHVIETTSKIYMVLEYCPGGELFDYIIAKDRLSEEETRVFFRQIISALAYVHS 127
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
GYAHRDLKPEN+L+D + NLKLIDFGLCAKP+GGL +L T CGSP YAAPE+I+GK Y
Sbjct: 128 QGYAHRDLKPENLLIDEDHNLKLIDFGLCAKPKGGLGFELLTCCGSPAYAAPELIQGKAY 187
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244
GSE DVWSMGV+LYALLCGFLPFD D+ LY KI GKY+ P W+SP+S ++ M+Q
Sbjct: 188 IGSEADVWSMGVLLYALLCGFLPFDDDNCMVLYRKITRGKYSNPHWLSPSSILLLNQMMQ 247
Query: 245 VEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQ 304
V+P +R+ ++ LL H WV G PV + + L D+D I MA + S
Sbjct: 248 VDPKRRLTVKHLLDHPWVMRG-YSTPVEWHSKYPLGHIDEDCITEMAVTFKQSKQRTIQL 306
Query: 305 LNEWTYNYDTCTYLLLLSRKKQGK 328
++EW Y+ T TYLLLL++K+QG+
Sbjct: 307 VSEWKYDQITATYLLLLAKKRQGR 330
|
|
| UNIPROTKB|F1NKU2 LOC100857167 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
Identities = 185/329 (56%), Positives = 247/329 (75%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
Y ++ Y L T+G+GGFAKVKL H+LTGEKVAIKIM K LG+DLPRVK EI+A+K+
Sbjct: 6 YEEILKYYELHETIGTGGFAKVKLGRHLLTGEKVAIKIMDKVALGDDLPRVKTEIDAMKN 65
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+SHQH+C+L+ VIETS IFMV+EYCPGGEL D+IV + RL E+E+R FFRQI+SA+AY+
Sbjct: 66 LSHQHVCRLYHVIETSKKIFMVLEYCPGGELFDYIVSKDRLSEEEARVFFRQIVSAIAYV 125
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H GYAHRDLKPEN+L+D NLKLIDFGLCAKP+GGL+ +L T CGSP YAAPE+I+GK
Sbjct: 126 HSQGYAHRDLKPENLLIDEEHNLKLIDFGLCAKPKGGLDYRLNTCCGSPAYAAPELIQGK 185
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
Y GSE D+WSMGV+LYALLCGFLPFD D++ LY +I GKY P W+SP+S ++ +
Sbjct: 186 AYIGSEADIWSMGVLLYALLCGFLPFDDDNVMALYRRITRGKYAVPKWLSPSSTLLLNQL 245
Query: 243 LQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMW 302
LQV+P KRI ++ LL H W+ G D V ++ + L D+D + ++ S +++
Sbjct: 246 LQVDPKKRITVKHLLSHPWLMQGYSD-AVQWQSKYPLGHLDEDCVTELSVFHNKSRENIS 304
Query: 303 SQLNEWTYNYDTCTYLLLLSRKKQGKQYY 331
+ +++W Y+ + TYLLL S+K +GK+ +
Sbjct: 305 ALISKWNYDQMSATYLLLQSKKFRGKRIH 333
|
|
| UNIPROTKB|Q91821 melk "Maternal embryonic leucine zipper kinase" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 8.8e-102, P = 8.8e-102
Identities = 186/326 (57%), Positives = 246/326 (75%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
Y +L Y L TVG+GGFAKVKLA+H++TGEKVAIKIM K +LG+DLPRVK EI+A+K+
Sbjct: 6 YEELLKYYELHETVGTGGFAKVKLASHLITGEKVAIKIMDKESLGDDLPRVKTEIDAMKN 65
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+SHQH+C+L+ VIET IFMV+EYCPGGEL D+I+ + RL E+E+R FFRQI+SAVAY+
Sbjct: 66 LSHQHVCRLYHVIETPKKIFMVLEYCPGGELFDYIIAKDRLTEEEARVFFRQIVSAVAYI 125
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H GYAHRDLKPEN+L+D +QNLKLIDFGLCAKP+GGL+ L T CGSP YAAPE+I+GK
Sbjct: 126 HSQGYAHRDLKPENLLIDEDQNLKLIDFGLCAKPKGGLDYHLMTCCGSPAYAAPELIQGK 185
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
Y GSE D+WSMGV++YAL+CG+LPFD D++ LY KI+ GKY P W+SP S ++ M
Sbjct: 186 AYIGSEADIWSMGVLMYALMCGYLPFDDDNVMVLYKKIMRGKYEIPKWLSPGSVLLLSQM 245
Query: 243 LQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMW 302
+QV+P KRI ++ LL H W+ G PV ++ + L D+D + ++ + S
Sbjct: 246 MQVDPKKRITVKHLLNHPWLMHG-YSCPVEWQSKYPLGYIDEDCVTELSVFYKYSRTSTT 304
Query: 303 SQLNEWTYNYDTCTYLLLLSRKKQGK 328
++EW+Y++ T +YLLL S+K GK
Sbjct: 305 RLISEWSYDHITASYLLLHSKKSHGK 330
|
|
| UNIPROTKB|Q28GW8 melk "Maternal embryonic leucine zipper kinase" [Xenopus (Silurana) tropicalis (taxid:8364)] | Back alignment and assigned GO terms |
|---|
Score = 1008 (359.9 bits), Expect = 1.1e-101, P = 1.1e-101
Identities = 186/326 (57%), Positives = 244/326 (74%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
Y +L Y L T+G+GGFAKVKLA+H+ TGEKVAIKIM K +LG+DLPRVK EI+A+K+
Sbjct: 6 YEELLKYYELHETIGTGGFAKVKLASHLTTGEKVAIKIMDKESLGDDLPRVKTEIDAMKN 65
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+SHQH+C+L+ VIET + IFMV+EYCPGGEL D+I+ + RL E E+R FFRQI+SAVAY+
Sbjct: 66 LSHQHVCRLYHVIETPNKIFMVLEYCPGGELFDYIIAKDRLTEDEARVFFRQIVSAVAYI 125
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H GYAHRDLKPEN+L+D +QNLKLIDFGLCAKP+GGL+ L T CGSP YAAPE+I+GK
Sbjct: 126 HSQGYAHRDLKPENLLIDEDQNLKLIDFGLCAKPKGGLDYHLMTCCGSPAYAAPELIQGK 185
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
Y GSE D+WSMGV++YAL+CG+LPFD D++ LY KI+ GKY P W+SP S ++ M
Sbjct: 186 AYIGSEADIWSMGVLMYALMCGYLPFDDDNVMVLYKKIMRGKYEIPKWLSPGSVLLLSQM 245
Query: 243 LQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMW 302
LQV+P KRI ++ LL H W+ G PV ++ + L D+D + ++ + S
Sbjct: 246 LQVDPKKRISVKHLLSHPWLMQG-YSCPVEWQSKYPLGYVDEDCVTELSVFYKCSRTSTS 304
Query: 303 SQLNEWTYNYDTCTYLLLLSRKKQGK 328
++EW Y++ T +YLLL S+K GK
Sbjct: 305 RLISEWNYDHITASYLLLHSKKSHGK 330
|
|
| MGI|MGI:106924 Melk "maternal embryonic leucine zipper kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 994 (355.0 bits), Expect = 3.4e-100, P = 3.4e-100
Identities = 190/329 (57%), Positives = 240/329 (72%)
Query: 1 MK-YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA 59
MK Y +L Y L T+G+GGFAKVKLA HVLTGE VAIKIM K LG DLPRVK EI+A
Sbjct: 1 MKDYDELLKYYELYETIGTGGFAKVKLACHVLTGEMVAIKIMDKNALGSDLPRVKTEIDA 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
LK + HQHIC+L+ V+ET + IFMV+EYCPGGEL D+I+ + RL E+E+R FRQILSAV
Sbjct: 61 LKSLRHQHICQLYHVLETKNKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQILSAV 120
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
AY+H GYAHRDLKPEN+L D N LKLIDFGLCAKP+G + LQT CGS YAAPE+I
Sbjct: 121 AYVHSQGYAHRDLKPENLLFDENHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELI 180
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
+GK Y GSE DVWSMG++LY L+CGFLPFD D++ LY KI+ GKY P W+SP+S ++
Sbjct: 181 QGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYEVPKWLSPSSILLL 240
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPD 299
+ MLQV+P KRI +++LL H WV M PV ++ L D+D + ++ H + S
Sbjct: 241 QQMLQVDPKKRISMRNLLNHPWV-MQDYSCPVEWQSKTPLTHLDEDCVTELSVHHRSSRQ 299
Query: 300 DMWSQLNEWTYNYDTCTYLLLLSRKKQGK 328
M ++ W Y++ T TYLLLL++K +GK
Sbjct: 300 TMEDLISSWQYDHLTATYLLLLAKKARGK 328
|
|
| RGD|1308974 Melk "maternal embryonic leucine zipper kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 1.2e-99, P = 1.2e-99
Identities = 186/329 (56%), Positives = 241/329 (73%)
Query: 1 MK-YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA 59
MK Y +L Y L T+G+GGFAKVKLA H+LTGE VAIKIM K LG DLPRVK EI+A
Sbjct: 1 MKDYDELLKYYELYETIGTGGFAKVKLACHILTGEMVAIKIMDKNALGSDLPRVKTEIDA 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
LK++ HQHIC+L+ V+ET + IFMV+EYCPGGEL D+I+ + RL E+E+R FRQILSAV
Sbjct: 61 LKNLRHQHICQLYHVLETKNKIFMVLEYCPGGELFDYIISQDRLSEEETRVIFRQILSAV 120
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
AY+H GYAHRDLKPEN+L D N LKLIDFGLCAKP+G + LQT CGS YAAPE+I
Sbjct: 121 AYVHSQGYAHRDLKPENLLFDENHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELI 180
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
+GK Y GSE DVWSMG++LY L+CGFLPFD D++ LY KI+ GKY P W+SP+S ++
Sbjct: 181 QGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYEVPKWLSPSSILLL 240
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPD 299
+ MLQV+P +RI +++LL H W+ + P+ ++ L D+D I ++ H + S
Sbjct: 241 QQMLQVDPKRRISMKNLLNHPWI-LQDYSCPIEWQSKASLTHLDEDCITELSVHHRNSRQ 299
Query: 300 DMWSQLNEWTYNYDTCTYLLLLSRKKQGK 328
M ++ W Y++ T TYLLLL++K +GK
Sbjct: 300 TMEDLISSWQYDHLTATYLLLLAKKARGK 328
|
|
| UNIPROTKB|F5H689 MELK "Maternal embryonic leucine zipper kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
Identities = 185/329 (56%), Positives = 242/329 (73%)
Query: 1 MK-YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA 59
MK Y +L Y L T+G+GGFAKVKLA H+LTGE VAIKIM K TLG DLPR+K EI A
Sbjct: 1 MKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEA 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
LK++ HQHIC+L+ V+ET++ IFMV+EYCPGGEL D+I+ + RL E+E+R FRQI+SAV
Sbjct: 61 LKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAV 120
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
AY+H GYAHRDLKPEN+L D LKLIDFGLCAKP+G + LQT CGS YAAPE+I
Sbjct: 121 AYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELI 180
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
+GK Y GSE DVWSMG++LY L+CGFLPFD D++ LY KI+ GKY P W+SP+S ++
Sbjct: 181 QGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLL 240
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPD 299
+ MLQV+P KRI +++LL H W+ M + PV ++ + DDD + ++ H + +
Sbjct: 241 QQMLQVDPKKRISMKNLLNHPWI-MQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQ 299
Query: 300 DMWSQLNEWTYNYDTCTYLLLLSRKKQGK 328
M ++ W Y++ T TYLLLL++K +GK
Sbjct: 300 TMEDLISLWQYDHLTATYLLLLAKKARGK 328
|
|
| UNIPROTKB|Q14680 MELK "Maternal embryonic leucine zipper kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
Identities = 185/329 (56%), Positives = 242/329 (73%)
Query: 1 MK-YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA 59
MK Y +L Y L T+G+GGFAKVKLA H+LTGE VAIKIM K TLG DLPR+K EI A
Sbjct: 1 MKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEA 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
LK++ HQHIC+L+ V+ET++ IFMV+EYCPGGEL D+I+ + RL E+E+R FRQI+SAV
Sbjct: 61 LKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAV 120
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
AY+H GYAHRDLKPEN+L D LKLIDFGLCAKP+G + LQT CGS YAAPE+I
Sbjct: 121 AYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELI 180
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
+GK Y GSE DVWSMG++LY L+CGFLPFD D++ LY KI+ GKY P W+SP+S ++
Sbjct: 181 QGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLL 240
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPD 299
+ MLQV+P KRI +++LL H W+ M + PV ++ + DDD + ++ H + +
Sbjct: 241 QQMLQVDPKKRISMKNLLNHPWI-MQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQ 299
Query: 300 DMWSQLNEWTYNYDTCTYLLLLSRKKQGK 328
M ++ W Y++ T TYLLLL++K +GK
Sbjct: 300 TMEDLISLWQYDHLTATYLLLLAKKARGK 328
|
|
| UNIPROTKB|E2RNL1 MELK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
Identities = 184/329 (55%), Positives = 241/329 (73%)
Query: 1 MK-YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA 59
MK Y +L Y L T+G+GGFAKVKLA H+LTGE VAIKIM K LG DLPR+K EI A
Sbjct: 1 MKDYDELLKYYELYETIGTGGFAKVKLACHILTGEMVAIKIMDKNALGSDLPRIKTEIEA 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
LK++ HQHIC+L+ V+ET++ IFMV+EYCPGGEL D+I+ + RL E+E+R FRQILSAV
Sbjct: 61 LKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQILSAV 120
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
AY+H GYAHRDLKPEN+L D LKLIDFGLCAKP+G + LQT CGS YAAPE+I
Sbjct: 121 AYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELI 180
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
+GK Y GSE DVWSMG++LY L+CGFLPFD D++ LY KI+ GKY P W+S +S ++
Sbjct: 181 QGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYEVPKWLSSSSILLL 240
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPD 299
+ MLQV+P KRI +++LL H W+ M + PV ++ + + D+D I ++ H + +
Sbjct: 241 QQMLQVDPKKRISMKNLLSHPWI-MHDYNCPVEWQSKNSIIHLDEDCITELSVHHRNNRQ 299
Query: 300 DMWSQLNEWTYNYDTCTYLLLLSRKKQGK 328
M ++ W Y++ T TYLLLL++K +GK
Sbjct: 300 TMEDLISLWQYDHLTATYLLLLAKKARGK 328
|
|
| UNIPROTKB|A9Q1J5 MELK "Maternal embryonic leucine zipper kinase" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 1.2e-97, P = 1.2e-97
Identities = 184/329 (55%), Positives = 242/329 (73%)
Query: 1 MK-YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA 59
MK Y +L Y L T+G+GGFAKVKLA H+LTGE VAIKIM K LG DLPRVK EI+A
Sbjct: 1 MKDYDELLKYYELYETIGTGGFAKVKLACHILTGEMVAIKIMDKNALGSDLPRVKTEIDA 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
LK++ HQHIC+L+ VIET++ IFMV+EYCPGGEL D+I+ RL E+E+R FRQI+SAV
Sbjct: 61 LKNLRHQHICQLYHVIETANKIFMVLEYCPGGELFDYIISHDRLSEEETRIVFRQIVSAV 120
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
AY+H GYAHRDLKPEN+L D LKLIDFGLCAKP+G + LQT CGS YAAPE+I
Sbjct: 121 AYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELI 180
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
+GK Y GSE DVWSMG++LY L+CGFLPFD D++ LY KI+ G+Y P W+SP+S ++
Sbjct: 181 QGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMKGQYDVPKWLSPSSVLLL 240
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPD 299
+ MLQV+P KRI +++LL H W+ M + PV ++ + L D+D + ++ H + +
Sbjct: 241 QQMLQVDPKKRIAMRNLLNHPWI-MHDYNCPVEWQSNAPLIHLDEDCVTELSVHHRNNRQ 299
Query: 300 DMWSQLNEWTYNYDTCTYLLLLSRKKQGK 328
M ++ W Y++ T TYLLLL++K +G+
Sbjct: 300 TMEDLISLWQYDHLTATYLLLLAKKARGR 328
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q00372 | SNF1_CANGA | 2, ., 7, ., 1, 1, ., 1 | 0.5058 | 0.4436 | 0.4117 | yes | N/A |
| Q14680 | MELK_HUMAN | 2, ., 7, ., 1, 0, ., 2 | 0.5613 | 0.5721 | 0.4992 | yes | N/A |
| F1QGZ6 | MELK_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.5833 | 0.5686 | 0.4778 | yes | N/A |
| Q28GW8 | MELK_XENTR | 2, ., 7, ., 1, 1, ., 1 | 0.5705 | 0.5721 | 0.4984 | yes | N/A |
| Q61846 | MELK_MOUSE | 2, ., 7, ., 1, 0, ., 2 | 0.5766 | 0.5721 | 0.5054 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 568 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-98 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-89 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-72 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-70 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-69 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-59 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-58 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-57 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-55 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-51 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-49 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-48 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-48 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-48 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-46 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-45 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-45 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-44 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-43 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-42 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-41 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-41 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-40 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-40 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-40 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-40 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-40 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-40 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-40 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-39 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-39 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-39 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-39 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-38 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-38 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-37 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-37 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-37 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-37 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-37 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-37 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-37 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-37 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-37 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-36 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-35 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-35 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-35 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-35 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-34 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-34 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-33 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-32 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-32 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-31 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-31 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-31 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-31 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-31 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-30 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-30 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-30 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-29 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-28 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-28 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-26 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-25 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-24 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-24 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-23 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-23 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-22 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-21 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-21 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-16 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-08 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-07 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-06 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-06 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-05 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 4e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 4e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-04 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-04 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 5e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 8e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.001 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 0.001 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.001 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.001 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.003 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.003 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.004 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.004 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 0.004 | |
| cd05151 | 170 | cd05151, ChoK, Choline Kinase (ChoK) | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 298 bits (765), Expect = 4e-98
Identities = 110/257 (42%), Positives = 157/257 (61%), Gaps = 7/257 (2%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
Y + +G G F KV LA TG+ VAIK++KK + +D R+ EI LK + H +I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
+L+ V E +++V+EYC GG+L D + +R RL E E+R + RQILSA+ YLH G H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RDLKPEN+LLD + ++KL DFGL + + G +L T G+P Y APEV+ GK YG
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPG--EKLTTFVGTPEYMAPEVLLGKG-YGKAV 177
Query: 190 DVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTEPPWM---SPNSRQIVRSMLQV 245
D+WS+GV+LY LL G PF D + +L+ KI K PP SP ++ ++R +L
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237
Query: 246 EPGKRIKIQDLLGHNWV 262
+P KR+ ++ L H +
Sbjct: 238 DPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 275 bits (705), Expect = 4e-89
Identities = 102/261 (39%), Positives = 142/261 (54%), Gaps = 9/261 (3%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHI 68
Y L R +GSG F V A H TG+ VA+KI+KK + + EI L+ +SH +I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+L E H+++V+EYC GG+L D++ L E E++ QIL + YLH G
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSE 188
HRDLKPEN+LLD N +K+ DFGL K S L T G+P Y APEV+ G YG +
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSID---QLYDKILNGKYTEPPW----MSPNSRQIVRS 241
DVWS+GV+LY LL G PF ++I QL +IL S ++ +++
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 242 MLQVEPGKRIKIQDLLGHNWV 262
L +P KR +++L H W
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (590), Expect = 4e-72
Identities = 96/251 (38%), Positives = 147/251 (58%), Gaps = 7/251 (2%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQ 73
+G G F KV L TG+ A+K++KK + + ++ E N L I+H I KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
+T +++V+EY PGGEL H+ + R E+ +R + +I+ A+ YLH LG +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
PEN+LLD + ++KL DFGL K S+ T CG+P Y APEV+ GK YG D WS
Sbjct: 121 PENILLDADGHIKLTDFGLA-KELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWS 178
Query: 194 MGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIK- 252
+GV+LY +L G PF ++ ++Y+KIL P ++SP +R ++ +LQ +P KR+
Sbjct: 179 LGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGS 238
Query: 253 --IQDLLGHNW 261
+++ H +
Sbjct: 239 GGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 5e-70
Identities = 98/246 (39%), Positives = 133/246 (54%), Gaps = 34/246 (13%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
+G GGF V LA TG+KVAIKI+KK L + EI LK ++H +I KL+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 76 ETSSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKP 134
E +H+++V+EYC GG L D + E +L E E QIL + YLH G HRDLKP
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 135 ENVLLDRNQ-NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
EN+LLD + +KL DFGL K +S L+T G+P Y APEV+ GK YY ++D+WS
Sbjct: 121 ENILLDSDNGKVKLADFGLS-KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 194 MGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKI 253
+GV+LY L P + ++R MLQ +P KR
Sbjct: 180 LGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 254 QDLLGH 259
+++L H
Sbjct: 209 KEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 223 bits (572), Expect = 5e-69
Identities = 95/267 (35%), Positives = 153/267 (57%), Gaps = 24/267 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL--------EINA 59
+ + +T+G+G F +V L H +G+ A+KI+ KA + VKL E
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI------VKLKQVEHVLNEKRI 54
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
L+ I H + L+ + S++++V+EY PGGEL H+ + R E +R + Q++ A+
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
YLH L +RDLKPEN+LLD + +K+ DFG + +G T CG+P Y APE+I
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEII 170
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
K YG D W++G+++Y +L G+ PF D+ Q+Y+KIL GK P + SP+++ ++
Sbjct: 171 LSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLI 229
Query: 240 RSMLQVEPGKRI-----KIQDLLGHNW 261
R++LQV+ KR+ + D+ H W
Sbjct: 230 RNLLQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 4e-59
Identities = 85/266 (31%), Positives = 144/266 (54%), Gaps = 21/266 (7%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKA-TLGED-LPRVKLEINALKHISHQHICKLFQ 73
+ G + +V LA TG+ AIK++KKA + ++ + +V E + L ++ KL+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 74 VIETSSHIFMVIEYCPGGE---LLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
+ ++++V+EY PGG+ LL+++ L E +R + +I+ A+ YLH G HR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENV---GSLDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 131 DLKPENVLLDRNQNLKLIDFGLC-------AKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
DLKP+N+L+D N +LKL DFGL E + + G+P+Y APEVI G+
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--PWMSPNSRQIVRS 241
+ D WS+G +LY L G PF ++ ++++ ILNGK P +S + ++
Sbjct: 178 -HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK 236
Query: 242 MLQVEPGKRI---KIQDLLGHNWVKM 264
+L +P KR+ I+++ H + K
Sbjct: 237 LLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 80/255 (31%), Positives = 136/255 (53%), Gaps = 8/255 (3%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQH 67
+Y + + +G G F KV L G+ +K + + + E + E+ LK ++H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG----EKESRAFFRQILSAVAYLH 123
I K ++ E + +V+EY GG+L I ++++ G E++ +F Q+ A+ YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRD+KP+N+ L N +KL DFG+ +K +T G+P Y +PE+ + K
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGI-SKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSM 242
Y ++D+WS+G +LY L PF+ +++ +L KIL G+Y P S R +V S+
Sbjct: 180 Y-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238
Query: 243 LQVEPGKRIKIQDLL 257
LQ +P +R I +L
Sbjct: 239 LQKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 1e-57
Identities = 90/257 (35%), Positives = 139/257 (54%), Gaps = 14/257 (5%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPR-VKLEINALKHISHQHICKLFQ 73
+G GGF +V+L A+K +KK + E + E L+ +H I KL++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
+ +I+M++EYC GGEL + +R E +R + ++ A YLH+ G +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
PEN+LLD N +KL+DFG K + G + T CG+P Y APE+I K Y D WS
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSG--QKTWTFCGTPEYVAPEIILNKG-YDFSVDYWS 177
Query: 194 MGVMLYALLCGFLPFDSDSIDQL--YDKIL--NGKYTEPPWMSPNSRQIVRSMLQVEPGK 249
+G++LY LL G PF D D + Y+ IL NGK P ++ ++ +++ +L+ P +
Sbjct: 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
Query: 250 RI-----KIQDLLGHNW 261
R+ I+D+ H W
Sbjct: 238 RLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 8e-56
Identities = 80/270 (29%), Positives = 140/270 (51%), Gaps = 23/270 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLEINALKHIS- 64
+ + + +G G F+ V LA T ++ AIKI+ K L ++ + VK+E L ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
H I KL+ + +++ V+EY P GELL +I + L EK +R + +IL A+ YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFG-------------------LCAKPEGGLESQLQ 165
G HRDLKPEN+LLD++ ++K+ DFG +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY 225
+ G+ Y +PE++ K G +D+W++G ++Y +L G PF + + KIL +Y
Sbjct: 181 SFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQD 255
+ PP P+++ ++ +L ++P R+ + +
Sbjct: 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-55
Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 14/264 (5%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQH 67
++ +G G F V LA TGE +A+K + E+L ++ EI L + H +
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 68 ICKLF--QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
I + + + E + + + +EY GG L + + +L E R + RQIL +AYLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
G HRD+K N+L+D + +KL DFG CAK + + G+P + APEVI+G++
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFG-CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 184 YYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPP----WMSPNSRQI 238
YG D+WS+G + + G P+ + + KI G EPP +S ++
Sbjct: 180 -YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI--GSSGEPPEIPEHLSEEAKDF 236
Query: 239 VRSMLQVEPGKRIKIQDLLGHNWV 262
+R L+ +P KR +LL H ++
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 1e-51
Identities = 102/307 (33%), Positives = 158/307 (51%), Gaps = 27/307 (8%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED----LPRVKLEINALKHISHQHIC 69
+ +G G F KV LA T E A+K++KK + +D + + AL H +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLT 59
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
+L +T +F V+EY GG+L+ HI R E +R + +I+ + +LH G +
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ-LQTSCGSPNYAAPEVIKGKQYYGSE 188
RDLK +NVLLD ++K+ DFG+C EG L T CG+P+Y APE++ Q YG
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSY-QPYGPA 176
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248
D W++GV+LY +L G PF+ D D+L+ IL + P W+S ++ I++S L P
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPE 236
Query: 249 KRIKI-----QDLLGH------NWVKMGPEDNPVSFRPDHELREK----DDDVIKVMADH 293
KR+ QD+ GH +W K+ ++ F+P + R DD+ K +
Sbjct: 237 KRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTK---EK 293
Query: 294 KQLSPDD 300
L+P D
Sbjct: 294 PVLTPPD 300
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 180 bits (456), Expect = 3e-51
Identities = 94/353 (26%), Positives = 148/353 (41%), Gaps = 32/353 (9%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQ- 66
Y + R +G G F +V LA + VA+K++ K +++ R EI L ++H
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG---EKESRAFFRQILSAVAYLH 123
+I KL+ + +++V+EY GG L D + + R G E E+ QILSA+ YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 124 HLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEGGLESQ-----LQTSCGSPNYAAPE 177
G HRD+KPEN+LLDR+ + +KLIDFGL + TS G+P Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 178 VIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTE---- 227
V+ G Y S +D+WS+G+ LY LL G PF+ + Q IL
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 228 -----PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG--PEDNPVSFRPDHELR 280
P +S + +++ +L +P R+ L H+ + E + +
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298
Query: 281 EKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGS 333
+ + S + + + L
Sbjct: 299 PLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSL 351
|
Length = 384 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 4e-49
Identities = 84/256 (32%), Positives = 134/256 (52%), Gaps = 12/256 (4%)
Query: 15 TVGSGGFAKVKLATHVLTGEKVAIKIMK--KATLGEDLPRVKLEINALKHISHQHICKLF 72
TVG+G F +V L ++ A+K+M + + V E LK +SH I +LF
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDL 132
++M++EY PGGEL ++ R + +I+ A+ YLH +RDL
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127
Query: 133 KPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVW 192
KPEN+LLD+ ++KL DFG K L + T CG+P Y APEVI+ K + D W
Sbjct: 128 KPENILLDKEGHIKLTDFGFAKK----LRDRTWTLCGTPEYLAPEVIQSKG-HNKAVDWW 182
Query: 193 SMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRI- 251
++G+++Y +L G+ PF D+ +Y+KIL GK P + ++ +++ +L V+ +R+
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLG 242
Query: 252 ----KIQDLLGHNWVK 263
D+ H W K
Sbjct: 243 NMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 91/310 (29%), Positives = 157/310 (50%), Gaps = 45/310 (14%)
Query: 15 TVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLF 72
+G G F +V L TG+ A+K+++K+ + + V+ E + L I KL+
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDL 132
+ H+++V+EY PGG+L++ ++ + E+ +R + +++ A+ +H LG+ HRD+
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127
Query: 133 KPENVLLDRNQNLKLIDFGLCAK------------------------PEGGLESQLQTSC 168
KP+N+L+D + ++KL DFGLC K Q +
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 169 ----GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK 224
G+P+Y APEV++G YG E D WS+GV+LY +L GF PF SD++ + Y+KI+N K
Sbjct: 188 NSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWK 246
Query: 225 YT-----EPPWMSPNSRQIVRSMLQVEPGKRIK-IQDLLGHNWVK----MGPEDNPVSFR 274
+ +PP SP + ++ +L +P R+ +++ H + K + F
Sbjct: 247 ESLRFPPDPPV-SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFV 304
Query: 275 PDHELREKDD 284
P EL D
Sbjct: 305 P--ELSSPLD 312
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 1e-48
Identities = 98/295 (33%), Positives = 156/295 (52%), Gaps = 23/295 (7%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKK-ATLGEDLPRVKLEINALKHISHQH--ICK 70
R +G G F KV LA +G A+K++KK L +D + + ++ H + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L+ +T +F V+E+ GG+L+ HI + +R E +R + +I SA+ +LH G +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL-QTSCGSPNYAAPEVIKGKQYYGSET 189
DLK +NVLLD + KL DFG+C EG + T CG+P+Y APE+++ + YG
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQ-EMLYGPSV 177
Query: 190 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 249
D W+MGV+LY +LCG PF++++ D L++ ILN + P W+S ++ I+++ + P
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 250 RIKIQDLLGH------------NWVKMGPEDNPVSFRPDHELREK----DDDVIK 288
R+ L G +W K+ FRP + RE D D IK
Sbjct: 238 RLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIK 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 8e-48
Identities = 97/273 (35%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED----LPRVKLEINALKHISHQHIC 69
+ +G G F KV LA T E AIK +KK + ED V+ + AL H +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLT 59
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
LF +T H+F V+EY GG+L+ HI R E +R + +I+ + +LH G +
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RDLK +NVLLD++ ++K+ DFG+C K E + T CG+P+Y APE++KG Q Y
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC-KENMNGEGKASTFCGTPDYIAPEILKG-QKYNESV 177
Query: 190 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 249
D WS GV+LY +L G PF + D+L+D ILN + P W+S ++ + + + +P K
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 250 RIKIQ-DLLGH------NWVKMGPEDNPVSFRP 275
R+ + D+ H +W ++ + P F+P
Sbjct: 238 RLGVDGDIRQHPFFRGIDWERLEKREIPPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 4e-47
Identities = 88/259 (33%), Positives = 141/259 (54%), Gaps = 15/259 (5%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHIC 69
+ T+G+G F +V++A H TGE AIK +KK + + + V E + L +SH I
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
+ + + ++ ++E+ GGEL H+ + R ++ + +++ A YLH +
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIY 141
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RDLKPEN+LLD ++K+ DFG K + + T CG+P Y APEVI+ K +G
Sbjct: 142 RDLKPENLLLDNKGHVKVTDFGFAKK----VPDRTFTLCGTPEYLAPEVIQSKG-HGKAV 196
Query: 190 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 249
D W+MGV+LY + G+ PF D+ ++Y+KIL G+ P W +R +V+ +LQ + K
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTK 256
Query: 250 RIKIQDLLGHNWVKMGPED 268
R LG +K G D
Sbjct: 257 R------LGT--LKGGVAD 267
|
Length = 329 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-46
Identities = 84/252 (33%), Positives = 124/252 (49%), Gaps = 8/252 (3%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQ 73
+G GGF +V A H TG++VAIK++K + E ++ EI LK H +I K +
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDL 132
+++V+E+C GG L D + Q L E + +++L + YLH G HRD+
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124
Query: 133 KPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVW 192
K N+LL + +KLIDFGL A+ T G+P + APEVI GK Y + D+W
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVINGKP-YDYKADIW 181
Query: 193 SMGVMLYALLCGFLPFDSDSIDQLYDKIL-NGKYT--EPPWMSPNSRQIVRSMLQVEPGK 249
S+G+ L G P+ + KI NG P S + ++ LQ P K
Sbjct: 182 SLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEK 241
Query: 250 RIKIQDLLGHNW 261
R + LL H +
Sbjct: 242 RPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 86/245 (35%), Positives = 141/245 (57%), Gaps = 10/245 (4%)
Query: 14 RTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATL---GEDLPRVKLEINALKHISHQH 67
+ +G GG+ KV V TG+ A+K++KKAT+ +D K E N L+ + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF-RQILSAVAYLHHLG 126
I L +T +++++EY GGEL H+ ER+ + +++ F+ +I A+ +LH G
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
+RDLKPEN+LLD ++KL DFGLC K + T CG+ Y APE++ + +G
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLC-KESIHEGTVTHTFCGTIEYMAPEILM-RSGHG 178
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
D WS+G ++Y +L G PF +++ + DKIL GK PP+++P +R +++ +L+
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 247 PGKRI 251
P R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 71/261 (27%), Positives = 127/261 (48%), Gaps = 12/261 (4%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALK---HISH 65
+ L R +G G F KV + T + A+K M K E V+ +N + ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNH 59
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+ L+ + ++++V++ GG+L H+ ++ + E++ + + +I+ A+ YLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
G HRD+KP+N+LLD ++ + DF + K + ++ G+P Y APEV+ +Q Y
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLC-RQGY 176
Query: 186 GSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
D WS+GV Y L G P+ DQ+ K P S + + +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236
Query: 243 LQVEPGKRI--KIQDLLGHNW 261
L+ +P KR+ ++DL H +
Sbjct: 237 LERDPQKRLGDNLKDLKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 82/223 (36%), Positives = 121/223 (54%), Gaps = 9/223 (4%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQ 73
VG GG+ +V LA TGE VA+K MKK+ L ++ V E + L + + KL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
+ ++++ +EY PGG+ + L E +R + ++ AV LH LGY HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
PEN L+D + ++KL DFGL G+ + + GSP+Y APEV++GK Y D WS
Sbjct: 129 PENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKG-YDFTVDYWS 183
Query: 194 MGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPN 234
+G MLY LCGF PF + ++ ++ + K T P + P
Sbjct: 184 LGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-44
Identities = 80/259 (30%), Positives = 127/259 (49%), Gaps = 10/259 (3%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISHQH 67
Y L +G G F V ++ TG+ VAIK + + E L + EI+ LK++ H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
I K IETS +++++EY G L I + E + Q+L +AYLH G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGS 187
HRD+K N+L ++ +KL DFG+ K + + G+P + APEVI+ G+
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATK-LNDVSKDDASVVGTPYWMAPEVIEMS---GA 176
Query: 188 ET--DVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPPWM-SPNSRQIVRSML 243
T D+WS+G + LL G P +D + + L+ +I+ + P SP + +
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALF-RIVQDDHPPLPEGISPELKDFLMQCF 235
Query: 244 QVEPGKRIKIQDLLGHNWV 262
Q +P R + LL H W+
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-44
Identities = 88/243 (36%), Positives = 136/243 (55%), Gaps = 9/243 (3%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINAL-KHISHQHICK 70
+ +G G F KV LA H G+ A+K+++K + ++ + E N L K++ H +
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T+ ++ V++Y GGEL H+ + E +R + +I SA+ YLH L +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS--CGSPNYAAPEVIKGKQYYGSE 188
DLKPEN+LLD ++ L DFGLC + G+E TS CG+P Y APEV++ KQ Y
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKE---GIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRT 176
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248
D W +G +LY +L G PF S ++YD ILN P +S ++R ++ +LQ +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRT 236
Query: 249 KRI 251
KR+
Sbjct: 237 KRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 8e-43
Identities = 88/296 (29%), Positives = 136/296 (45%), Gaps = 59/296 (19%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHI 68
Y +G G + V A TGE VA+K ++ E +P L EI+ LK + H +I
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 69 CKLFQVIETSSHIFMVIEYCPGGEL-LDHIVERQRLG--EKESRAFFRQILSAVAYLHHL 125
KL VI T +++V EYC ++ L ++++ ++ Q+L +AY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----------YA 174
HRDLKP+N+L++R+ LKL DFGL A+ + G P Y
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGL-AR-----------AFGIPLRTYTHEVVTLWYR 165
Query: 175 APEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYD--KIL---------- 221
APE++ G ++Y + D+WS+G + ++ G F DS IDQL+ +IL
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225
Query: 222 -----NGKYTEP-----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261
+ K T P P + P ++ MLQ P KRI ++ L H +
Sbjct: 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 83/243 (34%), Positives = 134/243 (55%), Gaps = 9/243 (3%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED----LPRVKLEINALKHISHQHIC 69
+ +G G F KV LA T E AIK++KK + +D + I AL H +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLT 59
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
L +T +F V+EY GG+L+ I ++ E SR + ++ A+ +LH G +
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-CGSPNYAAPEVIKGKQYYGSE 188
RDLK +N+LLD + KL DFG+C EG L T+ CG+P+Y APE+++ + YG
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ-ELEYGPS 176
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248
D W++GV++Y ++ G PF++D+ D L++ IL+ P W+S + I+++ + P
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPN 236
Query: 249 KRI 251
KR+
Sbjct: 237 KRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 7e-42
Identities = 84/288 (29%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQH 67
+Y + +G G V A TGE VA+K + L +P L EI AL+ H +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 68 ICKLFQVIETSSHIFMVIEYCPGG--ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+ KL V S +V+EY P E+L E + L E + +++ R +L VAY+H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-CGSPNYAAPEVIKGKQY 184
G HRDLKP N+L+ + LK+ DFGL A+ E +L + + Y APE++ G +
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGL-ARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 185 YGSETDVWSMGVMLYALLCG--FLPFDSDSIDQL-----------------------YDK 219
Y D+W++G + LL G P ++D I+QL Y+K
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236
Query: 220 ILNGKYTEPPW--MSPNSRQ----IVRSMLQVEPGKRIKIQDLLGHNW 261
I + P + P++ +++ +L +P KR+ + L H +
Sbjct: 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 98/321 (30%), Positives = 166/321 (51%), Gaps = 45/321 (14%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-----SHQ 66
R +G G +AKV L T A+K++KK + ED+ V+ E KH+ +H
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTE----KHVFETASNHP 56
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
+ L +T S +F VIE+ GG+L+ H+ +++L E+ +R + +I A+ +LH G
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS--CGSPNYAAPEVIKGKQY 184
+RDLK +NVLLD ++KL D+G+C + G+ TS CG+PNY APE+++G+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKE---GIRPGDTTSTFCGTPNYIAPEILRGED- 172
Query: 185 YGSETDVWSMGVMLYALLCGFLPFD----SDSIDQ-----LYDKILNGKYTEPPWMSPNS 235
YG D W++GV+++ ++ G PFD SD+ DQ L+ IL + P +S +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 236 RQIVRSMLQVEPGKRI------KIQDLLGH------NWVKMGPEDNPVSFRP----DHEL 279
+++ L +P +R+ +D+ H +W + + ++P D +L
Sbjct: 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDL 292
Query: 280 REKDDDVIKVMADHKQLSPDD 300
D + + QL+PDD
Sbjct: 293 DNFDP---QFTDEPVQLTPDD 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 75/254 (29%), Positives = 115/254 (45%), Gaps = 8/254 (3%)
Query: 17 GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE 76
G G V H TG+ A+K + E ++ E+ L+ ++ K +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 77 TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPE 135
I +V+EY GG L D + + ++ E RQIL + YLH HRD+KP
Sbjct: 70 KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 136 NVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMG 195
N+L++ +K+ DFG+ E L+ Q T G+ Y +PE I+G+ Y D+WS+G
Sbjct: 130 NLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERIQGE-SYSYAADIWSLG 187
Query: 196 VMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEPP--WMSPNSRQIVRSMLQVEPGKR 250
+ L G PF S +L I +G P SP R + + LQ +P KR
Sbjct: 188 LTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKR 247
Query: 251 IKIQDLLGHNWVKM 264
+LL H ++K
Sbjct: 248 PSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 81/264 (30%), Positives = 142/264 (53%), Gaps = 13/264 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISH 65
+ ++ VG G F +V++ TG+ A+K+MKK+ L E + + E + L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHH 124
I +L + ++++V+EY PGG+LL + + + E ++ + +++ A+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK---- 180
+GY HRD+KPENVL+DR ++KL DFG A+ + G+P+Y APEV+
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 181 -GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----KYTEPPWMSPNS 235
GK YG E D WS+GV+ Y ++ G PF + + Y+ I+N K+ E P +S +
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 236 RQIVRSMLQVEPGKRIKIQDLLGH 259
+++S+L +R+ + L H
Sbjct: 241 LDLIQSLL-CGQKERLGYEGLCCH 263
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 82/243 (33%), Positives = 133/243 (54%), Gaps = 9/243 (3%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINAL-KHISHQHICK 70
+ +G G F KV LA G A+K+++K T+ ++ + E N L K++ H +
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T+ ++ V++Y GGEL H+ + E +R + ++ SA+ YLH L +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS--CGSPNYAAPEVIKGKQYYGSE 188
DLKPEN+LLD ++ L DFGLC + G+E + TS CG+P Y APEV++ K+ Y
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKE---GVEPEETTSTFCGTPEYLAPEVLR-KEPYDRT 176
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248
D W +G +LY +L G PF S + Q+YD IL+ P + + ++ +L +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQR 236
Query: 249 KRI 251
+R+
Sbjct: 237 RRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 84/263 (31%), Positives = 136/263 (51%), Gaps = 18/263 (6%)
Query: 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL--EINALKHISHQHI 68
+LE T+G G F V+ G+ + K + + E + +L E+N L+ + H +I
Sbjct: 4 VLE-TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHPNI 61
Query: 69 CKLFQ--VIETSSHIFMVIEYCPGGELLDHI----VERQRLGEKESRAFFRQILSAVAYL 122
+ + + ++ +++V+EYC GG+L I ER+ + E+ Q+L A+
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 123 HHLGYA-----HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
H+ HRDLKP N+ LD N N+KL DFGL AK G S +T G+P Y +PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL-AKILGHDSSFAKTYVGTPYYMSPE 180
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM-SPNSR 236
+ Y ++D+WS+G ++Y L PF + + QL KI GK+ P+ S
Sbjct: 181 QLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239
Query: 237 QIVRSMLQVEPGKRIKIQDLLGH 259
++++SML V+P KR ++LL
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 85/272 (31%), Positives = 148/272 (54%), Gaps = 12/272 (4%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKK--ATLGEDLPRVKLEINALK-HISHQHICK 70
+ +G G F KV LA GE A+K +KK + +D+ +E L + +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L+ +T H+F V+E+ GG+L+ HI ++ R + + +I+ + +LH G +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +NV+LDR+ ++K+ DFG+C + G +++ T CG+P+Y APE+++G +Y S D
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGTPDYIAPEILQGLKYTFS-VD 178
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
WS GV+LY +L G PF D D+L++ I P W++ S+ I+ + + +P +R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238
Query: 251 IKIQ-DLLGH------NWVKMGPEDNPVSFRP 275
+ + ++ GH NW + + F+P
Sbjct: 239 LGVVGNIRGHPFFKTINWTALEKRELDPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 82/273 (30%), Positives = 137/273 (50%), Gaps = 37/273 (13%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLEINALKHISHQHICKL 71
+ +G G +V L TG+ A+K++ K + + + RV E L + H + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQ---RLGEKESRAFFRQILSAVAYLHHLGYA 128
+ +T +++ +V++YCPGGEL +++RQ L E+ +R + ++L A+ YLH LG
Sbjct: 67 YASFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLC--AKPEGGLESQ----------------LQTSC-- 168
+RDLKPEN+LL + ++ L DF L + E S+ S
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185
Query: 169 --------GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI 220
G+ Y APEVI G +GS D W++G++LY +L G PF + D+ + I
Sbjct: 186 SFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI 244
Query: 221 LNG--KYTEPPWMSPNSRQIVRSMLQVEPGKRI 251
L + P +S ++R ++R +L +P KR+
Sbjct: 245 LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 102/314 (32%), Positives = 164/314 (52%), Gaps = 31/314 (9%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHIS-HQHICK 70
R +G G +AKV L T A+K++KK + ED+ V+ E + + S H +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T S +F VIEY GG+L+ H+ +++L E+ +R + +I A+ YLH G +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS--CGSPNYAAPEVIKGKQYYGSE 188
DLK +NVLLD ++KL D+G+C + GL TS CG+PNY APE+++G+ YG
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGTPNYIAPEILRGED-YGFS 176
Query: 189 TDVWSMGVMLYALLCGFLPFD----SDSIDQ-----LYDKILNGKYTEPPWMSPNSRQIV 239
D W++GV+++ ++ G PFD SD+ DQ L+ IL + P +S + ++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
Query: 240 RSMLQVEPGKRI------KIQDLLGH------NWVKMGPEDNPVSFRPDHELREKDDDVI 287
+S L +P +R+ D+ GH +W M + F+P+ D+
Sbjct: 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFD 296
Query: 288 KVMADHK-QLSPDD 300
+ QL+PDD
Sbjct: 297 AQFTNEPVQLTPDD 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 4e-40
Identities = 88/245 (35%), Positives = 134/245 (54%), Gaps = 5/245 (2%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIM-KKATLGEDLPR-VKLEINAL-KHISHQHICK 70
+ +G G F KV LA H + A+K++ KKA L + + + E N L K++ H +
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T+ ++ V++Y GGEL H+ + E +R + +I SA+ YLH L +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLKPEN+LLD ++ L DFGLC K T CG+P Y APEV+ KQ Y D
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC-KENIEHNGTTSTFCGTPEYLAPEVLH-KQPYDRTVD 178
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
W +G +LY +L G PF S + ++YD ILN P ++ ++R ++ +LQ + KR
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238
Query: 251 IKIQD 255
+ +D
Sbjct: 239 LGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 79/240 (32%), Positives = 136/240 (56%), Gaps = 4/240 (1%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+ +G G F KV L TG+ A+KI+KK + +++ E L++ H + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+T + V+EY GGEL H+ + E +R + +I+SA+ YLH +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDV 191
LK EN++LD++ ++K+ DFGLC K + ++T CG+P Y APEV++ YG D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC-KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDW 178
Query: 192 WSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRI 251
W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++ +L+ +P +R+
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 86/285 (30%), Positives = 144/285 (50%), Gaps = 21/285 (7%)
Query: 12 LERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATL---GEDLPRVKLEINALKHI-S 64
L R +G+G + KV L V G+ A+K++KKAT+ + + E L+ +
Sbjct: 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ L +T + + ++++Y GGEL H+ +R+ E E R + +I+ A+ +LH
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ 123
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
LG +RD+K EN+LLD ++ L DFGL + E + + CG+ Y APEVI+G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 185 -YGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQIV 239
+ D WS+GV+ + LL G PF D S ++ +IL K P MS +R +
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFI 243
Query: 240 RSMLQVEPGKRI---KIQDLLGH------NWVKMGPEDNPVSFRP 275
+ +L+ +P KR+ ++ H +W + + P F+P
Sbjct: 244 QKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 1e-39
Identities = 78/241 (32%), Positives = 137/241 (56%), Gaps = 6/241 (2%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+ +G G F KV L TG A+KI++K + +++ E L++ H + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+T + V+EY GGEL H+ + E+ +R + +I+SA+ YLH +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEG-GLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
+K EN++LD++ ++K+ DFGLC EG + ++T CG+P Y APEV++ YG D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVD 177
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++ +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 251 I 251
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 82/243 (33%), Positives = 127/243 (52%), Gaps = 14/243 (5%)
Query: 17 GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLE-INALKHI-------SHQHI 68
G G F KV LA + TGE AIK +KK G+ + R ++E + K I H +
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKK---GDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
LF +T H+ V+EY GG+L+ HI E + + ++ + YLH
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIV 123
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSE 188
+RDLK +N+LLD +K+ DFGLC K G + T CG+P + APEV+ Y
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLC-KEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRA 181
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248
D W +GV++Y +L G PF D ++++D I+N + P ++S + I+R +L+ P
Sbjct: 182 VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPE 241
Query: 249 KRI 251
+R+
Sbjct: 242 RRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 82/295 (27%), Positives = 152/295 (51%), Gaps = 24/295 (8%)
Query: 12 LERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATL---GEDLPRVKLEINALKHISH 65
L + +G+G + KV L V TG+ A+K+++KA L + + + E N L+H+
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ 63
Query: 66 Q-HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ L +T + + ++++Y GGE+ H+ +R E E R + +I+ A+ +LH
Sbjct: 64 SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK 123
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
LG +RD+K EN+LLD ++ L DFGL + + + + CG+ Y APE+I+GK
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG 183
Query: 185 YGSETDVWSMGVMLYALLCGFLPF----DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
+G D WS+G++++ LL G PF + ++ ++ +IL P ++ P ++ ++
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLH 243
Query: 241 SMLQVEPGKRI-----KIQDLLGH------NWVKMGPEDNPVSFRPDHELREKDD 284
+L+ +P KR+ ++ H +W + FRP +R + D
Sbjct: 244 KLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRP--SIRNELD 296
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 84/283 (29%), Positives = 147/283 (51%), Gaps = 22/283 (7%)
Query: 14 RTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHIC 69
+ +G G F KV L + G+ A+K++KKATL D R K+E + L ++H I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
KL +T +++++++ GG+L + + E++ + + ++ A+ +LH LG +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RDLKPEN+LLD ++KL DFGL + E + + CG+ Y APEV+ ++ +
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSFCGTVEYMAPEVVN-RRGHTQSA 179
Query: 190 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 249
D WS GV+++ +L G LPF + IL K P ++SP ++ ++R++ + P
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239
Query: 250 RI-----KIQDLLGH------NWVK-----MGPEDNPVSFRPD 276
R+ ++++ H +W K + P P RPD
Sbjct: 240 RLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPD 282
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 5e-39
Identities = 89/279 (31%), Positives = 147/279 (52%), Gaps = 17/279 (6%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINAL-KHISHQHICK 70
+ +G G F KV LA L G+ A+K+++K + ++ + E N L K++ H +
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T+ ++ V+++ GGEL H+ + E +R + +I SA+ YLH + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-CGSPNYAAPEVIKGKQYYGSET 189
DLKPEN+LLD ++ L DFGLC EG +S T+ CG+P Y APEVI+ KQ Y +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNTV 177
Query: 190 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 249
D W +G +LY +L G PF + ++YD IL+ P S + I+ +L+ + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 250 RIKIQD----LLGH------NWVKMGPEDNPVSFRPDHE 278
R+ ++ + H +W + + P F P+ E
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVE 276
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 63/247 (25%), Positives = 115/247 (46%), Gaps = 10/247 (4%)
Query: 12 LERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
L + +G G F +V +VA+K +K+ + + E ++ + H +
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLG 126
+ KL V +++V+EY GG+LL ++ + R +L + +F QI + YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIKGKQYY 185
+ HRDL N L+ N +K+ DFGL ++ + + P + APE +K ++
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGL-SRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 186 GSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 243
S++DVWS GV+L+ + G P+ S +++ + + NG PP P ++
Sbjct: 182 -SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCW 240
Query: 244 QVEPGKR 250
+P R
Sbjct: 241 AEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 11/249 (4%)
Query: 11 ILERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
L + +G G F +V T +VA+K +K+ + + E ++ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHH 124
+I KL V + +V+EY PGG+LLD++ + + L + +F QI + YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIKGKQ 183
+ HRDL N L+ N +K+ DFGL ++ + P + APE +K +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGL-SRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 184 YYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRS 241
+ S++DVWS GV+L+ + G P+ S ++ + + G PP P +++
Sbjct: 181 -FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQ 239
Query: 242 MLQVEPGKR 250
+P R
Sbjct: 240 CWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 80/241 (33%), Positives = 136/241 (56%), Gaps = 6/241 (2%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+ +G G F KV L +G+ A+KI+KK + +++ E LK+ H + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+T + V+EY GGEL H+ + E +R + +I+SA+ YLH +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
LK EN++LD++ ++K+ DFGLC EG + + ++T CG+P Y APEV++ YG D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVD 177
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
W +GV++Y ++CG LPF + ++L++ IL P +S +++ ++ +L +P KR
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 251 I 251
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 85/287 (29%), Positives = 150/287 (52%), Gaps = 23/287 (8%)
Query: 12 LERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATL---GEDLPRVKLEINALKHISH 65
L + +G+G + KV L V +G+ A+K++KKAT+ + + E L+HI
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 66 Q-HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ L +T + + ++++Y GGEL H+ +R+R E+E + + +I+ A+ +LH
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK 123
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
LG +RD+K EN+LLD N ++ L DFGL + + + CG+ Y AP++++G
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183
Query: 185 -YGSETDVWSMGVMLYALLCGFLPF----DSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
+ D WSMGV++Y LL G PF + +S ++ +IL + P MS ++ I+
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDII 243
Query: 240 RSMLQVEPGKRI-----KIQDLLGH------NWVKMGPEDNPVSFRP 275
+ +L +P KR+ ++ H NW + + P F+P
Sbjct: 244 QRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 78/242 (32%), Positives = 140/242 (57%), Gaps = 16/242 (6%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-----EINALKHISHQHI 68
+ +G G F +V+L H + + A+K++ K E + R E + + H + + I
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF---EMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+L + +++MV+EY PGG+L++ ++ + EK +R + +++ A+ +H +G+
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK---GKQYY 185
HRD+KP+N+LLD++ +LKL DFG C K + + T+ G+P+Y +PEV+K G YY
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----YTEPPWMSPNSRQIVRS 241
G E D WS+GV LY +L G PF +DS+ Y KI++ K + + +S ++ ++ +
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICA 284
Query: 242 ML 243
L
Sbjct: 285 FL 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 80/256 (31%), Positives = 137/256 (53%), Gaps = 18/256 (7%)
Query: 19 GGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI--SHQHICKLFQV 74
G F V LA TG+ AIK++KK+ + + VK E A+ I ++ KL+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE-RAIMMIQGESPYVAKLYYS 65
Query: 75 IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKP 134
++ ++++V+EY GG+ I L E ++ + +++ V LH G HRD+KP
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP 125
Query: 135 ENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSM 194
EN+L+D+ +LKL DFGL GLE+ + G+P+Y APE I G +D WS+
Sbjct: 126 ENLLIDQTGHLKLTDFGL---SRNGLEN--KKFVGTPDYLAPETILGVG-DDKMSDWWSL 179
Query: 195 GVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSMLQVEPGKR 250
G +++ L G+ PF +++ D ++D IL+ + P + SP + ++ +L ++P KR
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
Query: 251 IK---IQDLLGHNWVK 263
+ Q++ H + K
Sbjct: 240 LGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 81/281 (28%), Positives = 125/281 (44%), Gaps = 44/281 (15%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLFQV 74
+G G + V A LTGE VAIK +K E +P+ L EI LK ++H +I KL V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 75 IETSSHIFMVIEYCPGGELLDHIVERQRLG--EKESRAFFRQILSAVAYLHHLGYAHRDL 132
+++V E+ L +++ ++ G E +++ Q+L +A+ H G HRDL
Sbjct: 67 FRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124
Query: 133 KPENVLLDRNQNLKLIDFGLC---AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
KPEN+L++ LKL DFGL P + T Y APE++ G + Y +
Sbjct: 125 KPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW----YRAPELLLGDKGYSTPV 180
Query: 190 DVWSMGVMLYALLCG--FLPFDSDSIDQLY----------DKILNGKYTEPPWM------ 231
D+WS+G + LL P S+ IDQL+ ++ +
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 232 -------------SPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
SP + ++ ML +P KRI + L H
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 79/243 (32%), Positives = 138/243 (56%), Gaps = 9/243 (3%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+ +G G F KV L TG A+KI+KK + +++ E L++ H + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH-HLGYAHR 130
+T + V+EY GGEL H+ + E +R + +I+SA+ YLH +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLE--SQLQTSCGSPNYAAPEVIKGKQYYGSE 188
DLK EN++LD++ ++K+ DFGLC + G++ + ++T CG+P Y APEV++ Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKTFCGTPEYLAPEVLEDNDY-GRA 176
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248
D W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++ +L+ +P
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPK 236
Query: 249 KRI 251
+R+
Sbjct: 237 QRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-37
Identities = 81/272 (29%), Positives = 141/272 (51%), Gaps = 12/272 (4%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKK--ATLGEDLPRVKLEINALKHI-SHQHICK 70
+ +G G F KV LA T + AIK +KK + +D+ +E L H +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L+ +T ++F V+EY GG+L+ HI + + + +I+ + +LH G +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +N+LLD + ++K+ DFG+C + G +++ T CG+P+Y APE++ G Q Y + D
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPDYIAPEILLG-QKYNTSVD 178
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
WS GV+LY +L G PF ++L+ I P W++ ++ I+ + EP +R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238
Query: 251 IKIQ-DLLGH------NWVKMGPEDNPVSFRP 275
+ ++ D+ H +W + + F+P
Sbjct: 239 LGVKGDIRQHPFFREIDWSALEEREIEPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 94/313 (30%), Positives = 168/313 (53%), Gaps = 31/313 (9%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHIS-HQHICK 70
R +G G +AKV L + A+K++KK + ED+ V+ E + + S + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T+S +F+VIEY GG+L+ H+ +++L E+ +R + +I A+ +LH G +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +NVLLD + ++KL D+G+C + G ++ T CG+PNY APE+++G++ YG D
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT-STFCGTPNYIAPEILRGEE-YGFSVD 178
Query: 191 VWSMGVMLYALLCGFLPF-------DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243
W++GV+++ ++ G PF D ++ D L+ IL P ++S + +++ L
Sbjct: 179 WWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFL 238
Query: 244 QVEPGKRIKIQ------DLLGH------NWVKMGPEDNPVSFRP----DHELREKDDDVI 287
+P +R+ Q D+ H +W + + F+P D+ L D
Sbjct: 239 NKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFD---T 295
Query: 288 KVMADHKQLSPDD 300
+ ++ QL+PDD
Sbjct: 296 QFTSEPVQLTPDD 308
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 81/231 (35%), Positives = 133/231 (57%), Gaps = 9/231 (3%)
Query: 2 KYIDLR---NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLE 56
K DLR Y + + +G G F +V+L H T + A+K++ K + D E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 57 INALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQIL 116
+ + + + +LF + +++MV+EY PGG+L++ ++ + EK +R + +++
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVV 152
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
A+ +H +G+ HRD+KP+N+LLD++ +LKL DFG C K + T+ G+P+Y +P
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212
Query: 177 EVIK---GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK 224
EV+K G YYG E D WS+GV LY +L G PF +DS+ Y KI+N K
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 91/305 (29%), Positives = 132/305 (43%), Gaps = 63/305 (20%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED---LPRVKL-EINALKHIS 64
+Y + +G G +A V A TG VAIK +K E + L EI L+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYL 122
H +I L V S+I +V E+ L+ +++ + L + +++ L + YL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN---------- 172
H HRDLKP N+L+ + LKL DFGL S GSPN
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLA------------RSFGSPNRKMTHQVVTR 166
Query: 173 -YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GKYTE 227
Y APE++ G ++YG D+WS+G + LL FLP DSD IDQL KI G TE
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQL-GKIFEALGTPTE 224
Query: 228 PPW--MS-------------PNSRQI-----------VRSMLQVEPGKRIKIQDLLGHNW 261
W ++ +QI ++ +L + P KRI + L H +
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
Query: 262 VKMGP 266
P
Sbjct: 285 FSNDP 289
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 75/252 (29%), Positives = 131/252 (51%), Gaps = 40/252 (15%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+ +G G F +V+L TG A+K ++K+ + E + V+ E + L + + KL
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ + +++++++EY PGG+++ ++++ E+E+R + + + A+ +H LGY HRD
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLC-----------------AKPEGGLESQLQT-------- 166
+KP+N+LLD ++KL DFGLC A P L+ +
Sbjct: 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186
Query: 167 ------------SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID 214
+ G+P+Y APEV + Y E D WS+GV++Y +L G+ PF SD+
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVF-LQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ 245
Query: 215 QLYDKILNGKYT 226
+ Y KI+N K T
Sbjct: 246 ETYRKIINWKET 257
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 80/245 (32%), Positives = 121/245 (49%), Gaps = 6/245 (2%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHI 68
YI R +G G F + L V K + L E R L EI L + H +I
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLG 126
+ + + + +EY GG L D IV ++ E+ + QI+SAV+Y+H G
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRD+K N+ L + +KL DFG+ +K G S +T G+P Y +PE+ +G + Y
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGI-SKILGSEYSMAETVVGTPYYMSPELCQGVK-YN 179
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQV 245
++D+W++G +LY LL FD+ + L KI+ G YT S +V S+LQ
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239
Query: 246 EPGKR 250
+P KR
Sbjct: 240 DPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQ 66
+ + + +G G + V + + A+K + ++ E V EI L ++H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG----EKESRAFFRQILSAVAYL 122
+I + + + +V+EY P G+L I +R++ E+E F Q+L + L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H HRDLK N+LL N +K+ D G+ + + +T G+P+Y APEV KG
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM---AKTQIGTPHYMAPEVWKG- 175
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRS 241
+ Y ++D+WS+G +LY + PF++ S+ L K+ GKY PP S + + +RS
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 242 MLQVEPGKRIKIQDLLGH 259
MLQV+P R +L
Sbjct: 236 MLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 85/243 (34%), Positives = 130/243 (53%), Gaps = 13/243 (5%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQH-ICKLF 72
+G G F KV LA T E AIKI+KK + +D+ +E L + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQRLGE-KESRAFF--RQILSAVAYLHHLGYAH 129
+T ++ V+EY GG+L+ HI Q++G+ KE A F +I + +LH G +
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ-LQTSCGSPNYAAPEVIKGKQYYGSE 188
RDLK +NV+LD ++K+ DFG+C E + +T CG+P+Y APE+I Q YG
Sbjct: 125 RDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEII-AYQPYGKS 181
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248
D W+ GV+LY +L G PFD + D+L+ I+ + P +S + I + +L P
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPA 241
Query: 249 KRI 251
KR+
Sbjct: 242 KRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 8e-36
Identities = 77/256 (30%), Positives = 126/256 (49%), Gaps = 14/256 (5%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
+G G +V AT TG++VAIK M+ ++ + EI +K H +I +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 76 ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYLHHLGYAHRDLK 133
+++V+EY GG L D I+ + + E + + R++L + YLH HRD+K
Sbjct: 85 LVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIK 143
Query: 134 PENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDV 191
+N+LL ++ ++KL DFG A+ E S+ + G+P + APEVIK K YG + D+
Sbjct: 144 SDNILLSKDGSVKLADFGFAAQLTKEK---SKRNSVVGTPYWMAPEVIKRKD-YGPKVDI 199
Query: 192 WSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSMLQVEPG 248
WS+G+M + G P + L+ G P SP + + L +P
Sbjct: 200 WSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259
Query: 249 KRIKIQDLLGHNWVKM 264
KR ++LL H ++K
Sbjct: 260 KRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 88/300 (29%), Positives = 134/300 (44%), Gaps = 66/300 (22%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKA-TLGEDLPRVKLEINALKHI-SHQH 67
Y + + +G G F V LA + TGE VAIK MKK E+ ++ E+ +L+ + H +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPN 59
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHL 125
I KL +V + ++ V EY G L + +R+ E R+ QIL +A++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN--------YAAPE 177
G+ HRDLKPEN+L+ + +K+ DFGL A+ + S+ P Y APE
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGL-ARE---IRSR------PPYTDYVSTRWYRAPE 168
Query: 178 VIKGKQYYGSETDVWSMG------VMLYALLCGFLPFDSDSIDQLYDKILN--GKYTEPP 229
++ Y S D+W++G L L G S IDQLY KI + G T+
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG-----SSEIDQLY-KICSVLGTPTKQD 222
Query: 230 W----------------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261
W SP + +++ ML+ +P KR L H +
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 79/251 (31%), Positives = 133/251 (52%), Gaps = 8/251 (3%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLF 72
R VG G F V L + V IK + + +D E LK +SH +I + +
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAHR 130
+ + +V+EY PGG L ++I +R L E FF QIL A+ ++H HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 131 DLKPENVLLDRNQN-LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
DLK +N+LLD+++ +K+ DFG+ +S+ T G+P Y +PE+ +GK Y ++
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGI--SKILSSKSKAYTVVGTPCYISPELCEGKP-YNQKS 182
Query: 190 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSMLQVEPG 248
D+W++G +LY L F++ ++ L KI++G + SP+ RQ++ SML ++P
Sbjct: 183 DIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPS 242
Query: 249 KRIKIQDLLGH 259
KR ++ ++
Sbjct: 243 KRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 8/226 (3%)
Query: 11 ILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
L + +G G F +V T GE KVA+K +K+ E+ E + +K +SH
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHL 125
+I +L V +++V EY PGG+LLD + + ++L K+ QI + YL
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIKGKQY 184
+ HRDL N L+ N +K+ DFGL + + P + APE +K ++
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 185 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPP 229
S++DVWS GV+L+ + G P+ S +++ + + +G P
Sbjct: 182 T-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP 226
|
Length = 258 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 84/245 (34%), Positives = 130/245 (53%), Gaps = 17/245 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED----LPRVKLEINALK----HISHQH 67
+G G F KV LA T E AIKI+KK + +D V+ + AL ++ H
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
C FQ T ++ V+EY GG+L+ I + R E + + +I + +LH G
Sbjct: 68 SC--FQ---TMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPE-GGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
+RDLK +NV+LD ++K+ DFG+C + G+ + +T CG+P+Y APE+I Q YG
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT--KTFCGTPDYIAPEIIA-YQPYG 179
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
D W+ GV+LY +L G PF+ + D+L+ I+ P MS + I + ++
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239
Query: 247 PGKRI 251
PGKR+
Sbjct: 240 PGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 87/248 (35%), Positives = 137/248 (55%), Gaps = 23/248 (9%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED----LPRVKLEINALKH----ISHQH 67
+G G F KV LA T E AIKI+KK + +D V+ + AL+ ++ H
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGE-KESRAFF--RQILSAVAYLHH 124
C FQ ++ ++ V+EY GG+L+ HI Q++G+ KE +A F +I + +LH
Sbjct: 68 SC--FQTVD---RLYFVMEYVNGGDLMYHI---QQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQ 183
G +RDLK +NV+LD ++K+ DFG+C E ++ +T CG+P+Y APE+I Q
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEII-AYQ 176
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243
YG D W+ GV+LY +L G PFD + D+L+ I+ + P +S + I + ++
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM 236
Query: 244 QVEPGKRI 251
P KR+
Sbjct: 237 TKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 5e-35
Identities = 81/266 (30%), Positives = 151/266 (56%), Gaps = 14/266 (5%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQH 67
Y + + +G G F +V+L H + + A+K++ K + D E + + +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
+ +LF + +++MV+EY PGG+L++ ++ + EK ++ + +++ A+ +H +G
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK---GKQY 184
HRD+KP+N+LLD++ +LKL DFG C K + + T+ G+P+Y +PEV+K G Y
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----YTEPPWMSPNSRQIVR 240
YG E D WS+GV L+ +L G PF +DS+ Y KI++ K + E +S +++ ++
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLIC 283
Query: 241 SML---QVEPGKRIKIQDLLGHNWVK 263
+ L +V G R ++++ H + K
Sbjct: 284 AFLTDREVRLG-RNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 83/268 (30%), Positives = 136/268 (50%), Gaps = 17/268 (6%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEIN---ALK 61
D + +Y +G G V A V TG++VAIK M + P+ +L IN ++
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL----QQQPKKELIINEILVMR 71
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAY 121
H +I +++V+EY GG L D + E + E + A R+ L A+ +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 130
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSPNYAAPEVI 179
LH HRD+K +N+LL + ++KL DFG CA+ PE +S+ T G+P + APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVV 187
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGK--YTEPPWMSPNSR 236
K YG + D+WS+G+M ++ G P+ + + + LY NG P +S R
Sbjct: 188 TRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
+ L+++ KR ++LL H ++K+
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 9e-35
Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 52/289 (17%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLFQV 74
+G G + +V A + TGE VA+K ++ E P + EI L+ + H +I +L ++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 75 I--ETSSHIFMVIEYCP----GGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+ + I+MV EY G LLD + E + + + +Q+L + YLH G
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP----NYAAPEVIKGKQY 184
HRD+K N+L++ + LKL DFGL A+P + + Y PE++ G
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGL-ARP---YTKRNSADYTNRVITLWYRPPELLLGATR 178
Query: 185 YGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKI--LNG--------KYTEPPWM-- 231
YG E D+WS+G +L L G F S ++QL +KI L G ++ PW
Sbjct: 179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTDENWPGVSKLPWFEN 237
Query: 232 -------------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261
P++ ++ +L ++P KRI L H +
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 81/260 (31%), Positives = 131/260 (50%), Gaps = 16/260 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLF-- 72
+G G F KV A ++ TGE +A+K ++ + + E+ L+ + H ++ K +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDL 132
+V +IFM EYC GG L + + + L E R + Q+L +AYLH G HRD+
Sbjct: 68 EVHREKVYIFM--EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 133 KPENVLLDRNQNLKLIDFGLCAK----PEGGLESQLQTSCGSPNYAAPEVIKGKQY--YG 186
KP N+ LD N +KL DFG CA + ++Q+ G+P Y APEVI G + +G
Sbjct: 126 KPANIFLDHNGVIKLGDFG-CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 187 SETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGK---YTEPPWMSPNSRQIVRSM 242
D+WS+G ++ + G P+ D+ Q+ + G + +SP + +
Sbjct: 185 RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRC 244
Query: 243 LQVEPGKRIKIQDLLGHNWV 262
L+ +P KR +LL H +V
Sbjct: 245 LESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 76/257 (29%), Positives = 133/257 (51%), Gaps = 13/257 (5%)
Query: 15 TVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEI---NALKHISHQHICKL 71
+G G + V HV TG VA+KI+ T +D+ ++ E+ + L+ +I K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ +++++EY GG + +++ + EK R++L A+ Y+H +G HRD
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDV 191
+K N+L+ N+KL DFG+ A S+ T G+P + APEVI +YY ++ D+
Sbjct: 127 IKAANILVTNTGNVKLCDFGVAALLNQN-SSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185
Query: 192 WSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM-----SPNSRQIVRSMLQVE 246
WS+G+ +Y + G P+ +D +L K ++PP + S R+ V + L E
Sbjct: 186 WSLGITIYEMATGNPPY--SDVDAFRAMMLIPK-SKPPRLEDNGYSKLLREFVAACLDEE 242
Query: 247 PGKRIKIQDLLGHNWVK 263
P +R+ ++LL W+K
Sbjct: 243 PKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 75/257 (29%), Positives = 123/257 (47%), Gaps = 11/257 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+ + +G G + V A H TG+ VAIK++ + EDL + EI+ LK +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPY 59
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHLG 126
I K + ++ +++V+EYC G + D + + L E+E A Q L + YLH
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRD+K N+LL+ KL DFG+ + + + T G+P + APEVI+ + Y
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVIGTPFWMAPEVIQ-EIGYN 177
Query: 187 SETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG---KYTEPPWMSPNSRQIVRSM 242
++ D+WS+G+ + G P D + ++ I N ++P SP V+
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWSPEFNDFVKKC 236
Query: 243 LQVEPGKRIKIQDLLGH 259
L +P +R LL H
Sbjct: 237 LVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 79/264 (29%), Positives = 128/264 (48%), Gaps = 27/264 (10%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPR----VKLEINALKHISHQHICKL 71
+G G F +V L V TG ++A+K + + + ++ EI LK++ H+ I +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ + + + +EY PGG + D + L E +R + RQIL V YLH HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC----------GSPNYAAPEVIKG 181
+K N+L D N+KL DF G +LQT C G+P + +PEVI G
Sbjct: 130 IKGANILRDSAGNVKLGDF--------GASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKIL--NGKYTEPPWMSPNSRQI 238
+ YG + DVWS+G + +L P+ + +++ ++ KI P +SP++R
Sbjct: 182 EG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNF 239
Query: 239 VRSMLQVEPGKRIKIQDLLGHNWV 262
+R KR ++LL H +V
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 4e-34
Identities = 62/261 (23%), Positives = 117/261 (44%), Gaps = 20/261 (7%)
Query: 14 RTVGSGGFAKVKLAT---HVLTGEKVAIKIMKKATLGEDLPRVKL--EINALKHISHQHI 68
+ +G G F +V +VA+K +K+ E+ R E +K + H ++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF---------RQILSAV 119
+L V +++V+EY GG+LLD++ + + + ++ QI +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-YAAPEV 178
YL + HRDL N L+ + +K+ DFGL + +T P + APE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 179 IKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSR 236
+K + S++DVWS GV+L+ + G P+ S +++ + + G P +
Sbjct: 179 LKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237
Query: 237 QIVRSMLQVEPGKRIKIQDLL 257
+++ S Q++P R +L+
Sbjct: 238 ELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 83/268 (30%), Positives = 149/268 (55%), Gaps = 26/268 (9%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-----EINALKHISHQHI 68
+ +G G F +V + TG+ A+KI+ K E L R + E + L + + I
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNK---WEMLKRAETACFREERDVLVNGDRRWI 63
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGY 127
L + +++++V++Y GG+LL + + RL E +R + +++ A+ +H LGY
Sbjct: 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY 123
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSPNYAAPEVIK----G 181
HRD+KP+NVLLD+N +++L DFG C + +G ++S + + G+P+Y +PE+++ G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVGTPDYISPEILQAMEDG 181
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-----TEPPWMSPNSR 236
K YG E D WS+GV +Y +L G PF ++S+ + Y KI+N K + +S ++
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241
Query: 237 QIVRSMLQVEPGKRI---KIQDLLGHNW 261
++R ++ P R+ +QD H +
Sbjct: 242 DLIRRLI-CSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-33
Identities = 77/247 (31%), Positives = 120/247 (48%), Gaps = 17/247 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKA----------TLGEDLPRVKLEINALKHISH 65
+G G F +V T A+K++ K T+GE R L L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGE---RNILVRTLLD--ES 55
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
I L +T S +++V +Y GGEL H+ + R E ++ + +++ A+ +LH
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
+RDLKPEN+LLD ++ L DFGL +K T CG+ Y APEV+ ++ Y
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGL-SKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIVRSMLQ 244
D WS+GV+++ + CG+ PF ++ Q+Y I GK P +S RQ V+ +L
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN 234
Query: 245 VEPGKRI 251
P R+
Sbjct: 235 RNPQHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 74/254 (29%), Positives = 116/254 (45%), Gaps = 10/254 (3%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLG----EDLPRVKLEINALKHISHQHICKL 71
+GSG F V ++ G+ A+K + A G E + +++ EI L + H +I +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
++++ +E PGG L + + E R + RQIL + YLH HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC-GSPNYAAPEVIKGKQYYGSETD 190
+K N+L+D N +KL DFG+ + E S GSP + APEVI + YG D
Sbjct: 128 IKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSPYWMAPEVIAQQGGYGLAAD 184
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--PPWMSPNSRQIVRSMLQVEPG 248
+WS+G + + G P+ KI K P +S ++ + LQ +P
Sbjct: 185 IWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPS 244
Query: 249 KRIKIQDLLGHNWV 262
R +LL H +V
Sbjct: 245 LRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 77/271 (28%), Positives = 134/271 (49%), Gaps = 13/271 (4%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQ 73
+G G F KV T A+K ++KA + ++ E L ++ I L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
++ +++V+ + GGEL H+ R +R + ++L A+ LH +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
PEN+LLD ++ L DFGLC K + + T CG+P Y APE++ G Y + D W+
Sbjct: 121 PENILLDYQGHIALCDFGLC-KLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWWT 178
Query: 194 MGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKI 253
+GV+LY +L G PF ++++++Y KIL P +++ ++ +L +P +R+
Sbjct: 179 LGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238
Query: 254 ---QDLLGH------NWVKMGPEDNPVSFRP 275
Q++ H +W K+ + F+P
Sbjct: 239 NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 94/330 (28%), Positives = 139/330 (42%), Gaps = 68/330 (20%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDL---PRVKLEINALKHISHQ 66
Y L + +GSG + V A TG KVAIK + +DL R+ EI L+H+ H+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHE 59
Query: 67 HICKLFQVI-----ETSSHIFMVIEYCPGGELLDH-----IVERQRLGEKESRAFFRQIL 116
+I L ++ E + +++V E L++ I Q L + + F QIL
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQIL 113
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ-------TSCG 169
+ YLH HRDLKP N+L++ N +LK+ DFGL A+ E + T
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL-ARGVDPDEDEKGFLTEYVVTRW- 171
Query: 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN------ 222
Y APE++ Y D+WS+G + LL F D IDQL + I+
Sbjct: 172 ---YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-NLIVEVLGTPS 227
Query: 223 -------------------GKYTEPPW------MSPNSRQIVRSMLQVEPGKRIKIQDLL 257
K + P SP + ++ ML +P KRI + L
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287
Query: 258 GHNWVKM--GPEDNPVSFRPDHELREKDDD 285
H ++ PED PV+ P DD+
Sbjct: 288 AHPYLAQLHDPEDEPVAKPPFDFDFFDDDE 317
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 74/214 (34%), Positives = 108/214 (50%), Gaps = 6/214 (2%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
N+Y + VG G + V + TGE VAIK K++ ED+ + L E+ L+ + H+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHL 125
+I L + +++V EY LL+ + L R++ Q+L A+AY H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
HRD+KPEN+L+ + LKL DFG S L + Y APE++ G Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 186 GSETDVWSMGVMLYALLCG--FLPFDSDSIDQLY 217
G DVW++G ++ LL G P DSD IDQLY
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSD-IDQLY 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 78/260 (30%), Positives = 134/260 (51%), Gaps = 26/260 (10%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKAT--LGEDLPRVKLEINALKHISHQHICKL 71
+ + +G + V L H T ++ A+K + K L + +V +E + L + + +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 72 FQVIETSSHIFMVIEYCPGGE---LLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
F ET H+ MV+EY GG+ LL +I L +R +F + + A+ YLH+ G
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYGIV 123
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKP---------EGGLES-----QLQTSCGSPNYA 174
HRDLKP+N+L+ ++KL DFGL EG +E + CG+P Y
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI 183
Query: 175 APEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW---M 231
APEVI +Q YG D W+MG++LY L G +PF D+ ++L+ ++++ P +
Sbjct: 184 APEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEAL 242
Query: 232 SPNSRQIVRSMLQVEPGKRI 251
+++ ++ +L+ P +R+
Sbjct: 243 PADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 89/303 (29%), Positives = 139/303 (45%), Gaps = 41/303 (13%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHI 63
++ N+Y+ + VG G F V A LTG+ VAIK IMK + R E+ LKH+
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 64 SHQHICKLFQV-IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
H++I L + I I+ V E G L ++ + L ++ + F QIL + Y+
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H G HRDLKP N+L++ N +LK+ DFGL A+ + + Q+ + Y APE++
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGL-ARIQ---DPQMTGYVSTRYYRAPEIMLTW 180
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLY----------DKILNGKYTEP--- 228
Q Y E D+WS G + +L G F D ++Q D ++N +E
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240
Query: 229 -----------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM--GPEDN 269
P++ ++ ML +P KRI + L H ++ P D
Sbjct: 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300
Query: 270 PVS 272
PV+
Sbjct: 301 PVA 303
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 86/261 (32%), Positives = 132/261 (50%), Gaps = 24/261 (9%)
Query: 17 GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE 76
G G F KV A H TG A KI++ + E+L +EI+ L H +I L++
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 77 TSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPE 135
+ ++++IE+C GG L ++E +R L E + R RQ+L A+ +LH HRDLK
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 136 NVLLDRNQNLKLIDFGLCAKPEGGLESQLQ---TSCGSPNYAAPEVIKGKQY----YGSE 188
N+LL + ++KL DFG+ AK +S LQ T G+P + APEV+ + + Y +
Sbjct: 133 NILLTLDGDVKLADFGVSAK----NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK 188
Query: 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-------WMSPNSRQIVRS 241
D+WS+G+ L L P + ++ KIL EPP W S + ++S
Sbjct: 189 ADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS---EPPTLDQPSKW-SSSFNDFLKS 244
Query: 242 MLQVEPGKRIKIQDLLGHNWV 262
L +P R +LL H +V
Sbjct: 245 CLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 72/261 (27%), Positives = 122/261 (46%), Gaps = 15/261 (5%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--------LPRVKLEINALKHISHQH 67
+GSG F V L + +GE +A+K ++ ++ L + EI LK + H++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
I + + H+ + +EY PGG + + E R F RQIL + YLH+ G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPE-----GGLESQLQTSCGSPNYAAPEVIKGK 182
HRD+K N+L+D +K+ DFG+ K E + GS + APEV+K +
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK-Q 186
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 241
Y + D+WS+G ++ +L G PF D + ++ N P +S + +
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEK 246
Query: 242 MLQVEPGKRIKIQDLLGHNWV 262
+++ KR +LL H ++
Sbjct: 247 TFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 70/249 (28%), Positives = 131/249 (52%), Gaps = 37/249 (14%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+ +G G F +V+L TG A+KI++KA + E + ++ E + L + K+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
F + ++++++E+ PGG+++ ++++ L E+ ++ + + + A+ +H LG+ HRD
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCA-------------------------------KPEGGL 160
+KP+N+LLD ++KL DFGLC K E
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186
Query: 161 ESQLQ---TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 217
+++ Q ++ G+P+Y APEV + Y D WS+GV++Y +L G+ PF S++ + Y
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 218 DKILNGKYT 226
K++N K T
Sbjct: 246 RKVMNWKET 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 23/265 (8%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQ 73
+G+G V H TG+ +A+K ++ ++ E++ L + +I +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHH-LGYAHR 130
+ I + +EY GG L D I++ R+ E+ +L + YLH HR
Sbjct: 67 AFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
D+KP N+L++ +KL DFG+ G L S +T G+ +Y APE I+G Y ++
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGV----SGQLVNSLAKTFVGTSSYMAPERIQGND-YSVKS 180
Query: 190 DVWSMGVMLYALLCGFLPF-----DSDSIDQLYDKILNGKYTEPPWM-----SPNSRQIV 239
D+WS+G+ L L G P+ D I +L I+N PP + SP+ + V
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PPPRLPSGKFSPDFQDFV 237
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKM 264
L +P +R ++LL H ++K
Sbjct: 238 NLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 71/249 (28%), Positives = 131/249 (52%), Gaps = 37/249 (14%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+ +G G F +V+L TG A+KI++KA + E + ++ E + L + K+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
F + ++++++E+ PGG+++ ++++ L E+E++ + + + A+ +H LG+ HRD
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCA-------------------------------KPEGGL 160
+KP+N+LLD ++KL DFGLC K E
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 161 ESQLQ---TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 217
++ Q ++ G+P+Y APEV + Y D WS+GV++Y +L G+ PF S++ + Y
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 218 DKILNGKYT 226
K++N K T
Sbjct: 246 KKVMNWKET 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 75/253 (29%), Positives = 132/253 (52%), Gaps = 11/253 (4%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIM--KKATLGEDLPRVKLEINALKHISHQHICKLFQ 73
+G G V +AT TG +VA+K M +K E L E+ ++ H +I +++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQHPNIVEMYS 83
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
+++V+E+ GG L D IV R+ E++ +L A+++LH G HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
+++LL + +KL DFG CA+ + + ++ G+P + APEVI + YG+E D+WS
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVI-SRLPYGTEVDIWS 200
Query: 194 MGVMLYALLCGFLPFDSDSIDQLYDKILNG---KYTEPPWMSPNSRQIVRSMLQVEPGKR 250
+G+M+ ++ G P+ ++ Q +I + K +SP R + ML +P +R
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR 260
Query: 251 IKIQDLLGHNWVK 263
+LL H ++
Sbjct: 261 ATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 74/219 (33%), Positives = 120/219 (54%), Gaps = 13/219 (5%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-----EINALKHISHQHI 68
+ +G G F +V + T A+KI+ K E L R + E N L + Q I
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNK---WEMLKRAETACFREERNVLVNGDCQWI 63
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGY 127
L + +++++V++Y GG+LL + + RL E +R + +++ A+ +H L Y
Sbjct: 64 TTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY 123
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK----GKQ 183
HRD+KP+NVLLD N +++L DFG C K Q + G+P+Y +PE+++ G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN 222
YG E D WS+GV +Y +L G PF ++S+ + Y KI+N
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEIN---ALK 61
D + +Y +G G V A V TG++VAIK + + P+ +L IN +K
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL----QKQPKKELIINEILVMK 71
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAY 121
+ + +I +F+V+EY GG L D +V + E + A R+ L A+ +
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSPNYAAPEVI 179
LH HRD+K +NVLL + ++KL DFG CA+ PE +S+ T G+P + APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVV 187
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG--KYTEPPWMSPNSR 236
++ YG + D+WS+G+M ++ G P+ + + + LY NG + P +SP R
Sbjct: 188 T-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265
+ L+++ KR ++LL H ++K+
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 83/285 (29%), Positives = 135/285 (47%), Gaps = 32/285 (11%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHICKL 71
+G GGF +V TG+ A K + K L GE + + +I L+ +S + I L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYLHHLGYAH 129
ET + +V+ GG+L HI G E+RA F QI+ + +LH +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RDLKPENVLLD + N+++ D GL + +GG +++ G+P Y APEV++G+ Y
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQGEV-YDFSV 175
Query: 190 DVWSMGVMLYALLCGFLPF-------DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
D +++G LY ++ G PF + + + + L P SP ++ + ++
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TLEMAVEYPDKFSPEAKDLCEAL 232
Query: 243 LQVEPGKRI-----KIQDLLGH------NWVKMGPEDNPVSFRPD 276
LQ +P KR+ ++ H NW ++ F PD
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 28/270 (10%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQH 67
+Y + R +GSG V A V GE A+K++ + E D R + E+ L +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN----- 87
Query: 68 ICKLFQVI--------------ETSSHIFMVIEYCPGGELLDHIVERQRLG----EKESR 109
C F ++ E I +V++Y G+L I R + E E+
Sbjct: 88 -CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 110 AFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL-QTSC 168
F Q+L AV ++H HRD+K N+LL N +KL DFG + + +T C
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE- 227
G+P Y APE+ + K Y + D++S+GV+LY LL PFD ++++++ K L G+Y
Sbjct: 207 GTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265
Query: 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257
PP +SP ++IV ++L +P +R LL
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 26/204 (12%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH-ICK 70
L +G G + KV A H TG+ VAIKIM + ++ +K E N L+ S+ I
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEIKEEYNILRKYSNHPNIAT 67
Query: 71 LFQVIETSSH------IFMVIEYCPGGELLDHIVER-----QRLGEKESRAFFRQILSAV 119
+ + +++V+E C GG + D +V+ +RL E+ R+ L +
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL---QTSCGSPNYAAP 176
AYLH HRD+K +N+LL +N +KL+DFG+ A+ L+S L T G+P + AP
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ----LDSTLGRRNTFIGTPYWMAP 182
Query: 177 EVIKGKQ----YYGSETDVWSMGV 196
EVI + Y + +DVWS+G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 73/259 (28%), Positives = 124/259 (47%), Gaps = 17/259 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMK-----KATLGEDLPRVKLEINALKHISHQHICK 70
+G+G F+ A V TG +A+K + + E + ++ EI + ++H HI +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
+ SH + +E+ GG + + + E + Q+L ++YLH HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 131 DLKPENVLLDRN-QNLKLIDFG----LCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
D+K N+L+D Q L++ DFG L AK G E Q Q G+ + APEV++G+Q Y
Sbjct: 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL-LGTIAFMAPEVLRGEQ-Y 185
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSID---QLYDKI--LNGKYTEPPWMSPNSRQIVR 240
G DVWS+G ++ + P++++ L KI + P +SP R +
Sbjct: 186 GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTL 245
Query: 241 SMLQVEPGKRIKIQDLLGH 259
L+++P R ++LL H
Sbjct: 246 RCLELQPEDRPPSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 23/267 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+ L +G G F +V A T + VAIK++ +++ ++ EI L +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
I K + S +++++EYC GG LD +++ +L E R++L + YLH G
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL---QTSCGSPNYAAPEVIKGKQY 184
HRD+K N+LL ++KL DFG+ G L S + T G+P + APEVIK +
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGV----SGQLTSTMSKRNTFVGTPFWMAPEVIK-QSG 174
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD--KIL------NGKYTEPPWMSPNSR 236
Y + D+WS+G+ L G P SD ++L N E S +
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPL-SD-----LHPMRVLFLIPKNNPPSLEGNKFSKPFK 228
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVK 263
V L +P +R ++LL H ++K
Sbjct: 229 DFVSLCLNKDPKERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 75/245 (30%), Positives = 135/245 (55%), Gaps = 18/245 (7%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-----EINALKHISHQHI 68
+ +G G F +V + + A+KI+ K E L R + E + L + +Q I
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNK---WEMLKRAETACFREERDVLVNGDNQWI 63
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGY 127
L + +++++V++Y GG+LL + + RL E +R + +++ A+ +H L Y
Sbjct: 64 TTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY 123
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK----GKQ 183
HRD+KP+N+L+D N +++L DFG C K Q + G+P+Y +PE+++ GK
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEPPW---MSPNSRQI 238
YG E D WS+GV +Y +L G PF ++S+ + Y KI+N K + P +S +++ +
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDL 243
Query: 239 VRSML 243
+R ++
Sbjct: 244 IRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 79/253 (31%), Positives = 135/253 (53%), Gaps = 19/253 (7%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIM--KKATLGEDLPRVKLEINALKHISHQHICKLFQ 73
+G G V +A +G +VA+K+M +K E L E+ ++ HQ++ ++++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
+++++E+ GG L D IV + RL E++ +L A+ YLH G HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
+++LL + +KL DFG CA+ + + ++ G+P + APEVI + YG+E D+WS
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVI-SRTPYGTEVDIWS 202
Query: 194 MGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-------WMSPNSRQIVRSMLQVE 246
+G+M+ ++ G P+ SDS Q ++ + PP +SP R + ML E
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRD----SPPPKLKNAHKISPVLRDFLERMLTRE 258
Query: 247 PGKRIKIQDLLGH 259
P +R Q+LL H
Sbjct: 259 PQERATAQELLDH 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 72/267 (26%), Positives = 121/267 (45%), Gaps = 18/267 (6%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+ Y L +G G A V A + EKVAIK + + ++ E+ A+ +H +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLD---HIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ K + +++V+ Y GG LLD R L E +++L + YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ---LQTSCGSPNYAAPEVIKG 181
G HRD+K N+LL + ++K+ DFG+ A G + +T G+P + APEV++
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS------ 235
Y + D+WS G+ L G P+ ++ L +PP + +
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKKYS 237
Query: 236 ---RQIVRSMLQVEPGKRIKIQDLLGH 259
R+++ LQ +P KR ++LL H
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLKH 264
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 84/292 (28%), Positives = 148/292 (50%), Gaps = 23/292 (7%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTG-EKVAIKIMKKATL--GEDLPRVKLEI 57
MKY D +I RT+G+G F +V LAT+ VAIK +K+ + + + V E
Sbjct: 27 MKYEDF--NFI--RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 58 NALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
L +I+H L+ + S++++V+E+ GGE + +R + QI+
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
YL L +RDLKPEN+LLD++ +K+ DFG ++++ T CG+P Y APE
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTRTYTLCGTPEYIAPE 198
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQ 237
++ +G D W++G+ +Y +L G PF ++ +Y KIL G P ++ N +
Sbjct: 199 ILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257
Query: 238 IVRSMLQVEPGKRI-----KIQDLLGH------NWVKMGPEDNPVSFRPDHE 278
+++ +L + KR Q++ H +WV + ++ V ++P ++
Sbjct: 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309
|
Length = 340 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 72/282 (25%), Positives = 135/282 (47%), Gaps = 53/282 (18%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+ +G G F +V+L TG+ A+K + K+ + + L VK E + L + L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ + + ++++++E+ PGG+L+ +++ E +R + + + A+ +H LG+ HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCA------------KPEGGLES----------------- 162
+KP+N+L+DR ++KL DFGL K G +
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 163 ------QLQT-----------SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGF 205
Q+ T + G+P+Y APE+ Q YG E D WS+G +++ L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGW 245
Query: 206 LPFDSDSIDQLYDKILNGKYT----EPPWMSPNSRQIVRSML 243
PF S++ + Y KI+N + T + +S + ++R ++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 77/255 (30%), Positives = 129/255 (50%), Gaps = 9/255 (3%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQH 67
+Y + + +G G F K+ LA E IK I ++ K E+ L + H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR---LGEKESRAFFRQILSAVAYLHH 124
I F + + +F+V+EYC GG+L+ I RQR E + ++F QI + ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 125 LGYAHRDLKPENVLLDRNQNL-KLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRD+K +N+ L +N + KL DFG+ + +E T G+P Y +PE+ + +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA-YTCVGTPYYLSPEICQNRP 178
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSM 242
Y ++TD+WS+G +LY L PF+ +++ QL KI G + P S + R ++ +
Sbjct: 179 Y-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQL 237
Query: 243 LQVEPGKRIKIQDLL 257
+V P R I +L
Sbjct: 238 FKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 69/256 (26%), Positives = 116/256 (45%), Gaps = 14/256 (5%)
Query: 10 YILERTVGSGGFAKV-----KLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+ + +G G F V K V +++ + M + E + E L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLD 57
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLD--HIVERQRLGEKESRAFFRQILSAVAYL 122
+I + ++ + +V+EY G+L + + L E + FF QIL +A+L
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H HRD+K N+ LD N+K+ D G+ AK + T G+P Y +PE+ + K
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGV-AKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM-SPNSRQIVRS 241
Y ++DVW++GV+LY G PFD+++ L KI+ G + M S Q++
Sbjct: 177 P-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235
Query: 242 MLQVEPGKRIKIQDLL 257
L + +R LL
Sbjct: 236 CLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 39/284 (13%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICK 70
+E+ +G G + V A LTGE VA+K ++ T E +P + EI+ LK ++H +I +
Sbjct: 4 VEK-IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 71 LFQVIETSSHIFMVIEYCPGG--ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
L V+ + + +++V E+ + +D L +++ Q+L +AY H
Sbjct: 63 LLDVVHSENKLYLVFEFLDLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSE 188
HRDLKP+N+L+DR LKL DFGL A+ G + Y APE++ G + Y +
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGL-ARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTP 180
Query: 189 TDVWSMGVMLYALLCGFLP-FDSDS-IDQLYDKIL------------------NGKYTEP 228
D+WS+G ++A + P F DS IDQL+ +I + K T P
Sbjct: 181 VDIWSIGC-IFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSLPDYKPTFP 238
Query: 229 PWMSPNSRQIV-----------RSMLQVEPGKRIKIQDLLGHNW 261
W + ++V ML +P KRI + L H +
Sbjct: 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 45/253 (17%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKAT--LGEDLPRVKLEINALKHISHQHICKL 71
+T+G G F +V L V T A+K ++KA + VK E + L ++ + KL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ + +++ V++Y PGG+++ ++ E +R + ++ A+ +H +G+ HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCA------------------------------------K 155
+KP+N+L+DR+ ++KL DFGLC K
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 156 PEGGLESQLQTSC------GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD 209
P + C G+PNY APEV+ Y D WS+GV+LY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFL 245
Query: 210 SDSIDQLYDKILN 222
+D+ + K++N
Sbjct: 246 ADTPAETQLKVIN 258
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 17/261 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMK--KATLGEDLPRVK-------LEINALKHISHQ 66
+G G + +V LA +V TGE +A+K ++ G R K EI LK + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
+I + T ++ + +EY PGG + + R E+ R F Q+L +AYLH G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC-GSPNYAAPEVIKGKQY- 184
HRDLK +N+L+D + K+ DFG+ K + ++ S GS + APEVI
Sbjct: 129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP------PWMSPNSRQI 238
Y ++ D+WS+G ++ + G P+ + K+ N + P +SP +
Sbjct: 189 YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDF 248
Query: 239 VRSMLQVEPGKRIKIQDLLGH 259
+ + + P R ++LL H
Sbjct: 249 LNACFTINPDNRPTARELLQH 269
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 79/257 (30%), Positives = 139/257 (54%), Gaps = 12/257 (4%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL--EINALKHISHQHICKLFQ 73
+G G V +AT TG++VA+K K L + R L E+ ++ H+++ ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
+++V+E+ GG L D IV R+ E++ +L A++YLH+ G HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
+++LL + +KL DFG CA+ + + ++ G+P + APEVI + YG+E D+WS
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKR-KSLVGTPYWMAPEVIS-RLPYGTEVDIWS 203
Query: 194 MGVMLYALLCGFLPFDSDSIDQLYDKI---LNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
+G+M+ ++ G P+ ++ Q +I L + + +S R + ML EP +R
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR 263
Query: 251 IKIQDLLGHNWVKM-GP 266
Q+LL H ++K+ GP
Sbjct: 264 ATAQELLQHPFLKLAGP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 83/261 (31%), Positives = 132/261 (50%), Gaps = 17/261 (6%)
Query: 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70
+++R +GSG + V A + TGE VAIK++K G+D ++ EI+ LK H +I
Sbjct: 7 LIQR-IGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 71 LFQVIETSSHIFMVIEYCPGGELLD-HIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
F +++V+EYC GG L D + V R L E + R+ L +AYLH G H
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIH 124
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI--KGKQYYGS 187
RD+K N+LL + ++KL DFG+ A+ + ++ ++ G+P + APEV + K Y
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDG 183
Query: 188 ETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPP-------WMSPNSRQIV 239
+ D+W++G+ L P FD + L+ +++ PP W SP +
Sbjct: 184 KCDIWALGITAIELAELQPPMFDLHPMRALF--LISKSNFPPPKLKDKEKW-SPVFHDFI 240
Query: 240 RSMLQVEPGKRIKIQDLLGHN 260
+ L +P KR LL H
Sbjct: 241 KKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 75/248 (30%), Positives = 122/248 (49%), Gaps = 11/248 (4%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
QY + R VG G F + L HV + +K A+K ++ + + E L + H +I
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRL-GEKESRAFFRQILSAVAYLHHLG 126
+ E H+++V+EYC GG+L+ I ++R +L E +F Q+ V ++H
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFG---LCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRD+K +N+ L +N +KL DFG L P + T G+P Y PE+ +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----GAYACTYVGTPYYVPPEIWENMP 176
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSM 242
Y +++D+WS+G +LY L PF ++S L K+ G Y P S R +++ M
Sbjct: 177 -YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 243 LQVEPGKR 250
+ P R
Sbjct: 236 FKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHICKL 71
+G GGF +V TG+ A K + K L G + V+ I L + + I L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI--LAKVHSRFIVSL 58
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHI--VERQRLGEKESRAFF--RQILSAVAYLHHLGY 127
+T + + +V+ GG+L HI V+ + G E RA F QI+S + +LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGS 187
+RDLKPENVLLD + N+++ D GL + + G +S+ + G+P + APE+++G++Y S
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QSKTKGYAGTPGFMAPELLQGEEYDFS 177
Query: 188 ETDVWSMGVMLYALLCGFLPF----DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243
D +++GV LY ++ PF + +L +ILN T P SP S+ ++L
Sbjct: 178 -VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236
Query: 244 QVEPGKRIKIQD-----LLGH------NWVKMGPEDNPVSFRPD 276
+P KR+ +D L H NW ++ P F PD
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 91/345 (26%), Positives = 149/345 (43%), Gaps = 67/345 (19%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHI 63
++ ++Y VGSG + +V A TG KVAIK + + R E+ LKH+
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 64 SHQHICKLFQVIETSSHI------FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
H+++ L V +S + ++V G L++IV+ Q+L + + QIL
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+ Y+H G HRDLKP N+ ++ + LK++DFGL A+ + ++ + Y APE
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL-ARH---TDDEMTGYVATRWYRAPE 185
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILN--GKYTEP------ 228
++ +Y D+WS+G ++ LL G F SD IDQL +I+N G E
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL-KRIMNLVGTPDEELLQKIS 244
Query: 229 -----------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK-- 263
+P + ++ ML ++P KRI + L H ++
Sbjct: 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304
Query: 264 MGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEW 308
PED PV+ D S + ++EW
Sbjct: 305 HDPEDEPVA--------PPYDQ-----------SFESRDLTVDEW 330
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 52/285 (18%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLFQV 74
+G G + V A + LTGE VA+K ++ T E +P + EI+ LK ++H +I KL V
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 75 IETSSHIFMVIEY-----------CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
I T + +++V E+ P + ++ +++ Q+L +A+ H
Sbjct: 68 IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLI----------KSYLFQLLQGLAFCH 117
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRDLKP+N+L++ +KL DFGL A+ G + Y APE++ G +
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGL-ARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLY----------DKILNG-------KY 225
YY + D+WS+G + ++ F DS IDQL+ + + G K
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236
Query: 226 TEPPW-----------MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
+ P W + + R ++ ML +P KRI + L H
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 79/269 (29%), Positives = 138/269 (51%), Gaps = 17/269 (6%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEIN---ALK 61
D + +Y +G G V A + TG++VAIK M + P+ +L IN ++
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL----QQQPKKELIINEILVMR 71
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAY 121
+ +I +++V+EY GG L D +V + E + A R+ L A+ +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSPNYAAPEVI 179
LH HRD+K +N+LL + ++KL DFG CA+ PE +S+ T G+P + APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVV 187
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG--KYTEPPWMSPNSR 236
++ YG + D+WS+G+M ++ G P+ + + + LY NG + P +S R
Sbjct: 188 T-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR 246
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265
+ L+++ +R ++LL H ++K+
Sbjct: 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 79/269 (29%), Positives = 135/269 (50%), Gaps = 17/269 (6%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEIN---ALK 61
D + +Y +G G V A V TG++VAI+ M + P+ +L IN ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMR 72
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAY 121
+ +I +++V+EY GG L D +V + E + A R+ L A+ +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSPNYAAPEVI 179
LH HRD+K +N+LL + ++KL DFG CA+ PE S + G+P + APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVV 188
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG--KYTEPPWMSPNSR 236
++ YG + D+WS+G+M ++ G P+ + + + LY NG + P +S R
Sbjct: 189 T-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265
+ L ++ KR ++LL H ++K+
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 22/261 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL--EINALKHISH 65
+ +E+ +G G F+ V A +L G VA+K ++ + + R EI+ LK + H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGEL---LDHIVERQRL-GEKESRAFFRQILSAVAY 121
++ K ++ + +V+E G+L + H +++RL E+ +F Q+ SA+ +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC----GSPNYAAPE 177
+H HRD+KP NV + +KL D GL G S T+ G+P Y +PE
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD---KILNGKYTEPP--WMS 232
I Y ++D+WS+G +LY + PF D ++ LY KI Y P S
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKCDYPPLPADHYS 234
Query: 233 PNSRQIVRSMLQVEPGKRIKI 253
R +V + +P KR I
Sbjct: 235 EELRDLVSRCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 85/275 (30%), Positives = 134/275 (48%), Gaps = 21/275 (7%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
+G G F KV A + TG A K+++ + E+L +EI L +H +I KL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 76 ETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHLGYAHRDLKP 134
++++IE+CPGG + ++E R L E + + RQ+L A+ YLH + HRDLK
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 135 ENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY----YGSETD 190
NVLL + ++KL DFG+ AK L+ + + G+P + APEV+ + Y + D
Sbjct: 139 GNVLLTLDGDIKLADFGVSAKNVKTLQRR-DSFIGTPYWMAPEVVMCETMKDTPYDYKAD 197
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM------SPNSRQIVRSMLQ 244
+WS+G+ L + P + ++ KI +EPP + S R +++ L
Sbjct: 198 IWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLSQPSKWSMEFRDFLKTALD 254
Query: 245 VEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHEL 279
P R LL H +V + S RP EL
Sbjct: 255 KHPETRPSAAQLLEHPFVS-----SVTSNRPLREL 284
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 83/276 (30%), Positives = 130/276 (47%), Gaps = 42/276 (15%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL-------KHIS 64
L + +G G F +V L TG ++A+K + + P E+NAL K++
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVK---QVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 65 HQHICKLFQVI----ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
H+ I + + + E + IFM E+ PGG + D + L E +R + RQIL V+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFM--EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC----------GS 170
YLH HRD+K N+L D N+KL DF G +LQT C G+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDF--------GASKRLQTICLSGTGMKSVTGT 172
Query: 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS----DSIDQLYDKILNGKYT 226
P + +PEVI G+ YG + D+WS+G + +L P+ +I ++ + N
Sbjct: 173 PYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL- 230
Query: 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262
PP +S + R ++ + VE R +LL H +V
Sbjct: 231 -PPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 83/295 (28%), Positives = 123/295 (41%), Gaps = 70/295 (23%)
Query: 19 GGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLFQVI-- 75
G + V A TGE VA+K +K E P L EIN L + H +I + +V+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 76 ETSSHIFMVIEYCPGGE-----LLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
I+MV+EY E L++ + +Q + E + Q+LS VA+LH HR
Sbjct: 76 SNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----------YAAPEVI 179
DLK N+LL+ LK+ DFGL + GSP Y APE++
Sbjct: 131 DLKTSNLLLNNRGILKICDFGLARE------------YGSPLKPYTQLVVTLWYRAPELL 178
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILN---------------- 222
G + Y + D+WS+G + LL F S IDQL +KI
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPTEKIWPGFSEL 237
Query: 223 -----GKYTEPPWMSPNSR-----------QIVRSMLQVEPGKRIKIQDLLGHNW 261
+T+ P+ + ++ +L +P KRI +D L H +
Sbjct: 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 84/264 (31%), Positives = 121/264 (45%), Gaps = 29/264 (10%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIM----KKATLGEDLPRVKLEINALKHISHQHIC 69
R +G G F V A V T E VAIK M K++ E + E+ L+ + H +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQQLRHPNTI 78
Query: 70 KLFQVIETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
+ ++V+EYC G ++L+ V ++ L E E A L +AYLH
Sbjct: 79 EYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK---QY 184
HRD+K N+LL +KL DFG + L S + G+P + APEVI QY
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSAS-----LVSPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 185 YGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPPWMSPNS-----RQI 238
G + DVWS+G+ L P F+ +++ LY N + P +S N R
Sbjct: 192 DG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLSSNDWSDYFRNF 246
Query: 239 VRSMLQVEPGKRIKIQDLLGHNWV 262
V S LQ P R ++LL H +V
Sbjct: 247 VDSCLQKIPQDRPSSEELLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 89/324 (27%), Positives = 141/324 (43%), Gaps = 49/324 (15%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIM---KKATLGEDLPRVKLEINALK 61
D+ +Y +G G + V ATH TG KVAIK + + T + R EI L+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ---RTLREIKILR 58
Query: 62 HISHQHICKLFQVI-----ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQIL 116
H++I + +I E+ + +++V E L +++ Q L + F QIL
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHLSNDHIQYFLYQIL 116
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC--AKPEGGLESQLQTSCGSPNYA 174
+ Y+H HRDLKP N+LL+ N +LK+ DFGL A PE L + Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 175 APEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQL--------------YDK 219
APE++ + Y D+WS+G +L +L F D + QL +
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 220 ILNGK----------YTEPPW------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
I++ + + PW P + ++ ML P KRI +++ L H +++
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296
Query: 264 M--GPEDNPVSFRP-DHELREKDD 284
P D PV+ P + DD
Sbjct: 297 QYHDPSDEPVAEEPFPFDFELFDD 320
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 79/273 (28%), Positives = 135/273 (49%), Gaps = 36/273 (13%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMK----KATLGEDLPRVKLEINALKHISHQHIC 69
+ +G G F +V L V TG ++A K ++ +++ ++ EI LK++ H+ I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 70 KLFQVI----ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+ + + E + IFM EY PGG + D + L E +R + RQIL ++YLH
Sbjct: 68 QYYGCLRDRAEKTLTIFM--EYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC----------GSPNYAA 175
HRD+K N+L D N+KL DF G +LQT C G+P + +
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDF--------GASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPPW---M 231
PEVI G+ YG + DVWS+G + +L P+ + +++ ++ + + T P +
Sbjct: 178 PEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--IATQPTNPQLPSHI 234
Query: 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
S ++R + + VE R ++LL H + ++
Sbjct: 235 SEHARDFLGCIF-VEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-26
Identities = 80/262 (30%), Positives = 128/262 (48%), Gaps = 13/262 (4%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
++ Y L + VGSG + V A ++ TGE A+KI+K G+D ++ EI +K H
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHC 66
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
+I F + +++ +EYC GG L D L E + R+ L +AYLH G
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEV--IKGKQY 184
HRD+K N+LL N ++KL DFG+ AK + ++ ++ G+P + APEV ++
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 185 YGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPPWM------SPNSRQ 237
Y D+W++G+ L P FD + L+ +++ +PP + S
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSKSNFQPPKLKDKTKWSSTFHN 243
Query: 238 IVRSMLQVEPGKRIKIQDLLGH 259
V+ L P KR + LL H
Sbjct: 244 FVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 83/289 (28%), Positives = 123/289 (42%), Gaps = 59/289 (20%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVK----LEINALKHISHQHICKL 71
VG G + V H TG+ VAIK + ED VK EI LK + H+++ L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLE---SEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIV--ERQR----LGEKESRAFFRQILSAVAYLHHL 125
+V +++V E+ +DH V + ++ L E R + QIL + + H
Sbjct: 66 IEVFRRKKRLYLVFEF------VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLC---AKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
HRD+KPEN+L+ ++ +KL DFG A P + T Y APE++ G
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW----YRAPELLVGD 175
Query: 183 QYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKIL------------------- 221
YG D+W++G ++ +L G P DSD IDQLY I
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 222 ------NGKYTEP-----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
K EP P +S + + L+++P R LL H
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 74/258 (28%), Positives = 120/258 (46%), Gaps = 12/258 (4%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP----RVKLEINALKHIS 64
+YIL++ +G G F V L + +K++K+ +GE P + E L +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESR----AFFRQILSAVA 120
H I K ++ EYC G +L + E + G+ S +F Q+L V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
Y+H HRDLK +N+ L +N LK+ DFG+ G + T G+P Y +PE +K
Sbjct: 121 YMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA-TTFTGTPYYMSPEALK 178
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIV 239
Q Y S++D+WS+G +LY + C F+ + + +I+ G P I+
Sbjct: 179 -HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237
Query: 240 RSMLQVEPGKRIKIQDLL 257
+SML +P R ++L
Sbjct: 238 QSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 91/364 (25%), Positives = 162/364 (44%), Gaps = 71/364 (19%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKK--ATLGEDLPRVKLEINALKHISHQHICKL 71
+T+G G F +V LA V T A+K ++K L + VK E + L ++ + +L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ + +++ V++Y PGG+++ ++ E +R + ++ AV +H +G+ HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCA------------------------------------- 154
+KP+N+L+DR+ ++KL DFGLC
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 155 ---KPEGGLESQLQTSC------GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGF 205
KP ++ C G+PNY APEV+ + Y D WS+GV+LY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQ 245
Query: 206 LPFDSDSIDQLYDKILNGKYTE--PPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261
PF + + + K++N + + PP +SP + ++ + + +D LG N
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGP-------EDRLGKNG 298
Query: 262 ---VKMGPEDNPVSFRPDHELREKDDDVIKVM------ADHKQLSPDDMWSQLNEWTYNY 312
+K P + F D LR++ I + ++ + PD +WS ++
Sbjct: 299 ADEIKAHPFFKTIDFSSD--LRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVN 356
Query: 313 DTCT 316
DT
Sbjct: 357 DTLN 360
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 37/283 (13%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICK 70
LE+ +G G +A V + TGE VA+K + E P + EI+ +K + H++I +
Sbjct: 5 LEK-LGEGTYATVYKGRNRTTGEIVALKEIHLDA-EEGTPSTAIREISLMKELKHENIVR 62
Query: 71 LFQVIETSSHIFMVIEYCPGG--ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
L VI T + + +V EY + +D R L ++F Q+L +A+ H
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSE 188
HRDLKP+N+L+++ LKL DFGL A+ G + + Y AP+V+ G + Y +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGL-ARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 189 TDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILN--GKYTEPPWMS------------- 232
D+WS+G ++ ++ G F +++ DQL KI G TE W
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPGTNNEDQLL-KIFRIMGTPTESTWPGISQLPEYKPTFPR 240
Query: 233 --------------PNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261
P ++ +LQ+ P RI D L H W
Sbjct: 241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 74/198 (37%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 14 RTVGSGGFAKVKL----ATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
R +G G F KV L + TGE VA+K +K+ ++ K EIN LK + H++I
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 70 KLFQVIETSSH--IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
K + +++EY P G L D++ + +L + F +QI +AYLH Y
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQHY 128
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLC-AKPEGGLESQLQTSCGSPNY-AAPEVIK-GKQY 184
HRDL NVLLD ++ +K+ DFGL A PEG +++ SP + A E +K K
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS 188
Query: 185 YGSETDVWSMGVMLYALL 202
Y S DVWS GV LY LL
Sbjct: 189 YAS--DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 33/268 (12%)
Query: 18 SGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQ--VI 75
G K +L TG A+K + + ++ E+ K +I K + +
Sbjct: 14 GGSVTKCRLKN---TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD 70
Query: 76 ETSSHIFMVIEYCPGGELLDHIVER-----QRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
E+SS I + +EYC GG L D I ++ R+GEK +L ++YLH HR
Sbjct: 71 ESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR 129
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
D+KP N+LL R +KL DFG+ + + S T G+ Y APE I+GK Y + +D
Sbjct: 130 DIKPSNILLTRKGQVKLCDFGVSGE---LVNSLAGTFTGTSFYMAPERIQGKPYSIT-SD 185
Query: 191 VWSMGVMLYALLCGFLPFDSDSID-----QLYDKILNGKYTEPPWM----------SPNS 235
VWS+G+ L + PF + +L I+N P + S
Sbjct: 186 VWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNPELKDEPGNGIKWSEEF 242
Query: 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+ ++ L+ +P +R D+L H W+K
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 70/262 (26%), Positives = 132/262 (50%), Gaps = 14/262 (5%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIK---IMKKATLGEDLPRVKLEINALKHISH 65
+Y+ + +G G F K L G++ IK I K + + R E+ L ++ H
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR--KEVAVLSNMKH 58
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR---LGEKESRAFFRQILSAVAYL 122
+I + + E + ++++V++YC GG+L I QR E + +F QI A+ ++
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHV 117
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC-GSPNYAAPEVIKG 181
H HRD+K +N+ L ++ +KL DFG+ +E L +C G+P Y +PE+ +
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICEN 175
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVR 240
+ Y +++D+W++G +LY + F++ ++ L KI+ G Y S + R +V
Sbjct: 176 RP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 241 SMLQVEPGKRIKIQDLLGHNWV 262
+ + P R + +L N++
Sbjct: 235 QLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 79/257 (30%), Positives = 124/257 (48%), Gaps = 13/257 (5%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
L + +GSG + V A +V TGE AIK++K GED V+ EI +K H +I
Sbjct: 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
F +++ +E+C GG L D L E + R+ L + YLH G HRD
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEV--IKGKQYYGSET 189
+K N+LL N ++KL DFG+ A+ + ++ ++ G+P + APEV ++ K Y
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 190 DVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPPWM------SPNSRQIVRSM 242
D+W++G+ L P FD + L+ ++ +PP + S + V+
Sbjct: 191 DIWAVGITAIELAELQPPMFDLHPMRALF--LMTKSNFQPPKLKDKMKWSNSFHHFVKMA 248
Query: 243 LQVEPGKRIKIQDLLGH 259
L P KR + LL H
Sbjct: 249 LTKNPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 82/323 (25%), Positives = 135/323 (41%), Gaps = 61/323 (18%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-------------EINALKH 62
+G G + KV+ A LTG+ VAIK +K + D+ + + E+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAY 121
I H++I L V I +V++ L +V+R+ RL E + + QIL+ +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK----PEGGLESQLQTSCGSPN----- 172
LH + HRDL P N+ ++ K+ DFGL + P S+ +T
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194
Query: 173 ----YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GK 224
Y APE++ G + Y D+WS+G + LL G P + + IDQL +I G
Sbjct: 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE-NEIDQL-GRIFELLGT 252
Query: 225 YTEPPW--------------MSPNSRQ------------IVRSMLQVEPGKRIKIQDLLG 258
E W P + +++S+L++ P +RI ++ L
Sbjct: 253 PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312
Query: 259 HNWVKMGPEDNPVSFRPDHELRE 281
H + K P S P + L +
Sbjct: 313 HEYFKSDPLPCDPSQLPFNFLTK 335
|
Length = 335 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 82/290 (28%), Positives = 133/290 (45%), Gaps = 37/290 (12%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
+QY +G G + V A +T E +A+K ++ E +P + EI+ LK + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKES--RAFFRQILSAVAYLHH 124
+I +L V+ + +++V EY +L H+ + + + QIL +AY H
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 125 LGYAHRDLKPENVLLDRNQN-LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRDLKP+N+L+DR N LKL DFGL A+ G + Y APE++ G +
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGL-ARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKIL------------------NGK 224
+Y + D+WS+G + ++ F DS ID+L+ KI + K
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEETWPGVTSLPDYK 238
Query: 225 YTEPPW-----------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
P W + P ++ ML+++P KRI + L H + K
Sbjct: 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 14 RTVGSGGFAKVKLATHVL----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
+ +G G F KV+L + TGE+VA+K + + + + EI L+ + H++I
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 70 KLFQVIETSSH--IFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLG 126
K V E + +++EY P G L D++ R ++ K F QI + YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG-SP-NYAAPEVIKGKQY 184
Y HRDL N+L++ +K+ DFGL + G SP + APE ++ ++
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189
Query: 185 YGSETDVWSMGVMLYALL 202
S +DVWS GV LY L
Sbjct: 190 S-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 72/281 (25%), Positives = 131/281 (46%), Gaps = 53/281 (18%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
+T+G G F +V LA V T A+K ++K + + VK E + L ++ + KL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ + +++ V++Y PGG+++ ++ + E +R + ++ A+ +H +G+ HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCA----------------------KPEGGLESQLQTSC- 168
+KP+N+L+D + ++KL DFGLC +P + C
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 169 -----------------------GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGF 205
G+PNY APEV+ K Y D WS+GV+L+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQ 245
Query: 206 LPFDSDSIDQLYDKILNGKYTE--PPW--MSPNSRQIVRSM 242
PF + + + K++N + T PP +SP + ++ +
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 76/272 (27%), Positives = 141/272 (51%), Gaps = 14/272 (5%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIM--KKATLGEDLPRVKLEINALKHISHQHICKLFQ 73
+G G V +AT +G+ VA+K M +K E L E+ ++ H+++ +++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
+++V+E+ GG L D IV R+ E++ A +L A++ LH G HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
+++LL + +KL DFG CA+ + + ++ G+P + APE+I + YG E D+WS
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPELIS-RLPYGPEVDIWS 201
Query: 194 MGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 249
+G+M+ ++ G P+ ++ ++ + D L K +SP+ + + +L +P +
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 250 RIKIQDLLGHNWV-KMGPEDNPVSFRPDHELR 280
R +LL H ++ K GP V + +R
Sbjct: 261 RATAAELLKHPFLAKAGPPSCIVPLMRQNRMR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 64/244 (26%), Positives = 115/244 (47%), Gaps = 15/244 (6%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
L T+G G F V L G+KVA+K +K E + + + H ++ +L
Sbjct: 10 LGATIGKGEFGDVMLGD--YRGQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQL 65
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAH 129
V+ + +++V EY G L+D++ R R + + F + + YL + H
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVH 125
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIKGKQYYGSE 188
RDL NVL+ + K+ DFGL + SQ Q S P + APE ++ K+ + ++
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKE-----ASQGQDSGKLPVKWTAPEALREKK-FSTK 179
Query: 189 TDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRSMLQVE 246
+DVWS G++L+ + G +P+ + + + G E P P ++++ +++
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELD 239
Query: 247 PGKR 250
P KR
Sbjct: 240 PAKR 243
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 73/253 (28%), Positives = 123/253 (48%), Gaps = 17/253 (6%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHIC 69
R +G GGF +V TG+ A K ++K + GE + + +I L+ ++ Q +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVV 63
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYLHHLGY 127
L ET + +V+ GG+L HI G +E RA F +IL + LH
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
+RDLKPEN+LLD ++++ D GL K PEG ++ G+ Y APEV+ Q Y
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLN-NQRYT 179
Query: 187 SETDVWSMGVMLYALLCGFLPF----DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
D W +G ++Y ++ G PF + +++ ++L + S ++ I + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239
Query: 243 LQVEPGKRIKIQD 255
L +P +R+ Q+
Sbjct: 240 LTKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 83/289 (28%), Positives = 124/289 (42%), Gaps = 59/289 (20%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVK----LEINALKHISHQHICKL 71
+G G + V + TG+ VAIK K ED P +K EI LK + H ++ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIV----ER--QRLGEKESRAFFRQILSAVAYLHHL 125
+V + +V EYC DH V E+ + + E + Q L AV + H
Sbjct: 66 IEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFG---LCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
HRD+KPEN+L+ + +KL DFG + P + T Y APE++ G
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW----YRAPELLVGD 175
Query: 183 QYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLY-------------------DKIL 221
YG DVW++G + LL G P SD +DQLY ++
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-VDQLYLIRKTLGDLIPRHQQIFSTNQFF 234
Query: 222 NG-KYTEPPWMSP--------NSRQI--VRSMLQVEPGKRIKIQDLLGH 259
G EP P +S + ++ LQ++P +R+ ++LL H
Sbjct: 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 91/327 (27%), Positives = 139/327 (42%), Gaps = 50/327 (15%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQH 67
+Y+ + +G G + V A + T EKVAIK + A D R EI L+H+ H++
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 68 ICKLFQVIE-TSSHIF--MVIEYCPGGELLD---H--IVERQRLGEKESRAFFRQILSAV 119
+ + ++ F + I Y EL+D H I Q L + + F Q+L +
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVY----ELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
Y+H HRDLKP N+LL+ N +LK+ DFGL A+ + + Y APE++
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQL--------------YDKILNGK 224
Y + DVWS+G + LL F D + QL I N K
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 225 ---YTEP-------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM--GP 266
Y P +P + ++ ML +P KRI +++ L H ++ P
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 267 EDNPVSFRP---DHELREKDDDVIKVM 290
D PV P D E ++ IK +
Sbjct: 301 SDEPVCQTPFSFDFEEDALTEEDIKEL 327
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 78/269 (28%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHICKL 71
+G GGF +V TG+ A K + K L GE + ++ EI L+ ++ I L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYLHHLGYAH 129
E+ +H+ +V+ GG+L HI G + R QI + +LH + +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RD+KPENVLLD N +L D GL + + G + G+ Y APE++K ++ Y
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGTNGYMAPEILK-EEPYSYPV 175
Query: 190 DVWSMGVMLYALLCGFLPF-------DSDSIDQ--LYD--KILNGKYTEPPWMSPNSRQI 238
D ++MG +Y ++ G PF + + + L D K + +TE S+ I
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEE------SKDI 229
Query: 239 VRSMLQVEP----GKRIKIQDLLGHNWVK 263
R L +P G R K D H + K
Sbjct: 230 CRLFLAKKPEDRLGSREKNDDPRKHEFFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ + KL+ + T ++++Y G+L D + + +L E E + RQ++ A+ LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 125 LGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEGGLESQLQTSC--GSPNYAAPEVIKG 181
H D+K ENVL DR + L D+GLC K G SC G+ +Y +PE IKG
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLC-KIIG------TPSCYDGTLDYFSPEKIKG 180
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY----TEPPWMSPNSRQ 237
Y S D W++GV+ Y LL G PF D ++L + L + +S N+
Sbjct: 181 HNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239
Query: 238 IVRSMLQVEPGKR-IKIQDLLGHNWVKM 264
V+SML+ R +++ H ++K+
Sbjct: 240 FVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 75/288 (26%), Positives = 116/288 (40%), Gaps = 54/288 (18%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHI---SHQHICKL 71
+G G + V A + TG VA+K ++ E +P L EI LK + H +I +L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 72 FQV-----IETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
V + + +V E+ L + L + + RQ+L V +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDFLHS 125
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
HRDLKP+N+L+ + +K+ DFGL A+ E L + + Y APEV+
Sbjct: 126 HRIVHRDLKPQNILVTSDGQVKIADFGL-ARIY-SFEMALTSVVVTLWYRAPEVLLQ-SS 182
Query: 185 YGSETDVWSMGVMLY------ALLCGFLPFDSDSIDQLYDKILN--GKYTEPPW------ 230
Y + D+WS+G + L G + DQL DKI + G +E W
Sbjct: 183 YATPVDMWSVGCIFAELFRRRPLFRG-----TSEADQL-DKIFDVIGLPSEEEWPRNVSL 236
Query: 231 -------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
+ +++ ML P KRI + L H
Sbjct: 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 33/276 (11%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLFQV 74
+G G + V + TG+ VA+K ++ + E +P + EI+ LK + H +I L V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 75 IETSSHIFMVIEY--CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDL 132
+ S ++++ E+ + LD + + Q + + +++ QIL + + H HRDL
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDL 127
Query: 133 KPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVW 192
KP+N+L+D +KL DFGL A+ G + Y APEV+ G Y + D+W
Sbjct: 128 KPQNLLIDNKGVIKLADFGL-ARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIW 186
Query: 193 SMGVMLYALLCGFLPFDSDS-IDQLY----------DKILNG-------KYTEPPWMSPN 234
S+G + + F DS IDQL+ + + G K T P W +
Sbjct: 187 SIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGS 246
Query: 235 SRQIVRS-----------MLQVEPGKRIKIQDLLGH 259
R V++ ML +P KRI + L H
Sbjct: 247 LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 73/256 (28%), Positives = 123/256 (48%), Gaps = 20/256 (7%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
+G G F +V T + VAIKI+ +++ ++ EI L ++ K +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 76 ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPE 135
+ +++++EY GG LD ++E L E + R+IL + YLH HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 136 NVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS--CGSPNYAAPEVIKGKQYYGSETDVWS 193
NVLL + +KL DFG+ + ++Q++ + G+P + APEVIK + Y S+ D+WS
Sbjct: 131 NVLLSEHGEVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPEVIK-QSAYDSKADIWS 186
Query: 194 MGVMLYALLCGFLPFDSDS-------IDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
+G+ L G P I + L G Y++P ++ V + L E
Sbjct: 187 LGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP------LKEFVEACLNKE 240
Query: 247 PGKRIKIQDLLGHNWV 262
P R ++LL H ++
Sbjct: 241 PSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 34/264 (12%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLEINALKHISHQHICKL 71
+ +GSG F V L VAIK++++ + ED + K+ + +SH ++ +L
Sbjct: 10 KELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIEEAKV----MMKLSHPNLVQL 64
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKES-RAFFRQILSAVAYLHHLGYAHR 130
+ V IF+V EY G LL+++ ER+ E + A+ YL G+ HR
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP---NYAAPEVIKGKQYYGS 187
DL N L+ + +K+ DFGL L+ Q +S G+ +A PEV + + S
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSR-FSS 180
Query: 188 ETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
++DVWS GV+++ + G +P++ S ++ + + G P ++P
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPT------------ 228
Query: 247 PGKRIKIQDLLGHNWVKMGPEDNP 270
++ ++ W PED P
Sbjct: 229 -----EVYTIMYSCW-HEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 16/260 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
+G G F KV A + TG A K++ + E+L +EI+ L H +I KL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 76 ETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHLGYAHRDLKP 134
++++++IE+C GG + ++E +R L E + R +Q L A+ YLH HRDLK
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131
Query: 135 ENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI----KGKQYYGSETD 190
N+L + ++KL DFG+ AK ++ + + G+P + APEV+ + Y + D
Sbjct: 132 GNILFTLDGDIKLADFGVSAKNTRTIQRR-DSFIGTPYWMAPEVVMCETSKDRPYDYKAD 190
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM------SPNSRQIVRSMLQ 244
VWS+G+ L + P + ++ KI +EPP + S + ++ L+
Sbjct: 191 VWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSEFKDFLKKCLE 247
Query: 245 VEPGKRIKIQDLLGHNWVKM 264
R LL H +V +
Sbjct: 248 KNVDARWTTTQLLQHPFVTV 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 13/261 (4%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMK-KATLGEDLPRVKLEINALKHISHQHI 68
Y R VG G + +V L H G++ IK + + + + E L + H +I
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 69 CKLFQVIE-TSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHL 125
+ E +++V+ +C GG+L + E+ + L E + +F QI A+ YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ---LQTSCGSPNYAAPEVIKGK 182
HRDLK +NV L R +K+ D G+ LE+Q T G+P Y +PE+ K
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV----LENQCDMASTLIGTPYYMSPELFSNK 177
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRS 241
Y ++DVW++G +Y + F++ ++ L +I+ GK P SP +++ +
Sbjct: 178 P-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236
Query: 242 MLQVEPGKRIKIQDLLGHNWV 262
ML P KR ++ +L ++
Sbjct: 237 MLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 83/331 (25%), Positives = 141/331 (42%), Gaps = 51/331 (15%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHI 63
D+ ++Y +GSG + V A +G+KVAIK + A L + L E+ L+H
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 64 SHQHICKLFQVIETSS----HIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSA 118
H +I + ++ +++V++ L HI+ Q L E+ R F Q+L
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFG----LCAKPEGGLESQLQTSCGSPNYA 174
+ Y+H HRDLKP N+L++ + L++ DFG L + P + Y
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW-YR 178
Query: 175 APEVIKGKQYYGSETDVWSMGVMLYALLC--GFLPFDSDSIDQLY----------DKILN 222
APE++ Y + D+WS+G + +L P + + QL +++LN
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP-GKNYVHQLKLILSVLGSPSEEVLN 237
Query: 223 --------------GKYTEPPW------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262
+ PW SP + ++ MLQ +P +RI ++ L H ++
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
Query: 263 K--MGPEDNPV---SFRPDHELREKDDDVIK 288
P+D P F D E E + +K
Sbjct: 298 AQYHDPDDEPTCPPPFDFDFEAIELSREQLK 328
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 34/288 (11%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHIC 69
R +G GGF +V TG+ A K ++K + GE + + +I L+ ++ + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVV 63
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYLHHLGY 127
L ET + +V+ GG+L HI G E RA F +I + LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
+RDLKPEN+LLD ++++ D GL + PEG ++ G+ Y APEV+K + Y
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVK-NERYT 179
Query: 187 SETDVWSMGVMLYALLCGFLPFDS-------DSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
D W +G ++Y ++ G PF + +++ K +Y+E S +R I
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV-KEDQEEYSEK--FSEAARSIC 236
Query: 240 RSMLQVEPGKRIKIQ-----DLLGH------NWVKMGPEDNPVSFRPD 276
R +L +PG R+ + ++ H N+ ++ F PD
Sbjct: 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 81/320 (25%), Positives = 137/320 (42%), Gaps = 48/320 (15%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHI 63
++ ++Y + VGSG + V A TG KVAIK + + E R E+ LKH+
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71
Query: 64 SHQHICKLFQVIETSSHI------FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
H+++ L V + ++V+ + G L +++ ++L E + Q+L
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLK 129
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+ Y+H G HRDLKP N+ ++ + LK++DFGL + + + + T Y APE
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW----YRAPE 185
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILNGKYTEP-------- 228
VI +Y D+WS+G ++ +L G F D +DQL + I+ T
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME-IMKVTGTPSKEFVQKLQ 244
Query: 229 -----------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM- 264
P +P + ++ ML ++ RI + L H + +
Sbjct: 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304
Query: 265 -GPEDNPVSFRPDHELREKD 283
PED + D E D
Sbjct: 305 HDPEDETEAPPYDDSFDEVD 324
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 76/255 (29%), Positives = 130/255 (50%), Gaps = 23/255 (9%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHIC 69
R +G GGF +V TG+ A K ++K + GE + + +I L+ ++ + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVV 63
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYLHHLGY 127
L ET + +V+ GG+L HI G +E RA F +I + LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
+RDLKPEN+LLD + ++++ D GL PEG ++ G+ Y APEV+K ++Y
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 187 SETDVWSMGVMLYALLCGFLPFDS-------DSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
S D W++G +LY ++ G PF + +++L K + +Y+E SP++R +
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEK--FSPDARSLC 236
Query: 240 RSMLQVEPGKRIKIQ 254
+ +L +P +R+ Q
Sbjct: 237 KMLLCKDPKERLGCQ 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 40/287 (13%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLFQV 74
+G G + V A +GE VA+K ++ + +P L EI L ++ H +I +L +V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 75 IETSS--HIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
+ IF+V+EYC LLD++ E + + Q+L + YLH HR
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENFIIHR 132
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK N+LL LK+ DFGL A+ G + + Y APE++ G Y + D
Sbjct: 133 DLKVSNLLLTDKGCLKIADFGL-ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAID 191
Query: 191 VWSMGVMLYALLCG--FLPFDSDSIDQL-----------------YDKI-LNGKYTEP-- 228
+W++G +L LL LP S+ I+QL + + L GK+T P
Sbjct: 192 MWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQ 250
Query: 229 ---------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266
PW+S +++ +L +P KR ++ L ++ K P
Sbjct: 251 PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 76/260 (29%), Positives = 127/260 (48%), Gaps = 21/260 (8%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
LER +G G F +V T E VAIKI+ +++ ++ EI L +I +
Sbjct: 9 LER-IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ + +++++EY GG LD +++ L E R+IL + YLH HRD
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ--TSCGSPNYAAPEVIKGKQYYGSET 189
+K NVLL ++KL DFG+ + ++Q++ T G+P + APEVIK + Y +
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPEVIK-QSAYDFKA 182
Query: 190 DVWSMGVMLYALLCGFLPF-DSDSIDQLY------DKILNGKYTEPPWMSPNSRQIVRSM 242
D+WS+G+ L G P D + L+ L G+Y++P ++ V +
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP------FKEFVEAC 236
Query: 243 LQVEPGKRIKIQDLLGHNWV 262
L +P R ++LL H ++
Sbjct: 237 LNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIM----KKATLGEDLPRVKLEINALKHISHQH 67
L + +G G F +V L TG ++A+K + +++ ++ EI LK++ H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 68 ICKLFQVIE--TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
I + + + + + +EY PGG + D + L E +R + RQIL V+YLH
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES--QLQTSCGSPNYAAPEVIKGKQ 183
HRD+K N+L D N+KL DFG + + S +++ G+P + +PEVI G+
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185
Query: 184 YYGSETDVWSMGVMLYALL 202
YG + DVWS+ + +L
Sbjct: 186 -YGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 67/291 (23%)
Query: 17 GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVK--LEINALKHIS-HQHICKLFQ 73
G G F++V A TG+ AIK MKK + L +V EI AL+ +S H +I +L +
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHF--KSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 74 VIETSSH-----IFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHLGY 127
V+ +F +++ L + I R+R L EK +++ Q+L ++ ++H G
Sbjct: 66 VLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYA---------APEV 178
HRD+KPEN+L+ + LKL DFG C P Y APE
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCR-----------GIYSKPPYTEYISTRWYRAPEC 169
Query: 179 IKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEP--------- 228
+ YYG + D+W++G + + +L F F ++ +DQ+ KI + T
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI-AKIHDVLGTPDAEVLKKFRK 228
Query: 229 --------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
P S +++ +L +P +RI + L H
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-QHICK 70
L VG+G + +V HV TG+ AIK+M E+ +KLEIN LK SH ++I
Sbjct: 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE--EIKLEINMLKKYSHHRNIAT 77
Query: 71 LFQVIETSS------HIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYL 122
+ S +++V+E+C G + D + + KE + R+IL +A+L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H HRD+K +NVLL N +KL+DFG+ A+ + + + T G+P + APEVI
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACD 196
Query: 183 Q----YYGSETDVWSMGV 196
+ Y +D+WS+G+
Sbjct: 197 ENPDATYDYRSDIWSLGI 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 64/291 (21%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLFQV 74
+G G + V A + T E VA+K ++ E +P L EI LK + H++I +L+ V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 75 IETSSHIFMVIEYCP----------GGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ + + +V EYC G++ IV ++F Q+L +A+ H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV----------KSFMFQLLKGLAFCHS 117
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----YAAPEVI 179
HRDLKP+N+L+++N LKL DFGL A+ G + C S Y P+V+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGL-ARAFG-----IPVRCYSAEVVTLWYRPPDVL 171
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPF--DSDSIDQLYDKILN--GKYTEPPW----- 230
G + Y + D+WS G + L P +D DQL +I G TE W
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEESWPGVSK 230
Query: 231 ----------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
++ R +++++L P +RI ++ L H
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 7e-22
Identities = 81/312 (25%), Positives = 133/312 (42%), Gaps = 48/312 (15%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQV 74
VGSG + V A TG +VA+K + + R E+ LKH+ H+++ L V
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 75 ------IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+E + +++V G L++IV+ Q+L + + QIL + Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII 142
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSE 188
HRDLKP N+ ++ + LK++DFGL + + + T Y APE++ +Y
Sbjct: 143 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW----YRAPEIMLNWMHYNQT 198
Query: 189 TDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPPWM---------------- 231
D+WS+G ++ LL G F +D IDQL IL T +
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISSESARNYIQSL 257
Query: 232 ---------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM--GPEDNPVSFR 274
+P + ++ ML ++ KRI L H + P+D PV+
Sbjct: 258 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 317
Query: 275 PDHELREKDDDV 286
D +D +
Sbjct: 318 YDQSFESRDLLI 329
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 82/289 (28%), Positives = 127/289 (43%), Gaps = 51/289 (17%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISH-QHICKLFQ 73
+G G + KV A TG+ VA+K + E +P L EI+ L+ +S +I +L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 74 VIETSSH-----IFMVIEYCPGGELLDHIVERQR-----LGEKESRAFFRQILSAVAYLH 123
V +++V EY +L + R L K ++F Q+L VA+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 124 HLGYAHRDLKPENVLLDRNQN-LKLIDFGLC---AKPEGGLESQLQTSCGSPNYAAPEVI 179
G HRDLKP+N+L+D+ + LK+ D GL + P ++ T Y APEV+
Sbjct: 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW----YRAPEVL 183
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYD--KILNGKYTEPPW------ 230
G +Y + D+WS+G + + F DS + QL K+L G TE W
Sbjct: 184 LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL-GTPTEQVWPGVSKL 242
Query: 231 --------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
+SP +++ ML+ +P KRI + L H
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 8e-22
Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 23/264 (8%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIM-----KKATLGEDLPRVKLEINALKHISHQHICK 70
+G G + V G+ +A+K + ++ +++ E++ LK + H +I +
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 71 LFQVI--ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+ + IFM E+ PGG + + L E + +QIL VAYLH+
Sbjct: 67 YLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKP------EGGLESQLQTSCGSPNYAAPEVIKGK 182
HRD+K NV+L N +KLIDFG CA+ G + L++ G+P + APEVI +
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFG-CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN-E 182
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKYTEPPW---MSPNSRQI 238
YG ++D+WS+G ++ + G P S D + ++ I + P S +
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDSFSAAAIDF 241
Query: 239 VRSMLQVEPGKRIKIQDLLGHNWV 262
V S L + +R LL H+++
Sbjct: 242 VTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 9e-22
Identities = 79/265 (29%), Positives = 124/265 (46%), Gaps = 17/265 (6%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRV---KLEINALKHISHQ 66
Y+L VG +AT G K++ K + D + + E++ L H
Sbjct: 69 YVLTTLVGRNPTTAAFVATR---GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHF 125
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEK------ESRAFFRQILSAVA 120
I K F ++ + +++EY GG+L I +QRL E E F QI+ A+
Sbjct: 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-CGSPNYAAPEVI 179
+H HRDLK N+ L +KL DFG + + + +S CG+P Y APE+
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW 243
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW-MSPNSRQI 238
+ K+Y + D+WS+GV+LY LL PF S ++ ++L GKY P +S + +
Sbjct: 244 ERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKAL 302
Query: 239 VRSMLQVEPGKRIKIQDLLGHNWVK 263
+ +L P R Q LL ++K
Sbjct: 303 LDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 94/339 (27%), Positives = 143/339 (42%), Gaps = 67/339 (19%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIK----IMKKATLGEDLPRVKLEINALKHIS- 64
Y + + +G G + V A T E VA+K + AT D R EI L+ +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT---DAQRTFREIMFLQELGD 65
Query: 65 HQHICKLFQVI--ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAF-FRQILSAVAY 121
H +I KL VI E I++V EY E H V R + E + + Q+L A+ Y
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM---ETDLHAVIRANILEDVHKRYIMYQLLKALKY 122
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC---AKPEGGLESQLQTSCGSPN-YAAPE 177
+H HRDLKP N+LL+ + +KL DFGL ++ E E+ + T + Y APE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTEPPWM----- 231
++ G Y D+WS+G +L +L G F S ++QL +KI+ PP
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL-EKIIE--VIGPPSAEDIES 239
Query: 232 --SPNSRQIVRSM--------------------------LQVEPGKRIKIQDLLGHNWVK 263
SP + ++ S+ L P KR+ ++ L H +V
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 264 --MGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
P D PV + + D+ +LS +
Sbjct: 300 QFHNPSDEPVL----------PYPITIPLDDNVKLSVAE 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 87/333 (26%), Positives = 151/333 (45%), Gaps = 56/333 (16%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDL---PRVKLEINALKHISHQHICK 70
VGSG + V A +KVA+K + + + L R E+ LKH+ H+++
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIG 78
Query: 71 LFQV------IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
L V IE + +++V G L++IV+ Q+L ++ + Q+L + Y+H
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
G HRDLKP NV ++ + L+++DFGL + + + + T Y APE++ +
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW----YRAPEIMLNWMH 192
Query: 185 YGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILN------------------GKY 225
Y D+WS+G ++ LL G F +D IDQL +I+ KY
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL-KRIMEVVGTPSPEVLKKISSEHARKY 251
Query: 226 TEP-PWM------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM--GPEDNP 270
+ P M +P + ++ ML ++ KRI + L H + PED P
Sbjct: 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEP 311
Query: 271 VSFRPDHELREKDDDVIKVMADHKQLSPDDMWS 303
+ D K+ + + + K+L+ +++ S
Sbjct: 312 EAEPYDESPENKE----RTIEEWKELTYEEVSS 340
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 20/254 (7%)
Query: 7 RNQYILERTVGSGGFAKV---KLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
R ++ LER +GSG F +V V +VAIKI+K L + + E+ ALK +
Sbjct: 5 REEFTLERKLGSGYFGEVWEGLWKNRV----RVAIKILKSDDLLK-QQDFQKEVQALKRL 59
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI--VERQRLGEKESRAFFRQILSAVAY 121
H+H+ LF V ++++ E G LL + E Q L Q+ +AY
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP---NYAAPEV 178
L HRDL N+L+ + K+ DFGL ++ + S + APE
Sbjct: 120 LEEQNSIHRDLAARNILVGEDLVCKVADFGLARL----IKEDVYLSSDKKIPYKWTAPEA 175
Query: 179 IKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSR 236
+ +++DVWS G++LY + G +P+ + ++YD+I G + P
Sbjct: 176 A-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY 234
Query: 237 QIVRSMLQVEPGKR 250
+I+ EP R
Sbjct: 235 KIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-21
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-QHICK 70
L VG+G + +V HV TG+ AIK+M G++ +K EIN LK SH ++I
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 71 LFQVI------ETSSHIFMVIEYCPGGELLDHI--VERQRLGEKESRAFFRQILSAVAYL 122
+ +++V+E+C G + D I + L E+ R+IL +++L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H HRD+K +NVLL N +KL+DFG+ A+ + + + T G+P + APEVI
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACD 186
Query: 183 Q----YYGSETDVWSMGVMLYALLCGFLPF 208
+ Y ++D+WS+G+ + G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 73/269 (27%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
+GSG F V L + L KVAIK +++ + E+ E + +SH + +L+ V
Sbjct: 12 IGSGQFGLVWLG-YWLEKRKVAIKTIREGAMSEE--DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 76 ETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKP 134
S I +V E+ G L D++ +R + ++ + +AYL HRDL
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAA 128
Query: 135 ENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP---NYAAPEVIKGKQYYGSETDV 191
N L+ NQ +K+ DFG+ L+ Q +S G+ +++PEV + Y S++DV
Sbjct: 129 RNCLVGENQVVKVSDFGMT---RFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDV 184
Query: 192 WSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
WS GV+++ + G P+++ S ++ + I G P ++ S
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS--------------- 229
Query: 251 IKIQDLLGHNWVKMGPEDNPVSFRPDHEL 279
+ +L+ H W K PED P H+L
Sbjct: 230 --VYELMQHCW-KERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 85/272 (31%), Positives = 125/272 (45%), Gaps = 37/272 (13%)
Query: 12 LERT--VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL--EINALKHISHQH 67
LER +GSG V H TG A+K++ ED R ++ EI L+ ++H +
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPN 133
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLD-HIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
+ K + + + I +++E+ GG L HI + Q L + RQILS +AYLH
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRH 188
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC----GSPNYAAPEVI--- 179
HRD+KP N+L++ +N+K+ DFG+ + +Q C G+ Y +PE I
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGV-----SRILAQTMDPCNSSVGTIAYMSPERINTD 243
Query: 180 --KGKQYYGSETDVWSMGVMLYALLCGFLPF------DSDSIDQLYDKILNGKYTEPP-W 230
G Y G D+WS+GV + G PF D S L I + E P
Sbjct: 244 LNHGA-YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS---LMCAICMSQPPEAPAT 299
Query: 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262
S R + LQ EP KR LL H ++
Sbjct: 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 86/295 (29%), Positives = 130/295 (44%), Gaps = 45/295 (15%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDL---PRVKLEINALKHISHQHI 68
+R +G G F V T G++VA+K M ++L RV E+ L H ++
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNV 61
Query: 69 CKLFQVIETS-----SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
+++ I++V E +L IV Q L + F QIL + YLH
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-CGSPNYAAPEVIKGK 182
G HRD+KP N+L++ N LK+ DFGL A+ E ES+ T + Y APE++ G
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGL-ARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYD-------------------K 219
++Y S D+WS+G + LL + F + S +D + D
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239
Query: 220 ILNGKYTEP--PWM----SPNSRQIVR---SMLQVEPGKRIKIQDLLGHNWVKMG 265
IL G + P P + S + + V ML +P KRI D L H ++ G
Sbjct: 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 83/281 (29%), Positives = 129/281 (45%), Gaps = 29/281 (10%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRV--KLEIN 58
KY N +GSG +V TG +A+K M++ E+ R+ L++
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV 67
Query: 59 ALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSA 118
H +I K + T S +F+ +E LD +++R + E + ++
Sbjct: 68 LKSHDC-PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPE-DILGKMTVAI 123
Query: 119 VAYLHHL----GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQLQT-SCGSPN 172
V LH+L G HRD+KP N+LLD + N+KL DFG+ G L +S+ +T S G
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI----SGRLVDSKAKTRSAGCAA 179
Query: 173 YAAPEVI---KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTEP 228
Y APE I Y DVWS+G+ L L G P+ + + ++ KIL EP
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEP 236
Query: 229 PWM------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
P + SP+ V L + KR K ++LL H +++
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 6e-21
Identities = 74/251 (29%), Positives = 125/251 (49%), Gaps = 12/251 (4%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL--EINALKHISHQH 67
+ +E+ +G G F++V AT +L G VA+K ++ L + R EI+ LK ++H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGEL---LDHIVERQRL-GEKESRAFFRQILSAVAYLH 123
+ K + + + +V+E G+L + H +++RL EK +F Q+ SA+ ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRD+KP NV + +KL D GL + + + G+P Y +PE I +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGL-GRFFSSKTTAAHSLVGTPYYMSPERIH-EN 181
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSID--QLYDKILNGKYTEPP--WMSPNSRQIV 239
Y ++D+WS+G +LY + PF D ++ L KI Y P S RQ+V
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241
Query: 240 RSMLQVEPGKR 250
+ +P KR
Sbjct: 242 NMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHIC 69
R +G GGF +V TG+ A K ++K + GE + + I L+ ++ + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVV 63
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYLHHLGY 127
L ET + +V+ GG+L HI G E RA F ++ + L
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
+RDLKPEN+LLD ++++ D GL + PEG ++ G+ Y APEVI ++Y
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 187 SETDVWSMGVMLYALLCGFLPFDS-------DSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
S D W +G ++Y ++ G PF + +D+ ++ + S +++ I
Sbjct: 181 S-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKEDQEEYSEKFSEDAKSIC 236
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFR 274
R +L P +R+ + G VK P ++F+
Sbjct: 237 RMLLTKNPKERLGCRG-NGAAGVKQHPIFKNINFK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 71/254 (27%), Positives = 123/254 (48%), Gaps = 9/254 (3%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
LER +G G F +V T + VAIKI+ +++ ++ EI L ++ K
Sbjct: 9 LER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ + +++++EY GG LD ++ E + ++IL + YLH HRD
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ--TSCGSPNYAAPEVIKGKQYYGSET 189
+K NVLL ++KL DFG+ + ++Q++ T G+P + APEVI+ + Y S+
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPEVIQ-QSAYDSKA 182
Query: 190 DVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248
D+WS+G+ L G P D + L+ N T S ++ + + L +P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPS 242
Query: 249 KRIKIQDLLGHNWV 262
R ++LL H ++
Sbjct: 243 FRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 56 EINALK-HISHQHICKLFQVIETSSHIFMV---IEYCPGGELLDHIVER-QRLGEKESRA 110
E+ +K + H +I + ++ + +++V IE P GE + + E+ QR E+
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 111 FFRQILSAVAYLHHLGY-AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169
F Q++ A+ YLH HRDL P N++L + + + DFGL AK + ES+L + G
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AK-QKQPESKLTSVVG 175
Query: 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP- 228
+ Y+ PE++K + Y G + DVW+ G +LY + PF S ++ L KI+ Y EP
Sbjct: 176 TILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY-EPL 233
Query: 229 --PWMSPNSRQIVRSMLQVEPGKRIKI 253
S + ++ S L + R I
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-20
Identities = 76/293 (25%), Positives = 145/293 (49%), Gaps = 36/293 (12%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQ 66
N+Y + + +G+G F +V L H T E K + L E + ++ +E+N ++ + H+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 67 HICKLFQ--VIETSSHIFMVIEYCPGGELLDHIVERQRL-GEKESRAFF---RQILSAVA 120
+I + + + + +++++E+C G+L +I + ++ G+ E A RQ+L A+A
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 121 YLHHLG-------YAHRDLKPENVLLD-----------RNQNL------KLIDFGLCAKP 156
Y H+L HRDLKP+N+ L + NL K+ DFGL
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 157 EGGLESQLQTSCGSPNYAAPEVI-KGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSID 214
G+ES + G+P Y +PE++ + Y ++D+W++G ++Y L G PF +++
Sbjct: 193 --GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250
Query: 215 QLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK-MGP 266
QL ++ G S +++++L + +R LG+ +K +GP
Sbjct: 251 QLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303
|
Length = 1021 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 54/287 (18%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-QHICKLFQV 74
+G G F V H +G +A+K ++ ++ R+ ++++ + S +I K +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 75 I--ETSSHIFMVIEYCPGGELLD----------HIVERQRLGEKESRAFFRQILSAVAY- 121
+ E I M EL+D + V + + E +IL +A
Sbjct: 72 LFREGDCWICM--------ELMDISLDKFYKYVYEVLKSVIPE--------EILGKIAVA 115
Query: 122 ----LHHL----GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT-SCGSPN 172
L++L HRD+KP N+LLDRN N+KL DFG+ + +S +T G
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRP 172
Query: 173 YAAPEVI--KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW 230
Y APE I + Y +DVWS+G+ LY + G P+ + ++D++ +PP
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKGDPPI 230
Query: 231 MSPNSR--------QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 269
+S + + L + KR K ++LL H ++K E N
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN 277
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISH 65
R LER +G+G F +V + T T KVA+K +K T+ E + E +K + H
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAFLQ---EAQIMKKLRH 60
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA--------FFRQILS 117
+ +L+ V I++V EY G LLD L E + QI
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF------LKSGEGKKLRLPQLVDMAAQIAE 114
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+AYL Y HRDL N+L+ N K+ DFGL E + + + + APE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 178 VIKGKQYYGSET---DVWSMGVMLYAL 201
YG T DVWS G++L +
Sbjct: 175 AAN----YGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 79/274 (28%), Positives = 131/274 (47%), Gaps = 36/274 (13%)
Query: 14 RTVGSGGFAKVKLATHVL----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
R +G G F KV+L + TGE+VA+K +K + G + +K EI L+++ H++I
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 70 KLFQVI--ETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLG 126
K + + + I +++E+ P G L +++ + ++ K+ + QI + YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNY-AAPEVIKGKQY 184
Y HRDL NVL++ +K+ DFGL E E ++ SP + APE + ++
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF 189
Query: 185 YGSETDVWSMGVMLYALL--CGFLPFDSDS------------------IDQLYDKILNGK 224
Y + +DVWS GV LY LL C DS+S + +L + GK
Sbjct: 190 YIA-SDVWSFGVTLYELLTYC-----DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 225 -YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257
PP Q++R + +P KR Q+L+
Sbjct: 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 79/262 (30%), Positives = 120/262 (45%), Gaps = 20/262 (7%)
Query: 7 RNQYILERTVGSGGFAKVKLATHV-LTGEK--VAIKIMKKATLGEDLPRVKLEINALKHI 63
R L R +G G F V ++ EK VA+K K T + E ++
Sbjct: 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF 64
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYL 122
H HI KL VI + +++V+E P GEL ++ V + L + Q+ +A+AYL
Sbjct: 65 DHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS-P-NYAAPEVIK 180
+ HRD+ NVL+ +KL DFGL E ES + S G P + APE I
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED--ESYYKASKGKLPIKWMAPESIN 181
Query: 181 GKQYYGSETDVWSMGVMLYALLC-GFLPF----DSDSIDQLYDKILNG-KYTEPPWMSPN 234
++ + S +DVW GV ++ +L G PF ++D I +I NG + PP P
Sbjct: 182 FRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI----GRIENGERLPMPPNCPPT 236
Query: 235 SRQIVRSMLQVEPGKRIKIQDL 256
++ +P KR + +L
Sbjct: 237 LYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 75/261 (28%), Positives = 126/261 (48%), Gaps = 26/261 (9%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKI-----MKKATLGEDLPRVKLEINALKHIS 64
+ +E+ +G G F++V AT +L + VA+K M A +D + EI+ LK ++
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLN 60
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGEL---LDHIVERQRL-GEKESRAFFRQILSAVA 120
H ++ K + + +V+E G+L + + +++RL E+ +F Q+ SAV
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC----GSPNYAAP 176
++H HRD+KP NV + +KL D GL G S T+ G+P Y +P
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTTAAHSLVGTPYYMSP 175
Query: 177 EVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID--QLYDKILNGKYTEPP--WMS 232
E I + Y ++D+WS+G +LY + PF D ++ L KI Y P S
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 233 PNSRQIVRSMLQVEPGKRIKI 253
R++V + +P +R I
Sbjct: 235 EKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 8e-20
Identities = 67/252 (26%), Positives = 122/252 (48%), Gaps = 15/252 (5%)
Query: 14 RTVGSGGFAKVKLATHVLTGE-KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLF 72
+ +G+G F VK G+ VAIK++K+ ++ ED E + +SH+ + +L+
Sbjct: 10 KELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSED--EFIEEAKVMMKLSHEKLVQLY 65
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
V I++V EY G LL+++ E +R + + + +AYL + HRD
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP---NYAAPEVIKGKQYYGSE 188
L N L+D +K+ DFGL L+ + +S GS ++ PEV+ + + S+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSK 181
Query: 189 TDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQVE 246
+DVW+ GV+++ + G +P++ + + +K+ G + P S I+ S +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEK 241
Query: 247 PGKRIKIQDLLG 258
+R Q LL
Sbjct: 242 AEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 73/256 (28%), Positives = 118/256 (46%), Gaps = 15/256 (5%)
Query: 13 ERTV-GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
ER V G G + V A + T ++AIK + + P + EI ++ H++I +
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQY 70
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLG---EKESRAFF--RQILSAVAYLHHLG 126
+ + +E PGG L + R + G + E F +QIL + YLH
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 127 YAHRDLKPENVLLDRNQN-LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI-KGKQY 184
HRD+K +NVL++ +K+ DFG K G+ +T G+ Y APEVI KG +
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTS-KRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQ--LYDKILNGKYTE-PPWMSPNSRQIVRS 241
YG+ D+WS+G + + G PF Q ++ + + E P +S ++ +
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247
Query: 242 MLQVEPGKRIKIQDLL 257
+ +P KR DLL
Sbjct: 248 CFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 69/249 (27%), Positives = 116/249 (46%), Gaps = 21/249 (8%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLP---RVKLEINALKHISHQHI 68
+G GGF +V TG+ A+K + K + GE L R+ L + + I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF--I 59
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+ T + +++ GG+L H+ + EKE R + +I+ + ++H+
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSE 188
+RDLKP N+LLD + ++++ D GL + + S G+ Y APEV++ Y S
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 189 TDVWSMGVMLYALLCGFLPF------DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
D +S+G ML+ LL G PF D ID++ L P SP + ++ +
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTVNVELPDSFSPELKSLLEGL 233
Query: 243 LQVEPGKRI 251
LQ + KR+
Sbjct: 234 LQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK--IMKKATLGEDLPRVKL-EIN 58
+ D ++Y +G G F +V A H T + VA+K +M+ E P L EI
Sbjct: 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIK 63
Query: 59 ALKHISHQHICKLFQVIET--------SSHIFMVIEYCPG--GELLDHIVERQRLGEKES 108
L+ + H+++ L ++ T ++V E+C LL + + L E
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI-- 121
Query: 109 RAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC---AKPEGGLESQLQ 165
+ + +L+ + Y+H HRD+K N+L+ ++ LKL DFGL + + ++
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMG 195
+ Y PE++ G++ YG D+W G
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 12/254 (4%)
Query: 14 RTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
+ +GSG F V + GEK VAIK +++AT + + E + + + H+C
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYA 128
+L + TS+ + ++ + P G LLD++ E + +G + + QI + YL
Sbjct: 73 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLV 131
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP--NYAAPEVIKGKQYYG 186
HRDL NVL+ Q++K+ DFGL AK G E + G + A E I + Y
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGL-AKLLGADEKEYHAEGGKVPIKWMALESIL-HRIYT 189
Query: 187 SETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQ 244
++DVWS GV ++ L+ G P+D ++ + G + +PP + + I+
Sbjct: 190 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 249
Query: 245 VEPGKRIKIQDLLG 258
++ R K ++L+
Sbjct: 250 IDADSRPKFRELII 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 66/251 (26%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
L +T+G G F V L + G KVA+K +K + E + + + H ++ +L
Sbjct: 10 LLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAF---LAEASVMTQLRHSNLVQL 64
Query: 72 FQVI-ETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYA 128
VI E +++V EY G L+D++ R R LG F + A+ YL +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIKGKQYYGS 187
HRDL NVL+ + K+ DFGL + S Q + P + APE ++ K+ + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKK-FST 178
Query: 188 ETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQV 245
++DVWS G++L+ + G +P+ + + ++ G K P P +++ +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHL 238
Query: 246 EPGKRIKIQDL 256
+ R L
Sbjct: 239 DAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 12/222 (5%)
Query: 17 GSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLF 72
GSG F V + GEK VAIK++++ T + + E + + H H+ +L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+ +S ++ + P G LLD++ + +G + + QI ++YL HRD
Sbjct: 76 GICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS-P-NYAAPEVIKGKQYYGSET 189
L NVL+ Q++K+ DFGL AK E + G P + A E I + Y ++
Sbjct: 135 LAARNVLVKTPQHVKITDFGL-AKLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKS 192
Query: 190 DVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPP 229
DVWS GV ++ L+ G P++ ++ D + G + +PP
Sbjct: 193 DVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 81/314 (25%), Positives = 126/314 (40%), Gaps = 68/314 (21%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHIS 64
LR+ IL + +G G F +V A + TG VA+K + + P L EI LK +
Sbjct: 7 LRDYEILGK-LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 65 HQHICKLFQ-VIETSSH-------IFMVIEYCPGGELLDHIV------ERQRLGEKESRA 110
H ++ L +E ++MV Y +DH + +L E + +
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPY------MDHDLSGLLENPSVKLTESQIKC 119
Query: 111 FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170
+ Q+L + YLH HRD+K N+L+D LK+ DFGL A+P G + G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL-ARPYDGPPPNPKGGGGG 178
Query: 171 PN-----------YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLY 217
Y PE++ G++ Y + D+W +G + + L SD IDQL
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQL- 236
Query: 218 DKI--LNGKYTEPPW----------------------------MSPNSRQIVRSMLQVEP 247
I L G TE W + P ++ +L ++P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296
Query: 248 GKRIKIQDLLGHNW 261
KR+ D L H +
Sbjct: 297 YKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 84/280 (30%), Positives = 124/280 (44%), Gaps = 26/280 (9%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKA--TLGEDLPRVKLEINALKHISHQHICKLFQ 73
+G G F V AT+ T E VA+K M + E + E+ L+ + H + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 74 VIETSSHIFMVIEYCPGG--ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
++V+EYC G +LL+ V ++ L E E A L +AYLH HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG--KQYYGSET 189
+K N+LL +KL DFG +K S + G+P + APEVI + Y +
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 190 DVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPPWMSPNS-----RQIVRSML 243
DVWS+G+ L P F+ +++ LY N + P + N R V L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLQSNEWTDSFRGFVDYCL 257
Query: 244 QVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKD 283
Q P +R +LL H++V+ D P D R KD
Sbjct: 258 QKIPQERPASAELLRHDFVR---RDRPARVLIDLIQRTKD 294
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-19
Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 25/238 (10%)
Query: 32 TGEKVAIKIMKKATLGEDLP-------RVKLEINALKHISHQHICKLFQVIETSSH-IFM 83
TG +VAIK+++ D P R + E + H +I L E +F
Sbjct: 2 TGHEVAIKLLR-----TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA 56
Query: 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---D 140
V EY PG L + + L E+ Q+L A+A H+ G HRDLKP+N+++
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 141 RNQNLKLIDFGLCAKPEGGLESQLQTSC------GSPNYAAPEVIKGKQYYGSETDVWSM 194
+ K++DFG+ G ++ + T G+P Y APE ++G+ +D+++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAW 175
Query: 195 GVMLYALLCGFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNS-RQIVRSMLQVEPGKR 250
G++ L G S+ ++ + L+ + PPW++ + Q++R L +P +R
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 18/262 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
+G G + V H TG +A+K ++ ++ +E++ L +I +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 76 ETSSHIFMVIEYCPGG---ELLDHIVERQRLGEKESRAFFRQILSAVAYL-HHLGYAHRD 131
++M +EY G +L V + + E R ++ + +L HRD
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL-QTSCGSPNYAAPEVIKG-----KQYY 185
+KP NVL++ N +KL DFG+ G L + L +T+ G +Y APE IK Y
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTY 184
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK---ILNGK-YTEPPWMSPNSRQIVRS 241
++DVWS+G+ + + G P+ ++ ++ + I++G T P S +++ V
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAK 244
Query: 242 MLQVEPGKRIKIQDLLGHNWVK 263
L P +R LL H W+
Sbjct: 245 CLNKIPNRRPTYAQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 7e-19
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTEPPWM---SPNSR 465
+ YG D+WS+GV+LY LL G PF D + +L+ KI K PP SP ++
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWV 491
++R +L +P KR+ ++ L H +
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 89/301 (29%), Positives = 122/301 (40%), Gaps = 66/301 (21%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHI 68
Y+ +G G +A V + G+ VA+K++ T E +P + E + LK + H +I
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANI 65
Query: 69 CKLFQVIETSSHIFMVIEYC-----------PGGELLDHIVERQRLGEKESRAFFRQILS 117
L +I T + V EY PGG L R F Q+L
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----------LHPYNVRLFMFQLLR 114
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC-AK--PEGGLESQLQTSCGSPNYA 174
+AY+H HRDLKP+N+L+ LKL DFGL AK P S++ T Y
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW----YR 170
Query: 175 APEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GKYTE--- 227
P+V+ G Y S D+W G + +L G P SD +QL +KI G TE
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL-EKIWTVLGVPTEDTW 229
Query: 228 ----------PPWMSPNSRQIVR-----------------SMLQVEPGKRIKIQDLLGHN 260
P W P Q +R ML + P RI QD L H
Sbjct: 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP 289
Query: 261 W 261
+
Sbjct: 290 Y 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-19
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 15/220 (6%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHI 63
+L +Y + VGSG + V A TGEKVAIK + + E R E+ LKH+
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71
Query: 64 SHQHICKLFQVIETSS------HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
H+++ L V ++ ++V+ Y L I+ L E + + Q+L
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHP-LSEDKVQYLVYQMLC 128
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+ Y+H G HRDLKP N+ ++ + LK++DFGL + + + T Y APE
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----YRAPE 184
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQL 216
VI +Y D+WS+G ++ +L G F D +DQL
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 9e-19
Identities = 83/263 (31%), Positives = 118/263 (44%), Gaps = 27/263 (10%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIM----KKATLGEDLPRVKLEINALKHISHQHIC 69
R +G G F V A V T E VAIK M K++ E + E+ L+ I H +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVKFLQRIKHPNSI 88
Query: 70 KLFQVIETSSHIFMVIEYCPGG--ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
+ ++V+EYC G +LL+ V ++ L E E A L +AYLH
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG--KQYY 185
HRD+K N+LL +KL DFG + S + G+P + APEVI + Y
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG-----SASIASPANSFVGTPYWMAPEVILAMDEGQY 201
Query: 186 GSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPPWMSPNS-----RQIV 239
+ DVWS+G+ L P F+ +++ LY N E P + N R V
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQSNEWSDYFRNFV 257
Query: 240 RSMLQVEPGKRIKIQDLLGHNWV 262
S LQ P R ++LL H +V
Sbjct: 258 DSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 31/254 (12%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLP---RVKLEINALKHISHQHI 68
+G GGF +V TG+ A+K + K + GE L R+ L + + I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF--I 59
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+ T + +++ GG+L H+ + E E R + +I+ + ++H+
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCA-----KPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
+RDLKP N+LLD + ++++ D GL KP S G+ Y APEV++
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------HASVGTHGYMAPEVLQKGV 171
Query: 184 YYGSETDVWSMGVMLYALLCGFLPF------DSDSIDQLYDKILNGKYTEPPWMSPNSRQ 237
Y S D +S+G ML+ LL G PF D ID++ L P SP R
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAVELPDSFSPELRS 228
Query: 238 IVRSMLQVEPGKRI 251
++ +LQ + +R+
Sbjct: 229 LLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 7/214 (3%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
N++ + VG G + V H T E VAIK K + E++ L E+ L+ + +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG--EKESRAFFRQILSAVAYLHH 124
+I +L + +++V EY L ++E G ++ R++ Q++ A+ + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
HRD+KPEN+L+ N LKL DFG G + + Y +PE++ G
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP- 177
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLY 217
YG D+WS+G +L L G F +S IDQL+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 71/249 (28%), Positives = 114/249 (45%), Gaps = 15/249 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP---RVKL--EINALKHISHQHICK 70
+G G F +V T + VA+K K EDLP ++K E LK H +I K
Sbjct: 3 LGKGNFGEVFKGT-LKDKTPVAVKTCK-----EDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAH 129
L V I++V+E PGG+ L + +++ L K+ F + +AYL H
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RDL N L+ N LK+ DFG+ + + G+ S + APE + + Y SE+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR-YSSES 175
Query: 190 DVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRSMLQVEP 247
DVWS G++L+ G P+ + Q +++ G P P+ ++++ +P
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235
Query: 248 GKRIKIQDL 256
R K +L
Sbjct: 236 ENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 40/237 (16%)
Query: 16 VGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLF 72
+G G F V+ +G K VA+K +K L + + E + + H+++ +L+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQ-------RLGEKESRAFFRQILSAVAYLHHL 125
V+ T + MV E P G LLD + + L + + QI + + YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCD-----YAVQIANGMRYLESK 116
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLC-AKPEGGLESQLQTSCGSP-NYAAPEVIKGKQ 183
+ HRDL N+LL + +K+ DFGL A P+ ++ P + APE ++ +
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
+ +DVW GV L+ + Y E PW + QI++
Sbjct: 177 -FSHASDVWMFGVTLWEMF---------------------TYGEEPWAGLSGSQILK 211
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 86/313 (27%), Positives = 134/313 (42%), Gaps = 59/313 (18%)
Query: 10 YILERTVGSGGFAKVKLATHVLT--GEKVAIK----IMKKATLGEDLPRVKLEINALKHI 63
Y L + +G G + V A + T E VAIK + K L R E+ L+H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL---AKRALRELKLLRHF 58
Query: 64 -SHQHICKLFQV-IETSSHIFMVIEYCPGGELLDH-----IVERQRLGEKESRAFFRQIL 116
H++I L+ + I + + Y EL++ I Q L + ++F QIL
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLY---EELMEADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL-CAKPEGGLESQ--LQTSCGSPNY 173
+ Y+H HRDLKP N+L++ + LK+ DFGL E E+ + + Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF--DSDSIDQLYDKILNGKYTEP--- 228
APE++ Q Y DVWS+G +L LL G P D +DQL ++IL T
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQL-NQILQVLGTPDEET 233
Query: 229 ----------------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHN 260
P +P + ++ +L +P KRI +++ L H
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293
Query: 261 WVKM--GPEDNPV 271
++ + P+D PV
Sbjct: 294 YLAIWHDPDDEPV 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 22/266 (8%)
Query: 15 TVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDL-PRVKLEINALKHIS-HQHICKLF 72
T+G G + KV + G K A+KI+ D+ ++ E N LK +S H ++ K +
Sbjct: 25 TIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 73 QV-----IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS----AVAYLH 123
+ ++ +++V+E C GG + D + + GE+ IL + +LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRD+K N+LL +KL+DFG+ A+ + TS G+P + APEVI +Q
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTPFWMAPEVIACEQ 200
Query: 184 Y----YGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILN--GKYTEPPWMSPNSR 236
Y + DVWS+G+ L G P D + L+ N +P S
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFN 260
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWV 262
+R L + KR + DLL H ++
Sbjct: 261 DFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 87/347 (25%), Positives = 144/347 (41%), Gaps = 84/347 (24%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP--------RVKLEINA 59
+Y + +GSG V A +TG+ VAIK + + P R E+
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVL 68
Query: 60 LKHISHQHICKLFQV------IETSSHIFMVIEYCPGGELLDH---IVERQRLGEKESRA 110
+K ++H++I L V +E +++V+E L+D V + L +
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSY 122
Query: 111 FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170
Q+L + +LH G HRDLKP N+++ + LK++DFGL G + +
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 180
Query: 171 PNYAAPEVIKGKQYYGSE-TDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEP 228
Y APEVI G Y E D+WS+G ++ ++ G + F +D IDQ ++KI+ T
Sbjct: 181 RYYRAPEVILGMGY--KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPS 237
Query: 229 P-WMS---PNSRQIVRS---------------------------------------MLQV 245
+MS P R V + ML +
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 246 EPGKRIKIQDLLGHNWVKMGPEDN----PVSFRPDHELREKDDDVIK 288
+P KRI + D L H ++ + + + P DH + E++ V +
Sbjct: 298 DPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEE 344
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
R L + +G+G F +V + + KVA+K +K T+ + E N +K + H
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHD 61
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIV--ERQRLGEKESRAFFRQILSAVAYLHH 124
+ +L+ V+ I+++ EY G LLD + E ++ + F QI +AY+
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
Y HRDL+ NVL+ + K+ DFGL E + + + + APE I
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN---- 177
Query: 185 YGS---ETDVWSMGVMLYALLC-GFLPF 208
+GS ++DVWS G++LY ++ G +P+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 72/242 (29%), Positives = 110/242 (45%), Gaps = 11/242 (4%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHISHQHICKLFQV 74
+G G F +V VA+K ++ TL DL + E LK SH +I +L V
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 75 IETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLK 133
I++V+E GG+ L + E RL KE + + YL HRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 134 PENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIKGKQYYGSETDVW 192
N L+ LK+ DFG+ + E G+ + P + APE + + Y SE+DVW
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR-YSSESDVW 180
Query: 193 SMGVMLY-ALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV---EPG 248
S G++L+ A G +P+ + S Q + I G P + P+ + R M + +PG
Sbjct: 181 SFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPD--AVYRLMERCWEYDPG 238
Query: 249 KR 250
+R
Sbjct: 239 QR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 72/279 (25%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 11 ILERTVGSGGFAKV--KLATHV--LTG-EKVAIKIMKKATLGEDLPRVKLEINALKHISH 65
+L +T+G G F KV A + G VA+K++K+ +L + E N LK ++H
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-----LGEKESR----------- 109
H+ KL+ + +++EY G L + E ++ LG +R
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 110 --------AFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161
+F QI + YL + HRDL NVL+ + +K+ DFGL ++ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGL-SRDVYEED 181
Query: 162 SQLQTSCGS--PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYD 218
S ++ S G + A E + Y +++DVWS GV+L+ ++ G P+ + ++L++
Sbjct: 182 SYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240
Query: 219 KILNGKYTE-PPWMSPNSRQIVRSMLQVEPGKRIKIQDL 256
+ G E P S ++ + + EP KR D+
Sbjct: 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 76/345 (22%), Positives = 137/345 (39%), Gaps = 53/345 (15%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK--IMKKATLGEDLPRVKLEINALKH 62
DL ++Y+ R +G G V A ++VA+K ++ + R EI ++
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR---EIKIIRR 58
Query: 63 ISHQHICKLFQVIETSSH--------IFMVIEYCPGGELLD----HIVERQRLGEKESRA 110
+ H +I K+++V+ S + + E ++ +++E+ L E+ +R
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL 118
Query: 111 FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLC--AKPEGGLESQLQTS 167
F Q+L + Y+H HRDLKP NV ++ LK+ DFGL P + L
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN----- 222
+ Y +P ++ Y D+W+ G + +L G F + IL
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 223 ----------------GKYT-EP--------PWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257
EP P ++P + + +L P R+ ++ L
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298
Query: 258 GHNWVKM--GPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
H ++ P D PVS P H + ++ DD++ + H + D
Sbjct: 299 MHPYMSCYSCPFDEPVSLHPFH-IEDELDDILLMTEIHSIIYNWD 342
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 67/244 (27%), Positives = 104/244 (42%), Gaps = 12/244 (4%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQ 73
+G G F V + +VA+K + + + E LK H +I KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 74 VIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA---YLHHLGYAHR 130
V I++V+E PGG LL + R++ + + L A A YL HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIK-GKQYYGSE 188
DL N L+ N LK+ DFG+ + EGG+ + APE + G+ Y SE
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR--YTSE 175
Query: 189 TDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRSMLQVE 246
+DVWS G++L+ G P+ S Q ++I +G P + P +++ +
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYD 235
Query: 247 PGKR 250
P R
Sbjct: 236 PENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 59/297 (19%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHICKLFQV 74
+G G + +V A TGE VA+K ++ E P + EI L+ ++H++I L ++
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 75 I----------ETSSHIFMVIEYCPGGELLDH----IVERQ--RLGEKESRAFFRQILSA 118
+ + ++V EY +DH ++E E ++F +Q+L
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEY------MDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEV 178
+ Y H + HRD+K N+LL+ +KL DFGL + Y PE+
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188
Query: 179 IKGKQYYGSETDVWSMGVMLYAL---------------------LCGF-----------L 206
+ G++ YG DVWS G +L L LCG L
Sbjct: 189 LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKL 248
Query: 207 P-FDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262
P F++ + Y + L +++ P + ++ ML ++P KR ++ L W+
Sbjct: 249 PYFNTMKPKKQYRRRLREEFSFIP---TPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 70/277 (25%), Positives = 125/277 (45%), Gaps = 46/277 (16%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
R LE+ +G+G F +V +AT+ KVA+K MK ++ + E N +K + H
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHD 61
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIV--ERQRLGEKESRAFFRQILSAVAYLHH 124
+ KL V+ T I+++ E+ G LLD + E + + F QI +A++
Sbjct: 62 KLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
Y HRDL+ N+L+ + K+ DFGL E + + + + APE I
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN---- 176
Query: 185 YGS---ETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 241
+GS ++DVWS G++L ++ Y P+ ++ +++R+
Sbjct: 177 FGSFTIKSDVWSFGILLMEIV---------------------TYGRIPYPGMSNPEVIRA 215
Query: 242 MLQVEPGKRI--------KIQDLLGHNWVKMGPEDNP 270
+ E G R+ ++ +++ W K PE+ P
Sbjct: 216 L---ERGYRMPRPENCPEELYNIMMRCW-KNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 63/253 (24%), Positives = 120/253 (47%), Gaps = 19/253 (7%)
Query: 14 RTVGSGGFAKVKLA---THVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70
+ +GSG F V L + KVAIK + + + E+ E + +SH + +
Sbjct: 10 KELGSGQFGVVHLGKWRAQI----KVAIKAINEGAMSEE--DFIEEAKVMMKLSHPKLVQ 63
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAH 129
L+ V +++V E+ G LL+++ +RQ +L + + + + + YL + H
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP---NYAAPEVIKGKQYYG 186
RDL N L+ +K+ DFG+ L+ + +S G+ ++ PEV + Y
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYV---LDDEYTSSSGAKFPVKWSPPEVFNFSK-YS 179
Query: 187 SETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRSMLQ 244
S++DVWS GV+++ + G +PF+ S ++ + I G P ++ + +++ S
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239
Query: 245 VEPGKRIKIQDLL 257
+P R +LL
Sbjct: 240 EKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 38/255 (14%)
Query: 7 RNQYILERTVGSGGFAKV--KLATHVLTGE---KVAIKIM-KKATLGEDLPRVKLEINAL 60
R + L R +G G F V LA V+ GE +VAIK + + A++ E + + E + +
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EASVM 63
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFR------- 113
K + H+ +L V+ T +V+E G+L ++ R R E E+
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKF 121
Query: 114 -----QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA--------KPEGGL 160
+I +AYL + HRDL N ++ + +K+ DFG+ + G
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK- 180
Query: 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219
L + APE +K + +++DVWS GV+L+ + P+ S +++
Sbjct: 181 -GLLPV-----RWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233
Query: 220 ILNGKYTEPPWMSPN 234
+++G + + P P+
Sbjct: 234 VIDGGHLDLPENCPD 248
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 47/285 (16%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGEK---VAIKIMKKATLG---EDLPRVKLEIN 58
R+ +L+R +G G F KV L H+ VA+K +K+ +D R E
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAE 60
Query: 59 ALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI--------------VERQRLG 104
L + H++I K + V MV EY G+L + L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 105 EKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164
+ QI S + YL + HRDL N L+ + +K+ DFG+ S+
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM---------SRD 171
Query: 165 QTSC------GSP----NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSI 213
+ G + PE I ++ + +E+DVWS GV+L+ + G P+ S
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230
Query: 214 DQLYDKILNGKYTEPPWMSP-NSRQIVRSMLQVEPGKRIKIQDLL 257
+++ + I G+ + P P I+ + +P +RI I+D+
Sbjct: 231 EEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-HVLTGEK----VAIKIMKKATLG--EDLPRVKLEINA 59
R +L+ +G G F KV LA H L E+ VA+K +K+A+ +D R E
Sbjct: 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAEL 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLD---------HIVERQR------LG 104
L + HQHI + + V + MV EY G+L I+ L
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120
Query: 105 EKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164
+ A QI S + YL L + HRDL N L+ + +K+ DFG+ ++
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 165 QTSCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILN 222
P + PE I ++ + +E+D+WS GV+L+ + G P+ S + + I
Sbjct: 181 GGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239
Query: 223 GKYTEPPWMSPNS-RQIVRSMLQVEPGKRIKIQDL 256
G+ E P P I++ Q EP +R+ I+D+
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 15/246 (6%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+ L +G G F V + TG+KVA+K +K + E + + H+++
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNL 61
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLG 126
+L VI + +++V+E G L++ + R R + + F + + YL
Sbjct: 62 VRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDL N+L+ + K+ DFGL G+++ + APE +K K+ +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV----KWTAPEALKHKK-FS 175
Query: 187 SETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRSMLQ 244
S++DVWS GV+L+ + G P+ S+ ++ + + G EPP P ++ S +
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235
Query: 245 VEPGKR 250
EP KR
Sbjct: 236 TEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 18/218 (8%)
Query: 15 TVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQ 73
T+G G + KV T+ G A+KI+ + ++ ++ E N L+ + H ++ K +
Sbjct: 29 TIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE--EIEAEYNILQSLPNHPNVVKFYG 86
Query: 74 VIETSSH-----IFMVIEYCPGG---ELLDHIVER-QRLGEKESRAFFRQILSAVAYLHH 124
+ + +++V+E C GG EL+ ++ QRL E L + +LH+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
HRD+K N+LL +KL+DFG+ A+ + TS G+P + APEVI +Q
Sbjct: 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQ 205
Query: 185 YGS----ETDVWSMGVMLYALLCGFLP-FDSDSIDQLY 217
Y DVWS+G+ L G P FD + L+
Sbjct: 206 YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 83/282 (29%), Positives = 119/282 (42%), Gaps = 26/282 (9%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKA--TLGEDLPRVKLEINALKHISHQHICKL 71
R +G G F V A V E VAIK M + E + E+ L+ + H + +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 72 FQVIETSSHIFMVIEYCPGG--ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
++V+EYC G +LL+ V ++ L E E A L +AYLH H
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG--KQYYGS 187
RD+K N+LL +KL DFG + + G+P + APEVI + Y
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 188 ETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPPWMSPNS-----RQIVRS 241
+ DVWS+G+ L P F+ +++ LY N E P + R V S
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSGHWSEYFRNFVDS 249
Query: 242 MLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKD 283
LQ P R + LL H +V + P + D R KD
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVL---RERPPTVIMDLIQRTKD 288
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 65/253 (25%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 14 RTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
+ +GSG F V + GE VAIK++++ T + + E + + ++C
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+L + TS+ + +V + P G LLD++ E + R+G ++ + QI ++YL +
Sbjct: 73 RLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP--NYAAPEVIKGKQYYG 186
HRDL NVL+ ++K+ DFGL A+ E++ G + A E I ++ +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGL-ARLLDIDETEYHADGGKVPIKWMALESILHRR-FT 189
Query: 187 SETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQ 244
++DVWS GV ++ L+ G P+D ++ D + G + +PP + + I+
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM 249
Query: 245 VEPGKRIKIQDLL 257
++ R + ++L+
Sbjct: 250 IDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 68/239 (28%), Positives = 108/239 (45%), Gaps = 9/239 (3%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQHI 68
Y+ +G G +A V LT VA+K I + G ++ E++ LK++ H +I
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANI 65
Query: 69 CKLFQVIETSSHIFMVIEYCPGG--ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
L +I T + +V EY + LD+ + + F Q+L ++Y H
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDSDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKP+N+L++ LKL DFGL A+ + + Y P+V+ G Y
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI--LNGKYTEPPWMSPNSRQIVRSML 243
+ D+W +G +LY + G F ++ + I L G TE W S + RS L
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 82/292 (28%), Positives = 118/292 (40%), Gaps = 66/292 (22%)
Query: 17 GSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
G G +A V LTG+ VA+K I + G ++ E + LK + H +I L +I
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDII 72
Query: 76 ETSSHIFMVIEY-----------CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
T + +V EY C GG + ++ R F Q+L +AY H
Sbjct: 73 HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNV-----------RLFLFQLLRGLAYCHQ 121
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLC-AK--PEGGLESQLQTSCGSPNYAAPEVIKG 181
HRDLKP+N+L+ LKL DFGL AK P +++ T Y P+V+ G
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW----YRPPDVLLG 177
Query: 182 KQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GKYTEPPW------- 230
Y + D+W +G + Y + G P +D DQL KI G TE W
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL-HKIFRVLGTPTEETWPGVSSNP 236
Query: 231 -----------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
P+ ++ LQ EP KRI + + H
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 70/262 (26%), Positives = 121/262 (46%), Gaps = 13/262 (4%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-HVLTGE----KVAIKIMKKATLGEDLPRVKLEINALK 61
RN +T+G+G F KV AT + L+ KVA+K++K + + E+ +
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 62 HI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSA 118
H+ +H++I L I ++ EYC G+LL+ + ++ L ++ +F Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPE 177
+A+L HRDL NVLL + +K+ DFGL ++ + P + APE
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQL-YDKILNG-KYTEPPWMSPN 234
I Y E+DVWS G++L+ + G P+ +D Y I G + +P
Sbjct: 214 SIF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272
Query: 235 SRQIVRSMLQVEPGKRIKIQDL 256
I+++ +P KR + +
Sbjct: 273 IYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 66/258 (25%), Positives = 115/258 (44%), Gaps = 14/258 (5%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+E+ +G G F +V L G+K VAIK +K + + E + + H +I
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 69 CKLFQVIETSSHIFMVIEYCPGGEL---LDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+L V+ S + ++ EY G L L + + R I S + YL +
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG-SP-NYAAPEVIKGKQ 183
Y HRDL N+L++ N K+ DFGL ++ E+ T G P + APE I +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGL-SRRLEDSEATYTTKGGKIPIRWTAPEAI-AYR 183
Query: 184 YYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRS 241
+ S +DVWS G++++ ++ G P+ S + + +G PP P++ Q++
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLD 243
Query: 242 MLQVEPGKRIKIQDLLGH 259
Q + +R ++
Sbjct: 244 CWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 30/82 (36%), Positives = 52/82 (63%), Gaps = 5/82 (6%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
YG D W++G+++Y +L G+ PF D+ Q+Y+KIL GK P + SP+++ ++R++LQ
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234
Query: 474 VEPGKRI-----KIQDLLGHNW 490
V+ KR+ + D+ H W
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 69/255 (27%), Positives = 117/255 (45%), Gaps = 13/255 (5%)
Query: 13 ERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
++ +G+G F +V + G K VAIK +K + E + + SH +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESR---AFFRQILSAVAYLHHLG 126
+L V+ ++ EY G L ++ R GE S R I + + YL +
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS-P-NYAAPEVIKGKQY 184
Y HRDL N+L++ N K+ DFGL E E TS G P + APE I ++
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK- 186
Query: 185 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRSM 242
+ S +DVWS G++++ ++ G P+ S ++ I +G P P++ Q++
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQC 246
Query: 243 LQVEPGKRIKIQDLL 257
Q + +R + D++
Sbjct: 247 WQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 58/283 (20%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISH 65
R L + +G+G F +V + T KVA+K +K T+ P L E +K + H
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMS---PESFLEEAQIMKKLRH 60
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAF--------FRQILS 117
+ +L+ V+ + I++V EY G LLD L + E RA Q+ +
Sbjct: 61 DKLVQLYAVV-SEEPIYIVTEYMSKGSLLDF------LKDGEGRALKLPNLVDMAAQVAA 113
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+AY+ + Y HRDL+ N+L+ K+ DFGL E + Q + + APE
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 178 -VIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS 235
+ G+ + ++DVWS G++L L+ G +P+ P M N+
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPY--------------------PGM--NN 209
Query: 236 RQIVRSMLQVEPGKR--------IKIQDLLGHNWVKMGPEDNP 270
R+++ QVE G R I + +L+ W K PE+ P
Sbjct: 210 REVLE---QVERGYRMPCPQDCPISLHELMLQCW-KKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISH 65
R L + +G+G F +V + + KVAIK +K+ ++ P L E N +K + H
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQH 60
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIV--ERQRLGEKESRAFFRQILSAVAYLH 123
+ +L+ V+ T I+++ EY G L+D + E +L + QI +A++
Sbjct: 61 PRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIKGK 182
Y HRDL+ N+L+ K+ DFGL E E + P + APE I
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAIN-- 176
Query: 183 QYYGS---ETDVWSMGVML 198
YG+ ++DVWS G++L
Sbjct: 177 --YGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 78/301 (25%), Positives = 123/301 (40%), Gaps = 51/301 (16%)
Query: 5 DLRNQYI-LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
DLRN+ + +G+G V H+ TG +A KK V+ +I I
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA----KKVVHIGAKSSVRKQILRELQI 56
Query: 64 SHQ----HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS-- 117
H+ +I + ++I M +E+ G L D I K+ +IL
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIY-------KKGGPIPVEILGKI 108
Query: 118 AVAYLHHLGY-------AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170
AVA + L Y HRD+KP N+L++ +KL DFG+ + + S T G+
Sbjct: 109 AVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGT 165
Query: 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-----------DSDSIDQLYDK 219
Y +PE I+G + Y ++DVWS+G+ + L G PF D I L +
Sbjct: 166 STYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224
Query: 220 ILNGKYTEPPWMSPNSR--QIVRSMLQV----EPGKRIKIQDLLGHNWVKMGPEDNPVSF 273
I+ EPP P+S + +R + +P +R Q L + V
Sbjct: 225 IVQ----EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280
Query: 274 R 274
+
Sbjct: 281 Q 281
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 80/278 (28%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-HVLTGEK----VAIKIMKKATLG--EDLPRVKLEINA 59
R +L+R +G G F KV LA + L+ K VA+K +K TL +D R E
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAEL 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI----------VERQ------RL 103
L ++ H+HI K + V + MV EY G+L + V+ Q L
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 104 GEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163
G + QI S + YL + HRDL N L+ N +K+ DFG+ +
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 164 LQTSCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKIL 221
+ P + PE I ++ + +E+DVWS GV+L+ + G P+ S ++ + I
Sbjct: 181 VGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239
Query: 222 NGKYTEPPWMSPNSRQIVRSML---QVEPGKRIKIQDL 256
G+ E P + P +++ ML Q EP +R+ I+++
Sbjct: 240 QGRVLERPRVCP--KEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 69/234 (29%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISH 65
R LE +G G F +V + T T +VAIK +K T+ P L E +K + H
Sbjct: 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRH 60
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLH 123
+ + +L+ V+ + I++V EY G LLD + + L + QI S +AY+
Sbjct: 61 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE-VIKGK 182
+ Y HRDL+ N+L+ N K+ DFGL E + Q + + APE + G+
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 183 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS 235
+ ++DVWS G++L L G +P+ ++ D++ G P P S
Sbjct: 180 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 231
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 46/296 (15%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQHI 68
YI +G G +A V LT VA+K I + G ++ E++ LK + H +I
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANI 66
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR------LGEKESRAFFRQILSAVAYL 122
L ++ T + +V EY LD +++ + + F QIL +AY
Sbjct: 67 VTLHDIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H HRDLKP+N+L++ LKL DFGL A+ + + Y P+V+ G
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGL-ARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLY--------------------DKIL 221
Y ++ D+W +G + + + G F ++ D+L+ D+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 222 N---GKYTEPPWMSPNSR------QIVRSMLQVEPGKRIKIQDLLGHNWVK-MGPE 267
N KY P ++ R +++ LQ E KRI ++ + H + + +G
Sbjct: 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR 295
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 79/324 (24%), Positives = 137/324 (42%), Gaps = 61/324 (18%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLF 72
+ +GSG V A + G VA+K + + + R E+ LK ++H++I L
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 73 QV------IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
V +E +++V+E L ++ + E+ S + Q+L + +LH G
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLY-QMLCGIKHLHSAG 143
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKP N+++ + LK++DFGL + + Y APEVI G Y
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMG-YK 200
Query: 187 SETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILNG---------------------- 223
D+WS+G ++ L+ G + F +D IDQ ++K++
Sbjct: 201 ENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259
Query: 224 -------KYTE--PPWMSPN-----------SRQIVRSMLQVEPGKRIKIQDLLGHN--- 260
+ E P W+ P+ +R ++ ML ++P KRI + + L H
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319
Query: 261 -WVKMGPEDNPVSFRPDHELREKD 283
W + P D +L E++
Sbjct: 320 VWYDPAEAEAPPPQIYDAQLEERE 343
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 62/234 (26%), Positives = 114/234 (48%), Gaps = 17/234 (7%)
Query: 11 ILERTVGSGGFA-KVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
I E G+GG KV+ L + I + K + + R E+ L + +I
Sbjct: 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSPYIV 66
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL---HHLG 126
+ + I + +E+ GG L + E +R+ E+ +L +AYL H +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI- 125
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRD+KP N+L++ +KL DFG+ + ++S + G+ +Y +PE ++G +Y
Sbjct: 126 -MHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGT-HYS 180
Query: 187 SETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDK-ILNGKYTEPPWMSPNSR 236
++D+WSMG+ L L G P D+ ++ ++ + +++G+ EP +SP R
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 39/283 (13%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D++ Q IL G G V A H+LT +A+K++ E ++ E+ L
Sbjct: 2 DIQYQEIL----GHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD 57
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGEL------LDHIVERQRLGEKESRAFFRQILSA 118
+I + + I + E+ GG L +H++ R + ++
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA----------VVKG 107
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEV 178
+ YL L HRD+KP N+L++ +KL DFG+ + + S +T G+ Y APE
Sbjct: 108 LTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPER 164
Query: 179 IKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-------QLYDKILNGKYTEPPWM 231
I G+Q YG +DVWS+G+ L G P+ + QL I++ +PP +
Sbjct: 165 ISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD---EDPPVL 220
Query: 232 -----SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 269
S + ++ +P +R ++L+ H ++ + N
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 14 RTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70
+ +G G F V +++ K VA+K +K+ + E + + + H I +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L V + + +V+E P G LL ++ +R+ + + + Q+ +AYL + HR
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 131 DLKPENVLLDRNQNLKLIDFGLC-AKPEGGLESQLQTSCGSP-NYAAPEVIKGKQYYG-- 186
DL NVLL K+ DFG+ A G + T+ P + APE I YG
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI----NYGKF 175
Query: 187 -SETDVWSMGVMLY 199
S++DVWS GV L+
Sbjct: 176 SSKSDVWSYGVTLW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 62/237 (26%), Positives = 112/237 (47%), Gaps = 31/237 (13%)
Query: 23 KVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH--QHICKLFQVIETSSH 80
KV L T + +K ++K++ + R +L I I H ++ L + I +
Sbjct: 8 KVLLVMDTRTQQTFILKGLRKSS---EYSRERLTI-----IPHCVPNMVCLHKYIVSEDS 59
Query: 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD 140
+F+V+++ GG+L HI + + E+ + + +++ A+ LH G RDL P N+LLD
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 141 RNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN----YAAPEVIKGKQYYGSETDVWSMGV 196
+++L F S+++ SC Y APEV G D WS+G
Sbjct: 120 DRGHIQLTYFSRW--------SEVEDSCDGEAVENMYCAPEV-GGISEETEACDWWSLGA 170
Query: 197 MLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQIVRSMLQVEPGKRI 251
+L+ LL G ++ + + +N T P W+S +R +++ +LQ P +R+
Sbjct: 171 ILFELLTG------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-16
Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 46/280 (16%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL--EINALKHISHQH 67
Y + R +G GG +V LA + +VA+K +++ L + + E + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR--------LGEKES-RAF---FRQI 115
I ++ + ++ + Y G L +++ L EK S AF F +I
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEG-YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 116 LSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-------- 167
+ + Y+H G HRDLKP+N+LL + ++D+G + E L
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 168 ---------CGSPNYAAPEVIKGKQYYGSE-TDVWSMGVMLYALLCGFLPF---DSDSI- 213
G+P+Y APE + G SE TD++++GV+LY +L P+ I
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240
Query: 214 --DQLYDKILNGKYTE-PPWMSPNSRQIVRSMLQVEPGKR 250
D + I Y E PP++S QI L V+P +R
Sbjct: 241 YRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-16
Identities = 44/148 (29%), Positives = 83/148 (56%), Gaps = 6/148 (4%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLEINALKHISHQ 66
++++ + + G F KV L + A+K++KKA + + +V+ E +AL
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGEL--LDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
I L+ +++++++++V+EY GG++ L HI E+ + + ++ A+ YLH
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHR 122
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGL 152
G HRDLKP+N+L+ ++KL DFGL
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGL 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 69/250 (27%), Positives = 120/250 (48%), Gaps = 13/250 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISH 65
R L+ +G G F +V + T T KVAIK +K T+ +P L E +K + H
Sbjct: 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRH 60
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLH 123
+ L+ V+ + I++V E+ G LLD + E + L + QI +AY+
Sbjct: 61 DKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE-VIKGK 182
+ Y HRDL+ N+L+ N K+ DFGL E + Q + + APE + G+
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 183 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVR 240
+ ++DVWS G++L L+ G +P+ ++ +++ G P P S ++++
Sbjct: 180 --FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237
Query: 241 SMLQVEPGKR 250
+ +P +R
Sbjct: 238 LCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 69/256 (26%), Positives = 116/256 (45%), Gaps = 11/256 (4%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+E+ +G+G F +V L G++ VAIK +K + E + + H +I
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLG 126
L V+ S + +V EY G L D + + + + R I S + YL +G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS-P-NYAAPEVIKGKQY 184
Y HRDL N+L++ N K+ DFGL E E+ T G P + APE I ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK- 185
Query: 185 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRSM 242
+ S +DVWS G++++ ++ G P+ S + I G P P + Q++
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDC 245
Query: 243 LQVEPGKRIKIQDLLG 258
Q + +R K + ++
Sbjct: 246 WQKDRNERPKFEQIVS 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSID---QLYDKILNGKYTEPPW----MSPNS 464
YG + DVWS+GV+LY LL G PF ++I QL +IL S +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233
Query: 465 RQIVRSMLQVEPGKRIKIQDLLGHNWV 491
+ +++ L +P KR +++L H W
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 27/83 (32%), Positives = 48/83 (57%), Gaps = 3/83 (3%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
+ YG D WS+GV+LY +L G PF ++ ++Y+KIL P ++SP +R ++
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISG 226
Query: 471 MLQVEPGKRIK---IQDLLGHNW 490
+LQ +P KR+ +++ H +
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 17/259 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVK---LEINALKHI 63
R ++ +G G + +V VA+K TL ED V+ E +K I
Sbjct: 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-----TLKEDTMEVEEFLKEAAVMKEI 59
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAY 121
H ++ +L V +++ E+ G LLD++ E RQ + QI SA+ Y
Sbjct: 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
L + HRDL N L+ N +K+ DFGL G + + + APE
Sbjct: 120 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---S 176
Query: 182 KQYY--GSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQ 237
Y ++DVW+ GV+L+ + G P+ + Q+Y+ + G E P P +
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236
Query: 238 IVRSMLQVEPGKRIKIQDL 256
++R+ Q P R ++
Sbjct: 237 LMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 65/242 (26%), Positives = 115/242 (47%), Gaps = 15/242 (6%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLF 72
+ +GSG V A + VAIK + + + R E+ +K ++H++I L
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 73 QV------IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
V +E +++V+E L +++ + E+ S + Q+L + +LH G
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCGIKHLHSAG 146
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKP N+++ + LK++DFGL G + + Y APEVI G Y
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMG-YK 203
Query: 187 SETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
D+WS+G ++ ++ G + F +D IDQ ++K++ T P + VR+ ++
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 246 EP 247
P
Sbjct: 263 RP 264
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 20/220 (9%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
Y L +G+G F V A + T EKVAIK + +D E+ +K+++H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDPQYKNRELLIMKNLNHINII 122
Query: 70 KLFQVIETSS------HIFM--VIEYCPGG--ELLDHIVER-QRLGEKESRAFFRQILSA 118
L T +IF+ V+E+ P + + H L + + Q+ A
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 119 VAYLHHLGYAHRDLKPENVLLD-RNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+AY+H HRDLKP+N+L+D LKL DFG G S + C S Y APE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS-VSYIC-SRFYRAPE 240
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQL 216
++ G Y + D+WS+G ++ ++ G+ F S+DQL
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 17/230 (7%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQHI 68
YI +G G +A V LT VA+K I + G ++ E++ LK + H +I
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANI 66
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVER------QRLGEKESRAFFRQILSAVAYL 122
L +I T + +V EY LD +++ + + F Q+L + Y
Sbjct: 67 VTLHDIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H HRDLKP+N+L++ LKL DFGL A+ + + Y P+++ G
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGL-ARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKYTEPPW 230
Y ++ D+W +G + Y + G F ++++ I G TE W
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 33/287 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-HVLTGEK----VAIKIMKKAT--LGEDLPRVKLEINA 59
R+ +L+R +G G F KV LA + L E+ VA+K +K A+ +D R E
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAEL 60
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL--------LDHIVERQ-----RLGEK 106
L ++ H+HI K + V + MV EY G+L D ++ + L +
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 107 ESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166
+ +QI + + YL + HRDL N L+ N +K+ DFG+ ++
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 167 SCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK 224
P + PE I ++ + +E+DVWS+GV+L+ + G P+ S +++ + I G+
Sbjct: 181 HTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239
Query: 225 YTEPPWMSPNSRQIVRSML---QVEPGKRIKIQDL--LGHNWVKMGP 266
+ P P +++ ML Q EP R+ I+++ L N K P
Sbjct: 240 VLQRPRTCP--KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 27/74 (36%), Positives = 43/74 (58%), Gaps = 1/74 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
Y ++D+WS+G +LY L PF+ +++ +L KIL G+Y P S R +V S+L
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239
Query: 473 QVEPGKRIKIQDLL 486
Q +P +R I +L
Sbjct: 240 QKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKA-TLGEDLPRVKLEINALKHISHQH 67
+Y ++ +G G + V A TGEKVAIK + D R+ EI L+ + H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 68 ICKLFQVIETSSH-----IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
I ++ ++ S I++V E +L I L + + F Q+L A+ Y+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLC--AKPEGGLESQLQTSCGSPNYAAPEVIK 180
H HRDLKP+N+L + + LK+ DFGL A + + Y APE+
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 178
Query: 181 GKQY--YGSETDVWSMGVMLYALLCG 204
G + Y D+WS+G + +L G
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 72/291 (24%), Positives = 115/291 (39%), Gaps = 58/291 (19%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMK-KATLGEDLPRVKLEINALKHISHQHICKLFQV 74
+G G +A V + G+ VA+K+++ + G ++ E + LK + H +I L +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 75 IETSSHIFMVIEYC-----------PGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
I T + +V EY PGG +++ + F Q+L ++Y+H
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENV-----------KLFLFQLLRGLSYIH 120
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRDLKP+N+L+ LKL DFGL A+ + + Y P+V+ G
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKILN-GKYTEPPW---------- 230
Y + D+W +G + ++ G F D DQL L G E W
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239
Query: 231 -------MSPNSRQ-------------IVRSMLQVEPGKRIKIQDLLGHNW 261
N RQ + +LQ P R+ Q L H +
Sbjct: 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-14
Identities = 78/327 (23%), Positives = 140/327 (42%), Gaps = 61/327 (18%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLF 72
+ +GSG V A + VAIK + + + R E+ +K ++H++I L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 73 QV------IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
V +E +++V+E L +++ + E+ S + Q+L + +LH G
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCGIKHLHSAG 139
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKP N+++ + LK++DFGL G + + Y APEVI G Y
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMG-YK 196
Query: 187 SETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNG---------KYTEP-------- 228
D+WS+G ++ ++ + F D IDQ ++K++ K +P
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 229 ---------PWMSPNS----------------RQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
P + P+S R ++ ML ++P KRI + + L H ++
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315
Query: 264 MGPEDNPVSFRP----DHELREKDDDV 286
+ + V P D +L E++ +
Sbjct: 316 VWYDPAEVEAPPPQIYDKQLDEREHTI 342
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 16 VGSGGFAKVKLATHVL----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
+G G F V+L + TGE VA+K ++ +T E L + EI LK + H +I K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKY 70
Query: 72 FQVIETSS--HIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYA 128
V ++ ++ +V+EY P G L D++ + R+RL ++ + QI + YL Y
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYV 130
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSPNY-AAPEVIKGKQYY 185
HRDL N+L++ +K+ DFGL K P+ +++ SP + APE + + +
Sbjct: 131 HRDLATRNILVESENRVKIGDFGL-TKVLPQDKEYYKVREPGESPIFWYAPESLT-ESKF 188
Query: 186 GSETDVWSMGVMLYAL 201
+DVWS GV+LY L
Sbjct: 189 SVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 62/250 (24%), Positives = 116/250 (46%), Gaps = 29/250 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLATHV-LTGEK------VAIKIMKKATLGEDLPRVKLEINA 59
R++ L + +G G F +V +A + + +K VA+K++K +DL + E+
Sbjct: 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73
Query: 60 LKHIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFR----- 113
+K I H++I L +++++EY G L +++ R+ G + S R
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 114 -----------QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
Q+ + YL HRDL NVL+ N +K+ DFGL A+ ++
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL-ARDVNNIDY 192
Query: 163 QLQTSCGS--PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219
+T+ G + APE + + Y ++DVWS GV+++ + G P+ +++L+
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 220 ILNGKYTEPP 229
+ G + P
Sbjct: 252 LKEGHRMDKP 261
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 29/237 (12%)
Query: 16 VGSGGFAKVKLATHVLTGEKV--AIKIMKKATLGEDLPRVKLEINALKHISHQ-HICKLF 72
+G G F +V A G ++ AIK MK+ +D E+ L + H +I L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKE----------SRAFFRQIL------ 116
E ++++ IEY P G LLD + + R+ E + S +Q+L
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 117 -SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--PNY 173
+ YL + HRDL N+L+ N K+ DFGL G E ++ + G +
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPVRW 177
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPP 229
A E + Y + +DVWS GV+L+ ++ G P+ + +LY+K+ G E P
Sbjct: 178 MAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 29/241 (12%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKV--AIKIMKKATLGEDLPRVKLEINAL-KHISHQHI 68
E +G G F +V A G K+ AIK++K+ D E+ L K H +I
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKE--------------SRAFFRQ 114
L E ++++ IEY P G LLD + + R+ E + S+ +
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLD-FLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 115 ILSAVAYLHHLG---YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS- 170
+ +L + HRDL NVL+ N K+ DFGL G E ++ + G
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRL 180
Query: 171 -PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEP 228
+ A E + Y +++DVWS GV+L+ ++ G P+ + +LY+K+ G E
Sbjct: 181 PVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239
Query: 229 P 229
P
Sbjct: 240 P 240
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 28/270 (10%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-----KVAIKIMKKATLGEDLPRVKLEINALK 61
R++ L + +G G F +V A V VA+K++K +DL + E+ +K
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMK 70
Query: 62 HI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESR----------- 109
I H++I L V +++V+EY G L D + R+ GE S
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 110 -----AFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164
+F Q+ + +L HRDL NVL+ + +K+ DFGL A+ ++
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGL-ARDIHHIDYYR 189
Query: 165 QTSCGS-P-NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKIL 221
+T+ G P + APE + + Y ++DVWS GV+L+ + G P+ +++L+ +
Sbjct: 190 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248
Query: 222 NGKYTEPPWMSPNS-RQIVRSMLQVEPGKR 250
G E P ++R P +R
Sbjct: 249 EGYRMEKPQNCTQELYHLMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 16/258 (6%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+ER +G+G F ++ L ++ VAI ++ + E L H +I
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLG 126
+L VI + + +V EY G LD + + +L + + S + YL +G
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG-SPN-YAAPEVIKGKQY 184
Y H+ L VL++ + K+ F E E+ T G SP +AAPE I+ +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ-YHH 184
Query: 185 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRSM 242
+ S +DVWS G++++ ++ G P+ S + + +G P PN Q++
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDC 244
Query: 243 LQVEPGKRIK---IQDLL 257
Q E G+R + I +L
Sbjct: 245 WQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 69/252 (27%), Positives = 115/252 (45%), Gaps = 12/252 (4%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKV----AIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
+ +GSG F V V GE V AIKI+ + T + E + + H H+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+L V S I +V + P G LLD++ E + +G + + QI + YL
Sbjct: 73 RLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP--NYAAPEVIKGKQYYG 186
HRDL NVL+ ++K+ DFGL EG E + G + A E I ++ +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALECIHYRK-FT 189
Query: 187 SETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQ 244
++DVWS GV ++ L+ G P+D ++ D + G + +PP + + ++
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWM 249
Query: 245 VEPGKRIKIQDL 256
++ R K ++L
Sbjct: 250 IDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 63/250 (25%), Positives = 118/250 (47%), Gaps = 29/250 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLATHV-LTGEK------VAIKIMKKATLGEDLPRVKLEINA 59
R++ +L + +G G F +V +A + L EK VA+K++K +DL + E+
Sbjct: 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 76
Query: 60 LKHI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER----------------QR 102
+K I H++I L +++++EY G L +++ R ++
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 103 LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
L K+ + Q+ + YL HRDL NVL+ + +K+ DFGL A+ ++
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL-ARDIHHIDY 195
Query: 163 QLQTSCGS--PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219
+T+ G + APE + + Y ++DVWS GV+L+ + G P+ +++L+
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
Query: 220 ILNGKYTEPP 229
+ G + P
Sbjct: 255 LKEGHRMDKP 264
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
Y ++D+WS+G +LY + PF++ S+ L K+ GKY PP S + + +RSML
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237
Query: 473 QVEPGKRIKIQDLLGH 488
QV+P R +L
Sbjct: 238 QVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 76/298 (25%), Positives = 115/298 (38%), Gaps = 70/298 (23%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP----RVKLEINALKHISHQHICKL 71
+G G + V A +G VA+K ++ T + LP R + L+ H +I +L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 72 FQVIETS-----SHIFMVIEYC------------PGGELLDHIVERQRLGEKESRAFFRQ 114
V TS + + +V E+ P G + I + RQ
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETI-----------KDLMRQ 116
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYA 174
L + +LH HRDLKPEN+L+ +KL DFGL + L + Y
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYR 174
Query: 175 APEVIKGKQYYGSETDVWSMGVMLY------ALLCGFLPFDSDSIDQLYDKILNGKYTEP 228
APEV+ + Y + D+WS+G + L CG ++D + +++D I G E
Sbjct: 175 APEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCG--NSEADQLGKIFDLI--GLPPED 229
Query: 229 PW----------MSPNSRQIVRS---------------MLQVEPGKRIKIQDLLGHNW 261
W SP + V+S ML P KRI L H +
Sbjct: 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 27/240 (11%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKV--AIKIMKKATLGEDLPRVKLEINALKHIS-HQHI 68
+ +G G F +V A G ++ AIK MK+ +D E+ L + H +I
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ----------------RLGEKESRAFF 112
L E ++++ IEY P G LLD + + + L ++ F
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS-- 170
+ + YL + HRDL N+L+ N K+ DFGL G E ++ + G
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 186
Query: 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPP 229
+ A E + Y + +DVWS GV+L+ ++ G P+ + +LY+K+ G E P
Sbjct: 187 VRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 54/163 (33%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 115 ILSAVAYLH-HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQLQT-SCGSP 171
I+ A+ YLH L HRD+KP NVL++RN +KL DFG+ G L +S +T G
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI----SGYLVDSVAKTIDAGCK 167
Query: 172 NYAAPEVIKG---KQYYGSETDVWSMGVMLYALLCGFLPFDS--DSIDQLYDKILNGKYT 226
Y APE I ++ Y ++DVWS+G+ + L G P+DS QL +
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-----E 222
Query: 227 EPP------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
EP SP + V L+ +R +LL H + +
Sbjct: 223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 26/135 (19%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
S Q YG D W++GV+LY +L G PF+ D D+L+ IL + P W+S ++ I++
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILK 228
Query: 470 SMLQVEPGKRIKI-----QDLLGH------NWVKMGPE--DNPLREK----------DDD 506
S L P KR+ QD+ GH +W K+ + P + K DD+
Sbjct: 229 SFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDE 288
Query: 507 VIKVMADHKQLSPDD 521
K + L+P D
Sbjct: 289 FTK---EKPVLTPPD 300
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 27/74 (36%), Positives = 45/74 (60%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
YG D W+MGV+LY +LCG PF++++ D L++ ILN + P W+S ++ I+++ +
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232
Query: 474 VEPGKRIKIQDLLG 487
P R+ L G
Sbjct: 233 KNPTMRLGSLTLGG 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 66/279 (23%), Positives = 127/279 (45%), Gaps = 30/279 (10%)
Query: 7 RNQYILERTVGSGGFAKVKLATHV-LTGEK------VAIKIMKKATLGEDLPRVKLEINA 59
R + L + +G G F +V +A + + +K VA+K++K +DL + E+
Sbjct: 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEM 70
Query: 60 LKHI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER----------------QR 102
+K I H++I L +++++EY G L +++ R ++
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 103 LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
L K+ + Q+ + YL HRDL NVL+ + +K+ DFGL A+ ++
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGL-ARDVHNIDY 189
Query: 163 QLQTSCGS--PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219
+T+ G + APE + + Y ++DVWS GV+L+ + G P+ +++L+
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
Query: 220 ILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257
+ G + +P + I+R P +R + L+
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 24/200 (12%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKI-MKKATLGEDLPRVKLEINALKHISHQHI 68
Y + +T+ G +V +AT + V +KI K TL E + L++++H +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM--------LLQNVNHPSV 119
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHLGY 127
++ + + + MV+ + +L ++ +R R L ++ +QIL + YLH
Sbjct: 120 IRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEG-----GLESQLQTSCGSPNYAAPEVIKGK 182
HRD+K EN+ ++ + + D G P GL ++T+ APEV+ +
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN-------APEVL-AR 230
Query: 183 QYYGSETDVWSMGVMLYALL 202
Y S+ D+WS G++L+ +L
Sbjct: 231 DKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 16/228 (7%)
Query: 16 VGSGGFAKVKLATH-VLTGEK-VAIKIMKK----ATLGEDLPRVKLEINALKHISHQHIC 69
+GSG F VK + + EK VA+KI+K L ++L R E N ++ + + +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---EANVMQQLDNPYIV 59
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAH 129
++ + E S +V+E G L + + + + EK Q+ + YL + H
Sbjct: 60 RMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES--QLQTSCGSP-NYAAPEVIKGKQYYG 186
RDL NVLL K+ DFGL +K G E+ + +T P + APE + + +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGL-SKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FS 176
Query: 187 SETDVWSMGVMLY-ALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSP 233
S++DVWS GV+++ A G P+ +++ I +G+ E P P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCP 224
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+E +G+G F +V L G++ VAIK +K + E + + H +I
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGE---KESRAFFRQILSAVAYLHHL 125
L V+ S + ++ E+ G L + RQ G+ + R I + + YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC-GSP---NYAAPEVIKG 181
Y HRDL N+L++ N K+ DFGL E TS G + APE I
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 182 KQYYGSETDVWSMGVMLYALL 202
++ + S +DVWS G++++ ++
Sbjct: 186 RK-FTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 53/172 (30%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 40 IMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY--CPGGELLDHI 97
I+K T G+ R EI+ LK ISH+ I L S + MV+ C +L ++
Sbjct: 123 IVKAVTGGKTPGR---EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYV 176
Query: 98 VERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157
L +++ R++L A+AYLH G HRD+K EN+ LD +N L DFG K +
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 158 GGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF 208
++ Q G+ +PE++ Y ++TD+WS G++L+ + +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--PWMSPNSRQIV 468
Q + D WS+G +LY L G PF ++ ++++ ILNGK P +S + ++
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234
Query: 469 RSMLQVEPGKRI---KIQDLLGHNWVKM 493
+L +P KR+ I+++ H + K
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 9/190 (4%)
Query: 16 VGSGGFAKVKLATHVLTGEK--VAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQ 73
+GSG F VK + + ++ VAIK++K + E + + + +I ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 74 VIETSSHIFMVIEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDL 132
V E + + +V+E GG L + ++ + Q+ + YL + HRDL
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121
Query: 133 KPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP---NYAAPEVIKGKQYYGSET 189
NVLL K+ DFGL +K G +S + + APE I ++ + S +
Sbjct: 122 AARNVLLVNQHYAKISDFGL-SKALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSRS 179
Query: 190 DVWSMGVMLY 199
DVWS G+ ++
Sbjct: 180 DVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 10 YILERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATL-GEDLPRVKLEINALKHISH 65
+ L R +G G F V+ A + +KVA+K++K D+ E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 66 QHICKLFQVIETSSH-----IFMVI-EYCPGGELLDHIVERQRLGEKESRA-------FF 112
++ KL V S I MVI + G+L ++ R+GE+ F
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP- 171
I S + YL + HRDL N +L+ N + + DFGL K G + C S
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG--DYYRQGCASKL 177
Query: 172 --NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTE 227
+ A E + Y + +DVW+ GV ++ ++ G P+ ++Y+ ++ G + +
Sbjct: 178 PVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236
Query: 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDL 256
PP + +++ EP R Q L
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
+G D W+MGV+LY + G+ PF D+ ++Y+KIL G+ P W +R +V+ +LQ
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQ 251
Query: 474 VEPGKRIKIQDLLGHNWVKMGPED 497
+ KR LG +K G D
Sbjct: 252 TDHTKR------LGT--LKGGVAD 267
|
Length = 329 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 12/250 (4%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISH 65
R L R +G+G F +V T VA+K +K T+ +D E +K + H
Sbjct: 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLA---EAQIMKKLRH 60
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHI--VERQRLGEKESRAFFRQILSAVAYLH 123
+ +L+ V I++V E G LL+++ + L + Q+ S +AYL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIKGK 182
Y HRDL NVL+ N K+ DFGL A+ + + P + APE
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGL-ARVIKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 183 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVR 240
+ + ++DVWS G++L ++ G +P+ + ++ ++ G + PP I+
Sbjct: 180 R-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238
Query: 241 SMLQVEPGKR 250
+ +P R
Sbjct: 239 DCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 73/329 (22%), Positives = 124/329 (37%), Gaps = 90/329 (27%)
Query: 9 QYILERTVGSGGFAKVKLA--THVLTGEKVAIKIMK---KATLGEDLPRVKLEINALKHI 63
+Y +E +G G + +V A + G++ AIK K + G + EI L+ +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL 59
Query: 64 SHQHICKLFQVIETSSH--IFMVIEYCPGGEL-LDHIVERQRLGEKESRAFFR------- 113
H+++ L +V + ++++ +Y E L I++ R + + +
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYA---EHDLWQIIKFHR--QAKRVSIPPSMVKSLL 114
Query: 114 -QILSAVAYLHHLGYAHRDLKPENVLLDRNQN----LKLIDFGL---CAKPEGGLESQLQ 165
QIL+ V YLH HRDLKP N+L+ +K+ D GL P L+
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-------LK 167
Query: 166 TSCGSPN------YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-----DSDS-- 212
Y APE++ G ++Y D+W++G + LL F
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227
Query: 213 ---IDQLYDKILN--GKYTE-----------------------------PPWM------S 232
DQL ++I G TE WM
Sbjct: 228 PFQRDQL-ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD 286
Query: 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261
++R +L+ +P KRI ++ L H +
Sbjct: 287 SQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 56 EINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQI 115
E+ L + +I + + I + +E+ GG L + + R+ E+ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 116 LSAVAYL---HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN 172
+ + YL H + HRD+KP N+L++ +KL DFG+ + ++S + G+ +
Sbjct: 113 IKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRS 167
Query: 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILNGKYTEPP 229
Y +PE ++G +Y ++D+WSMG+ L + G P D+ ++ ++ + G E
Sbjct: 168 YMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226
Query: 230 WMSPNSRQIVRSMLQVEPGKR 250
SP R R + P R
Sbjct: 227 -TSPRPRPPGRPLSSYGPDSR 246
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 71/296 (23%), Positives = 128/296 (43%), Gaps = 55/296 (18%)
Query: 14 RTVGSGGFAKV--KLATHVL---TGE-KVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+GSG F +V AT +L +G +VA+K ++K ++ E + + + +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHI--VERQRLGE-----KESRAFFRQILSAVA 120
I KL V + ++++E GG+LL ++ +R G KE +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 121 YLHHLGYAHRDLKPENVLL-----DRNQNLKLIDFGLCA--------KPEGGLESQLQTS 167
YL + + HRDL N L+ D ++ +K+ DFGL + EG E L
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG--EGLLPV- 177
Query: 168 CGSPNYAAPE-VIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY 225
+ APE ++ GK + +++DVWS GV+++ +L G P+ + + ++ + G
Sbjct: 178 ----RWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231
Query: 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELRE 281
+ P P+ KI L+ + W + P + P R L+
Sbjct: 232 LQKPENCPD-----------------KIYQLMTNCWAQD-PSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 6/147 (4%)
Query: 56 EINALKHISHQHICKLFQVIETSSHIFMVI-EYCPGGELLDHIVERQR-LGEKESRAFFR 113
E L+ +SH + L V +V+ +Y +L ++ R R LG + A R
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 114 QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-CGSPN 172
Q+LSA+ Y+H G HRD+K ENVL++ +++ L DFG G + G+ +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 173 YAAPEVIKGKQYYGSETDVWSMGVMLY 199
APEV+ G Y S D+WS G++++
Sbjct: 328 TNAPEVLAGDPYTPS-VDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 28/86 (32%), Positives = 46/86 (53%), Gaps = 9/86 (10%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQL--YDKIL--NGKYTEPPWMSPNSRQIVR 469
Y D WS+G++LY LL G PF D D + Y+ IL NGK P ++ ++ +++
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK 228
Query: 470 SMLQVEPGKRI-----KIQDLLGHNW 490
+L+ P +R+ I+D+ H W
Sbjct: 229 QLLRRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 56 EINALKHISHQHICKLFQVIETSSHIFMVI---EYCPGGELLDHIVE-RQRLGEKESRAF 111
EI AL ++H++I K+ +++ + ++ +M+ ++ + D + + R K++RA
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272
Query: 112 FRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP 171
+Q+L AV Y+H HRD+K EN+ L+ + + L DFG E E+ G+
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332
Query: 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLP 207
+PE++ G Y TD+WS G++L +L F P
Sbjct: 333 ATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCP 368
|
Length = 501 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 19/70 (27%), Positives = 41/70 (58%)
Query: 415 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 474
G +D+W++G ++Y +L G PF + + KIL +Y+ PP P+++ ++ +L +
Sbjct: 200 GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVL 259
Query: 475 EPGKRIKIQD 484
+P R+ + +
Sbjct: 260 DPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 65/297 (21%), Positives = 119/297 (40%), Gaps = 53/297 (17%)
Query: 17 GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE 76
G+G V H +G +A K++ ++ E+ L + +I +
Sbjct: 10 GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY 69
Query: 77 TSSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKP 134
+ I + +E+ GG L D ++++ R+ E +L + YL HRD+KP
Sbjct: 70 SDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKP 128
Query: 135 ENVLLDRNQNLKLIDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWS 193
N+L++ +KL DFG+ G L +S + G+ +Y +PE ++G Y ++D+WS
Sbjct: 129 SNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQGTH-YTVQSDIWS 183
Query: 194 MGVMLYALLCG---------------FLPFDSDS---------------------IDQLY 217
+G+ L + G F S+ I +L
Sbjct: 184 LGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELL 243
Query: 218 DKILNGKYTEPPWM-----SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 269
D I+N PP + S + V L+ P +R +++L H ++K +
Sbjct: 244 DYIVNE---PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 67/261 (25%), Positives = 118/261 (45%), Gaps = 26/261 (9%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEK-VAIKIMKKATLGEDLPRVKL-EINALKHIS-- 64
QY +G G + KV A + G + VA+K ++ T E +P + E+ L+H+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 65 -HQHICKLFQVIETS-----SHIFMVIEYCPGGELLDHIVERQRLG--EKESRAFFRQIL 116
H ++ +LF V S + + +V E+ +L ++ + G + + Q+L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
+ +LH HRDLKP+N+L+ + +KL DFGL + L + + Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAP 178
Query: 177 EVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-----DSDSIDQLYDKILNGKYTEPPWM 231
EV+ + Y + D+WS+G ++A + P D D + ++ D I G E W
Sbjct: 179 EVLL-QSSYATPVDLWSVGC-IFAEMFRRKPLFRGSSDVDQLGKILDVI--GLPGEEDW- 233
Query: 232 SPNSRQIVRSMLQVEPGKRIK 252
P + R + + I+
Sbjct: 234 -PRDVALPRQAFHSKSAQPIE 253
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 27/120 (22%), Positives = 53/120 (44%), Gaps = 12/120 (10%)
Query: 40 IMKKATLGEDLPRVKLEINALKHISHQHIC--KLFQVIETSSHIFMVIEYCPGGELLDHI 97
++K E + E+ L+ ++ + + K+ E+ ++++E+ G E LD +
Sbjct: 25 VLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG-ETLDEV 83
Query: 98 VERQRLGEKESRAFFRQILSAVAYLHHLGYA---HRDLKPENVLLDRNQNLKLIDFGLCA 154
E ++ Q+ +A LH L H DL P N+L+D + L +ID+
Sbjct: 84 SEEEK------EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 44/246 (17%)
Query: 7 RNQYILERTVGSGGFAKVKL------------ATHVLTGEK--VAIKIMKKATLGEDLPR 52
R Q L+ +G G F +V L G+ VA+K+++
Sbjct: 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND 63
Query: 53 VKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF 112
EI + + + +I +L V + + M+ EY G+L Q L ++E + F
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL------NQFLSQREIESTF 117
Query: 113 R------------------QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154
QI S + YL L + HRDL N L+ + +K+ DFG+
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 155 KPEGGLESQLQTSCGSP-NYAAPE-VIKGKQYYGSETDVWSMGVMLYAL--LCGFLPFDS 210
G ++Q P + A E ++ GK + + +DVW+ GV L+ + LC P+
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSL 235
Query: 211 DSIDQL 216
S +Q+
Sbjct: 236 LSDEQV 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 61.3 bits (147), Expect = 5e-10
Identities = 29/155 (18%), Positives = 48/155 (30%), Gaps = 13/155 (8%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTE-------- 456
S Y S +D+WS+G+ LY LL G PF+ + Q IL
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 457 -PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHK 515
P +S + +++ +L +P R+ L H+ +
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRL 302
Query: 516 QLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGLP 550
L P + + L S + L
Sbjct: 303 SLPPSLEALISSLNSLAISGSDLKLDDSNFSKELA 337
|
Length = 384 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 37/122 (30%), Positives = 65/122 (53%), Gaps = 16/122 (13%)
Query: 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP 228
G+P+Y APE++ GK + G D W++GV L+ L G PF+ ++ Q++ ILN +
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN---RDI 597
Query: 229 PW------MSPNSRQIVRSMLQVEPGKRIKIQDLLGH------NWVKMGPEDNPVSFRPD 276
PW +S N++ + +L ++P KR +++L H +W + + P +PD
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 277 HE 278
E
Sbjct: 658 DE 659
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 48/295 (16%)
Query: 15 TVGSGGFAKVKLATHVLTGEKVAIKI--MKKATLGEDLPRVKLEINALKHISHQHICKLF 72
V LA H T VA+K + + EDL ++ EI + + H +I
Sbjct: 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYV 65
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKES--RAFFRQILSAVAYLHHLGYAHR 130
S +++V G D + G E + +L+A+ Y+H G+ HR
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125
Query: 131 DLKPENVLLDRNQNLKLIDF-GLCAKPEGGLESQL-----QTSCGSPNYAAPEVIKGK-Q 183
+K ++LL + + L + + G ++ ++S + + +PEV++ Q
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ 185
Query: 184 YYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG-------KYTEPPWM---- 231
Y ++D++S+G+ L G +PF D + L +K+ G K T P +
Sbjct: 186 GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RGTVPCLLDKSTYPLYEDSMS 244
Query: 232 -----------------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
S + Q V LQ +P R LL H++ K
Sbjct: 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 62/253 (24%), Positives = 115/253 (45%), Gaps = 35/253 (13%)
Query: 7 RNQYILERTVGSGGFAKVKLAT----------HVLTGEKVAIKIMKKATLGEDLPRVKLE 56
R++ +L + +G G F +V A +T VA+K++K +DL + E
Sbjct: 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVT---VAVKMLKDNATDKDLADLISE 67
Query: 57 INALKHIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEK--------- 106
+ +K I H++I L V +++++EY G L + + R+ G
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 107 ESRAFFRQILSAV-------AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159
E + F+ ++S YL HRDL NVL+ + +K+ DFGL A+
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL-ARGVHD 186
Query: 160 LESQLQTSCGS--PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQL 216
++ +TS G + APE + + Y ++DVWS G++++ + G P+ +++L
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
Query: 217 YDKILNGKYTEPP 229
+ + G + P
Sbjct: 246 FKLLREGHRMDKP 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 27/240 (11%)
Query: 12 LERTVGSGGFAKVK--LATHVLTGEKVAIKIMKKA----TLGEDLPRVKLEINALKHISH 65
L +T+G G F V + KVA+K MK A + ED E +K H
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS---EAVCMKEFDH 59
Query: 66 QHICKL----FQVIETSSHI--FMVIEYCPGGELLDHIVERQRLGEKESR-------AFF 112
++ +L Q +E+ + +++ + G+L ++ RLG+ F
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFM 118
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP-EGGLESQLQTSCGSP 171
I S + YL + HRDL N +L+ N N+ + DFGL K G Q + +
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPP 229
+ A E + + Y +++DVWS GV ++ + G P+ ++YD + G + +PP
Sbjct: 179 KWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 59/240 (24%), Positives = 92/240 (38%), Gaps = 33/240 (13%)
Query: 7 RNQYILERTVGSGGFAKVKLA-THVLTGEKVAIKIMKKATLGEDLPRVKL---------- 55
R +G G F +V L L L VK+
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 56 -----EINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGE----LLDHIVERQRLGEK 106
E+ L +S +I +L V + M++EY G+ L H+ E L
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 107 ESRAFFR-------QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159
F QI S + YL L + HRDL N L+ +N +K+ DFG+
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 160 LESQLQTSCGSP-NYAAPE-VIKGKQYYGSETDVWSMGVMLYAL--LCGFLPFDSDSIDQ 215
++Q P + A E V+ GK + +++DVW+ GV L+ + LC P++ + Q
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 14 RTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
+ +GSG F V + G+ VAIK ++ + + + + A+ + H +I
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 70 KLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFR---QILSAVAYLHHLG 126
+L + +S + +V + P G LLDH+ RQ + + QI + YL
Sbjct: 73 RLLGICPGAS-LQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFG----LCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
HR+L N+LL + +++ DFG L + S+ +T + A E I
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI---KWMALESILFG 186
Query: 183 QYYGSETDVWSMGVMLYALL 202
+ Y ++DVWS GV ++ ++
Sbjct: 187 R-YTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 26/217 (11%)
Query: 16 VGSGGFAKVKLATHVLTGEK-----VAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70
+G G F KV E+ VAIK +K+ + + E + + H +I
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFR----------------Q 114
L V M+ EY G+L + +V + + + Q
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NY 173
I + + YL + HRDL N L+ +K+ DFGL ++Q+ P +
Sbjct: 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192
Query: 174 AAPEVI-KGKQYYGSETDVWSMGVMLYALLC-GFLPF 208
PE I GK + +E+D+WS GV+L+ + G P+
Sbjct: 193 MPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 60/226 (26%), Positives = 92/226 (40%), Gaps = 35/226 (15%)
Query: 7 RNQYILERTVGSGGFAKVKLATH--VLTGEK---VAIKIMKK---ATLGEDLPRVKLEIN 58
RN R +G G F +V A +L E VA+K++K+ A + D R E
Sbjct: 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAA 60
Query: 59 ALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL--------------LDHIVERQR-- 102
+ H +I KL V + ++ EY G+L L H R
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 103 ------LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156
L E +Q+ + +AYL + HRDL N L+ N +K+ DFGL
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 157 EGGLESQLQTSCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYAL 201
+ + P + PE I + Y +E+DVW+ GV+L+ +
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 37/129 (28%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
+G D WS+G ++Y +L G PF +++ + DKIL GK PP+++P +R +++ +L+
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLK 236
Query: 474 VEPGKR----------IKIQDLLGH-NW-----VKMGPEDNPLREKDDDVIKVMADH-KQ 516
P R ++ H NW K+ P PL + ++DV + + +Q
Sbjct: 237 RNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQ 296
Query: 517 L---SPDDM 522
SPDD
Sbjct: 297 TPVDSPDDS 305
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 26/87 (29%), Positives = 38/87 (43%), Gaps = 5/87 (5%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEPP--WMSPNSRQ 466
+ Y D+WS+G+ L G PF S +L I +G P SP R
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKM 493
+ + LQ +P KR +LL H ++K
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 27/74 (36%), Positives = 46/74 (62%), Gaps = 1/74 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
Y + D++S+GV+LY LL PFD ++++++ K L G+Y PP +SP ++IV ++L
Sbjct: 222 YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALL 281
Query: 473 QVEPGKRIKIQDLL 486
+P +R LL
Sbjct: 282 SSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 41/166 (24%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 56 EINALKHISHQHICKLFQVIETSSHIFMVIE------YCPGGELLDHIVERQRLGEKESR 109
E + L+ I+H I +L + +++ YC ++ ++ + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC-------YLAAKRNIAICDIL 185
Query: 110 AFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169
A R +L A+ YLH HRD+K EN+ ++ ++ L DFG P ++ G
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYAL-LCGFLPFDSDSID 214
+ APE++ + YG D+WS G++L+ + C F+ D +D
Sbjct: 246 TIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290
|
Length = 391 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 71/324 (21%), Positives = 122/324 (37%), Gaps = 74/324 (22%)
Query: 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALK 61
R++ L + +G G F KV A+ + VA+K++K+ + + E+ L
Sbjct: 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILI 65
Query: 62 HI-SHQHICKLFQVIETSSHIFMVI-EYCPGGELLDHI---------------------- 97
HI +H ++ L + MVI E+C G L + +
Sbjct: 66 HIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFR 125
Query: 98 -------VERQRLGEKESRAFFR---------------------------------QILS 117
V+R+ + S F R Q+
Sbjct: 126 AMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVAR 185
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAP 176
+ +L HRDL N+LL N +K+ DFGL + + S P + AP
Sbjct: 186 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245
Query: 177 EVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG--KYTEPPWMSP 233
E I K Y +++DVWS GV+L+ + G P+ I++ + + L + P +P
Sbjct: 246 ESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATP 304
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLL 257
+I+ + Q +P +R L+
Sbjct: 305 EIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 27/99 (27%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 389 CKVGQVINLLRSAIVLCSAPS-------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS 441
CK G + + + C P + YG D W++GV++Y ++ G PF++D+
Sbjct: 143 CKEGILNGVTTTT--FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
Query: 442 IDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRI 480
D L++ IL+ P W+S + I+++ + P KR+
Sbjct: 201 EDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 407 APSSKQYYGSET--DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS 464
AP Q G D W++G+++Y +L G+ PF D+ +Y+KIL GK P + +
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYA 225
Query: 465 RQIVRSMLQVEPGKRI-----KIQDLLGHNWVK 492
+ +++ +L V+ +R+ D+ H W K
Sbjct: 226 KDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 25/206 (12%)
Query: 36 VAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLD 95
VA+KI++ E+ L + +I +L V + M+ EY G+L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 96 HIVERQRLGEKESRA-------------------FFRQILSAVAYLHHLGYAHRDLKPEN 136
+ ++E+ QI S + YL L + HRDL N
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168
Query: 137 VLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVI-KGKQYYGSETDVWSM 194
L+ N +K+ DFG+ G ++Q P + A E I GK + + +DVW+
Sbjct: 169 CLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAF 226
Query: 195 GVMLYALL--CGFLPFDSDSIDQLYD 218
GV L+ +L C P+ + +Q+ +
Sbjct: 227 GVTLWEILMLCKEQPYGELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 56/231 (24%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 15 TVGSGGFAKVKLA----THVLTGEK-VAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
T+G G F +V LA GE V +K ++K + E++ + +SH+++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 70 KLF-QVIETSSHIFMVIEYCPGGEL---------LDHIVERQRLGEKESRAFFRQILSAV 119
+L E H +M++EY G+L D ++ L K+ A QI +
Sbjct: 72 RLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
+L + + HRDL N L+ + +K+ L +L+ + + APE +
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 180 KGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPP 229
+ + +++DVWS GV+++ + G LPF S +++ +++ GK P
Sbjct: 191 QEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 26/70 (37%), Positives = 37/70 (52%), Gaps = 1/70 (1%)
Query: 109 RAFFRQILSAVAYLHHLGYAHRDLKPENVLLD-RNQNLKLIDFGLCAKPEGGLESQLQTS 167
+ RQIL A+ LH G HRD+KP+N++ + + K+ID G A G+ +
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 168 CGSPNYAAPE 177
P YAAPE
Sbjct: 318 LLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 60/266 (22%), Positives = 110/266 (41%), Gaps = 22/266 (8%)
Query: 11 ILERTVGSGGFAKV---KLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQ 66
L + +G G F V +L+ + KVA+K MK ++ E +K H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 67 HICKLFQVIETSSHI------FMVIEYCPGGELLDHIVERQRLGEKESR-------AFFR 113
++ KL V +S + +++ + G+L ++ RLG + F
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFMV 120
Query: 114 QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP-EGGLESQLQTSCGSPN 172
I + YL + + HRDL N +L + + + DFGL K G Q + +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPW 230
+ A E + + Y S++DVW+ GV ++ + G P+ ++YD + +G + +P
Sbjct: 181 WIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239
Query: 231 MSPNSRQIVRSMLQVEPGKRIKIQDL 256
++ S + +P R L
Sbjct: 240 CLDELYDLMYSCWRADPKDRPTFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 21/46 (45%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---QLYDKILS 368
G YG + DVWS+GV+LY LL G PF ++I QL +IL
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILG 216
|
Length = 260 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 25/84 (29%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----KYTEPPWMSPNS 464
K YG E D WS+GV+ Y ++ G PF + + Y+ I+N K+ E P +S +
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 465 RQIVRSMLQVEPGKRIKIQDLLGH 488
+++S+L +R+ + L H
Sbjct: 241 LDLIQSLL-CGQKERLGYEGLCCH 263
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 24/69 (34%), Positives = 37/69 (53%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471
Q YG D W+ GV+LY +L G PF+ + D+L+ I+ P MS + I + +
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235
Query: 472 LQVEPGKRI 480
+ PGKR+
Sbjct: 236 MTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 45/233 (19%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPR----VKLEINALKHISHQHICKL 71
+G G F KV A E A+KI++ ++P+ K+EI ++ +
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVR------NVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 72 FQVIET-------SSHIFMVI-EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
F +++ + H+ +V+ +Y P LLD I++ + Q A+ Y H
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPC--LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH 248
Query: 124 -HLGYAHRDLKPENVLLDRNQN----------------LKLIDFGLCAKPEGGLESQLQT 166
L H DLKPEN+L++ + +++ D G C E +T
Sbjct: 249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD-----ERHSRT 303
Query: 167 SCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLY 217
+ S +Y +PEV+ G + S TD+WSMG ++Y L G L +D+ D+++ L+
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355
|
Length = 467 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 25/69 (36%), Positives = 39/69 (56%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471
Q Y D WS GV+LY +L G PF + D+L+D ILN + P W+S ++ + +
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230
Query: 472 LQVEPGKRI 480
+ +P KR+
Sbjct: 231 FERDPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 67/289 (23%), Positives = 123/289 (42%), Gaps = 27/289 (9%)
Query: 7 RNQYILERTVGSGGFAKV--KLATHVLTGE---KVAIK-IMKKATLGEDLPRVKLEINAL 60
R + L R +G G F V A ++ GE +VA+K + + A+L E + + E + +
Sbjct: 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN-EASVM 63
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGE----------KESRA 110
K + H+ +L V+ +V+E G+L ++ + E +E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 111 FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170
+I +AYL+ + HRDL N ++ + +K+ DFG+ E+ G
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRKGGK 180
Query: 171 P----NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY 225
+ APE +K + + +D+WS GV+L+ + P+ S +Q+ +++G Y
Sbjct: 181 GLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 226 TEPPWMSPNSRQIVRSML-QVEPGKRIKIQDLLGHNWVKMGPEDNPVSF 273
+ P P + M Q P R +++ + P VSF
Sbjct: 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 19/177 (10%)
Query: 56 EINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRL---GEKESRAFF 112
EI + + +I +L V TS + M+ EY G+L + + R EK
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTI 127
Query: 113 R---------QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163
QI S + YL L + HRDL N L+ +N +K+ DFG+ G +
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 164 LQTSCGSP-NYAAPE-VIKGKQYYGSETDVWSMGVMLYALL--CGFLPFDSDSIDQL 216
+Q P + + E ++ GK + + +DVW+ GV L+ +L C P+ S +Q+
Sbjct: 188 IQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 1/80 (1%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM-SPNSRQIV 468
+ Y ++D+WS+G ++Y L PF + + QL KI GK+ P+ S +++
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVI 242
Query: 469 RSMLQVEPGKRIKIQDLLGH 488
+SML V+P KR ++LL
Sbjct: 243 KSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 21/67 (31%), Positives = 42/67 (62%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
YG D W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++ +L+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 231
Query: 474 VEPGKRI 480
+P +R+
Sbjct: 232 KDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 24/69 (34%), Positives = 37/69 (53%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471
Q YG D W+ GV+LY +L G PFD + D+L+ I+ + P +S + I + +
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235
Query: 472 LQVEPGKRI 480
L P KR+
Sbjct: 236 LTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 69/325 (21%), Positives = 114/325 (35%), Gaps = 73/325 (22%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTG-----EKVAIKIMKKATLGEDLPRVKLEINALK 61
R++ L + +G G F KV A+ VA+K++K+ + + E+ L
Sbjct: 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILI 65
Query: 62 HISHQ-HICKLFQVIETSSHIFMVI-EYCP------------------------GGELLD 95
HI H ++ L MVI EYC E+
Sbjct: 66 HIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQ 125
Query: 96 HIVERQRLGEKESR-------------------------------------AFFRQILSA 118
++QRL S ++ Q+
Sbjct: 126 KEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARG 185
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPE 177
+ +L HRDL N+LL N +K+ DFGL + + P + APE
Sbjct: 186 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLY-DKILNG-KYTEPPWMSPN 234
I K Y +++DVWS GV+L+ + G P+ ID+ + ++ G + P + +P
Sbjct: 246 SIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPE 304
Query: 235 SRQIVRSMLQVEPGKRIKIQDLLGH 259
I+ P R +L+
Sbjct: 305 IYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 60/267 (22%), Positives = 112/267 (41%), Gaps = 29/267 (10%)
Query: 7 RNQYILERTVGSGGFAKV--KLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALK 61
R + + R +G G F V +A V+ E +VAIK + +A + E + +K
Sbjct: 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 64
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA----------- 110
+ H+ +L V+ +++E G+L ++ R E E+
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMI 122
Query: 111 -FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169
+I +AYL+ + HRDL N ++ + +K+ DFG+ E+ G
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRKGG 179
Query: 170 SP----NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK 224
+ +PE +K + + +DVWS GV+L+ + P+ S +Q+ ++ G
Sbjct: 180 KGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238
Query: 225 YTEPPWMSPNSR-QIVRSMLQVEPGKR 250
+ P P+ +++R Q P R
Sbjct: 239 LLDKPDNCPDMLFELMRMCWQYNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 19/126 (15%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-----EP 457
VL YG E D WS+GV+LY +L GF PF SD++ + Y+KI+N K + +P
Sbjct: 201 VLRG-----TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDP 255
Query: 458 PWMSPNSRQIVRSMLQVEPGKRIK-IQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQ 516
P SP + ++ +L +P R+ +++ H + K +N K V ++
Sbjct: 256 PV-SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPELS----- 308
Query: 517 LSPDDM 522
SP D
Sbjct: 309 -SPLDT 313
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 23/69 (33%), Positives = 37/69 (53%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471
Q YG D W+ GV+LY +L G PFD + D+L+ I+ + P +S + I + +
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235
Query: 472 LQVEPGKRI 480
+ P KR+
Sbjct: 236 MTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 24 VKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82
V LA + TGE V ++ I +A E + ++ E++ K +H +I + ++
Sbjct: 16 VNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 75
Query: 83 MVIEYCPGGELLDHIVERQRLGEKE-SRAFFRQ-ILSAVAYLHHLGYAHRDLKPENVLLD 140
+V + G D I G E + A+ Q +L A+ Y+HH+GY HR +K ++L+
Sbjct: 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135
Query: 141 RN---------QNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA-------PEVIKGK-Q 183
+ NL +I+ G +L+ P Y+ PEV++ Q
Sbjct: 136 VDGKVYLSGLRSNLSMINHG----------QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ 185
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG 223
Y +++D++S+G+ L G +PF Q+ + LNG
Sbjct: 186 GYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 17/41 (41%), Positives = 26/41 (63%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ YG D WS+GV+LY +L G PF ++ ++Y+KIL
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 25/70 (35%), Positives = 38/70 (54%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
KQ Y D W +G +LY +L G PF S ++YD ILN P +S ++R ++
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEG 229
Query: 471 MLQVEPGKRI 480
+LQ + KR+
Sbjct: 230 LLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 21/67 (31%), Positives = 42/67 (62%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
YG D W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++ +L+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLK 232
Query: 474 VEPGKRI 480
+P +R+
Sbjct: 233 KDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 35/117 (29%), Positives = 54/117 (46%), Gaps = 18/117 (15%)
Query: 392 GQVINLLRSAIVLCS---APSSKQ--YYGSETDVWSMGVMLYALLCGFLPF-----DSDS 441
GQ++N L V S AP Q Y ++D+WS+G+ L L G P+ D
Sbjct: 149 GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 442 IDQLYDKILNGKYTEPPWM-----SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493
I +L I+N PP + SP+ + V L +P +R ++LL H ++K
Sbjct: 209 IFELLQYIVNE---PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 4e-07
Identities = 18/42 (42%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILS 368
+ YG D+WS+GV+LY LL G PF D + +L+ KI
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 211
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 23/85 (27%), Positives = 36/85 (42%), Gaps = 5/85 (5%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILNGKYTEPPWMSPNSRQI 467
+Q Y D WS+GV Y L G P+ DQ+ K P S +
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232
Query: 468 VRSMLQVEPGKRI--KIQDLLGHNW 490
+ +L+ +P KR+ ++DL H +
Sbjct: 233 INKLLERDPQKRLGDNLKDLKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 1/82 (1%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471
Y D WS GV+LY +L G PF D D+L++ I P W++ S+ I+ +
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL 230
Query: 472 LQVEPGKRIKIQ-DLLGHNWVK 492
+ +P +R+ + ++ GH + K
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 25/74 (33%), Positives = 41/74 (55%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
KQ Y D W +G +LY +L G PF S + ++YD ILN P ++ ++R ++
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 229
Query: 471 MLQVEPGKRIKIQD 484
+LQ + KR+ +D
Sbjct: 230 LLQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 16 VGSGGFAKVKLATHVLTG----EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
+G F K+ L G + VAIK +K + + E + + + H +I L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQ-----------------RLGEKESRAFFRQ 114
V+ + M+ EY G+L + ++ R L + Q
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NY 173
I + + YL + H+DL N+L+ ++K+ D GL + ++Q P +
Sbjct: 133 IAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRW 192
Query: 174 AAPE-VIKGKQYYGSETDVWSMGVMLYALLC-GFLPF 208
PE ++ GK + S++D+WS GV+L+ + G P+
Sbjct: 193 MPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 5/150 (3%)
Query: 114 QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-N 172
Q+ + +L HRDL N+LL N +K+ DFGL + + P
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILN--GKYTEPP 229
+ APE I + Y ++DVWS GV+L+ + G P+ ID+ + + L + P
Sbjct: 247 WMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 305
Query: 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
+ +P Q + EP +R +L+ H
Sbjct: 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 41/197 (20%)
Query: 56 EINALKHISHQHICKLFQVIETSS--HIFMVIEYCPGGELLDHIVERQRLGEKESR---- 109
EI L+ + H ++ L +V + S ++++ +Y L HI++ R + +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD--LWHIIKFHRASKANKKPMQL 105
Query: 110 ------AFFRQILSAVAYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCA----- 154
+ QIL + YLH HRDLKP N+L+ +K+ D G
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 155 -KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--------- 204
KP L+ + T Y APE++ G ++Y D+W++G + LL
Sbjct: 166 LKPLADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
Query: 205 ----FLPFDSDSIDQLY 217
PF D +D+++
Sbjct: 222 DIKTSNPFHHDQLDRIF 238
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 24/69 (34%), Positives = 37/69 (53%)
Query: 109 RAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC 168
+ RQ+L+ + LH +G HRD+KPEN+L+ + +K+IDFG G+
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM 371
Query: 169 GSPNYAAPE 177
P Y+ PE
Sbjct: 372 LDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 21/67 (31%), Positives = 42/67 (62%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
YG D W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++ +L+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLK 231
Query: 474 VEPGKRI 480
+P +R+
Sbjct: 232 KDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 47/204 (23%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKK----ATLGEDLPRVKLEINALKHISHQHICKL 71
+G+G F KV L G A ++K+ AT E L ++ E+ + ++H ++ +
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFLQ-EVQPYRELNHPNVLQC 60
Query: 72 F-QVIETSSHIFMVIEYCPGGELLDHIVERQRL--GEKESRAFFR---QILSAVAYLHHL 125
Q IE+ ++ +V+E+CP G+L +++ + + + R ++ S + +LH
Sbjct: 61 LGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGL--CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
+ H DL N L + ++K+ D+GL PE ++ + + APE+++ +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIRG 178
Query: 184 Y------YGSETDVWSMGVMLYAL 201
++++WS+GV ++ L
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 23/64 (35%), Positives = 37/64 (57%), Gaps = 4/64 (6%)
Query: 413 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----YTEPPWMSPNSRQIV 468
YYG E D WS+GV LY +L G PF +DS+ Y KI++ K + + +S ++ ++
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLI 282
Query: 469 RSML 472
+ L
Sbjct: 283 CAFL 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 1/68 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIVRSML 472
Y D WS+GV+++ + CG+ PF ++ Q+Y I GK P +S RQ V+ +L
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLL 233
Query: 473 QVEPGKRI 480
P R+
Sbjct: 234 NRNPQHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 16/234 (6%)
Query: 14 RTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70
R +G G F V T + + + A+K + + T E++ + E +K SH ++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 71 LFQVI---ETSSHIFMVIEYCPGGELLDHIVERQRLGE-KESRAFFRQILSAVAYLHHLG 126
L + E S + V+ Y G+L + I K+ F Q+ + YL
Sbjct: 61 LLGICLPSEGSPLV--VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP---NYAAPEVIKGKQ 183
+ HRDL N +LD + +K+ DFGL + G+ + A E ++ Q
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ-TQ 177
Query: 184 YYGSETDVWSMGVMLYALLC-GFLPF-DSDSIDQLYDKILNGKYTEPPWMSPNS 235
+ +++DVWS GV+L+ L+ G P+ D DS D + +L G+ P P+
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-ITVYLLQGRRLLQPEYCPDP 230
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 56 EINALKHISHQHICKLFQVI--ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESR---- 109
EI L+ + H ++ L +V ++++ +Y L HI++ R + +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD--LWHIIKFHRASKANKKPVQL 105
Query: 110 ------AFFRQILSAVAYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCA----- 154
+ QIL + YLH HRDLKP N+L+ +K+ D G
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 155 -KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALL 202
KP L+ + T Y APE++ G ++Y D+W++G + LL
Sbjct: 166 LKPLADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 7/81 (8%)
Query: 419 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSMLQV 474
D WS+G +++ L G+ PF +++ D ++D IL+ + P + SP + ++ +L +
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234
Query: 475 EPGKRIK---IQDLLGHNWVK 492
+P KR+ Q++ H + K
Sbjct: 235 DPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 23/74 (31%), Positives = 37/74 (50%), Gaps = 1/74 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM-SPNSRQIVRSML 472
Y ++DVW++GV+LY G PFD+++ L KI+ G + M S Q++ L
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 473 QVEPGKRIKIQDLL 486
+ +R LL
Sbjct: 238 TKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 16/38 (42%), Positives = 26/38 (68%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
YG D W++G+++Y +L G+ PF D+ Q+Y+KIL
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 22/69 (31%), Positives = 40/69 (57%), Gaps = 2/69 (2%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSM 471
+GS D W++G++LY +L G PF + D+ + IL + P +S ++R ++R +
Sbjct: 209 HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKL 268
Query: 472 LQVEPGKRI 480
L +P KR+
Sbjct: 269 LVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 21/71 (29%), Positives = 41/71 (57%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
++ Y D W +GV++Y +L G PF D ++++D I+N + P ++S + I+R
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR 233
Query: 470 SMLQVEPGKRI 480
+L+ P +R+
Sbjct: 234 RLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 21/67 (31%), Positives = 40/67 (59%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
YG D W +GV++Y ++CG LPF + ++L++ IL P +S +++ ++ +L
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLI 231
Query: 474 VEPGKRI 480
+P KR+
Sbjct: 232 KDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 22/47 (46%), Positives = 29/47 (61%)
Query: 323 RKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+ + G YYG E D WS+GV LY +L G PF +DS+ Y KI+ H
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH 262
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 22/47 (46%), Positives = 30/47 (63%)
Query: 323 RKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+ + G YYG E D WS+GV LY +L G PF +DS+ Y KI++H
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWM--SPNSRQIVR 469
Y E D WS+GV++Y +L G+ PF SD+ + Y KI+N K T P + SP ++ +++
Sbjct: 216 YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIK 275
Query: 470 SMLQVEPGKRIK---IQDLLGHNWVKMGPEDNPLREK 503
+ E +R+ + ++ H + K G + +RE+
Sbjct: 276 RLC-CEAERRLGNNGVNEIKSHPFFK-GVDWEHIRER 310
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 11/86 (12%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-------WMSP 462
S+ YG+E D+WS+G+M+ ++ G P+ SDS Q ++ + PP +SP
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----SPPPKLKNAHKISP 245
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGH 488
R + ML EP +R Q+LL H
Sbjct: 246 VLRDFLERMLTREPQERATAQELLDH 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 34 EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93
+ VAIK +K G K E + H +I L V+ + M+ YC +L
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 94 LDHIVERQRLGEK-------------ESRAFFR---QILSAVAYL--HHLGYAHRDLKPE 135
+ +V R + E F QI + + +L HH+ H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHV--VHKDLATR 153
Query: 136 NVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIK-GKQYYGSETDVWS 193
NVL+ N+K+ D GL + +L + P + +PE I GK + ++D+WS
Sbjct: 154 NVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWS 211
Query: 194 MGVMLYALLC-GFLPF 208
GV+L+ + G P+
Sbjct: 212 YGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 23/273 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHV-LTGE----KVAIKIMKKATLGEDLPRVKLEINALK 61
R+ L R +G G F +V + G+ +VA+K + ++ +D +E +
Sbjct: 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS 64
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFF------RQ 114
+HQ+I +L V F+++E GG+L + E R R S R
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGLCAKPEGGLESQLQTSCGS- 170
+ YL + HRD+ N LL + K+ DFG+ A+ +
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM-ARDIYRASYYRKGGRAML 183
Query: 171 P-NYAAPEV-IKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE 227
P + PE + G + S+TDVWS GV+L+ + G++P+ + ++ + + G +
Sbjct: 184 PIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241
Query: 228 PPWMSPNS-RQIVRSMLQVEPGKRIKIQDLLGH 259
PP P +I+ Q P R +L
Sbjct: 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALK 61
R+ +L RT+GSG F +V AT H + KVA+K++K + + E+ +
Sbjct: 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMS 95
Query: 62 HIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHI 97
H+ H +I L I+++ EYC G+L+D++
Sbjct: 96 HLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 49.4 bits (116), Expect = 3e-06
Identities = 17/79 (21%), Positives = 31/79 (39%)
Query: 324 KKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFP 383
Y S +D+WS+G+ LY LL G PF+ + + L + + T ++
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 384 TILLPCKVGQVINLLRSAI 402
+LL+ +
Sbjct: 241 PSNPELISKAASDLLKKLL 259
|
Length = 384 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 1/67 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSML 472
Y ++D+W++G +LY LL FD+ + L KI+ G YT S +V S+L
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237
Query: 473 QVEPGKR 479
Q +P KR
Sbjct: 238 QQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 21/52 (40%), Positives = 30/52 (57%)
Query: 323 RKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPIC 374
+ + G YYG E D WS+GV L+ +L G PF +DS+ Y KI+ H +
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 5/145 (3%)
Query: 110 AFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169
+F Q+ +++L HRDL N+LL + K+ DFGL ++ +
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 170 SP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID-QLYDKILNGKYT 226
P + APE I Y E+DVWS G++L+ + G P+ +D + Y I G
Sbjct: 278 LPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336
Query: 227 EPPWMSPNSR-QIVRSMLQVEPGKR 250
P +P+ I++S +P KR
Sbjct: 337 LSPECAPSEMYDIMKSCWDADPLKR 361
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
YG D W+MGV+LY +LCG PF++++ D L++ IL+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 23/71 (32%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
+ D WS+GV+ + LL G PF D S ++ +IL K P MS +R ++
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQ 244
Query: 470 SMLQVEPGKRI 480
+L+ +P KR+
Sbjct: 245 KLLEKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 22/76 (28%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
Y ++D+W++G +LY L F++ ++ L KI++G + SP+ RQ++ SML
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237
Query: 473 QVEPGKRIKIQDLLGH 488
++P KR ++ ++
Sbjct: 238 NLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 19/73 (26%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW---MSPNSRQI 467
+Q YG D W+MG++LY L G +PF D+ ++L+ ++++ P + +++ +
Sbjct: 190 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDL 249
Query: 468 VRSMLQVEPGKRI 480
+ +L+ P +R+
Sbjct: 250 ISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 24/71 (33%), Positives = 32/71 (45%), Gaps = 8/71 (11%)
Query: 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR 141
+V+EY G ELL +E R R++ V LH G H DL N++L
Sbjct: 75 LIVMEYIEG-ELLKDALEEARPD------LLREVGRLVGKLHKAGIVHGDLTTSNIIL-S 126
Query: 142 NQNLKLIDFGL 152
+ IDFGL
Sbjct: 127 GGRIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 46/230 (20%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+Q + + + + ++ G KV I I + EI L+ I +
Sbjct: 32 DQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITEN------------EIKNLRRIDSNN 79
Query: 68 ICKLF----QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
I K++ +++ + +++EYC G L + + + + L K + L+
Sbjct: 80 ILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTK---LDMAIDCCKGLY 136
Query: 124 HL----GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
+L +++L + L+ N LK+I GL E L S + Y + +++
Sbjct: 137 NLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVNFMVYFSYKML 192
Query: 180 KGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP 228
Y + D++S+GV+L+ + G +PF++ + ++YD I+N +
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK 242
|
Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 110 AFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169
+F Q+ + +L HRDL NVLL + + +K+ DFGL + S G
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI---MHDSNYVSKG 297
Query: 170 SP----NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQ-LYDKILNG 223
S + APE I Y + +DVWS G++L+ + G P+ +D Y+KI +G
Sbjct: 298 STFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
Query: 224 KYTEPPWMSPNS-RQIVRSMLQVEPGKR 250
P + I+ EP KR
Sbjct: 357 YRMAKPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 21/72 (29%), Positives = 37/72 (51%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471
Q Y + D WS GV+LY +L G PF ++L+ I P W++ ++ I+ +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL 230
Query: 472 LQVEPGKRIKIQ 483
EP +R+ ++
Sbjct: 231 FVREPERRLGVK 242
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 22/41 (53%), Positives = 27/41 (65%)
Query: 413 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK 453
YYG E D WS+GV LY +L G PF +DS+ Y KI+N K
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 20/43 (46%), Positives = 29/43 (67%)
Query: 327 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
GK YG E D WS+GV +Y +L G PF ++S+ + Y KI++H
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSID---QLYDKI--LNGKYTEPPWMSPNSRQ 466
+ YG DVWS+G ++ + P++++ L KI + P +SP R
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD 242
Query: 467 IVRSMLQVEPGKRIKIQDLLGH 488
+ L+++P R ++LL H
Sbjct: 243 VTLRCLELQPEDRPPSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 17/51 (33%), Positives = 28/51 (54%)
Query: 319 LLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+L + GK YG E D WS+GV+ Y ++ G PF + + Y+ I++
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 16/145 (11%)
Query: 98 VERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157
V + L E+E A Q L A+ LH + L + LL G A
Sbjct: 9 VRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DGSVAFKT 60
Query: 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQL 216
+ S P + APEVI+G Q Y + D++S+G+ LY L LP + + +
Sbjct: 61 P------EQSRPDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAI 113
Query: 217 YDKILNGKYTEPPWMSPNSRQIVRS 241
+ +LNG + P N + +
Sbjct: 114 LEILLNGMPADDPRDRSNLEGVSAA 138
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 19/131 (14%)
Query: 114 QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS---CGS 170
QI ++YLH G H+D+ N ++D +K+ D L L C
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD--------NALSRDLFPMDYHCLG 176
Query: 171 PN------YAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG 223
N + A E + + Y S +DVWS GV+L+ L+ G P+ ++ + +G
Sbjct: 177 DNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235
Query: 224 KYTEPPWMSPN 234
P P+
Sbjct: 236 YRLAQPINCPD 246
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 9e-06
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 2/49 (4%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS-HFMPI 373
Q K Y ++D+WS+G +LY L PF+ +++ +L KIL + PI
Sbjct: 176 QNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 23/87 (26%), Positives = 40/87 (45%), Gaps = 7/87 (8%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPP----WMSPNS 464
+ YG D+WS+G + + G P+ + + KI G EPP +S +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI--GSSGEPPEIPEHLSEEA 233
Query: 465 RQIVRSMLQVEPGKRIKIQDLLGHNWV 491
+ +R L+ +P KR +LL H ++
Sbjct: 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 24/86 (27%), Positives = 44/86 (51%), Gaps = 3/86 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---KYTEPPWMSPNSRQ 466
S+ YG+E D+WS+G+M+ ++ G P+ ++ Q +I + K +SP R
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVK 492
+ ML +P +R +LL H ++
Sbjct: 248 FLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 21/50 (42%), Positives = 32/50 (64%)
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+L + GK YG E D WS+GV +Y +L G PF ++S+ + Y KI++H
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 24/74 (32%), Positives = 40/74 (54%), Gaps = 1/74 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
Y ++TD+WS+G +LY L PF+ +++ QL KI G + P S + R ++ +
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238
Query: 473 QVEPGKRIKIQDLL 486
+V P R I +L
Sbjct: 239 KVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 28/108 (25%), Positives = 53/108 (49%), Gaps = 15/108 (13%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW------MSPNS 464
+ +G D W++GV L+ L G PF+ ++ Q++ ILN + PW +S N+
Sbjct: 554 GKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN---RDIPWPEGEEKLSVNA 610
Query: 465 RQIVRSMLQVEPGKRIKIQDLLGH------NWVKMGPEDNPLREKDDD 506
+ + +L ++P KR +++L H +W + + P + DD
Sbjct: 611 QNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPDD 658
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 2/52 (3%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPN 463
Y D WS+G MLY LCGF PF + ++ ++ + K T P + P
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 36/141 (25%), Positives = 58/141 (41%), Gaps = 24/141 (17%)
Query: 389 CKVGQVINLLRSAIVLCSAPS-------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS 441
CK G I + C P KQ Y + D W +G +LY +L G PF
Sbjct: 143 CKEG--IAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200
Query: 442 IDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQD----LLGH------NWV 491
+ ++YD IL+ P S + I+ +L+ + +R+ ++ + H +W
Sbjct: 201 VAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT 260
Query: 492 -----KMGPEDNPLREKDDDV 507
K+ P NP E DD+
Sbjct: 261 DLEQKKIPPPFNPNVEGPDDI 281
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 13/41 (31%), Positives = 23/41 (56%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
Q + D WS+G +LY L G PF ++ ++++ IL+
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 18/41 (43%), Positives = 25/41 (60%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
Q YG D W++GV+LY +L G PF+ D D+L+ IL
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 20/70 (28%), Positives = 35/70 (50%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
K+ Y D W +G +LY +L G PF S + Q+YD IL+ P + + ++
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVG 229
Query: 471 MLQVEPGKRI 480
+L + +R+
Sbjct: 230 LLHKDQRRRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 23/66 (34%), Positives = 38/66 (57%), Gaps = 4/66 (6%)
Query: 419 DVWSMGVMLYALLCGFLPF----DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 474
D WSMGV++Y LL G PF + +S ++ +IL + P MS ++ I++ +L
Sbjct: 190 DWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMK 249
Query: 475 EPGKRI 480
+P KR+
Sbjct: 250 DPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 5/144 (3%)
Query: 111 FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170
F Q+ + +L HRD+ NVLL + K+ DFGL ++ +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 171 P-NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY--T 226
P + APE I Y ++DVWS G++L+ + G P+ ++ + K++ Y +
Sbjct: 277 PVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS 335
Query: 227 EPPWMSPNSRQIVRSMLQVEPGKR 250
P + P I++ +EP +R
Sbjct: 336 RPDFAPPEIYSIMKMCWNLEPTER 359
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 23/89 (25%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
Y D W++GV+LY +L G PF ++++++Y KIL P +++ ++ +L
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLS 229
Query: 474 VEPGKRIKI---QDLLGH------NWVKM 493
+P +R+ Q++ H +W K+
Sbjct: 230 RDPTRRLGYNGAQEIKNHPFFSQLSWKKL 258
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 24/75 (32%), Positives = 43/75 (57%), Gaps = 5/75 (6%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEPPW- 459
+L + K YG E D WS+GV +Y +L G PF ++S+ + Y KI+N K + P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
Query: 460 --MSPNSRQIVRSML 472
+S +++ ++R ++
Sbjct: 234 TDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 17/39 (43%), Positives = 22/39 (56%), Gaps = 2/39 (5%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQL--YDKIL 367
Y D WS+G++LY LL G PF D D + Y+ IL
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
+GK Y D WS+G MLY LCGF PF + ++ ++ +
Sbjct: 171 RGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 413 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----YTEPPWMSPNSRQIV 468
YYG E D WS+GV L+ +L G PF +DS+ Y KI++ K + E +S +++ ++
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLI 282
Query: 469 RSML---QVEPGKRIKIQDLLGHNWVK 492
+ L +V G R ++++ H + K
Sbjct: 283 CAFLTDREVRLG-RNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 20/65 (30%), Positives = 37/65 (56%), Gaps = 4/65 (6%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EPPWMSPNSRQI 467
Q YG E D WS+G +++ L G+ PF S++ + Y KI+N + T + +S + +
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDL 282
Query: 468 VRSML 472
+R ++
Sbjct: 283 IRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 406 SAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTEPPWM---- 460
P Y DVWS+G+ L L G P+ + + ++ KIL EPP +
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEPPSLPPNE 243
Query: 461 --SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
SP+ V L + KR K ++LL H +++
Sbjct: 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 20/42 (47%), Positives = 29/42 (69%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
YG E D WS+GV+LY +L GF PF SD++ + Y+KI++
Sbjct: 204 GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 19/75 (25%), Positives = 41/75 (54%), Gaps = 4/75 (5%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPF----DSDSIDQLYDKILNGKYTEPPWMSPNSR 465
K +G D WS+G++++ LL G PF + ++ ++ +IL P ++ P ++
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239
Query: 466 QIVRSMLQVEPGKRI 480
++ +L+ +P KR+
Sbjct: 240 DLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
Q YG D W+ GV+LY +L G PF+ + D+L+ I+ H
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-----TEPPWMSPNSR 465
K YG E D WS+GV +Y +L G PF ++S+ + Y KI+N K + +S ++
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241
Query: 466 QIVRSMLQVEPGKRI---KIQDLLGHNW 490
++R ++ P R+ +QD H +
Sbjct: 242 DLIRRLI-CSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 26/236 (11%)
Query: 12 LERTVGSG--GFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHI 68
L+ +G G V LA H TG V ++I E+ L ++ E+ H +I
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 69 CKLFQVIETSSHIFMV---IEYCPGGELLDHIVERQRLGEKESRAFFRQIL----SAVAY 121
+ V T S ++++ + Y LL + E S A IL + Y
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLL-----KTYFPEGMSEALIGNILFGALRGLNY 116
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFG-LCAKPEGGLESQL-----QTSCGSPNYAA 175
LH GY HR++K ++L+ + + L L + G ++++ Q S + +
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 176 PEVIKGKQY-YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW 230
PE+++ Y Y ++D++S+G+ L G +PF D L ++L K PP+
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPF----QDMLRTQMLLQKLKGPPY 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMK--KATLGEDLPRVKLEINALKHI-SHQHICK-L 71
+G+G F KV L + + T VA ++K KA L+ I H +I + L
Sbjct: 3 IGNGWFGKV-LLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRL-GEKESRAFFR---QILSAVAYLHHLGY 127
Q +E +V EYC G+L ++ + Q + R +I + V ++H +
Sbjct: 62 GQCVEAIP-YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS---CGSPNYAAPEVI---KG 181
H DL N L + +K+ D+G+ P E ++T C + APE++ G
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGI--GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 182 KQYYGSET---DVWSMGVMLYALL 202
+T +VW++GV L+ L
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 50/217 (23%)
Query: 9 QYILERTVGSGGFAKV----KLATHVLTGEKVA-IKIMKKATLGE---------DLPRVK 54
++ +++ +G GGF V + H + + VA I+ ++ T+ D+ ++
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72
Query: 55 LEINALKHISHQHI-----CKLFQVIETSSHIFMVIE--YCPGGELLDHIVERQRLGEKE 107
L N + +I H I C F+ + F+++E E+ I + + K
Sbjct: 73 LWKN-IHNIDHLGIPKYYGCGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNK---KL 127
Query: 108 SRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167
+ + +L+ + Y+H G +H D+KPEN+++D N +ID+G+
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGI--------------- 172
Query: 168 CGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALL 202
A+ +I GK +Y + D G + YA L
Sbjct: 173 ------ASHFIIHGKHIEYSKEQKD-LHRGTLYYAGL 202
|
Length = 294 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 34/85 (40%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPN 463
AP K YY ++D+WS+GV+LY L P
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PE 189
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGH 488
+ ++R MLQ +P KR +++L H
Sbjct: 190 LKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 23/87 (26%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGK--YTEPPWMSPNSRQ 466
+++ YG + D+WS+G+M ++ G P+ + + + LY NG P +S R
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKM 493
+ L+++ KR ++LL H ++K+
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 20/50 (40%), Positives = 31/50 (62%)
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+L + G YG E D WS+GV +Y +L G PF ++S+ + Y KI++H
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 18/41 (43%), Positives = 25/41 (60%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
Q YG D W+ GV+LY +L G PFD + D+L+ I+ H
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 9e-05
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 29/108 (26%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYD--KIL---------------NGK 453
++Y + D+WS+G + ++ G F DS IDQL+ +IL + K
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 454 YTEP-----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 490
T P P + P ++ MLQ P KRI ++ L H +
Sbjct: 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI---LNGKYTEPPWMSPNSRQ 466
S+ YG+E D+WS+G+M+ ++ G P+ ++ Q +I L + + +S R
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKM-GP 495
+ ML EP +R Q+LL H ++K+ GP
Sbjct: 251 FLDLMLVREPSQRATAQELLQHPFLKLAGP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 1/83 (1%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW-MSPNSRQIVR 469
++ Y + D+WS+GV+LY LL PF S ++ ++L GKY P +S + ++
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD 304
Query: 470 SMLQVEPGKRIKIQDLLGHNWVK 492
+L P R Q LL ++K
Sbjct: 305 PLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 26/95 (27%), Positives = 48/95 (50%), Gaps = 6/95 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-----KVAIKIMKKATLGEDLPRVKLEINALK 61
R+ +T+G+G F KV AT G+ +VA+K++K + ++ + E+ L
Sbjct: 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS 96
Query: 62 HI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLD 95
H+ H++I L + ++ EYC G+LL+
Sbjct: 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 19/62 (30%), Positives = 34/62 (54%)
Query: 419 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478
D WS GV+++ +L G LPF + IL K P ++SP ++ ++R++ + P
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239
Query: 479 RI 480
R+
Sbjct: 240 RL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 17/37 (45%), Positives = 25/37 (67%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
Y E D WS+GV++Y +L G+ PF SD+ + Y KI+
Sbjct: 216 YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII 252
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 18/41 (43%), Positives = 25/41 (60%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
Q YG D W+ GV+LY +L G PFD + D+L+ I+ H
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 398 LRSAIVLCSAPSSKQY--YGSETDVWSMGVMLY-ALLCGFLPFDSDSIDQLYDKILNGKY 454
++ V +AP + Y Y SE+DVWS G++L+ A G +P+ + S Q + I G
Sbjct: 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR 214
Query: 455 TEPPWMSPNSRQIVRSMLQV---EPGKR 479
P + P+ + R M + +PG+R
Sbjct: 215 LPCPELCPD--AVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 25/69 (36%), Positives = 30/69 (43%), Gaps = 5/69 (7%)
Query: 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ 143
V+EY G L D I + SR R V LH G H DL N++L
Sbjct: 77 VMEYIEGEPLKDLINSNGMEELELSREIGRL----VGKLHSAGIIHGDLTTSNMIL-SGG 131
Query: 144 NLKLIDFGL 152
+ LIDFGL
Sbjct: 132 KIYLIDFGL 140
|
Length = 211 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 16/49 (32%), Positives = 26/49 (53%), Gaps = 5/49 (10%)
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
LL+ K GK +D+W++G ++Y +L G PF + + KIL
Sbjct: 193 LLNEKPAGKS-----SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 23/76 (30%), Positives = 41/76 (53%), Gaps = 9/76 (11%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFD----SDSIDQ-----LYDKILNGKYTEPPWMSPNS 464
YG D W++GV+++ ++ G PFD SD+ DQ L+ IL + P +S +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 465 RQIVRSMLQVEPGKRI 480
+++S L +P +R+
Sbjct: 233 ASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 16/41 (39%), Positives = 28/41 (68%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+Q YG D W+MG++LY L G +PF D+ ++L+ +++S
Sbjct: 190 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 23/74 (31%), Positives = 34/74 (45%), Gaps = 6/74 (8%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD---KILNGKYTEPP--WMSPNSRQIV 468
Y ++D+WS+G +LY + PF D ++ LY KI Y P S R +V
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKCDYPPLPADHYSEELRDLV 241
Query: 469 RSMLQVEPGKRIKI 482
+ +P KR I
Sbjct: 242 SRCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 10/100 (10%)
Query: 407 APSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSR- 465
PS++ Y +DVWS+G+ LY + G P+ + ++D++ +PP +S +
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKGDPPILSNSEER 237
Query: 466 -------QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 498
+ L + KR K ++LL H ++K E N
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN 277
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 18/38 (47%), Positives = 26/38 (68%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN 451
YG E D WS+GV +Y +L G PF ++S+ + Y KI+N
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 14 RTVGSGGFAKVKLA--THVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICK- 70
+ +G+G F KV L T +V +K ++ + ++ + E + + H ++ +
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEK---ESRAFFR---QILSAVAYLHH 124
L Q E + ++ +V+E+CP G+L ++ R E + R +I + +LH
Sbjct: 61 LGQCTEVTPYL-LVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGL--CAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
+ H DL N LL + +K+ D+GL E + Q + APE++
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-PLRWIAPELV--D 175
Query: 183 QYYGS--------ETDVWSMGVMLYALL 202
+ +G+ E++VWS+GV ++ L
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 24/88 (27%), Positives = 48/88 (54%), Gaps = 3/88 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG--KYTEPPWMSPNSRQ 466
+++ YG + D+WS+G+M ++ G P+ + + + LY NG + P +SP R
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMG 494
+ L+++ KR ++LL H ++K+
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLKLA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 24/70 (34%), Positives = 34/70 (48%), Gaps = 8/70 (11%)
Query: 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142
+V+EY G + L ++E R+I V LH G H DL N+++ R+
Sbjct: 74 IVMEYIEG-KPLKDVIEEGNDE------LLREIGRLVGKLHKAGIVHGDLTTSNIIV-RD 125
Query: 143 QNLKLIDFGL 152
L LIDFGL
Sbjct: 126 DKLYLIDFGL 135
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 9/70 (12%)
Query: 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142
+V+EY GG+ L ++E + R++ VA LH G H DL N ++ R+
Sbjct: 413 IVMEYI-GGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RD 463
Query: 143 QNLKLIDFGL 152
L LIDFGL
Sbjct: 464 DRLYLIDFGL 473
|
Length = 535 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 13/39 (33%), Positives = 25/39 (64%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+ D W++G+++Y +L G+ PF D+ +Y+KIL+
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 15/40 (37%), Positives = 27/40 (67%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
+ YG D W++GV++Y ++ G PF++D+ D L++ IL
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 5e-04
Identities = 21/77 (27%), Positives = 37/77 (48%), Gaps = 4/77 (5%)
Query: 407 APSSKQY--YGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSP 462
AP S + + S++DVWS GV+L+ + G P+ S +++ + + NG PP P
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP 230
Query: 463 NSRQIVRSMLQVEPGKR 479
++ +P R
Sbjct: 231 ELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 20/77 (25%), Positives = 36/77 (46%), Gaps = 4/77 (5%)
Query: 407 APSSKQY--YGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSP 462
AP S + + S++DVWS GV+L+ + G P+ S ++ + + G PP P
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP 231
Query: 463 NSRQIVRSMLQVEPGKR 479
+++ +P R
Sbjct: 232 ELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 22/76 (28%), Positives = 38/76 (50%), Gaps = 13/76 (17%)
Query: 83 MVIEYCPGGELLD------HIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPEN 136
+ +E+ G ++ D ++R+ L E RAF RQ+L G+ H D P N
Sbjct: 243 LTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL-------RDGFFHADPHPGN 295
Query: 137 VLLDRNQNLKLIDFGL 152
+L+ + + L+DFG+
Sbjct: 296 ILVRSDGRIVLLDFGI 311
|
Length = 517 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 13/33 (39%), Positives = 23/33 (69%)
Query: 336 DVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
D WS+G +++ L G+ PF +++ D ++D ILS
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 6e-04
Identities = 34/113 (30%), Positives = 47/113 (41%), Gaps = 32/113 (28%)
Query: 413 YYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GKYTEPPW--MS----- 461
+YG D+WS+G + LL FLP DSD IDQL KI G TE W ++
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQL-GKIFEALGTPTEENWPGVTSLPDY 236
Query: 462 --------PNSRQI-----------VRSMLQVEPGKRIKIQDLLGHNWVKMGP 495
+QI ++ +L + P KRI + L H + P
Sbjct: 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 19/66 (28%), Positives = 36/66 (54%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
+G D W++G+ +Y +L G PF ++ +Y KIL G P ++ N + +++ +L
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLS 264
Query: 474 VEPGKR 479
+ KR
Sbjct: 265 HDLTKR 270
|
Length = 340 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 22/89 (24%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 408 PSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK---ILNGKY-TEPPWMSPN 463
P+ Y ++DVWS+G+ + + G P+ ++ ++ + I++G T P S +
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
++ V L P +R LL H W+
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 23/60 (38%), Positives = 33/60 (55%), Gaps = 8/60 (13%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-SHFMPICT-------ILISQYF 382
Y ++TD+WS+G +LY L PF+ +++ QL KI +F PI LISQ F
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 23/78 (29%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 406 SAPSSKQY--YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSP 462
+AP + ++ + S++DVWS GV+L+ + G P+ S+ ++ + + G EPP P
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCP 223
Query: 463 NS-RQIVRSMLQVEPGKR 479
++ S + EP KR
Sbjct: 224 ADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 17/92 (18%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILL 387
K+ Y D W +G +LY +L G PF S + Q+YD IL P L
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-------------PLQLP 216
Query: 388 PCKVGQVINLLRSAIVLCSAPSSKQYYGSETD 419
K +LL + ++ G++ D
Sbjct: 217 GGKTVAACDLLVGLL----HKDQRRRLGAKAD 244
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 25/86 (29%), Positives = 46/86 (53%), Gaps = 8/86 (9%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM-----SPNSRQ 466
+YY ++ D+WS+G+ +Y + G P+ +D +L K ++PP + S R+
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMMLIPK-SKPPRLEDNGYSKLLRE 233
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVK 492
V + L EP +R+ ++LL W+K
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 56 EINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQI 115
E AL+ + + K+ + I + H +V+EY G EL R RL + +I
Sbjct: 159 EFEALQRL-YPEGVKVPKPIAWNRHA-VVMEYIEGVEL-----YRLRLDVENPDEILDKI 211
Query: 116 LSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDF 150
L V + G H DL N+L+ + ++ +ID+
Sbjct: 212 LEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 18/39 (46%), Positives = 23/39 (58%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
Q Y D WS GV+LY +L G PF + D+L+D IL
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 16/38 (42%), Positives = 26/38 (68%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+G D W+MGV+LY + G+ PF D+ ++Y+KIL+
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 15/37 (40%), Positives = 25/37 (67%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
YG D W +GV++Y ++CG LPF + ++L++ IL
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 13/36 (36%), Positives = 22/36 (61%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI 366
Y D WS+GV+++ + CG+ PF ++ Q+Y I
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 19/79 (24%), Positives = 40/79 (50%), Gaps = 1/79 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
Y +++D+W++G +LY + F++ ++ L KI+ G Y S + R +V +
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237
Query: 473 QVEPGKRIKIQDLLGHNWV 491
+ P R + +L N++
Sbjct: 238 KRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 28/130 (21%), Positives = 53/130 (40%), Gaps = 18/130 (13%)
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLID---FGLCAKPEGGLESQLQTSCG 169
R + SA A LH G+ D+ + L+ + + L+D F + A + G
Sbjct: 124 RNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN-----GTLHLCPVG 178
Query: 170 SPNYAAPEVIKGKQYYG----SETDVWSMGVMLYALLCGF------LPFDSDSIDQLYDK 219
+ PE+ + G + D + + V+++ LL G +P SD+ + L
Sbjct: 179 VSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238
Query: 220 ILNGKYTEPP 229
I +G++
Sbjct: 239 IAHGRFAYAS 248
|
Length = 637 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 15/37 (40%), Positives = 25/37 (67%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
YG D W +GV++Y ++CG LPF + ++L++ IL
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 34/145 (23%), Positives = 52/145 (35%), Gaps = 37/145 (25%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLY----------DKILNGKYTEP--- 457
Q Y E D+WS G + +L G F D ++Q D ++N +E
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240
Query: 458 -----------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM--GPEDN 498
P++ ++ ML +P KRI + L H ++ P D
Sbjct: 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300
Query: 499 PLREKDDDVIKVMADHKQLSPDDMW 523
P+ E+ D AD P D W
Sbjct: 301 PVAEEKFDWSFNDADL----PVDTW 321
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 17/42 (40%), Positives = 27/42 (64%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT 455
Y D WS+GV++Y +L G+ PF S++ + Y K++N K T
Sbjct: 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKET 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 17/42 (40%), Positives = 27/42 (64%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT 455
Y D WS+GV++Y +L G+ PF S++ + Y K++N K T
Sbjct: 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKET 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 17/77 (22%), Positives = 34/77 (44%), Gaps = 10/77 (12%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPF-------DSDSIDQLYDKILNGKYTEPPWMSPN 463
+ Y D +++G LY ++ G PF + + + + L P SP
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TLEMAVEYPDKFSPE 224
Query: 464 SRQIVRSMLQVEPGKRI 480
++ + ++LQ +P KR+
Sbjct: 225 AKDLCEALLQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 16/40 (40%), Positives = 26/40 (65%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
Q YG E D WS+G +++ L G+ PF S++ + Y KI++
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIIN 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 4/82 (4%)
Query: 408 PSSKQY--YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS 464
P S Y + +E+D+WS GV+L+ + G P+ S + + I G+ E P P
Sbjct: 193 PESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPE 252
Query: 465 -RQIVRSMLQVEPGKRIKIQDL 485
I++ Q EP +R+ I+D+
Sbjct: 253 VYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-----KVAIKIMKKATLGEDLPRVKLEINALK 61
R+ +L R +GSG F KV T KVA+K++K + + E+ +
Sbjct: 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMT 95
Query: 62 HI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI 97
H+ H +I L S I+++ EYC G+L++++
Sbjct: 96 HLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 15/37 (40%), Positives = 25/37 (67%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
YG D W +GV++Y ++CG LPF + ++L++ IL
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 15/37 (40%), Positives = 25/37 (67%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
YG D W +GV++Y ++CG LPF + ++L++ IL
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 17/40 (42%), Positives = 22/40 (55%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
KQ Y D W +G +LY +L G PF S ++YD IL
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 19/41 (46%), Positives = 25/41 (60%), Gaps = 1/41 (2%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI 366
QG +Y S D WS GV+LY +L G PF D D+L++ I
Sbjct: 169 QGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.004
Identities = 18/75 (24%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 414 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSM 471
+ S++DVWS GV+L+ + G P+ S +++ + + G P + +++ S
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSC 243
Query: 472 LQVEPGKRIKIQDLL 486
Q++P R +L+
Sbjct: 244 WQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.004
Identities = 28/124 (22%), Positives = 45/124 (36%), Gaps = 19/124 (15%)
Query: 33 GEKVAIKIMKKAT-LGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91
+K ++I T L + + E K + I + + + ++ E+ G
Sbjct: 21 NKKYVVRIPGNGTELLINR---ENEAENSKLAAEAGIGPKLYYFDPETGV-LITEFIEGS 76
Query: 92 ELLDHIVERQRLGEKESRAFFRQILSAVAYLH-----HLGYAHRDLKPENVLLDRNQNLK 146
ELL + +I + LH L H DL P N LLD + L
Sbjct: 77 ELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGR-LW 127
Query: 147 LIDF 150
LID+
Sbjct: 128 LIDW 131
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0590|consensus | 601 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG2052|consensus | 513 | 99.98 | ||
| KOG3653|consensus | 534 | 99.98 | ||
| KOG1345|consensus | 378 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG4717|consensus | 864 | 99.97 | ||
| KOG0616|consensus | 355 | 99.97 | ||
| KOG0575|consensus | 592 | 99.96 | ||
| KOG0615|consensus | 475 | 99.96 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0583|consensus | 370 | 99.96 | ||
| KOG0604|consensus | 400 | 99.95 | ||
| KOG0590|consensus | 601 | 99.95 | ||
| KOG0598|consensus | 357 | 99.95 | ||
| KOG1024|consensus | 563 | 99.95 | ||
| KOG0660|consensus | 359 | 99.95 | ||
| KOG0599|consensus | 411 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0033|consensus | 355 | 99.95 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0581|consensus | 364 | 99.94 | ||
| KOG0661|consensus | 538 | 99.94 | ||
| KOG1164|consensus | 322 | 99.94 | ||
| KOG0605|consensus | 550 | 99.93 | ||
| KOG0694|consensus | 694 | 99.93 | ||
| KOG0592|consensus | 604 | 99.93 | ||
| KOG1163|consensus | 341 | 99.93 | ||
| KOG0690|consensus | 516 | 99.93 | ||
| KOG0586|consensus | 596 | 99.93 | ||
| KOG0597|consensus | 808 | 99.93 | ||
| KOG0611|consensus | 668 | 99.92 | ||
| KOG1165|consensus | 449 | 99.92 | ||
| KOG0593|consensus | 396 | 99.92 | ||
| KOG0578|consensus | 550 | 99.91 | ||
| KOG0198|consensus | 313 | 99.91 | ||
| KOG1240|consensus | 1431 | 99.91 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0663|consensus | 419 | 99.9 | ||
| KOG0606|consensus | 1205 | 99.9 | ||
| KOG0659|consensus | 318 | 99.9 | ||
| KOG0032|consensus | 382 | 99.9 | ||
| KOG0600|consensus | 560 | 99.89 | ||
| KOG0591|consensus | 375 | 99.89 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0201|consensus | 467 | 99.89 | ||
| KOG0610|consensus | 459 | 99.89 | ||
| KOG0696|consensus | 683 | 99.88 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG0580|consensus | 281 | 99.88 | ||
| KOG0614|consensus | 732 | 99.88 | ||
| KOG0595|consensus | 429 | 99.88 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.88 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.88 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.87 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1035|consensus | 1351 | 99.87 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.87 | |
| KOG0612|consensus | 1317 | 99.87 | ||
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.86 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.86 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.86 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.86 | |
| KOG0607|consensus | 463 | 99.86 | ||
| KOG0585|consensus | 576 | 99.86 | ||
| KOG0667|consensus | 586 | 99.86 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.86 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.86 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.86 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.86 | |
| KOG0658|consensus | 364 | 99.86 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.85 | |
| KOG4158|consensus | 598 | 99.85 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG0983|consensus | 391 | 99.85 | ||
| KOG0589|consensus | 426 | 99.85 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.85 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.85 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.85 | |
| KOG0582|consensus | 516 | 99.85 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.85 | |
| KOG4279|consensus | 1226 | 99.85 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.85 | |
| KOG0594|consensus | 323 | 99.85 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.85 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.85 | |
| KOG0195|consensus | 448 | 99.84 | ||
| KOG0596|consensus | 677 | 99.84 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG0986|consensus | 591 | 99.84 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.84 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-62 Score=470.98 Aligned_cols=260 Identities=40% Similarity=0.729 Sum_probs=235.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC------chHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE------DLPRVKLEINALKHISHQHICKLFQVIETS 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 78 (568)
.+.+.|.+.+.||+|+||.|.+|..+.||+.||||++.+..... ....+.+|+++|++|+|||||+++++|+..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 46788999999999999999999999999999999998765432 233467999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC---CCeEEEeecCccC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN---QNLKLIDFGLCAK 155 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~ 155 (568)
+..|+||||++||+|.+++..++.+.+...+.+++|++.||.|||++||+||||||+|||+..+ -.+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999766 5799999999998
Q ss_pred CCCCCccccccccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCC---
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYTEPP--- 229 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~-~~~~i~~~~~~~~~--- 229 (568)
... .+.+.+.||||.|.|||++.+. .++..++||||+||+||-+++|.+||....... +.++|..|.+.+.+
T Consensus 329 ~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 329 SGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred ccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 653 4678899999999999999754 345568999999999999999999998776555 88999999987653
Q ss_pred -CCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 230 -WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 230 -~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
.++.++.+||++||..||++|||++|+|+||||+..+
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 3899999999999999999999999999999999654
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-59 Score=474.64 Aligned_cols=323 Identities=37% Similarity=0.642 Sum_probs=289.2
Q ss_pred CccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCC-cC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q psy6203 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKAT-LG-EDLPRVKLEINALKHISHQHICKLFQVIETSS 79 (568)
Q Consensus 2 ~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 79 (568)
.-.+-.+-|++++.||.|+.|.|.+|+|..||+.+|||++.+.. .. .....+++||-+|+.+.||||+++|++|++..
T Consensus 6 ~~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 6 SHKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 34556678999999999999999999999999999999998762 22 23457899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
++|+|.||++||.|++++..++++++.++.++++||+.|+.|||..+|+||||||+|+|++..+++||+|||+|.....+
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 239 (568)
..+.+.||+|.|+|||++.|.+|.+.++||||+|||||.||||++||++++...++.+++.|.+..|..+++++++||
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLL 243 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHH
Confidence 678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCCHHHHhcCcccccCCCCCCC---------CCCCCCcCCcCCHHHHHHHHhc-cCCCHHHHHHHHHhcC
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPV---------SFRPDHELREKDDDVIKVMADH-KQLSPDDMWSQLNEWT 309 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~ 309 (568)
.+||..||++|+|.+||+.|||+.-.....+. .........+.|+.+++.|.-. ..-+++.+.+.|.+..
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~iLwc~~d~~kl~~kLls~~ 323 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLCILWCGRDPEKLVEKLLSPD 323 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhhheeecCChHHHHHHHcCCC
Confidence 99999999999999999999999843322111 1111223457899999988764 4568899999999999
Q ss_pred CChhHHHHHHHhhhhcc
Q psy6203 310 YNYDTCTYLLLLSRKKQ 326 (568)
Q Consensus 310 ~~~~~~~~~~~~~~~~~ 326 (568)
-|.....|+||.+++.+
T Consensus 324 ~n~EK~~Y~LLl~~k~r 340 (786)
T KOG0588|consen 324 DNDEKTLYFLLLRRKRR 340 (786)
T ss_pred cchhHHHHHHHHHhhcc
Confidence 99999999999988764
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-59 Score=471.85 Aligned_cols=257 Identities=36% Similarity=0.677 Sum_probs=241.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
.+|..++.||+|||+.||.+++..+|+.||+|++.+..+.. ..+.+.+||++.++|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999999865543 4568899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+|+.++|..+++.++.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|+..... .....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~Erk~ 176 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-GERKK 176 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc-ccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987654 24557
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
+.||||.|+|||++.... ++..+||||+||++|.||+|++||...+..+.+.+|....+..|..+|.++++||.+||+.
T Consensus 177 TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred eecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcC
Confidence 889999999999998666 5999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCC
Q psy6203 246 EPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 246 dP~~Rps~~ell~hp~~~~~~ 266 (568)
||.+|||+++||.|+||+.+-
T Consensus 256 ~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 256 NPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred CcccCCCHHHHhcCHhhhCCC
Confidence 999999999999999996543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=432.36 Aligned_cols=256 Identities=36% Similarity=0.694 Sum_probs=237.7
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|+++++||+|+||+|++++.+.|++.||+|++++..+.+ +......|..+|.+++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 367999999999999999999999999999999999887654 367788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
+||+.||+|+.++.+.+.++|..++-++..|+.||.|||++|||||||||+|||+|..|+++|+|||+|+..... ....
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~~t 182 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GDAT 182 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-CCcc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999865433 3455
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-CCCChHHHHHHHHcc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP-PWMSPNSRQIVRSML 243 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~li~~~L 243 (568)
.+.|||+.|||||++.+.. |+.++|.||||+++|+|++|.+||.+.+.....++|..++...+ ..++.+++++|+++|
T Consensus 183 ~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLL 261 (357)
T ss_pred ccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHh
Confidence 6789999999999999887 69999999999999999999999999999999999999995544 459999999999999
Q ss_pred ccCcCCCC----CHHHHhcCccccc
Q psy6203 244 QVEPGKRI----KIQDLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rp----s~~ell~hp~~~~ 264 (568)
+.||.+|. ++.+|-+||||+.
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCccccc
Confidence 99999996 6999999999984
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-56 Score=426.33 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=229.8
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-EEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS-HIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~E~ 87 (568)
+.+.++.||+|+.|+||+|+|+.|++.+|+|++.........+++.+|+++++..+||+||++|+.|..++ .++|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 56678899999999999999999999999999965444445678899999999999999999999999999 49999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|+||+|.+++...++++|.....++.+|++||.|||+ .+||||||||+|||++..|.|||||||.+...... ...+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~t 236 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANT 236 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hccc
Confidence 9999999999988999999999999999999999995 99999999999999999999999999999876543 5578
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCC-CCCC-CChHHHHHH
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD-----SIDQLYDKILNGKYT-EPPW-MSPNSRQIV 239 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~-----~~~~~~~~i~~~~~~-~~~~-~~~~~~~li 239 (568)
++||..|||||.+.+.. |+.++||||||++++|+++|++||... +.-+++..|..+..+ .|.. .|+++++||
T Consensus 237 fvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred ccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 89999999999999987 699999999999999999999999764 677888899887655 4554 899999999
Q ss_pred HHccccCcCCCCCHHHHhcCccccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..||++||.+|+|+.|+++|||++.
T Consensus 316 ~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred HHHhcCCcccCCCHHHHhcCHHHhh
Confidence 9999999999999999999999984
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-55 Score=447.85 Aligned_cols=259 Identities=50% Similarity=0.890 Sum_probs=241.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC----CchHHHHHHHHHHHhCC-CCCcceeeEEEEeCC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG----EDLPRVKLEINALKHIS-HQHICKLFQVIETSS 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~ 79 (568)
...++|.+++.||+|+||+|++|.+..+|..||+|++.+.... ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467999999999999999999999999999999988775222 23456778999999999 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-CCeEEEeecCccCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEG 158 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 158 (568)
.+|+|||||.||+|++++.+.+++.|.+++.+++||++|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998764
Q ss_pred CCccccccccCCccccccccccCcc-cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC-ChHHH
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQ-YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM-SPNSR 236 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~ 236 (568)
.......+.|||+.|+|||++.+.. +.+.++||||+||+||.|++|..||...+...++..|..+.+..|.++ |++++
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEAR 252 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHH
Confidence 2345678899999999999999987 778999999999999999999999999999999999999999999999 99999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+|+.+||..||.+|+|+.++++||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999995
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-55 Score=434.23 Aligned_cols=320 Identities=37% Similarity=0.676 Sum_probs=283.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+.+-|.+.+.||+|.|+.|.+|+|..||+.||||++.+..+.+ ....+..|+..|+.++|||||++|++..+...+||
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 45677999999999999999999999999999999999887754 24567789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE-cCCCCeEEEeecCccCCCCCCc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL-DRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|+|+-++|+|+++|.+. ..++|+.+++++.||+.|+.|||...||||||||+|+.+ ..-|-+||+|||++..+.++
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 99999999999999875 569999999999999999999999999999999999876 56689999999999988765
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 241 (568)
..+.+.||+..|.|||++.|..|..+++||||||||||.|++|++||...+..+....|+..++..|..++.++++||.+
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS 252 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence 56789999999999999999999899999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCCCHHHHhcCcccccCCCCCC--CCCCCCCcCCcCC-HHHHHHHHhccCCCHHHHHHHHHhcCCChhHHHHH
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWVKMGPEDNP--VSFRPDHELREKD-DDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYL 318 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 318 (568)
||..||.+|.|.++|..|+|++.+.+... .+......+.+.+ ..++..|....-.+.+++.+.|...+||..|++|+
T Consensus 253 MLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvsr~~L~ee~Ha~IIq~Mv~G~IAs~e~Il~aLe~n~YNhiTATYf 332 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVSRHHLPEEAHATIIQQMVAGAIASEEDILRALENNEYNHITATYF 332 (864)
T ss_pred HHhcCchhhccHHHHhccccccCCCCCccccCceeehhhCChHHHHHHHHHHhcccccCHHHHHHHHhccccchhhhHHH
Confidence 99999999999999999999985433211 1112222333333 35677777777789999999999999999999999
Q ss_pred HHhhhhcc
Q psy6203 319 LLLSRKKQ 326 (568)
Q Consensus 319 ~~~~~~~~ 326 (568)
||-++..+
T Consensus 333 LLAEr~Lr 340 (864)
T KOG4717|consen 333 LLAERVLR 340 (864)
T ss_pred HHHHHHHH
Confidence 98877554
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=409.68 Aligned_cols=252 Identities=36% Similarity=0.716 Sum_probs=237.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|+++++||.|+||+|.+++++.+|..||+|++++...- ...+...+|..+|+.+.||+++++++.+.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5789999999999999999999999999999999876653 23556788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++||.|+.++++.+++++..++-++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.... ..-
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----rT~ 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----RTW 199 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----cEE
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987654 356
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
+.||||.|+|||+++..+ |+.++|.|||||++|||+.|.+||...+..+++++|..++..+|..+++++++||+++|+.
T Consensus 200 TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred EecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhh
Confidence 789999999999999887 5999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCC-----CHHHHhcCccccc
Q psy6203 246 EPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rp-----s~~ell~hp~~~~ 264 (568)
|-.+|. ...+|.+||||+.
T Consensus 279 D~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 279 DLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred hhHhhhcCcCCCccccccCccccc
Confidence 999993 5789999999984
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-55 Score=438.13 Aligned_cols=256 Identities=30% Similarity=0.585 Sum_probs=236.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|.+++.||+|+|++|++|+++.+++.||||++.+..+- ...+.+.+|-.+|.+| .||.|++|+..|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 5899999999999999999999999999999999887653 2356788899999999 799999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc---
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE--- 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--- 161 (568)
+||+++|+|.++|.+-+.|++..++.++.||+.||+|||++|||||||||+|||+|.+|++||+|||.|+.......
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876543211
Q ss_pred ---------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy6203 162 ---------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMS 232 (568)
Q Consensus 162 ---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 232 (568)
+...+++||..|++||++.... .++.+|||+||||+|+|+.|.+||.+.+..-++++|+.-.+.+++.++
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp 311 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFP 311 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCC
Confidence 1114578999999999998876 489999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.+++||+++|..||.+|+|++||.+||||..
T Consensus 312 ~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 312 EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 99999999999999999999999999999974
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=421.08 Aligned_cols=260 Identities=39% Similarity=0.667 Sum_probs=236.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.+..++|.+.+.||+|+||+||+|+++.++..||||.+.+.... +..+.+..|+.+|+.++|||||+++++++.++.+|
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 35568999999999999999999999999999999999887643 34566788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC------CCeEEEeecCccCC
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN------QNLKLIDFGLCAKP 156 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~------~~~kl~DFG~a~~~ 156 (568)
+|||||.||+|.++|..++.++|..++.++.||+.||++||+++||||||||+|||++.. -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999765 35899999999987
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCh
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE---PPWMSP 233 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~ 233 (568)
..+ ....+.||+|.|||||++.... |+.|+|+||+|+|+|+|++|+.||...+..++...+..+.... +...++
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 653 4567889999999999998766 6899999999999999999999999999999999888876543 345788
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
...+|+...|+.+|.+|.+..+-+.|+++...+
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 888999999999999999999999999998655
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=416.37 Aligned_cols=258 Identities=44% Similarity=0.783 Sum_probs=242.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+++.+|++.++||+|+||+|.+|.....|+.||||.+++..+.+ +.-.+.+||+||+.|+||||+.+|++|++.+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 56779999999999999999999999999999999999887754 4557889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||||..+|+|+++|.+++.++|.+++.+++||++|+.|||.++|+|||||.+|||+|.|+++||+|||++..+... .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--K 207 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999877653 5
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHc
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 242 (568)
.++++||+|-|.+||++.|.+|-++.+|-|||||+||.|+.|.+||++.+...+..+|.+|.+..|+. +.++.-||+.|
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwm 286 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWM 286 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHH
Confidence 67899999999999999999998999999999999999999999999999999999999999977664 56788999999
Q ss_pred cccCcCCCCCHHHHhcCcccccC
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
|..||++|.|+++|..|-|++.+
T Consensus 287 LmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HhcCcccchhHHHHhhhheeecc
Confidence 99999999999999999999854
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=398.92 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=218.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|+.+.++|+|+||.|++|+++.||+.||||.+..+..... .+...+||++|++|+|||+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 579999999999999999999999999999999876543322 3456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
||+..-|.++-.....++++.++.++.|++.|+.|||++++|||||||+|||++.+|.+||||||+|+..... ....+.
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~YTD 160 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDNYTD 160 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC-cchhhh
Confidence 9977555444444567999999999999999999999999999999999999999999999999999987642 345567
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--------------C-------CC
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--------------G-------KY 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--------------~-------~~ 225 (568)
.+.|.+|.|||.+.|...|+.++||||+||++.||++|.+.|++.+.-+....|.. . .+
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 78999999999999987899999999999999999999999998775544333321 1 11
Q ss_pred CCC----------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 226 TEP----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 226 ~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+.+ +.++.-+.+|+++||..||.+|++.+|+|.||||.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 111 23567789999999999999999999999999994
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=419.54 Aligned_cols=258 Identities=31% Similarity=0.631 Sum_probs=230.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++++.||+|+||.||+|+.+.||..+|+|+++++.+- .....+..|-.+|...++|+||++|..|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 36899999999999999999999999999999999987653 3567788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC------
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG------ 158 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~------ 158 (568)
|||++||++..+|...+.++++.++.++.+++.|+..||+.|+|||||||+|+|||..|++||+|||+|.-...
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999842111
Q ss_pred -----------------CCc-----c------------------ccccccCCccccccccccCcccCCcccceechhhHH
Q psy6203 159 -----------------GLE-----S------------------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVML 198 (568)
Q Consensus 159 -----------------~~~-----~------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 198 (568)
... . .....+|||.|+|||++.+.. |+..+|.||||||+
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIM 378 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHH
Confidence 000 0 001237999999999999988 69999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCC--CCCC--CCCChHHHHHHHHccccCcCCCCC---HHHHhcCcccccCC
Q psy6203 199 YALLCGFLPFDSDSIDQLYDKILNGK--YTEP--PWMSPNSRQIVRSMLQVEPGKRIK---IQDLLGHNWVKMGP 266 (568)
Q Consensus 199 ~~lltG~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~~~ 266 (568)
||||.|.+||.++++.+.+.+|.+.. +.+| ...+++++|||.+||. ||++|.. ++||..||||+...
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 99999999999999999999998875 3344 4578999999999999 9999985 99999999998543
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=393.20 Aligned_cols=257 Identities=35% Similarity=0.675 Sum_probs=236.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
-|.+.|++.+.||+|.|+.|+++.+..||+.+|+|+++..... .+.+.+.+|+.|-+.|+|||||++.+.+.+.+..|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 4678999999999999999999999999999999999866543 467889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC---CCeEEEeecCccCCCCCC
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN---QNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~ 160 (568)
|+|+++|++|..-|..+.-++|..+..+++||++||.|||.+||||||+||+|+++.+. ..+||+|||+|....++
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g- 166 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG- 166 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc-
Confidence 99999999999999888889999999999999999999999999999999999999543 35999999999887633
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 236 (568)
......+|||.|||||++...+ |+..+||||.|||||-|+.|.+||.+.+...++++|..+.+..++ .++++++
T Consensus 167 -~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 167 -EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred -cccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 4556778999999999998877 699999999999999999999999999999999999999887654 4899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||++||..||.+|+|+.|+|+|||++.
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcc
Confidence 9999999999999999999999999984
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=419.56 Aligned_cols=317 Identities=40% Similarity=0.648 Sum_probs=280.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
-.+.|.+.++||+|.|++|.+|++..||..||+|++++..... ....+.+|+++|+.|+|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3468999999999999999999999999999999999877653 245688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+.+|++++++.+.++..+..++.++.|+++|++|||+++|||||||++|||++.+.++||+|||++..... ....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~l 211 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLML 211 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--cccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998764 3567
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.||++.|+|||++.|..+.++.+|+||+|+++|.|+.|.+||++.+..++..+...+++..+-.++.++.++|+++|.
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLV 291 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhc
Confidence 88999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCHHHHhcCcccccCCCCCCCCCCCCCcCCcCCHHHHHHHHhccCCCHHHHHHHHHhcCCChhHHHHHHHhhhh
Q psy6203 245 VEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRK 324 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 324 (568)
.+|.+|+++++++.|.|+..+....-..+.........+...+ .+....++...++.+.|...+|+..+++|.++..++
T Consensus 292 l~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~~~~~~~~~r~-~~m~~~G~~~~~i~~sL~~~k~d~i~a~y~ll~~~~ 370 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKDRWRNDLLEARLLAPLIERSTPFILAKRI-LHMNSIGHRRLKIEESLAKQKFDDINATYLLLGYRK 370 (596)
T ss_pred cCccccCCHHHhhhhcccchhhhhhhhhcccccCccchhhHHH-HHHHhhccchhhHHHHHhhhhHHHHHHHHhhcchhh
Confidence 9999999999999999998654441111111111112222222 334457899999999999999999999999987765
Q ss_pred c
Q psy6203 325 K 325 (568)
Q Consensus 325 ~ 325 (568)
.
T Consensus 371 ~ 371 (596)
T KOG0586|consen 371 Q 371 (596)
T ss_pred h
Confidence 4
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=408.79 Aligned_cols=263 Identities=25% Similarity=0.421 Sum_probs=228.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIETS--SHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l 83 (568)
.+.|+.+++||+|+||.||+|++..||+.||+|.+......+. .....+||.||++|+||||+++.++..+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3568889999999999999999999999999999987664433 44678899999999999999999998776 68999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|+|||+. +|.-++.. .-.|++.+++.+++||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+........
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 9999964 78888766 357999999999999999999999999999999999999999999999999999977666555
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC--------CC----
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKYT--------EP---- 228 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~~--------~~---- 228 (568)
..+..+-|.+|.|||++.|...|+.++|+||.||||.||++|++.|.+.+..+.++.|.. |.+. .|
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 577778899999999999999999999999999999999999999999987777776643 1111 01
Q ss_pred ---------------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCCCCCC
Q psy6203 229 ---------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNP 270 (568)
Q Consensus 229 ---------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 270 (568)
..++..+.+|+..||..||.+|.||.++|+|+||...+.+.+
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~ 411 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCD 411 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCC
Confidence 126778899999999999999999999999999975554433
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=408.01 Aligned_cols=258 Identities=36% Similarity=0.670 Sum_probs=226.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-------------CchHHHHHHHHHHHhCCCCCcceeeE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-------------EDLPRVKLEINALKHISHQHICKLFQ 73 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~Ei~~l~~l~hpnIv~l~~ 73 (568)
-|+|++++.||+|.||.|.+|++..+++.||||++.+.... ...+.+.+||.+|++|.|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 47999999999999999999999999999999999865432 12457899999999999999999999
Q ss_pred EEEeC--CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeec
Q psy6203 74 VIETS--SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 74 ~~~~~--~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
+..+. +.+|||+|||..|.+...-.....+++.+++.|+++++.||.|||.+|||||||||+|+|++++|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 99654 5899999999999876543222339999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCC----CccccccccCCccccccccccC---cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q psy6203 152 LCAKPEGG----LESQLQTSCGSPNYAAPEVIKG---KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK 224 (568)
Q Consensus 152 ~a~~~~~~----~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~ 224 (568)
.+.....+ ....+...+|||.|+|||.+.+ ..+.+.+.||||+||+||+|+.|+.||-++...+++.+|.+..
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 98765222 1223445689999999999976 3455788999999999999999999999999999999999998
Q ss_pred CCCCCC--CChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 225 YTEPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 225 ~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+|.. +.+++++||.+||.+||++|+++.+|..|||+..
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 877765 7999999999999999999999999999999984
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=393.04 Aligned_cols=244 Identities=28% Similarity=0.490 Sum_probs=217.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeE-EEEeCC-EEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQ-VIETSS-HIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~-~~~~~~-~~~lV 84 (568)
.+|+|+++||.|+||+||++.+..+|..+|.|.+.-..... ..+....|+.+|++|+|||||++++ .|.+++ .++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 46999999999999999999999999999999987544432 3456778999999999999999998 454444 48999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--ceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 85 IEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHH--LG--YAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~--~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
||||++|+|.+.|+. ++.++|..+++++.|++.||..||+ .+ |+||||||.||+++.+|.+||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999863 4679999999999999999999999 55 999999999999999999999999999887
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CC-CCCChH
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EP-PWMSPN 234 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~-~~~~~~ 234 (568)
... .....+.+|||.||+||.+.+.+ |+++|||||+||++|||+.-.+||.+++..++.++|.++.++ .| ...|.+
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTD 256 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence 653 33456678999999999999887 699999999999999999999999999999999999999886 34 468999
Q ss_pred HHHHHHHccccCcCCCCCH
Q psy6203 235 SRQIVRSMLQVEPGKRIKI 253 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~ 253 (568)
+..||..|+.+||+.||+.
T Consensus 257 l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHccCCcccCCCc
Confidence 9999999999999999986
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=417.58 Aligned_cols=254 Identities=34% Similarity=0.592 Sum_probs=238.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|.+.+.||+|+||.||+|+.+.|.+.||+|.+.+.... .+...+.+|++|++.|+|||||.++++|++..++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6899999999999999999999999999999999876544 356789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
||.| +|..++...+.++|+.++.++.|+++||.|||+++|+|||+||.|||++.+|.+|+||||+|+....+ ......
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeee
Confidence 9966 99999999999999999999999999999999999999999999999999999999999999876653 345566
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccC
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 246 (568)
..|||.|||||++.+.+ |+..+|+||||||+||+++|++||...+..++.+.|.......|...+..+.+|++.+|.+|
T Consensus 160 ikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred ccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence 77999999999999777 69999999999999999999999999999999999999999899999999999999999999
Q ss_pred cCCCCCHHHHhcCccccc
Q psy6203 247 PGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 247 P~~Rps~~ell~hp~~~~ 264 (568)
|.+|+|..+++.|||.+.
T Consensus 239 P~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred hhhcccHHHHhcChHHhh
Confidence 999999999999999973
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=375.63 Aligned_cols=260 Identities=29% Similarity=0.437 Sum_probs=225.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.+|...++||+|.||.||+|++..||+.||||.++.....+. .....+||+.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 579999999999999999999999999999999987765443 3357789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|++ .+|...|+.+ ..++..+++.++.++++||+|||++.|+||||||.|+|++++|.+||+|||+|+......... .
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-~ 159 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-T 159 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-c
Confidence 995 6899999865 468999999999999999999999999999999999999999999999999999877653332 3
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCC----------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTE---------------- 227 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~---------------- 227 (568)
..+.|.+|.|||++.|...|+..+||||.|||+.||+.|.+-|.+++.-+....|.+. .+..
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 3478999999999999998999999999999999999999999998876666665431 1111
Q ss_pred ----C------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCCCCC
Q psy6203 228 ----P------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 269 (568)
Q Consensus 228 ----~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 269 (568)
+ +..+.++.||+.+||.+||.+|+|+.|+|+|+||+..|.+.
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 1 12567889999999999999999999999999999655443
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=408.31 Aligned_cols=260 Identities=31% Similarity=0.491 Sum_probs=225.0
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCC-EE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSS-HI 81 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~-~~ 81 (568)
..+.++|.++++||.|+||.||+|+.+.+|+.||||.+++....-+.-.-.||++.|++|+ |||||++.+++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4577899999999999999999999999999999999987654322223467999999999 999999999998887 99
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
|+||||| ..+|+++++.+ ..|++..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+.....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-
Confidence 9999999 56899999876 56999999999999999999999999999999999999998999999999999976653
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CC--------------
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GK-------------- 224 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~-------------- 224 (568)
...+..+.|.+|+|||++....+|+.+.||||+|||++|+.+=++.|.|.+.-+.+.+|.. |.
T Consensus 164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3456778999999999999988999999999999999999999999998775544444432 11
Q ss_pred ---CCCC-----------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 225 ---YTEP-----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 225 ---~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
+.+| +..++++.++|.+||.+||++||||+|+|+||||....
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1111 23688999999999999999999999999999998643
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=374.42 Aligned_cols=252 Identities=29% Similarity=0.583 Sum_probs=235.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|.||.||+|+.+.++-.||+|++.++.+.. -...+.+|+++.+.|+||||+++|++|.+...+|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 67999999999999999999999999999999998776532 2457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIV--ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||..+|+|+..+. ..+++++..+..++.|++.||.|||.++|+||||||+|+|++..|.+||+|||-+..... ..
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---NK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC---CC
Confidence 9999999999998 457899999999999999999999999999999999999999999999999999876543 34
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
..+.|||..|.+||+..+.. ++..+|+|++|++.||++.|.+||.+.+..+.+++|....+.+|..++.+++|+|.+||
T Consensus 179 R~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLL 257 (281)
T ss_pred ceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHh
Confidence 56789999999999999887 48899999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCCHHHHhcCcccc
Q psy6203 244 QVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 244 ~~dP~~Rps~~ell~hp~~~ 263 (568)
.++|.+|.+..|++.|||+.
T Consensus 258 ~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 258 VKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ccCccccccHHHHhhhHHHH
Confidence 99999999999999999986
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=416.96 Aligned_cols=255 Identities=32% Similarity=0.623 Sum_probs=235.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 84 (568)
++|.++++||+|+||+|+++..+.+++.||||++++..+- ++.+....|..|+...+ ||.++.++..|++.+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 6899999999999999999999999999999999987653 45677888988888775 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+.||++. ++...+.+++..++-|+..|+.||+|||++|||+||||.+|||+|.+|.+||+|||+++..... ....
T Consensus 448 mey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~T 525 (694)
T KOG0694|consen 448 MEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDRT 525 (694)
T ss_pred EEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC-CCcc
Confidence 9999999944 4445578999999999999999999999999999999999999999999999999999875533 3467
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.||||.|+|||++.+.. |+.++|.|||||+||||+.|..||.+++.+++++.|.+..+..|.++|.++.++++++|.
T Consensus 526 sTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~ 604 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLR 604 (694)
T ss_pred ccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhc
Confidence 8999999999999999887 699999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCC-----HHHHhcCcccccC
Q psy6203 245 VEPGKRIK-----IQDLLGHNWVKMG 265 (568)
Q Consensus 245 ~dP~~Rps-----~~ell~hp~~~~~ 265 (568)
.||++|.. +++|..||||+..
T Consensus 605 k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 605 KNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred cCcccccCCCCCCchhhhhCCccccC
Confidence 99999986 5889999999843
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=398.16 Aligned_cols=258 Identities=32% Similarity=0.497 Sum_probs=219.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC--EEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS--HIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~lV 84 (568)
..++..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|++++|||||+.++...... .+++.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 356888999999999999999999999999999987663222 567899999999999999999999754444 69999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-CCCeEEEeecCccCCCC--CC
Q psy6203 85 IEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEG--GL 160 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~--~~ 160 (568)
|||+++|+|.+++...+ .+++..++.+.+||++||.|||++|||||||||+|||++. ++.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999999876 7999999999999999999999999999999999999999 79999999999887653 11
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC-CCHHHHHHHHHcC--CCCCCCCCChHHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNG--KYTEPPWMSPNSRQ 237 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 237 (568)
........||+.|||||++.+.....+++|||||||++.||+||+.||.. ....+..-.+... .+..|..+++++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD 254 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 12234567999999999998543334599999999999999999999986 3333333333333 34677889999999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
||.+|++.||++||||+++|+|||++..
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999853
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=381.47 Aligned_cols=270 Identities=28% Similarity=0.379 Sum_probs=229.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchH-HHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHISHQHICKLFQVIETS--SHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l 83 (568)
.+.|+.+.+|++|+||.||+|+++.|++.||+|.++...-.+... ...+||.+|.+++|||||.+-++.... +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 357899999999999999999999999999999998665433322 456899999999999999999998654 57999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||||+ .+|..++..- .+|+..+++.++.|+++||+|||.+.|+||||||+|+|++..|.+||+|||+|+..... ..
T Consensus 155 VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k 232 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LK 232 (419)
T ss_pred eHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-cc
Confidence 999996 4888888764 48999999999999999999999999999999999999999999999999999988765 34
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC---------------
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKY--------------- 225 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~--------------- 225 (568)
..+..+.|.+|.|||++.|.+.|+.+.|+||+|||+.||+++++.|.+.+..+...+|.. |.+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 456667899999999999999999999999999999999999999999887666666533 111
Q ss_pred --CCC------------C-CCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCCCCCCCCCCCCCc
Q psy6203 226 --TEP------------P-WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHE 278 (568)
Q Consensus 226 --~~~------------~-~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~ 278 (568)
.++ . .++....+|+..+|.+||.+|.||+|.|.|+||...|.+.+....|..+
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P 380 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWP 380 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCc
Confidence 011 0 1457889999999999999999999999999999877666555554443
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=385.62 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=221.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc-CCchHHHHHHHHHHHhCCCCCcceeeEEEEe-----C
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISHQHICKLFQVIET-----S 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~ 78 (568)
++..+|...+.||+|+||.|+.|.++.+|+.||+|.+..... ....++..+|+++|+.++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 456678888999999999999999999999999998864322 2346788899999999999999999999854 4
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
+.+|+|+|++ +.+|.+.|+.+..++++.++.++.||+.||+|+|+.||+||||||+|++++.+..+||+|||+|+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5799999999 679999998888899999999999999999999999999999999999999999999999999987643
Q ss_pred C-CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Q psy6203 159 G-LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-------------- 223 (568)
Q Consensus 159 ~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-------------- 223 (568)
. ....++..+.|.+|.|||++.....|+.+.||||+|||+.||++|++.|.+.+.-..+..|..-
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2 1233466788999999999988777899999999999999999999999887654444433221
Q ss_pred ---------CCCC--------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 ---------KYTE--------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 ---------~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.... -+..++.+.+|+.+||..||.+|+|++|+|+|||+..
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 1111 1357899999999999999999999999999999984
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=403.71 Aligned_cols=258 Identities=40% Similarity=0.721 Sum_probs=236.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCC-CCCcceeeEEEEeCCE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHIS-HQHICKLFQVIETSSH 80 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~ 80 (568)
.++...|++.+.||+|.||.||+|+++.||+.+|+|++.+..... ....+.+|+.+|+++. |||||.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 456789999999999999999999999999999999998877643 3468999999999998 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC----CCeEEEeecCccCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN----QNLKLIDFGLCAKP 156 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~----~~~kl~DFG~a~~~ 156 (568)
+++|||+|.||+|++.|... .++|..+..++.|++.|++|||+.||+||||||+|+|+... +.+|++|||+|...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999887 49999999999999999999999999999999999999543 47999999999887
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMS 232 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 232 (568)
.. .......|||+.|+|||++.... |+..+||||+||++|.|++|.+||.+.+.......|..+.+.+. +.++
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 65 45677889999999999998766 69999999999999999999999999999999999999987543 3479
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
..++++|++||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999999853
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=418.22 Aligned_cols=458 Identities=24% Similarity=0.407 Sum_probs=333.6
Q ss_pred eecccCCeEEEEEEE---cCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEeccC
Q psy6203 15 TVGSGGFAKVKLATH---VLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVIEYCP 89 (568)
Q Consensus 15 ~lG~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 89 (568)
++|+|+||.|++++. ...|..||+|++++..... .......|..++..++ ||.+|+++..++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998753 3457789999998766532 2224555778888887 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccC
Q psy6203 90 GGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169 (568)
Q Consensus 90 ~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~g 169 (568)
||+|...+.+...+.+...+.+...++-|++++|+.+|+|||+|++||+++.+|.+++.|||+++..... ...||
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~-----~~~cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE-----KIACG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh-----hhccc
Confidence 9999999988889999999999999999999999999999999999999999999999999998765432 12299
Q ss_pred CccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCC
Q psy6203 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 249 (568)
Q Consensus 170 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 249 (568)
|..|||||++.+ ...++|.||+|++.++|+||..||.+ +...+|...++..|..++..+++++..++..+|..
T Consensus 156 t~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~n 228 (612)
T KOG0603|consen 156 TYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPEN 228 (612)
T ss_pred chhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHH
Confidence 999999999983 36789999999999999999999987 77888999899999999999999999999999999
Q ss_pred CCC-----HHHHhcCcccccCCC------CCCCCCCCCCc-----------------------------------CCcCC
Q psy6203 250 RIK-----IQDLLGHNWVKMGPE------DNPVSFRPDHE-----------------------------------LREKD 283 (568)
Q Consensus 250 Rps-----~~ell~hp~~~~~~~------~~~~~~~~~~~-----------------------------------~~~~~ 283 (568)
|.. +.|+++|++|..... ..+..+.+... .+...
T Consensus 229 rLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva 308 (612)
T KOG0603|consen 229 RLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVA 308 (612)
T ss_pred HhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccC
Confidence 985 579999999963211 11111111100 00001
Q ss_pred HHHHHHHHhccCCCHHHHHHHHHhc-----CCChhH---HHHHHHhhhhc--------------cCCccCCCCcch----
Q psy6203 284 DDVIKVMADHKQLSPDDMWSQLNEW-----TYNYDT---CTYLLLLSRKK--------------QGKQYYGSETDV---- 337 (568)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~~-----~~~~~~---~~~~~~~~~~~--------------~~~~~~~~~~~~---- 337 (568)
..++.......-...-+....+.+. ++.... ..+.+....+. +..++..+-.++
T Consensus 309 ~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 309 PGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred hHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCC
Confidence 1111110000000000000000000 000000 00111111110 011222222222
Q ss_pred ---hhh-----HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------C---------cceeEEEccccCccccc
Q psy6203 338 ---WSM-----GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------M---------PICTILISQYFPTILLP 388 (568)
Q Consensus 338 ---~~~-----g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~---------~~~~iki~dfG~~~~~~ 388 (568)
|.+ |+.+.+-++....+. .++..++.++++++ + .+++|+|+|||++....
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 221 445544455444555 78888999999864 2 34567888999765543
Q ss_pred CCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCHHHHH
Q psy6203 389 CKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTEPPWMSPNSRQ 466 (568)
Q Consensus 389 ~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~ 466 (568)
.+ ..+-|-|..|+|||+ ....|+.++||||||++||+||+|+.||...... +++..|..+.+. .++|..++|
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKd 541 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKD 541 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHH
Confidence 22 345577889999999 7889999999999999999999999999876544 667766665444 889999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCccc
Q psy6203 467 IVRSMLQVEPGKRIKIQDLLGHNWV 491 (568)
Q Consensus 467 li~~~L~~dp~~R~t~~~~l~hp~~ 491 (568)
||+.||+.||.+|+++.+++.||||
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999999
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=387.63 Aligned_cols=263 Identities=30% Similarity=0.463 Sum_probs=230.3
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+..-.+.|++...||.|..++||+|+.+.+++.||||++.......+.+.+.+|+..|+.++||||++++..|..++.+|
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 34456789999999999999999999999999999999998888777889999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 83 MVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
+||.||.+|++.+++... ..++|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+.......
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999999874 459999999999999999999999999999999999999999999999999876433221
Q ss_pred c---cccccccCCcccccccc-ccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------
Q psy6203 161 E---SQLQTSCGSPNYAAPEV-IKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP-------- 228 (568)
Q Consensus 161 ~---~~~~~~~gt~~y~aPE~-l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~-------- 228 (568)
. ....+.+||++|||||+ .+....|+.|+||||||++..||.+|..||....+.++.-.-.++.++.+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD 260 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence 1 12256789999999999 45555689999999999999999999999988776665555555554422
Q ss_pred --CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 229 --PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 229 --~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
...+..++++|..||++||.+|||++++|+|+||+..
T Consensus 261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 1267789999999999999999999999999999853
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=403.65 Aligned_cols=257 Identities=31% Similarity=0.536 Sum_probs=228.1
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+....|...++||+|+.|.||.|+...+++.||+|.+...... ..+.+.+|+.+|+..+|+|||++++.|...+.+++
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 45677899999999999999999999999999999999876543 34567889999999999999999999988899999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||++||+|.+.+.. ..++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|....... ..
T Consensus 348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-~K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-SK 425 (550)
T ss_pred EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc-Cc
Confidence 9999999999888754 559999999999999999999999999999999999999999999999999998876643 24
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC--CCCCCChHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYT--EPPWMSPNSRQIVR 240 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~--~~~~~~~~~~~li~ 240 (568)
..+.+|||+|||||++.... |++++||||||++++||+-|.+||-..+. ..++....+|.+. .+..+|+.+++|+.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred cccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 56779999999999998877 69999999999999999999999975554 4444444555543 46679999999999
Q ss_pred HccccCcCCCCCHHHHhcCccccc
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||+.|+.+|++|.|+|+||||+.
T Consensus 505 ~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHhhcchhcCCCHHHHhcChhhhh
Confidence 999999999999999999999974
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=401.02 Aligned_cols=252 Identities=34% Similarity=0.651 Sum_probs=231.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||+|++..+|+.||+|++.+.... .....+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999999765322 23456888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~ 173 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TF 173 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----cc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998765332 23
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+..+.+..+....+.++++.+++||.+||+.
T Consensus 174 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT 252 (329)
T ss_pred eecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhc
Confidence 457999999999998776 5899999999999999999999999988888889999998888888999999999999999
Q ss_pred CcCCCCC-----HHHHhcCccccc
Q psy6203 246 EPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps-----~~ell~hp~~~~ 264 (568)
||.+|++ +++++.||||+.
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999997 799999999974
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=372.06 Aligned_cols=257 Identities=36% Similarity=0.625 Sum_probs=231.1
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC---Cc----hHHHHHHHHHHHhC-CCCCcceeeEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG---ED----LPRVKLEINALKHI-SHQHICKLFQVIE 76 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~----~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 76 (568)
++-+.|.-.+.||.|..+.|..+.++.+|..+|+|++....-. +. .+....|+.||+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456788899999999999999999999999999998743322 21 23456699999998 5999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 77 TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 77 ~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
++..+++|+|.|+.|.|+|++.+...++|.+.+.|++|++.|+.|||.++||||||||+|||++++.++||+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCccccccccCCcccccccccc-----CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--C
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIK-----GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--P 229 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~--~ 229 (568)
..+ ..+...||||+|.|||.+. +.+.|+..+|+||+|||+|.|+.|.+||......-+...|..|++.+. .
T Consensus 174 ~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 174 EPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred CCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 765 5677889999999999985 345578899999999999999999999998877778889999988753 3
Q ss_pred --CCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 230 --WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 230 --~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.+|...++||.+||+.||.+|+|++|+|.||||.
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 3788999999999999999999999999999995
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=395.49 Aligned_cols=252 Identities=33% Similarity=0.614 Sum_probs=229.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 5799999999999999999999999999999999754322 23456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----cc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998765332 23
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+..+.+..+....+...++.+++||++||+.
T Consensus 157 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred cccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCC
Confidence 457999999999998766 5899999999999999999999999999888999999988888888999999999999999
Q ss_pred CcCCCCC-----HHHHhcCccccc
Q psy6203 246 EPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps-----~~ell~hp~~~~ 264 (568)
||.+|++ ++|++.||||+.
T Consensus 236 dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CHHHccCCccCCHHHHhcCccccC
Confidence 9999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=396.48 Aligned_cols=249 Identities=32% Similarity=0.642 Sum_probs=224.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 91 (568)
+.||+|+||.||+|.+..+|+.||+|++++.... .....+.+|+.++++++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999864322 23456778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCc
Q psy6203 92 ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP 171 (568)
Q Consensus 92 ~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~ 171 (568)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+||+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceecCc
Confidence 99999988889999999999999999999999999999999999999999999999999998753221 12234567999
Q ss_pred cccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCC
Q psy6203 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRI 251 (568)
Q Consensus 172 ~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 251 (568)
.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+..+....+..+++++.+||++||+.||++||
T Consensus 160 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred cccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 999999998766 5899999999999999999999999998888888888888888888999999999999999999999
Q ss_pred -----CHHHHhcCccccc
Q psy6203 252 -----KIQDLLGHNWVKM 264 (568)
Q Consensus 252 -----s~~ell~hp~~~~ 264 (568)
++.++++||||..
T Consensus 239 ~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 239 GGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCHHHHHcCCCcCC
Confidence 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=393.75 Aligned_cols=252 Identities=30% Similarity=0.558 Sum_probs=228.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCC-cEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTG-EKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||.||+|.+..++ ..||+|++.+... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 57999999999999999999876655 6899999875432 22345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~----~~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RT 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC----Cc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999876532 22
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+..+....+..+++.+.++|++||+
T Consensus 186 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 264 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLS 264 (340)
T ss_pred ceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 4567999999999998765 588999999999999999999999999888888999998888888899999999999999
Q ss_pred cCcCCCC-----CHHHHhcCccccc
Q psy6203 245 VEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
.||.+|+ |++++++||||..
T Consensus 265 ~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 265 HDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred cCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999995 8999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=388.46 Aligned_cols=247 Identities=29% Similarity=0.586 Sum_probs=223.1
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
||+|+||.||+|++..+++.||+|++.+... ......+.+|+.++++++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999999999999999976432 22345677899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCccc
Q psy6203 94 LDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNY 173 (568)
Q Consensus 94 ~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y 173 (568)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+.|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccCCccc
Confidence 999988889999999999999999999999999999999999999999999999999998754322 1223456799999
Q ss_pred cccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCC--
Q psy6203 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRI-- 251 (568)
Q Consensus 174 ~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-- 251 (568)
+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+..+....+..+++.+.++|.+||+.||.+||
T Consensus 160 ~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 160 LAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 9999998766 5899999999999999999999999999889999999888888888999999999999999999997
Q ss_pred -CHHHHhcCccccc
Q psy6203 252 -KIQDLLGHNWVKM 264 (568)
Q Consensus 252 -s~~ell~hp~~~~ 264 (568)
++.|++.||||+.
T Consensus 239 ~~~~e~l~hp~~~~ 252 (312)
T cd05585 239 NGAQEIKNHPFFSQ 252 (312)
T ss_pred CCHHHHHcCCCcCC
Confidence 5899999999984
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=383.87 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=214.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||+|++..++..||+|+++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999999999999999997654333445677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~~~~~ 162 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSN 162 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-CccccC
Confidence 974 8998887644 5799999999999999999999999999999999999999999999999998754322 122334
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------CC-
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK-------------------YT- 226 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~-------------------~~- 226 (568)
..|++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+....+.... ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 5689999999998776557899999999999999999999998877665544432210 00
Q ss_pred ----------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 ----------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 ----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..+.+++++.+||++||++||.+|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=388.85 Aligned_cols=249 Identities=32% Similarity=0.627 Sum_probs=223.8
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 91 (568)
+.||+|+||.||+|++..+|+.||+|++.+.... .....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999865322 23456778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCc
Q psy6203 92 ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP 171 (568)
Q Consensus 92 ~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~ 171 (568)
+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGTP 159 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccCCc
Confidence 99999988888999999999999999999999999999999999999999999999999998753322 12234567999
Q ss_pred cccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCC
Q psy6203 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRI 251 (568)
Q Consensus 172 ~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 251 (568)
.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+..+....+..+++++.+||.+||+.||.+|+
T Consensus 160 ~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred CccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 999999998766 5899999999999999999999999888888888888888888888999999999999999999997
Q ss_pred -----CHHHHhcCccccc
Q psy6203 252 -----KIQDLLGHNWVKM 264 (568)
Q Consensus 252 -----s~~ell~hp~~~~ 264 (568)
++.|+++||||..
T Consensus 239 ~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 239 GGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCHHHHhcCCCcCC
Confidence 8999999999973
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=381.47 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=213.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++.+.||+|+||.||+|+++.+++.||+|++...... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 5899999999999999999999999999999999765432 234567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 99887776555455679999999999999999999999999999999999999999999999999987654332223344
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--C-------------------C
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K-------------------Y 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~-------------------~ 225 (568)
..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+... . .
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 161 YVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred cccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 57899999999998776 588999999999999999999999876654332222110 0 0
Q ss_pred CC-----------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 TE-----------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 ~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
+. ...+++++.+||++||++||++|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 11267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=387.16 Aligned_cols=256 Identities=30% Similarity=0.586 Sum_probs=223.0
Q ss_pred CeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcC---CchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLG---EDLPRVKLEINALKHIS-HQHICKLFQVIETSSHI 81 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~ 81 (568)
+|++.+.||+|+||.||+|++. .+++.||+|++.+.... .....+..|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999999764322 23456778999999995 89999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|+||||+++|+|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC----CCHHHHHHHHHcCCCCCCCCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS----DSIDQLYDKILNGKYTEPPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (568)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.. .....+...+.......+..+++.+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 3334567999999999998765568899999999999999999999964 234556666777777777789999999
Q ss_pred HHHHccccCcCCCC-----CHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
+|.+||+.||++|| +++++++||||+.
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999999 8899999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=392.57 Aligned_cols=255 Identities=28% Similarity=0.575 Sum_probs=220.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.... .....+..|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999764322 23456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE---- 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---- 161 (568)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864321100
Q ss_pred ------------------------------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC
Q psy6203 162 ------------------------------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD 211 (568)
Q Consensus 162 ------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~ 211 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012457999999999998766 589999999999999999999999998
Q ss_pred CHHHHHHHHHcCC--CCCCC--CCChHHHHHHHHccccCcC---CCCCHHHHhcCccccc
Q psy6203 212 SIDQLYDKILNGK--YTEPP--WMSPNSRQIVRSMLQVEPG---KRIKIQDLLGHNWVKM 264 (568)
Q Consensus 212 ~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~L~~dP~---~Rps~~ell~hp~~~~ 264 (568)
+..+....+.... ...++ .++++++++|.+|+. +|. .||+++|+++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 8888888887643 33333 478999999999775 454 4589999999999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=362.77 Aligned_cols=251 Identities=35% Similarity=0.687 Sum_probs=219.0
Q ss_pred cccCeEEE-eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe----CC
Q psy6203 6 LRNQYILE-RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET----SS 79 (568)
Q Consensus 6 ~~~~Y~i~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----~~ 79 (568)
+.++|.+. ++||-|-.|+|..|.++.||+++|+|++. +.+..++|+++.-.. .|||||.++++|++ ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL------DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 56778775 67999999999999999999999999985 334677888876555 59999999999864 35
Q ss_pred EEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC---CCeEEEeecCcc
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN---QNLKLIDFGLCA 154 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~ 154 (568)
.+.+|||.++||+|++.|.+++. ++|.++..|++||..|+.|||+.+|.||||||+|+|...+ ..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 68899999999999999998765 9999999999999999999999999999999999999654 469999999998
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCC-
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPP- 229 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~----~~~~~~~i~~~~~~~~~- 229 (568)
..... ..+.+.|-||.|.|||++.... |+..+|+||+||++|-|++|.+||.+.. ...+..+|..|.+.+|.
T Consensus 213 ~t~~~--~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQEP--GDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCCC--ccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 76542 4567889999999999997666 6999999999999999999999997653 23567789999887764
Q ss_pred -C--CChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 230 -W--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 230 -~--~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
| +|.+++++|+.+|..+|.+|.|++++++|||+...
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 3 89999999999999999999999999999999853
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=387.49 Aligned_cols=249 Identities=31% Similarity=0.634 Sum_probs=223.4
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 91 (568)
+.||+|+||.||+|++..+|..||+|++...... .....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999864321 23456678999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCc
Q psy6203 92 ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP 171 (568)
Q Consensus 92 ~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~ 171 (568)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccCCc
Confidence 99999988888999999999999999999999999999999999999999999999999998753221 12234457999
Q ss_pred cccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCC
Q psy6203 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRI 251 (568)
Q Consensus 172 ~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 251 (568)
.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.......+..+++++.++|.+||+.||.+|+
T Consensus 160 ~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred CcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 999999998766 5899999999999999999999999988888888888888888888999999999999999999998
Q ss_pred -----CHHHHhcCccccc
Q psy6203 252 -----KIQDLLGHNWVKM 264 (568)
Q Consensus 252 -----s~~ell~hp~~~~ 264 (568)
++.++++||||..
T Consensus 239 ~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 239 GGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCHHHHHcCCCcCC
Confidence 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=385.76 Aligned_cols=249 Identities=35% Similarity=0.679 Sum_probs=222.9
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||+||+|+++.+++.||+|++.+... ......+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999976432 22345667788888876 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGT 159 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccccC
Confidence 999999988889999999999999999999999999999999999999999999999999998753222 1223456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+....+..+++++.++|++||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 160 PDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred ccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 9999999998765 588999999999999999999999999999999999998888888999999999999999999999
Q ss_pred CCH------HHHhcCccccc
Q psy6203 251 IKI------QDLLGHNWVKM 264 (568)
Q Consensus 251 ps~------~ell~hp~~~~ 264 (568)
|++ ++++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 239 LGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCHHHHHcCCCcCC
Confidence 998 99999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=392.25 Aligned_cols=255 Identities=31% Similarity=0.637 Sum_probs=221.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||+||+|++..+|+.||||++.+.... .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 5799999999999999999999999999999999864322 23456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc---
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES--- 162 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--- 162 (568)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998643211000
Q ss_pred ----------------------------------ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCC
Q psy6203 163 ----------------------------------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF 208 (568)
Q Consensus 163 ----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf 208 (568)
...+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCCC
Confidence 111346999999999998766 589999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCC--CCCC--CCChHHHHHHHHccccCcCCCCC---HHHHhcCccccc
Q psy6203 209 DSDSIDQLYDKILNGKY--TEPP--WMSPNSRQIVRSMLQVEPGKRIK---IQDLLGHNWVKM 264 (568)
Q Consensus 209 ~~~~~~~~~~~i~~~~~--~~~~--~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~ 264 (568)
...+..+....+..... ..+. .+++++.+||.+||. +|.+|++ ++|++.||||+.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99888877777765432 2222 468999999999997 9999998 999999999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=386.64 Aligned_cols=252 Identities=33% Similarity=0.595 Sum_probs=223.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||+|++..+++.||+|++.+.... .....+..|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999999865332 23456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccC
Confidence 9999999999998888999999999999999999999999999999999999999999999999999876433 234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCC------CCChHHHH
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPP------WMSPNSRQ 237 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~--~~~~------~~~~~~~~ 237 (568)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+..... ..+. .+++++.+
T Consensus 157 ~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 567999999999998775 68999999999999999999999999888877776654321 1121 35899999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
||.+||..+|.+||++++++.||||..
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 999999999999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=367.44 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=219.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCC-cceeeEEEEeCC------
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQH-ICKLFQVIETSS------ 79 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~------ 79 (568)
..|..+++||+|+||+||+|+++.+|+.||+|.+......+ .-....+|+.+|+.|+|+| |+++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34777888999999999999999999999999998665432 2345688999999999999 999999998877
Q ss_pred EEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQ----RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK 155 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 155 (568)
.+++|+||+ ..+|..++.... .++...++.+++||+.||+|||+++|+||||||+|||++++|.+||+|||+|+.
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 899999999 568999997654 577889999999999999999999999999999999999999999999999986
Q ss_pred CCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC--------
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKY-------- 225 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~-------- 225 (568)
..-.. ......++|.+|.|||++.|...|+...||||+|||++||+++++.|.+.+..+....|.. |.+
T Consensus 170 ~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 55332 2345667899999999999998899999999999999999999999999887766666543 111
Q ss_pred --------CCC------------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 226 --------TEP------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 226 --------~~~------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
.++ +..+++..+++.+||+++|.+|.|+..+|.||||...+
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 111 11345889999999999999999999999999998543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=382.59 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=212.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|++..+++.||+|++...........+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999999999999999999765443334467789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 161 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYS 161 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-CccCC
Confidence 995 6788877654 56899999999999999999999999999999999999999999999999998654322 12234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHc--CCCC----------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILN--GKYT---------------- 226 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~--~~~~---------------- 226 (568)
..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.. .......+.. +...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 45689999999998776657889999999999999999999997643 2222222211 0000
Q ss_pred -----CC---------CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 -----EP---------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 -----~~---------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+ ...++.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 00 013567899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=370.89 Aligned_cols=258 Identities=30% Similarity=0.529 Sum_probs=227.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
+.|++++.||.|.-|+||+|+.+.++..+|+|++.+..... ...+.+.|.+||+.++||.++.+|..|+.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 35788899999999999999999999999999999876643 3456777999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC-----
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG----- 158 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~----- 158 (568)
|||+||+|..+..++ +.+++..++-++..++-||+|||-.|||.|||||+|||+.++|+|.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999999999888764 5799999999999999999999999999999999999999999999999998632110
Q ss_pred ----------------------------C-C---------------------ccccccccCCccccccccccCcccCCcc
Q psy6203 159 ----------------------------G-L---------------------ESQLQTSCGSPNYAAPEVIKGKQYYGSE 188 (568)
Q Consensus 159 ----------------------------~-~---------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~ 188 (568)
. . ....+.++||-.|+|||++.|.. .+.+
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsA 315 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSA 315 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCch
Confidence 0 0 01123357999999999999987 4899
Q ss_pred cceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCChHHHHHHHHccccCcCCCCC----HHHHhcCccc
Q psy6203 189 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP--WMSPNSRQIVRSMLQVEPGKRIK----IQDLLGHNWV 262 (568)
Q Consensus 189 ~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps----~~ell~hp~~ 262 (568)
+|.|+|||.+|||+.|..||.+.+..+.+.+|......+|. .++..++|||+++|.+||.+|.. |.||.+||||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 99999999999999999999999999999999988766554 57899999999999999999998 9999999999
Q ss_pred ccCC
Q psy6203 263 KMGP 266 (568)
Q Consensus 263 ~~~~ 266 (568)
+...
T Consensus 396 ~gVn 399 (459)
T KOG0610|consen 396 EGVN 399 (459)
T ss_pred cCCC
Confidence 8543
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=386.47 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=231.5
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..+....|+..+.||+|+||.||+|.+..+++.||+|++.........+.++.|+.+|.+++++||.++|+.+..+..++
T Consensus 8 ~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 8 KIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred cCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 34556789999999999999999999999999999999998877777888999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
++||||.||++.+.+.....+.|.++..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||++........
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 9999999999999998877789999999999999999999999999999999999999999999999999987665433
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRS 241 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~ 241 (568)
...+.+|||.|||||++.+.. |+.++||||||++.+||++|.+|+....+..+.-.|-+..++ .....++.+++||..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred ccccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence 337889999999999999655 699999999999999999999999876664443334333332 233588999999999
Q ss_pred ccccCcCCCCCHHHHhcCccccc
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
||++||+.||||.++|.|+|++.
T Consensus 246 CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HhhcCcccCcCHHHHhhhHHHHh
Confidence 99999999999999999999994
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.05 Aligned_cols=254 Identities=32% Similarity=0.589 Sum_probs=226.8
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCC-CCcceeeEEEEeCCEEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISH-QHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~ 85 (568)
+|++.+.||+|+||.||+|.+..+++.||+|++.+... ......+..|+.++..++| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986432 2334567789999999976 46888999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CCcee
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643221 12234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
..+||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+....+.......+..+++++.+++.+||..
T Consensus 160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTK 238 (324)
T ss_pred eecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 567999999999998776 5889999999999999999999999999889999998888888888999999999999999
Q ss_pred CcCCCCCH-----HHHhcCccccc
Q psy6203 246 EPGKRIKI-----QDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps~-----~ell~hp~~~~ 264 (568)
||.+|+++ +++++||||+.
T Consensus 239 ~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 239 HPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999986 89999999974
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=383.90 Aligned_cols=249 Identities=33% Similarity=0.614 Sum_probs=223.0
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||.||+|++..+++.||+|++.+... ......+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999986432 22344567788888866 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC-CccccccccC
Confidence 999999988889999999999999999999999999999999999999999999999999998753322 1223455799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.....+.+..+....+..+++++.++|.+||+.||++|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 160 PDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred ccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 9999999998766 589999999999999999999999999999999999998888888899999999999999999999
Q ss_pred C-------CHHHHhcCccccc
Q psy6203 251 I-------KIQDLLGHNWVKM 264 (568)
Q Consensus 251 p-------s~~ell~hp~~~~ 264 (568)
+ +++++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 239 LGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCCCCCHHHHhcCCccCC
Confidence 9 9999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=376.66 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=218.3
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+.... .....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 488999999999999999999999999999998765432 223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++|+|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--Cee
Confidence 99999999887643 46899999999999999999999999999999999999999999999999998764332 122
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCCCCChHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILNGKYTEPPWMSPNSRQIVR 240 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~ 240 (568)
....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+. ..+...+.......+..+++++.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred cCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 3457899999999998766 58999999999999999999999987543 233444445555566778999999999
Q ss_pred HccccCcCCCCC-----HHHHhcCccccc
Q psy6203 241 SMLQVEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rps-----~~ell~hp~~~~ 264 (568)
+||+.||.+||+ ++++++||||..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 999999999997 899999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=389.37 Aligned_cols=256 Identities=32% Similarity=0.594 Sum_probs=222.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||+|++..+++.||+|++.+.... .....+..|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 6799999999999999999999999999999999754322 23345778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 99999999998865 46899999999999999999999999999999999999999999999999998765433222334
Q ss_pred cccCCccccccccccCcc---cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCC--CCChHHHHH
Q psy6203 166 TSCGSPNYAAPEVIKGKQ---YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEPP--WMSPNSRQI 238 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~l 238 (568)
..+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+....+..+.... ...+. .++.++++|
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 281 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHH
Confidence 567999999999986532 36889999999999999999999999988888888887643 23333 579999999
Q ss_pred HHHccccCcCC--CCCHHHHhcCccccc
Q psy6203 239 VRSMLQVEPGK--RIKIQDLLGHNWVKM 264 (568)
Q Consensus 239 i~~~L~~dP~~--Rps~~ell~hp~~~~ 264 (568)
|.+||+.+|.+ |+|++|+++||||+.
T Consensus 282 i~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 282 ICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=385.94 Aligned_cols=249 Identities=32% Similarity=0.635 Sum_probs=223.0
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 91 (568)
+.||+|+||.||+|.+..+|+.||+|++.+.... .....+..|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999865332 23456678999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 92 ELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 92 ~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
+|..++.....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGT 159 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-CcccccccCC
Confidence 999999888889999999999999999999997 79999999999999999999999999998753321 1223455799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.......+..+++++.+||.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 160 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred cccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 9999999998766 589999999999999999999999998888888888888888888899999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q psy6203 251 I-----KIQDLLGHNWVKM 264 (568)
Q Consensus 251 p-----s~~ell~hp~~~~ 264 (568)
+ ++.++++||||..
T Consensus 239 ~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 239 LGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 9999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=388.70 Aligned_cols=255 Identities=33% Similarity=0.706 Sum_probs=224.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||+||+|++..+|+.||+|++.+.... .....+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 5799999999999999999999999999999999865332 33456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL----- 160 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----- 160 (568)
||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987654322
Q ss_pred -----------------------ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHH
Q psy6203 161 -----------------------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 217 (568)
Q Consensus 161 -----------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~ 217 (568)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 11223456999999999998875 589999999999999999999999988887777
Q ss_pred HHHHc--CCCCCCC--CCChHHHHHHHHccccCcCCCCC-HHHHhcCccccc
Q psy6203 218 DKILN--GKYTEPP--WMSPNSRQIVRSMLQVEPGKRIK-IQDLLGHNWVKM 264 (568)
Q Consensus 218 ~~i~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps-~~ell~hp~~~~ 264 (568)
..+.. .....+. .+++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77766 3333333 369999999999998 9999999 999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=382.19 Aligned_cols=249 Identities=33% Similarity=0.656 Sum_probs=221.2
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||.||+|+++.+|+.||+|++++... .........|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999986432 23345566788887754 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|..++..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccCCC
Confidence 999999988888999999999999999999999999999999999999999999999999998643221 1233456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++.+.+..+....+.+++++++++|.+||+.||++|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 160 PDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred cCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 9999999998776 589999999999999999999999999988888888888887888899999999999999999999
Q ss_pred CCH-HHHhcCccccc
Q psy6203 251 IKI-QDLLGHNWVKM 264 (568)
Q Consensus 251 ps~-~ell~hp~~~~ 264 (568)
|++ +++++||||+.
T Consensus 239 ~~~~~~~~~h~~f~~ 253 (316)
T cd05620 239 LGVVGNIRGHPFFKT 253 (316)
T ss_pred CCChHHHHcCCCcCC
Confidence 998 58999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=381.89 Aligned_cols=250 Identities=34% Similarity=0.637 Sum_probs=222.9
Q ss_pred EeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcC---CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 13 ERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLG---EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++.||+|+||.||+|++. .+++.||+|++.+.... .....+..|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47889999999864321 223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|+++++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 159 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHT 159 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998753322 122344
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccC
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 246 (568)
.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+..+....++.+++.+.++|.+||+.|
T Consensus 160 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 160 FCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred cCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 57999999999998766 58899999999999999999999999988888889988888888899999999999999999
Q ss_pred cCCCC-----CHHHHhcCccccc
Q psy6203 247 PGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 247 P~~Rp-----s~~ell~hp~~~~ 264 (568)
|++|| ++++++.||||+.
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCC
Confidence 99999 8999999999974
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=382.60 Aligned_cols=252 Identities=31% Similarity=0.571 Sum_probs=222.5
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHH---HhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINAL---KHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l---~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
|++.+.||+|+||.||+|.+..+|+.||+|++++.... .....+.+|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999865321 2344566676655 567899999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++|++|...+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CCcc
Confidence 999999999888754 57999999999999999999999999999999999999999999999999998653322 2233
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
...+|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+..+....+..+++.+.++|.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 4567999999999998766 588999999999999999999999999988888889888888888899999999999999
Q ss_pred cCcCCCC-----CHHHHhcCccccc
Q psy6203 245 VEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
.||.+|| ++.++++||||+.
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 7999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=390.72 Aligned_cols=255 Identities=28% Similarity=0.552 Sum_probs=218.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|+++++||+|+||+||+|++..+++.||+|++.+... ......+.+|+.++++++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999999999999999999976432 123456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL----- 160 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----- 160 (568)
|||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred -----------------------------------------ccccccccCCccccccccccCcccCCcccceechhhHHH
Q psy6203 161 -----------------------------------------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLY 199 (568)
Q Consensus 161 -----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 199 (568)
.....+.+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHH
Confidence 00112347999999999998776 589999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC--CCC--CCCCChHHHHHHHHccccCcCCCCC---HHHHhcCccccc
Q psy6203 200 ALLCGFLPFDSDSIDQLYDKILNGK--YTE--PPWMSPNSRQIVRSMLQVEPGKRIK---IQDLLGHNWVKM 264 (568)
Q Consensus 200 ~lltG~~pf~~~~~~~~~~~i~~~~--~~~--~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~ 264 (568)
+|++|.+||.+.+..+....+.... ... ...+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 9999999999888776666665532 222 3457999999999987 49999997 999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=390.98 Aligned_cols=255 Identities=27% Similarity=0.581 Sum_probs=218.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||+||+|.+..+|+.||+|++.+... ......+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 579999999999999999999999999999999875432 123456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE---- 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---- 161 (568)
||++||+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999853211000
Q ss_pred --------c----------------------------------ccccccCCccccccccccCcccCCcccceechhhHHH
Q psy6203 162 --------S----------------------------------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLY 199 (568)
Q Consensus 162 --------~----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 199 (568)
. .....+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhhh
Confidence 0 001246999999999998766 589999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC--CCCCC--CCChHHHHHHHHccccCcCCC---CCHHHHhcCccccc
Q psy6203 200 ALLCGFLPFDSDSIDQLYDKILNGK--YTEPP--WMSPNSRQIVRSMLQVEPGKR---IKIQDLLGHNWVKM 264 (568)
Q Consensus 200 ~lltG~~pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~L~~dP~~R---ps~~ell~hp~~~~ 264 (568)
+|++|.+||.+.+..+.+..+.... ...+. .+++++++||.+||. +|.+| +|+.|++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999999999888777777776532 22333 478999999999998 77765 59999999999983
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=388.64 Aligned_cols=256 Identities=28% Similarity=0.517 Sum_probs=217.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..|++++.||+|+||+||+|++..+++.||+|++.+.... .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3689999999999999999999999999999999765432 23456888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL----- 160 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----- 160 (568)
||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999875321000
Q ss_pred -----------------------------------------ccccccccCCccccccccccCcccCCcccceechhhHHH
Q psy6203 161 -----------------------------------------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLY 199 (568)
Q Consensus 161 -----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 199 (568)
.....+.+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHHH
Confidence 00012357999999999998766 589999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC--CCCCC--CCCChHHHHHHHHccc--cCcCCCCCHHHHhcCccccc
Q psy6203 200 ALLCGFLPFDSDSIDQLYDKILNG--KYTEP--PWMSPNSRQIVRSMLQ--VEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 200 ~lltG~~pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~L~--~dP~~Rps~~ell~hp~~~~ 264 (568)
+|++|..||...+..+....+... ....+ ..+++++.+||.+|+. .+|..|++++|++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 999999999888776666665532 22333 3579999999999654 45556999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=385.16 Aligned_cols=256 Identities=31% Similarity=0.576 Sum_probs=223.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|.+.+.||+|+||+||+|.+..+|+.||+|++++... .+....+..|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 579999999999999999999999999999999986543 223456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999876 6899999999999999999999999999999999999999999999999999876543322223
Q ss_pred ccccCCccccccccccC-----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC----CCCCCCCChHH
Q psy6203 165 QTSCGSPNYAAPEVIKG-----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----YTEPPWMSPNS 235 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~ 235 (568)
....||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....+..+.... ++..+.+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 34579999999999863 3346789999999999999999999999888777777776543 22334578999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+||.+||+ ||.+|||+++++.||||..
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 999999998 9999999999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=390.61 Aligned_cols=255 Identities=28% Similarity=0.536 Sum_probs=219.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|+||.||+|++..+++.||+|++.+... ......+.+|+.+|++++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999875432 123456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL----- 160 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----- 160 (568)
|||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999974221000
Q ss_pred -------------------------------------ccccccccCCccccccccccCcccCCcccceechhhHHHHHHh
Q psy6203 161 -------------------------------------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC 203 (568)
Q Consensus 161 -------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt 203 (568)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehhh
Confidence 00012347999999999998766 5899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCC--CC--CCCCChHHHHHHHHccccCcCCCC---CHHHHhcCccccc
Q psy6203 204 GFLPFDSDSIDQLYDKILNGKY--TE--PPWMSPNSRQIVRSMLQVEPGKRI---KIQDLLGHNWVKM 264 (568)
Q Consensus 204 G~~pf~~~~~~~~~~~i~~~~~--~~--~~~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~~~~ 264 (568)
|+.||.+.+..+....+..... .. ...+++++.++|.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 9999998887776666654322 22 2357899999999977 5999999 9999999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=386.14 Aligned_cols=258 Identities=30% Similarity=0.567 Sum_probs=221.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
..++|++.+.||+|+||.||+|++..+++.||+|++.+.... .....+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 347899999999999999999999999999999999754322 234467789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..........
T Consensus 121 v~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 9999999999998865 468999999999999999999999999999999999999999999999999987654322222
Q ss_pred cccccCCccccccccccCcc---cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCC--CCChHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQ---YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEPP--WMSPNSR 236 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~ 236 (568)
..+.+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+.......+.... ...+. .+++.++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 34567999999999987542 36789999999999999999999999988887777776643 33333 4689999
Q ss_pred HHHHHccccCcCC--CCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGK--RIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~--Rps~~ell~hp~~~~ 264 (568)
++|.+||+.++.+ |+|++|+++||||+.
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 9999999865544 899999999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=380.19 Aligned_cols=254 Identities=31% Similarity=0.577 Sum_probs=226.2
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
+|.+.+.||+|+||.||+|++..+++.||+|++.+.... ........|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999865322 2234566688888777 4899999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||+++|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-CCccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998753321 12234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+...+...+.......+..+++++.+++.+||+.
T Consensus 160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred cCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHccc
Confidence 567999999999998776 5899999999999999999999999999999999999888888888999999999999999
Q ss_pred CcCCCCCH-----HHHhcCccccc
Q psy6203 246 EPGKRIKI-----QDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps~-----~ell~hp~~~~ 264 (568)
||.+|+++ .++++||||+.
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred CHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=381.35 Aligned_cols=249 Identities=33% Similarity=0.626 Sum_probs=217.8
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||.||+|++..+++.||+|++++.... +....+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865432 2345678899999988 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccccCC
Confidence 999999988889999999999999999999999999999999999999999999999999998643221 1233456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCChHHHHHHHH
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---------SIDQLYDKILNGKYTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 241 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|+.||... ......+.+.......+..+++.+.++|++
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 238 (329)
T cd05588 160 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKG 238 (329)
T ss_pred ccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998766 588999999999999999999999531 223456667777777888899999999999
Q ss_pred ccccCcCCCCC------HHHHhcCccccc
Q psy6203 242 MLQVEPGKRIK------IQDLLGHNWVKM 264 (568)
Q Consensus 242 ~L~~dP~~Rps------~~ell~hp~~~~ 264 (568)
||+.||.+|+| ++++++||||..
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 239 FLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999997 789999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=379.50 Aligned_cols=249 Identities=36% Similarity=0.680 Sum_probs=219.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHh-CCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKH-ISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||.||+|++..+++.||+|++++.... ........|..++.. .+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999864321 233445567777765 4799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCC
Confidence 9999999888899999999999999999999999999999999999999999999999999987543221 233456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+.......+..+++++.++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 160 PDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred ccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 9999999998776 589999999999999999999999999988888888888777888899999999999999999999
Q ss_pred CCH-HHHhcCccccc
Q psy6203 251 IKI-QDLLGHNWVKM 264 (568)
Q Consensus 251 ps~-~ell~hp~~~~ 264 (568)
|++ ++++.||||..
T Consensus 239 ~~~~~~l~~h~~~~~ 253 (316)
T cd05592 239 LGVDGDIRQHPFFRG 253 (316)
T ss_pred CCChHHHHcCcccCC
Confidence 986 58999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=380.16 Aligned_cols=249 Identities=34% Similarity=0.627 Sum_probs=219.6
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEIN-ALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||+||+|.+..+|+.||+|++.+.... .....+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999999999999999999764322 22234444544 56789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccccCC
Confidence 999999988889999999999999999999999999999999999999999999999999998753222 2233455799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..++...+..+....++.+++.+.++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 160 PEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred hhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 9999999998766 589999999999999999999999999988999999888888888899999999999999999999
Q ss_pred CCH----HHHhcCccccc
Q psy6203 251 IKI----QDLLGHNWVKM 264 (568)
Q Consensus 251 ps~----~ell~hp~~~~ 264 (568)
|++ .++++||||..
T Consensus 239 ~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 239 LGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCHHHHHcCCCcCC
Confidence 997 69999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=377.78 Aligned_cols=249 Identities=31% Similarity=0.620 Sum_probs=220.4
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHh-CCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKH-ISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||+||+|++..+++.||+|+++.... .........|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999986532 2334456667888876 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCceeeecCC
Confidence 999999988888999999999999999999999999999999999999999999999999998753221 1223455799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..++.+.+..+....+.+++.++.++|.+||+.||++|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 160 PDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred ccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhc
Confidence 9999999998766 589999999999999999999999998888888888877777778899999999999999999999
Q ss_pred CCHH-HHhcCccccc
Q psy6203 251 IKIQ-DLLGHNWVKM 264 (568)
Q Consensus 251 ps~~-ell~hp~~~~ 264 (568)
|++. +++.||||+.
T Consensus 239 ~~~~~~l~~h~~~~~ 253 (316)
T cd05619 239 LGVKGDIRQHPFFRE 253 (316)
T ss_pred CCChHHHHcCcccCC
Confidence 9996 9999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=378.63 Aligned_cols=249 Identities=35% Similarity=0.669 Sum_probs=222.9
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||+||+|.+..+++.||+|++++... ......+..|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999986532 22345667888888888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccceecC
Confidence 999999988889999999999999999999999999999999999999999999999999998653222 1223445799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.......+..+++.+.+||++||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 160 PDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred ccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHc
Confidence 9999999998776 589999999999999999999999998888888888888888888899999999999999999999
Q ss_pred CCH-----HHHhcCccccc
Q psy6203 251 IKI-----QDLLGHNWVKM 264 (568)
Q Consensus 251 ps~-----~ell~hp~~~~ 264 (568)
||+ .+++.||||+.
T Consensus 239 ~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 239 LGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 999 99999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=380.30 Aligned_cols=255 Identities=31% Similarity=0.490 Sum_probs=234.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeCCE-EEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIETSSH-IFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~~lV 84 (568)
.++|..++.+|+|+||.+++++++..+..||+|.+......+. ......|+.+++++.|||||.+.+.|..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4689999999999999999999999999999999987665543 3367789999999999999999999998887 9999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|+||+||+|.+.|.+. ..++|+.+..++.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|+..... ..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-~~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-DS 161 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc-hh
Confidence 9999999999999864 46899999999999999999999999999999999999999999999999999987654 23
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 241 (568)
...+.+|||.|++||++.+.+ |+.|+|||||||++|||++-+++|.+.+...+..+|..+. .+.+...+.+++.+|+.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHH
Confidence 566788999999999999988 5999999999999999999999999999999999999988 46677899999999999
Q ss_pred ccccCcCCCCCHHHHhcCcccc
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~~ 263 (568)
||..+|..||++.++|.+|.+.
T Consensus 241 ~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HhhcCCccCCCHHHHhhChhhh
Confidence 9999999999999999998876
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=384.02 Aligned_cols=255 Identities=28% Similarity=0.618 Sum_probs=221.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||+||+|.+..+++.||+|++..... .+....+..|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999975432 233557788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE---- 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---- 161 (568)
||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864321100
Q ss_pred ------------------------------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC
Q psy6203 162 ------------------------------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD 211 (568)
Q Consensus 162 ------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~ 211 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCCC
Confidence 0012357999999999998776 589999999999999999999999998
Q ss_pred CHHHHHHHHHcCC--CCCCC--CCChHHHHHHHHccccCcCCCC---CHHHHhcCccccc
Q psy6203 212 SIDQLYDKILNGK--YTEPP--WMSPNSRQIVRSMLQVEPGKRI---KIQDLLGHNWVKM 264 (568)
Q Consensus 212 ~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~~~~ 264 (568)
+.......+.... ...++ .+++++++||.+|+. ||.+|+ +++|+++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 8888877777532 23333 378999999999875 999998 4899999999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=377.99 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=217.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|++..+|..||+|++...........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 47899999999999999999999999999999998764322334578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 160 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 160 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccc
Confidence 999999999998888899999999999999999999986 6999999999999999999999999998755332 233
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHH------------------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL------------------------ 221 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~------------------------ 221 (568)
...||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..++...+.
T Consensus 161 ~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 457899999999998766 6899999999999999999999997665544332211
Q ss_pred ----------------------cCCCCC--CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 222 ----------------------NGKYTE--PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 222 ----------------------~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
....+. ...+++++++||.+||+.||++|||++|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 111110 1136789999999999999999999999999999984
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=376.89 Aligned_cols=249 Identities=34% Similarity=0.648 Sum_probs=216.6
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||+||+|++..+++.||+|++++.... .....+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999875432 2345677888888776 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccccccCC
Confidence 999999988889999999999999999999999999999999999999999999999999998753221 1223456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCChHHHHHHHH
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS---------DSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 241 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.. .....+.+.+.......|..++..+.++|++
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~ 238 (329)
T cd05618 160 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 238 (329)
T ss_pred ccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998776 58899999999999999999999952 1233455667777777888899999999999
Q ss_pred ccccCcCCCCC------HHHHhcCccccc
Q psy6203 242 MLQVEPGKRIK------IQDLLGHNWVKM 264 (568)
Q Consensus 242 ~L~~dP~~Rps------~~ell~hp~~~~ 264 (568)
||+.||.+||| +.++++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 239 FLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999998 589999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=379.21 Aligned_cols=250 Identities=31% Similarity=0.617 Sum_probs=222.6
Q ss_pred EeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 13 ERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
++.||+|+||.||++++. .+|+.||+|++.+.... .....+..|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999863 57899999999865432 23345678999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccccc
Q psy6203 89 PGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC 168 (568)
Q Consensus 89 ~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 168 (568)
++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......+
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 159 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSFC 159 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCceeccc
Confidence 99999999988888999999999999999999999999999999999999999999999999998764332 12234567
Q ss_pred CCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcC
Q psy6203 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 248 (568)
Q Consensus 169 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~ 248 (568)
||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.......+..+++.+.+||++||+.||.
T Consensus 160 g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 160 GTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred CChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 999999999998765 5889999999999999999999999988888888888888888888999999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q psy6203 249 KRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 249 ~Rps-----~~ell~hp~~~~ 264 (568)
+||| +++++.||||..
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCC
Confidence 9999 788999999974
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=375.62 Aligned_cols=254 Identities=31% Similarity=0.577 Sum_probs=225.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 85 (568)
+|++.+.||+|+||+||+|.++.+|+.||+|++.+... ......+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47899999999999999999999999999999986432 223455677888888886 578889999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-Ccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754322 12234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
..+||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+...+...+.......+..+++++.+++.+||+.
T Consensus 160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred CccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccc
Confidence 557999999999998766 5899999999999999999999999999888889998888888888999999999999999
Q ss_pred CcCCCCC-----HHHHhcCccccc
Q psy6203 246 EPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps-----~~ell~hp~~~~ 264 (568)
||.+|++ .+++++||||..
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 239 HPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred CHhhCCCCCCCCHHHHhcCcccCC
Confidence 9999997 579999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=354.95 Aligned_cols=257 Identities=33% Similarity=0.637 Sum_probs=225.1
Q ss_pred cCeEE-EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYIL-ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 85 (568)
+-|++ .+.||+|+|+.|--|....+|..||||++.+. ......++.+|++++.+.+ |+||++++++|+++..+||||
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 34554 36799999999999999999999999999887 3445678899999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC---CeEEEeecCccCCC-----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---NLKLIDFGLCAKPE----- 157 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~~----- 157 (568)
|-+.||.|..+|.++..++|.++..++++|+.||.|||.+||.||||||+|||..... -+|||||.+.....
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999999999999999999999999999999999999999999999999999996654 48999998865321
Q ss_pred -CCCccccccccCCcccccccccc----CcccCCcccceechhhHHHHHHhCCCCCCCC---------------CHHHHH
Q psy6203 158 -GGLESQLQTSCGSPNYAAPEVIK----GKQYYGSETDVWSMGVMLYALLCGFLPFDSD---------------SIDQLY 217 (568)
Q Consensus 158 -~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---------------~~~~~~ 217 (568)
......+.+.+|+..|||||+.. ...+|+.++|.||||||+|-|++|.+||.+. -.+.++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 11223455678999999999863 3456899999999999999999999999652 145688
Q ss_pred HHHHcCCCCCCCC----CChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 218 DKILNGKYTEPPW----MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 218 ~~i~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
+.|+.|.+.+|.. +|.+++++|..+|..|+.+|.++.++++|||++..
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 9999999998863 89999999999999999999999999999999854
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=359.05 Aligned_cols=255 Identities=32% Similarity=0.622 Sum_probs=235.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|..+++||+|.||+|-+|+.+.+|+.||+|++++.-+- +.......|-.+|+..+||.+..+--.|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 6788999999999999999999999999999999876543 23445566889999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||+.||+|+-++.....++|+.++.+-..|++||.|||+++||.||||.+|+|+|.+|++||+|||+++..-.. .....
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t~k 326 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDTTK 326 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc-cceec
Confidence 99999999999988889999999999999999999999999999999999999999999999999998864332 34668
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
+.||||.|+|||++.... |+.++|.|.+||++|||++|++||...+.+.+++.|..+...+|..++++++.|+..+|.+
T Consensus 327 TFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKK 405 (516)
T ss_pred cccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhc
Confidence 899999999999999887 5999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCC-----HHHHhcCccccc
Q psy6203 246 EPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps-----~~ell~hp~~~~ 264 (568)
||.+|.. +.||.+|+||..
T Consensus 406 dP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred ChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999974 899999999974
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=380.83 Aligned_cols=257 Identities=32% Similarity=0.583 Sum_probs=220.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+.... .....+..|+.+++.++||||+++++.+.+.+.+|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 37899999999999999999999999999999998754321 2334577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 122 ~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 122 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 999999999998865 4689999999999999999999999999999999999999999999999999876543322233
Q ss_pred ccccCCccccccccccCcc---cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC--CCCCCChHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQ---YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YT--EPPWMSPNSRQ 237 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~~--~~~~~~~~~~~ 237 (568)
...+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+....+..+.... .. ....++..+++
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHH
Confidence 4567999999999987542 36789999999999999999999999998888888887643 22 23458999999
Q ss_pred HHHHccccCcCC--CCCHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGK--RIKIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~--Rps~~ell~hp~~~~ 264 (568)
+|.+||..++.+ |++++|+++||||+.
T Consensus 281 li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 281 LICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 999999844443 789999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=383.47 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=208.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.++++++||||+++++++......++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3689999999999999999999999999999997532 246789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.............
T Consensus 164 ~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 99 57899999888889999999999999999999999999999999999999999999999999987543322223345
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC-------HHHHHHHHH------------------
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-------IDQLYDKIL------------------ 221 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-------~~~~~~~i~------------------ 221 (568)
.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .......+.
T Consensus 243 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 67999999999998766 6899999999999999999998764321 111111110
Q ss_pred --------cCCCC----CC-----CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 222 --------NGKYT----EP-----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 222 --------~~~~~----~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
..... .+ ..++.++.+||.+||+.||.+|||++|+|+||||...+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 00000 00 12456889999999999999999999999999998543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=376.13 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=210.0
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS-----SHIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~ 82 (568)
+|++.+.||+|+||.||+|.+..+|..||+|++...... .....+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999998753221 2345678899999999999999999988543 3589
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC--
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-- 160 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 160 (568)
+||||| +++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999 57899999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc-----------------
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN----------------- 222 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~----------------- 222 (568)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1122345799999999998652 3468899999999999999999999987654332211110
Q ss_pred ----------CCCC----CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 223 ----------GKYT----EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 223 ----------~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.... ..+..++.+.++|.+||+.||++|||++|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000 012367889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=373.47 Aligned_cols=257 Identities=30% Similarity=0.597 Sum_probs=218.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||+||++++..+++.||+|++.+.... .....+..|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999753221 23456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999876543322222
Q ss_pred ccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCC---CCCChHH
Q psy6203 165 QTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEP---PWMSPNS 235 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~~ 235 (568)
...+||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..+....+.... ...+ ..+++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 33569999999999863 2346789999999999999999999999888777777776532 2222 3478999
Q ss_pred HHHHHHccccCcCC--CCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGK--RIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~--Rps~~ell~hp~~~~ 264 (568)
+++|++||..++++ |++++++++||||..
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 99999999765444 889999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=376.37 Aligned_cols=249 Identities=32% Similarity=0.610 Sum_probs=219.0
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEIN-ALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||+||+|.+..+|+.||+|++.+.... .....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999999999999999764322 22334455554 46779999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccccCC
Confidence 999999988889999999999999999999999999999999999999999999999999998753222 1233456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..++...+..+....++..+..+.++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 160 PEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred hhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhc
Confidence 9999999998766 588999999999999999999999999988888888888877777899999999999999999999
Q ss_pred CCH----HHHhcCccccc
Q psy6203 251 IKI----QDLLGHNWVKM 264 (568)
Q Consensus 251 ps~----~ell~hp~~~~ 264 (568)
|++ .+++.||||+.
T Consensus 239 ~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 239 LGAKEDFLEIQEHPFFES 256 (325)
T ss_pred CCCCCCHHHHhcCCCcCC
Confidence 976 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=374.98 Aligned_cols=248 Identities=33% Similarity=0.609 Sum_probs=217.4
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHH-HHHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEI-NALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei-~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||+||+|++..+++.||+|++.+.... .....+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999764321 1222334444 456789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcccccCC
Confidence 999999988888999999999999999999999999999999999999999999999999998753221 1223456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......++.+++.+.++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 160 PEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred ccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 9999999998766 588999999999999999999999999888888888888777778899999999999999999999
Q ss_pred CCHH----HHhcCcccc
Q psy6203 251 IKIQ----DLLGHNWVK 263 (568)
Q Consensus 251 ps~~----ell~hp~~~ 263 (568)
+++. ++++|+||.
T Consensus 239 ~~~~~~~~~i~~~~~~~ 255 (325)
T cd05602 239 LGAKDDFMEIKNHIFFS 255 (325)
T ss_pred CCCCCCHHHHhcCcccC
Confidence 9876 899999996
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=358.23 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=210.5
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----EEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS-----HIFM 83 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~l 83 (568)
.|.-.+++|.|+||.||.|....+++.||||.+-.... .-.+|+.+|+.++|||||++.-+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 57889999999999999999999999999998765432 2246999999999999999998885332 3468
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-CCeEEEeecCccCCCC
Q psy6203 84 VIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEG 158 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 158 (568)
||||++ .+|.+.++. +.+++.-.++-+..||++||.|||+.||+||||||+|||+|.+ |.+||||||.|+....
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 999996 489888874 5789999999999999999999999999999999999999976 8999999999988765
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--------------CC
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--------------GK 224 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--------------~~ 224 (568)
+. ...+...|..|+|||.+.|...|+.+.||||.||++.||+-|++.|.+++.......|.+ ..
T Consensus 179 ~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 GE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 43 235566799999999999999999999999999999999999999999876555544422 11
Q ss_pred ---CC------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 225 ---YT------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 225 ---~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.. .....++++.+|+.++|+++|.+|.++.|++.||||..
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 00 11236899999999999999999999999999999974
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=373.65 Aligned_cols=249 Identities=32% Similarity=0.596 Sum_probs=218.5
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEIN-ALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||.||+|++..+|+.||+|++.+.... .....+..|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999764322 12334445544 57889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
++|...+.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFCGT 159 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccccccCC
Confidence 999999988888999999999999999999999999999999999999999999999999998753221 1223455799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+...+...+..+....++..+..+.++|.+||+.||.+|
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 160 PEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred cccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 9999999998765 588999999999999999999999999988888999888888888889999999999999999999
Q ss_pred CCH----HHHhcCccccc
Q psy6203 251 IKI----QDLLGHNWVKM 264 (568)
Q Consensus 251 ps~----~ell~hp~~~~ 264 (568)
+++ .++++|+||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 239 LGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCCCHHHHhCCCCcCC
Confidence 975 59999999973
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=371.94 Aligned_cols=247 Identities=27% Similarity=0.497 Sum_probs=211.8
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcE-EEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCC-EEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEK-VAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSS-HIFMVI 85 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~ 85 (568)
...+.+.||+|+||+||+|..+ |+. ||+|++....... ....+.+|+.+|++++|||||++++++.+.. .++|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3455677999999999999975 555 9999998655432 2568999999999999999999999998887 799999
Q ss_pred eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCceEEcCCC-CeEEEeecCccCCCCCCc
Q psy6203 86 EYCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLG-YAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 161 (568)
||+++|+|.+++.. +..++...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999999988 678999999999999999999999999 99999999999999998 99999999997654321
Q ss_pred cccccccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHH-cCC-CCCCCCCChHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-NGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~-~~~-~~~~~~~~~~~~~l 238 (568)
.......||+.|||||++.+. ..|+.|+||||||+++|||+||..||......++...+. .+. +..+...++.+..|
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 222336799999999999952 447999999999999999999999999888766666654 333 34455689999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~ 258 (568)
+.+||..||.+||+..+++.
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999864
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=377.97 Aligned_cols=248 Identities=30% Similarity=0.543 Sum_probs=216.6
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC---CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI---SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
||+|+||+||+|++..+|+.||+|++.+.... ........|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999754322 1223444566666655 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCccCC
Confidence 999999988889999999999999999999999999999999999999999999999999998753322 1233456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCChHHHHHHHHccccCcCC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIVRSMLQVEPGK 249 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~li~~~L~~dP~~ 249 (568)
+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+..+....+. .+++++.++|++||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~ 239 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQH 239 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHH
Confidence 99999999977655789999999999999999999999999888888888887766654 47899999999999999999
Q ss_pred CC----CHHHHhcCccccc
Q psy6203 250 RI----KIQDLLGHNWVKM 264 (568)
Q Consensus 250 Rp----s~~ell~hp~~~~ 264 (568)
|| ++.++++||||+.
T Consensus 240 R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 240 RLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CCCCCCCHHHHhcCccccC
Confidence 98 7999999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=370.43 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=215.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|.+.+.||+|+||.||+|++..+++.||+|.++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999999999999999997654433444677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 163 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSN 163 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-ccccc
Confidence 964 888887654 458999999999999999999999999999999999999999999999999987543221 12234
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------------CC
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---------------------KY 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~---------------------~~ 225 (568)
..+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+... .+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 467899999999877655789999999999999999999999887665444333210 00
Q ss_pred ---------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ---------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
...+.+++++.+||.+||+.||.+|||+.|++.||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 011246889999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=382.63 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=216.1
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----EEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSS-----HIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~ 82 (568)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478999999999999999999999999999998654221 23456788999999999999999999998776 789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999995 689888888888999999999999999999999999999999999999999999999999998765433223
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN-------------------- 222 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~-------------------- 222 (568)
......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 334456899999999998866678999999999999999999999988765554443321
Q ss_pred ---CCC---------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 223 ---GKY---------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 223 ---~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
... ......++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1123357889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=371.66 Aligned_cols=249 Identities=33% Similarity=0.656 Sum_probs=217.1
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||+||+|.+..+++.||+|++.+.... .....+..|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865432 2345677899999888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceecccCC
Confidence 999999988889999999999999999999999999999999999999999999999999998753221 1233456799
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC-------CCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS-------DSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.. .....+...+.......+..++..+.++|.+||
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L 238 (327)
T cd05617 160 PNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFL 238 (327)
T ss_pred cccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 9999999998766 58999999999999999999999953 233455666667777778889999999999999
Q ss_pred ccCcCCCCC------HHHHhcCccccc
Q psy6203 244 QVEPGKRIK------IQDLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rps------~~ell~hp~~~~ 264 (568)
+.||.+|++ ++++++||||+.
T Consensus 239 ~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 239 NKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred ccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 999999998 579999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=377.65 Aligned_cols=252 Identities=31% Similarity=0.473 Sum_probs=213.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-C-----CCcceeeEEEEeC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-H-----QHICKLFQVIETS 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----pnIv~l~~~~~~~ 78 (568)
.+..+|.|.+.||+|+||.|.+|.+..|++.||||+++... .-..+...|+.+|..|+ | -|+|+++++|...
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 34558999999999999999999999999999999998654 23445667999999997 4 3899999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC--CCeEEEeecCcc
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN--QNLKLIDFGLCA 154 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~--~~~kl~DFG~a~ 154 (568)
+++|||+|.+ +.+|+++++.++ .++...++.++.||+.||.+||+.||||+|||||||||.+- ..|||+|||.|.
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999999999 679999998764 58899999999999999999999999999999999999654 369999999998
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----------- 223 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~----------- 223 (568)
..... ..+.+.+..|+|||++.|.+ |+.+.||||||||++||++|.+.|.+++..+.+..|..-
T Consensus 340 ~~~q~----vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 340 FESQR----VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccCCc----ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 76543 23677899999999999998 589999999999999999999999998876665554320
Q ss_pred -----------------------------------------CCCCCC-----------CCChHHHHHHHHccccCcCCCC
Q psy6203 224 -----------------------------------------KYTEPP-----------WMSPNSRQIVRSMLQVEPGKRI 251 (568)
Q Consensus 224 -----------------------------------------~~~~~~-----------~~~~~~~~li~~~L~~dP~~Rp 251 (568)
....|+ .....+.+||++||.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 000010 0123568999999999999999
Q ss_pred CHHHHhcCccccc
Q psy6203 252 KIQDLLGHNWVKM 264 (568)
Q Consensus 252 s~~ell~hp~~~~ 264 (568)
|+.|+|+||||..
T Consensus 495 tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 495 TPAQALNHPFLTG 507 (586)
T ss_pred CHHHHhcCccccc
Confidence 9999999999984
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=364.88 Aligned_cols=247 Identities=30% Similarity=0.503 Sum_probs=211.9
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
||+|+||+||+|.+..+|+.||+|.+.+..... ....+..|+.+++.++||||+++.+++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999987643322 234667899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccC
Q psy6203 94 LDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169 (568)
Q Consensus 94 ~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~g 169 (568)
.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccccCC
Confidence 888743 3568999999999999999999999999999999999999999999999999987544322 22334578
Q ss_pred CccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 170 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... .......+.......+..+++.+.+++.+||+.
T Consensus 160 ~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 160 TPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence 99999999998776 5889999999999999999999997643 233444455555556677899999999999999
Q ss_pred CcCCCC-----CHHHHhcCccccc
Q psy6203 246 EPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rp-----s~~ell~hp~~~~ 264 (568)
||++|| |++++++||||+.
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhc
Confidence 999999 8899999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=363.19 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=217.9
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.|++.+.||+|+||+||++.+..+++.||+|++....... ....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 5899999999999999999999999999999997644322 22356779999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++...... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--Ccc
Confidence 99999999888653 46899999999999999999999999999999999999999999999999998764332 122
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCCCCChHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ----LYDKILNGKYTEPPWMSPNSRQIVR 240 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~li~ 240 (568)
...+|++.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+... +...+.......+..+++.+.+||.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred ccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 3457899999999998765 5889999999999999999999998765433 3334444455556678999999999
Q ss_pred HccccCcCCCC-----CHHHHhcCccccc
Q psy6203 241 SMLQVEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
+||+.||.+|| ++++++.||||..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 99999999999 9999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=370.10 Aligned_cols=257 Identities=29% Similarity=0.553 Sum_probs=219.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.++||+|+||.||+++++.+++.||+|++.+.... .....+..|+.++..++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999998753221 22345778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999875433222223
Q ss_pred ccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCC---CCCChHH
Q psy6203 165 QTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEP---PWMSPNS 235 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~--~~~---~~~~~~~ 235 (568)
...+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+..+....+..... ..+ ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 34579999999999863 33468899999999999999999999999888888888766532 222 3478999
Q ss_pred HHHHHHccccCcCC--CCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGK--RIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~--Rps~~ell~hp~~~~ 264 (568)
++||++||..++.+ |++++|+++||||..
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 99999999765554 789999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=385.18 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=206.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC--------
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS-------- 78 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-------- 78 (568)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457999999999999999999999999999999885432 2345799999999999999999887432
Q ss_pred CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCc
Q psy6203 79 SHIFMVIEYCPGGELLDHIV----ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLC 153 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a 153 (568)
..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 247799999964 6776664 346799999999999999999999999999999999999998665 6999999999
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--C-------
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K------- 224 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~------- 224 (568)
+...... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+... .
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 8654321 2234578999999999887666799999999999999999999999887655444433221 0
Q ss_pred --------C------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 225 --------Y------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 225 --------~------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. ..+...++++.+||.+||++||.+|||+.|+|.||||..
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 0 012346789999999999999999999999999999974
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=369.54 Aligned_cols=257 Identities=29% Similarity=0.553 Sum_probs=219.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||++++..+++.||+|++.+.... .....+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999999753221 22345778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999987 46799999999999999999999999999999999999999999999999999876543322223
Q ss_pred ccccCCccccccccccCc----ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCC---CCCChHH
Q psy6203 165 QTSCGSPNYAAPEVIKGK----QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEP---PWMSPNS 235 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~~ 235 (568)
...+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+....+.... ...+ ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 345799999999998752 235789999999999999999999999888877777776543 2223 2368999
Q ss_pred HHHHHHccccCcCC--CCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGK--RIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~--Rps~~ell~hp~~~~ 264 (568)
+++|.+||..++.+ |++++++++||||..
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 99999999976654 579999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=371.19 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=216.1
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.++||+|+||.||+|.+..++..+|+|++...........+.+|++++++++||||+++++++.+.+..|+||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 35789999999999999999999999999999999876432233456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---cc
Confidence 9999999999998888899999999999999999999985 7999999999999999999999999998754322 22
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHH-------------------------
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK------------------------- 219 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~------------------------- 219 (568)
....|++.|+|||++.+.. ++.++|||||||++|+|++|..||.......+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 3456899999999998765 58899999999999999999999976544333211
Q ss_pred -------------------HHcCCCC-CC-CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 220 -------------------ILNGKYT-EP-PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 220 -------------------i~~~~~~-~~-~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.....+ .+ ...++++++||.+||+.||++|||+.|++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 1111111 11 125678999999999999999999999999999984
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=362.19 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=206.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcC-CCcEEEEEEeecCCcCC-chHHHHHHHHHHHhC---CCCCcceeeEEEE-----e
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVL-TGEKVAIKIMKKATLGE-DLPRVKLEINALKHI---SHQHICKLFQVIE-----T 77 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~-----~ 77 (568)
++|++.+.||+|+||+||+|++.. +|..||+|++......+ ......+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999865 46889999987654332 233456677777765 6999999999885 3
Q ss_pred CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK 155 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 155 (568)
...+++||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 6899888653 4589999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-C--------
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-T-------- 226 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~-------- 226 (568)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+..... +
T Consensus 160 ~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 160 YSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred ccCC--cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 4432 2334557899999999997765 58899999999999999999999998776665555543210 0
Q ss_pred ------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 ------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 ------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..+.+++.+++||.+||+.||++|||+.|+|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012467788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=375.02 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=210.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+|+.+++.++|+||+++++++...+.+|+||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 57889999999999999999999999999999987544333345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 228 (353)
T PLN00034 154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSS 228 (353)
T ss_pred CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cccccc
Confidence 999998643 346788889999999999999999999999999999999999999999999987654321 122345
Q ss_pred cCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCC---HHHHHHHHHcC-CCCCCCCCChHHHHHH
Q psy6203 168 CGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNG-KYTEPPWMSPNSRQIV 239 (568)
Q Consensus 168 ~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~---~~~~~~~i~~~-~~~~~~~~~~~~~~li 239 (568)
.||..|+|||++.. ..+.+.++|||||||++|+|++|+.||.... ...+...+... ....+..+++++.+||
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 308 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFI 308 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHH
Confidence 79999999998743 2334568999999999999999999997433 22333333222 3334556889999999
Q ss_pred HHccccCcCCCCCHHHHhcCccccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+||+.||++|||+.|+++||||..
T Consensus 309 ~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 309 SCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HHHccCChhhCcCHHHHhcCccccc
Confidence 9999999999999999999999984
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=352.79 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=219.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC----chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE----DLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+.|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999999999999999987543321 23467889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||+++++|.+.+...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987543221111
Q ss_pred c--ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCChHHHHHH
Q psy6203 164 L--QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIV 239 (568)
Q Consensus 164 ~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li 239 (568)
. ....|+..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+... ....+..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1 3346788999999998776 689999999999999999999999776555444444333 3345567889999999
Q ss_pred HHccccCcCCCCCHHHHhcCccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+||..+|.+|||+.|+++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=361.72 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=215.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 67999999999999999999999999999999987654433445677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
++ ++|.+.+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... .....
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 163 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSN 163 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Ccccc
Confidence 96 5888888653 568999999999999999999999999999999999999999999999999987543221 12233
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------CCCC
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-------------------KYTE 227 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-------------------~~~~ 227 (568)
..+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+... ....
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 457899999999877665788999999999999999999999887765544333211 0000
Q ss_pred -----------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 228 -----------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 228 -----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+.+++.+++||.+||+.||.+|||++|+++||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1246788999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=369.67 Aligned_cols=254 Identities=26% Similarity=0.465 Sum_probs=207.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSS---- 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 79 (568)
.+.++|++.+.||+|+||.||+|.+..+|..||+|++...... .....+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4568999999999999999999999999999999998754322 23456778999999999999999999986443
Q ss_pred --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 80 --HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 80 --~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999965 5666653 358899999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--------------- 222 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--------------- 222 (568)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 175 ~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 175 TN--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cC--ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 32 2234457899999999998766 58899999999999999999999987654332221110
Q ss_pred -------CCCC--------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 223 -------GKYT--------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 223 -------~~~~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.... .....++.+++||.+||+.||++|||+.|+|+||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000 01123578899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.99 Aligned_cols=254 Identities=25% Similarity=0.454 Sum_probs=211.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
++.++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 5678999999999999999999999999999999998754322 2234567899999999999999999987543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 79 -SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 79 -~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
...|++||++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999998 788887764 4679999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK------------- 224 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~------------- 224 (568)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 170 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 170 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred C----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 3 22345789999999999875557899999999999999999999998766544433332110
Q ss_pred ---------C-CC--------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 225 ---------Y-TE--------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 225 ---------~-~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. .. ....++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0 00 0124667899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=357.70 Aligned_cols=252 Identities=37% Similarity=0.730 Sum_probs=228.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||++.+..+++.||+|++...... .....+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 5799999999999999999999999999999998764432 23456888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CC
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765433 23
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
..+|++.|+|||.+.+.. .+.++||||||+++|+|++|..||...+.....+.+..+....+...++.++++|.+||..
T Consensus 157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 157 TLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccC
Confidence 456899999999987765 5889999999999999999999998888777888888888888888899999999999999
Q ss_pred CcCCCC-----CHHHHhcCccccc
Q psy6203 246 EPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rp-----s~~ell~hp~~~~ 264 (568)
||.+|+ +++|+++||||..
T Consensus 236 ~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CHHHccCcccCCHHHHHcCccccc
Confidence 999999 9999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=383.99 Aligned_cols=259 Identities=32% Similarity=0.539 Sum_probs=225.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSS---- 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 79 (568)
...++|++.+.||+|+||+||+|++..+|+.||||++...... .....+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3458999999999999999999999999999999999765443 23456788999999999999999988775332
Q ss_pred ----EEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeec
Q psy6203 80 ----HIFMVIEYCPGGELLDHIVER----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 80 ----~~~lV~E~~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
.+++||||+++|+|.+++..+ ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 378999999999999998653 468999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCCC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCC
Q psy6203 152 LCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPP 229 (568)
Q Consensus 152 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~ 229 (568)
+++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..++...+..+... .++
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 987643321 12234567999999999998766 589999999999999999999999999988888888776553 566
Q ss_pred CCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 230 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+++++.+++.+||+.||.+|||+.++++|||++.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 78999999999999999999999999999999874
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=382.33 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=222.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCC-CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLT-GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
..|.+.+.||+|++|.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++||||+++++++...+..|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3499999999999999999998887 7889999765432 1233467789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-
Q psy6203 87 YCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 87 ~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 161 (568)
|++||+|.+++.. ..++++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999999988754 35689999999999999999999999999999999999999999999999999886543221
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVR 240 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~ 240 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+... .+..+++++.++|.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 304 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD 304 (478)
T ss_pred ccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHH
Confidence 1234567999999999998765 589999999999999999999999998888888888777654 45568899999999
Q ss_pred HccccCcCCCCCHHHHhcCccccc
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||..||++|||+.+++.|+|++.
T Consensus 305 ~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 305 PLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999973
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=369.52 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=209.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3568999999999999999999999999999999998754322 2345677899999999999999999987543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 79 -SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 79 -~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
..+|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999964 6777764 358899999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY------------ 225 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~------------ 225 (568)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 178 ~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 178 TS--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CC--CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 32 2234457899999999998766 58899999999999999999999988766554444322100
Q ss_pred ----------C--------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ----------T--------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ----------~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. .....+..+++||.+||+.||.+|||++|+|+||||..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00113467899999999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.86 Aligned_cols=252 Identities=38% Similarity=0.688 Sum_probs=213.0
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
|++++.||+|+||+||++.+..+++.||+|++........ .....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987654322 123355999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccccc
Q psy6203 89 PGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC 168 (568)
Q Consensus 89 ~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 168 (568)
++++|.+++.....+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+..... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9999999999888999999999999999999999999999999999999999999999999999875311 123445567
Q ss_pred CCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCC----CCCCChHHHHHHHH
Q psy6203 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---DQLYDKILNGKYTE----PPWMSPNSRQIVRS 241 (568)
Q Consensus 169 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~---~~~~~~i~~~~~~~----~~~~~~~~~~li~~ 241 (568)
+++.|+|||++.....++.++||||||+++|+|++|..||..... .............. ....++.+.++|.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 899999999998333468999999999999999999999988732 23333332221111 11224899999999
Q ss_pred ccccCcCCCCCHHHHhcCccc
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~ 262 (568)
||+.||++|||+.++++||||
T Consensus 240 ~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HSSSSGGGSTTHHHHHTSGGG
T ss_pred HccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=363.77 Aligned_cols=245 Identities=28% Similarity=0.455 Sum_probs=214.4
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
.+++++.||+|.||.||+|..+.+ ..||+|.++..... .+.+.+|+++|++|+|+|||++++++..++.+||||||+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 345678899999999999998633 47999999876543 346779999999999999999999999988999999999
Q ss_pred CCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 89 PGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 89 ~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+.|+|.+++.. +..++..+...++.||++|++||+++++|||||-..|||++++..+||+|||+|+....+.......
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999999987 5679999999999999999999999999999999999999999999999999999544432222222
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 244 (568)
.--...|.|||.+.... ++.+||||||||+||||+| |+.|+.+.+..++.+.+.+|.. +.|+.+|+++-+++..|+.
T Consensus 364 ~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred CCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhh
Confidence 22355799999998776 6999999999999999999 9999999999999999999854 5677899999999999999
Q ss_pred cCcCCCCCHHHHh
Q psy6203 245 VEPGKRIKIQDLL 257 (568)
Q Consensus 245 ~dP~~Rps~~ell 257 (568)
.+|++|||++.+.
T Consensus 443 ~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 443 EDPEDRPTFETLR 455 (468)
T ss_pred CCcccCCCHHHHH
Confidence 9999999999664
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.42 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=205.3
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhC---CCCCcceeeEEEEe-----CC
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHI---SHQHICKLFQVIET-----SS 79 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~-----~~ 79 (568)
+|++.+.||+|+||+||+|+++.+|+.||+|.++...... ......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5999999999999999999999999999999987643322 223455677777665 79999999998864 34
Q ss_pred EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
..++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 6899999996 5888888654 358999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-------------- 223 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-------------- 223 (568)
.. .......||+.|+|||++.+.. ++.++||||+||++|+|++|.+||.+.+.......+...
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 160 CQ--MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred Cc--ccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 32 1223456899999999998766 689999999999999999999999877665544443221
Q ss_pred ----CC---------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 224 ----KY---------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 224 ----~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+ ...+.++..+.++|.+||++||.+|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0112467788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=391.98 Aligned_cols=191 Identities=25% Similarity=0.409 Sum_probs=165.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|.+.++||+|+||+||+|.+..+++.||||++....... ....+..|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 378999999999999999999999999999999997654322 235678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~-~~~~ 161 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR-ELNM 161 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC-cccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999865432 2233
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVML 198 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 198 (568)
....+|+.|++||.......-...+++||+|.-.
T Consensus 162 ~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~ 195 (669)
T cd05610 162 MDILTTPSMAKPKNDYSRTPGQVLSLISSLGFNT 195 (669)
T ss_pred cccccCccccCccccccCCCCceeeeeeecCcCC
Confidence 4567899999999875544445567889988543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=394.76 Aligned_cols=259 Identities=32% Similarity=0.588 Sum_probs=233.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|.|+++||+|+||.|.+++++.|++.||+|++.+-..- .+..-|..|-.+|..-+.+-|++++-.|++++++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 36899999999999999999999999999999999874322 2345677889999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|..++.+..+++++.++.++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|-....+..-..
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 99999999999999888999999999999999999999999999999999999999999999999999887775555566
Q ss_pred ccccCCcccccccccc----CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCC--CCCChHHH
Q psy6203 165 QTSCGSPNYAAPEVIK----GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEP--PWMSPNSR 236 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~ 236 (568)
...+|||.|+|||+++ +...|++.+|.||+||++|||+.|..||..++..+.+.+|.+- .+.+| ..+|++++
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeak 313 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAK 313 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHH
Confidence 7779999999999995 2245799999999999999999999999999999999999876 45555 55999999
Q ss_pred HHHHHccccCcCCCCC---HHHHhcCcccccCC
Q psy6203 237 QIVRSMLQVEPGKRIK---IQDLLGHNWVKMGP 266 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps---~~ell~hp~~~~~~ 266 (568)
+||.+++. +|+.|.. ++++..||||...+
T Consensus 314 dLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 314 DLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 99999997 7889998 99999999998543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=382.01 Aligned_cols=250 Identities=23% Similarity=0.401 Sum_probs=203.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCC------CCcceeeEEEEeC-C
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH------QHICKLFQVIETS-S 79 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~~~~~-~ 79 (568)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++... +
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 478999999999999999999999999999999996432 122345667777777654 4588899988754 5
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCC---------------
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQ--------------- 143 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~--------------- 143 (568)
++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 789999998 88999999888899999999999999999999998 5999999999999998765
Q ss_pred -CeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc
Q psy6203 144 -NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN 222 (568)
Q Consensus 144 -~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~ 222 (568)
.+||+|||.+..... .....+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+....+..
T Consensus 285 ~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 285 CRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred ceEEECCCCccccCcc----ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 499999998764322 234567999999999998876 58999999999999999999999987765443333221
Q ss_pred C--CCC-------------------------C---------------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCc
Q psy6203 223 G--KYT-------------------------E---------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHN 260 (568)
Q Consensus 223 ~--~~~-------------------------~---------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 260 (568)
. .++ . ....++.+.+||.+||++||.+|||++|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 1 000 0 001235678999999999999999999999999
Q ss_pred cccc
Q psy6203 261 WVKM 264 (568)
Q Consensus 261 ~~~~ 264 (568)
||..
T Consensus 440 ~~~~ 443 (467)
T PTZ00284 440 YVLK 443 (467)
T ss_pred cccc
Confidence 9984
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.63 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=213.4
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+..|+.++++++|+||+.+++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4788999999999999999999999999999987654322 23456779999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--cc
Confidence 99999999988653 358999999999999999999999999999999999999999999999999987544321 22
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH---HHHHHH-HcCCCCCCCCCChHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---QLYDKI-LNGKYTEPPWMSPNSRQIVR 240 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~---~~~~~i-~~~~~~~~~~~~~~~~~li~ 240 (568)
....|++.|+|||++.+.. ++.++||||+||++|+|++|..||...... .....+ .......+..+++++.+|+.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred cCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 3447899999999998766 589999999999999999999999764321 111222 11222345568899999999
Q ss_pred HccccCcCCCCC-----HHHHhcCccccc
Q psy6203 241 SMLQVEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rps-----~~ell~hp~~~~ 264 (568)
+||+.||++||| ++|+++||||+.
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999999999 999999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=366.31 Aligned_cols=254 Identities=25% Similarity=0.451 Sum_probs=208.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4568999999999999999999999999999999998764332 2345677899999999999999999998643
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 79 -SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 79 -~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
...|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999965 6766664 358899999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-------------- 223 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-------------- 223 (568)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 171 TS--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred Cc--cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 32 2234457899999999998766 588999999999999999999999876644332221110
Q ss_pred --------CC--------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 --------KY--------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 --------~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.. ......+.++++||.+||+.||++|||+.|+|+||||..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00 001123567899999999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=356.56 Aligned_cols=253 Identities=22% Similarity=0.356 Sum_probs=214.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||++.+..++..+|+|.+...........+.+|++++++++||||+++++++.+++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 57999999999999999999999999999999987543222345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---cccc
Confidence 9999999999888889999999999999999999998 59999999999999999999999999998654322 2234
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------------
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----------------------- 223 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~----------------------- 223 (568)
.+|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+...
T Consensus 158 ~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 57899999999987765 588999999999999999999999765543332222110
Q ss_pred -------------CCC-CC-CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 -------------KYT-EP-PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 -------------~~~-~~-~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+ .+ ..+++++.+|+.+||..||++|||+.|++.||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 000 01 125778999999999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=352.25 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=207.3
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
||+|+||.||+++++.+|+.||+|.+....... .......|++++++++||||+++++++++....|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999999999999999987543322 233456699999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCc
Q psy6203 94 LDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP 171 (568)
Q Consensus 94 ~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~ 171 (568)
.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... ......|++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCC
Confidence 98886543 58899999999999999999999999999999999999999999999999987654321 223456899
Q ss_pred cccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCC-CCCChHHHHHHHHccccC
Q psy6203 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEP-PWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 172 ~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~----~~~~~~~i~~~~~~~~-~~~~~~~~~li~~~L~~d 246 (568)
.|+|||++.+.. ++.++||||+||++|+|++|..||.... ..++...........+ ..+++++.+||.+||+.|
T Consensus 159 ~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 237 (277)
T cd05607 159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK 237 (277)
T ss_pred CccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccC
Confidence 999999998776 6899999999999999999999997543 2334444444433322 357899999999999999
Q ss_pred cCCCCCH----HHHhcCccccc
Q psy6203 247 PGKRIKI----QDLLGHNWVKM 264 (568)
Q Consensus 247 P~~Rps~----~ell~hp~~~~ 264 (568)
|++||++ ++++.||||+.
T Consensus 238 P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 238 PEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HhhCCCCccchhhhhcChhhcC
Confidence 9999999 77889999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=364.04 Aligned_cols=251 Identities=25% Similarity=0.457 Sum_probs=205.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeC-C
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETS-S 79 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~-~ 79 (568)
.++|++.++||+|+||.||+|.+. .++..||+|++...........+.+|+.+++.+ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 578999999999999999999752 345789999987544333456788899999999 899999999988654 4
Q ss_pred EEEEEEeccCCCChHHHHHhc-----------------------------------------------------------
Q psy6203 80 HIFMVIEYCPGGELLDHIVER----------------------------------------------------------- 100 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~----------------------------------------------------------- 100 (568)
.+++||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999998752
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc-ccccccCCcccccc
Q psy6203 101 ---QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAP 176 (568)
Q Consensus 101 ---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aP 176 (568)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ......+++.|+||
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 23778888999999999999999999999999999999999999999999998754322111 11233456789999
Q ss_pred ccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHH-HHHHHHHcCC-CCCCCCCChHHHHHHHHccccCcCCCCCH
Q psy6203 177 EVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID-QLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKI 253 (568)
Q Consensus 177 E~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 253 (568)
|++.+.. ++.++|||||||++|+|++ |..||.+.... .....+..+. ...+...++.+.+++.+||+.||.+|||+
T Consensus 246 E~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 324 (338)
T cd05102 246 ESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTF 324 (338)
T ss_pred HHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 9998766 5899999999999999997 99999875533 3444444443 33455678999999999999999999999
Q ss_pred HHHhc
Q psy6203 254 QDLLG 258 (568)
Q Consensus 254 ~ell~ 258 (568)
.|+++
T Consensus 325 ~el~~ 329 (338)
T cd05102 325 SALVE 329 (338)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=343.49 Aligned_cols=252 Identities=28% Similarity=0.525 Sum_probs=218.5
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEe
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET-SSHIFMVIE 86 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E 86 (568)
.|++.+.||+|++|.||++.+..+++.||+|.+...... ...+.+.+|+.++++++|||++++++.+.. ...+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 589999999999999999999999999999998754432 234567889999999999999999998864 446899999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++++|.+++... ..+++.++..++.|++.||.+||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-CDMA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc-CCcc
Confidence 99999999999763 45899999999999999999999999999999999999999999999999998755332 1223
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHcc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L 243 (568)
....+++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+..+.. ..+...++.+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 4456899999999998766 58899999999999999999999998887777666666655 345568899999999999
Q ss_pred ccCcCCCCCHHHHhcCccc
Q psy6203 244 QVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 244 ~~dP~~Rps~~ell~hp~~ 262 (568)
+.||++|||+.+++.||||
T Consensus 239 ~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 239 SKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=370.03 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=228.2
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+.++.+.|+..||.|+||+||+|..+.++-..|.|++.... .+..+.+.-||.||..++||+||++++.|...+.++|
T Consensus 28 lnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 28 LNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred CCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 345667889999999999999999999998888999887543 3456678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+.|||.||-....+.+ ...+++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||++...... ..
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 9999999998888776 457999999999999999999999999999999999999999999999999998765432 22
Q ss_pred ccccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNS 235 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~ 235 (568)
...++.|||+|||||+... ...|+.++||||||++|.+|..+.+|...-++..++-+|....++ .|...+..+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 3456789999999999753 234789999999999999999999999888888887777776554 355678899
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccCCC
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 267 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 267 (568)
.||+++||.+||..||++.++|.||||...+.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 99999999999999999999999999985443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=342.63 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=222.0
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|.+.+.||+|++|.||+|.+..+++.||+|.+...... .....+..|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588999999999999999999999999999998754332 3456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 88 CPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 88 ~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NFAN 159 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-chhh
Confidence 9999999999764 578999999999999999999999999999999999999999999999999987654321 2223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CCCCChHHHHHHHHccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L~ 244 (568)
...|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+..+..+. +..++..+.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 456889999999998766 5889999999999999999999999888777777777765543 33678999999999999
Q ss_pred cCcCCCCCHHHHhcCccc
Q psy6203 245 VEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~ 262 (568)
.+|++||++.+++.|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=349.47 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=213.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++.+.||+|++|.||+|.+..+|+.||+|++...... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 5799999999999999999999999999999998754322 223457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|+++++|..++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD 159 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccC
Confidence 999988888777667899999999999999999999999999999999999999999999999999876544321 2233
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------C------C
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---------------K------Y 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~---------------~------~ 225 (568)
..++..|+|||.+.+...++.++||||||+++|+|++|.+||.+.+..+....+... . .
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 457889999999877555688999999999999999999999876654333222110 0 0
Q ss_pred CC----------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 TE----------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 ~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
+. .+.++..+.+||.+||+.||++|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 12357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=350.36 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=209.4
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||+|++|.||+|.+..++..||+|.+......+ ....+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5899999999999999999999999999999987543322 245678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 88 CPGGELLDHIVER---QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 88 ~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVY 158 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccc
Confidence 96 6888887542 568999999999999999999999999999999999999999999999999987543221 122
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--C------------------
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K------------------ 224 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~------------------ 224 (568)
....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 33457889999999877665688999999999999999999999876543322211100 0
Q ss_pred ---C------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 225 ---Y------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 225 ---~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
. .....+++++.++|.+||+.||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=349.94 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=215.8
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||+|++|.||+|.+..+|+.||+|++...... .....+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999999999999999999865432 2345788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.............
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999999865 4568999999999999999999999999999999999999999999999999987654432222344
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------------C
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK---------------------Y 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~---------------------~ 225 (568)
..|+..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+.......+.... +
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 5789999999998776656889999999999999999999998776554443332210 0
Q ss_pred C---------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 226 T---------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 226 ~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
. ..+..+..+.++|.+||+.||++|||+++++.||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123568899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=349.51 Aligned_cols=254 Identities=25% Similarity=0.434 Sum_probs=217.4
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.|+..+.||+|+||+||+|.+..+++.||+|.+....... ....+.+|+.+++.++|+||+.+++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788999999999999999999999999999987654322 23456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--Ccc
Confidence 99999999888653 36999999999999999999999999999999999999999999999999998654322 122
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCCCCChHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ----LYDKILNGKYTEPPWMSPNSRQIVR 240 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~li~ 240 (568)
....|++.|+|||++.+.. ++.++|+||+||++|+|++|..||....... +...+.......+..+++++.+|+.
T Consensus 159 ~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred cCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 3457899999999998765 5889999999999999999999998765543 2333344444556668899999999
Q ss_pred HccccCcCCCCC-----HHHHhcCcccccC
Q psy6203 241 SMLQVEPGKRIK-----IQDLLGHNWVKMG 265 (568)
Q Consensus 241 ~~L~~dP~~Rps-----~~ell~hp~~~~~ 265 (568)
+||+.||.+||| +.+++.|+||+..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 999999999999 8899999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=357.63 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=194.7
Q ss_pred EeeecccCCeEEEEEEEc--CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecc
Q psy6203 13 ERTVGSGGFAKVKLATHV--LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET--SSHIFMVIEYC 88 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~ 88 (568)
+++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.++++++||||+++++++.. ...+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 578999999999999975 4678999999865432 2356789999999999999999999854 45789999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE----cCCCCeEEEeecCccC
Q psy6203 89 PGGELLDHIVER---------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAK 155 (568)
Q Consensus 89 ~~g~L~~~i~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG~a~~ 155 (568)
. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 4 5888887532 258999999999999999999999999999999999999 4567899999999876
Q ss_pred CCCCCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH---------HHHHHHHHc--
Q psy6203 156 PEGGLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---------DQLYDKILN-- 222 (568)
Q Consensus 156 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~---------~~~~~~i~~-- 222 (568)
...... .......||+.|+|||++.+...++.++||||+||++|+|++|.+||..... ......+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 543211 1234557899999999998766678999999999999999999999964321 011111110
Q ss_pred --------------------------CCCCC----------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 223 --------------------------GKYTE----------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 223 --------------------------~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..... ....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 01134578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.95 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=209.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||+|+||.||+|.+..+|+.||+|.+....... ....+.+|+.++++++||||+++++++.+.+..|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999999999999999987543322 234567899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
++ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 158 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSA 158 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcCC
Confidence 96 578887765 5679999999999999999999999999999999999999999999999999987544321 12234
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCC-CCCCHHHHHHHHHcC----------------C---C-
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG----------------K---Y- 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf-~~~~~~~~~~~i~~~----------------~---~- 225 (568)
..+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+..+.+... . +
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 467899999999887666788999999999999999998875 555544443333210 0 0
Q ss_pred ---------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 ---------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 ---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
...+.+++++.++|.+||+.||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=345.14 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=220.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||.|+||+||+|.+..++..+|+|++...........+.+|+.+++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999998899999999997655444567789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc--
Q psy6203 88 CPGGELLDHIVER---QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES-- 162 (568)
Q Consensus 88 ~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-- 162 (568)
+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999999764 45899999999999999999999999999999999999999999999999998755432211
Q ss_pred -ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-C-----CCCChHH
Q psy6203 163 -QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-P-----PWMSPNS 235 (568)
Q Consensus 163 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~-~-----~~~~~~~ 235 (568)
......|+..|+|||++.....++.++|+|||||++|+|++|..||...+.......+....... + ..+++.+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 12334689999999998776456899999999999999999999998777665555554443221 1 2467889
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+++.+||..||++|||+.+++.||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=348.38 Aligned_cols=253 Identities=29% Similarity=0.428 Sum_probs=213.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 4689999999999999999999999999999999875432 234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~ 165 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKS 165 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccccc
Confidence 9999999999988889999999999999999999999999999999999999999999999999998654322 122234
Q ss_pred ccCCcccccccccc--CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----CCCChHHHHHH
Q psy6203 167 SCGSPNYAAPEVIK--GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP-----PWMSPNSRQIV 239 (568)
Q Consensus 167 ~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~~li 239 (568)
..|++.|+|||++. ....++.++|+|||||++|+|++|..||...................+ ..++..+.++|
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence 56899999999974 223357899999999999999999999865543333223322322221 23678899999
Q ss_pred HHccccCcCCCCCHHHHhcCcc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNW 261 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~ 261 (568)
.+||+.||++|||++++++|||
T Consensus 246 ~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 246 KMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.08 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=217.2
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--------chHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--------DLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
+|.+.+.||+|++|.||+|.+..+++.||+|.+....... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999899999999887543321 12457789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
.++||||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654211
Q ss_pred c-----cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCChH
Q psy6203 161 E-----SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-KYTEPPWMSPN 234 (568)
Q Consensus 161 ~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 234 (568)
. .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... ....+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1112345889999999998765 588999999999999999999999876655544444443 23445568899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
+.++|.+||+.||.+||++.|+++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=366.31 Aligned_cols=253 Identities=27% Similarity=0.382 Sum_probs=207.2
Q ss_pred cccCeEEEeeecccCCeEEEEEEEc--CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHV--LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+..+|.+++.||+|+||.||+|... .++..||+|.+.... ...+|+.+|++++||||+++++++...+..|+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4567999999999999999999754 356789999876432 35679999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-c
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-S 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~ 162 (568)
|||++ +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ .
T Consensus 164 v~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 164 VMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred Eehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 99999 468999997778899999999999999999999999999999999999999999999999999876543221 1
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH---HHHHHHHHc----C------------
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---DQLYDKILN----G------------ 223 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~---~~~~~~i~~----~------------ 223 (568)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+... ...+..+.. .
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 223457999999999998766 58899999999999999999999965431 111111110 0
Q ss_pred -------------CCCCC-----CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 224 -------------KYTEP-----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 224 -------------~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
.+..+ ...+.++.++|.+||..||++|||+.|+|.||||...+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 00111 12466789999999999999999999999999998544
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=348.06 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=222.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||.|++|.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 57999999999999999999999999999999997654444556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
+++++|.+++... ++++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccccc
Confidence 9999999998765 89999999999999999999999999999999999999999999999999987654321 223345
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCC-CChHHHHHHHHcccc
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPW-MSPNSRQIVRSMLQV 245 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~-~~~~~~~li~~~L~~ 245 (568)
.+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+..+..+ .+.. +++++.+++.+||..
T Consensus 159 ~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 159 VGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237 (274)
T ss_pred cCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence 6888999999998776 689999999999999999999999877666555555554332 2333 788999999999999
Q ss_pred CcCCCCCHHHHhcCccccc
Q psy6203 246 EPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps~~ell~hp~~~~ 264 (568)
||++|||+++++.||||..
T Consensus 238 ~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 238 DPKERPSAKELLKHKFIKK 256 (274)
T ss_pred ChhhCcCHHHHhhChhhcC
Confidence 9999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=352.80 Aligned_cols=257 Identities=31% Similarity=0.563 Sum_probs=222.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+..|+.+++.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765432 3456888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc--
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-- 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 161 (568)
||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 5689999999999999999999999999999999999999999999999998764322110
Q ss_pred --------------------------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH
Q psy6203 162 --------------------------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ 215 (568)
Q Consensus 162 --------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~ 215 (568)
.......||..|+|||++.+.. ++.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0112346788999999998766 5889999999999999999999999888777
Q ss_pred HHHHHHcCCCCCCCC--CChHHHHHHHHccccCcCCCCC----HHHHhcCcccccC
Q psy6203 216 LYDKILNGKYTEPPW--MSPNSRQIVRSMLQVEPGKRIK----IQDLLGHNWVKMG 265 (568)
Q Consensus 216 ~~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps----~~ell~hp~~~~~ 265 (568)
.+..+.......+.. .++.+.++|.+||..||++||| ++|++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777776655544433 6899999999999999999999 9999999999854
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=350.79 Aligned_cols=258 Identities=31% Similarity=0.482 Sum_probs=221.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+..++|++.+.||.|+||.||+|.+..++..+|+|++.... ......+..|+.++++++||||+++++++...+..|+|
T Consensus 2 ~~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred CchhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 34678999999999999999999998899999999986442 22345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QK 159 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-cc
Confidence 9999999999998764 579999999999999999999999999999999999999999999999999876543221 12
Q ss_pred cccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCChHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSR 236 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~ 236 (568)
.....+++.|+|||++.. ...++.++|||||||++|+|++|..||...+.......+..+.. ..+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 234468999999999852 22357789999999999999999999988877776667766543 23456789999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++|.+||+.||.+|||+.++++||||..
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 9999999999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.51 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=220.7
Q ss_pred CccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 2 ~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
.+.+...+|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++.+......
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 3556778999999999999999999999999999999998765432 346788899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 999999999999998854 568999999999999999999999999999999999999999999999999987543321
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHH-cCCC--CCCCCCChHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-NGKY--TEPPWMSPNSRQI 238 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~-~~~~--~~~~~~~~~~~~l 238 (568)
.......|++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+. .+.. ..+..+++.+.++
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred cccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 1223446889999999988765 5889999999999999999999998776543332222 2221 2344578899999
Q ss_pred HHHccccCcCCCCCHHHHhcCccccc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
|.+||..||++|||+.++++||||..
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhc
Confidence 99999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=347.54 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=210.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46899999999999999999999999999999987653333345688899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCC
Confidence 999988654 45789999999999999999999999999999999999999999999999998754332 22345
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCC--CCCCChHHHHH
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-------IDQLYDKILNGKYTE--PPWMSPNSRQI 238 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-------~~~~~~~i~~~~~~~--~~~~~~~~~~l 238 (568)
+|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||.... .......+....... ....++++.++
T Consensus 154 ~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 7899999999998766 5889999999999999999999996422 122233333222221 23478899999
Q ss_pred HHHccccCcCCCCCHHHHhcCccccc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.+||+.||.+||+++|++.||||..
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCccccc
Confidence 99999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=345.87 Aligned_cols=251 Identities=21% Similarity=0.333 Sum_probs=212.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++..........+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357999999999999999999865 34578999998765433334567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++++|||.+.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999999998764 57899999999999999999999999999999999999999999999999987654322111
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVR 240 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~ 240 (568)
......++..|+|||.+.+.. ++.++|||||||++|++++ |..||...+..+..+.+..+.. +.+...+..+.+++.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML 242 (266)
T ss_pred cccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 112234567899999998766 5889999999999999775 9999998888888777776633 455667899999999
Q ss_pred HccccCcCCCCCHHHHhc
Q psy6203 241 SMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~ 258 (568)
+||+.+|.+|||+++|++
T Consensus 243 ~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 243 DCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHcCCCchhCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=350.81 Aligned_cols=262 Identities=27% Similarity=0.420 Sum_probs=216.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIETS--SHI 81 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 81 (568)
+..++|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+|+.++++++|+||+++++++... +..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 345789999999999999999999999999999999875443222 23456799999999999999999998755 568
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 578888765 4678999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----------------- 223 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~----------------- 223 (568)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 12223346788999999877655789999999999999999999999888776665554431
Q ss_pred --CCCCC-----------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCCCC
Q psy6203 224 --KYTEP-----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 268 (568)
Q Consensus 224 --~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 268 (568)
.+..+ ...++.+.++|.+||+.||++|||++|++.||||+..+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 01000 1257889999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=345.90 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=214.1
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 44578999999999999999999999999999999987543 23345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++++|.+++..++.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKR 163 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-ccc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987653221 122
Q ss_pred ccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----CCCCChHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-----PPWMSPNSRQ 237 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~~ 237 (568)
....|++.|+|||.+.+ ...++.++|+||+||++|+|++|..||...+.......+....+.. ...++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 34468899999999853 2335788999999999999999999996554333222222222221 1236789999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNW 261 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~ 261 (568)
+|++||+.||++|||++++++|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=343.96 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=221.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.... .....+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 589999999999999999999999999999999865432 235678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccc
Confidence 99999999999887889999999999999999999999999999999999999999999999999987654331 2234
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
..|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+ ...+...........+...++.+.++|.+||
T Consensus 159 ~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (258)
T cd05578 159 TSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237 (258)
T ss_pred cCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHc
Confidence 56888999999998766 6889999999999999999999998766 4444444443555667778999999999999
Q ss_pred ccCcCCCCCH--HHHhcCccc
Q psy6203 244 QVEPGKRIKI--QDLLGHNWV 262 (568)
Q Consensus 244 ~~dP~~Rps~--~ell~hp~~ 262 (568)
+.||.+||++ +|+++||||
T Consensus 238 ~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 238 ERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cCChhHcCCccHHHHhcCCCC
Confidence 9999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=348.39 Aligned_cols=258 Identities=30% Similarity=0.468 Sum_probs=218.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
...+.|++.+.||+|+||.||+|++..++..||+|++.... ......+..|+.+++.++||||+++++.+..++..|+|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 45578999999999999999999999999999999987543 22345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+++++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence 999999999888765 467899999999999999999999999999999999999999999999999987653322 112
Q ss_pred cccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSR 236 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~ 236 (568)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.....+ .+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 234468899999999853 223577899999999999999999999877666655555544332 2445788999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++|.+||+.||++||+++++++||||..
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=350.01 Aligned_cols=256 Identities=29% Similarity=0.544 Sum_probs=221.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999998765431 23456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE---- 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---- 161 (568)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998763211000
Q ss_pred ----------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---
Q psy6203 162 ----------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--- 228 (568)
Q Consensus 162 ----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~--- 228 (568)
.......++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0111235788999999987765 58999999999999999999999998888888887776654332
Q ss_pred CCCChHHHHHHHHccccCcCCCCC---HHHHhcCccccc
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIK---IQDLLGHNWVKM 264 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~ 264 (568)
..+++++.++|.+||+.||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 247889999999999999999998 799999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=347.08 Aligned_cols=259 Identities=30% Similarity=0.493 Sum_probs=221.8
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+.+...+|++.+.||.|++|.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 34556789999999999999999999999999999999875432 33567788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+|+||+++++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 170 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-S 170 (296)
T ss_pred EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc-c
Confidence 99999999999998864 468999999999999999999999999999999999999999999999999987544321 1
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCCCCChHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK---YTEPPWMSPNSRQIV 239 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li 239 (568)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+.... ...+..+++.+.++|
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred cCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 223456889999999988765 5889999999999999999999998876654444443322 223455789999999
Q ss_pred HHccccCcCCCCCHHHHhcCcccccC
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.+||..||.+|||+.+++.||||+..
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHhhhc
Confidence 99999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=356.79 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=206.1
Q ss_pred EEeeeccc--CCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 12 LERTVGSG--GFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 12 i~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
++++||+| +|++||++.++.+|+.||+|++....... ....+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 57889999 78899999999999999999997654332 3456778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-----
Q psy6203 89 PGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE----- 161 (568)
Q Consensus 89 ~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~----- 161 (568)
++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999653 4589999999999999999999999999999999999999999999999986543211100
Q ss_pred -cccccccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------
Q psy6203 162 -SQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT------------- 226 (568)
Q Consensus 162 -~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~------------- 226 (568)
.......++..|+|||++.+. ..++.++|||||||++|+|++|..||..............+..+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 011223567889999999763 34688999999999999999999999765544333332222111
Q ss_pred ---------------------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 ---------------------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 ---------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
....+++.+.+||.+||+.||++|||++|+++||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=384.27 Aligned_cols=257 Identities=26% Similarity=0.487 Sum_probs=214.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIET--SSHI 81 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 81 (568)
.+.++|++++.||+|+||+||+|.+..++..||+|++....... ....+..|+.++++|+|||||+++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34579999999999999999999999999999999987654332 34568889999999999999999998854 4578
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CceecCCCCCceEEcC---------
Q psy6203 82 FMVIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHL-------GYAHRDLKPENVLLDR--------- 141 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-------~ivHrDlkp~NIll~~--------- 141 (568)
||||||+++|+|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999875 25799999999999999999999984 4999999999999964
Q ss_pred --------CCCeEEEeecCccCCCCCCccccccccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCCC
Q psy6203 142 --------NQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDS 212 (568)
Q Consensus 142 --------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~~ 212 (568)
.+.+||+|||++...... ......+||+.|+|||++.+. ..++.++||||||||+|+|++|..||...+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 235899999998765332 223455799999999998643 346889999999999999999999997554
Q ss_pred -HHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 213 -IDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 213 -~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
...+...+..+........++++.+||..||+.+|.+||++.|+|.|||++
T Consensus 248 ~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 444555554443333345789999999999999999999999999999997
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=346.18 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=217.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+.|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 457899999999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++++|..++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 162 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDS 162 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-cccccc
Confidence 999999888765 467999999999999999999999999999999999999999999999999998754332 122334
Q ss_pred ccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCChHHHHHH
Q psy6203 167 SCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSRQIV 239 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li 239 (568)
..+++.|+|||++.. ...++.++||||+||++|+|++|.+||...+..+....+..... ..+..++..+.++|
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 568999999999842 23357799999999999999999999988776665555554432 23445788999999
Q ss_pred HHccccCcCCCCCHHHHhcCccccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+||+.||.+|||++++++||||+.
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHccCChhhCcCHHHHhcCCCEec
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=340.22 Aligned_cols=253 Identities=30% Similarity=0.469 Sum_probs=217.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... +....+.+|+.++++++||||+++++++.+.+.+|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 5789999999999999999999999999999999976543 245678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 159 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRK 159 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hccc
Confidence 99999999998776 789999999999999999999999999999999999999999999999999987644321 1223
Q ss_pred cccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----CCCCCChHHHHH
Q psy6203 166 TSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-----EPPWMSPNSRQI 238 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~~l 238 (568)
...++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||...+.......+....+. .+...+.++.++
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence 45688899999998765 13578999999999999999999999877655544444444222 123356789999
Q ss_pred HHHccccCcCCCCCHHHHhcCcc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNW 261 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~ 261 (568)
+.+||..||.+|||+++++.|+|
T Consensus 240 i~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.08 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=213.8
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeC----
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETS---- 78 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~---- 78 (568)
.+..+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 356788999999999999999999999999999999987543 2345678899999998 699999999998653
Q ss_pred --CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 79 --SHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 79 --~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
..+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4689999999999999998763 468999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCccccccccCCccccccccccCc----ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCC
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGK----QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEP 228 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~--~~~ 228 (568)
..... ........|++.|+|||++.+. ..++.++||||+||++|+|++|..||...........+..... ...
T Consensus 160 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 160 QLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred ecccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 54322 1223455789999999998632 2367899999999999999999999976654444433333221 122
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
...+..+.+|+.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 3467899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=338.97 Aligned_cols=252 Identities=25% Similarity=0.537 Sum_probs=221.1
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||+|+||.||++.+..+|+.||+|.+...... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 699999999999999999999999999999998754332 2345788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 88 CPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 88 ~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
+++++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-ELAR 159 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hhhh
Confidence 99999999987643 57899999999999999999999999999999999999999999999999987554321 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~ 244 (568)
...|++.|+|||++.+.. .+.++|+|||||++|+|++|..||...+..+....+..+... .+...+.++.++|.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 345888999999998766 588999999999999999999999888887777777766654 455678999999999999
Q ss_pred cCcCCCCCHHHHhcCccc
Q psy6203 245 VEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~ 262 (568)
.+|++||++.++++||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=348.70 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=214.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 57999999999999999999999899999999987544322 24467789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|+++++|..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD 159 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCc
Confidence 99999888887766679999999999999999999999999999999999999999999999999987644322 22334
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--C-------------------C
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K-------------------Y 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~-------------------~ 225 (568)
..++..|+|||++.+...++.++||||||+++|+|++|.+||...+..+....+... . .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 567899999999877655688999999999999999999999776543332222210 0 0
Q ss_pred ----------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 ----------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 ----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
...+.++..+.+|+.+||+.||++||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.37 Aligned_cols=254 Identities=24% Similarity=0.445 Sum_probs=215.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||+|.+..+|..||+|.+...........+.+|+.++++++||||+++++.+...+..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999999999999999887543223345788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 88 CPGGELLDHIVER---QRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 88 ~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
+++++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---L 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---c
Confidence 9999999888763 379999999999999999999997 59999999999999999999999999998754322 2
Q ss_pred cccccCCccccccccccCcc-----cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHH---HHHcCC-CCCCCCCChH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQ-----YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD---KILNGK-YTEPPWMSPN 234 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~---~i~~~~-~~~~~~~~~~ 234 (568)
.....+++.|+|||.+.+.. .++.++|||||||++|+|++|..||.......... .+..+. ...++.++++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 23456888999999985432 24778999999999999999999997655444333 333333 3345568899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.++|.+||+.+|++||+++++++||||..
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=348.49 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=219.6
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+.+...+|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 45677899999999999999999999999999999999875443 23456788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 170 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-c
Confidence 99999999999998854 568999999999999999999999999999999999999999999999999987543321 1
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc-CCC--CCCCCCChHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN-GKY--TEPPWMSPNSRQIV 239 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~-~~~--~~~~~~~~~~~~li 239 (568)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+.. +.. ..+..+++.+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred CcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 223456889999999998765 58899999999999999999999977654332222222 221 23445788899999
Q ss_pred HHccccCcCCCCCHHHHhcCcccccC
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.+||..||++|||+++++.||||+..
T Consensus 250 ~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHHccCChhhCcCHHHHhcCchhccc
Confidence 99999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.31 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=217.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+-|.++.+||+|+||.||+|.|+.+|..+|+|.+.- ..+.+.+..|+.+|++++.|+||++|+.+-....++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 347788999999999999999999999999998764 35788899999999999999999999999888999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|..|+..+.++. +++++|+++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|...... ....++
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNT 188 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNT 188 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCc
Confidence 999999999985 578999999999999999999999999999999999999999999999999998765543 233467
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCCCCCCCChHHHHHHHHcc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---KYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~~L 243 (568)
..|||.|||||++..-. |+.++||||||++..||..|++||..-.+....-.|-.. .+..|...|.++.|||++||
T Consensus 189 VIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred cccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 78999999999998776 588999999999999999999999654332211111111 11123346788999999999
Q ss_pred ccCcCCCCCHHHHhcCcccccC
Q psy6203 244 QVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 244 ~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.++|++|.|+.++++|||++..
T Consensus 268 iK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred cCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999999999999853
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=353.26 Aligned_cols=260 Identities=29% Similarity=0.447 Sum_probs=210.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----C
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS-----S 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~ 79 (568)
++.++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+..|+.++++++||||+++++++... .
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46789999999999999999999999999999999986433233345677899999999999999999987544 3
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
..|+||||+. ++|.+.+. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999995 58887774 467999999999999999999999999999999999999999999999999998754332
Q ss_pred Cc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Q psy6203 160 LE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--------------- 222 (568)
Q Consensus 160 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--------------- 222 (568)
.. .......|++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 1123356899999999886655568899999999999999999999976654332221110
Q ss_pred C-----------CCC-----CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 223 G-----------KYT-----EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 223 ~-----------~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
. ... ..+..++++.++|.+||+.||++|||+.|+++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000 0134578899999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=348.89 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=228.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.+.|+.-++||+|+||.||-|+.+.||+.||+|.+.+..+.. ......+|-.+|.+++.+.||.+--.|++.+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 367888999999999999999999999999999987665432 233566799999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|..|.||+|.-+|.+.+ .+++..+..++.+|+.||++||+.+||.|||||+|||+|+.|+++|+|+|+|.....+.
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-- 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-- 341 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC--
Confidence 99999999999998765 79999999999999999999999999999999999999999999999999999877653
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCChHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQI 238 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~l 238 (568)
.....+||.+|||||++.+.. |+...|.|||||++|+|+.|+.||... ..+++-+++.......+..+|+++++|
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 344558999999999999887 799999999999999999999999653 345667777777777888999999999
Q ss_pred HHHccccCcCCCCC-----HHHHhcCcccccC
Q psy6203 239 VRSMLQVEPGKRIK-----IQDLLGHNWVKMG 265 (568)
Q Consensus 239 i~~~L~~dP~~Rps-----~~ell~hp~~~~~ 265 (568)
.+.+|++||.+|.. ++++.+||||+.-
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999999984 7799999999853
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=344.55 Aligned_cols=253 Identities=27% Similarity=0.461 Sum_probs=207.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|++|.||+|.++.+++.||+|.+...........+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 78999999999999999999999899999999987654333334567899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSN 162 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccccc
Confidence 97 4899988654 468999999999999999999999999999999999999999999999999986543211 11122
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcC-------------------C--
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNG-------------------K-- 224 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~-------------------~-- 224 (568)
..++..|+|||++.+...++.++||||+||++|+|++|..||.... ..+....+... .
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 3468899999998765556889999999999999999999997654 22222211110 0
Q ss_pred CC---------CCCCCC--hHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 225 YT---------EPPWMS--PNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 225 ~~---------~~~~~~--~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.. ..+.++ .++.+++.+||+.||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=305.25 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=218.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCch-HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDL-PRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.+|.-.++||+|.||+|++|++..+++.||+|.+......+.. ....+||-+|+.++|.|||+++++...+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 3577788999999999999999999999999999876554433 457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||. .+|..+... ++.+..+.++.++.|+++||.|||++++.||||||+|+||+.+|.+|++|||+++....... -..
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr-cys 159 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYS 159 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eee
Confidence 994 577777754 57899999999999999999999999999999999999999999999999999987665422 234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHc--CCCCCC--------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILN--GKYTEP-------------- 228 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~--~~~~~~-------------- 228 (568)
..+.|.+|.+|.++.|...|+...|+||.|||+.|+.. |.+.|.+.+..+...+|.. |.+...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 45679999999999999999999999999999999987 7888999998887777743 111110
Q ss_pred -------------CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 -------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 -------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.++...+++++++|.-+|.+|++++++++||||..
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 123445689999999999999999999999999973
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.26 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=215.5
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
-+||+|+||+||.|++..|....|||.+..... ...+.+..||.+.++|+|.|||++++.+..++.+-|.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 369999999999999999999999999876543 3456788899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc-CCCCeEEEeecCccCCCCCCccccccccC
Q psy6203 94 LDHIVER-QRL--GEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD-RNQNLKLIDFGLCAKPEGGLESQLQTSCG 169 (568)
Q Consensus 94 ~~~i~~~-~~l--~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~g 169 (568)
.++++.+ +++ +|.....+.+||++||.|||++.|||||||-+|+|++ -.|.+||+|||-++...+ ......++.|
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFTG 738 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFTG 738 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccccc
Confidence 9999864 777 7888999999999999999999999999999999996 468999999999887543 3455677889
Q ss_pred Ccccccccccc-CcccCCcccceechhhHHHHHHhCCCCCCCC-CHHHHHHH--HHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 170 SPNYAAPEVIK-GKQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDK--ILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 170 t~~y~aPE~l~-~~~~~~~~~DiwSlG~il~~lltG~~pf~~~-~~~~~~~~--i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
|..|||||++. |...|+.++|||||||++.||.||++||... +.+..+-+ +.+..++.|..++.+++.||.+|+.+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 99999999995 4456899999999999999999999999543 33322222 22334566777889999999999999
Q ss_pred CcCCCCCHHHHhcCcccccC
Q psy6203 246 EPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 246 dP~~Rps~~ell~hp~~~~~ 265 (568)
||.+||+|.++|..||+...
T Consensus 819 d~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CcccCccHHHhccCcccccC
Confidence 99999999999999999855
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=339.84 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=212.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC----CchHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG----EDLPRVKLEINALKHISHQHICKLFQVIET--SSHI 81 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 81 (568)
.+|++.+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.++++++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 5799999999999999999999999999999998754322 123467889999999999999999999865 3678
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL- 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 160 (568)
+++|||+++++|.+.+...+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred -ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCChHHHH
Q psy6203 161 -ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQ 237 (568)
Q Consensus 161 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 237 (568)
........++..|+|||.+.+.. ++.++||||+||++|+|++|+.||......+....+... ....+..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 11122345888999999998765 588999999999999999999999876544444333322 22335567888999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
++ +||..+|++|||++|+++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=337.16 Aligned_cols=249 Identities=29% Similarity=0.510 Sum_probs=218.1
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
+|++.+.||+|+||.||++.+..++..+|+|.++........+.+..|+.+++.++||||+++++.+.+.+.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58999999999999999999999999999999875543344567888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 89 PGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 89 ~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-ccccc
Confidence 999999988653 458999999999999999999999999999999999999999999999999987543321 12234
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHcccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~~ 245 (568)
..|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+..+... .+..++..+.++|.+||+.
T Consensus 160 ~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 160 YVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred ccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence 56889999999998766 588999999999999999999999988887777777666554 4556889999999999999
Q ss_pred CcCCCCCHHHHhcC
Q psy6203 246 EPGKRIKIQDLLGH 259 (568)
Q Consensus 246 dP~~Rps~~ell~h 259 (568)
||++|||+.+++.-
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=335.57 Aligned_cols=252 Identities=31% Similarity=0.491 Sum_probs=223.0
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||.|+||.|+.+++..+++.+|+|.+...... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 699999999999999999999999999999998765432 3345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 88 CPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 88 ~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SMAE 159 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-cccc
Confidence 9999999999765 468999999999999999999999999999999999999999999999999987654322 1234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CCCCChHHHHHHHHccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L~ 244 (568)
...|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+..+.+.. +...+.++.++|.+||.
T Consensus 160 ~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 160 TVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 456899999999988765 5889999999999999999999999888888888877776543 34578999999999999
Q ss_pred cCcCCCCCHHHHhcCccc
Q psy6203 245 VEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~ 262 (568)
.+|.+|||+.++++|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=346.74 Aligned_cols=259 Identities=28% Similarity=0.403 Sum_probs=216.1
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC---C-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG---E-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+|++.+.||+|++|.||+|.+..+|+.||+|.+...... . ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999865443 1 233566799999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+ +++|.+++.... .+++..+..++.||++||.|||++||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RK 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-cc
Confidence 9999 899999997765 79999999999999999999999999999999999999999999999999987654321 22
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C----------------
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--Y---------------- 225 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~---------------- 225 (568)
.....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+.... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 2334568899999998765556889999999999999999988887766544444432210 0
Q ss_pred -----C-----CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCCCCC
Q psy6203 226 -----T-----EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 269 (568)
Q Consensus 226 -----~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 269 (568)
. .....+..+.++|.+||+.||++|||+.|++.||||...+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 0 0123467889999999999999999999999999999655433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=339.34 Aligned_cols=245 Identities=36% Similarity=0.683 Sum_probs=216.6
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
||.|++|.||+|.+..+++.||+|++.+.... .....+.+|+.+++.++||||+++++.+.+++..|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999765432 2346788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCccc
Q psy6203 94 LDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNY 173 (568)
Q Consensus 94 ~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y 173 (568)
.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCc
Confidence 9999888889999999999999999999999999999999999999999999999999987654331 22344688999
Q ss_pred cccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC--HHHHHHHHH--cCCCCCCCCCChHHHHHHHHccccCcCC
Q psy6203 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKIL--NGKYTEPPWMSPNSRQIVRSMLQVEPGK 249 (568)
Q Consensus 174 ~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~--~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP~~ 249 (568)
+|||.+.+.. ++.++|+||+|+++|+|++|..||.... .......+. ......+...++++.++|.+||+.||++
T Consensus 159 ~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 237 (262)
T cd05572 159 VAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237 (262)
T ss_pred cChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence 9999987665 5889999999999999999999998766 666666666 3455566667899999999999999999
Q ss_pred CCC-----HHHHhcCcccc
Q psy6203 250 RIK-----IQDLLGHNWVK 263 (568)
Q Consensus 250 Rps-----~~ell~hp~~~ 263 (568)
||+ ++|+++||||+
T Consensus 238 R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 238 RLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred CcCCcccCHHHHhcChhhh
Confidence 999 99999999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.98 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=214.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeC----
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETS---- 78 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~---- 78 (568)
.+..++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 355788999999999999999999999999999999986532 2235677899999999 799999999998653
Q ss_pred -CEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 79 -SHIFMVIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 79 -~~~~lV~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
+..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 368999999999999998853 457899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCccccccccccCcc----cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---C
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQ----YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---T 226 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~ 226 (568)
....... .......|+..|+|||++.... .++.++|||||||++|+|++|+.||...........+..+.. .
T Consensus 176 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 176 AQLTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred hhccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 7643321 1123346889999999986432 247899999999999999999999987765554445544422 2
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.+...+..+.++|.+||+.||++||++.|+++||||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2344678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=363.61 Aligned_cols=248 Identities=24% Similarity=0.325 Sum_probs=204.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++++|||||++++++...+..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4579999999999999999999999999999996322 235689999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc-cc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES-QL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~ 164 (568)
++ .++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 241 ~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 241 KY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 99 56888888664 56999999999999999999999999999999999999999999999999998764332111 12
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCC---C------
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS--------DSIDQLYDKILNGKYT---E------ 227 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~--------~~~~~~~~~i~~~~~~---~------ 227 (568)
...+||+.|+|||++.+.. ++.++|||||||++|||++|..|+-. ....++.+.+...... .
T Consensus 320 ~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 2456999999999998876 58999999999999999998765422 1123333333322110 0
Q ss_pred --------------------C-----CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 228 --------------------P-----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 228 --------------------~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+ ..+++++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 0 02456889999999999999999999999999997
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.98 Aligned_cols=253 Identities=35% Similarity=0.641 Sum_probs=222.6
Q ss_pred ccccCeEE--EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 5 DLRNQYIL--ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 5 ~~~~~Y~i--~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
++..-|+| .++||+|.||+||-|.++.+|+.||||++.+..+. .....+++|+.||+++.||.||.+...|++.+.+
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv 638 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV 638 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence 34455665 47899999999999999999999999999987664 3456789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC---CeEEEeecCccCC
Q psy6203 82 FMVIEYCPGGELLDHIV--ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---NLKLIDFGLCAKP 156 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~ 156 (568)
++|||-+ .|+..+.|. +++++++...+.++.||+.||.|||-+||+|+||||+|||+.+.. ++||||||+|+.+
T Consensus 639 FVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 639 FVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 9999999 556666664 468999999999999999999999999999999999999996553 6999999999987
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC----CC
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW----MS 232 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~----~~ 232 (568)
... +...+.+|||.|+|||+++++. |+..-|+||.|||+|--++|.+||..+ +++-++|++..+..|+. ++
T Consensus 718 gEk--sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis 792 (888)
T KOG4236|consen 718 GEK--SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEIS 792 (888)
T ss_pred chh--hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcC
Confidence 653 3446678999999999999877 588999999999999999999999755 35667888887766543 89
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+++.|||..+|+..-.+|.|++..|.|||++
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence 9999999999999999999999999999998
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=343.79 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=210.3
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||.|++|.||+|.+..+|+.||+|.+....... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5899999999999999999999999999999987543322 235688899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 88 CPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 88 ~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT 158 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cccc
Confidence 95 688888865 3568999999999999999999999999999999999999999999999999987543321 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-CC-------------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-KY------------------- 225 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-~~------------------- 225 (568)
...+++.|+|||++.+...++.++|||||||++|+|+||+.||.+.+......++... ..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 3457889999999877665688999999999999999999999876654333222110 00
Q ss_pred ---------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 ---------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 ---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
...+.+++++.++|.+||+.||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=341.24 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=214.0
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+|+..+.||+|++|.||+|.+..+++.||+|++....... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999999999999999987543221 23567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCccCCCCCCc-
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~- 161 (568)
||||+++++|.+++...+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 599999999876543211
Q ss_pred --cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH---HHHHHHH--cCCCCCCCCCChH
Q psy6203 162 --SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---QLYDKIL--NGKYTEPPWMSPN 234 (568)
Q Consensus 162 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~---~~~~~i~--~~~~~~~~~~~~~ 234 (568)
.......|+..|+|||.+.+.. ++.++|+||+||++|+|++|..||...... .....+. ......+..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112346788999999987765 588999999999999999999999754432 2222221 2233445568899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+.+++.+||..+|++|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=338.89 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=213.7
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-----CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-----EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+|++.+.||+|+||.||+|.+ .+|+.+|+|.+...... .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 47889999998754321 123467889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC----
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG---- 159 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---- 159 (568)
||||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999988653211
Q ss_pred -CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCCCCCCCChHH
Q psy6203 160 -LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---KYTEPPWMSPNS 235 (568)
Q Consensus 160 -~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~ 235 (568)
.........|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 111223446899999999998765 588999999999999999999999876544433333332 123455688999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.++|.+||+.+|.+||++.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=342.55 Aligned_cols=249 Identities=30% Similarity=0.473 Sum_probs=206.4
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeC--CEEEEEEe
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETS--SHIFMVIE 86 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~lV~E 86 (568)
|++.+.||+|+||.||+|.+..+++.||+|+++............+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999999876533323334456888899885 99999999999887 88999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|++ ++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++....... ...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~ 156 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYT 156 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcC
Confidence 996 5888888764 57899999999999999999999999999999999999999 999999999987654321 223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC------------------CCCC
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG------------------KYTE 227 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~------------------~~~~ 227 (568)
...+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+....+... .+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 3457899999998765555688999999999999999999999877655443333210 1111
Q ss_pred -----------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 228 -----------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 228 -----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+.++..+.++|.+||++||++|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 12467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=342.78 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=206.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.+..+|..||+|++...........+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46899999999999999999999999999999998765433333466789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+. ++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++....... ....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~ 161 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYS 161 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCC
Confidence 995 677777654 3568889999999999999999999999999999999999999999999999987543221 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH-HHHHHHHc--CC------------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILN--GK------------------ 224 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-~~~~~i~~--~~------------------ 224 (568)
...+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+.. +....+.. +.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 4457899999999876555688999999999999999999999764421 22111110 00
Q ss_pred -CC--CC---------CCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 225 -YT--EP---------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 225 -~~--~~---------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.. .+ ...++.+.+++.+||+.||.+|||++|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 00 0125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=343.00 Aligned_cols=239 Identities=21% Similarity=0.304 Sum_probs=206.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc--hHHHHHHHHHHHhCCCCCcceeeEEEEe----CCEEEEEEec
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLEINALKHISHQHICKLFQVIET----SSHIFMVIEY 87 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 87 (568)
..||+|++|.||+|.. +|+.||+|.+........ .+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999986 789999999976543221 3567799999999999999999999876 4578999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++|+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccc
Confidence 99999999999888899999999999999999999984 9999999999999999999999999998754322 123
Q ss_pred ccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCChHHHHHHHHcc
Q psy6203 167 SCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L 243 (568)
..|++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..++...+..+ .+..+...++.+++|+.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 4688999999999762 34689999999999999999999999988888887777544 33444468899999999999
Q ss_pred ccCcCCCCCHHHHhc
Q psy6203 244 QVEPGKRIKIQDLLG 258 (568)
Q Consensus 244 ~~dP~~Rps~~ell~ 258 (568)
+.||++|||++|++.
T Consensus 260 ~~dp~~Rps~~ell~ 274 (283)
T PHA02988 260 SHDSIKRPNIKEILY 274 (283)
T ss_pred cCCcccCcCHHHHHH
Confidence 999999999999985
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.09 Aligned_cols=254 Identities=28% Similarity=0.488 Sum_probs=212.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC----CchHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG----EDLPRVKLEINALKHISHQHICKLFQVIETS--SHI 81 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 81 (568)
++|++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999999999999999988643221 1235678899999999999999999998763 568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL- 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 160 (568)
++||||+++++|.+++.....+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999999999887889999999999999999999999999999999999999999999999999987543211
Q ss_pred -ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCChHHHH
Q psy6203 161 -ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEPPWMSPNSRQ 237 (568)
Q Consensus 161 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 237 (568)
........|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.... ...+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 11223346889999999998765 5889999999999999999999998765444444443322 2234557788999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+|.+|+. +|++||+++|++.|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=342.61 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=212.7
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
+|++.+.||.|++|.||+|++..+|+.||+|++...........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999986554444556778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 89 PGGELLDHIVER---QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 89 ~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
++ +|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~ 158 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFS 158 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cccc
Confidence 75 888888654 358999999999999999999999999999999999999999999999999987543321 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------------C
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--------------------Y 225 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--------------------~ 225 (568)
...+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+.... .
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 34578899999998776556889999999999999999999998776555444332210 0
Q ss_pred C---------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 T---------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 ~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
+ ..+..++.+.++|.+||+.||.+||++.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 012357888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=340.47 Aligned_cols=256 Identities=30% Similarity=0.459 Sum_probs=214.7
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCC---
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSS--- 79 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~--- 79 (568)
.+..++|++.+.||+|++|.||+|.+..+++.+|+|++..... ....+.+|+.+++++ +||||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3567899999999999999999999998999999999876542 345788999999999 6999999999996544
Q ss_pred ---EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecC
Q psy6203 80 ---HIFMVIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL 152 (568)
Q Consensus 80 ---~~~lV~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 152 (568)
.+|+||||+++++|.+++.. +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999998865 35789999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCc----ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGK----QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-- 226 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-- 226 (568)
+...... ........|++.|+|||++... ..++.++|||||||++|+|++|..||...........+..+...
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 160 SAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred ceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 8754332 1223345689999999998542 33577899999999999999999999866554444455444322
Q ss_pred -CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 -EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 -~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+...+..+.+||.+||..||++|||+.|++.|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 122367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=339.07 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=212.5
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--C-------chHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--E-------DLPRVKLEINALKHISHQHICKLFQVIETSS 79 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 79 (568)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+...... . ..+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999989999999988643211 1 1245778999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
..++||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred Cc-cccccccCCccccccccccCcc-cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCC----CCC
Q psy6203 160 LE-SQLQTSCGSPNYAAPEVIKGKQ-YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEP----PWM 231 (568)
Q Consensus 160 ~~-~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~----~~~ 231 (568)
.. .......|+..|+|||.+.+.. .++.++|+||||+++|++++|..||......+....+... ....+ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 11 1123446889999999987654 3588999999999999999999999765544333333222 11222 235
Q ss_pred ChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 232 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
+..+.++|.+||.+||++|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=341.94 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=204.9
Q ss_pred eecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc--hHHHHHHHHHH---HhCCCCCcceeeEEEEeCCEEEEEEeccC
Q psy6203 15 TVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLEINAL---KHISHQHICKLFQVIETSSHIFMVIEYCP 89 (568)
Q Consensus 15 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~Ei~~l---~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 89 (568)
.||+|+||.||++.+..+++.+|+|.+.+...... .....+|..++ ...+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999876543221 22233444333 34479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccC
Q psy6203 90 GGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169 (568)
Q Consensus 90 ~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~g 169 (568)
+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ......|
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCcCC
Confidence 9999999988888999999999999999999999999999999999999999999999999998654332 1233468
Q ss_pred CccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccC
Q psy6203 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 170 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 246 (568)
++.|+|||.+.+...++.++||||+||++|+|++|..||... ....+...........++.+++++.++|.+||+.|
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 237 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCC
Confidence 999999999875444688999999999999999999999653 22333333333344556678999999999999999
Q ss_pred cCCCC-----CHHHHhcCccccc
Q psy6203 247 PGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 247 P~~Rp-----s~~ell~hp~~~~ 264 (568)
|.+|+ |++++++||||+.
T Consensus 238 p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 238 VSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHhcCCCCCCHHHHHhCccccC
Confidence 99999 6999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=342.26 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=211.7
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEE-----e
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIE-----T 77 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~-----~ 77 (568)
.+..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 457789999999999999999999999999999999886432 2234677899999999 6999999999873 4
Q ss_pred CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
.+..++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4678999999999999988753 356889999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCccccccccccCc----ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---C
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGK----QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---T 226 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~ 226 (568)
...... ........|++.|+|||++.+. ..++.++||||+||++|+|++|..||...........+..... .
T Consensus 172 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T cd06638 172 AQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250 (286)
T ss_pred eecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc
Confidence 764332 1122345689999999998532 2357899999999999999999999987665443333322221 1
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+...+..+.++|.+||+.||++|||+.|+++|+||
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 234467889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=342.03 Aligned_cols=255 Identities=29% Similarity=0.517 Sum_probs=218.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC---CCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS---HQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV 84 (568)
+.|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++ |||++++++++......|+|
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 358899999999999999999999999999999876544445667888999999986 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKR 158 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-ccc
Confidence 999999999998865 579999999999999999999999999999999999999999999999999987654432 223
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCC-CCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPP-WMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~-~~~~~~~~li~~~ 242 (568)
....|+..|+|||.+.+...++.++|+|||||++|+|++|..||...........+.....+ .+. ..+.++.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence 34468999999999876555688999999999999999999999877665544443333222 222 2678999999999
Q ss_pred cccCcCCCCCHHHHhcCccccc
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~~ 264 (568)
|+.||++||++.+++.|+||+.
T Consensus 239 l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 239 LDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred cCCCcccCcCHHHHhhChHhhc
Confidence 9999999999999999999974
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=343.04 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=214.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++.+.||+|+||.||+|.+..+++.||+|+++..... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 5799999999999999999999999999999998754332 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|++++.+..+......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 99887776666666779999999999999999999999999999999999999999999999999987655433223344
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------C-CC
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--------------------G-KY 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--------------------~-~~ 225 (568)
..++..|+|||++.+...++.++||||||+++|+|++|.+||.+.+..+....+.. + .+
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 56889999999998774578999999999999999999999987654332222111 0 00
Q ss_pred -----------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 -----------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 -----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..+..+++++.+||++||..+|++|||+++++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0122347889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.12 Aligned_cols=262 Identities=28% Similarity=0.479 Sum_probs=221.9
Q ss_pred CccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 2 ~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
+..+..+.|.....||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 16 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 16 SPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred ccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 44566778888899999999999999999999999999986533 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|+||||+++++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~- 172 (292)
T cd06658 95 WVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV- 172 (292)
T ss_pred EEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence 99999999999998874 4578999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCCCCChHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK---YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~l 238 (568)
.......|++.|+|||.+.+.. ++.++||||+|+++|+|++|..||...+.......+.... .......+..+.++
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred ccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHH
Confidence 2223456899999999987765 5889999999999999999999998877666555554332 22233478899999
Q ss_pred HHHccccCcCCCCCHHHHhcCcccccCCC
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWVKMGPE 267 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~~~~~~ 267 (568)
+.+||..||.+|||++|+++||||...+.
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 99999999999999999999999996443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=335.69 Aligned_cols=252 Identities=28% Similarity=0.429 Sum_probs=217.2
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC----CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG----EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+|+..+.||+|++|+||+|.+..++..||+|.+...... +....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 588899999999999999999889999999998754322 2345788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--cc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987654322 23
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~ 242 (568)
....|++.|+|||.+.....++.++|+|||||++|+|++|..||...........+.. .....+..+++.+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 238 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHH
Confidence 4456899999999987655358899999999999999999999977664444433333 22234556889999999999
Q ss_pred cccCcCCCCCHHHHhcCccc
Q psy6203 243 LQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~ 262 (568)
|+.+|++|||+.+++.|||+
T Consensus 239 l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 239 LQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hhcCcccCcCHHHHhcCCCC
Confidence 99999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=343.48 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=220.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
+...|+..+.||+|+||.||+|.+..++..||+|++...........+.+|+.++++++||||+++++.+.+.+..|+||
T Consensus 2 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred hHHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45678899999999999999999999999999999886544444567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccc
Confidence 99999999998864 578999999999999999999999999999999999999999999999999986654321 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 244 (568)
...++..|+|||++.+.. .+.++|+|||||++|+|++|..||...+.......+..+.. ..+...+..+.+++.+||+
T Consensus 160 ~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred cccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 346788999999998765 58899999999999999999999987776655555444322 2334567889999999999
Q ss_pred cCcCCCCCHHHHhcCccccc
Q psy6203 245 VEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~ 264 (568)
.+|++||++++++.||||..
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred cCcccCcCHHHHHhChHhhh
Confidence 99999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=355.84 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=199.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
..|++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.++++++||||+++++++...+..++|||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4699999999999999999999999999999985432 234689999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~ 215 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLG 215 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccccc
Confidence 94 688888765 467999999999999999999999999999999999999999999999999998753322 12234
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCC-CCCCCCH----------HHHHHHHHc-C----CCC----
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFL-PFDSDSI----------DQLYDKILN-G----KYT---- 226 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~-pf~~~~~----------~~~~~~i~~-~----~~~---- 226 (568)
..||+.|+|||++.+.. ++.++|||||||++|+|+++.. +|..... ..+...+.. + .++
T Consensus 216 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 56899999999998766 5899999999999999998544 4432110 111111110 0 000
Q ss_pred ------------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 227 ------------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 227 ------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
....++.++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 0012466778899999999999999999999999997
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.69 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=207.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE-----eCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE-----TSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-----~~~~ 80 (568)
-.++|+|.+.||+|||+.|+++++..++..||+|.+.... .++.+...+|++..++++||||++++++.. ....
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3579999999999999999999999999999999988665 456778899999999999999999988753 2345
Q ss_pred EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 81 IFMVIEYCPGGELLDHIVER----QRLGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
.||+++|...|+|.+.|... ..++|.++..|+.+|++||++||+.. +.||||||.|||+.+.+.++|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 89999999999999999753 36999999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCCccc--------cccccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCCCC--HHHHHHHHHc
Q psy6203 155 KPEGGLESQ--------LQTSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILN 222 (568)
Q Consensus 155 ~~~~~~~~~--------~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~~~--~~~~~~~i~~ 222 (568)
......... ......|..|.|||.+.-. ...+.++|||||||++|.|+.|..||+..- -..+.-.+.+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 644321111 1112358899999998532 235789999999999999999999995211 0111223444
Q ss_pred CCCCCC--CCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 223 GKYTEP--PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 223 ~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+.+.+| ..+|..+.++|++||+.||.+||++.+++.+
T Consensus 258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 444443 3489999999999999999999999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=358.93 Aligned_cols=250 Identities=24% Similarity=0.440 Sum_probs=206.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCC-----cEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTG-----EKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHI 81 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 81 (568)
++|++.+.||+|+||.||+|.+..+| ..||+|+++..........+.+|+.+++.+ +||||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 57999999999999999999865444 579999997654434456688899999999 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-------------------------------------------------------------
Q psy6203 82 FMVIEYCPGGELLDHIVER------------------------------------------------------------- 100 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~------------------------------------------------------------- 100 (568)
++|||||++|+|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc-cccccCC
Q psy6203 101 ---------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ-LQTSCGS 170 (568)
Q Consensus 101 ---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt 170 (568)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... .....++
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 246788899999999999999999999999999999999999999999999987643321111 1122356
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC--CCCCCCCCChHHHHHHHHccccCc
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSMLQVEP 247 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP 247 (568)
+.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+... ....+...++++.+++.+||+.||
T Consensus 278 ~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 356 (374)
T cd05106 278 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEP 356 (374)
T ss_pred cceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCCh
Confidence 6899999997765 6899999999999999997 99999776544333333332 233455678999999999999999
Q ss_pred CCCCCHHHHhc
Q psy6203 248 GKRIKIQDLLG 258 (568)
Q Consensus 248 ~~Rps~~ell~ 258 (568)
.+|||+.++++
T Consensus 357 ~~RPs~~~l~~ 367 (374)
T cd05106 357 TERPTFSQISQ 367 (374)
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=358.44 Aligned_cols=252 Identities=26% Similarity=0.433 Sum_probs=207.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEE-----cCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATH-----VLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 80 (568)
.++|++.++||+|+||+||+|.+ ..++..||+|+++........+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 3456789999997554334456788899999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-----------------------------------------------------------
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ----------------------------------------------------------- 101 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~----------------------------------------------------------- 101 (568)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc-c
Q psy6203 102 ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ-L 164 (568)
Q Consensus 102 ----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~ 164 (568)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... .
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 46788899999999999999999999999999999999999999999999987654321111 1
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHH-HHHHHHHcCCC-CCCCCCChHHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID-QLYDKILNGKY-TEPPWMSPNSRQIVRS 241 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~-~~~~~i~~~~~-~~~~~~~~~~~~li~~ 241 (568)
....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...... ...+.+..+.. ..+...+.++.+|+.+
T Consensus 274 ~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 352 (375)
T cd05104 274 GNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352 (375)
T ss_pred CCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence 1233566799999998766 5899999999999999998 89999776543 34444444432 3345578899999999
Q ss_pred ccccCcCCCCCHHHHhcC
Q psy6203 242 MLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~h 259 (568)
||+.||++|||+.|+++.
T Consensus 353 cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 353 CWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=346.22 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=204.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC----------------CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcce
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL----------------TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~ 70 (568)
.++|++.++||+|+||.||+|.+.. ++..||+|++...........+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4789999999999999999998532 344799999876433333456888999999999999999
Q ss_pred eeEEEEeCCEEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecC
Q psy6203 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQ-------------------RLGEKESRAFFRQILSAVAYLHHLGYAHRD 131 (568)
Q Consensus 71 l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~-------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 131 (568)
+++++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999999999999999999999986532 357788899999999999999999999999
Q ss_pred CCCCceEEcCCCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh--CCCCC
Q psy6203 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC--GFLPF 208 (568)
Q Consensus 132 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt--G~~pf 208 (568)
|||+|||++.++.+||+|||++........ .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999999999999999999875433211 1122334678899999987766 6899999999999999986 66888
Q ss_pred CCCCHHHHHHHHHc----C----CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHh
Q psy6203 209 DSDSIDQLYDKILN----G----KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257 (568)
Q Consensus 209 ~~~~~~~~~~~i~~----~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 257 (568)
...+..+....+.. . ....++..++.+.+|+.+||+.||.+|||++||.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 87666555444321 1 1223456788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.92 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=208.5
Q ss_pred eecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc--hHHHHHH---HHHHHhCCCCCcceeeEEEEeCCEEEEEEeccC
Q psy6203 15 TVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLE---INALKHISHQHICKLFQVIETSSHIFMVIEYCP 89 (568)
Q Consensus 15 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E---i~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 89 (568)
.||+|+||.||+|.+..+++.||+|++.+...... ......| +..++...||||+++++.+...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999876543211 1122333 334555689999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccC
Q psy6203 90 GGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169 (568)
Q Consensus 90 ~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~g 169 (568)
|++|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...... .....+|
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCcCC
Confidence 9999999988888999999999999999999999999999999999999999999999999998754332 2234578
Q ss_pred CccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccC
Q psy6203 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 170 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 246 (568)
+..|+|||++.+...++.++||||+||++|+|++|..||... ........+.......+...++.+.+++.+||..+
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~ 237 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 237 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcC
Confidence 999999999976544688999999999999999999999765 34444444444555666668999999999999999
Q ss_pred cCCCC-----CHHHHhcCccccc
Q psy6203 247 PGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 247 P~~Rp-----s~~ell~hp~~~~ 264 (568)
|.+|| ++.++++||||+.
T Consensus 238 p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 238 VNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred HHhccCCCCCCHHHHHhCccccC
Confidence 99999 9999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=333.35 Aligned_cols=251 Identities=31% Similarity=0.535 Sum_probs=219.0
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 699999999999999999999999999999998765433 2356788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCccCCCCCCcccc
Q psy6203 88 CPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 88 ~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~ 164 (568)
+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++ .+||+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~ 158 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK--SKA 158 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--ccc
Confidence 9999999999764 3589999999999999999999999999999999999998654 5899999998765432 122
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHcc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L 243 (568)
....|+..|+|||.+.+.. ++.++||||+|+++|+|++|..||...+.......+..+.. +.+..+++++.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 159 YTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237 (256)
T ss_pred cccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHc
Confidence 3356889999999998765 58899999999999999999999988887777766665543 345568999999999999
Q ss_pred ccCcCCCCCHHHHhcCccc
Q psy6203 244 QVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 244 ~~dP~~Rps~~ell~hp~~ 262 (568)
+.||++|||+.|++.||||
T Consensus 238 ~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 238 NLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cCChhhCCCHHHHhhCCCC
Confidence 9999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=341.55 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=217.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|++|.||+|.++.+++.+|+|.+...........+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999999999999999988765444456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---AK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---hh
Confidence 9999999999876 789999999999999999999999 999999999999999999999999999986543221 11
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCC-CCCC-CChHHHHH
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD-----SIDQLYDKILNGKYT-EPPW-MSPNSRQI 238 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~-----~~~~~~~~i~~~~~~-~~~~-~~~~~~~l 238 (568)
...++..|+|||.+.+.. ++.++||||||+++|+|++|..||... ...+..+.+..+..+ .+.. +++++.++
T Consensus 158 ~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 158 TFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred cccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 256889999999998765 689999999999999999999999654 333444444444332 2233 78899999
Q ss_pred HHHccccCcCCCCCHHHHhcCcccc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
|.+||..||++|||+.+++.||||+
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhh
Confidence 9999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=343.65 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=215.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCC-----cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTG-----EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
++|++.+.||+|+||.||+|.+...+ ..||+|.+...........+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 57899999999999999999976555 6799999875443333456888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeE
Q psy6203 83 MVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK 146 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 146 (568)
++|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 999999999999999764 4578899999999999999999999999999999999999999999
Q ss_pred EEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q psy6203 147 LIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK 224 (568)
Q Consensus 147 l~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~ 224 (568)
|+|||++........ .......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+.
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875432211 1223345688999999987766 5899999999999999998 999999888888888887665
Q ss_pred C-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 225 Y-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 225 ~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
. ..+..+++++.+|+.+||+.||.+||++.|++++
T Consensus 244 ~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 244 LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4 3455689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=336.74 Aligned_cols=251 Identities=29% Similarity=0.464 Sum_probs=216.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.+..++..+|+|.+..... ...+.+|+.++++++||||+++++.+.+....|+++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 4789999999999999999999998899999999875432 5678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AKRN 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc-cccc
Confidence 9999999999875 4578999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCCCCChHHHHHHHHc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK---YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~ 242 (568)
...++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+.... ...+..++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred cccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 345788999999998765 5889999999999999999999998766554443333222 223345678999999999
Q ss_pred cccCcCCCCCHHHHhcCccc
Q psy6203 243 LQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~ 262 (568)
|+.||++|||+.|++.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=348.75 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=193.2
Q ss_pred EeeecccCCeEEEEEEEcC--CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE--eCCEEEEEEecc
Q psy6203 13 ERTVGSGGFAKVKLATHVL--TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE--TSSHIFMVIEYC 88 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E~~ 88 (568)
+.+||+|+||+||+|++.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++. .....++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 4689999999999999654 56889999886543 2235778999999999999999999884 456789999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE----cCCCCeEEEeecCccC
Q psy6203 89 PGGELLDHIVER---------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAK 155 (568)
Q Consensus 89 ~~g~L~~~i~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG~a~~ 155 (568)
+ ++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 5 5788777521 248899999999999999999999999999999999999 4567899999999976
Q ss_pred CCCCCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH---------HHHHHHHc--
Q psy6203 156 PEGGLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---------QLYDKILN-- 222 (568)
Q Consensus 156 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~---------~~~~~i~~-- 222 (568)
...... .......||+.|+|||++.+...++.++|||||||++|+|+||.+||...... .....+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 543221 12234568999999999987665789999999999999999999999643211 00000000
Q ss_pred --------------------------CCCC----------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 223 --------------------------GKYT----------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 223 --------------------------~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.... .....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 011234568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.24 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=209.4
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS------ 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------ 78 (568)
++.++|.+.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 578999999999999999999999999999999999876543 3456688899999999999999999876543
Q ss_pred --------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-CCCeEEEe
Q psy6203 79 --------SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-NQNLKLID 149 (568)
Q Consensus 79 --------~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~D 149 (568)
...|+||||++ ++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35799999996 58888775 457999999999999999999999999999999999999974 55789999
Q ss_pred ecCccCCCCCCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC---
Q psy6203 150 FGLCAKPEGGLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--- 224 (568)
Q Consensus 150 FG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--- 224 (568)
||++........ .......++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999865432111 111233578899999988665557889999999999999999999998765444333322110
Q ss_pred ---------------------CC------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 225 ---------------------YT------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 225 ---------------------~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.. ..+.++.++.+||.+||+.||.+|||++|++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 11346788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.28 Aligned_cols=254 Identities=31% Similarity=0.541 Sum_probs=215.8
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||+|+||.||+|.+..+++.||+|.++..... .....+..|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 699999999999999999999889999999999866543 2456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc---c
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ---L 164 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~---~ 164 (568)
+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999999999887789999999999999999999999999999999999999999999999999987654322211 1
Q ss_pred ccccCCccccccccccCcc--cCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcC-CCCCCCC--CChHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQ--YYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNG-KYTEPPW--MSPNSRQI 238 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~-~~~~~~~--~~~~~~~l 238 (568)
....+++.|+|||++.+.. ..+.++||||||+++|+|++|..||.... .......+..+ ....+.. +++.+.++
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHH
Confidence 2356788999999987654 25789999999999999999999997653 33333333333 2233333 48899999
Q ss_pred HHHccccCcCCCCCHHHHhcCccc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
|.+||+.+|++|||+.|++.|||+
T Consensus 241 i~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 241 LDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=341.16 Aligned_cols=254 Identities=29% Similarity=0.424 Sum_probs=208.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCC-CCCcceeeEEEEeCCE-----
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHIS-HQHICKLFQVIETSSH----- 80 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~----- 80 (568)
++|++.+.||+|+||.||+|.+..+|+.||+|.+....... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 57999999999999999999999999999999987543322 2356788999999995 6999999999877665
Q ss_pred EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-CCCeEEEeecCcc
Q psy6203 81 IFMVIEYCPGGELLDHIVER-----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-NQNLKLIDFGLCA 154 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~ 154 (568)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999975 788888643 35799999999999999999999999999999999999998 8899999999987
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK---------- 224 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~---------- 224 (568)
...... .......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+....
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 160 AFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred ecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 543321 112233578899999998765556899999999999999999999998766544333322110
Q ss_pred ---------CC---------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 225 ---------YT---------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 225 ---------~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+. ..+.+++.+.+||.+||+.||.+|||++|++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0134688899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.86 Aligned_cols=259 Identities=24% Similarity=0.418 Sum_probs=208.9
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCC--
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSS-- 79 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 79 (568)
+.+.-++|++.+.||+|+||.||+|.+..+++.||+|.+......+ ....+.+|+.++++++||||+++++++...+
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 4456678999999999999999999999999999999987543322 2334567999999999999999999986543
Q ss_pred ------EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecC
Q psy6203 80 ------HIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL 152 (568)
Q Consensus 80 ------~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 152 (568)
..++||||+. ++|.+.+... ..+++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999995 5788877654 3789999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCc---cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC-
Q psy6203 153 CAKPEGGLE---SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKYT- 226 (568)
Q Consensus 153 a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~~- 226 (568)
+........ .......++..|+|||.+.+...++.++||||||+++|+|++|..||.+.+.......+.. +..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 875433211 1122345788999999987765568899999999999999999999987765443322221 1000
Q ss_pred ----------------C-------------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 ----------------E-------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 ----------------~-------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
. +...++.+.+||.+||..||.+|||++|+++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 01135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=369.49 Aligned_cols=246 Identities=37% Similarity=0.579 Sum_probs=208.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEE-EEe---C---C
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQV-IET---S---S 79 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~-~~~---~---~ 79 (568)
.+++|.+.|.+|||+.||+|++...|..||+|++-.. .......+.+||.+|++|+ |+|||.+++. ... . -
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4688999999999999999999988899999988755 3456778999999999997 9999999993 211 1 2
Q ss_pred EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEcCCCCeEEEeecCccC
Q psy6203 80 HIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLDRNQNLKLIDFGLCAK 155 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 155 (568)
.++|.||||.||.|.+++.++ ..|+|.++++|+.|+++|+.+||... |||||||-|||||+.+|+.||||||.+..
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 578999999999999999854 56999999999999999999999987 99999999999999999999999999875
Q ss_pred CCCCCcccc--------ccccCCcccccccccc---CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q psy6203 156 PEGGLESQL--------QTSCGSPNYAAPEVIK---GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK 224 (568)
Q Consensus 156 ~~~~~~~~~--------~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~ 224 (568)
......... -....|+.|+|||++. +.+ .+.|+|||+|||+||-|+....||..... -.|+++.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p-I~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~ 270 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP-IGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGN 270 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC-CcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEecc
Confidence 433221100 0124699999999973 444 58999999999999999999999987632 2578898
Q ss_pred CCCCC--CCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 225 YTEPP--WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 225 ~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
|.+|+ .++..+++||+.||+.||++||++-|++.+
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 88776 589999999999999999999999998864
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=339.87 Aligned_cols=256 Identities=32% Similarity=0.564 Sum_probs=230.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
.+|.++.+||+|+||+|.+|..+.|.+.||||++++.-+- ++.+-...|-++|... +-|.+++++..|++-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4688999999999999999999999999999999876542 2333344566677665 468999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+.||+|--+|.+-+++.|..+..++..|+-||-+||++||+.||||.+|||++.+|++||+|||+++...-+ ....
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~~TT 507 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-GVTT 507 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-Ccce
Confidence 999999999999999999999999999999999999999999999999999999999999999999998864332 3456
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.||||.|+|||++.-.+ |+.++|.||+||+||||+.|++||++.+.+++++.|.......|..+|.++.++++.+|.
T Consensus 508 kTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~lt 586 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLT 586 (683)
T ss_pred eeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhh
Confidence 7899999999999998776 699999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCH-----HHHhcCcccccC
Q psy6203 245 VEPGKRIKI-----QDLLGHNWVKMG 265 (568)
Q Consensus 245 ~dP~~Rps~-----~ell~hp~~~~~ 265 (568)
+.|.+|..+ .+|-.||||+..
T Consensus 587 K~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 587 KHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred cCCccccCCCCccccchhhCcchhhc
Confidence 999999864 689999999843
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=350.30 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=214.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc-CCchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
++.++|++.+.||+|+||+||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 357899999999999999999999999999999999875422 22345667899999999999999999987644
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
...|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999995 78999998888899999999999999999999999999999999999999999999999999876543
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc---C------------
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN---G------------ 223 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~---~------------ 223 (568)
.. .......++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+.. .
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 21 2223456789999999987644478999999999999999999999987654332221110 0
Q ss_pred ----------CC------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 224 ----------KY------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 224 ----------~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.. ...+.+++.+.++|++||+.||++|||++++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0123478899999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=335.38 Aligned_cols=249 Identities=24% Similarity=0.431 Sum_probs=215.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
...|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 356999999999999999999999999999999987542 234568889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999998754 3588999999999999999999999999999999999999999999999999876543321111
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~ 242 (568)
....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..+ ....+...++++.++|.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 241 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRAC 241 (263)
T ss_pred CCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 2223466899999988766 5889999999999999998 99999988888887777665 3445566889999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|+.||++|||+.++++
T Consensus 242 l~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 242 WQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ccCCcccCCCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=343.50 Aligned_cols=253 Identities=30% Similarity=0.410 Sum_probs=211.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIETS--SHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV 84 (568)
++|++.+.||+|+||.||+|.+..+++.+|+|.++.....+. ...+.+|+.++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 579999999999999999999999999999999976543322 23566799999999999999999998877 889999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+. ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99996 5898888764 458999999999999999999999999999999999999999999999999987654321 12
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK------------------- 224 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~------------------- 224 (568)
.....+++.|+|||.+.+...++.++||||||+++|+|++|.+||...+.......+....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 2334578899999998776556889999999999999999999998776555444332110
Q ss_pred ------------CCCCCC-CChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 225 ------------YTEPPW-MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 225 ------------~~~~~~-~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
...+.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 001111 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=341.47 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=216.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||+||++.+..+|+.||+|++...........+.+|+++++.++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 68999999999999999999999999999999987654334456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... ....
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~~~~ 161 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADT 161 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---ccCc
Confidence 9999999999888889999999999999999999997 59999999999999999999999999997654221 2234
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH-----------HHHHHHHcCCC-CCCC-CCCh
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-----------QLYDKILNGKY-TEPP-WMSP 233 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-----------~~~~~i~~~~~-~~~~-~~~~ 233 (568)
.+|+..|+|||++.+.. ++.++|||||||++|+|++|..||...... +....+..... ..+. .++.
T Consensus 162 ~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 57899999999987665 588999999999999999999999765431 22333333222 2222 2678
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.+.+|+.+||+.||++|||++|+++|+||...
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 89999999999999999999999999999743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=340.98 Aligned_cols=254 Identities=32% Similarity=0.636 Sum_probs=225.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 84 (568)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.... .....+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 5799999999999999999999999999999998764432 22456788999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc---
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE--- 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--- 161 (568)
||++++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999875433211
Q ss_pred ----------------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Q psy6203 162 ----------------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY 225 (568)
Q Consensus 162 ----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~ 225 (568)
.......++..|+|||++.+.. .+.++||||||++++++++|..||...+.......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 1222345788999999987765 58899999999999999999999998887777777777777
Q ss_pred CCCCCCChHHHHHHHHccccCcCCCCCH----HHHhcCccc
Q psy6203 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKI----QDLLGHNWV 262 (568)
Q Consensus 226 ~~~~~~~~~~~~li~~~L~~dP~~Rps~----~ell~hp~~ 262 (568)
..+..+++.+.++|.+||+.||++|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888889999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=340.14 Aligned_cols=246 Identities=30% Similarity=0.501 Sum_probs=210.6
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
||+|+||+||+|.+..+|+.||+|++.+.... .....+..|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998764332 2234566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCc
Q psy6203 94 LDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP 171 (568)
Q Consensus 94 ~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~ 171 (568)
.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+...... .......++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccCCC
Confidence 99998765 7999999999999999999999999999999999999999999999999998754332 2223446788
Q ss_pred cccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCCCCChHHHHHHHHccccCc
Q psy6203 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 247 (568)
Q Consensus 172 ~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 247 (568)
.|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ..+...+.......+...++.+.++|.+||+.||
T Consensus 159 ~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 159 GYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 999999998766 68899999999999999999999976543 3333444444445556689999999999999999
Q ss_pred CCCC-----CHHHHhcCccccc
Q psy6203 248 GKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 248 ~~Rp-----s~~ell~hp~~~~ 264 (568)
.+|| ++.+++.||||+.
T Consensus 238 ~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 238 EKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hHccCCCcccHHHHHhChhhhc
Confidence 9999 8999999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.58 Aligned_cols=254 Identities=24% Similarity=0.418 Sum_probs=207.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHH-HHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA-LKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++.+.||+|+||.||+|.+..+|+.||+|+++.....+....+..|+.+ ++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5799999999999999999999999999999999765443333455556664 566789999999999999999999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 87 YCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 87 ~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|++ |+|.+++.. +..+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 996 678777754 24689999999999999999999997 99999999999999999999999999987653321
Q ss_pred cccccccCCccccccccccCc---ccCCcccceechhhHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCC-CCCChHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGK---QYYGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILNGKYTEP-PWMSPNS 235 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~~lltG~~pf~~~--~~~~~~~~i~~~~~~~~-~~~~~~~ 235 (568)
......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||... ....+...+.......+ ..++.++
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 11234688899999998652 23578999999999999999999999642 22333333322222222 3478999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.++|.+||..+|.+|||+++++.||||..
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 99999999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.69 Aligned_cols=252 Identities=31% Similarity=0.531 Sum_probs=219.7
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET--SSHIFMVI 85 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~ 85 (568)
+|++.+.||.|+||.||+|.+..+|..||+|++...... .....+..|+.+++.++||||+++++.+.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 589999999999999999999999999999998765433 234567889999999999999999998753 45689999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 86 EYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLH-----HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 86 E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH-----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
||+++++|.+++.. ...+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999865 367899999999999999999999 999999999999999999999999999998865
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHH
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNS 235 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~ 235 (568)
.... .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+...+.+.+..+... .+...+..+
T Consensus 161 ~~~~-~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 161 GHDS-SFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred cCCc-ccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence 4432 1133456899999999998766 588999999999999999999999988877777777776653 455688999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+++.+||+.+|++|||+.++++|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=345.47 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=218.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..+.|++.+.||+|+||.||+|.+..++..||+|.+...........+.+|+.++++++||||+++++.+...+..|+||
T Consensus 2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 45678888999999999999999999999999999875544344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence 99999999988754 678999999999999999999999999999999999999999999999999987544321 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 244 (568)
...|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+..+.. ..+...+.++.++|.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 346788999999998765 58899999999999999999999976655554444443332 2334577889999999999
Q ss_pred cCcCCCCCHHHHhcCcccc
Q psy6203 245 VEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~ 263 (568)
.+|++|||+.+++.||||.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 239 KDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred CCcccCcCHHHHHHhHHHH
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.55 Aligned_cols=255 Identities=29% Similarity=0.440 Sum_probs=210.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe------
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET------ 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~------ 77 (568)
...+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34578999999999999999999999999999999986543 2335678899999998 69999999999843
Q ss_pred CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK 155 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 155 (568)
.+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46789999999999999998753 4588999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCccccccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPP 229 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~--~~~ 229 (568)
..... .......|++.|+|||.+.. ...++.++|||||||++|+|++|..||...........+...... ...
T Consensus 171 ~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 171 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 43211 12334568999999999853 223578899999999999999999999766544433333332221 123
Q ss_pred CCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 230 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.++.++.+||.+||+.||.+|||+.|++.||||
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 478899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.06 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=213.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe----CCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET----SSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~ 80 (568)
+.++|++.+.||+|++|.||+|.+..+|+.||+|++...... .....+.+|+.++++++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 568999999999999999999999999999999998754322 234567789999999999999999998753 357
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
.|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999995 6899999877889999999999999999999999999999999999999999999999999986543221
Q ss_pred c---cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--C------------
Q psy6203 161 E---SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--G------------ 223 (568)
Q Consensus 161 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~------------ 223 (568)
. .......|+..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+.. +
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 1 1123447899999999987655568999999999999999999999977654332221111 0
Q ss_pred --------CC----CC-----CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 224 --------KY----TE-----PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 224 --------~~----~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
.. .. .+..++++.++|++||+.||.+|||+++++.||||...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00 00 133688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=333.86 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=222.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|++|.||+|.+..+++.||+|++...........+.+|+..+++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 57999999999999999999999999999999987654333456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-DQCNT 159 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC-Ccccc
Confidence 9999999999888889999999999999999999999 999999999999999999999999999987654322 12224
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---CHHHHHHHHHcCCC-CCCCC-CChHHHHHHHH
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKY-TEPPW-MSPNSRQIVRS 241 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---~~~~~~~~i~~~~~-~~~~~-~~~~~~~li~~ 241 (568)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|..||... ...+....+..... ..+.. ++..+.++|.+
T Consensus 160 ~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (264)
T cd06623 160 FVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238 (264)
T ss_pred eeecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence 56789999999987764 688999999999999999999999776 45555555554433 33444 78899999999
Q ss_pred ccccCcCCCCCHHHHhcCccccc
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
||..+|++|||+.++++||||+.
T Consensus 239 ~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 239 CLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.50 Aligned_cols=247 Identities=31% Similarity=0.537 Sum_probs=217.3
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEE
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHI 81 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 81 (568)
...+.+.|.+...+|.|+||.|..+.+..+++..++|++.+... ....|+.++... +||||+++++++.+..+.
T Consensus 317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cCCcchhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCcee
Confidence 44678899999999999999999999999999999999987622 233466555544 699999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE-cCCCCeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL-DRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-~~~~~~kl~DFG~a~~~~~~~ 160 (568)
|+|||++.|+.|.+.+.....+. .++..|+.+|+.|+.|||++|||||||||+|||+ ++.|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999999999998776666 8888999999999999999999999999999999 68899999999998865543
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCChHHHHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTEPPWMSPNSRQIV 239 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~li 239 (568)
..+.|-|..|.|||++.... |++++||||||++||+|++|..||...... ++..++..+.+. ..+|.++++||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred ---hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 34557789999999999666 699999999999999999999999776555 777777666554 78999999999
Q ss_pred HHccccCcCCCCCHHHHhcCccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+||+.||.+|+++.+++.|||+
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.48 Aligned_cols=247 Identities=28% Similarity=0.455 Sum_probs=205.6
Q ss_pred ccccCeEEEeee--cccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEE
Q psy6203 5 DLRNQYILERTV--GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHI 81 (568)
Q Consensus 5 ~~~~~Y~i~~~l--G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 81 (568)
++.++|++.+.+ |+|+||.||++.++.++..+|+|++........ |+.....+ +||||+++++.+...+..
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 345677887777 999999999999999999999999876533211 22222222 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~ 160 (568)
|+||||+++++|.+++..+..+++.++..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999999999999998888999999999999999999999999999999999999999988 9999999998754322
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCCCCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL----YDKILNGKYTEPPWMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~ 236 (568)
....|+..|+|||++.+.. ++.++||||+|+++|+|++|..||........ ...........+...++.+.
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN 238 (267)
T ss_pred ----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence 2345889999999998766 58899999999999999999999975543221 11112333344556899999
Q ss_pred HHHHHccccCcCCCCC-HHHHhcCcccc
Q psy6203 237 QIVRSMLQVEPGKRIK-IQDLLGHNWVK 263 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps-~~ell~hp~~~ 263 (568)
++|.+||+.||.+||+ ++|+|+||||+
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999999999999996 69999999996
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.05 Aligned_cols=252 Identities=27% Similarity=0.470 Sum_probs=207.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS------ 78 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------ 78 (568)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.... .....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 568999999999999999999999999999999998754322 2345677899999999999999999988643
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
...|+||||+. ++|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999995 5888877543 89999999999999999999999999999999999999999999999999876543
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--------------- 223 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--------------- 223 (568)
. .......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+...
T Consensus 171 ~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 171 S--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred C--CCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 2 1233456889999999998766 589999999999999999999999876644333332110
Q ss_pred -------CCC--------------C-------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 224 -------KYT--------------E-------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 224 -------~~~--------------~-------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
... . +...++.+.++|.+||+.||.+|||+.|+|.||||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000 0 112355689999999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.68 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=220.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..+-|++.+.||+|+||.||+|.+..++..||+|++...........+.+|+.++++++||||+++++.+..++..|+||
T Consensus 2 ~~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HHHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 34668899999999999999999998999999999875544344567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||+++++|.+++.. ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRN 159 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-hhhhc
Confidence 99999999988854 57899999999999999999999999999999999999999999999999998654332 11223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 244 (568)
...++..|+|||.+.+.. .+.++|+||+||++|+|++|..||...+.......+..+.. ..+..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 346888999999987665 57899999999999999999999987776666655554433 2445678899999999999
Q ss_pred cCcCCCCCHHHHhcCccccc
Q psy6203 245 VEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~ 264 (568)
.+|.+||++.+++.||||..
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred CChhhCcCHHHHHhCHHHhh
Confidence 99999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=332.04 Aligned_cols=247 Identities=24% Similarity=0.414 Sum_probs=211.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||++..+ .+..+|+|.+..... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 56899999999999999999875 456899998764432 235678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+.............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999999998753 568999999999999999999999999999999999999999999999999987643322211122
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~ 244 (568)
..++..|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+..+... .+...+..+.+++.+||+
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~ 239 (256)
T cd05114 161 AKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239 (256)
T ss_pred CCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 23566899999998665 5889999999999999999 99999988888888888776543 345578889999999999
Q ss_pred cCcCCCCCHHHHhc
Q psy6203 245 VEPGKRIKIQDLLG 258 (568)
Q Consensus 245 ~dP~~Rps~~ell~ 258 (568)
.||.+|||++++++
T Consensus 240 ~~p~~Rps~~~l~~ 253 (256)
T cd05114 240 EKPEGRPTFAELLR 253 (256)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=351.73 Aligned_cols=251 Identities=30% Similarity=0.393 Sum_probs=215.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
...|.-++.||.|+||-||-|++..+.+.||||.+..+... +.+..+..|+..|++++|||+|.+-++|-.+...|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34566778899999999999999999999999998754322 3456788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||| -|+-.|++. -++++-+.++..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|.... .
T Consensus 105 MEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----P 178 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----P 178 (948)
T ss_pred HHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-----c
Confidence 9999 567777775 35789999999999999999999999999999999999999999999999999887643 3
Q ss_pred cccccCCcccccccccc--CcccCCcccceechhhHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCC-CCCChHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIK--GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYTEP-PWMSPNSRQIV 239 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~-~~~~i~~~~~~~~-~~~~~~~~~li 239 (568)
.++++|||+|||||++. ....|+-++||||||+++.||.-.++|.-..+... ++.-..+..+..+ +..|..+..|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 46789999999999985 33447889999999999999999999976666544 4444444444433 34688999999
Q ss_pred HHccccCcCCCCCHHHHhcCcccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
..||++-|.+|||.+++|.|+|+.
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhc
Confidence 999999999999999999999997
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.19 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=215.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
.++|.+.+.||+|+||.||+|.+.. ++..||+|+++.....+....+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568999999999999999998753 35789999987654433456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEE
Q psy6203 82 FMVIEYCPGGELLDHIVER--------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKL 147 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl 147 (568)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999999999754 24788899999999999999999999999999999999999999999
Q ss_pred EeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q psy6203 148 IDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY 225 (568)
Q Consensus 148 ~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~ 225 (568)
+|||++........ .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+..+..
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999875432211 1112334578899999998776 5889999999999999998 9999988888888888877765
Q ss_pred CC-CCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 226 TE-PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 226 ~~-~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.. +...+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 43 4468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=337.82 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=209.8
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
|++.+.||.|++|.||+|.+..+|..||+|++......+ ....+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678999999999999999999999999999987654332 2346778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 89 PGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 89 ~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+ ++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTH 158 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccCc
Confidence 4 68999987665 78999999999999999999999999999999999999999999999999987543221 11223
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------------
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----------------------- 223 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~----------------------- 223 (568)
..+++.|+|||++.+...++.++||||||+++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 356889999999877655688999999999999999999999876653332222110
Q ss_pred --C----CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 224 --K----YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 224 --~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
. ....+.+++.+.++|.+||+.||.+|||++|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 01123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=334.52 Aligned_cols=247 Identities=33% Similarity=0.606 Sum_probs=218.1
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
||+|+||.||+|.+..+|+.+|+|++...... .....+.+|+.++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999998765432 3355788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-------ccccc
Q psy6203 94 LDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-------SQLQT 166 (568)
Q Consensus 94 ~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-------~~~~~ 166 (568)
.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998878899999999999999999999999999999999999999999999999999775433211 12233
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC--ChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM--SPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~li~~~L~ 244 (568)
..++..|+|||.+.+.. .+.++|+||||+++|+|++|..||......+....+..+....+... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 45788999999987766 58899999999999999999999998888888888887766665554 8999999999999
Q ss_pred cCcCCCCCH---HHHhcCcccc
Q psy6203 245 VEPGKRIKI---QDLLGHNWVK 263 (568)
Q Consensus 245 ~dP~~Rps~---~ell~hp~~~ 263 (568)
.+|.+|||+ .++|+||||+
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred CCHhhcCCCccHHHHhcCcccc
Confidence 999999999 9999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=341.56 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=208.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcE--EEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEK--VAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||.||+|.+..++.. +|+|.+...........+.+|+.++.++ +||||+++++++...+..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5899999999999999999999887765 4666665332223345678899999999 899999999999999999999
Q ss_pred EeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 85 IEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
|||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 99999999999997542 47889999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CC
Q psy6203 149 DFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YT 226 (568)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~ 226 (568)
|||++...... .......++..|+|||.+.+.. ++.++|||||||++|+|+| |..||...+..+....+..+. ..
T Consensus 167 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd05088 167 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243 (303)
T ss_pred ccccCcccchh--hhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCC
Confidence 99998643211 1111223466799999987665 6889999999999999998 999998888777777665542 23
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+...++++.+|+.+||+.+|++||++++++.+
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=332.56 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=214.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCC---CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||.||+|.+..+ ...||+|.++..........+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 6799999999999999999998654 4579999987654444455678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-c
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-S 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~ 162 (568)
|||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........ .
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 9999999999998764 5789999999999999999999999999999999999999999999999999886542111 1
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVR 240 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 240 (568)
......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+..+. .+.+...++.+.+++.
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLML 242 (266)
T ss_pred eccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 111223467899999988765 5889999999999999998 999998888777777776653 3445567899999999
Q ss_pred HccccCcCCCCCHHHHhcC
Q psy6203 241 SMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~h 259 (568)
+||+.+|++||++.+++++
T Consensus 243 ~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 243 DCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=337.24 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=210.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++.+.||+|++|.||+|.+..+|+.||+|.+...... .....+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6799999999999999999999999999999998754432 223567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-CCCeEEEeecCccCCCCCCccc
Q psy6203 87 YCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|++ ++|.+.+..... +++..+..++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++....... ..
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RT 159 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-cc
Confidence 995 578888765433 578889999999999999999999999999999999985 4579999999987543321 12
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------------
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY---------------- 225 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~---------------- 225 (568)
.....+++.|+|||.+.+...++.++||||+||++|+|++|.+||...+..+....+... ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 233457889999999877655688999999999999999999999876654433332210 00
Q ss_pred -----C------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 -----T------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 -----~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. ..+.+++.+.++|.+||+.||++||++.++++||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 0 12346788999999999999999999999999999984
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=345.78 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=212.5
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCC---
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSS--- 79 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 79 (568)
..+.++|++.+.||+|+||.||+|.+..+|..||+|++....... ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 357889999999999999999999999999999999986543222 2346778999999999999999999987553
Q ss_pred ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 80 ---HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 80 ---~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
.+++||||+ +++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 778887775 467999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY----------- 225 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~----------- 225 (568)
... .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||...+.......+.....
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 169 DSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 332 22345789999999987654468899999999999999999999987665433333222110
Q ss_pred --------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 226 --------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 226 --------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
...+.+++.+.++|.+||+.||.+|||+.+++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0113467889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=336.46 Aligned_cols=256 Identities=32% Similarity=0.571 Sum_probs=218.6
Q ss_pred CeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcC---CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLG---EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHI 81 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 81 (568)
+|++.+.||+|+||.||+|.+. .+|..||+|++...... .....+.+|+.+++++ +|+||+++++.++.+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 47899999998764321 2245678899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCChHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSR 236 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (568)
.......|+..|+|||.+.+. ..++.++||||||+++|+|++|..||... ....+...+.....+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 223345689999999998753 23578899999999999999999999643 3344555555566666677899999
Q ss_pred HHHHHccccCcCCCC-----CHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
+++.+||+.||++|| ++++++.||||..
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 999999999999997 8999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=334.39 Aligned_cols=256 Identities=27% Similarity=0.480 Sum_probs=219.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
....|...+.||+|++|.||++.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred chHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 34567778899999999999999999999999998864332 23456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++|++|.+++.. .++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence 99999999999876 679999999999999999999999999999999999999999999999999876543321 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---CCCCChHHHHHHHHc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE---PPWMSPNSRQIVRSM 242 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~li~~~ 242 (568)
...|++.|+|||.+.+.. ++.++||||+||++|+|++|..||...+.......+..+.... +..++..+.+++.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 356899999999998766 5889999999999999999999998877766666666553222 233778999999999
Q ss_pred cccCcCCCCCHHHHhcCcccccC
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
|+.+|++|||+.++++||||+..
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred cccChhhCcCHHHHccCcccccC
Confidence 99999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=336.38 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=213.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
.++|++.+.||+|+||.||+|.++. .+..||+|.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 5789999999999999999997652 34579999886543222334577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeec
Q psy6203 82 FMVIEYCPGGELLDHIVERQ----------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
|+||||+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999999997532 34567889999999999999999999999999999999999999999999
Q ss_pred CccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCC
Q psy6203 152 LCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEP 228 (568)
Q Consensus 152 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~ 228 (568)
+++....... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..+.. ..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9875432211 1112234567899999988765 5889999999999999998 7899988888777777765543 445
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhc------Ccccc
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLG------HNWVK 263 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~------hp~~~ 263 (568)
...++.+.+++.+||+.||++|||+.++++ ||||.
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 567889999999999999999999999987 89887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.55 Aligned_cols=253 Identities=28% Similarity=0.469 Sum_probs=214.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc----CCchHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHICKLFQVIETS--SHI 81 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 81 (568)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.++++++||||+++++.+.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 689999999999999999999999999999998754321 12345788899999999999999999998664 468
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL- 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 160 (568)
++||||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987643211
Q ss_pred -ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCChHHHH
Q psy6203 161 -ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEPPWMSPNSRQ 237 (568)
Q Consensus 161 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 237 (568)
........|+..|+|||.+.+.. .+.++|+|||||++|+|++|+.||..........++.... ...+..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 11123346889999999998765 5889999999999999999999998766555444444332 3356678899999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
+|.+||+ +|..||++.+++.|||+
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=331.23 Aligned_cols=245 Identities=30% Similarity=0.562 Sum_probs=209.5
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHH-HhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINAL-KHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||.||+|.+..+|+.||+|++.+..... ....+..|..++ ...+||||+++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999987643321 222344454443 455899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCC
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 170 (568)
++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCC
Confidence 99999998888899999999999999999999999999999999999999999999999998765432 2334688
Q ss_pred ccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCChHHHHHHHHccccC
Q psy6203 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE----PPWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 171 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~L~~d 246 (568)
+.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+..+.... ...+++.+.++|.+||+.|
T Consensus 157 ~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 157 PDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred cCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 9999999998776 6899999999999999999999999888888777776654432 2347899999999999999
Q ss_pred cCCCCC---HHHHhcCccccc
Q psy6203 247 PGKRIK---IQDLLGHNWVKM 264 (568)
Q Consensus 247 P~~Rps---~~ell~hp~~~~ 264 (568)
|++||+ ++|++.||||+.
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHccCCCcHHHHHcChHhhc
Confidence 999995 579999999973
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=335.09 Aligned_cols=253 Identities=21% Similarity=0.322 Sum_probs=211.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46889999999999999999998652 3567999988643322234467889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEee
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ----------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
.++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999999987532 3567788999999999999999999999999999999999999999999
Q ss_pred cCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CC
Q psy6203 151 GLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TE 227 (568)
Q Consensus 151 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~ 227 (568)
|++......... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+.....+.+..+.. ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK 242 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 998754322111 112234577899999998765 5899999999999999999 7899998888777777666544 44
Q ss_pred CCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 228 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+...++.+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 243 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.60 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=210.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET--SSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~ 85 (568)
++|...+.||.|++|.||+|.+..+++.+|+|.+...........+.+|++++++++||||+++++++.+ .+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5799999999999999999999999999999998865443345678899999999999999999998854 34789999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 86 EYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999999887653 3568999999999999999999999999999999999999999999999999976543221
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCC-C------C
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD-----SIDQLYDKILNGKYTE-P------P 229 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~-----~~~~~~~~i~~~~~~~-~------~ 229 (568)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|..||... ...+....+....... + .
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred --cccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 12345788999999987765 588999999999999999999999765 2334444444322111 1 1
Q ss_pred CCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 230 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..++.+.++|.+||..||.+|||+.|++.||||+.
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 24578999999999999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=335.22 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=211.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEc----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHV----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+.|++.+.||+|+||+||+|... .++..+|+|.+...........+.+|+.+++.++||||+++++++...+..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 57899999999999999999853 35578999998754433344578889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeE
Q psy6203 84 VIEYCPGGELLDHIVER-----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK 146 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 146 (568)
||||+++++|.+++..+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 99999999999998532 2477888999999999999999999999999999999999999999
Q ss_pred EEeecCccCCCCCC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q psy6203 147 LIDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK 224 (568)
Q Consensus 147 l~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~ 224 (568)
|+|||++....... ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+...+.+.+....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 243 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987643321 11223344677899999997765 5899999999999999998 999998877777777766554
Q ss_pred C-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 225 Y-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 225 ~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
. +.+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3 3455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=329.99 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=211.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 468999999999999999999864 567899998765332 34678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++...........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999998653 5688999999999999999999999999999999999999999999999999876543222222
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........+..+. .+....++.++.+++.+|
T Consensus 162 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 240 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240 (261)
T ss_pred CCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 2234567899999987765 5889999999999999998 999999888777777776553 233445788999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|..+|++|||++++++
T Consensus 241 l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 241 WKEKAEERPTFDYLQS 256 (261)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=335.00 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=211.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
.++|++.+.||+|++|.||+|.+.. ++..||+|.+...........+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4689999999999999999999987 77889999886543322344678899999999999999999999988899
Q ss_pred EEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC---CeEEEeec
Q psy6203 82 FMVIEYCPGGELLDHIVERQ-------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---NLKLIDFG 151 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG 151 (568)
++||||++|++|.+++...+ .+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999997653 488999999999999999999999999999999999998765 59999999
Q ss_pred CccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCC
Q psy6203 152 LCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEP 228 (568)
Q Consensus 152 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~ 228 (568)
++......... .......+..|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......+... ....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP 243 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 98765321111 111223356899999998766 6899999999999999997 99999988877777666544 33455
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
..++..+.+++.+||+.||++|||+.++++|
T Consensus 244 ~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 244 KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=346.18 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=214.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE---
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSH--- 80 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--- 80 (568)
++.++|++.+.||+|++|.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 5788999999999999999999999999999999998754322 233556789999999999999999988865554
Q ss_pred ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 81 ---IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 81 ---~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799888864 579999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----------- 226 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~----------- 226 (568)
.. .....++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 32 234467889999999876545688999999999999999999999877665544444322110
Q ss_pred --------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 227 --------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 227 --------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.....++.+.++|.+||+.||.+|||+.+++.||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 012358899999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=329.18 Aligned_cols=252 Identities=29% Similarity=0.558 Sum_probs=217.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|.+.+.||+|+||.||+|.++.+|..+|+|.+...... .....+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 589999999999999999999999999999998765332 2345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC-eEEEeecCccCCCCCCcccc
Q psy6203 88 CPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN-LKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 88 ~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~~ 164 (568)
+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +||+|||.+....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccc
Confidence 99999999987643 4789999999999999999999999999999999999988864 6999999987654321 222
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHcc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSML 243 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L 243 (568)
....|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+..+... ..+..+.++.++|.+||
T Consensus 160 ~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred cccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 3346899999999987765 588999999999999999999999887776666666555443 34557889999999999
Q ss_pred ccCcCCCCCHHHHhcCccc
Q psy6203 244 QVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 244 ~~dP~~Rps~~ell~hp~~ 262 (568)
..+|++|||+.|++.||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=326.47 Aligned_cols=252 Identities=31% Similarity=0.559 Sum_probs=222.5
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|.+.+.||.|+||.||++.+..++..||+|++...... .....+..|+++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 689999999999999999999999999999999765432 3456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 88 CPGGELLDHIVER----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 88 ~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 9999999999764 679999999999999999999999999999999999999999999999999987654332 12
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSM 242 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 242 (568)
.....|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..++.......... .+...+..+.+++.+|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred ecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 33456889999999987766 588999999999999999999999888877777777665443 3446889999999999
Q ss_pred cccCcCCCCCHHHHhcCccc
Q psy6203 243 LQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~ 262 (568)
|..+|++|||+.++|+||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=330.43 Aligned_cols=248 Identities=26% Similarity=0.450 Sum_probs=210.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 46889999999999999999876 567899999865432 234677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
++|++|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++............
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999999764 568999999999999999999999999999999999999999999999999987543321111111
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~ 244 (568)
..++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+..+. ...+...++.+.+++.+||.
T Consensus 161 ~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05059 161 TKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH 239 (256)
T ss_pred CCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 22345799999998765 5889999999999999999 899998887777777776653 34455679999999999999
Q ss_pred cCcCCCCCHHHHhcC
Q psy6203 245 VEPGKRIKIQDLLGH 259 (568)
Q Consensus 245 ~dP~~Rps~~ell~h 259 (568)
.+|++|||+.|+++.
T Consensus 240 ~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 240 EKPEDRPAFKKLLSQ 254 (256)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=329.07 Aligned_cols=244 Identities=25% Similarity=0.426 Sum_probs=205.3
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
+.||+|+||.||+|.+..+++.||+|.+......+....+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999999999999999886543333345788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc-ccccCCc
Q psy6203 94 LDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL-QTSCGSP 171 (568)
Q Consensus 94 ~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~~~~gt~ 171 (568)
.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........... ....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 9999764 4689999999999999999999999999999999999999999999999999875432211110 1112345
Q ss_pred cccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHHHccccCcCC
Q psy6203 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQVEPGK 249 (568)
Q Consensus 172 ~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~ 249 (568)
.|+|||.+.+.. ++.++|||||||++|+|++ |..||...+.......+..+ ....+...+..+.+++.+||+.||++
T Consensus 161 ~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 161 KWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred eecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence 699999998766 5889999999999999998 99999877766666666554 33445567899999999999999999
Q ss_pred CCCHHHHhc
Q psy6203 250 RIKIQDLLG 258 (568)
Q Consensus 250 Rps~~ell~ 258 (568)
|||+.+++.
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=342.64 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=215.3
Q ss_pred ccccCeEE-EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-------------hHHHHHHHHHHHhCCCCCcce
Q psy6203 5 DLRNQYIL-ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-------------LPRVKLEINALKHISHQHICK 70 (568)
Q Consensus 5 ~~~~~Y~i-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~Ei~~l~~l~hpnIv~ 70 (568)
++.++|.. .+.||+|+||+||+|.+..+++.||+|++........ ...+.+|+.++++++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 56778865 5779999999999999999999999999875433221 124678999999999999999
Q ss_pred eeEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEee
Q psy6203 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 71 l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
+++++...+..++||||+. |+|.+++.....+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999996 689999988888999999999999999999999999999999999999999999999999
Q ss_pred cCccCCCCC-------------CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHH
Q psy6203 151 GLCAKPEGG-------------LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 217 (568)
Q Consensus 151 G~a~~~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~ 217 (568)
|++...... .........+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998654311 0111223356889999999987665688999999999999999999999887765554
Q ss_pred HHHHcCC--CC--------------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 218 DKILNGK--YT--------------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 218 ~~i~~~~--~~--------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
..+.... .. .....+..+.++|.+||+.||++|||++|++.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 4432210 00 012347789999999999999999999999999999843
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=340.63 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=209.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcE----EEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
++|++.+.||+|+||.||+|.+..+++. ||+|+++..........+..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 5799999999999999999998766654 8999987543333456788899999999999999999998764 5689
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence 99999999999999874 46889999999999999999999999999999999999999999999999998865432211
Q ss_pred -ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHH
Q psy6203 163 -QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIV 239 (568)
Q Consensus 163 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 239 (568)
......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+. .+.++..+.++.+++
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (316)
T cd05108 166 YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 244 (316)
T ss_pred eeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 112223467899999998766 5899999999999999997 999998887776655554443 344566788999999
Q ss_pred HHccccCcCCCCCHHHHhcC
Q psy6203 240 RSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~h 259 (568)
.+||..||.+|||+.+++.+
T Consensus 245 ~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 245 VKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=339.12 Aligned_cols=256 Identities=29% Similarity=0.508 Sum_probs=217.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
....|.....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 34556677789999999999999999999999999875432 23456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 99999999887644 578999999999999999999999999999999999999999999999999986543321 1223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCChHHHHHHHHc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~ 242 (568)
..+|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+..... ......++.+.++|.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 456899999999998766 58899999999999999999999987776666655544322 22335788999999999
Q ss_pred cccCcCCCCCHHHHhcCcccccC
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
|+.+|.+||+++++++||||...
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccC
Confidence 99999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=332.81 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=213.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC-----CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT-----GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
..++|++.+.||+|+||.||+|.+... +..||+|.+...........+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 467899999999999999999988644 378999998654332334567889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEee
Q psy6203 81 IFMVIEYCPGGELLDHIVER----------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 99999999999999998653 23678899999999999999999999999999999999999999999999
Q ss_pred cCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCC
Q psy6203 151 GLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTE 227 (568)
Q Consensus 151 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~ 227 (568)
|+++....... .......++..|+|||.+.+.. ++.++|||||||++|++++ |..||...+..+....+..+. ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCC
Confidence 99875432211 1223345678999999987665 5889999999999999998 999999888888777776553 345
Q ss_pred CCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 228 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+...+..+.+++.+||+.+|++|||+.++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6667899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=335.17 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=212.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
+++|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 468999999999999999999863 345678999886543 22345688899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 82 FMVIEYCPGGELLDHIVERQ-------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
++||||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999997543 48999999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC
Q psy6203 149 DFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT 226 (568)
Q Consensus 149 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~ 226 (568)
|||++........ .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......+..+...
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875433211 1112334577899999998765 5889999999999999998 99999888888888888877643
Q ss_pred -CCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 227 -EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 227 -~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+...++++.+|+.+||+.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44567899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=316.06 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=213.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
|+.+++..||.|+.|+|++++.+.+|...|||.+.+....+..+++...+.++... ++|.||+.+++|..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34456778999999999999999999999999999887767777888888876655 48999999999999999999999
Q ss_pred ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIV-ERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
.+. ..+..++. -.++++|..+-++...+++||.||.+ +||+|||+||+|||+|..|++||||||++....... ..
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah 248 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH 248 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence 983 33444443 25789999999999999999999975 589999999999999999999999999987765432 23
Q ss_pred ccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCC---CCCChHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTEP---PWMSPNSRQI 238 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~---~~~~~~~~~l 238 (568)
....|.+.|||||.+.- .+.|+-.+||||||++++||+||..||.+.+ .-+++..+.+..++.. ..+|+.+++|
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f 328 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF 328 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence 44568999999999853 3457889999999999999999999998843 4466677777555432 2389999999
Q ss_pred HHHccccCcCCCCCHHHHhcCccccc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+..||++|+.+||...++|+|||++.
T Consensus 329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 329 VKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHhhcCcccCcchHHHhcCcceee
Confidence 99999999999999999999999983
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.28 Aligned_cols=255 Identities=29% Similarity=0.375 Sum_probs=214.6
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
.+...+|.+.+.||+|+||+||+|.+..+|+.||+|++...... +....+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 45677899999999999999999999999999999998654322 2235678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
|+||||+. |+|.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99999996 577777654 467999999999999999999999999999999999999999999999999998654322
Q ss_pred ccccccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-C-CCCCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-E-PPWMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~-~~~~~~~~~ 236 (568)
....+++.|+|||++.+ ...++.++||||||+++|+|++|..||...+.......+...... . +...+..+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 23467889999999852 234688999999999999999999999877765554444433222 1 223678899
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++|.+||+.||++||++.+++.||||..
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 9999999999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=342.53 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=204.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc-CCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..|++++.||+||.+.||++..- ..+.||+|.+..... ......+.+|+..|.+|+ |.+||+++++-..++.+|+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 46999999999999999999864 445677765543322 234667899999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc-
Q psy6203 86 EYCPGGELLDHIVERQRL-GEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ- 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l-~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~- 163 (568)
||= ..+|...+.++... +.-.++.+..|++.|+.++|..||||.||||.|+|+ -.|.+||+|||+|.....+....
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccccee
Confidence 986 57999999876553 335888999999999999999999999999999999 46889999999998776543332
Q ss_pred cccccCCccccccccccCcc----------cCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcCC--CCCCCC
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQ----------YYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGK--YTEPPW 230 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~----------~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~~--~~~~~~ 230 (568)
..+.+||+.|||||.+.... ..+.++||||||||||+|+.|+.||..-. ...-+..|.... .+++..
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~ 597 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDI 597 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCC
Confidence 24568999999999985432 14678999999999999999999996532 333344444432 234443
Q ss_pred CChH-HHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 231 MSPN-SRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 231 ~~~~-~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
-+.. +.++++.||..||.+|||+.++|+|||+..
T Consensus 598 ~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 598 PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3333 999999999999999999999999999984
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=334.15 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=211.3
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEe
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS--SHIFMVIE 86 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~E 86 (568)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... .....+.+|+.+++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78999999999999999999999999999999876422 2334677899999999999999999999888 89999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|++ ++|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++............
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 996 4888888765 57999999999999999999999999999999999999999999999999998765443222223
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT------------------- 226 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~------------------- 226 (568)
...++..|+|||.+.+...++.++||||||+++|+|++|+.||...+.......+......
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 3457889999998876655789999999999999999999999887765544444321000
Q ss_pred -----------CCCC-CChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 -----------EPPW-MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 -----------~~~~-~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.... .++.+.+++.+||+.||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=344.87 Aligned_cols=255 Identities=30% Similarity=0.458 Sum_probs=216.7
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc-CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----EEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISHQHICKLFQVIETSS-----HIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~ 82 (568)
+|++.+.||+|++|.||+|.+..+|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++...+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999998999999999876432 234567888999999999999999999987765 789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 161 (568)
+||||++ ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999996 58999998878899999999999999999999999999999999999999999999999999876544321
Q ss_pred -cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--C------------
Q psy6203 162 -SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--T------------ 226 (568)
Q Consensus 162 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~--~------------ 226 (568)
.......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+..+....+..... .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1233446789999999998874578999999999999999999999988776655554433110 0
Q ss_pred -----------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 -----------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 -----------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+.+++.+.++|.+||+.||++|||+++++.||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 01235788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.07 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=207.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
.......||+|+||.||+|.+..++..||+|.+..... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 33445689999999999999999999999998875432 23457889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-CCCeEEEeecCccCCCCCCcccc
Q psy6203 89 PGGELLDHIVER-QRL--GEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 89 ~~g~L~~~i~~~-~~l--~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++...... ....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-~~~~ 166 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-NPCT 166 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC-CCcc
Confidence 999999999764 455 88889999999999999999999999999999999976 678999999998754322 1222
Q ss_pred ccccCCccccccccccCcc-cCCcccceechhhHHHHHHhCCCCCCCCCHH--HHHHH-HHcCCCCCCCCCChHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQ-YYGSETDVWSMGVMLYALLCGFLPFDSDSID--QLYDK-ILNGKYTEPPWMSPNSRQIVR 240 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~~lltG~~pf~~~~~~--~~~~~-i~~~~~~~~~~~~~~~~~li~ 240 (568)
....|++.|+|||++.+.. .++.++|+||+|+++|+|++|..||...... ..... ........+..+++++.+++.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 3345889999999986532 3578999999999999999999999654321 11111 122233455668899999999
Q ss_pred HccccCcCCCCCHHHHhcCccc
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~ 262 (568)
+||+.+|.+|||+.|++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=324.54 Aligned_cols=252 Identities=30% Similarity=0.500 Sum_probs=220.3
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||+|++|.||++.+..+++.||+|.+...... .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 589999999999999999999999999999999866432 2356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
+++++|.+++.....+++..+..++.|++.||.+||+.||+||||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASV 159 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-ccccc
Confidence 99999999998888899999999999999999999999999999999999999999999999999886654322 12345
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCCCCChHHHHHHHHccccC
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-NGKYTEPPWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~L~~d 246 (568)
.++..|+|||.+.+.. ++.++||||+|+++|+|++|..||...+.......+. ......+..+++.+.+++.+||..+
T Consensus 160 ~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 6889999999987766 6889999999999999999999997665444333333 3444556678899999999999999
Q ss_pred cCCCCCHHHHhcCccc
Q psy6203 247 PGKRIKIQDLLGHNWV 262 (568)
Q Consensus 247 P~~Rps~~ell~hp~~ 262 (568)
|++|||+.+++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=327.45 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=211.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|++|.||+|.+. +++.||+|.++.... ....+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3578999999999999999999975 457899999875432 3456888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++++|.+++.... .+++..+..++.|++.||.+||++||+||||||+||+++.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999999997654 68999999999999999999999999999999999999999999999999987654321111
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 241 (568)
......+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+.......+.... .+.+...+..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 11122345799999987765 5889999999999999999 999999888777777776542 33455678999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||+.+|++||++++++.
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=337.81 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=210.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSS----- 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----- 79 (568)
..++|++.+.||+|+||.||+|.++.+|+.||+|+++..... .....+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457899999999999999999999999999999998754322 22346678999999999999999999987654
Q ss_pred -----EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 80 -----HIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 80 -----~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
.+++||||+++ ++.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999975 777777653 46899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---CC-----
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---KY----- 225 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~---~~----- 225 (568)
...............++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+....+... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 7654332222222346788999999876555688999999999999999999999876654444333221 00
Q ss_pred ----------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 ----------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.....+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.62 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=210.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||+||+|.... +..+|+|.+..... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 579999999999999999998753 45699998875432 235688899999999999999999999988899999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+.............
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999999764 468999999999999999999999999999999999999999999999999987543321111112
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~ 244 (568)
..++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+.......+..+... .+...+..+.+++.+||+
T Consensus 161 ~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05113 161 SKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWH 239 (256)
T ss_pred CccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 23556899999998765 5889999999999999998 99999888877777777766443 344568899999999999
Q ss_pred cCcCCCCCHHHHhcC
Q psy6203 245 VEPGKRIKIQDLLGH 259 (568)
Q Consensus 245 ~dP~~Rps~~ell~h 259 (568)
.||.+|||+.+++.+
T Consensus 240 ~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 240 EKAEERPTFQQLLSS 254 (256)
T ss_pred CCcccCCCHHHHHHh
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=336.26 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=209.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCc--EEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGE--KVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||.||+|....++. .+++|.++..........+.+|+.+++++ +||||+++++++...+..|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999877765 46888876433223345688899999999 799999999999999999999
Q ss_pred EeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 85 IEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
|||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999997542 47889999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-C
Q psy6203 149 DFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-T 226 (568)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~ 226 (568)
|||++....... .......+..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+..+.. .
T Consensus 162 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 162 DFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred CcCCCcccccee--ccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999986432211 111122355799999987765 5889999999999999997 9999998888887777766533 3
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+..+++.+.+|+.+||+.||.+|||++++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 455688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.86 Aligned_cols=252 Identities=26% Similarity=0.458 Sum_probs=212.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCC-----cEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTG-----EKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 80 (568)
.++|++.+.||+|+||.||++.+...+ ..+|+|.+...........+.+|+.+++++ +||||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 478999999999999999999976443 689999987654333445678899999999 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN 144 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 144 (568)
+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe
Confidence 99999999999999998642 45889999999999999999999999999999999999999999
Q ss_pred eEEEeecCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q psy6203 145 LKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILN 222 (568)
Q Consensus 145 ~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~ 222 (568)
+||+|||++......... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 249 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence 999999998764432111 111223456899999987665 5889999999999999997 9999998888887777766
Q ss_pred CCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 223 GKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 223 ~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+.. ..+...+..+.+|+.+||..||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 250 GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 543 3455678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=338.25 Aligned_cols=253 Identities=25% Similarity=0.447 Sum_probs=212.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcC-------CCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVL-------TGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET 77 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 77 (568)
..++|.+.+.||+|+||.||+|.+.. ++..+|+|.+...........+..|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 35789999999999999999998643 23569999987653333455678899999999 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR 141 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 141 (568)
.+..|+||||+++|+|.+++.... .++..++..++.|++.||+|||++|++||||||+||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 999999999999999999997642 4788899999999999999999999999999999999999
Q ss_pred CCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6203 142 NQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219 (568)
Q Consensus 142 ~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~ 219 (568)
++.+||+|||.+........ .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 99999999999875432111 1111223456899999998765 5889999999999999998 8999998888887777
Q ss_pred HHcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 220 ILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 220 i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+.. ..+...+.++.+|+.+||..+|.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 766643 4556688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.62 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=204.7
Q ss_pred CeEEEeeecccCCeEEEEEEEcC--CCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVL--TGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETS--SHIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~ 82 (568)
+|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+. +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 899999999986431 12235677899999999999999999999888 8899
Q ss_pred EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC----CCCeEEEeecCc
Q psy6203 83 MVIEYCPGGELLDHIVER-----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR----NQNLKLIDFGLC 153 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~----~~~~kl~DFG~a 153 (568)
+||||++ ++|.+.+... ..+++..++.++.||+.||.|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 4777776432 36899999999999999999999999999999999999999 899999999998
Q ss_pred cCCCCCCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH---------HHHHHHc
Q psy6203 154 AKPEGGLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ---------LYDKILN 222 (568)
Q Consensus 154 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~---------~~~~i~~ 222 (568)
........ .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+..... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76533221 122334678999999998776556889999999999999999999997543221 0000000
Q ss_pred --------------------------CCCCCC-----------CCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 223 --------------------------GKYTEP-----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 223 --------------------------~~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.....+ ...+..+.++|.+||+.||++|||+.|++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000011 1356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.40 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=210.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6899999999999999999999999999999988754322 22345788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 86 EYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 99999999988853 3458999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCC--CCCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILNGKYTE--PPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~--~~~~~~~i~~~~~~~--~~~~~~~~~~ 237 (568)
.......|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.... .......+.....+. ....+..+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred HHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 1223446889999999998766 5889999999999999999999996543 345555555444332 2246788999
Q ss_pred HHHHccccCcCCCCCHHHHhcC
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~h 259 (568)
++.+||+.+|++|||+.++++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.12 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=207.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCC-----CcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLT-----GEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETS 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~ 78 (568)
--.++|++++.||+|+||.||+|.+... +..||+|++.........+.+.+|+.++++++ ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 3467899999999999999999987533 34699999976543334567889999999996 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q psy6203 79 SHIFMVIEYCPGGELLDHIVER---------------------------------------------------------- 100 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~---------------------------------------------------------- 100 (568)
+..|+|||||++|+|.+++..+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988642
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC
Q psy6203 101 --------------------------------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142 (568)
Q Consensus 101 --------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 142 (568)
..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999999
Q ss_pred CCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHH-HHHHH
Q psy6203 143 QNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID-QLYDK 219 (568)
Q Consensus 143 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~-~~~~~ 219 (568)
+.+||+|||++........ .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...... .....
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999875432211 1122335678899999998765 5899999999999999997 99999775443 33444
Q ss_pred HHcC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 220 ILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 220 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+..+ ....+...+.++.+++.+||+.||++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4444 23345568899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=343.93 Aligned_cols=235 Identities=23% Similarity=0.411 Sum_probs=204.6
Q ss_pred EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCC
Q psy6203 13 ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGE 92 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~ 92 (568)
++=||+|+.|-||+|+. .++.||||.++.. -+.+|+.|++|+||||+.|.++|.....+|||||||..|.
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 45589999999999985 5789999987532 2357899999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCcc
Q psy6203 93 LLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN 172 (568)
Q Consensus 93 L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~ 172 (568)
|...++....++......+..+|+.|++|||.+.|||||||.-||||..+..|||+|||-++..... +....++||..
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVa 276 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVA 276 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHh
Confidence 9999999999999999999999999999999999999999999999999999999999988765432 45567899999
Q ss_pred ccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 173 y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
|||||++.+.+ .+.|+|||||||+|||||||..||..-+...++--+-.. .++.|...++.++=||++||+-.|..|
T Consensus 277 WMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 277 WMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred hhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 99999999887 599999999999999999999999755433322222111 345677788999999999999999999
Q ss_pred CCHHHHhcCc
Q psy6203 251 IKIQDLLGHN 260 (568)
Q Consensus 251 ps~~ell~hp 260 (568)
|++.+||.|-
T Consensus 356 PSFrqil~Hl 365 (904)
T KOG4721|consen 356 PSFRQILLHL 365 (904)
T ss_pred ccHHHHHHHH
Confidence 9999999983
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=327.49 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=208.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.++||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.++++++||||+++++.+.. +..++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 357899999999999999999988655 4699999875432 23568889999999999999999998754 5679999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||.+..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999999753 458899999999999999999999999999999999999999999999999987554322112
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 241 (568)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+..+. ...+...+..+.+++.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 22334667899999987666 5889999999999999999 899998887777777766543 33445688999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||+.||++|||+.++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=331.86 Aligned_cols=256 Identities=31% Similarity=0.495 Sum_probs=221.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+..+.|++.+.||+|++|.||+|.+..++..||+|++..... ....+..|+.+++.++|+||+++++.+...+..|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 567789999999999999999999998999999999976543 455788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
+||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 172 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SK 172 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-hh
Confidence 99999999999998876 89999999999999999999999999999999999999999999999999876543321 12
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIVR 240 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~ 240 (568)
.....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+...... .+..++..+.++|.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 23345788999999988765 588999999999999999999999887766555555443322 22237889999999
Q ss_pred HccccCcCCCCCHHHHhcCccccc
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||+.+|.+|||+.+++.|+||+.
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=335.87 Aligned_cols=258 Identities=30% Similarity=0.483 Sum_probs=217.2
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+..++|++.+.||+|+||.||++.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..|+
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 3456899999999999999999999988999999999864332 234567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|+||+++++|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-~~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc-cc
Confidence 9999999999998865 458899999999999999999999999999999999999999999999999876544322 12
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc-CCC--CCCCCCChHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN-GKY--TEPPWMSPNSRQIVR 240 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~-~~~--~~~~~~~~~~~~li~ 240 (568)
.....|++.|+|||.+.+.. ++.++|+|||||++|++++|..||...+.......+.. +.. ..+..++..+.++|.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred cccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 23346889999999987765 58899999999999999999999987665433332222 222 223346788999999
Q ss_pred HccccCcCCCCCHHHHhcCcccccC
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
+||..+|++||++.+++.|+||+..
T Consensus 251 ~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred HHccCChhhCcCHHHHhcCHHHhcC
Confidence 9999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=344.12 Aligned_cols=253 Identities=25% Similarity=0.457 Sum_probs=205.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe-C
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET-S 78 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-~ 78 (568)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.........+.+..|+.++.++ +||||+++++++.. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3578999999999999999999754 345789999987543333345677899999999 79999999998764 4
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q psy6203 79 SHIFMVIEYCPGGELLDHIVER---------------------------------------------------------- 100 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~---------------------------------------------------------- 100 (568)
..++++|||+++++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5789999999999999998642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc-ccccccCCcccccc
Q psy6203 101 ---QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAP 176 (568)
Q Consensus 101 ---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aP 176 (568)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788999999999999999999999999999999999999999999999998764332111 12233456789999
Q ss_pred ccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCC-CCCCCCChHHHHHHHHccccCcCCCCCH
Q psy6203 177 EVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQ-LYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKI 253 (568)
Q Consensus 177 E~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~-~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~ 253 (568)
|++.+.. ++.++|||||||++|+|++ |..||.+....+ ....+..+.. ..+...++++.+++.+||+.+|++||++
T Consensus 245 E~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 9998776 5899999999999999998 999997654333 3344444332 3345578899999999999999999999
Q ss_pred HHHhcC
Q psy6203 254 QDLLGH 259 (568)
Q Consensus 254 ~ell~h 259 (568)
+|+++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.99 Aligned_cols=245 Identities=39% Similarity=0.720 Sum_probs=219.8
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
||+|+||.||++.+..+++.+|+|++.+..... ....+..|+.++++++||||+++++.++.++..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999999899999999988764432 345788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCccc
Q psy6203 94 LDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNY 173 (568)
Q Consensus 94 ~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y 173 (568)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccc
Confidence 9999888889999999999999999999999999999999999999999999999999987654321 123345688899
Q ss_pred cccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCCCH
Q psy6203 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKI 253 (568)
Q Consensus 174 ~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 253 (568)
+|||.+.+.. .+.++|+||||+++|++++|..||...+..+....+.......+...+..+.++|++||..||++||++
T Consensus 160 ~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~ 238 (250)
T cd05123 160 LAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGS 238 (250)
T ss_pred cChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence 9999987765 588999999999999999999999888877778888877778888889999999999999999999999
Q ss_pred ---HHHhcCccc
Q psy6203 254 ---QDLLGHNWV 262 (568)
Q Consensus 254 ---~ell~hp~~ 262 (568)
+++++||||
T Consensus 239 ~~~~~l~~~~~f 250 (250)
T cd05123 239 GGAEEIKAHPFF 250 (250)
T ss_pred ccHHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=341.31 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=209.9
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC----
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS---- 78 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 78 (568)
..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.... .....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 35678999999999999999999999999999999998754322 2245677899999999999999999988543
Q ss_pred --CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 79 --SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 79 --~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
...|++++++ +++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478899887 7899887754 56999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY----------- 225 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~----------- 225 (568)
.. ......+++.|+|||.+.+...++.++|||||||++|+|++|..||...+.......+.....
T Consensus 171 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 171 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 32 223446789999999987755568899999999999999999999977654443332221100
Q ss_pred ------------CC--------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ------------TE--------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ------------~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.. ....++++.++|.+||+.||.+|||+.++++||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00 0125788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=325.80 Aligned_cols=245 Identities=25% Similarity=0.444 Sum_probs=214.7
Q ss_pred eeecccCCeEEEEEEEcCC---CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||.||+|.+... +..||+|++...........+..|+.+++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999866 8899999998665444466788999999999999999999999999999999999999
Q ss_pred CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 91 GELLDHIVER---------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 91 g~L~~~i~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999875 7799999999999999999999999999999999999999999999999999876543211
Q ss_pred -cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 -SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
.......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..++.+.+..+. ...+..+++++.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL 239 (262)
T ss_pred cccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence 1223345788999999988765 6899999999999999999 699999988888888877653 34566789999999
Q ss_pred HHHccccCcCCCCCHHHHhcC
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~h 259 (568)
+.+||+.||.+|||+.|++.+
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=335.43 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=207.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|+..+.||+|+||.||++.+..+++.||+|.+...........+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 456778899999999999999999999999999876544444557788999999996 9999999999999999999999
Q ss_pred ccCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 87 YCPGGELLDHI---V--ERQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 87 ~~~~g~L~~~i---~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
|+. +++.++. . ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 985 4554433 2 236799999999999999999999975 99999999999999999999999999987543321
Q ss_pred ccccccccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC-C----CCCCC
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYT-E----PPWMS 232 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~-~----~~~~~ 232 (568)
......|++.|+|||++.+. ..++.++||||+||++|+|++|+.||..... .+....+..+..+ . +..++
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 163 --AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred --ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 11234688999999999766 3568899999999999999999999976542 1222233222221 1 12378
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.++.+||.+||+.||++|||+++++.||||+.
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 89999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.72 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=206.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeC-------
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETS------- 78 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------- 78 (568)
.++|++.+.||+|+||.||+|.+..+++.+|+|++......+ ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 579999999999999999999999999999999987554322 234567899999999999999999987443
Q ss_pred -CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 79 -SHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 79 -~~~~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
..+++||||+. ++|...+.. ...+++..+..++.||++||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 35799999995 467776654 457999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcc----------ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-
Q psy6203 157 EGGLES----------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY- 225 (568)
Q Consensus 157 ~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~- 225 (568)
...... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.....+.+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 322111 112235688899999987665568899999999999999999999987776554444322100
Q ss_pred ----------------------CCC-------CCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 226 ----------------------TEP-------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 226 ----------------------~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..+ ...++.+.++|.+||+.||.+|||+.|++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 1244678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=321.20 Aligned_cols=249 Identities=33% Similarity=0.526 Sum_probs=215.2
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
+|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 58899999999999999999998999999999976543 34567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 89 PGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 89 ~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
++++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~ 157 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM 157 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence 999999998776 6899999999999999999999999999999999999999999999999999876554321 3445
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCC--CCCChHHHHHHHHccc
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEP--PWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~--~~~~~~~~~li~~~L~ 244 (568)
.++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+..... ..+ ..++..+.++|.+||+
T Consensus 158 ~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 158 VGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred ecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 6889999999998766 58899999999999999999999987754444434333222 222 2237899999999999
Q ss_pred cCcCCCCCHHHHhcCcc
Q psy6203 245 VEPGKRIKIQDLLGHNW 261 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~ 261 (568)
.||++|||+.|++.|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=326.22 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=209.1
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.++||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++||||+++++++. .+..|+||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 4578999999999999999999875 567799999876443 2356889999999999999999999885 45689999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999998763 458999999999999999999999999999999999999999999999999987644322111
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 241 (568)
.....++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||.+.+..+....+..+ ..+.+...+..+.+|+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred ccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 22223566899999987665 5889999999999999999 89999888877777777654 334455678999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||..||++|||++++.+
T Consensus 239 ~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 239 CWKKDPEERPTFEYLQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=346.01 Aligned_cols=253 Identities=32% Similarity=0.587 Sum_probs=232.4
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
+.+++..||-|+||.|-++..+.....+|+|++++..+-+ ..+.+..|-.+|...+.|.||++|-.|.++.++|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4567889999999999999977666669999999877643 35567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
-|-||+|+..++.++.|.+..++.++..+++|+.|||++|||.|||||+|++++.+|.+||.|||+|+....+ ...-+
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~KTwT 578 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RKTWT 578 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC--Cceee
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987764 45678
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~ 244 (568)
+||||.|.|||++.+.. .+.++|.||||+++|||++|.+||.+.+....+..|+.| ...+|..++..+.+||+++..
T Consensus 579 FcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred ecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence 99999999999999877 489999999999999999999999999999999999988 456788899999999999999
Q ss_pred cCcCCCCC-----HHHHhcCccccc
Q psy6203 245 VEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps-----~~ell~hp~~~~ 264 (568)
.+|.+|.. +.||-.|.||..
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhhhc
Confidence 99999986 899999999973
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=327.80 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=211.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCc---EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||.||+|.+..++. .+|+|.++..........+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 579999999999999999999875543 69999887544333456788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 9999999999999764 568999999999999999999999999999999999999999999999999987654322111
Q ss_pred cc--cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHH
Q psy6203 164 LQ--TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIV 239 (568)
Q Consensus 164 ~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 239 (568)
.. ...++..|+|||.+.+.. ++.++|+|||||++|++++ |..||...+..+....+..+. .+.+...++.+.+++
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM 242 (267)
T ss_pred eecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHH
Confidence 11 122356899999998765 5899999999999999886 999998877777777776653 233445788999999
Q ss_pred HHccccCcCCCCCHHHHhc
Q psy6203 240 RSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~ 258 (568)
.+||+.+|.+|||+.++++
T Consensus 243 ~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 243 LDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHcccCchhCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=334.67 Aligned_cols=253 Identities=24% Similarity=0.430 Sum_probs=211.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcC-------CCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVL-------TGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIE 76 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 76 (568)
...++|.+.+.||+|+||.||+|++.. .+..+|+|.+...........+..|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 345789999999999999999998642 34579999987543333455678899999999 5999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc
Q psy6203 77 TSSHIFMVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD 140 (568)
Q Consensus 77 ~~~~~~lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 140 (568)
..+..|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999999753 2478889999999999999999999999999999999999
Q ss_pred CCCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHH
Q psy6203 141 RNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYD 218 (568)
Q Consensus 141 ~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~ 218 (568)
.++.+||+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999876532211 1112223456899999998765 5889999999999999999 899999888888888
Q ss_pred HHHcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 219 KILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 219 ~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+..+.. ..+...+.++.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7776643 345567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=360.11 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=195.2
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCC-cEEEEEEe--------------ecCC-c-CCchHHHHHHHHHHHhCCCCCc
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTG-EKVAIKIM--------------KKAT-L-GEDLPRVKLEINALKHISHQHI 68 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~-~~vavK~~--------------~~~~-~-~~~~~~~~~Ei~~l~~l~hpnI 68 (568)
+.++|++++.||+|+||+||+|..+... ...+.|.+ .+.. . ......+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998765432 22222211 1100 0 1123457889999999999999
Q ss_pred ceeeEEEEeCCEEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC
Q psy6203 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVER-----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ 143 (568)
Q Consensus 69 v~l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 143 (568)
+++++++...+..|+|||++ +++|.+++... .......++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 56787776542 2344677889999999999999999999999999999999999
Q ss_pred CeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCC-CCCC--C-HHHHHHH
Q psy6203 144 NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP-FDSD--S-IDQLYDK 219 (568)
Q Consensus 144 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~p-f~~~--~-~~~~~~~ 219 (568)
.+||+|||++..............+||+.|+|||++.+.. ++.++|||||||++|+|++|..+ |... . ..++.+.
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999999765443222333467999999999998776 58999999999999999998754 4322 1 2222222
Q ss_pred HHcC---------------------CCC-----C-----CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 220 ILNG---------------------KYT-----E-----PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 220 i~~~---------------------~~~-----~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+... .+. . ...++.++.++|.+||++||.+|||+.|+|.||||..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 1110 000 0 0124567888999999999999999999999999974
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=324.44 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=210.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
-+.++|++.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 45789999999999999999999864 678899999875443 3457888999999999999999999874 4568999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||+++++|.+++... ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999999998753 46899999999999999999999999999999999999999999999999998765422111
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVR 240 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 240 (568)
......++..|+|||++.+.. ++.++||||||+++|+|++ |++||.+.+..+....+..+. .+.+...+.++.+++.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred cccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 222334567899999987665 5889999999999999999 999999888777777766553 2344557889999999
Q ss_pred HccccCcCCCCCHHHHhc
Q psy6203 241 SMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~ 258 (568)
+||+.+|++|||++++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 238 LCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHccCChhhCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=330.94 Aligned_cols=256 Identities=32% Similarity=0.567 Sum_probs=216.2
Q ss_pred CeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcC---CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLG---EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHI 81 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 81 (568)
+|++.+.||+|++|.||++.+. .+++.||+|++++.... .....+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46788999998754321 2235677899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|+||||+++++|.+.+.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccccCCccccccccccCcc-cCCcccceechhhHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCChHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQ-YYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSR 236 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~~lltG~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (568)
.......|+..|+|||.+.+.. ..+.++||||||+++|+|++|..||... ...++.+.+.......+..+++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 2223346899999999986543 3478899999999999999999999643 2344455566666667777899999
Q ss_pred HHHHHccccCcCCCCC---HHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIK---IQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps---~~ell~hp~~~~ 264 (568)
++|.+||+.||++||| +.++|+||||+.
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 9999999999999998 567799999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=329.03 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=210.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCc----EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.++|++.+.||+|+||+||+|.+..+|. .||+|++...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 3689999999999999999999877776 48999987554333455778899999999999999999998754 578
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999999999764 5699999999999999999999999999999999999999999999999999876543211
Q ss_pred c-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 S-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
. ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.......+...+..+. .+.+...++++.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMI 243 (279)
T ss_pred eeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHH
Confidence 1 111223467899999997765 5889999999999999998 999998877777766666653 34456688999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~ 258 (568)
+.+||+.||++||++.+++.
T Consensus 244 i~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 244 MVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.37 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=212.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCC-----CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLT-----GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.+|++.+.||+|+||.||+|.+..+ +..||+|++...........+..|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4578899999999999999987543 57899999875432223456788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeE
Q psy6203 83 MVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK 146 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 146 (568)
+++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 999999999999998532 3478888999999999999999999999999999999999999999
Q ss_pred EEeecCccCCCCCC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q psy6203 147 LIDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK 224 (568)
Q Consensus 147 l~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~ 224 (568)
|+|||+++...... ........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+..+.+..+.
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987543221 11223344678999999987666 5889999999999999998 889999888888888887776
Q ss_pred CC-CCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 225 YT-EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 225 ~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.. .+...+..+.+++.+||+.+|.+||++++|+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 53 456688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=322.00 Aligned_cols=253 Identities=30% Similarity=0.487 Sum_probs=218.3
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS--SHIFMVI 85 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~ 85 (568)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ...+.+.+|+.++++++||||+++++.+... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 588999999999999999999999999999998765432 2356788999999999999999999999888 8999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc-cc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES-QL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~ 164 (568)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765543210 12
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHc--CCCCCCCCCChHHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILN--GKYTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~--~~~~~~~~~~~~~~~li~~ 241 (568)
....++..|+|||.+.+.. .+.++||||||+++|+|++|..||.... .......+.. .....+...+..+.++|.+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 239 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239 (260)
T ss_pred cCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence 3456889999999998766 5889999999999999999999997765 3333333332 2334556678999999999
Q ss_pred ccccCcCCCCCHHHHhcCccc
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~ 262 (568)
||+.||++||++.|++.||||
T Consensus 240 ~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 240 CLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.32 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=214.5
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
-.++|++.+.||.|+||.||+|.+.. +..+|+|++..... .....+..|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 45689999999999999999999977 88999999876542 23456888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+........ .
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~ 160 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-L 160 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-c
Confidence 999999999999753 4689999999999999999999999999999999999999999999999999876543211 1
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 241 (568)
.....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+..+ ..+.+...++.+.+++.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred ccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHH
Confidence 12334567899999987765 5889999999999999998 89999888877777777654 334556788999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||+.||.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 240 CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.88 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=208.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCc----EEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEe-CCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIET-SSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~ 80 (568)
...|++++.||+|+||.||+|..+.++. .+|+|.++....... ....-+|+.+++.|+||||+.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3579999999999999999997665543 689999886643322 3456789999999999999999999876 788
Q ss_pred EEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC----CCeEEEeec
Q psy6203 81 IFMVIEYCPGGELLDHIVE-----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN----QNLKLIDFG 151 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~----~~~kl~DFG 151 (568)
+++++||.+ -+|++.|.- .+.++...++.|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999996 589998863 2468999999999999999999999999999999999999877 899999999
Q ss_pred CccCCCCCCcc--ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH---------HHHHHHH
Q psy6203 152 LCAKPEGGLES--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---------DQLYDKI 220 (568)
Q Consensus 152 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~---------~~~~~~i 220 (568)
+++........ .....+.|.+|.|||++.|...|+++.||||+|||+.||+|-.+.|.+... .....+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99876654322 223446799999999999999999999999999999999998888754311 1122222
Q ss_pred Hc--CCCCC---------C--------------------------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 221 LN--GKYTE---------P--------------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 221 ~~--~~~~~---------~--------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.+ |.+.. | ..-++...+|+.+||++||.+|+|++++|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 21 11110 0 11355688999999999999999999999999998
Q ss_pred cCC
Q psy6203 264 MGP 266 (568)
Q Consensus 264 ~~~ 266 (568)
..+
T Consensus 342 ~d~ 344 (438)
T KOG0666|consen 342 EDP 344 (438)
T ss_pred cCC
Confidence 543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=330.12 Aligned_cols=247 Identities=31% Similarity=0.519 Sum_probs=205.7
Q ss_pred EEEeeecccCCeEEEEEEEc----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 11 ILERTVGSGGFAKVKLATHV----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.+.+.||.|+||.||+|... ..+..|+||.++.....+....+.+|++.+++++||||+++++++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 47899999999999999987 44678999999654333346788899999999999999999999998888999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC-Cccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG-LESQ 163 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~ 163 (568)
|+++|+|.+++... ..+++.....++.||+.||.|||+++++|+||+++||+++.++.+||+|||++...... ....
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999886 78999999999999999999999999999999999999999999999999998765221 1112
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 241 (568)
.....+...|+|||.+.+.. ++.++||||||+++|||++ |..||...+..++...+..+.. ..+...+..+.++|.+
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp STTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHH
Confidence 23334677899999998766 5899999999999999999 7899998888888888876654 3455689999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||..||++|||+.++++
T Consensus 241 C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HT-SSGGGS--HHHHHH
T ss_pred HcCCChhhCcCHHHHHh
Confidence 99999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=333.29 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=208.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 80 (568)
.++|.+.+.||+|+||.||+|.+. .++..||+|.++........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 468999999999999999999752 345689999987654334456788999999999 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
.|+||||+.+|+|.+++.... .+++.++..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++.....
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999997643 389999999999999999999999999999999999999999999999999876543
Q ss_pred CCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHH-HHHcCC-CCCCCCCChH
Q psy6203 159 GLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYD-KILNGK-YTEPPWMSPN 234 (568)
Q Consensus 159 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~-~i~~~~-~~~~~~~~~~ 234 (568)
.... ......++..|+|||.+.+.. ++.++||||+||++|+|++ |..||.......... .+..+. ...+...++.
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHH
Confidence 2111 112234577899999998766 5889999999999999998 999998766544433 333332 2334567899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.+++.+||..+|++|||+.|++.
T Consensus 273 ~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 273 IYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=332.15 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=210.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCC----------------cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcce
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTG----------------EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~ 70 (568)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...........+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999876544 4589999876543334567888999999999999999
Q ss_pred eeEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE
Q psy6203 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQ-----------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL 139 (568)
Q Consensus 71 l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 139 (568)
+++++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999997755 68999999999999999999999999999999999999
Q ss_pred cCCCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh--CCCCCCCCCHHHH
Q psy6203 140 DRNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC--GFLPFDSDSIDQL 216 (568)
Q Consensus 140 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt--G~~pf~~~~~~~~ 216 (568)
+.++.++|+|||++........ .......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+.
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 9999999999999875432211 1122345678899999987765 5899999999999999998 7889987776666
Q ss_pred HHHHHcC--------CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 217 YDKILNG--------KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 217 ~~~i~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...+... ....+...+.++.+++.+||+.||.+|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 5555432 11233456789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=323.28 Aligned_cols=250 Identities=30% Similarity=0.506 Sum_probs=220.4
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... .....+..|+.++++++||||+++++++.+....|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 589999999999999999999999999999998765432 2345667899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 88 CPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 88 ~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence 999999999866 356899999999999999999999999999999999999999999999999998765443 2
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSM 242 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 242 (568)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..++...+..+.++ .+...+.++.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred cccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence 23356889999999998765 588999999999999999999999998888777777766654 3456788999999999
Q ss_pred cccCcCCCCCHHHHhcCccc
Q psy6203 243 LQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~ 262 (568)
|+.+|++|||+.++++||++
T Consensus 237 l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 237 LQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred cCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=338.41 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=209.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+....+ ....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 45689999999999999999999999999999999987643222 234577899999999999999999998654
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 79 -SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 79 -~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
..+|+||||+. .+|...+ ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 35699999995 4676654 3468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK------------- 224 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~------------- 224 (568)
.. .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 169 AE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 21 2234678899999998765446889999999999999999999998876544433332210
Q ss_pred ----------CCC--------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 225 ----------YTE--------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 225 ----------~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
... .+..++.+.+||.+||+.||.+||++++++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 12357789999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=324.70 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=204.5
Q ss_pred eecccCCeEEEEEEE--cCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCC
Q psy6203 15 TVGSGGFAKVKLATH--VLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 15 ~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 91 (568)
.||+|+||.||+|.. ..++..+|+|+++...... ..+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 689999999999964 4577899999987543322 24567889999999999999999998854 5678999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc--ccccccC
Q psy6203 92 ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES--QLQTSCG 169 (568)
Q Consensus 92 ~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~g 169 (568)
+|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ......+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 99999988888999999999999999999999999999999999999999999999999998765432211 1122234
Q ss_pred CccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccccCc
Q psy6203 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEP 247 (568)
Q Consensus 170 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP 247 (568)
+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..++.+.+..+.. +.+...++++.++|.+||+.||
T Consensus 161 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p 239 (257)
T cd05116 161 PVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239 (257)
T ss_pred CccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence 67899999987655 5889999999999999998 9999998888788777776643 4566789999999999999999
Q ss_pred CCCCCHHHHhc
Q psy6203 248 GKRIKIQDLLG 258 (568)
Q Consensus 248 ~~Rps~~ell~ 258 (568)
++||++++|..
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05116 240 DERPGFAVVEL 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=329.35 Aligned_cols=250 Identities=30% Similarity=0.474 Sum_probs=208.6
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecc
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
|++.+.||+|++|+||+|....+++.||+|.+.............+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999988999999999876543323334557899999999 999999999999999999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 89 PGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 89 ~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+|+|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCcCC
Confidence 889999887764 7899999999999999999999999999999999999999999999999998765432 12234
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------CCC-
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-------------------KYT- 226 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-------------------~~~- 226 (568)
..++..|+|||++.+...++.++|+||||+++++|++|++||...+.......+... ...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 568889999999876555688999999999999999999999776554433322210 000
Q ss_pred ----------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 ----------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 ----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..+..++.+.++|.+||+.||++|||++|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=362.22 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=204.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.++||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999987543222 2356888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 86 EYCPGGELLDHIVER-----------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 86 E~~~~g~L~~~i~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
||++|++|.+++... ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999988641 234566788999999999999999999999999999999999999999999987
Q ss_pred CCCCCC-----------------ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHH
Q psy6203 155 KPEGGL-----------------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 217 (568)
Q Consensus 155 ~~~~~~-----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~ 217 (568)
...... .......+||+.|+|||++.+.. ++.++|||||||++|+|+||..||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 542110 00112346999999999998776 589999999999999999999999876544332
Q ss_pred HHHHcCCC---CCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 218 DKILNGKY---TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 218 ~~i~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
........ .....+++.+.+++.+||+.||++|++..+.+.
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22111111 112347889999999999999999987666554
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.60 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=213.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCC-----CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLT-----GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
++|++.+.||+|+||.||+|+.+.+ .+.+|+|.+...........+.+|+.++++++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 6899999999999999999997643 46799998865443324567889999999999999999999999989999
Q ss_pred EEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 83 MVIEYCPGGELLDHIVERQ---------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999998655 6899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC--CCCC
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT--EPPW 230 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~--~~~~ 230 (568)
...............+++.|+|||.+.+.. .+.++||||||+++|+|++ |..||...........+..+... .+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC
Confidence 654332222233445677899999987665 5789999999999999998 88999877777777777655543 3456
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+..+.+++.+||+.||.+|||+.|++.+
T Consensus 244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 78999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=340.29 Aligned_cols=258 Identities=30% Similarity=0.446 Sum_probs=211.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc-CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeC--CE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHI-SHQHICKLFQVIETS--SH 80 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--~~ 80 (568)
.+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+..... ......+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 467899999999999999999999998999999998864322 12334567899999999 999999999998643 46
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
.|+||||++ ++|.+++..+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999996 5898888665 78999999999999999999999999999999999999999999999999987543322
Q ss_pred c----cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------
Q psy6203 161 E----SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK------------ 224 (568)
Q Consensus 161 ~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~------------ 224 (568)
. .......|++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 122334689999999998766556889999999999999999999997765443332221110
Q ss_pred ---------------C----CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 225 ---------------Y----TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 225 ---------------~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. ...+..+.++.++|.+||+.||++|||+.++++|||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 0 011236788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.11 Aligned_cols=252 Identities=25% Similarity=0.446 Sum_probs=218.4
Q ss_pred ccCe-EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecC---CcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE--
Q psy6203 7 RNQY-ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKA---TLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH-- 80 (568)
Q Consensus 7 ~~~Y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-- 80 (568)
.++| +...+||+|+|-+||+|.|..+|..||--.++.. ...+..+++..|+.+|+.|+||||+++|++|.+...
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3455 4567899999999999999999999885444322 223456789999999999999999999999987655
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCceEEcCC-CCeEEEeecCccCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL--GYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPE 157 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 157 (568)
+.+|+|++..|+|..++++.++++...++.|++||++||.|||++ .|+|||||-+||+|+.+ |.|||+|+|+|+...
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 889999999999999999999999999999999999999999988 59999999999999755 899999999998765
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC--CCCCChH
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKYTE--PPWMSPN 234 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~~~~i~~~~~~~--~~~~~~~ 234 (568)
.. ......|||.|||||+... .|+..+||||||+++.||+|+..||.. .+..++++++..|..+. ...-.|+
T Consensus 198 ~s---~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 198 KS---HAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred cc---ccceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 43 3345689999999999973 379999999999999999999999965 56788999999987653 2335799
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+++||.+||.. ..+|+|+.|+|.||||..
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 99999999999 999999999999999985
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=323.07 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=212.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 4678999999999999999999975 557899999875432 3457889999999999999999999999888999999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999999764 368999999999999999999999999999999999999999999999999987654321111
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 241 (568)
.....++..|+|||.+.+.. ++.++||||+||++|+|++ |+.||.+.+.......+..+. .+.+...+.++.+++.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 12223456899999998765 5889999999999999998 999999888877777776653 34455678899999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||+.+|++||+++++++
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=323.19 Aligned_cols=243 Identities=24% Similarity=0.404 Sum_probs=205.8
Q ss_pred eeecccCCeEEEEEEEcCCC---cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTG---EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
++||+|+||.||+|....++ ..+|+|.+...........+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876554 7899999876654334567888999999999999999999876 4567999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc--cccc
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL--QTSC 168 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~--~~~~ 168 (568)
++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 99999998888899999999999999999999999999999999999999999999999999876543221111 1112
Q ss_pred CCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccccC
Q psy6203 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 169 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~d 246 (568)
++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..++...+..+.. ..+...++.+.++|.+||..|
T Consensus 160 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 238 (257)
T cd05060 160 WPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYR 238 (257)
T ss_pred ccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 346799999997765 5889999999999999998 9999988887777777766543 455668899999999999999
Q ss_pred cCCCCCHHHHhc
Q psy6203 247 PGKRIKIQDLLG 258 (568)
Q Consensus 247 P~~Rps~~ell~ 258 (568)
|++|||+.++++
T Consensus 239 p~~Rp~~~~l~~ 250 (257)
T cd05060 239 PEDRPTFSELES 250 (257)
T ss_pred hhhCcCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=334.61 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=207.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCC--CcEEEEEEeecCCcC-CchHHHHHHHHHHHhC-CCCCcceeeEEEEe----CCE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLT--GEKVAIKIMKKATLG-EDLPRVKLEINALKHI-SHQHICKLFQVIET----SSH 80 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----~~~ 80 (568)
+|++.+.||+|+||.||+|.+..+ +..||+|++...... .....+.+|+.+++++ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999888 899999998753222 1244677899999999 59999999987532 246
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
+|++|||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999995 6899999888889999999999999999999999999999999999999999999999999987543321
Q ss_pred c---cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Q psy6203 161 E---SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-------------- 223 (568)
Q Consensus 161 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-------------- 223 (568)
. .......||+.|+|||.+.+...++.++||||+||++|+|++|.+||...+.......+...
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 11233468999999999876555689999999999999999999999876544333222110
Q ss_pred -----------CCC------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 -----------KYT------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 -----------~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
... ..+..+..+.+++.+||+.||.+|||+.|++.|||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 000 11235788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.49 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=202.3
Q ss_pred Eeeeccc--CCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccC
Q psy6203 13 ERTVGSG--GFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCP 89 (568)
Q Consensus 13 ~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 89 (568)
...||.| +||+||+|.+..+|+.||+|++...... +..+.+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3456776 9999999999999999999998765432 234678889999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc-----
Q psy6203 90 GGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES----- 162 (568)
Q Consensus 90 ~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~----- 162 (568)
+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++++|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998764 35899999999999999999999999999999999999999999999999864322111000
Q ss_pred -ccccccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Q psy6203 163 -QLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-------------- 226 (568)
Q Consensus 163 -~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-------------- 226 (568)
......++..|+|||++.+. ..++.++||||+||++|+|++|..||......+.......+...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 01112356679999999764 23578999999999999999999999876544433332221110
Q ss_pred ---------------------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 ---------------------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 ---------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+...++.+.+||++||+.||++|||++|+++||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 01124667899999999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.37 Aligned_cols=249 Identities=28% Similarity=0.455 Sum_probs=211.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||+|.+..+|+.||+|.++..... .....+.+|+.++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6899999999999999999999999999999998753322 22457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 86 EYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 99999999998864 3458999999999999999999999999999999999999999999999999987543321
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCC-CCC-CCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILNGKYT-EPP-WMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~--~~~~~~~~i~~~~~~-~~~-~~~~~~~~ 237 (568)
.......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||... +..+..+.+..+... .+. ..+..+.+
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred cccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 1223446889999999998766 588999999999999999999999654 334455555555443 222 57789999
Q ss_pred HHHHccccCcCCCCCHHHHhc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~ 258 (568)
+|.+||..+|++|||+.++++
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=374.14 Aligned_cols=260 Identities=29% Similarity=0.498 Sum_probs=224.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+.-+++-...||.|.||.||.|.+..+|+..|+|.++-.... ...+.+.+|..++..|+|||+|++|++-.+.+.++|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 334566778999999999999999999999999988754432 3456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC---c
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL---E 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~ 161 (568)
||||+||+|.+.+...+-.+|...+.+..|++.|+.|||+.|||||||||.||+++.+|.+|++|||.|....... .
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999999999877778888999999999999999999999999999999999999999999999998765542 1
Q ss_pred cccccccCCccccccccccCcc--cCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcC-CCCCCCCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQ--YYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNG-KYTEPPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~-~~~~~~~~~~~~~~ 237 (568)
...+...||+.|||||++.+.. ....++|||||||++.||+||+.||...+ .-+++-.+-.| .++.|..+|++.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 2345568999999999997643 24568999999999999999999997543 33455555555 55678889999999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
||.+||..||.+|.++.|+++|.|-+..
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 9999999999999999999999988754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.46 Aligned_cols=255 Identities=28% Similarity=0.398 Sum_probs=213.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+..+.|...+.||+|+||+||+|.+..+|+.||+|++...... .....+..|+.+++.++|||++++++++.+.+..|
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 4455688889999999999999999999999999998754332 22346778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+. |+|.+.+.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 9999995 577777754 4578999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 237 (568)
......|+..|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.....+ .....+..+++
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1234568899999999852 233688999999999999999999999876655544444433322 22346778999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
|+.+||+.+|.+||++.+++.||||...
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=326.83 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=206.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcE----EEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
++|++.+.||+|+||+||+|.+..++.. +++|.+...........+..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 6789999999999999999998877764 66676643322223456777888899999999999999875 455789
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 161 (568)
|+||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999999999999976 45789999999999999999999999999999999999999999999999999875433211
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC-CCCCChHHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIV 239 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li 239 (568)
.......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.......+.+..+.... +...+.++.+++
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM 244 (279)
T ss_pred cccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHH
Confidence 1122345677899999998766 5899999999999999998 999999887777666666655433 344677899999
Q ss_pred HHccccCcCCCCCHHHHhc
Q psy6203 240 RSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~ 258 (568)
.+|+..||++|||+.|++.
T Consensus 245 ~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 245 VKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=320.89 Aligned_cols=243 Identities=27% Similarity=0.436 Sum_probs=205.4
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
++||+|+||.||+|... ++..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 47899999999999864 68899999987544323344678899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCcc
Q psy6203 94 LDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN 172 (568)
Q Consensus 94 ~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~ 172 (568)
.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...............++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 9998754 468899999999999999999999999999999999999999999999999987543322222222344678
Q ss_pred ccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccccCcCCC
Q psy6203 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 173 y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
|+|||++.+.. ++.++||||||+++|++++ |..||...........+..+.. ..+..++..+.+++.+||+.+|++|
T Consensus 160 y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 160 WTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred ccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 99999997665 5889999999999999998 9999988887777777665532 3455688999999999999999999
Q ss_pred CCHHHHhc
Q psy6203 251 IKIQDLLG 258 (568)
Q Consensus 251 ps~~ell~ 258 (568)
||+.|+++
T Consensus 239 p~~~~l~~ 246 (250)
T cd05085 239 PKFSELQK 246 (250)
T ss_pred CCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=329.45 Aligned_cols=251 Identities=31% Similarity=0.468 Sum_probs=210.8
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999999999999998765433 23456788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 89 PGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 89 ~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
++ +|.+.+... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~ 158 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHY 158 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCc
Confidence 65 888887663 689999999999999999999999999999999999999999999999999987654432 122234
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------CC--
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK-------------------YT-- 226 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~-------------------~~-- 226 (568)
.++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+....+.... ..
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 578899999999876457899999999999999999999998776554443332110 00
Q ss_pred ---------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 ---------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 ---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..+.++.++.++|.+||+.||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 012357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.94 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=206.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ....+.+|+.++++++|||++++++++. .+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 47899999999999999999987654 4699998765432 2356788999999999999999999875 456899999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999999764 3478999999999999999999999999999999999999999999999999875533221112
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+..+. ...+...+..+.+++.+|
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239 (260)
T ss_pred CCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence 2234567899999987766 5889999999999999999 999998887777777766552 334556789999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|..||++||+++++++
T Consensus 240 l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 240 WKKDPDERPTFEYIQS 255 (260)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=321.52 Aligned_cols=243 Identities=24% Similarity=0.496 Sum_probs=211.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.. .|+.||+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 36789999999999999999986 478999999875542 45678889999999999999999999998899999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999999998765 79999999999999999999999999999999999999999999999999987653221
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~ 242 (568)
....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+...+...+..+ ....+...++.+.++|.+|
T Consensus 157 ~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 157 DSGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred ccCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 1233466799999987665 5889999999999999997 99999988888777776654 3334556789999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|..+|++|||+.+++.
T Consensus 236 l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPTFKQLRE 251 (256)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=326.25 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=210.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||.||+|.+..++..+|+|.+......+ ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999887543222 2356788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 86 EYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999998863 3568999999999999999999999999999999999999999999999999887554321
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCC--CCCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI--DQLYDKILNGKYTE--PPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~--~~~~~~i~~~~~~~--~~~~~~~~~~ 237 (568)
.......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+... ......+....+.. +...++.+.+
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred cccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 2223456899999999997766 58899999999999999999999975533 34445554443332 2347889999
Q ss_pred HHHHccccCcCCCCCHHHHhc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~ 258 (568)
++.+||+.||++|||+.+|++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=325.13 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=207.9
Q ss_pred eEEEeeecccCCeEEEEEEEcCC---CcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE-----
Q psy6203 10 YILERTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSH----- 80 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~----- 80 (568)
|++.+.||+|+||.||+|....+ +..||+|.++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 478999998754332 234578889999999999999999998765443
Q ss_pred -EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 81 -IFMVIEYCPGGELLDHIVER------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 81 -~~lV~E~~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999888542 36899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCC
Q psy6203 154 AKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPW 230 (568)
Q Consensus 154 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~ 230 (568)
+........ ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+..+.+..+.. ..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence 764432111 111223567899999987665 5899999999999999999 9999988888888777776543 45667
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.++.+.+++.+||+.||++|||+.|++.+
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=328.84 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=210.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.+|.+.+.||+|+||.||+|.+.. ++..+++|.+..... .....+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 469999999999999999998643 455688998764332 22356888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeE
Q psy6203 83 MVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK 146 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 146 (568)
+||||+++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 999999999999999754 2378999999999999999999999999999999999999999999
Q ss_pred EEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q psy6203 147 LIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK 224 (568)
Q Consensus 147 l~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~ 224 (568)
|+|||++........ .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+..+.+..+.
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 242 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence 999999875433211 1122345678899999988765 5889999999999999998 999998888877777777766
Q ss_pred CC-CCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 225 YT-EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 225 ~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.. .+...+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 243 VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 54 34456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=330.74 Aligned_cols=253 Identities=24% Similarity=0.440 Sum_probs=212.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEEc-------CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHV-------LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET 77 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 77 (568)
..++|.+.+.||+|+||.||+|++. .++..||+|.+...........+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3568999999999999999999753 234579999987543334456788999999999 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR 141 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 141 (568)
.+..|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 99999999999999999999764 24677889999999999999999999999999999999999
Q ss_pred CCCeEEEeecCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6203 142 NQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219 (568)
Q Consensus 142 ~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~ 219 (568)
++.+||+|||++......... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..++...
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 999999999998765332111 122234567899999997765 5889999999999999998 8899999888888888
Q ss_pred HHcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 220 ILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 220 i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+.. ..+...+..+.+|+.+||+.+|.+|||+.|++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 766543 3445678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.10 Aligned_cols=250 Identities=30% Similarity=0.423 Sum_probs=200.0
Q ss_pred ccCe-EEEeeecccCCeEEEEEE----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC--C
Q psy6203 7 RNQY-ILERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS--S 79 (568)
Q Consensus 7 ~~~Y-~i~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~ 79 (568)
.++| ++.+.||+|+||+||++. ...++..||+|+++..........+.+|+.++++++||||+++++++... .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 4666 999999999999998864 34567899999987654333445678899999999999999999987653 4
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
..++||||+++++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 68999999999999999865 46999999999999999999999999999999999999999999999999998765432
Q ss_pred Ccc--ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH---------------HHHHHHHc
Q psy6203 160 LES--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---------------QLYDKILN 222 (568)
Q Consensus 160 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~---------------~~~~~i~~ 222 (568)
... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... .....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 111 112234566799999987765 588999999999999999999998543211 11111111
Q ss_pred C-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 223 G-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 223 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+ ..+.+...+..+.+++.+||+.||++|||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 12234557889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=342.72 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=210.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
+...++..||+|+||+||+|++. -.||||+++..... +..+.|++|+.++++-+|.||+-+.+++..++. .||+.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 45678899999999999999975 35999999876654 356789999999999999999999999988776 89999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC-CCcccc
Q psy6203 87 YCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG-GLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~~~~ 164 (568)
+|+|.+|+.++.- +.+|.....+.|++||+.|+.|||.++|||||||..||++.++++|||+|||++..... ......
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 9999999999974 45788899999999999999999999999999999999999999999999999863221 223345
Q ss_pred ccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----CCCCChHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-----PPWMSPNSRQ 237 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~~ 237 (568)
....|...|||||++.. .-.|++.+||||||+++|||++|..||...+.++++-++-.|.... ....+.++++
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~ 627 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKR 627 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHH
Confidence 56678999999999863 2347999999999999999999999999888887776666664332 2235669999
Q ss_pred HHHHccccCcCCCCCHHHHhc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~ 258 (568)
|+..||.+++++||...+||.
T Consensus 628 Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 628 LLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHhcCcccCccHHHHHH
Confidence 999999999999999999887
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=329.93 Aligned_cols=254 Identities=25% Similarity=0.449 Sum_probs=214.1
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
.|....+||+|+||.||++.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 3444578999999999999999999999999875432 223456888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccccc
Q psy6203 89 PGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC 168 (568)
Q Consensus 89 ~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 168 (568)
++++|.+++. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... .......
T Consensus 100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 9999988764 4578999999999999999999999999999999999999999999999999876543321 1223346
Q ss_pred CCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCChHHHHHHHHcccc
Q psy6203 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 169 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~L~~ 245 (568)
|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.+..+....+..... .....+++.+.+++.+||+.
T Consensus 178 ~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 178 GTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred cCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 889999999987655 58899999999999999999999988776655555543322 22345788999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCC
Q psy6203 246 EPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 246 dP~~Rps~~ell~hp~~~~~~ 266 (568)
||.+||++.+++.||||....
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CcccCcCHHHHhcChHHhccC
Confidence 999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.76 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=209.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET-SSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~ 82 (568)
.+.++|++.+.||.|+||.||+|.+..+|+.||+|++.+.... .....+..|+.+++.++||||+++++++.. .+..|
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4678999999999999999999999999999999988654322 234567789999999999999999999865 56789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+||||+ +++|.+++. ...+++..+..++.||++||.|||++||+||||+|+||+++.++.++|+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 999999 668887775 45688999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc---------------C----
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN---------------G---- 223 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~---------------~---- 223 (568)
......+++.|+|||.+.+...++.++|||||||++|+|++|..||...........+.+ +
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 223446788999999987645578999999999999999999999977654322111110 0
Q ss_pred -------CCC-----CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 -------KYT-----EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 -------~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
... ..+.+++.+.++|.+||+.+|++|||+++++.||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 000 01246789999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=323.89 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=210.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCc---EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+.|++.+.||+|+||.||+|.+..+++ .||+|++...........+..|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 569999999999999999999887765 59999987543333356788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc-
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES- 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~- 162 (568)
|||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 9999999999998763 56899999999999999999999999999999999999999999999999998654332111
Q ss_pred cccccc---CCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHH
Q psy6203 163 QLQTSC---GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQ 237 (568)
Q Consensus 163 ~~~~~~---gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 237 (568)
...... .+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+.......+... ..+.+...+..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 242 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ 242 (269)
T ss_pred ccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHH
Confidence 111111 245799999998766 5889999999999999886 99999888877777776544 23445567889999
Q ss_pred HHHHccccCcCCCCCHHHHhc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~ 258 (568)
++.+||+.+|.+||++++++.
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=326.36 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=206.4
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCc--EEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC------CE
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGE--KVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS------SH 80 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 80 (568)
|.+++.||+|+||.||+|....++. .+|+|.++..... .....+..|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3578999999999999999877765 6899988764322 2345678899999999999999999976422 25
Q ss_pred EEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 81 IFMVIEYCPGGELLDHIVE------RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 6899999999999988743 2347899999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Q psy6203 155 KPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWM 231 (568)
Q Consensus 155 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 231 (568)
........ ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+..+.. ..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 65432111 112234577899999998765 5899999999999999999 8999988888787777777643 445668
Q ss_pred ChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 232 ~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+.++|.+||+.||++|||+++++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=329.03 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=208.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 2356888888754433335578889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE
Q psy6203 84 VIEYCPGGELLDHIVER------------------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL 139 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 139 (568)
||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999998642 247788999999999999999999999999999999999
Q ss_pred cCCCCeEEEeecCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHH
Q psy6203 140 DRNQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLY 217 (568)
Q Consensus 140 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~ 217 (568)
++++.+||+|||++......... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....+.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999998754322111 112234567899999987665 5899999999999999998 99999988888877
Q ss_pred HHHHcC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 218 DKILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 218 ~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.+..+ ....+...+.++.+++.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 776654 23345568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=330.42 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=204.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCC--------------cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceee
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTG--------------EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLF 72 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~ 72 (568)
.++|++.+.||+|+||.||+|++..++ ..||+|.+...........+.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 468999999999999999999875432 358999987543323345688899999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc
Q psy6203 73 QVIETSSHIFMVIEYCPGGELLDHIVERQ------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD 140 (568)
Q Consensus 73 ~~~~~~~~~~lV~E~~~~g~L~~~i~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 140 (568)
+++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999986532 367888999999999999999999999999999999999
Q ss_pred CCCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh--CCCCCCCCCHHHHH
Q psy6203 141 RNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC--GFLPFDSDSIDQLY 217 (568)
Q Consensus 141 ~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt--G~~pf~~~~~~~~~ 217 (568)
.++.+||+|||++........ .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+..
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 999999999999875432211 1112234567899999988766 5899999999999999988 67888877666554
Q ss_pred HHHHc-----C---CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 218 DKILN-----G---KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 218 ~~i~~-----~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
..+.. + ....++..++.+.+|+.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 44321 1 12234557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=320.59 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=213.5
Q ss_pred eEEEeeecccCCeEEEEEEEcCCC----cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTG----EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
+++.+.||.|+||.||+|.+..++ ..||+|++...........+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357899999999999999998766 8999999976544335668889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++++|.+++..... +++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999976544 9999999999999999999999999999999999999999999999999987654331111
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~ 241 (568)
.....+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||...+.....+.+..+... .+...+.++.+++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred cccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 11223678999999986554 6899999999999999998 89999888888888777766543 445578999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||..||++|||+.|+++
T Consensus 240 ~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 240 CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HCcCChhhCcCHHHHHh
Confidence 99999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.03 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=211.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCc---EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|+..+.||+|+||.||+|.+..++. .+|+|.+...........+..|+.++++++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 578999999999999999999876665 69999886543333355688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+++++|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999999998764 578999999999999999999999999999999999999999999999999987554321111
Q ss_pred ccc--ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHH
Q psy6203 164 LQT--SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIV 239 (568)
Q Consensus 164 ~~~--~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li 239 (568)
... ...+..|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......+..+.. +.+...+..+.+++
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 243 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLM 243 (268)
T ss_pred eeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 111 12345799999998765 5889999999999999997 9999988887777777765532 33445788999999
Q ss_pred HHccccCcCCCCCHHHHhc
Q psy6203 240 RSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~ 258 (568)
.+||+.+|++||++.++++
T Consensus 244 ~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 244 LQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=328.75 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=211.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...........+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 5789999999999999999998753 67889999987544333345688899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE
Q psy6203 82 FMVIEYCPGGELLDHIVERQ----------------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL 139 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~----------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 139 (568)
++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 99999999999999997532 36788899999999999999999999999999999999
Q ss_pred cCCCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHH
Q psy6203 140 DRNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLY 217 (568)
Q Consensus 140 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~ 217 (568)
+.++.++|+|||++........ .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999865432211 1112223466799999987765 5889999999999999997 88899888888877
Q ss_pred HHHHcCCCC-CCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 218 DKILNGKYT-EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 218 ~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
..+..+... .+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 777766543 35567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.59 Aligned_cols=254 Identities=30% Similarity=0.389 Sum_probs=214.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+....|...+.||+|+||.||+|.+..++..||+|.+...... +....+..|+.++++++|||++++++++.+.+..+
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 4556789999999999999999999999999999998754322 22456788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 99999964 77777654 56789999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 237 (568)
.....|++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+.......+..+... .....++.+.+
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 234468899999999742 233688999999999999999999999877665555555444332 23347888999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++.+||+.+|.+||++.+++.|+|+..
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhc
Confidence 999999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=316.80 Aligned_cols=255 Identities=33% Similarity=0.636 Sum_probs=230.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|.++.+||+|+|++|.++++++|.+.||+|++++.... ++..-++.|-.+..+- +||.+|-++..|+++..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5799999999999999999999999999999999987654 4566777787777665 699999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
.||++||+|--++..+.+++|+.++.+...|+.||.|||++||+.||||.+|+|++..|++||+|+|+++..... ....
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~-gd~t 408 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTT 408 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC-Cccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999998865433 3456
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCChHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS--------DSIDQLYDKILNGKYTEPPWMSPNSR 236 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~--------~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (568)
.+.||||.|+|||++.|.. |+..+|.|+|||+++||+.|+.||+. ++.+-+++-|.......|..+|-.+.
T Consensus 409 stfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas 487 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKAS 487 (593)
T ss_pred ccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhH
Confidence 7899999999999999988 59999999999999999999999952 23455778888888889999999999
Q ss_pred HHHHHccccCcCCCCC------HHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIK------IQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps------~~ell~hp~~~~ 264 (568)
.+++..|++||.+|.. ..++..|+||+.
T Consensus 488 ~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 488 HVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred HHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 9999999999999964 789999999984
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=328.70 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=204.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC----------------CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcce
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL----------------TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~ 70 (568)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++...........+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 5689999999999999999986532 344689999875433333457889999999999999999
Q ss_pred eeEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE
Q psy6203 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQ-----------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL 139 (568)
Q Consensus 71 l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 139 (568)
+++++...+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999987642 36677899999999999999999999999999999999
Q ss_pred cCCCCeEEEeecCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh--CCCCCCCCCHHHH
Q psy6203 140 DRNQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC--GFLPFDSDSIDQL 216 (568)
Q Consensus 140 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt--G~~pf~~~~~~~~ 216 (568)
+.++.++|+|||++......... ......+++.|+|||...+.. ++.++|||||||++|+|++ |..||...+..+.
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999998754332111 112233467899999887665 6899999999999999998 7899987665554
Q ss_pred HHHHHc--------CCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 217 YDKILN--------GKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 217 ~~~i~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...... ...+.+...++.+.+|+.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 433211 122344567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.76 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=210.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 47899999999999999999875 467899998875433 234688899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++++|.+++... +.++++.+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999999998764 568999999999999999999999999999999999999999999999999987543321111122
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 244 (568)
..++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.........+.+..+.. ..+...+..+.+|+.+||+
T Consensus 161 ~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 239 (256)
T cd05112 161 TKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWK 239 (256)
T ss_pred CccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 23467899999998765 5889999999999999998 9999998888777777766533 3345578999999999999
Q ss_pred cCcCCCCCHHHHhcC
Q psy6203 245 VEPGKRIKIQDLLGH 259 (568)
Q Consensus 245 ~dP~~Rps~~ell~h 259 (568)
.+|++|||+.+++++
T Consensus 240 ~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 240 ERPEDRPSFSLLLHQ 254 (256)
T ss_pred cChhhCCCHHHHHHh
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.41 Aligned_cols=253 Identities=25% Similarity=0.436 Sum_probs=211.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC-------CcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT-------GEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET 77 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 77 (568)
...+|++++.||+|+||.||+|++... +..||+|.+...........+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 346799999999999999999986532 2368999887543333456788899999999 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR 141 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 141 (568)
.+..++||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 999999999999999999997532 3677888999999999999999999999999999999999
Q ss_pred CCCeEEEeecCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6203 142 NQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219 (568)
Q Consensus 142 ~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~ 219 (568)
++.+||+|||+++........ ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999998754332111 112223456799999998765 5889999999999999998 8999999888888887
Q ss_pred HHcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 220 ILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 220 i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+.. ..+...+..+.+++.+||+.+|++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 766543 3455678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.62 Aligned_cols=242 Identities=22% Similarity=0.339 Sum_probs=202.0
Q ss_pred eecccCCeEEEEEEEc--CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCC
Q psy6203 15 TVGSGGFAKVKLATHV--LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGE 92 (568)
Q Consensus 15 ~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~ 92 (568)
.||+|+||.||+|.+. .++..||+|++.........+.+.+|+.++++++||||++++++++ .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999765 3456799999876543333466889999999999999999999886 456899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc--cccccC
Q psy6203 93 LLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ--LQTSCG 169 (568)
Q Consensus 93 L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~g 169 (568)
|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......... .....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 9999875 4578999999999999999999999999999999999999999999999999987543321111 111223
Q ss_pred CccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccccCc
Q psy6203 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEP 247 (568)
Q Consensus 170 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP 247 (568)
++.|+|||.+.+.. ++.++|||||||++|++++ |..||.......+...+..+.. ..+...++++.++|.+||..||
T Consensus 161 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 161 PLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred CcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 57899999987665 5889999999999999996 9999988887777777766543 4456678999999999999999
Q ss_pred CCCCCHHHHhc
Q psy6203 248 GKRIKIQDLLG 258 (568)
Q Consensus 248 ~~Rps~~ell~ 258 (568)
++||++.++.+
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05115 240 EDRPNFAKVEE 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.81 Aligned_cols=257 Identities=28% Similarity=0.398 Sum_probs=209.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l 83 (568)
--.++|++.+.||+|+||.||+|.+..+++.||+|.++..........+..|+.++.+.. ||||+++++++.+....|+
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 345789999999999999999999998899999999986544333445666777666664 9999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
||||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.......
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 999984 577777655 4578999999999999999999997 599999999999999999999999999987543321
Q ss_pred cccccccCCccccccccccCcc---cCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC-CC--CCCChH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQ---YYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYT-EP--PWMSPN 234 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~-~~--~~~~~~ 234 (568)
......+++.|+|||.+.+.. .++.++||||||+++|+|++|+.||..... .+....+...... .+ ..++.+
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 112335788999999987542 357899999999999999999999976332 3344444443322 22 236889
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.+|+.+||..||.+|||+++++.||||..
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 999999999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.99 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=209.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
..+|.+.++||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 357899999999999999999743 346689999876433 22345788899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeE
Q psy6203 82 FMVIEYCPGGELLDHIVERQ---------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK 146 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~---------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 146 (568)
++||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||++++++.+|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 99999999999999997643 478899999999999999999999999999999999999999999
Q ss_pred EEeecCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q psy6203 147 LIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK 224 (568)
Q Consensus 147 l~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~ 224 (568)
|+|||++......... ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...........+..+.
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999998654322111 112233567899999988766 5899999999999999998 999998777766666666554
Q ss_pred -CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 225 -YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 225 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...+..+++.+.++|.+||+.||.+||++++++.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3445568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.83 Aligned_cols=241 Identities=26% Similarity=0.479 Sum_probs=206.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEE-EeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI-ETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lV~E 86 (568)
.+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.++++++|+|++++++++ ...+..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 5789999999999999999976 47889999986432 345688899999999999999999975 45567899999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc----C
Confidence 999999999997654 4789999999999999999999999999999999999999999999999998754322 1
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~ 242 (568)
....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..++...+..+.. ..++..++.+.+++.+|
T Consensus 157 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 157 DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 2334567899999987765 5889999999999999997 9999998888877777766532 34556889999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|+.+|++|||+.++++
T Consensus 236 l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 236 WHLDAATRPSFLQLRE 251 (256)
T ss_pred hcCChhhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=326.62 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=211.6
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
|++.+.||+|++|.||+|.+..+++.||+|++...... .....+..|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999999865422 23456778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 89 PGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 89 ~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
+ ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 158 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTHE 158 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCcc
Confidence 7 5899999876 579999999999999999999999999999999999999999999999999987654321 122334
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------------CCC-
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--------------------KYT- 226 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--------------------~~~- 226 (568)
.++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+... .++
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 56788999999877645789999999999999999999999887655444333210 000
Q ss_pred --------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 --------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 --------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..+..+..+.++|.+||..||++||++++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 012247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=325.70 Aligned_cols=253 Identities=30% Similarity=0.449 Sum_probs=209.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCC--C----CcceeeEEEEeC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH--Q----HICKLFQVIETS 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h--p----nIv~l~~~~~~~ 78 (568)
.+.++|.+.+++|+|+||.|..+.+..++..||||+++... .-.+....|+++|.++.+ | -+|++.++|+-.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 46899999999999999999999999999999999997543 233456679999999942 3 378888999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---------------
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR--------------- 141 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--------------- 141 (568)
++.|||+|.+ |-++++++.+++ +++...++.+.+|+++++++||+.+++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999999 779999998764 6889999999999999999999999999999999999842
Q ss_pred -----CCCeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH-
Q psy6203 142 -----NQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ- 215 (568)
Q Consensus 142 -----~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~- 215 (568)
+..|+|+|||.|+..... ..+.+.|..|.|||++.+-+ ++.++||||+||||+|+.||...|.+.+..+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 235899999998875433 25667899999999999987 6999999999999999999999998765433
Q ss_pred --HHHHHHcC------------------CCCCCCC-------------------------CChHHHHHHHHccccCcCCC
Q psy6203 216 --LYDKILNG------------------KYTEPPW-------------------------MSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 216 --~~~~i~~~------------------~~~~~~~-------------------------~~~~~~~li~~~L~~dP~~R 250 (568)
++++|... ....+.. ...++.|||++||.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 45554331 0110000 11246799999999999999
Q ss_pred CCHHHHhcCcccccC
Q psy6203 251 IKIQDLLGHNWVKMG 265 (568)
Q Consensus 251 ps~~ell~hp~~~~~ 265 (568)
+|+.|+|.||||+..
T Consensus 398 iTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 398 ITLREALSHPFFARL 412 (415)
T ss_pred ccHHHHhcCHHhhcC
Confidence 999999999999853
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.28 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=210.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC---CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
-.++|.+.+.||+|+||.||+|.+... ...||+|...........+.+.+|+.++++++||||+++++++.+ +..|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 356799999999999999999987644 346899988654323344578889999999999999999999875 4578
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999999999997643 589999999999999999999999999999999999999999999999999875543321
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIV 239 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 239 (568)
.......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+..+. ...+...++.+.+++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241 (270)
T ss_pred eecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 1112223456899999987665 5889999999999999986 999998888777776766654 345567889999999
Q ss_pred HHccccCcCCCCCHHHHhcC
Q psy6203 240 RSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~h 259 (568)
.+|+..+|++|||+.+++..
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.29 Aligned_cols=242 Identities=26% Similarity=0.425 Sum_probs=202.3
Q ss_pred eeecccCCeEEEEEEEcCCCc--EEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVLTGE--KVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|+||.||+|.+..++. .+|+|.++..........+..|+.+++++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999988776 46888876433233445788899999999 799999999999999999999999999
Q ss_pred CChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 91 GELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 91 g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
|+|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999997543 47889999999999999999999999999999999999999999999999975
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCC
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMS 232 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~ 232 (568)
..... ........+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+.......+..+. ...+...+
T Consensus 161 ~~~~~--~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05047 161 GQEVY--VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237 (270)
T ss_pred ccchh--hhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence 32211 1111223456799999987665 5889999999999999997 999998888777777776543 23445578
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.++.+++.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHH
Confidence 89999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=336.08 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=205.8
Q ss_pred cccccCeEEEeeecccCCeEEEEEEE-----cCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATH-----VLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET 77 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 77 (568)
.--.++|++.+.||+|+||.||+|.+ ..+++.||||+++..........+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 33457899999999999999999984 3567899999997654333455678899999999 68999999998754
Q ss_pred -CCEEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q psy6203 78 -SSHIFMVIEYCPGGELLDHIVER-------------------------------------------------------- 100 (568)
Q Consensus 78 -~~~~~lV~E~~~~g~L~~~i~~~-------------------------------------------------------- 100 (568)
...+++|||||++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45689999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-ccccccc
Q psy6203 101 -----------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-SQLQTSC 168 (568)
Q Consensus 101 -----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~ 168 (568)
..++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1356778889999999999999999999999999999999999999999999876432211 1112234
Q ss_pred CCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHH-HHHHHHHcCC-CCCCCCCChHHHHHHHHcccc
Q psy6203 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID-QLYDKILNGK-YTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 169 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~ 245 (568)
++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...... .....+..+. ...+...++++.+++.+||+.
T Consensus 243 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 243 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 567899999987765 5889999999999999997 99999765432 3334444443 344556788999999999999
Q ss_pred CcCCCCCHHHHhcC
Q psy6203 246 EPGKRIKIQDLLGH 259 (568)
Q Consensus 246 dP~~Rps~~ell~h 259 (568)
||++|||+.|+++|
T Consensus 322 ~p~~Rps~~eil~~ 335 (343)
T cd05103 322 EPSQRPTFSELVEH 335 (343)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.91 Aligned_cols=251 Identities=28% Similarity=0.515 Sum_probs=212.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC----CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG----EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888877888877653321 1233566799999999999999999999989999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 85 IEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
|||+++++|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988864 356899999999999999999999999999999999999975 679999999987653321
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIV 239 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li 239 (568)
.......|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+..+..+ .+...+.++.++|
T Consensus 160 -~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 160 -DLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237 (260)
T ss_pred -ccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHH
Confidence 2223456889999999987655 578899999999999999999999887777766666655443 3445788999999
Q ss_pred HHccccCcCCCCCHHHHhcCccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+||+.||++||++.|++.||||
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.53 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=212.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCc----EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.++|++.+.||+|+||.||+|.++.+|. .+|+|.+...........+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4689999999999999999999877765 5899988765433344678889999999999999999999987 7889
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999999999764 5689999999999999999999999999999999999999999999999999876543221
Q ss_pred cc-cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 SQ-LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 ~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
.. .....++..|+|||.+.+.. ++.++|+|||||++|++++ |..||.+....++...+..+. .+.+...+..+.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMV 243 (279)
T ss_pred ceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 11 11122356899999987655 5889999999999999998 999999988888877777654 34455678899999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~ 258 (568)
+.+||..||++|||+.++++
T Consensus 244 ~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 244 LVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.45 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=205.6
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhC---CCCCcceeeEEEEeCCE-----
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHI---SHQHICKLFQVIETSSH----- 80 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~----- 80 (568)
|++.+.||+|+||.||+|.++.+++.||+|++......+. ...+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999988899999999975433221 23455687777665 59999999999988776
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
.+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999996 58988887643 589999999999999999999999999999999999999999999999999876543
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------C-----
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-------T----- 226 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-------~----- 226 (568)
. .......++..|+|||++.+.. ++.++|+||+||++|+|++|.+||...+..+...++..... .
T Consensus 160 ~--~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 160 E--MALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred C--cccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 2 1223345788999999998766 58899999999999999999999988876665555432100 0
Q ss_pred ---------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 ---------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 ---------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
..+.+++.+.++|.+||+.||.+||+++|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001245778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=340.69 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=206.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~ 80 (568)
.++|.+.++||+|+||.||+|++. .++..||+|+++..........+..|+.+|.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356888999999999999999864 3456899999976543333456888999999997 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-----------------------------------------------------------
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ----------------------------------------------------------- 101 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~----------------------------------------------------------- 101 (568)
.++|||||++|+|.+++...+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986431
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC
Q psy6203 102 ---------------------------------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142 (568)
Q Consensus 102 ---------------------------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 142 (568)
.+++..+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence 25667788899999999999999999999999999999999
Q ss_pred CCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHH-HHH
Q psy6203 143 QNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQL-YDK 219 (568)
Q Consensus 143 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~-~~~ 219 (568)
+.+||+|||++........ .......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+. ...
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~ 354 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA 354 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence 9999999999875432211 1112335678899999998765 5889999999999999998 8999977554443 344
Q ss_pred HHcCC-CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 220 ILNGK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 220 i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+. ...+..++.++.+|+.+||..+|.+||++.||+..
T Consensus 355 ~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 355 IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44442 34456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=317.34 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=209.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
-..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 45789999999999999999999864 55679999886532 234568889999999999999999999887 778999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999999763 45788899999999999999999999999999999999999999999999998754432211
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVR 240 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~ 240 (568)
......++..|+|||++.+.. ++.++|+|||||++|++++ |..||.+.+...+...+..+.. +.+...+.++.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred cccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 222234567799999997765 5889999999999999998 9999998887777776665532 334567889999999
Q ss_pred HccccCcCCCCCHHHHhc
Q psy6203 241 SMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~ 258 (568)
+||+.+|++||++.+++.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.28 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=197.0
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecCC-cCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHH
Q psy6203 20 GFAKVKLATHVLTGEKVAIKIMKKAT-LGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIV 98 (568)
Q Consensus 20 ~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~i~ 98 (568)
++|.||++++..+++.||+|++.... ..+....+..|+.+++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 45666777777799999999997653 23455688999999999999999999999999999999999999999999997
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc------cccccccCC
Q psy6203 99 ER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE------SQLQTSCGS 170 (568)
Q Consensus 99 ~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~gt 170 (568)
.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........ .......++
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 63 4689999999999999999999999999999999999999999999999998764322111 112334577
Q ss_pred ccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHH-HHHHcCCC-----------------------
Q psy6203 171 PNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY-DKILNGKY----------------------- 225 (568)
Q Consensus 171 ~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~-~~i~~~~~----------------------- 225 (568)
..|+|||++.+. ..++.++||||+||++|+|++|..||......... +.+.....
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE 251 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence 889999998753 33688999999999999999999999765533322 22211100
Q ss_pred ----------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ----------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.....+++++.+|+.+||+.||++|||++++|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 000113467889999999999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.70 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=210.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET-SSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~ 81 (568)
+++|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5789999999999999999999876 3578999988754333345667889999999999999999998765 5678
Q ss_pred EEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 82 FMVIEYCPGGELLDHIVER--------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 9999999999999998653 45889999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCC
Q psy6203 154 AKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPW 230 (568)
Q Consensus 154 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~ 230 (568)
+........ ......++..|+|||++.+.. ++.++|||||||++|++++ |+.||...+..++...+..+.. ..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPIN 243 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCc
Confidence 754332111 112234567899999997765 5899999999999999999 9999988877777766665532 34455
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.++++.+++.+||..||++|||+.+++.
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 244 CPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=316.88 Aligned_cols=243 Identities=26% Similarity=0.432 Sum_probs=206.2
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCCh
Q psy6203 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGEL 93 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L 93 (568)
++||+|+||.||+|.+.. ++.||+|++...........+..|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999877 9999999987654433455788899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc-ccccCCc
Q psy6203 94 LDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL-QTSCGSP 171 (568)
Q Consensus 94 ~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-~~~~gt~ 171 (568)
.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........... ....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9998663 5689999999999999999999999999999999999999999999999999875442211111 1223456
Q ss_pred cccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHHHccccCcCC
Q psy6203 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQVEPGK 249 (568)
Q Consensus 172 ~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~ 249 (568)
.|+|||.+.+.. ++.++|||||||++|+|++ |..||...........+..+ ....+...+..+.+++.+||+.+|.+
T Consensus 160 ~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 160 KWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred ccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence 799999987765 5899999999999999999 89999887776666666554 23445567899999999999999999
Q ss_pred CCCHHHHhc
Q psy6203 250 RIKIQDLLG 258 (568)
Q Consensus 250 Rps~~ell~ 258 (568)
|||++|+++
T Consensus 239 Rp~~~ell~ 247 (251)
T cd05041 239 RPSFSEIYN 247 (251)
T ss_pred CcCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.55 Aligned_cols=254 Identities=29% Similarity=0.362 Sum_probs=212.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+..+.|...+.||+|+||.||+|++..++..+|+|.+...... .....+..|+.+++.++|+|++++++++...+..+
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3456788899999999999999999999999999998753222 22346778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+. |+|.+.+.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 9999996 578777654 45689999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 237 (568)
.....|++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+.......+..+..+ .....+..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 123468899999999853 223578999999999999999999999776554444444443332 23357888999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+|++||+.+|++||++++++.|||+..
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccc
Confidence 999999999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=323.56 Aligned_cols=239 Identities=20% Similarity=0.303 Sum_probs=197.5
Q ss_pred eeecccCCeEEEEEEEcCCCc-------EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 14 RTVGSGGFAKVKLATHVLTGE-------KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+..|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999999866544 38888876432 2234567789999999999999999999999899999999
Q ss_pred ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC--------eEEEeecCccCCC
Q psy6203 87 YCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN--------LKLIDFGLCAKPE 157 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--------~kl~DFG~a~~~~ 157 (568)
|+++|+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999997644 5899999999999999999999999999999999999987764 6999999876543
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCChHHH
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGKYTEPPWMSPNSR 236 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (568)
. .....+++.|+|||++.+...++.++|||||||++|+|++| .+||...+..... .+.......+...+.++.
T Consensus 160 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (258)
T cd05078 160 P-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELA 233 (258)
T ss_pred C-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHH
Confidence 2 12346788999999998755568899999999999999998 5677665544432 233444555666778999
Q ss_pred HHHHHccccCcCCCCCHHHHhcC
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~h 259 (568)
+++.+||+.||++|||++++++.
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.23 Aligned_cols=262 Identities=24% Similarity=0.420 Sum_probs=214.0
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEe----
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIET---- 77 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---- 77 (568)
+.+..+.|+-..+||+|.||.||+|+++.+|+.||+|++-...-.+. -....+|+++|..|+|+|++.+++++..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 34566788889999999999999999999999999986543322222 2245679999999999999999888742
Q ss_pred ----CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecC
Q psy6203 78 ----SSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL 152 (568)
Q Consensus 78 ----~~~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 152 (568)
...+|+||.+|+ .+|..++.+. .+++..++.+++.+++.||.|+|.+.|+|||+||.|+||+.+|.+||+|||+
T Consensus 92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 235899999995 5888888765 6899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCC---ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC--
Q psy6203 153 CAKPEGGL---ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKY-- 225 (568)
Q Consensus 153 a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~-- 225 (568)
++...... .......+.|.+|.+||.+.|...|+++.|||..|||+.+|+||.+.+.+++..+....|.. |..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 96543321 12233456799999999999998899999999999999999999999998887665554421 111
Q ss_pred ---C---------------CC-------------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 226 ---T---------------EP-------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 226 ---~---------------~~-------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
+ .+ -.-++++.+|+.+||..||.+|++++++++|.||...
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 00 0124578899999999999999999999999999843
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=323.33 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=203.1
Q ss_pred cCeEEEeeecccCCeEEEEEEE----cCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATH----VLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS--SHI 81 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 81 (568)
..|++.+.||+|+||.||+|.. ..++..||+|.++..........+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578999999999999999974 4578899999987554334456788999999999999999999998765 578
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
++||||++|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999998764 458999999999999999999999999999999999999999999999999987654321
Q ss_pred c--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---------------CHHHHHHHHHcC
Q psy6203 161 E--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---------------SIDQLYDKILNG 223 (568)
Q Consensus 161 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---------------~~~~~~~~i~~~ 223 (568)
. .......++..|+|||++.+.. ++.++|||||||++|+|+++..|+... ........+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 1 1122345677899999987765 588999999999999999987664221 111122222232
Q ss_pred C-CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 224 K-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 224 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
. .+.+..+++.+.+|+.+||+.||++|||+++++.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2 23455678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.63 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=210.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCc---E-EEEEEeecCC--cCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGE---K-VAIKIMKKAT--LGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~---~-vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+-.+.++||+|+||.||+|..+..+. . ||+|..+... ..+....+.+|.++|++++|||||++||+......++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 44566999999999999998776533 3 8999887522 2244667889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
||||+|.||+|.+++.+.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++....-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~-- 315 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY-- 315 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce--
Confidence 9999999999999999876 4999999999999999999999999999999999999999999999999998765311
Q ss_pred cccc-cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHc-CCC-CCCCCCChHHHH
Q psy6203 162 SQLQ-TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILN-GKY-TEPPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~-~~~-~~~~~~~~~~~~ 237 (568)
.... ...-...|+|||.+... .|++++||||+||++||+++ |..||.+....++...|.. +.. +.+...+..+..
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK 394 (474)
T ss_pred eeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence 1111 11245689999999877 47999999999999999999 8889999999999999944 433 345567788899
Q ss_pred HHHHccccCcCCCCCHHHHhc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~ 258 (568)
++.+|+..||++|||+.++.+
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHhccCChhhccCHHHHHH
Confidence 999999999999999999864
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=316.69 Aligned_cols=243 Identities=24% Similarity=0.397 Sum_probs=205.0
Q ss_pred eeecccCCeEEEEEEEcC-CCc--EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHVL-TGE--KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
+.||+|++|.||+|.+.. .++ .||+|.+...........+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 333 6999998876543445678899999999999999999999988 889999999999
Q ss_pred CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc--cccc
Q psy6203 91 GELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES--QLQT 166 (568)
Q Consensus 91 g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~ 166 (568)
++|.+.+.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999998754 6899999999999999999999999999999999999999999999999998765432111 1122
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC--CCCCCCCCChHHHHHHHHcc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L 243 (568)
..++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+... ....+...+..+.+++.+||
T Consensus 160 ~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 160 LKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 45678899999987766 5889999999999999998 99999887777776666532 22334457889999999999
Q ss_pred ccCcCCCCCHHHHhc
Q psy6203 244 QVEPGKRIKIQDLLG 258 (568)
Q Consensus 244 ~~dP~~Rps~~ell~ 258 (568)
+.+|.+|||+.++++
T Consensus 239 ~~~p~~Rps~~~~~~ 253 (257)
T cd05040 239 AHNPADRPTFAALRE 253 (257)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.73 Aligned_cols=254 Identities=28% Similarity=0.528 Sum_probs=208.7
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe---------
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET--------- 77 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------- 77 (568)
.++|+.++.||+||||.||+|+++.+|+.||||.+...........+.+|+..|.+|+|||||++|..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45778899999999999999999999999999999876533445678899999999999999998754200
Q ss_pred ----------------------------------------------C---------------------------------
Q psy6203 78 ----------------------------------------------S--------------------------------- 78 (568)
Q Consensus 78 ----------------------------------------------~--------------------------------- 78 (568)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CEEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcC
Q psy6203 79 -------------------------------SHIFMVIEYCPGGELLDHIVERQRL-GEKESRAFFRQILSAVAYLHHLG 126 (568)
Q Consensus 79 -------------------------------~~~~lV~E~~~~g~L~~~i~~~~~l-~~~~~~~i~~qi~~aL~~LH~~~ 126 (568)
..+||-||||+...|.+++..+... ....++++++||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 1268999999988777777665544 47789999999999999999999
Q ss_pred ceecCCCCCceEEcCCCCeEEEeecCccCCC-----------------CCCccccccccCCccccccccccCcc--cCCc
Q psy6203 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPE-----------------GGLESQLQTSCGSPNYAAPEVIKGKQ--YYGS 187 (568)
Q Consensus 127 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~ 187 (568)
||||||||.||++++++.|||+|||+|+... +......+..+||.-|+|||++.+.. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999987611 11112345568999999999998766 5899
Q ss_pred ccceechhhHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCCC----CChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 188 ETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYTEPPW----MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 188 ~~DiwSlG~il~~lltG~~pf~~~-~~~~~~~~i~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
|+||||||+|++||+ .||... ....+...+..+..+.+.. --+.-..+|++||+.||.+||||.|+|++.||
T Consensus 798 KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 999999999999998 467543 3445666777777776632 33566899999999999999999999999999
Q ss_pred c
Q psy6203 263 K 263 (568)
Q Consensus 263 ~ 263 (568)
.
T Consensus 875 p 875 (1351)
T KOG1035|consen 875 P 875 (1351)
T ss_pred C
Confidence 6
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=318.41 Aligned_cols=239 Identities=19% Similarity=0.280 Sum_probs=195.2
Q ss_pred eeecccCCeEEEEEEEcCC------------CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 14 RTVGSGGFAKVKLATHVLT------------GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
+.||+|+||.||+|..... ...+|+|.+.... ......+..|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4689999999999985322 2358888876543 22344677889999999999999999999998899
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC-------eEEEeecCc
Q psy6203 82 FMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN-------LKLIDFGLC 153 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-------~kl~DFG~a 153 (568)
++||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999998888653 56899999999999999999999999999999999999987664 899999987
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMS 232 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~ll-tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 232 (568)
..... .....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+.. ....+........+
T Consensus 160 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (262)
T cd05077 160 ITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSC 233 (262)
T ss_pred ccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCCh
Confidence 65432 123457889999999875555788999999999999998 589998876654443 23334444444456
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+++.+||.+||+.||.+||++.+|+.+
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=333.86 Aligned_cols=255 Identities=28% Similarity=0.553 Sum_probs=216.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
.-|..++.||-|+||+|.+++...|...||+|.+.+...- .....++.|-+||..-+.+-||+||-.|++++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4578899999999999999999999999999999876542 34557788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC--------
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE-------- 157 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~-------- 157 (568)
+|++||++-.++...+-|.|+.++.++..+..|+++.|..|+|||||||+|||||.+|+|||+|||+|+-+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999985221
Q ss_pred -CCC----cc----------------------------ccccccCCccccccccccCcccCCcccceechhhHHHHHHhC
Q psy6203 158 -GGL----ES----------------------------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG 204 (568)
Q Consensus 158 -~~~----~~----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG 204 (568)
.+. ++ .....+||+.|+|||++.... |+..+|.||.|||||||+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhC
Confidence 000 00 001236999999999998776 58899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC----CCCCCCCCChHHHHHHHHccccCcCCCCC---HHHHhcCccccc
Q psy6203 205 FLPFDSDSIDQLYDKILNG----KYTEPPWMSPNSRQIVRSMLQVEPGKRIK---IQDLLGHNWVKM 264 (568)
Q Consensus 205 ~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~ 264 (568)
.+||-.++.-+...++.+. .++....+++++.++|.+++. +++.|.. ++|+..||||+.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 9999877655544444433 223345689999999998775 7888874 788999999984
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=348.16 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=217.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.+-...+.||+|+||+||+|+... ....||||.++..........|++|++++..|+|||||++++++..++.+|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 345677899999999999998543 235799999987665445678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 83 MVIEYCPGGELLDHIVERQ--------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
+|+|||..|||.+++.... +++..+...|+.||+.|+.||-++.+|||||-..|+|+.++-.|||+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEec
Confidence 9999999999999997531 27888999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCccccc-cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-
Q psy6203 149 DFGLCAKPEGGLESQLQ-TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY- 225 (568)
Q Consensus 149 DFG~a~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~- 225 (568)
|||+++..-........ ...-..+|||||.+.-++ ++.+|||||+||+|||+++ |+.||.+.+.+++.+.|..|..
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL 724 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLL 724 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcc
Confidence 99999875433222222 223456899999998877 6999999999999999998 9999999999999999999876
Q ss_pred CCCCCCChHHHHHHHHccccCcCCCCCHHHHh
Q psy6203 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257 (568)
Q Consensus 226 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 257 (568)
+.|...+.++.+|+..||+.+|.+||++.||-
T Consensus 725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 725 SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 45677999999999999999999999999984
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.72 Aligned_cols=229 Identities=24% Similarity=0.399 Sum_probs=193.9
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHH
Q psy6203 19 GGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIV 98 (568)
Q Consensus 19 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~i~ 98 (568)
|.+|.||+|+++.+++.||+|.+.... ...+|...+....||||+++++++.+.+..++||||++||+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999987643 22345555556679999999999999999999999999999999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCcccccccc
Q psy6203 99 ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEV 178 (568)
Q Consensus 99 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~ 178 (568)
....+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~ 153 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEV 153 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcc
Confidence 8888999999999999999999999999999999999999999999999999987654332 223456778999999
Q ss_pred ccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCCCH-----
Q psy6203 179 IKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKI----- 253 (568)
Q Consensus 179 l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~----- 253 (568)
+.+.. ++.++|+||+|+++|+|++|..||........ .......+..+++.+.++|.+||+.||++||++
T Consensus 154 ~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 154 GGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred cCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 87665 58899999999999999999988764332110 012234567789999999999999999999986
Q ss_pred HHHhcCccc
Q psy6203 254 QDLLGHNWV 262 (568)
Q Consensus 254 ~ell~hp~~ 262 (568)
+++++||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=320.66 Aligned_cols=238 Identities=20% Similarity=0.259 Sum_probs=193.7
Q ss_pred eecccCCeEEEEEEEcCC------------------------CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcce
Q psy6203 15 TVGSGGFAKVKLATHVLT------------------------GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICK 70 (568)
Q Consensus 15 ~lG~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~ 70 (568)
.||+|+||.||+|....+ ...||+|++..... .....+..|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 699999999999975322 13588888864321 22345777899999999999999
Q ss_pred eeEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC------
Q psy6203 71 LFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ------ 143 (568)
Q Consensus 71 l~~~~~~~~~~~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~------ 143 (568)
+++++...+..++||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 99999999999999999999999998865 46789999999999999999999999999999999999997654
Q ss_pred -CeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHH-hCCCCCCCCCHHHHHHHHH
Q psy6203 144 -NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKIL 221 (568)
Q Consensus 144 -~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~ll-tG~~pf~~~~~~~~~~~i~ 221 (568)
.+|++|||++...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||...+..+.... .
T Consensus 161 ~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~ 234 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-Y 234 (274)
T ss_pred ceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-H
Confidence 3899999987543221 22357788999999876555689999999999999985 69999987665544332 2
Q ss_pred cCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 222 NGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 222 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
......+...++.+.++|.+||+.+|++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 33334445567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=317.46 Aligned_cols=244 Identities=18% Similarity=0.308 Sum_probs=192.6
Q ss_pred eeecccCCeEEEEEEEcC--CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCC
Q psy6203 14 RTVGSGGFAKVKLATHVL--TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 91 (568)
+.||+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999996533 345788887764433333456778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-cccc
Q psy6203 92 ELLDHIVERQ-----RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-SQLQ 165 (568)
Q Consensus 92 ~L~~~i~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~ 165 (568)
+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999997643 246778899999999999999999999999999999999999999999999865332211 1112
Q ss_pred cccCCccccccccccC------cccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHc-CCCC-----CCCCCC
Q psy6203 166 TSCGSPNYAAPEVIKG------KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILN-GKYT-----EPPWMS 232 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~-~~~~-----~~~~~~ 232 (568)
...+++.|+|||++.. ...++.++|||||||++|+|++ |..||......+....+.. +... .+...+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 2345678999999753 2235789999999999999999 8899987766555444433 3222 223467
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.+.+++..|+ .||++|||++++++
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHH
Confidence 88899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=322.85 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=207.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCc----EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.++|++.+.||+|+||.||+|.+..+|. .+|+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3578999999999999999999887776 46888876543323334678899999999999999999998654 467
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 9999999999999987654 689999999999999999999999999999999999999999999999999876543211
Q ss_pred c-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 S-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
. ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.........+..+. ++.++..+..+.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243 (303)
T ss_pred ccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 1 122234577899999988766 5889999999999999997 999998877666655555443 33445578899999
Q ss_pred HHHccccCcCCCCCHHHHhcC
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~h 259 (568)
+.+|+..+|++||++.+++..
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=326.81 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=198.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-EEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS-HIFMVI 85 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~ 85 (568)
.++|.-...||+|+||.||+|.-. +|..||||.+....... ...|.+|+.++.+++|||+|+++++|.+.+ ..+||+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 357777889999999999999965 45899999877654332 456999999999999999999999999888 599999
Q ss_pred eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 86 EYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLG---YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
||+++|+|.+++.... .+++....+|+.+++.||+|||+.. ||||||||+|||+|++.+.||+|||+|+.....
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~- 230 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG- 230 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-
Confidence 9999999999998754 8999999999999999999999854 999999999999999999999999999655431
Q ss_pred ccccccc-cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC------HHHH-HHHHHcCCCC------
Q psy6203 161 ESQLQTS-CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS------IDQL-YDKILNGKYT------ 226 (568)
Q Consensus 161 ~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~------~~~~-~~~i~~~~~~------ 226 (568)
.....+. .||.+|+|||++.... .+.++|||||||++.|++||+.|.+... ..+. ...+..+...
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred ccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 2222233 7999999999998755 5899999999999999999998876432 1111 1223332211
Q ss_pred CC-CCCC--hH---HHHHHHHccccCcCCCCCHHHHhc
Q psy6203 227 EP-PWMS--PN---SRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 227 ~~-~~~~--~~---~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.. ...+ .. +..+..+|++.+|.+||++.|++.
T Consensus 310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 01 1122 22 456778999999999999999754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.25 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=198.7
Q ss_pred eeecccCCeEEEEEEEcC---CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE-eCCEEEEEEeccC
Q psy6203 14 RTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE-TSSHIFMVIEYCP 89 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lV~E~~~ 89 (568)
+.||+|+||.||+|.+.. .+..+|+|.+...........+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 345799998764332233457778999999999999999999765 4556899999999
Q ss_pred CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc---cccc
Q psy6203 90 GGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE---SQLQ 165 (568)
Q Consensus 90 ~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~ 165 (568)
+++|.+++... ...++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999999764 4567788889999999999999999999999999999999999999999999875432111 0111
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHcc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L 243 (568)
...++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+.......+..+.. ..+...++.+.+++.+||
T Consensus 161 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 239 (262)
T cd05058 161 GAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW 239 (262)
T ss_pred cCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHc
Confidence 234567899999987765 5889999999999999999 5777887777777766666543 334557889999999999
Q ss_pred ccCcCCCCCHHHHhc
Q psy6203 244 QVEPGKRIKIQDLLG 258 (568)
Q Consensus 244 ~~dP~~Rps~~ell~ 258 (568)
+.+|++||++.|++.
T Consensus 240 ~~~p~~Rp~~~~il~ 254 (262)
T cd05058 240 HPKPEMRPTFSELVS 254 (262)
T ss_pred CCChhhCCCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=316.94 Aligned_cols=244 Identities=22% Similarity=0.380 Sum_probs=204.0
Q ss_pred eeecccCCeEEEEEEEcCCC------cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 14 RTVGSGGFAKVKLATHVLTG------EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
+.||+|+||.||+|.+...+ ..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46899999999999976544 679999886544334456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-----CeEEEeecCccC
Q psy6203 88 CPGGELLDHIVER-------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-----NLKLIDFGLCAK 155 (568)
Q Consensus 88 ~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-----~~kl~DFG~a~~ 155 (568)
+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999642 3478899999999999999999999999999999999999877 899999999875
Q ss_pred CCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCC
Q psy6203 156 PEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMS 232 (568)
Q Consensus 156 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~ 232 (568)
...... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+..+ .+..+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence 432211 1112234577899999998766 5899999999999999998 99999887776666666544 334556688
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
..+.++|.+||+.+|.+||+++++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.41 Aligned_cols=244 Identities=19% Similarity=0.292 Sum_probs=193.3
Q ss_pred eeecccCCeEEEEEEEc--CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCC
Q psy6203 14 RTVGSGGFAKVKLATHV--LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 91 (568)
+.||+|+||.||+|... .++..+|+|.+...........+.+|+.++++++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999754 3556799998875543333446788999999999999999999999989999999999999
Q ss_pred ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-cccc
Q psy6203 92 ELLDHIVERQ-----RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-SQLQ 165 (568)
Q Consensus 92 ~L~~~i~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~ 165 (568)
+|.+++.... ..++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 9999987532 356778889999999999999999999999999999999999999999999865332211 1112
Q ss_pred cccCCccccccccccCcc------cCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHc-CCCCC-----CCCCC
Q psy6203 166 TSCGSPNYAAPEVIKGKQ------YYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILN-GKYTE-----PPWMS 232 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~------~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~-~~~~~-----~~~~~ 232 (568)
...+++.|+|||++.+.. .++.++|||||||++|+|++ |..||......+....... ..... ....+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 345788899999986421 24779999999999999996 9999987665554333222 22211 12357
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.+.+++.+|+ .+|++|||++||+.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 88999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.43 Aligned_cols=240 Identities=26% Similarity=0.438 Sum_probs=204.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.++++++||||+++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 579999999999999999986 478899999986432 335678899999999999999999998654 47999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 88 CPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 88 ~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VD 155 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc----CC
Confidence 99999999997643 5789999999999999999999999999999999999999999999999998754321 11
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHcc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L 243 (568)
....+..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...+..+....+..+.. ..+..+++.+.+++.+||
T Consensus 156 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 156 NSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence 223456899999987665 5889999999999999997 9999998888777777766532 334557899999999999
Q ss_pred ccCcCCCCCHHHHhc
Q psy6203 244 QVEPGKRIKIQDLLG 258 (568)
Q Consensus 244 ~~dP~~Rps~~ell~ 258 (568)
+.+|++||++++++.
T Consensus 235 ~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 235 ETEPKKRPSFHKLRE 249 (254)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.85 Aligned_cols=236 Identities=20% Similarity=0.250 Sum_probs=194.3
Q ss_pred eeecccCCeEEEEEEEcCCC----------cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 14 RTVGSGGFAKVKLATHVLTG----------EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999998776 35788877644321 5678889999999999999999999887 77899
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-------CeEEEeecCccC
Q psy6203 84 VIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-------NLKLIDFGLCAK 155 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-------~~kl~DFG~a~~ 155 (568)
||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999999999998765 789999999999999999999999999999999999999887 799999999876
Q ss_pred CCCCCccccccccCCccccccccccCc-ccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCh
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSP 233 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 233 (568)
... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+........... ...+.....
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (259)
T cd05037 158 VLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPMPDCA 231 (259)
T ss_pred ccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCCCCch
Confidence 432 1233567789999999776 346889999999999999999 68888766544333333222 222222347
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+.++|.+||..+|.+|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=349.73 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=217.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCc-----EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGE-----KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
...-++...||+|+||.||.|.-..... .||+|.+++.........|.+|..+|+.++|||||++++++-+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456788999999999999998654322 49999998776556677899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 82 FMVIEYCPGGELLDHIVER-------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
+|++|||+||+|..+|++. ..++..+...++.||++|.+||+++++|||||...|+|++....+||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999999875 348889999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccc-cCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHH-HHcCCCCCCCCC
Q psy6203 155 KPEGGLESQLQTS-CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK-ILNGKYTEPPWM 231 (568)
Q Consensus 155 ~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~-i~~~~~~~~~~~ 231 (568)
............. .-...|||||.+.... ++.++|||||||++||++| |..||.+.+..+++.. ...|..+.|+..
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C 929 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC 929 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence 5443222221111 2245899999998755 7999999999999999999 9999999988888874 455677888889
Q ss_pred ChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 232 SPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 232 ~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+..+.+++..||+.+|++||++..|++
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999999999999999999987
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=312.14 Aligned_cols=244 Identities=18% Similarity=0.288 Sum_probs=192.8
Q ss_pred eeecccCCeEEEEEEEcCC--CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCC
Q psy6203 14 RTVGSGGFAKVKLATHVLT--GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 91 (568)
+.||+|+||.||+|..... ...+++|.+...........+.+|+.+++.++||||+++++.+.+....|+||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 23466776655433334567888999999999999999999999999999999999999
Q ss_pred ChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC-Ccccccc
Q psy6203 92 ELLDHIVER----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG-LESQLQT 166 (568)
Q Consensus 92 ~L~~~i~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~ 166 (568)
+|.+++.+. ...++..+..++.||+.||+|||+.+|+||||||+|||++.++.++|+|||++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999999764 34567788899999999999999999999999999999999999999999987543221 1112234
Q ss_pred ccCCccccccccccCc------ccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC------CCCCCCCh
Q psy6203 167 SCGSPNYAAPEVIKGK------QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY------TEPPWMSP 233 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~------~~~~~~~~ 233 (568)
.+++..|+|||++... ..++.++|||||||++|+|++ |..||...+..+....+..+.. ..+...++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 5688999999997532 124678999999999999997 5789987776666655543321 12334688
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+.+++..|+ .+|++|||++++++
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHH
Confidence 8999999999 68999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=315.09 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=199.4
Q ss_pred ccCeEEEeeecccCCeEEEEEE----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe--CCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET--SSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~ 80 (568)
..+|++.+.||+|+||.||+|. +..++..||+|.+.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 3589999999999999999997 44578899999986543 2234578899999999999999999998743 346
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 89999999999999999764 56899999999999999999999999999999999999999999999999998865432
Q ss_pred Cccc--cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Q psy6203 160 LESQ--LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----------------QLYDKIL 221 (568)
Q Consensus 160 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~----------------~~~~~i~ 221 (568)
.... .....++..|+|||++.+.. ++.++|||||||++|+|++|..|+...... .+.+.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 2111 11122345699999998765 588999999999999999987775432211 1111122
Q ss_pred cC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 222 NG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 222 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+ ..+.+..++.++.+|+.+||..+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22 22334567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=312.24 Aligned_cols=248 Identities=25% Similarity=0.483 Sum_probs=209.5
Q ss_pred CeEEEeeecccCCeEEEEEEEcC-CCcEEEEEEeecCCc---------CCchHHHHHHHHHHHh-CCCCCcceeeEEEEe
Q psy6203 9 QYILERTVGSGGFAKVKLATHVL-TGEKVAIKIMKKATL---------GEDLPRVKLEINALKH-ISHQHICKLFQVIET 77 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~ 77 (568)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 678999998864321 1123456678887765 799999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGL 152 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~ 152 (568)
.+..++||||+++++|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3568999999999999999999996 7899999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-C-CC
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-P-PW 230 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~-~-~~ 230 (568)
+....... ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+..+.... + ..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 87654322 334456899999999998765 5899999999999999999999998887777777776665432 2 25
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.++.+.++|.+||+.||++||++.|+..+
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 78999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=316.30 Aligned_cols=259 Identities=28% Similarity=0.468 Sum_probs=215.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc------hHHHHHHHHHHHhCCCCCcceeeEEEE-e
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED------LPRVKLEINALKHISHQHICKLFQVIE-T 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~ 77 (568)
-+.++|-++..||+|||+.||+|.+....+.||||+-.......+ .+..-+|..|.+.|+||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 356789999999999999999999999999999998654433222 234567999999999999999999995 5
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCceEEcC---CCCeEEEeecC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL--GYAHRDLKPENVLLDR---NQNLKLIDFGL 152 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~---~~~~kl~DFG~ 152 (568)
.+.+|-|+|||+|.+|.-+++..+.++|.+++.|+.||+.||.||.+. .|||-||||.|||+.. .|.+||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 667899999999999999999999999999999999999999999865 6999999999999943 46899999999
Q ss_pred ccCCCCCCc------cccccccCCccccccccccC---cccCCcccceechhhHHHHHHhCCCCCCCCCHH-HHHH--HH
Q psy6203 153 CAKPEGGLE------SQLQTSCGSPNYAAPEVIKG---KQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYD--KI 220 (568)
Q Consensus 153 a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-~~~~--~i 220 (568)
++...+... .......||-+|++||.+.- .+..+.++||||+|||+|..+.|+.||..+... .+.+ .|
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 987654322 12344579999999999852 344688999999999999999999999765432 2221 22
Q ss_pred Hc---CCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 221 LN---GKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 221 ~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
++ -.++..+.+++++++||++||++.-++|..+.++..||||.
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 22 24555677999999999999999999999999999999997
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.71 Aligned_cols=250 Identities=17% Similarity=0.227 Sum_probs=192.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC---CcEEEEEEeecCCcCCchH----------HHHHHHHHHHhCCCCCcceee
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLGEDLP----------RVKLEINALKHISHQHICKLF 72 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~----------~~~~Ei~~l~~l~hpnIv~l~ 72 (568)
..++|++.+.||+|+||+||+|.+..+ +..+|+|+..........+ ....+...+..++|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 457899999999999999999998877 6677888644322110000 112233445667899999999
Q ss_pred EEEEeCC----EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 73 QVIETSS----HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 73 ~~~~~~~----~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
+...... ..+++||++ ..++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8765443 457888988 45677777665567899999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCc------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH-H-------
Q psy6203 149 DFGLCAKPEGGLE------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-D------- 214 (568)
Q Consensus 149 DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~------- 214 (568)
|||+|+....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+. .
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 9999875432111 1122346999999999998776 59999999999999999999999976632 1
Q ss_pred -HHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 215 -QLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 215 -~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+....+..+... .+..++.+.++++.|+..+|++||+.+++++
T Consensus 248 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 CDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223344444333 2345789999999999999999999999875
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.09 Aligned_cols=248 Identities=27% Similarity=0.529 Sum_probs=207.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCC--EEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSS--HIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~--~~~l 83 (568)
.++|++.+++|+|.++.|+.|.+..++++++||+++... .+.+.+|++||..|. ||||++++++..+.. ..-+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 468999999999999999999999999999999998543 457899999999997 999999999987653 5679
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-CCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~ 162 (568)
|+||+.+.+...+. ..++..+++.++.+++.||.|||++||+|||+||.|++|+.. -.++|+|+|+|.....+.+
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence 99999887766554 458899999999999999999999999999999999999865 4699999999998877643
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCC-CCC-CHHHHHHH--HH----------c------
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSD-SIDQLYDK--IL----------N------ 222 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf-~~~-~~~~~~~~--i~----------~------ 222 (568)
.+..+.+..|--||++..-+.|+..-|+|||||++..|+..+-|| .+. +.+++.+- +. .
T Consensus 189 -YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 189 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred -eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 355678899999999998888899999999999999999999887 333 33332211 10 0
Q ss_pred -------CCCCCC-----------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 223 -------GKYTEP-----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 223 -------~~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+...-. ..+++++.||+.++|.+|-.+|+|+.|++.||||.
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 011100 12579999999999999999999999999999997
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=313.19 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=203.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEc----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHV----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET--SSHI 81 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 81 (568)
..|++.+.||+|+||.||+|... .++..+|+|++...........+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56888999999999999999864 34789999999765433235678899999999999999999999877 5578
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 99999999999999997654 68999999999999999999999999999999999999999999999999987654321
Q ss_pred cc--ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH---------------HHHHHHHcC
Q psy6203 161 ES--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---------------QLYDKILNG 223 (568)
Q Consensus 161 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~---------------~~~~~i~~~ 223 (568)
.. ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... .+...+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 11 111223456799999987765 588999999999999999999998653221 122222222
Q ss_pred -CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 224 -KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 224 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
..+.+...+.++.+++.+||+.+|.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22334556789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=310.34 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=204.7
Q ss_pred eEEEeeecccCCeEEEEEEEcC---CCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q psy6203 10 YILERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSS------ 79 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------ 79 (568)
|.+.++||+|+||.||+|.... ++..||+|++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998643 5789999998754322 23456788999999999999999999886432
Q ss_pred EEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 80 HIFMVIEYCPGGELLDHIVER------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
..++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347899999999998887532 24788999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q psy6203 154 AKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPW 230 (568)
Q Consensus 154 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~ 230 (568)
........ .......+++.|++||.+.+.. ++.++|||||||++|+|++ |.+||.+.+.......+..+. ...++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 76433211 1112334567899999987765 5889999999999999999 899998888777777666553 344556
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.++.+.+++.+||+.+|++|||+.+++.+
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=302.04 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=210.5
Q ss_pred EEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHH-hCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALK-HISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 12 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
-+..||.|+||+|++-.++.+|+..|||.+.......+..++..|.+... .-++||||++|+..-.++..+|.||+++
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 35679999999999999999999999999988776666677888887654 4469999999999989999999999994
Q ss_pred CChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 91 GELLDHIV-----ERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 91 g~L~~~i~-----~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
.+|..+.. ++..++|..+-.|..-.+.||.||-. .+|||||+||+|||++..|.+||||||++.....+.. .
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--k 224 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--K 224 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--h
Confidence 46554432 35679999999999999999999975 5899999999999999999999999999876554321 2
Q ss_pred ccccCCccccccccccCccc-CCcccceechhhHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCC------CCCChHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQY-YGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYTEP------PWMSPNSR 236 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~-~~~~~DiwSlG~il~~lltG~~pf~~~-~~~~~~~~i~~~~~~~~------~~~~~~~~ 236 (568)
+...|...|||||.+..... |+-+||+||||++|||+.||..|+.+- +.-+....+..|.++.. -..+..+.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~ 304 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMV 304 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHH
Confidence 33468889999999965443 788999999999999999999999763 34455556667766532 23788999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCcccccCCCC
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 268 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 268 (568)
.+|..||.+|-+.||+..+++.+||++.....
T Consensus 305 ~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 305 RFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred HHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 99999999999999999999999999965443
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=331.21 Aligned_cols=241 Identities=32% Similarity=0.488 Sum_probs=197.3
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC------EEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS------HIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~~~ 82 (568)
.+...+.||+|+||.||+++++.||+.||||.+++.......+..-+|+++|++|+|||||+++++-++.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34556889999999999999999999999999987665556778889999999999999999999865443 468
Q ss_pred EEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc--CCC--CeEEEeecCccC
Q psy6203 83 MVIEYCPGGELLDHIVE---RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD--RNQ--NLKLIDFGLCAK 155 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~~--~~kl~DFG~a~~ 155 (568)
+|||||.||||...+.+ ...+++.+.+.++..++.||.|||++||+||||||.||++. .+| ..||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999999974 35699999999999999999999999999999999999984 334 369999999998
Q ss_pred CCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC----CHHHHHHHHHcCC-------
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGK------- 224 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~----~~~~~~~~i~~~~------- 224 (568)
...+ +...+.+||+.|.+||++....+|+..+|.|||||++|+++||..||... +..++...+...+
T Consensus 174 l~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 7664 46778899999999999986566899999999999999999999999432 2223333332211
Q ss_pred --------------CCCCCCCChH----HHHHHHHccccCcCCCC
Q psy6203 225 --------------YTEPPWMSPN----SRQIVRSMLQVEPGKRI 251 (568)
Q Consensus 225 --------------~~~~~~~~~~----~~~li~~~L~~dP~~Rp 251 (568)
++.+..+++. +-..+..+|..+|.+|-
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 2223334443 34678889999999998
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.49 Aligned_cols=450 Identities=22% Similarity=0.244 Sum_probs=306.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+.+++|+++.++|+|+||.||+++++.+++..|+|+++... ..+...++.|+-+++..+|||||.+++.+...+..++.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 67889999999999999999999999999999999998654 35667788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||||.||+|.+...-.++++|.++...++..+.||+|||++|=+|||||-.||++++.|.+|++|||.+..+.... ...
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Kr 169 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKR 169 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hhh
Confidence 9999999999988888999999999999999999999999999999999999999999999999999988765432 234
Q ss_pred ccccCCcccccccccc--CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----CCCChHHHH
Q psy6203 165 QTSCGSPNYAAPEVIK--GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP-----PWMSPNSRQ 237 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~~ 237 (568)
..+.||+.|||||+.. ....|...+|||++|++..|+-.-++|-...........+....+..| ...++.+.+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 5678999999999863 233468899999999999999877777544333333334444444333 336788999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccccCC-----------CCCCC--CCCCCCcCCcCCHHHHHHHHhccCCCHHHHHHH
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMGP-----------EDNPV--SFRPDHELREKDDDVIKVMADHKQLSPDDMWSQ 304 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~~~-----------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (568)
|++.+|.++|.+|||++.+|.|||+...- ..+|. .........+.-..+...+......+..++..
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~- 328 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV- 328 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-
Confidence 99999999999999999999999997420 01111 11000000000000111111100000000000
Q ss_pred HHhcCCChhHHHHHHHhhhhccCCccCCCCcchhhhHHHHHHHHhCCCCCChhhHHHHHHHHhhccCcceeEEEccccCc
Q psy6203 305 LNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPT 384 (568)
Q Consensus 305 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~~~~~~iki~dfG~~ 384 (568)
.+..+.+....|.++. ..+...+..+...+ ..| ..+.+....+..||+..
T Consensus 329 -se~~~~~~~~~~~~r~--et~~l~~l~~~~~~-~~d--------------------------~~l~s~~~~~~~~~~v~ 378 (829)
T KOG0576|consen 329 -SEIALEQYQFAYPLRK--ETRPLAELHSSYKV-HRD--------------------------NILGSEEEVKLLDFAVP 378 (829)
T ss_pred -hhHhhhhhhhhhhhhh--hccccccccccccc-Ccc--------------------------cccccccccccccccCC
Confidence 0000000001111111 11111111000000 000 00223355677888843
Q ss_pred ccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----C
Q psy6203 385 ILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP-----P 458 (568)
Q Consensus 385 ~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~-----~ 458 (568)
..+ ......++..+|+.+++|++ ....+....|.||+|+--.+|.-|-+|-.+.. .....+..+. ..| .
T Consensus 379 ~~L--~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p-~s~~L~~~~ 453 (829)
T KOG0576|consen 379 PQL--TRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGP-NSPMLTDKS 453 (829)
T ss_pred ccc--CcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCC-Cccccchhh
Confidence 332 22224677899999999996 77778889999999998888988988876521 1111111111 000 0
Q ss_pred CCCHHH-HHHHHHccCCCcCCCCCHHHHhcCcccc
Q psy6203 459 WMSPNS-RQIVRSMLQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 459 ~~s~~~-~~li~~~L~~dp~~R~t~~~~l~hp~~~ 492 (568)
..++.. .++...|+..-|..|.....++-|.+|.
T Consensus 454 aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfn 488 (829)
T KOG0576|consen 454 AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFN 488 (829)
T ss_pred hcCcccccCCcccccCCCCCCCcchhhHHHHHHhc
Confidence 112222 2477889999999999999998888886
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=329.71 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=218.2
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEE-----e
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIE-----T 77 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~-----~ 77 (568)
.+..+.++|.++||.|.+|.||+++++.+|+..|+|++.... +..+.++.|.++|+.+ .|||++.+|++|. .
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 355678999999999999999999999999999999987654 3345788899999988 4999999999984 3
Q ss_pred CCEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK 155 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 155 (568)
++.++||||||.||+..|++++ ..++.|+.+..|++.++.||.+||.+.++|||||-.|||++.++.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 4689999999999999999975 46789999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCccccccccCCccccccccccCcc----cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CC
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGKQ----YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EP 228 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~ 228 (568)
.... ....++.+|||.|||||++...+ -|+..+|+||||++..||.-|.+|+....+...+-.|-...++ -+
T Consensus 173 ldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp 251 (953)
T KOG0587|consen 173 LDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP 251 (953)
T ss_pred eecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence 6543 33457889999999999996543 2567899999999999999999999766554333333222211 12
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
...+..+.++|..||.+|-.+||+..++|.|||++.
T Consensus 252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 346788999999999999999999999999999983
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=352.67 Aligned_cols=483 Identities=24% Similarity=0.404 Sum_probs=337.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC-CCcEEEEEEeecCC-cCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL-TGEKVAIKIMKKAT-LGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l 83 (568)
...|.+.+.||+|+|+.|-++.... +...+|+|.+.... ..........|..+-+.+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4678999999999999999887643 34456777665543 1222344555887777787 9999999999999999999
Q ss_pred EEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCceEEcCCC-CeEEEeecCccCCCC-
Q psy6203 84 VIEYCPGGELLDHI-VERQ-RLGEKESRAFFRQILSAVAYLH-HLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEG- 158 (568)
Q Consensus 84 V~E~~~~g~L~~~i-~~~~-~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~- 158 (568)
+++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.++ .++++|||+|.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999998 5554 6788899999999999999999 99999999999999999999 999999999987654
Q ss_pred -CCccccccccC-CccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH-H-HHHHHc-C--CCCCCCCC
Q psy6203 159 -GLESQLQTSCG-SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-L-YDKILN-G--KYTEPPWM 231 (568)
Q Consensus 159 -~~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~-~-~~~i~~-~--~~~~~~~~ 231 (568)
+........+| ++.|+|||...+..+..+..|+||.|+++.-+++|..||....... . ...+.. + .......+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 33444566788 9999999999887677889999999999999999999996543221 1 111111 1 12333457
Q ss_pred ChHHHHHHHHccccCcCCCCCHHHHhcCccccc-CCCCCCC--CCCC----CCcC---C-c-CCHHHHH--------HHH
Q psy6203 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM-GPEDNPV--SFRP----DHEL---R-E-KDDDVIK--------VMA 291 (568)
Q Consensus 232 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~-~~~~~~~--~~~~----~~~~---~-~-~~~~~~~--------~~~ 291 (568)
+....+++.+++..+|..|.+.+++-.+||+.. ....... ...+ .... + . ....++. ...
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~ 338 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAK 338 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccccccccccccccccccccccCccccccccCCccceeeecccCceEEEE
Confidence 889999999999999999999999999999986 1100000 0000 0000 0 0 0000000 000
Q ss_pred hccCC--CHHHH-H----HHHHhcCCCh--------------hHHHHHHHhhhhccCCccCCCCcchhhhHHHHHHHHhC
Q psy6203 292 DHKQL--SPDDM-W----SQLNEWTYNY--------------DTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCG 350 (568)
Q Consensus 292 ~~~~~--~~~~~-~----~~l~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~l~~~~~~ 350 (568)
..... .+.+. . ....+..|+. ....-.++..- +....+.+ =.|..+ +||.++..
T Consensus 339 ~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~--~~~~~~~~--mE~~~~-Dlf~~~~~ 413 (601)
T KOG0590|consen 339 RRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ--EIDGILQS--MEYCPY-DLFSLVMS 413 (601)
T ss_pred ecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh--hcccchhh--hhcccH-HHHHHHhc
Confidence 00000 00000 0 0000111111 11000011000 11111111 234445 88888888
Q ss_pred CCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCcccccCCCC---ceecccccccccccC
Q psy6203 351 FLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILLPCKVG---QVINLLRSAIVLCSA 407 (568)
Q Consensus 351 ~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~~~~~~---~~~~~~~gt~~~~~p 407 (568)
.+.+...++..+|+|++.|+ ...+.+||+|||.+.+...... ......+|+-.|.||
T Consensus 414 ~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~ap 493 (601)
T KOG0590|consen 414 NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAP 493 (601)
T ss_pred ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCc
Confidence 78999999999999999874 2334789999997755544332 345678999999999
Q ss_pred CC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH--HH-------HHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 408 PS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY--DK-------ILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 408 e~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~--~~-------i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
|+ ...|....+||||+|+++..|++|+.||......+.. .. +..+....-..++...+.+|.+||+.||
T Consensus 494 E~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P 573 (601)
T KOG0590|consen 494 EVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDP 573 (601)
T ss_pred ccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCCh
Confidence 98 7788888999999999999999999999875543221 11 1112222223478889999999999999
Q ss_pred CCCCCHHHHhcCcccccC
Q psy6203 477 GKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~t~~~~l~hp~~~~~ 494 (568)
.+|+|+++|++.+||+..
T Consensus 574 ~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 574 TKRITIEQILNDEWIRSI 591 (601)
T ss_pred hheecHHHHhhChHhhhc
Confidence 999999999999999853
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=298.79 Aligned_cols=254 Identities=27% Similarity=0.466 Sum_probs=213.3
Q ss_pred EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----EEEEE
Q psy6203 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSS-----HIFMV 84 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~lV 84 (568)
+-.+.||-|+||.||.+.+..+|+.||+|.+...... ...+++-+|+++|..++|.|++..+++.+..+ .+|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999999999999999988643221 23567888999999999999999999886543 46889
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
+|++ ..+|...|..-..++.+.++-+++||++||+|||+.||.||||||.|+|+++|..+||||||+++.........+
T Consensus 136 TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 9999 678999998889999999999999999999999999999999999999999999999999999998766555555
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHH-----------------------
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL----------------------- 221 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~----------------------- 221 (568)
...+.|..|.|||++.|...|+.+.||||.|||+.||+..+..|...+.-+..+.|.
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 666789999999999999889999999999999999999999998766555444332
Q ss_pred cCCCCCCC-----------CCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 222 NGKYTEPP-----------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 222 ~~~~~~~~-----------~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
++....|. .-..+..+++..+|..||++|++.++.+.|++...+
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 12221111 123456789999999999999999999999998643
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=295.62 Aligned_cols=251 Identities=28% Similarity=0.497 Sum_probs=208.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc-CCchHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISHQHICKLFQVIETS------S 79 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~ 79 (568)
..+|.-++.+|.|.- .|..|-+..+++.||+|.+..... ....++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 458888999999999 888899999999999998765522 23567888999999999999999999998533 3
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
.+|+|||++ ..+|.+.+. -.++-..+..|+.|++.|++|||+.||+||||||+||++..+..+||.|||+|+.....
T Consensus 95 e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 689999999 568888876 45778889999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC----------------
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---------------- 223 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~---------------- 223 (568)
-..+..+.|..|.|||++.+.. +...+||||+||++.||++|+..|.+.+.-+.+.++...
T Consensus 172 --~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred --cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 3456678899999999999888 689999999999999999999999876543333222110
Q ss_pred --------C---CC----CC-----------CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 --------K---YT----EP-----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 --------~---~~----~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+ .. +| +.-+..+++++.+||..||++|.|++++|.|||++.
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 0 00 01 112346789999999999999999999999999983
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=332.81 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=179.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCC----CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEE------EE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLT----GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQV------IE 76 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~------~~ 76 (568)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .+....| .++...+.++..+... ..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46899999999999999999999988 89999998764321 1111111 1222223333332222 23
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCc
Q psy6203 77 TSSHIFMVIEYCPGGELLDHIVERQR--------------------LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPEN 136 (568)
Q Consensus 77 ~~~~~~lV~E~~~~g~L~~~i~~~~~--------------------l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 136 (568)
.....++||||+.+++|.+++..... ..+..+..++.||+.||.|||++||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 55678999999999999999865321 1234467899999999999999999999999999
Q ss_pred eEEcC-CCCeEEEeecCccCCCCCCccccccccCCccccccccccCcc---------------------cCCcccceech
Q psy6203 137 VLLDR-NQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ---------------------YYGSETDVWSM 194 (568)
Q Consensus 137 Ill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~DiwSl 194 (568)
||++. ++.+||+|||+|+.............++|+.|+|||.+.... .++.++||||+
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 579999999999865444334445678999999999764221 12345699999
Q ss_pred hhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------------CCCCCChHHHHHHHHccccCcCCCCCH
Q psy6203 195 GVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---------------------EPPWMSPNSRQIVRSMLQVEPGKRIKI 253 (568)
Q Consensus 195 G~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---------------------~~~~~~~~~~~li~~~L~~dP~~Rps~ 253 (568)
||++|+|+++..|+... ...+...+...... ..........+||.+||++||.+|||+
T Consensus 366 GviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 99999999987775432 11222222111110 001123345689999999999999999
Q ss_pred HHHhcCccccc
Q psy6203 254 QDLLGHNWVKM 264 (568)
Q Consensus 254 ~ell~hp~~~~ 264 (568)
.|+|+||||..
T Consensus 445 ~e~L~Hpff~~ 455 (566)
T PLN03225 445 KAALAHPYFDR 455 (566)
T ss_pred HHHhCCcCcCC
Confidence 99999999984
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=323.94 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=222.3
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCc---EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
.-.|.++||.|.||.|+.|+-+..|+ .||||.++....+.....|..|..||-+++||||++|.++......+.||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45789999999999999999887764 699999987766566677999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++|+|..+++++ +.|+..+...+++.|+.|++||-++|+|||||...|||++.+-.+|++|||+++...++.....
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 999999999999875 6799999999999999999999999999999999999999999999999999997765543334
Q ss_pred ccccC--CccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHH
Q psy6203 165 QTSCG--SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVR 240 (568)
Q Consensus 165 ~~~~g--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 240 (568)
.+..| ...|.|||.+..++ ++.++||||+|+++||.++ |..||...+.+++++.|..|- ++.|...+..+.+|+.
T Consensus 790 tt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMl 868 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLML 868 (996)
T ss_pred cccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHH
Confidence 44444 35899999998877 6999999999999999876 999999999999999998884 4566678999999999
Q ss_pred HccccCcCCCCCHHHHhc
Q psy6203 241 SMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~ 258 (568)
.||++|-.+||++.||+.
T Consensus 869 dCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 869 DCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHhhcCCCHHHHHH
Confidence 999999999999999876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=291.73 Aligned_cols=240 Identities=45% Similarity=0.776 Sum_probs=210.5
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCChHHHHHh
Q psy6203 20 GFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE 99 (568)
Q Consensus 20 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~i~~ 99 (568)
+||.||+|.+..+|+.+|+|++.........+.+.+|+..+++++|+||+++++.+......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997655433257888999999999999999999999999999999999999999999987
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCccccccccc
Q psy6203 100 RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179 (568)
Q Consensus 100 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l 179 (568)
...++...+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHH
Confidence 7669999999999999999999999999999999999999999999999999987654321 33445688899999998
Q ss_pred cCcccCCcccceechhhHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCCC---CChHHHHHHHHccccCcCCCCCHHH
Q psy6203 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKYTEPPW---MSPNSRQIVRSMLQVEPGKRIKIQD 255 (568)
Q Consensus 180 ~~~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rps~~e 255 (568)
.+.. ++.++||||+|+++++|++|..||.. .......+.+..+....... ++.++.+++.+||..+|++||++.+
T Consensus 159 ~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 159 LGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred ccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 7655 57899999999999999999999987 66666777666665554433 7889999999999999999999999
Q ss_pred HhcCccc
Q psy6203 256 LLGHNWV 262 (568)
Q Consensus 256 ll~hp~~ 262 (568)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.40 Aligned_cols=245 Identities=28% Similarity=0.450 Sum_probs=210.7
Q ss_pred EEEeeecccCCeEEEEEEEcC--CC--cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 11 ILERTVGSGGFAKVKLATHVL--TG--EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.+.+.||.|-||.||.|.-.. .| -.||||..+.....++.+.|..|..+|+.++|||||++++++.+. ..+||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 445789999999999997532 23 358999988766666788999999999999999999999999654 5799999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
+++-|.|..++..+ ..++......++.||+.||.|||+.+.|||||-..|||+.+...+||+|||+++...........
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS 550 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS 550 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence 99999999999865 56888899999999999999999999999999999999999999999999999987765433333
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHcc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L 243 (568)
...-..-|||||.+.-.. ++.++|||-|||++||++. |..||.+-...++.-.+.+|. ++.|+..++.+-.|+.+||
T Consensus 551 ~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcW 629 (974)
T KOG4257|consen 551 RGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCW 629 (974)
T ss_pred ccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHh
Confidence 333356899999997666 6999999999999999987 999999887777777777764 5778899999999999999
Q ss_pred ccCcCCCCCHHHHh
Q psy6203 244 QVEPGKRIKIQDLL 257 (568)
Q Consensus 244 ~~dP~~Rps~~ell 257 (568)
.+||.+||++.++.
T Consensus 630 ayeP~kRPrftei~ 643 (974)
T KOG4257|consen 630 AYEPSKRPRFTEIK 643 (974)
T ss_pred ccCcccCCcHHHHH
Confidence 99999999987754
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=301.60 Aligned_cols=132 Identities=33% Similarity=0.467 Sum_probs=114.7
Q ss_pred cc-cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-----C---CCcceeeEEEE
Q psy6203 6 LR-NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-----H---QHICKLFQVIE 76 (568)
Q Consensus 6 ~~-~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----h---pnIv~l~~~~~ 76 (568)
|. ++|.+.++||.|.|++||+|.+..+.+.||+|+.+.... -.+....||++|++++ | .+||+|++.|.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 44 899999999999999999999999999999999985432 2345677999999883 3 47999999996
Q ss_pred e----CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEc
Q psy6203 77 T----SSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLD 140 (568)
Q Consensus 77 ~----~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~ 140 (568)
. +.++|+|+|++ |.+|+.+|... +.++...++.|++||+.||.|||.. ||||-||||+|||+.
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 4 45899999999 88999999764 5699999999999999999999965 999999999999973
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=307.70 Aligned_cols=252 Identities=29% Similarity=0.481 Sum_probs=209.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCC------CCcceeeEEEEeC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH------QHICKLFQVIETS 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~~~~~ 78 (568)
-+.++|.+....|+|-||+|..|.+...|..||||++..... -.+.=..|+++|++|+. -|+++++..|...
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 356899999999999999999999999999999999986532 12344579999999962 3899999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCcc
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQ---RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCA 154 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~ 154 (568)
+++|||+|-+ .-+|.+.+.+-+ .+....++.++.|+..||..|-..||+|.||||+|||+++.. .+||||||.|.
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 9999999998 568999998744 477889999999999999999999999999999999998764 58999999988
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCC-----
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKYTE----- 227 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~~~----- 227 (568)
....+ .......+..|.|||++.|-+ |+...|+||+||+||||.||+..|++.+..+++...+. |.++-
T Consensus 586 ~~~en---eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASEN---EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccc---cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 76543 334445678899999999988 58999999999999999999999999887766543322 11110
Q ss_pred -----------------------------------C-----------CCC-------ChHHHHHHHHccccCcCCCCCHH
Q psy6203 228 -----------------------------------P-----------PWM-------SPNSRQIVRSMLQVEPGKRIKIQ 254 (568)
Q Consensus 228 -----------------------------------~-----------~~~-------~~~~~~li~~~L~~dP~~Rps~~ 254 (568)
| +.+ -..+++|+.+||..||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 0 001 13578999999999999999999
Q ss_pred HHhcCcccc
Q psy6203 255 DLLGHNWVK 263 (568)
Q Consensus 255 ell~hp~~~ 263 (568)
|+|.||||.
T Consensus 742 qAL~HpFi~ 750 (752)
T KOG0670|consen 742 QALKHPFIT 750 (752)
T ss_pred HHhcCCccc
Confidence 999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.87 Aligned_cols=257 Identities=19% Similarity=0.301 Sum_probs=188.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc----------------CCCcEEEEEEeecCCcCC-------------chHHHHHHH
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV----------------LTGEKVAIKIMKKATLGE-------------DLPRVKLEI 57 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~Ei 57 (568)
.++|.+.++||+|+||+||+|... ..++.||||.+....... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 234679999986432110 112234577
Q ss_pred HHHHhCCCCCc-----ceeeEEEEe--------CCEEEEEEeccCCCChHHHHHhc------------------------
Q psy6203 58 NALKHISHQHI-----CKLFQVIET--------SSHIFMVIEYCPGGELLDHIVER------------------------ 100 (568)
Q Consensus 58 ~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~g~L~~~i~~~------------------------ 100 (568)
.++.+++|.++ +++++++.. .+..++||||+++++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777876554 666666642 35689999999999999988642
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCcccccccccc
Q psy6203 101 QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180 (568)
Q Consensus 101 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 180 (568)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++...............+|+.|+|||.+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 12345678899999999999999999999999999999999999999999998754432222222234589999999985
Q ss_pred Cccc-------------------C--CcccceechhhHHHHHHhCCC-CCCCCC-----------HHHHHHHHHcCCCCC
Q psy6203 181 GKQY-------------------Y--GSETDVWSMGVMLYALLCGFL-PFDSDS-----------IDQLYDKILNGKYTE 227 (568)
Q Consensus 181 ~~~~-------------------~--~~~~DiwSlG~il~~lltG~~-pf~~~~-----------~~~~~~~i~~~~~~~ 227 (568)
.... + ..+.||||+||++|+|++|.. ||.... ....+..+....+.+
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 4221 1 124799999999999999875 664321 111122222333333
Q ss_pred --CCCCChHHHHHHHHccccCc---CCCCCHHHHhcCcccc
Q psy6203 228 --PPWMSPNSRQIVRSMLQVEP---GKRIKIQDLLGHNWVK 263 (568)
Q Consensus 228 --~~~~~~~~~~li~~~L~~dP---~~Rps~~ell~hp~~~ 263 (568)
....++.+++|+.+||..+| .+|+|++|+|+||||.
T Consensus 464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 34578999999999999866 6899999999999996
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=307.22 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=210.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++.-.+.++||+|-||.|.+|.-. .+.+||+|.++..........|..|+++|.+|+|||||+++++|..++.+++|||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 356678999999999999999853 4689999999876655556789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|++.|+|.+++.+... ........|+.||++|++||.+.++|||||.+.|+|++.++++||+|||+++..-.+.....
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999999987643 34455667999999999999999999999999999999999999999999985444332222
Q ss_pred c-cccCCccccccccccCcccCCcccceechhhHHHHHHh--CCCCCCCCCHHHHHHHHHcC--------CCCCCCCCCh
Q psy6203 165 Q-TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC--GFLPFDSDSIDQLYDKILNG--------KYTEPPWMSP 233 (568)
Q Consensus 165 ~-~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt--G~~pf~~~~~~~~~~~i~~~--------~~~~~~~~~~ 233 (568)
+ ..+-...|||||.+..++ ++.++|+|++|+++||+++ ...||...+.+++.++...- .+..|+..+.
T Consensus 696 qgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence 2 234567999999998776 6999999999999999865 78899888877776654321 1234566788
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+.+++.+|+..|..+|||.+++..
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHHHH
Confidence 9999999999999999999999854
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.34 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=217.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCC---cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTG---EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++..+.++||+|+||.|+.|.+...+ -.||||++...........|.+|+.+|.+|+|||++++|++..+ ..+.+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34566789999999999999987543 35899999877666567789999999999999999999999987 667899
Q ss_pred EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
||+++.|+|.+.+.+ +..|.......++.||+.|+.||.+++.|||||-..|+|+-....|||+|||+.+....+...
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999999987 356888899999999999999999999999999999999999999999999999876654322
Q ss_pred ccc--cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 163 QLQ--TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 163 ~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
... ..--...|+|||.+.... ++.++|+|++||++|||+| |..||.+.+..++.++|..+. ++-|+..+.++.++
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i 347 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI 347 (1039)
T ss_pred eEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence 211 112345799999999877 6999999999999999998 899999999999999988664 45677789999999
Q ss_pred HHHccccCcCCCCCHHHHhcCcccc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
++.||..+|.+|||+..|.+.-+..
T Consensus 348 mk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 348 MKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHhccCCccccccHHHHHHhHHHH
Confidence 9999999999999999987554443
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=301.48 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=215.7
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecc
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYC 88 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 88 (568)
+.....+||-|.||.||.|.+++..-.||||.++...+ ....|..|..+|+.++|||+|+++++|..+..+|||+|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 44667899999999999999999999999999986654 4668999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 89 PGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 89 ~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
..|+|++++++. ..++.-....++.||.+|+.||..+++|||||-..|+|+.++..+|++|||+++....+.....-.
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence 999999999864 346667778899999999999999999999999999999999999999999999876543222111
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 244 (568)
.--...|.|||-+.-+. ++.++|||+|||+|||+.| |..||.+-+..+++..+.++.. ..|..+++.+.+|++.||+
T Consensus 426 AKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~ 504 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWN 504 (1157)
T ss_pred ccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhc
Confidence 22356799999998766 5889999999999999998 9999999999999998887754 4577799999999999999
Q ss_pred cCcCCCCCHHHHh
Q psy6203 245 VEPGKRIKIQDLL 257 (568)
Q Consensus 245 ~dP~~Rps~~ell 257 (568)
++|.+||++.|+-
T Consensus 505 WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 505 WSPSDRPSFAEIH 517 (1157)
T ss_pred CCcccCccHHHHH
Confidence 9999999998873
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.27 Aligned_cols=242 Identities=27% Similarity=0.442 Sum_probs=196.6
Q ss_pred EeeecccCCeE-EEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 13 ERTVGSGGFAK-VKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 13 ~~~lG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
.+.+|.|+.|+ ||+|. ..|+.||||.+-.. ......+|+..|+.-+ |||||++|+.-.+....||..|.| .
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 46789999985 78888 47889999987543 3456789999999874 999999999999999999999999 5
Q ss_pred CChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---CC--CeEEEeecCccCCCCCCc
Q psy6203 91 GELLDHIVERQR----LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---NQ--NLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 91 g~L~~~i~~~~~----l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~--~~kl~DFG~a~~~~~~~~ 161 (568)
.+|.+++..... ......+.++.|+++||++||+.+||||||||+||||+. ++ .++|+|||+|++...+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 699999976411 112455788999999999999999999999999999976 34 689999999998766543
Q ss_pred c--ccccccCCccccccccccCcccCCcccceechhhHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCC---CCChHH
Q psy6203 162 S--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGKYTEPP---WMSPNS 235 (568)
Q Consensus 162 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~ 235 (568)
+ ...+..||-+|+|||++..... +.++|||||||++|+.++| ..||...-. -..+|..+.+.... ....++
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred hhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccCchHHH
Confidence 3 2345679999999999987764 6789999999999999985 899965432 23467777664321 122289
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+||.+||.+||..||+|.++|.||+|..
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 99999999999999999999999999973
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=299.80 Aligned_cols=199 Identities=34% Similarity=0.618 Sum_probs=180.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-------CchHHHHHHHHHHHhCC---CCCcceeeEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-------EDLPRVKLEINALKHIS---HQHICKLFQVIET 77 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~ 77 (568)
..|..++.+|+|+||.|++|.++.....|+||.+.+...- ...-.+-.||+||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4599999999999999999999999999999998876542 12334667999999997 9999999999999
Q ss_pred CCEEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 78 SSHIFMVIEYC-PGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 78 ~~~~~lV~E~~-~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
++++||+||-- +|-+|+++|.-+..++|.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999987 56799999999999999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCC
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD 209 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~ 209 (568)
..+ ....++||..|+|||++.|.+|.+..-|||+||++||.++....||.
T Consensus 721 ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 KSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 543 45677899999999999999998999999999999999999888874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=333.74 Aligned_cols=238 Identities=19% Similarity=0.247 Sum_probs=188.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
...|...+.||+|+||.||+|.+..+|..||+|.+..... ....|+..+++++|||||++++++.+.+..|+|||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3456677899999999999999999999999998864321 12346888999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH---HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|+++|+|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 999999999985 4889999999999999999999 6799999999999999998888775 665433221
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC-----HHHHHHHHHc---------CCC----
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-----IDQLYDKILN---------GKY---- 225 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-----~~~~~~~i~~---------~~~---- 225 (568)
.....||+.|+|||++.+.. ++.++|||||||++|||+||+.||.... ..+....... ...
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 12336889999999998766 6899999999999999999999985321 1111111110 000
Q ss_pred CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 226 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
..+.....++.+++.+|++.||++|||+.|+++.
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000112346789999999999999999999874
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=291.26 Aligned_cols=219 Identities=25% Similarity=0.388 Sum_probs=188.7
Q ss_pred cCCccCCCCcch-----hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEcc
Q psy6203 326 QGKQYYGSETDV-----WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQ 380 (568)
Q Consensus 326 ~~~~~~~~~~~~-----~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~d 380 (568)
+....|.++.+. |..||+||+++...|+|+|.+++.+|+||+.|+ +...||||+|
T Consensus 76 ~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIAD 155 (786)
T KOG0588|consen 76 RLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIAD 155 (786)
T ss_pred eeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeec
Confidence 445668888887 455999999999999999999999999999874 2234799999
Q ss_pred ccCcccccCCCCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy6203 381 YFPTILLPCKVGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP 458 (568)
Q Consensus 381 fG~~~~~~~~~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~ 458 (568)
||.|-+ ..+|..+.+.||+|.|.+||+ +..|.|.++||||+|||||.||+|+.||+++|...++.++..|.|..|.
T Consensus 156 FGMAsL--e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs 233 (786)
T KOG0588|consen 156 FGMASL--EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS 233 (786)
T ss_pred cceeec--ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC
Confidence 996543 456778899999999999998 8899999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCCC-----------------CCCCCChHHHHHHHhccC-CCHH
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN-----------------PLREKDDDVIKVMADHKQ-LSPD 520 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~-~~~~ 520 (568)
.+|++|++||.+||..||.+|+|.+||++|||+....... .....++.+++.|.--+. -+++
T Consensus 234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~iLwc~~d~~ 313 (786)
T KOG0588|consen 234 NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLCILWCGRDPE 313 (786)
T ss_pred cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhhheeecCChH
Confidence 9999999999999999999999999999999997543211 122567788888865444 4788
Q ss_pred HHHHHHHhcCCChHHHHHHHHHhchh
Q psy6203 521 DMWSQLNEWTYNYDTCTYLLLLSRKK 546 (568)
Q Consensus 521 ~~~~~l~~~~~~~~~~~~~~l~~~~~ 546 (568)
.+.+.|.....|..+..|+||.+++.
T Consensus 314 kl~~kLls~~~n~EK~~Y~LLl~~k~ 339 (786)
T KOG0588|consen 314 KLVEKLLSPDDNDEKTLYFLLLRRKR 339 (786)
T ss_pred HHHHHHcCCCcchhHHHHHHHHHhhc
Confidence 89999999999999999999987664
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=304.99 Aligned_cols=249 Identities=25% Similarity=0.469 Sum_probs=212.1
Q ss_pred CeEEEeeecccCCeEEEEEEEcC-------CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVL-------TGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSH 80 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~ 80 (568)
+..+.+.||+|.||.|++|.-.. ....||||.++......+.+.+..|+++|+.+. ||||+.+++.+...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 34667799999999999997431 145799999987766666778999999999995 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN 144 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 144 (568)
+++|+|||..|+|.++++.++ .++..+...++.||+.|++||++.++|||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998765 3888899999999999999999999999999999999999999
Q ss_pred eEEEeecCccCCCCCCccccccccC--CccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCC-HHHHHHHH
Q psy6203 145 LKLIDFGLCAKPEGGLESQLQTSCG--SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDS-IDQLYDKI 220 (568)
Q Consensus 145 ~kl~DFG~a~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~-~~~~~~~i 220 (568)
+||+|||+|+..............| ...|||||.+.... |+.++||||+|++|||++| |..||.+-. ..++.+.+
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l 535 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL 535 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence 9999999998654432222222233 33599999999854 7999999999999999998 899998755 66777778
Q ss_pred HcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 221 LNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 221 ~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
..|.. ..|...++++.++++.|++.+|++||+..++.+
T Consensus 536 ~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 536 KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 88765 566778999999999999999999999998864
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=251.62 Aligned_cols=212 Identities=19% Similarity=0.391 Sum_probs=174.2
Q ss_pred EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEeccC
Q psy6203 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIEYCP 89 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 89 (568)
.-+..||+|++|.|-+.++..+|...|+|.+...-......++.+|+++..+. .+|.+|.+|+.......++|.||.+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M- 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM- 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-
Confidence 34577999999999999999999999999998665444566778888876654 6999999999999999999999999
Q ss_pred CCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 90 GGELLDHIV----ERQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 90 ~g~L~~~i~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
..+|..+.. ..+.++|..+-+|+..++.||.|||++ .|+|||+||+|||++.+|++|+||||++....++...
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-- 205 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-- 205 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH--
Confidence 457765543 357899999999999999999999986 8999999999999999999999999998765543221
Q ss_pred ccccCCccccccccccC---cccCCcccceechhhHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC
Q psy6203 165 QTSCGSPNYAAPEVIKG---KQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKY 225 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~~~~i~~~~~ 225 (568)
+...|...|||||.+.. ...|+-++||||||+++.||.+++.||+. .+.-+...++.....
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 22457789999999853 23478899999999999999999999964 445555666655433
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=290.16 Aligned_cols=246 Identities=25% Similarity=0.411 Sum_probs=213.7
Q ss_pred EEEeeecccCCeEEEEEEEcCCCc----EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 11 ILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
+..++||+|+||+||+|.+.-.|+ +||+|++......+....+..|+-+|.+++|||++++++++.... +-||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 446889999999999998876654 689999887776666778899999999999999999999998766 789999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc-
Q psy6203 87 YCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL- 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~- 164 (568)
|+++|.|.++++. +.++.......|..||++|+.|||++++|||||-..|+|+.+-..+||.|||+++..........
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 9999999999986 46799999999999999999999999999999999999999999999999999987655432221
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....-.+.|||=|.+.... |+.++||||+||++||++| |..|+.+.+.+++-+.+..|. ++.|+..+-++.-++.+|
T Consensus 858 ~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkC 936 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKC 936 (1177)
T ss_pred cccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHH
Confidence 1112356799999988776 6999999999999999998 999999999999888887764 567788899999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|..|++.||+++++..
T Consensus 937 wmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 937 WMIDADSRPTFKELAE 952 (1177)
T ss_pred hccCcccCccHHHHHH
Confidence 9999999999998764
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=273.37 Aligned_cols=254 Identities=30% Similarity=0.486 Sum_probs=202.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcC---CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCC
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSS 79 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~ 79 (568)
..+.+.|.++++||+|+|++||++.+.. .++.||+|.+.... .-.++.+|+++|..+. +.||+++.+.+..++
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4567889999999999999999999877 78899999887543 3457889999999995 899999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-CCeEEEeecCccCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEG 158 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 158 (568)
...+||||++..+..++.. .++..+++.+++.++.||.++|.+|||||||||+|+|.+.. +.-.|+|||+|.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 9999999999988887774 47799999999999999999999999999999999999754 6789999999861100
Q ss_pred -------------------CCc------------------------cccccccCCccccccccccCcccCCcccceechh
Q psy6203 159 -------------------GLE------------------------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMG 195 (568)
Q Consensus 159 -------------------~~~------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG 195 (568)
+.. ...-...||++|.|||++...+.-++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 000 0000135899999999998877778999999999
Q ss_pred hHHHHHHhCCCCCCCC--CHHHHHHHH-------------HcCC---------------------------CC-------
Q psy6203 196 VMLYALLCGFLPFDSD--SIDQLYDKI-------------LNGK---------------------------YT------- 226 (568)
Q Consensus 196 ~il~~lltG~~pf~~~--~~~~~~~~i-------------~~~~---------------------------~~------- 226 (568)
||+..++++..||-.. +...+.+.+ ..|. .+
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999998321 111111000 0011 00
Q ss_pred ---CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 227 ---EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 227 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.....+..+.+|+.+||..||.+|+|++++|.||||.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 0012345788999999999999999999999999998
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=267.41 Aligned_cols=245 Identities=23% Similarity=0.414 Sum_probs=190.1
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHH--hCCCCCcceeeEEEEeCC----
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALK--HISHQHICKLFQVIETSS---- 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~--~l~hpnIv~l~~~~~~~~---- 79 (568)
+..+-.+.+.||+|.||.||+|++ .|+.||||++... +.....+|.+|.+ .|+|+||+.+++.-..++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhheeEEEEEecCccccceeeccc--cCCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 345678999999999999999997 5899999999753 3445667777766 469999999998764332
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCceEEcCCCCeEEEeec
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL--------GYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
.++||++|.+.|||+|++.. ..++.+...+++..+++||++||.. .|.|||||..|||+..+|.+.|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 68999999999999999976 7799999999999999999999952 49999999999999999999999999
Q ss_pred CccCCCCC---CccccccccCCccccccccccCccc----CC-cccceechhhHHHHHHh-----C-----CCCCCC---
Q psy6203 152 LCAKPEGG---LESQLQTSCGSPNYAAPEVIKGKQY----YG-SETDVWSMGVMLYALLC-----G-----FLPFDS--- 210 (568)
Q Consensus 152 ~a~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~----~~-~~~DiwSlG~il~~llt-----G-----~~pf~~--- 210 (568)
+|...... ..-..+..+||..|||||++...-. .+ ..+||||||.++||++. | .+||..
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99765443 2234567799999999999864321 11 25899999999999975 2 567743
Q ss_pred --CCHHHHHHHHHcC--CCCCCC-CCCh----HHHHHHHHccccCcCCCCCHHHHh
Q psy6203 211 --DSIDQLYDKILNG--KYTEPP-WMSP----NSRQIVRSMLQVEPGKRIKIQDLL 257 (568)
Q Consensus 211 --~~~~~~~~~i~~~--~~~~~~-~~~~----~~~~li~~~L~~dP~~Rps~~ell 257 (568)
.+.+++.+-+.-. .+.+|. |-+. .+.++++.|+..||.-|.|+--+.
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 3444544433332 223332 3332 346789999999999999986653
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=270.38 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=189.5
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHh--CCCCCcceeeEEEEeCC----EEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH--ISHQHICKLFQVIETSS----HIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~----~~~ 82 (568)
.-++.+.||+|.||.||+|.- +++.||||++... +.+.+.+|-+|.+. ++|+||+++++.-+... .++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345678999999999999984 6799999999753 34567778777764 57999999999876555 789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------cCceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH---------LGYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~---------~~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
||+||.+.|+|.+++.. ..+++....+++..+++||+|||+ ..|+|||||..|||+.++++..|+|||+|
T Consensus 285 LVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999999965 568999999999999999999996 35999999999999999999999999999
Q ss_pred cCCCCCCc-cccccccCCccccccccccCcccCC-----cccceechhhHHHHHHhCC------------CCCC-----C
Q psy6203 154 AKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYG-----SETDVWSMGVMLYALLCGF------------LPFD-----S 210 (568)
Q Consensus 154 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~-----~~~DiwSlG~il~~lltG~------------~pf~-----~ 210 (568)
.....+.. ......+||..|||||++.|.-... .+.||||+|.++|||++.. +||. .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 87654321 2233468999999999998764433 3579999999999999753 2332 1
Q ss_pred CCHHHHHHHHHcC--CCCCCCC-----CChHHHHHHHHccccCcCCCCCHHHH
Q psy6203 211 DSIDQLYDKILNG--KYTEPPW-----MSPNSRQIVRSMLQVEPGKRIKIQDL 256 (568)
Q Consensus 211 ~~~~~~~~~i~~~--~~~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~el 256 (568)
.+.+++.+.+... ++.++.. ....+++.+..|+..||+.|.|+.=+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 3445555554433 2333322 23457899999999999999997643
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=253.72 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=198.0
Q ss_pred CccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEE-EEeCC
Q psy6203 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQV-IETSS 79 (568)
Q Consensus 2 ~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~-~~~~~ 79 (568)
+..++.+.|.|.+.||+|.||.+.+|+|+.+++.+|+|.+.+... ....|.+|..---.|. |.||+..|++ |++.+
T Consensus 18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 346788999999999999999999999999999999999876542 3457888876544554 8999998875 68888
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc-C-CCCeEEEeecCccCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD-R-NQNLKLIDFGLCAKPE 157 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~-~~~~kl~DFG~a~~~~ 157 (568)
.++++|||++.|+|..-+.. ..+.|...+.++.|+++||.|+|++++||||||.+||||- . ...+||||||..+..+
T Consensus 96 ~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999999999988755 4588999999999999999999999999999999999993 2 3479999999876543
Q ss_pred CCCccccccccCCccccccccccCc----ccCCcccceechhhHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCC-CC
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGK----QYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILNGKYT-EP 228 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~~lltG~~pf~~~~~----~~~~~~i~~~~~~-~~ 228 (568)
.- ....--+..|.+||+.... -...+.+|||.||+++|.++||.+||..... ..-+.+...+..+ .|
T Consensus 175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 21 1112235678999986422 2236678999999999999999999974322 2223333333332 22
Q ss_pred ---CCCChHHHHHHHHccccCcCCC---CCHHHHhcCcccc
Q psy6203 229 ---PWMSPNSRQIVRSMLQVEPGKR---IKIQDLLGHNWVK 263 (568)
Q Consensus 229 ---~~~~~~~~~li~~~L~~dP~~R---ps~~ell~hp~~~ 263 (568)
..+++.+..+.++-|..+|++| -++......-|..
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 2378899999999999999999 4555555566653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=247.90 Aligned_cols=213 Identities=46% Similarity=0.777 Sum_probs=187.4
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCCCChHH
Q psy6203 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLD 95 (568)
Q Consensus 16 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~ 95 (568)
||+|++|.||++....+++.+++|++...........+.+|+..++.++|++|+++++++......+++||++.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999865433234678899999999999999999999999899999999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-CCCeEEEeecCccCCCCCCccccccccCCccc
Q psy6203 96 HIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEGGLESQLQTSCGSPNY 173 (568)
Q Consensus 96 ~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y 173 (568)
++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+...|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~ 159 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAY 159 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCc
Confidence 98765 57899999999999999999999999999999999999998 89999999999876543211 12334578899
Q ss_pred cccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCCCH
Q psy6203 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKI 253 (568)
Q Consensus 174 ~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 253 (568)
++||.+.....++.++|+||+|+++++| ..+.+++.+|++.||++||++
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 9999987753468899999999999999 688999999999999999999
Q ss_pred HHHhcCc
Q psy6203 254 QDLLGHN 260 (568)
Q Consensus 254 ~ell~hp 260 (568)
.++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=250.51 Aligned_cols=219 Identities=42% Similarity=0.680 Sum_probs=187.4
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccC
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCP 89 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 89 (568)
|.+.+.||+|++|.||++.+..+++.+|+|.+...........+.+|+..+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999988999999999865433245678889999999999999999999999899999999999
Q ss_pred CCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccccc
Q psy6203 90 GGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC 168 (568)
Q Consensus 90 ~g~L~~~i~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 168 (568)
+++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+...............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 9999999987666 899999999999999999999999999999999999999999999999998765443211223456
Q ss_pred CCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC
Q psy6203 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS--DSIDQLYDKILNGKYTEP 228 (568)
Q Consensus 169 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~--~~~~~~~~~i~~~~~~~~ 228 (568)
++..|++||.+.+...++.++|+||||+++++|++|+.||.. .+...+.+.+..+.....
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW 222 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence 788999999984333357799999999999999999999977 455577888877765443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=266.24 Aligned_cols=219 Identities=23% Similarity=0.432 Sum_probs=187.1
Q ss_pred ccCCccCCCCcchhhh-----HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccce---------eEE
Q psy6203 325 KQGKQYYGSETDVWSM-----GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPIC---------TIL 377 (568)
Q Consensus 325 ~~~~~~~~~~~~~~~~-----g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~---------~ik 377 (568)
.+....+.+.|.+|.+ ||+||+||-. ..-+.|+-++++|.||++++ +||. -||
T Consensus 80 VRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 80 VRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred eeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceE
Confidence 3455667888888765 7899999775 34699999999999999873 4443 579
Q ss_pred EccccCcccccCCCCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q psy6203 378 ISQYFPTILLPCKVGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT 455 (568)
Q Consensus 378 i~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~ 455 (568)
++||||++.+ .+|..+.+.||+..|-|||. +..|..++|||||||||||-|++|++||...|..+.+-.|+.+++.
T Consensus 160 LTDFGFSNkf--~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt 237 (864)
T KOG4717|consen 160 LTDFGFSNKF--QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT 237 (864)
T ss_pred eeeccccccC--CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc
Confidence 9999998764 57888999999999999998 7888999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCCC----C------CCC-CChHHHHHHHhccCCCHHHHHH
Q psy6203 456 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN----P------LRE-KDDDVIKVMADHKQLSPDDMWS 524 (568)
Q Consensus 456 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~----~------~~~-~~~~~~~~~~~~~~~~~~~~~~ 524 (568)
.|..+|.+|+|||..||+.||.+|.+.++|..|+|++...... | +++ ....+++.|....-.+.+++.+
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvsr~~L~ee~Ha~IIq~Mv~G~IAs~e~Il~ 317 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVSRHHLPEEAHATIIQQMVAGAIASEEDILR 317 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceeehhhCChHHHHHHHHHHhcccccCHHHHHH
Confidence 9999999999999999999999999999999999998543211 1 122 2344567777777789999999
Q ss_pred HHHhcCCChHHHHHHHHHhch
Q psy6203 525 QLNEWTYNYDTCTYLLLLSRK 545 (568)
Q Consensus 525 ~l~~~~~~~~~~~~~~l~~~~ 545 (568)
.|.+.+||+++|+||||.++.
T Consensus 318 aLe~n~YNhiTATYfLLAEr~ 338 (864)
T KOG4717|consen 318 ALENNEYNHITATYFLLAERV 338 (864)
T ss_pred HHhccccchhhhHHHHHHHHH
Confidence 999999999999999987654
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=246.02 Aligned_cols=153 Identities=25% Similarity=0.413 Sum_probs=140.2
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..||+||.+++..++|+|..+|.+..||+.++ .+.+.|||+|||||.... + .+.+
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---~-rT~T 200 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---G-RTWT 200 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---C-cEEE
Confidence 666999999999999999999999999999874 445678999999886543 2 2678
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.||||.|+|||. ..++|+.+||||||||++|||++|.+||.+.++.+++++|+.+...+|+.+|++++|||+++|+.|-
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~ 280 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDL 280 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhh
Confidence 999999999998 8899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-----CHHHHhcCcccccC
Q psy6203 477 GKRI-----KIQDLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~-----t~~~~l~hp~~~~~ 494 (568)
.+|. +..++..||||+..
T Consensus 281 t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 281 TKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HhhhcCcCCCccccccCcccccc
Confidence 9996 47899999999854
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=264.01 Aligned_cols=166 Identities=22% Similarity=0.421 Sum_probs=146.3
Q ss_pred cCCCCcchhhh-----HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCc
Q psy6203 330 YYGSETDVWSM-----GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPT 384 (568)
Q Consensus 330 ~~~~~~~~~~~-----g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~ 384 (568)
.++.+..||.. -+.|.++++.+++|.|.+||.+++||+.|+ +| .-+|||+|||+|
T Consensus 86 ~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 86 FFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEeccccee
Confidence 35555556554 378889999999999999999999999875 22 227999999987
Q ss_pred ccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Q psy6203 385 ILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPN 463 (568)
Q Consensus 385 ~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 463 (568)
-.+.. ++....+.||||.|.|||+ .+.+|+..|||||+|||||.||.|+|||...+..+.+.+|....+.+|..+|.+
T Consensus 166 t~le~-~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~ 244 (592)
T KOG0575|consen 166 TQLEY-DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAE 244 (592)
T ss_pred eeecC-cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHH
Confidence 65432 4556789999999999999 899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 464 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
|++||.+||..||.+|||+++++.|+||+.+..
T Consensus 245 A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 245 AKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 999999999999999999999999999975533
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=256.57 Aligned_cols=156 Identities=24% Similarity=0.471 Sum_probs=136.6
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc-----------ceeEEEccccCcccccCCCCce
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP-----------ICTILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~-----------~~~iki~dfG~~~~~~~~~~~~ 394 (568)
|.-||+||+.+.+++.+.|+.-+.+|.|++.++ +| .|.+||+|||+|... ..+..
T Consensus 257 ~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~--g~~sf 334 (475)
T KOG0615|consen 257 YVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS--GEGSF 334 (475)
T ss_pred EecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc--cccee
Confidence 344999999999999999999999999999874 23 357899999987664 36778
Q ss_pred ecccccccccccCCC----CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCC--CC--CCCHHHH
Q psy6203 395 INLLRSAIVLCSAPS----SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYTE--PP--WMSPNSR 465 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~-~~~~i~~~~~~~--~~--~~s~~~~ 465 (568)
+++.||||.|.|||+ +..+|+.+||+||+|||||.+++|.+||.+..... +.++|..|.+.+ +. .+|++++
T Consensus 335 m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~ 414 (475)
T KOG0615|consen 335 MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEAL 414 (475)
T ss_pred hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHH
Confidence 999999999999998 45578889999999999999999999999876555 889999999875 22 3899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
+||++||+.||++|+|++|+|+||||+..+
T Consensus 415 dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 415 DLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 999999999999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=292.41 Aligned_cols=200 Identities=19% Similarity=0.260 Sum_probs=147.9
Q ss_pred HhCCC-CCcceeeEEE-------EeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecC
Q psy6203 61 KHISH-QHICKLFQVI-------ETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131 (568)
Q Consensus 61 ~~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 131 (568)
+.++| +||+++++++ .....++.+||++ +++|.+++.. ...+++.+++.++.||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34456 6888888877 2334577888987 6799999975 35699999999999999999999999999999
Q ss_pred CCCCceEEcCCC-------------------CeEEEeecCccCCCCCC---------------ccccccccCCccccccc
Q psy6203 132 LKPENVLLDRNQ-------------------NLKLIDFGLCAKPEGGL---------------ESQLQTSCGSPNYAAPE 177 (568)
Q Consensus 132 lkp~NIll~~~~-------------------~~kl~DFG~a~~~~~~~---------------~~~~~~~~gt~~y~aPE 177 (568)
|||+||||+..| .+|++|||+++...... .......+||+.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 999999996544 45555666554321000 00011235899999999
Q ss_pred cccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CCCCChHHHHHHHHccccCcCCCCCHHHH
Q psy6203 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSMLQVEPGKRIKIQDL 256 (568)
Q Consensus 178 ~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~el 256 (568)
++.+.. ++.++|||||||++|||++|.+|+.... .....+.....+. .....+...+++.+||++||.+|||+.|+
T Consensus 186 ~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 186 EDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 998876 5899999999999999999998875432 1222222221111 11234567899999999999999999999
Q ss_pred hcCccccc
Q psy6203 257 LGHNWVKM 264 (568)
Q Consensus 257 l~hp~~~~ 264 (568)
++||||..
T Consensus 263 l~h~~~~~ 270 (793)
T PLN00181 263 LQSEFINE 270 (793)
T ss_pred hhchhhhh
Confidence 99999974
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=253.94 Aligned_cols=165 Identities=26% Similarity=0.568 Sum_probs=146.8
Q ss_pred CccCCCCcchh-----hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------Ccc-eeEEEccc
Q psy6203 328 KQYYGSETDVW-----SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPI-CTILISQY 381 (568)
Q Consensus 328 ~~~~~~~~~~~-----~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~-~~iki~df 381 (568)
...+.+.+++| ..||+|++++...+++.|++++.+|+|+++|+ ... .++||+||
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 44456666553 44899999999999999999999999999975 334 79999999
Q ss_pred cCcccccCCCCceecccccccccccCCC--CCC-CCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy6203 382 FPTILLPCKVGQVINLLRSAIVLCSAPS--SKQ-YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP 458 (568)
Q Consensus 382 G~~~~~~~~~~~~~~~~~gt~~~~~pe~--~~~-~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~ 458 (568)
|++.... ..+....+.|||+.|+|||+ +.. |.+.++||||+||+||.|++|+.||...+...++.+|..+.+.+|.
T Consensus 166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~ 244 (370)
T KOG0583|consen 166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS 244 (370)
T ss_pred ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC
Confidence 9887654 34456889999999999998 445 7789999999999999999999999999999999999999999999
Q ss_pred CC-CHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 459 WM-SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 459 ~~-s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
++ |+++++||.+||..||.+|+|+.+++.||||+.
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99 999999999999999999999999999999996
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=231.87 Aligned_cols=193 Identities=19% Similarity=0.343 Sum_probs=159.8
Q ss_pred HHHHHHHHhCCC--CCChhhHHHHHHHHhhcc-----------------------CcceeEEEccccCcccccCCCCcee
Q psy6203 341 GVMLYALLCGFL--PFDSDSIDQLYDKILSHF-----------------------MPICTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 341 g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~-----------------------~~~~~iki~dfG~~~~~~~~~~~~~ 395 (568)
||+||.-+..++ +|.|.+|..|++||-.++ -.+|.+|++|||||..... ...+
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~~~L 220 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--PGDL 220 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC--Cccc
Confidence 899998887655 599999999999998764 2245789999998765432 3346
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCC--C--CCHHHHH
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPP--W--MSPNSRQ 466 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~----~~~~~~~i~~~~~~~~~--~--~s~~~~~ 466 (568)
.+-|-||+|.|||+ +...|+.++|+||+||+||.|++|.|||.+.. ...+..+|..|.+.||. | +|+.++|
T Consensus 221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKd 300 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKD 300 (400)
T ss_pred cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHH
Confidence 78899999999998 77789999999999999999999999998754 34577889999888764 3 8999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCCCCCCCCCCChHHHHHHHhccCCCHHHHHHHHHhcCCChHH
Q psy6203 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDT 535 (568)
Q Consensus 467 li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 535 (568)
+|+++|..+|.+|+|+++++.|||+.........+......++...+.++..++++.+.|++++.++..
T Consensus 301 lIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~~a~e~w~dvqeem~~~lA~mrv~~~~ 369 (400)
T KOG0604|consen 301 LIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLKEAVEAWDDVQEEMTETLATMRVDPLQ 369 (400)
T ss_pred HHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcchhhhhhHHHHHHHHHHHHhcccCcce
Confidence 999999999999999999999999998766555555555666666677777889999999998866543
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-30 Score=276.18 Aligned_cols=257 Identities=30% Similarity=0.521 Sum_probs=203.6
Q ss_pred cCe-EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecC----CcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 8 NQY-ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKA----TLGED-LPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 8 ~~Y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
..| .-...+|.|++|.|+.+......+..+.|.+... ..... ...+..|+-+-..+.|||++.....+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 4578899999999998888777776776655421 11111 12255577777889999998887777666655
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+-+||||++ +|+.++...+.++..++..++.|++.||+|+|+.||.||||||+|++++.+|.+||+|||.+........
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 666999999 9999998888999999999999999999999999999999999999999999999999999876544333
Q ss_pred ---cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHH--H-------HHHcCCCCCCC
Q psy6203 162 ---SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY--D-------KILNGKYTEPP 229 (568)
Q Consensus 162 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~--~-------~i~~~~~~~~~ 229 (568)
......+|+..|+|||++.+..+.....||||.|++++.|++|+.||......+.. . .+..|......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 33456689999999999999998888899999999999999999999654332211 1 11112222223
Q ss_pred CCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 230 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.++.+.+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 477888999999999999999999999999999853
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=239.83 Aligned_cols=163 Identities=22% Similarity=0.390 Sum_probs=141.2
Q ss_pred CCCCcch-----hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcc
Q psy6203 331 YGSETDV-----WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTI 385 (568)
Q Consensus 331 ~~~~~~~-----~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~ 385 (568)
+++..+. |..||+|+-+|...+.|+|+.|+.++..|+.|+ +|| ++|+++|||++.
T Consensus 94 FQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 94 FQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred cccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence 4555555 445999999999999999999999999999874 344 478999999776
Q ss_pred cccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHH
Q psy6203 386 LLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPN 463 (568)
Q Consensus 386 ~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~ 463 (568)
.. ++.+....++|||+.|||||. .+.+|+.+||||||||++|||++|.+||.+.+...++++|..++.. .|..+|++
T Consensus 174 ~~-~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ 252 (357)
T KOG0598|consen 174 ED-LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEE 252 (357)
T ss_pred hc-ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHH
Confidence 43 344556788999999999998 7779999999999999999999999999999999999999999955 45559999
Q ss_pred HHHHHHHccCCCcCCCC----CHHHHhcCcccccC
Q psy6203 464 SRQIVRSMLQVEPGKRI----KIQDLLGHNWVKMG 494 (568)
Q Consensus 464 ~~~li~~~L~~dp~~R~----t~~~~l~hp~~~~~ 494 (568)
+++||+++|.+||++|+ ++.++.+||||+.-
T Consensus 253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 99999999999999997 48899999999853
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=234.51 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=204.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCC-----cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE-eCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTG-----EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE-TSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~ 80 (568)
+.++++...+-+|.||.||.|.++... +.|-+|.++.....-....+..|--.+..+.|||+..+.++.. +...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 356788888999999999999765432 3455677665443334556777888888899999999999874 4456
Q ss_pred EEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecC
Q psy6203 81 IFMVIEYCPGGELLDHIVER--------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL 152 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 152 (568)
.+.++.+..-|+|..++... +.++..+...++.|++.|++|||+.||||.||-..|.+|++.-++||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 78888999889999999731 2466778888999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCcccccc-ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCC
Q psy6203 153 CAKPEGGLESQLQT-SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPP 229 (568)
Q Consensus 153 a~~~~~~~~~~~~~-~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~ 229 (568)
++..-+....-+.. .-....|||||.+.+.. |+.++|+|||||++|||+| |+.|+..-++.++..-++.|.. ..|-
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~ 521 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF 521 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC
Confidence 88754432221111 12345799999999877 6999999999999999998 9999999999999998888854 5566
Q ss_pred CCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 230 ~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.++++..++.-||..+|++||+.+|+..
T Consensus 522 NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 522 NCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 79999999999999999999999999853
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=234.02 Aligned_cols=170 Identities=19% Similarity=0.234 Sum_probs=136.8
Q ss_pred CCCcchhh----hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCcccc
Q psy6203 332 GSETDVWS----MGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILL 387 (568)
Q Consensus 332 ~~~~~~~~----~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~ 387 (568)
..-.|+|. |+.+|.++++....|+++-++.++.|+|.|+ ...|.+||||||+|+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 33445554 4889999999887899999999999999874 33567899999998876
Q ss_pred cCC-CCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Q psy6203 388 PCK-VGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----------- 453 (568)
Q Consensus 388 ~~~-~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~----------- 453 (568)
... ....++..+.|.||.|||. ....|+.++||||+|||++||++|++.|+|.+..+++..|+.-.
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 432 1234677899999999998 78889999999999999999999999999998877776664411
Q ss_pred ------------CCCC--------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCCCCCC
Q psy6203 454 ------------YTEP--------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLR 501 (568)
Q Consensus 454 ------------~~~~--------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~ 501 (568)
+..| +..++.+.||+.+||++||.+|+|++|+|+|||+.....+...|
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 1111 34799999999999999999999999999999999765544433
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=225.66 Aligned_cols=150 Identities=23% Similarity=0.425 Sum_probs=135.4
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
-|+||+++...-.++|+++|.||+|++.++ +| +-||||+|||||.. ..+|..++..||
T Consensus 107 rGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~--l~~GekLrelCG 184 (411)
T KOG0599|consen 107 RGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ--LEPGEKLRELCG 184 (411)
T ss_pred cchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec--cCCchhHHHhcC
Confidence 489999999999999999999999999874 33 33789999998765 457888999999
Q ss_pred ccccccCCC-------CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCC--CCHHHHHHHH
Q psy6203 401 AIVLCSAPS-------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--PPW--MSPNSRQIVR 469 (568)
Q Consensus 401 t~~~~~pe~-------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~--~~~--~s~~~~~li~ 469 (568)
||.|.|||. ...+|+..||+||+|||||.++.|.+||-.....-+++.|..|.+.+ |.| .|...+|||+
T Consensus 185 TPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIs 264 (411)
T KOG0599|consen 185 TPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLIS 264 (411)
T ss_pred CCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHH
Confidence 999999995 67899999999999999999999999999888888899999998875 555 7899999999
Q ss_pred HccCCCcCCCCCHHHHhcCcccc
Q psy6203 470 SMLQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 470 ~~L~~dp~~R~t~~~~l~hp~~~ 492 (568)
+||+.||.+|+|++|+|+||||.
T Consensus 265 rlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 265 RLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHeeCchhcccHHHHhcChHHH
Confidence 99999999999999999999995
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=222.53 Aligned_cols=158 Identities=30% Similarity=0.382 Sum_probs=128.5
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccC
Q psy6203 91 GELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169 (568)
Q Consensus 91 g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~g 169 (568)
|+|.+++..+ ..+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCC
Confidence 6899999874 56999999999999999999999998 999999999999999 9998764332 2268
Q ss_pred CccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCC-------CCCCCh--HHHHHH
Q psy6203 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYTE-------PPWMSP--NSRQIV 239 (568)
Q Consensus 170 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~~-------~~~~~~--~~~~li 239 (568)
|+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+..+.... +..++. .+.++|
T Consensus 67 ~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 99999999998876 58999999999999999999999975432 23333333222211 112333 689999
Q ss_pred HHccccCcCCCCCHHHHhcCcccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.+||..||.+|||+.|++.|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999986
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=219.51 Aligned_cols=151 Identities=25% Similarity=0.480 Sum_probs=132.8
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCCceecc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|++|+.-+..+.-|+|..+--+++|||.++ .+| .-+|++|||.|.... .|.+...
T Consensus 94 G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G 171 (355)
T KOG0033|consen 94 GGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHG 171 (355)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--Ccccccc
Confidence 677766555557899999999999999875 222 358999999765543 6777888
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHcc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSRQIVRSML 472 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L 472 (568)
.+|||.||+||+ .+..|+.++||||+|||||.|+.|.+||.+++...+++.|..+.+..|+ .+|+++++||++||
T Consensus 172 ~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML 251 (355)
T KOG0033|consen 172 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRML 251 (355)
T ss_pred ccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHh
Confidence 999999999998 8899999999999999999999999999999999999999999887543 38999999999999
Q ss_pred CCCcCCCCCHHHHhcCccccc
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~ 493 (568)
..||.+|+|+.|+|+|||+++
T Consensus 252 ~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 252 TVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ccChhhhccHHHHhCCchhcc
Confidence 999999999999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=234.43 Aligned_cols=177 Identities=21% Similarity=0.250 Sum_probs=135.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcC-CCcEEEEEEeecCCc----CCchHHHHHHHHHHHhCCCCCcce-eeEEEEeC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVL-TGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHICK-LFQVIETS 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~~ 78 (568)
.+.++|.+.+.||+|+||+||+|++.. +++.||||++..... ......+.+|+.+|++++|+||+. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 456889999999999999999999876 677789998753311 112456889999999999999985 5432
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCceEEcCCCCeEEEeecCccCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDL-KPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDl-kp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
+..|+||||++|++|.. +. ... ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+...
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 45799999999999963 21 111 1468899999999999999999999 9999999999999999999998544
Q ss_pred CCCc-------cccccccCCccccccccccCcc-----cCCccccee
Q psy6203 158 GGLE-------SQLQTSCGSPNYAAPEVIKGKQ-----YYGSETDVW 192 (568)
Q Consensus 158 ~~~~-------~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~Diw 192 (568)
.... .......+++.|+|||.+.... ..+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 3211 1123557889999999985432 123446766
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=226.39 Aligned_cols=252 Identities=35% Similarity=0.599 Sum_probs=210.6
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCC-CcceeeEEEEeCCEEEEEEe
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQ-HICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lV~E 86 (568)
|.+.+.||.|+||.||++.+. ..+|+|.+....... ....+.+|+.++..+.|+ +|+++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999987 789999998766544 366788999999999988 79999999988888899999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCccCCCCCCcc
Q psy6203 87 YCPGGELLDHIVERQ---RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~ 162 (568)
++.++++.+.+.... .+++..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997777664 799999999999999999999999999999999999999988 7999999998754332211
Q ss_pred -----ccccccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCC-CCCC
Q psy6203 163 -----QLQTSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYT-EPPW 230 (568)
Q Consensus 163 -----~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~~~----~~~~~~~i~~~~~~-~~~~ 230 (568)
......||..|+|||.+.+. ..++...|+||+|++++++++|..||.... .......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 24567899999999999874 356889999999999999999999987765 34555555444433 2222
Q ss_pred CC--------hHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 231 MS--------PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 231 ~~--------~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.. ..+.+++..++..+|..|.+..+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 11 47899999999999999999999999977663
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=227.54 Aligned_cols=154 Identities=21% Similarity=0.314 Sum_probs=134.4
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc-------------Cc--------ceeEEEccccCcccccCCCCceec
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF-------------MP--------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~-------------~~--------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|-.||+|..+++..+.++|.....+..++|+|+ +| .+.|||||||.+..+... ...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN 235 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence 334888888888888999999999999999874 33 347899999977655433 578
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCC-CCCC-CCHHHHHHH
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD-----SIDQLYDKILNGKYT-EPPW-MSPNSRQIV 468 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~-----~~~~~~~~i~~~~~~-~~~~-~s~~~~~li 468 (568)
+++||..|||||. .+..|+.++||||||+++.||++|+.||... +..+++..|..+.++ .|.. +|+++++||
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 9999999999998 8889999999999999999999999999875 678899999997655 6775 999999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 469 RSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 469 ~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..||++||.+|+|+.|+++|||++..
T Consensus 316 ~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 99999999999999999999999854
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=233.55 Aligned_cols=153 Identities=22% Similarity=0.301 Sum_probs=130.5
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
|.++||+++++ ..+|+|++|+.||.||++|+ +|| -.|||+|||+|+-....+. .+.+
T Consensus 92 Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP--YTeY 169 (538)
T KOG0661|consen 92 MDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP--YTEY 169 (538)
T ss_pred hhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC--cchh
Confidence 47999999997 46899999999999999874 333 3589999998887655443 6788
Q ss_pred ccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CC-----------------CCCC
Q psy6203 399 RSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GK-----------------YTEP 457 (568)
Q Consensus 399 ~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~--~~-----------------~~~~ 457 (568)
+.|.||.|||+ ...+|+.++||||+|||++|+.+-+|.|+|.+..+++.+|+. |. +.+|
T Consensus 170 VSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P 249 (538)
T KOG0661|consen 170 VSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFP 249 (538)
T ss_pred hhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCC
Confidence 99999999998 888999999999999999999999999999999998888754 11 1122
Q ss_pred -----------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 458 -----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 458 -----------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+..++++.+||.+||..||++||||+|+++||||+..
T Consensus 250 ~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 250 QVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred cCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 2268999999999999999999999999999999854
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=226.78 Aligned_cols=248 Identities=27% Similarity=0.352 Sum_probs=193.7
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCC-cEEEEEEeecCCcCCchHHHHHHHHHHHhCCC----CCcceeeEEE-EeCCEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTG-EKVAIKIMKKATLGEDLPRVKLEINALKHISH----QHICKLFQVI-ETSSHIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h----pnIv~l~~~~-~~~~~~~ 82 (568)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.++..+.. +++..+++.. ......|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 8999999999999999999988775 67899987765433222 67889999998862 6899999999 5777899
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-----CCeEEEeecCcc-
Q psy6203 83 MVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-----QNLKLIDFGLCA- 154 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-----~~~kl~DFG~a~- 154 (568)
+||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999999 89999987543 579999999999999999999999999999999999999765 359999999998
Q ss_pred -CCCCCCc-----c-c-cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH---HHHHHHHcC
Q psy6203 155 -KPEGGLE-----S-Q-LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---QLYDKILNG 223 (568)
Q Consensus 155 -~~~~~~~-----~-~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~---~~~~~i~~~ 223 (568)
....... . . .....||..|+++.+..+... +.+.|+||++.++.+++.|..||.+.... .........
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 3222111 0 0 123459999999999988874 89999999999999999999999765422 112222221
Q ss_pred CCC--CCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 224 KYT--EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 224 ~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
... .....+..+.++...+-..+...+|....+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 111 123345677788777777889999988777554
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=232.45 Aligned_cols=156 Identities=20% Similarity=0.300 Sum_probs=131.3
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------C--------cceeEEEccccCcccccC--------
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------M--------PICTILISQYFPTILLPC-------- 389 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~--------~~~~iki~dfG~~~~~~~-------- 389 (568)
|..||++..+|-..+.|+|+.+++++.+.+-|+ + ..++||++|||++..+.+
T Consensus 222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 556999999999999999999999999988653 3 346899999997633211
Q ss_pred ---------------CCC-----c------------------eecccccccccccCCC-CCCCCCCccceeehhHHHHHH
Q psy6203 390 ---------------KVG-----Q------------------VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYAL 430 (568)
Q Consensus 390 ---------------~~~-----~------------------~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~em 430 (568)
+.. . .....+|||-|+|||+ .+++|+..|||||||||||||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 000 0 1123789999999999 788899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC--CCCCCC--CCHHHHHHHHHccCCCcCCCCC---HHHHhcCcccccC
Q psy6203 431 LCGFLPFDSDSIDQLYDKILNGK--YTEPPW--MSPNSRQIVRSMLQVEPGKRIK---IQDLLGHNWVKMG 494 (568)
Q Consensus 431 l~g~~pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~~~~li~~~L~~dp~~R~t---~~~~l~hp~~~~~ 494 (568)
|.|.|||.++++.+++++|.... +.+|.. .|++++|||.+||+ ||++|++ ++||.+||||+..
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999999999998865 556644 78999999999998 9999996 8999999999854
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=240.15 Aligned_cols=165 Identities=18% Similarity=0.286 Sum_probs=143.0
Q ss_pred CccCCCCcch-----hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEcccc
Q psy6203 328 KQYYGSETDV-----WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYF 382 (568)
Q Consensus 328 ~~~~~~~~~~-----~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG 382 (568)
...|++++++ |..||+ +-++...+.|+|..|+.+...|+.|+ +.-+.+||+|||
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred ccccccCCeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccc
Confidence 3448888888 455888 44444458999999999999998874 345689999999
Q ss_pred CcccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy6203 383 PTILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMS 461 (568)
Q Consensus 383 ~~~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s 461 (568)
++.-... .|..+.|+||||.|||||+ ....|+.+||||||||+||||+.|++||+|++..+++..|....+..|.++|
T Consensus 514 lcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls 592 (694)
T KOG0694|consen 514 LCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 592 (694)
T ss_pred cccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence 6554432 3456889999999999999 8889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHccCCCcCCCCC-----HHHHhcCcccccC
Q psy6203 462 PNSRQIVRSMLQVEPGKRIK-----IQDLLGHNWVKMG 494 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~~~~~ 494 (568)
.++.++++++|.+||++|++ ++++++||||+.-
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999999999999997 5899999999843
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=231.99 Aligned_cols=157 Identities=20% Similarity=0.331 Sum_probs=138.0
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCC-------
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCK------- 390 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~------- 390 (568)
|..+|+|.++|+..|.|.|..+|.+..+|+.++ +| ...|||+|||-|..+...
T Consensus 155 ~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~ 234 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENP 234 (604)
T ss_pred ecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCc
Confidence 445899999999999999999999999999864 33 447899999966544211
Q ss_pred --CCc---eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Q psy6203 391 --VGQ---VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS 464 (568)
Q Consensus 391 --~~~---~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 464 (568)
.+. ...++|||-.|.+||. ....-++++|+||||||+|+|+.|+|||.+.|..-++++|....+.+|+.+++.+
T Consensus 235 ~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a 314 (604)
T KOG0592|consen 235 VDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDA 314 (604)
T ss_pred cCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHH
Confidence 111 1356999999999998 7788899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 465 RQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 465 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+|||+++|+.||.+|+|++||.+||||...
T Consensus 315 ~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 315 RDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred HHHHHHHHccCccccccHHHHhhCcccccC
Confidence 999999999999999999999999999743
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=202.91 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=191.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCC-CCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-QHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV 84 (568)
..++|+++++||+|+||.+|+|.+..+|+.||||+-.... ..+.+..|..+.+.|++ ..|..+..+..+..+-.+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 4579999999999999999999999999999999865433 33467788999998875 6788888888888888999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC---CCeEEEeecCccCCCCCC
Q psy6203 85 IEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN---QNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~ 160 (568)
|++. |.+|.++..- ...++...+..++-|++.-++|+|.++.+||||||+|+|+.-+ ..+.|+|||+|+...+..
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 9999 8999998863 4679999999999999999999999999999999999999633 468999999998754422
Q ss_pred cc------ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCC---
Q psy6203 161 ES------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEP--- 228 (568)
Q Consensus 161 ~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---~~~~~~~~i~~~~~~~~--- 228 (568)
.. ......||..|++-....+... +...|+=|+|.++..+..|..||.+- +..+-+++|.+.+...+
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV 247 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH
Confidence 11 1123468999999888777664 78899999999999999999999864 44556677766655433
Q ss_pred --CCCChHHHHHHHHccccCcCCCC
Q psy6203 229 --PWMSPNSRQIVRSMLQVEPGKRI 251 (568)
Q Consensus 229 --~~~~~~~~~li~~~L~~dP~~Rp 251 (568)
...|.++.-.+.-|-..--++-|
T Consensus 248 LC~G~P~EF~myl~Y~R~L~F~E~P 272 (341)
T KOG1163|consen 248 LCKGFPAEFAMYLNYCRGLGFEEKP 272 (341)
T ss_pred HhCCCcHHHHHHHHHHhhcCCCCCC
Confidence 23566776666666554433333
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=218.53 Aligned_cols=156 Identities=22% Similarity=0.381 Sum_probs=141.6
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..||+||-++...+.|+|+.+|.+=..|++++ .+.++|||+|||+..-. ...|..+++
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~g~t~kT 327 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKYGDTTKT 327 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc-ccccceecc
Confidence 667999999999999999999999999999874 66789999999965433 245667899
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
+||||.|.|||+ ....|+.+||||.+||+||||++|+.||...+...++..|+.....+|..+|++++.|+.++|.+||
T Consensus 328 FCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP 407 (516)
T KOG0690|consen 328 FCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDP 407 (516)
T ss_pred ccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcCh
Confidence 999999999999 7778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCcccccC
Q psy6203 477 GKRIK-----IQDLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~t-----~~~~l~hp~~~~~ 494 (568)
.+|++ +.|+++|+||...
T Consensus 408 ~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 408 KKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HhhcCCCchhHHHHHhhhhhccC
Confidence 99996 7899999999743
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=234.90 Aligned_cols=219 Identities=24% Similarity=0.363 Sum_probs=183.1
Q ss_pred cCCccCCCCcc-----hhhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEcc
Q psy6203 326 QGKQYYGSETD-----VWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQ 380 (568)
Q Consensus 326 ~~~~~~~~~~~-----~~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~d 380 (568)
|..+++.++.. .|+.|+++|+++..++...|.+++.+|.|+++++ ...-||||+|
T Consensus 119 kl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 119 KLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred eeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeec
Confidence 33444454443 3777999999999999999999999999999975 2233799999
Q ss_pred ccCcccccCCCCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy6203 381 YFPTILLPCKVGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP 458 (568)
Q Consensus 381 fG~~~~~~~~~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~ 458 (568)
|||+..+. .+....+.||++.|.|||. +.+|.++.+|+||+|+++|.|+.|.+||.|.+...+-..++.+.+.+|.
T Consensus 199 fgfS~~~~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~ 276 (596)
T KOG0586|consen 199 FGFSTFFD--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF 276 (596)
T ss_pred cccceeec--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc
Confidence 99988754 6778899999999999998 7789999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCC---CCCCCC----ChHHHHHHHhccCCCHHHHHHHHHhcCC
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED---NPLREK----DDDVIKVMADHKQLSPDDMWSQLNEWTY 531 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 531 (568)
.+|.+|.+||+++|..+|.+|+++++++.|.|....... .+.... ....-..+....++..+++.+.|.+.++
T Consensus 277 ~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~~~~~~~~~r~~~m~~~G~~~~~i~~sL~~~k~ 356 (596)
T KOG0586|consen 277 YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIERSTPFILAKRILHMNSIGHRRLKIEESLAKQKF 356 (596)
T ss_pred eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhcccccCccchhhHHHHHHHhhccchhhHHHHHhhhhH
Confidence 999999999999999999999999999999999855332 111111 1111112445678888999999999999
Q ss_pred ChHHHHHHHHHhchh
Q psy6203 532 NYDTCTYLLLLSRKK 546 (568)
Q Consensus 532 ~~~~~~~~~l~~~~~ 546 (568)
+++.++|.+|..++.
T Consensus 357 d~i~a~y~ll~~~~~ 371 (596)
T KOG0586|consen 357 DDINATYLLLGYRKQ 371 (596)
T ss_pred HHHHHHHhhcchhhh
Confidence 999999999988765
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=229.90 Aligned_cols=162 Identities=22% Similarity=0.370 Sum_probs=144.9
Q ss_pred CCCCcchhhh----HHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCccc
Q psy6203 331 YGSETDVWSM----GVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTIL 386 (568)
Q Consensus 331 ~~~~~~~~~~----g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~ 386 (568)
|.+..+.|.+ -|+|++++...+.++|+.++.+-.++++++ .+++.+|+||||+|+.
T Consensus 70 fEt~~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 70 FETSAHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARA 149 (808)
T ss_pred hcccceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhh
Confidence 6777776543 249999999999999999999999999874 3455789999999987
Q ss_pred ccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Q psy6203 387 LPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSR 465 (568)
Q Consensus 387 ~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 465 (568)
... ...+.+...|||.|||||. ....|+..+|+||+|||+|||.+|+|||...+..++...|......+|...|..+.
T Consensus 150 m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~ 228 (808)
T KOG0597|consen 150 MST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFV 228 (808)
T ss_pred ccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHH
Confidence 654 3446778899999999998 88899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
.||+++|.+||.+|+|..+++.|||.+.
T Consensus 229 nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 229 NFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 9999999999999999999999999974
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-26 Score=219.01 Aligned_cols=163 Identities=26% Similarity=0.491 Sum_probs=144.4
Q ss_pred ccCCCCcch-----hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccC
Q psy6203 329 QYYGSETDV-----WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFP 383 (568)
Q Consensus 329 ~~~~~~~~~-----~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~ 383 (568)
..|.++..| |+-||+||+|+..++.|+|.++|.+|+||++++ +.+|||||+|||+
T Consensus 120 EVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 120 EVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred hhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccch
Confidence 345666655 667999999999999999999999999999974 5678999999998
Q ss_pred cccccCCCCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy6203 384 TILLPCKVGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMS 461 (568)
Q Consensus 384 ~~~~~~~~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s 461 (568)
++... .+..+.++||+|-|.+||. +..|-|+.||.|||||+||.|+.|..||+|.+...+.++|..|.+..|..-|
T Consensus 200 SNly~--~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PS 277 (668)
T KOG0611|consen 200 SNLYA--DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPS 277 (668)
T ss_pred hhhhc--cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCc
Confidence 87753 3456889999999999998 7778899999999999999999999999999999999999999998877544
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
++.-||..||..||++|.|++++.+|=|+..+
T Consensus 278 -dA~gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 278 -DASGLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred -hHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 57889999999999999999999999998754
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=206.46 Aligned_cols=214 Identities=23% Similarity=0.414 Sum_probs=182.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV 84 (568)
..-.|+++++||+|+||.++.|.+..+++.||||.-... ++.+.+..|....+.|. .++|..+|-+.+..-+-.||
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 345799999999999999999999999999999986543 35668889999999886 69999999988888888999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-----CeEEEeecCccCCCC
Q psy6203 85 IEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-----NLKLIDFGLCAKPEG 158 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-----~~kl~DFG~a~~~~~ 158 (568)
||++ |.+|.|+..- ..+|+...+..++.|++.-++|+|++..|.|||||+|+||..-+ .|.|+|||+|+...+
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9999 8899998864 46799999999999999999999999999999999999996443 589999999987654
Q ss_pred CCcc------ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC---CCHHHHHHHHHcCC
Q psy6203 159 GLES------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS---DSIDQLYDKILNGK 224 (568)
Q Consensus 159 ~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~---~~~~~~~~~i~~~~ 224 (568)
.... ...+..||..||+-....|.+. +...|+=|||-++++.|-|.+||.+ .+..+-+++|-..+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 4322 1234469999999999998885 8899999999999999999999976 45666677775443
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=208.01 Aligned_cols=151 Identities=17% Similarity=0.217 Sum_probs=122.5
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccccc
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSA 401 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt 401 (568)
..|.++-+--.-.+++.++.+..|++.++ +|| +.+|+||||||+.+.. +|...++++.|
T Consensus 86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVAT 164 (396)
T KOG0593|consen 86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVAT 164 (396)
T ss_pred HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhhhhh
Confidence 34444433333478888999999999864 343 3579999999988765 78888999999
Q ss_pred cccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------------CCCC-
Q psy6203 402 IVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK---------------------YTEP- 457 (568)
Q Consensus 402 ~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~---------------------~~~~- 457 (568)
.||.|||. +...||.+|||||+||++.||++|.|.|+|.+..+++..|...- ++.|
T Consensus 165 RWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~ 244 (396)
T KOG0593|consen 165 RWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPE 244 (396)
T ss_pred hhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCC
Confidence 99999997 77999999999999999999999999999999888876664311 1111
Q ss_pred ---------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 458 ---------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 458 ---------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+.+|.-+.||+++||..||.+|++++|++.||||..
T Consensus 245 ~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 245 HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 236778899999999999999999999999999953
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-25 Score=223.91 Aligned_cols=159 Identities=18% Similarity=0.331 Sum_probs=131.6
Q ss_pred Ccchhhh-----HHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCccccc
Q psy6203 334 ETDVWSM-----GVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILLP 388 (568)
Q Consensus 334 ~~~~~~~-----g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~~ 388 (568)
+.++|.. |+.|-+++.. -.+.|..|..+.+.+++|+ ...+++||+||||+....
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred cceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 3556554 6677666665 4699999999999999874 234579999999987665
Q ss_pred CCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCC--CCCCCCHHH
Q psy6203 389 CKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI-LNGKYT--EPPWMSPNS 464 (568)
Q Consensus 389 ~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i-~~~~~~--~~~~~s~~~ 464 (568)
.... ...+.+|||+|||||+ ..+.||+++||||||+++.||+-|.|||-.+++..-+..| ..|.+. .|..+|+.+
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~ 499 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPEL 499 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHH
Confidence 4433 5788999999999998 8889999999999999999999999999987766555444 456554 577899999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 465 RQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 465 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+||+.+||+.|+.+|++|.|+|+||||+..
T Consensus 500 kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 500 KDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 999999999999999999999999999653
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-25 Score=215.20 Aligned_cols=158 Identities=16% Similarity=0.230 Sum_probs=127.1
Q ss_pred hhhHHHHHHHHhCCC-CCChhhHHHHHHHHhhcc------------Cc---------ceeEEEccccCcccccC--CCCc
Q psy6203 338 WSMGVMLYALLCGFL-PFDSDSIDQLYDKILSHF------------MP---------ICTILISQYFPTILLPC--KVGQ 393 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~-~~~e~~~~~~~~qil~~~------------~~---------~~~iki~dfG~~~~~~~--~~~~ 393 (568)
|..||+|.+++.+.+ .|+|..|+.+.+||+.|+ +| .+.+||+|||.+..... ....
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 556899999999877 899999999999999874 22 35789999997655442 2222
Q ss_pred eecccccccccccCCC-CC-CCCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Q psy6203 394 VINLLRSAIVLCSAPS-SK-QYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGK--YTEPPWMSPNSRQIV 468 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~~-~~~~~~~DiWSlG~il~eml~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~s~~~~~li 468 (568)
......||+.|||||+ .. ..-+.++||||+||++.||+||++||.. ....+.+..|.... +.+|..+|+++++||
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl 256 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFL 256 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 3456899999999998 42 2333599999999999999999999987 44444445555443 568899999999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 469 RSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 469 ~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
.+||.+||++||||+++|+|||.....
T Consensus 257 ~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 257 RKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999999999999999997643
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=237.20 Aligned_cols=241 Identities=29% Similarity=0.375 Sum_probs=186.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHH---HHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVK---LEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
++..+|...+.||++.|=+|.+|++. .|. |+||++-+....-....+. .|++ ...++|||++.+.-+.......
T Consensus 20 d~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 20 DLSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred cCccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHH
Confidence 34447888999999999999999975 454 9999998766443333333 3444 5566899999998888888888
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccC---CCC
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK---PEG 158 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~---~~~ 158 (568)
|||-+|. ..+|+|.+..+.-+..-+.+.|+.||+.||..||..||+|||||.+|||+++-+-+.|+||..-+. ..+
T Consensus 97 ylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9999999 568999998888889999999999999999999999999999999999999999999999975432 111
Q ss_pred C---CccccccccCCccccccccccCc----------ccCCcccceechhhHHHHHHh-CCCCCCC-----------CCH
Q psy6203 159 G---LESQLQTSCGSPNYAAPEVIKGK----------QYYGSETDVWSMGVMLYALLC-GFLPFDS-----------DSI 213 (568)
Q Consensus 159 ~---~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~~llt-G~~pf~~-----------~~~ 213 (568)
+ ......+...-.+|.|||.+... +..+++.||||+||+++||++ |.+||.- .+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 1 11112223334589999987431 224678899999999999998 7899842 122
Q ss_pred HHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 214 DQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 214 ~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+.+++.| -+..++.+|..|++.||++|.+|++.|+.
T Consensus 256 e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2333322 24578999999999999999999999974
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=196.43 Aligned_cols=140 Identities=24% Similarity=0.294 Sum_probs=112.5
Q ss_pred EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-c-------h-----------------HHHHHHHHHHHhCCCCC
Q psy6203 13 ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-D-------L-----------------PRVKLEINALKHISHQH 67 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~-------~-----------------~~~~~Ei~~l~~l~hpn 67 (568)
...||+|++|.||+|.+. +|+.||+|+++...... . . .....|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 89999999997643211 0 0 12245999999998887
Q ss_pred cceeeEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCceEEcCCCCeE
Q psy6203 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL-HHLGYAHRDLKPENVLLDRNQNLK 146 (568)
Q Consensus 68 Iv~l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivHrDlkp~NIll~~~~~~k 146 (568)
+.....+.... .+|||||++|+++.........+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75444332222 389999999887776655567899999999999999999999 799999999999999998 57899
Q ss_pred EEeecCccCC
Q psy6203 147 LIDFGLCAKP 156 (568)
Q Consensus 147 l~DFG~a~~~ 156 (568)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-24 Score=199.45 Aligned_cols=172 Identities=19% Similarity=0.212 Sum_probs=133.1
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc--hH------HHHHHHHHHHhCCCCCcceeeEEEEe
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LP------RVKLEINALKHISHQHICKLFQVIET 77 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~------~~~~Ei~~l~~l~hpnIv~l~~~~~~ 77 (568)
+.++|++.+.||.|+||.||++.. ++..+|+|++........ .. .+++|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 578999999999999999999765 467899999975543221 11 26789999999999999999988654
Q ss_pred C--------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEe
Q psy6203 78 S--------SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLID 149 (568)
Q Consensus 78 ~--------~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~D 149 (568)
. +..+|||||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 3579999999999998763 2333 2456999999999999999999999999999988 99999
Q ss_pred ecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHH
Q psy6203 150 FGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALL 202 (568)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~ll 202 (568)
||.+........ ...++.... ++.++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a-------------~d~~vler~-y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKA-------------KDRIDLERH-YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhh-------------HHHHHHHhH-hcccccccceeEeehHHH
Confidence 998654422110 011333344 467899999999987654
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-24 Score=201.42 Aligned_cols=153 Identities=22% Similarity=0.296 Sum_probs=123.6
Q ss_pred HHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccccc
Q psy6203 343 MLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSA 401 (568)
Q Consensus 343 ~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt 401 (568)
+|..++... .+|...+++.++.|+|+|+ +|+ +.+||+|||+|+.... +-...+..+.|
T Consensus 162 DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs-p~k~~T~lVVT 240 (419)
T KOG0663|consen 162 DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS-PLKPYTPLVVT 240 (419)
T ss_pred hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC-CcccCcceEEE
Confidence 344555553 4999999999999999874 333 4689999998877543 22335667999
Q ss_pred cccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC-----------------CCC---
Q psy6203 402 IVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKY-----------------TEP--- 457 (568)
Q Consensus 402 ~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~--~~~-----------------~~~--- 457 (568)
.||.|||. +.+.|++++|+||+|||++||++++|.|+|.+..+++.+|.. |.+ .++
T Consensus 241 LWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~p 320 (419)
T KOG0663|consen 241 LWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHP 320 (419)
T ss_pred eeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCC
Confidence 99999997 888999999999999999999999999999999998888865 111 111
Q ss_pred ---------CC-CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 458 ---------PW-MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 458 ---------~~-~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
.. +|..+.+|+.++|..||.+|+||+|+|+|.||.+.+.
T Consensus 321 yn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 321 YNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred chhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 11 4688999999999999999999999999999987543
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=231.40 Aligned_cols=219 Identities=30% Similarity=0.562 Sum_probs=173.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|..++.|..|+||-||+++|+.+.+.+|+|+ ++.+. .+++ ++..-..|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc---cccccCCccee----------------
Confidence 35689999999999999999999999999999954 33221 0111 23333444444
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-----
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL----- 160 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----- 160 (568)
|+-...++.-++++.+. +.|++|||+.||+|||+||+|++|+.-|.+|++|||+++......
T Consensus 136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 55566666556666554 789999999999999999999999999999999999976432111
Q ss_pred ---------ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--
Q psy6203 161 ---------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-- 229 (568)
Q Consensus 161 ---------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~-- 229 (568)
.-.....||||.|+|||++.... |+..+|.|++|+|+|+.+.|..||.+++.++++..+.......++
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d 281 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED 281 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence 01123358999999999998766 699999999999999999999999999999999988776554433
Q ss_pred -CCChHHHHHHHHccccCcCCCC---CHHHHhcCcccc
Q psy6203 230 -WMSPNSRQIVRSMLQVEPGKRI---KIQDLLGHNWVK 263 (568)
Q Consensus 230 -~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~~~ 263 (568)
.++++++++|.++|+.+|..|. .+-++.+|+||+
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~ 319 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQ 319 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhcccee
Confidence 4789999999999999999996 577888999996
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=194.92 Aligned_cols=156 Identities=19% Similarity=0.229 Sum_probs=125.1
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Cccee--------EEEccccCcccccCCCCceecccc
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPICT--------ILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~~--------iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
-.+|..+++. ...|+..+++.++.++++|+ +||.| +||+|||+|+....... .....+
T Consensus 84 ~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~~~~V 162 (318)
T KOG0659|consen 84 PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQTHQV 162 (318)
T ss_pred cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-ccccce
Confidence 3566667775 56889999999999988864 55554 68899998887654332 233348
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---CC---------------
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT---EP--------------- 457 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~---~~--------------- 457 (568)
.|.||.|||. +.+.|+..|||||+|||++||+.|.|-|+|+++.+++..|... .+. +|
T Consensus 163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P 242 (318)
T KOG0659|consen 163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP 242 (318)
T ss_pred eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCC
Confidence 8999999997 8899999999999999999999999999999999998888652 211 11
Q ss_pred --------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCC
Q psy6203 458 --------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 497 (568)
Q Consensus 458 --------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 497 (568)
+..|+++.||+.+||.+||.+|+|+.|+++|+||+..+.+
T Consensus 243 ~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 243 KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 1257888999999999999999999999999999975443
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=211.88 Aligned_cols=151 Identities=23% Similarity=0.437 Sum_probs=133.3
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc------------ceeEEEccccCcccccCCCCceec
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP------------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~------------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
||+||+.+... .|+|.++..++.|+++++ ++ ...||++|||++.... .+....
T Consensus 120 GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~--~~~~~~ 196 (382)
T KOG0032|consen 120 GGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK--PGERLH 196 (382)
T ss_pred CchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc--CCceEe
Confidence 89999998876 599999999999999874 11 2369999999776543 366788
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
+.|||+.|+|||+ ....|+..+||||+||++|.|++|.+||.+.+......+|..+.+.++ +.+|..+++||.+|
T Consensus 197 ~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~l 276 (382)
T KOG0032|consen 197 TIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKL 276 (382)
T ss_pred eecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHh
Confidence 9999999999999 668999999999999999999999999999999999999999987653 33799999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccC
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
|..||.+|+|+.++|+|||++..
T Consensus 277 l~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 277 LEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred cccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999865
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=208.33 Aligned_cols=144 Identities=16% Similarity=0.220 Sum_probs=122.9
Q ss_pred CCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCcccccCCCCceecccccccccccCCC-
Q psy6203 351 FLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS- 409 (568)
Q Consensus 351 ~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~- 409 (568)
...|+|..|+-+|.|+++|+ +..+++||+|||+|+..........+..+.|.||.+||.
T Consensus 212 ~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 212 GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELL 291 (560)
T ss_pred CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHh
Confidence 45899999999999999975 234578999999998766666556778899999999997
Q ss_pred -CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC--------CC-------------------CC
Q psy6203 410 -SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKYT--------EP-------------------PW 459 (568)
Q Consensus 410 -~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~--~~~~--------~~-------------------~~ 459 (568)
+...|+.+||+||+||||.||++|+|.|.|.+..+++.+|.+ |.+. .| ..
T Consensus 292 LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~ 371 (560)
T KOG0600|consen 292 LGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKD 371 (560)
T ss_pred cCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhcc
Confidence 889999999999999999999999999999999999988865 2111 11 12
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+++.+.+|+..||..||++|.||.++|+|+||...
T Consensus 372 ~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 372 FPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred CCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 68899999999999999999999999999999644
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=193.12 Aligned_cols=141 Identities=18% Similarity=0.300 Sum_probs=121.2
Q ss_pred HHHHHHHHh----CCCCCChhhHHHHHHHHhhcc----------------Ccce--------eEEEccccCcccccCCCC
Q psy6203 341 GVMLYALLC----GFLPFDSDSIDQLYDKILSHF----------------MPIC--------TILISQYFPTILLPCKVG 392 (568)
Q Consensus 341 g~~l~~~~~----~~~~~~e~~~~~~~~qil~~~----------------~~~~--------~iki~dfG~~~~~~~~~~ 392 (568)
+|+|-+++. ....|+|..+-++|.|++.++ +||+ ++|+.|||+++.+..+..
T Consensus 104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t 183 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT 183 (375)
T ss_pred ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence 355555544 467899999999999999864 3443 679999998887765443
Q ss_pred ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CC-CCCCHHHHHHHH
Q psy6203 393 QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EP-PWMSPNSRQIVR 469 (568)
Q Consensus 393 ~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~-~~-~~~s~~~~~li~ 469 (568)
...+.+|||+||+||. ...+|+.++||||+||++|||+.-++||.|++..++..+|..|.++ .| ...|.+...||.
T Consensus 184 -fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~ 262 (375)
T KOG0591|consen 184 -FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELIN 262 (375)
T ss_pred -HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHH
Confidence 4678999999999998 8889999999999999999999999999999999999999999886 56 568999999999
Q ss_pred HccCCCcCCCCCH
Q psy6203 470 SMLQVEPGKRIKI 482 (568)
Q Consensus 470 ~~L~~dp~~R~t~ 482 (568)
.|+..||+.||+.
T Consensus 263 ~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 263 MCIAVDPEQRPDT 275 (375)
T ss_pred HHccCCcccCCCc
Confidence 9999999999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=189.67 Aligned_cols=142 Identities=21% Similarity=0.293 Sum_probs=114.8
Q ss_pred EEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--------------------c-----hHHHHHHHHHHHhCCCC
Q psy6203 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--------------------D-----LPRVKLEINALKHISHQ 66 (568)
Q Consensus 12 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~Ei~~l~~l~hp 66 (568)
+.+.||+|++|.||+|.+. +|+.||||+++...... . .....+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999998653110 0 11235789999999999
Q ss_pred CcceeeEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCe
Q psy6203 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNL 145 (568)
Q Consensus 67 nIv~l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~ 145 (568)
+|.....+.... .|+||||++|+++.........+++..+..++.|++.+|.++|+ .||+||||||+||+++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 885554443333 38999999888665544455678899999999999999999999 9999999999999998 8899
Q ss_pred EEEeecCccCCC
Q psy6203 146 KLIDFGLCAKPE 157 (568)
Q Consensus 146 kl~DFG~a~~~~ 157 (568)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-24 Score=212.40 Aligned_cols=154 Identities=18% Similarity=0.184 Sum_probs=128.3
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..||.+.++++....+.|.++..+++.++.++ ++ .+++|++|||.+..+..+.. ...++
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-rr~tf 171 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-RRKTF 171 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh-ccccc
Confidence 34788888888877889999999999999874 22 24789999997655443332 35889
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHccCCCc
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dp 476 (568)
+|||+|||||+ ...+|+.++||||||++.+||++|.|||....+..++..|-+..++ ....+|+.+++|+..||.+||
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 99999999999 7789999999999999999999999999998876666556554443 344689999999999999999
Q ss_pred CCCCCHHHHhcCccccc
Q psy6203 477 GKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t~~~~l~hp~~~~ 493 (568)
+.||+|.++++|+|++.
T Consensus 252 ~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 252 EFRPSAKELLKHKFIKR 268 (467)
T ss_pred ccCcCHHHHhhhHHHHh
Confidence 99999999999999986
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=202.88 Aligned_cols=157 Identities=19% Similarity=0.286 Sum_probs=129.6
Q ss_pred hhhHHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------CcceeEEE--------ccccCcccc--------
Q psy6203 338 WSMGVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MPICTILI--------SQYFPTILL-------- 387 (568)
Q Consensus 338 ~~~g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~~~~iki--------~dfG~~~~~-------- 387 (568)
|-+||+|+.++.. .+.|+|+.||.+...++-|+ +||.||+| +||-++...
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 4458999988876 56899999999999999764 67766555 455432110
Q ss_pred ---------------------------c--------------------CCCCceecccccccccccCCC-CCCCCCCccc
Q psy6203 388 ---------------------------P--------------------CKVGQVINLLRSAIVLCSAPS-SKQYYGSETD 419 (568)
Q Consensus 388 ---------------------------~--------------------~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~D 419 (568)
. ...+...+.++||-.|.|||+ .+.+++.+||
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD 317 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD 317 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence 0 000112345899999999999 9999999999
Q ss_pred eeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHccCCCcCCCCC----HHHHhcCccccc
Q psy6203 420 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP--WMSPNSRQIVRSMLQVEPGKRIK----IQDLLGHNWVKM 493 (568)
Q Consensus 420 iWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dp~~R~t----~~~~l~hp~~~~ 493 (568)
||+|||.+|||+.|..||.|.+..+.+.+|+...+.+|. .+|..++|||+++|++||.+|++ |.||.+||||+.
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 999999999999999999999999999999999888775 47899999999999999999998 999999999985
Q ss_pred C
Q psy6203 494 G 494 (568)
Q Consensus 494 ~ 494 (568)
.
T Consensus 398 V 398 (459)
T KOG0610|consen 398 V 398 (459)
T ss_pred C
Confidence 4
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-23 Score=201.25 Aligned_cols=156 Identities=22% Similarity=0.295 Sum_probs=136.0
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..||+|+-.+..-|.|.|..|..+...|.-++ ...++|||+|||.+.-... .+..+++
T Consensus 431 yvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~~~TTkT 509 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-DGVTTKT 509 (683)
T ss_pred EecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-CCcceee
Confidence 455999988888889999999988877776553 3456899999996433222 3445789
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
+||||.|+|||. ....|+.++||||+||+||||+.|++||.|++..++++.|.......|..+|.++.++++++|.+.|
T Consensus 510 FCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P 589 (683)
T KOG0696|consen 510 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHP 589 (683)
T ss_pred ecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCC
Confidence 999999999998 8899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCH-----HHHhcCcccccC
Q psy6203 477 GKRIKI-----QDLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~t~-----~~~l~hp~~~~~ 494 (568)
.+|+++ .++..||||...
T Consensus 590 ~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 590 GKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred ccccCCCCccccchhhCcchhhc
Confidence 999974 689999999743
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-23 Score=208.66 Aligned_cols=156 Identities=21% Similarity=0.394 Sum_probs=133.1
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|++++...+.+++..++.++.|++.++ +++ +.+||+|||++..... .+.....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~ 154 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT 154 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccc
Confidence 334788999998888999999999999999864 333 3578999997654322 2333456
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+.......+..+...+|..+++++.+||.+||..||
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 789999999998 6778999999999999999999999999999888888888888888999999999999999999999
Q ss_pred CCCC-----CHHHHhcCcccccC
Q psy6203 477 GKRI-----KIQDLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~-----t~~~~l~hp~~~~~ 494 (568)
++|+ ++.++++||||...
T Consensus 235 ~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 235 KQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=198.04 Aligned_cols=233 Identities=27% Similarity=0.412 Sum_probs=151.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCC----------CCcceeeEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISH----------QHICKLFQVIE 76 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~h----------pnIv~l~~~~~ 76 (568)
....++.||.|+++.||.+++..||+.+|+|++...... ...+.+++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456678999999999999999999999999988654422 345666766655444322 12222233321
Q ss_pred ---------eC---C-----EEEEEEeccCCCChHHHHHh---cCCC----CHHHHHHHHHHHHHHHHHHHHcCceecCC
Q psy6203 77 ---------TS---S-----HIFMVIEYCPGGELLDHIVE---RQRL----GEKESRAFFRQILSAVAYLHHLGYAHRDL 132 (568)
Q Consensus 77 ---------~~---~-----~~~lV~E~~~~g~L~~~i~~---~~~l----~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 132 (568)
.. + +.+++|+-+ .++|.+++.. .... .......+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 236788887 6788877642 2222 12222456699999999999999999999
Q ss_pred CCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCccccccccccCc-------ccCCcccceechhhHHHHHHhCC
Q psy6203 133 KPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK-------QYYGSETDVWSMGVMLYALLCGF 205 (568)
Q Consensus 133 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~~lltG~ 205 (568)
+|+|++++.+|.+.|+||+........ ......+..|.+||..... ..++.+.|.|+||+++|.|++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999977654432 1113356789999986432 23578899999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCC
Q psy6203 206 LPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 206 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 250 (568)
.||........... .+.....++..++.||..+|+.||.+|
T Consensus 248 lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99976543221111 223333688999999999999999988
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-23 Score=187.61 Aligned_cols=153 Identities=19% Similarity=0.352 Sum_probs=136.1
Q ss_pred hhhHHHHHHHHh--CCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCcee
Q psy6203 338 WSMGVMLYALLC--GFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~--~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~ 395 (568)
|+.++++|..+. ...+|.|..+..+..|+..++ ++| +.+||+|||.+.... ....
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~kR 179 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNKR 179 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---CCCc
Confidence 344688888888 567899999999999998874 333 368999999665533 3457
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCC
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 474 (568)
.+.|||.-|.+||. .+..++..||+|++|++.||++.|.+||.+.+..+++++|.+..+.+|..+|.+++|||.+||.+
T Consensus 180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~ 259 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVK 259 (281)
T ss_pred eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhcc
Confidence 89999999999997 88899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCHHHHhcCccccc
Q psy6203 475 EPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 475 dp~~R~t~~~~l~hp~~~~ 493 (568)
+|.+|.+..|++.|||+..
T Consensus 260 ~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 260 NPIERLALTEVMDHPWIVA 278 (281)
T ss_pred CccccccHHHHhhhHHHHh
Confidence 9999999999999999864
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-23 Score=206.99 Aligned_cols=151 Identities=19% Similarity=0.334 Sum_probs=137.8
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
||+|+..++.++.|.+..++.+...++.+| +||. -+|+.|||||... ..|..+.++||
T Consensus 504 GGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki--~~g~KTwTFcG 581 (732)
T KOG0614|consen 504 GGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI--GSGRKTWTFCG 581 (732)
T ss_pred CchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh--ccCCceeeecC
Confidence 899999999999999999999999999875 4444 4689999987653 46677889999
Q ss_pred ccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 401 AIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 401 t~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
||.|.|||. ..++++.+||.||||+++|||++|.|||.+.++...++.|++| ...+|..++..+.+||+++...+|.
T Consensus 582 TpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ 661 (732)
T KOG0614|consen 582 TPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPT 661 (732)
T ss_pred CcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcH
Confidence 999999998 8899999999999999999999999999999999999999998 4668999999999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q psy6203 478 KRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t-----~~~~l~hp~~~~ 493 (568)
+|++ +.+|.+|.||..
T Consensus 662 ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 662 ERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred hhhccccCChHHHHhhhhhhc
Confidence 9996 899999999974
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-23 Score=201.72 Aligned_cols=153 Identities=23% Similarity=0.376 Sum_probs=136.1
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------------eeEEEccccCcccccCCCCce
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------------CTILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------------~~iki~dfG~~~~~~~~~~~~ 394 (568)
||+|-+|++.++.++|+.++.+|+||-+|+ +|| -.+||+|||||+.+ .++..
T Consensus 93 gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L--~~~~~ 170 (429)
T KOG0595|consen 93 GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL--QPGSM 170 (429)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC--CchhH
Confidence 899999999999999999999999999874 333 24799999998875 47778
Q ss_pred ecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHH
Q psy6203 395 INLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSRQIVRS 470 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~ 470 (568)
..+.||+|.|||||+ ....|+.|+|+||+|+|+|+|++|++||...+..+++..+..+.. .+|...++...+|+..
T Consensus 171 a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ 250 (429)
T KOG0595|consen 171 AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLIS 250 (429)
T ss_pred HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhH
Confidence 899999999999999 678899999999999999999999999999999999998887754 3466788899999999
Q ss_pred ccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
+|+.+|..|.+..+...|++....+
T Consensus 251 ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 251 LLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHhcCccccCchHHhhhhhhcccCc
Confidence 9999999999999999999987544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=207.14 Aligned_cols=151 Identities=23% Similarity=0.414 Sum_probs=130.1
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...+.++++.++.++.|++.++ ++ .+++||+|||++..... ...+.
T Consensus 100 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~----~~~~~ 175 (329)
T PTZ00263 100 VVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----RTFTL 175 (329)
T ss_pred CCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC----Cccee
Confidence 34788888998888999999999999998764 23 34688899997654321 12346
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. ....++.++||||+||++|+|++|++||.+.+....+..+..+.+.+|.++++.+++||.+||..||.
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~ 255 (329)
T PTZ00263 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHT 255 (329)
T ss_pred cCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHH
Confidence 89999999998 66778999999999999999999999999999889999999999999999999999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q psy6203 478 KRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t-----~~~~l~hp~~~~ 493 (568)
+|++ ++++++||||..
T Consensus 256 ~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 256 KRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HcCCCCCCCHHHHhcCCccCC
Confidence 9997 799999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=204.30 Aligned_cols=156 Identities=19% Similarity=0.308 Sum_probs=132.5
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++...++|++..+..++.|++.++ +++ +.+||+|||++....... .....
T Consensus 74 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 74 FINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 344788999998888999999999999999864 333 357889999775432222 22445
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+.+..+..+...+|..+++++++||.+||..||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCH
Confidence 689999999998 6678999999999999999999999999999988999999998888999999999999999999999
Q ss_pred CCCC---CHHHHhcCcccccC
Q psy6203 477 GKRI---KIQDLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~---t~~~~l~hp~~~~~ 494 (568)
.+|+ ++.++++||||...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 58999999999853
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=205.03 Aligned_cols=155 Identities=23% Similarity=0.404 Sum_probs=132.6
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++...+.+++..+..++.|++.++ ++ .+.+||+|||++..... .+.....
T Consensus 77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~-~~~~~~~ 155 (320)
T cd05590 77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTST 155 (320)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-CCCcccc
Confidence 344789999998888999999999999998764 33 33578999997654322 2223455
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+++..+..+....|.++++++.+||++||+.||
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 689999999998 6678899999999999999999999999999999999999998888899999999999999999999
Q ss_pred CCCCCH------HHHhcCccccc
Q psy6203 477 GKRIKI------QDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t~------~~~l~hp~~~~ 493 (568)
.+|+++ +++++||||..
T Consensus 236 ~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 236 TMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HHCCCCCCCCCHHHHHcCCCcCC
Confidence 999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=202.46 Aligned_cols=152 Identities=20% Similarity=0.345 Sum_probs=130.8
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|++++...+.+++..+..++.|++.++ ++ .+.+||+|||++..... ....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----~~~~ 157 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----RTWT 157 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC----Cccc
Confidence 334788999998888999999999999999864 22 34688999997654321 1234
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..++.++||||+||++|+|++|+.||.+.+....+..+..+...+|..+++.+++||++||+.||
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence 579999999998 6677899999999999999999999999999999999999999988999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q psy6203 477 GKRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t-----~~~~l~hp~~~~ 493 (568)
.+|++ ++++++||||..
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHccCCccCCHHHHhcCccccC
Confidence 99995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=181.62 Aligned_cols=189 Identities=18% Similarity=0.191 Sum_probs=140.3
Q ss_pred EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc---hHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEe
Q psy6203 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED---LPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.+...|++|+||+|+++.. .+.+++.+.+........ ...+.+|+++|++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678899999999998875 677888777765443211 225788999999996 5889999886 34699999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCceEEcCCCCeEEEeecCccCCCCCCcc--c
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDL-KPENVLLDRNQNLKLIDFGLCAKPEGGLES--Q 163 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDl-kp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~ 163 (568)
|+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|......... .
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999998754321 1 2357889999999999999999999 799999999999999999999854432110 0
Q ss_pred c----------ccccCCccccccccccCcccCC-cccceechhhHHHHHHhCCCCCCCCC
Q psy6203 164 L----------QTSCGSPNYAAPEVIKGKQYYG-SETDVWSMGVMLYALLCGFLPFDSDS 212 (568)
Q Consensus 164 ~----------~~~~gt~~y~aPE~l~~~~~~~-~~~DiwSlG~il~~lltG~~pf~~~~ 212 (568)
+ .....++.|++|+.-.--...+ ...+.++.|+-+|.++|+..++.+++
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0112577888887643221112 45677899999999999999876543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-21 Score=209.73 Aligned_cols=203 Identities=18% Similarity=0.243 Sum_probs=142.9
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCE----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q psy6203 52 RVKLEINALKHISHQHICKLFQVIETSSH----IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127 (568)
Q Consensus 52 ~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~----~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 127 (568)
..+.|+..+.++.|+|++.++.+--.... ..+..++|...++...+..-+..+...++.+..++++||.|+|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34557777888899999999888643322 23445889999999999888999999999999999999999999966
Q ss_pred eecCCCCC---ceEEcCCCCeEEE--eecCccCCCCCCccccccccCCccccccccccCccc-CCcccceechhhHHHHH
Q psy6203 128 AHRDLKPE---NVLLDRNQNLKLI--DFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY-YGSETDVWSMGVMLYAL 201 (568)
Q Consensus 128 vHrDlkp~---NIll~~~~~~kl~--DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~DiwSlG~il~~l 201 (568)
.|.-+..+ +--.+..+.+.++ ||+.+....... ......-+..+.|||....... .+...|+|.+|.....+
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 66555544 3334455666666 888776554322 1122234556778888765542 12336999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCh-HHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 202 LCGFLPFDSDSIDQLYDKILNGKYTEPPWMSP-NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 202 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
..|..+-... .....+ .+..+. ...+.+.+|+.-++++|+++.+++.|+|.+...
T Consensus 386 ~~~~~i~~~~---~~~~~~-------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 386 SQGEDISEKS---AVPVSL-------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhcCcccccc---cchhhh-------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 8876542111 111111 111122 678899999999999999999999999998543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=205.52 Aligned_cols=152 Identities=20% Similarity=0.320 Sum_probs=130.6
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++...+.++++.+..++.|++.++ ++ .+++||+|||++..... ...+
T Consensus 112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~----~~~~ 187 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RTYT 187 (340)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC----Ccce
Confidence 334788999998888999999999999998763 33 33578899997654321 1245
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..++.++||||+||++|||++|.+||.+.+....+..+..+...+|..+++.+.++|++||..||
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp 267 (340)
T PTZ00426 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDL 267 (340)
T ss_pred ecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 689999999998 6677899999999999999999999999999988889999999888899999999999999999999
Q ss_pred CCCC-----CHHHHhcCccccc
Q psy6203 477 GKRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~-----t~~~~l~hp~~~~ 493 (568)
.+|+ |++++++||||..
T Consensus 268 ~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 268 TKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHcCCCCCCCHHHHHcCCCcCC
Confidence 9996 8999999999975
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=217.47 Aligned_cols=156 Identities=24% Similarity=0.347 Sum_probs=132.6
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCcccccCCCCce-ec
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILLPCKVGQV-IN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~~~~~~~~-~~ 396 (568)
|-+||+|..++...+++||+=||++..-++-|+ .+.++||++|||-+. .....|.. ..
T Consensus 156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl-km~~dG~V~s~ 234 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL-KMDADGTVRSS 234 (1317)
T ss_pred cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH-hcCCCCcEEec
Confidence 445999999999999999999999999988653 345678999999433 33345554 45
Q ss_pred ccccccccccCCC------CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCC--CCCCHHHHH
Q psy6203 397 LLRSAIVLCSAPS------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEP--PWMSPNSRQ 466 (568)
Q Consensus 397 ~~~gt~~~~~pe~------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~ 466 (568)
..+|||-|.+||+ +...||..|||||+||++|||+.|..||.+++..+.|.+|+.- .+.|| ..+|+++++
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakd 314 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKD 314 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHH
Confidence 6799999999997 3367999999999999999999999999999999999999986 56777 559999999
Q ss_pred HHHHccCCCcCCCCC---HHHHhcCcccccCC
Q psy6203 467 IVRSMLQVEPGKRIK---IQDLLGHNWVKMGP 495 (568)
Q Consensus 467 li~~~L~~dp~~R~t---~~~~l~hp~~~~~~ 495 (568)
||.+++ .+|+.|++ ++++..||||....
T Consensus 315 LI~~ll-~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 315 LIEALL-CDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHh-cChhhhcccccHHHHHhCccccCCC
Confidence 999998 78899998 99999999998543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-22 Score=201.68 Aligned_cols=153 Identities=19% Similarity=0.324 Sum_probs=131.2
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|..++...+.+++..+..++.|++.++ ++ .+.+||+|||++...... +......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccccc
Confidence 4778888888888999999999999998764 23 346789999976543222 22345568
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+.+..+..+....|.++++++.+||.+||..||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999998 667789999999999999999999999999999999999999988889999999999999999999999
Q ss_pred CC-------CHHHHhcCccccc
Q psy6203 479 RI-------KIQDLLGHNWVKM 493 (568)
Q Consensus 479 R~-------t~~~~l~hp~~~~ 493 (568)
|+ +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-22 Score=201.26 Aligned_cols=155 Identities=20% Similarity=0.379 Sum_probs=130.7
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|+.++...+.+++..++.++.|++.++ +++ +.+||+|||++....... .....
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 334788888888888999999999999999764 333 357889999765432222 22345
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..++.++||||+||++|+|++|++||.+.+..+....+......+|..+++++.+||.+||..||
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCH
Confidence 689999999998 6677899999999999999999999999998888888888888888899999999999999999999
Q ss_pred CCCC-----CHHHHhcCccccc
Q psy6203 477 GKRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~-----t~~~~l~hp~~~~ 493 (568)
++|+ ++.++++||||..
T Consensus 235 ~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 235 NKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHcCCCCCCCHHHHhcCCCcCC
Confidence 9997 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-22 Score=200.65 Aligned_cols=154 Identities=21% Similarity=0.321 Sum_probs=129.6
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...+++++..+..++.|++.++ +++ +.+||+|||++...... .......
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTF 156 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceecc
Confidence 34788888888888999999999999999864 333 35789999976532211 1224567
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..|+.++||||+||++|+|++|+.||.+.+..+....+....+..|.+++.++++||.+||..||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPT 236 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 89999999998 66778999999999999999999999999999888888888888888899999999999999999999
Q ss_pred CCCCH-HHHhcCccccc
Q psy6203 478 KRIKI-QDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~-~~~l~hp~~~~ 493 (568)
+|+++ +++++||||+.
T Consensus 237 ~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 237 RRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HcCCChHHHHcCCCcCC
Confidence 99997 68999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=199.63 Aligned_cols=155 Identities=21% Similarity=0.367 Sum_probs=131.8
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++.+...+.++++.+..++.|++.++ ++ .+.+||+|||++..... .+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 160 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTF 160 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc-CCCccccc
Confidence 34788999998888999999999999998764 33 33578899997653322 22234456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..++.++||||+||++|||++|++||.+.+....+..+..+....|+.+++++.+||.+||..||+
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 240 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHh
Confidence 89999999998 66678999999999999999999999999999888889999998889999999999999999999999
Q ss_pred CCC-----CHHHHhcCcccccC
Q psy6203 478 KRI-----KIQDLLGHNWVKMG 494 (568)
Q Consensus 478 ~R~-----t~~~~l~hp~~~~~ 494 (568)
+|+ +++++++||||...
T Consensus 241 ~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 241 SRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcCCCCCCCHHHHhcCCCcCCC
Confidence 999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-22 Score=188.72 Aligned_cols=155 Identities=21% Similarity=0.440 Sum_probs=128.4
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc-----------ceeEEEccccCccccc----CCC--
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP-----------ICTILISQYFPTILLP----CKV-- 391 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~-----------~~~iki~dfG~~~~~~----~~~-- 391 (568)
||.|.+.|..+.+|.|.++.++.+.|.+++ +| .+-||||||-++.... +.+
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 788889999999999999999999988764 23 3458999997642221 111
Q ss_pred CceecccccccccccCCC------CCCCCCCccceeehhHHHHHHHhCCCCCCCCC---------------HHHHHHHHH
Q psy6203 392 GQVINLLRSAIVLCSAPS------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---------------IDQLYDKIL 450 (568)
Q Consensus 392 ~~~~~~~~gt~~~~~pe~------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~---------------~~~~~~~i~ 450 (568)
...+.+-||+-.|||||+ ...+|+.++|.||||||+|.||+|.+||.|.- ...++..|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 123556799999999996 56789999999999999999999999998632 245788999
Q ss_pred cCCCCCCCC----CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 451 NGKYTEPPW----MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 451 ~~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
.|.+.+|.. +|.+++|||+.+|.+|+..|.++.++++|||+..-.
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 999999854 899999999999999999999999999999998543
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-22 Score=198.10 Aligned_cols=143 Identities=24% Similarity=0.440 Sum_probs=121.3
Q ss_pred CC-CChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccC----CCCceeccccccccccc
Q psy6203 352 LP-FDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPC----KVGQVINLLRSAIVLCS 406 (568)
Q Consensus 352 ~~-~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~----~~~~~~~~~~gt~~~~~ 406 (568)
.+ |.+.++|.+++.++.|+ +||. .+||+|||.+..... +....+...+|||.|+|
T Consensus 204 ~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~A 283 (576)
T KOG0585|consen 204 KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFA 283 (576)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccc
Confidence 35 99999999999999774 4444 689999996654311 11112444799999999
Q ss_pred CCC-----CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHccCCCcCCC
Q psy6203 407 APS-----SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW--MSPNSRQIVRSMLQVEPGKR 479 (568)
Q Consensus 407 pe~-----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dp~~R 479 (568)
||. ...+.+.+.||||+||+||+|+.|+.||.++...+++.+|......+|.. +++.++|||++||++||.+|
T Consensus 284 PE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~R 363 (576)
T KOG0585|consen 284 PELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQR 363 (576)
T ss_pred hHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhe
Confidence 997 25678899999999999999999999999999999999999998888865 79999999999999999999
Q ss_pred CCHHHHhcCcccccC
Q psy6203 480 IKIQDLLGHNWVKMG 494 (568)
Q Consensus 480 ~t~~~~l~hp~~~~~ 494 (568)
+++.++..|||....
T Consensus 364 i~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 364 ITLPDIKLHPWVTRD 378 (576)
T ss_pred eehhhheecceeccC
Confidence 999999999999865
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-22 Score=204.53 Aligned_cols=150 Identities=19% Similarity=0.276 Sum_probs=118.2
Q ss_pred HHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Ccce----------eEEEccccCcccccCCCCceec
Q psy6203 341 GVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MPIC----------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 341 g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~~~----------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
+.+||++++. ...|+-..+|.+.+||+.++ +||. .|||.|||.| |-.+....
T Consensus 271 ~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS----c~~~q~vy 346 (586)
T KOG0667|consen 271 STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS----CFESQRVY 346 (586)
T ss_pred hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc----cccCCcce
Confidence 6899999997 35799999999999999874 4444 5677777732 22333344
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------------
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK---------------------- 453 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~---------------------- 453 (568)
+.+-+.+|.|||+ .+..|+.++||||||||++||++|.|.|+|++..+++..|..--
T Consensus 347 tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~ 426 (586)
T KOG0667|consen 347 TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLK 426 (586)
T ss_pred eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccC
Confidence 6778889999998 88899999999999999999999999999999988887764310
Q ss_pred ------------------------------CCCCCC-----------CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q psy6203 454 ------------------------------YTEPPW-----------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 454 ------------------------------~~~~~~-----------~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~ 492 (568)
...|+. -...+.|||++||..||.+|+|+.++|+|||+.
T Consensus 427 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 427 GFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred CceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 001100 123568999999999999999999999999998
Q ss_pred cC
Q psy6203 493 MG 494 (568)
Q Consensus 493 ~~ 494 (568)
..
T Consensus 507 ~~ 508 (586)
T KOG0667|consen 507 GT 508 (586)
T ss_pred cc
Confidence 44
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=199.57 Aligned_cols=155 Identities=22% Similarity=0.334 Sum_probs=130.8
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++...+.+++..+..++.|++.++ ++ .+.+||+|||++....... .....
T Consensus 77 ~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 77 YLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 334788988998888999999999999999764 23 3357899999775433222 23455
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..++.++||||+||++|+|++|+.||.+.+..+++..+....+..|..++.++.+||.+||..||
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 689999999998 6667899999999999999999999999999988888888888888888999999999999999999
Q ss_pred CCCCCH-HHHhcCccccc
Q psy6203 477 GKRIKI-QDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t~-~~~l~hp~~~~ 493 (568)
++|+++ +++++||||..
T Consensus 236 ~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 236 TKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HHcCCChHHHHcCcccCC
Confidence 999986 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=199.92 Aligned_cols=154 Identities=21% Similarity=0.331 Sum_probs=130.8
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...+.|++..+..++.|++.++ +++. .+||+|||++...... +......
T Consensus 83 ~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 161 (323)
T cd05616 83 VNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVTTKTF 161 (323)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-CCccccC
Confidence 34788888888888999999999999998764 3333 5788999976543222 2234567
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. ....|+.++||||+||++|||++|++||.+.+..+++..+......+|..+++++.+||.+||+.||.
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~ 241 (323)
T cd05616 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPG 241 (323)
T ss_pred CCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHH
Confidence 89999999998 66779999999999999999999999999999999999999988888989999999999999999999
Q ss_pred CCCCH-----HHHhcCccccc
Q psy6203 478 KRIKI-----QDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~-----~~~l~hp~~~~ 493 (568)
+|+++ .++++||||..
T Consensus 242 ~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 242 KRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred hcCCCCCCCHHHHhcCCCcCC
Confidence 99984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=200.82 Aligned_cols=157 Identities=17% Similarity=0.332 Sum_probs=127.0
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++.....++++.++.++.|++.++ ++ .+.+||+|||++.............
T Consensus 86 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~ 165 (332)
T cd05614 86 YVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165 (332)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCcccc
Confidence 334788888888888999999999999999764 23 3468899999876543333333445
Q ss_pred cccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy6203 398 LRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471 (568)
Q Consensus 398 ~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 471 (568)
.+||+.|+|||. +...++.++||||+||++|||++|+.||... ........+....+.+|..+++.+.+||.+|
T Consensus 166 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (332)
T cd05614 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKL 245 (332)
T ss_pred ccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 689999999997 4456899999999999999999999999743 3345556677777778888999999999999
Q ss_pred cCCCcCCCC-----CHHHHhcCcccccC
Q psy6203 472 LQVEPGKRI-----KIQDLLGHNWVKMG 494 (568)
Q Consensus 472 L~~dp~~R~-----t~~~~l~hp~~~~~ 494 (568)
|..||++|+ +++++++||||+..
T Consensus 246 l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 246 LRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred cCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999 78899999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=199.23 Aligned_cols=154 Identities=21% Similarity=0.301 Sum_probs=130.9
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...+.+++..+..++.|++.++ +++ +.+||+|||++....... ......
T Consensus 83 ~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 161 (324)
T cd05587 83 VNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTF 161 (324)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cceeee
Confidence 34788988998888999999999999998864 333 357899999765432222 224456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..++.++||||+||++|+|++|++||.+.+..+.+..+......+|..+++++.+||.+||..||.
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~ 241 (324)
T cd05587 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPA 241 (324)
T ss_pred cCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 89999999998 66778999999999999999999999999999999999999988888889999999999999999999
Q ss_pred CCCCH-----HHHhcCccccc
Q psy6203 478 KRIKI-----QDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~-----~~~l~hp~~~~ 493 (568)
+|+++ +++++||||..
T Consensus 242 ~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 242 KRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HcCCCCCCCHHHHhcCCCcCC
Confidence 99986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=198.82 Aligned_cols=156 Identities=19% Similarity=0.284 Sum_probs=130.2
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++.....+++..+..++.|++.++ ++ ...+||+|||++....... .....
T Consensus 77 y~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 77 YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 344788988998878899999999999998764 23 3357889999765432222 12345
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+++..+....+..|.+++.++++||.+||..||
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCH
Confidence 689999999998 6677899999999999999999999999999888888888877777888899999999999999999
Q ss_pred CCCCCHH-HHhcCcccccC
Q psy6203 477 GKRIKIQ-DLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~t~~-~~l~hp~~~~~ 494 (568)
++|+++. ++++||||...
T Consensus 236 ~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 236 ERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred hhcCCChHHHHcCcccCCC
Confidence 9999996 99999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.6e-22 Score=190.46 Aligned_cols=154 Identities=18% Similarity=0.224 Sum_probs=118.6
Q ss_pred HHHHHHHhC----CCCCChhhHHHHHHHHhhc------------cCcce---------eEEEccccCcccccCCCCceec
Q psy6203 342 VMLYALLCG----FLPFDSDSIDQLYDKILSH------------FMPIC---------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 342 ~~l~~~~~~----~~~~~e~~~~~~~~qil~~------------~~~~~---------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.+|+++++. ...++.-+|+-++.||..| ++||. .+||||||-|..+.. |....
T Consensus 106 ~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~--~epni 183 (364)
T KOG0658|consen 106 ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK--GEPNI 183 (364)
T ss_pred HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc--CCCce
Confidence 555555552 4567777777777777765 35554 479999997765543 33345
Q ss_pred ccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C---------------CCCC
Q psy6203 397 LLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K---------------YTEP 457 (568)
Q Consensus 397 ~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~---------------~~~~ 457 (568)
+...|.+|.|||. +.+.|+.++||||+|||++||+.|++.|+|++..+++..|.+. . ..+|
T Consensus 184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p 263 (364)
T KOG0658|consen 184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFP 263 (364)
T ss_pred eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCc
Confidence 6677888888886 8999999999999999999999999999999988887776441 1 1111
Q ss_pred ------------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCC
Q psy6203 458 ------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 497 (568)
Q Consensus 458 ------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 497 (568)
...++++.+|+.++|+.+|.+|.++.|+++||||+....+
T Consensus 264 ~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 264 QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 2368999999999999999999999999999999865443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=198.86 Aligned_cols=156 Identities=20% Similarity=0.390 Sum_probs=131.4
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|+.++...+.|++..++.++.|++.++ +++ +.+||+|||++...... ......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 154 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence 344788888888888999999999999999764 333 35788999976543222 222345
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..++.++||||+||++|||++|+.||.+.+.......+......+|..+++++.+||.+||..||
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 689999999998 6677899999999999999999999999999888888888888888888999999999999999999
Q ss_pred CCCC-----CHHHHhcCcccccC
Q psy6203 477 GKRI-----KIQDLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~-----t~~~~l~hp~~~~~ 494 (568)
++|+ ++.++++||||...
T Consensus 235 ~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 235 KQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HHhCCCCCCCHHHHHcCCCcCCC
Confidence 9998 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=189.25 Aligned_cols=189 Identities=26% Similarity=0.434 Sum_probs=140.4
Q ss_pred CCCCcceeeEEEEe---------------------------CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q psy6203 64 SHQHICKLFQVIET---------------------------SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQIL 116 (568)
Q Consensus 64 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~ 116 (568)
+|||||++..+|.+ ...+|+||..++ .+|..++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999887643 235899999884 5888888654 456677788999999
Q ss_pred HHHHHHHHcCceecCCCCCceEE--cCCC--CeEEEeecCccCCCC-----CCccccccccCCccccccccccCccc---
Q psy6203 117 SAVAYLHHLGYAHRDLKPENVLL--DRNQ--NLKLIDFGLCAKPEG-----GLESQLQTSCGSPNYAAPEVIKGKQY--- 184 (568)
Q Consensus 117 ~aL~~LH~~~ivHrDlkp~NIll--~~~~--~~kl~DFG~a~~~~~-----~~~~~~~~~~gt~~y~aPE~l~~~~~--- 184 (568)
+|+.|||.+||.|||+|.+|||+ ++++ .+.|+|||.+-.... ...+..-...|.-.-||||+....+.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999999 3444 478999997643221 11122233457888999999864331
Q ss_pred --CCcccceechhhHHHHHHhCCCCCCCCCHHHH-HHHHHcC-CCCCCCCCChHHHHHHHHccccCcCCCCCHH
Q psy6203 185 --YGSETDVWSMGVMLYALLCGFLPFDSDSIDQL-YDKILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQ 254 (568)
Q Consensus 185 --~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~-~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 254 (568)
.=.++|.|+.|.+.||+++...||.+....-+ .....+. -+..+..+++.+++++..+|+.||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 11378999999999999999999976321111 0112222 3345677999999999999999999999854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=178.65 Aligned_cols=133 Identities=22% Similarity=0.302 Sum_probs=107.4
Q ss_pred EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-----CCCCcceeeEEEEeCC---EEE-E
Q psy6203 13 ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-----SHQHICKLFQVIETSS---HIF-M 83 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-----~hpnIv~l~~~~~~~~---~~~-l 83 (568)
.+.||+|+||.||. ++.++.. +||++..... .....+.+|+.+++.+ +||||++++++++++. .++ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 57899999999995 7777666 6998875432 2345789999999999 5799999999998874 434 7
Q ss_pred EEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCceecCCCCCceEEcCC----CCeEEEeecC
Q psy6203 84 VIEY--CPGGELLDHIVERQRLGEKESRAFFRQILSAV-AYLHHLGYAHRDLKPENVLLDRN----QNLKLIDFGL 152 (568)
Q Consensus 84 V~E~--~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~ivHrDlkp~NIll~~~----~~~kl~DFG~ 152 (568)
|||| +.+++|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.
T Consensus 83 I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 557999999965 456666 35678888887 99999999999999999999743 3799999543
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=179.92 Aligned_cols=163 Identities=22% Similarity=0.280 Sum_probs=127.1
Q ss_pred cCCCCcchhhhHHHHHHH-----Hh-CCCCCChhhHHHHHHHHhhcc-------------Ccc--------eeEEEcccc
Q psy6203 330 YYGSETDVWSMGVMLYAL-----LC-GFLPFDSDSIDQLYDKILSHF-------------MPI--------CTILISQYF 382 (568)
Q Consensus 330 ~~~~~~~~~~~g~~l~~~-----~~-~~~~~~e~~~~~~~~qil~~~-------------~~~--------~~iki~dfG 382 (568)
++-+.+|+|+ +.+++.. ++ -.++++|..+..+...+++++ .|| +|||+||||
T Consensus 159 yFi~n~dV~I-cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 159 YFITNTDVFI-CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred EEeeCchHHH-HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence 3556778887 3444432 22 257899999998888888764 333 478999999
Q ss_pred CcccccCCCCceecccccccccccCCC----CCCCCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-
Q psy6203 383 PTILLPCKVGQVINLLRSAIVLCSAPS----SKQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYTE- 456 (568)
Q Consensus 383 ~~~~~~~~~~~~~~~~~gt~~~~~pe~----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~-~~~~~~~~i~~~~~~~- 456 (568)
++..+... .+.+-..|.+.|||||. ....|+-.+||||||++++||.||+.||.+. +..+++.+|+...++.
T Consensus 238 IsGrlvdS--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L 315 (391)
T KOG0983|consen 238 ISGRLVDS--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL 315 (391)
T ss_pred ccceeecc--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC
Confidence 76443322 22344578899999996 4678999999999999999999999999985 4778888998876652
Q ss_pred CC--CCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 457 PP--WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 457 ~~--~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
|. .+|+++++|+..||++|+.+||...++|+|||+....
T Consensus 316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 32 3899999999999999999999999999999998653
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=198.64 Aligned_cols=154 Identities=21% Similarity=0.271 Sum_probs=136.3
Q ss_pred hhhHHHHHHHHhCC--CCCChhhHHHHHHHHhhcc--------------------CcceeEEEccccCcccccCCCCcee
Q psy6203 338 WSMGVMLYALLCGF--LPFDSDSIDQLYDKILSHF--------------------MPICTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~--------------------~~~~~iki~dfG~~~~~~~~~~~~~ 395 (568)
|.-||++.+.+... ..|+|+.+..+|.|++.++ .+...|++.|||+|+....+.+ ..
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-~a 163 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-LA 163 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh-hh
Confidence 44589999888763 5899999999999999874 3345789999998877655442 56
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
.+.+||++||.||. .+..|+.++|||||||++|||++-+++|.+.+...+..+|..+. .+.|...|.+.+.+|+.||.
T Consensus 164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~ 243 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLR 243 (426)
T ss_pred heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhh
Confidence 78999999999998 88999999999999999999999999999999999999999987 56788899999999999999
Q ss_pred CCcCCCCCHHHHhcCcccc
Q psy6203 474 VEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 474 ~dp~~R~t~~~~l~hp~~~ 492 (568)
.+|..||++.++|.+|...
T Consensus 244 ~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 244 KNPEHRPSALELLRRPHLL 262 (426)
T ss_pred cCCccCCCHHHHhhChhhh
Confidence 9999999999999999876
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=198.08 Aligned_cols=156 Identities=26% Similarity=0.387 Sum_probs=131.5
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------C--------cceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------M--------PICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~--------~~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|...+...+.+++..+..++.|++.++ + ..+.+||+|||++...... +.....
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (318)
T cd05570 77 YVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTST 155 (318)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccc
Confidence 334788888888878999999999999999864 2 2346788999976543222 222345
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..++.++||||+||++|+|++|+.||.+.+.......+......+|..+++++.+||++||..||
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 689999999998 6677899999999999999999999999999988888889888888888899999999999999999
Q ss_pred CCCCCH-----HHHhcCcccccC
Q psy6203 477 GKRIKI-----QDLLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~t~-----~~~l~hp~~~~~ 494 (568)
++|||+ .++++||||+..
T Consensus 236 ~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 236 EKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=210.14 Aligned_cols=150 Identities=17% Similarity=0.154 Sum_probs=114.4
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc-------------Ccce------------------------eEEEccccC
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF-------------MPIC------------------------TILISQYFP 383 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~-------------~~~~------------------------~iki~dfG~ 383 (568)
|+.|.+++...++|++..+..++.|++.++ +|+. .+||+|||.
T Consensus 215 g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~ 294 (467)
T PTZ00284 215 GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294 (467)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCc
Confidence 677888888888999999999999988764 2222 277888885
Q ss_pred cccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Q psy6203 384 TILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----- 457 (568)
Q Consensus 384 ~~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----- 457 (568)
+.. ........+||+.|+|||. .+..|+.++|||||||++|||++|++||.+.+..+.+..+......+|
T Consensus 295 ~~~----~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~ 370 (467)
T PTZ00284 295 CCD----ERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAG 370 (467)
T ss_pred ccc----CccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Confidence 432 1222346789999999998 667899999999999999999999999998876555443322110000
Q ss_pred -----------------------C--------------CCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 458 -----------------------P--------------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 458 -----------------------~--------------~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
. ..++.+.|||.+||++||.+|+|++|+++||||...
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 371 RCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0 013557799999999999999999999999999864
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=200.63 Aligned_cols=156 Identities=21% Similarity=0.338 Sum_probs=129.9
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++...+.+++..+..++.|++.++ +++ +.+||+|||++....... .....
T Consensus 77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 77 YMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred CCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 334788888888888999999999999999864 333 357889999765432222 23456
Q ss_pred cccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~s~~~~~li~~~L~~ 474 (568)
.+||+.|+|||. ....|+.++||||+||++|+|++|+.||.+.+..+.+..+..+...+|. .+++++.+||++||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 789999999997 4567899999999999999999999999999988888899888777765 4799999999999999
Q ss_pred CcCCCC----CHHHHhcCcccccC
Q psy6203 475 EPGKRI----KIQDLLGHNWVKMG 494 (568)
Q Consensus 475 dp~~R~----t~~~~l~hp~~~~~ 494 (568)
||.+|+ +++++++||||...
T Consensus 236 ~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 236 NPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CHHHCCCCCCCHHHHhcCccccCC
Confidence 999998 68999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=192.23 Aligned_cols=165 Identities=18% Similarity=0.303 Sum_probs=129.8
Q ss_pred CCCCcchhhh-----HHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccC
Q psy6203 331 YGSETDVWSM-----GVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFP 383 (568)
Q Consensus 331 ~~~~~~~~~~-----g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~ 383 (568)
+.+...+|.+ ||.+.++++.. .-|.|..|..|++++|.|+ .|+ ++||++|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 3444445543 77788887752 2399999999999999875 344 4678888885
Q ss_pred cccccCCCCc---ee-cccccccccccCCC---CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q psy6203 384 TILLPCKVGQ---VI-NLLRSAIVLCSAPS---SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE 456 (568)
Q Consensus 384 ~~~~~~~~~~---~~-~~~~gt~~~~~pe~---~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~ 456 (568)
+..+ .+.|. .. .+++||++|||||+ ...+|+.|+||||+|++..||.+|..||..-.+.+++-.-+.+.++.
T Consensus 173 sa~l-~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 173 SASL-FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeee-cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 4322 22332 12 67899999999998 66789999999999999999999999999998888877777777763
Q ss_pred CC----------CCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 457 PP----------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 457 ~~----------~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
+. .++..++.+|..||++||.+|||++++++|+||+....
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 32 26778999999999999999999999999999986543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=197.65 Aligned_cols=154 Identities=21% Similarity=0.291 Sum_probs=129.8
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|..++...+.+++..+..++.|++.++ +++ +.+||+|||++..... ........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 156 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTSTF 156 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCccccc
Confidence 34788888888888999999999999999864 333 3578899997654322 12223456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..++.++||||+||++|+|++|.+||.+.+..+.+..+..+....++.+++.+.+||.+||+.||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 89999999998 66778999999999999999999999999999889999999888888888999999999999999999
Q ss_pred CCCCH----HHHhcCccccc
Q psy6203 478 KRIKI----QDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~----~~~l~hp~~~~ 493 (568)
+|+++ .++++||||..
T Consensus 237 ~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 237 KRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCC
Confidence 99997 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=193.53 Aligned_cols=151 Identities=16% Similarity=0.102 Sum_probs=111.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|+.+..+......++++.+..++.|++.++ +++ +.+||+|||++...............|
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 163 (287)
T cd07848 84 KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA 163 (287)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccccccc
Confidence 344444444456799999999999999864 233 357899999776543322222345678
Q ss_pred ccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------CCCC---
Q psy6203 401 AIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK-------------------YTEP--- 457 (568)
Q Consensus 401 t~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~-------------------~~~~--- 457 (568)
|+.|+|||. .+..++.++||||+||++|+|++|++||.+.+..+....+.... ...|
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T cd07848 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVN 243 (287)
T ss_pred ccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCccc
Confidence 999999997 55668999999999999999999999999877654433332210 0011
Q ss_pred ----------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q psy6203 458 ----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 491 (568)
Q Consensus 458 ----------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 491 (568)
..+|+++.+||++||++||++|+|++++++||||
T Consensus 244 ~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 244 HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-22 Score=203.61 Aligned_cols=154 Identities=18% Similarity=0.300 Sum_probs=127.3
Q ss_pred hHHHHHHHHhC-CCCC--ChhhHHHHHHHHhhcc------------Cc---------ceeEEEccccCcccccCCCCcee
Q psy6203 340 MGVMLYALLCG-FLPF--DSDSIDQLYDKILSHF------------MP---------ICTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~--~e~~~~~~~~qil~~~------------~~---------~~~iki~dfG~~~~~~~~~~~~~ 395 (568)
.||.|-++++. =||+ .|..+..+-+|||+|+ +| .+.+||+|||-+..+.. -+..+
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~T 733 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCT 733 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCccc
Confidence 48999999986 4788 8999999999999985 12 23689999996644322 23346
Q ss_pred cccccccccccCCC---CCCCCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHH--HcCCCCCCCCCCHHHHHHHH
Q psy6203 396 NLLRSAIVLCSAPS---SKQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKI--LNGKYTEPPWMSPNSRQIVR 469 (568)
Q Consensus 396 ~~~~gt~~~~~pe~---~~~~~~~~~DiWSlG~il~eml~g~~pf~~~-~~~~~~~~i--~~~~~~~~~~~s~~~~~li~ 469 (568)
.++.||..|||||+ +..+||.++||||+||++.||.||+|||... ++...+.++ .+..+++|..+|.+|+.||.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence 78999999999998 7789999999999999999999999999753 344444443 34467789999999999999
Q ss_pred HccCCCcCCCCCHHHHhcCcccccC
Q psy6203 470 SMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 470 ~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+|+..||..||+|.++|+.||++..
T Consensus 814 rcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 814 RCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHcCCCcccCccHHHhccCcccccC
Confidence 9999999999999999999999865
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=200.33 Aligned_cols=155 Identities=21% Similarity=0.395 Sum_probs=130.2
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc-------------Ccce--------eEEEccccCcccccCCCCceec
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF-------------MPIC--------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~-------------~~~~--------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|..|++|+.++...+.++++.+..++.|++.++ +++. .+||+|||++..... .+....
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~ 154 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMK 154 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC-CCcccc
Confidence 344788888888878999999999998888653 3333 478899997654322 222344
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d 475 (568)
..+||+.|+|||. .+..++.++||||+||++|+|++|+.||.+.+.......+......+|..+++++.+||.+||..|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d 234 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD 234 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 5689999999998 667889999999999999999999999999988888888888888889999999999999999999
Q ss_pred cCCCC-----CHHHHhcCccccc
Q psy6203 476 PGKRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 476 p~~R~-----t~~~~l~hp~~~~ 493 (568)
|++|+ ++.++++||||..
T Consensus 235 P~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 235 PKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHHhCCCCCCCHHHHhcCCCcCC
Confidence 99997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=187.28 Aligned_cols=154 Identities=17% Similarity=0.287 Sum_probs=120.6
Q ss_pred HHHHHHHhCCC----CCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCceecc
Q psy6203 342 VMLYALLCGFL----PFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 342 ~~l~~~~~~~~----~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
.+|-.++.... .++...++.+|+|++.|+ +||. .+|++|||+|+..... ......
T Consensus 101 ~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip-~~~yt~ 179 (323)
T KOG0594|consen 101 RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP-MRTYTP 179 (323)
T ss_pred ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC-cccccc
Confidence 44455555433 467788999999999874 4554 5799999988865432 223566
Q ss_pred cccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC----------------CCC
Q psy6203 398 LRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKY----------------TEP 457 (568)
Q Consensus 398 ~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~--~~~----------------~~~ 457 (568)
.++|.||.|||+ +.+.|+..+||||+|||++||+++++.|+|.+..+++..|.. |.+ .+|
T Consensus 180 evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~ 259 (323)
T KOG0594|consen 180 EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFP 259 (323)
T ss_pred cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCc
Confidence 789999999998 777899999999999999999999999999999888888755 111 111
Q ss_pred CC------------CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 458 PW------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 458 ~~------------~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
.+ .++++.+++.+||+.+|.+|.|+..++.||||...+.
T Consensus 260 ~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 260 KWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 11 3468999999999999999999999999999986543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=197.28 Aligned_cols=154 Identities=18% Similarity=0.270 Sum_probs=125.0
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...+++++..++.++.|++.++ ++ .+.+||+|||++..... .+......
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~~ 156 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTSTF 156 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCccccc
Confidence 34788888888778999999999999999864 23 33588999997654222 22334567
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD---------SIDQLYDKILNGKYTEPPWMSPNSRQIV 468 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li 468 (568)
+||+.|+|||. .+..++.++||||+||++|+|++|++||... ......+.+.......|..+++++.+||
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 89999999998 6677899999999999999999999999631 1223556677777888889999999999
Q ss_pred HHccCCCcCCCCC------HHHHhcCccccc
Q psy6203 469 RSMLQVEPGKRIK------IQDLLGHNWVKM 493 (568)
Q Consensus 469 ~~~L~~dp~~R~t------~~~~l~hp~~~~ 493 (568)
++||..||.+|+| ++++++||||..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999997 789999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=196.24 Aligned_cols=155 Identities=21% Similarity=0.303 Sum_probs=131.6
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...++|++..+..++.|++.++ +++ +.+||+|||++...... +......
T Consensus 83 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~~~~~~ 161 (323)
T cd05615 83 VNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTF 161 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-CccccCc
Confidence 34788999998888999999999999999864 333 35789999976543222 2234556
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..++.++||||+||++|+|++|++||.+.+.......+.......|..+++++.+|+.+||.+||.
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~ 241 (323)
T cd05615 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPS 241 (323)
T ss_pred cCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHh
Confidence 89999999998 66778999999999999999999999999999888999999988888889999999999999999999
Q ss_pred CCCC-----HHHHhcCcccccC
Q psy6203 478 KRIK-----IQDLLGHNWVKMG 494 (568)
Q Consensus 478 ~R~t-----~~~~l~hp~~~~~ 494 (568)
+|++ .+++++||||...
T Consensus 242 ~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 242 KRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred hCCCCCCCCHHHHhcCcccCCC
Confidence 9997 4799999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=195.09 Aligned_cols=152 Identities=18% Similarity=0.300 Sum_probs=128.2
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------C--------cceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------M--------PICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~--------~~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|..++.+ ..|++..+..++.|++.++ + ..+.+||+|||++..... .+......+
T Consensus 85 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~ 162 (324)
T cd05589 85 AGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG-FGDRTSTFC 162 (324)
T ss_pred CCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC-CCCcccccc
Confidence 36777777765 5799999999999999764 2 234688999997643221 222345678
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..++.++||||+||++|+|++|++||.+.+..+....+..+....|..+++++.+||.+||..||.+
T Consensus 163 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 242 (324)
T cd05589 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242 (324)
T ss_pred cCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence 9999999998 667889999999999999999999999999998889999988888888899999999999999999999
Q ss_pred CC-----CHHHHhcCccccc
Q psy6203 479 RI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 479 R~-----t~~~~l~hp~~~~ 493 (568)
|| ++.++++||||+.
T Consensus 243 R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 243 RLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCCCCCCCHHHHhhCCCcCC
Confidence 99 6999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=180.79 Aligned_cols=237 Identities=21% Similarity=0.342 Sum_probs=187.3
Q ss_pred EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-hHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccC
Q psy6203 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCP 89 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 89 (568)
.+.-+|.+...|..|+|++. |..+++|++.-...... ...|..|.-.|+-+.||||+.+++.+....++.++..|++
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34567889999999999974 56678898876544322 2357778888999999999999999999999999999999
Q ss_pred CCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEcCCCCeEEE--eecCccCCCCCCccc
Q psy6203 90 GGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLDRNQNLKLI--DFGLCAKPEGGLESQ 163 (568)
Q Consensus 90 ~g~L~~~i~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~--DFG~a~~~~~~~~~~ 163 (568)
.|+|++.+.+... .+..++.+++.++++|++|||+.. |.---|....+++|++-+.+|+ |--++-..
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe------- 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------- 343 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-------
Confidence 9999999987644 567789999999999999999864 4445688899999998876664 32222111
Q ss_pred cccccCCccccccccccCcccC--CcccceechhhHHHHHHhCCCCCCCCCHHHHHHHH-HcC-CCCCCCCCChHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYY--GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI-LNG-KYTEPPWMSPNSRQIV 239 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~--~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i-~~~-~~~~~~~~~~~~~~li 239 (568)
....-+|.|+|||.++..+.. -.++|+|||++++|||.|...||..-+..+.--+| ..| ....|+.+++....|+
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 112347899999999865532 34789999999999999999999877766554443 233 4568899999999999
Q ss_pred HHccccCcCCCCCHHHHh
Q psy6203 240 RSMLQVEPGKRIKIQDLL 257 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell 257 (568)
+-|+..||.+||..+.++
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 999999999999988764
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-21 Score=194.75 Aligned_cols=152 Identities=16% Similarity=0.227 Sum_probs=115.2
Q ss_pred HHHHHHHhCCCC-CChhhHHHHHHHHhhcc------------Ccce-------eEEEccccCcccccCCCCc-eeccccc
Q psy6203 342 VMLYALLCGFLP-FDSDSIDQLYDKILSHF------------MPIC-------TILISQYFPTILLPCKVGQ-VINLLRS 400 (568)
Q Consensus 342 ~~l~~~~~~~~~-~~e~~~~~~~~qil~~~------------~~~~-------~iki~dfG~~~~~~~~~~~-~~~~~~g 400 (568)
++|-..|+.... .+.-.++.++.|+|.++ +||+ .+|+.|||+|+....+... ...+-+|
T Consensus 444 ~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kdsQvG 523 (677)
T KOG0596|consen 444 IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDSQVG 523 (677)
T ss_pred ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeeccccC
Confidence 566677775433 33357899999998764 5555 5899999999887766544 4556799
Q ss_pred ccccccCCC---CC---------CCCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHcC--CCCCCCCCCHH-H
Q psy6203 401 AIVLCSAPS---SK---------QYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNG--KYTEPPWMSPN-S 464 (568)
Q Consensus 401 t~~~~~pe~---~~---------~~~~~~~DiWSlG~il~eml~g~~pf~~~-~~~~~~~~i~~~--~~~~~~~~s~~-~ 464 (568)
|+.||+||. .. -..+.++||||||||||+|+.|++||..- +...-+..|..- ..++|..-+.. +
T Consensus 524 T~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~l 603 (677)
T KOG0596|consen 524 TVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDEL 603 (677)
T ss_pred cccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHH
Confidence 999999995 11 12678999999999999999999999753 244445555543 23455444444 8
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 465 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 465 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
.++++.||..||++|||+.++|+|||+..
T Consensus 604 i~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 604 IDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 99999999999999999999999999974
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-21 Score=195.83 Aligned_cols=155 Identities=21% Similarity=0.302 Sum_probs=130.5
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++...+.+++..++.++.|++.++ +++ +.+||+|||++.......+ ....
T Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 334788888998888999999999999999864 333 3578899997754332222 3456
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..++.++||||+||++|+|++|.+||.+.+..+.+..+.......++.+++.+.++|.+||+.||
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 789999999998 6678999999999999999999999999999988888888888777788899999999999999999
Q ss_pred CCCCCHH----HHhcCccccc
Q psy6203 477 GKRIKIQ----DLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t~~----~~l~hp~~~~ 493 (568)
.+|+++. ++++|+||..
T Consensus 236 ~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 236 TKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHCCCCCCCHHHHhcCcccCC
Confidence 9999865 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=193.85 Aligned_cols=164 Identities=16% Similarity=0.254 Sum_probs=128.0
Q ss_pred CCCCcchhhh-----HHHHHHHHhCCC--CCChhhHHHHHHHHhhcc------------CcceeEEEccccCc------c
Q psy6203 331 YGSETDVWSM-----GVMLYALLCGFL--PFDSDSIDQLYDKILSHF------------MPICTILISQYFPT------I 385 (568)
Q Consensus 331 ~~~~~~~~~~-----g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~------------~~~~~iki~dfG~~------~ 385 (568)
|.+++++..+ ||+|.-+|...+ -|+|+.++.+..+|+-|+ +||.||++.|+|.. .
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence 5666665332 777766666555 799999999999998763 66777666666622 2
Q ss_pred cccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCC
Q psy6203 386 LLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPPWM 460 (568)
Q Consensus 386 ~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 460 (568)
+.....|......+||..|||||+ .+.-|+.++|||||||++|||+.|+.||.... ..++-+.+....-..|..+
T Consensus 334 Avei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kF 413 (591)
T KOG0986|consen 334 AVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKF 413 (591)
T ss_pred EEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccccc
Confidence 222344555666799999999998 55569999999999999999999999997643 2355566777777788999
Q ss_pred CHHHHHHHHHccCCCcCCCCC-----HHHHhcCcccccC
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIK-----IQDLLGHNWVKMG 494 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~~~~~ 494 (568)
|+++++|...+|++||.+|++ ++++.+||||+..
T Consensus 414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 999999999999999999996 6799999999853
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-21 Score=196.00 Aligned_cols=154 Identities=16% Similarity=0.333 Sum_probs=130.5
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++.....++++.+..++.|++.++ ++ .+.+||+|||++...... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCceecc
Confidence 34688888988878899999999999999764 22 335788999976543322 1223456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|++||. ....++.++||||+||++|+|++|+.||.+.+..+.+..+.......|..+++++.+||.+||+.||+
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 89999999998 66778999999999999999999999999999888888898888888989999999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q psy6203 478 KRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t-----~~~~l~hp~~~~ 493 (568)
+|++ ++++++||||..
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCC
Confidence 9999 778999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-21 Score=195.92 Aligned_cols=154 Identities=18% Similarity=0.278 Sum_probs=129.3
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|+.++...+++++..+..++.|++.++ +++ +.+||+|||++....... ......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF 156 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence 34778888888888999999999999999864 333 357889999765432222 223456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..|+.++||||+||++|+|++|.+||.+.+..+++..+.......++..+..+.++|.+||..||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHH
Confidence 89999999998 66778999999999999999999999999999888889998888777778999999999999999999
Q ss_pred CCCCH----HHHhcCccccc
Q psy6203 478 KRIKI----QDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~----~~~l~hp~~~~ 493 (568)
+|+++ .++++||||..
T Consensus 237 ~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 237 RRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred hcCCCCCCHHHHhcCCCcCC
Confidence 99986 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-21 Score=193.94 Aligned_cols=154 Identities=19% Similarity=0.294 Sum_probs=124.1
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|..++...+.+++..++.++.|++.++ ++ .+.+||+|||++..... .+......
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~-~~~~~~~~ 156 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTF 156 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-CCCccccc
Confidence 34678888888778999999999999998764 23 34688999997654322 22234567
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDS---------DSIDQLYDKILNGKYTEPPWMSPNSRQIV 468 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~~~~li 468 (568)
+||+.|+|||. .+..++.++||||+||++|+|++|++||.. .........+......+|..++..+.+||
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 89999999998 667889999999999999999999999952 11233556677777888989999999999
Q ss_pred HHccCCCcCCCCC------HHHHhcCccccc
Q psy6203 469 RSMLQVEPGKRIK------IQDLLGHNWVKM 493 (568)
Q Consensus 469 ~~~L~~dp~~R~t------~~~~l~hp~~~~ 493 (568)
++||..||++|+| ++++++||||..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999998 479999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=181.35 Aligned_cols=143 Identities=21% Similarity=0.239 Sum_probs=115.1
Q ss_pred CeEEEeeecccCCeEEEEEE-EcCCCcEEEEEEeecCCcCC-----------------------chHHHHHHHHHHHhCC
Q psy6203 9 QYILERTVGSGGFAKVKLAT-HVLTGEKVAIKIMKKATLGE-----------------------DLPRVKLEINALKHIS 64 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~ 64 (568)
-|.+.+.||+|++|.||+|. +..+|+.||+|++....... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 77799999999987543210 0123567999999997
Q ss_pred CC--CcceeeEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCceEEcC
Q psy6203 65 HQ--HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG-YAHRDLKPENVLLDR 141 (568)
Q Consensus 65 hp--nIv~l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~ 141 (568)
+. .+.++++. . ..++||||++|++|.........+....+..++.||+.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 33444442 2 34899999999888776545556777778899999999999999999 99999999999998
Q ss_pred CCCeEEEeecCccCC
Q psy6203 142 NQNLKLIDFGLCAKP 156 (568)
Q Consensus 142 ~~~~kl~DFG~a~~~ 156 (568)
++.++|+|||.|...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999987643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 568 | ||||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-101 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-28 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-69 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-66 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-66 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-66 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-66 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-66 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-65 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-65 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-65 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-65 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-64 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-64 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-64 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-64 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-64 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-63 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-63 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-61 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-47 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-47 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-46 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-46 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-45 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-45 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-45 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-44 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-44 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-44 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-43 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-43 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-43 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-43 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-42 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-42 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-41 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-41 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-41 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-41 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-40 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-40 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-40 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-40 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-40 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-40 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-40 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-40 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-40 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-40 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-40 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-40 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-39 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-39 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-39 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-39 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-39 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-39 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-39 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-39 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-39 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-39 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-39 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-39 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-39 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-39 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-39 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-39 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-39 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-39 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-39 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-39 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-39 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-39 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-39 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-39 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-39 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-39 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-39 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-39 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-39 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-39 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-39 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-39 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-39 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-39 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-39 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-39 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-38 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-38 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-38 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-38 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-38 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-38 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-38 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-38 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-38 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-38 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-38 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-38 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-38 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-38 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-38 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-38 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-38 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-38 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-38 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-38 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-38 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-38 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-38 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-38 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-38 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-38 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-38 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-38 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-38 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-38 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-38 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-38 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-38 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-37 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-37 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-37 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-37 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-37 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-37 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-37 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-37 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-37 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-37 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-37 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-37 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-37 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-37 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-37 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-37 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-37 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-37 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-37 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-37 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-37 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-37 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-37 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-37 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-37 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-37 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-37 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-37 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-37 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-37 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-37 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-37 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-37 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-37 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-36 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-36 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-36 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-36 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-36 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-36 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-36 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-36 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-36 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-36 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-36 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-36 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-36 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-36 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-35 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-35 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-35 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-35 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-35 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-35 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-35 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-35 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-35 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-35 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-35 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-35 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-35 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-35 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-35 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-35 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-35 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-35 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-35 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-35 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-35 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-34 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-34 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-34 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-34 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-34 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-34 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-34 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-34 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-34 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-34 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-34 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-34 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-34 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-33 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-33 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-33 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-33 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-33 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-33 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-33 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-33 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-33 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-33 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-33 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-33 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-33 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-33 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-33 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-33 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-32 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-32 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-32 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-32 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-32 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-32 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-32 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-32 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-32 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-32 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-32 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-32 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-32 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-32 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-31 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-31 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-31 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-31 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-31 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-31 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-31 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-31 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-31 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-31 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-31 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-31 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-31 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-31 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-31 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-31 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-31 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-31 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-31 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-31 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-31 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-31 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-31 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-31 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-31 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-31 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-31 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-31 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-31 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-31 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-31 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-31 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-31 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-31 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-31 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-31 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-31 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-31 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-31 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-31 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-31 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-31 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-31 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-31 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-31 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-31 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-31 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-31 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-30 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-30 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-30 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-30 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-30 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-30 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-30 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-30 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-30 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-30 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-30 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-30 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-30 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-30 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-30 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-30 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-30 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-30 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-30 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-30 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-30 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-30 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-30 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-30 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-30 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-30 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-30 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-30 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-30 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-30 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-29 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-29 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-29 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-28 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-28 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-28 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-28 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-28 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-28 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-27 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-27 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-27 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-27 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-26 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-25 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-24 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-24 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-24 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-24 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-23 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-23 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-23 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-23 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-22 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-21 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-21 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-21 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-21 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-20 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-20 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-20 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-20 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-20 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-20 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-20 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-20 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-20 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-20 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-20 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-20 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-20 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-20 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-20 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-20 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-20 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-20 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-20 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-20 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-20 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-20 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-20 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-20 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-20 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-20 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-20 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-20 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-20 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-20 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-20 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-20 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-20 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-19 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-19 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-19 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-19 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-18 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-18 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-18 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-18 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-18 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-17 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-13 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-13 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-13 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-13 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-12 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 |
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-156
Identities = 129/316 (40%), Positives = 196/316 (62%), Gaps = 4/316 (1%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQH 67
Y L +T+G G FAKVKLA H+LTG +VAIKI+ K L L ++ E+ +K ++H +
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
I KLF+VIET +++++EY GGE+ D++V R+ EKE+R+ FRQI+SAV Y H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGS 187
HRDLK EN+LLD + N+K+ DFG + G +L CG+P YAAPE+ +GK+Y G
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 188 ETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 247
E DVWS+GV+LY L+ G LPFD ++ +L +++L GKY P +MS + +++ L + P
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNP 253
Query: 248 GKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNE 307
KR ++ ++ W+ G E++ + + EL D I +M S +++ L++
Sbjct: 254 IKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMG-YSQEEIQESLSK 312
Query: 308 WTYNYDTCTYLLLLSR 323
Y+ T TYLLL +
Sbjct: 313 MKYDEITATYLLLGRK 328
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 48/150 (32%), Positives = 81/150 (54%), Gaps = 12/150 (8%)
Query: 406 SAP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSP 462
+AP K+Y G E DVWS+GV+LY L+ G LPFD ++ +L +++L GKY P +MS
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLR--------EKDDDVIKVMADH 514
+ +++ L + P KR ++ ++ W+ G E++ L+ D I +M
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299
Query: 515 KQLSPDDMWSQLNEWTYNYDTCTYLLLLSR 544
S +++ L++ Y+ T TYLLL +
Sbjct: 300 G-YSQEEIQESLSKMKYDEITATYLLLGRK 328
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 7/62 (11%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-------SHFMPICTILI 378
QGK+Y G E DVWS+GV+LY L+ G LPFD ++ +L +++L + C L+
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245
Query: 379 SQ 380
+
Sbjct: 246 KR 247
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-151
Identities = 134/323 (41%), Positives = 188/323 (58%), Gaps = 6/323 (1%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQ 66
YI+ T+G G F KVKLATH T +KVA+K + + L + RV+ EI+ LK + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
HI KL+ VI T + I MVIEY GGEL D+IVE++R+ E E R FF+QI+ A+ Y H
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPEN+LLD N N+K+ DFGL G + L+TSCGSPNYAAPEVI GK Y G
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E DVWS G++LY +L G LPFD + I L+ K+ + Y P ++SP ++ ++R M+ +
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246
Query: 247 PGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLN 306
P +RI IQ++ W + D + + + D ++ + + S D + L
Sbjct: 247 PMQRITIQEIRRDPWFNVNLPD-YLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALR 305
Query: 307 EWTYNYDTCTYLLLLSRKKQGKQ 329
N Y LL + ++
Sbjct: 306 SDENNEVKEAYNLLHENQVIQEK 328
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPN 463
AP + K Y G E DVWS G++LY +L G LPFD + I L+ K+ + Y P ++SP
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPG 234
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG-------PEDNPLREKDDDVIKVMADHKQ 516
++ ++R M+ +P +RI IQ++ W + E+ D ++ + +
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMG 294
Query: 517 LSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGLPLRLN 554
S D + L N Y LL + L +
Sbjct: 295 FSEDYIVEALRSDENNEVKEAYNLLHENQVIQEKLEHH 332
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 25/62 (40%), Positives = 32/62 (51%), Gaps = 7/62 (11%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS-------HFMPICTILI 378
GK Y G E DVWS G++LY +L G LPFD + I L+ K+ S P LI
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239
Query: 379 SQ 380
+
Sbjct: 240 RR 241
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-149
Identities = 143/324 (44%), Positives = 193/324 (59%), Gaps = 5/324 (1%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQ 66
YIL T+G G F KVK+ H LTG KVA+KI+ + + + +++ EI LK H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
HI KL+QVI T S IFMV+EY GGEL D+I + RL EKESR F+QILS V Y H
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPENVLLD + N K+ DFGL G L+TSCGSPNYAAPEVI G+ Y G
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAG 194
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E D+WS GV+LYALLCG LPFD D + L+ KI +G + P +++P+ +++ MLQV+
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 254
Query: 247 PGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQL- 305
P KR I+D+ H W K P + DD+ +K + + + S +++ S L
Sbjct: 255 PMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLY 314
Query: 306 NEWTYNYDTCTYLLLLSRKKQGKQ 329
N + Y L++ ++ +
Sbjct: 315 NRNHQDPLAVAYHLIIDNRRIMNE 338
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-40
Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 12/174 (6%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPN 463
AP S + Y G E D+WS GV+LYALLCG LPFD D + L+ KI +G + P +++P+
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPS 242
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG--------PEDNPLREKDDDVIKVMADHK 515
+++ MLQV+P KR I+D+ H W K DD+ +K + +
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKF 302
Query: 516 QLSPDDMWSQL-NEWTYNYDTCTYLLLLSRKKQGLPLRLNTEFTRKYRSRQQVP 568
+ S +++ S L N + Y L++ ++ + T S
Sbjct: 303 ECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDH 356
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 26/62 (41%), Positives = 33/62 (53%), Gaps = 7/62 (11%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS-------HFMPICTILI 378
G+ Y G E D+WS GV+LYALLCG LPFD D + L+ KI + P L+
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL 247
Query: 379 SQ 380
Sbjct: 248 KH 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 410 bits (1057), Expect = e-142
Identities = 127/259 (49%), Positives = 164/259 (63%), Gaps = 4/259 (1%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQ 66
Y+L T+G G F KVK+ H LTG KVA+KI+ + + + ++K EI LK H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
HI KL+QVI T + FMV+EY GGEL D+I + R+ E E+R F+QILSAV Y H
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPENVLLD + N K+ DFGL G L+TSCGSPNYAAPEVI G+ Y G
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E D+WS GV+LYALLCG LPFD + + L+ KI G + P +++ + ++ MLQV+
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVD 249
Query: 247 PGKRIKIQDLLGHNWVKMG 265
P KR I+D+ H W K
Sbjct: 250 PLKRATIKDIREHEWFKQD 268
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 39/91 (42%), Positives = 55/91 (60%), Gaps = 3/91 (3%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPN 463
AP S + Y G E D+WS GV+LYALLCG LPFD + + L+ KI G + P +++ +
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494
++ MLQV+P KR I+D+ H W K
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 24/62 (38%), Positives = 32/62 (51%), Gaps = 7/62 (11%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS-------HFMPICTILI 378
G+ Y G E D+WS GV+LYALLCG LPFD + + L+ KI + L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242
Query: 379 SQ 380
Sbjct: 243 MH 244
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-136
Identities = 86/261 (32%), Positives = 135/261 (51%), Gaps = 4/261 (1%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+ L +T+G G + +V+LA + +T E VA+KI+ + +K EI K ++H+++
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
K + + ++ +EYC GGEL D I + E +++ FF Q+++ V YLH +G
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPE-GGLESQLQTSCGSPNYAAPEVIKGKQYYGS 187
HRD+KPEN+LLD NLK+ DFGL E L CG+ Y APE++K ++++
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 188 ETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPPW--MSPNSRQIVRSMLQ 244
DVWS G++L A+L G LP+ Q Y K PW + ++ +L
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 247
Query: 245 VEPGKRIKIQDLLGHNWVKMG 265
P RI I D+ W
Sbjct: 248 ENPSARITIPDIKKDRWYNKP 268
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 26/101 (25%), Positives = 40/101 (39%), Gaps = 6/101 (5%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPPW--M 460
AP ++++ DVWS G++L A+L G LP+ Q Y K PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 461 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLR 501
++ +L P RI I D+ W + R
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 10/65 (15%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILS---------HFMPICT 375
+ ++++ DVWS G++L A+L G LP+ Q Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 376 ILISQ 380
L+ +
Sbjct: 240 ALLHK 244
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-136
Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 4/283 (1%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+ L +T+G G + +V+LA + +T E VA+KI+ + +K EI K ++H+++
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
K + + ++ +EYC GGEL D I + E +++ FF Q+++ V YLH +G
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPE-GGLESQLQTSCGSPNYAAPEVIKGKQYYGS 187
HRD+KPEN+LLD NLK+ DFGL E L CG+ Y APE++K ++++
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 188 ETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILNGKYTEPPW--MSPNSRQIVRSMLQ 244
DVWS G++L A+L G LP+D Q Y K PW + ++ +L
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 247
Query: 245 VEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVI 287
P RI I D+ W + R +
Sbjct: 248 ENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGF 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 6/105 (5%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILNGKYTEPPW--M 460
AP ++++ DVWS G++L A+L G LP+D Q Y K PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 461 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDD 505
++ +L P RI I D+ W + R +
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 279
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 15/65 (23%), Positives = 26/65 (40%), Gaps = 10/65 (15%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKIL---------SHFMPICT 375
+ ++++ DVWS G++L A+L G LP+D Q Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 376 ILISQ 380
L+ +
Sbjct: 240 ALLHK 244
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 396 bits (1018), Expect = e-135
Identities = 86/300 (28%), Positives = 134/300 (44%), Gaps = 16/300 (5%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-------LPRVKLEINALK 61
+Y +GSG F V A ++V +K +KK + ED L +V LEI L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 62 HISHQHICKLFQVIETSSHIFMVIE-YCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
+ H +I K+ + E +V+E + G +L I RL E + FRQ++SAV
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
YL HRD+K EN+++ + +KLIDFG A E G T CG+ Y APEV+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPEVLM 202
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
G Y G E ++WS+GV LY L+ PF ++ + P +S +V
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVS 256
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
+LQ P +R ++ L+ WV ++ + + + V+ +
Sbjct: 257 GLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLS 316
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 17/126 (13%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPN 463
AP Y G E ++WS+GV LY L+ PF ++ + P +S
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKE 250
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG--------PEDNPLREKDDDVIKVMADHK 515
+V +LQ P +R ++ L+ WV E + + + V+ +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEM 310
Query: 516 QLSPDD 521
Sbjct: 311 GNRSLS 316
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 15/62 (24%), Positives = 23/62 (37%), Gaps = 13/62 (20%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS-------HFMPICTILI 378
G Y G E ++WS+GV LY L+ PF ++ + L+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLV 255
Query: 379 SQ 380
S
Sbjct: 256 SG 257
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 394 bits (1013), Expect = e-134
Identities = 104/347 (29%), Positives = 169/347 (48%), Gaps = 14/347 (4%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+Y + +GSG F +L LT E VA+K +++ ++ V+ EI + + H +I
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE--NVQREIINHRSLRHPNI 78
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
+ +VI T +H+ +++EY GGEL + I R E E+R FF+Q+LS V+Y H +
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138
Query: 129 HRDLKPENVLLDRNQ--NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLK EN LLD + LK+ DFG SQ +++ G+P Y APEV+ ++Y G
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK----ILNGKYTEPP--WMSPNSRQIVR 240
DVWS GV LY +L G PF+ + Y K IL+ KY+ P +SP ++
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS 256
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
+ +P RI I ++ H+W + ++ ++ + ++ + Q+ +
Sbjct: 257 RIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEA 316
Query: 301 MWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYAL 347
+ + L L SE D+ S G ++YAL
Sbjct: 317 TIPAVRNRCLDDFMTDNLDLDDDMDDFDS--ESEIDIDSSGEIVYAL 361
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 34/158 (21%), Positives = 59/158 (37%), Gaps = 17/158 (10%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK----ILNGKYTEPP- 458
AP ++Y G DVWS GV LY +L G PF+ + Y K IL+ KY+ P
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244
Query: 459 -WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG--------PEDNPLREKDDDVIK 509
+SP ++ + +P RI I ++ H+W ++ + ++
Sbjct: 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQ 304
Query: 510 VMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQ 547
+ Q+ + + + L L
Sbjct: 305 SLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDD 342
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 16/43 (37%), Positives = 22/43 (51%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
++Y G DVWS GV LY +L G PF+ + Y K +
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-134
Identities = 88/292 (30%), Positives = 141/292 (48%), Gaps = 12/292 (4%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL---GEDLPRVKLEINALKHISH 65
+Y++ +G G + KVK T + A+KI+KK L VK EI L+ + H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 66 QHICKLFQVI--ETSSHIFMVIEYCPGG--ELLDHIVERQRLGEKESRAFFRQILSAVAY 121
+++ +L V+ E ++MV+EYC G E+LD + E+ R ++ +F Q++ + Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEY 124
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ-LQTSCGSPNYAAPEVIK 180
LH G H+D+KP N+LL LK+ G+ +TS GSP + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 181 G-KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
G + G + D+WS GV LY + G PF+ D+I +L++ I G Y P P ++
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLL 244
Query: 240 RSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMA 291
+ ML+ EP KR I+ + H+W + P D + M
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFRKKHP--PAEAPVPIPPSPDTKDRWRSMT 294
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
+ G + D+WS GV LY + G PF+ D+I +L++ I G Y P P +++
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKG 246
Query: 471 MLQVEPGKRIKIQDLLGHNWVKMGPEDN------PLREKDDDVIKVMA 512
ML+ EP KR I+ + H+W + P D + M
Sbjct: 247 MLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMT 294
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 17/60 (28%), Positives = 28/60 (46%), Gaps = 7/60 (11%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS-------HFMPICTILISQ 380
+ G + D+WS GV LY + G PF+ D+I +L++ I P + L+
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKG 246
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-129
Identities = 87/281 (30%), Positives = 142/281 (50%), Gaps = 20/281 (7%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINAL 60
L +QY + +GSGGF V V VAIK ++K + + + RV +E+ L
Sbjct: 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 61 KHISHQ--HICKLFQVIETSSHIFMVIEYC-PGGELLDHIVERQRLGEKESRAFFRQILS 117
K +S + +L E +++E P +L D I ER L E+ +R+FF Q+L
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 160
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
AV + H+ G HRD+K EN+L+D N+ LKLIDFG A + + G+ Y+ P
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPP 217
Query: 177 EVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSR 236
E I+ +Y+G VWS+G++LY ++CG +PF+ D ++I+ G+ +S +
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQ 271
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDH 277
++R L + P R +++ H W++ P H
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIH 310
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 25/102 (24%), Positives = 48/102 (47%), Gaps = 9/102 (8%)
Query: 406 SAP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSP 462
S P +Y+G VWS+G++LY ++CG +PF+ D ++I+ G+ +S
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSS 268
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKD 504
+ ++R L + P R +++ H W++ E
Sbjct: 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 310
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 17/62 (27%), Positives = 30/62 (48%), Gaps = 13/62 (20%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-------SHFMPICTILI 378
+ +Y+G VWS+G++LY ++CG +PF+ D ++I+ C LI
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLI 274
Query: 379 SQ 380
Sbjct: 275 RW 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 375 bits (966), Expect = e-128
Identities = 85/275 (30%), Positives = 135/275 (49%), Gaps = 20/275 (7%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHI 63
+Y L +G GGF V + +VAIK++ + + D LE+ L +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 64 S----HQHICKLFQVIETSSHIFMVIEY-CPGGELLDHIVERQRLGEKESRAFFRQILSA 118
H + +L ET +V+E P +L D+I E+ LGE SR FF Q+++A
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 119 VAYLHHLGYAHRDLKPENVLLD-RNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+ + H G HRD+K EN+L+D R KLIDFG A G+ Y+ PE
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPE 208
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQ 237
I QY+ VWS+G++LY ++CG +PF+ D +IL + P +SP+
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCA 262
Query: 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVS 272
++R L +P R ++++L W++ ED P++
Sbjct: 263 LIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 406 SAP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSP 462
S P S QY+ VWS+G++LY ++CG +PF+ D +IL + P +SP
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSP 258
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLR 501
+ ++R L +P R ++++L W++ ED PL
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 13/62 (20%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-------SHFMPICTILI 378
QY+ VWS+G++LY ++CG +PF+ D +IL +H P C LI
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCALI 264
Query: 379 SQ 380
+
Sbjct: 265 RR 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-124
Identities = 90/268 (33%), Positives = 144/268 (53%), Gaps = 6/268 (2%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQ 66
+Y+ R +G GGFAK + T E A KI+ K+ L ++ +EI+ + ++HQ
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
H+ E + +F+V+E C LL+ R+ L E E+R + RQI+ YLH
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLK N+ L+ + +K+ DFGL K E + + CG+PNY APEV+ K +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKK-GHS 193
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E DVWS+G ++Y LL G PF++ + + Y +I +Y+ P ++P + +++ MLQ +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253
Query: 247 PGKRIKIQDLLGHNWVKMG--PEDNPVS 272
P R I +LL + G P P++
Sbjct: 254 PTARPTINELLNDEFFTSGYIPARLPIT 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 29/91 (31%), Positives = 50/91 (54%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
SK+ + E DVWS+G ++Y LL G PF++ + + Y +I +Y+ P ++P + +++
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPL 500
MLQ +P R I +LL + G L
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 7/60 (11%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-------SHFMPICTILISQ 380
K+ + E DVWS+G ++Y LL G PF++ + + Y +I H P+ LI +
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-122
Identities = 90/260 (34%), Positives = 141/260 (54%), Gaps = 4/260 (1%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL--EINALKHISHQ 66
+Y+ R +G GGFAK + T E A KI+ K+ L + R K+ EI+ + ++HQ
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
H+ E + +F+V+E C LL+ R+ L E E+R + RQI+ YLH
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLK N+ L+ + +K+ DFGL K E + + CG+PNY APEV+ K +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKK-GHS 219
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
E DVWS+G ++Y LL G PF++ + + Y +I +Y+ P ++P + +++ MLQ +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279
Query: 247 PGKRIKIQDLLGHNWVKMGP 266
P R I +LL + G
Sbjct: 280 PTARPTINELLNDEFFTSGY 299
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 29/91 (31%), Positives = 50/91 (54%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
SK+ + E DVWS+G ++Y LL G PF++ + + Y +I +Y+ P ++P + +++
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPL 500
MLQ +P R I +LL + G L
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGYIPARL 304
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 7/60 (11%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-------SHFMPICTILISQ 380
K+ + E DVWS+G ++Y LL G PF++ + + Y +I H P+ LI +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-121
Identities = 80/287 (27%), Positives = 141/287 (49%), Gaps = 33/287 (11%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--------------------- 46
NQY L+ +G G + VKLA + A+K++ K L
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 47 ----GEDLPRVKLEINALKHISHQHICKLFQVIE--TSSHIFMVIEYCPGGELLDHIVER 100
+ +V EI LK + H ++ KL +V++ H++MV E G +++ +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131
Query: 101 QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160
+ L E ++R +F+ ++ + YLH+ HRD+KP N+L+ + ++K+ DFG+ + +G
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS- 190
Query: 161 ESQLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD 218
++ L + G+P + APE + K + G DVW+MGV LY + G PF + I L+
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 219 KILNGKYTEP--PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
KI + P P ++ + + ++ ML P RI + ++ H WV
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 2/88 (2%)
Query: 407 APSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--PWMSPNS 464
+ + K + G DVW+MGV LY + G PF + I L+ KI + P P ++ +
Sbjct: 210 SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDL 269
Query: 465 RQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
+ ++ ML P RI + ++ H WV
Sbjct: 270 KDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 18/41 (43%), Positives = 23/41 (56%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
K + G DVW+MGV LY + G PF + I L+ KI S
Sbjct: 214 KIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 344 bits (886), Expect = e-116
Identities = 85/263 (32%), Positives = 143/263 (54%), Gaps = 5/263 (1%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISH 65
+ + +G G FA V A + TG +VAIK++ K + + RV+ E+ + H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHH 124
I +L+ E S+++++V+E C GE+ ++ R E E+R F QI++ + YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
G HRDL N+LL RN N+K+ DFGL + + + T CG+PNY +PE+
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-HEKHYTLCGTPNYISPEIATRS-A 188
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244
+G E+DVWS+G M Y LL G PFD+D++ +K++ Y P ++S ++ ++ +L+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLR 248
Query: 245 VEPGKRIKIQDLLGHNWVKMGPE 267
P R+ + +L H ++
Sbjct: 249 RNPADRLSLSSVLDHPFMSRNSS 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 26/93 (27%), Positives = 50/93 (53%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
++ +G E+DVWS+G M Y LL G PFD+D++ +K++ Y P ++S ++ ++
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLRE 502
+L+ P R+ + +L H ++ E
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 7/60 (11%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-------SHFMPICTILISQ 380
+ +G E+DVWS+G M Y LL G PFD+D++ +K++ S LI Q
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-110
Identities = 104/313 (33%), Positives = 154/313 (49%), Gaps = 20/313 (6%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-------EDLPRVKLEI 57
LR++YI+ +T+GSG +VKLA T +KVAIKI+ K + V+ EI
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 58 NALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
LK ++H I K+ + ++V+E GGEL D +V +RL E + +F Q+L
Sbjct: 67 EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 118 AVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYA 174
AV YLH G HRDLKPENVLL + + +K+ DFG +K G S ++T CG+P Y
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-SKILGE-TSLMRTLCGTPTYL 183
Query: 175 APEVIKGKQY--YGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYT--EPP 229
APEV+ Y D WS+GV+L+ L G+ PF L D+I +GKY
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 230 W--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVI 287
W +S + +V+ +L V+P R ++ L H W++ E +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303
Query: 288 KVMADHKQLSPDD 300
+ P +
Sbjct: 304 LAQPSTSRKRPRE 316
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 9/106 (8%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYT--EPPW--MSPN 463
Y D WS+GV+L+ L G+ PF L D+I +GKY W +S
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 250
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIK 509
+ +V+ +L V+P R ++ L H W++ D ++ K D++
Sbjct: 251 ALDLVKKLLVVDPKARFTTEEALRHPWLQ----DEDMKRKFQDLLS 292
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 16/46 (34%), Positives = 21/46 (45%), Gaps = 1/46 (2%)
Query: 324 KKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILS 368
G Y D WS+GV+L+ L G+ PF L D+I S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 328 bits (844), Expect = e-110
Identities = 103/274 (37%), Positives = 156/274 (56%), Gaps = 12/274 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D+ Y LE T+G G + +VK+A T + A K + K + ED+ R K EI +K +
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLD 64
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
H +I +L++ E ++ I++V+E C GGEL + +V ++ E ++ + +LSAVAY H
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 125 LGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
L AHRDLKPEN L + LKLIDFGL A+ + G ++T G+P Y +P+V++G
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVLEG 182
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 237
YG E D WS GVM+Y LLCG+ PF + + ++ KI G +T E W +SP +
Sbjct: 183 L--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240
Query: 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPV 271
++R +L P +RI L H W + +P
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
+ YG E D WS GVM+Y LLCG+ PF + + ++ KI G +T E W +SP +
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPL 500
++R +L P +RI L H W + +P
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 18/41 (43%), Positives = 25/41 (60%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ YG E D WS GVM+Y LLCG+ PF + + ++ KI
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-109
Identities = 76/273 (27%), Positives = 135/273 (49%), Gaps = 6/273 (2%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISH 65
+ + + R +G G F V LA +A+K++ K+ L +++ EI H+ H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+I +++ I++++E+ P GEL + + R E+ S F ++ A+ Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
HRD+KPEN+L+ LK+ DFG +T CG+ +Y PE+I+GK +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGK-TH 189
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
+ D+W GV+ Y L G PFDS S + + +I+N PP++S S+ ++ +L+
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 249
Query: 246 EPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHE 278
P +R+ ++ ++ H WVK +
Sbjct: 250 HPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 25/85 (29%), Positives = 47/85 (55%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
+ + + D+W GV+ Y L G PFDS S + + +I+N PP++S S+ ++
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 244
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMG 494
+L+ P +R+ ++ ++ H WVK
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVKAN 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 7/60 (11%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-------SHFMPICTILISQ 380
+ + + D+W GV+ Y L G PFDS S + + +I+ LIS+
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 321 bits (826), Expect = e-107
Identities = 68/260 (26%), Positives = 140/260 (53%), Gaps = 6/260 (2%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLEINALKHISH 65
+ + R +G G F V LA + +A+K++ KA L + +++ E+ H+ H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+I +L+ ++ +++++EY P G + + + + E+ + + ++ +A++Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
HRD+KPEN+LL LK+ DFG S+ CG+ +Y PE+I+G+ +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTDLCGTLDYLPPEMIEGRM-H 184
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
+ D+WS+GV+ Y L G PF++++ + Y +I ++T P +++ +R ++ +L+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 244
Query: 246 EPGKRIKIQDLLGHNWVKMG 265
P +R ++++L H W+
Sbjct: 245 NPSQRPMLREVLEHPWITAN 264
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 22/100 (22%), Positives = 52/100 (52%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
+ + + D+WS+GV+ Y L G PF++++ + Y +I ++T P +++ +R ++
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIK 509
+L+ P +R ++++L H W+ + + K
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 15/60 (25%), Positives = 28/60 (46%), Gaps = 7/60 (11%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL-------SHFMPICTILISQ 380
+ + + D+WS+GV+ Y L G PF++++ + Y +I LIS+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-106
Identities = 87/267 (32%), Positives = 135/267 (50%), Gaps = 11/267 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHI 63
+ Y ++ +G G F+ V+ H TG + A KI+ L D +++ E + +
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
H +I +L I+ S ++V + GGEL + IV R+ E ++ +QIL ++AY H
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 124 HLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
G HR+LKPEN+LL + +KL DFGL + G+P Y +PEV+K
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLK 180
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 236
Y D+W+ GV+LY LL G+ PF + +LY +I G Y P W ++P ++
Sbjct: 181 KDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVK 263
++ SML V P KRI L W+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWIC 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
K Y D+W+ GV+LY LL G+ PF + +LY +I G Y P W ++P ++
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDV 507
++ SML V P KRI L W+ + D V
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 4e-12
Identities = 16/41 (39%), Positives = 24/41 (58%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
K Y D+W+ GV+LY LL G+ PF + +LY +I +
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-106
Identities = 67/321 (20%), Positives = 126/321 (39%), Gaps = 53/321 (16%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----------------GEDLP 51
N Y + RT+ G F K+ L + A+K +K+ L
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 52 RVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIV--------ERQRL 103
K E+ + I +++ +I ++++ EY +L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 104 GEKESRAFFRQILSAVAYLH-HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
+ + + +L++ +Y+H HRD+KP N+L+D+N +KL DFG
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-- 206
Query: 163 QLQTSCGSPNYAAPEVIKGKQ-YYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKI 220
++ S G+ + PE + Y G++ D+WS+G+ LY + +PF S+ +L++ I
Sbjct: 207 -IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 221 LNGKYTEP-------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261
P ++S ++ L+ P +RI +D L H W
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 262 VKMGPEDNPVSFRPDHELREK 282
+ ++ F EL +K
Sbjct: 326 LADTNIEDLREF--SKELYKK 344
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 27/119 (22%), Positives = 49/119 (41%), Gaps = 21/119 (17%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYTEP------------ 457
Y G++ D+WS+G+ LY + +PF S+ +L++ I P
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTN 285
Query: 458 -------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIK 509
++S ++ L+ P +RI +D L H W+ + LRE ++ K
Sbjct: 286 KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE-DLREFSKELYK 343
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 13/42 (30%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILS 368
Y G++ D+WS+G+ LY + +PF S+ +L++ I +
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = e-106
Identities = 101/276 (36%), Positives = 149/276 (53%), Gaps = 20/276 (7%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-------EDLPRVKLEI 57
LR++YI+ +T+GSG +VKLA T +KVAI+I+ K + V+ EI
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 58 NALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
LK ++H I K+ + ++V+E GGEL D +V +RL E + +F Q+L
Sbjct: 192 EILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 118 AVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYA 174
AV YLH G HRDLKPENVLL + + +K+ DFG +K G S ++T CG+P Y
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-SKILGE-TSLMRTLCGTPTYL 308
Query: 175 APEVIKGKQY--YGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYT--EPP 229
APEV+ Y D WS+GV+L+ L G+ PF L D+I +GKY
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 230 W--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
W +S + +V+ +L V+P R ++ L H W++
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 9/106 (8%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYT--EPPW--MSPN 463
Y D WS+GV+L+ L G+ PF L D+I +GKY W +S
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIK 509
+ +V+ +L V+P R ++ L H W++ D ++ K D++
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQ----DEDMKRKFQDLLS 417
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 16/46 (34%), Positives = 21/46 (45%), Gaps = 1/46 (2%)
Query: 324 KKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILS 368
G Y D WS+GV+L+ L G+ PF L D+I S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-106
Identities = 84/271 (30%), Positives = 137/271 (50%), Gaps = 14/271 (5%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+ + +I +R +GSG F V L +G + IK + K + +++ EI LK +
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ----RLGEKESRAFFRQILSAVA 120
H +I K+F+V E ++++V+E C GGELL+ IV Q L E +Q+++A+A
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 121 YLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
Y H H+DLKPEN+L + +K+IDFGL + + G+ Y APE
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE 196
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW-MSPN 234
V K + D+WS GV++Y LL G LPF S++++ K + ++P
Sbjct: 197 VFKRD--VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254
Query: 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265
+ +++ ML +P +R +L H W K
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 24/87 (27%), Positives = 43/87 (49%), Gaps = 3/87 (3%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW-MSPNSRQI 467
K+ + D+WS GV++Y LL G LPF S++++ K + ++P + +
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258
Query: 468 VRSMLQVEPGKRIKIQDLLGHNWVKMG 494
++ ML +P +R +L H W K
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 15/41 (36%), Positives = 24/41 (58%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
K+ + D+WS GV++Y LL G LPF S++++ K
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-105
Identities = 92/276 (33%), Positives = 142/276 (51%), Gaps = 19/276 (6%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-------EDLPRVKLEI 57
+ +Y + +G G + V+ H TG + A+KIM+ E + E
Sbjct: 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 58 NALKHIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQIL 116
+ L+ ++ H HI L E+SS +F+V + GEL D++ E+ L EKE+R+ R +L
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
AV++LH HRDLKPEN+LLD N ++L DFG E G +L+ CG+P Y AP
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAP 268
Query: 177 EVIKGKQY-----YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPP 229
E++K YG E D+W+ GV+L+ LL G PF + I+ G+Y P
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328
Query: 230 W--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
W S + ++ +LQV+P R+ + L H + +
Sbjct: 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 402 IVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW 459
I+ CS + YG E D+W+ GV+L+ LL G PF + I+ G+Y P W
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329
Query: 460 --MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
S + ++ +LQV+P R+ + L H + +
Sbjct: 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 15/49 (30%), Positives = 22/49 (44%)
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
L + YG E D+W+ GV+L+ LL G PF + I+
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-104
Identities = 90/277 (32%), Positives = 139/277 (50%), Gaps = 20/277 (7%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKA--------TLGEDLPRVKLE 56
Y + +G G + V+ H T ++ A+KI+ + E E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 57 INALKHIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQI 115
++ L+ +S H +I +L ET++ F+V + GEL D++ E+ L EKE+R R +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 116 LSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
L + LH L HRDLKPEN+LLD + N+KL DFG + + G +L+ CG+P+Y A
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 191
Query: 176 PEVIKGKQY-----YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EP 228
PE+I+ YG E D+WS GV++Y LL G PF + I++G Y P
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251
Query: 229 PW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
W S + +V L V+P KR ++ L H + +
Sbjct: 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 402 IVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW 459
I+ CS + YG E D+WS GV++Y LL G PF + I++G Y P W
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 460 --MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
S + +V L V+P KR ++ L H + +
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 16/49 (32%), Positives = 22/49 (44%)
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ YG E D+WS GV++Y LL G PF + I+S
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 318 bits (816), Expect = e-104
Identities = 87/267 (32%), Positives = 135/267 (50%), Gaps = 11/267 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHI 63
+ Y ++ +G G F+ V+ H TG + A KI+ L D +++ E + +
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
H +I +L I+ S ++V + GGEL + IV R+ E ++ +QIL ++AY H
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 124 HLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
G HR+LKPEN+LL + +KL DFGL + G+P Y +PEV+K
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLK 203
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 236
Y D+W+ GV+LY LL G+ PF + +LY +I G Y P W ++P ++
Sbjct: 204 KDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVK 263
++ SML V P KRI L W+
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWIC 289
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 33/105 (31%), Positives = 49/105 (46%), Gaps = 5/105 (4%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
K Y D+W+ GV+LY LL G+ PF + +LY +I G Y P W ++P ++
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVM 511
++ SML V P KRI L W+ E D + +
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWIC-NRERVASAIHRQDTVDCL 307
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 16/41 (39%), Positives = 24/41 (58%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
K Y D+W+ GV+LY LL G+ PF + +LY +I +
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-104
Identities = 100/270 (37%), Positives = 156/270 (57%), Gaps = 12/270 (4%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
M+ ++R +I +GSG F++V L LTG+ A+K +KK+ D ++ EI L
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD-SSLENEIAVL 60
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
K I H++I L + E+++H ++V++ GGEL D I+ER EK++ +Q+LSAV
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 121 YLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
YLH G HRDLKPEN+L + N + + DFGL +K E + T+CG+P Y APE
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL-SKMEQ--NGIMSTACGTPGYVAPE 177
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSP 233
V+ K Y D WS+GV+ Y LLCG+ PF ++ +L++KI G Y P W +S
Sbjct: 178 VLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+++ + +L+ +P +R + L H W+
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 5/98 (5%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 465
+++ Y D WS+GV+ Y LLCG+ PF ++ +L++KI G Y P W +S +++
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVK-MGPEDNPLRE 502
+ +L+ +P +R + L H W+ +
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYP 277
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 16/41 (39%), Positives = 26/41 (63%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
++ Y D WS+GV+ Y LLCG+ PF ++ +L++KI
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-104
Identities = 68/301 (22%), Positives = 116/301 (38%), Gaps = 47/301 (15%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH 65
+ ++L +G G A V H TG+ AIK+ + + E LK ++H
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 66 QHICKLFQVIE--TSSHIFMVIEYCPGGELLDHIVERQR---LGEKESRAFFRQILSAVA 120
++I KLF + E T+ H +++E+CP G L + E L E E R ++ +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 121 YLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
+L G HR++KP N++ D KL DFG + E Q + G+ Y P
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHP 184
Query: 177 EVIKGK-------QYYGSETDVWSMGVMLYALLCGFLPFD----SDSIDQLYDKILNGKY 225
++ + + YG+ D+WS+GV Y G LPF ++ KI+ GK
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 226 TE-------------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHN 260
+ + ++ ++L+ + K
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 261 W 261
Sbjct: 305 S 305
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 18/113 (15%), Positives = 34/113 (30%), Gaps = 29/113 (25%)
Query: 407 APSSKQYYGSETDVWSMGVMLYALLCGFLPFD----SDSIDQLYDKILNGKYTE------ 456
++ YG+ D+WS+GV Y G LPF ++ KI+ GK +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 457 -------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 490
+ ++ ++L+ + K
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-103
Identities = 89/267 (33%), Positives = 148/267 (55%), Gaps = 12/267 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHI 63
+Y + +G G F +V +T ++ A+K++ KA+ +D + E+ LK +
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
H +I KLF+++E SS ++V E GGEL D I++R+R E ++ +Q+ S + Y+H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 124 HLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
HRDLKPEN+LL +++ ++K+IDFGL + ++++ G+ Y APEV++
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLR 196
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 236
G Y + DVWS GV+LY LL G PF + + ++ GKY P W +S +++
Sbjct: 197 GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVK 263
++R ML P RI L H W++
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 4/86 (4%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
+ Y + DVWS GV+LY LL G PF + + ++ GKY P W +S +++
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVK 492
++R ML P RI L H W++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 14/41 (34%), Positives = 22/41 (53%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ Y + DVWS GV+LY LL G PF + + ++ +
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-101
Identities = 68/301 (22%), Positives = 116/301 (38%), Gaps = 47/301 (15%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH 65
+ ++L +G G A V H TG+ AIK+ + + E LK ++H
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 66 QHICKLFQVIE--TSSHIFMVIEYCPGGELLDHIVERQR---LGEKESRAFFRQILSAVA 120
++I KLF + E T+ H +++E+CP G L + E L E E R ++ +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 121 YLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
+L G HR++KP N++ D KL DFG + E Q + G+ Y P
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHP 184
Query: 177 EVIKGK-------QYYGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILNGKY 225
++ + + YG+ D+WS+GV Y G LPF ++ KI+ GK
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 226 TE-------------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHN 260
+ + ++ ++L+ + K
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 261 W 261
Sbjct: 305 S 305
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 18/113 (15%), Positives = 34/113 (30%), Gaps = 29/113 (25%)
Query: 407 APSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILNGKYTE------ 456
++ YG+ D+WS+GV Y G LPF ++ KI+ GK +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 457 -------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 490
+ ++ ++L+ + K
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 13/46 (28%), Positives = 23/46 (50%)
Query: 324 KKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+K ++ YG+ D+WS+GV Y G LPF + +++
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-100
Identities = 72/294 (24%), Positives = 130/294 (44%), Gaps = 35/294 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
+ + +G G F +V A + L AIK ++ E L + E+ L ++HQ
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQ 62
Query: 67 HICKLFQV-------------IETSSHIFMVIEYCPGGELLDHIVERQRLGEK-ESRAFF 112
++ + + ++ S +F+ +EYC G L D I ++ E F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE-------------GG 159
RQIL A++Y+H G HRDLKP N+ +D ++N+K+ DFGL G
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK 219
L ++ G+ Y A EV+ G +Y + D++S+G++ + ++ + K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK 240
Query: 220 ILNGKYTEPPWM----SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 269
+ + PP ++I+R ++ +P KR + LL W+ + +D
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 18/104 (17%), Positives = 43/104 (41%), Gaps = 9/104 (8%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM--- 460
A +Y + D++S+G++ + ++ + K+ + PP
Sbjct: 198 ATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDN 255
Query: 461 -SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREK 503
++I+R ++ +P KR + LL W+ + +D ++E
Sbjct: 256 KMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEA 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 7/43 (16%), Positives = 19/43 (44%), Gaps = 2/43 (4%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
G +Y + D++S+G++ + ++ + K+ S
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRS 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-100
Identities = 91/294 (30%), Positives = 154/294 (52%), Gaps = 17/294 (5%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHI 63
+Y + +G G F +V +T ++ A+K++ KA+ +D + E+ LK +
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
H +I KLF+++E SS ++V E GGEL D I++R+R E ++ +Q+ S + Y+H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 124 HLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
HRDLKPEN+LL +++ ++K+IDFGL + ++++ G+ Y APEV++
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLR 196
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 236
G Y + DVWS GV+LY LL G PF + + ++ GKY P W +S +++
Sbjct: 197 GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVM 290
++R ML P RI L H W++ + P D + + +
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTI--SDLPS---LESAMTNI 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 29/108 (26%), Positives = 48/108 (44%), Gaps = 7/108 (6%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
+ Y + DVWS GV+LY LL G PF + + ++ GKY P W +S +++
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN---PLREKDDDVIKVM 511
++R ML P RI L H W++ + + + +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNI 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 14/41 (34%), Positives = 22/41 (53%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ Y + DVWS GV+LY LL G PF + + ++ +
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-100
Identities = 87/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHI 63
+Y L +G G F+ V+ VL G++ A I+ L D +++ E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
H +I +L I H +++ + GGEL + IV R+ E ++ +QIL AV + H
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 124 HLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
+G HR+LKPEN+LL + +KL DFGL + EG + G+P Y +PEV++
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVLR 186
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 236
YG D+W+ GV+LY LL G+ PF + +LY +I G Y P W ++P ++
Sbjct: 187 KDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVK 263
++ ML + P KRI + L H W+
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWIS 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
K YG D+W+ GV+LY LL G+ PF + +LY +I G Y P W ++P ++
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVM 511
++ ML + P KRI + L H W+ + + +
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWIS-HRSTVASCMHRQETVDCL 290
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
K YG D+W+ GV+LY LL G+ PF + +LY +I +
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = e-100
Identities = 95/283 (33%), Positives = 151/283 (53%), Gaps = 13/283 (4%)
Query: 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINA 59
++Y +R +G G F +V L +TG++ A+K++ K + D + E+
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
LK + H +I KL++ E + ++V E GGEL D I+ R+R E ++ RQ+LS +
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 120 AYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
Y+H HRDLKPEN+LL ++ N+++IDFGL E +++ G+ Y AP
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAP 197
Query: 177 EVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MS 232
EV+ G Y + DVWS GV+LY LL G PF+ + + K+ GKYT P W +S
Sbjct: 198 EVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255
Query: 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRP 275
+++ ++R ML P RI +D L H W++ ++ P
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
Y + DVWS GV+LY LL G PF+ + + K+ GKYT P W +S +++
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPED--NPLREKDDDVIKVM 511
++R ML P RI +D L H W++ ++ + D+ I +
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNI 307
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 15/41 (36%), Positives = 21/41 (51%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
Y + DVWS GV+LY LL G PF+ + + K+
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 8e-99
Identities = 92/278 (33%), Positives = 144/278 (51%), Gaps = 16/278 (5%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-----GEDLPRVKLEINA 59
+ + Y + +GSG FA V+ TG++ A K +KK L G ++ E+N
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
L+ I H +I L + E + + +++E GGEL D + E++ L E E+ F +QIL V
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 120 AYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
YLH AH DLKPEN++L N +KLIDFG+ K E G ++ + G+P + A
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFVA 179
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--M 231
PE++ + G E D+WS+GV+ Y LL G PF ++ + I Y E +
Sbjct: 180 PEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238
Query: 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 269
S ++ +R +L +P +R+ I L H+W+K N
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQIVR 469
G E D+WS+GV+ Y LL G PF ++ + I Y E + S ++ +R
Sbjct: 188 LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 247
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKD 504
+L +P +R+ I L H+W+K +R +D
Sbjct: 248 RLLVKDPKRRMTIAQSLEHSWIK-AIRRRNVRGED 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 7e-10
Identities = 14/38 (36%), Positives = 21/38 (55%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
G E D+WS+GV+ Y LL G PF ++ + I +
Sbjct: 188 LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 9e-99
Identities = 89/275 (32%), Positives = 141/275 (51%), Gaps = 18/275 (6%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINA 59
+ + Y L +G G F+ V+ + TG++ A+KI+ A G +K E +
Sbjct: 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 79
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG----EKESRAFFRQI 115
+ H HI +L + + ++MV E+ G +L IV+R G E + + RQI
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 116 LSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN 172
L A+ Y H HRD+KP VLL + + +KL FG+ A G G+P+
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV-AIQLGESGLVAGGRVGTPH 198
Query: 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW 230
+ APEV+K + YG DVW GV+L+ LL G LPF ++L++ I+ GKY W
Sbjct: 199 FMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQW 256
Query: 231 --MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+S +++ +VR ML ++P +RI + + L H W+K
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 6/105 (5%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
++ YG DVW GV+L+ LL G LPF ++L++ I+ GKY W +S +++
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKD 265
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVM 511
+VR ML ++P +RI + + L H W+K + + + ++ +
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWLK-ERDRYAYKIHLPETVEQL 309
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 16/41 (39%), Positives = 25/41 (60%), Gaps = 1/41 (2%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
++ YG DVW GV+L+ LL G LPF ++L++ I+
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIK 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 1e-98
Identities = 92/316 (29%), Positives = 144/316 (45%), Gaps = 54/316 (17%)
Query: 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG----EDLPRVKLEI 57
++L+ +Y L+ +G G + V++A T AIKIM K + +D+ R+K E+
Sbjct: 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79
Query: 58 NALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG------------- 104
+K + H +I +L++V E +I +V+E C GG LLD +
Sbjct: 80 RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 105 ---------------------------EKESRAFFRQILSAVAYLHHLGYAHRDLKPENV 137
EK RQI SA+ YLH+ G HRD+KPEN
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199
Query: 138 LL--DRNQNLKLIDFGL---CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY-YGSETDV 191
L +++ +KL+DFGL K G + T G+P + APEV+ YG + D
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 192 WSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQIVRSMLQVEP 247
WS GV+L+ LL G +PF + ++LN K P + +SP +R ++ ++L
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319
Query: 248 GKRIKIQDLLGHNWVK 263
+R L H W+
Sbjct: 320 DERFDAMRALQHPWIS 335
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 25/87 (28%), Positives = 43/87 (49%), Gaps = 4/87 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 465
+ + YG + D WS GV+L+ LL G +PF + ++LN K P + +SP +R
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR 308
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVK 492
++ ++L +R L H W+
Sbjct: 309 DLLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 14/44 (31%), Positives = 23/44 (52%)
Query: 325 KQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ YG + D WS GV+L+ LL G +PF + ++L+
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 3e-98
Identities = 93/285 (32%), Positives = 148/285 (51%), Gaps = 16/285 (5%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-----GEDLPRVKL 55
+ ++ + Y +GSG FA VK TG + A K +KK G ++
Sbjct: 4 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 56 EINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQI 115
E++ LK I H ++ L +V E + + +++E GGEL D + E++ L E+E+ F +QI
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 116 LSAVAYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP 171
L+ V YLH L AH DLKPEN++L +K+IDFGL K + G ++ + G+P
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTP 181
Query: 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPP 229
+ APE++ + G E D+WS+GV+ Y LL G PF D+ + + Y +
Sbjct: 182 EFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 230 W--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVS 272
+ S ++ +R +L +P KR+ IQD L H W+K +S
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 285
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 33/119 (27%), Positives = 52/119 (43%), Gaps = 6/119 (5%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQIVR 469
G E D+WS+GV+ Y LL G PF D+ + + Y + + S ++ +R
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPDDMWSQLNE 528
+L +P KR+ IQD L H W+K L K V M K+ + + +
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV--NMEKFKKFAARKKSNNGSG 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 14/38 (36%), Positives = 21/38 (55%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
G E D+WS+GV+ Y LL G PF D+ + + +
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = 5e-98
Identities = 91/293 (31%), Positives = 146/293 (49%), Gaps = 23/293 (7%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG------------EDLPR 52
+ Y R +GSG + +V L + AIK++KK+ +
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 53 VKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF 112
+ EI+ LK + H +I KLF V E + ++V E+ GGEL + I+ R + E ++
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169
+QILS + YLH HRD+KPEN+LL + N+K++DFGL + +L+ G
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLG 210
Query: 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--E 227
+ Y APEV+K K Y + DVWS GV++Y LLCG+ PF + + K+ GKY
Sbjct: 211 TAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 228 PPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHE 278
W +S ++++++ ML + KR ++ L W+K + S +
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLC 321
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 6/107 (5%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
K+ Y + DVWS GV++Y LLCG+ PF + + K+ GKY W +S +++
Sbjct: 221 KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN--PLREKDDDVIKVM 511
+++ ML + KR ++ L W+K + ++ + M
Sbjct: 281 LIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 16/41 (39%), Positives = 24/41 (58%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
K+ Y + DVWS GV++Y LLCG+ PF + + K+
Sbjct: 221 KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = 2e-97
Identities = 93/267 (34%), Positives = 150/267 (56%), Gaps = 12/267 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHI 63
L Y + +GSG + +V L +T + AIKI++K ++ ++ E+ LK +
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
H +I KL+ E + ++V+E GGEL D I+ R + E ++ +Q+LS V YLH
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 124 HLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
HRDLKPEN+LL +++ +K++DFGL A E +++ G+ Y APEV++
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPEVLR 211
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 236
K Y + DVWS+GV+L+ LL G+ PF + ++ K+ GKYT P W +S ++
Sbjct: 212 KK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+++ MLQ + +RI Q L H W+K
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIK 296
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 7/108 (6%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 466
++ Y + DVWS+GV+L+ LL G+ PF + ++ K+ GKYT P W +S ++
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMG---PEDNPLREKDDDVIKVM 511
+++ MLQ + +RI Q L H W+K E + I+ M
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENM 318
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 14/41 (34%), Positives = 25/41 (60%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
++ Y + DVWS+GV+L+ LL G+ PF + ++ K+
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 3e-97
Identities = 101/277 (36%), Positives = 152/277 (54%), Gaps = 14/277 (5%)
Query: 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALK 61
L + + +E +G G + V T + A+K++KK + + EI L
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLL 103
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAY 121
+SH +I KL ++ ET + I +V+E GGEL D IVE+ E+++ +QIL AVAY
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 122 LHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEV 178
LH G HRDLKPEN+L + LK+ DFGL E ++T CG+P Y APE+
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEI 221
Query: 179 IKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYT--EPPW--MSP 233
++G YG E D+WS+G++ Y LLCGF PF + DQ ++ +ILN +Y P W +S
Sbjct: 222 LRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNP 270
N++ +VR ++ ++P KR+ L H WV +
Sbjct: 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV 317
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKYT--EPPW--MSPNSR 465
YG E D+WS+G++ Y LLCGF PF + DQ ++ +ILN +Y P W +S N++
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIK 509
+VR ++ ++P KR+ L H WV + + ++
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQ 327
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 19/42 (45%), Positives = 28/42 (66%), Gaps = 1/42 (2%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILS 368
YG E D+WS+G++ Y LLCGF PF + DQ ++ +IL+
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 4e-97
Identities = 91/291 (31%), Positives = 145/291 (49%), Gaps = 16/291 (5%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-----GEDLPRVKLEINA 59
+ + Y + +GSG FA VK TG + A K +KK G ++ E++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
L+ + H ++ L V E + + +++E GGEL D + +++ L E+E+ +F +QIL V
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 120 AYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
YLH AH DLKPEN++L ++KLIDFGL + E G + + G+P + A
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVA 186
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPPW--M 231
PE++ + G E D+WS+GV+ Y LL G PF D+ + I + Y E +
Sbjct: 187 PEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREK 282
S ++ +R +L E KR+ IQ+ L H W+ + R E
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 4/96 (4%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPPW--MSPNSRQIVR 469
G E D+WS+GV+ Y LL G PF D+ + I + Y E + S ++ +R
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDD 505
+L E KR+ IQ+ L H W+ + ++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRES 290
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 16/38 (42%), Positives = 21/38 (55%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
G E D+WS+GV+ Y LL G PF D+ + I S
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 3e-96
Identities = 93/309 (30%), Positives = 155/309 (50%), Gaps = 24/309 (7%)
Query: 1 MKYIDLRNQYIL---ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEI 57
MK Y L ++ +G G F+ + H + + A+KI+ K + EI
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEI 56
Query: 58 NALKHIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQIL 116
ALK H +I KL +V H F+V+E GGEL + I +++ E E+ R+++
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV 116
Query: 117 SAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNY 173
SAV+++H +G HRDLKPEN+L + N +K+IDFG A+ + L+T C + +Y
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF-ARLKPPDNQPLKTPCFTLHY 175
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD-------SIDQLYDKILNGKY- 225
AAPE++ + Y D+WS+GV+LY +L G +PF S S ++ KI G +
Sbjct: 176 AAPELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 226 -TEPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREK 282
W +S ++ +++ +L V+P KR+K+ L + W++ G + + L
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSS 294
Query: 283 DDDVIKVMA 291
V +
Sbjct: 295 GAAVHTCVK 303
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 13/107 (12%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSD-------SIDQLYDKILNGKY--TEPPW-- 459
+ Y D+WS+GV+LY +L G +PF S S ++ KI G + W
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE--DNPLREKD 504
+S ++ +++ +L V+P KR+K+ L + W++ G + NPL D
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPD 289
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 16/48 (33%), Positives = 24/48 (50%), Gaps = 7/48 (14%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSD-------SIDQLYDKILS 368
+ Y D+WS+GV+LY +L G +PF S S ++ KI
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 5e-96
Identities = 92/291 (31%), Positives = 144/291 (49%), Gaps = 16/291 (5%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-----GEDLPRVKLEINA 59
+ + Y + +GSG FA VK TG + A K +KK G ++ E++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
L+ + H +I L V E + + +++E GGEL D + +++ L E+E+ +F +QIL V
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 120 AYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
YLH AH DLKPEN++L ++KLIDFGL + E G + + G+P + A
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVA 186
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPPW--M 231
PE++ + G E D+WS+GV+ Y LL G PF D+ + I Y E +
Sbjct: 187 PEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREK 282
S ++ +R +L E KR+ IQ+ L H W+ + R E
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 28/96 (29%), Positives = 44/96 (45%), Gaps = 4/96 (4%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPPW--MSPNSRQIVR 469
G E D+WS+GV+ Y LL G PF D+ + I Y E + S ++ +R
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDD 505
+L E KR+ IQ+ L H W+ + ++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRES 290
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 15/38 (39%), Positives = 21/38 (55%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
G E D+WS+GV+ Y LL G PF D+ + I +
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 9e-96
Identities = 85/275 (30%), Positives = 141/275 (51%), Gaps = 19/275 (6%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
I + Y ++ +G G ++ K H T + A+KI+ K+ EI L
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEIL 69
Query: 61 KHIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
H +I L V + ++++V E GGELLD I+ ++ E+E+ A I V
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 120 AYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
YLH G HRDLKP N+L +++++ DFG AK L T C + N+ A
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF-AKQLRAENGLLMTPCYTANFVA 188
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS---DSIDQLYDKILNGKY--TEPPW 230
PEV++ +Q Y + D+WS+GV+LY +L G+ PF + D+ +++ +I +GK+ + W
Sbjct: 189 PEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247
Query: 231 --MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+S ++ +V ML V+P +R+ +L H W+
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 30/103 (29%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDS---DSIDQLYDKILNGKY--TEPPW--MSPN 463
+Q Y + D+WS+GV+LY +L G+ PF + D+ +++ +I +GK+ + W +S
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE--DNPLREKD 504
++ +V ML V+P +R+ +L H W+ + L +D
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDS---DSIDQLYDKILS 368
+Q Y + D+WS+GV+LY +L G+ PF + D+ +++ +I S
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 4e-95
Identities = 75/288 (26%), Positives = 131/288 (45%), Gaps = 20/288 (6%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISH- 65
Y + + +GSGG +KV + + AIK + + L + EI L +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 66 -QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
I +L+ T +I+MV+E +L + +++ + E +++++ +L AV +H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKG-- 181
G H DLKP N L+ + LKLIDFG+ + + G+ NY PE IK
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 182 --------KQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKIL-NGKYTEPPW 230
K ++DVWS+G +LY + G PF + I +L+ I N + P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHE 278
+ + +++ L+ +P +RI I +LL H +V++ + E
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 312
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 27/110 (24%), Positives = 53/110 (48%), Gaps = 5/110 (4%)
Query: 397 LLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKIL-NGK 453
++ SK ++DVWS+G +LY + G PF + I +L+ I N +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 454 YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREK 503
P + + +++ L+ +P +RI I +LL H +V+ + +P+ +
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ--IQTHPVNQM 306
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 14/53 (26%), Positives = 24/53 (45%), Gaps = 2/53 (3%)
Query: 322 SRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKILSHFMP 372
+ K ++DVWS+G +LY + G PF + I +L+ I +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 8e-95
Identities = 83/283 (29%), Positives = 147/283 (51%), Gaps = 13/283 (4%)
Query: 1 MKYIDLRNQYILERT--VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEIN 58
K + + Y + +T +G G F +V TG K+A KI+K + +D VK EI+
Sbjct: 80 AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEIS 138
Query: 59 ALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILS 117
+ + H ++ +L+ E+ + I +V+EY GGEL D I++ L E ++ F +QI
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE 198
Query: 118 AVAYLHHLGYAHRDLKPENVLLDR--NQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
+ ++H + H DLKPEN+L + +K+IDFGL + + +L+ + G+P + A
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLA 256
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--M 231
PEV+ + TD+WS+GV+ Y LL G PF D+ + + IL ++ + + +
Sbjct: 257 PEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI 315
Query: 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFR 274
S +++ + +L E RI + L H W+ + +S +
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQ 358
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 24/98 (24%), Positives = 46/98 (46%), Gaps = 4/98 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 465
+ + TD+WS+GV+ Y LL G PF D+ + + IL ++ + + +S ++
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREK 503
+ + +L E RI + L H W+ + L +
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQ 358
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 15/41 (36%), Positives = 23/41 (56%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ TD+WS+GV+ Y LL G PF D+ + + IL+
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 302 bits (774), Expect = 1e-94
Identities = 76/336 (22%), Positives = 132/336 (39%), Gaps = 46/336 (13%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+ ++ +G+GGF V H TGE+VAIK ++ ++ R LEI +K ++H ++
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 69 CKLFQVIETSSHI------FMVIEYCPGGELLDHIVERQR---LGEKESRAFFRQILSAV 119
+V + + + +EYC GG+L ++ + + L E R I SA+
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQN---LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
YLH HRDLKPEN++L K+ID G + + G G+ Y AP
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAP 192
Query: 177 EVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMS---- 232
E+++ K+Y D WS G + + + GF PF + + + K E +
Sbjct: 193 ELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 233 -----------PNSR---------QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVS 272
PN + ++ ML +R + D+ +S
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL--DSILS 309
Query: 273 FRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEW 308
+ + V ++ ++ L W
Sbjct: 310 LKLLSVMNMVSGRVHTY-----PVTENENLQNLKSW 340
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 22/145 (15%), Positives = 44/145 (30%), Gaps = 29/145 (20%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMS---------- 461
+ Y D WS G + + + GF PF + + + K E +
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257
Query: 462 -----PNSR---------QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDV 507
PN + ++ ML +R + D+ L K V
Sbjct: 258 SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL--DSILSLKLLSV 315
Query: 508 IKVMAD---HKQLSPDDMWSQLNEW 529
+ +++ ++ ++ L W
Sbjct: 316 MNMVSGRVHTYPVTENENLQNLKSW 340
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 10/42 (23%), Positives = 18/42 (42%), Gaps = 1/42 (2%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
+ K+Y D WS G + + + GF PF + + +
Sbjct: 196 EQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 292 bits (748), Expect = 4e-94
Identities = 75/288 (26%), Positives = 130/288 (45%), Gaps = 20/288 (6%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISH- 65
Y + + +GSGG +KV + + AIK + L + EI L +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 66 -QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
I +L+ T +I+MV+E +L + +++ + E +++++ +L AV +H
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKG-- 181
G H DLKP N L+ + LKLIDFG+ + + G+ NY PE IK
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 182 --------KQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKIL-NGKYTEPPW 230
K ++DVWS+G +LY + G PF + I +L+ I N + P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHE 278
+ + +++ L+ +P +RI I +LL H +V++ + E
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 32/147 (21%), Positives = 65/147 (44%), Gaps = 5/147 (3%)
Query: 406 SAPSSKQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKIL-NGKYTEPPWMSP 462
SK ++DVWS+G +LY + G PF + I +L+ I N + P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG--PEDNPLREKDDDVIKVMADHKQLSPD 520
+ + +++ L+ +P +RI I +LL H +V++ P + + +++ V+ L+
Sbjct: 296 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSP 355
Query: 521 DMWSQLNEWTYNYDTCTYLLLLSRKKQ 547
+ + + Y + + S K
Sbjct: 356 NSILKAAKTLYEHYSGGESHNSSSSKT 382
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 14/53 (26%), Positives = 24/53 (45%), Gaps = 2/53 (3%)
Query: 322 SRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKILSHFMP 372
+ K ++DVWS+G +LY + G PF + I +L+ I +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 6e-94
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 15/283 (5%)
Query: 2 KYIDLRNQY-ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINA 59
+ N Y + + +G G FA V+ TG++ A K +KK G + + EI
Sbjct: 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81
Query: 60 LKHISHQ-HICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQIL 116
L+ + L +V E +S I +++EY GGE+ + + + E + +QIL
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 117 SAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNY 173
V YLH H DLKP+N+LL ++K++DFG+ K +L+ G+P Y
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW- 230
APE++ + TD+W++G++ Y LL PF + + Y I E +
Sbjct: 200 LAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258
Query: 231 -MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVS 272
+S + ++S+L P KR + L H+W++ +N
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFH 301
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 24/106 (22%), Positives = 45/106 (42%), Gaps = 4/106 (3%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQIVR 469
+ TD+W++G++ Y LL PF + + Y I E + +S + ++
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQ 269
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHK 515
S+L P KR + L H+W++ +N ++ DH
Sbjct: 270 SLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHS 315
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 11/38 (28%), Positives = 19/38 (50%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ TD+W++G++ Y LL PF + + Y I
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 1e-93
Identities = 73/266 (27%), Positives = 130/266 (48%), Gaps = 12/266 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+L +Y++ +G G F V + + K +K G D VK EI+ L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR 59
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLH 123
H++I L + E+ + M+ E+ G ++ + I L E+E ++ Q+ A+ +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 124 HLGYAHRDLKPENVLL--DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
H D++PEN++ R+ +K+I+FG + + G + +P Y APEV +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH 177
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 237
+ TD+WS+G ++Y LL G PF +++ Q+ + I+N +YT E + +S +
Sbjct: 178 DV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 238 IVRSMLQVEPGKRIKIQDLLGHNWVK 263
V +L E R+ + L H W+K
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLK 262
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 9/106 (8%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 465
+ TD+WS+G ++Y LL G PF +++ Q+ + I+N +YT E + +S +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVM 511
V +L E R+ + L H W+K + VI+ +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLK-----QKIERVSTKVIRTL 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 13/38 (34%), Positives = 25/38 (65%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ TD+WS+G ++Y LL G PF +++ Q+ + I++
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 1e-92
Identities = 75/306 (24%), Positives = 137/306 (44%), Gaps = 17/306 (5%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+ + Y + +GSG F V TG K + D VK EI+ + +
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLH 106
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLH 123
H + L E + +++E+ GGEL D I ++ E E + RQ + ++H
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 124 HLGYAHRDLKPENVLL--DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
H D+KPEN++ + ++K+IDFGL K ++ + + +AAPE++
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR 224
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSRQ 237
+ G TD+W++GV+ Y LL G PF + + + + E + +SP ++
Sbjct: 225 EP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283
Query: 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMG------PEDNPVSFRPDHELREKDDDVIKVMA 291
++++LQ EP KR+ + D L H W+K + + +++EK D
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQP 343
Query: 292 DHKQLS 297
+++
Sbjct: 344 AIGRIA 349
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 5/106 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPW--MSPNSR 465
++ G TD+W++GV+ Y LL G PF + + + + E + +SP ++
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVM 511
++++LQ EP KR+ + D L H W+K G N +
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLK-GDHSNLTSRIPSSRYNKI 327
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 12/41 (29%), Positives = 21/41 (51%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
++ G TD+W++GV+ Y LL G PF + + +
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 1e-92
Identities = 73/293 (24%), Positives = 132/293 (45%), Gaps = 22/293 (7%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISH- 65
Y + + +GSGG +KV + + AIK + + L + EI L +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 66 -QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
I +L+ T +I+MV+E +L + +++ + E +++++ +L AV +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
G H DLKP N L+ + LKLIDFG+ + + G+ NY PE IK
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 184 Y----------YGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKILNGKYT--EPP 229
++DVWS+G +LY + G PF + I +L+ I++ + P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 244
Query: 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREK 282
+ + +++ L+ +P +RI I +LL H +V++ + E +
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 28/121 (23%), Positives = 58/121 (47%), Gaps = 7/121 (5%)
Query: 406 SAPSSKQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKILNGKYT--EPPWMS 461
SK ++DVWS+G +LY + G PF + I +L+ I++ + P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPDIPE 247
Query: 462 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG--PEDNPLREKDDDVIKVMADHKQLSP 519
+ + +++ L+ +P +RI I +LL H +V++ P + + +++ V+ L+
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNS 307
Query: 520 D 520
Sbjct: 308 P 308
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 14/53 (26%), Positives = 24/53 (45%), Gaps = 2/53 (3%)
Query: 322 SRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKILSHFMP 372
+ K ++DVWS+G +LY + G PF + I +L+ I +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 6e-92
Identities = 85/301 (28%), Positives = 146/301 (48%), Gaps = 35/301 (11%)
Query: 5 DLRNQYILERTV-GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
+ Y L+ V G G A+V+ +++T ++ A+KI++K RV E+ L
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQC 67
Query: 64 S-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
H+++ +L + E ++V E GG +L HI +R+ E E+ + + SA+ +L
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 123 HHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLES------QLQTSCGSPNY 173
H+ G AHRDLKPEN+L ++ +K+ DF L + + + +L T CGS Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 174 AAPEVIKGKQY----YGSETDVWSMGVMLYALLCGFLPFDSDSI---------------D 214
APEV++ Y D+WS+GV+LY LL G+ PF +
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 215 QLYDKILNGKYT--EPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNP 270
L++ I GKY + W +S ++ ++ +L + +R+ +L H WV+ +N
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307
Query: 271 V 271
+
Sbjct: 308 L 308
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 29/117 (24%), Positives = 51/117 (43%), Gaps = 19/117 (16%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---------------DQLYD 447
V+ + Y D+WS+GV+LY LL G+ PF + L++
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 448 KILNGKYT--EPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPL 500
I GKY + W +S ++ ++ +L + +R+ +L H WV+ +N L
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL 308
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 13/38 (34%), Positives = 19/38 (50%)
Query: 321 LSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS 358
+ + Y D+WS+GV+LY LL G+ PF
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 9e-90
Identities = 104/332 (31%), Positives = 163/332 (49%), Gaps = 37/332 (11%)
Query: 1 MKYIDLRNQYILERTV-GSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA 59
K + + Y L + V G G KV H TG+K A+K++ + P+ + E++
Sbjct: 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDH 74
Query: 60 LKHIS-HQHICKLFQVIETSSH----IFMVIEYCPGGELLDHIVER--QRLGEKESRAFF 112
S HI + V E H + +++E GGEL I ER Q E+E+
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169
R I +A+ +LH AHRD+KPEN+L +++ LKL DFG + LQT C
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCY 191
Query: 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKY 225
+P Y APEV+ + Y D+WS+GV++Y LLCGF PF S++ + +I G+Y
Sbjct: 192 TPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250
Query: 226 T--EPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELRE 281
P W +S +++Q++R +L+ +P +R+ I + H W+ + V P H R
Sbjct: 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN---QSMVVPQTPLHTAR- 306
Query: 282 KDDDVIKVMADHKQLSPDDMWSQLNEWTYNYD 313
V++ DH ++M S L +YD
Sbjct: 307 ----VLQEDKDHWDEVKEEMTSALATMRVDYD 334
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 12/134 (8%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYT--EPPW--MSP 462
+ Y D+WS+GV++Y LLCGF PF S++ + +I G+Y P W +S
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE--DNPLREKDDDVIKVMADHKQLSPD 520
+++Q++R +L+ +P +R+ I + H W+ PL V++ DH +
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA--RVLQEDKDHWDEVKE 320
Query: 521 DMWSQLNEWTYNYD 534
+M S L +YD
Sbjct: 321 EMTSALATMRVDYD 334
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 16/41 (39%), Positives = 25/41 (60%)
Query: 327 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
G + Y D+WS+GV++Y LLCGF PF S++ + +
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-89
Identities = 82/289 (28%), Positives = 137/289 (47%), Gaps = 11/289 (3%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
+K+ + + Y + +G+G F V T TG A K + D V+ EI +
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTM 208
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAV 119
+ H + L E + + M+ E+ GGEL + + E ++ E E+ + RQ+ +
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268
Query: 120 AYLHHLGYAHRDLKPENVLL--DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
++H Y H DLKPEN++ R+ LKLIDFGL A + ++ + G+ +AAPE
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPE 326
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWM--SP 233
V +GK G TD+WS+GV+ Y LL G PF ++ D+ + + + + + S
Sbjct: 327 VAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREK 282
+ + +R +L +P R+ I L H W+ G S P +
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 4/109 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWM--SPNSR 465
+ G TD+WS+GV+ Y LL G PF ++ D+ + + + + + S + +
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADH 514
+R +L +P R+ I L H W+ G + + D
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 437
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 15/38 (39%), Positives = 22/38 (57%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
G TD+WS+GV+ Y LL G PF ++ D+ + S
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 5e-89
Identities = 92/306 (30%), Positives = 144/306 (47%), Gaps = 36/306 (11%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHI 68
+ + +G G KV + T EK A+K+++ P+ + E+ S HI
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHI 117
Query: 69 CKLFQVIETS----SHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYL 122
++ V E + +V+E GGEL I +R Q E+E+ + I A+ YL
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 123 HHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
H + AHRD+KPEN+L N LKL DFG + + L T C +P Y APEV+
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVL 235
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILNGKYT--EPPW--M 231
+ Y D+WS+GV++Y LLCG+ PF S+ + +I G+Y P W +
Sbjct: 236 G-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG------PEDNPVSFRPDHELREKDDD 285
S + ++R++L+ EP +R+ I + + H W+ P + D E E D
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE---D 351
Query: 286 VIKVMA 291
V + M
Sbjct: 352 VKEEMT 357
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILNGKYT--EPPW--MSP 462
+ Y D+WS+GV++Y LLCG+ PF S+ + +I G+Y P W +S
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE--DNPL 500
+ ++R++L+ EP +R+ I + + H W+ + PL
Sbjct: 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 16/46 (34%), Positives = 25/46 (54%), Gaps = 4/46 (8%)
Query: 327 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILS 368
G + Y D+WS+GV++Y LLCG+ PF S+ + +I
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 4e-88
Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 22/281 (7%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
Y+ + +G GGF+ V L + G A+K + +D + E + + +H
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHP 86
Query: 67 HICKLFQVIETSS----HIFMVIEYCPGGELLDHIVERQ----RLGEKESRAFFRQILSA 118
+I +L ++++ + G L + I + L E + I
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ--------TSCGS 170
+ +H GYAHRDLKP N+LL L+D G + +E Q +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 171 PNYAAPEVIKGKQY--YGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYTE 227
+Y APE+ + + TDVWS+G +LYA++ G P+D + + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 228 PPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266
P S Q++ SM+ V+P +R I LL P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 25/89 (28%), Positives = 38/89 (42%), Gaps = 3/89 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYTEPPW--MSPNSRQ 466
S TDVWS+G +LYA++ G P+D + + + P S Q
Sbjct: 219 SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ 278
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495
++ SM+ V+P +R I LL P
Sbjct: 279 LLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 14/47 (29%), Positives = 22/47 (46%), Gaps = 2/47 (4%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI--DQLYDKILSHF 370
Q TDVWS+G +LYA++ G P+D D + + +
Sbjct: 218 QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 1e-86
Identities = 78/303 (25%), Positives = 128/303 (42%), Gaps = 34/303 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-H 65
+ + R + GGFA V A V +G + A+K + E + E+ +K +S H
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGH 85
Query: 66 QHICKLF-------QVIETSSHIFMVIEYCPGGELLDHIVERQ---RLGEKESRAFFRQI 115
+I + + +T F+++ G+L++ + + + L F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 116 LSAVAYLHHLG--YAHRDLKPENVLLDRNQNLKLIDFGLCAKP-----------EGGLES 162
AV ++H HRDLK EN+LL +KL DFG L
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 163 QLQTSCGSPNYAAPEVI--KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI 220
+ T +P Y PE+I G + D+W++G +LY L PF+ D +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRI 261
Query: 221 LNGKYTEPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHE 278
+NGKY+ PP ++R+MLQV P +R+ I +++ ++ N P E
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ-EIAAARNVNPKSPITE 320
Query: 279 LRE 281
L E
Sbjct: 321 LLE 323
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 26/112 (23%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW--MSPNSRQI 467
S G + D+W++G +LY L PF+ D +I+NGKY+ PP +
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRIVNGKYSIPPHDTQYTVFHSL 281
Query: 468 VRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSP 519
+R+MLQV P +R+ I +++ + + ++++ + +
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATL 333
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 9/33 (27%), Positives = 16/33 (48%)
Query: 327 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI 359
G + D+W++G +LY L PF+ +
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 2e-84
Identities = 74/326 (22%), Positives = 126/326 (38%), Gaps = 50/326 (15%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
L+N + E+ +G G V G VA+K M + +EI L
Sbjct: 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI----DFCDIALMEIKLLTESD 66
Query: 65 -HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-------RLGEKESRAFFRQIL 116
H ++ + + T +++ +E C L D + + E + RQI
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 117 SAVAYLHHLGYAHRDLKPENVLLD-------------RNQNLKLIDFGLCAKPEGG---L 160
S VA+LH L HRDLKP+N+L+ N + + DFGLC K + G
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 161 ESQLQTSCGSPNYAAPEVIKG------KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSI 213
+ L G+ + APE+++ K+ D++SMG + Y +L G PF
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 214 DQLYDKILNGKYT-----EPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266
+ I+ G ++ + + ++ M+ +P KR +L H
Sbjct: 246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303
Query: 267 EDNP----VSFRPDHELREKDDDVIK 288
+ VS R + E R+ ++
Sbjct: 304 KKLEFLLKVSDRLEIENRDPPSALLM 329
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 23/133 (17%), Positives = 49/133 (36%), Gaps = 17/133 (12%)
Query: 402 IVLCSAPSSKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT----- 455
+ + +K+ D++SMG + Y +L G PF + I+ G ++
Sbjct: 204 LEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMK 261
Query: 456 EPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMAD 513
+ + ++ M+ +P KR +L H + K + + ++D
Sbjct: 262 CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP-------KSKKLEFLLKVSD 314
Query: 514 HKQLSPDDMWSQL 526
++ D S L
Sbjct: 315 RLEIENRDPPSAL 327
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 3/52 (5%)
Query: 318 LLLLSRKKQGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILS 368
LL S Q K+ D++SMG + Y +L G PF + I+
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIR 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-80
Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 51/294 (17%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+ + + + +G G KV + T EK A+K+++ P+ + E+ S
Sbjct: 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRAS 68
Query: 65 -HQHICKLFQVIETS----SHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILS 117
HI ++ V E + +V+E GGEL I +R Q E+E+ + I
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 118 AVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYA 174
A+ YLH + AHRD+KPEN+L N LKL DFG
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------- 166
Query: 175 APEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILNGKYT--EP 228
A E K Y D+WS+GV++Y LLCG+ PF S+ + +I G+Y P
Sbjct: 167 AKETTGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 229 PW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELR 280
W +S + ++R++L+ EP +R+ I + + H W+ + V P H R
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM---QSTKVPQTPLHTSR 275
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 11/114 (9%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILNGKYT--EPPW--MSP 462
+ Y D+WS+GV++Y LLCG+ PF S+ + +I G+Y P W +S
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQ 516
+ ++R++L+ EP +R+ I + + H W+ + + + +V+ + K+
Sbjct: 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIM---QSTKVPQTPLHTSRVLKEDKE 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 15/45 (33%), Positives = 24/45 (53%), Gaps = 4/45 (8%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILS 368
+ Y D+WS+GV++Y LLCG+ PF S+ + +I
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-79
Identities = 75/269 (27%), Positives = 130/269 (48%), Gaps = 15/269 (5%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQ 66
Y + T+G+G + + + G+ + K + ++ E + + E+N L+ + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 67 HICKLFQVI--ETSSHIFMVIEYCPGGELLDHIVERQRLG----EKESRAFFRQILSAVA 120
+I + + I T++ +++V+EYC GG+L I + + E+ Q+ A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 121 YLHHLGYA-----HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
H HRDLKP NV LD QN+KL DFGL A+ S +T G+P Y +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL-ARILNHDTSFAKTFVGTPYYMS 184
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPN 234
PE + Y ++D+WS+G +LY L PF + S +L KI GK+ P S
Sbjct: 185 PEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+I+ ML ++ R ++++L + +
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 23/80 (28%), Positives = 41/80 (51%), Gaps = 1/80 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
Y ++D+WS+G +LY L PF + S +L KI GK+ P S +I+ ML
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRML 252
Query: 473 QVEPGKRIKIQDLLGHNWVK 492
++ R ++++L + +
Sbjct: 253 NLKDYHRPSVEEILENPLIL 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 16/44 (36%), Positives = 23/44 (52%), Gaps = 1/44 (2%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS-HFMPI 373
Y ++D+WS+G +LY L PF + S +L KI F I
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 253 bits (646), Expect = 5e-79
Identities = 46/300 (15%), Positives = 89/300 (29%), Gaps = 54/300 (18%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHIS-- 64
+ +G AT TGE + + + ++K E+ L+ +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 65 --------------------HQHICKLFQVIETSSH-----IFMVIEYC------PGGEL 93
K+ +V F + G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 94 LDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153
L H + L Q++ +A LHH G H L+P +++LD+ + L F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 154 AKPEGGLESQLQTSCGSPNYAAPEVIK----------GKQYYGSETDVWSMGVMLYALLC 203
+ + S S + PE+ + D W++G+++Y + C
Sbjct: 254 VR-----DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 204 GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
LP D+ + I + R ++ L+ R+ + +
Sbjct: 309 ADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 13/96 (13%), Positives = 30/96 (31%), Gaps = 4/96 (4%)
Query: 397 LLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE 456
L + + D W++G+++Y + C LP D+ + I
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS---- 328
Query: 457 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
+ R ++ L+ R+ + +
Sbjct: 329 CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 10/49 (20%), Positives = 21/49 (42%)
Query: 321 LSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+S + + D W++G+++Y + C LP D+ + I
Sbjct: 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS 328
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 7e-77
Identities = 63/260 (24%), Positives = 127/260 (48%), Gaps = 6/260 (2%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQ 66
+Y+ + +G G F K L G + IK + + + + + E+ L ++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHH 124
+I + + E + +++V++YC GG+L I + E + +F QI A+ ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
HRD+K +N+ L ++ ++L DFG+ A+ + G+P Y +PE+ + K
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGI-ARVLNSTVELARACIGTPYYLSPEICENKP- 201
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 243
Y +++D+W++G +LY L F++ S+ L KI++G + S + R +V +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261
Query: 244 QVEPGKRIKIQDLLGHNWVK 263
+ P R + +L ++
Sbjct: 262 KRNPRDRPSVNSILEKGFIA 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 19/80 (23%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
Y +++D+W++G +LY L F++ S+ L KI++G + S + R +V +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261
Query: 473 QVEPGKRIKIQDLLGHNWVK 492
+ P R + +L ++
Sbjct: 262 KRNPRDRPSVNSILEKGFIA 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 13/38 (34%), Positives = 24/38 (63%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
Y +++D+W++G +LY L F++ S+ L KI+S
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-73
Identities = 64/276 (23%), Positives = 117/276 (42%), Gaps = 32/276 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
+ +GSGGF +V A H + G+ IK +K + + E+ AL + H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHV 64
Query: 67 HICKLFQVIETSSH----------------IFMVIEYCPGGELLDHIVER--QRLGEKES 108
+I + + +F+ +E+C G L I +R ++L + +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 109 RAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC 168
F QI V Y+H +RDLKP N+ L + +K+ DFGL + + + S
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--DGKRTRSK 182
Query: 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE 227
G+ Y +PE I + YG E D++++G++L LL F+ + + + +G
Sbjct: 183 GTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGII-- 236
Query: 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+ +++ +L +P R ++L V
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 17/84 (20%), Positives = 36/84 (42%), Gaps = 6/84 (7%)
Query: 410 SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 468
S Q YG E D++++G++L LL F+ + + + +G + ++
Sbjct: 194 SSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGII--SDIFDKKEKTLL 248
Query: 469 RSMLQVEPGKRIKIQDLLGHNWVK 492
+ +L +P R ++L V
Sbjct: 249 QKLLSKKPEDRPNTSEILRTLTVW 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 57/270 (21%), Positives = 105/270 (38%), Gaps = 21/270 (7%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQH 67
+ + +G G + + VA+K + E E+ L+ H +
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP----ECFSFADREVQLLRESDEHPN 79
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLG 126
+ + F + ++ IE C L +++ ++ E +Q S +A+LH L
Sbjct: 80 VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 127 YAHRDLKPENVLL-----DRNQNLKLIDFGLCAKPEGGLES--QLQTSCGSPNYAAPEVI 179
HRDLKP N+L+ + DFGLC K G S + G+ + APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 180 KG--KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPW---MSP 233
K+ D++S G + Y ++ G PF Q +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+R+++ M+ ++P KR + +L H +
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 16/88 (18%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPW---MSPNS 464
K+ D++S G + Y ++ G PF Q + +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260
Query: 465 RQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
R+++ M+ ++P KR + +L H +
Sbjct: 261 RELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 9/44 (20%), Positives = 17/44 (38%), Gaps = 1/44 (2%)
Query: 324 KKQGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKI 366
+ K+ D++S G + Y ++ G PF Q +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 3e-72
Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQH 67
+ + +G G F+ V LA + T + AIKI++K + + +P V E + + + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 68 ICKL---FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
KL FQ ++ + Y GELL +I + E +R + +I+SA+ YLH
Sbjct: 92 FVKLYFTFQ---DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLC-AKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
G HRDLKPEN+LL+ + ++++ DFG +++ + G+ Y +PE++ K
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK- 207
Query: 184 YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243
+D+W++G ++Y L+ G PF + + ++ KI+ +Y P P +R +V +L
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 267
Query: 244 QVEPGKRI------KIQDLLGHNW 261
++ KR+ L H +
Sbjct: 268 VLDATKRLGCEEMEGYGPLKAHPF 291
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 20/87 (22%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
+++ +D+W++G ++Y L+ G PF + + ++ KI+ +Y P P +R +V
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 264
Query: 470 SMLQVEPGKRI------KIQDLLGHNW 490
+L ++ KR+ L H +
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 10/41 (24%), Positives = 24/41 (58%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
++ +D+W++G ++Y L+ G PF + + ++ KI+
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-71
Identities = 67/259 (25%), Positives = 108/259 (41%), Gaps = 11/259 (4%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHI-SHQ 66
+ +G G + +V G A+K G D R E+ + + + H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHL 125
+L Q E +++ E C G L H L E + + R L A+A+LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
G H D+KP N+ L KL DFGL + + G P Y APE+++G Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GAGEVQEGDPRYMAPELLQGS--Y 232
Query: 186 GSETDVWSMGVMLYALLCGF-LPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244
G+ DV+S+G+ + + C LP + QL L ++ +S R ++ ML+
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMMLE 290
Query: 245 VEPGKRIKIQDLLGHNWVK 263
+P R + LL ++
Sbjct: 291 PDPKLRATAEALLALPVLR 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 20/80 (25%), Positives = 37/80 (46%), Gaps = 3/80 (3%)
Query: 414 YGSETDVWSMGVMLYALLCGF-LPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 472
YG+ DV+S+G+ + + C LP + QL L ++ +S R ++ ML
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 473 QVEPGKRIKIQDLLGHNWVK 492
+ +P R + LL ++
Sbjct: 290 EPDPKLRATAEALLALPVLR 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 12/43 (27%), Positives = 19/43 (44%), Gaps = 1/43 (2%)
Query: 331 YGSETDVWSMGVMLYALLCGF-LPFDSDSIDQLYDKILSHFMP 372
YG+ DV+S+G+ + + C LP + QL L
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFT 274
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 2e-70
Identities = 41/299 (13%), Positives = 83/299 (27%), Gaps = 48/299 (16%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQ 66
+ L + G + V L V E A+K+ +L R+ A + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 67 HICKLFQVI--------------------------ETSSHIFMVIEYCPG------GELL 94
+ ++ +++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 95 DHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154
V R G Q++ A L G H P+N+ + + L L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA-L 241
Query: 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQY-YGSETDVWSMGVMLYALLCGFLPFDSDS- 212
G ++ S YA E + + + W +G+ +Y + C FLPF +
Sbjct: 242 WKVG---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 213 -IDQLYDKILNGKYTEPPW-------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
I + + + + ++ L + +R+ + +
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 12/94 (12%), Positives = 31/94 (32%), Gaps = 9/94 (9%)
Query: 408 PSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILNGKYTEPPW------ 459
+S + + W +G+ +Y + C FLPF + I + +
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT 323
Query: 460 -MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
+ + ++ L + +R+ + +
Sbjct: 324 PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 9/50 (18%), Positives = 18/50 (36%), Gaps = 2/50 (4%)
Query: 325 KQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILSHFMP 372
+ + W +G+ +Y + C FLPF + I + +
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-70
Identities = 83/261 (31%), Positives = 143/261 (54%), Gaps = 12/261 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISH 65
+Q+ +T+G+G F +V L H +G A+KI+ K + + + E L+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+ KL + +S+++MV+EY GGE+ H+ R E +R + QI+ YLH L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
+RDLKPEN+L+D+ +++ DFG + ++ + T CG+P APE+I K Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEIILSKG-Y 215
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
D W++GV++Y + G+ PF +D Q+Y+KI++GK P S + + ++R++LQV
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 246 EPGKRI-----KIQDLLGHNW 261
+ KR + D+ H W
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKW 296
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
Y D W++GV++Y + G+ PF +D Q+Y+KI++GK P S + + ++R++LQ
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
Query: 474 VEPGKRI-----KIQDLLGHNW 490
V+ KR + D+ H W
Sbjct: 275 VDLTKRFGNLKNGVNDIKNHKW 296
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 15/38 (39%), Positives = 25/38 (65%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
Y D W++GV++Y + G+ PF +D Q+Y+KI+S
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 9e-70
Identities = 45/299 (15%), Positives = 92/299 (30%), Gaps = 43/299 (14%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKH---- 62
+ +G AT TGE + + + ++K E+ L+
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 63 ------------------ISHQHICKLFQVIETSSHIFMVIEYCP-----------GGEL 93
+ K+ +V ++++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 94 LDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC 153
L H + L Q++ +A LHH G H L+P +++LD+ + L F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQY----YGSETDVWSMGVMLYALLCGFLPFD 209
+ S + P A ++ Q+ D W++G+ +Y + C LP
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 210 SDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 268
D+ + I + R ++ L+ R+ + + +
Sbjct: 319 DDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 6e-19
Identities = 13/95 (13%), Positives = 29/95 (30%), Gaps = 4/95 (4%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSP 462
+L D W++G+ +Y + C LP D+ + I +
Sbjct: 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF----RSCKNIPQ 338
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 497
R ++ L+ R+ + + +
Sbjct: 339 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 10/50 (20%), Positives = 19/50 (38%)
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+L + D W++G+ +Y + C LP D+ + I
Sbjct: 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS 332
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-69
Identities = 81/295 (27%), Positives = 145/295 (49%), Gaps = 26/295 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISH 65
+ + RT+G+G F +V L G A+K++KK + + E L ++H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 66 QHICKL---FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
I ++ FQ + IFM+++Y GGEL + + QR ++ + ++ A+ YL
Sbjct: 66 PFIIRMWGTFQ---DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H +RDLKPEN+LLD+N ++K+ DFG + T CG+P+Y APEV+ K
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYTLCGTPDYIAPEVVSTK 178
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242
Y D WS G+++Y +L G+ PF + + Y+KILN + PP+ + + + ++ +
Sbjct: 179 P-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237
Query: 243 LQVEPGKRI-----KIQDLLGH------NWVKMGPEDNPVSFRPDHELREKDDDV 286
+ + +R+ +D+ H W K+ + + P +++ D
Sbjct: 238 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEP--PIQQGQGDT 290
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 21/82 (25%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 473
Y D WS G+++Y +L G+ PF + + Y+KILN + PP+ + + + ++ ++
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239
Query: 474 VEPGKRI-----KIQDLLGHNW 490
+ +R+ +D+ H W
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPW 261
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 14/39 (35%), Positives = 23/39 (58%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
Y D WS G+++Y +L G+ PF + + Y+KIL+
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 4e-69
Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 32/284 (11%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+ + +G GGF V A + + AIK ++ +V E+ AL + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 68 ICKLFQVIET------------SSHIFMVIEYCPGGELLDHIVERQRLGEKESRA---FF 112
I + F ++++ ++ C L D + R + E+E F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-----------PEGGLE 161
QI AV +LH G HRDLKP N+ + +K+ DFGL
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKI 220
++ G+ Y +PE I G Y + D++S+G++L+ LL PF + + +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240
Query: 221 LNGKYTE-PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
N K+ P +V+ ML P +R + +++ + +
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 20/99 (20%), Positives = 42/99 (42%), Gaps = 7/99 (7%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTE-PPWMSPNSRQI 467
Y + D++S+G++L+ LL PF + + + N K+ P +
Sbjct: 203 HGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVM 259
Query: 468 VRSMLQVEPGKRIKIQDLLGHNWVKMG--PEDNPLREKD 504
V+ ML P +R + +++ + + P LR++
Sbjct: 260 VQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRS 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-67
Identities = 77/239 (32%), Positives = 134/239 (56%), Gaps = 4/239 (1%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKL 71
+ +G G F KV L TG A+KI++K + ++ E L++ H + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
+T + V+EY GGEL H+ + E+ +R + +I+SA+ YLH +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDV 191
+K EN++LD++ ++K+ DFGLC K + ++T CG+P Y APEV++ YG D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLC-KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDW 188
Query: 192 WSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++ +L+ +P +R
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 21/69 (30%), Positives = 41/69 (59%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
YG D W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
Query: 471 MLQVEPGKR 479
+L+ +P +R
Sbjct: 239 LLKKDPKQR 247
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 15/42 (35%), Positives = 25/42 (59%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
YG D W +GV++Y ++CG LPF + ++L++ IL
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 7e-67
Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 22/286 (7%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISH 65
+ + + R +G G F KV + T + A+K M K ++ V E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 66 QHICKL---FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+ L FQ +FMV++ GG+L H+ + E+ + F +++ A+ YL
Sbjct: 75 PFLVNLWYSFQ---DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI--K 180
+ HRD+KP+N+LLD + ++ + DF + A +Q+ T G+ Y APE+ +
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAPEMFSSR 189
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILNGKYTEPPWMSPNSRQ 237
Y D WS+GV Y LL G P+ S S ++ T P S
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249
Query: 238 IVRSMLQVEPGKRI-KIQDLLGH------NWVKMGPEDNPVSFRPD 276
+++ +L+ P +R ++ D+ NW + + F P+
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPN 295
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 20/81 (24%), Positives = 34/81 (41%), Gaps = 4/81 (4%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
Y D WS+GV Y LL G P+ S S ++ T P S +++
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 471 MLQVEPGKRI-KIQDLLGHNW 490
+L+ P +R ++ D+ +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPY 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 19/61 (31%), Positives = 26/61 (42%), Gaps = 9/61 (14%)
Query: 314 TCTYL---LLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKIL 367
T Y+ + SRK G Y D WS+GV Y LL G P+ S S ++
Sbjct: 177 TKPYMAPEMFSSRKGAG---YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE 233
Query: 368 S 368
+
Sbjct: 234 T 234
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 218 bits (559), Expect = 9e-67
Identities = 79/246 (32%), Positives = 127/246 (51%), Gaps = 14/246 (5%)
Query: 14 RTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATL---GEDLPRVKLEINALKHISHQH 67
R +G GG+ KV V TG+ A+K++KKA + +D K E N L+ + H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 68 ICKL---FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
I L FQ T +++++EY GGEL + E + + +I A+ +LH
Sbjct: 83 IVDLIYAFQ---TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
G +RDLKPEN++L+ ++KL DFGLC K + T CG+ Y APE++
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLC-KESIHDGTVTHTFCGTIEYMAPEILMRSG- 197
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244
+ D WS+G ++Y +L G PF ++ + DKIL K PP+++ +R +++ +L+
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLK 257
Query: 245 VEPGKR 250
R
Sbjct: 258 RNAASR 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 19/69 (27%), Positives = 37/69 (53%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
+ + D WS+G ++Y +L G PF ++ + DKIL K PP+++ +R +++
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKK 254
Query: 471 MLQVEPGKR 479
+L+ R
Sbjct: 255 LLKRNAASR 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 13/42 (30%), Positives = 22/42 (52%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+ + D WS+G ++Y +L G PF ++ + DKIL
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-66
Identities = 90/330 (27%), Positives = 164/330 (49%), Gaps = 37/330 (11%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKL 71
+ +G G F +V+L H T + A+K++ K + + D E + + + + +L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 72 ---FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA 128
FQ +++MV+EY PGG+L+ +++ + EK +R + +++ A+ +H +G+
Sbjct: 135 FYAFQ---DDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 129 HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK---QYY 185
HRD+KP+N+LLD++ +LKL DFG C K + T+ G+P+Y +PEV+K + YY
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----YTEPPWMSPNSRQIVRS 241
G E D WS+GV LY +L G PF +DS+ Y KI+N K + + +S ++ ++ +
Sbjct: 251 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA 310
Query: 242 MLQVEPGKRIK---IQDLLGH------NWVKMGPEDNPVSFRPDHELREKDD----DVIK 288
L + R+ ++++ H W D P +L D D ++
Sbjct: 311 FL-TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP--DLSSDIDTSNFDDLE 367
Query: 289 VMADHKQLSPDDMWSQLNE-----WTYNYD 313
++ P N+ +TY +
Sbjct: 368 EDKGEEETFPIPKAFVGNQLPFVGFTYYSN 397
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----YTEPPWMSPNSR 465
YYG E D WS+GV LY +L G PF +DS+ Y KI+N K + + +S ++
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305
Query: 466 QIVRSMLQVEPGKRIK---IQDLLGHNW 490
++ + L + R+ ++++ H +
Sbjct: 306 NLICAFL-TDREVRLGRNGVEEIKRHLF 332
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 22/47 (46%), Positives = 30/47 (63%)
Query: 323 RKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+ + G YYG E D WS+GV LY +L G PF +DS+ Y KI++H
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 7e-66
Identities = 80/250 (32%), Positives = 134/250 (53%), Gaps = 12/250 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLGE-DLPRVKLEINALKHI 63
+Q+ L + +G G F KV L + + A+K++KKATL D R K+E + L +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 64 SHQHICKL---FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
+H I KL FQ T +++++++ GG+L + + E++ + + ++ A+
Sbjct: 84 NHPFIVKLHYAFQ---TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
+LH LG +RDLKPEN+LLD ++KL DFGL K E + + CG+ Y APEV+
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-KESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
+ + D WS GV+++ +L G LPF + IL K P ++SP ++ ++R
Sbjct: 200 RRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258
Query: 241 SMLQVEPGKR 250
+ + P R
Sbjct: 259 MLFKRNPANR 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 19/69 (27%), Positives = 35/69 (50%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
++ + D WS GV+++ +L G LPF + IL K P ++SP ++ ++R
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259
Query: 471 MLQVEPGKR 479
+ + P R
Sbjct: 260 LFKRNPANR 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 5e-07
Identities = 12/42 (28%), Positives = 20/42 (47%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
++ + D WS GV+++ +L G LPF + IL
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-65
Identities = 85/249 (34%), Positives = 132/249 (53%), Gaps = 11/249 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINAL-KHIS 64
+ + + +G G F KV LA H A+K+++K + + + + E N L K++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 65 HQHICKL---FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAY 121
H + L FQ T+ ++ V++Y GGEL H+ + E +R + +I SA+ Y
Sbjct: 98 HPFLVGLHFSFQ---TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
LH L +RDLKPEN+LLD ++ L DFGLC K S T CG+P Y APEV+
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-KENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 241
+ Y D W +G +LY +L G PF S + ++YD ILN P ++ ++R ++
Sbjct: 214 QP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
Query: 242 MLQVEPGKR 250
+LQ + KR
Sbjct: 273 LLQKDRTKR 281
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 24/69 (34%), Positives = 38/69 (55%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
KQ Y D W +G +LY +L G PF S + ++YD ILN P ++ ++R ++
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
Query: 471 MLQVEPGKR 479
+LQ + KR
Sbjct: 273 LLQKDRTKR 281
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 17/42 (40%), Positives = 24/42 (57%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
KQ Y D W +G +LY +L G PF S + ++YD IL+
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-65
Identities = 76/268 (28%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKL 71
+ +G G F++V + TG+ A+KIM K + + ++ + E + L + + I +L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEK--ESRAFF--RQILSAVAYLHHLGY 127
+ +++++V+EY GG+LL + + GE+ A F +I+ A+ +H LGY
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMAIDSVHRLGY 183
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK----- 182
HRD+KP+N+LLDR +++L DFG C K + + G+P+Y +PE+++
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 183 -QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-----TEPPWMSPNSR 236
YG E D W++GV Y + G PF +DS + Y KI++ K + +R
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303
Query: 237 QIVRSMLQVEPGKRI---KIQDLLGHNW 261
++ +L P R+ D H +
Sbjct: 304 DFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 9/93 (9%)
Query: 406 SAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-----TEPPWM 460
YG E D W++GV Y + G PF +DS + Y KI++ K +
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
Query: 461 SPNSRQIVRSMLQVEPGKRI---KIQDLLGHNW 490
+R ++ +L P R+ D H +
Sbjct: 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 18/52 (34%), Positives = 26/52 (50%)
Query: 318 LLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+L G YG E D W++GV Y + G PF +DS + Y KI+ +
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-65
Identities = 75/240 (31%), Positives = 126/240 (52%), Gaps = 5/240 (2%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKH-ISHQHICK 70
+ +G G F KV LA T + AIK +KK + D+ +E L H +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
+F +T ++F V+EY GG+L+ HI + + + +I+ + +LH G +R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +N+LLD++ ++K+ DFG+C K +++ T CG+P+Y APE++ G++ Y D
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMC-KENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVD 200
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
WS GV+LY +L G PF ++L+ I P W+ ++ ++ + EP KR
Sbjct: 201 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 21/69 (30%), Positives = 32/69 (46%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
Q Y D WS GV+LY +L G PF ++L+ I P W+ ++ ++
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
Query: 471 MLQVEPGKR 479
+ EP KR
Sbjct: 252 LFVREPEKR 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 15/42 (35%), Positives = 20/42 (47%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
Q Y D WS GV+LY +L G PF ++L+ I
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 9e-65
Identities = 82/287 (28%), Positives = 139/287 (48%), Gaps = 20/287 (6%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHI-SHQHICK 70
+G G F KV L+ T E A+KI+KK + + D+ +E L + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T ++ V+EY GG+L+ HI + R E + + +I + +L G +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +NV+LD ++K+ DFG+C K +T CG+P+Y APE+I + YG D
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMC-KENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVD 203
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
W+ GV+LY +L G PF+ + D+L+ I+ P MS + I + ++ PGKR
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
Query: 251 I-----KIQDLLGH------NWVKMGPEDNPVSFRPDHELREKDDDV 286
+ +D+ H +W K+ ++ ++P + +
Sbjct: 264 LGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP----KACGRNA 306
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 24/69 (34%), Positives = 36/69 (52%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
Q YG D W+ GV+LY +L G PF+ + D+L+ I+ P MS + I +
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254
Query: 471 MLQVEPGKR 479
++ PGKR
Sbjct: 255 LMTKHPGKR 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 17/42 (40%), Positives = 25/42 (59%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
Q YG D W+ GV+LY +L G PF+ + D+L+ I+ H
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-64
Identities = 85/294 (28%), Positives = 148/294 (50%), Gaps = 29/294 (9%)
Query: 8 NQYILERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATL---GEDLPRVKLEINALK 61
+ L + +G+G + KV L + TG+ A+K++KKAT+ + + E L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 62 HISHQH-ICKL---FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
HI + L FQ T + + ++++Y GGEL H+ +R+R E E + + +I+
Sbjct: 114 HIRQSPFLVTLHYAFQ---TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
A+ +LH LG +RD+K EN+LLD N ++ L DFGL + + CG+ Y AP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 178 VIKGKQY-YGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILNGKYTEPPWMS 232
+++G + D WS+GV++Y LL G PF D ++ +IL + P MS
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290
Query: 233 PNSRQIVRSMLQVEPGKRI-----KIQDLLGH------NWVKMGPEDNPVSFRP 275
++ +++ +L +P KR+ ++ H NW + + P F+P
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 344
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 23/81 (28%), Positives = 38/81 (46%), Gaps = 8/81 (9%)
Query: 407 AP----SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILNGKYTEPP 458
AP + D WS+GV++Y LL G PF D ++ +IL + P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287
Query: 459 WMSPNSRQIVRSMLQVEPGKR 479
MS ++ +++ +L +P KR
Sbjct: 288 EMSALAKDLIQRLLMKDPKKR 308
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 15/54 (27%), Positives = 24/54 (44%), Gaps = 7/54 (12%)
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILSH 369
++ G + D WS+GV++Y LL G PF D ++ +IL
Sbjct: 231 IVRGGDSG---HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-64
Identities = 87/240 (36%), Positives = 137/240 (57%), Gaps = 5/240 (2%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHI-SHQHICK 70
R +G G F KV LA TG+ A+K++KK + + D+ E L +H + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
LF +T +F V+E+ GG+L+ HI + +R E +R + +I+SA+ +LH G +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +NVLLD + KL DFG+C K T CG+P+Y APE+++ YG D
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMC-KEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVD 206
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
W+MGV+LY +LCG PF++++ D L++ ILN + P W+ ++ I++S + P R
Sbjct: 207 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 25/69 (36%), Positives = 42/69 (60%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
+ YG D W+MGV+LY +LCG PF++++ D L++ ILN + P W+ ++ I++S
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS 257
Query: 471 MLQVEPGKR 479
+ P R
Sbjct: 258 FMTKNPTMR 266
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+ YG D W+MGV+LY +LCG PF++++ D L++ IL+
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 3e-64
Identities = 69/267 (25%), Positives = 120/267 (44%), Gaps = 12/267 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISH 65
+ +E+ +G G F++V A +L G VA+K ++ L + EI+ LK ++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG----EKESRAFFRQILSAVAY 121
++ K + + + +V+E G+L I ++ E+ +F Q+ SA+ +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
+H HRD+KP NV + +KL D GL + + + G+P Y +PE I
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGL-GRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILNGKYTEPPW--MSPNSRQ 237
Y ++D+WS+G +LY + PF D ++ L KI Y P S RQ
Sbjct: 211 NG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 238 IVRSMLQVEPGKRIKIQDLLGHNWVKM 264
+V + +P KR + +
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMH 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 22/84 (26%), Positives = 35/84 (41%), Gaps = 4/84 (4%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILNGKYTEPPW--MSPNSRQIVR 469
Y ++D+WS+G +LY + PF D ++ L KI Y P S RQ+V
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 272
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKM 493
+ +P KR + +
Sbjct: 273 MCINPDPEKRPDVTYVYDVAKRMH 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 16/62 (25%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILS-HFMPICTILISQYFPTILL 387
Y ++D+WS+G +LY + PF D ++ L KI + P+ + S+ ++
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 272
Query: 388 PC 389
C
Sbjct: 273 MC 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-64
Identities = 50/279 (17%), Positives = 94/279 (33%), Gaps = 28/279 (10%)
Query: 8 NQYILERTVGSGGFAKVKLATH-----VLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
+ +G G FA+V AT +K +K+ K A E + LK
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY-IGTQLMERLKP 123
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER-----QRLGEKESRAFFRQILS 117
K + + +V E G LL+ I + + + +F ++L
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 118 AVAYLHHLGYAHRDLKPENVLL-----------DRNQNLKLIDFGLCAKPEGGLESQ-LQ 165
+ +H H D+KP+N +L D + L LID G + +
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY 225
C + + E++ K + + D + + +Y +L G + + + L +
Sbjct: 244 AKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL 302
Query: 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
+ + ML + + DLL K+
Sbjct: 303 PHLDMWN----EFFHVMLNIPDCHHLPSLDLLRQKLKKV 337
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 12/84 (14%), Positives = 28/84 (33%), Gaps = 4/84 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
S + + + D + + +Y +L G + + + L + + +
Sbjct: 258 SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWN----EFFH 313
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKM 493
ML + + DLL K+
Sbjct: 314 VMLNIPDCHHLPSLDLLRQKLKKV 337
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-63
Identities = 79/273 (28%), Positives = 144/273 (52%), Gaps = 22/273 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHIS 64
R + + + +G G F +V + + A+KI+ K + + + E + L +
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 65 HQHICKL---FQVIETSSHIFMVIEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAVA 120
+ I L FQ +++++V++Y GG+LL + RL E+ +R + +++ A+
Sbjct: 133 SKWITTLHYAFQ---DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
+H L Y HRD+KP+N+L+D N +++L DFG C K Q + G+P+Y +PE+++
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 181 ----GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-----TEPPWM 231
GK YG E D WS+GV +Y +L G PF ++S+ + Y KI+N K T+ +
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 232 SPNSRQIVRSMLQVEPGKRI---KIQDLLGHNW 261
S N++ ++R ++ R+ I+D H +
Sbjct: 310 SENAKDLIRRLIC-SREHRLGQNGIEDFKKHPF 341
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-----TEP 457
+L + K YG E D WS+GV +Y +L G PF ++S+ + Y KI+N K T+
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306
Query: 458 PWMSPNSRQIVRSMLQVEPGKRI---KIQDLLGHNW 490
+S N++ ++R ++ R+ I+D H +
Sbjct: 307 TDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPF 341
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 21/50 (42%), Positives = 32/50 (64%)
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+L + GK YG E D WS+GV +Y +L G PF ++S+ + Y KI++H
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-63
Identities = 78/240 (32%), Positives = 132/240 (55%), Gaps = 5/240 (2%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKL 71
+ +G G F KV L TG A+KI+KK + ++ E L++ H + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH-HLGYAHR 130
+T + V+EY GGEL H+ + E +R + +I+SA+ YLH +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK EN++LD++ ++K+ DFGLC K + ++T CG+P Y APEV++ Y G D
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLC-KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 331
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
W +GV++Y ++CG LPF + ++L++ IL + P + P ++ ++ +L+ +P +R
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 20/69 (28%), Positives = 40/69 (57%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
YG D W +GV++Y ++CG LPF + ++L++ IL + P + P ++ ++
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382
Query: 471 MLQVEPGKR 479
+L+ +P +R
Sbjct: 383 LLKKDPKQR 391
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 15/42 (35%), Positives = 25/42 (59%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
YG D W +GV++Y ++CG LPF + ++L++ IL
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-63
Identities = 89/286 (31%), Positives = 149/286 (52%), Gaps = 26/286 (9%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHI-SHQHICK 70
R +G G +AKV L T A+K++KK + + D+ V+ E + + +H +
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T S +F VIEY GG+L+ H+ +++L E+ +R + +I A+ YLH G +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +NVLLD ++KL D+G+C K T CG+PNY APE+++G+ YG D
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVD 192
Query: 191 VWSMGVMLYALLCGFLPF---------DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 241
W++GV+++ ++ G PF D ++ D L+ IL + P +S + +++S
Sbjct: 193 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 252
Query: 242 MLQVEPGKRI------KIQDLLGH------NWVKMGPEDNPVSFRP 275
L +P +R+ D+ GH +W M + F+P
Sbjct: 253 FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 298
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 25/104 (24%), Positives = 47/104 (45%), Gaps = 21/104 (20%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPF---------DSDSIDQLYDKILNGKYTEPPWMS 461
+ YG D W++GV+++ ++ G PF D ++ D L+ IL + P +S
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 462 PNSRQIVRSMLQVEPGKRI------KIQDLLGH------NWVKM 493
+ +++S L +P +R+ D+ GH +W M
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 14/51 (27%), Positives = 25/51 (49%), Gaps = 9/51 (17%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPF---------DSDSIDQLYDKILSH 369
+ YG D W++GV+++ ++ G PF D ++ D L+ IL
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-62
Identities = 88/286 (30%), Positives = 149/286 (52%), Gaps = 26/286 (9%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHI-SHQHICK 70
R +G G +AKV L T A++++KK + + D+ V+ E + + +H +
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T S +F VIEY GG+L+ H+ +++L E+ +R + +I A+ YLH G +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +NVLLD ++KL D+G+C K T CG+PNY APE+++G+ YG D
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVD 235
Query: 191 VWSMGVMLYALLCGFLPF---------DSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 241
W++GV+++ ++ G PF D ++ D L+ IL + P +S + +++S
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 295
Query: 242 MLQVEPGKRI------KIQDLLGH------NWVKMGPEDNPVSFRP 275
L +P +R+ D+ GH +W M + F+P
Sbjct: 296 FLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 341
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 25/104 (24%), Positives = 47/104 (45%), Gaps = 21/104 (20%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPF---------DSDSIDQLYDKILNGKYTEPPWMS 461
+ YG D W++GV+++ ++ G PF D ++ D L+ IL + P +S
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286
Query: 462 PNSRQIVRSMLQVEPGKRI------KIQDLLGH------NWVKM 493
+ +++S L +P +R+ D+ GH +W M
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 14/51 (27%), Positives = 25/51 (49%), Gaps = 9/51 (17%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPF---------DSDSIDQLYDKILSH 369
+ YG D W++GV+++ ++ G PF D ++ D L+ IL
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-61
Identities = 77/240 (32%), Positives = 123/240 (51%), Gaps = 5/240 (2%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICK 70
+G G F KV L+ T E A+KI+KK + +D+ +E L + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHR 130
L +T ++ V+EY GG+L+ HI + R E + + +I + +L G +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 131 DLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETD 190
DLK +NV+LD ++K+ DFG+C K +T CG+P+Y APE+I + YG D
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMC-KENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVD 524
Query: 191 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 250
W+ GV+LY +L G PF+ + D+L+ I+ P MS + I + ++ PGKR
Sbjct: 525 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 24/69 (34%), Positives = 36/69 (52%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRS 470
Q YG D W+ GV+LY +L G PF+ + D+L+ I+ P MS + I +
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575
Query: 471 MLQVEPGKR 479
++ PGKR
Sbjct: 576 LMTKHPGKR 584
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 17/42 (40%), Positives = 25/42 (59%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
Q YG D W+ GV+LY +L G PF+ + D+L+ I+ H
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-60
Identities = 75/247 (30%), Positives = 122/247 (49%), Gaps = 12/247 (4%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKL 71
R +G GGF +V TG+ A K + K L + +E L + + I L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHI--VERQRLGEKESRAFF--RQILSAVAYLHHLGY 127
ET + + +V+ GG++ HI V+ G +E RA F QI+S + +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGS 187
+RDLKPENVLLD + N+++ D GL +++ + G+P + APE++ G++ Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPELLLGEE-YDF 368
Query: 188 ETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243
D +++GV LY ++ PF + +L ++L T P SP S+ ++L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 244 QVEPGKR 250
Q +P KR
Sbjct: 429 QKDPEKR 435
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 20/73 (27%), Positives = 34/73 (46%), Gaps = 4/73 (5%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQ 466
+ Y D +++GV LY ++ PF + +L ++L T P SP S+
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 467 IVRSMLQVEPGKR 479
++LQ +P KR
Sbjct: 423 FCEALLQKDPEKR 435
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 10/46 (21%), Positives = 20/46 (43%), Gaps = 4/46 (8%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILSH 369
+ Y D +++GV LY ++ PF + +L ++L
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-59
Identities = 73/290 (25%), Positives = 129/290 (44%), Gaps = 23/290 (7%)
Query: 14 RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKL 71
R +G GGF +V TG+ A K ++K + + E L+ ++ + + L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--RQILSAVAYLHHLGYAH 129
ET + +V+ GG+L HI + G E+RA F +I + LH +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSET 189
RDLKPEN+LLD + ++++ D GL ++ G+ Y APEV+K ++ Y
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSP 366
Query: 190 DVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
D W++G +LY ++ G PF +++ + SP +R + +L
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCK 426
Query: 246 EPGKRI-----KIQDLLGH------NWVKMGPEDNPVSFRPD-HELREKD 283
+P +R+ +++ H N+ ++G F+PD + KD
Sbjct: 427 DPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKD 476
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 15/73 (20%), Positives = 30/73 (41%), Gaps = 4/73 (5%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQ 466
+ Y D W++G +LY ++ G PF +++ + SP +R
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS 418
Query: 467 IVRSMLQVEPGKR 479
+ +L +P +R
Sbjct: 419 LCSQLLCKDPAER 431
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 9/46 (19%), Positives = 19/46 (41%), Gaps = 4/46 (8%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILSH 369
+ Y D W++G +LY ++ G PF +++ +
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-58
Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 22/297 (7%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHIS- 64
N + + R +G GGF +V TG+ A+K + K + E L +S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 65 --HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
I + T + +++ GG+L H+ + E + R + +I+ + ++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H+ +RDLKP N+LLD + ++++ D GL + + S G+ Y APEV++
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACD---FSKKKPHASVGTHGYMAPEVLQKG 365
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 239
Y S D +S+G ML+ LL G PF + ++ L P SP R ++
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 240 RSMLQVEPGKRI-----KIQDLLGH------NWVKMGPEDNPVSFRPDHELREKDDD 285
+LQ + +R+ Q++ +W + + P P D
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADA 482
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 22/79 (27%), Positives = 33/79 (41%), Gaps = 6/79 (7%)
Query: 407 AP---SSKQYYGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILNGKYTEPPWM 460
AP Y S D +S+G ML+ LL G PF + ++ L P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417
Query: 461 SPNSRQIVRSMLQVEPGKR 479
SP R ++ +LQ + +R
Sbjct: 418 SPELRSLLEGLLQRDVNRR 436
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 14/47 (29%), Positives = 21/47 (44%), Gaps = 3/47 (6%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILSH 369
Q Y S D +S+G ML+ LL G PF + ++ L+
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-57
Identities = 60/283 (21%), Positives = 105/283 (37%), Gaps = 34/283 (12%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHIS- 64
++ +GSG F V L G AIK KK G D E+ A +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR----LGEKESRAFFRQILSAVA 120
H H+ + F H+ + EYC GG L D I E R E E + Q+ +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNL-------------------KLIDFGLCAKPEGGLE 161
Y+H + H D+KP N+ + R K+ D G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-----I 184
Query: 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 221
S Q G + A EV++ + + D++++ + + + + +I
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---GDQWHEIR 241
Query: 222 NGKYTE-PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
G+ P +S ++++ M+ +P +R L+ H+ +
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 10/80 (12%), Positives = 33/80 (41%), Gaps = 4/80 (5%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSML 472
+ + D++++ + + + + +I G+ P +S ++++ M+
Sbjct: 208 HLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIRQGRLPRIPQVLSQEFTELLKVMI 264
Query: 473 QVEPGKRIKIQDLLGHNWVK 492
+P +R L+ H+ +
Sbjct: 265 HPDPERRPSAMALVKHSVLL 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-51
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 18/223 (8%)
Query: 56 EINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKE---SRAFF 112
+I + S ++ Q ++++ ++ C L D + R L ++E F
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-----------PEGGLE 161
QI AV +LH G HRDLKP N+ + +K+ DFGL
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 221
+ G+ Y +PE I G Y + D++S+G++L+ LL F ++ +
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQ--MERVRIITDVR 287
Query: 222 NGKYTEPPWM-SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
N K+ P +V+ ML P +R + D++ + +
Sbjct: 288 NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 17/84 (20%), Positives = 36/84 (42%), Gaps = 3/84 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM-SPNSRQIV 468
Y + D++S+G++L+ LL F ++ + N K+ P +V
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFSTQ--MERVRIITDVRNLKFPLLFTQKYPQEHMMV 306
Query: 469 RSMLQVEPGKRIKIQDLLGHNWVK 492
+ ML P +R + D++ + +
Sbjct: 307 QDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 17/82 (20%), Positives = 29/82 (35%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
+ + +G GGF V A + + AIK ++ +V E+ AL + H
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 67 HICKLFQVIETSSHIFMVIEYC 88
I + F + E
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMD 86
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 61/259 (23%), Positives = 113/259 (43%), Gaps = 16/259 (6%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLF-- 72
+G G F V T +VA ++ L + R K E LK + H +I + +
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 73 --QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYA-- 128
++ I +V E G L ++ + + K R++ RQIL + +LH
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 129 HRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGS 187
HRDLK +N+ + ++K+ D GL S + G+P + APE+ + K Y
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEEK--YDE 208
Query: 188 ETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPPW--MSPNSRQIVRSMLQ 244
DV++ G+ + + P+ + + Q+Y ++ +G P ++I+ ++
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 245 VEPGKRIKIQDLLGHNWVK 263
+R I+DLL H + +
Sbjct: 269 QNKDERYSIKDLLNHAFFQ 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 16/85 (18%), Positives = 39/85 (45%), Gaps = 3/85 (3%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKYTEPPW--MSPNSRQI 467
++ Y DV++ G+ + + P+ + + Q+Y ++ +G P ++I
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 468 VRSMLQVEPGKRIKIQDLLGHNWVK 492
+ ++ +R I+DLL H + +
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-49
Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 10/265 (3%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI 75
+G G + V + ++AIK + + + EI KH+ H++I +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 76 ETSSHIFMVIEYCPGG---ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDL 132
+ I + +E PGG LL + E+ + +QIL + YLH HRD+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 133 KPENVLLD-RNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY-YGSETD 190
K +NVL++ + LK+ DFG +K G+ +T G+ Y APE+I YG D
Sbjct: 149 KGDNVLINTYSGVLKISDFG-TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 191 VWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKY--TEPPWMSPNSRQIVRSMLQVEP 247
+WS+G + + G PF + K+ K P MS ++ + + +P
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDP 267
Query: 248 GKRIKIQDLLGHNWVKMGPEDNPVS 272
KR DLL ++K+ +
Sbjct: 268 DKRACANDLLVDEFLKVSSKKKKTQ 292
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 24/104 (23%), Positives = 41/104 (39%), Gaps = 7/104 (6%)
Query: 407 AP----SSKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKY--TEPPW 459
AP + YG D+WS+G + + G PF + K+ K P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES 250
Query: 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREK 503
MS ++ + + +P KR DLL ++K+ + + K
Sbjct: 251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 63/271 (23%), Positives = 106/271 (39%), Gaps = 17/271 (6%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
Y + + + VG G F +V TG + A+K ++ + E+ A
Sbjct: 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAG 106
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+S I L+ + + + +E GG L I + L E + + Q L + YL
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 123 HHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEGGLESQLQTSC----GSPNYAAPE 177
H H D+K +NVLL + L DFG + + + G+ + APE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG---KYTEPPWMSP 233
V+ GK ++ D+WS M+ +L G P+ KI + PP +P
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIPPSCAP 284
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
+ Q ++ L+ EP R +L +
Sbjct: 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 5/84 (5%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG---KYTEPPWMSPNSRQIVR 469
++ D+WS M+ +L G P+ KI + PP +P + Q ++
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKM 493
L+ EP R +L +
Sbjct: 292 EGLRKEPVHRASAMELRRKVGKAL 315
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-46
Identities = 73/264 (27%), Positives = 130/264 (49%), Gaps = 7/264 (2%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D R +G G V LA +G +VA+K+M + + E+ ++
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQ 100
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
H ++ ++++ +++++E+ GG L D IV + RL E++ +L A+AYLH
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
G HRD+K +++LL + +KL DFG CA+ + + ++ G+P + APEVI
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSL- 217
Query: 185 YGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRS 241
Y +E D+WS+G+M+ ++ G P F + + + K +SP R +
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 242 MLQVEPGKRIKIQDLLGHNWVKMG 265
ML +P +R Q+LL H ++
Sbjct: 278 MLVRDPQERATAQELLDHPFLLQT 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 3/96 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPWMSPNSRQ 466
S+ Y +E D+WS+G+M+ ++ G P F + + + K +SP R
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLRE 502
+ ML +P +R Q+LL H ++ L
Sbjct: 274 FLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 7/264 (2%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D + +Y +G G V A V TG++VAI+ M + EI ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENK 75
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ +I +++V+EY GG L D +V + E + A R+ L A+ +LH
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
HRD+K +N+LL + ++KL DFG CA+ S+ T G+P + APEV+ K
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKA- 192
Query: 185 YGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRS 241
YG + D+WS+G+M ++ G P + + + LY NG + P +S R +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 242 MLQVEPGKRIKIQDLLGHNWVKMG 265
L+++ KR ++LL H ++K+
Sbjct: 253 CLEMDVEKRGSAKELLQHQFLKIA 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 24/96 (25%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPWMSPNSRQ 466
+++ YG + D+WS+G+M ++ G P + + + LY NG + P +S R
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLRE 502
+ L+++ KR ++LL H ++K+ + L
Sbjct: 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 18/275 (6%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D + +G G F +V T + VAIKI+ +++ ++ EI L
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
++ K + + +++++EY GG LD ++E L E + R+IL + YLH
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHS 137
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
HRD+K NVLL + +KL DFG+ + + T G+P + APEVIK
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSA- 195
Query: 185 YGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKI-------LNGKYTEPPWMSPNSR 236
Y S+ D+WS+G+ L G P + + L+ I L G Y S +
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNY------SKPLK 248
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPV 271
+ V + L EP R ++LL H ++ +
Sbjct: 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-45
Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 26/253 (10%)
Query: 6 LRNQYILERTVGSGGFAKVKLAT-HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+ QY ++ + GG + LA + G V +K + + E E L +
Sbjct: 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV 137
Query: 65 HQHICKLFQVIETSSHI-----FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
H I ++F +E + ++V+EY G L Q+L E+ A+ +IL A+
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPAL 195
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS--CGSPNYAAPE 177
+YLH +G + DLKPEN++L Q LKLID G G+P + APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGA-VSRIN------SFGYLYGTPGFQAPE 247
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQ 237
+++ TD++++G L AL + +D L + + +
Sbjct: 248 IVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------DPVLKTYDSYGR 299
Query: 238 IVRSMLQVEPGKR 250
++R + +P +R
Sbjct: 300 LLRRAIDPDPRQR 312
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 11/62 (17%), Positives = 25/62 (40%), Gaps = 6/62 (9%)
Query: 418 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477
TD++++G L AL + +D L + + +++R + +P
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNGRYVDGLPED------DPVLKTYDSYGRLLRRAIDPDPR 310
Query: 478 KR 479
+R
Sbjct: 311 QR 312
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 8/28 (28%), Positives = 14/28 (50%)
Query: 335 TDVWSMGVMLYALLCGFLPFDSDSIDQL 362
TD++++G L AL + +D L
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNGRYVDGL 284
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 14/255 (5%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED---LPRVKLEINALKH 62
+ +Y + +G GG + V LA + KVAIK + E L R + E++
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQ 67
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+SHQ+I + V E ++V+EY G L ++I L + F QIL + +
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC--GSPNYAAPEVIK 180
H + HRD+KP+N+L+D N+ LK+ DFG+ AK S QT+ G+ Y +PE K
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGI-AKALSE-TSLTQTNHVLGTVQYFSPEQAK 185
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-----IDQLYDKILNGKYTEPPWMSPNS 235
G+ TD++S+G++LY +L G PF+ ++ I + D + N + +
Sbjct: 186 GE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244
Query: 236 RQIVRSMLQVEPGKR 250
++ + + R
Sbjct: 245 SNVILRATEKDKANR 259
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 14/67 (20%), Positives = 31/67 (46%), Gaps = 5/67 (7%)
Query: 418 TDVWSMGVMLYALLCGFLPFDSDS-----IDQLYDKILNGKYTEPPWMSPNSRQIVRSML 472
TD++S+G++LY +L G PF+ ++ I + D + N + + ++
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRAT 252
Query: 473 QVEPGKR 479
+ + R
Sbjct: 253 EKDKANR 259
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-45
Identities = 75/300 (25%), Positives = 132/300 (44%), Gaps = 17/300 (5%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+ + +G G + V A H TG+ VAIK + + DL + EI+ ++
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCD 82
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLH 123
H+ K + ++ +++V+EYC G + D I R + L E E + L + YLH
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
+ HRD+K N+LL+ + KL DFG+ + + ++ T G+P + APEVI+
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIG 201
Query: 184 YYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVR 240
Y D+WS+G+ + G P D + ++ N + +P S N V+
Sbjct: 202 -YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDD 300
L P +R LL H +V+ + LR+ ++ + V ++ +
Sbjct: 261 QCLVKSPEQRATATQLLQHPFVRSA--------KGVSILRDLINEAMDVKLKRQESQQRE 312
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 23/115 (20%), Positives = 45/115 (39%), Gaps = 3/115 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPWMSPNSRQ 466
+ Y D+WS+G+ + G P D + ++ N + +P S N
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPDD 521
V+ L P +R LL H +V+ + LR+ ++ + V ++ +
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQRE 312
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 78/315 (24%), Positives = 129/315 (40%), Gaps = 61/315 (19%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
+Y +G G + V + TG+ VAIK ++ + ++ L EI LK + H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHL 125
++ L +V + +V EYC +L + QR + E ++ Q L AV + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----------YA 174
HRD+KPEN+L+ ++ +KL DFG A+ P+ Y
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGF-AR-----------LLTGPSDYYDDEVATRWYR 169
Query: 175 APEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GKYTE--- 227
+PE++ G YG DVW++G + LL G P SD +DQLY I G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-VDQLY-LIRKTLGDLIPRHQ 227
Query: 228 --------------PPW------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261
P +S + +++ L ++P +R+ + LL H +
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
Query: 262 VKMGPEDNPVSFRPD 276
+ E ++ D
Sbjct: 288 FENIREIEDLAKEHD 302
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 26/112 (23%), Positives = 41/112 (36%), Gaps = 35/112 (31%)
Query: 412 QYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GKYTE----------- 456
YG DVW++G + LL G P SD +DQLY I G
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-VDQLY-LIRKTLGDLIPRHQQVFSTNQY 235
Query: 457 ------PPW------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 490
P +S + +++ L ++P +R+ + LL H +
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-44
Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 10/276 (3%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D + + +G G F KV A + TG A K+++ + E+L +EI L
Sbjct: 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCD 74
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLH 123
H +I KL ++++IE+CPGG + ++E R L E + + RQ+L A+ +LH
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRDLK NVL+ +++L DFG+ AK L + + G+P + APEV+ +
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCET 193
Query: 184 Y----YGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPWMSPNSR 236
Y + D+WS+G+ L + P + + + L + P S R
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVS 272
++ L P R LL H +V + +
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 22/103 (21%), Positives = 36/103 (34%), Gaps = 3/103 (2%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KYTEPPW 459
V+ Y + D+WS+G+ L + P + + + L + P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247
Query: 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLRE 502
S R ++ L P R LL H +V + LRE
Sbjct: 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 22/285 (7%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
+ + R+ Y L+ +GSG A V+ A EKVAIK + + + EI A+
Sbjct: 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAF--------F 112
H +I + +++V++ GG +LD I GE +S
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ----TSC 168
R++L + YLH G HRD+K N+LL + ++++ DFG+ A G + T
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG---- 223
G+P + APEV++ + Y + D+WS G+ L G P+ + L + N
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 224 -----KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+ R+++ LQ +P KR +LL H + +
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 12/249 (4%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED---LPRVKLEINALKHISHQ 66
Y L R VG GG V A + VA+K+M TL D R++ E +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
H+ + E +++ + G +L + + L + A RQI SA+ H G
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLC-AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
HRD+KPEN+L+ + L+DFG+ A + L +QL + G+ Y APE
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESH-A 212
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRS 241
D++++ +LY L G P+ D + + +N P P + ++
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIPRPSTVRPGIPVAFDAVIAR 271
Query: 242 MLQVEPGKR 250
+ P R
Sbjct: 272 GMAKNPEDR 280
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 76/322 (23%), Positives = 133/322 (41%), Gaps = 67/322 (20%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
+Y VG G + V + TG VAIK ++ + + ++ + EI LK + H+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 67 HICKLFQVIETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
++ L +V + ++V E+ + L+ L + + + QI++ + + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----------Y 173
HRD+KPEN+L+ ++ +KL DFG A+ + +P Y
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGF-AR-----------TLAAPGEVYDDEVATRWY 190
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GKYTE-- 227
APE++ G YG DVW++G ++ + G P DSD IDQLY I+ G
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLY-HIMMCLGNLIPRH 248
Query: 228 ---------------PPW------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHN 260
P +S + + L ++P KR +LL H+
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308
Query: 261 WVKMGPEDNPVSFRPDHELREK 282
+ + + + R EL+ K
Sbjct: 309 FFQ----MDGFAERFSQELQLK 326
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 35/117 (29%)
Query: 412 QYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GKYTE----------- 456
YG DVW++G ++ + G P DSD IDQLY I+ G
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLY-HIMMCLGNLIPRHQELFNKNPV 257
Query: 457 ------PPW------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495
P +S + + L ++P KR +LL H++ +M
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 63/256 (24%), Positives = 118/256 (46%), Gaps = 15/256 (5%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKH 62
I + I E+ +G+G F V A G VA+KI+ + + + E+ +K
Sbjct: 34 IPWCDLNIKEK-IGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 90
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI---VERQRLGEKESRAFFRQILSAV 119
+ H +I + ++ +V EY G L + R++L E+ + + +
Sbjct: 91 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 120 AYLHHLGYA--HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
YLH+ HR+LK N+L+D+ +K+ DFGL ++ + +++ G+P + APE
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL-SRLKASTFLSSKSAAGTPEWMAPE 209
Query: 178 VIKGKQYYGSE-TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPPWMSPN 234
V++ + +E +DV+S GV+L+ L P+ + + Q+ + P ++P
Sbjct: 210 VLRDEPS--NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 235 SRQIVRSMLQVEPGKR 250
I+ EP KR
Sbjct: 268 VAAIIEGCWTNEPWKR 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 16/258 (6%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKH 62
I Q + + +GSG F V G+ VA+K++ L K E+ L+
Sbjct: 21 IP-DGQITVGQRIGSGSFGTVYKGK--WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRK 76
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAY 121
H +I T+ + +V ++C G L H+ + K+ RQ + Y
Sbjct: 77 TRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGL-CAKPEGGLESQLQTSCGSPNYAAPEVIK 180
LH HRDLK N+ L + +K+ DFGL K Q + GS + APEVI+
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 181 GKQY--YGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGK-----YTEPPWMS 232
+ Y ++DV++ G++LY L+ G LP+ + ++ DQ+ + + G
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 233 PNSRQIVRSMLQVEPGKR 250
++++ L+ + +R
Sbjct: 256 KRMKRLMAECLKKKRDER 273
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 83/308 (26%), Positives = 138/308 (44%), Gaps = 35/308 (11%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D + L VG+G + +V HV TG+ AIK+M G++ +K EIN LK S
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYS 78
Query: 65 -HQHICKLF------QVIETSSHIFMVIEYCPGGELLD--HIVERQRLGEKESRAFFRQI 115
H++I + +++V+E+C G + D + L E+ R+I
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 116 LSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
L +++LH HRD+K +NVLL N +KL+DFG+ A+ + + + T G+P + A
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMA 197
Query: 176 PEVIKGKQY----YGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPP- 229
PEVI + Y ++D+WS+G+ + G P D + L+ I P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPR---NPAPR 253
Query: 230 -----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSF-------RPDH 277
W S + + S L +R + L+ H +++ P + V R
Sbjct: 254 LKSKKW-SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKK 312
Query: 278 ELREKDDD 285
+ EKD+
Sbjct: 313 KRGEKDET 320
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 23/121 (19%), Positives = 45/121 (37%), Gaps = 12/121 (9%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYTEPP--- 458
V+ + Y ++D+WS+G+ + G P D + L+ I P
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPR---NPAPRLK 255
Query: 459 ---WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHK 515
W S + + S L +R + L+ H +++ P + +R + D I +
Sbjct: 256 SKKW-SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKR 314
Query: 516 Q 516
Sbjct: 315 G 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-41
Identities = 76/307 (24%), Positives = 129/307 (42%), Gaps = 28/307 (9%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
ID + +E VG G F V A + VAIK ++ + + E+ L +
Sbjct: 5 IDY-KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIV---ELRQLSRV 58
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFR---QILSAVA 120
+H +I KL+ + + +V+EY GG L + + + L + Q VA
Sbjct: 59 NHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 121 YLHHLGYA---HRDLKPENVLLDRNQN-LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
YLH + HRDLKP N+LL LK+ DFG +++ + + GS + AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAP 172
Query: 177 EVIKGKQYYGSE-TDVWSMGVMLYALLCGFLPFD--SDSIDQLYDKILNGKY-TEPPWMS 232
EV +G Y SE DV+S G++L+ ++ PFD ++ + NG +
Sbjct: 173 EVFEGSNY--SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 233 PNSRQIVRSMLQVEPGKR---IKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKV 289
++ +P +R +I ++ H D P+ + H L +D ++
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEP 290
Query: 290 MADHKQL 296
D +
Sbjct: 291 YVDFAEF 297
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 76/267 (28%), Positives = 108/267 (40%), Gaps = 11/267 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMK--KATLGEDLPRVKLEINALKH 62
D + R +G G F V A V E VAIK M E + E+ L+
Sbjct: 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+ H + + ++V+EYC G V ++ L E E A L +AYL
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H HRD+K N+LL +KL DFG + + + G+P + APEVI
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFVGTPYWMAPEVILAM 225
Query: 183 Q--YYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYT-EPPWMSPNSRQI 238
Y + DVWS+G+ L P F+ +++ LY N + S R
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285
Query: 239 VRSMLQVEPGKRIKIQDLLGHNWVKMG 265
V S LQ P R + LL H +V
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRE 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 26/118 (22%), Positives = 41/118 (34%), Gaps = 2/118 (1%)
Query: 407 APSSKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYT-EPPWMSPNS 464
+ Y + DVWS+G+ L P F+ +++ LY N + S
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282
Query: 465 RQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPDDM 522
R V S LQ P R + LL H +V + + + + L M
Sbjct: 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKM 340
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 17/259 (6%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED---LPRVKLEINALKH 62
L ++Y L +G GG ++V LA + VA+K+++ A L D R + E
Sbjct: 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAA 68
Query: 63 ISHQHICKLFQVIET----SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSA 118
++H I ++ E ++V+EY G L D + + K + A
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL-QTSC--GSPNYAA 175
+ + H G HRD+KP N+++ +K++DFG+ A+ + + QT+ G+ Y +
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWM 231
PE +G + +DV+S+G +LY +L G PF DS + + + P +
Sbjct: 188 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 232 SPNSRQIVRSMLQVEPGKR 250
S + +V L P R
Sbjct: 247 SADLDAVVLKALAKNPENR 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 18/66 (27%), Positives = 29/66 (43%), Gaps = 4/66 (6%)
Query: 418 TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSMLQ 473
+DV+S+G +LY +L G PF DS + + + P +S + +V L
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALA 259
Query: 474 VEPGKR 479
P R
Sbjct: 260 KNPENR 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 70/270 (25%), Positives = 114/270 (42%), Gaps = 18/270 (6%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL-KHISHQ 66
N +GSG +V TG +A+K M+++ E+ R+ ++++ + K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-L 125
+I + F T++ +F+ +E + + E+ I+ A+ YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ--TSCGSPNYAAPEVIK--- 180
G HRD+KP N+LLD +KL DFG+ + L S G Y APE I
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGR----LVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 181 -GKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILNG---KYTEPPWMSPN 234
K Y DVWS+G+ L L G P+ + + L K+L S +
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-TKVLQEEPPLLPGHMGFSGD 259
Query: 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
+ V+ L + KR K LL H+++K
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 6/96 (6%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILNG---KYTEP 457
+ +K Y DVWS+G+ L L G P+ + + L K+L
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-TKVLQEEPPLLPGH 253
Query: 458 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493
S + + V+ L + KR K LL H+++K
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 62/263 (23%), Positives = 107/263 (40%), Gaps = 21/263 (7%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-LPRVKLEINALKH 62
I Q + +G G F +V GE VAI+++ ED L K E+ A +
Sbjct: 30 IP-FEQLEIGELIGKGRFGQVYHGRW--HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQ 85
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAY 121
H+++ + H+ ++ C G L + + L ++R ++I+ + Y
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGL----CAKPEGGLESQLQTSCGSPNYAAPE 177
LH G H+DLK +NV D N + + DFGL G E +L+ G + APE
Sbjct: 146 LHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 178 VIKG--------KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP 229
+I+ K + +DV+++G + Y L PF + + + ++ G
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264
Query: 230 --WMSPNSRQIVRSMLQVEPGKR 250
M I+ E +R
Sbjct: 265 QIGMGKEISDILLFCWAFEQEER 287
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 52/274 (18%), Positives = 109/274 (39%), Gaps = 25/274 (9%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQ 66
+ +G G + V+ HV +G+ +A+K ++ ++ R+ ++++
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 67 HICKLFQVIETSSHIFMVIEYCPGG--ELLDHIVERQ-RLGEKESRAFFRQILSAVAYLH 123
+ + +++ +E + ++++ + E I+ A+ +LH
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 124 H-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ--TSCGSPNYAAPEVIK 180
L HRD+KP NVL++ +K+ DFG+ L + G Y APE I
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY----LVDDVAKDIDAGCKPYMAPERIN 182
Query: 181 GKQY---YGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILNGKYTEPPWM---- 231
+ Y ++D+WS+G+ + L P+DS QL +++ P +
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-KQVVEE---PSPQLPADK 238
Query: 232 -SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
S L+ +R +L+ H + +
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 11/87 (12%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILNGKYTEPPWM-----SPNSRQ 466
Y ++D+WS+G+ + L P+DS QL +++ P + S
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-KQVVEE---PSPQLPADKFSAEFVD 245
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKM 493
L+ +R +L+ H + +
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 88/306 (28%), Positives = 119/306 (38%), Gaps = 63/306 (20%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED---LPRVKL-EINALKHI 63
+Y +G G FA V A T + VAIK +K E + R L EI L+ +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAY 121
SH +I L S+I +V ++ ++ L +A+ L + Y
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEY 127
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN--------- 172
LH HRDLKP N+LLD N LKL DFGL AK S GSPN
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGL-AK-----------SFGSPNRAYTHQVVT 175
Query: 173 --YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKI-------- 220
Y APE++ G + YG D+W++G +L LL FLP DSD +DQL +I
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQL-TRIFETLGTPT 233
Query: 221 ---------LNGKYTEPPWMSPNSRQIV-----------RSMLQVEPGKRIKIQDLLGHN 260
L T + I + + P RI L
Sbjct: 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
Query: 261 WVKMGP 266
+ P
Sbjct: 294 YFSNRP 299
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 26/114 (22%), Positives = 37/114 (32%), Gaps = 32/114 (28%)
Query: 412 QYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKI-----------------LNG 452
+ YG D+W++G +L LL FLP DSD +DQL +I L
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQL-TRIFETLGTPTEEQWPDMCSLPD 245
Query: 453 KYTEPPWMSPNSRQIV-----------RSMLQVEPGKRIKIQDLLGHNWVKMGP 495
T + I + + P RI L + P
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 50/258 (19%), Positives = 101/258 (39%), Gaps = 20/258 (7%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPR-VKLEINALKH 62
ID Q + ++ G + +K++K R E L+
Sbjct: 7 IDF-KQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63
Query: 63 ISHQHICKLFQVIET--SSHIFMVIEYCPGGELLDHIVERQRLGEKESRA--FFRQILSA 118
SH ++ + ++ + H ++ + P G L + + E +S+A F +
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 119 VAYLHHLGYA--HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
+A+LH L L +V++D + ++ + Q +P + AP
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV------KFSFQSPGRMYAPAWVAP 177
Query: 177 EVIKGKQY--YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPPWMS 232
E ++ K D+WS V+L+ L+ +PF S ++ K+ T PP +S
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 233 PNSRQIVRSMLQVEPGKR 250
P+ ++++ + +P KR
Sbjct: 238 PHVSKLMKICMNEDPAKR 255
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 21/262 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISH 65
+ I +G G F + TH TGE + +K + + E+ R L E+ ++ + H
Sbjct: 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEH 66
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHH 124
++ K V+ + + EY GG L I + + +F + I S +AYLH
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGL-------------CAKPEGGLESQLQTSCGSP 171
+ HRDL N L+ N+N+ + DFGL + + T G+P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKY--TEP 228
+ APE+I G+ Y + DV+S G++L ++ D + + G P
Sbjct: 187 YWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 229 PWMSPNSRQIVRSMLQVEPGKR 250
P P+ I ++P KR
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKR 267
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 76/300 (25%), Positives = 126/300 (42%), Gaps = 62/300 (20%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
+Y +G G + V A + T E VA+K ++ E +P L EI LK + H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 67 HICKLFQVIETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+I +L V+ + + +V E+C + D L + ++F Q+L + + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----------Y 173
HRDLKP+N+L++RN LKL +FGL A+ + G P Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGL-AR-----------AFGIPVRCYSAEVVTLWY 167
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCG---FLPFDSDSIDQLYDKILN--GKYTE- 227
P+V+ G + Y + D+WS G + L P + DQL +I G TE
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQL-KRIFRLLGTPTEE 225
Query: 228 --------------PPWMSPNS-RQIV-----------RSMLQVEPGKRIKIQDLLGHNW 261
P + + S +V +++L+ P +RI ++ L H +
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 65/280 (23%), Positives = 116/280 (41%), Gaps = 33/280 (11%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQ 66
+G G + V H +G+ +A+K ++ ++ ++ ++++ + S
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVER------QRLGEKESRAFFRQILSAVA 120
+I + + + ++ +E D + + E+ + A+
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 121 YLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSC------GSPNY 173
+L L HRD+KP N+LLDR+ N+KL DFG+ QL S G Y
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG--------QLVDSIAKTRDAGCRPY 191
Query: 174 AAPEVIKGKQY---YGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG-----K 224
APE I Y +DVWS+G+ LY L G P+ +S+ +++ G
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251
Query: 225 YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
+E SP+ V L + KR K ++LL H ++ M
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNG-----KYTEPPWMSP 462
+S+Q Y +DVWS+G+ LY L G P+ +S+ +++ G +E SP
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260
Query: 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493
+ V L + KR K ++LL H ++ M
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 63/300 (21%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
+Y VG G + V A G VA+K ++ E +P + EI+ LK + H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 67 HICKLFQVIETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+I L VI + + +V E+ ++LD + L + + + + Q+L VA+ H
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----------Y 173
HRDLKP+N+L++ + LKL DFGL A+ + G P Y
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGL-AR-----------AFGIPVRSYTHEVVTLWY 185
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--------- 222
AP+V+ G + Y + D+WS+G + ++ G P +D DQL KI +
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-DDQL-PKIFSILGTPNPRE 243
Query: 223 ----------GKYTEPPWMSPNSRQIV-----------RSMLQVEPGKRIKIQDLLGHNW 261
+ T + I+ +ML +P KRI +D + H +
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 57/302 (18%), Positives = 112/302 (37%), Gaps = 49/302 (16%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+ + +G+G V +H +G +A K++ ++ E+ L + +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LG 126
I + + I + +E+ GG L + + R+ E+ ++ + YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRD+KP N+L++ +KL DFG+ + +S + G+ +Y +PE ++G +Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG-THYS 208
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP------------------ 228
++D+WSMG+ L + G P +L +
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 229 ----PWM----------------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262
P M S + V L P +R ++ L+ H ++
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
Query: 263 KM 264
K
Sbjct: 329 KR 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-39
Identities = 91/350 (26%), Positives = 140/350 (40%), Gaps = 78/350 (22%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKL-EINALKHISHQ 66
Y + +G+G F V A +GE VAIK +++ R K E+ ++ + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 107
Query: 67 HICKLFQVIETSS------HIFMVIEYCPG---GELLDHIVERQRLGEKESRAFFRQILS 117
+I +L +S ++ +V++Y P + +Q L + + Q+
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEGGLESQLQTSCGSPN---- 172
++AY+H G HRD+KP+N+LLD + LKL DFG AK Q G PN
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS-AK---------QLVRGEPNVSYI 217
Query: 173 ----YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYD--KIL--- 221
Y APE+I G Y S DVWS G +L LL G P DS +DQL + K+L
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTP 276
Query: 222 --------NGKYTE--------PPW-------MSPNSRQIVRSMLQVEPGKRIKIQDLLG 258
N YTE PW P + + +L+ P R+ +
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336
Query: 259 HNWVKM--GPEDNPVSFRP--------DHELREKDDDVIKVMADHKQLSP 298
H++ P + R EL ++ H ++
Sbjct: 337 HSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQA 386
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 62/299 (20%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
+Y +G G + V A + GE A+K ++ E +P + EI+ LK + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 67 HICKLFQVIETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+I KL+ VI T + +V E+ +LLD L +++F Q+L+ +AY H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----------Y 173
HRDLKP+N+L++R LK+ DFGL A+ + G P Y
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGL-AR-----------AFGIPVRKYTHEIVTLWY 166
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKIL---------- 221
AP+V+ G + Y + D+WS+G + ++ G P S+ DQL +I
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQL-MRIFRILGTPNSKN 224
Query: 222 --------NGKYTEPPWMSPNSRQIV-----------RSMLQVEPGKRIKIQDLLGHNW 261
+ + ML+++P +RI + L H +
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 74/328 (22%), Positives = 120/328 (36%), Gaps = 68/328 (20%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
YI +G G +A V LT VA+K ++ E P + E++ LK + H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHA 60
Query: 67 HICKLFQVIETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+I L +I T + +V EY + LD + + F Q+L +AY H
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN-----------Y 173
HRDLKP+N+L++ LKL DFGL A+ + P Y
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGL-AR-----------AKSIPTKTYDNEVVTLWY 166
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--------- 222
P+++ G Y ++ D+W +G + Y + G P + +QL I
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQL-HFIFRILGTPTEET 224
Query: 223 ----------GKYTEPPWMSPNSRQIV-----------RSMLQVEPGKRIKIQDLLGHNW 261
Y P + + +LQ E RI +D + H +
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 262 VKMGPED-----NPVSFRPDHELREKDD 284
E + S E++ + +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKE 312
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 70/264 (26%), Positives = 116/264 (43%), Gaps = 26/264 (9%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKAT---LGEDLPRVKLEINAL 60
ID + LE +G GGF KV A G++VA+K + + + + V+ E
Sbjct: 4 ID-FAELTLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
+ H +I L V ++ +V+E+ GG L + +R+ + QI +
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMN 119
Query: 121 YLHHLGYA---HRDLKPENVLLDR--------NQNLKLIDFGLCAKPEGGLESQLQTSCG 169
YLH HRDLK N+L+ + N+ LK+ DFGL A+ + ++ G
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL-AREWH--RTTKMSAAG 176
Query: 170 SPNYAAPEVIKGKQYYGSE-TDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--T 226
+ + APEVI+ + S+ +DVWS GV+L+ LL G +PF + + K
Sbjct: 177 AYAWMAPEVIRASMF--SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234
Query: 227 EPPWMSPNSRQIVRSMLQVEPGKR 250
P +++ +P R
Sbjct: 235 IPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 73/305 (23%), Positives = 130/305 (42%), Gaps = 68/305 (22%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
++Y +G G + +V A +T E VAIK ++ E +P + E++ LK + H+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 67 HICKLFQVIETSSHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+I +L VI + + ++ EY + +D + + ++F Q+++ V + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAENDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 125 LGYAHRDLKPENVLLDRNQ-----NLKLIDFGLCAKPEGGLESQLQTSCGSPN------- 172
HRDLKP+N+LL + LK+ DFGL A+ + G P
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL-AR-----------AFGIPIRQFTHEI 198
Query: 173 ----YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--GK 224
Y PE++ G ++Y + D+WS+ + +L P DS+ IDQL KI G
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQL-FKIFEVLGL 256
Query: 225 YTE----------------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDL 256
+ + ++ +ML+++P KRI ++
Sbjct: 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316
Query: 257 LGHNW 261
L H +
Sbjct: 317 LEHPY 321
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 76/326 (23%), Positives = 129/326 (39%), Gaps = 72/326 (22%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKL-EINALKHIS 64
+Q+ +G+G +A V + TG VA+K +K L + P + EI+ +K +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELK 61
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPG--GELLDHIVERQR---LGEKESRAFFRQILSAV 119
H++I +L+ VI T + + +V E+ + +D L + F Q+L +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN------- 172
A+ H HRDLKP+N+L+++ LKL DFGL A+ + G P
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGL-AR-----------AFGIPVNTFSSEV 169
Query: 173 ----YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKIL----- 221
Y AP+V+ G + Y + D+WS G +L ++ G P +D +QL I
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQL-KLIFDIMGT 227
Query: 222 -------------NGKYTEPPWMSPNSRQIVR----------------SMLQVEPGKRIK 252
+ RQ+++ +LQ+ P R+
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
Query: 253 IQDLLGHNWVKMGPEDNPVSFRPDHE 278
+ L H W + H
Sbjct: 288 AKQALHHPWFAEYYHHASMGGSRSHH 313
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 57/258 (22%), Positives = 105/258 (40%), Gaps = 25/258 (9%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL------EINALKHISH 65
E+ +G GGF V V VAIK + + ++ E+ + +++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHH 124
+I KL+ + + MV+E+ P G+L ++++ + I + Y+ +
Sbjct: 83 PNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 125 LGYA--HRDLKPENVLLD-----RNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
HRDL+ N+ L K+ DFGL ++ + G+ + APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-SQQS---VHSVSGLLGNFQWMAPE 196
Query: 178 VIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE----PPWMS 232
I + + Y + D +S ++LY +L G PFD S ++ + + P
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 233 PNSRQIVRSMLQVEPGKR 250
P R ++ +P KR
Sbjct: 257 PRLRNVIELCWSGDPKKR 274
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 68/368 (18%), Positives = 126/368 (34%), Gaps = 68/368 (18%)
Query: 3 YIDLRNQYILERTVGSG--GFAKVKLATHVLTGEKVAIKIMK-KATLGEDLPRVKLEINA 59
++ Y L +G G V LA + TGE V ++ + +A E + ++ E++
Sbjct: 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILS 117
K +H +I + +++V + G D I + E + +L
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG------LESQLQTSCGSP 171
A+ Y+HH+GY HR +K ++L+ + + L + + S
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 172 NYAAPEVIK-GKQYYGSETDVWSMGVMLYALLCGFLPF---------------------- 208
+ +PEV++ Q Y +++D++S+G+ L G +PF
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 209 ---------------------DSDSIDQLYDKILNGKYTEPPWM---SPNSRQIVRSMLQ 244
SDS+ + NG P+ SP+ V LQ
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 245 VEPGKRIKIQDLLGHNWVKMGPEDNPVSFRP----------DHELREKDDDVIKVMADHK 294
P R LL H++ K + + +D I + +
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNL 379
Query: 295 QLSPDDMW 302
+ D W
Sbjct: 380 EELEVDDW 387
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 82/301 (27%), Positives = 130/301 (43%), Gaps = 67/301 (22%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQ 66
Y + +G+G F V A V + E VAIK + + D R K E+ ++ + H
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ-----D-KRFKNRELQIMRIVKHP 92
Query: 67 HICKLFQVIETSSH------IFMVIEYCPG--GELLDHIVE-RQRLGEKESRAFFRQILS 117
++ L ++ + +V+EY P H + +Q + + + Q+L
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPEGGLESQLQTSCGSPN---- 172
++AY+H +G HRD+KP+N+LLD LKLIDFG AK G PN
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS-AK---------ILIAGEPNVSYI 202
Query: 173 ----YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYD--KIL--- 221
Y APE+I G Y + D+WS G ++ L+ G P +S IDQL + K+L
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES-GIDQLVEIIKVLGTP 261
Query: 222 --------NGKYTEP--------PW-------MSPNSRQIVRSMLQVEPGKRIKIQDLLG 258
N Y E P+ P++ ++ +L+ P R+ + L
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 259 H 259
H
Sbjct: 322 H 322
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 73/296 (24%), Positives = 129/296 (43%), Gaps = 55/296 (18%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQ 66
+ Y L R +G G +++V A ++ EKV +KI+K ++K EI L+++
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGP 91
Query: 67 HICKLFQVI--ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+I L ++ S +V E+ + Q L + + R + +IL A+ Y H
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS 148
Query: 125 LGYAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEGGLESQLQT-SCGSPNYAAPEVIKGK 182
+G HRD+KP NV++D ++ L+LID+GL E Q S + PE++
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGL---AEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPF--DSDSIDQL------------------------ 216
Q Y D+WS+G ML +++ PF D+ DQL
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 217 --YDKILNGKYTEPPWMS--PNSRQIVRS---------MLQVEPGKRIKIQDLLGH 259
++ IL G+++ W + Q + S +L+ + R+ ++ + H
Sbjct: 266 PRFNDIL-GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 35/255 (13%), Positives = 65/255 (25%), Gaps = 42/255 (16%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED---LPRVKLEINALKH 62
+Y L G + A +VA+ + L L
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD-PQGVLPDDVLQETLSRTLRLSR 87
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
I + ++ V+ T + +V E+ GG L + + + + +A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAA 145
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H G A P V + + ++ L
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA----- 179
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP-------PWMSPNS 235
+ D+ +G LYALL P + +P +
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 236 RQIVRSMLQVEPGKR 250
+ +Q + G R
Sbjct: 237 SAVAARSVQGDGGIR 251
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 12/72 (16%), Positives = 21/72 (29%), Gaps = 7/72 (9%)
Query: 415 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP-------PWMSPNSRQI 467
+ D+ +G LYALL P + +P + +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 468 VRSMLQVEPGKR 479
+Q + G R
Sbjct: 240 AARSVQGDGGIR 251
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 8/30 (26%), Positives = 12/30 (40%)
Query: 332 GSETDVWSMGVMLYALLCGFLPFDSDSIDQ 361
+ D+ +G LYALL P +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 79/329 (24%), Positives = 140/329 (42%), Gaps = 50/329 (15%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHI 63
++R Y + VGSG + V A TG KVAIK + + R E+ LKH+
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 64 SHQHICKLFQVI------ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
H+++ L V + + ++V+ + G L +++ ++LGE + Q+L
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLK 139
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+ Y+H G HRDLKP N+ ++ + LK++DFGL + + + + T Y APE
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----YRAPE 195
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN--GKYTEPPWM--- 231
VI Y D+WS+G ++ ++ G F SD +DQL +I+ G
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKVTGTPPAEFVQRLQ 254
Query: 232 SPNSRQIVRS--------------------------MLQVEPGKRIKIQDLLGHNWVKM- 264
S ++ ++ ML ++ +R+ + L H + +
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 265 -GPEDNPVS--FRPDHELREKDDDVIKVM 290
ED P + + ++ D K +
Sbjct: 315 HDTEDEPQVQKYDDSFDDVDRTLDEWKRV 343
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 77/328 (23%), Positives = 129/328 (39%), Gaps = 58/328 (17%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQHI 68
Y+ VGSG + V A +GEKVAIK + + R E+ LKH+ H+++
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 69 CKLFQVI------ETSSHIFMVIEYCPGGELLD---HIVERQRLGEKESRAFFRQILSAV 119
L V ++V+ + + + E++ + Q+L +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMP------FMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
Y+H G HRDLKP N+ ++ + LK++DFGL + + + T Y APEVI
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----YRAPEVI 195
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN--GKYTEPPWM---SP 233
+Y D+WS+G ++ +L G F D +DQL +IL G
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVTGVPGTEFVQKLNDK 254
Query: 234 NSRQIVRS--------------------------MLQVEPGKRIKIQDLLGHNWVKM--G 265
++ ++S ML+++ KR+ L H + +
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 266 PEDNPVS---FRPDHELREKDDDVIKVM 290
PE+ + F E + D K
Sbjct: 315 PEEETEAQQPFDDSLEHEKLTVDEWKQH 342
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 70/299 (23%), Positives = 109/299 (36%), Gaps = 69/299 (23%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL----EINALKHIS---HQHI 68
+G G + V A +G VA+K ++ G + + E+ L+ + H ++
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 69 CKLFQVIETSSH-----IFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAVAY 121
+L V TS + +V E+ LD L + + RQ L + +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDF 135
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN--------- 172
LH HRDLKPEN+L+ +KL DFGL A+
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGL-AR-----------IYSYQMALTPVVVTL 183
Query: 173 -YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--G---- 223
Y APEV+ Y + D+WS+G + + +S+ DQL KI + G
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQL-GKIFDLIGLPPE 240
Query: 224 ----------KYTEPPWMSPNSRQIVR-----------SMLQVEPGKRIKIQDLLGHNW 261
+ PP + +V ML P KRI L H++
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 8e-04
Identities = 23/106 (21%), Positives = 36/106 (33%), Gaps = 31/106 (29%)
Query: 414 YGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--G--------------KYT 455
Y + D+WS+G + + +S+ DQL KI + G +
Sbjct: 196 YATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQL-GKIFDLIGLPPEDDWPRDVSLPRGA 253
Query: 456 EPPWMSPNSRQIVR-----------SMLQVEPGKRIKIQDLLGHNW 490
PP + +V ML P KRI L H++
Sbjct: 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 68/331 (20%), Positives = 127/331 (38%), Gaps = 69/331 (20%)
Query: 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQHIC 69
L + +G G F +V A H TG+KVA+K + E P L EI L+ + H+++
Sbjct: 21 KLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 70 KLFQVIETSSH--------IFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSAV 119
L ++ T + I++V ++C LL ++ + E + + +L+ +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGL 137
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL---CAKPEGGLESQLQTSCGSPN---- 172
Y+H HRD+K NVL+ R+ LKL DFGL + + ++ +
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-----TNRVVTL 192
Query: 173 -YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN------- 222
Y PE++ G++ YG D+W G ++ + + +++ QL I
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQL-ALISQLCGSITP 250
Query: 223 ------------GKYTEPPWMSPNSRQIVRS-------------MLQVEPGKRIKIQDLL 257
K + +++ +L ++P +RI D L
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310
Query: 258 GHNWVKMGPEDNPVSFRPD------HELREK 282
H++ P + + E
Sbjct: 311 NHDFFWSDPMPSDLKGMLSTHLTSMFEYLAP 341
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 86/329 (26%), Positives = 139/329 (42%), Gaps = 50/329 (15%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKA-TLGEDLPRVKLEINALKHI 63
++ +Y VGSG + V A TG +VA+K + + R E+ LKH+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 64 SHQHICKLFQVI------ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
H+++ L V E + +++V G L++IV+ Q+L + + QIL
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+ Y+H HRDLKP N+ ++ + LK++DFGL + + T Y APE
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----YRAPE 199
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN--GKYTEPPWM--- 231
++ +Y D+WS+G ++ LL G F +D IDQL IL G
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKIS 258
Query: 232 SPNSRQIVRS--------------------------MLQVEPGKRIKIQDLLGHNWVKM- 264
S ++R ++S ML ++ KRI L H +
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 265 -GPEDNPVS--FRPDHELREKDDDVIKVM 290
P+D PV+ + E R+ D K +
Sbjct: 319 HDPDDEPVADPYDQSLESRDLLIDEWKSL 347
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 89/345 (25%), Positives = 132/345 (38%), Gaps = 65/345 (18%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK---IMKKATLGEDLPRVKLEINALK 61
++ + + L+ +G G + V ATH TGE VAIK K R EI LK
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKILK 64
Query: 62 HISHQHICKLFQVI-----ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQIL 116
H H++I +F + E + ++++ E L ++ Q L + + F Q L
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN---- 172
AV LH HRDLKP N+L++ N +LK+ DFGL + + +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 173 -----YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN--GK 224
Y APEV+ Y DVWS G +L L F D QL I G
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL-LLIFGIIGT 241
Query: 225 YTEPPWM----SPNSRQIVRS--------------------------MLQVEPGKRIKIQ 254
+ SP +R+ ++S ML +P KRI +
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 255 DLLGHNWVKM--GPEDNPVS-------FRPDHELREKDDDVIKVM 290
+ L H +++ P D P F DH +K +
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKL 346
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 82/330 (24%), Positives = 134/330 (40%), Gaps = 47/330 (14%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D+ +Y +G G + V A L +VAIK + R EI L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 65 HQHICKLFQVIETSSH-----IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
H++I + +I + +++V + L +++ Q L F QIL +
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL--CAKPEGGLESQLQTSCGSPNYAAPE 177
Y+H HRDLKP N+LL+ +LK+ DFGL A P+ L + Y APE
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN--GKYTEPPWM--- 231
++ + Y D+WS+G +L +L F +DQL + IL G ++
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQEDLNCII 260
Query: 232 SPNSRQIVRS--------------------------MLQVEPGKRIKIQDLLGHNWVKM- 264
+ +R + S ML P KRI+++ L H +++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320
Query: 265 -GPEDNPVSFRP---DHELREKDDDVIKVM 290
P D P++ P D EL + + +K +
Sbjct: 321 YDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 49/225 (21%), Positives = 86/225 (38%), Gaps = 25/225 (11%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKL 71
L VG G + +V + GE VA+KI + E+ + H++I
Sbjct: 12 LLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWF--RETELYNTVMLRHENILGF 67
Query: 72 FQVIETSSH----IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
TS H ++++ Y G L D++ + L I S +A+LH +
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 128 --------AHRDLKPENVLLDRNQNLKLIDFGL-CAKPEGGLESQLQ--TSCGSPNYAAP 176
AHRDLK +N+L+ +N + D GL + + + G+ Y AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 177 EVIKGKQYYGSET-----DVWSMGVMLYALLCGFLPFDSDSIDQL 216
EV+ D+W+ G++L+ + + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 70/302 (23%), Positives = 114/302 (37%), Gaps = 68/302 (22%)
Query: 11 ILERTVGSGGFAKVKLATHV-LTGEKVAIKIMKKATLGEDLPRVKL-EINALKHIS---H 65
+ +G G + KV A + G VA+K ++ T E +P + E+ L+H+ H
Sbjct: 15 CVAE-IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 66 QHICKLFQVIETS-----SHIFMVIEYCPG--GELLDHIVERQRLGEKESRAFFRQILSA 118
++ +LF V S + + +V E+ LD + + + + Q+L
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRG 132
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPN------ 172
+ +LH HRDLKP+N+L+ + +KL DFGL A+
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-AR-----------IYSFQMALTSVV 180
Query: 173 ----YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYDKILN--G- 223
Y APEV+ Y + D+WS+G + + SD +DQL KIL+ G
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQL-GKILDVIGL 237
Query: 224 -------------KYTEPPWMSPNSRQIV-----------RSMLQVEPGKRIKIQDLLGH 259
+ + + V L P KRI L H
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 260 NW 261
+
Sbjct: 298 PY 299
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 77/346 (22%), Positives = 134/346 (38%), Gaps = 74/346 (21%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIK------IMKKATLGEDLPRVKLEINALK 61
+++ +ER G G F V+L TG VAIK + L + L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL--------QIMQDLA 74
Query: 62 HISHQHICKLFQVIETSSH-------IFMVIEYCPG--GELLDHIV-ERQRLGEKESRAF 111
+ H +I +L T + +V+EY P + + + F
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 112 FRQILSAVAYLHH--LGYAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEGGLESQLQTSC 168
Q++ ++ LH + HRD+KP NVL++ + LKL DFG AK E + C
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS-AKKLSPSEPNVAYIC 193
Query: 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSDSIDQLYD--KIL--- 221
S Y APE+I G Q+Y + D+WS+G + ++ G D+ S QL++ ++L
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-SAGQLHEIVRVLGCP 251
Query: 222 --------NGKYTE--------PPW----------MSPNSRQIVRSMLQVEPGKRIKIQD 255
N +T+ PW + + ++ ++LQ P +R+K +
Sbjct: 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311
Query: 256 LLGHNWVKM--GPEDNPVSFRP---------DHELREKDDDVIKVM 290
L H + P + + +E+ + +
Sbjct: 312 ALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKL 357
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 71/340 (20%), Positives = 127/340 (37%), Gaps = 80/340 (23%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS--- 64
+YIL R +G G F+ V LA ++ VA+KI++ + + + EI L+ ++
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDAD 76
Query: 65 --------HQHICKL---FQVI-ETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRA 110
HI KL F H+ MV E G LL I + + + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 111 FFRQILSAVAYLH-HLGYAHRDLKPENVLLDRNQ------NLKLIDFGLCAKPEGGLESQ 163
+Q+L + Y+H G H D+KPENVL++ +K+ D G + +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-------SDSIDQL 216
+Q + Y +PEV+ G +G D+WS +++ L+ G F+ + D +
Sbjct: 196 IQ----TREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 217 ------------------------YDKILNGKYTE--------------PPWMSPNSRQI 238
++ + + +++I
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 239 ---VRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRP 275
+ MLQ++P KR L+ H W+K +
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 34/178 (19%), Positives = 61/178 (34%), Gaps = 43/178 (24%)
Query: 331 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILLPCK 390
+G D+WS +++ L+ G F+ D Y K H I +L P+ L
Sbjct: 212 WGCGADIWSTACLIFELITGDFLFEPDE-GHSYTKDDDHIAQIIELL--GELPSYL---- 264
Query: 391 VGQVINLLRSAIVLCSAPSSKQYYGSETDVWSMGVM----LYALLCGFLPFDSDSIDQLY 446
L + ++ ++ S + ++ + L +L F D ++
Sbjct: 265 -------------LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 447 DKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKD 504
D + MLQ++P KR L+ H W+K +R D
Sbjct: 312 D-------------------FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 11/251 (4%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
+L +G G F +V VA+K ++ + + E LK SH
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYLHHL 125
+I +L V I++V+E GG+ L + E RL K + + YL
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNY----AAPEVIKG 181
HRDL N L+ LK+ DFG+ ++ E + S G APE +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGM-SREE--ADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 182 KQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIV 239
+ Y SE+DVWS G++L+ G P+ + S Q + + G P +++
Sbjct: 290 GR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348
Query: 240 RSMLQVEPGKR 250
EPG+R
Sbjct: 349 EQCWAYEPGQR 359
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 66/317 (20%), Positives = 124/317 (39%), Gaps = 54/317 (17%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK--IMKKATLGEDLPRVKLEINALKH 62
DL ++Y+ + +G GG V A ++VAIK ++ + EI ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRR 64
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGG--------ELLD----HIVERQRLGEKESRA 110
+ H +I K+F+++ S E ++ +++E+ L E+ +R
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 111 FFRQILSAVAYLHHLGYAHRDLKPENVLLD-RNQNLKLIDFGL--CAKPEGGLESQLQTS 167
F Q+L + Y+H HRDLKP N+ ++ + LK+ DFGL P + L
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN---- 222
+ Y +P ++ Y D+W+ G + +L G F + ++Q+ IL
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLILESIPV 243
Query: 223 --------------------GKYTEPPW------MSPNSRQIVRSMLQVEPGKRIKIQDL 256
P +S + + +L P R+ ++
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 257 LGHNWVKM--GPEDNPV 271
L H ++ + P D P+
Sbjct: 304 LSHPYMSIYSFPMDEPI 320
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 49/222 (22%), Positives = 85/222 (38%), Gaps = 24/222 (10%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
L G F V A E VA+KI + + + E+ +L + H++
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHEN 79
Query: 68 ICKLF----QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
I + + ++++ + G L D + + + E + +AYLH
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLH 138
Query: 124 H----------LGYAHRDLKPENVLLDRNQNLKLIDFGL-CAKPEGGLESQLQTSCGSPN 172
+HRD+K +NVLL N + DFGL G G+
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 173 YAAPEVIKGKQYYGSE----TDVWSMGVMLYALLCGFLPFDS 210
Y APEV++G + + D+++MG++L+ L D
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 78/347 (22%), Positives = 133/347 (38%), Gaps = 73/347 (21%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHI 63
+ +Y + +GSG V A + VAIK + + R E+ +K +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 64 SHQHICKLFQVI------ETSSHIFMVIEYCPGGELLD---HIVERQRLGEKESRAFFRQ 114
+H++I L V E +++V+E L+D V + L + Q
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLCQVIQMELDHERMSYLLYQ 135
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL--CAKPEGGLESQLQTSCGSPN 172
+L + +LH G HRDLKP N+++ + LK++DFGL A + + T
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 191
Query: 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN--GKYTEP- 228
Y APEVI G Y D+WS+G ++ ++ G + F +D IDQ +K++ G
Sbjct: 192 YRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW-NKVIEQLGTPCPEF 249
Query: 229 -PWMSPNSRQIVRS--------------------------------------MLQVEPGK 249
+ P R V + ML ++ K
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309
Query: 250 RIKIQDLLGHNWVKM--GPEDNPVS----FRPDHELREKDDDVIKVM 290
RI + + L H ++ + P + + RE + K +
Sbjct: 310 RISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 47/233 (20%), Positives = 89/233 (38%), Gaps = 26/233 (11%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
+ Q + + +G G + +V + GEKVA+K+ + EI +
Sbjct: 34 TIAK-QIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWF--RETEIYQTVLM 88
Query: 64 SHQHICKLF----QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
H++I + + + ++++ +Y G L D++ + L K +S +
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGL 147
Query: 120 AYLHHLGY--------AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS---C 168
+LH + AHRDLK +N+L+ +N + D GL K
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 169 GSPNYAAPEVIKGKQYYGSET-----DVWSMGVMLYALLCGFLPFDSDSIDQL 216
G+ Y PEV+ D++S G++L+ + + QL
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 78/409 (19%), Positives = 135/409 (33%), Gaps = 101/409 (24%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHI 63
+ + YI++ +G G + V LA T + VAIK + + D R+ EI L +
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82
Query: 64 SHQHICKLFQVIETSS-----HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSA 118
+I +L+ +I +++V+E +L L E+ + +L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL--CAKPEGGLESQLQTSCGSPN---- 172
++H G HRDLKP N LL+++ ++K+ DFGL E
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 173 ---------------YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS------- 210
Y APE+I ++ Y D+WS G + LL +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
Query: 211 ----------------------DSIDQLYDKILN-------------------------G 223
+ DQL + I N
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQL-NIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320
Query: 224 KYTEPPW------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM--GPEDNPVSFRP 275
+S + ++ SML+ P KRI I L H ++K + S +
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKK 380
Query: 276 -DHELREKDD---DVIK------VMADHKQLSPDDMWSQLNEWTYNYDT 314
+ ++ V + H +L +++ YN +
Sbjct: 381 IILPFDDWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNFYNNEK 429
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 9/249 (3%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKK-ATLGEDLPRVKLEINALKHISH 65
R ++ +G G + +V VA+K +K+ E+ + E +K I H
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKH 275
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHI--VERQRLGEKESRAFFRQILSAVAYLH 123
++ +L V +++ E+ G LLD++ RQ + QI SA+ YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
+ HR+L N L+ N +K+ DFGL G + + + APE + +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 184 YYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQIVRS 241
+ ++DVW+ GV+L+ + G P+ + Q+Y+ + E P P +++R+
Sbjct: 396 -FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 454
Query: 242 MLQVEPGKR 250
Q P R
Sbjct: 455 CWQWNPSDR 463
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 75/352 (21%), Positives = 129/352 (36%), Gaps = 98/352 (27%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQ 66
+Y L +T+G+G F V + +G++ A+K ++ +D E++ +K + H
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL------QDPRYKNRELDIMKVLDHV 60
Query: 67 HICKLFQVIETSSHIFMVIEYCPGG--------------------------------ELL 94
+I KL T+ P E +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 95 D---------HIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-N 144
I + + + Q+ AV ++H LG HRD+KP+N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 145 LKLIDFGLCAKPEGGLESQLQTSCGSPN--------YAAPEVIKGKQYYGSETDVWSMGV 196
LKL DFG AK + P+ Y APE++ G Y D+WS+G
Sbjct: 181 LKLCDFGS-AK---------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 197 MLYALLCGFLPFDSDS-IDQLYD--KIL-----------NGKYTE---PPWMSPNSRQIV 239
+ L+ G F ++ IDQL +I+ N YTE P + + R+I+
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290
Query: 240 RS------------MLQVEPGKRIKIQDLLGHNWVKM--GPEDNPVSFRPDH 277
+L+ EP RI + + H + ++ V +
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNF 342
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 70/336 (20%), Positives = 114/336 (33%), Gaps = 62/336 (18%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE----------DLPRVK 54
+++ Y ++R + SG + V G VAIK + RV
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 55 LEINALKHISHQHICKLFQVI-----ETSSHIFMVIEYCPGGELLDHIVERQR--LGEKE 107
EI L H H +I L + +++V E L ++ QR + +
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQH 135
Query: 108 SRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL--CAKPEGGLESQLQ 165
+ F IL + LH G HRDL P N+LL N ++ + DF L + +
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN-- 222
Y APE++ + + D+WS G ++ + F S +QL +KI+
Sbjct: 196 HRW----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL-NKIVEVV 250
Query: 223 ------------------------GKYTEPPW------MSPNSRQIVRSMLQVEPGKRIK 252
W P + ++ ML+ P +RI
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 253 IQDLLGHNWVKM--GPEDNPVSFRPDHELREKDDDV 286
+ L H + + P D E DV
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDV 346
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 47/222 (21%), Positives = 88/222 (39%), Gaps = 25/222 (11%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+L+ ++G G F +V GE+VA+KI + EI + H++I
Sbjct: 43 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWF--REAEIYQTVMLRHENI 98
Query: 69 CKLF----QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH- 123
+ T + +++V +Y G L D++ R + + S +A+LH
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 124 -------HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS---CGSPNY 173
AHRDLK +N+L+ +N + D GL + + ++ G+ Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 174 AAPEVIKGKQYYGSET-----DVWSMGVMLYALLCGFLPFDS 210
APEV+ D+++MG++ + +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 67/255 (26%), Positives = 117/255 (45%), Gaps = 16/255 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKH 62
++ + +GSG F V + GEK VAIK +++AT + + E +
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAY 121
+ + H+C+L + +S + ++ + P G LLD++ E + +G + + QI + Y
Sbjct: 74 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS-P-NYAAPEVI 179
L HRDL NVL+ Q++K+ DFGL AK G E + G P + A E I
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGL-AKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 180 KGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQI 238
+ Y ++DVWS GV ++ L+ G P+D ++ + G+ P + +
Sbjct: 192 LHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID--V 248
Query: 239 VRSMLQ---VEPGKR 250
M + ++ R
Sbjct: 249 YMIMRKCWMIDADSR 263
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 78/342 (22%), Positives = 133/342 (38%), Gaps = 73/342 (21%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQHI 68
Y + +GSG V A + VAIK + + R E+ +K ++H++I
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 69 CKLFQVI------ETSSHIFMVIEYCPGGELLD---HIVERQRLGEKESRAFFRQILSAV 119
L V E +++V+E L+D V + L + Q+L +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVME------LMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL--CAKPEGGLESQLQTSCGSPNYAAPE 177
+LH G HRDLKP N+++ + LK++DFGL A + + T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPE 233
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILN-------------- 222
VI G Y D+WS+G ++ ++ + F D IDQ +K++
Sbjct: 234 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFMKKLQ 291
Query: 223 ----------GKYTEPPW------------------MSPNSRQIVRSMLQVEPGKRIKIQ 254
KY + + +R ++ ML ++P KRI +
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 255 DLLGHNWVKM--GPEDNPVS----FRPDHELREKDDDVIKVM 290
D L H ++ + P + + + RE + K +
Sbjct: 352 DALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 393
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 49/241 (20%), Positives = 88/241 (36%), Gaps = 33/241 (13%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
+DL N +LE +G G + V + L VA+K+ A + I + +
Sbjct: 10 LDLDNLKLLEL-IGRGRYGAVYKGS--LDERPVAVKVFSFANRQNF--INEKNIYRVPLM 64
Query: 64 SHQHICKLF-----QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSA 118
H +I + + +V+EY P G L ++ S +
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRG 123
Query: 119 VAYLH---------HLGYAHRDLKPENVLLDRNQNLKLIDFGL-------CAKPEGGLES 162
+AYLH +HRDL NVL+ + + DFGL G ++
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 163 QLQTSCGSPNYAAPEVIKGK------QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL 216
+ G+ Y APEV++G + + D++++G++ + +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 217 Y 217
Y
Sbjct: 244 Y 244
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 74/375 (19%), Positives = 122/375 (32%), Gaps = 100/375 (26%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHISHQ 66
++Y + +G+G + V A L VAIK I++ D R+ EI L ++H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 67 HICKLFQVIETSS-----HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAY 121
H+ K+ ++ +++V+E + L E + +L V Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGL-----------CAKPEGGLESQLQTSCGS 170
+H G HRDLKP N L++++ ++K+ DFGL P E +
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 171 PN---------------YAAPEVIKGKQYYGSETDVWSMG-------------------- 195
Y APE+I ++ Y DVWS+G
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 196 ------------VMLYALLCGFLPFDSDSIDQLYDKILN--GKYTEPPWM---SPNSRQI 238
F + DQL + I N G +E ++++
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL-NVIFNILGTPSEEDIEALEKEDAKRY 350
Query: 239 VRS--------------------------MLQVEPGKRIKIQDLLGHNWVKM--GPEDNP 270
+R ML P KRI I + L H + K E
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVET 410
Query: 271 VSFRP-DHELREKDD 284
+ + +
Sbjct: 411 NATEKVRLPFNDWMN 425
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 61/342 (17%), Positives = 108/342 (31%), Gaps = 78/342 (22%)
Query: 11 ILERTVGSGGFAKVKLAT--HVLTGEKVAIKIMKKATLGEDLPRVKL-EINALKHISHQH 67
VG G + V A + A+K ++ + EI L+ + H +
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG----TGISMSACREIALLRELKHPN 79
Query: 68 ICKLFQVI--ETSSHIFMVIEYCPG--GELLDHIVERQR------LGEKESRAFFRQILS 117
+ L +V ++++ +Y ++ + L ++ QIL
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQN----LKLIDFGLCAKPEGGLESQLQTSCGSPN- 172
+ YLH HRDLKP N+L+ +K+ D G A+ S L+
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFN---SPLKPLADLDPV 195
Query: 173 -----YAAPEVIKGKQYYGSETDVWSMGVMLYALLCG--FLPFDSD--------SIDQL- 216
Y APE++ G ++Y D+W++G + LL + DQL
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 217 ----------------------------------YDKILNGKYTEP--PWMSPNSRQIVR 240
Y KY E + +++
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREK 282
+L ++P KRI + + + P F K
Sbjct: 316 KLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPK 357
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 11/231 (4%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKH 62
++ + +GSG F V + GEK VAIK +++AT + + E +
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAY 121
+ + H+C+L + +S + ++ + P G LLD++ E + +G + + QI + Y
Sbjct: 74 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS-P-NYAAPEVI 179
L HRDL NVL+ Q++K+ DFGL AK G E + G P + A E I
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGL-AKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 180 KGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP 229
+ Y ++DVWS GV ++ L+ G P+D ++ + G+ P
Sbjct: 192 LHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVL----TGEKVAIKIMKKATLG--EDLPRVKLEINAL 60
+ +G G F V++ + TGE VA+K ++ +T D R EI L
Sbjct: 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEIL 65
Query: 61 KHISHQHICKLFQVIETSSH--IFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILS 117
K + H +I K V ++ + +++EY P G L D++ + ++R+ + + QI
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSP-NYA 174
+ YL Y HRDL N+L++ +K+ DFGL K P+ +++ SP +
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL-TKVLPQDKEFFKVKEPGESPIFWY 184
Query: 175 APEVIKGKQYYGSETDVWSMGVMLY 199
APE + ++ +DVWS GV+LY
Sbjct: 185 APESLTESKFS-VASDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVL----TGEKVAIKIMKKATLGE--DLPRVKLEINAL 60
+ +G G F V++ + TGE VA+K ++ +T D R EI L
Sbjct: 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEIL 96
Query: 61 KHISHQHICKLFQVIETSSH--IFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILS 117
K + H +I K V ++ + +++EY P G L D++ + ++R+ + + QI
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSP-NYA 174
+ YL Y HRDL N+L++ +K+ DFGL K P+ +++ SP +
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL-TKVLPQDKEYYKVKEPGESPIFWY 215
Query: 175 APEVIKGKQYYGSETDVWSMGVMLY 199
APE + ++ +DVWS GV+LY
Sbjct: 216 APESLTESKFS-VASDVWSFGVVLY 239
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 70/263 (26%), Positives = 116/263 (44%), Gaps = 16/263 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKH 62
+ ++ +G+G F +V + K VAIK +K + E +
Sbjct: 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ 102
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAY 121
SH +I +L VI + ++ EY G L + E + R I + + Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG-SP-NYAAPEVI 179
L ++ Y HRDL N+L++ N K+ DFGL E E+ TS G P + APE I
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 180 K-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQ 237
K + S +DVWS G++++ ++ G P+ S ++ I +G P P++
Sbjct: 223 SYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA-- 278
Query: 238 IVRSML---QVEPGKRIKIQDLL 257
I + M+ Q E +R K D++
Sbjct: 279 IYQLMMQCWQQERARRPKFADIV 301
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVL----TGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
+ R +G G F KV+L + TGE+VA+K +K + G + +K EI L++
Sbjct: 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN 79
Query: 63 ISHQHICKLFQVIETSSH--IFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAV 119
+ H++I K + I +++E+ P G L +++ + ++ K+ + QI +
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSP-NYAAP 176
YL Y HRDL NVL++ +K+ DFGL K ++ SP + AP
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL-TKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 177 EVIKGKQYYGSETDVWSMGVMLY 199
E + ++Y +DVWS GV L+
Sbjct: 199 ECLMQSKFY-IASDVWSFGVTLH 220
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 70/253 (27%), Positives = 115/253 (45%), Gaps = 19/253 (7%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-KVAIKIMKK-ATLGEDLPRVKLEINALKHIS 64
R LE +G G F +V + T G +VAIK +K E + E +K +
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGT--WNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLR 237
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA----FFRQILSAVA 120
H+ + +L+ V+ + I++V EY G LLD + + G+ QI S +A
Sbjct: 238 HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMA 294
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVI 179
Y+ + Y HRDL+ N+L+ N K+ DFGL A+ E + P + APE
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGL-ARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 180 KGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQ 237
+ + ++DVWS G++L L G +P+ ++ D++ G P P S
Sbjct: 354 LYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412
Query: 238 IVRSMLQVEPGKR 250
++ + EP +R
Sbjct: 413 LMCQCWRKEPEER 425
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 74/330 (22%), Positives = 118/330 (35%), Gaps = 77/330 (23%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH 65
+ +Y + + +G G F +V A + VA+K+++ + EI L+H+
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRK 152
Query: 66 Q------HICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILS 117
Q ++ + + +HI M E L + I + Q R F IL
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 118 AVAYLHHLGYAHRDLKPENVLL--DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAA 175
+ LH H DLKPEN+LL +K+IDFG + + +Q+ Y A
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF----YRA 267
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQL------------------ 216
PEVI G + YG D+WS+G +L LL G+ D DQL
Sbjct: 268 PEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326
Query: 217 ------YDKILNGKYTEPPWMS-------------------PNSRQI------------- 238
+Y +S P SR+
Sbjct: 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 239 --VRSMLQVEPGKRIKIQDLLGHNWVKMGP 266
++ L+ +P R+ L H W++
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 17/252 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKK-ATLGEDLPRVKLEINALKHISH 65
R LE +G G F +V + T T +VAIK +K E + E +K + H
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQ---EAQVMKKLRH 321
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA----FFRQILSAVAY 121
+ + +L+ V+ + I++V EY G LLD + + G+ QI S +AY
Sbjct: 322 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEVIK 180
+ + Y HRDL+ N+L+ N K+ DFGL A+ E + P + APE
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGL-ARLIEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 181 GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQI 238
+ + ++DVWS G++L L G +P+ ++ D++ G P P S +
Sbjct: 438 YGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496
Query: 239 VRSMLQVEPGKR 250
+ + EP +R
Sbjct: 497 MCQCWRKEPEER 508
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 11/231 (4%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGEDLPRVKLEINALKH 62
+ + +GSG F V + GE V IK+++ + + V + A+
Sbjct: 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 71
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAY 121
+ H HI +L + S + +V +Y P G LLDH+ + R LG + + QI + Y
Sbjct: 72 LDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG-SP-NYAAPEVI 179
L G HR+L NVLL +++ DFG+ A + QL S +P + A E I
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGV-ADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 180 KGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP 229
+ Y ++DVWS GV ++ L+ G P+ + ++ D + G+ P
Sbjct: 190 HFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP 239
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 63/253 (24%), Positives = 113/253 (44%), Gaps = 23/253 (9%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
+ L +T+G G F V L G KVA+K +K + E + + + H
Sbjct: 20 MKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLA---EASVMTQLRHS 74
Query: 67 HICKLFQVI-ETSSHIFMVIEYCPGGELLDHI--VERQRLGEKESRAFFRQILSAVAYLH 123
++ +L VI E +++V EY G L+D++ R LG F + A+ YL
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVIK 180
+ HRDL NVL+ + K+ DFGL K T P + APE ++
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGL-TKEA------SSTQDTGKLPVKWTAPEALR 187
Query: 181 -GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQ 237
K + +++DVWS G++L+ + G +P+ + + ++ G + P P + +
Sbjct: 188 EKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245
Query: 238 IVRSMLQVEPGKR 250
++++ ++ R
Sbjct: 246 VMKNCWHLDAAMR 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 83/362 (22%), Positives = 135/362 (37%), Gaps = 85/362 (23%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIK-IMKKATLGEDLPRVKLEINALKHIS-HQ 66
+Y L + +G G + V + TGE VA+K I D R EI L +S H+
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 67 HICKLFQVI--ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+I L V+ + +++V +Y L ++ L + Q++ + YLH
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGL----CAKPEGGLESQLQTSCGSPN-------- 172
G HRD+KP N+LL+ ++K+ DFGL L + + N
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 173 --------YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQLYDKILNG 223
Y APE++ G Y D+WS+G +L +LCG F S +++QL ++I+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL-ERIIG- 245
Query: 224 KYTEPP-------WMSPNSRQIVRS----------------------------------- 241
+ P SP ++ ++ S
Sbjct: 246 -VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 242 -------MLQVEPGKRIKIQDLLGHNWVKM--GPEDNPVS---FRPDHELREKDD-DVIK 288
+LQ P KRI D L H +V + P + P K D +
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYR 364
Query: 289 VM 290
+
Sbjct: 365 NL 366
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKH 62
+ R +G G F KV L + T + VA+K +K + K EI+ L+
Sbjct: 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT 89
Query: 63 ISHQHICKLFQVIETSSH--IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
+ H+HI K E + + +V+EY P G L D++ R +G + F +QI +A
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMA 148
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSP-NYAAPE 177
YLH Y HRDL NVLLD ++ +K+ DFGL AK PEG +++ SP + APE
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL-AKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 178 VIKGKQYYGSETDVWSMGVMLY 199
+K ++Y +DVWS GV LY
Sbjct: 208 CLKEYKFY-YASDVWSFGVTLY 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 15/230 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-HVLTGE--KVAIKIMKKATLGEDLPRVKL--EINALK 61
L +G G F V+ +G+ VA+K +K L + E+NA+
Sbjct: 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVA 120
+ H+++ +L+ V+ + + MV E P G LLD + + Q + Q+ +
Sbjct: 77 SLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP---NYAAPE 177
YL + HRDL N+LL +K+ DFGL + + + APE
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 178 VIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKY 225
+K + +D W GV L+ + G P+ + Q+ KI
Sbjct: 195 SLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 71/343 (20%), Positives = 129/343 (37%), Gaps = 92/343 (26%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPR----VKLEINALK 61
++Y ++ +G G F +V A + E VAIKI+K + ++E+ L+
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK------NKKAFLNQAQIEVRLLE 105
Query: 62 HISHQ------HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG--EKESRAFFR 113
++ +I L + +H+ +V E L D + G +R F +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 114 QILSAVAYLHH--LGYAHRDLKPENVLL--DRNQNLKLIDFGLCAKPEGGLESQLQTSCG 169
Q+ +A+ +L L H DLKPEN+LL + +K++DFG + + +Q
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ---- 220
Query: 170 SPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDSIDQL------------ 216
S Y +PEV+ G Y D+WS+G +L + G F ++ +DQ+
Sbjct: 221 SRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279
Query: 217 ------------YDKILNGKYTE-----------PPWMSPNSRQI--------------- 238
++K+ +G + PP +
Sbjct: 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES 339
Query: 239 -------------VRSMLQVEPGKRIKIQDLLGHNWVKMGPED 268
+ ML +P RI+ L H++ K ++
Sbjct: 340 GHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 61/252 (24%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
+ L +T+G G F V L G KVA+K +K + E + + + H
Sbjct: 192 MKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLA---EASVMTQLRHS 246
Query: 67 HICKLFQVIETSSHIFMVI-EYCPGGELLDHI--VERQRLGEKESRAFFRQILSAVAYLH 123
++ +L VI ++ EY G L+D++ R LG F + A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVIK 180
+ HRDL NVL+ + K+ DFGL K T P + APE ++
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGL-TK------EASSTQDTGKLPVKWTAPEALR 359
Query: 181 GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-RQI 238
K+ + +++DVWS G++L+ + G +P+ + + ++ G + P P + +
Sbjct: 360 EKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV 418
Query: 239 VRSMLQVEPGKR 250
+++ ++ R
Sbjct: 419 MKNCWHLDAATR 430
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 60/258 (23%), Positives = 108/258 (41%), Gaps = 17/258 (6%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGE--KVAIKIMKKATLGEDLPRVKL-EINAL 60
+D + + ++ +GSG F VK + + VA+KI+K L L E N +
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
+ + + +I ++ + + +V+E G L ++ + + + +K Q+ +
Sbjct: 73 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPE 177
YL + HRDL NVLL K+ DFGL +K E+ + P + APE
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQHYAKISDFGL-SKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 178 VIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS 235
I K + S++DVWS GV+++ G P+ ++ + G+ P P
Sbjct: 191 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 248
Query: 236 RQIVRSMLQ---VEPGKR 250
+ M + R
Sbjct: 249 --MYDLMNLCWTYDVENR 264
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 68/343 (19%), Positives = 115/343 (33%), Gaps = 88/343 (25%)
Query: 6 LRNQYILERTVGSGGFAKVKLAT-HVLTGEKVAIKIMKKATLGEDLPRV----KLEINAL 60
L+ +Y + +G G F KV H +VA+KI++ ++ + +LEIN L
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR------NVGKYREAARLEINVL 70
Query: 61 KHISHQ------HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG--EKESRAFF 112
K I + + H+ + E G + + E R
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQN-------------------LKLIDFGLC 153
Q+ A+ +LH H DLKPEN+L ++ +++ DFG
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SDS 212
+ + T Y PEVI + DVWS+G +L+ GF F ++
Sbjct: 190 TFDHEHHTTIVATRH----YRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 213 IDQL------------------------YDKILN-------GKYTEPPWMSPNSR----- 236
+ L Y L G+Y + S
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 237 -------QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVS 272
++R ML+ +P +RI + + L H + +
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSF 347
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 19/260 (7%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
++ + +GSG F V L + KVAIK +++ + E+ E + +SH
Sbjct: 7 PSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEE--DFIEEAEVMMKLSHP 63
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHL 125
+ +L+ V + I +V E+ G L D++ R + + +AYL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVIK-G 181
HRDL N L+ NQ +K+ DFG+ + L+ Q +S G+ P +A+PEV
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGM-TRFV--LDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 182 KQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240
+ Y S++DVWS GV+++ + G +P+++ S ++ + I G P ++ + +
Sbjct: 181 R--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH--VYQ 236
Query: 241 SML---QVEPGKRIKIQDLL 257
M + P R LL
Sbjct: 237 IMNHCWRERPEDRPAFSRLL 256
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 71/262 (27%), Positives = 128/262 (48%), Gaps = 23/262 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-KVAIKIMKK-ATLGEDLPRVKLEINALKHIS 64
R + L + +GSG F VKL G+ VA+K++K+ + ++ + E + +S
Sbjct: 7 REEITLLKELGSGQFGVVKLG--KWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLS 61
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYLH 123
H + K + V I++V EY G LL+++ + L + + +A+L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVIK 180
+ HRDL N L+DR+ +K+ DFG+ + L+ Q +S G+ P ++APEV
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGM-TRYV--LDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 181 -GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQI 238
K Y S++DVW+ G++++ + G +P+D + ++ K+ G P ++ ++ I
Sbjct: 179 YFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT--I 234
Query: 239 VRSML---QVEPGKRIKIQDLL 257
+ M P KR Q LL
Sbjct: 235 YQIMYSCWHELPEKRPTFQQLL 256
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 70/262 (26%), Positives = 115/262 (43%), Gaps = 15/262 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHI 63
+++ VG+G F +V L +K VAIK +K + E + +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYL 122
H +I +L V+ S + +V EY G L + + + + R I S + YL
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG-SP-NYAAPEVIK 180
+GY HRDL N+L++ N K+ DFGL E E+ T G P + +PE I
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 181 -GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQI 238
K + S +DVWS G++L+ ++ G P+ S + + G PP P + +
Sbjct: 224 YRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA--L 279
Query: 239 VRSML---QVEPGKRIKIQDLL 257
+ ML Q + R K + ++
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIV 301
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 15/262 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHI 63
++ +E+ +GSG +V + G+ VAIK +K E + +
Sbjct: 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYL 122
H +I +L V+ +V EY G L + + + R + + + YL
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCG-SP-NYAAPEVIK 180
LGY HRDL NVL+D N K+ DFGL E ++ T+ G P + APE I
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 181 -GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQI 238
+ S +DVWS GV+++ +L G P+ + + + + G P P++ +
Sbjct: 228 FRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA--L 283
Query: 239 VRSML---QVEPGKRIKIQDLL 257
+ ML + +R + ++
Sbjct: 284 HQLMLDCWHKDRAQRPRFSQIV 305
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 16/231 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKK-ATLGEDLPRVKLEINALKHISH 65
R ++ +G G + +V VA+K +K+ E+ + E +K I H
Sbjct: 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKH 68
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHI--VERQRLGEKESRAFFRQILSAVAYLH 123
++ +L V +++ E+ G LLD++ RQ + QI SA+ YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVIK 180
+ HRDL N L+ N +K+ DFGL ++ G+ P + APE +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGL-SRLM--TGDTYTAHAGAKFPIKWTAPESLA 185
Query: 181 -GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP 229
K + ++DVW+ GV+L+ + G P+ + Q+Y+ + E P
Sbjct: 186 YNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 234
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 62/262 (23%), Positives = 123/262 (46%), Gaps = 23/262 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-KVAIKIMKK-ATLGEDLPRVKLEINALKHIS 64
+ +G+G F VK G+ VAIK++K+ + ++ E + ++S
Sbjct: 23 PKDLTFLKELGTGQFGVVKYG--KWRGQYDVAIKMIKEGSMSEDEFIE---EAKVMMNLS 77
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYLH 123
H+ + +L+ V IF++ EY G LL+++ R R ++ + + A+ YL
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVIK 180
+ HRDL N L++ +K+ DFGL ++ L+ + +S GS P ++ PEV+
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGL-SRYV--LDDEYTSSVGSKFPVRWSPPEVLM 194
Query: 181 -GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQI 238
K + S++D+W+ GV+++ + G +P++ + + + I G P ++ +
Sbjct: 195 YSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK--V 250
Query: 239 VRSML---QVEPGKRIKIQDLL 257
M + +R + LL
Sbjct: 251 YTIMYSCWHEKADERPTFKILL 272
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 72/340 (21%), Positives = 123/340 (36%), Gaps = 94/340 (27%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRV----KLEINALK 61
L N +++ R +G G F +V L H+ + A+K+++ ++ + K+E + LK
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR------NIKKYTRSAKIEADILK 86
Query: 62 HISHQ-----HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG--EKESRAFFRQ 114
I + +I K H+ ++ E G L + I G ++ + + +
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDRNQ-------------------------NLKLID 149
IL A+ YL + H DLKPEN+LLD +KLID
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 150 FGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD 209
FG S + T Y APEVI + +D+WS G +L L G L F
Sbjct: 206 FGCATFKSDYHGSIINTRQ----YRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFR 260
Query: 210 -SDSIDQLY------------------------------------DKILNGKYTEPPWMS 232
+ ++ L + + +
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 233 PNSRQI---------VRSMLQVEPGKRIKIQDLLGHNWVK 263
+I + S+LQ++P R +LL H +++
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 10/233 (4%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGE--KVAIKIMKKATLGEDLPRVKLEINALK 61
+ N I + +G G F V+ + + + VAIK++K+ T D + E +
Sbjct: 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 391
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVA 120
+ + +I +L V + + +V+E GG L +V R+ + Q+ +
Sbjct: 392 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPE 177
YL + HR+L NVLL K+ DFGL +K G +S P + APE
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGL-SKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 178 VIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP 229
I ++ + S +DVWS GV ++ L G P+ ++ I GK E P
Sbjct: 510 CINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 561
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 79/339 (23%), Positives = 124/339 (36%), Gaps = 90/339 (26%)
Query: 6 LRNQYILERTVGSGGFAKVKLAT-HVLTGEKVAIKIMKKATLGEDLPRV----KLEINAL 60
L +Y + T+G G F KV H G VA+KI+K ++ R + EI L
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK------NVDRYCEAARSEIQVL 65
Query: 61 KHISHQ------HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG--EKESRAFF 112
+H++ ++ + E HI +V E G D I E L R
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 113 RQILSAVAYLHHLGYAHRDLKPENVLLDRNQN-------------------LKLIDFGLC 153
QI +V +LH H DLKPEN+L ++ +K++DFG
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-S 183
Query: 154 AKPEGGLESQ-LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-SD 211
A + S + T Y APEVI + DVWS+G +L GF F D
Sbjct: 184 ATYDDEHHSTLVSTRH----YRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 212 SIDQL------------------------YDKILNGKYTEPP--WMSPNSRQI------- 238
S + L + L+ ++S + +
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 239 ----------VRSMLQVEPGKRIKIQDLLGHNWVKMGPE 267
++ ML+ +P KRI +++ L H + + +
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 12/227 (5%)
Query: 11 ILERTVGSGGFAKVKLATHVLTGE--KVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
I + +G G F V+ + + + VAIK++K+ T D + E + + + +I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYLHHLGY 127
+L V + + +V+E GG L + +R+ + Q+ + YL +
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVIK-GKQ 183
HRDL NVLL K+ DFGL +K G +S P + APE I K
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGL-SKALGADDSYYTARSAGKWPLKWYAPECINFRK- 189
Query: 184 YYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP 229
+ S +DVWS GV ++ L G P+ ++ I GK E P
Sbjct: 190 -FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 69/254 (27%), Positives = 112/254 (44%), Gaps = 16/254 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHI 63
R + L R +G G F V ++ VAIK K T + E ++
Sbjct: 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYL 122
H HI KL VI T + +++++E C GEL + + L + Q+ +A+AYL
Sbjct: 449 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS---P-NYAAPEV 178
+ HRD+ NVL+ N +KL DFGL ++ +E P + APE
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGL-SR---YMEDSTYYKASKGKLPIKWMAPES 563
Query: 179 IKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS-R 236
I ++ + S +DVW GV ++ +L G PF + + +I NG+ P P +
Sbjct: 564 INFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 622
Query: 237 QIVRSMLQVEPGKR 250
++ +P +R
Sbjct: 623 SLMTKCWAYDPSRR 636
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVL----TGEKVAIKIMKKATLG--EDLPRVKLEINAL 60
+G G F V+L + TG VA+K ++ + D R EI L
Sbjct: 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQIL 78
Query: 61 KHISHQHICKLFQVIETSSH--IFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILS 117
K + I K V + +V+EY P G L D + R RL + QI
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSCGSP-NYA 174
+ YL HRDL N+L++ ++K+ DFGL AK P ++ SP +
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL-AKLLPLDKDYYVVREPGQSPIFWY 197
Query: 175 APEVIKGKQYYGSETDVWSMGVMLY 199
APE + + ++DVWS GV+LY
Sbjct: 198 APESLSDNIFS-RQSDVWSFGVVLY 221
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 15/232 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHI 63
R + L R +G G F V ++ VAIK K T + E ++
Sbjct: 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 73
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYL 122
H HI KL VI T + +++++E C GEL + + L + Q+ +A+AYL
Sbjct: 74 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVI 179
+ HRD+ NVL+ N +KL DFGL E +S + P + APE I
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTYYKASKGKLPIKWMAPESI 189
Query: 180 K-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP 229
+ + S +DVW GV ++ +L G PF + + +I NG+ P
Sbjct: 190 NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 239
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 24/234 (10%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-KVAIKIMKK-ATLGEDLPRVKLEINALKHIS 64
R L +G+G F +V + G KVA+K +K+ + + E N +K +
Sbjct: 12 RETLKLVERLGAGQFGEVWMG--YYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQ 66
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA----FFRQILSAVA 120
HQ + +L+ V+ T I+++ EY G L+D + + G K + QI +A
Sbjct: 67 HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPE 177
++ Y HRDL+ N+L+ + K+ DFGL +++ G+ P + APE
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGL---ARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 178 VIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP 229
I G + ++DVWS G++L ++ G +P+ + ++ + G P
Sbjct: 181 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 72/369 (19%), Positives = 116/369 (31%), Gaps = 122/369 (33%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS- 64
+Y + R +G G F+ V L+ + + VA+K++K A + EI LK +
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE--TALDEIRLLKSVRN 92
Query: 65 -------HQHICKL---FQVI-ETSSHIFMVIEYCPGGELLDHIVER---QRLGEKESRA 110
+ + +L F++ +HI MV E G L + + Q L +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 111 FFRQILSAVAYLH-HLGYAHRDLKPENVLL------------------------------ 139
+Q+L + YLH H D+KPEN+LL
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 140 -------------------DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
+K+ D G +QT Y + EV+
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT----RQYRSLEVLI 266
Query: 181 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK------------------ILN 222
G Y + D+WS M + L G F+ S ++ I+
Sbjct: 267 GSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325
Query: 223 GKYTE---------------PPWMSPNSR---------------QIVRSMLQVEPGKRIK 252
GKY++ PW + ML++ P KR
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385
Query: 253 IQDLLGHNW 261
+ L H W
Sbjct: 386 AAECLRHPW 394
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 23/125 (18%), Positives = 36/125 (28%), Gaps = 48/125 (38%)
Query: 414 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK------------------ILNGKYT 455
Y + D+WS M + L G F+ S ++ I+ GKY+
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 456 E---------------PPWMSPNSR---------------QIVRSMLQVEPGKRIKIQDL 485
+ PW + ML++ P KR +
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
Query: 486 LGHNW 490
L H W
Sbjct: 390 LRHPW 394
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 23/255 (9%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-KVAIKIMKK-ATLGEDLPRVKLEINALKHIS 64
R LE+ +G+G F +V +AT KVA+K MK + E E N +K +
Sbjct: 187 RESLKLEKKLGAGQFGEVWMAT--YNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTLQ 241
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA----FFRQILSAVA 120
H + KL V+ T I+++ E+ G LLD + + G K+ F QI +A
Sbjct: 242 HDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPE 177
++ Y HRDL+ N+L+ + K+ DFGL A+ +++ G+ P + APE
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGL-ARVI--EDNEYTAREGAKFPIKWTAPE 355
Query: 178 VIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS- 235
I + ++DVWS G++L ++ G +P+ S ++ + G P P
Sbjct: 356 AINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 414
Query: 236 RQIVRSMLQVEPGKR 250
I+ + P +R
Sbjct: 415 YNIMMRCWKNRPEER 429
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 62/263 (23%), Positives = 112/263 (42%), Gaps = 20/263 (7%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHI 63
R +L R +G G F +V + VA+K KK ++ + E +K++
Sbjct: 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYL 122
H HI KL +I ++++E P GEL ++ + L + QI A+AYL
Sbjct: 71 DHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEVI 179
+ HRD+ N+L+ + +KL DFGL ++ + + + P + +PE I
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGL-SRYI--EDEDYYKASVTRLPIKWMSPESI 186
Query: 180 K-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQ 237
+ + + +DVW V ++ +L G PF + + G P + P
Sbjct: 187 NFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV-- 242
Query: 238 IVRSMLQ---VEPGKRIKIQDLL 257
+ M + +P R + +L+
Sbjct: 243 LYTLMTRCWDYDPSDRPRFTELV 265
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 64/302 (21%), Positives = 122/302 (40%), Gaps = 29/302 (9%)
Query: 7 RNQYILERTVGSGGFAKV--KLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALK 61
R + + R +G G F V +A V+ E +VAIK + +A + E + +K
Sbjct: 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 83
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA----------F 111
+ H+ +L V+ +++E G+L ++ +
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 112 FRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS- 170
+I +AYL+ + HRDL N ++ + +K+ DFG+ + + + G
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM-TRDIYETDYYRKGGKGLL 202
Query: 171 P-NYAAPEVIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE 227
P + +PE +K G + + +DVWS GV+L+ + P+ S +Q+ ++ G +
Sbjct: 203 PVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260
Query: 228 PPWMSPN-SRQIVRSML---QVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKD 283
P N + M Q P R +++ +M P VSF E + +
Sbjct: 261 KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPE 317
Query: 284 DD 285
+
Sbjct: 318 PE 319
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 42/248 (16%), Positives = 86/248 (34%), Gaps = 39/248 (15%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-------KVAIKIMKKATLGEDLPRVKL-EIN 58
I ++G G F K+ G+ +V +K++ KA + +
Sbjct: 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAAS 64
Query: 59 ALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILS 117
+ +SH+H+ + V +V E+ G L ++ + + +Q+ +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNL--------KLIDFGLCAKPEGGLESQLQTSCG 169
A+ +L H ++ +N+LL R ++ KL D G+ + + +
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-SI---TVLPK------ 174
Query: 170 SPNY-------AAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKIL 221
+ PE I+ + TD WS G L+ + G P + +
Sbjct: 175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
Query: 222 NGKYTEPP 229
+ P
Sbjct: 233 DRHQLPAP 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 54/232 (23%), Positives = 100/232 (43%), Gaps = 10/232 (4%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHI 63
R +R +G G F V ++ + + AIK + + T + + E ++ +
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 64 SHQHICKLFQVIETSSHIFMVI-EYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAY 121
+H ++ L ++ + V+ Y G+LL I ++ K+ +F Q+ + Y
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS--P-NYAAPEV 178
L + HRDL N +LD + +K+ DFGL +Q + P + A E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 179 IKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP 229
++ + +++DVWS GV+L+ LL G P+ L + G+ P
Sbjct: 200 LQ-TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 62/268 (23%), Positives = 111/268 (41%), Gaps = 18/268 (6%)
Query: 4 IDLRNQYI-LERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINA 59
I + + +G G F V T + K A+K + + T ++ + E
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 60 LKHISHQHICKLFQVI-ETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILS 117
+K SH ++ L + + +V+ Y G+L + I E K+ F Q+
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP--EGGLESQLQTSCGS-P-NY 173
+ YL + HRDL N +LD +K+ DFGL A+ + S + P +
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 174 AAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWMS 232
A E ++ Q + +++DVWS GV+L+ L+ G P+ + + +L G+ P
Sbjct: 199 MALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257
Query: 233 PNSRQIVRSML---QVEPGKRIKIQDLL 257
P+ + ML + R +L+
Sbjct: 258 PD--PLYEVMLKCWHPKAEMRPSFSELV 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 61/269 (22%), Positives = 112/269 (41%), Gaps = 18/269 (6%)
Query: 3 YIDLRNQYI-LERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEIN 58
I + + +G G F V T + K A+K + + T ++ + E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 59 ALKHISHQHICKLFQVI-ETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQIL 116
+K SH ++ L + + +V+ Y G+L + I E K+ F Q+
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 202
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP--EGGLESQLQTSCGS-P-N 172
+ +L + HRDL N +LD +K+ DFGL A+ + +S + P
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVK 261
Query: 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPPWM 231
+ A E ++ Q + +++DVWS GV+L+ L+ G P+ + + +L G+ P
Sbjct: 262 WMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320
Query: 232 SPNSRQIVRSML---QVEPGKRIKIQDLL 257
P+ + ML + R +L+
Sbjct: 321 CPD--PLYEVMLKCWHPKAEMRPSFSELV 347
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 77/289 (26%), Positives = 118/289 (40%), Gaps = 54/289 (18%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-HVLTGEK----VAIKIMKKATLGE--DLPRVKLEINA 59
R +L+R +G G F KV LA + L+ K VA+K +K TL D R E
Sbjct: 14 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAEL 70
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA--------- 110
L ++ H+HI K + V + MV EY G+L +
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 111 -------FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL---------CA 154
QI S + YL + HRDL N L+ N +K+ DFG+
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 155 KPEGGLESQLQTSCGSP-NYAAPEVIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSD 211
+ P + PE I K + +E+DVWS GV+L+ + G P+
Sbjct: 191 VGGHTM---------LPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 212 SIDQLYDKILNGKYTEPPWMSPNSRQIVRSML---QVEPGKRIKIQDLL 257
S ++ + I G+ E P + P ++ ML Q EP +R+ I+++
Sbjct: 240 SNTEVIECITQGRVLERPRVCPK--EVYDVMLGCWQREPQQRLNIKEIY 286
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 31/247 (12%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK--VAIKIMKKATLGEDLPRVKLEINALKHI- 63
N + +G G F +V A G + AIK MK+ +D E+ L +
Sbjct: 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 83
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA------------- 110
H +I L E ++++ IEY P G LLD + + + L + A
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 111 ---FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE---GGLESQL 164
F + + YL + HRDL N+L+ N K+ DFGL E +L
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 165 QTSCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILN 222
P + A E + Y + +DVWS GV+L+ ++ G P+ + +LY+K+
Sbjct: 204 ------PVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256
Query: 223 GKYTEPP 229
G E P
Sbjct: 257 GYRLEKP 263
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 58/273 (21%), Positives = 103/273 (37%), Gaps = 26/273 (9%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKL-EINALKH 62
Q+ L R +G G F V+ A KVA+K++K + L E +K
Sbjct: 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE 81
Query: 63 ISHQHICKLFQV------IETSSHIFMVIEYCPGGELLDHIVER------QRLGEKESRA 110
H H+ KL V +++ + G+L ++ L +
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 111 FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS 170
F I + YL + HRDL N +L + + + DFGL ++ + Q
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL-SRKIYSGDYYRQGCASK 200
Query: 171 -P-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE 227
P + A E + Y +DVW+ GV ++ ++ G P+ ++Y+ ++ G +
Sbjct: 201 LPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 228 PPWMSPNSRQIVRSMLQ---VEPGKRIKIQDLL 257
P ++ M Q +P +R L
Sbjct: 260 QPPECME--EVYDLMYQCWSADPKQRPSFTCLR 290
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGE---KVAIKIMKKATLGE--DLPRVKLEINA 59
R +L+ +G G F KV LA ++L + VA+K +K+A+ D R E
Sbjct: 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAEL 96
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA--------- 110
L + HQHI + F V + MV EY G+L + + +
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 111 ------FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP-------E 157
Q+ + + YL L + HRDL N L+ + +K+ DFG+ ++
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM-SRDIYSTDYYR 215
Query: 158 GGLESQLQTSCGSP-NYAAPEVIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSID 214
G + L P + PE I K + +E+DVWS GV+L+ + G P+ S
Sbjct: 216 VGGRTML------PIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267
Query: 215 QLYDKILNGKYTEPPWMSPNSRQIVRSML---QVEPGKRIKIQDLL 257
+ D I G+ E P P ++ M Q EP +R I+D+
Sbjct: 268 EAIDCITQGRELERPRACPP--EVYAIMRGCWQREPQQRHSIKDVH 311
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 63/250 (25%), Positives = 106/250 (42%), Gaps = 28/250 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGE---KVAIKIMKKATLGEDLPRVKLEINALK 61
RN+ +T+G+G F KV AT ++ + VA+K++K + + + E+ L
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81
Query: 62 HI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLD------------------HIVERQR 102
++ +H +I L ++ EYC G+LL+ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 103 LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
L ++ +F Q+ +A+L HRDL N+LL + K+ DFGL +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 163 QLQTSCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSID-QLYDK 219
++ + P + APE I Y E+DVWS G+ L+ L G P+ +D + Y
Sbjct: 202 VVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 220 ILNGKYTEPP 229
I G P
Sbjct: 261 IKEGFRMLSP 270
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 29/279 (10%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-----KVAIKIMKKATLGEDLPRVKLEINALK 61
RN +T+G+G F KV AT G+ KVA+K++K ++ + E+ +
Sbjct: 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 62 HI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA---------- 110
H+ H++I L + ++ EYC G+LL+ + + R+ E +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 111 ----FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166
F Q+ +A+L HRD+ NVLL K+ DFGL ++
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 167 SCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSID-QLYDKILNG 223
+ P + APE I Y ++DVWS G++L+ + G P+ ++ + Y + +G
Sbjct: 225 NARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283
Query: 224 KYTEPPWMSPNSRQIVRSML---QVEPGKRIKIQDLLGH 259
P +P I M +EP R Q +
Sbjct: 284 YQMAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSF 320
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 31/251 (12%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGE-----KVAIKIMKKATLGEDLPRVKLEINA 59
R++ +L + +G G F +V LA + + KVA+K++K +DL + E+
Sbjct: 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 127
Query: 60 LKHI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDH----------------IVERQR 102
+K I H++I L +++++EY G L ++ ++
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 103 LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
L K+ + Q+ + YL HRDL NVL+ + +K+ DFGL A+ ++
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL-ARDIHHIDY 246
Query: 163 QLQTSCGS-P-NYAAPEVIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYD 218
+T+ G P + APE + Y ++DVWS GV+L+ + G P+ +++L+
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304
Query: 219 KILNGKYTEPP 229
+ G + P
Sbjct: 305 LLKEGHRMDKP 315
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-Q 66
+ + + +G G F +++L ++ T E VAIK+ + P++ LE K +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGD 65
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--------RQILSA 118
I +++ + MV+E G L+ + + R F Q++S
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLC------DRTFSLKTVLMIAIQLISR 117
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLK-----LIDFGLCAK---PEGGL---ESQLQTS 167
+ Y+H +RD+KPEN L+ R N +IDF L + PE + ++
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177
Query: 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP---FDSDSIDQLYDKILNGK 224
G+ Y + GK+ D+ ++G M L G LP +D++ + Y KI + K
Sbjct: 178 TGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236
Query: 225 YTEPP 229
P
Sbjct: 237 RATPI 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 21/237 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-Q 66
N+Y L R +GSG F + L T + GE+VAIK+ T P++ +E K +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGV 65
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHH 124
I + + MV+E G L+ + + K Q++S + Y+H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 125 LGYAHRDLKPENVLLDRNQN---LKLIDFGLCAK---PEGGL---ESQLQTSCGSPNYAA 175
+ HRD+KP+N L+ + + +IDFGL K + + G+ YA+
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLP---FDSDSIDQLYDKILNGKYTEPP 229
G + D+ S+G +L G LP + + Q Y++I K + P
Sbjct: 184 INTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 60/272 (22%), Positives = 109/272 (40%), Gaps = 25/272 (9%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKL-EINALKH 62
RN IL + +G G F V KVA+K MK + L E +K
Sbjct: 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD 92
Query: 63 ISHQHICKLFQVI-----ETSSHIFMVIEYCPGGELLDHIVER------QRLGEKESRAF 111
SH ++ +L V + +++ + G+L +++ + + + F
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 112 FRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGS- 170
I + YL + + HRDL N +L + + + DFGL +K + Q
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL-SKKIYSGDYYRQGRIAKM 211
Query: 171 P-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEP 228
P + A E + + Y S++DVW+ GV ++ + G P+ ++YD +L+G +
Sbjct: 212 PVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270
Query: 229 PWMSPNSRQIVRSML---QVEPGKRIKIQDLL 257
P + ++ M + +P R L
Sbjct: 271 PEDCLD--ELYEIMYSCWRTDPLDRPTFSVLR 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 32/254 (12%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-HVLTGE----KVAIKIMKKATLGEDLPRVKLEINALK 61
R +L +T+G G F KV AT L G VA+K++K+ +L + E N LK
Sbjct: 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDH------------------------I 97
++H H+ KL+ + +++EY G L
Sbjct: 82 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 98 VERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157
+ + L + +F QI + YL + HRDL N+L+ + +K+ DFGL
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 158 GGLESQLQTSCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQ 215
++ P + A E + Y +++DVWS GV+L+ ++ G P+ ++
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 216 LYDKILNGKYTEPP 229
L++ + G E P
Sbjct: 261 LFNLLKTGHRMERP 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 60/250 (24%), Positives = 115/250 (46%), Gaps = 29/250 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGE-----KVAIKIMKKATLGEDLPRVKLEINA 59
R++ L + +G G F +V +A + + VA+K++K +DL + E+
Sbjct: 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 139
Query: 60 LKHI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDH----------------IVERQR 102
+K I H++I L +++++EY G L ++ V ++
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 103 LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
+ K+ + Q+ + YL HRDL NVL+ N +K+ DFGL A+ ++
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL-ARDINNIDY 258
Query: 163 QLQTSCGS-P-NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219
+T+ G P + APE + + Y ++DVWS GV+++ + G P+ +++L+
Sbjct: 259 YKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 220 ILNGKYTEPP 229
+ G + P
Sbjct: 318 LKEGHRMDKP 327
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 43/283 (15%)
Query: 7 RNQYILERTVGSGGFAKV--KLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALK 61
R L R +G G F +V + + +VA+K + + +D +E +
Sbjct: 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 88
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLD-------HIVERQRLGEKESRAFFRQ 114
+HQ+I + V S F+++E GG+L + L + R
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGL---------CAKPEGGLES 162
I YL + HRD+ N LL + K+ DFG+ K +
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-- 206
Query: 163 QLQTSCGSP-NYAAPEVIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDK 219
P + PE G + S+TD WS GV+L+ + G++P+ S S ++ +
Sbjct: 207 -------LPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257
Query: 220 ILNGKYTEPPWMSPNSRQIVRSML---QVEPGKRIKIQDLLGH 259
+ +G +PP P + R M Q +P R +L
Sbjct: 258 VTSGGRMDPPKNCPG--PVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 63/288 (21%), Positives = 102/288 (35%), Gaps = 51/288 (17%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGE---KVAIKIMKKATLGEDLPRVKLEINALK 61
+ +G F KV GE VAIK +K G + E
Sbjct: 8 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA 67
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRA----------- 110
+ H ++ L V+ + M+ YC G+L + +V R + S
Sbjct: 68 RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 111 -----FFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL---------CAKP 156
QI + + YL H+DL NVL+ N+K+ D GL
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 157 EGGLESQLQTSCGSP-NYAAPEVIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSI 213
L P + APE I GK + ++D+WS GV+L+ + G P+ S
Sbjct: 188 GNSL---------LPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 214 DQLYDKILNGKYTEPPWMSPN-SRQIVRSML---QVEPGKRIKIQDLL 257
+ + I N + P + + M+ P +R + +D+
Sbjct: 237 QDVVEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIH 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 60/250 (24%), Positives = 115/250 (46%), Gaps = 29/250 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGE-----KVAIKIMKKATLGEDLPRVKLEINA 59
R++ L + +G G F +V +A + + VA+K++K +DL + E+
Sbjct: 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 60 LKHI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDH----------------IVERQR 102
+K I H++I L +++++EY G L ++ V ++
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 103 LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
+ K+ + Q+ + YL HRDL NVL+ N +K+ DFGL A+ ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL-ARDINNIDY 212
Query: 163 QLQTSCGS-P-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDK 219
+T+ G P + APE + + Y ++DVWS GV+++ + G P+ +++L+
Sbjct: 213 YKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 220 ILNGKYTEPP 229
+ G + P
Sbjct: 272 LKEGHRMDKP 281
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 64/281 (22%), Positives = 108/281 (38%), Gaps = 43/281 (15%)
Query: 7 RNQYILERTVGSGGFAKV--KLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALK 61
R L R +G G F +V + + +VA+K + + +D +E +
Sbjct: 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 129
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLD-------HIVERQRLGEKESRAFFRQ 114
+HQ+I + V S F+++E GG+L + L + R
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGL---------CAKPEGGLES 162
I YL + HRD+ N LL + K+ DFG+ K +
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM-- 247
Query: 163 QLQTSCGSP-NYAAPEVIK-GKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDK 219
P + PE G + S+TD WS GV+L+ + G++P+ S S ++ +
Sbjct: 248 -------LPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298
Query: 220 ILNGKYTEPPWMSPNSRQIVRSML---QVEPGKRIKIQDLL 257
+ +G +PP P + R M Q +P R +L
Sbjct: 299 VTSGGRMDPPKNCPG--PVYRIMTQCWQHQPEDRPNFAIIL 337
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 7e-20
Identities = 57/237 (24%), Positives = 102/237 (43%), Gaps = 21/237 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQ 66
N++ L R +GSG F ++ L T++ T E+VAIK+ T P++ E + +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGT 63
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHH 124
I + + +V++ G L+ + ++L K Q+++ V ++H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 125 LGYAHRDLKPENVLLDRNQN---LKLIDFGLCAK---PEGGL---ESQLQTSCGSPNYAA 175
+ HRD+KP+N L+ + + +IDFGL K + + G+ YA+
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLP---FDSDSIDQLYDKILNGKYTEPP 229
G + D+ S+G +L L G LP + + Q Y+KI K
Sbjct: 182 VNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 52/245 (21%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-Q 66
Y + R +G G F + T++L ++VAIK + + D P+++ E K ++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCT 66
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFF--------RQILSA 118
I ++ + H +VI+ G L+ +++ R F +Q+L+
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLC------GRKFSVKTVAMAAKQMLAR 118
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLK-----LIDFGLCAK---PEGGL---ESQLQTS 167
V +H +RD+KP+N L+ R + ++DFG+ P + +
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP---FDSDSIDQLYDKILNGK 224
G+ Y + G++ D+ ++G + L G LP + + Q Y++I K
Sbjct: 179 SGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237
Query: 225 YTEPP 229
+ P
Sbjct: 238 QSTPL 242
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 33/255 (12%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-HVLTGE----KVAIKIMKKATLGEDLPRVKLEINALK 61
R + +GSG F KV AT + ++ +VA+K++K+ + + E+ +
Sbjct: 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 103
Query: 62 HI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLD-----------------------HI 97
+ SH++I L S I+++ EYC G+LL+
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 98 VERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157
+ L ++ F Q+ + +L HRDL NVL+ + +K+ DFGL
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 158 GGLESQLQTSCGSP-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSID- 214
++ + P + APE + + Y ++DVWS G++L+ + G P+ +D
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 215 QLYDKILNGKYTEPP 229
Y I NG + P
Sbjct: 283 NFYKLIQNGFKMDQP 297
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 54/265 (20%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGE---KVAIKIMKKATLGEDLPRVKLEINALK 61
RN R +G G F +V A +L E VA+K++K+ + + E +
Sbjct: 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--------------------- 100
+ +I KL V + ++ EY G+L + +
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 101 ---QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL----- 152
L E RQ+ + +AYL + HRDL N L+ N +K+ DFGL
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 153 -----CAKPEGGLESQLQTSCGSP-NYAAPEVIK-GKQYYGSETDVWSMGVMLYALL-CG 204
A + P + PE I + Y +E+DVW+ GV+L+ + G
Sbjct: 226 SADYYKADGNDAI----------PIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYG 273
Query: 205 FLPFDSDSIDQLYDKILNGKYTEPP 229
P+ + +++ + +G P
Sbjct: 274 LQPYYGMAHEEVIYYVRDGNILACP 298
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 56/250 (22%), Positives = 101/250 (40%), Gaps = 29/250 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLAT--HVLTGE---KVAIKIMKKATLGEDLPRVKLEINALK 61
R++ L + +G G F +V A + VA+K++K+ + + E+ L
Sbjct: 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 62 HI-SHQHICKLFQV-IETSSHIFMVIEYCPGGELLD----------------HIVERQRL 103
HI H ++ L + + +++E+C G L + + L
Sbjct: 86 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 104 GEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163
+ + Q+ + +L HRDL N+LL +K+ DFGL A+
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL-ARDIYKDPDY 204
Query: 164 LQTSCGS-P-NYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSID-QLYDK 219
++ P + APE I + Y ++DVWS GV+L+ + G P+ ID + +
Sbjct: 205 VRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 220 ILNGKYTEPP 229
+ G P
Sbjct: 264 LKEGTRMRAP 273
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 49/257 (19%), Positives = 93/257 (36%), Gaps = 37/257 (14%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
NQ++L + +GSGGF + LA EK A ++K ++ + E+ + ++ +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY--QENGPLFSELKFYQRVAKKD 94
Query: 68 ICKLFQVIETSSHI-------------------FMVIEYCPGGELLDHIVERQRLGEKES 108
K + + ++ FMV+E G +L + +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV 153
Query: 109 RAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK--LIDFGLCAK---PEGGL--- 160
++L + Y+H Y H D+K N+LL + L D+GL +
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP------FDSDSID 214
E+ + G+ + + + KG +DV +G + LCG LP
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272
Query: 215 QLYDKILNGKYTEPPWM 231
+ + + W
Sbjct: 273 AKTNLLDELPQSVLKWA 289
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 37/220 (16%)
Query: 16 VGSGGFAKV-KLATHVLTGEKVAIKIMKKATLGEDLPRVK---LEINALKHISHQHICKL 71
+G GGF V K + VA+K + + EI + H+++ +L
Sbjct: 39 MGEGGFGVVYK---GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS-------------A 118
+ +V Y P G LLD + LS
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG----------TPPLSWHMRCKIAQGAANG 145
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTS-CGSPNYAA 175
+ +LH + HRD+K N+LLD K+ DFGL A+ + ++ + + G+ Y A
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGL-ARASEKFA-QTVMTSRIVGTTAYMA 203
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ 215
PE ++G+ S D++S GV+L ++ G D Q
Sbjct: 204 PEALRGEITPKS--DIYSFGVVLLEIITGLPAVDEHREPQ 241
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 46/256 (17%), Positives = 86/256 (33%), Gaps = 39/256 (15%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTG--------EKVAIKIMKKATLGEDLPRVKLEINA 59
Q+ L+ + A T +K ++K+ K G A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA 99
Query: 60 LKHISHQHICKLFQV------------IETSSHIFMVIEYCPGGELLDHIVE---RQRLG 104
K + KL+ + + F+V+ G L ++ + L
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLS 157
Query: 105 EKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK--LIDFGLCAK--PEGG- 159
E+ ++L A+ +LH Y H ++ EN+ +D + L +G + P G
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 160 ---LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP---FDSDSI 213
+E G + + ++ KG +D+ S+G + L GFLP ++
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE 276
Query: 214 DQLYDKILNGKYTEPP 229
D + K P
Sbjct: 277 DIMKQKQKFVDKPGPF 292
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 67/256 (26%), Positives = 100/256 (39%), Gaps = 61/256 (23%)
Query: 13 ERTVGSGGFAKV---KLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISHQHI 68
+ +G G F KV L G KVA+K + G + EI L H H+
Sbjct: 44 KFLIGHGVFGKVYKGVLRD----GAKVALKRRTPESSQGI--EEFETEIETLSFCRHPHL 97
Query: 69 CKLFQVIETSSHIFMVIEYCPGGELLDHIVER----------QRLGEKESRAFFRQIL-- 116
L + + + ++ +Y G L H+ QRL +I
Sbjct: 98 VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EICIG 147
Query: 117 SA--VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK--PEGGLESQLQTSC-GSP 171
+A + YLH HRD+K N+LLD N K+ DFG+ +K E ++ L T G+
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI-SKKGTELD-QTHLSTVVKGTL 205
Query: 172 NYAAPE-VIKGKQYYGSETDVWSMGVMLYALLCGFLPFD-------------------SD 211
Y PE IKG+ S DV+S GV+L+ +LC +
Sbjct: 206 GYIDPEYFIKGRLTEKS--DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 212 SIDQLYDKILNGKYTE 227
++Q+ D L K
Sbjct: 264 QLEQIVDPNLADKIRP 279
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 47/265 (17%), Positives = 86/265 (32%), Gaps = 57/265 (21%)
Query: 8 NQYILERTVGSGGFAKVKLA-----THVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
+ + +G GGF + LA V + +K+ D + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS-----DNGPLFTELKFYQR 89
Query: 63 ISHQHICKLFQVIETSSHI-------------------FMVIEYCPGGELLDHIVERQRL 103
+ + + ++ FM+++ G L I E
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN-- 145
Query: 104 GEKESRAFFR--------QILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK--LIDFGLC 153
++ F R +IL + Y+H Y H D+K N+LL+ + L+D+GL
Sbjct: 146 ----AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 154 AK--PEGGL----ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP 207
+ PEG + G+ + + + G D+ +G + L G LP
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLP 260
Query: 208 ---FDSDSIDQLYDKILNGKYTEPP 229
D KI +
Sbjct: 261 WEDNLKDPKYVRDSKIRYRENIASL 285
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 68/248 (27%), Positives = 102/248 (41%), Gaps = 46/248 (18%)
Query: 16 VGSGGFAKV---KLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLF 72
+G GGF KV +LA G VA+K +K+ + + E+ + H+++ +L
Sbjct: 38 LGRGGFGKVYKGRLAD----GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 73 QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEK---ESRAFFRQILSA---VAYLH--- 123
T + +V Y G + + ER R R L + +AYLH
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR--QRIALGSARGLAYLHDHC 151
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-CGSPNYAAPE-VIKG 181
HRD+K N+LLD + DFGL AK ++ + T+ G+ + APE + G
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 210
Query: 182 KQYYGSE-TDVWSMGVMLYALLCGFLPFD---------------------SDSIDQLYDK 219
K SE TDV+ GVML L+ G FD ++ L D
Sbjct: 211 KS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267
Query: 220 ILNGKYTE 227
L G Y +
Sbjct: 268 DLQGNYKD 275
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 5e-12
Identities = 50/304 (16%), Positives = 91/304 (29%), Gaps = 66/304 (21%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIM-----------KKATLGED 49
+ + +G G F +V VAIKI+ + T E
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 50 LPRVKL-----EINALKHISHQHICKLFQV------------------------------ 74
LP + + ++ + L V
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 75 IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLK 133
+F+V+E+ GG L+ + + +++ Q+ +++A L + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQM-RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 134 PENVLLDRNQNLKLIDFGL---CAKPEGGLESQLQTSCGSP-----------NYAAPEVI 179
NVLL + KL P GL+ + S ++
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTEPPWMSPNSRQI 238
G Y + M + P+ + + L DK+L + +P +QI
Sbjct: 250 TGDGDYQFDI-YRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQI 308
Query: 239 VRSM 242
R +
Sbjct: 309 KRKI 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 45/197 (22%), Positives = 76/197 (38%), Gaps = 15/197 (7%)
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
L I+ +E S + E P D + + + Q+ +
Sbjct: 153 LDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC------YSFQVAKGM 206
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSP-NYAAPEV 178
+L HRDL N+LL +K+ DFGL + + P + APE
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 179 IKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID-QLYDKILNGKYTEPPWMSPNSR 236
I + Y ++DVWS GV+L+ + G P+ ID + ++ G P +
Sbjct: 267 IF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-- 323
Query: 237 QIVRSMLQ---VEPGKR 250
++ ++ML EP +R
Sbjct: 324 EMYQTMLDCWHGEPSQR 340
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 29/153 (18%), Positives = 60/153 (39%), Gaps = 11/153 (7%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALK 61
R++ L + +G G F +V A T VA+K++K+ + + E+ L
Sbjct: 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 80
Query: 62 HI-SHQHICKLF-QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
HI H ++ L + + +++E+C G L ++ ++ E + +
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR----NEFVPYKTKGARFR 136
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL 152
++G DLK + +Q+ F
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 3e-07
Identities = 84/538 (15%), Positives = 148/538 (27%), Gaps = 158/538 (29%)
Query: 2 KYIDLRN--------QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKA---TLGE-D 49
Y+ LR + +L G G K +A V KV K+ K L +
Sbjct: 136 PYLKLRQALLELRPAKNVL--IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 50 LPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKES- 108
P LE+ L+ + +Q + SS+I + I EL + + +
Sbjct: 194 SPETVLEM--LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ-AELRRLLKSKPY---ENCL 247
Query: 109 ------------RAF-FR-QIL------SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148
AF +IL +L H L ++ L ++ L
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL- 306
Query: 149 DFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP 207
L ++ T +P +++ +
Sbjct: 307 -LLKYLDCRPQDLPREVLT--TNP-------------------------RRLSIIAESIR 338
Query: 208 FDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG-- 265
+ D + + K T I S+ +EP + ++
Sbjct: 339 DGLATWDN-WKHVNCDKLT---------TIIESSLNVLEP-------AEYRKMFDRLSVF 381
Query: 266 PEDNPVSFRPDHEL-----REKDDDVIKVMAD-HKQLSPDDMWSQLNEWTYNYDTCTYLL 319
P + P L DV+ V+ HK S + + +
Sbjct: 382 PPSAHI---PTILLSLIWFDVIKSDVMVVVNKLHKY-------SLVEKQPKESTISIPSI 431
Query: 320 LLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFD--SDSIDQ-LYDKILSHFMPICTI 376
L K + + E + V Y + F D +DQ Y I H I
Sbjct: 432 YLELKVKLEN----EYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
Query: 377 LISQYFPTILLPCKVGQVINL------LRSAIVLCSAPSS-----------KQYYGSETD 419
F + L + +R +A S K Y
Sbjct: 488 ERMTLFRMVFL--------DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP 539
Query: 420 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477
+ ++ A+L FLP ++ + ++ KYT+ ++R L E
Sbjct: 540 KYER--LVNAIL-DFLP-------KIEENLICSKYTD----------LLRIALMAEDE 577
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 36/263 (13%), Positives = 80/263 (30%), Gaps = 87/263 (33%)
Query: 352 LPFDSDSIDQLYDKILSHFMPI------C--------TILISQYFPTIL-LPCKVGQVIN 396
+ F++ Y ILS F C +IL + I+ V +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 397 LLRSAIVLCSAPSS--KQYYGS--ETDVWSMGVMLYALLCGFL-------PFDSDSIDQL 445
L L S +++ + Y FL + ++
Sbjct: 67 LF---WTLLSKQEEMVQKFVEEVLRIN--------Y----KFLMSPIKTEQRQPSMMTRM 111
Query: 446 YDKILNGKYTEPPWMSPN--SR-----QIVRSMLQVEPGKRI------------------ 480
Y + + Y + + SR ++ +++L++ P K +
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 481 ---KIQDLLGHN--WVKMGPEDNPLREKDDDVIKVMAD-HKQLSPDDMWSQLNEWTYNY- 533
K+Q + W+ + ++P + V++++ Q+ P+ W+ ++ + N
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSP-----ETVLEMLQKLLYQIDPN--WTSRSDHSSNIK 224
Query: 534 -------DTCTYLLLLSRKKQGL 549
LL + L
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCL 247
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 19/70 (27%), Positives = 30/70 (42%), Gaps = 10/70 (14%)
Query: 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142
+++ Y G D I +++ +I V LH H DL N + D
Sbjct: 416 IMMSYINGKLAKDVI--------EDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD-- 465
Query: 143 QNLKLIDFGL 152
++L +IDFGL
Sbjct: 466 KDLYIIDFGL 475
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.96 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.96 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.95 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.94 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.94 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.94 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.91 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.91 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.91 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.9 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.9 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.9 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.9 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.9 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.9 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.9 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.89 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.89 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.89 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.89 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.89 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.89 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.89 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.89 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.89 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.88 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.88 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.88 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.88 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.88 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.88 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.88 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.87 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.87 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.87 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.87 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.87 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.87 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.87 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.87 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.87 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.87 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.87 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.86 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.86 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.86 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.86 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.86 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.86 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.86 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.86 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.85 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.85 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.85 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.85 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.85 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.85 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.85 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.85 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.85 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.85 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.85 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.85 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.85 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.85 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.85 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.85 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.85 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.85 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.85 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.85 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.85 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.85 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.85 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.84 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.84 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.84 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.84 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.84 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.84 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.84 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.84 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.84 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.84 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.84 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.84 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.84 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.84 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.84 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.84 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.83 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.83 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.83 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.83 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.83 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.83 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.82 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.82 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.82 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.82 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.82 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.82 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.82 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.82 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.82 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.81 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.81 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.81 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.81 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.81 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.81 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.81 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.81 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.81 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.81 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.81 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.8 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.8 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.8 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.8 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.8 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.8 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.8 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.8 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.8 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.8 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.8 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.8 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.79 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.79 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.79 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.79 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.79 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.79 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.79 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.79 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.78 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.78 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.78 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.78 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.77 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.77 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.77 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.77 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.76 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.76 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.76 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.76 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.76 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.76 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.76 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.75 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.75 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.75 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.75 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.74 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.74 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.74 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.74 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.74 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.74 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.74 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.74 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.74 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.74 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.74 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.73 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.73 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.73 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.73 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.73 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.73 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.73 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.73 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.73 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.73 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.73 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.73 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.73 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.72 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.72 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.72 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.72 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.72 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.72 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.72 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.72 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.71 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.71 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.71 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.71 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.71 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.71 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.71 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.71 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.71 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.7 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.7 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.7 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.7 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.7 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.7 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.7 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.7 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.7 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.7 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.69 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.69 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.69 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.69 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.69 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.68 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.68 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.67 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.67 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.67 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.67 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.67 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.67 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.67 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.67 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.66 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.66 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.65 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.65 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.65 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.65 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.64 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.64 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.62 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.62 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.62 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.61 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-64 Score=504.90 Aligned_cols=256 Identities=28% Similarity=0.565 Sum_probs=237.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ......+.+|+++|++++|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999986543 244678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC-Ccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG-LESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~ 164 (568)
|||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999865432 22345
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.|||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+++.+|.++.+.++..+++++++||.+||+
T Consensus 192 ~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~ 270 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLV 270 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSC
T ss_pred cCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHcc
Confidence 6779999999999998876 599999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCHHH------HhcCccccc
Q psy6203 245 VEPGKRIKIQD------LLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~~e------ll~hp~~~~ 264 (568)
+||.+|||++| |++||||+.
T Consensus 271 ~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 271 LDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp SSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999988 588999984
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-64 Score=496.86 Aligned_cols=254 Identities=50% Similarity=0.878 Sum_probs=222.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+.... .....+.+|+.+|++++|||||++++++++++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999999876543 23567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||| +|+|.+++.+++++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~ 169 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLK 169 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--CccC
Confidence 999 7899999999999999999999999999999999999999999999999999999999999999865432 3345
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
+.+||+.|+|||++.+..+++.++|||||||++|+|+||++||.+.+..++.+.+.++.+..+..+|+++++||.+||+.
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCS
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence 67899999999999988877889999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCHHHHhcCccccc
Q psy6203 246 EPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps~~ell~hp~~~~ 264 (568)
||++|||++|+++||||+.
T Consensus 250 dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 250 NPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SGGGSCCHHHHHHCHHHHT
T ss_pred ChhHCcCHHHHHcCccccc
Confidence 9999999999999999983
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-63 Score=499.72 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=232.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+..+.|++.++||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|++++|||||++++++++++.+|||
T Consensus 71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456789999999999999999999999999999999986543 3456688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||||+||+|.+++.. +++++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCCB
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-CCcc
Confidence 999999999998865 67999999999999999999999999999999999999999999999999999876543 2345
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIVRS 241 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~ 241 (568)
.+.+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+++..+..+... .+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 6779999999999998776 599999999999999999999999999998888888776433 334589999999999
Q ss_pred ccccCcCCCCCHHHHhcCcccccC
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
||+.||++|||++|+|+||||+..
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999853
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-63 Score=503.43 Aligned_cols=255 Identities=24% Similarity=0.504 Sum_probs=226.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++++.||+|+||+||+|+++.+|+.||||++.+..... ..+.+.+|+.+|++|+|||||++++++++++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999999999999999998765432 35678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||+||+|.++|..+ ..+++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~ 182 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELA 182 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-cccc
Confidence 99999999999754 35799999999999999999999999999999999999999999999999999865432 1233
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHcc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSML 243 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L 243 (568)
.+.+||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+++.++..+.++ .+..+|+++++||.+||
T Consensus 183 ~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 261 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 5668999999999998876 699999999999999999999999999999999999888764 55679999999999999
Q ss_pred ccCcCCCCCHHHHhcCccccc
Q psy6203 244 QVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.||++|||++|+|+||||+.
T Consensus 262 ~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 262 KRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CSSGGGSCCHHHHHTSHHHHT
T ss_pred cCChhHCcCHHHHhcCHHhhc
Confidence 999999999999999999973
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-63 Score=494.49 Aligned_cols=255 Identities=31% Similarity=0.606 Sum_probs=226.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
++|++++.||+|+||+||+|++. .+++.||+|++++.... .....+.+|+.+|++++|||||++++++++++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999984 46789999999865432 234467889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~ 182 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKK 182 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------CC
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC-Ccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999865432 234
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
..+.+||+.|||||++.+.. |+.++|||||||++|+|+||.+||.+.+..++...|.++.+..|..+|+++++||.+||
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 261 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 45678999999999998876 58999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCC-----HHHHhcCccccc
Q psy6203 244 QVEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rps-----~~ell~hp~~~~ 264 (568)
+.||++||| ++|+++||||+.
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999998 589999999984
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=500.35 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=232.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+..+.|+++++||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 556789999999999999999999999999999999986543 3456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||||+||+|.+++.. +.+++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... ....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRR 304 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCCB
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-Cccc
Confidence 999999999998864 67999999999999999999999999999999999999999999999999999876443 2344
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCChHHHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSRQIVRS 241 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~ 241 (568)
.+.+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+++..|..+.. ..+..+|+++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 6779999999999998776 69999999999999999999999999999888888877643 3345689999999999
Q ss_pred ccccCcCCCCCHHHHhcCcccccC
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
||+.||++|||++|+|+||||+..
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCC
Confidence 999999999999999999999843
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-61 Score=474.64 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=221.5
Q ss_pred cCe-EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEe----CCEE
Q psy6203 8 NQY-ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIET----SSHI 81 (568)
Q Consensus 8 ~~Y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~ 81 (568)
++| ++.++||+|+||+||+|.++.++..||+|++....... ....+.+|+.+|++|+|||||++++++++ .+.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 455 78889999999999999999999999999998655432 34678899999999999999999999875 3568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEcC-CCCeEEEeecCccCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~ 158 (568)
|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||++. +|.+||+|||+|+....
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999999999999999999999999999999999998 999999999999974 78999999999976433
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCChHH
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKYT--EPPWMSPNS 235 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~ 235 (568)
....+.+||+.|||||++.+. |+.++|||||||++|+|+||++||.+ .+...+...+..+..+ .+...++++
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~~--y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred ---CccCCcccCccccCHHHcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence 234567899999999998753 69999999999999999999999975 4566677777766543 345678999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++||.+||+.||++|||++|+|+||||+.
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999983
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-60 Score=479.05 Aligned_cols=251 Identities=26% Similarity=0.342 Sum_probs=222.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.+.|++.++||+|+||+||+|+++.+|+.||||+++..... .+|+.+|++++|||||++++++.+++.+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35699999999999999999999999999999999865432 369999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCccCCCCCCc----
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLE---- 161 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~---- 161 (568)
||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+.......
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 999999999999999999999999999999999999999999999999999999988 599999999986543211
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQI 238 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~l 238 (568)
......+||+.|||||++.+.. |+.++|||||||++|+|+||.+||.+.+..++...|..+..+ .++.+++++.+|
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 289 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHH
T ss_pred ecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHH
Confidence 1223458999999999999876 699999999999999999999999988777777778776653 467799999999
Q ss_pred HHHccccCcCCCCCHHHH-------------hcCccccc
Q psy6203 239 VRSMLQVEPGKRIKIQDL-------------LGHNWVKM 264 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~el-------------l~hp~~~~ 264 (568)
|.+||++||.+|||+.|+ |+|||+..
T Consensus 290 i~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 290 IQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 999999999999999997 57999873
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=464.55 Aligned_cols=314 Identities=41% Similarity=0.732 Sum_probs=275.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.+.... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999999999999999999876543 2355688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Ccc
Confidence 999999999999999899999999999999999999999999999999999999999999999999998765433 234
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
...+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+..++...+..+.+..|..+++++.+||++||+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLV 250 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCC
Confidence 56789999999999998876678999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCHHHHhcCcccccCCCCCCCCCCCCCcCCcCCHHHHHHHHhccCCCHHHHHHHHHhcCCChhHHHHHHHhh
Q psy6203 245 VEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLS 322 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 322 (568)
.||.+|||++|+++||||+...................++..+..+. ..+++.+++.+.+.+..++..+++|+||.+
T Consensus 251 ~dP~~R~t~~eil~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~y~ll~~ 327 (328)
T 3fe3_A 251 LNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMV-GMGYSQEEIQESLSKMKYDEITATYLLLGR 327 (328)
T ss_dssp SSTTTSCCHHHHTTCTTTTTTCTTCCCCCCCCCCCCCCCHHHHHHHH-HTTCCHHHHHHHHHTTCCSHHHHHHHHHTC
T ss_pred CChhHCcCHHHHhcCHhhcCCCcccccCcccCCCcCcccHHHHHHHH-HCCCCHHHHHHHHHcCCCCHHHHHHHHhcC
Confidence 99999999999999999986543322211112222334555555554 478999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-59 Score=482.66 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=225.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe------
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET------ 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 77 (568)
++.++|++++.||+|+||+||+|+++.+|+.||||++++.... .....+.+|+.+|++|+|||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 4568999999999999999999999999999999999765432 234567889999999999999999999764
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
.+.+|||||||+ |+|.+++..++.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367899999995 6899999988999999999999999999999999999999999999999999999999999998653
Q ss_pred CC---CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------
Q psy6203 158 GG---LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE------- 227 (568)
Q Consensus 158 ~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~------- 227 (568)
.. ......+.+||+.|+|||++.+..+++.++||||+|||+|+|++|++||.+.+..+.+..|.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 12334567999999999999988778999999999999999999999999999888777765421111
Q ss_pred ------------------------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 228 ------------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 228 ------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.+.+++++.+||.+||++||.+|||++|+|+||||+..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 12468899999999999999999999999999999853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-57 Score=463.01 Aligned_cols=256 Identities=25% Similarity=0.448 Sum_probs=213.0
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETS 78 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 78 (568)
..++.++|++.++||+|+||+||+|+++ .+++.||+|.+.+.. ....+.+|+++|+.+ +|||||++++++++.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 3567899999999999999999999875 467899999986543 345788999999998 699999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-CCeEEEeecCccCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKPE 157 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 157 (568)
+++|+|||||+||+|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999999999999998 469999999999999999999999999999999999999877 799999999997543
Q ss_pred CCC---------------------------ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC
Q psy6203 158 GGL---------------------------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS 210 (568)
Q Consensus 158 ~~~---------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~ 210 (568)
... .....+.+||+.|+|||++.+...|+.++||||+||++|+|++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 211 11234568999999999998877789999999999999999999999954
Q ss_pred -CCHHHHHHHHHc--------------------------------------CC----------------CCCCCCCChHH
Q psy6203 211 -DSIDQLYDKILN--------------------------------------GK----------------YTEPPWMSPNS 235 (568)
Q Consensus 211 -~~~~~~~~~i~~--------------------------------------~~----------------~~~~~~~~~~~ 235 (568)
.+..+....|.. .. ......+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 333333322211 00 01123478999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+|||++||++||.+|||++|+|+||||+.
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999983
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=458.78 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=204.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-------
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS------- 79 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------- 79 (568)
.++|++++.||+|+||+||+|+++.+|+.||||+++........+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3579999999999999999999999999999999976543334567889999999999999999999987544
Q ss_pred -----EEEEEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeec
Q psy6203 80 -----HIFMVIEYCPGGELLDHIVERQRL---GEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 80 -----~~~lV~E~~~~g~L~~~i~~~~~l---~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
.+|+|||||+||+|.+++..+..+ .+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 479999999999999999876554 456688999999999999999999999999999999999999999999
Q ss_pred CccCCCCCCc-----------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHH
Q psy6203 152 LCAKPEGGLE-----------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDK 219 (568)
Q Consensus 152 ~a~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~ 219 (568)
+|+....... ....+.+||+.|||||++.+.. |+.++|||||||++|||++ ||.+... ......
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 9986543211 1223458999999999998876 6999999999999999996 7865432 233444
Q ss_pred HHcCCCCC-CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 220 ILNGKYTE-PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 220 i~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+....++. .+..++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 55544431 1235678899999999999999999999999999984
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-57 Score=487.91 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=227.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHH---HHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKL---EINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~---Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
++|+++++||+|+||+||+|+++.+|+.||||++.+.... .....+.+ ++.+++.++|||||+++++|++.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 6899999999999999999999999999999999865431 22233333 466777889999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
||||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~--- 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCChHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEPPWMSPNSRQIV 239 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~li 239 (568)
...+.|||+.|||||++.+...|+.++|||||||++|+|++|.+||.+. +..++...+....+..+..+|+++++||
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI 425 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHH
Confidence 3456799999999999976555799999999999999999999999753 4566778888888889999999999999
Q ss_pred HHccccCcCCCCC-----HHHHhcCccccc
Q psy6203 240 RSMLQVEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 240 ~~~L~~dP~~Rps-----~~ell~hp~~~~ 264 (568)
.+||+.||.+|++ ++||++||||+.
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999998 799999999984
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-57 Score=449.28 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=220.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
+++|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+++|++++|||||++++++.+++.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 468999999999999999999875 357889999997543 22356789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 82 FMVIEYCPGGELLDHIVER-------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
|||||||++|+|.+++... ..+++.++..|+.||+.||.|||+++||||||||+|||++.++.+||+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-
Q psy6203 149 DFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY- 225 (568)
Q Consensus 149 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~- 225 (568)
|||+|+....... ......+||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..++...+..+..
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999975433211 1223346899999999998776 6999999999999999998 9999999999999999988764
Q ss_pred CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 226 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+.|..+++++.+|+.+||+.||++|||++|+ |+|++
T Consensus 250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 5677899999999999999999999999999 45665
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=454.06 Aligned_cols=316 Identities=42% Similarity=0.690 Sum_probs=274.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.+... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45799999999999999999999999999999999975432 2334578899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||+ +|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....+ ..
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~ 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NF 163 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BT
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--cc
Confidence 99999 7899999999899999999999999999999999999999999999999999999999999998865543 33
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
..+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.....+...+..+.+..+..+++++.+||.+||
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHc
Confidence 45678999999999999887668899999999999999999999988776666666666677778889999999999999
Q ss_pred ccCcCCCCCHHHHhcCcccccCCCCCCCCCCCCCcCCcCCHHHHHHHHhccCCCHHHHHHHHHhcCCChhHHHHHHHhhh
Q psy6203 244 QVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSR 323 (568)
Q Consensus 244 ~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 323 (568)
+.||.+|||++|+++||||+...... ............+.++...+.+..+++.+++.+.|.+..++..+++|.||..+
T Consensus 244 ~~dP~~Rpt~~eil~hp~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~y~ll~~~ 322 (336)
T 3h4j_B 244 VADPMQRITIQEIRRDPWFNVNLPDY-LRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALRSDENNEVKEAYNLLHEN 322 (336)
T ss_dssp CSSGGGSCCHHHHTTCHHHHTTCCGG-GSCCCCCCCCCCCHHHHHHHHHTTCCCHHHHHHHTTSSSCCSSTTHHHHHHHH
T ss_pred CCChhHCcCHHHHHhChhhccCCccc-cCCchhcccccCCHHHHHHHHHHcCCCHHHHHHHHhcCCCCHHHHHHHHHHhC
Confidence 99999999999999999998532211 11111222245577888888888899999999999999999999999999876
Q ss_pred hc
Q psy6203 324 KK 325 (568)
Q Consensus 324 ~~ 325 (568)
+.
T Consensus 323 ~~ 324 (336)
T 3h4j_B 323 QV 324 (336)
T ss_dssp HH
T ss_pred hh
Confidence 54
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-56 Score=445.33 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=220.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+++++.++||+|+||+||+|+.. .+++.||||+++........+.+.+|+.+|++++|||||++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 57899999999999999999853 4678999999976554455678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeE
Q psy6203 83 MVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK 146 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 146 (568)
||||||++|+|.+++..+ ..+++.++..|+.||+.||+|||+++||||||||+|||+++++.+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 999999999999999643 3589999999999999999999999999999999999999999999
Q ss_pred EEeecCccCCCCCC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q psy6203 147 LIDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK 224 (568)
Q Consensus 147 l~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~ 224 (568)
|+|||+|+...... .......+||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..++...+..+.
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~ 264 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 264 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999997643321 22334568999999999998776 6999999999999999998 899999999999999998876
Q ss_pred C-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 225 Y-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 225 ~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
. +.|+.+++++.+|+.+||+.||.+|||+.||+++
T Consensus 265 ~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 265 VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4 4567799999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=478.80 Aligned_cols=257 Identities=30% Similarity=0.604 Sum_probs=233.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.+.++|++++.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|+.|+|||||+++++|++.+.+|||
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 345799999999999999999999999999999999976542 2346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC--CCeEEEeecCccCCCCCCc
Q psy6203 85 IEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN--QNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~--~~~kl~DFG~a~~~~~~~~ 161 (568)
||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999999999999964 4679999999999999999999999999999999999999854 89999999999876543
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 237 (568)
....+.+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..|..+.+..+ ..+|+++++
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 3445678999999999999876 59999999999999999999999999999999999998876654 458999999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
||.+||+.||.+|||++|+|+||||+..
T Consensus 390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999999999999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=447.10 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=213.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
++|.+.++||+|+||+||+|+++ .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57899999999999999999865 368899999997543 223567899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEE
Q psy6203 83 MVIEYCPGGELLDHIVER---------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKL 147 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl 147 (568)
||||||++|+|.+++... +++++.++..|+.||+.||.|||+++||||||||+|||++.++.+||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 999999999999999753 35899999999999999999999999999999999999999999999
Q ss_pred EeecCccCCCCCC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-
Q psy6203 148 IDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK- 224 (568)
Q Consensus 148 ~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~- 224 (568)
+|||+|+...... .......+||+.|||||++.+.. ++.++|||||||++|||+| |+.||.+.+..++...+..+.
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~ 278 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999998654322 22234567999999999998876 6999999999999999999 999999999989888888774
Q ss_pred CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 225 YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 225 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
++.|..+++++.+|+.+||+.||++|||++||+.+
T Consensus 279 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 279 LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55677899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=439.07 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=204.7
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
.+++++.++||+|+||+||+|++. ..||||+++..... +..+.+.+|+.+|++++|||||++++++. .+.+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEE
Confidence 467889999999999999999853 36999998755433 23567899999999999999999999875 45689999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC-Cccc
Q psy6203 86 EYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG-LESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~ 163 (568)
|||+||+|.+++... .++++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+..... ....
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999999999999764 67999999999999999999999999999999999999999999999999999865432 1233
Q ss_pred cccccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC-----CCCCCChHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYT-----EPPWMSPNS 235 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~-----~~~~~~~~~ 235 (568)
..+.+||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+. ..+...+..+... .++.+++++
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l 270 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAM 270 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHH
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHH
Confidence 4567899999999999643 2368999999999999999999999987554 4444455444322 234578999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcC
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+|+.+||+.||++|||+.|++++
T Consensus 271 ~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 271 KRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=440.98 Aligned_cols=252 Identities=23% Similarity=0.428 Sum_probs=217.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCC-----cEEEEEEeecCCcCCchHHHHHHHHHHHhCCC-CCcceeeEEEEe-CC
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTG-----EKVAIKIMKKATLGEDLPRVKLEINALKHISH-QHICKLFQVIET-SS 79 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~-~~ 79 (568)
.++|++++.||+|+||+||+|.+..++ +.||||.+...........+.+|+.+|++++| ||||++++++.. .+
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 578999999999999999999986543 67999999765544445678899999999975 999999999865 45
Q ss_pred EEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ 143 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 143 (568)
.+|||||||++|+|.+++... ..+++.++..++.||+.||+|||+++||||||||+|||++.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 789999999999999999753 3489999999999999999999999999999999999999999
Q ss_pred CeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCC-HHHHHHHH
Q psy6203 144 NLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDS-IDQLYDKI 220 (568)
Q Consensus 144 ~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~-~~~~~~~i 220 (568)
.+||+|||+|+....... ....+.+||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+ ...+...+
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999986544322 2234567999999999998776 6999999999999999998 999998765 34555666
Q ss_pred HcCC-CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 221 LNGK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 221 ~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
..+. +..|+..++++.+|+.+||+.||++|||+.||++|
T Consensus 302 ~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6654 56677899999999999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=452.97 Aligned_cols=317 Identities=45% Similarity=0.746 Sum_probs=245.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|.+++.||+|+||.||+|++..+|+.||||++.+... .+....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999976432 23356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~~ 172 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFL 172 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CCB
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999999875442 234
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...+...+..+.+..+..+++++.+||.+||+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQ 252 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcC
Confidence 56789999999999998776688999999999999999999999999988999999999988888999999999999999
Q ss_pred cCcCCCCCHHHHhcCcccccCCCCCCCCCCCCCcCCcCCHHHHHHHHhccCCCHHHHHHHHHhc-CCChhHHHHHHHhhh
Q psy6203 245 VEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEW-TYNYDTCTYLLLLSR 323 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~ 323 (568)
.||.+|||++|+++||||+........+..+.......+++.+..+.+..+.+.+++.+.+.+. ..+..+++|.++..+
T Consensus 253 ~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~ 332 (476)
T 2y94_A 253 VDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDN 332 (476)
T ss_dssp SSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-------------------------------
T ss_pred CCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhc
Confidence 9999999999999999998432111111111111122233444444445567777787777664 467888999998776
Q ss_pred hc
Q psy6203 324 KK 325 (568)
Q Consensus 324 ~~ 325 (568)
+.
T Consensus 333 ~~ 334 (476)
T 2y94_A 333 RR 334 (476)
T ss_dssp CC
T ss_pred hh
Confidence 43
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=426.81 Aligned_cols=258 Identities=34% Similarity=0.592 Sum_probs=235.4
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhCCCCCcceeeEEEEe
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHISHQHICKLFQVIET 77 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 77 (568)
..++.++|++.+.||+|+||+||+|.++.+|+.||+|++.+..... ....+.+|+.+|++++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 3578899999999999999999999999999999999998765432 24678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC----CeEEEeecCc
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ----NLKLIDFGLC 153 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a 153 (568)
.+.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999999998888999999999999999999999999999999999999998777 7999999999
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----C
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----P 229 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~ 229 (568)
...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+..+.+..+ .
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred eEcCCC--CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 865543 2345568999999999998766 58999999999999999999999999999999999998877665 4
Q ss_pred CCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 230 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.+++.+++||.+||..||.+|||++|+++||||+
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 6899999999999999999999999999999997
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=423.39 Aligned_cols=255 Identities=31% Similarity=0.628 Sum_probs=234.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|+||+||+|+++.+|+.||+|++.+... ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999999976432 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .....
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~ 163 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CCccc
Confidence 99999999999998899999999999999999999999999999999999999999999999999998764332 22345
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+...+...+..+....+..+++++.+||.+||+.
T Consensus 164 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~ 242 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 678999999999998776 5899999999999999999999999999999999999998888889999999999999999
Q ss_pred CcCCCC-----CHHHHhcCccccc
Q psy6203 246 EPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rp-----s~~ell~hp~~~~ 264 (568)
||.+|| +++|+++||||+.
T Consensus 243 dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 243 DPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999 9999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=429.07 Aligned_cols=255 Identities=35% Similarity=0.680 Sum_probs=230.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ......+.+|..+++.+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 689999999999999999999999999999999986432 23456678899999988 699999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~~~ 181 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTT 181 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC------
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-Cccc
Confidence 999999999999999899999999999999999999999999999999999999999999999999998764332 2334
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+....+..+++++.+||++||+
T Consensus 182 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 260 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT 260 (353)
T ss_dssp ----CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 5678999999999998766 589999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCH------HHHhcCccccc
Q psy6203 245 VEPGKRIKI------QDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~------~ell~hp~~~~ 264 (568)
.||.+||++ +|+++||||+.
T Consensus 261 ~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 261 KNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp SSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred hCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999998 89999999984
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=422.59 Aligned_cols=256 Identities=31% Similarity=0.623 Sum_probs=234.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 83 (568)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++... ......+..|..++..+ +||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 3789999999999999999999999999999999986532 33456778899999876 89999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~ 174 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAK 174 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-CCc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998764332 223
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
..+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+....+..+++++.+||.+||
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 253 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred ccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHh
Confidence 45678999999999998876 58999999999999999999999999999999999999988888999999999999999
Q ss_pred ccCcCCCCCHH-HHhcCccccc
Q psy6203 244 QVEPGKRIKIQ-DLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rps~~-ell~hp~~~~ 264 (568)
+.||.+||++. ++++||||+.
T Consensus 254 ~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 254 VREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTT
T ss_pred cCCHhHcCCChHHHHcCccccC
Confidence 99999999998 9999999984
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=415.09 Aligned_cols=253 Identities=30% Similarity=0.622 Sum_probs=233.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 3689999999999999999999999999999999986432 23456788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VT 160 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CB
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----cc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999976543 23
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+..+....++.+++++.++|.+||+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 4568999999999998776 589999999999999999999999999999999999999888889999999999999999
Q ss_pred cCcCCCC-----CHHHHhcCccccc
Q psy6203 245 VEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
.||.+|| +++|+++||||+.
T Consensus 240 ~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 240 RDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred cCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999 9999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=424.46 Aligned_cols=255 Identities=33% Similarity=0.636 Sum_probs=229.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|+++++||+|+||+||+|+++.+++.||+|++++.... .....+..|..++.++ +||||+++++++.+.+.+|+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 6899999999999999999999999999999999876433 2345688899999877 899999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~ 210 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT 210 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCB
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-CCcc
Confidence 999999999999998899999999999999999999999999999999999999999999999999999763322 2345
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCChHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS---------DSIDQLYDKILNGKYTEPPWMSPNS 235 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (568)
.+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.. .....+.+.+..+....+..+++++
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 289 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred ccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHH
Confidence 5678999999999998876 58999999999999999999999953 2345577888888888999999999
Q ss_pred HHHHHHccccCcCCCCCH------HHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKI------QDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~------~ell~hp~~~~ 264 (568)
++||++||+.||.+||++ +|+++||||+.
T Consensus 290 ~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred HHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999999999999985 79999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=431.73 Aligned_cols=259 Identities=33% Similarity=0.661 Sum_probs=232.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..+.++|++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.++++++||||+++++++.+.+..|
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 45778999999999999999999999999999999999865532 23456889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc---CCCCeEEEeecCccCCCCC
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD---RNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~ 159 (568)
+|||||+||+|.+.+..++.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999999999999999999999999999999999999999999999999998 4578999999999766543
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCChHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNS 235 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~ 235 (568)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..++...+..+.+..+. .+++++
T Consensus 167 -~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 167 -QQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp -CCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred -CceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 22334568999999999998766 589999999999999999999999999999999999888766543 579999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 99999999999999999999999999973
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=418.64 Aligned_cols=256 Identities=30% Similarity=0.569 Sum_probs=233.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 83 (568)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ......+..|..++..+ +||||+++++++++.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 3689999999999999999999999999999999986532 23456788899999988 79999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~ 177 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVT 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-Ccc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999864322 223
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
..+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+....+..+++++.+||.+||
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 256 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 256 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 45678999999999998776 58999999999999999999999999999999999999999899999999999999999
Q ss_pred ccCcCCCCC-----HHHHhcCccccc
Q psy6203 244 QVEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rps-----~~ell~hp~~~~ 264 (568)
+.||.+||+ ++|+++||||+.
T Consensus 257 ~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 257 TKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred hcCHHHcCCCCCCCHHHHhcCccccC
Confidence 999999995 699999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=417.60 Aligned_cols=253 Identities=33% Similarity=0.631 Sum_probs=234.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999976532 23456788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC----c
Confidence 999999999999998889999999999999999999999999999999999999999999999999999865432 3
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+....+..+++++.+||.+||+
T Consensus 196 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred ccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 4568999999999998776 589999999999999999999999999999999999999988889999999999999999
Q ss_pred cCcCCCCC-----HHHHhcCccccc
Q psy6203 245 VEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps-----~~ell~hp~~~~ 264 (568)
.||.+||+ ++|+++||||+.
T Consensus 275 ~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred cCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999998 999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=414.52 Aligned_cols=255 Identities=33% Similarity=0.636 Sum_probs=229.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+..... ....+.+|+.+++++ +||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 68999999999999999999999999999999998765433 245678899999988 899999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ....
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~~~~ 167 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT 167 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-TCCB
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-CCcc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998764322 2234
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCChHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS---------DSIDQLYDKILNGKYTEPPWMSPNS 235 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (568)
.+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.. .....+...+..+....+..+++++
T Consensus 168 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 246 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 246 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHH
Confidence 5678999999999998876 58999999999999999999999965 3455677788888888888999999
Q ss_pred HHHHHHccccCcCCCCCH------HHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKI------QDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~------~ell~hp~~~~ 264 (568)
.+||.+||+.||.+||++ +|+++||||+.
T Consensus 247 ~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 999999999999999995 89999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=414.22 Aligned_cols=255 Identities=27% Similarity=0.512 Sum_probs=231.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 57899999999999999999999999999999999987432 2345688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC--CCCeEEEeecCccCCCCCCc
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR--NQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~ 161 (568)
||||+||+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-- 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence 9999999999999765 47999999999999999999999999999999999999987 789999999999876543
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 237 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+..+.+..+ +.+++++.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 2334567999999999998765 58999999999999999999999999999999999988877655 368999999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
||.+||..||.+|||+.|+|+||||+.
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 999999999999999999999999984
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=405.78 Aligned_cols=260 Identities=28% Similarity=0.472 Sum_probs=228.7
Q ss_pred CccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 2 ~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
...+..++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.++++++||||+++++++...+..
T Consensus 14 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp BSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 345678899999999999999999999999999999999976543 3456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 999999999999999865 469999999999999999999999999999999999999999999999999987654432
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCCCCCCCChHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---KYTEPPWMSPNSRQI 238 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~l 238 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... ....+..+++.+.+|
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred cccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 2344567999999999998876 589999999999999999999999888776655554432 233455689999999
Q ss_pred HHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
|.+||+.||.+|||++|+++||||+..
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=410.53 Aligned_cols=257 Identities=35% Similarity=0.615 Sum_probs=232.0
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHISHQHICKLFQVIETS 78 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 78 (568)
.++.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 467789999999999999999999999999999999998654321 356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC----CeEEEeecCcc
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ----NLKLIDFGLCA 154 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a~ 154 (568)
+..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999999998888999999999999999999999999999999999999998887 79999999998
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CC
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PW 230 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~ 230 (568)
..... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......+ ..
T Consensus 167 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp ECCTT--SCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred ECCCC--CccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 65432 2334567999999999998766 58999999999999999999999999998888888877766554 45
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 789999999999999999999999999999997
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=417.97 Aligned_cols=257 Identities=33% Similarity=0.644 Sum_probs=231.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+.++|++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.++++++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4567899999999999999999999999999999999866543 234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC---CeEEEeecCccCCCCCC
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---NLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~~~~~~~ 160 (568)
||||++||+|.+.+..+..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 999999999999998888999999999999999999999999999999999999997654 5999999999866532
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 236 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+.+..+. .+++++.
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred -cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 2334568999999999998766 589999999999999999999999999999999999888776543 4789999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||.+||+.||.+|||+.|+|+||||..
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999973
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=411.21 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=195.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC----EEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS----HIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~ 82 (568)
..+|.+.++||+|+||+||+|++ +|+.||||+++.... .....+.|+..+.+++|||||++++++.+++ .+|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 46799999999999999999986 689999999975431 1223445676677899999999999997653 689
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL--------GYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
||||||++|+|.+++.. ..++++.+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999999965 5699999999999999999999987 99999999999999999999999999987
Q ss_pred CCCCCCc---cccccccCCccccccccccCcc-----cCCcccceechhhHHHHHHhCCCCCCC---------------C
Q psy6203 155 KPEGGLE---SQLQTSCGSPNYAAPEVIKGKQ-----YYGSETDVWSMGVMLYALLCGFLPFDS---------------D 211 (568)
Q Consensus 155 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~~lltG~~pf~~---------------~ 211 (568)
....... ......+||+.|||||++.+.. .++.++|||||||++|||+||.+||.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 6443221 1223458999999999997642 257799999999999999999776532 1
Q ss_pred CHHHHHHHHHcCCCC--CCCC-----CChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 212 SIDQLYDKILNGKYT--EPPW-----MSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 212 ~~~~~~~~i~~~~~~--~~~~-----~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...++...+...... .|.. .++.+.+|+.+||+.||++|||+.||++
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 234455555444332 2221 2246789999999999999999999976
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=422.76 Aligned_cols=258 Identities=31% Similarity=0.585 Sum_probs=228.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976322 12344578899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...........
T Consensus 148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999999999998865 5799999999999999999999999999999999999999999999999999987654433334
Q ss_pred ccccCCccccccccccCcc---cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCCCCCCCChHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGKQ---YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----KYTEPPWMSPNSRQ 237 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~ 237 (568)
.+.+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+.......+..+ .++....+++++++
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 306 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHH
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHH
Confidence 5678999999999997654 2578999999999999999999999999999888888764 33444568999999
Q ss_pred HHHHccccCcCC--CCCHHHHhcCcccccC
Q psy6203 238 IVRSMLQVEPGK--RIKIQDLLGHNWVKMG 265 (568)
Q Consensus 238 li~~~L~~dP~~--Rps~~ell~hp~~~~~ 265 (568)
||.+||+.+|.+ |++++||++||||+..
T Consensus 307 li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 307 LICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999999988 9999999999999853
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=415.75 Aligned_cols=256 Identities=25% Similarity=0.475 Sum_probs=231.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||.||+|++..+++.||+|++.+... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3789999999999999999999999999999999976432 23456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~ 171 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQI 171 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CCB
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cce
Confidence 999999999999998889999999999999999999999999999999999999999999999999999865432 344
Q ss_pred ccccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCCCCCCCChHHHHHH
Q psy6203 165 QTSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDS---DSIDQLYDKILNGKYTEPPWMSPNSRQIV 239 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~li 239 (568)
.+.+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. ....++...+.......+..+++.+.+||
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li 251 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHH
Confidence 567899999999999742 2368899999999999999999999964 45667777788888888889999999999
Q ss_pred HHccccCcCCCCC-HHHHhcCccccc
Q psy6203 240 RSMLQVEPGKRIK-IQDLLGHNWVKM 264 (568)
Q Consensus 240 ~~~L~~dP~~Rps-~~ell~hp~~~~ 264 (568)
.+||+.||.+||+ ++++++||||+.
T Consensus 252 ~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 252 KKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999998 999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=399.55 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=218.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999998665433 24677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+++ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 159 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYS 159 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-ccccc
Confidence 9975 55555544 678999999999999999999999999999999999999999999999999999765432 22334
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCC-CCCCCHHHHHHHHHcC--CC-----------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KY----------------- 225 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~p-f~~~~~~~~~~~i~~~--~~----------------- 225 (568)
..+||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+....+... ..
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 567899999999998877679999999999999999987776 6666766666655331 00
Q ss_pred ----------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ----------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
...+.+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 112347889999999999999999999999999999983
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=407.85 Aligned_cols=256 Identities=30% Similarity=0.580 Sum_probs=222.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcC---CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLG---EDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
.++|++.+.||+|+||.||+|++. .+|+.||+|++++.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 478999999999999999999985 68999999999865432 234567789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 174 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD- 174 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 240 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 240 (568)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+..+....++.+++++.+||.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 253 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12334568999999999998766 58999999999999999999999999999999999999988888999999999999
Q ss_pred HccccCcCCCC-----CHHHHhcCccccc
Q psy6203 241 SMLQVEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
+||+.||.+|| +++|+++||||+.
T Consensus 254 ~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999 8999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=408.56 Aligned_cols=261 Identities=33% Similarity=0.576 Sum_probs=222.6
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35679999999999999999999999999999999999765544444568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC-Ccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG-LES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~ 162 (568)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754322 122
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCC--CCCCChHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTE--PPWMSPNSRQIV 239 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~~~--~~~~~~~~~~li 239 (568)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||...+.. ............. ...+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 3345689999999999988776678999999999999999999999765432 2233333333322 245899999999
Q ss_pred HHccccCcCCCCCHHHHhcCccccc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+||+.||.+|||++|+++||||+.
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHccCChhhCcCHHHHhhChhhcc
Confidence 9999999999999999999999984
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=415.63 Aligned_cols=256 Identities=32% Similarity=0.603 Sum_probs=225.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHH-HHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINA-LKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+..... ....+..|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999999999999999998765432 23455667666 567899999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~~~ 195 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NST 195 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-CCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-CCc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998753322 223
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
..+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+....++.+++++++||.+||
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL 274 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 274 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHT
T ss_pred cccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHc
Confidence 45678999999999998776 68999999999999999999999999999999999999988888899999999999999
Q ss_pred ccCcCCCCCH----HHHhcCccccc
Q psy6203 244 QVEPGKRIKI----QDLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rps~----~ell~hp~~~~ 264 (568)
+.||.+||++ .++++||||+.
T Consensus 275 ~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 275 QKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp CSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred ccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999997 69999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=423.10 Aligned_cols=259 Identities=29% Similarity=0.571 Sum_probs=227.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.++||+|+||+||+|+++.+++.||+|++.+... ......+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 4789999999999999999999999999999999976322 12234578899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 999999999999987 5789999999999999999999999999999999999999999999999999997655443333
Q ss_pred cccccCCcccccccccc----CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCC---CCCChH
Q psy6203 164 LQTSCGSPNYAAPEVIK----GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEP---PWMSPN 234 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~---~~~~~~ 234 (568)
....+||+.|+|||++. +...++.++|||||||++|+|++|..||.+.+..+....+... .+..+ ..++++
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 312 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHH
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHH
Confidence 44568999999999997 2334689999999999999999999999999998888888653 23333 348999
Q ss_pred HHHHHHHccccCcCC--CCCHHHHhcCcccccC
Q psy6203 235 SRQIVRSMLQVEPGK--RIKIQDLLGHNWVKMG 265 (568)
Q Consensus 235 ~~~li~~~L~~dP~~--Rps~~ell~hp~~~~~ 265 (568)
+++||++||..+|++ |++++|+++||||+..
T Consensus 313 ~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 313 AKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 999999999999988 9999999999999843
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=412.36 Aligned_cols=256 Identities=36% Similarity=0.630 Sum_probs=216.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
...++|++.+.||+|+||+||+|++..+|+.||+|++..... ....+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 456899999999999999999999999999999999976542 335788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC--eEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN--LKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 162 (568)
|||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... .
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~ 172 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 172 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--C
Confidence 999999999999998889999999999999999999999999999999999999987765 999999998743322 2
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCC--CCChHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPP--WMSPNSR 236 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~----~~~~~~~i~~~~~~~~~--~~~~~~~ 236 (568)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+ .......+....+..+. .+++++.
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence 23456799999999999887765556999999999999999999997643 45566667666665554 5799999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||.+||+.||.+|||+.|+++||||..
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 9999999999999999999999999963
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=411.56 Aligned_cols=257 Identities=33% Similarity=0.602 Sum_probs=224.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc----CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
.+.++|++.+.||+|+||+||+|.++.+|+.||||++..... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 356789999999999999999999999999999999975332 1235678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC---eEEEeecCc
Q psy6203 81 IFMVIEYCPGGELLDHIVER----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN---LKLIDFGLC 153 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a 153 (568)
+|+|||||+|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999999888653 35899999999999999999999999999999999999987654 999999999
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----C
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----P 229 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~ 229 (568)
....... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. ..++...+..+.+..+ .
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence 7655431 2234567999999999998776 589999999999999999999999875 4566777777766554 4
Q ss_pred CCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 230 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 68999999999999999999999999999999983
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=425.24 Aligned_cols=256 Identities=31% Similarity=0.622 Sum_probs=224.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3689999999999999999999999999999999986432 22345677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+++|+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~ 305 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GAT 305 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-Ccc
Confidence 9999999999999988999999999999999999999998 99999999999999999999999999998764332 233
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcc
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 243 (568)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+...+...+.......+..+++++.+||.+||
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 384 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 45678999999999998776 59999999999999999999999999999999999999988888999999999999999
Q ss_pred ccCcCCCC-----CHHHHhcCccccc
Q psy6203 244 QVEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
+.||.+|| |++|+++||||+.
T Consensus 385 ~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 385 KKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999999 9999999999984
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=404.13 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=208.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 57899999999999999999999999999999999876544455678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 87 YCPGGELLDHIVER------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 87 ~~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
|++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 997 5899998754 358999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------------
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY------------- 225 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~------------- 225 (568)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 163 -NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp -CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred -ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 22345578999999999987655799999999999999999999999998877766665431 10
Q ss_pred -------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 -------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+..+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 011246789999999999999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=400.07 Aligned_cols=255 Identities=31% Similarity=0.581 Sum_probs=219.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-------------------------chHHHHHHHHHHH
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-------------------------DLPRVKLEINALK 61 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------~~~~~~~Ei~~l~ 61 (568)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999997654211 1356889999999
Q ss_pred hCCCCCcceeeEEEEe--CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE
Q psy6203 62 HISHQHICKLFQVIET--SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL 139 (568)
Q Consensus 62 ~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 139 (568)
+++||||+++++++.+ .+..|+||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999999999999986 56899999999999998754 44679999999999999999999999999999999999999
Q ss_pred cCCCCeEEEeecCccCCCCCCccccccccCCccccccccccCccc--CCcccceechhhHHHHHHhCCCCCCCCCHHHHH
Q psy6203 140 DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY--YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 217 (568)
Q Consensus 140 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~ 217 (568)
+.++.+||+|||++....... ......+||+.|+|||++.+... ++.++|||||||++|+|++|..||...+...+.
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999987654321 22345679999999999976542 477899999999999999999999998888888
Q ss_pred HHHHcCCCCCC--CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 218 DKILNGKYTEP--PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 218 ~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
..+.......+ +.+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 87777655443 46899999999999999999999999999999996
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=416.96 Aligned_cols=258 Identities=29% Similarity=0.549 Sum_probs=225.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ......+.+|..++..++||||+++++++.+.+.+|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 4789999999999999999999999999999999976432 12334578899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 9999999999999875 479999999999999999999999999999999999999999999999999998765433323
Q ss_pred cccccCCccccccccccC------cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCC---CCCCC
Q psy6203 164 LQTSCGSPNYAAPEVIKG------KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTE---PPWMS 232 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~~~---~~~~~ 232 (568)
....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+.+..+.... ... +..++
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 299 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCC
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCC
Confidence 345689999999999973 2346899999999999999999999999999888888887532 222 35689
Q ss_pred hHHHHHHHHccccCcCCC---CCHHHHhcCcccccC
Q psy6203 233 PNSRQIVRSMLQVEPGKR---IKIQDLLGHNWVKMG 265 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~R---ps~~ell~hp~~~~~ 265 (568)
+++++||++||. +|.+| ++++|+++||||+..
T Consensus 300 ~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999999 99998 599999999999853
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=393.89 Aligned_cols=256 Identities=32% Similarity=0.612 Sum_probs=222.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.+.++|++.+.||+|+||.||+|.+..++..||+|++...........+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 46689999999999999999999999999999999998766555677899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE---cCCCCeEEEeecCccCCC
Q psy6203 85 IEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~ 157 (568)
|||+++|+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999999864 3679999999999999999999999999999999999999 456789999999987654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---CCCChH
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP---PWMSPN 234 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~ 234 (568)
.. ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+........ ..++++
T Consensus 179 ~~--~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 179 SD--EHSTNAAGTALYMAPEVFKRD--VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp ----------CTTGGGCCHHHHTTC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred Cc--ccCcCcccccCcCChHHhccC--CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence 32 223456799999999998643 58899999999999999999999999988888777766554432 347899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999983
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=392.33 Aligned_cols=258 Identities=33% Similarity=0.640 Sum_probs=232.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 5789999999999999999999999999999999999865543 234678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC---eEEEeecCccCCCCCC
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN---LKLIDFGLCAKPEGGL 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~~~ 160 (568)
||||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 9999999999999998899999999999999999999999999999999999999986655 999999998765432
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 236 (568)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+..+....+ ..+++++.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred -ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 2234567999999999998776 58999999999999999999999999999888888888766544 35789999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
+||.+||+.||.+|||++|+++||||+..
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=400.03 Aligned_cols=257 Identities=34% Similarity=0.606 Sum_probs=232.4
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHISHQHICKLFQVIETS 78 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 78 (568)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 456788999999999999999999999999999999998654332 356789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC----CeEEEeecCcc
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ----NLKLIDFGLCA 154 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a~ 154 (568)
+..++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999998888899999999999999999999999999999999999999888 79999999987
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CC
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PW 230 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~ 230 (568)
..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......+ ..
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 168 EIEDG--VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp ECCTT--CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ecCcc--ccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 65443 2234557999999999998766 58999999999999999999999999998888888888776654 46
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.++.+.+||.+||+.||.+|||++|+++||||+
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~ 277 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 889999999999999999999999999999997
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=405.27 Aligned_cols=259 Identities=34% Similarity=0.638 Sum_probs=211.0
Q ss_pred CCccccccCeEEE---eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEE
Q psy6203 1 MKYIDLRNQYILE---RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIE 76 (568)
Q Consensus 1 m~~~~~~~~Y~i~---~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~ 76 (568)
|+...+.++|++. +.||+|+||.||+|.++.+|+.||||++.+. ....+.+|+.+++.+. ||||+++++++.
T Consensus 1 m~~~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~ 76 (325)
T 3kn6_A 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFH 76 (325)
T ss_dssp -CCCHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CCCCcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 6777888999996 8899999999999999999999999999753 3456788999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC---CeEEEeecCc
Q psy6203 77 TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---NLKLIDFGLC 153 (568)
Q Consensus 77 ~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a 153 (568)
+.+..|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred cCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999998766 7999999999
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCC
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD-------SIDQLYDKILNGKYT 226 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~-------~~~~~~~~i~~~~~~ 226 (568)
...... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. ...++...+..+.+.
T Consensus 157 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 157 RLKPPD-NQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp EECCC-----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred eecCCC-CCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 765432 22345567899999999998776 589999999999999999999999764 345677888888776
Q ss_pred CCC----CCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 227 EPP----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 227 ~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.+. .+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 553 479999999999999999999999999999999853
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=401.94 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=214.8
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..+.++|++.+.||+|+||+||+|++. +|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 357799999999999999999999985 58999999997654332 2457889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||++ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 96 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 173 (311)
T 3niz_A 96 LVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-V 173 (311)
T ss_dssp EEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-C
T ss_pred EEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-c
Confidence 9999997 4788887664 45999999999999999999999999999999999999999999999999999865432 1
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC-------------
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKYT------------- 226 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~~------------- 226 (568)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.. +...
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 2334557899999999998766679999999999999999999999987665444444322 1100
Q ss_pred ---------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 ---------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 ---------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+.+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 01236789999999999999999999999999999984
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=391.67 Aligned_cols=256 Identities=39% Similarity=0.736 Sum_probs=232.9
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.++.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 4677899999999999999999999999999999999986543 446788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE---cCCCCeEEEeecCccCCCCCC
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~ 160 (568)
||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999999999999988999999999999999999999999999999999999999 78889999999998765433
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 236 (568)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+..+....+. .+++.+.
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred -cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 233456799999999998764 689999999999999999999999999998888888888776654 5899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||.+||+.||.+|||+.|+|+||||+.
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 9999999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=394.16 Aligned_cols=256 Identities=26% Similarity=0.588 Sum_probs=230.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||.||+|.+..++..||+|++...... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 47899999999999999999999999999999998754322 2345688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---cc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998654332 23
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
....||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.......+..+++.+.+||.+||+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 243 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 243 (279)
T ss_dssp ---CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCC
T ss_pred cccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhc
Confidence 4457899999999998765 588999999999999999999999999999999999988888888999999999999999
Q ss_pred cCcCCCCCHHHHhcCcccccCC
Q psy6203 245 VEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~~~ 266 (568)
.||.+|||+.|+++||||+...
T Consensus 244 ~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 244 HNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp SSGGGSCCHHHHHHCHHHHHHC
T ss_pred cChhhCCCHHHHhhCccccCCc
Confidence 9999999999999999998543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=407.74 Aligned_cols=254 Identities=32% Similarity=0.610 Sum_probs=224.0
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 82 (568)
..+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+... ...+|+.++.++ +||||+++++++.+.+.+|
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 3567899999999999999999999999999999999986542 234688888887 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-C---CeEEEeecCccCCCC
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-Q---NLKLIDFGLCAKPEG 158 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~---~~kl~DFG~a~~~~~ 158 (568)
+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..+ + .+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988899999999999999999999999999999999999998543 3 599999999986543
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCCCC----CCC
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS---DSIDQLYDKILNGKYTEP----PWM 231 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~---~~~~~~~~~i~~~~~~~~----~~~ 231 (568)
. .....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+ .+..++...+..+.+..+ ..+
T Consensus 173 ~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 173 E-NGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp T-TCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred C-CCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 2 22345668999999999998765 58899999999999999999999975 467788888888877654 458
Q ss_pred ChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 232 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++++++||.+||+.||.+|||+.|+++||||..
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999999999999999999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=424.32 Aligned_cols=257 Identities=35% Similarity=0.649 Sum_probs=229.8
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC------------CchHHHHHHHHHHHhCCCCCccee
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG------------EDLPRVKLEINALKHISHQHICKL 71 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~Ei~~l~~l~hpnIv~l 71 (568)
..+.++|+++++||+|+||+||+|.++.+++.||+|++.+.... .....+.+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 35778999999999999999999999999999999999865432 234678899999999999999999
Q ss_pred eEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC---CeEEE
Q psy6203 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---NLKLI 148 (568)
Q Consensus 72 ~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~ 148 (568)
++++.+.+.+|+|||||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999999889999999999999999999999999999999999999998776 69999
Q ss_pred eecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy6203 149 DFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP 228 (568)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~ 228 (568)
|||++...... ......+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..++...+..+.+..+
T Consensus 192 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 192 DFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCTTCEECCTT--SCBCCCCSCTTTCCHHHHTTC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ECCCCEEcCCC--CccccccCCcCCCCHHHhccC--CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999866543 234556799999999998753 68999999999999999999999999999999999998887655
Q ss_pred ----CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 ----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 ----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+++++++||++||+.||.+|||++|+|+||||+.
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 568999999999999999999999999999999984
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=414.68 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=209.1
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCC-CCCcceeeEEEEeCC--E
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHIS-HQHICKLFQVIETSS--H 80 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~--~ 80 (568)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3568999999999999999999999999999999998654322 23456778999999997 999999999997554 7
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC-
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG- 159 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 159 (568)
+|+||||++ ++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 899999996 689888865 57999999999999999999999999999999999999999999999999998754221
Q ss_pred -------------------CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6203 160 -------------------LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI 220 (568)
Q Consensus 160 -------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i 220 (568)
........+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1112344689999999999987666799999999999999999999999998877666665
Q ss_pred HcC--CC---------------------------------------------CCCCCCChHHHHHHHHccccCcCCCCCH
Q psy6203 221 LNG--KY---------------------------------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKI 253 (568)
Q Consensus 221 ~~~--~~---------------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~ 253 (568)
... .+ ..+...++++.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 421 00 0112568899999999999999999999
Q ss_pred HHHhcCccccc
Q psy6203 254 QDLLGHNWVKM 264 (568)
Q Consensus 254 ~ell~hp~~~~ 264 (568)
+|+|+||||+.
T Consensus 324 ~e~l~Hp~~~~ 334 (388)
T 3oz6_A 324 NDALKHPFVSI 334 (388)
T ss_dssp HHHTTSTTTTT
T ss_pred HHHhCCHHHHH
Confidence 99999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=408.08 Aligned_cols=258 Identities=28% Similarity=0.521 Sum_probs=228.5
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+.+..++
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 3566899999999999999999999999999999999975432 234568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC--CCCeEEEeecCccCCCCCC
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR--NQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~~~~~~~ 160 (568)
||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 99999999999998765 47999999999999999999999999999999999999974 467999999999875443
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 236 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....+..+ ..+++++.
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred -cceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 2334557999999999998766 58999999999999999999999999988888888877765443 35799999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
+||.+||+.||.+|||+.|+|+||||+..
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 99999999999999999999999999843
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=411.53 Aligned_cols=263 Identities=23% Similarity=0.359 Sum_probs=219.1
Q ss_pred ccccccCeEEEeeeccc--CCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q psy6203 3 YIDLRNQYILERTVGSG--GFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSS 79 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 79 (568)
+..-.++|++.+.||+| +||.||+|++..+|+.||||++....... ....+.+|+.++++++||||+++++++.+.+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 34567899999999999 99999999999999999999998665432 3456788999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999875 679999999999999999999999999999999999999999999999999875432
Q ss_pred CC------CccccccccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----
Q psy6203 158 GG------LESQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY----- 225 (568)
Q Consensus 158 ~~------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~----- 225 (568)
.. ........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+..+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 11122334789999999999873 3468999999999999999999999977554333322222111
Q ss_pred -----------------------------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 -----------------------------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 -----------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.+..+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 123447889999999999999999999999999999985
Q ss_pred C
Q psy6203 265 G 265 (568)
Q Consensus 265 ~ 265 (568)
.
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=394.41 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=214.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++.+.||+|+||+||+|++ .+|+.||+|++...... .....+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 68899999999765432 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYT 158 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-ccccc
Confidence 9965 899888764 67999999999999999999999999999999999999999999999999998754322 12234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC------------------
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY------------------ 225 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~------------------ 225 (568)
..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 4578999999999987666799999999999999999999999988776665555321 00
Q ss_pred ---------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ---------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.....+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 011347889999999999999999999999999999983
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=390.20 Aligned_cols=256 Identities=30% Similarity=0.598 Sum_probs=233.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 3789999999999999999999999999999999975432 22346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---CB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc---cc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998654432 23
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
...+|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.......++.+++++.++|.+||+
T Consensus 170 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLR 248 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSC
T ss_pred ccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhh
Confidence 4557999999999998766 589999999999999999999999999988888889888888888999999999999999
Q ss_pred cCcCCCCCHHHHhcCcccccCC
Q psy6203 245 VEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~~~ 266 (568)
.||.+|||++|+++||||+...
T Consensus 249 ~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 249 YHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp SSGGGSCCHHHHHTCHHHHHHC
T ss_pred cCHhhCCCHHHHhhCHHHHhhc
Confidence 9999999999999999998543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=388.92 Aligned_cols=256 Identities=50% Similarity=0.842 Sum_probs=225.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .+....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999975432 23456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~ 167 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFL 167 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--cce
Confidence 999999999999998889999999999999999999999999999999999999999999999999998765442 223
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
...+||+.|+|||++.+....+.++||||||+++|+|++|..||...+.......+..+....+..+++.+.++|.+||+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 247 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHcc
Confidence 45578999999999988765578999999999999999999999999988888899888888888899999999999999
Q ss_pred cCcCCCCCHHHHhcCccccc
Q psy6203 245 VEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~ 264 (568)
.||.+|||+.|+++||||+.
T Consensus 248 ~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 248 VDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp SSGGGSCCHHHHHHSHHHHT
T ss_pred CChhhCCCHHHHHhChhhcc
Confidence 99999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=422.85 Aligned_cols=258 Identities=34% Similarity=0.655 Sum_probs=230.4
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc-CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..+.++|++.+.||+|+||+||+|.+..+|+.||||++.+... ......+.+|+.++++++||||+++++++.+.+.+|
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 3567899999999999999999999999999999999975432 234667889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc---CCCCeEEEeecCccCCCCC
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD---RNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~ 159 (568)
+|||||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999999999889999999999999999999999999999999999999995 4567999999999765443
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNS 235 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~ 235 (568)
......+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..++...+..+.+..+ ..+++++
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp ------CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred --CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 234456799999999999864 68999999999999999999999999999999999988876543 3479999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
++||.+||+.||.+|||+.|+|+||||+..
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999853
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=402.89 Aligned_cols=254 Identities=39% Similarity=0.669 Sum_probs=210.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 46788999999999999999999999999999999998643 234677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---CCCeEEEeecCccCCCCCCc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~~~~~~~ 161 (568)
|||+++++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-- 204 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-- 204 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--
Confidence 999999999999988888999999999999999999999999999999999999975 889999999998765432
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCC----CCCChHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYTEP----PWMSPNSR 236 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~~~----~~~~~~~~ 236 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+..+....+ ..+++++.
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp --------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 2234567999999999998776 58999999999999999999999976544 446677777665433 45789999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||.+||+.||++|||+.|+|+||||..
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=421.93 Aligned_cols=256 Identities=36% Similarity=0.666 Sum_probs=226.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+.++|++++.||+|+||+||+|+++.++..||+|++.+.... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4567899999999999999999999999999999999876432 345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC---CCeEEEeecCccCCCCCC
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN---QNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~ 160 (568)
|||||+||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 99999999999999988999999999999999999999999999999999999999764 45999999998765433
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 236 (568)
......+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..++...+..+.+..+ ..+++.++
T Consensus 193 -~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHTTC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred -ccccccCCCcCeeCHHHHccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 234556899999999998743 68999999999999999999999999999999999988876654 35899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||.+||+.||.+|||+.|+|+||||+.
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCccccc
Confidence 9999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=395.89 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=216.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 3579999999999999999999999999999999987654322 245677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYY 159 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-ccc
Confidence 9999999999998888889999999999999999999999999999999999999999999999999987654321 223
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------------
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--------------------- 223 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--------------------- 223 (568)
...+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 45578999999999987666799999999999999999999999988766655443221
Q ss_pred CCCC----------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 KYTE----------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 ~~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+. .+.+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 0111 1347888999999999999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=424.22 Aligned_cols=256 Identities=36% Similarity=0.685 Sum_probs=232.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.+.... .....+.+|+.++++++||||+++++++.+.+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4668899999999999999999999999999999999866442 34667899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE---cCCCCeEEEeecCccCCCCC
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 159 (568)
+|||||.+|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999999998999999999999999999999999999999999999999 46789999999998765443
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNS 235 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~ 235 (568)
......+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..++...+..+.+..+ ..+++++
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 183 --KKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp --CSHHHHTTGGGTCCHHHHHTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred --cccccCCCCccccCceeecCC--CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 233456799999999999763 68999999999999999999999999999999999988876543 3489999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++||.+||+.||.+|||+.|+|+||||+.
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 99999999999999999999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=388.43 Aligned_cols=261 Identities=34% Similarity=0.585 Sum_probs=235.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998654332 3456788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-c
Confidence 999999999999999888899999999999999999999999999999999999999999999999999987654321 2
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHc
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 242 (568)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+..+....+..+++.+.++|.+|
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHH
Confidence 234457999999999998766 5889999999999999999999999999888888888888888888999999999999
Q ss_pred cccCcCCCCCHHHHhcCcccccCCC
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVKMGPE 267 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~~~~~ 267 (568)
|+.||++|||++|+++||||.....
T Consensus 250 l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 250 LQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred cccChhhCcCHHHHhhChheecCCc
Confidence 9999999999999999999985543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=434.76 Aligned_cols=255 Identities=31% Similarity=0.576 Sum_probs=234.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++++.||+|+||+||+|+++.+++.||||++++... ......+..|..++..+ +||||+++++++++.+.+|||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 679999999999999999999999999999999986432 33456788899999988 699999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~ 499 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTT 499 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT-TCCB
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC-Cccc
Confidence 999999999999998899999999999999999999999999999999999999999999999999999854322 2334
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..++++.|..+....+..+++++.+||++||+
T Consensus 500 ~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~ 578 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 578 (674)
T ss_dssp CCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSC
T ss_pred ccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 5678999999999998776 599999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCH-----HHHhcCccccc
Q psy6203 245 VEPGKRIKI-----QDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~-----~ell~hp~~~~ 264 (568)
.||.+||++ +||++||||+.
T Consensus 579 ~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 579 KHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp SSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CCHHHCCCCCCCcHHHHhcCccccC
Confidence 999999997 99999999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=395.58 Aligned_cols=259 Identities=32% Similarity=0.624 Sum_probs=219.9
Q ss_pred ccccCeEEE-eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILE-RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 82 (568)
.+.++|++. +.||+|+||+||+|.+..+++.||||++.... ......+.+|+.++.++ +||||+++++++.+.+.+|
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 567899995 78999999999999999999999999997653 23456788999999985 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC---eEEEeecCccCCCCC
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN---LKLIDFGLCAKPEGG 159 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~~ 159 (568)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999998889999999999999999999999999999999999999988776 999999998754321
Q ss_pred C------ccccccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCC---------------HH
Q psy6203 160 L------ESQLQTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDS---------------ID 214 (568)
Q Consensus 160 ~------~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~---------------~~ 214 (568)
. .......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+ ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 1 112234569999999999874 1236889999999999999999999997653 34
Q ss_pred HHHHHHHcCCCCCC----CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 215 QLYDKILNGKYTEP----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 215 ~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+...+..+.+..+ ..+++.+++||.+||+.||.+|||+.|+++||||+.
T Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 56677777776655 358999999999999999999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=401.10 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=212.5
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
..++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4579999999999999999999999999999999997654332 234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc-----CCCCeEEEeecCccCCCCC
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD-----RNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-----~~~~~kl~DFG~a~~~~~~ 159 (568)
|||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 112 ~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 99996 59999999888999999999999999999999999999999999999994 4455999999998764432
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCC---------
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEP--------- 228 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~--------- 228 (568)
.......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... .....
T Consensus 191 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 191 -IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 123345578999999999987666799999999999999999999999988877666555431 11000
Q ss_pred -------------------CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 -------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 -------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 116789999999999999999999999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=422.33 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=229.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 4689999999999999999999999999999999976432 23455678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--~ 340 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--Q 340 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC--c
Confidence 99999999999997654 4999999999999999999999999999999999999999999999999999875433 2
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCChHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQI 238 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~l 238 (568)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. ....+...+.......+..+++++++|
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 334568999999999998866 589999999999999999999999875 356677777777777888899999999
Q ss_pred HHHccccCcCCCC-----CHHHHhcCccccc
Q psy6203 239 VRSMLQVEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 239 i~~~L~~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
|.+||+.||.+|| +++|+++||||+.
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999 8999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=400.04 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=211.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||+||+|.+..+++.||+|++...........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999999999999999997554332222345699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 159 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDN 159 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-cccccc
Confidence 96 5898888765 45999999999999999999999999999999999999999999999999998764432 223345
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC------------------
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT------------------ 226 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~------------------ 226 (568)
.+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... ...
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 578999999999987666799999999999999999999999998877766655431 110
Q ss_pred ----------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 227 ----------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 227 ----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
..+.+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 012468899999999999999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=392.76 Aligned_cols=259 Identities=37% Similarity=0.702 Sum_probs=228.2
Q ss_pred CCccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 1 m~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
|...++.++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 2 m~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp ----CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CcccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 5567788999999999999999999999999999999999986432 233568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE---cCCCCeEEEeecCccCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~ 157 (568)
.|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999988899999999999999999999999999999999999999 778899999999987543
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCh
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSP 233 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 233 (568)
.. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+...+...+..+.+..+ ..+++
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred CC---ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 32 234457999999999998766 58999999999999999999999999998888888888765433 45789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+.+||.+||+.||.+|||++|+++||||..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=410.45 Aligned_cols=263 Identities=28% Similarity=0.440 Sum_probs=213.5
Q ss_pred CccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC--
Q psy6203 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS-- 78 (568)
Q Consensus 2 ~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-- 78 (568)
+..++.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+|++++||||+++++++...
T Consensus 20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 4456889999999999999999999999999999999999754322 2346788999999999999999999999766
Q ss_pred ---CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccC
Q psy6203 79 ---SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK 155 (568)
Q Consensus 79 ---~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 155 (568)
+.+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 57999999995 69999998888899999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCc---------------------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhC----------
Q psy6203 156 PEGGLE---------------------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG---------- 204 (568)
Q Consensus 156 ~~~~~~---------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG---------- 204 (568)
...... ......+||+.|+|||++.+...++.++|||||||++|+|++|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 543211 1235668999999999976666679999999999999999984
Q ss_pred -CCCCCCCCH-----------------HHHHHHH------------------------HcCCCCC-------CCCCChHH
Q psy6203 205 -FLPFDSDSI-----------------DQLYDKI------------------------LNGKYTE-------PPWMSPNS 235 (568)
Q Consensus 205 -~~pf~~~~~-----------------~~~~~~i------------------------~~~~~~~-------~~~~~~~~ 235 (568)
.++|.+.+. ......+ ....... .+.+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 444544320 1111111 1111111 13579999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.+||.+||+.||.+|||++|+|+||||+..
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 999999999999999999999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=395.32 Aligned_cols=260 Identities=34% Similarity=0.591 Sum_probs=235.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34678999999999999999999999999999999998654332 3456888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-c
Confidence 999999999999999888899999999999999999999999999999999999999999999999999987654321 2
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHc
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 242 (568)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+..+.+..+..+++.+.+||.+|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 234567999999999998766 5889999999999999999999999998888888888888888888999999999999
Q ss_pred cccCcCCCCCHHHHhcCcccccCC
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
|+.||.+|||++|+++||||....
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=391.88 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=214.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC----CchHHHHHHHHHHHhCC---CCCcceeeEEEEeC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG----EDLPRVKLEINALKHIS---HQHICKLFQVIETS 78 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~ 78 (568)
+.++|++.+.||+|+||+||+|++..+|+.||+|++...... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 568999999999999999999999999999999998754321 12346777888877764 99999999999876
Q ss_pred C-----EEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeec
Q psy6203 79 S-----HIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 79 ~-----~~~lV~E~~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
. ..++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 5899999996 699999987654 9999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---
Q psy6203 152 LCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT--- 226 (568)
Q Consensus 152 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~--- 226 (568)
++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ...
T Consensus 166 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 166 LARIYSYQ--MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CTTTSTTC--CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccCCC--cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99765432 2335567999999999998776 589999999999999999999999998887776666431 100
Q ss_pred ----------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 ----------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 ----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 01347889999999999999999999999999999984
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=402.49 Aligned_cols=252 Identities=33% Similarity=0.553 Sum_probs=222.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-------chHHHHHHHHHHHhCCCCCcceeeEEEEe
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-------DLPRVKLEINALKHISHQHICKLFQVIET 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 77 (568)
++.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45679999999999999999999999999999999998764322 23456779999999999999999999999
Q ss_pred CCEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 78 SSHIFMVIEYCPGG-ELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 78 ~~~~~lV~E~~~~g-~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
.+..++||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999766 99999988889999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHH
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSR 236 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (568)
... ......+||+.|+|||++.+..+++.++|||||||++|+|++|..||.... .........+..+++++.
T Consensus 181 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 181 ERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELM 252 (335)
T ss_dssp CTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHH
T ss_pred CCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHH
Confidence 443 233456799999999999887766889999999999999999999997532 223344555667899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||.+||+.||.+|||++|+++||||+.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccC
Confidence 9999999999999999999999999984
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=399.22 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=219.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEe------
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIET------ 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 77 (568)
+..++|++.+.||+|+||+||+|++..+|+.||+|++....... ....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45689999999999999999999999999999999987654332 34567889999999999999999999977
Q ss_pred --CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 78 --SSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 78 --~~~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
.+.+|+||||+++ +|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4568999999965 777777653 679999999999999999999999999999999999999999999999999987
Q ss_pred CCCCC---CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-
Q psy6203 155 KPEGG---LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW- 230 (568)
Q Consensus 155 ~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~- 230 (568)
..... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+.......++.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 64322 11223455789999999999876667999999999999999999999999988777666654321111110
Q ss_pred -------------------------------CChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 231 -------------------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 231 -------------------------------~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
.++.+.+||.+||+.||.+|||++|+|+||||+..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 267799999999999999999999999999998543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=419.28 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=229.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ......+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3789999999999999999999999999999999976532 23456788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 85 IEYCPGGELLDHIVER----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999999999763 469999999999999999999999999999999999999999999999999998654432
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. ...++...+.......+..+++.+.
T Consensus 344 -~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 421 (543)
T 3c4z_A 344 -TKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421 (543)
T ss_dssp -CCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred -cccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHH
Confidence 2234568999999999998866 689999999999999999999999765 4577888888888888889999999
Q ss_pred HHHHHccccCcCCCCC-----HHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps-----~~ell~hp~~~~ 264 (568)
+||.+||+.||.+||+ ++++++||||+.
T Consensus 422 ~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999999996 589999999984
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=414.28 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=200.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe-----C
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET-----S 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~ 78 (568)
.+.++|++++.||+|+||+||+|.++.+|+.||||++.+.... .....+.+|+.+|++++||||+++++++.. .
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 4568999999999999999999999999999999998754322 234678899999999999999999999843 3
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
+.+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 5799999998 679999998888899999999999999999999999999999999999999999999999999986532
Q ss_pred CCc--------------------------cccccccCCccccccccccCcccCCcccceechhhHHHHHHh---------
Q psy6203 159 GLE--------------------------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC--------- 203 (568)
Q Consensus 159 ~~~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt--------- 203 (568)
... ......+||+.|+|||++.+...++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 211 123455789999999987655557999999999999999998
Q ss_pred --CCCCCCCCCH--------------------HHHHHHHHc--CCC-----------------------------CCCCC
Q psy6203 204 --GFLPFDSDSI--------------------DQLYDKILN--GKY-----------------------------TEPPW 230 (568)
Q Consensus 204 --G~~pf~~~~~--------------------~~~~~~i~~--~~~-----------------------------~~~~~ 230 (568)
|.++|.+.+. ......+.. |.. ...+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 7777766441 111111110 000 01134
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 68999999999999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=385.18 Aligned_cols=256 Identities=34% Similarity=0.636 Sum_probs=227.1
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4578999999999999999999999999999999998654332 35678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC----CeEEEeecCccCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ----NLKLIDFGLCAKP 156 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~a~~~ 156 (568)
.++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999998888999999999999999999999999999999999999998877 7999999998765
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCC
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMS 232 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~ 232 (568)
... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+....+.......+ ...+
T Consensus 163 ~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 163 EAG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred cCC--CcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 432 2234457999999999998766 58999999999999999999999999998888888877766544 4578
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=387.65 Aligned_cols=257 Identities=33% Similarity=0.635 Sum_probs=204.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.++++++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45789999999999999999999999999999999975432 2234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 167 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-E 167 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-C
Confidence 99999999999999875 679999999999999999999999999999999999999999999999999987654321 1
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHc
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 242 (568)
.....+||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+....+..+..+++++.++|.+|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 223457899999999998765 5889999999999999999999998876655555655566667778899999999999
Q ss_pred cccCcCCCCCHHHHhcCccccc
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~~ 264 (568)
|+.||.+|||++++++||||..
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC-
T ss_pred cccCHhhCCCHHHHhcCccccC
Confidence 9999999999999999999984
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=390.09 Aligned_cols=253 Identities=28% Similarity=0.488 Sum_probs=224.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
..|...+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 35889999999999999999999999999999997654 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......
T Consensus 124 ~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 201 (321)
T 2c30_A 124 LQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 201 (321)
T ss_dssp CCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCC
T ss_pred CCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccccc
Confidence 99999999875 4579999999999999999999999999999999999999999999999999987654332 223456
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHHHHHHHHccc
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~~L~ 244 (568)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.....+ .+..+++.+.++|.+||+
T Consensus 202 ~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 280 (321)
T 2c30_A 202 VGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280 (321)
T ss_dssp CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred cCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHcc
Confidence 7999999999998765 589999999999999999999999998888877777665433 233578999999999999
Q ss_pred cCcCCCCCHHHHhcCccccc
Q psy6203 245 VEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~~ell~hp~~~~ 264 (568)
.||.+|||+.|+++||||..
T Consensus 281 ~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 281 RDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp SSTTTSCCHHHHHTSGGGGG
T ss_pred CChhhCcCHHHHhcChhhcc
Confidence 99999999999999999984
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=402.15 Aligned_cols=255 Identities=31% Similarity=0.576 Sum_probs=220.1
Q ss_pred cccCeEE--EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 6 LRNQYIL--ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 6 ~~~~Y~i--~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+.+.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3455666 6789999999999999999999999999986432 234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE--cCCCCeEEEeecCccCCCCCC
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL--DRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~ 160 (568)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 99999999999988754 569999999999999999999999999999999999999 56678999999999865443
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 236 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....+..+ ..+++++.
T Consensus 243 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 320 (373)
T 2x4f_A 243 -EKLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320 (373)
T ss_dssp -CBCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred -cccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence 2334557999999999998765 68999999999999999999999999998888888887766544 45899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||.+||+.||.+|||+.|+|+||||+.
T Consensus 321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 321 EFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999999999999999999999999983
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=384.29 Aligned_cols=260 Identities=33% Similarity=0.573 Sum_probs=224.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 35689999999999999999999999999999999998665445567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-ccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 163 (568)
|||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 9999999999999877889999999999999999999999999999999999999999999999999987543221 122
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCC--CCCCChHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTE--PPWMSPNSRQIVR 240 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~~~--~~~~~~~~~~li~ 240 (568)
....+||+.|+|||++.+...++.++||||||+++|+|++|..||...+.. .....+....... ...+++.+.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence 345679999999999987765578999999999999999999999765432 2333333333222 2357899999999
Q ss_pred HccccCcCCCCCHHHHhcCccccc
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||+.||.+|||++|+++||||+.
T Consensus 244 ~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 244 KILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHCCCCchhCCCHHHHhcCccccC
Confidence 999999999999999999999984
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=400.39 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=214.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
++.++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 56789999999999999999999999999999999986543222 245678999999999999999999999765
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 79 -SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 79 -~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3469999999 8899998865 679999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY---------- 225 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~---------- 225 (568)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+... ..
T Consensus 180 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 180 S----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp S----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred c----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 3 2345678999999999987555799999999999999999999999988876665554321 10
Q ss_pred -------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 226 -------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 226 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
...+..++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 1123568999999999999999999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=415.63 Aligned_cols=253 Identities=25% Similarity=0.442 Sum_probs=208.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS------ 78 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------ 78 (568)
+.++|++++.||+|+||+||+|.+..+|+.||||++.+.... .....+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 458999999999999999999999999999999999865322 2355788999999999999999999999654
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
..+|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 468999999965 5666664 4599999999999999999999999999999999999999999999999999986543
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY------------- 225 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~------------- 225 (568)
. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred C--cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 2 2345568999999999998876 68999999999999999999999999887666655543100
Q ss_pred ---------CCC---------CC-----------CChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ---------TEP---------PW-----------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ---------~~~---------~~-----------~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
... .. .++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000 00 1467899999999999999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=396.70 Aligned_cols=257 Identities=35% Similarity=0.609 Sum_probs=228.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-------chHHHHHHHHHHHhC-CCCCcceeeEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-------DLPRVKLEINALKHI-SHQHICKLFQVIE 76 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 76 (568)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34578999999999999999999999999999999997654211 134577899999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 77 TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 77 ~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
..+..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++...
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccCCccccccccccCc-----ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGK-----QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--- 228 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~--- 228 (568)
... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+..+.+..+
T Consensus 251 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 251 EPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 543 233456899999999998632 2368899999999999999999999999888888888887766543
Q ss_pred -CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 229 -PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 229 -~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
...++.+.+||.+||+.||.+|||+.|+++||||+
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 35788999999999999999999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=384.20 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=221.1
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
..+.++|++.+.||+|+||.||+|++..+++.||+|++....... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 456789999999999999999999999999999999987654332 245788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 82 FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999999889999999999999999999999999999999999999999999999999999986554333
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----CCCCCChHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-----EPPWMSPNSR 236 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~ 236 (568)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.............+ .++.+++.+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp --------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred cccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 3344567999999999998876 588999999999999999999999998877766555555433 2356889999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++|.+||+.||.+||+..+.+.+.|...
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 9999999999999997777777777654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=397.67 Aligned_cols=265 Identities=28% Similarity=0.371 Sum_probs=217.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC----chHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE----DLPRVKLEINALKHISHQHICKLFQVIETSS 79 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 79 (568)
....++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 455689999999999999999999999999999999987543321 1346788999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
..++||||+++ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999975 888888764 4689999999999999999999999999999999999999999999999999886543
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCC---------
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTE--------- 227 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~--------- 227 (568)
. .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+... ....
T Consensus 165 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 P-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp C-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred C-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 2 223345679999999999987666789999999999999999999999998877776666432 1100
Q ss_pred -----------------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCCCCCC
Q psy6203 228 -----------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNP 270 (568)
Q Consensus 228 -----------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~ 270 (568)
...+++++.+||.+||+.||.+|||++|+|+||||+..+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 0345789999999999999999999999999999986554443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=398.47 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=216.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-----CCCcceeeEEEEeCC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-----HQHICKLFQVIETSS 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~~~~~~~~ 79 (568)
-+.++|++.++||+|+||+||+|++..+++.||||++.... ........|+.+++.+. ||||+++++++...+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 45789999999999999999999999999999999997432 23446778999999986 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC----------------
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---------------- 141 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---------------- 141 (568)
..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999999 999999998754 5999999999999999999999999999999999999975
Q ss_pred ---------CCCeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC
Q psy6203 142 ---------NQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS 212 (568)
Q Consensus 142 ---------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~ 212 (568)
++.+||+|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78899999999976443 224567999999999998876 6899999999999999999999999888
Q ss_pred HHHHHHHHHcCCCCCCC----------------------------------------------CCChHHHHHHHHccccC
Q psy6203 213 IDQLYDKILNGKYTEPP----------------------------------------------WMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 213 ~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~li~~~L~~d 246 (568)
..+....+.....+.+. ..++.+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 77666555432221110 12367789999999999
Q ss_pred cCCCCCHHHHhcCcccc
Q psy6203 247 PGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 247 P~~Rps~~ell~hp~~~ 263 (568)
|.+|||+.|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999995
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=404.17 Aligned_cols=251 Identities=33% Similarity=0.624 Sum_probs=208.9
Q ss_pred ccccCeEEE-eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHH-hCCCCCcceeeEEEEe----C
Q psy6203 5 DLRNQYILE-RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALK-HISHQHICKLFQVIET----S 78 (568)
Q Consensus 5 ~~~~~Y~i~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~----~ 78 (568)
.+.++|.+. +.||+|+||+||+|.++.+|+.||||++... ..+.+|+.++. ..+||||+++++++.. .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 455778887 7899999999999999999999999998632 35778888874 5589999999999876 5
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---CCCeEEEeecCc
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGLC 153 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a 153 (568)
+.+|+|||||+||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67899999999999999998653 5999999999999999999999999999999999999987 788999999999
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCC-
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILNGKYTEP- 228 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~----~~~~~i~~~~~~~~- 228 (568)
...... ....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.. .....+..+.+..+
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 212 KETTSH--NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccCCC--CccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 865432 2345678999999999997766 689999999999999999999999765422 24455666655444
Q ss_pred ---CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 ---PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 ---~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+++++.+||++||+.||.+|||+.|+++||||..
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 458999999999999999999999999999999984
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=401.28 Aligned_cols=261 Identities=35% Similarity=0.608 Sum_probs=221.6
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc----CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL----GEDLPRVKLEINALKHISHQHICKLFQVIETSS 79 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 79 (568)
.++.++|++.+.||+|+||.||+|.+..+++.||+|++.+... ......+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 4677899999999999999999999999999999999975432 234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q psy6203 80 HIFMVIEYCPGGELLDHIVE----------------------------------------RQRLGEKESRAFFRQILSAV 119 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~----------------------------------------~~~l~~~~~~~i~~qi~~aL 119 (568)
..++||||++||+|.+++.. ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998842 11235778899999999999
Q ss_pred HHHHHcCceecCCCCCceEEcCCC--CeEEEeecCccCCCC---CCccccccccCCccccccccccCc-ccCCcccceec
Q psy6203 120 AYLHHLGYAHRDLKPENVLLDRNQ--NLKLIDFGLCAKPEG---GLESQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWS 193 (568)
Q Consensus 120 ~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwS 193 (568)
.|||++||+||||||+||+++.++ .+||+|||++..... ..........||+.|+|||++.+. ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998776 899999999875322 111223456799999999999752 44689999999
Q ss_pred hhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 194 MGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 194 lG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
|||++|+|++|..||.+.+..+....+..+....+. .+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 999999999999999999888888888776654332 37899999999999999999999999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.06 Aligned_cols=260 Identities=26% Similarity=0.400 Sum_probs=219.5
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
.++.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.++++++||||+++++++...
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 456789999999999999999999999999999999997544333346788999999999999999999999655
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
...|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 46899999996 589988865 5799999999999999999999999999999999999999999999999999876543
Q ss_pred CCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC---------
Q psy6203 159 GLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY--------- 225 (568)
Q Consensus 159 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~--------- 225 (568)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 211 12345589999999999876666799999999999999999999999887755554444320 00
Q ss_pred -----------C---------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 226 -----------T---------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 226 -----------~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
+ ..+.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0 113478999999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=398.26 Aligned_cols=257 Identities=30% Similarity=0.570 Sum_probs=224.8
Q ss_pred cCeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCc---CCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATL---GEDLPRVKLEINALKHI-SHQHICKLFQVIETSSH 80 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 80 (568)
++|++.+.||+|+||.||+|++. .+|+.||||++++... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 68999999999999999999985 4899999999875432 12344567799999999 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
.|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999987654333
Q ss_pred ccccccccCCccccccccccCc-ccCCcccceechhhHHHHHHhCCCCCCC----CCHHHHHHHHHcCCCCCCCCCChHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGK-QYYGSETDVWSMGVMLYALLCGFLPFDS----DSIDQLYDKILNGKYTEPPWMSPNS 235 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~~lltG~~pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (568)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. .....+...+.......+..+++.+
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHH
Confidence 3334456899999999999863 3368899999999999999999999964 3456667777777778888899999
Q ss_pred HHHHHHccccCcCCCC-----CHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
.+||.+||+.||.+|| |++|+++||||..
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 9999999999999999 9999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=394.31 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=218.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
...++|++.+.||+|+||.||+|++..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+..|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45689999999999999999999999999999999987654332 23457789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 180 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEV 180 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC-ccc
Confidence 9999999999888877788999999999999999999999999999999999999999999999999998765432 123
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--C-----------------
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K----------------- 224 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~----------------- 224 (568)
....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 345679999999999987655789999999999999999999999988766555444311 0
Q ss_pred CCC------------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 225 YTE------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 225 ~~~------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
... .+.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 000 1246889999999999999999999999999999983
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=393.69 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=220.6
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCC--
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSS-- 79 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 79 (568)
..+.++|++.+.||+|+||.||+|++..+++.||+|++....... ....+.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 357899999999999999999999999999999999998654332 2356788999999999999999999987543
Q ss_pred --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 80 --HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 80 --~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
..|+||||++|++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 359999999999999999988999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCC
Q psy6203 158 GGLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE----PPWM 231 (568)
Q Consensus 158 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~----~~~~ 231 (568)
.... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....... ...+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp --------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred ccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 3211 1223456899999999998776 5899999999999999999999999988877766666554433 2458
Q ss_pred ChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 232 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
++++.++|.+||+.||.+||++.+++.|+|++...
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999999998543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=380.15 Aligned_cols=259 Identities=34% Similarity=0.580 Sum_probs=228.1
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--------chHHHHHHHHHHHhCC-CCCcceeeEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--------DLPRVKLEINALKHIS-HQHICKLFQV 74 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~Ei~~l~~l~-hpnIv~l~~~ 74 (568)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 457789999999999999999999999999999999997654211 1345778999999995 9999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 75 IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 75 ~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
+...+..++||||+++++|.+++..+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCccccccccCCcccccccccc-----CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIK-----GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP- 228 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~- 228 (568)
..... .......||+.|+|||++. ....++.++||||||+++|+|++|..||...+.......+..+....+
T Consensus 173 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 173 QLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 65432 2334567999999999985 233468899999999999999999999999888888888877766543
Q ss_pred ---CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 ---PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 ---~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+++.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 247899999999999999999999999999999984
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=406.70 Aligned_cols=256 Identities=38% Similarity=0.664 Sum_probs=212.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-------CchHHHHHHHHHHHhCCCCCcceeeEEEEe
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-------EDLPRVKLEINALKHISHQHICKLFQVIET 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 77 (568)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++.+.... .....+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3568999999999999999999999999999999999865422 122357889999999999999999999854
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC---CeEEEeecCcc
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---NLKLIDFGLCA 154 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG~a~ 154 (568)
+..|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 56899999999999999998888999999999999999999999999999999999999997554 59999999998
Q ss_pred CCCCCCccccccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCC---
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTEP--- 228 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~~~--- 228 (568)
..... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.... ...+...+..+.+...
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 75432 33456689999999999863 3346889999999999999999999997643 2344556666665543
Q ss_pred -CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 229 -PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 229 -~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
..+++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 404 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence 35799999999999999999999999999999997
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=392.92 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=212.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS------ 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------ 79 (568)
+.++|++.+.||+|+||.||+|+++.+|+.||||++...........+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 45789999999999999999999999999999999986654445678899999999999999999999986543
Q ss_pred ---------------------------------------------------EEEEEEeccCCCChHHHHHhcCC---CCH
Q psy6203 80 ---------------------------------------------------HIFMVIEYCPGGELLDHIVERQR---LGE 105 (568)
Q Consensus 80 ---------------------------------------------------~~~lV~E~~~~g~L~~~i~~~~~---l~~ 105 (568)
..++|||||++++|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999987543 456
Q ss_pred HHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-----------cccccccCCcccc
Q psy6203 106 KESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE-----------SQLQTSCGSPNYA 174 (568)
Q Consensus 106 ~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-----------~~~~~~~gt~~y~ 174 (568)
..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 67899999999999999999999999999999999999999999999876544311 1223457999999
Q ss_pred ccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CCCCChHHHHHHHHccccCcCCCCCH
Q psy6203 175 APEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSMLQVEPGKRIKI 253 (568)
Q Consensus 175 aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~ 253 (568)
|||++.+.. ++.++|||||||++|+|++|..|+.. .......+.....+. ....++++.+||.+||+.||.+|||+
T Consensus 244 aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 244 SPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp CHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred ChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 999998876 58999999999999999999877532 223344444443322 12357888999999999999999999
Q ss_pred HHHhcCcccc
Q psy6203 254 QDLLGHNWVK 263 (568)
Q Consensus 254 ~ell~hp~~~ 263 (568)
+|+++||||+
T Consensus 321 ~~~l~~~~f~ 330 (332)
T 3qd2_B 321 TDIIENAIFE 330 (332)
T ss_dssp HHHHHSTTCC
T ss_pred HHHhhchhhh
Confidence 9999999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=378.79 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=216.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHI-SHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 82 (568)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++....... ....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 45689999999999999999999999999999999998654332 345678899999999 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC----------------
Q psy6203 83 MVIEYCPGGELLDHIVER----QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN---------------- 142 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------------- 142 (568)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999999765 679999999999999999999999999999999999999844
Q ss_pred ---CCeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHH
Q psy6203 143 ---QNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK 219 (568)
Q Consensus 143 ---~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~ 219 (568)
..+||+|||.+...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+.... ....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~ 239 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE 239 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH
Confidence 47999999998765432 234689999999999877556789999999999999999998775543 2344
Q ss_pred HHcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 220 ILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 220 i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+..+.. ..+..+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 455544 455678999999999999999999999999999999984
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=397.50 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=211.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe-------
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET------- 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------- 77 (568)
...++|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 456899999999999999999999999999999999875432 22369999999999999999999843
Q ss_pred -------------------------------CCEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Q psy6203 78 -------------------------------SSHIFMVIEYCPGGELLDHIV----ERQRLGEKESRAFFRQILSAVAYL 122 (568)
Q Consensus 78 -------------------------------~~~~~lV~E~~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~aL~~L 122 (568)
...+++||||++ |+|.+.+. ....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345899999997 57766664 357899999999999999999999
Q ss_pred HHcCceecCCCCCceEEc-CCCCeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHH
Q psy6203 123 HHLGYAHRDLKPENVLLD-RNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYAL 201 (568)
Q Consensus 123 H~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~l 201 (568)
|++||+||||||+|||++ .++.+||+|||+|...... .......||+.|+|||++.+...++.++||||+||++|+|
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 999999999999999997 6889999999999865433 2334557899999999998776679999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC--C---------------CC------------CCCCCChHHHHHHHHccccCcCCCCC
Q psy6203 202 LCGFLPFDSDSIDQLYDKILNG--K---------------YT------------EPPWMSPNSRQIVRSMLQVEPGKRIK 252 (568)
Q Consensus 202 ltG~~pf~~~~~~~~~~~i~~~--~---------------~~------------~~~~~~~~~~~li~~~L~~dP~~Rps 252 (568)
++|..||.+.+..+....+... . .. .+...++++.+||.+||+.||.+|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999988876666555321 0 00 23457889999999999999999999
Q ss_pred HHHHhcCccccc
Q psy6203 253 IQDLLGHNWVKM 264 (568)
Q Consensus 253 ~~ell~hp~~~~ 264 (568)
+.|+|+||||+.
T Consensus 316 ~~e~l~hp~f~~ 327 (383)
T 3eb0_A 316 PYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHTSGGGHH
T ss_pred HHHHhcCHHHHH
Confidence 999999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=389.36 Aligned_cols=259 Identities=30% Similarity=0.518 Sum_probs=224.2
Q ss_pred cccccCeEEE-eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCC-CCCcceeeEEEEeCCE
Q psy6203 4 IDLRNQYILE-RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHIS-HQHICKLFQVIETSSH 80 (568)
Q Consensus 4 ~~~~~~Y~i~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~ 80 (568)
.++.++|.+. +.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3577899998 89999999999999999999999999998654432 3567889999999995 6999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---CCCeEEEeecCccC
Q psy6203 81 IFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGLCAK 155 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~ 155 (568)
.|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999999998553 67999999999999999999999999999999999999987 78999999999986
Q ss_pred CCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCC
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWM 231 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~ 231 (568)
.... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......+ ..+
T Consensus 184 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 184 IGHA--CELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp C-----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cCCc--cccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence 5432 2234567999999999998776 58999999999999999999999999988888777766554332 357
Q ss_pred ChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 232 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 8999999999999999999999999999999854
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=378.35 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=220.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe----CC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET----SS 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~ 79 (568)
.-...|++.+.||+|+||.||+|.+..++..||+|++...... .....+.+|+.++++++||||+++++++.. ..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 3445699999999999999999999999999999999865543 235678899999999999999999999875 45
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEc-CCCCeEEEeecCccCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLD-RNQNLKLIDFGLCAKP 156 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 156 (568)
.+++||||+++++|.+++.....+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999998889999999999999999999999999 99999999999997 7889999999998754
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCh
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKYT--EPPWMSP 233 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~ 233 (568)
... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .+.......+..+..+ .+...++
T Consensus 183 ~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 183 RAS---FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ccc---ccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 432 23455799999999998754 68999999999999999999999987 4555566666555332 3345778
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++.+||.+||+.||.+|||++|+++||||+.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999983
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=390.17 Aligned_cols=254 Identities=28% Similarity=0.365 Sum_probs=220.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+..++|++.+.||+|+||+||+|++..+|+.||||++....... ....+.+|+.++++++||||+++++++.+.+..|
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 34567999999999999999999999999999999997654322 2356788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+. |+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 9999996 678887754 56799999999999999999999999999999999999999999999999999876532
Q ss_pred cccccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 237 (568)
....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+..+..+ .+...++.+.+
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 284 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 234579999999999853 334688999999999999999999999888776666566554433 23457899999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
||.+||+.||.+|||++++++||||..
T Consensus 285 li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 285 FVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHcccChhhCcCHHHHhhChhhhc
Confidence 999999999999999999999999973
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=395.74 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=218.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 35789999999999999999999999999999999986543334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||+++++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++..... ...
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~ 187 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMA 187 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HC-
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc---ccc
Confidence 9999999999999888999999999999999999999996 999999999999999999999999999864321 123
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHH--------------------------
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD-------------------------- 218 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~-------------------------- 218 (568)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..++..
T Consensus 188 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ---CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred cCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 3457999999999998776 5899999999999999999999998766544322
Q ss_pred ----------------HHHcCCCCC--CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 219 ----------------KILNGKYTE--PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 219 ----------------~i~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+....... ...+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 222222211 2236889999999999999999999999999999984
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=383.63 Aligned_cols=260 Identities=31% Similarity=0.608 Sum_probs=224.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc---CCchHHHHHHHHHHHhCCCCCcceeeEEEE--eCC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL---GEDLPRVKLEINALKHISHQHICKLFQVIE--TSS 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~ 79 (568)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.++++++||||+++++++. +.+
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 356899999999999999999999999999999999976432 234567889999999999999999999984 456
Q ss_pred EEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
..|+||||++++ |.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 789999999876 7777765 4579999999999999999999999999999999999999999999999999987654
Q ss_pred CC-CccccccccCCccccccccccCcc-cCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHH
Q psy6203 158 GG-LESQLQTSCGSPNYAAPEVIKGKQ-YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS 235 (568)
Q Consensus 158 ~~-~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (568)
.. .........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+..+.+..+..+++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 32 122234557999999999997643 3477999999999999999999999999999999999999888888899999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.+||.+||+.||.+|||++|+++||||+..
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=379.61 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=229.1
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+..+.|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 45678999999999999999999999999999999998766555677899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 176 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 176 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCB
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-ccc
Confidence 999999999998854 679999999999999999999999999999999999999999999999999987654321 223
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHcc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L 243 (568)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+..+.. ..+..+++.+.+||.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHc
Confidence 4567999999999998766 58899999999999999999999998887777666655543 345578999999999999
Q ss_pred ccCcCCCCCHHHHhcCccccc
Q psy6203 244 QVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 244 ~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.||.+|||+.|+++||||..
T Consensus 256 ~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHHHH
T ss_pred CCChhhCcCHHHHhhChhhhc
Confidence 999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=379.61 Aligned_cols=256 Identities=34% Similarity=0.663 Sum_probs=228.4
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 4567999999999999999999999999999999999765433 346678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC---CCeEEEeecCccCCCCCC
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN---QNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~ 160 (568)
||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~- 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence 99999999999999888899999999999999999999999999999999999999764 46999999998765432
Q ss_pred ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSR 236 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 236 (568)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..++...+..+....+ ..+++++.
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 178 -TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp -SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred -CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 222344689999999998764 58899999999999999999999999998888888888766543 45789999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++|.+||+.||.+|||+.|+++||||+.
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 9999999999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=396.39 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=201.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
++.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 4668999999999999999999999999999999998754322 2345678899999999999999999999654
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 79 -SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 79 -~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
...|+|||++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899988865 679999999999999999999999999999999999999999999999999987644
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY---------- 225 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~---------- 225 (568)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+... .+
T Consensus 184 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 184 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred c----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2 2345679999999999987556799999999999999999999999988876655554321 00
Q ss_pred -----------CC--------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 226 -----------TE--------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 226 -----------~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.. .+..++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 00 12467899999999999999999999999999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=382.97 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=206.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
.++|++.++||+|+||+||+|++..+|+.||||++....... .......|+..+.++ +||||+++++++.+.+..|+|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 478999999999999999999999999999999986543321 223344555555544 899999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~ 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GA 212 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CC
Confidence 9999 67898888764 46999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~ 241 (568)
.....||+.|+|||++.+ . ++.++|||||||++|+|++|..||.... ....+..+..+ .+..+++++.+||.+
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~ 287 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-S-YGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVM 287 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-C-CSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-C-CCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHH
Confidence 345579999999999986 3 6899999999999999999976665432 23334443332 235688999999999
Q ss_pred ccccCcCCCCCHHHHhcCccccc
Q psy6203 242 MLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
||+.||++|||++|+|+||||+.
T Consensus 288 ~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 288 MLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999983
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=389.63 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=215.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC--EE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS--HI 81 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~ 81 (568)
..+.++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++...+ ..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 3467899999999999999999999999999999999987655555677889999999999999999999998765 78
Q ss_pred EEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE----cCCCCeEEEeecCcc
Q psy6203 82 FMVIEYCPGGELLDHIVERQ---RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCA 154 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG~a~ 154 (568)
|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997643 39999999999999999999999999999999999999 777889999999998
Q ss_pred CCCCCCccccccccCCccccccccccC-------cccCCcccceechhhHHHHHHhCCCCCCCC----CHHHHHHHHHcC
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKG-------KQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNG 223 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~~lltG~~pf~~~----~~~~~~~~i~~~ 223 (568)
..... ......+||+.|+|||++.. ...++.++|||||||++|+|++|..||... ...++...+..+
T Consensus 165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 65443 23345679999999999862 234689999999999999999999999632 234455555544
Q ss_pred CCC---------------------CC----CCCChHHHHHHHHccccCcCCCCCHHHHhcCcc
Q psy6203 224 KYT---------------------EP----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261 (568)
Q Consensus 224 ~~~---------------------~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 261 (568)
.+. .. ..+++.+.++|.+||+.||++|||++|+|+||=
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 321 11 123457889999999999999999999999973
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=388.87 Aligned_cols=261 Identities=30% Similarity=0.433 Sum_probs=217.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
.++.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 367899999999999999999999999999999999996543223345677899999999999999999988654
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
...|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 67899999996 689888865 6799999999999999999999999999999999999999999999999999876542
Q ss_pred CCc---------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC--
Q psy6203 159 GLE---------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKY-- 225 (568)
Q Consensus 159 ~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~--~~~-- 225 (568)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+.. +..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 211 1123357899999999987655578999999999999999999999998876654443321 100
Q ss_pred ----------------------C------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 226 ----------------------T------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 226 ----------------------~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
. ..+.+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0 0135789999999999999999999999999999998543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=387.26 Aligned_cols=256 Identities=39% Similarity=0.680 Sum_probs=216.1
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-------CchHHHHHHHHHHHhCCCCCcceeeEEEEe
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-------EDLPRVKLEINALKHISHQHICKLFQVIET 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 77 (568)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 4678999999999999999999999999999999999764321 123357889999999999999999999976
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC---eEEEeecCcc
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN---LKLIDFGLCA 154 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~ 154 (568)
.+ .|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 65 8999999999999999988889999999999999999999999999999999999999987664 9999999987
Q ss_pred CCCCCCccccccccCCcccccccccc--CcccCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCC---
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIK--GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYTEP--- 228 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~~~--- 228 (568)
..... ......+||+.|+|||++. +...++.++|||||||++|+|++|..||..... ..+...+..+.....
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 65432 2234457999999999974 233468899999999999999999999976432 234445555555432
Q ss_pred -CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 229 -PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 229 -~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
..+++.+.+||.+||+.||.+|||+.|+++||||+
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 45789999999999999999999999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=400.60 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=214.4
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC------CCCCcceeeEEEEeC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI------SHQHICKLFQVIETS 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l------~hpnIv~l~~~~~~~ 78 (568)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++...
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 45678999999999999999999999999999999997532 2234567788888776 578999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC--eEEEeecCcc
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN--LKLIDFGLCA 154 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~ 154 (568)
+.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999995 68999987753 4999999999999999999999999999999999999999887 9999999987
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC------
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT------ 226 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~------ 226 (568)
.... ...+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+... ..+
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCC----cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 6433 234568999999999998876 599999999999999999999999988876665544321 000
Q ss_pred ---------------------------------------------------CCCCCChHHHHHHHHccccCcCCCCCHHH
Q psy6203 227 ---------------------------------------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQD 255 (568)
Q Consensus 227 ---------------------------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e 255 (568)
.+...++.+.+||.+||+.||.+|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 00123678999999999999999999999
Q ss_pred HhcCccccc
Q psy6203 256 LLGHNWVKM 264 (568)
Q Consensus 256 ll~hp~~~~ 264 (568)
+|+||||+.
T Consensus 406 ~L~Hpw~~~ 414 (429)
T 3kvw_A 406 ALRHPWLRR 414 (429)
T ss_dssp HHTSTTTC-
T ss_pred HhCChhhcc
Confidence 999999984
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=387.42 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=212.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCC--CCcceeeEEEEeCCEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISH--QHICKLFQVIETSSHIF 82 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~ 82 (568)
..++|++.+.||+|+||.||+|.+ .+++.||+|++....... ....+.+|+.++++++| |||+++++++.+.+.+|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 356799999999999999999997 468999999998654332 24578899999999986 99999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+|||+ .+++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 99994 5889999999999999999999999999999999999999999999999996 688999999999865433221
Q ss_pred -ccccccCCccccccccccC----------cccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcC--CCCCC
Q psy6203 163 -QLQTSCGSPNYAAPEVIKG----------KQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNG--KYTEP 228 (568)
Q Consensus 163 -~~~~~~gt~~y~aPE~l~~----------~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~--~~~~~ 228 (568)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.... .......+... ....+
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 2335679999999999864 2346889999999999999999999997643 33333444433 33456
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
...++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 6678899999999999999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=382.85 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=211.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEe--CCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIET--SSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~~~~~l 83 (568)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.++++++ ||||+++++++.+ ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 57899999999999999999999999999999998743 3467889999999997 9999999999987 667899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~ 162 (568)
||||+++++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... .
T Consensus 111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~ 185 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--Q 185 (330)
T ss_dssp EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT--C
T ss_pred EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC--C
Confidence 999999999998874 489999999999999999999999999999999999999777 8999999999765433 2
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC-CHHHHHH-------------HHHcCCCCC-
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYD-------------KILNGKYTE- 227 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~-~~~~~~~-------------~i~~~~~~~- 227 (568)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||... +..+... .+.......
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 3345679999999999987566799999999999999999999999432 2222211 111111111
Q ss_pred -----------------------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 228 -----------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 228 -----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+..+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 1127899999999999999999999999999999984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=394.06 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=207.3
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSS---- 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 79 (568)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3568999999999999999999999999999999999764332 23456788999999999999999999997654
Q ss_pred --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 80 --HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 80 --~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
..|+||||++ ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7899999996 57888875 569999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--------- 228 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~--------- 228 (568)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 179 ~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 179 TS--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cc--cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 32 2234567999999999998866 68999999999999999999999999887777666654321110
Q ss_pred ---------------------------C------CCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 ---------------------------P------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 ---------------------------~------~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. ..++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 01467899999999999999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=381.94 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=220.0
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.++.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 467889999999999999999999999999999999987543 2446778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 9999999999998876 467999999999999999999999999999999999999999999999999987532111 11
Q ss_pred ccccccCCcccccccccc----CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHH
Q psy6203 163 QLQTSCGSPNYAAPEVIK----GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNS 235 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~ 235 (568)
......||+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+..+... .+..++..+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 123456899999999984 2334688999999999999999999999988877777666655433 244578999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.++|.+||+.||.+|||+.|+++||||+.
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred HHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 99999999999999999999999999983
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=379.04 Aligned_cols=256 Identities=20% Similarity=0.318 Sum_probs=201.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCch-HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDL-PRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
..++|++.+.||+|+||+||+|.+..+|+.||+|++......... ..+..+...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 458999999999999999999999999999999999765332222 2334455557888999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 85 IEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
|||++ |+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 99996 588777653 46899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccccCCcccccccccc---CcccCCcccceechhhHHHHHHhCCCCCCC-CCH-HHHHHHHHcCCCCCC-CCCCh
Q psy6203 160 LESQLQTSCGSPNYAAPEVIK---GKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSI-DQLYDKILNGKYTEP-PWMSP 233 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~-~~~~~~i~~~~~~~~-~~~~~ 233 (568)
.......||+.|+|||++. ....++.++|||||||++|+|++|..||.. ... ..+...+.......+ ..+++
T Consensus 164 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (290)
T 3fme_A 164 --VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred --ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCH
Confidence 2223447999999999972 334468899999999999999999999975 333 333444444433333 45899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 242 ~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 9999999999999999999999999999984
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=393.03 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=214.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCC--CCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHIS--HQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~~lV 84 (568)
.+|++.+.||+|+||+||+|.+.. ++.||||++...... .....+.+|+.+|++++ ||||+++++++...+.+|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 459999999999999999999864 899999999865433 23467889999999996 59999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc-c
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES-Q 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~ 163 (568)
|| +.+++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......... .
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence 99 56889999999988999999999999999999999999999999999999995 689999999999865433211 2
Q ss_pred cccccCCccccccccccCc----------ccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcCC--CCCCCC
Q psy6203 164 LQTSCGSPNYAAPEVIKGK----------QYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGK--YTEPPW 230 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~~--~~~~~~ 230 (568)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... .......+.... ...+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCC
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCcc
Confidence 3456799999999998752 246889999999999999999999997643 334445555443 345666
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 293 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred chHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 78999999999999999999999999999999843
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=375.90 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=224.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIET--SSHI 81 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 81 (568)
...++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+ .+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34689999999999999999999999999999999998654432 34568889999999999999999998854 5789
Q ss_pred EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceecCCCCCceEEcCCCCeEEEeecC
Q psy6203 82 FMVIEYCPGGELLDHIVER----QRLGEKESRAFFRQILSAVAYLHHLG-----YAHRDLKPENVLLDRNQNLKLIDFGL 152 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~ 152 (568)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999753 34999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWM 231 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 231 (568)
+....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..++...+..+.. ..+..+
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred heeecccc-ccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCccc
Confidence 87654321 1223457899999999998776 58999999999999999999999999988888888887766 455678
Q ss_pred ChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 232 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++++.++|.+||+.||.+|||++|+++|+|+..
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 999999999999999999999999999999984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=390.03 Aligned_cols=254 Identities=24% Similarity=0.481 Sum_probs=224.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc----------------hHHHHHHHHHHHhCCCCCcc
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED----------------LPRVKLEINALKHISHQHIC 69 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~Ei~~l~~l~hpnIv 69 (568)
+.++|++.+.||+|+||.||+|.+ +|+.||+|++........ ...+.+|+.++++++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 347999999999999999999998 899999999975543221 17889999999999999999
Q ss_pred eeeEEEEeCCEEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEc
Q psy6203 70 KLFQVIETSSHIFMVIEYCPGGELLDH------IVE--RQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLD 140 (568)
Q Consensus 70 ~l~~~~~~~~~~~lV~E~~~~g~L~~~------i~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~ 140 (568)
++++++.+.+..|+||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999998 655 5779999999999999999999999 9999999999999999
Q ss_pred CCCCeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCc-ccceechhhHHHHHHhCCCCCCCCCH-HHHHH
Q psy6203 141 RNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGS-ETDVWSMGVMLYALLCGFLPFDSDSI-DQLYD 218 (568)
Q Consensus 141 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~ 218 (568)
.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||...+. .+...
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 9999999999998765432 3345679999999999987743455 99999999999999999999988766 77788
Q ss_pred HHHcCCCCCC-------------------CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 219 KILNGKYTEP-------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 219 ~i~~~~~~~~-------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+..+....+ ..+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 8887766665 568999999999999999999999999999999983
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=377.90 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=217.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.++++++||||+++++++...+..|+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 45678999999999999999999999999999999997643 456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 85 IEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ..
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 181 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AK 181 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SC
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cc
Confidence 999999999999974 5689999999999999999999999999999999999999999999999999987654321 22
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCChHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSRQIVR 240 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~ 240 (568)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+..... ..+..+++.+.+||.
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 34557899999999998776 58999999999999999999999988776655555444332 234457899999999
Q ss_pred HccccCcCCCCCHHHHhcCccccc
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||+.||.+|||+.++++||||+.
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred HHccCChhhCcCHHHHHhCHHHhc
Confidence 999999999999999999999984
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=379.66 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=213.2
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
..++|++.+.||+|+||+||+|++ +|+.||+|++...... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 357899999999999999999986 6889999999765433 2345688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 85 IEYCPGGELLDHIVERQR---LGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
|||+++|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999999976543 999999999999999999999999 999999999999999999999999998754332
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCChHHHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL--NGKYTEPPWMSPNSRQ 237 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ 237 (568)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+. ......+..+++++.+
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 193 -FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp ----------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred -ccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 12234567999999999998876 5899999999999999999999999988887776663 3345567789999999
Q ss_pred HHHHccccCcCCCCCHHHHhc--Ccccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLG--HNWVK 263 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~--hp~~~ 263 (568)
||.+||+.||.+|||+.++++ +++++
T Consensus 271 li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999987 56665
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=379.41 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=216.5
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe-----
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET----- 77 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----- 77 (568)
.+..++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 456789999999999999999999999999999999997543 3446788999999999 79999999999977
Q ss_pred -CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 78 -SSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 78 -~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 56899999999999999999864 579999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCccccccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CC
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EP 228 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~--~~ 228 (568)
...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.....+ .+
T Consensus 178 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 2x7f_A 178 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred ecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence 654321 22344579999999999863 233688999999999999999999999888776666555554332 23
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 457899999999999999999999999999999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=384.16 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=198.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 46799999999999999999999988999999999876544444567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 86 EYCPGGELLDHIVE--------RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 86 E~~~~g~L~~~i~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999999999874 4569999999999999999999999999999999999999999999999999986543
Q ss_pred CCC----ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------
Q psy6203 158 GGL----ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT------- 226 (568)
Q Consensus 158 ~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~------- 226 (568)
... ........||+.|+|||++.+...++.++|||||||++|+|++|..||...+..............
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence 221 112234579999999999876444689999999999999999999999876655544444333221
Q ss_pred ---CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 ---EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
....+++++.++|.+||+.||.+|||+.|+++||||+.
T Consensus 253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 12347889999999999999999999999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=402.67 Aligned_cols=248 Identities=17% Similarity=0.248 Sum_probs=204.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHH---HHHHhCCCCCcceee-------E
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEI---NALKHISHQHICKLF-------Q 73 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei---~~l~~l~hpnIv~l~-------~ 73 (568)
..++|++.+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999999999999999999864332 3456788999 455566899999998 7
Q ss_pred EEEeCCE-----------------EEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCcee
Q psy6203 74 VIETSSH-----------------IFMVIEYCPGGELLDHIVERQRLGE-------KESRAFFRQILSAVAYLHHLGYAH 129 (568)
Q Consensus 74 ~~~~~~~-----------------~~lV~E~~~~g~L~~~i~~~~~l~~-------~~~~~i~~qi~~aL~~LH~~~ivH 129 (568)
++++.+. .|+||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 7776543 89999999 6899999987665665 778889999999999999999999
Q ss_pred cCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCccccccccccCc----------ccCCcccceechhhHHH
Q psy6203 130 RDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK----------QYYGSETDVWSMGVMLY 199 (568)
Q Consensus 130 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~ 199 (568)
|||||+|||++.++.+||+|||+|..... .....+| +.|+|||++.+. ..++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999886432 3345578 999999999876 23689999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 200 ALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 200 ~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+|++|..||.+.+.......+.. ....+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHHHSSCCC------CCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred HHHHCCCCCcccccccchhhhhh----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 99999999977654433333322 2356899999999999999999999999999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=389.76 Aligned_cols=253 Identities=28% Similarity=0.482 Sum_probs=213.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE--
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHI-- 81 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-- 81 (568)
++.++|.+.+.||+|+||.||+|.+..+|+.||+|++......+ ....+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 46789999999999999999999999999999999997654322 245678899999999999999999999877654
Q ss_pred ----EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 82 ----FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 82 ----~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
|+||||+. ++|.+.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999996 6888776 3459999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C----------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--Y---------- 225 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~--~---------- 225 (568)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.... .
T Consensus 196 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 196 A----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred c----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 3 23455789999999999875557999999999999999999999999888766655553210 0
Q ss_pred -------------C------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 -------------T------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 -------------~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. ..+.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 0 12346899999999999999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=380.49 Aligned_cols=259 Identities=24% Similarity=0.418 Sum_probs=212.3
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE-------
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE------- 76 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~------- 76 (568)
.++.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 367899999999999999999999999999999999987543 223467889999999999999999999873
Q ss_pred -------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc-CCCCeEEE
Q psy6203 77 -------TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD-RNQNLKLI 148 (568)
Q Consensus 77 -------~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kl~ 148 (568)
..+..|+||||++ |+|.+++. .+++++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3468899999997 69999885 46799999999999999999999999999999999999997 56789999
Q ss_pred eecCccCCCCCC--ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q psy6203 149 DFGLCAKPEGGL--ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT 226 (568)
Q Consensus 149 DFG~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~ 226 (568)
|||++....... ........+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999988654321 122334567999999999877555789999999999999999999999988876666555432211
Q ss_pred ------------------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 227 ------------------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 227 ------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
..+.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 123578999999999999999999999999999999843
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=388.89 Aligned_cols=252 Identities=24% Similarity=0.449 Sum_probs=219.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-------CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-------LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETS 78 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 78 (568)
.++|++.+.||+|+||.||+|++. .++..||+|+++..........+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999975 345679999997654333456788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 142 (568)
+.+|+||||+++|+|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 99999999999999999998653 47899999999999999999999999999999999999999
Q ss_pred CCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy6203 143 QNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKI 220 (568)
Q Consensus 143 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i 220 (568)
+.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...+
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999985543211 2223446788999999998776 6899999999999999999 99999998888888877
Q ss_pred HcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 221 LNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 221 ~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
..+.. ..+..+++++.++|.+||+.||.+|||+.|++++
T Consensus 319 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77653 4566789999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=393.49 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=207.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS------ 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------ 79 (568)
...+|++.+.||+|+||+||+|++..+++ ||+|.+..... ...+|+.+++.++||||+++++++...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 45689999999999999999999987765 88887764332 1236999999999999999999996543
Q ss_pred EEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc-CCCCeEEEeecCcc
Q psy6203 80 HIFMVIEYCPGGELLDHIV----ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD-RNQNLKLIDFGLCA 154 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 154 (568)
.+++||||++++ +.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+
T Consensus 112 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 112 FLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 388999999764 444433 256899999999999999999999999999999999999998 78999999999997
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----------- 223 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~----------- 223 (568)
..... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 191 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 191 ILIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp ECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 65433 22345678999999999987766799999999999999999999999988866655544321
Q ss_pred --------CCC----------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 --------KYT----------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 --------~~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.++ .++..++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 000 12347899999999999999999999999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=392.47 Aligned_cols=250 Identities=28% Similarity=0.432 Sum_probs=208.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC------CE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS------SH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~ 80 (568)
..+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 3479999999999999999999999999999999875432 234699999999999999999998532 24
Q ss_pred EEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-CCeEEEeecCccC
Q psy6203 81 IFMVIEYCPGGELLDHIV----ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAK 155 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~ 155 (568)
+++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6799999975 6666554 25679999999999999999999999999999999999999965 5689999999986
Q ss_pred CCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG------------ 223 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~------------ 223 (568)
.... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 207 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 5432 22345678999999999987655799999999999999999999999988765554444320
Q ss_pred -----CCC------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 -----KYT------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 -----~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+. .++..++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 111 12346889999999999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=396.12 Aligned_cols=259 Identities=23% Similarity=0.374 Sum_probs=197.9
Q ss_pred ccccCeEE-EeeecccCCeEEEEEEEc--CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe--CC
Q psy6203 5 DLRNQYIL-ERTVGSGGFAKVKLATHV--LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET--SS 79 (568)
Q Consensus 5 ~~~~~Y~i-~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~ 79 (568)
.+.+.|++ +++||+|+||+||+|+++ .+++.||+|++.... ....+.+|+.+|++++||||+++++++.. ..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 45677887 568999999999999976 568899999997543 23467889999999999999999999954 67
Q ss_pred EEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE----cCCCCeE
Q psy6203 80 HIFMVIEYCPGGELLDHIVER---------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL----DRNQNLK 146 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~k 146 (568)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 8999999995 5888887632 249999999999999999999999999999999999999 6778999
Q ss_pred EEeecCccCCCCCCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH---------H
Q psy6203 147 LIDFGLCAKPEGGLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---------Q 215 (568)
Q Consensus 147 l~DFG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~---------~ 215 (568)
|+|||+|........ ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999976543211 22345679999999999988666799999999999999999999999765431 2
Q ss_pred HHHHHHc--CCCCCC------------------------------------CCCChHHHHHHHHccccCcCCCCCHHHHh
Q psy6203 216 LYDKILN--GKYTEP------------------------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257 (568)
Q Consensus 216 ~~~~i~~--~~~~~~------------------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell 257 (568)
....+.. +..... ...++.+.+||.+||+.||.+|||++|+|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 2222221 111100 11267899999999999999999999999
Q ss_pred cCcccccCCC
Q psy6203 258 GHNWVKMGPE 267 (568)
Q Consensus 258 ~hp~~~~~~~ 267 (568)
+||||+..+.
T Consensus 333 ~hp~f~~~~~ 342 (405)
T 3rgf_A 333 QDPYFLEDPL 342 (405)
T ss_dssp TSGGGTSSSC
T ss_pred cChhhccCCC
Confidence 9999986543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=369.78 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=220.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
-.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 3578999999999999999999986 577899999986543 3457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999999999654 5689999999999999999999999999999999999999999999999999876544322233
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+..+. ...+...++.+.+++.+|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 243 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 243 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred cCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHH
Confidence 4455788999999998766 5899999999999999999 999999999988888888764 345566899999999999
Q ss_pred cccCcCCCCCHHHHhcC
Q psy6203 243 LQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 243 L~~dP~~Rps~~ell~h 259 (568)
|+.||.+|||+.|+++|
T Consensus 244 l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 244 WRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCcccCcCHHHHHHH
Confidence 99999999999999976
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=381.36 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=218.1
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCc---EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..++|++.+.||+|+||.||+|.+..+++ .||||++...........+.+|+.++++++||||+++++++.+.+..|
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 35789999999999999999999986665 499999976543334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999999754 6799999999999999999999999999999999999999999999999999986543321
Q ss_pred c--ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHH
Q psy6203 162 S--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQ 237 (568)
Q Consensus 162 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 237 (568)
. ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..++...+..+. .+.+..+++.+.+
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 285 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHH
Confidence 1 122334678899999998766 5899999999999999999 999999999888888887763 4556678999999
Q ss_pred HHHHccccCcCCCCCHHHHhc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~ 258 (568)
||.+||..||.+|||+.|+++
T Consensus 286 li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 286 LMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=381.74 Aligned_cols=252 Identities=33% Similarity=0.570 Sum_probs=221.6
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhCC--CCCcceeeEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHIS--HQHICKLFQVIE 76 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~ 76 (568)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 357789999999999999999999999999999999998654332 2245667999999996 599999999999
Q ss_pred eCCEEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc-CCCCeEEEeecCcc
Q psy6203 77 TSSHIFMVIEYCPG-GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD-RNQNLKLIDFGLCA 154 (568)
Q Consensus 77 ~~~~~~lV~E~~~~-g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 154 (568)
..+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 89999999889999999999999999999999999999999999999998 77899999999987
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChH
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPN 234 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 234 (568)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.... .+..+....+..++++
T Consensus 199 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 269 (320)
T 3a99_A 199 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 269 (320)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred ccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHH
Confidence 65432 23445799999999999877656788999999999999999999997542 3345566677789999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.+||.+||+.||.+|||++|+++||||+.
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 999999999999999999999999999983
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=367.21 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=220.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 3578999999999999999999875 567899999976543 3457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 9999999999998754 599999999999999999999999999999999999999999999999999886554433333
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 242 (568)
....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||...+.......+..+... .+...++.+.++|.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 241 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSC 241 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHT
T ss_pred cCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHH
Confidence 3445678899999998766 5889999999999999999 99999998888888887776543 4556799999999999
Q ss_pred cccCcCCCCCHHHHhcC
Q psy6203 243 LQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 243 L~~dP~~Rps~~ell~h 259 (568)
|+.||.+|||+.|+++|
T Consensus 242 l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 242 WHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=384.43 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=202.7
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE------
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH------ 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~------ 80 (568)
.++|++.+.||+|+||+||+|++..+|+.||||++..... .......|+..++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 4689999999999999999999999999999999865432 23356678888899999999999999965433
Q ss_pred -EEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HcCceecCCCCCceEEcC-CCCeEEEeecC
Q psy6203 81 -IFMVIEYCPGGELLDHIV----ERQRLGEKESRAFFRQILSAVAYLH--HLGYAHRDLKPENVLLDR-NQNLKLIDFGL 152 (568)
Q Consensus 81 -~~lV~E~~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~-~~~~kl~DFG~ 152 (568)
+++||||+++ +|.+.+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 8999999976 4544443 4567999999999999999999999 999999999999999996 89999999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY------- 225 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~------- 225 (568)
+...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 179 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 9865543 2234557899999999998776679999999999999999999999999887766665543100
Q ss_pred -------------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 226 -------------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 226 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
......++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 11122567899999999999999999999999999998543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=391.83 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=220.4
Q ss_pred ccCeEEEeeecccCCeEEEEEE-----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLAT-----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
.++|++.+.||+|+||+||+|. +..++..||||++...........+.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4789999999999999999999 45678899999997544334455788899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC---CeEEEeec
Q psy6203 82 FMVIEYCPGGELLDHIVERQ-------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---NLKLIDFG 151 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~DFG 151 (568)
|+||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999999998653 589999999999999999999999999999999999998555 59999999
Q ss_pred CccCCCC-CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCC
Q psy6203 152 LCAKPEG-GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEP 228 (568)
Q Consensus 152 ~a~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~ 228 (568)
+++.... ..........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..++...+..+.. ..+
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~ 308 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9864311 1112233456899999999998766 6899999999999999998 9999999999998888887654 456
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
..+++.+.+||.+||+.||.+|||+.++++|.|+.
T Consensus 309 ~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 67899999999999999999999999999998875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=373.01 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=208.1
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCC---CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS 79 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 79 (568)
+.-..++|++.+.||+|+||.||+|.+..+ +..||+|++...........+.+|+.++++++||||+++++++. .+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 445678999999999999999999998654 45699999875443334567889999999999999999999984 56
Q ss_pred EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
..|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 6899999999999999998654 699999999999999999999999999999999999999999999999999876544
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHH
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSR 236 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 236 (568)
..........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..+. .+.++.+++.+.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 247 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 247 (281)
T ss_dssp ----------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 3222333445788999999998665 5899999999999999996 999999887777777777664 456677899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcC
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~h 259 (568)
++|.+||+.||.+|||+.|++++
T Consensus 248 ~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 248 SLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=385.95 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=208.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc----------hHHHHHHHHHHHhCCCCCcceeeEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED----------LPRVKLEINALKHISHQHICKLFQV 74 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~Ei~~l~~l~hpnIv~l~~~ 74 (568)
.+.++|++.+.||+|+||.||+|.+. +|+.||||++........ ...+.+|+.++++++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 56789999999999999999999985 489999999865433211 2678899999999999999999999
Q ss_pred EEe-----CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 75 IET-----SSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 75 ~~~-----~~~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
+.. ...+|+||||++ |+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 854 347899999996 6888888654 479999999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-----
Q psy6203 149 DFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG----- 223 (568)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~----- 223 (568)
|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 177 Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 177 DFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99998754332 22344578999999999987555799999999999999999999999988876665555321
Q ss_pred ------------------CC-C--------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 224 ------------------KY-T--------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 224 ------------------~~-~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
.. . ..+..++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 00 0 123468889999999999999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=374.02 Aligned_cols=254 Identities=29% Similarity=0.539 Sum_probs=209.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe-------
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET------- 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------- 77 (568)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 45689999999999999999999999999999999996432 234678889999999999999999998865
Q ss_pred ------CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEee
Q psy6203 78 ------SSHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 78 ------~~~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 35789999999999999999864 36789999999999999999999999999999999999999999999999
Q ss_pred cCccCCCCCC-------------ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC-CCHHHH
Q psy6203 151 GLCAKPEGGL-------------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQL 216 (568)
Q Consensus 151 G~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~ 216 (568)
|++....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||.. .+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9987654211 1123445789999999999876557899999999999999998 5543 334455
Q ss_pred HHHHHcCCCCCCC----CCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 217 YDKILNGKYTEPP----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 217 ~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
...+.......++ ..++.+.++|.+||+.||.+|||+.|+++||||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence 6666665544443 3567799999999999999999999999999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=381.17 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=212.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEE-cCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCC------CcceeeEEEEe
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATH-VLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ------HICKLFQVIET 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hp------nIv~l~~~~~~ 77 (568)
.+.++|++.+.||+|+||+||+|.+ ..+|+.||+|++.... .....+.+|+.+++.++|+ +|+++++++..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 3568999999999999999999998 5678999999987432 2345678899999988665 49999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC--------------
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-------------- 141 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-------------- 141 (568)
.+..++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred -----CCCeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHH
Q psy6203 142 -----NQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL 216 (568)
Q Consensus 142 -----~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~ 216 (568)
++.+||+|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 66899999999876433 224557999999999998776 58999999999999999999999998876655
Q ss_pred HHHHHcCCCCC--------------------------------------------CCCCChHHHHHHHHccccCcCCCCC
Q psy6203 217 YDKILNGKYTE--------------------------------------------PPWMSPNSRQIVRSMLQVEPGKRIK 252 (568)
Q Consensus 217 ~~~i~~~~~~~--------------------------------------------~~~~~~~~~~li~~~L~~dP~~Rps 252 (568)
...+....... ....++++.+||.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 44432211110 1112467889999999999999999
Q ss_pred HHHHhcCccccc
Q psy6203 253 IQDLLGHNWVKM 264 (568)
Q Consensus 253 ~~ell~hp~~~~ 264 (568)
+.|+++||||+.
T Consensus 323 ~~ell~hp~f~~ 334 (339)
T 1z57_A 323 LREALKHPFFDL 334 (339)
T ss_dssp HHHHTTSGGGGG
T ss_pred HHHHhcCHHHHH
Confidence 999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=379.79 Aligned_cols=256 Identities=33% Similarity=0.575 Sum_probs=211.8
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhC----CCCCcceeeEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHI----SHQHICKLFQV 74 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l----~hpnIv~l~~~ 74 (568)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 456789999999999999999999999999999999997654321 223455689999888 89999999999
Q ss_pred EEeCCEEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc-CCCCeEEEeecC
Q psy6203 75 IETSSHIFMVIEY-CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD-RNQNLKLIDFGL 152 (568)
Q Consensus 75 ~~~~~~~~lV~E~-~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~ 152 (568)
+...+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888999999999999999999999999999999999999999 789999999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMS 232 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 232 (568)
+...... ......||+.|+|||++.+....+.++|||||||++|+|++|..||.... .+.......+..++
T Consensus 187 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 187 GALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVS 257 (312)
T ss_dssp CEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSC
T ss_pred hhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCC
Confidence 8765432 23455799999999999876655668999999999999999999997542 34445666777899
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcCcccccCCCC
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 268 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 268 (568)
+.+.++|.+||+.||++|||++|+++||||+.....
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 999999999999999999999999999999854443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=378.40 Aligned_cols=259 Identities=24% Similarity=0.417 Sum_probs=201.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCc---EEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
-..++|++.+.||+|+||.||+|.+..++. .||+|++...... .....+.+|+.++++++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999999887765 8999999765432 345678899999999999999999999987765
Q ss_pred E------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 81 I------FMVIEYCPGGELLDHIVERQ------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 81 ~------~lV~E~~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
. ++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 5 99999999999999997543 69999999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-C
Q psy6203 149 DFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-Y 225 (568)
Q Consensus 149 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~ 225 (568)
|||++........ .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..+. .
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 258 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred eccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence 9999876543221 1222345688999999998766 5899999999999999999 999999888777777777664 4
Q ss_pred CCCCCCChHHHHHHHHccccCcCCCCC-------HHHHhcCccccc
Q psy6203 226 TEPPWMSPNSRQIVRSMLQVEPGKRIK-------IQDLLGHNWVKM 264 (568)
Q Consensus 226 ~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~ell~hp~~~~ 264 (568)
..++.+++++.+||.+||+.||.+||| +++++.|||+..
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 566778999999999999999999999 778889999984
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=368.96 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=217.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
-.++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 3478999999999999999999876 677899999986543 3457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999999976 56799999999999999999999999999999999999999999999999999876544322233
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~ 242 (568)
....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+..+.. ..+...++.+.++|.+|
T Consensus 179 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 257 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 257 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred cCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHH
Confidence 3445788999999998766 5899999999999999998 9999999988888888877744 34556789999999999
Q ss_pred cccCcCCCCCHHHHhcC
Q psy6203 243 LQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 243 L~~dP~~Rps~~ell~h 259 (568)
|+.||.+|||+.|+++|
T Consensus 258 l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 258 WHEKADERPTFKILLSN 274 (283)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhHCcCHHHHHHH
Confidence 99999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=382.63 Aligned_cols=253 Identities=28% Similarity=0.481 Sum_probs=212.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCE---
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSH--- 80 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--- 80 (568)
++.++|.+.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 45689999999999999999999999999999999997654322 24567889999999999999999999977653
Q ss_pred ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 81 ---IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 81 ---~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
+|+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999996 68887763 459999999999999999999999999999999999999999999999999987643
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-------------- 223 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-------------- 223 (568)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 178 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 178 A----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred C----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2 2344578999999999987555789999999999999999999999988766655544321
Q ss_pred ----------------C-CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 ----------------K-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 ----------------~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. ....+.+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0 0122457899999999999999999999999999999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=384.25 Aligned_cols=253 Identities=25% Similarity=0.458 Sum_probs=221.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC-------CcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT-------GEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET 77 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 77 (568)
..++|++.+.||+|+||.||+|++..+ +..||+|++...........+.+|+.+++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 457999999999999999999997643 3579999997654334456788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR 141 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 141 (568)
.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 999999999999999999998754 4999999999999999999999999999999999999999
Q ss_pred CCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6203 142 NQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219 (568)
Q Consensus 142 ~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~ 219 (568)
++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986543211 2233446788999999998766 6899999999999999999 9999999999888888
Q ss_pred HHcCC-CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 220 ILNGK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 220 i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+. ...+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 306 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87764 34566789999999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=380.15 Aligned_cols=250 Identities=34% Similarity=0.652 Sum_probs=184.7
Q ss_pred ccccCeEEEe-eecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHH-HHHHhCCCCCcceeeEEEEe----C
Q psy6203 5 DLRNQYILER-TVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEI-NALKHISHQHICKLFQVIET----S 78 (568)
Q Consensus 5 ~~~~~Y~i~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei-~~l~~l~hpnIv~l~~~~~~----~ 78 (568)
.+.++|++.+ .||+|+||+||+|.++.+|+.||+|++.... ....|+ ..++.++||||+++++++.. .
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 5778999965 6999999999999999999999999986431 223333 34667799999999999976 4
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---CCCeEEEeecCc
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGLC 153 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a 153 (568)
..+++||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999998753 6999999999999999999999999999999999999976 455999999998
Q ss_pred cCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCC-
Q psy6203 154 AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL----YDKILNGKYTEP- 228 (568)
Q Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~----~~~i~~~~~~~~- 228 (568)
...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+..+....+
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 179 KETTQN---ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp EEC-------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred eecccc---ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 765432 234567899999999997765 58899999999999999999999977654433 222333332222
Q ss_pred ---CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 ---PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 ---~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 458999999999999999999999999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=372.36 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=216.4
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEc-CCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhC---CCCCcceeeEEEE--
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHV-LTGEKVAIKIMKKATLGE-DLPRVKLEINALKHI---SHQHICKLFQVIE-- 76 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~-- 76 (568)
....++|++.+.||+|+||.||+|++. .+|+.||+|++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 445689999999999999999999995 678999999987544322 233566777777766 8999999999987
Q ss_pred ---eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeec
Q psy6203 77 ---TSSHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 77 ---~~~~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
.....++||||++ |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5567899999997 69999997753 49999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----
Q psy6203 152 LCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY---- 225 (568)
Q Consensus 152 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~---- 225 (568)
++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 166 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 166 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ccccccCC--CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 98765432 2334567899999999998776 589999999999999999999999988877666665421 00
Q ss_pred ---------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ---------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.....+++.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 112457889999999999999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=389.87 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=205.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC--------CCCcceeeEEEE-
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS--------HQHICKLFQVIE- 76 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~l~~~~~- 76 (568)
+.++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4689999999999999999999999999999999997432 23456788999999885 788999999987
Q ss_pred ---eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCC-------
Q psy6203 77 ---TSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQ------- 143 (568)
Q Consensus 77 ---~~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~------- 143 (568)
....+|+||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 456899999999 66777777654 5699999999999999999999998 999999999999998775
Q ss_pred ------------------------------------------CeEEEeecCccCCCCCCccccccccCCccccccccccC
Q psy6203 144 ------------------------------------------NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181 (568)
Q Consensus 144 ------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 181 (568)
.+||+|||++..... .....+||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcccCChhhcC
Confidence 799999999876543 2344579999999999988
Q ss_pred cccCCcccceechhhHHHHHHhCCCCCCCCC------HHHHHHHHHc--CCC----------------------------
Q psy6203 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDS------IDQLYDKILN--GKY---------------------------- 225 (568)
Q Consensus 182 ~~~~~~~~DiwSlG~il~~lltG~~pf~~~~------~~~~~~~i~~--~~~---------------------------- 225 (568)
.. ++.++|||||||++|+|++|..||...+ .......+.. +..
T Consensus 268 ~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 76 6899999999999999999999997543 1121211111 110
Q ss_pred ------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 226 ------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 226 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
..+...++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 01112345688999999999999999999999999997
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=380.59 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=220.2
Q ss_pred cccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
..++|++.+.||+|+||.||+|++. .+++.||+|+++..........+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999987 35589999999765433345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCc
Q psy6203 81 IFMVIEYCPGGELLDHIVER------------------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPEN 136 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 136 (568)
.|+||||+++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 99999999999999999763 568999999999999999999999999999999999
Q ss_pred eEEcCCCCeEEEeecCccCCCCCC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHH
Q psy6203 137 VLLDRNQNLKLIDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID 214 (568)
Q Consensus 137 Ill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~ 214 (568)
||++.++.+||+|||++....... ........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 999999999999999987543211 11223456889999999998766 6899999999999999999 99999999988
Q ss_pred HHHHHHHcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 215 QLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 215 ~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
++...+..+.. ..+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 284 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88888887765 4566789999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=374.94 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=219.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
..++|++.+.||+|+||.||+|.+. .++..||+|++...........+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3578999999999999999999984 45588999999765433345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCc
Q psy6203 81 IFMVIEYCPGGELLDHIVERQR------------------------LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPEN 136 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~------------------------l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 136 (568)
.++||||+++++|.+++..... +++.++..++.||+.||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 9999999999999999987543 8899999999999999999999999999999999
Q ss_pred eEEcCCCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHH
Q psy6203 137 VLLDRNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID 214 (568)
Q Consensus 137 Ill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~ 214 (568)
|+++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999876543211 1223445788999999998765 5899999999999999999 99999988887
Q ss_pred HHHHHHHcCCC-CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 215 QLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 215 ~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+...+..+.. ..+..+++.+.++|.+||+.||.+|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 260 RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77777776643 4556789999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=386.80 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=217.7
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.+..+++.||||+++.....+....+.+|+.+|++++||||+++++++...+..|+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 46899999999999999999999999999999998754322233467789999999999999999999999899999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc-
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL- 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~- 164 (568)
|+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 99999999999865 4699999999999999999999999999999999999999999999999999876443211111
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+..+. .+.+...++++.+||.+|
T Consensus 273 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 1223567899999998765 5899999999999999998 999999998888887777664 455667899999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|+.||++|||++++++
T Consensus 352 l~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 352 WAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=386.06 Aligned_cols=253 Identities=24% Similarity=0.441 Sum_probs=214.0
Q ss_pred cccCeEEEeeecccCCeEEEEEE-----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLAT-----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSS 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 79 (568)
..++|++.+.||+|+||.||+|+ +..+++.||||++...........+.+|+.+++++ +||||+++++++...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 46899999999999999999999 55677899999997654334456788999999999 7899999999998755
Q ss_pred -EEEEEEeccCCCChHHHHHhcCC--------------------------------------------------------
Q psy6203 80 -HIFMVIEYCPGGELLDHIVERQR-------------------------------------------------------- 102 (568)
Q Consensus 80 -~~~lV~E~~~~g~L~~~i~~~~~-------------------------------------------------------- 102 (568)
..++|||||++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999976533
Q ss_pred ----------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-ccccccccCCc
Q psy6203 103 ----------LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQLQTSCGSP 171 (568)
Q Consensus 103 ----------l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~gt~ 171 (568)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ........||+
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 8999999999999999999999999999999999999999999999999997653322 12233456899
Q ss_pred cccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCH-HHHHHHHHcC-CCCCCCCCChHHHHHHHHccccCcC
Q psy6203 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSI-DQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQVEPG 248 (568)
Q Consensus 172 ~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~ 248 (568)
.|+|||++.+.. ++.++|||||||++|+|++ |..||.+... ..+...+..+ ....+...++++.++|.+||+.||.
T Consensus 260 ~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 338 (359)
T 3vhe_A 260 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 338 (359)
T ss_dssp GGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred eeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 999999998765 6899999999999999998 9999987653 3344444444 4456677899999999999999999
Q ss_pred CCCCHHHHhcC
Q psy6203 249 KRIKIQDLLGH 259 (568)
Q Consensus 249 ~Rps~~ell~h 259 (568)
+|||+.|+++|
T Consensus 339 ~Rps~~ell~~ 349 (359)
T 3vhe_A 339 QRPTFSELVEH 349 (359)
T ss_dssp GSCCHHHHHHH
T ss_pred hCCCHHHHHHH
Confidence 99999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=368.10 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=208.4
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..-++|++.+.||+|+||.||+|.+..+++.||+|++......+ ....+.+|+.++++++||||+++++++...+..|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999999999999999997654322 2357888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998765443323
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIV 239 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li 239 (568)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+...+...+...... .++.+++.+.++|
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred cccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 334567999999999998765 588999999999999999999999988776555555444322 3456899999999
Q ss_pred HHccccCcCCCC-CHHHHhc
Q psy6203 240 RSMLQVEPGKRI-KIQDLLG 258 (568)
Q Consensus 240 ~~~L~~dP~~Rp-s~~ell~ 258 (568)
.+||+.||++|| |+++++.
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHH
T ss_pred HHhccCCHHHHHHhHHHHHH
Confidence 999999999999 7888775
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=367.61 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=222.1
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
-..++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 35678999999999999999999999999999999997543 3456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999999864 45999999999999999999999999999999999999999999999999999876544333
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVR 240 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~ 240 (568)
......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||...+.......+... ....+..+++.+.+||.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 334455788999999998766 5899999999999999999 99999988877777777665 34556678999999999
Q ss_pred HccccCcCCCCCHHHHhc
Q psy6203 241 SMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~ 258 (568)
+||+.||.+|||+.|+++
T Consensus 247 ~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 247 ACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhCCChhhCcCHHHHHH
Confidence 999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=367.45 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=209.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 479999999999999999999999999999999885432 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc---
Q psy6203 87 YCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES--- 162 (568)
Q Consensus 87 ~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--- 162 (568)
|+++++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9999999999987 567999999999999999999999999999999999999999999999999998764332111
Q ss_pred ----------ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH-----HHHHHHcCCCCC
Q psy6203 163 ----------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-----LYDKILNGKYTE 227 (568)
Q Consensus 163 ----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~-----~~~~i~~~~~~~ 227 (568)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....... ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~ 244 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--RYC 244 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--HTC
T ss_pred cccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--ccC
Confidence 112457999999999998866 5899999999999999999999986432100 0001111 123
Q ss_pred CCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 228 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
++.+++.+.++|.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5667899999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=365.89 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=211.0
Q ss_pred EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
.....||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 33458999999999999999999999999997653 23456788999999999999999999999999999999999999
Q ss_pred CChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-CCCeEEEeecCccCCCCCCcccccc
Q psy6203 91 GELLDHIVER---QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 91 g~L~~~i~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++...... ......
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 182 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-NPCTET 182 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-CCcccc
Confidence 9999999765 24678999999999999999999999999999999999987 899999999998765432 122345
Q ss_pred ccCCccccccccccCcc-cCCcccceechhhHHHHHHhCCCCCCCCCH-HH-HHH-HHHcCCCCCCCCCChHHHHHHHHc
Q psy6203 167 SCGSPNYAAPEVIKGKQ-YYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQ-LYD-KILNGKYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~-~~~-~i~~~~~~~~~~~~~~~~~li~~~ 242 (568)
..||+.|+|||++.+.. .++.++||||||+++|+|++|..||..... .. ... .........+..+++++.+||.+|
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHT
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHH
Confidence 57999999999987542 358899999999999999999999965432 22 222 223334456677899999999999
Q ss_pred cccCcCCCCCHHHHhcCcccccC
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
|+.||++|||++|+++||||+..
T Consensus 263 l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 263 FEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp TCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ccCChhhCCCHHHHhcChhhhhc
Confidence 99999999999999999999853
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=375.72 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=212.7
Q ss_pred CCccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q psy6203 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSS 79 (568)
Q Consensus 1 m~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 79 (568)
|...-+.++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++++ +||||+++++++...+
T Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 2 MGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp --CCEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred CceEEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 3445678899999999999999999999999999999999876532 33578899999999 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC-----eEEEeecCc
Q psy6203 80 HIFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN-----LKLIDFGLC 153 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-----~kl~DFG~a 153 (568)
..++||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999999999 9999999986 478999999999999999999999999999999999999998887 999999999
Q ss_pred cCCCCCCcc------ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC---CCHHHHHHHHHcCC
Q psy6203 154 AKPEGGLES------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS---DSIDQLYDKILNGK 224 (568)
Q Consensus 154 ~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~---~~~~~~~~~i~~~~ 224 (568)
......... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+ ....+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 764332111 124567999999999998876 58999999999999999999999987 44555555554433
Q ss_pred CCCCC----CCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 225 YTEPP----WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 225 ~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...+. ...+++.++|..||+.||.+||+++++++
T Consensus 237 ~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 237 RATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22221 12349999999999999999999998875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=369.70 Aligned_cols=247 Identities=18% Similarity=0.292 Sum_probs=212.5
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCC-------cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTG-------EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS 78 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 78 (568)
..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3579999999999999999999998877 479999986543 23456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC--------eEEEe
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN--------LKLID 149 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--------~kl~D 149 (568)
+..++||||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999999987654 999999999999999999999999999999999999998887 99999
Q ss_pred ecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCC
Q psy6203 150 FGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGKYTEP 228 (568)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~~~~ 228 (568)
||++..... .....||+.|+|||++.+...++.++|||||||++|+|++| .+||...+..... .........+
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (289)
T 4fvq_A 165 PGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQLP 238 (289)
T ss_dssp CCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCCC
T ss_pred CcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCCCC
Confidence 999865432 13345889999999998755579999999999999999995 5566655554444 3344455666
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
...++++.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6778999999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=373.73 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=215.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEE--EEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKV--AIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||.||+|++..+|..+ |+|.+...........+.+|+.+++++ +||||+++++++.+.+..|+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 78999999999999999999999898865 999987654444566788999999999 899999999999999999999
Q ss_pred EeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 85 IEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 99999999999997654 69999999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CC
Q psy6203 149 DFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YT 226 (568)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~ 226 (568)
|||++...... .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+. ..
T Consensus 185 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (327)
T 1fvr_A 185 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 261 (327)
T ss_dssp CTTCEESSCEE--CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred ccCcCcccccc--ccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCC
Confidence 99998753321 1223345788999999997765 5899999999999999998 999999999888888877663 34
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+..+++.+.+||.+||+.||.+|||++|+++|
T Consensus 262 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 556789999999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=383.12 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=211.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CC-----CcceeeEEEEeC
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQ-----HICKLFQVIETS 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----nIv~l~~~~~~~ 78 (568)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ |+ +|+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 45689999999999999999999999999999999997432 22456677888888875 45 499999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCceecCCCCCceEEc--CCCCeEEEeecC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLH--HLGYAHRDLKPENVLLD--RNQNLKLIDFGL 152 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~--~~~~~kl~DFG~ 152 (568)
+..|+||||++ ++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999999995 5999999865 46999999999999999999999 57999999999999995 477899999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP---- 228 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~---- 228 (568)
+..... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 208 a~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQ----RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceeccc----ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 976543 234567999999999998876 68999999999999999999999999887776665543110000
Q ss_pred --------------------------------CC----------------------------CChHHHHHHHHccccCcC
Q psy6203 229 --------------------------------PW----------------------------MSPNSRQIVRSMLQVEPG 248 (568)
Q Consensus 229 --------------------------------~~----------------------------~~~~~~~li~~~L~~dP~ 248 (568)
+. .++++.+||.+||+.||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 00 013789999999999999
Q ss_pred CCCCHHHHhcCccccc
Q psy6203 249 KRIKIQDLLGHNWVKM 264 (568)
Q Consensus 249 ~Rps~~ell~hp~~~~ 264 (568)
+|||++|+|+||||+.
T Consensus 363 ~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKK 378 (382)
T ss_dssp TSCCHHHHTTSGGGCC
T ss_pred hCCCHHHHhcCccccc
Confidence 9999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=378.42 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=211.1
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCC-cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCC------cceeeEEEEe
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTG-EKVAIKIMKKATLGEDLPRVKLEINALKHISHQH------ICKLFQVIET 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~~~~ 77 (568)
-+.++|++.+.||+|+||+||+|.+..++ ..||+|++.... .....+.+|+.+++.++|++ ++.+++++..
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 35789999999999999999999998877 689999997432 23456788999999987665 8999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE----------------
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---------------- 139 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---------------- 139 (568)
.+..++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999999 67777777665 369999999999999999999999999999999999999
Q ss_pred ---cCCCCeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHH
Q psy6203 140 ---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL 216 (568)
Q Consensus 140 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~ 216 (568)
+.++.+||+|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5678999999999876433 224557999999999998776 58999999999999999999999998876655
Q ss_pred HHHHHcCCCCCC--------------------------------------------CCCChHHHHHHHHccccCcCCCCC
Q psy6203 217 YDKILNGKYTEP--------------------------------------------PWMSPNSRQIVRSMLQVEPGKRIK 252 (568)
Q Consensus 217 ~~~i~~~~~~~~--------------------------------------------~~~~~~~~~li~~~L~~dP~~Rps 252 (568)
...+.......+ ...++++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 443322111110 112357889999999999999999
Q ss_pred HHHHhcCccccc
Q psy6203 253 IQDLLGHNWVKM 264 (568)
Q Consensus 253 ~~ell~hp~~~~ 264 (568)
+.|+|+||||+.
T Consensus 328 ~~e~l~hp~f~~ 339 (355)
T 2eu9_A 328 LAEALLHPFFAG 339 (355)
T ss_dssp HHHHTTSGGGGG
T ss_pred HHHHhcChhhcC
Confidence 999999999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=359.82 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=219.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 578999999999999999999986 678899999986543 34578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 87 YCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 87 ~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++............
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999999765 56899999999999999999999999999999999999999999999999998765432222233
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHcc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSML 243 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L 243 (568)
...+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+..+.. ..+...++.+.+++.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l 242 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 242 (267)
T ss_dssp STTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHc
Confidence 445788999999998665 5899999999999999999 8999999988888888877643 345668999999999999
Q ss_pred ccCcCCCCCHHHHhcC
Q psy6203 244 QVEPGKRIKIQDLLGH 259 (568)
Q Consensus 244 ~~dP~~Rps~~ell~h 259 (568)
+.||.+|||+.+++++
T Consensus 243 ~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 243 RERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=375.24 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=214.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcE----EEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.++|++.+.||+|+||+||+|.+..+++. ||+|.+...........+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57899999999999999999999888876 77777654443344456778999999999999999999986 45689
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999999764 5799999999999999999999999999999999999999999999999999987544322
Q ss_pred c-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 S-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
. ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+. ...+...++++.++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMV 249 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHH
T ss_pred cccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHH
Confidence 2 234456788999999998766 6899999999999999999 999999888777777777764 44566688999999
Q ss_pred HHHccccCcCCCCCHHHHhcC
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~h 259 (568)
|.+||+.||.+|||+.|+++|
T Consensus 250 i~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 250 MVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=373.75 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=208.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEE----EEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKV----AIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.++|++.+.||+|+||+||+|++..+++.+ |+|.+...........+.+|+.++++++||||+++++++.+.+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 478999999999999999999998887754 7777765444445678899999999999999999999998765 78
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 99999999999999987 46799999999999999999999999999999999999999999999999999875433211
Q ss_pred -cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 -SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
.......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+. ...+...+.++.++
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251 (327)
T ss_dssp -------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred cccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 1223345688999999998766 5899999999999999999 999999888777777776654 45566789999999
Q ss_pred HHHccccCcCCCCCHHHHhcC
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~h 259 (568)
+.+||+.||.+|||+.|++++
T Consensus 252 i~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 252 MVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=387.86 Aligned_cols=251 Identities=15% Similarity=0.188 Sum_probs=191.4
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhC--CCCCcceee-------EEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI--SHQHICKLF-------QVIE 76 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l--~hpnIv~l~-------~~~~ 76 (568)
.+|++.+.||+|+||+||+|.+..+|+.||+|++...... .....+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999876532 2345667785444444 699987754 5655
Q ss_pred eC-----------------CEEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHcCceecCC
Q psy6203 77 TS-----------------SHIFMVIEYCPGGELLDHIVER-QRLGEKES------RAFFRQILSAVAYLHHLGYAHRDL 132 (568)
Q Consensus 77 ~~-----------------~~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~------~~i~~qi~~aL~~LH~~~ivHrDl 132 (568)
.. ..+|+||||++ |+|.+++... ..+++... ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 34899999998 8999999864 33444444 577799999999999999999999
Q ss_pred CCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCccccccccccC-cccCCcccceechhhHHHHHHhCCCCCCCC
Q psy6203 133 KPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG-KQYYGSETDVWSMGVMLYALLCGFLPFDSD 211 (568)
Q Consensus 133 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~~lltG~~pf~~~ 211 (568)
||+|||++.++.+||+|||+|...... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999865421 224457799999999976 234689999999999999999999999766
Q ss_pred CHHHH--HHH-----HHcCCC--CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 212 SIDQL--YDK-----ILNGKY--TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 212 ~~~~~--~~~-----i~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
..... ... .....+ +..+.+++.+.+||.+||+.||++|||+.|+|+||||+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 32210 000 001111 22346899999999999999999999999999999997
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=372.26 Aligned_cols=253 Identities=24% Similarity=0.450 Sum_probs=218.5
Q ss_pred cccCeEEEeeecccCCeEEEEEEEc-------CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHV-------LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET 77 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 77 (568)
..++|++.+.||+|+||.||+|++. .++..||+|++...........+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3579999999999999999999986 457789999997654333456788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQ----------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR 141 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 141 (568)
.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 999999999999999999998653 3899999999999999999999999999999999999999
Q ss_pred CCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6203 142 NQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219 (568)
Q Consensus 142 ~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~ 219 (568)
++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 99999999999876543221 1223345788999999998765 5899999999999999999 9999999998888887
Q ss_pred HHcCC-CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 220 ILNGK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 220 i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+. ...+..+++.+.++|.+||+.||.+|||+.|++++
T Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77664 34566789999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=375.46 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=212.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 80 (568)
.++|++.+.||+|+||.||+|.+. .++..||+|++...........+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 478999999999999999999973 356789999998655445567889999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCce
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ-----------------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENV 137 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~-----------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 137 (568)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 999999999999999997643 378999999999999999999999999999999999
Q ss_pred EEcCCCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHH
Q psy6203 138 LLDRNQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQ 215 (568)
Q Consensus 138 ll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~ 215 (568)
|++.++.+||+|||++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+...
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 999999999999999875433211 1223445788999999998765 5899999999999999998 999998765443
Q ss_pred H-HHHHHcC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 216 L-YDKILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 216 ~-~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
. ...+..+ ....+...++++.+||.+||+.||.+|||+.|+++|-.-
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 3 3334433 334566789999999999999999999999999987543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=361.81 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=211.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 83 (568)
-+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.+ +|+||+++++++......++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 356889999999999999999999999999999999875432 33578899999999 79999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC-----eEEEeecCccCCC
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN-----LKLIDFGLCAKPE 157 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-----~kl~DFG~a~~~~ 157 (568)
||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++....
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999 99999999875 46999999999999999999999999999999999999987776 9999999987654
Q ss_pred CCCc------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC--
Q psy6203 158 GGLE------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYT-- 226 (568)
Q Consensus 158 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---~~~~~~~~i~~~~~~-- 226 (568)
.... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. ...+....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 3221 1234557999999999998776 589999999999999999999999773 344444444332211
Q ss_pred ---CCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 227 ---EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 227 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
....+++++.++|.+||+.||.+|||++++++
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 22467899999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.03 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=209.7
Q ss_pred ccCeEEEeeecccCCeEEEEEE----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC--CE
Q psy6203 7 RNQYILERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS--SH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~ 80 (568)
.++|++.+.||+|+||.||+|+ +..+++.||+|++...........+.+|+.++++++||||+++++++... +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3579999999999999999999 56789999999998665555667889999999999999999999999876 67
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 8999999999999999954 467999999999999999999999999999999999999999999999999998765443
Q ss_pred Cc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---------------CHHHHHHHHHc
Q psy6203 160 LE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---------------SIDQLYDKILN 222 (568)
Q Consensus 160 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---------------~~~~~~~~i~~ 222 (568)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..|+... ........+..
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 21 2233456888999999998766 588999999999999999999886322 12233334443
Q ss_pred C-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 223 G-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 223 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+ ....+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3 34556778999999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=372.52 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=191.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEIN-ALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
.++|++.+.||+|+||.||+|.+..+|+.||||++...........+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 4789999999999999999999999999999999986543333344555665 677789999999999999999999999
Q ss_pred eccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 86 EYCPGGELLDHIVE-----RQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 86 E~~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
||+++ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 99975 78877763 56799999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccccccccCCcccccccccc---CcccCCcccceechhhHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC-C----CCC
Q psy6203 160 LESQLQTSCGSPNYAAPEVIK---GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYT-E----PPW 230 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~-~~~~~~i~~~~~~-~----~~~ 230 (568)
.......||+.|+|||++. ....++.++|||||||++|+|++|..||...+. .+....+..+... . ...
T Consensus 180 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3aln_A 180 --IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred --cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence 1223347999999999984 223368899999999999999999999976432 2222222222222 1 134
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+++.+.+||.+||+.||.+|||+.|+++||||..
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 7899999999999999999999999999999973
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=362.83 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=217.1
Q ss_pred ccCeEEEe-eecccCCeEEEEEEEc--CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILER-TVGSGGFAKVKLATHV--LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~-~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++...........+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 56777776 9999999999999864 467889999998654333456788999999999999999999999 4556899
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 161 (568)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999999999999654 5699999999999999999999999999999999999999999999999999876543221
Q ss_pred -cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 -SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..++...+..+. ...++.+++++.++
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 245 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 245 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHH
Confidence 1123345689999999997665 5899999999999999998 999999888888888877765 34567789999999
Q ss_pred HHHccccCcCCCCCHHHHhcCcc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNW 261 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~ 261 (568)
|.+||+.||.+|||+.++++|.+
T Consensus 246 i~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 246 MSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999998755
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=368.84 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=210.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEE----EEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKV----AIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.++|++.+.||+|+||.||+|.+..+++.+ |+|.+...........+.+|+.++++++||||+++++++...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 578999999999999999999998888765 6666654444455678899999999999999999999998765 78
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 99999999999999987 46799999999999999999999999999999999999999999999999999976543211
Q ss_pred -cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 -SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+. .+.+...++++.++
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 251 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251 (327)
T ss_dssp -------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred cccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 1223345688999999998766 5899999999999999999 999999888777777776664 45666789999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~ 258 (568)
|.+||+.||.+|||+.|+++
T Consensus 252 i~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 252 MRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=378.74 Aligned_cols=251 Identities=29% Similarity=0.494 Sum_probs=205.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-----------CCCcceeeEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-----------HQHICKLFQVI 75 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~~~~ 75 (568)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++++++ ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 468999999999999999999999999999999997432 13456788999998876 89999999999
Q ss_pred EeCC----EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcC------C
Q psy6203 76 ETSS----HIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDR------N 142 (568)
Q Consensus 76 ~~~~----~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~------~ 142 (568)
...+ .+++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++. .
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 7654 789999999 89999999863 4599999999999999999999998 9999999999999953 3
Q ss_pred CCeEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH------HHH
Q psy6203 143 QNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI------DQL 216 (568)
Q Consensus 143 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~------~~~ 216 (568)
+.+||+|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+. ...
T Consensus 175 ~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCC----CCCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 4799999999876543 234457999999999998876 58999999999999999999999976541 111
Q ss_pred HHHHHc------------------------------------------CCCCCCCCCChHHHHHHHHccccCcCCCCCHH
Q psy6203 217 YDKILN------------------------------------------GKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQ 254 (568)
Q Consensus 217 ~~~i~~------------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 254 (568)
...+.. .....+...++++.+||.+||+.||.+|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 111111 11122233457789999999999999999999
Q ss_pred HHhcCcccccC
Q psy6203 255 DLLGHNWVKMG 265 (568)
Q Consensus 255 ell~hp~~~~~ 265 (568)
|+|+||||+..
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 99999999853
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=365.20 Aligned_cols=256 Identities=27% Similarity=0.358 Sum_probs=198.7
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchH-HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.-.++|++.+.||+|+||.||+|.+..+|+.||||++.......... .+..+..+++.++||||+++++++.+.+..|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34578999999999999999999999999999999998654332222 33344556888899999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHL-GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
||||+ ++.+..+... ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-- 178 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--
Confidence 99999 5555555543 47899999999999999999999996 9999999999999999999999999998765432
Q ss_pred cccccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCC---CCCCh
Q psy6203 162 SQLQTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKYTEP---PWMSP 233 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~~~~i~~~~~~~~---~~~~~ 233 (568)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.. ....+....+..+..... ..+++
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence 22334579999999999852 33468899999999999999999999976 445556666655544322 34789
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
++.+||.+||+.||.+|||++|+++||||+
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 999999999999999999999999999997
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=356.64 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=203.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC---CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG---EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.++|++.+.||+|+||.||+|.+ +|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 47899999999999999999997 4889999998764332 235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCceEEcC--------CCCeEEEeecC
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG---YAHRDLKPENVLLDR--------NQNLKLIDFGL 152 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~--------~~~~kl~DFG~ 152 (568)
||||+++++|.+++. .+.+++..+..++.|++.||.|||++| |+||||||+||+++. ++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999998874 568999999999999999999999999 899999999999986 67899999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCC
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPPW 230 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~--~~~~~ 230 (568)
+...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+..... ..+..
T Consensus 163 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 163 AREWHRT---TKMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccccccc---cccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 8765432 223457999999999998765 58999999999999999999999999887777766665543 44567
Q ss_pred CChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 231 ~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+++.+.++|.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=369.33 Aligned_cols=253 Identities=20% Similarity=0.320 Sum_probs=219.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
..++|++.+.||+|+||.||+|.+. .+++.||+|++...........+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 4578999999999999999999876 45788999999765433344568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEee
Q psy6203 81 IFMVIEYCPGGELLDHIVER----------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcC
Confidence 99999999999999999753 45799999999999999999999999999999999999999999999999
Q ss_pred cCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CC
Q psy6203 151 GLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TE 227 (568)
Q Consensus 151 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~ 227 (568)
|++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..+.. ..
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 261 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCC
Confidence 99875432211 1223345788999999998765 5899999999999999999 8999999988888888877654 45
Q ss_pred CCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 228 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+++.+.++|.+||+.||.+|||+.|+++|
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 262 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66789999999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=369.23 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=214.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEE-----cCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATH-----VLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSS 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 79 (568)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++...........+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 357999999999999999999985 4567899999997654333456788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQ------------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR 141 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 141 (568)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 9999999999999999998654 4899999999999999999999999999999999999999
Q ss_pred CCCeEEEeecCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHH-HHH
Q psy6203 142 NQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQ-LYD 218 (568)
Q Consensus 142 ~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~-~~~ 218 (568)
++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+..... ...
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 999999999998765443221 123345788999999998765 6899999999999999999 999998765433 333
Q ss_pred HHHcC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 219 KILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 219 ~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+..+ ....+...++.+.++|.+||+.||.+|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 33333 233456689999999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=372.18 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=216.2
Q ss_pred cccCeEEEeeecccCCeEEEEEE-----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLAT-----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
..++|++.+.||+|+||.||+|+ +..++..||+|++...........+.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 35799999999999999999999 5667889999999754433345578889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC---CCeEEEee
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ-------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN---QNLKLIDF 150 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DF 150 (568)
.|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999999998753 48999999999999999999999999999999999999844 46999999
Q ss_pred cCccCCCCCC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CC
Q psy6203 151 GLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TE 227 (568)
Q Consensus 151 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~ 227 (568)
|++....... ........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+..+.. ..
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 266 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 266 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC
Confidence 9986432211 11223456899999999997765 5899999999999999998 9999999888888888877643 45
Q ss_pred CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 228 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+..+++.+.++|.+||+.||.+|||+.++++|.|..
T Consensus 267 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 267 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 567899999999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=361.43 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=211.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC---CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..++|++.+.||+|+||+||+|.+... +..||+|++...........+.+|+.++++++||||+++++++.+. ..|
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 457899999999999999999987543 3469999987654333456788999999999999999999998654 568
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999999999765 4699999999999999999999999999999999999999999999999999886554322
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIV 239 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li 239 (568)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......+..+ ..+.+..+++.+.++|
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLM 247 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 2334456788999999997665 5899999999999999998 99999877666666666554 3455667899999999
Q ss_pred HHccccCcCCCCCHHHHhcC
Q psy6203 240 RSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~h 259 (568)
.+||+.||.+|||+.|++++
T Consensus 248 ~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 248 TRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCchhCcCHHHHHHH
Confidence 99999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=365.09 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=206.4
Q ss_pred cccCeEEEeeecccCCeEEEEEE----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe--CC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET--SS 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~ 79 (568)
..++|++.+.||+|+||+||+|+ +..+++.||+|++.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 45799999999999999999998 56789999999987542 2234578899999999999999999999854 35
Q ss_pred EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
.+++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 6899999999999999998754 599999999999999999999999999999999999999999999999999876543
Q ss_pred CCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH----------------HHHHHH
Q psy6203 159 GLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----------------QLYDKI 220 (568)
Q Consensus 159 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~----------------~~~~~i 220 (568)
... .......+++.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 221 1223345777899999998776 589999999999999999999998653221 222333
Q ss_pred Hc-CCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 221 LN-GKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 221 ~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.. ...+.+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 33 344566778999999999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=378.79 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=206.0
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.++|++.+.||+|+||.||+|++. .++..||||+++..........+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999987 46778999999765433345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
||||+++|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999999999765 46999999999999999999999999999999999999999999999999998765432211
Q ss_pred c--cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 163 Q--LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 163 ~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
. .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..++...+..+. .+.+...++.+.++
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 282 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL 282 (373)
T ss_dssp ----------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHH
T ss_pred ceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence 1 12223577899999998766 5899999999999999998 999999988888888877663 34455688999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~ 258 (568)
|.+||+.||.+|||+.++++
T Consensus 283 i~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 283 MLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=360.36 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=213.9
Q ss_pred ccCeEEEe-eecccCCeEEEEEEE--cCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 7 RNQYILER-TVGSGGFAKVKLATH--VLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 7 ~~~Y~i~~-~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.++|++.+ .||+|+||.||+|.+ ..+++.||+|++....... ....+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46899998 999999999999954 5677899999997654332 256788999999999999999999999 566789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998765433211
Q ss_pred --ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHH
Q psy6203 163 --QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQI 238 (568)
Q Consensus 163 --~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l 238 (568)
......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..++...+..+.. ..+..+++.+.++
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 122334678999999998766 5889999999999999999 9999999988888888877653 4566789999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~ 258 (568)
|.+||+.||.+|||+.++++
T Consensus 253 i~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=389.95 Aligned_cols=249 Identities=23% Similarity=0.401 Sum_probs=220.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.++.++..||||+++... .....+.+|+.+|++++||||+++++++...+.+|+|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 467999999999999999999999999999999997643 245678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 99999999999864 4589999999999999999999999999999999999999999999999999987654322223
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++.+.+..+. ...+..+++.+.+||.+|
T Consensus 377 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 455 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 3345678999999998766 5899999999999999999 999999888777777776653 345667899999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|+.||.+|||+.++++
T Consensus 456 l~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 456 WQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCcChhHCcCHHHHHH
Confidence 9999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=367.72 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=212.2
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCC----cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTG----EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
..++|++.+.||+|+||.||+|.+..++ ..||+|++...........+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3468999999999999999999987654 359999997654333345688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999999999765 679999999999999999999999999999999999999999999999999987654322
Q ss_pred cc--ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHH
Q psy6203 161 ES--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSR 236 (568)
Q Consensus 161 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 236 (568)
.. ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..++...+..+. .+.+..+++.+.
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 280 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 280 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred ccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHH
Confidence 11 112234678999999998766 5899999999999999999 999999988888888887763 455667899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcC
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~h 259 (568)
++|.+||+.||.+|||+.+++++
T Consensus 281 ~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 281 QLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=357.06 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=216.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
-..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.++++++||||+++++++.. +..++|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 45689999999999999999999975 56789999997543 245678899999999999999999999864 558999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999999987543 7999999999999999999999999999999999999999999999999998865543322
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVR 240 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 240 (568)
......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+..+. ...+..+++.+.++|.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 244 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHH
Confidence 333445788999999998665 5889999999999999999 999999988888888877664 3445678999999999
Q ss_pred HccccCcCCCCCHHHHhc
Q psy6203 241 SMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~ 258 (568)
+||+.||++|||++++++
T Consensus 245 ~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 245 LCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhccChhhCCCHHHHHH
Confidence 999999999999999876
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=363.25 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=211.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCC--CCCcceeeEEEEeCCEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHIS--HQHICKLFQVIETSSHIF 82 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~~ 82 (568)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.++++++ ||||+++++++.+.+..|
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3467999999999999999999985 5899999999765433 23467889999999997 599999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 161 (568)
+||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence 9999 55889999999988999999999999999999999999999999999999996 58999999999876543221
Q ss_pred cccccccCCccccccccccCc----------ccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcCC--CCCC
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGK----------QYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGK--YTEP 228 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~~--~~~~ 228 (568)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... .......+.... ...+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 122345799999999998752 246889999999999999999999997643 333334444432 3445
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
...++++.++|.+||+.||.+|||+.|+++||||+..
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 6678999999999999999999999999999999853
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=355.21 Aligned_cols=247 Identities=24% Similarity=0.430 Sum_probs=209.2
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc------hHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED------LPRVKLEINALKHISHQHICKLFQVIETSS 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 79 (568)
..++|++.+.||+|+||.||+|++..+++.||+|++........ ...+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 35799999999999999999999999999999999876543322 257889999999999999999999997666
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEcCCCC-----eEEEeec
Q psy6203 80 HIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLDRNQN-----LKLIDFG 151 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~-----~kl~DFG 151 (568)
++||||+++++|.+.+... ..+++..+..++.|++.||.|||++| |+||||||+||+++.++. +||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 7999999999999988754 57999999999999999999999999 999999999999988776 9999999
Q ss_pred CccCCCCCCccccccccCCccccccccccC-cccCCcccceechhhHHHHHHhCCCCCCCCCHHH--HHHHHHcC--CCC
Q psy6203 152 LCAKPEGGLESQLQTSCGSPNYAAPEVIKG-KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ--LYDKILNG--KYT 226 (568)
Q Consensus 152 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~--~~~~i~~~--~~~ 226 (568)
++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+... ....+... ...
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 9875433 2345679999999999843 2335889999999999999999999997654322 23333333 334
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+..+++.+.++|.+||+.||.+|||++|+++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 56678999999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=382.91 Aligned_cols=252 Identities=27% Similarity=0.481 Sum_probs=211.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC--EEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS--HIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~ 82 (568)
.+.++|++.+.||+|+||+||+|++..+|+.||||++...........+.+|+.++++++||||+++++++...+ ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 457899999999999999999999999999999999987655555677889999999999999999999998765 789
Q ss_pred EEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE----cCCCCeEEEeecCccC
Q psy6203 83 MVIEYCPGGELLDHIVERQ---RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL----DRNQNLKLIDFGLCAK 155 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG~a~~ 155 (568)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999999997543 39999999999999999999999999999999999999 7777899999999986
Q ss_pred CCCCCccccccccCCccccccccccCc-------ccCCcccceechhhHHHHHHhCCCCCCC----CCHHHHHHHHHcCC
Q psy6203 156 PEGGLESQLQTSCGSPNYAAPEVIKGK-------QYYGSETDVWSMGVMLYALLCGFLPFDS----DSIDQLYDKILNGK 224 (568)
Q Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~~lltG~~pf~~----~~~~~~~~~i~~~~ 224 (568)
.... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. ....+....+..+.
T Consensus 166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 5442 233456799999999998641 3357899999999999999999999963 23345555555554
Q ss_pred CCC---------------------C----CCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 225 YTE---------------------P----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 225 ~~~---------------------~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.. . ..+++.+.++|.+||+.||++|||++|+++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 321 1 113456789999999999999999999865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=355.24 Aligned_cols=244 Identities=18% Similarity=0.307 Sum_probs=211.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS--SHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l 83 (568)
.++|++.+.||+|+||.||+|++. |+.||+|++...... .....+.+|+.++++++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 478999999999999999999984 889999999865433 2345688999999999999999999999877 78899
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 84 VIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
||||+++|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 999999999999998765 4899999999999999999999999 9999999999999999999999998865432
Q ss_pred CccccccccCCccccccccccCccc--CCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCChHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQY--YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNS 235 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 235 (568)
.....||+.|+|||++.+... ++.++|||||||++|+|++|..||...+.......+... ....+..+++++
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 234568999999999987543 233799999999999999999999988877776665544 334566789999
Q ss_pred HHHHHHccccCcCCCCCHHHHhc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.++|.+||+.||.+|||++|+++
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=383.23 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=216.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.+|++++||||+++++++. .+..|+||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 3578999999999999999999985 56789999997644 34668899999999999999999999986 56789999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999999754 378999999999999999999999999999999999999999999999999998654322222
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 241 (568)
.....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+. .+.+..+++++.+||.+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 420 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 23345678999999998665 6899999999999999999 999999998888888877663 45566789999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||+.||++|||+++++.
T Consensus 421 cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhHCcCHHHHHH
Confidence 99999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=379.51 Aligned_cols=242 Identities=26% Similarity=0.479 Sum_probs=212.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC-EEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS-HIFMVI 85 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~ 85 (568)
.++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++++||||+++++++...+ .+|+||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 468999999999999999999874 7899999997543 4567899999999999999999999987665 799999
Q ss_pred eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 99999999999987654 799999999999999999999999999999999999999999999999998754322
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 241 (568)
.....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..++...+..+. ...+..+++.+.+||.+
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp ----CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 22336788999999998776 6899999999999999998 999999888777777777763 45667789999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||+.||.+|||+.++++
T Consensus 422 cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhHCcCHHHHHH
Confidence 99999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.97 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=200.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC----EEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS----HIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~l 83 (568)
++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.++++++||||+++++++.... .+++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 68999999999999999999874 7899999996543 22345566899999999999999999998743 4799
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CceecCCCCCceEEcCCCCeEEEeecCc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL----------GYAHRDLKPENVLLDRNQNLKLIDFGLC 153 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~ivHrDlkp~NIll~~~~~~kl~DFG~a 153 (568)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 100 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 9999999999999965 5699999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCc-cccccccCCccccccccccCc----ccCCcccceechhhHHHHHHhCCCCCCCC----------------C
Q psy6203 154 AKPEGGLE-SQLQTSCGSPNYAAPEVIKGK----QYYGSETDVWSMGVMLYALLCGFLPFDSD----------------S 212 (568)
Q Consensus 154 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~~lltG~~pf~~~----------------~ 212 (568)
........ ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+. .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 76443221 223345799999999999863 23467899999999999999999999653 2
Q ss_pred HHHHHHHHHcCCCCCC--C-----CCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 213 IDQLYDKILNGKYTEP--P-----WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 213 ~~~~~~~i~~~~~~~~--~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...+...+........ . ..++++.+||.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3333333333322211 1 12345899999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.04 Aligned_cols=253 Identities=24% Similarity=0.447 Sum_probs=213.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEE-----cCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATH-----VLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSS 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 79 (568)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++...........+.+|+.+++++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 457999999999999999999985 3567899999997654333455788999999999 6999999999987654
Q ss_pred -EEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC
Q psy6203 80 -HIFMVIEYCPGGELLDHIVERQR----------------LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142 (568)
Q Consensus 80 -~~~lV~E~~~~g~L~~~i~~~~~----------------l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 142 (568)
.+++||||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 58999999999999999987543 8999999999999999999999999999999999999999
Q ss_pred CCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCH-HHHHHH
Q psy6203 143 QNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSI-DQLYDK 219 (568)
Q Consensus 143 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~-~~~~~~ 219 (568)
+.+||+|||++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+... ......
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 9999999999876543221 1223456789999999998766 5899999999999999998 9999977553 344444
Q ss_pred HHcC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 220 ILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 220 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+ ....+...++.+.++|.+||+.||.+|||+.|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4444 345566789999999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=357.84 Aligned_cols=247 Identities=26% Similarity=0.442 Sum_probs=213.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe-------
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET------- 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------- 77 (568)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 45678999999999999999999999999999999997543 356789999999999999999998864
Q ss_pred ---------CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeE
Q psy6203 78 ---------SSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLK 146 (568)
Q Consensus 78 ---------~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 146 (568)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999999754 6799999999999999999999999999999999999999999999
Q ss_pred EEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q psy6203 147 LIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT 226 (568)
Q Consensus 147 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~ 226 (568)
|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||... ......+..+.
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~-- 235 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI-- 235 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC--
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc--
Confidence 99999987654432 234457999999999998766 589999999999999999999887432 23444444443
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.+..+++.+.++|.+||+.||.+|||+.|+++|.|.-
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3456889999999999999999999999999998875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=356.47 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=205.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
..++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3468999999999999999999999999999999997644322 34567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 84 VIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999864 466999999999999999999999999999999999999999999999999998765432
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCC--CCCCChHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILNGKYTE--PPWMSPNS 235 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~--~~~~~~~~i~~~~~~~--~~~~~~~~ 235 (568)
. .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.+. +.......+..+.++. ...+++++
T Consensus 190 ~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 190 T-TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp ----------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred C-ccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 1 2233456899999999998766 589999999999999999999999754 3455666666665443 24578999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcC
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+||.+||+.||.+|||+.+++++
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=357.92 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=207.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEE-EeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI-ETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~l 83 (568)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 567899999999999999999999999999999999876442 34688999999999988766655554 67788999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE---cCCCCeEEEeecCccCCCCC
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 159 (568)
||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999974 4679999999999999999999999999999999999999 48889999999998765432
Q ss_pred Cc------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC---
Q psy6203 160 LE------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKYTE--- 227 (568)
Q Consensus 160 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~---~~~~~~~i~~~~~~~--- 227 (568)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+ ..+....+.......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 21 1124557999999999998876 5899999999999999999999997632 222233332222222
Q ss_pred --CCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 228 --PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 228 --~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...+++++.++|.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 2567899999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.49 Aligned_cols=253 Identities=26% Similarity=0.464 Sum_probs=212.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCc-----EEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGE-----KVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSS 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 79 (568)
..++|++.+.||+|+||.||+|.+..++. .||+|++...........+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999999987664 79999997654333456788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCe
Q psy6203 80 HIFMVIEYCPGGELLDHIVER--------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNL 145 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 145 (568)
..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 999999999999999999753 357999999999999999999999999999999999999999999
Q ss_pred EEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHH-Hc
Q psy6203 146 KLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKI-LN 222 (568)
Q Consensus 146 kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i-~~ 222 (568)
||+|||++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+ ..
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 9999999875433211 1223345788999999998765 5899999999999999998 99999876543333333 33
Q ss_pred C-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 223 G-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 223 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+ ....+...++.+.++|.+||+.||.+|||+.|++++
T Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 2 234456689999999999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=360.98 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=206.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcC---CCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCC--
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSS-- 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 79 (568)
..++|++.+.||+|+||.||+|.+.. ++..||+|++...... .....+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34789999999999999999998765 4568999998765432 23456888999999999999999999997655
Q ss_pred ---EEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEee
Q psy6203 80 ---HIFMVIEYCPGGELLDHIVE------RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 80 ---~~~lV~E~~~~g~L~~~i~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 35999999999999999853 356999999999999999999999999999999999999999999999999
Q ss_pred cCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCC
Q psy6203 151 GLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTE 227 (568)
Q Consensus 151 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~ 227 (568)
|++........ .......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+.......+..+. ...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence 99876543211 1223345788999999998766 5899999999999999999 999999888777777777664 445
Q ss_pred CCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 228 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 228 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66789999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=356.69 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=211.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCc---EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE-EE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI-FM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-~l 83 (568)
-.|.+.+.||+|+||+||+|.+..++. .||+|++...........+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 357788999999999999999766554 79999987644333456788999999999999999999999766655 99
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC--
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-- 160 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 160 (568)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999999976 4678999999999999999999999999999999999999999999999999987543321
Q ss_pred -ccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHH
Q psy6203 161 -ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQ 237 (568)
Q Consensus 161 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 237 (568)
........+|+.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+..+. ...+..+++.+.+
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 259 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence 11223446788999999998776 5899999999999999999 566677767666666666654 3456678999999
Q ss_pred HHHHccccCcCCCCCHHHHhc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~ 258 (568)
+|.+||+.||.+|||+.++++
T Consensus 260 li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999886
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=379.24 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=212.7
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|++++||||+++++++.+ +..|+|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4689999999999999999999864 46799999976542 34678999999999999999999999866 67899999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 9999999999974 35699999999999999999999999999999999999999999999999999986543322222
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+. .+.+..+++.+.+||.+|
T Consensus 339 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 417 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 417 (452)
T ss_dssp ----CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred cCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 3345788999999998765 6899999999999999999 999999998888888887764 445677899999999999
Q ss_pred cccCcCCCCCHHHHhc--Ccccc
Q psy6203 243 LQVEPGKRIKIQDLLG--HNWVK 263 (568)
Q Consensus 243 L~~dP~~Rps~~ell~--hp~~~ 263 (568)
|+.||++|||++++++ ..++.
T Consensus 418 l~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 418 WRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ccCChhhCcCHHHHHHHHHHHhc
Confidence 9999999999999986 34444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=368.32 Aligned_cols=255 Identities=23% Similarity=0.280 Sum_probs=207.5
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|+||.||+|++ .+|+.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 106 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 106 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence 457899999999999999999985 4789999999987654444557899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 86 EYCPGGELLDHIVERQ----RLGEKESRAFFRQILSAVAYLHHL---GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
||+++|+|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 186 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence 9999999999997643 499999999999999999999999 999999999999999999999999999986554
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-CCC---
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--------IDQLYDKILNG-KYT--- 226 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~--------~~~~~~~i~~~-~~~--- 226 (568)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ........... ...
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 3uim_A 187 KDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV 265 (326)
T ss_dssp SSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred ccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence 3333444556999999999997766 5899999999999999999999995211 11111111111 000
Q ss_pred -------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 227 -------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 227 -------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
.+...++.+.+++.+||+.||.+|||+.|+++|-+-
T Consensus 266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 011123678999999999999999999999998543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=376.54 Aligned_cols=251 Identities=27% Similarity=0.473 Sum_probs=198.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 83 (568)
.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... ...+.+|+.+++++ +||||+++++++.+.+.+|+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 567788889999999999998754 4689999999987532 34677899999876 89999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-------------C
Q psy6203 84 VIEYCPGGELLDHIVERQRLG-------EKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-------------Q 143 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~-------~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-------------~ 143 (568)
|||||+ |+|.+++....... +..+..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 69999997654332 33457899999999999999999999999999999754 4
Q ss_pred CeEEEeecCccCCCCCCcc---ccccccCCccccccccccC------cccCCcccceechhhHHHHHHh-CCCCCCCCCH
Q psy6203 144 NLKLIDFGLCAKPEGGLES---QLQTSCGSPNYAAPEVIKG------KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSI 213 (568)
Q Consensus 144 ~~kl~DFG~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~ 213 (568)
.+||+|||++......... .....+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 7999999999865543211 2234579999999999975 2346899999999999999999 9999976543
Q ss_pred HHHHHHHHcCCCCCCC-------CCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 214 DQLYDKILNGKYTEPP-------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 214 ~~~~~~i~~~~~~~~~-------~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.+ ..+..+....+. .+++++.+||.+||+.||.+|||+.|+++||||.
T Consensus 246 ~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 33 234444333221 1357899999999999999999999999999996
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=356.19 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=201.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEE-EeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI-ETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~l 83 (568)
.+.++|++.+.||+|+||+||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..+..+ ...+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 5678999999999999999999999999999999987654432 3577899999999988776666554 77888999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE---cCCCCeEEEeecCccCCCCC
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 159 (568)
||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999975 4679999999999999999999999999999999999999 78899999999998765432
Q ss_pred Cc------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCC---
Q psy6203 160 LE------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---DQLYDKILNGKYTE--- 227 (568)
Q Consensus 160 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~---~~~~~~i~~~~~~~--- 227 (568)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+. ......+.......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 21 1223557999999999998876 58999999999999999999999976321 12222222222222
Q ss_pred --CCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 228 --PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 228 --~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...+++++.+||.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2557899999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=357.92 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=209.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCC---cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEE-EeCCEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTG---EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVI-ETSSHI 81 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~ 81 (568)
...+|++.+.||+|+||.||+|.+..++ ..||+|.+...........+.+|+.++++++||||+++++++ ...+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3457999999999999999999976443 358999987644333456788999999999999999999985 456678
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 82 FMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999999999999976 4568999999999999999999999999999999999999999999999999987654321
Q ss_pred c---cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC-CCCCCChHH
Q psy6203 161 E---SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNS 235 (568)
Q Consensus 161 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~ 235 (568)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+..+... .+..+++.+
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 261 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred hhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHH
Confidence 1 1123345788999999998766 5899999999999999999 67788777766666666666544 456689999
Q ss_pred HHHHHHccccCcCCCCCHHHHhc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.++|.+||+.||.+|||+.|+++
T Consensus 262 ~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 262 YEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=353.49 Aligned_cols=243 Identities=26% Similarity=0.482 Sum_probs=205.1
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeC-CEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETS-SHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~lV 84 (568)
..++|++.+.||+|+||.||+|.+ +|+.||+|++.... ..+.+.+|+.++++++||||+++++++... +..|+|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 347899999999999999999987 48899999987542 456788999999999999999999987544 478999
Q ss_pred EeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 85 IEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 999999999999976543 899999999999999999999999999999999999999999999999998754432
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVR 240 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~ 240 (568)
.....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+..+ ....+..+++.+.++|.
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 248 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 248 (278)
T ss_dssp ------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred -ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence 22346788999999998765 5899999999999999998 99999988877777777665 34456678999999999
Q ss_pred HccccCcCCCCCHHHHhc
Q psy6203 241 SMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~ 258 (568)
+||+.||.+|||+.|+++
T Consensus 249 ~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 249 NCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhcCChhhCCCHHHHHH
Confidence 999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=361.74 Aligned_cols=251 Identities=31% Similarity=0.449 Sum_probs=208.0
Q ss_pred cccCe-EEEeeecccCCeEEEEEE----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe--C
Q psy6203 6 LRNQY-ILERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET--S 78 (568)
Q Consensus 6 ~~~~Y-~i~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~ 78 (568)
+.++| ++++.||+|+||+||++. +..+|+.||+|++...........+.+|+.++++++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 56666 999999999999998875 3457899999999865433345678899999999999999999999987 4
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
..+++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 689999999999999999865 4599999999999999999999999999999999999999999999999999986544
Q ss_pred CCc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH---------------HHHHHHH
Q psy6203 159 GLE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---------------QLYDKIL 221 (568)
Q Consensus 159 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~---------------~~~~~i~ 221 (568)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .+...+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 321 1223446888999999998766 588999999999999999999999654321 2223333
Q ss_pred cC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 222 NG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 222 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+ ....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33 34456678999999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=362.02 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=205.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE----eCCEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE----TSSHIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----~~~~~~ 82 (568)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++. .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 468999999999999999999999999999999986532 234567889999999999999999999986 234789
Q ss_pred EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 83 MVIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999999976 46799999999999999999999999999999999999999999999999998875432
Q ss_pred CCcc--------ccccccCCccccccccccCcc--cCCcccceechhhHHHHHHhCCCCCCCCC--HHHHHHHHHc-CCC
Q psy6203 159 GLES--------QLQTSCGSPNYAAPEVIKGKQ--YYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILN-GKY 225 (568)
Q Consensus 159 ~~~~--------~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~~lltG~~pf~~~~--~~~~~~~i~~-~~~ 225 (568)
.... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.... .......+.. ...
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence 1110 112345799999999987543 25789999999999999999999995311 0111222222 223
Q ss_pred CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 226 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+.++.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 4445689999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=368.44 Aligned_cols=251 Identities=20% Similarity=0.239 Sum_probs=199.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcC---CCcEEEEEEeecCCcCC----------chHHHHHHHHHHHhCCCCCcceee
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLGE----------DLPRVKLEINALKHISHQHICKLF 72 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----------~~~~~~~Ei~~l~~l~hpnIv~l~ 72 (568)
..++|++.+.||+|+||.||+|.+.. ++..+|+|++....... ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 35789999999999999999999987 78899999987653210 122356788889999999999999
Q ss_pred EEEEe----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC--CeE
Q psy6203 73 QVIET----SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ--NLK 146 (568)
Q Consensus 73 ~~~~~----~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~k 146 (568)
+++.. ....|+||||+ +++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99987 77899999999 999999998877999999999999999999999999999999999999998887 999
Q ss_pred EEeecCccCCCCCC------ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC--CCHHHHHH
Q psy6203 147 LIDFGLCAKPEGGL------ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS--DSIDQLYD 218 (568)
Q Consensus 147 l~DFG~a~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~--~~~~~~~~ 218 (568)
|+|||+++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+ .+......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999997543211 11124457999999999998775 58999999999999999999999965 23222221
Q ss_pred HHHc--CCCC-------CCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 219 KILN--GKYT-------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 219 ~i~~--~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.... ...+ ....+++++.++|.+||+.||++|||++++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1111 1111 11267899999999999999999999999976
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.43 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=197.1
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
..++|++.+.||+|+||+||+|.+. ..||+|+++..... .....+.+|+.++++++||||++++++. ..+..++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 4578999999999999999999853 46999999765433 2346788999999999999999999965 55668999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC-Ccc
Q psy6203 85 IEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG-LES 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~ 162 (568)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999999999999964 457999999999999999999999999999999999999999999999999998754321 122
Q ss_pred ccccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-----CCCCChH
Q psy6203 163 QLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYTE-----PPWMSPN 234 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf~~~-~~~~~~~~i~~~~~~~-----~~~~~~~ 234 (568)
......||+.|+|||++.. ...++.++|||||||++|+|++|..||... ....+...+..+.... ...+++.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 2344579999999999862 233588999999999999999999999774 4455555555554332 2357899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.+||.+||+.||.+|||+.++++
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.50 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=211.6
Q ss_pred ccCeEEEeeecccCCeEEEEEE----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE--eCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE--TSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~ 80 (568)
.++|++.+.||+|+||.||+|+ +..+++.||+|++.... ......+.+|+.++++++||||+++++++. +.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 4799999999999999999999 56789999999987543 123456889999999999999999999986 4567
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
.|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999999999999976 456999999999999999999999999999999999999999999999999999865433
Q ss_pred Cc--cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH---------------HHHHHHHHc
Q psy6203 160 LE--SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---------------DQLYDKILN 222 (568)
Q Consensus 160 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~---------------~~~~~~i~~ 222 (568)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ..+...+..
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 21 1223446888999999998766 58999999999999999999999865432 223333433
Q ss_pred C-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 223 G-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 223 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+ ....+..+++.+.+||.+||+.||.+|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 344566789999999999999999999999999654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=368.17 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=209.2
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
.....++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 345678999999999999999999996 478999999886543 234567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 83 MVIEYCPGGELLDHIVERQ----RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999886543 589999999999999999999999999999999999999999999999999875432
Q ss_pred CC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH------H-HHHHHcCCCC----
Q psy6203 159 GL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ------L-YDKILNGKYT---- 226 (568)
Q Consensus 159 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~------~-~~~i~~~~~~---- 226 (568)
.. ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+ . ......+...
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 21 12223446899999999998766 5899999999999999999999997543211 1 1111122111
Q ss_pred --C----CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcc
Q psy6203 227 --E----PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 261 (568)
Q Consensus 227 --~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 261 (568)
. ++..+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 1123456889999999999999999999998643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=353.26 Aligned_cols=232 Identities=32% Similarity=0.609 Sum_probs=193.6
Q ss_pred cccccCeEEE-eeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHH-HhCCCCCcceeeEEEEe----
Q psy6203 4 IDLRNQYILE-RTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL-KHISHQHICKLFQVIET---- 77 (568)
Q Consensus 4 ~~~~~~Y~i~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~---- 77 (568)
..+.++|.+. +.||+|+||.||+|.+..+++.||+|++.. .....+|+.++ +.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 4567889888 789999999999999999999999999864 23577888887 56689999999999987
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---CCCeEEEeecC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGL 152 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~ 152 (568)
.+.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 678999999999999999998754 6999999999999999999999999999999999999988 78899999998
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCC
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK----ILNGKYTEP 228 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~----i~~~~~~~~ 228 (568)
+..... . .++.++|||||||++|+|++|..||...+....... +..+....+
T Consensus 167 a~~~~~-----------------------~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 167 AKETTG-----------------------E-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp CEECTT-----------------------C-GGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred cccccc-----------------------c-cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 754321 1 257899999999999999999999977654433211 112222222
Q ss_pred ----CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 229 ----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 229 ----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 4578999999999999999999999999999999843
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=354.35 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=197.1
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHh--CCCCCcceeeEEEEe----C
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH--ISHQHICKLFQVIET----S 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~----~ 78 (568)
.+.++|++.+.||+|+||+||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++.. .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 4678999999999999999999987 6899999998653 23445566666665 799999999998654 3
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceecCCCCCceEEcCCCCeEEEee
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH--------HLGYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
...++||||+++|+|.+++. ...+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 46899999999999999994 467999999999999999999999 999999999999999999999999999
Q ss_pred cCccCCCCCCcc---ccccccCCccccccccccCccc-----CCcccceechhhHHHHHHhC----------CCCCCCC-
Q psy6203 151 GLCAKPEGGLES---QLQTSCGSPNYAAPEVIKGKQY-----YGSETDVWSMGVMLYALLCG----------FLPFDSD- 211 (568)
Q Consensus 151 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwSlG~il~~lltG----------~~pf~~~- 211 (568)
|++......... .....+||+.|+|||++.+... ++.++|||||||++|+|++| ..||...
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 998654332111 1234479999999999987632 34789999999999999999 8888542
Q ss_pred ----CHHHHHHHHHcCCC--CCCC-----CCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 212 ----SIDQLYDKILNGKY--TEPP-----WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 212 ----~~~~~~~~i~~~~~--~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
........+..... ..+. ..++.+.+||.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22333332222211 1111 13467999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=375.15 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=196.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.+|.+.+.||+|+||+|+. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+.+..|+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 4699999999999999764 4456899999999865432 2356899999999 79999999999999999999999
Q ss_pred ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---C--CCeEEEeecCccCCCCCC
Q psy6203 87 YCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---N--QNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~--~~~kl~DFG~a~~~~~~~ 160 (568)
||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|.......
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 995 69999997653 4666678899999999999999999999999999999953 2 357899999998654321
Q ss_pred c--cccccccCCccccccccccC--cccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC---CCCCC
Q psy6203 161 E--SQLQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE---PPWMS 232 (568)
Q Consensus 161 ~--~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~~~---~~~~~ 232 (568)
. ......+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||...........+....... ....+
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHH
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccccc
Confidence 1 22345679999999999974 2335779999999999999999 999997665444332222222211 12235
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+.+.+||.+||+.||.+|||++|+++||||.
T Consensus 258 ~~~~~li~~~L~~dP~~Rps~~evl~hp~f~ 288 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred HHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence 5689999999999999999999999999997
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=368.21 Aligned_cols=250 Identities=16% Similarity=0.246 Sum_probs=198.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC-----CcEEEEEEeecCCcCC----------chHHHHHHHHHHHhCCCCCcce
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT-----GEKVAIKIMKKATLGE----------DLPRVKLEINALKHISHQHICK 70 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~----------~~~~~~~Ei~~l~~l~hpnIv~ 70 (568)
..++|++.+.||+|+||.||+|.+..+ ++.||+|++....... .......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998765 5789999987543110 0112334566677888999999
Q ss_pred eeEEEEeC----CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc--CCC
Q psy6203 71 LFQVIETS----SHIFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD--RNQ 143 (568)
Q Consensus 71 l~~~~~~~----~~~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~~ 143 (568)
+++++... ...|+||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 4589999999 99999999876 6799999999999999999999999999999999999999 889
Q ss_pred CeEEEeecCccCCCCCCc------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH-HH
Q psy6203 144 NLKLIDFGLCAKPEGGLE------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QL 216 (568)
Q Consensus 144 ~~kl~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-~~ 216 (568)
.+||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.... ..
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 999999999975432211 1123446999999999998876 699999999999999999999999753211 11
Q ss_pred HHHH-----------HcCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 217 YDKI-----------LNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 217 ~~~i-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.... ....+ .....++++.+++..||+.||.+|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111 11111 12457899999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=363.27 Aligned_cols=244 Identities=16% Similarity=0.211 Sum_probs=203.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCC--------CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcce--------
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLT--------GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICK-------- 70 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~-------- 70 (568)
.++|++.+.||+|+||.||+|++..+ ++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 57999999999999999999999874 889999998754 25788999999999999988
Q ss_pred -------eeEEEEe-CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc
Q psy6203 71 -------LFQVIET-SSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD 140 (568)
Q Consensus 71 -------l~~~~~~-~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 140 (568)
+++++.. .+..|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 6777766 78899999999 99999999875 7899999999999999999999999999999999999999
Q ss_pred CCC--CeEEEeecCccCCCCCCc------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC-
Q psy6203 141 RNQ--NLKLIDFGLCAKPEGGLE------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD- 211 (568)
Q Consensus 141 ~~~--~~kl~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~- 211 (568)
.++ .+||+|||++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 998 899999999976543211 1123447999999999998776 589999999999999999999999765
Q ss_pred -CHHHHHHHH---HcCCCCCC------CCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 212 -SIDQLYDKI---LNGKYTEP------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 212 -~~~~~~~~i---~~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+...+.... ........ ..+++++.+||.+||+.||.+|||++++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 333333222 22222211 246899999999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=352.71 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=205.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcC-CCc--EEEEEEeecCCcC--CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVL-TGE--KVAIKIMKKATLG--EDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
..++|++.+.||+|+||+||+|++.. +++ .||+|++...... +..+.+.+|+.++++++||||+++++++.+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 35789999999999999999998654 333 6899998765432 23567889999999999999999999997765
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 89999999999999999764 67999999999999999999999999999999999999999999999999998765433
Q ss_pred Ccc--ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC--CCCCCCCChH
Q psy6203 160 LES--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK--YTEPPWMSPN 234 (568)
Q Consensus 160 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 234 (568)
... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.... .+.+..++++
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred ccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 211 123345788999999998765 5889999999999999999 999999998888888877654 3445678999
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+.++|.+||+.||.+|||+.+++++
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999873
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=384.79 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=214.0
Q ss_pred cCeEEEe-eecccCCeEEEEEEEcC--CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILER-TVGSGGFAKVKLATHVL--TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~-~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
+++.+.+ .||+|+||.||+|.+.. ++..||||+++..........+.+|+.+|++++||||+++++++.. +.+|+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4566666 89999999999998763 4567999999876544566789999999999999999999999976 568999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc-
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES- 162 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~- 162 (568)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999999999999754 56999999999999999999999999999999999999999999999999999865432211
Q ss_pred -ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHH
Q psy6203 163 -QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIV 239 (568)
Q Consensus 163 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li 239 (568)
......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..++...+..+.. ..+..+++++.+||
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 572 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM 572 (613)
T ss_dssp --------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 112234568999999998665 6899999999999999998 9999999888888888887754 45667899999999
Q ss_pred HHccccCcCCCCCHHHH---hcCccccc
Q psy6203 240 RSMLQVEPGKRIKIQDL---LGHNWVKM 264 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~el---l~hp~~~~ 264 (568)
.+||+.||.+|||+.++ |++.|+..
T Consensus 573 ~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 573 SDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999997 45666554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=368.00 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=202.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCC---cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE-eCCEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTG---EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE-TSSHIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~l 83 (568)
..|++.+.||+|+||+||+|.+..++ ..||+|.+...........+.+|+.++++++||||+++++++. ..+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35889999999999999999976443 4689999876443344567889999999999999999999864 4567899
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999764 45899999999999999999999999999999999999999999999999998754332111
Q ss_pred ---ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHH
Q psy6203 163 ---QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQ 237 (568)
Q Consensus 163 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~ 237 (568)
......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+..+.. ..+..+++.+.+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~ 327 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327 (373)
T ss_dssp ---------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 122345788999999998766 5899999999999999999 7888987766666666666654 345678999999
Q ss_pred HHHHccccCcCCCCCHHHHhcC
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~h 259 (568)
+|.+||+.||.+|||+.|++++
T Consensus 328 li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 328 VMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=381.37 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=216.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|++++||||+++++++.+ +..||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 35789999999999999999999864 46799999986542 34678999999999999999999999866 6789999
Q ss_pred eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++|+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 99999999999975 3569999999999999999999999999999999999999999999999999997654322122
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 241 (568)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....++...+..+. ...+..+++.+.+||.+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 499 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 499 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 23345678999999998765 6899999999999999999 999999998888888887764 34566789999999999
Q ss_pred ccccCcCCCCCHHHHhc
Q psy6203 242 MLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~ 258 (568)
||+.||++|||+++|++
T Consensus 500 cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 500 CWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhHCcCHHHHHH
Confidence 99999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=352.40 Aligned_cols=240 Identities=26% Similarity=0.438 Sum_probs=198.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||+||+|.+ .++.||+|++... .....+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 36899999999999999999987 4789999998643 345678899999999999999999998764 4799999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCceecCCCCCceEEcCCCC-eEEEeecCccCCCCC
Q psy6203 87 YCPGGELLDHIVERQ---RLGEKESRAFFRQILSAVAYLHH---LGYAHRDLKPENVLLDRNQN-LKLIDFGLCAKPEGG 159 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~ 159 (568)
|+++++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999998654 37899999999999999999999 89999999999999998886 799999998754322
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC--CHHHHHHHHHcCC-CCCCCCCChHHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILNGK-YTEPPWMSPNSR 236 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~--~~~~~~~~i~~~~-~~~~~~~~~~~~ 236 (568)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||... ........+..+. ...+..+++.+.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred ----cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence 23446899999999998766 589999999999999999999999753 3333444444443 345567899999
Q ss_pred HHHHHccccCcCCCCCHHHHhc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~ 258 (568)
++|.+||+.||.+|||++++++
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=358.36 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=188.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEE--------e
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIE--------T 77 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~--------~ 77 (568)
..+|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++++. ||||+++++++. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 358999999999999999999999999999999986543 223456788999999996 999999999984 3
Q ss_pred CCEEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEcCCCCeEEEeecC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVE---RQRLGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLDRNQNLKLIDFGL 152 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~ 152 (568)
...+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 446899999995 789888865 467999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCcc-----------ccccccCCcccccccccc--CcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHH
Q psy6203 153 CAKPEGGLES-----------QLQTSCGSPNYAAPEVIK--GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK 219 (568)
Q Consensus 153 a~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~ 219 (568)
+......... .....+||+.|+|||++. ....++.++|||||||++|+|++|..||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 8765432111 112456899999999983 233368899999999999999999999976554433222
Q ss_pred HHcCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 220 ILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 220 i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
. .........++.+.+||.+||+.||.+|||+.|+++|-+-
T Consensus 265 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 265 K--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred c--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 1223345577889999999999999999999999998543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=384.18 Aligned_cols=244 Identities=21% Similarity=0.327 Sum_probs=208.7
Q ss_pred EeeecccCCeEEEEEEE--cCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccC
Q psy6203 13 ERTVGSGGFAKVKLATH--VLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCP 89 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 89 (568)
.+.||+|+||.||+|.+ ..+++.||||+++...... ....+.+|+.+|++++|||||++++++.. +..++||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 35899999999999954 4567899999998654332 35678999999999999999999999965 45889999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc--cccccc
Q psy6203 90 GGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE--SQLQTS 167 (568)
Q Consensus 90 ~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~ 167 (568)
+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 999999999888999999999999999999999999999999999999999999999999999876543221 122334
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHcccc
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~ 245 (568)
.+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..++...+..+.. ..+..+++++.+||.+||+.
T Consensus 533 ~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 533 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp --CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 5688999999998766 5899999999999999998 9999999999888888887754 45667899999999999999
Q ss_pred CcCCCCCHHHHhc
Q psy6203 246 EPGKRIKIQDLLG 258 (568)
Q Consensus 246 dP~~Rps~~ell~ 258 (568)
||++|||++++++
T Consensus 612 dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 612 DVENRPGFAAVEL 624 (635)
T ss_dssp STTTSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=384.81 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=213.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC---CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+...........+.+|+.++++++||||+++++++. .+..|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 457899999999999999999998654 45799998875433233467889999999999999999999984 45689
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 9999999999999998654 699999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIV 239 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 239 (568)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..+. .+.++.+++.+.+||
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 625 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 625 (656)
T ss_dssp -------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred eeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHH
Confidence 2333445788999999998765 6899999999999999997 999999988888888877664 456778999999999
Q ss_pred HHccccCcCCCCCHHHHhc
Q psy6203 240 RSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~ 258 (568)
.+||..||.+|||+.++++
T Consensus 626 ~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 626 TKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=352.42 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=207.6
Q ss_pred ccCeEEEeeecccCCeEEEEEE----EcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC--E
Q psy6203 7 RNQYILERTVGSGGFAKVKLAT----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS--H 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~ 80 (568)
.++|++.+.||+|+||.||+|+ +..+|+.||+|++.... ......+.+|+.++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 4579999999999999999998 46689999999987542 234567889999999999999999999986543 6
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 89999999999999999875 46999999999999999999999999999999999999999999999999998765433
Q ss_pred Ccc--ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCH----------------HHHHHHHH
Q psy6203 160 LES--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----------------DQLYDKIL 221 (568)
Q Consensus 160 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~----------------~~~~~~i~ 221 (568)
... ......+++.|+|||++.+.. ++.++|||||||++|+|++|..||..... ..+.+.+.
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 211 123345788899999998766 58899999999999999999999864311 11223333
Q ss_pred cC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 222 NG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 222 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+ ..+.+..+++++.++|.+||+.||.+|||+.|+++
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 32 34556778999999999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=351.44 Aligned_cols=247 Identities=21% Similarity=0.347 Sum_probs=196.4
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC--CCCCcceeeEEEEeC----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI--SHQHICKLFQVIETS---- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l--~hpnIv~l~~~~~~~---- 78 (568)
.+.++|++.+.||+|+||.||+|++. |+.||||++.... .....+|.+++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 35679999999999999999999874 8999999986432 23445555555554 899999999999887
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCceEEcCCCCeEEEee
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL--------GYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
...|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 789999999999999999965 5799999999999999999999999 9999999999999999999999999
Q ss_pred cCccCCCCCCcc---ccccccCCccccccccccCcccCCc------ccceechhhHHHHHHhC----------CCCCCCC
Q psy6203 151 GLCAKPEGGLES---QLQTSCGSPNYAAPEVIKGKQYYGS------ETDVWSMGVMLYALLCG----------FLPFDSD 211 (568)
Q Consensus 151 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~------~~DiwSlG~il~~lltG----------~~pf~~~ 211 (568)
|++......... .....+||+.|+|||++.+... +. ++|||||||++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN-RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCC-TTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccC-CccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 998755432211 1234579999999999987653 33 38999999999999999 6777542
Q ss_pred -----CHHHHHHHHHcCCC--CCCC-----CCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 212 -----SIDQLYDKILNGKY--TEPP-----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 212 -----~~~~~~~~i~~~~~--~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
........+..... ..+. .+++++.+||.+||+.||.+|||+.|+++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 22333333322222 1221 245668999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=361.43 Aligned_cols=244 Identities=18% Similarity=0.254 Sum_probs=198.8
Q ss_pred ccCeEEEeeecccCCeEEEEE-----EEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC---CCCcceeeEEEEeC
Q psy6203 7 RNQYILERTVGSGGFAKVKLA-----THVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS---HQHICKLFQVIETS 78 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~ 78 (568)
.++|++.+.||+|+||+||+| .+..+++.||+|++... ....+..|+.+++.++ |+||+++++++...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 467999999999999999999 46778999999998753 3456788888888887 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-----------C
Q psy6203 79 SHIFMVIEYCPGGELLDHIVE-----RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-----------N 142 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-----------~ 142 (568)
+..|+|||||++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999974 467999999999999999999999999999999999999988 8
Q ss_pred CCeEEEeecCccCCCC-CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6203 143 QNLKLIDFGLCAKPEG-GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 221 (568)
Q Consensus 143 ~~~kl~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~ 221 (568)
+.+||+|||+|..... .........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......... .
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~ 295 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---P 295 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---E
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCcee---e
Confidence 9999999999964321 1123345668999999999998877 699999999999999999999999543221000 0
Q ss_pred cCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 222 NGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 222 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
... ......++.+.+++..||+.+|.+|++..+.+.+
T Consensus 296 ~~~-~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 296 EGL-FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp CSC-CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred chh-ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 011 1112346788999999999999999765555544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=353.86 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=209.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
..++|++.+.||+|+||.||+|.+.. .+|+|++...... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 34789999999999999999999753 4999998765432 2345577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC----
Q psy6203 85 IEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG---- 159 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---- 159 (568)
|||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 99999999999997654 699999999999999999999999999999999999997 689999999997653211
Q ss_pred CccccccccCCccccccccccC--------cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--C
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKG--------KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--P 229 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~--~ 229 (568)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+..+..+.. .
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 266 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI 266 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCS
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcC
Confidence 1122334568999999999875 23368899999999999999999999999998888888877655433 3
Q ss_pred CCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 230 WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 230 ~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.+++++.++|.+||..||.+|||+.++++
T Consensus 267 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 267 GMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp SCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 47889999999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=389.34 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=206.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe------C
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET------S 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~ 78 (568)
...++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3458999999999999999999999999999999998764333345678889999999999999999998755 6
Q ss_pred CEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCC---eEEEeecC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQ---RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQN---LKLIDFGL 152 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~ 152 (568)
+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 67899999999999999998643 6999999999999999999999999999999999999997765 99999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHH---------H----
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD---------K---- 219 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~---------~---- 219 (568)
+...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......... .
T Consensus 171 a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQG--ELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSC--CCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccc--cccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9875443 2234567999999999998766 5899999999999999999999997653322110 0
Q ss_pred -HHcCCCC------CC----CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 220 -ILNGKYT------EP----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 220 -i~~~~~~------~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
...+... .+ ..+++.+.+||.+||..||.+|||+.|+++||||+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 0011111 11 12467899999999999999999999999999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=363.50 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=207.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCC-CCcceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-QHICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~l 83 (568)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.++| ++|..+..++...+..+|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 5679999999999999999999999999999999998765432 347789999999987 566666677788889999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEE---cCCCCeEEEeecCccCCCCC
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 159 (568)
||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 9999999975 5679999999999999999999999999999999999999 68899999999999765432
Q ss_pred Ccc------ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC---CHHHHHHHHHcCCC-----
Q psy6203 160 LES------QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKY----- 225 (568)
Q Consensus 160 ~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~---~~~~~~~~i~~~~~----- 225 (568)
... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. ...+.+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 211 123567999999999998876 589999999999999999999999763 33333433332221
Q ss_pred CCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 226 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
.....+++++.+||..||+.||.+||++++|++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 112457899999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.56 Aligned_cols=247 Identities=22% Similarity=0.343 Sum_probs=202.3
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc---CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL---GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
.|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 355569999999999999985 688999999875432 223567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-
Q psy6203 86 EYCPGGELLDHIVE---RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 86 E~~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 161 (568)
||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999999874 35699999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH----HHHHHHHcCCC-----------C
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILNGKY-----------T 226 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~----~~~~~i~~~~~-----------~ 226 (568)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||...... .+...+..... .
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 122345799999999998764 588999999999999999999999764322 22222222211 1
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112234678999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=348.89 Aligned_cols=252 Identities=20% Similarity=0.329 Sum_probs=192.3
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHH--HHhCCCCCcceeeEEEEe-----CC
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINA--LKHISHQHICKLFQVIET-----SS 79 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~--l~~l~hpnIv~l~~~~~~-----~~ 79 (568)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|..+ +..++||||+++++.+.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 47899999999999999999976 78999999997543 2333444444 456899999999986542 23
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceecCCCCCceEEcCCCCeEEEee
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL---------GYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
.+++||||+++|+|.+++... ..++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred eEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 679999999999999999654 458999999999999999999999 9999999999999999999999999
Q ss_pred cCccCCCCCC-------ccccccccCCccccccccccCc------ccCCcccceechhhHHHHHHhCCCCCCC-CC----
Q psy6203 151 GLCAKPEGGL-------ESQLQTSCGSPNYAAPEVIKGK------QYYGSETDVWSMGVMLYALLCGFLPFDS-DS---- 212 (568)
Q Consensus 151 G~a~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~~lltG~~pf~~-~~---- 212 (568)
|++....... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. .+
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9997643221 1122345799999999999762 2356789999999999999999766532 11
Q ss_pred -------------HHHHHHHHHcC--CCCCCCC------CChHHHHHHHHccccCcCCCCCHHHH------hcCcccccC
Q psy6203 213 -------------IDQLYDKILNG--KYTEPPW------MSPNSRQIVRSMLQVEPGKRIKIQDL------LGHNWVKMG 265 (568)
Q Consensus 213 -------------~~~~~~~i~~~--~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~el------l~hp~~~~~ 265 (568)
.......+... ....+.. .++.+.+||.+||+.||++|||+.|+ +.++|-+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 11111112111 1122222 33479999999999999999999999 457888743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.95 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=203.4
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHh--CCCCCcceeeEEEEeCC----
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH--ISHQHICKLFQVIETSS---- 79 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~---- 79 (568)
+.++|++.+.||+|+||.||+|.+ +|+.||+|++... ....+.+|++++.. ++||||+++++++...+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 457899999999999999999997 5899999998643 24567788888887 78999999999998776
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceecCCCCCceEEcCCCCeEEEeec
Q psy6203 80 HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH--------HLGYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 80 ~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
..|+||||+++|+|.+++.. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999965 57999999999999999999999 8999999999999999999999999999
Q ss_pred CccCCCCCCcc---ccccccCCccccccccccCccc-----CCcccceechhhHHHHHHhC----------CCCCCCC--
Q psy6203 152 LCAKPEGGLES---QLQTSCGSPNYAAPEVIKGKQY-----YGSETDVWSMGVMLYALLCG----------FLPFDSD-- 211 (568)
Q Consensus 152 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwSlG~il~~lltG----------~~pf~~~-- 211 (568)
++......... ......||+.|+|||++.+... ++.++|||||||++|+|++| ..||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 98754432211 2244579999999999976532 23689999999999999999 7888653
Q ss_pred ---CHHHHHHHHHcCCCCC--CC-----CCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 212 ---SIDQLYDKILNGKYTE--PP-----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 212 ---~~~~~~~~i~~~~~~~--~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
....+...+....... +. ..++.+.+||.+||+.||.+|||+.|+++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 3445555554433221 11 123578899999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.87 Aligned_cols=241 Identities=21% Similarity=0.284 Sum_probs=194.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc-------CCchHHHHHHHHHHHhCC---------CCCcce
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-------GEDLPRVKLEINALKHIS---------HQHICK 70 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~Ei~~l~~l~---------hpnIv~ 70 (568)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ......+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36899999999999999999997 789999999986542 123467889999998885 777777
Q ss_pred eeEEEE------------------------------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q psy6203 71 LFQVIE------------------------------TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120 (568)
Q Consensus 71 l~~~~~------------------------------~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~ 120 (568)
+.+++. +.+.+|+|||||++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 766643 26789999999999987777644 67899999999999999999
Q ss_pred HHH-HcCceecCCCCCceEEcCCC--------------------CeEEEeecCccCCCCCCccccccccCCccccccccc
Q psy6203 121 YLH-HLGYAHRDLKPENVLLDRNQ--------------------NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179 (568)
Q Consensus 121 ~LH-~~~ivHrDlkp~NIll~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l 179 (568)
||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||++
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhh
Confidence 999 99999999999999999887 899999999986542 245799999999999
Q ss_pred cCcccCCcccceechhhH-HHHHHhCCCCCCCCCH-HHHHHHHHcC-CCCCC------CCCChHHHHHHHHccccCcCCC
Q psy6203 180 KGKQYYGSETDVWSMGVM-LYALLCGFLPFDSDSI-DQLYDKILNG-KYTEP------PWMSPNSRQIVRSMLQVEPGKR 250 (568)
Q Consensus 180 ~~~~~~~~~~DiwSlG~i-l~~lltG~~pf~~~~~-~~~~~~i~~~-~~~~~------~~~~~~~~~li~~~L~~dP~~R 250 (568)
.+.. +.++||||+|++ .+++++|..||..... ......+... ..... +.+++++++||++||+.|
T Consensus 250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 8765 789999998777 7788999999854321 2233333321 12111 136788999999999977
Q ss_pred CCHHHHh-cCcccc
Q psy6203 251 IKIQDLL-GHNWVK 263 (568)
Q Consensus 251 ps~~ell-~hp~~~ 263 (568)
|++|+| +||||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.73 Aligned_cols=246 Identities=17% Similarity=0.218 Sum_probs=195.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHHHHHHHHHhCCC-CCcc---------e-----
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISH-QHIC---------K----- 70 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~h-pnIv---------~----- 70 (568)
..|.+.+.||+|+||+||+|.+..+|+.||||++...... ...+.+.+|+.+++.++| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3588999999999999999999999999999998744322 236788999999999987 3221 1
Q ss_pred -------eeEEEEe-----CCEEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecC
Q psy6203 71 -------LFQVIET-----SSHIFMVIEYCPGGELLDHIVE-------RQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131 (568)
Q Consensus 71 -------l~~~~~~-----~~~~~lV~E~~~~g~L~~~i~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 131 (568)
+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 22467888877 7899988842 23477888999999999999999999999999
Q ss_pred CCCCceEEcCCCCeEEEeecCccCCCCCCccccccccCCcccccccccc---------CcccCCcccceechhhHHHHHH
Q psy6203 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK---------GKQYYGSETDVWSMGVMLYALL 202 (568)
Q Consensus 132 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~~~DiwSlG~il~~ll 202 (568)
|||+|||++.++.+||+|||+++.... .....+| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999876442 2455678 9999999993 3333688999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 203 CGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 203 tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+|+.||...+.......+.. ....+++.+.+||.+||+.||.+|||+.|+++||||+
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 99999987665443333322 2345789999999999999999999999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=333.37 Aligned_cols=222 Identities=17% Similarity=0.152 Sum_probs=186.6
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+.++|++.+.||+|+||.||+|++..+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 5688999999999999999999999999999999998654432 23678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||++|++|.+++.. + ....++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999999854 3 4666789999999999999999999999999999999999999998543
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHH---HHHcCCCC----CCCCCChHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD---KILNGKYT----EPPWMSPNSR 236 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~---~i~~~~~~----~~~~~~~~~~ 236 (568)
|++| ++.++|||||||++|+|++|+.||.+.+...... ....+... ..+.+++++.
T Consensus 175 ---------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ---------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ---------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ---------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 3332 5789999999999999999999998765322110 11111111 1245889999
Q ss_pred HHHHHccccCcCCCCCHHHHhcC
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~h 259 (568)
++|.+||+.||.+| |+.|+++.
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHHH
Confidence 99999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=381.32 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=200.5
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcC-CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE----
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVL-TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH---- 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~---- 80 (568)
+.++|++.+.||+|+||.||+|.+.. +|+.||||++......+....+.+|+.++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 45899999999999999999999976 7899999998754332334567889999999999999999999987655
Q ss_pred -EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 81 -IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 81 -~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
.||||||++|++|.+.+.. .+++.++..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 7999999999999987654 79999999999999999999999999999999999999875 8999999998765432
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCChHHHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--PPWMSPNSRQ 237 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~ 237 (568)
...+||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+.... +.... ....++.+.+
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYGR 299 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCHHHHH
T ss_pred -----CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCHHHHH
Confidence 4557999999999987653 78999999999999999999998653211 00000 0113578999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
||.+||+.||.+||+..+.+.|+|+.
T Consensus 300 li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=316.75 Aligned_cols=232 Identities=18% Similarity=0.150 Sum_probs=162.8
Q ss_pred EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC---------chHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEE
Q psy6203 13 ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE---------DLPRVKLEINALKHI-SHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 82 (568)
....+.|+.|.+..++...+|+.||+|++.+..... ....+.+|+++|+++ .|+||+++++++++++.+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 344678888888888888899999999998653221 234688999999999 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||||++|++|.+.|...+++++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-~~ 394 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-CS 394 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC-Cc
Confidence 999999999999999998888875 47899999999999999999999999999999999999999999876543 23
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHc
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 242 (568)
...+.+||+.|+|||++.+. +..++|+||+|++++++.+|..++ ...+.. . +. ....+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~-~---~~-~~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ-E---PV-ERWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH--------HHHHHT-S---CG-GGCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCC--CCCcccccccccchhhhccccchh--------HHHhhc-C---CC-CCCcHHHHHHHH
Confidence 44567899999999999875 367899999999998887664432 111111 1 11 112345667777
Q ss_pred cccCcCCCCCHHHHhcCcccc
Q psy6203 243 LQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 243 L~~dP~~Rps~~ell~hp~~~ 263 (568)
...+|..|+.......|+|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 778888888777776677654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=272.31 Aligned_cols=157 Identities=19% Similarity=0.347 Sum_probs=138.6
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCC-Cceec
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKV-GQVIN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~-~~~~~ 396 (568)
|..||+|++++...++|+|.+++.++.||+.|+ +|+ ++|||+|||+|....... .....
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 192 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccccc
Confidence 334899999999889999999999999999874 343 468999999887654332 33456
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d 475 (568)
+.|||+.|||||. .+..|+.++||||+||++|||++|++||.+.+..+++.+|..+.+.+|..+|+++++||.+||++|
T Consensus 193 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~d 272 (311)
T 4aw0_A 193 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272 (311)
T ss_dssp CCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred CcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCC
Confidence 7899999999998 667899999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCHHH------HhcCcccccC
Q psy6203 476 PGKRIKIQD------LLGHNWVKMG 494 (568)
Q Consensus 476 p~~R~t~~~------~l~hp~~~~~ 494 (568)
|++|+|++| +++||||+..
T Consensus 273 p~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 273 ATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp GGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999987 5899999754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=263.88 Aligned_cols=151 Identities=29% Similarity=0.580 Sum_probs=125.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|++|++++...++|+|.+++.++.|++.|+ +|| +++||+|||+|... .......+.+|
T Consensus 96 ~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~--~~~~~~~~~~G 173 (275)
T 3hyh_A 96 GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCG 173 (275)
T ss_dssp CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------------
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec--CCCCccCCeeE
Confidence 678999999889999999999999999874 333 46899999987643 23334567899
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
|+.|||||. +..|++.++||||+||++|+|++|++||.+.+..+++..|..+.+.+|..+|+++++||.+||++||++
T Consensus 174 T~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 253 (275)
T 3hyh_A 174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 253 (275)
T ss_dssp -CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred CcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhH
Confidence 999999998 555678999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCccccc
Q psy6203 479 RIKIQDLLGHNWVKM 493 (568)
Q Consensus 479 R~t~~~~l~hp~~~~ 493 (568)
|||++|+++||||+.
T Consensus 254 R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 254 RISIHEIMQDDWFKV 268 (275)
T ss_dssp SCCHHHHHHCHHHHT
T ss_pred CcCHHHHHcCccccc
Confidence 999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=266.21 Aligned_cols=155 Identities=16% Similarity=0.333 Sum_probs=135.3
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|++++...++|+|.+++.++.|++.|+ +|+ +++||+|||+|+.... ......+
T Consensus 107 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-~~~~~~~ 185 (304)
T 3ubd_A 107 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYS 185 (304)
T ss_dssp CCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------CCCCS
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC-CCccccc
Confidence 334889999999889999999999999999874 343 4689999998765432 2234567
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|||||. .+..|+.++||||+||++|||++|++||.+.+..+++.+|..+.+.+|..+|+++++||.+||++||
T Consensus 186 ~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 265 (304)
T 3ubd_A 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265 (304)
T ss_dssp CCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCH
Confidence 899999999998 7778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q psy6203 477 GKRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t-----~~~~l~hp~~~~ 493 (568)
++||| ++|+++||||+.
T Consensus 266 ~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 266 ANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp GGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHCCCCCcCCHHHHHcCccccC
Confidence 99998 589999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=263.96 Aligned_cols=155 Identities=17% Similarity=0.234 Sum_probs=132.7
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++.. +.|+|++++.++.||+.|+ +| .++|||+|||+|..... ......+.
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-~~~~~~~~ 230 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSL 230 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-SSCCBCCC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC-CCCccccc
Confidence 348999999986 6799999999999999874 34 34689999998765433 23346778
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHccCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~~L~~ 474 (568)
+||+.|||||. ....|+.++||||+||++|||++|++||.+.+..+++..|..+..+ .+..+|+++++||.+||++
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 310 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 310 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCC
Confidence 99999999998 7778999999999999999999999999999999999988876433 3345899999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCC
Q psy6203 475 EPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 475 dp~~R~t~~~~l~hp~~~~~~ 495 (568)
||++|||++|+++||||+...
T Consensus 311 dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 311 DPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp STTTSCCHHHHTTCGGGGGCC
T ss_pred ChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=253.79 Aligned_cols=202 Identities=27% Similarity=0.499 Sum_probs=167.7
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++...+++++.+++.++.|++.++ ++ .+++||+|||++.... .+......+
T Consensus 97 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~--~~~~~~~~~ 174 (328)
T 3fe3_A 97 SGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFC 174 (328)
T ss_dssp TTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS--SSCGGGTTS
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC--CCCcccccc
Confidence 3788999998888999999999999999874 33 3468999999775433 333456789
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
||+.|+|||. +..+++.++||||+||++|+|++|++||.+.+..++...+..+.+..|..+|+++.+||.+||..||.
T Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 254 (328)
T 3fe3_A 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPI 254 (328)
T ss_dssp SSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTT
T ss_pred CCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChh
Confidence 9999999998 56666789999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCcccccCCCCC-------CC-CCCChHHHHHHHhccCCCHHHHHHHHHhcCCChHHHHHHHHHhc
Q psy6203 478 KRIKIQDLLGHNWVKMGPEDN-------PL-REKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSR 544 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 544 (568)
+|||++|+++||||+...... +. .......++.+ ...+++.+++.+.+.+..+++.+++|++|.+|
T Consensus 255 ~R~t~~eil~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~y~ll~~k 328 (328)
T 3fe3_A 255 KRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIM-VGMGYSQEEIQESLSKMKYDEITATYLLLGRK 328 (328)
T ss_dssp TSCCHHHHTTCTTTTTTCTTCCCCCCCCCCCCCCCHHHHHHH-HHTTCCHHHHHHHHHTTCCSHHHHHHHHHTC-
T ss_pred HCcCHHHHhcCHhhcCCCcccccCcccCCCcCcccHHHHHHH-HHCCCCHHHHHHHHHcCCCCHHHHHHHHhcCC
Confidence 999999999999998643221 11 12233334333 45688999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=263.77 Aligned_cols=155 Identities=17% Similarity=0.234 Sum_probs=133.1
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++.. +.|+|.+++.++.||+.|+ +| .++|||+|||+|..... ......+.
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~-~~~~~~~~ 307 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSL 307 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS-SCCCBCCC
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC-CCcccccc
Confidence 348999999975 6799999999999999874 33 45789999998865433 23346778
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHccCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~~L~~ 474 (568)
|||+.|||||+ .+..|+.++|||||||++|||++|++||.+.+..+++..|.....+ .+..+|+++++||.+||++
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 387 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 387 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCC
Confidence 99999999998 7778999999999999999999999999999999999988876432 3456899999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCC
Q psy6203 475 EPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 475 dp~~R~t~~~~l~hp~~~~~~ 495 (568)
||++|+|++|+|+||||+...
T Consensus 388 dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 388 DPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp STTTSCCHHHHTTCGGGGGCC
T ss_pred ChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=261.84 Aligned_cols=155 Identities=18% Similarity=0.310 Sum_probs=132.6
Q ss_pred hhhHHHHHHHHh--CCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCcee
Q psy6203 338 WSMGVMLYALLC--GFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~--~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~ 395 (568)
|..|++|++++. +...++|..++.++.||+.|+ +|+ ++|||+|||+|+.... .....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-~~~~~ 182 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELA 182 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH-HHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC-Ccccc
Confidence 334889999995 345789999999999999874 343 4689999998765422 12234
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHccC
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~ 473 (568)
.+.+||+.|||||. .+..|+.++|||||||++|||++|++||.+.+..+++.+|..+.++ .+..+|+++++||.+||+
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcc
Confidence 56799999999998 7778999999999999999999999999999999999999988764 567899999999999999
Q ss_pred CCcCCCCCHHHHhcCccccc
Q psy6203 474 VEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 474 ~dp~~R~t~~~~l~hp~~~~ 493 (568)
+||++|||++|+++||||+.
T Consensus 263 ~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 263 RNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp SSGGGSCCHHHHHTSHHHHT
T ss_pred CChhHCcCHHHHhcCHHhhc
Confidence 99999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=250.36 Aligned_cols=153 Identities=15% Similarity=0.249 Sum_probs=126.7
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------Cc---------ceeEEEccccCcccccCCCCce
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------MP---------ICTILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------~~---------~~~iki~dfG~~~~~~~~~~~~ 394 (568)
|..|++|++++...+++++..++.++.||++|+ +| .+++||+|||+|.... +..
T Consensus 110 y~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~---~~~ 186 (290)
T 3fpq_A 110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASF 186 (290)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---TTS
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC---CCc
Confidence 334899999999889999999999999999864 22 2468999999886432 234
Q ss_pred ecccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHc
Q psy6203 395 INLLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYT--EPPWMSPNSRQIVRSM 471 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~-~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~~ 471 (568)
..+.+||+.|||||.-...|+.++||||+||++|||++|++||.+. +...++..+..+..+ ++...++++++||.+|
T Consensus 187 ~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 266 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266 (290)
T ss_dssp BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHH
Confidence 5678999999999983345999999999999999999999999865 455666777766543 4566899999999999
Q ss_pred cCCCcCCCCCHHHHhcCccccc
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
|++||++|||++|+++||||++
T Consensus 267 L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 267 IRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=260.15 Aligned_cols=156 Identities=16% Similarity=0.188 Sum_probs=128.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCC---CCceecc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCK---VGQVINL 397 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~---~~~~~~~ 397 (568)
+++|++++...++|++..++.++.||+.|+ +|+ +++||+|||+|+..... ......+
T Consensus 142 ~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~ 221 (398)
T 4b99_A 142 ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE 221 (398)
T ss_dssp SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCS
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcccccccccc
Confidence 567999999999999999999999999874 444 46789999988654322 2234567
Q ss_pred cccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Q psy6203 398 LRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE------------------- 456 (568)
Q Consensus 398 ~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~------------------- 456 (568)
.+||++|+|||+ +..+|+.++||||+|||+|||++|++||.+.+..+++..|......+
T Consensus 222 ~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~ 301 (398)
T 4b99_A 222 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS 301 (398)
T ss_dssp SCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHS
T ss_pred ceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc
Confidence 899999999997 56789999999999999999999999999999988888876432111
Q ss_pred ------------CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 457 ------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 457 ------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
.+.+|++++|||.+||++||++|+|++|+|+||||+....
T Consensus 302 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 302 LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1246899999999999999999999999999999986543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-29 Score=251.17 Aligned_cols=158 Identities=18% Similarity=0.176 Sum_probs=130.3
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------e-eEEEccccCcccccCCC-C---
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------C-TILISQYFPTILLPCKV-G--- 392 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~-~iki~dfG~~~~~~~~~-~--- 392 (568)
|..|++|++++...++|+|.+++.++.|++.|+ +|+ + .+||+|||+|+....+. +
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 344899999999889999999999999999874 333 2 48999999887653321 1
Q ss_pred ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHH
Q psy6203 393 QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIV 468 (568)
Q Consensus 393 ~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li 468 (568)
....+.+||+.|||||. .+..|+.++||||+||++|||++|++||.+.+..+++.+|..+.++ .|+.+|+++.+||
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 290 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHH
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHH
Confidence 11234689999999998 7788999999999999999999999999998887888888877653 5778999999999
Q ss_pred HHccCCCcCCCCCHHHH-------------hcCcccccCC
Q psy6203 469 RSMLQVEPGKRIKIQDL-------------LGHNWVKMGP 495 (568)
Q Consensus 469 ~~~L~~dp~~R~t~~~~-------------l~hp~~~~~~ 495 (568)
.+||++||.+|||+.|+ ++|||+....
T Consensus 291 ~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 291 QEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 99999999999999997 5799997643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=263.76 Aligned_cols=160 Identities=18% Similarity=0.195 Sum_probs=136.2
Q ss_pred CCCCcchh-----hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcc
Q psy6203 331 YGSETDVW-----SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTI 385 (568)
Q Consensus 331 ~~~~~~~~-----~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~ 385 (568)
+.+...+| ..||+|+++|...++|+|..++.++.||+.|+ +|| ++|||+|||+|.
T Consensus 261 f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 261 FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence 44455554 34999999999989999999999999999874 343 468999999876
Q ss_pred cccCCCCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCC
Q psy6203 386 LLPCKVGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEPPWM 460 (568)
Q Consensus 386 ~~~~~~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~ 460 (568)
.... ....+.|||+.|||||+ .+.+|+.++|||||||++|||++|++||.+. +...+...+....+.+|..+
T Consensus 341 ~~~~---~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~ 417 (689)
T 3v5w_A 341 DFSK---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417 (689)
T ss_dssp ECSS---CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ecCC---CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence 5422 23567899999999998 4678999999999999999999999999864 45567788888899999999
Q ss_pred CHHHHHHHHHccCCCcCCCCC-----HHHHhcCccccc
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~~~~ 493 (568)
|+++++||.+||++||.+|+| ++|+++||||+.
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999999999999999999998 799999999974
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-28 Score=263.75 Aligned_cols=185 Identities=21% Similarity=0.217 Sum_probs=143.5
Q ss_pred EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc-------hHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 11 ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-------LPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 11 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
...+.||+|+||+||+|. ..+..+|+|.......... .+.+.+|+.++++++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345789999999999994 5678999998765433211 2347899999999999999955555556777799
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999865 6789999999999999999999999999999988 99999999998765422111
Q ss_pred ------cccccCCccccccccccC--cccCCcccceechhhHHHHHHhCCCCC
Q psy6203 164 ------LQTSCGSPNYAAPEVIKG--KQYYGSETDVWSMGVMLYALLCGFLPF 208 (568)
Q Consensus 164 ------~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~~lltG~~pf 208 (568)
..+.+||+.|+|||++.+ .. |+..+|+||..+-..+.+.++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~-Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEG-YKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHH-HHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHhcccc
Confidence 235689999999999976 33 577899999988888877766655
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-28 Score=245.80 Aligned_cols=203 Identities=23% Similarity=0.416 Sum_probs=166.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
++++++++...+++++.+++.++.|+++++ ++ .+++||+|||++... ..+....+.+|
T Consensus 92 ~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~--~~~~~~~~~~g 169 (336)
T 3h4j_B 92 GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCG 169 (336)
T ss_dssp CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT--TTSBTTCCCTT
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec--cCCcccccccC
Confidence 578888888778999999999999999874 33 346899999977543 23344567799
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
|+.|+|||. +..+++.++||||+||++|+|++|++||.+.+...+...+..+.+..|..+|+++.+||.+||..||.+
T Consensus 170 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 249 (336)
T 3h4j_B 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQ 249 (336)
T ss_dssp STTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGG
T ss_pred CcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhH
Confidence 999999998 444558899999999999999999999998876666666666777788899999999999999999999
Q ss_pred CCCHHHHhcCcccccCCCC-------CCCCCCChHHHHHHHhccCCCHHHHHHHHHhcCCChHHHHHHHHHhch
Q psy6203 479 RIKIQDLLGHNWVKMGPED-------NPLREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRK 545 (568)
Q Consensus 479 R~t~~~~l~hp~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 545 (568)
|||++|+++||||+..... .........+...+.+..+++.+++.+.|.+.++++.+++|++|.+++
T Consensus 250 Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~y~ll~~~~ 323 (336)
T 3h4j_B 250 RITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALRSDENNEVKEAYNLLHENQ 323 (336)
T ss_dssp SCCHHHHTTCHHHHTTCCGGGSCCCCCCCCCCCHHHHHHHHHTTCCCHHHHHHHTTSSSCCSSTTHHHHHHHHH
T ss_pred CcCHHHHHhChhhccCCccccCCchhcccccCCHHHHHHHHHHcCCCHHHHHHHHhcCCCCHHHHHHHHHHhCh
Confidence 9999999999999854221 111233466677777788999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=243.66 Aligned_cols=151 Identities=14% Similarity=0.178 Sum_probs=114.2
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce---------eEEEccccCcccccCCC-------
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC---------TILISQYFPTILLPCKV------- 391 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~---------~iki~dfG~~~~~~~~~------- 391 (568)
.|++|+++++ .|++.+++.++.|++.|+ +||. .+||+|||+|+......
T Consensus 103 ~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~ 179 (361)
T 4f9c_A 103 EHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFV 179 (361)
T ss_dssp CCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC
T ss_pred CcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccc
Confidence 3788889885 499999999999999874 4443 57899999875432111
Q ss_pred --------------------CceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHH
Q psy6203 392 --------------------GQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDK 448 (568)
Q Consensus 392 --------------------~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~-~~~~~~~~~ 448 (568)
.....+.+||+.|+|||. +..+|+.++||||+|||+|||++|++||.+ .+..+++..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~ 259 (361)
T 4f9c_A 180 QSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQ 259 (361)
T ss_dssp --------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 112345689999999997 556899999999999999999999999954 445555444
Q ss_pred HHc--C------------------------------------CC----------------CCCCCCCHHHHHHHHHccCC
Q psy6203 449 ILN--G------------------------------------KY----------------TEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 449 i~~--~------------------------------------~~----------------~~~~~~s~~~~~li~~~L~~ 474 (568)
|.. | .. .....+|++++|||++||++
T Consensus 260 I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~ 339 (361)
T 4f9c_A 260 IMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDL 339 (361)
T ss_dssp HHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCS
T ss_pred HHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcC
Confidence 421 0 00 01134789999999999999
Q ss_pred CcCCCCCHHHHhcCccccc
Q psy6203 475 EPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 475 dp~~R~t~~~~l~hp~~~~ 493 (568)
||++|+|++|+|+||||++
T Consensus 340 dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 340 NPASRITAEEALLHPFFKD 358 (361)
T ss_dssp CTTTSCCHHHHHTSGGGTT
T ss_pred ChhHCcCHHHHhcCcccCC
Confidence 9999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=257.98 Aligned_cols=155 Identities=19% Similarity=0.373 Sum_probs=134.7
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Cc----------ceeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MP----------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~----------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.||+|++++.. .+.|+|.+++.++.||+.|+ +| .+.|||+|||+|... +.+....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~--~~~~~~~ 314 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVK 314 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC--CTTSEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc--cCCCcee
Confidence 38899999864 46899999999999999874 23 246899999987654 3444567
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
+.+||+.|||||. .+..|+.++||||+||++|||++|++||.+.+..+++..|..+.+.++ ..+|+++++||.+|
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~ 394 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 7899999999998 777899999999999999999999999999999999999999877654 45899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
|++||.+|||++|+|+||||+....
T Consensus 395 L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 395 LLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp SCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred ccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999999999999999986543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=238.84 Aligned_cols=204 Identities=27% Similarity=0.519 Sum_probs=139.2
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|++++...+.+++.++..++.|++.++ ++ .+++||+|||++.... .+....+.+
T Consensus 99 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~--~~~~~~~~~ 176 (476)
T 2y94_A 99 SGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC 176 (476)
T ss_dssp SSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--TTCCBCCCC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc--ccccccccC
Confidence 3789999999889999999999999999864 33 3468999999876532 334456779
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
||+.|+|||. +..+++.++||||+||++|+|++|++||.+.+...++.++..+.+..|..+++++.+||.+||..||.
T Consensus 177 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~ 256 (476)
T 2y94_A 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPM 256 (476)
T ss_dssp SCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTT
T ss_pred CCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCch
Confidence 9999999998 44566899999999999999999999999999889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCcccccCCCCCCC---CCC-----ChHHHHHHHhccCCCHHHHHHHHHhc-CCChHHHHHHHHHhch
Q psy6203 478 KRIKIQDLLGHNWVKMGPEDNPL---REK-----DDDVIKVMADHKQLSPDDMWSQLNEW-TYNYDTCTYLLLLSRK 545 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~~~~~~~~---~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~l~~~~ 545 (568)
+|||++|+++||||+........ +.. ..+.+..+.+..+...+++.+.+... ..++.++.|++|.+++
T Consensus 257 ~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~~ 333 (476)
T 2y94_A 257 KRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNR 333 (476)
T ss_dssp TSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-------------------------------C
T ss_pred hCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhch
Confidence 99999999999999864321111 111 11222222234455566777666654 4577888899887654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=220.55 Aligned_cols=146 Identities=19% Similarity=0.210 Sum_probs=118.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----------------chHHHHHHHHHHHhCCCCCcce
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----------------DLPRVKLEINALKHISHQHICK 70 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~~Ei~~l~~l~hpnIv~ 70 (568)
..|.+++.||+|+||.||+|.+ .+|+.||+|+++...... ....+.+|+.++++++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4566779999999999999999 889999999996432210 2345789999999998 4 66
Q ss_pred eeEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEee
Q psy6203 71 LFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDF 150 (568)
Q Consensus 71 l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 150 (568)
+.+++.. +..|+||||++|++|.+ +. ...+..++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 6665544 44699999999999987 31 234567999999999999999999999999999999 999999999
Q ss_pred cCccCCCCCCccccccccCCcccccccccc
Q psy6203 151 GLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180 (568)
Q Consensus 151 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 180 (568)
|+|.. +..+.|||++.
T Consensus 237 G~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE--------------TTSTTHHHHHH
T ss_pred CCCeE--------------CCCCCHHHHHH
Confidence 99753 34578999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-25 Score=228.05 Aligned_cols=153 Identities=24% Similarity=0.437 Sum_probs=129.3
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|++++...+.|++..++.++.|++.++ +++ +++||+|||++..... .+....+.+
T Consensus 107 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-~~~~~~~~~ 185 (353)
T 3txo_A 107 NGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-NGVTTATFC 185 (353)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-CCccccccC
Confidence 3788999998888999999999999999864 333 4678999997754322 233456779
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+++..|..+...+|.++++++.+||++||.+||.+
T Consensus 186 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHH
Confidence 9999999998 666789999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCH------HHHhcCccccc
Q psy6203 479 RIKI------QDLLGHNWVKM 493 (568)
Q Consensus 479 R~t~------~~~l~hp~~~~ 493 (568)
|+++ +++++||||+.
T Consensus 266 R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTT
T ss_pred ccCCcccCCHHHHhhCCcccC
Confidence 9998 89999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=220.62 Aligned_cols=154 Identities=20% Similarity=0.374 Sum_probs=134.4
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++...+.|+++.++.++.|++.++ ++ .+++||+|||++..... .+....+.
T Consensus 87 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~~~~~~~~ 165 (337)
T 1o6l_A 87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF 165 (337)
T ss_dssp CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-TTCCBCCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-CCCccccc
Confidence 34788999998888999999999999999864 33 34688999997754322 23345678
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+...++..+..+...+|..+|+++.+||.+||..||.
T Consensus 166 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~ 245 (337)
T 1o6l_A 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 245 (337)
T ss_dssp EECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTT
T ss_pred ccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 99999999998 67789999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCC-----CHHHHhcCccccc
Q psy6203 478 KRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~-----t~~~~l~hp~~~~ 493 (568)
+|+ +++|+++||||..
T Consensus 246 ~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 246 QRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TSTTCSTTTHHHHHTSGGGTT
T ss_pred HhcCCCCCCHHHHHcCCCcCC
Confidence 999 8999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=223.76 Aligned_cols=152 Identities=14% Similarity=0.163 Sum_probs=110.0
Q ss_pred hHHHHHHHHhCCCCCCh---hhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC----
Q psy6203 340 MGVMLYALLCGFLPFDS---DSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG---- 392 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e---~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~---- 392 (568)
.|++|.+++.+.+.+++ ..+..++.|+++|+ +||. ++||+|||+|+....+..
T Consensus 98 ~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~ 177 (299)
T 4g31_A 98 RKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177 (299)
T ss_dssp CSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC------------
T ss_pred CCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCcccccc
Confidence 37899999998776655 44788999999874 4443 689999998865432211
Q ss_pred -------ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC-CCCCCCH
Q psy6203 393 -------QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYT-EPPWMSP 462 (568)
Q Consensus 393 -------~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~-~~~~~~i~~~~~~-~~~~~s~ 462 (568)
....+.+||+.|||||. .+..|+.++||||+||++|||++ ||.+... ...+..+....++ .+...++
T Consensus 178 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~ 254 (299)
T 4g31_A 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYP 254 (299)
T ss_dssp --------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCH
T ss_pred ccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCH
Confidence 12345689999999998 77789999999999999999996 8876432 2344555554443 2234577
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 463 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.+.+||.+||++||++|||+.|+++||||+..
T Consensus 255 ~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 255 CEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 88999999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-25 Score=223.21 Aligned_cols=155 Identities=20% Similarity=0.273 Sum_probs=134.7
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...+.|++..++.++.|++.++ ++ .+++||+|||++...... .....+.
T Consensus 100 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~ 178 (345)
T 1xjd_A 100 LNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTF 178 (345)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCC
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-CCcccCC
Confidence 34789999998878999999999999999864 33 346899999977543222 2235677
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+++..|..+.+.+|.++++++.+||.+||..||.
T Consensus 179 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~ 258 (345)
T 1xjd_A 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPE 258 (345)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGG
T ss_pred CCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHh
Confidence 99999999998 66789999999999999999999999999999999999999999889999999999999999999999
Q ss_pred CCCCHH-HHhcCcccccC
Q psy6203 478 KRIKIQ-DLLGHNWVKMG 494 (568)
Q Consensus 478 ~R~t~~-~~l~hp~~~~~ 494 (568)
+|||+. ++++||||+..
T Consensus 259 ~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 259 KRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp GSBTTBSCGGGSGGGTTC
T ss_pred HcCCChHHHHcCccccCC
Confidence 999998 99999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=221.27 Aligned_cols=153 Identities=22% Similarity=0.314 Sum_probs=133.6
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++...+.|++..++.++.|++.++ ++ .+.+||+|||++..... .+....+.+
T Consensus 104 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~~~~~~~~~ 182 (353)
T 2i0e_A 104 NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKTFC 182 (353)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-TTCCBCCCC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-CCccccccc
Confidence 3788999998878999999999999999864 33 34688999997754322 233456789
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..|+.++|||||||++|||++|++||.+.+..+++..|..+.+.+|..+|+++.+||.+||..||.+
T Consensus 183 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp SCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTS
T ss_pred CCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999998 677899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCC-----HHHHhcCccccc
Q psy6203 479 RIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 479 R~t-----~~~~l~hp~~~~ 493 (568)
|++ ++++++||||+.
T Consensus 263 R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 263 RLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CTTCSTTHHHHHHTSGGGTT
T ss_pred cCCCCCCCHHHHhcCccccC
Confidence 995 699999999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-24 Score=215.58 Aligned_cols=151 Identities=16% Similarity=0.199 Sum_probs=113.3
Q ss_pred hhhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCC-Ccee
Q psy6203 338 WSMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKV-GQVI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~-~~~~ 395 (568)
|..|++|++++.. .++|++.++..++.|++.|+ +| ..++||+|||+|+...... ....
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 3448999999965 46899999999999999874 33 3468999999887653322 2335
Q ss_pred cccccccccccCCC--C--CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC-----CCCCCCCHHHH
Q psy6203 396 NLLRSAIVLCSAPS--S--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-LYDKILNGKY-----TEPPWMSPNSR 465 (568)
Q Consensus 396 ~~~~gt~~~~~pe~--~--~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~-~~~~i~~~~~-----~~~~~~s~~~~ 465 (568)
.+.+||+.|||||. . ...|+.++||||+||++|||+||++||.+.+... +...+..+.. ..+..+++++.
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 271 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMK 271 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHH
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHH
Confidence 66799999999997 2 3469999999999999999999999999876544 4444444422 13456889999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+||.+||+.||++|||+.|++++
T Consensus 272 ~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 272 RLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999887543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=216.44 Aligned_cols=153 Identities=18% Similarity=0.232 Sum_probs=126.1
Q ss_pred hhhHHHHHHHHhCC-------------CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCc
Q psy6203 338 WSMGVMLYALLCGF-------------LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPT 384 (568)
Q Consensus 338 ~~~g~~l~~~~~~~-------------~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~ 384 (568)
|..||+|.+++... ..|++.++..++.|+++|+ +|+ .++||+|||+|
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla 175 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 175 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccc
Confidence 44478999988753 3799999999999999874 333 36899999988
Q ss_pred ccccCCCCc-eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Q psy6203 385 ILLPCKVGQ-VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWM 460 (568)
Q Consensus 385 ~~~~~~~~~-~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 460 (568)
+........ .....+||+.|||||. ....|+.++||||+||++|||+| |++||.+.+..+++..+..+.. +.|..+
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 255 (299)
T 4asz_A 176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 255 (299)
T ss_dssp HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTC
T ss_pred eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 654332221 2234579999999998 56679999999999999999998 9999999999999999988764 568889
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~ 492 (568)
|+++.+||.+||+.||++|||++++ |+|++
T Consensus 256 ~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 256 PQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred hHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 9999999999999999999999999 45665
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=4.3e-24 Score=215.78 Aligned_cols=150 Identities=22% Similarity=0.421 Sum_probs=132.4
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++...+.|++..++.++.|++.++ ++ .+.+||+|||++.... ....+.+
T Consensus 89 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----~~~~~~~ 164 (318)
T 1fot_A 89 EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLC 164 (318)
T ss_dssp CSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----SCBCCCC
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC----Ccccccc
Confidence 4789999999888999999999999999864 33 3467899999765432 1235678
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+....+..|..+...+|..+++++.+||.+||..||.+
T Consensus 165 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~ 244 (318)
T 1fot_A 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQ 244 (318)
T ss_dssp SCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred CCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999998 777899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CC-----CHHHHhcCccccc
Q psy6203 479 RI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 479 R~-----t~~~~l~hp~~~~ 493 (568)
|+ +++++++||||+.
T Consensus 245 R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 245 RLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CTTSSTTTTHHHHTSGGGSS
T ss_pred cCCCcCCCHHHHhcCccccC
Confidence 99 8999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-24 Score=218.31 Aligned_cols=152 Identities=22% Similarity=0.336 Sum_probs=131.9
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce------------eEEEccccCcccccCCCCcee
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC------------TILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~------------~iki~dfG~~~~~~~~~~~~~ 395 (568)
.|++|++++...++|++.++..++.|++.++ +++. .+||+|||++.... .+...
T Consensus 98 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~--~~~~~ 175 (361)
T 2yab_A 98 SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF 175 (361)
T ss_dssp CSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC--TTCCC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC--CCCcc
Confidence 3789999999888999999999999999874 2322 57899999765432 23335
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRS 470 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~ 470 (568)
...+||+.|+|||. ....|+.++||||+||++|+|++|.+||.+.+..+.+..|..+.+.++ ..+|+++++||.+
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 255 (361)
T 2yab_A 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRK 255 (361)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHH
T ss_pred ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHH
Confidence 66789999999998 667899999999999999999999999999999999999999887765 5689999999999
Q ss_pred ccCCCcCCCCCHHHHhcCccccc
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
||..||.+|||++|+++||||+.
T Consensus 256 ~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 256 LLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HCCCChhHCcCHHHHhcCcCcCC
Confidence 99999999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-24 Score=221.84 Aligned_cols=154 Identities=19% Similarity=0.301 Sum_probs=130.2
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++...+.|++..++.++.|++.++ +++ +++||+|||++.... ..+....+.
T Consensus 135 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~-~~~~~~~~~ 213 (396)
T 4dc2_A 135 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGDTTSTF 213 (396)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC-CTTCCBCCC
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc-cCCCccccc
Confidence 34788999998888999999999999999864 333 467899999775432 233446678
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD---------SIDQLYDKILNGKYTEPPWMSPNSRQIV 468 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li 468 (568)
+||+.|+|||. .+..|+.++||||+||++|||++|++||.+. ....+...+....+.+|..+|+++++||
T Consensus 214 ~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 293 (396)
T 4dc2_A 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 293 (396)
T ss_dssp CBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHH
Confidence 99999999998 7778999999999999999999999999642 2345678888889999999999999999
Q ss_pred HHccCCCcCCCCCH------HHHhcCccccc
Q psy6203 469 RSMLQVEPGKRIKI------QDLLGHNWVKM 493 (568)
Q Consensus 469 ~~~L~~dp~~R~t~------~~~l~hp~~~~ 493 (568)
++||+.||.+|+|+ +|+++||||+.
T Consensus 294 ~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 294 KSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred HHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99999999999985 79999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-24 Score=215.47 Aligned_cols=151 Identities=21% Similarity=0.257 Sum_probs=119.0
Q ss_pred hhhHHHHHHHHhCC---------------CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEcccc
Q psy6203 338 WSMGVMLYALLCGF---------------LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYF 382 (568)
Q Consensus 338 ~~~g~~l~~~~~~~---------------~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG 382 (568)
|..||+|.+++... ++|++.++..++.|+.+|+ +|+ .++||+|||
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFG 203 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccc
Confidence 44588898888753 4699999999999998864 343 368999999
Q ss_pred CcccccCCC-CceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCC
Q psy6203 383 PTILLPCKV-GQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPP 458 (568)
Q Consensus 383 ~~~~~~~~~-~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~ 458 (568)
+|+...... .......+||+.|||||. ....|+.++||||+||++|||+| |++||.+.+..+++..+..+. ++.|.
T Consensus 204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~ 283 (329)
T 4aoj_A 204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR 283 (329)
T ss_dssp ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCT
T ss_pred cceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 887543322 223345789999999998 77789999999999999999998 999999999999998888874 56788
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
.+++++.+||.+||..||++|||++|++++
T Consensus 284 ~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 284 ACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 899999999999999999999999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=8.2e-24 Score=216.60 Aligned_cols=151 Identities=23% Similarity=0.381 Sum_probs=132.8
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...++|++..++.++.|++.++ +++ +.+||+|||++..... ...+.
T Consensus 123 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~----~~~~~ 198 (350)
T 1rdq_E 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTL 198 (350)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----CBCCC
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC----Ccccc
Confidence 34789999998888999999999999999864 333 4678899997654322 23467
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+++..|..+.+.+|..+++++.+||.+||+.||.
T Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~ 278 (350)
T 1rdq_E 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTT
T ss_pred cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 89999999998 66789999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q psy6203 478 KRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t-----~~~~l~hp~~~~ 493 (568)
+|++ ++++++||||+.
T Consensus 279 ~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 279 KRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp TCTTSSTTTTHHHHTSGGGTT
T ss_pred hccCCccCCHHHHHhCcCcCC
Confidence 9998 999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-24 Score=221.01 Aligned_cols=154 Identities=17% Similarity=0.242 Sum_probs=118.9
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccC-----------
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPC----------- 389 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~----------- 389 (568)
+++|.++++. ..+++..+..++.|++.++ ++ .+.+||+|||+++....
T Consensus 94 ~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 172 (388)
T 3oz6_A 94 ETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172 (388)
T ss_dssp SEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGC
T ss_pred CcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccc
Confidence 3567777776 5899999999999999864 33 34689999998764321
Q ss_pred ---------CCCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C--
Q psy6203 390 ---------KVGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--Y-- 454 (568)
Q Consensus 390 ---------~~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~--~-- 454 (568)
.........+||++|+|||. +...|+.++||||+||++|||++|++||.+.+..+.+..|.... +
T Consensus 173 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~ 252 (388)
T 3oz6_A 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSN 252 (388)
T ss_dssp CC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 11223455789999999997 45789999999999999999999999999999887777765310 0
Q ss_pred -------------------------------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q psy6203 455 -------------------------------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWV 491 (568)
Q Consensus 455 -------------------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 491 (568)
..+...++++.+||.+||+.||++|||++|+++||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 253 EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332 (388)
T ss_dssp HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTT
T ss_pred HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHH
Confidence 0112578999999999999999999999999999999
Q ss_pred ccCC
Q psy6203 492 KMGP 495 (568)
Q Consensus 492 ~~~~ 495 (568)
+...
T Consensus 333 ~~~~ 336 (388)
T 3oz6_A 333 SIFH 336 (388)
T ss_dssp TTTC
T ss_pred HHhc
Confidence 7543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.5e-24 Score=218.57 Aligned_cols=154 Identities=21% Similarity=0.290 Sum_probs=133.8
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++...+.|++..++.++.|++.++ ++ .+++||+|||++..... .+....+.
T Consensus 121 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-~~~~~~~~ 199 (373)
T 2r5t_A 121 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNSTTSTF 199 (373)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-CCCCCCSB
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-CCCccccc
Confidence 34788999998888999999999999999864 33 34688999997754322 22345678
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..|+.++|||||||++|||++|.+||.+.+..+++..|..+...+|+.+++++++||.+||+.||.
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~ 279 (373)
T 2r5t_A 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRT 279 (373)
T ss_dssp SCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGG
T ss_pred cCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHH
Confidence 99999999998 77789999999999999999999999999999999999999998888999999999999999999999
Q ss_pred CCCCH----HHHhcCccccc
Q psy6203 478 KRIKI----QDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~----~~~l~hp~~~~ 493 (568)
+|+++ +++++||||+.
T Consensus 280 ~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 280 KRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp GSTTTTTTHHHHHTSGGGTT
T ss_pred hCCCCCCCHHHHhCCccccC
Confidence 99986 69999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=215.12 Aligned_cols=153 Identities=19% Similarity=0.304 Sum_probs=128.6
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++...+.|++..++.++.|++.++ ++ .+++||+|||++.... ..+....+.+
T Consensus 93 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~-~~~~~~~~~~ 171 (345)
T 3a8x_A 93 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGDTTSTFC 171 (345)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC-CTTCCBCCCC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc-CCCCcccccC
Confidence 3788888888778999999999999999864 33 3468899999765432 2233456779
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDS---------DSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 469 (568)
||+.|+|||. .+..|+.++||||+||++|||++|++||.. .+...+...+......+|..+|+++++||.
T Consensus 172 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 251 (345)
T 3a8x_A 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251 (345)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999998 667889999999999999999999999975 334556778888888899999999999999
Q ss_pred HccCCCcCCCCCH------HHHhcCccccc
Q psy6203 470 SMLQVEPGKRIKI------QDLLGHNWVKM 493 (568)
Q Consensus 470 ~~L~~dp~~R~t~------~~~l~hp~~~~ 493 (568)
+||..||.+|+|+ +++++||||+.
T Consensus 252 ~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 9999999999995 89999999974
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-24 Score=211.77 Aligned_cols=151 Identities=15% Similarity=0.171 Sum_probs=124.5
Q ss_pred hhhHHHHHHHHhCC----------------CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccc
Q psy6203 338 WSMGVMLYALLCGF----------------LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQY 381 (568)
Q Consensus 338 ~~~g~~l~~~~~~~----------------~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~df 381 (568)
|..||+|.++|... ..|++.++..++.||.+|+ +|+ .++||+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DF 189 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDL 189 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCS
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCc
Confidence 33478888888542 4689999999999999874 343 36899999
Q ss_pred cCcccccCCC-CceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCC
Q psy6203 382 FPTILLPCKV-GQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEP 457 (568)
Q Consensus 382 G~~~~~~~~~-~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~ 457 (568)
|+|+...... .......+||+.|||||. ....|+.++||||+||++|||+| |++||.+.+..++...|..+.. +.|
T Consensus 190 Glar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 269 (308)
T 4gt4_A 190 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP 269 (308)
T ss_dssp CCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 9886543322 223456789999999998 55679999999999999999998 8999999999999999988754 567
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 458 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 458 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
..+++++.+||.+||..||++|||+.|++++
T Consensus 270 ~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 270 DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8899999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-24 Score=217.42 Aligned_cols=151 Identities=16% Similarity=0.235 Sum_probs=122.8
Q ss_pred hhhHHHHHHHHhC----------------CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccc
Q psy6203 338 WSMGVMLYALLCG----------------FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQY 381 (568)
Q Consensus 338 ~~~g~~l~~~~~~----------------~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~df 381 (568)
|..||+|.++|+. ...|+++++..++.||++|+ +|+ .++||+||
T Consensus 150 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DF 229 (353)
T 4ase_A 150 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 229 (353)
T ss_dssp CCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcc
Confidence 4448999999974 24589999999999999874 333 46899999
Q ss_pred cCcccccCCCCc-eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCH-HHHHHHHHcCC-CCC
Q psy6203 382 FPTILLPCKVGQ-VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSI-DQLYDKILNGK-YTE 456 (568)
Q Consensus 382 G~~~~~~~~~~~-~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~-~~~~~~i~~~~-~~~ 456 (568)
|+|+....+... ...+.+||+.|||||. ....|+.++||||+||++|||+| |++||.+.+. ..+...+..+. ++.
T Consensus 230 Glar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~ 309 (353)
T 4ase_A 230 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 309 (353)
T ss_dssp GGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC
T ss_pred hhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCC
Confidence 998765443332 3456789999999998 66679999999999999999998 9999998764 44555565553 567
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 457 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 457 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
|..+++++.+||.+||..||++|||+.|+++|
T Consensus 310 p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 310 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 88899999999999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=221.03 Aligned_cols=153 Identities=24% Similarity=0.450 Sum_probs=131.1
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++.+...+.|++.++..++.|++.++ +++ +.+||+|||++..... ......
T Consensus 93 ~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~-~~~~~~ 171 (444)
T 3soa_A 93 TGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWF 171 (444)
T ss_dssp BCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT-TCCBCC
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC-CCceee
Confidence 3789999998888999999999999999874 232 4588999997754432 222345
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~ 471 (568)
..+||+.|+|||. .+..|+.++||||+||++|+|++|.+||.+.+...++..+..+.+.+|. .+|+++.+||.+|
T Consensus 172 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 251 (444)
T 3soa_A 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 251 (444)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred cccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 6789999999998 6678999999999999999999999999999999999999988776543 5899999999999
Q ss_pred cCCCcCCCCCHHHHhcCccccc
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
|..||.+|||+.|+++||||+.
T Consensus 252 L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 252 LTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp SCSSTTTSCCHHHHHHSCTTHH
T ss_pred cCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=233.79 Aligned_cols=155 Identities=21% Similarity=0.332 Sum_probs=136.9
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|++++...+.|++..++.++.||+.++ +++ +++||+|||++..... .+....+
T Consensus 423 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~~~~~~~ 501 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKT 501 (674)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-TTCCBCC
T ss_pred CcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-CCccccc
Confidence 334899999999888999999999999999874 333 4678999998764332 2334567
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. ....|+.++|||||||++|||++|++||.+.+..+++..|..+.+.+|..+|+++.+||++||++||
T Consensus 502 ~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP 581 (674)
T 3pfq_A 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 581 (674)
T ss_dssp CCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSS
T ss_pred ccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCH
Confidence 899999999998 7778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCH-----HHHhcCccccc
Q psy6203 477 GKRIKI-----QDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t~-----~~~l~hp~~~~ 493 (568)
.+|+++ +|+++||||+.
T Consensus 582 ~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 582 GKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp TTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHCCCCCCCcHHHHhcCccccC
Confidence 999997 99999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-23 Score=218.20 Aligned_cols=156 Identities=20% Similarity=0.383 Sum_probs=119.3
Q ss_pred hHHHHHHHHhCCC--CCChhhHHHHHHHHhhcc------------Cc-----------ceeEEEccccCcccccCCCCce
Q psy6203 340 MGVMLYALLCGFL--PFDSDSIDQLYDKILSHF------------MP-----------ICTILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 340 ~g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~------------~~-----------~~~iki~dfG~~~~~~~~~~~~ 394 (568)
.|++|++++...+ .|++.++..++.|++.++ ++ .+.+||+|||++.... ....
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~--~~~~ 219 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNS 219 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC--CCCc
Confidence 3789999998753 699999999999999864 22 3458899999776432 2223
Q ss_pred ecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCC----CCCCHHHH
Q psy6203 395 INLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILNGKYTEP----PWMSPNSR 465 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~----~~~~~i~~~~~~~~----~~~s~~~~ 465 (568)
..+.+||+.|+|||. ....|+.++||||+||++|+|++|++||.+.+.. .....+..+.+.+| ..+++++.
T Consensus 220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 299 (400)
T 1nxk_A 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 299 (400)
T ss_dssp -------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHH
Confidence 456789999999998 6778999999999999999999999999876532 24556666666544 35899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCCCC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 497 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 497 (568)
+||.+||..||.+|||++|+++||||......
T Consensus 300 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 331 (400)
T 1nxk_A 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331 (400)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTS
T ss_pred HHHHHHCCCChhHCcCHHHHhcCccccCCCCC
Confidence 99999999999999999999999999865443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-23 Score=219.79 Aligned_cols=157 Identities=21% Similarity=0.305 Sum_probs=130.2
Q ss_pred hhhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 338 WSMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|..|++|++++.. .+.|++..++.++.|++.++ +|+ +++||+|||++............
T Consensus 155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 234 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234 (437)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECC
T ss_pred cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccc
Confidence 3448999999987 57899999999999999864 343 46789999987655443333345
Q ss_pred ccccccccccCCC-C-----CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCC---CCCHHHH
Q psy6203 397 LLRSAIVLCSAPS-S-----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPP---WMSPNSR 465 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~-----~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~~~~---~~s~~~~ 465 (568)
..+||+.|+|||. . ...|+.++||||+||++|||++|++||.+.+..+.+.+|... .+.+|. .+|++++
T Consensus 235 ~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~ 314 (437)
T 4aw2_A 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314 (437)
T ss_dssp SCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHH
T ss_pred cccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHH
Confidence 5799999999997 2 567999999999999999999999999999999999888764 344443 4899999
Q ss_pred HHHHHccCCCcCC--CCCHHHHhcCcccccC
Q psy6203 466 QIVRSMLQVEPGK--RIKIQDLLGHNWVKMG 494 (568)
Q Consensus 466 ~li~~~L~~dp~~--R~t~~~~l~hp~~~~~ 494 (568)
+||++||+.+|++ |++++|+++||||+..
T Consensus 315 dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 315 DLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred HHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 9999999999988 9999999999999853
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-23 Score=210.48 Aligned_cols=153 Identities=19% Similarity=0.313 Sum_probs=128.8
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++...+.+++..+..++.|++.++ ++ .+++||+|||++..... .+......+
T Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 182 (327)
T 3a62_A 104 SGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHTFC 182 (327)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----------CTTS
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc-CCccccccC
Confidence 3788888988888999999999999998864 23 34688999997654322 223345678
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+....+..+..+...+|..+++++.+||.+||..||.+
T Consensus 183 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~ 262 (327)
T 3a62_A 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAAS 262 (327)
T ss_dssp SCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGG
T ss_pred CCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhh
Confidence 9999999998 677889999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CC-----CHHHHhcCccccc
Q psy6203 479 RI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 479 R~-----t~~~~l~hp~~~~ 493 (568)
|| +++++++||||+.
T Consensus 263 R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 263 RLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp STTSSTTTHHHHHHSGGGSS
T ss_pred ccCCCCCCHHHHHcCCcccC
Confidence 99 7899999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.5e-23 Score=220.01 Aligned_cols=155 Identities=19% Similarity=0.241 Sum_probs=113.8
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCC--------
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVG-------- 392 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~-------- 392 (568)
+++|.+++.....|++..++.++.||+.++ +| .+.+||+|||+++.......
T Consensus 140 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 219 (458)
T 3rp9_A 140 DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219 (458)
T ss_dssp SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC--
T ss_pred ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccC
Confidence 678889999888999999999999999874 33 44789999998765432111
Q ss_pred ------------------ceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHh-----------CCCCCCCCC
Q psy6203 393 ------------------QVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLC-----------GFLPFDSDS 441 (568)
Q Consensus 393 ------------------~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~-----------g~~pf~~~~ 441 (568)
......+||++|+|||. ....|+.++||||+|||+|||++ |++||.+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp -------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred ccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence 12455789999999996 67789999999999999999998 888998764
Q ss_pred H--------------------HHHHHHHHc--CCC-----------------------------CCCCCCCHHHHHHHHH
Q psy6203 442 I--------------------DQLYDKILN--GKY-----------------------------TEPPWMSPNSRQIVRS 470 (568)
Q Consensus 442 ~--------------------~~~~~~i~~--~~~-----------------------------~~~~~~s~~~~~li~~ 470 (568)
. .+.+..|.. +.+ ...+..++++.+||.+
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 379 (458)
T 3rp9_A 300 CFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKR 379 (458)
T ss_dssp -----------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHH
T ss_pred cccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 2 122222211 000 0113468999999999
Q ss_pred ccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
||.+||.+|||++|+++||||+...
T Consensus 380 mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 380 MLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhccCccccCCHHHHhcCHhhhhcC
Confidence 9999999999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-23 Score=216.85 Aligned_cols=155 Identities=22% Similarity=0.298 Sum_probs=127.3
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++.. ..|++..++.++.|++.++ +++ +++||+|||++............+.
T Consensus 151 ~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~ 229 (410)
T 3v8s_A 151 MPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229 (410)
T ss_dssp CTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCC
Confidence 348899999886 5799999999999999864 333 4688999998765433222234578
Q ss_pred ccccccccCCC--CC---CCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCC--CCCCHHHHHHHH
Q psy6203 399 RSAIVLCSAPS--SK---QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEP--PWMSPNSRQIVR 469 (568)
Q Consensus 399 ~gt~~~~~pe~--~~---~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~li~ 469 (568)
+||+.|+|||. .. .+|+.++||||+||++|||++|++||.+.+..+++.+|..+. +.+| ..+|+++++||.
T Consensus 230 ~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~ 309 (410)
T 3v8s_A 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309 (410)
T ss_dssp CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHH
T ss_pred cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHH
Confidence 99999999997 22 238999999999999999999999999999999999988753 3344 469999999999
Q ss_pred HccCCCcCC--CCCHHHHhcCcccccC
Q psy6203 470 SMLQVEPGK--RIKIQDLLGHNWVKMG 494 (568)
Q Consensus 470 ~~L~~dp~~--R~t~~~~l~hp~~~~~ 494 (568)
+||+.+|.+ |++++|+++||||+..
T Consensus 310 ~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 310 AFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999988 9999999999999853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.5e-23 Score=216.70 Aligned_cols=156 Identities=21% Similarity=0.308 Sum_probs=115.3
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCC--------
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVG-------- 392 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~-------- 392 (568)
+++|.+++.....|++..++.++.|++.++ ++ .+.+||+|||++........
T Consensus 113 ~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 192 (432)
T 3n9x_A 113 DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192 (432)
T ss_dssp SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------
T ss_pred CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccc
Confidence 468889999888999999999999999874 33 34689999998765432211
Q ss_pred -------------ceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHh-----------CCCCCCCCC-----
Q psy6203 393 -------------QVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLC-----------GFLPFDSDS----- 441 (568)
Q Consensus 393 -------------~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~-----------g~~pf~~~~----- 441 (568)
......+||++|+|||. ....|+.++||||+||++|||++ |.++|.+.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~ 272 (432)
T 3n9x_A 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLS 272 (432)
T ss_dssp ------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC--
T ss_pred ccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccC
Confidence 12467899999999996 67789999999999999999998 566666643
Q ss_pred ------------HHHHHHHHHc--C----------------------CCCCC-------CCCCHHHHHHHHHccCCCcCC
Q psy6203 442 ------------IDQLYDKILN--G----------------------KYTEP-------PWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 442 ------------~~~~~~~i~~--~----------------------~~~~~-------~~~s~~~~~li~~~L~~dp~~ 478 (568)
..+.+..|.. | ....+ +.+++++.+||.+||+.||++
T Consensus 273 ~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 352 (432)
T 3n9x_A 273 PDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNK 352 (432)
T ss_dssp --------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTT
T ss_pred cccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCccc
Confidence 1222222211 1 11111 358999999999999999999
Q ss_pred CCCHHHHhcCcccccCCC
Q psy6203 479 RIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 479 R~t~~~~l~hp~~~~~~~ 496 (568)
|||++|+++||||+....
T Consensus 353 R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 353 RITIDQALDHPYLKDVRK 370 (432)
T ss_dssp SCCHHHHHTCGGGTTTCC
T ss_pred CCCHHHHhcChhhhhccC
Confidence 999999999999986543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-23 Score=218.19 Aligned_cols=153 Identities=20% Similarity=0.386 Sum_probs=129.9
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc-------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF-------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~-------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++...+.|++..+..++.|++.++ +++ +.+||+|||++..... .+......
T Consensus 231 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~~~~~~ 309 (446)
T 4ejn_A 231 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTF 309 (446)
T ss_dssp SSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------CCS
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-CCcccccc
Confidence 3678888888778999999999988888653 333 3578999997754322 23345678
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+...+...+......+|..+++++.+||.+||..||.
T Consensus 310 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~ 389 (446)
T 4ejn_A 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPK 389 (446)
T ss_dssp SSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTT
T ss_pred cCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHH
Confidence 99999999998 66778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCC-----CHHHHhcCccccc
Q psy6203 478 KRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~-----t~~~~l~hp~~~~ 493 (568)
+|| |++|+++||||+.
T Consensus 390 ~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 390 QRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp TSTTCSTTTHHHHHTSGGGTT
T ss_pred HhCCCCCCCHHHHHhCccccC
Confidence 999 9999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=7.3e-23 Score=211.04 Aligned_cols=151 Identities=16% Similarity=0.210 Sum_probs=121.7
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|++|.+++.. ..+++..+..++.|++.++ ++ .+.+||+|||++..... .....+|
T Consensus 113 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~----~~~~~~~ 187 (367)
T 1cm8_A 113 GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVV 187 (367)
T ss_dssp SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSCS
T ss_pred CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc----ccCcCcC
Confidence 6778788776 6899999999999999864 23 45689999997765321 2355789
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------------------
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY---------------------- 454 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~---------------------- 454 (568)
|++|+|||. +...|+.++||||+||++|||++|++||.+.+..+.+..|... .+
T Consensus 188 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 267 (367)
T 1cm8_A 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 267 (367)
T ss_dssp CGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCC
T ss_pred CCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCC
Confidence 999999997 5578999999999999999999999999999887777666431 11
Q ss_pred -------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 455 -------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 455 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
..++..++.+.+||.+||..||.+|||++|+++||||+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 268 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 012357899999999999999999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=209.26 Aligned_cols=153 Identities=19% Similarity=0.290 Sum_probs=129.5
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|.+++...+.|++..++.++.|++.++ +++ +.+||+|||++.... .+....+.
T Consensus 97 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--~~~~~~~~ 174 (384)
T 4fr4_A 97 LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTM 174 (384)
T ss_dssp CTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--TTCCBCCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--CCCceecc
Confidence 34789999999988999999999999999864 333 467899999775432 33345678
Q ss_pred ccccccccCCC-C---CCCCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy6203 399 RSAIVLCSAPS-S---KQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471 (568)
Q Consensus 399 ~gt~~~~~pe~-~---~~~~~~~~DiWSlG~il~eml~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 471 (568)
+||+.|+|||. . +..|+.++||||+||++|+|++|++||.+. ........+......+|..+|+++.+||.+|
T Consensus 175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~l 254 (384)
T 4fr4_A 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKL 254 (384)
T ss_dssp CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHH
Confidence 99999999997 2 456999999999999999999999999753 4566777777888888999999999999999
Q ss_pred cCCCcCCCCC-HHHHhcCccccc
Q psy6203 472 LQVEPGKRIK-IQDLLGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~t-~~~~l~hp~~~~ 493 (568)
|..||.+||+ ++++++||||+.
T Consensus 255 L~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 255 LEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp SCSSGGGSCCSHHHHHTSGGGTT
T ss_pred hcCCHhHhcccHHHHHcChhhhc
Confidence 9999999998 899999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-23 Score=210.68 Aligned_cols=152 Identities=24% Similarity=0.420 Sum_probs=129.9
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++.....+++.++..++.|++.++ +++. .+||+|||++.... ......
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~--~~~~~~ 188 (362)
T 2bdw_A 111 TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWH 188 (362)
T ss_dssp CSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT--TCCSCC
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec--CCcccc
Confidence 3788999998888999999999999999864 2332 38899999765433 222345
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~ 471 (568)
..+||+.|+|||. .+..|+.++||||+||++|+|++|.+||.+.+...++..+..+.+.+|. .+++++.+||.+|
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHH
T ss_pred cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 6789999999998 6678999999999999999999999999999999999999888776553 4799999999999
Q ss_pred cCCCcCCCCCHHHHhcCccccc
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
|..||.+|||+.++++||||..
T Consensus 269 L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 269 LTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp SCSSGGGSCCHHHHTTSHHHHT
T ss_pred cCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-23 Score=209.36 Aligned_cols=153 Identities=23% Similarity=0.386 Sum_probs=130.9
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Cc----------ceeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MP----------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~----------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++... .++++.++..++.|++.++ ++ .+.+||+|||++.... .+....
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~--~~~~~~ 161 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFR 161 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--TTCEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC--CCCccc
Confidence 368899998765 4899999999999999874 22 3468899999765532 334456
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
..+||+.|+|||. .+..++.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++ ..+|+++.+||.+|
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence 6789999999998 667789999999999999999999999999999999999998887765 46899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccC
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
|..||.+|||+.|+++||||+..
T Consensus 242 L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 242 LVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHSC
T ss_pred cCCChhHCcCHHHHhcChhhccC
Confidence 99999999999999999999854
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-23 Score=212.20 Aligned_cols=154 Identities=22% Similarity=0.381 Sum_probs=128.5
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce------------eEEEccccCcccccCCCCcee
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC------------TILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~------------~iki~dfG~~~~~~~~~~~~~ 395 (568)
.|++|.+++...+.|++.++..++.|++.++ +++. .+||+|||++....... ...
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 177 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLL 177 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-CCB
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-Cce
Confidence 3788999998888999999999999999864 2322 37899999876543332 234
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDS---DSIDQLYDKILNGKYTEP----PWMSPNSRQI 467 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~---~~~~~~~~~i~~~~~~~~----~~~s~~~~~l 467 (568)
.+.+||+.|+|||. .+..|+.++||||+||++|+|++|.+||.+ .+..+++..+..+.+.++ ..+|+++++|
T Consensus 178 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 257 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDL 257 (342)
T ss_dssp CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHH
T ss_pred eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHH
Confidence 56789999999998 555688999999999999999999999986 457778888888877654 4589999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 468 VRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 468 i~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
|.+||..||++|||+.++++||||...
T Consensus 258 i~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 258 VSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 999999999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-23 Score=206.92 Aligned_cols=158 Identities=23% Similarity=0.401 Sum_probs=113.3
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCceecc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|++|.+++...++|++.++..++.|++.++ +++. .+||+|||++..... .+.....
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 168 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKT 168 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC-CCCcccc
Confidence 788999999888999999999999999864 2332 578999997764332 2233456
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCC----CCCHHHH
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-------IDQLYDKILNGKYTEPP----WMSPNSR 465 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~-------~~~~~~~i~~~~~~~~~----~~s~~~~ 465 (568)
.+||+.|+|||. ....|+.++||||+||++|+|++|++||.+.+ ..+.+..+..+.+.++. .+|++++
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAK 248 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHH
Confidence 789999999998 66779999999999999999999999998743 35677888888776653 4899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCCCCCC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNP 499 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~ 499 (568)
+||.+||..||.+|||++|+++||||+.......
T Consensus 249 ~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~ 282 (325)
T 3kn6_A 249 DLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282 (325)
T ss_dssp HHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred HHHHHHCCCChhHCCCHHHHhcChhhccCccCCC
Confidence 9999999999999999999999999987654433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-22 Score=206.15 Aligned_cols=152 Identities=24% Similarity=0.378 Sum_probs=129.4
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce------------eEEEccccCcccccCCCCcee
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC------------TILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~------------~iki~dfG~~~~~~~~~~~~~ 395 (568)
.|++|.+++...+++++.++..++.|++.++ +++. .+||+|||++.... .+...
T Consensus 97 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~--~~~~~ 174 (326)
T 2y0a_A 97 AGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEF 174 (326)
T ss_dssp CSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC--TTSCC
T ss_pred CCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC--CCCcc
Confidence 3789999999888999999999999999864 3332 47899999765432 22334
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRS 470 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~ 470 (568)
...+||+.|+|||. ....|+.++||||+||++|+|++|.+||.+.+..+.+..+....+.++ ..+++.+.+||.+
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (326)
T 2y0a_A 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254 (326)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHH
T ss_pred ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHH
Confidence 56789999999998 667899999999999999999999999999998888888887766654 4689999999999
Q ss_pred ccCCCcCCCCCHHHHhcCccccc
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
||..||.+|||++|+++||||+.
T Consensus 255 ~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 255 LLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HccCChhhCCCHHHHhcCCCccC
Confidence 99999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=7e-23 Score=213.87 Aligned_cols=154 Identities=21% Similarity=0.307 Sum_probs=125.4
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|++++... ..|+++.++.++.|++.++ +| .+++||+|||++..............
T Consensus 144 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~ 223 (412)
T 2vd5_A 144 VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223 (412)
T ss_dssp CSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccccee
Confidence 478999998764 4899999999999998764 33 34689999998765443333234457
Q ss_pred ccccccccCCC-C-------CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCC---CCCCHHHH
Q psy6203 399 RSAIVLCSAPS-S-------KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTEP---PWMSPNSR 465 (568)
Q Consensus 399 ~gt~~~~~pe~-~-------~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~~~ 465 (568)
+||+.|+|||. . ...|+.++||||+||++|||++|++||.+.+..+.+.+|.... ..+| ..+|++++
T Consensus 224 ~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~ 303 (412)
T 2vd5_A 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303 (412)
T ss_dssp CSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHH
T ss_pred ccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHH
Confidence 99999999997 2 4679999999999999999999999999999999888887642 3333 57999999
Q ss_pred HHHHHccCCCcCCCC---CHHHHhcCcccccC
Q psy6203 466 QIVRSMLQVEPGKRI---KIQDLLGHNWVKMG 494 (568)
Q Consensus 466 ~li~~~L~~dp~~R~---t~~~~l~hp~~~~~ 494 (568)
+||++||+ +|.+|+ +++|+++||||+..
T Consensus 304 dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 304 DFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999 999985 89999999999854
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=203.25 Aligned_cols=154 Identities=16% Similarity=0.273 Sum_probs=125.1
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++.. ..+++..+..++.|++.++ ++ .+++||+|||++....... ......+
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 177 (297)
T 3fxz_A 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMV 177 (297)
T ss_dssp TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCC
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccCCcc
Confidence 47888888886 4799999999999999864 33 3467889999765543222 2345678
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHccCCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---KYTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L~~d 475 (568)
||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+.......+... ....|..+++.+.+||.+||..|
T Consensus 178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 257 (297)
T 3fxz_A 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 257 (297)
T ss_dssp SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSS
T ss_pred CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 9999999998 6667899999999999999999999999998877666555443 23346678999999999999999
Q ss_pred cCCCCCHHHHhcCcccccCC
Q psy6203 476 PGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 476 p~~R~t~~~~l~hp~~~~~~ 495 (568)
|++|||++|+++||||+...
T Consensus 258 p~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 258 VEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp TTTSCCHHHHTTCGGGGGCC
T ss_pred hhHCcCHHHHhhChhhcccC
Confidence 99999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.3e-23 Score=217.99 Aligned_cols=149 Identities=17% Similarity=0.289 Sum_probs=111.9
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccccc
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRSA 401 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~gt 401 (568)
+.+.+.+.. .+++..++.++.|++.++ ++ .+++||+|||++.... .+......+||
T Consensus 151 ~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~--~~~~~~~~~gt 226 (464)
T 3ttj_A 151 ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 226 (464)
T ss_dssp EEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-------CCCC----CC
T ss_pred CCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC--CCcccCCCccc
Confidence 345556654 499999999999999864 33 3468999999775432 23345667999
Q ss_pred cccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------------------
Q psy6203 402 IVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT------------------------- 455 (568)
Q Consensus 402 ~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~------------------------- 455 (568)
+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+.+..|......
T Consensus 227 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (464)
T 3ttj_A 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 306 (464)
T ss_dssp CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCC
T ss_pred ccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCC
Confidence 99999998 6678999999999999999999999999999988777776542100
Q ss_pred ------CCCC-----------CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 456 ------EPPW-----------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 456 ------~~~~-----------~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+|.. .++++++||.+||+.||++|||++|+++||||+..
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 307 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred CChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0000 15679999999999999999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=217.25 Aligned_cols=156 Identities=22% Similarity=0.393 Sum_probs=128.7
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++.+...++|++..+..++.|++.++ +++ +.+||+|||++.... .+....
T Consensus 104 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~ 181 (486)
T 3mwu_A 104 TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMK 181 (486)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC--CC----
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC--CCCccC
Confidence 3688888888778999999999999999874 233 357889999765432 233345
Q ss_pred ccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHcc
Q psy6203 397 LLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSML 472 (568)
Q Consensus 397 ~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L 472 (568)
..+||+.|+|||.....|+.++||||+||++|+|++|.+||.+.+..+++..+..+.+.++ ..+|+++++||.+||
T Consensus 182 ~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 261 (486)
T 3mwu_A 182 DRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261 (486)
T ss_dssp CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHT
T ss_pred CCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHc
Confidence 6789999999998444599999999999999999999999999999999999988876543 348999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCCCC
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKMGPED 497 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~~~~~ 497 (568)
..||.+|||+.++++||||+.....
T Consensus 262 ~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 262 TFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp CSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred CCChhhCcCHHHHhcCHhhccCccc
Confidence 9999999999999999999865443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-22 Score=206.55 Aligned_cols=153 Identities=24% Similarity=0.443 Sum_probs=114.1
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce----------eEEEccccCcccccCCCCceecc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC----------TILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~----------~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
.|++|.+++...++|++..+..++.|++.++ +++. .+||+|||++.... .......
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--~~~~~~~ 176 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKS 176 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc--ccCCCCC
Confidence 3788889988878999999999999999864 3332 28899999765322 2223455
Q ss_pred cccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q psy6203 398 LRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPP--WMSPNSRQIVR 469 (568)
Q Consensus 398 ~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~----~~~~~~~i~~~~~~~~~--~~s~~~~~li~ 469 (568)
.+||+.|+|||. +..+++.++||||+||++|+|++|++||.+.+ .......+....+.+|. .+++++++||.
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 256 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS 256 (361)
T ss_dssp ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHH
T ss_pred CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHH
Confidence 689999999997 55555666999999999999999999998754 35566677777666655 58999999999
Q ss_pred HccCCCcCCCCCHHHHhcCcccccC
Q psy6203 470 SMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 470 ~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+||..||.+|||++|+++||||...
T Consensus 257 ~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 257 RIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHccCChhHCcCHHHHHhCcchhcC
Confidence 9999999999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.8e-22 Score=201.47 Aligned_cols=152 Identities=18% Similarity=0.247 Sum_probs=119.7
Q ss_pred HHHHHHHHhCCCC--CChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 341 GVMLYALLCGFLP--FDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 341 g~~l~~~~~~~~~--~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
+++|.+++..... +++..+..++.|++.++ +++ +++||+|||++.... ........
T Consensus 102 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 179 (308)
T 3g33_A 102 DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPV 179 (308)
T ss_dssp CCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTST--TCCCSGGG
T ss_pred hcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccC--CCcccCCc
Confidence 3577788876544 99999999999999864 333 467899999765432 22334567
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC--------------------
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YT-------------------- 455 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~--~~-------------------- 455 (568)
+||+.|+|||. ....|+.++||||+||++|+|++|++||.+.+..+.+..+.... ++
T Consensus 180 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (308)
T 3g33_A 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP 259 (308)
T ss_dssp GCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCC
T ss_pred cccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCC
Confidence 89999999998 56678999999999999999999999999999888777765421 10
Q ss_pred -----CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 456 -----EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 456 -----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..+.+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 260 RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 013478899999999999999999999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.86 E-value=3.1e-22 Score=215.27 Aligned_cols=155 Identities=19% Similarity=0.219 Sum_probs=129.2
Q ss_pred hhhHHHHHHHHhCC----CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc
Q psy6203 338 WSMGVMLYALLCGF----LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ 393 (568)
Q Consensus 338 ~~~g~~l~~~~~~~----~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~ 393 (568)
|..|++|.+++... ..|++..+..++.|++.++ +++ +++||+|||++...... ..
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~-~~ 344 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QT 344 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-CC
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC-Cc
Confidence 33488999988763 4799999999999999864 333 46889999977653322 22
Q ss_pred eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy6203 394 VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQIV 468 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~~li 468 (568)
.....+||+.|+|||. .+..|+.++||||+||++|||++|++||.+. +...+...+......+|..+|+++.+||
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 424 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFC 424 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHH
Confidence 2345699999999998 6778999999999999999999999999875 4567788888888889999999999999
Q ss_pred HHccCCCcCCCCC-----HHHHhcCccccc
Q psy6203 469 RSMLQVEPGKRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 469 ~~~L~~dp~~R~t-----~~~~l~hp~~~~ 493 (568)
.+||.+||.+||+ ++++++||||+.
T Consensus 425 ~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 425 EALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999996 589999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=4.1e-22 Score=206.59 Aligned_cols=154 Identities=19% Similarity=0.369 Sum_probs=128.8
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc----------eeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI----------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~----------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|.+++... ..|++.++..++.|++.++ +++ +.+||+|||++..... .....
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~--~~~~~ 208 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVK 208 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--TSCEE
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC--Cccee
Confidence 378898988764 4799999999999999874 222 3588999997765432 22345
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
..+||+.|+|||. ....++.++||||+||++|+|++|.+||.+.+..+.+..+..+...++ ..+++++.+||.+|
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 288 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 5689999999998 667899999999999999999999999999998888888887765543 45899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccCC
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
|..||.+|||++|+++||||+...
T Consensus 289 L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 289 LQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp SCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred cCCChhHCcCHHHHhhCccccCCc
Confidence 999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-22 Score=197.54 Aligned_cols=154 Identities=21% Similarity=0.391 Sum_probs=131.2
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++...+++++..+..++.|++.++ ++ .+++||+|||++..... ......+
T Consensus 97 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~ 173 (284)
T 2vgo_A 97 PRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---LRRRTMC 173 (284)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS---SCBCCCC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc---ccccccc
Confidence 3678888888778899999999999999864 23 34678899996643221 1234568
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..++.++||||+||++|+|++|.+||.+.+..+....+......+|..+++++.+||.+||..||.+
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 253 (284)
T 2vgo_A 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQ 253 (284)
T ss_dssp SCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGG
T ss_pred CCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhh
Confidence 9999999998 666789999999999999999999999999998888889998888889999999999999999999999
Q ss_pred CCCHHHHhcCcccccCCC
Q psy6203 479 RIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 479 R~t~~~~l~hp~~~~~~~ 496 (568)
|||++++++||||+....
T Consensus 254 Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 254 RLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp SCCHHHHHTCHHHHHHCC
T ss_pred CCCHHHHhhCHHHHhhcc
Confidence 999999999999986543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.7e-22 Score=200.20 Aligned_cols=152 Identities=16% Similarity=0.201 Sum_probs=114.9
Q ss_pred HHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 342 VMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 342 ~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
+++.+++.. ...+++..+..++.|++.++ +++ +.+||+|||++...... .......+|
T Consensus 103 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~ 181 (311)
T 3niz_A 103 KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV 181 (311)
T ss_dssp EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-CC---CCCC
T ss_pred CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-cccccCCcc
Confidence 355555554 45699999999999999864 333 35789999977554322 223445688
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---------------------
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT--------------------- 455 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~--------------------- 455 (568)
|+.|+|||. +...|+.++||||+||++|+|++|++||.+.+..+.+..+... .+.
T Consensus 182 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T 3niz_A 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVF 261 (311)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCC
T ss_pred cCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccc
Confidence 999999997 5578999999999999999999999999987766555554331 100
Q ss_pred -------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 456 -------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 456 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..+.+++++.+||.+||+.||++|||++|+++||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 013367899999999999999999999999999999854
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-22 Score=197.99 Aligned_cols=154 Identities=18% Similarity=0.388 Sum_probs=128.4
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++....++++..+..++.|++.++ +++ +++||+|||++.... ........
T Consensus 92 ~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~---~~~~~~~~ 168 (279)
T 3fdn_A 92 PLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLC 168 (279)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----------C
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC---cccccccC
Confidence 3678888888778899999999999999864 333 357888898653321 12234568
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..++.++||||+||++|+|++|.+||.+.+..+....+......+|..+++++.+||.+||..||.+
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 248 (279)
T 3fdn_A 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQ 248 (279)
T ss_dssp CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGG
T ss_pred CCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhh
Confidence 9999999998 677889999999999999999999999999999999999998888899999999999999999999999
Q ss_pred CCCHHHHhcCcccccCCC
Q psy6203 479 RIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 479 R~t~~~~l~hp~~~~~~~ 496 (568)
|||++|+++||||+....
T Consensus 249 Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 249 RPMLREVLEHPWITANSS 266 (279)
T ss_dssp SCCHHHHHHCHHHHHHCS
T ss_pred CCCHHHHhhCccccCCcc
Confidence 999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-22 Score=203.37 Aligned_cols=152 Identities=14% Similarity=0.176 Sum_probs=115.4
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cccee-------------EEEccccCcccccCCCCceec
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPICT-------------ILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~~-------------iki~dfG~~~~~~~~~~~~~~ 396 (568)
++|.+++.....+++..+..++.|++.++ +++.| +||+|||++...... .....
T Consensus 117 ~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~ 195 (329)
T 3gbz_A 117 NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFT 195 (329)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--------
T ss_pred CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc-ccccC
Confidence 47888888888899999999999999864 34433 678999976543222 22344
Q ss_pred ccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCC---------C------
Q psy6203 397 LLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YTE---------P------ 457 (568)
Q Consensus 397 ~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~--~~~---------~------ 457 (568)
..+||+.|+|||. +...|+.++||||+||++|+|++|++||.+.+..+.+..+.... +.. +
T Consensus 196 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (329)
T 3gbz_A 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275 (329)
T ss_dssp ----CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred CCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhh
Confidence 5678999999997 45679999999999999999999999999998877776665421 100 0
Q ss_pred -------------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 458 -------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 458 -------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 276 PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 1167899999999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.6e-22 Score=214.61 Aligned_cols=153 Identities=18% Similarity=0.257 Sum_probs=128.4
Q ss_pred hhHHHHHHHHhCCC--CCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 339 SMGVMLYALLCGFL--PFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 339 ~~g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
..|++|.+++...+ .|++..++.++.||+.++ +++ +++||+|||++.... .+....
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~--~~~~~~ 343 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIK 343 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC--TTCCEE
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc--cCcccc
Confidence 34899999987654 499999999999999764 333 468999999775532 233345
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 471 (568)
..+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+ ...+...+......+|..+|+++++||.+|
T Consensus 344 ~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~l 423 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423 (576)
T ss_dssp CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHh
Confidence 6799999999998 66779999999999999999999999998753 456777777777788889999999999999
Q ss_pred cCCCcCCCC-----CHHHHhcCccccc
Q psy6203 472 LQVEPGKRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~-----t~~~~l~hp~~~~ 493 (568)
|..||.+|+ +++|+++||||+.
T Consensus 424 L~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 424 LCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp TCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred ccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999 7899999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.85 E-value=9e-22 Score=196.15 Aligned_cols=153 Identities=13% Similarity=0.207 Sum_probs=116.0
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|..+..+....+.+++..+..++.|++.++ ++ .+++||+|||.+...... .......+|
T Consensus 85 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~ 163 (292)
T 3o0g_A 85 QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVV 163 (292)
T ss_dssp EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCCCSCCS
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccccCCcc
Confidence 333334445567899999999999999864 33 346789999977554322 223455688
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCC-CCCCCHHHHHHHHHcC--CC---------------------
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNG--KY--------------------- 454 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~p-f~~~~~~~~~~~i~~~--~~--------------------- 454 (568)
|+.|+|||. +...|+.++||||+||++|+|++|..| |.+.+..+.+..+... .+
T Consensus 164 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T 3o0g_A 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243 (292)
T ss_dssp CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC
T ss_pred ccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccccc
Confidence 999999997 556699999999999999999987666 6777777766666431 00
Q ss_pred ------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 455 ------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 455 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
...+.+++++++||.+||+.||++|||++|+++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 0113478899999999999999999999999999999853
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-22 Score=205.97 Aligned_cols=151 Identities=18% Similarity=0.208 Sum_probs=107.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|++|.+++.. ..+++..+..++.|++.++ ++ .+.+||+|||++.... ......+|
T Consensus 117 ~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~~ 191 (367)
T 2fst_X 117 GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVA 191 (367)
T ss_dssp CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------------C
T ss_pred CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc----ccCCCcCc
Confidence 4556666665 6799999999999999864 33 3468899999765432 12345789
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC---------------------C
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY---------------------T 455 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~---------------------~ 455 (568)
|++|+|||. +...|+.++||||+||++|+|++|++||.+.+..+.+..|... .+ .
T Consensus 192 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 271 (367)
T 2fst_X 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271 (367)
T ss_dssp CCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCC
T ss_pred CcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCC
Confidence 999999997 4478999999999999999999999999999887776665431 10 0
Q ss_pred C--------CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 456 E--------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 456 ~--------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
. .+..++.+.+||.+||+.||.+|||++|+++||||+....
T Consensus 272 ~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 272 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0 1246889999999999999999999999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=200.71 Aligned_cols=154 Identities=15% Similarity=0.237 Sum_probs=117.8
Q ss_pred HHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCC---CCceeccc
Q psy6203 343 MLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCK---VGQVINLL 398 (568)
Q Consensus 343 ~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~---~~~~~~~~ 398 (568)
++.+.+.. ...+++.++..++.|++.++ +++ +++||+|||++...... ........
T Consensus 109 ~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 188 (351)
T 3mi9_A 109 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188 (351)
T ss_dssp EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSS
T ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCc
Confidence 44444443 46799999999999999864 333 46789999977544321 12234556
Q ss_pred ccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----------------
Q psy6203 399 RSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW----------------- 459 (568)
Q Consensus 399 ~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------------- 459 (568)
+||+.|+|||. +...|+.++||||+||++|+|++|++||.+.+.......+......+++.
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (351)
T 3mi9_A 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 268 (351)
T ss_dssp CSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCC
T ss_pred ccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccc
Confidence 88999999997 55679999999999999999999999999998877776665422111110
Q ss_pred ---------------CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 460 ---------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 460 ---------------~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
.++.+.+||.+||+.||.+|||++|+++||||.....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 269 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp SSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred cccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 2678999999999999999999999999999986443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6e-22 Score=199.99 Aligned_cols=144 Identities=13% Similarity=0.209 Sum_probs=113.5
Q ss_pred CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccccccccccCCC--
Q psy6203 352 LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS-- 409 (568)
Q Consensus 352 ~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~-- 409 (568)
..+++..++.++.|++.++ ++ .+++||+|||++....... ......+||+.|+|||.
T Consensus 103 ~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~ 181 (317)
T 2pmi_A 103 RGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLM 181 (317)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-CCCCCCCSCCTTCCHHHHT
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-ccCCCCcccccccCchHhh
Confidence 4699999999999999864 33 3468899999775543222 22345689999999997
Q ss_pred CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC--------------------------------C
Q psy6203 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY--------------------------------T 455 (568)
Q Consensus 410 ~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~--------------------------------~ 455 (568)
+...|+.++||||+||++|+|++|++||.+.+..+.+..+... .+ .
T Consensus 182 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (317)
T 2pmi_A 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH 261 (317)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGG
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccc
Confidence 4467999999999999999999999999999887777666431 10 0
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 456 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 456 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
.+..+++++.+||.+||+.||++|||++|+++||||+....
T Consensus 262 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 262 TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred ccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 11246889999999999999999999999999999986543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.3e-22 Score=213.45 Aligned_cols=154 Identities=23% Similarity=0.399 Sum_probs=131.3
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++...+.|++..+..++.|++.++ +++. .+||+|||++..... +....
T Consensus 129 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~ 206 (504)
T 3q5i_A 129 EGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLR 206 (504)
T ss_dssp TTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCT--TSCBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCC--CCccc
Confidence 3788888888778999999999999999874 3332 478999997754432 23345
Q ss_pred ccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHcc
Q psy6203 397 LLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSML 472 (568)
Q Consensus 397 ~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L 472 (568)
..+||+.|+|||.....|+.++||||+||++|+|++|.+||.+.+..+++..+..+.+.++ ..+|+++++||.+||
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 286 (504)
T 3q5i_A 207 DRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLML 286 (504)
T ss_dssp CCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHT
T ss_pred cccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHc
Confidence 6789999999998445689999999999999999999999999999999999999887665 568999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCC
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
..||.+|||++|+++||||+...
T Consensus 287 ~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 287 TYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCChhHCCCHHHHhcCHhhhhch
Confidence 99999999999999999998654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.8e-21 Score=189.10 Aligned_cols=139 Identities=19% Similarity=0.261 Sum_probs=109.2
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcE--EEEEEeecCCcC--C---------------------chHHHHHHHHHHHhC
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEK--VAIKIMKKATLG--E---------------------DLPRVKLEINALKHI 63 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~--~---------------------~~~~~~~Ei~~l~~l 63 (568)
.|.+.+.||+|+||.||+|.+..+|+. ||||+++..... . ....+.+|+.+|+++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778999 999997643211 0 012578899999999
Q ss_pred CCCCc--ceeeEEEEeCCEEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCC
Q psy6203 64 SHQHI--CKLFQVIETSSHIFMVIEYCPG-G----ELLDHIVERQRLGEKESRAFFRQILSAVAYLH-HLGYAHRDLKPE 135 (568)
Q Consensus 64 ~hpnI--v~l~~~~~~~~~~~lV~E~~~~-g----~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~ 135 (568)
.|+++ ..+++. +..+|||||+.+ | +|.+.... .++..+..++.||+.||.||| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88764 444432 245899999932 3 66665432 345678899999999999999 999999999999
Q ss_pred ceEEcCCCCeEEEeecCccCC
Q psy6203 136 NVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 136 NIll~~~~~~kl~DFG~a~~~ 156 (568)
|||++. .++|+|||+|...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999988 8999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.85 E-value=7.5e-22 Score=196.37 Aligned_cols=151 Identities=15% Similarity=0.169 Sum_probs=113.7
Q ss_pred HHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 342 VMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 342 ~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
++|.+++.. .+.+++..+..++.|++.++ +++ +.+||+|||++...... .......+|
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~ 162 (288)
T 1ob3_A 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIV 162 (288)
T ss_dssp EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------C
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-ccccccccc
Confidence 466666664 46899999999999999864 333 46788999976543221 122345688
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---------------------
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT--------------------- 455 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~--------------------- 455 (568)
|+.|+|||. +...|+.++||||+||++|+|++|++||.+.+..+.+..+... ...
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T 1ob3_A 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242 (288)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred cccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccccc
Confidence 999999997 4567999999999999999999999999998877766665431 100
Q ss_pred ------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 456 ------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 456 ------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
.+..+++++.+||.+||..||++|||++|+++||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 11347899999999999999999999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.8e-22 Score=198.72 Aligned_cols=149 Identities=21% Similarity=0.383 Sum_probs=118.9
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccccc
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSA 401 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt 401 (568)
+.|.+++. ..++++..+..++.|++.++ +++ +++||+|||++...... .......+||
T Consensus 123 ~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt 200 (298)
T 2zv2_A 123 GPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-DALLSNTVGT 200 (298)
T ss_dssp CBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSS-SCEECCCCSC
T ss_pred CcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccc-cccccCCcCC
Confidence 34434333 36899999999999999764 333 46789999977654322 2234567899
Q ss_pred cccccCCC-CCC---CCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHccCCC
Q psy6203 402 IVLCSAPS-SKQ---YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP--PWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 402 ~~~~~pe~-~~~---~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~s~~~~~li~~~L~~d 475 (568)
+.|+|||. ... +++.++||||+||++|+|++|++||.+.+.......+......+| ..+++++.+||.+||..|
T Consensus 201 ~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 280 (298)
T 2zv2_A 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKN 280 (298)
T ss_dssp GGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSC
T ss_pred ccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcC
Confidence 99999998 222 358899999999999999999999999988888888877766554 468999999999999999
Q ss_pred cCCCCCHHHHhcCcccc
Q psy6203 476 PGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 476 p~~R~t~~~~l~hp~~~ 492 (568)
|++|||+.|+++||||+
T Consensus 281 p~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 281 PESRIVVPEIKLHPWVT 297 (298)
T ss_dssp TTTSCCHHHHTTCHHHH
T ss_pred hhhCCCHHHHhcCcccc
Confidence 99999999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=200.74 Aligned_cols=154 Identities=23% Similarity=0.428 Sum_probs=117.6
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc-----------ceeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP-----------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~-----------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|.+++...+.+++.++..++.|++.++ ++ ...+||+|||++.... ......
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~--~~~~~~ 208 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMK 208 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC--cccccc
Confidence 3688999999888999999999999999864 22 3457889999765432 222345
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYTEP----PWMSPNSRQIVRS 470 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~-~~~~~~i~~~~~~~~----~~~s~~~~~li~~ 470 (568)
..+||+.|+|||. .+..|+.++||||+||++|+|++|..||.+.+. ...+..+..+....+ ..+++++.+||.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 288 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence 6789999999998 666799999999999999999999999987654 446777777765432 4589999999999
Q ss_pred ccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
||..||++|||+.|+++||||....
T Consensus 289 ~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 289 LIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp TSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999998543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-22 Score=214.73 Aligned_cols=154 Identities=24% Similarity=0.397 Sum_probs=129.3
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++...++|++..+..++.|++.++ +++ +.+||+|||++.... ......
T Consensus 109 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~ 186 (484)
T 3nyv_A 109 TGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMK 186 (484)
T ss_dssp CSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC--CCCSHH
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc--cccccc
Confidence 3788999998888999999999999999874 233 457889999765432 223345
Q ss_pred ccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHcc
Q psy6203 397 LLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSML 472 (568)
Q Consensus 397 ~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L 472 (568)
..+||+.|+|||.....|+.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++ ..+|+++++||.+||
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 266 (484)
T 3nyv_A 187 DKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 266 (484)
T ss_dssp HHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHT
T ss_pred cCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHC
Confidence 6789999999998333689999999999999999999999999999999999988876543 348999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccCC
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
..||.+|||+.|+++||||+...
T Consensus 267 ~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 267 TYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999998543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.5e-22 Score=195.27 Aligned_cols=152 Identities=30% Similarity=0.580 Sum_probs=120.1
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|++|.+++...+++++..+..++.|++.++ ++ .+++||+|||.+.... .+......+|
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~--~~~~~~~~~~ 172 (276)
T 2h6d_A 95 GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCG 172 (276)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC--C---------
T ss_pred CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC--CCcceecccC
Confidence 678888888778899999999999999864 23 3467889999665432 2223455689
Q ss_pred ccccccCCC-C-CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 401 AIVLCSAPS-S-KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 401 t~~~~~pe~-~-~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
|+.|+|||. . ..+++.++||||+||++|+|++|+.||.+.+.......+..+....|..+++.+.+||.+||..||.+
T Consensus 173 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 252 (276)
T 2h6d_A 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLK 252 (276)
T ss_dssp ----CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhh
Confidence 999999998 3 33457899999999999999999999999998888889988888888889999999999999999999
Q ss_pred CCCHHHHhcCcccccC
Q psy6203 479 RIKIQDLLGHNWVKMG 494 (568)
Q Consensus 479 R~t~~~~l~hp~~~~~ 494 (568)
|||++++++||||+..
T Consensus 253 Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 253 RATIKDIREHEWFKQD 268 (276)
T ss_dssp SCCHHHHHHSHHHHTT
T ss_pred CCCHHHHHhChhhccC
Confidence 9999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.5e-22 Score=200.85 Aligned_cols=155 Identities=18% Similarity=0.319 Sum_probs=121.9
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCC-CCceeccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCK-VGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~-~~~~~~~~ 398 (568)
.|++|.+++.....+++..+..++.|++.++ +++ +++||+|||++...... ........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 167 (323)
T 3tki_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167 (323)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSC
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCC
Confidence 3678888888888999999999999999864 333 46789999977543322 22234567
Q ss_pred ccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCC--CCCCHHHHHHHHHccC
Q psy6203 399 RSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTEP--PWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 399 ~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li~~~L~ 473 (568)
+||+.|+|||. +..+++.++||||+||++|+|++|++||.+.+.. ..+..........+ ..+++++.+||.+||.
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 247 (323)
T 3tki_A 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 247 (323)
T ss_dssp CSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSC
T ss_pred ccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHcc
Confidence 89999999998 5666788999999999999999999999876543 33333333333322 4589999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccC
Q psy6203 474 VEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 474 ~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.||.+|||++|+++||||+..
T Consensus 248 ~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 248 ENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp SSTTTSCCHHHHTTCTTTTCC
T ss_pred CChhhCcCHHHHhhChhhccc
Confidence 999999999999999999854
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=197.83 Aligned_cols=152 Identities=22% Similarity=0.343 Sum_probs=128.9
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce------------eEEEccccCcccccCCCCcee
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC------------TILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~------------~iki~dfG~~~~~~~~~~~~~ 395 (568)
.|++|.+++...+++++..+..++.|++.++ +++. .+||+|||.+.... .+...
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~ 175 (321)
T 2a2a_A 98 SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF 175 (321)
T ss_dssp CSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC--TTCCC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC--ccccc
Confidence 3788999999888999999999999999864 2332 47889999765432 22234
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRS 470 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~ 470 (568)
....||+.|+|||. ....++.++||||+||++|+|++|..||.+.+..+.+..+......++ ...++.+.+||.+
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 255 (321)
T 2a2a_A 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRK 255 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHT
T ss_pred cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHH
Confidence 55689999999998 667889999999999999999999999999999898888888776654 5689999999999
Q ss_pred ccCCCcCCCCCHHHHhcCccccc
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
||..||++|||++|+++||||..
T Consensus 256 ~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 256 LLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HcCCChhhCcCHHHHhcCccccC
Confidence 99999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.5e-22 Score=212.78 Aligned_cols=152 Identities=24% Similarity=0.428 Sum_probs=128.8
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++....++++..+..++.|++.++ +++. .+||+|||++..... .....
T Consensus 119 ~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~--~~~~~ 196 (494)
T 3lij_A 119 KGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMK 196 (494)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT--TBCBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC--Ccccc
Confidence 3678888888778999999999999999874 3333 378899997755432 23345
Q ss_pred ccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHcc
Q psy6203 397 LLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSML 472 (568)
Q Consensus 397 ~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L 472 (568)
..+||+.|+|||.....|+.++||||+||++|+|++|.+||.+.+..+++..+..+.+.++ ..+|+++++||.+||
T Consensus 197 ~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 276 (494)
T 3lij_A 197 ERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQML 276 (494)
T ss_dssp CCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHT
T ss_pred ccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHC
Confidence 6789999999998445689999999999999999999999999999999999988877654 348999999999999
Q ss_pred CCCcCCCCCHHHHhcCccccc
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+.||.+|||+.|+++||||+.
T Consensus 277 ~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 277 QFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp CSSTTTSCCHHHHHTCHHHHH
T ss_pred CCChhhCccHHHHhcCccccc
Confidence 999999999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.3e-22 Score=199.22 Aligned_cols=154 Identities=14% Similarity=0.202 Sum_probs=113.8
Q ss_pred HHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 342 VMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 342 ~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
++|.+++.. ...+++..+..++.|++.++ +++ +++||+|||++...... .......+|
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~ 162 (324)
T 3mtl_A 84 KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVV 162 (324)
T ss_dssp EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------------
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-ccccccccC
Confidence 456666654 35699999999999999864 333 36788999976543222 223445688
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---------------------
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT--------------------- 455 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~--------------------- 455 (568)
|+.|+|||. +...|+.++||||+||++|+|++|++||.+.+..+.+..+... .+.
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (324)
T 3mtl_A 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKY 242 (324)
T ss_dssp CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCC
T ss_pred cccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccc
Confidence 999999997 5578999999999999999999999999999887777666441 110
Q ss_pred -------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 456 -------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 456 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
.++.+++++.+||.+||+.||.+|||++|+++||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 01246889999999999999999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.5e-22 Score=210.28 Aligned_cols=150 Identities=17% Similarity=0.239 Sum_probs=116.0
Q ss_pred HHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccce----------eEEEccccCcccccCCCCceec
Q psy6203 341 GVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPIC----------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 341 g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~~----------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
+++|++++... ..|++..++.++.|++.++ +++. .+||+|||++... +....
T Consensus 182 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~----~~~~~ 257 (429)
T 3kvw_A 182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE----HQRVY 257 (429)
T ss_dssp CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET----TCCCC
T ss_pred CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec----CCccc
Confidence 45777877754 3599999999999999864 3333 2788999976432 22244
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC------------------
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YT------------------ 455 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~--~~------------------ 455 (568)
+.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+.+..+.... ++
T Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~ 337 (429)
T 3kvw_A 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKG 337 (429)
T ss_dssp SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTS
T ss_pred ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCC
Confidence 6789999999998 56678999999999999999999999999998877666554210 00
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 456 ---------------------------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 456 ---------------------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.+...++++.+||.+||+.||++|||++|+++||||+..
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 338 YPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp CBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred CcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 011237889999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.8e-22 Score=200.36 Aligned_cols=155 Identities=19% Similarity=0.342 Sum_probs=118.5
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCC-----
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKV----- 391 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~----- 391 (568)
.|++|.+++....++++.++..++.|++.++ +++. .+||+|||++.......
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 94 RGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 3678888888778999999999999999864 3333 27899999765432211
Q ss_pred -CceecccccccccccCCC-C-----CCCCCCccceeehhHHHHHHHhCCCCCCCCC---------------HHHHHHHH
Q psy6203 392 -GQVINLLRSAIVLCSAPS-S-----KQYYGSETDVWSMGVMLYALLCGFLPFDSDS---------------IDQLYDKI 449 (568)
Q Consensus 392 -~~~~~~~~gt~~~~~pe~-~-----~~~~~~~~DiWSlG~il~eml~g~~pf~~~~---------------~~~~~~~i 449 (568)
.......+||+.|+|||. . ...|+.++||||+||++|+|++|++||.+.+ ...+...+
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 253 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence 112334679999999997 2 2568899999999999999999999998764 24466777
Q ss_pred HcCCCCCC----CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 450 LNGKYTEP----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 450 ~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..+.+.+| ..+++++++||.+||..||.+|||++|+++||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 77777766 4589999999999999999999999999999999854
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=7.9e-22 Score=202.41 Aligned_cols=154 Identities=19% Similarity=0.320 Sum_probs=125.0
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++....++++..+..++.|++.++ +++ +++||+|||++..............+
T Consensus 142 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 221 (355)
T 1vzo_A 142 NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221 (355)
T ss_dssp CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGG
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcc
Confidence 3678888988878999999999999999864 333 46789999977654333333344578
Q ss_pred cccccccCCC-C--CCCCCCccceeehhHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcc
Q psy6203 400 SAIVLCSAPS-S--KQYYGSETDVWSMGVMLYALLCGFLPFDSD----SIDQLYDKILNGKYTEPPWMSPNSRQIVRSML 472 (568)
Q Consensus 400 gt~~~~~pe~-~--~~~~~~~~DiWSlG~il~eml~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 472 (568)
||+.|+|||. . ...++.++|||||||++|+|++|+.||... ....+...+....+..|..+++.+.+||.+||
T Consensus 222 gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 301 (355)
T 1vzo_A 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 301 (355)
T ss_dssp SCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHh
Confidence 9999999997 3 356889999999999999999999999753 34566677777788888899999999999999
Q ss_pred CCCcCCCC-----CHHHHhcCccccc
Q psy6203 473 QVEPGKRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 473 ~~dp~~R~-----t~~~~l~hp~~~~ 493 (568)
..||.+|| |++++++||||+.
T Consensus 302 ~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 302 MKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred hhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999 9999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.7e-22 Score=204.29 Aligned_cols=154 Identities=18% Similarity=0.281 Sum_probs=120.5
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-------eEEEccccCcccccCCCC-ceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-------TILISQYFPTILLPCKVG-QVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-------~iki~dfG~~~~~~~~~~-~~~~~~~g 400 (568)
|++|.+++.....+++.++..++.|++.++ +++. .+||+|||++........ ......+|
T Consensus 139 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 218 (390)
T 2zmd_A 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218 (390)
T ss_dssp SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------CCSCC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccCCCCCc
Confidence 578889998888999999999999999864 4444 578899998765432221 12456789
Q ss_pred ccccccCCC--C----------CCCCCCccceeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC--CCCCCCCCHHHH
Q psy6203 401 AIVLCSAPS--S----------KQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGK--YTEPPWMSPNSR 465 (568)
Q Consensus 401 t~~~~~pe~--~----------~~~~~~~~DiWSlG~il~eml~g~~pf~~~~-~~~~~~~i~~~~--~~~~~~~s~~~~ 465 (568)
|+.|+|||. . ...|+.++|||||||++|||++|++||.+.. ....+..+.... ..+|...++++.
T Consensus 219 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (390)
T 2zmd_A 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 298 (390)
T ss_dssp CGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHH
T ss_pred CCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHH
Confidence 999999997 2 2469999999999999999999999998753 445566666554 346777889999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+||.+||..||.+|||+.|+++||||+..
T Consensus 299 ~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 299 DVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 99999999999999999999999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.4e-22 Score=195.15 Aligned_cols=154 Identities=22% Similarity=0.424 Sum_probs=103.0
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++... .++++..+..++.|++.++ ++ .+++||+|||.+...... .......
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 172 (278)
T 3cok_A 94 HNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-HEKHYTL 172 (278)
T ss_dssp TTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC-CCcceec
Confidence 367888888864 6899999999999999864 33 346788999976543221 1223456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
+||+.|+|||. ....++.++||||+||++|+|++|++||...+.......+....+..|..+++++.+||.+||..||+
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 252 (278)
T 3cok_A 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPA 252 (278)
T ss_dssp -------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGG
T ss_pred cCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHh
Confidence 89999999998 66778999999999999999999999999877666666666666777888999999999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q psy6203 478 KRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~~ 494 (568)
+|||++++++||||...
T Consensus 253 ~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 253 DRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp GSCCHHHHTTSTTTC--
T ss_pred hCCCHHHHhcCccccCC
Confidence 99999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.7e-22 Score=204.68 Aligned_cols=156 Identities=20% Similarity=0.270 Sum_probs=114.6
Q ss_pred hHHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCC------C
Q psy6203 340 MGVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCK------V 391 (568)
Q Consensus 340 ~g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~------~ 391 (568)
.|++|.+++... ..+++..+..++.|++.++ +++. .+||+|||.+...... .
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~ 188 (389)
T 3gni_B 109 AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188 (389)
T ss_dssp TTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCB
T ss_pred CCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccc
Confidence 367888888764 6799999999999999864 4443 5678899865432111 1
Q ss_pred CceecccccccccccCCC-CC--CCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------
Q psy6203 392 GQVINLLRSAIVLCSAPS-SK--QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-------------- 454 (568)
Q Consensus 392 ~~~~~~~~gt~~~~~pe~-~~--~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~-------------- 454 (568)
.......+||+.|+|||. .. ..|+.++||||+||++|+|++|++||.+.+..+.+..+..+..
T Consensus 189 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (389)
T 3gni_B 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEEL 268 (389)
T ss_dssp CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------
T ss_pred ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccc
Confidence 112234589999999998 33 6799999999999999999999999988665444433322211
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 455 --------------------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 455 --------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
+.+..+++++.+||.+||+.||++|||++|+++||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 269 TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 12345789999999999999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=195.61 Aligned_cols=153 Identities=21% Similarity=0.338 Sum_probs=125.2
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++.. ..+++..+..++.|++.++ +++ +.+||+|||++....... ......+
T Consensus 125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 202 (321)
T 2c30_A 125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLV 202 (321)
T ss_dssp CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCC
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-ccccccc
Confidence 36788888875 5799999999999999763 333 467899999765543222 2245678
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHccCCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~~L~~d 475 (568)
||+.|+|||. ....++.++||||+||++|+|++|++||.+.+..+....+.....+ .+..+++.+.+||.+||..|
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSS
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCC
Confidence 9999999998 6677899999999999999999999999999888888777765443 23458899999999999999
Q ss_pred cCCCCCHHHHhcCcccccC
Q psy6203 476 PGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 476 p~~R~t~~~~l~hp~~~~~ 494 (568)
|++|||++++++||||...
T Consensus 283 p~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 283 PQERATAQELLDHPFLLQT 301 (321)
T ss_dssp TTTSCCHHHHHTSGGGGGC
T ss_pred hhhCcCHHHHhcChhhccC
Confidence 9999999999999999854
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=194.67 Aligned_cols=155 Identities=22% Similarity=0.350 Sum_probs=132.0
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|++|.+++.....+++.++..++.|++.++ ++ .+++||+|||.+...... +.......|
T Consensus 99 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~ 177 (294)
T 2rku_A 99 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCG 177 (294)
T ss_dssp TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST-TCCBCCCCS
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC-ccccccccC
Confidence 677888888778899999999999999864 23 336789999976544322 223455689
Q ss_pred ccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCCC
Q psy6203 401 AIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKR 479 (568)
Q Consensus 401 t~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 479 (568)
|+.|+|||. ....++.++||||+||++|+|++|+.||.+.+..+....+..+....|..+++.+.+||.+||..||++|
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 257 (294)
T 2rku_A 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 257 (294)
T ss_dssp CCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhC
Confidence 999999998 6677899999999999999999999999999988888888888888899999999999999999999999
Q ss_pred CCHHHHhcCcccccCCC
Q psy6203 480 IKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 480 ~t~~~~l~hp~~~~~~~ 496 (568)
||++++++||||.....
T Consensus 258 ps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 258 PTINELLNDEFFTSGYI 274 (294)
T ss_dssp CCGGGGGGSHHHHTSCC
T ss_pred cCHHHHhhChheecCCc
Confidence 99999999999986544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-21 Score=200.77 Aligned_cols=153 Identities=21% Similarity=0.337 Sum_probs=127.0
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++.....+++..+..++.|++.++ +++ +.+||+|||++.... .+.....
T Consensus 181 ~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~--~~~~~~~ 258 (365)
T 2y7j_A 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRE 258 (365)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC--TTCCBCC
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC--CCccccc
Confidence 334778888888778899999999999999853 333 357889999665432 2333456
Q ss_pred cccccccccCCC-------CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Q psy6203 398 LRSAIVLCSAPS-------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQ 466 (568)
Q Consensus 398 ~~gt~~~~~pe~-------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~ 466 (568)
.+||+.|+|||. ....|+.++|||||||++|+|++|++||.+.+....+..+..+.+.++ ...++.+.+
T Consensus 259 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 338 (365)
T 2y7j_A 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338 (365)
T ss_dssp CCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHH
T ss_pred CCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHH
Confidence 789999999996 134689999999999999999999999999988888888888776653 458899999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccc
Q psy6203 467 IVRSMLQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 467 li~~~L~~dp~~R~t~~~~l~hp~~~ 492 (568)
||.+||..||++|||++++++||||+
T Consensus 339 li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 339 LISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHcCCChhHCcCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-22 Score=203.73 Aligned_cols=185 Identities=21% Similarity=0.355 Sum_probs=110.1
Q ss_pred hHHHHHHHHhCCC--CCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCce
Q psy6203 340 MGVMLYALLCGFL--PFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 340 ~g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~~ 394 (568)
.|++|.+++...+ +|++..+..++.|++.++ +++. .+||+|||++.... ...
T Consensus 109 ~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~---~~~ 185 (336)
T 3fhr_A 109 EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNA 185 (336)
T ss_dssp TTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc---ccc
Confidence 4789999998653 799999999999999864 2332 37888999765432 122
Q ss_pred ecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCC----CCCCHHHH
Q psy6203 395 INLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL----YDKILNGKYTEP----PWMSPNSR 465 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~----~~~i~~~~~~~~----~~~s~~~~ 465 (568)
....+||+.|+|||. ....|+.++||||+||++|+|++|++||.+.+.... ...+..+....| ..+++++.
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK 265 (336)
T ss_dssp ------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHH
T ss_pred cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHH
Confidence 345688999999998 667789999999999999999999999987664433 233333333332 45899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCCCCCCCCCCChHHHHHHHhccCCCHHHHHHHHH
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPDDMWSQLN 527 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 527 (568)
+||.+||..||.+|||++|+++||||+........+...........+.+....+++.+.+.
T Consensus 266 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 327 (336)
T 3fhr_A 266 QLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSALA 327 (336)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBCSHHHHHHHTGGGHHHHHHHHHHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhcCccccccccCCCCccccccccccccchhhHHHHHHHHHHH
Confidence 99999999999999999999999999875544443333333344444433333344444433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=195.74 Aligned_cols=155 Identities=18% Similarity=0.194 Sum_probs=116.0
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|+.+.+++...+.+++..+..++.|+++++ +++ +.+||+|||.+..... ........+
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 163 (311)
T 4agu_A 85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEV 163 (311)
T ss_dssp SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----------
T ss_pred CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC-cccccCCCc
Confidence 3678888888888999999999999999864 333 4578899997654332 222345568
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------------CCCC
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---------------------KYTE 456 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~---------------------~~~~ 456 (568)
||+.|+|||. +...++.++||||+||++|+|++|++||.+.+..+....+... ..+.
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 4agu_A 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243 (311)
T ss_dssp --GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCC
T ss_pred CCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCC
Confidence 9999999997 5678999999999999999999999999998876665544321 0111
Q ss_pred C----------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 457 P----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 457 ~----------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
+ +.+++++.+||.+||..||.+|||++|+++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 1 34788999999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=9.8e-22 Score=202.41 Aligned_cols=152 Identities=19% Similarity=0.266 Sum_probs=119.2
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCC--ceecccc
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVG--QVINLLR 399 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~--~~~~~~~ 399 (568)
++|.+++.. +++++..+..++.|++.++ ++ .+++||+|||.+........ ......+
T Consensus 114 ~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 192 (364)
T 3qyz_A 114 TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192 (364)
T ss_dssp EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCC
T ss_pred cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccc
Confidence 567777775 5799999999999999864 33 34688999997754432211 1234568
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC--------------------C
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY--------------------T 455 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~--------------------~ 455 (568)
||+.|+|||. ....|+.++||||+||++|+|++|++||.+.+..+.+..+... .+ +
T Consensus 193 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (364)
T 3qyz_A 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLP 272 (364)
T ss_dssp SCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSC
T ss_pred cccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcC
Confidence 9999999996 6677999999999999999999999999998876666555421 00 0
Q ss_pred ---------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 456 ---------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 456 ---------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.++.+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 273 HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred CccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 114578999999999999999999999999999999865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.8e-22 Score=204.15 Aligned_cols=153 Identities=18% Similarity=0.258 Sum_probs=126.6
Q ss_pred hhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc----------eeEEEccccCcccccCCCCcee
Q psy6203 339 SMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI----------CTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 339 ~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~----------~~iki~dfG~~~~~~~~~~~~~ 395 (568)
..|++|.+++.. ...+++.++..++.|++.++ +++ ..+||+|||++.... .....
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~--~~~~~ 245 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKL 245 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC--TTCBC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC--Ccccc
Confidence 336777777654 45799999999999999863 232 357899999765432 22334
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRS 470 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~ 470 (568)
...+||+.|+|||. ....++.++||||+||++|+|++|++||.+.+..+.+..+....+.++ ..+++++.+||.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 55689999999998 777899999999999999999999999999999999888888766544 4589999999999
Q ss_pred ccCCCcCCCCCHHHHhcCccccc
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
||..||.+|||++|+++||||+.
T Consensus 326 ~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.9e-22 Score=194.13 Aligned_cols=152 Identities=25% Similarity=0.466 Sum_probs=128.1
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|.+++...+.+++..+..++.|++.++ +++ ..+||+|||.+.... .+....
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~--~~~~~~ 166 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMR 166 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC--TTSCBC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc--Cccchh
Confidence 3678888888778899999999999999864 233 357788999765432 233345
Q ss_pred ccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHcc
Q psy6203 397 LLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSRQIVRSML 472 (568)
Q Consensus 397 ~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L 472 (568)
...||+.|+|||.....++.++||||+||++|+|++|++||.+.+..+....+..+....|. .+++.+.+||.+||
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 246 (277)
T ss_dssp CCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHT
T ss_pred ccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHc
Confidence 67899999999983345899999999999999999999999999999999999888877764 68999999999999
Q ss_pred CCCcCCCCCHHHHhcCccccc
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~ 493 (568)
..||.+|||+.++++||||+.
T Consensus 247 ~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 247 TKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CSSTTTSCCHHHHTTSHHHHH
T ss_pred cCChhhCcCHHHHhcCHHHhc
Confidence 999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=192.81 Aligned_cols=152 Identities=24% Similarity=0.417 Sum_probs=127.0
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCceecc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|++|.+.+.....+++..+..++.|++.++ +++. .+||+|||.+.... .......
T Consensus 89 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~ 166 (284)
T 3kk8_A 89 GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHG 166 (284)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC--SSCBCCC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc--cCccccC
Confidence 677888887778899999999999999864 2222 37889999764432 2333455
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHcc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSML 472 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L 472 (568)
..||+.|+|||. ....++.++||||+||++|+|++|++||.+.+.......+..+....| ..+++++.+||.+||
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (284)
T 3kk8_A 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246 (284)
T ss_dssp SCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred CCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHc
Confidence 789999999998 667789999999999999999999999999998888888888766544 358999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccC
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..||++|||++|+++||||+..
T Consensus 247 ~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 247 TVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp CSSTTTSCCHHHHTTSHHHHSC
T ss_pred ccChhhCCCHHHHhcCccccCC
Confidence 9999999999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.3e-22 Score=204.75 Aligned_cols=150 Identities=20% Similarity=0.222 Sum_probs=114.8
Q ss_pred HHHHHHHHhCC--CCCChhhHHHHHHHHhhcc--------------Ccc----------eeEEEccccCcccccCCCCce
Q psy6203 341 GVMLYALLCGF--LPFDSDSIDQLYDKILSHF--------------MPI----------CTILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 341 g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~--------------~~~----------~~iki~dfG~~~~~~~~~~~~ 394 (568)
+++|.+++... ..+++..++.++.|++.++ +++ +.+||+|||++.... ..
T Consensus 139 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~----~~ 214 (382)
T 2vx3_A 139 SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG----QR 214 (382)
T ss_dssp CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT----CC
T ss_pred CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc----cc
Confidence 35777777653 5699999999999988753 222 347888999765432 22
Q ss_pred ecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------------
Q psy6203 395 INLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP---------------- 457 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~---------------- 457 (568)
....+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+.+..+.......|
T Consensus 215 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 294 (382)
T 2vx3_A 215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEK 294 (382)
T ss_dssp CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEE
T ss_pred cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHh
Confidence 356789999999998 666799999999999999999999999999988877776654211000
Q ss_pred --------------------C-C---------------------------CCHHHHHHHHHccCCCcCCCCCHHHHhcCc
Q psy6203 458 --------------------P-W---------------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHN 489 (568)
Q Consensus 458 --------------------~-~---------------------------~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 489 (568)
+ . .++++.+||.+||+.||++|||++|+++||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp 374 (382)
T 2vx3_A 295 LPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS 374 (382)
T ss_dssp CTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCc
Confidence 0 0 013688999999999999999999999999
Q ss_pred ccccC
Q psy6203 490 WVKMG 494 (568)
Q Consensus 490 ~~~~~ 494 (568)
||+..
T Consensus 375 ~f~~~ 379 (382)
T 2vx3_A 375 FFKKT 379 (382)
T ss_dssp GGCC-
T ss_pred ccccC
Confidence 99854
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-21 Score=200.18 Aligned_cols=151 Identities=26% Similarity=0.474 Sum_probs=121.0
Q ss_pred HHHHHHHHhC----CCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCc
Q psy6203 341 GVMLYALLCG----FLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQ 393 (568)
Q Consensus 341 g~~l~~~~~~----~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~ 393 (568)
|++|.+++.. ...+++..+..++.|++.++ +++. .+||+|||++..... .+.
T Consensus 110 g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~~~ 188 (351)
T 3c0i_A 110 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGL 188 (351)
T ss_dssp SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT-TSC
T ss_pred CCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecC-CCe
Confidence 5666555542 34699999999999999864 3332 278899997754432 222
Q ss_pred eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Q psy6203 394 VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIV 468 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li 468 (568)
.....+||+.|+|||. ....|+.++||||+||++|+|++|++||.+. ...++..+..+.+..+ ..+++++.+||
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 267 (351)
T 3c0i_A 189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLV 267 (351)
T ss_dssp BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 3456789999999998 6667899999999999999999999999886 4567777777776654 46899999999
Q ss_pred HHccCCCcCCCCCHHHHhcCccccc
Q psy6203 469 RSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 469 ~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
.+||..||++|||+.++++||||+.
T Consensus 268 ~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 268 RRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHCCCChhHCcCHHHHhcChhhcC
Confidence 9999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-21 Score=198.63 Aligned_cols=156 Identities=22% Similarity=0.358 Sum_probs=132.2
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++.....+++.++..++.|++.++ +++ +.+||+|||++...... +......+
T Consensus 124 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 202 (335)
T 2owb_A 124 RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLC 202 (335)
T ss_dssp TTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST-TCCBCCCC
T ss_pred CCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC-cccccccC
Confidence 3678888888778899999999999999864 333 36789999977554322 22345578
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. ....++.++|||||||++|+|++|+.||.+.+..+.+..+..+.+..|..+++.+.+||.+||..||++
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 282 (335)
T 2owb_A 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTA 282 (335)
T ss_dssp SCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhH
Confidence 9999999998 666789999999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCCHHHHhcCcccccCCC
Q psy6203 479 RIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 479 R~t~~~~l~hp~~~~~~~ 496 (568)
|||++|+++||||.....
T Consensus 283 Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 283 RPTINELLNDEFFTSGYI 300 (335)
T ss_dssp SCCGGGGGGSHHHHTSCC
T ss_pred CcCHHHHhcCccccCCCc
Confidence 999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.8e-21 Score=201.11 Aligned_cols=145 Identities=15% Similarity=0.192 Sum_probs=115.6
Q ss_pred hCCCCCChhhHHHHHHHHhhcc------------C---------cceeEEEccccCcccccCCCCceecccccccccccC
Q psy6203 349 CGFLPFDSDSIDQLYDKILSHF------------M---------PICTILISQYFPTILLPCKVGQVINLLRSAIVLCSA 407 (568)
Q Consensus 349 ~~~~~~~e~~~~~~~~qil~~~------------~---------~~~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~p 407 (568)
.....+++..++.++.|++.++ + ..+.+||+|||.+..... +......+||+.|+||
T Consensus 133 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~--~~~~~~~~~t~~y~aP 210 (394)
T 4e7w_A 133 KLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNVSYICSRYYRAP 210 (394)
T ss_dssp HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT--TCCCCSSCSCGGGCCH
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC--CCCCcccccCcCccCH
Confidence 3456899999999999998864 2 244688999997765432 2334567889999999
Q ss_pred CC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C---------------CC------------C
Q psy6203 408 PS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K---------------YT------------E 456 (568)
Q Consensus 408 e~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~---------------~~------------~ 456 (568)
|. +...|+.++||||+||++|||++|++||.+.+..+.+..+... . .. +
T Consensus 211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (394)
T 4e7w_A 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF 290 (394)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHS
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhc
Confidence 97 5567999999999999999999999999999877776665431 0 00 2
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 457 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 457 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
+..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred cccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 344789999999999999999999999999999998653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=199.74 Aligned_cols=154 Identities=18% Similarity=0.277 Sum_probs=117.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-------eEEEccccCcccccCCCC-ceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-------TILISQYFPTILLPCKVG-QVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-------~iki~dfG~~~~~~~~~~-~~~~~~~g 400 (568)
|++|.+++...+++++.++..++.|++.++ +++. .+||+|||++........ ......+|
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 171 (343)
T 3dbq_A 92 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 171 (343)
T ss_dssp SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC------------CC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccCCCCcC
Confidence 678999999888999999999999999864 4444 578899998765433222 12346689
Q ss_pred ccccccCCC-C-----------CCCCCCccceeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHcC--CCCCCCCCCHHHH
Q psy6203 401 AIVLCSAPS-S-----------KQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNG--KYTEPPWMSPNSR 465 (568)
Q Consensus 401 t~~~~~pe~-~-----------~~~~~~~~DiWSlG~il~eml~g~~pf~~~~-~~~~~~~i~~~--~~~~~~~~s~~~~ 465 (568)
|+.|+|||. . ...|+.++||||+||++|+|++|++||.+.. ....+..+... ...+|...++++.
T Consensus 172 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (343)
T 3dbq_A 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 251 (343)
T ss_dssp CCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHH
T ss_pred CcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 999999996 1 2678999999999999999999999998743 34445555543 3346777889999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+||.+||..||.+|||+.|+++||||+..
T Consensus 252 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 252 DVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 99999999999999999999999999854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-21 Score=200.63 Aligned_cols=148 Identities=18% Similarity=0.204 Sum_probs=116.1
Q ss_pred HHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccc---------------------------------
Q psy6203 341 GVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPI--------------------------------- 373 (568)
Q Consensus 341 g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~--------------------------------- 373 (568)
|++|.+++... ..+++.++..++.|++.++ +++
T Consensus 119 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (360)
T 3llt_A 119 GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198 (360)
T ss_dssp CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESC
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCC
Confidence 67888888754 3599999999999999864 333
Q ss_pred eeEEEccccCcccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q psy6203 374 CTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG 452 (568)
Q Consensus 374 ~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~ 452 (568)
..+||+|||++..... .....+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+.+..+...
T Consensus 199 ~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 274 (360)
T 3llt_A 199 TGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274 (360)
T ss_dssp CCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHh
Confidence 3467888997654221 2345689999999998 6677999999999999999999999999998877766665443
Q ss_pred CCCCC--------------------------C--------------------CCCHHHHHHHHHccCCCcCCCCCHHHHh
Q psy6203 453 KYTEP--------------------------P--------------------WMSPNSRQIVRSMLQVEPGKRIKIQDLL 486 (568)
Q Consensus 453 ~~~~~--------------------------~--------------------~~s~~~~~li~~~L~~dp~~R~t~~~~l 486 (568)
..+.| . ..++.+.+||.+||+.||.+|||++|++
T Consensus 275 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 275 IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354 (360)
T ss_dssp TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 22222 1 1236778999999999999999999999
Q ss_pred cCcccc
Q psy6203 487 GHNWVK 492 (568)
Q Consensus 487 ~hp~~~ 492 (568)
+||||+
T Consensus 355 ~hp~f~ 360 (360)
T 3llt_A 355 KHKFLE 360 (360)
T ss_dssp TSGGGC
T ss_pred cCcccC
Confidence 999995
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=5.9e-22 Score=204.64 Aligned_cols=149 Identities=17% Similarity=0.286 Sum_probs=107.8
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccccc
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSA 401 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt 401 (568)
+.+.+++.. .+++..+..++.|++.++ +++ +.+||+|||++.... ........+||
T Consensus 114 ~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~--~~~~~~~~~gt 189 (371)
T 2xrw_A 114 ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 189 (371)
T ss_dssp EEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------------------
T ss_pred CCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc--cccccCCceec
Confidence 346666653 589999999999999864 333 467899999765432 22234557899
Q ss_pred cccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------------------
Q psy6203 402 IVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE------------------------ 456 (568)
Q Consensus 402 ~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~------------------------ 456 (568)
+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+.+..+.......
T Consensus 190 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (371)
T 2xrw_A 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG 269 (371)
T ss_dssp CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCC
T ss_pred CCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccc
Confidence 99999998 66779999999999999999999999999999888777776532111
Q ss_pred ------------CCC------CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 457 ------------PPW------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 457 ------------~~~------~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
|.. .++++++||.+||+.||.+|||++|+++||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 270 YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 000 15678999999999999999999999999999854
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.84 E-value=4.2e-21 Score=196.26 Aligned_cols=154 Identities=14% Similarity=0.145 Sum_probs=120.1
Q ss_pred HHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccccc
Q psy6203 343 MLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSA 401 (568)
Q Consensus 343 ~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt 401 (568)
.+.+++.. ...+++..+..++.|+++++ +++ +.+||+|||++..... ........+||
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~t 175 (346)
T 1ua2_A 97 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVT 175 (346)
T ss_dssp EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-CCCCCCCSCCC
T ss_pred CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC-CcccCCccccc
Confidence 56566654 35799999999999998764 333 4678999997755432 22234567899
Q ss_pred cccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---C------------------
Q psy6203 402 IVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT---E------------------ 456 (568)
Q Consensus 402 ~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~---~------------------ 456 (568)
+.|+|||. +...|+.++||||+||++|+|++|.+||.+.+..+.+..+... .+. .
T Consensus 176 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (346)
T 1ua2_A 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 255 (346)
T ss_dssp CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCC
T ss_pred ccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCC
Confidence 99999997 5567999999999999999999999999999988877776542 110 0
Q ss_pred -----CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCC
Q psy6203 457 -----PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 497 (568)
Q Consensus 457 -----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 497 (568)
....++++.+||.+||..||.+|||++|+++||||+..+..
T Consensus 256 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 256 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred ChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 03457899999999999999999999999999999865443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3e-21 Score=195.69 Aligned_cols=154 Identities=18% Similarity=0.238 Sum_probs=121.3
Q ss_pred HHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Cc-----------ceeEEEccccCcccccCCCCcee
Q psy6203 341 GVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MP-----------ICTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 341 g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~-----------~~~iki~dfG~~~~~~~~~~~~~ 395 (568)
|++|.+++.. ...+++..+..++.|++.++ ++ .+.+||+|||++.... .....
T Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~--~~~~~ 190 (327)
T 3lm5_A 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACEL 190 (327)
T ss_dssp TEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--------
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC--Ccccc
Confidence 5677777754 36799999999999999864 22 3468899999765432 22234
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRS 470 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~ 470 (568)
...+||+.|+|||. ....++.++||||+||++|+|++|++||.+.+..+....+.......+ ..+++.+.+||.+
T Consensus 191 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 270 (327)
T 3lm5_A 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQS 270 (327)
T ss_dssp ---CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHH
Confidence 55689999999998 667899999999999999999999999999998888877776654432 4588999999999
Q ss_pred ccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
||..||.+|||++++++||||+....
T Consensus 271 ~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 271 LLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HcCCChhhCcCHHHHhCCHhhccccc
Confidence 99999999999999999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.9e-21 Score=198.58 Aligned_cols=149 Identities=13% Similarity=0.167 Sum_probs=119.4
Q ss_pred HHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc---------ceeEEEccccCcccccCCCCceecccccc
Q psy6203 343 MLYALLCGFLPFDSDSIDQLYDKILSHF------------MP---------ICTILISQYFPTILLPCKVGQVINLLRSA 401 (568)
Q Consensus 343 ~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~---------~~~iki~dfG~~~~~~~~~~~~~~~~~gt 401 (568)
.+..++.....+++..++.++.|++.++ ++ .+.+||+|||.+..... +......+||
T Consensus 127 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t 204 (383)
T 3eb0_A 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICS 204 (383)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT--TSCCCCCCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC--CCCCcCcccC
Confidence 4455566678999999999999999864 22 34689999997754432 2234566889
Q ss_pred cccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C---------------CC-------
Q psy6203 402 IVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K---------------YT------- 455 (568)
Q Consensus 402 ~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~---------------~~------- 455 (568)
+.|+|||. +...|+.++||||+||++|+|++|++||.+.+..+.+..+... . ..
T Consensus 205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 284 (383)
T 3eb0_A 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284 (383)
T ss_dssp SSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCC
T ss_pred CCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcc
Confidence 99999997 5567999999999999999999999999999887777666431 0 01
Q ss_pred -----CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 456 -----EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 456 -----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+|...++++.+||.+||..||.+|||+.|+++||||+.
T Consensus 285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred cHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 34457899999999999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=7.3e-21 Score=199.66 Aligned_cols=145 Identities=16% Similarity=0.181 Sum_probs=114.9
Q ss_pred HhCCCCCChhhHHHHHHHHhhcc------------Ccc---------eeEEEccccCcccccCCCCceeccccccccccc
Q psy6203 348 LCGFLPFDSDSIDQLYDKILSHF------------MPI---------CTILISQYFPTILLPCKVGQVINLLRSAIVLCS 406 (568)
Q Consensus 348 ~~~~~~~~e~~~~~~~~qil~~~------------~~~---------~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~ 406 (568)
......+++..++.++.|++.++ +++ +.+||+|||++..... +......+||+.|+|
T Consensus 147 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~t~~y~a 224 (420)
T 1j1b_A 147 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRA 224 (420)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT--TCCCCSCCSCTTSCC
T ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc--CCCceeeeeCCCcCC
Confidence 34467899999999999998764 332 3579999998765432 223455789999999
Q ss_pred CCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------CCC------------
Q psy6203 407 APS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-----------------KYT------------ 455 (568)
Q Consensus 407 pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~-----------------~~~------------ 455 (568)
||. +...|+.++||||+||++|||++|++||.+.+..+.+..+... .+.
T Consensus 225 PE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 304 (420)
T 1j1b_A 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 304 (420)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHH
T ss_pred HHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHh
Confidence 997 4568999999999999999999999999999877766655431 111
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 456 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 456 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+++..++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 305 ~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 305 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 224568999999999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-21 Score=192.79 Aligned_cols=151 Identities=21% Similarity=0.431 Sum_probs=125.9
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc-----------ceeEEEccccCcccccCCCCceecc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP-----------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~-----------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|++|.+++...+.+++..+..++.|++.++ ++ ...+||+|||++.... ......
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~ 166 (304)
T 2jam_A 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMST 166 (304)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC---CBTTHH
T ss_pred CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC---CCcccc
Confidence 678888887778899999999999999863 22 3357788999664322 112345
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHcc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSML 472 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L 472 (568)
.+||+.|+|||. .+..++.++||||+||++|+|++|.+||.+.+...+...+..+.+.++ ..+++++.+||.+||
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (304)
T 2jam_A 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246 (304)
T ss_dssp HHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHH
T ss_pred ccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHc
Confidence 679999999998 667789999999999999999999999999998888888888765543 458999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccC
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..||.+|||++++++||||...
T Consensus 247 ~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 247 EKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999854
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-21 Score=191.45 Aligned_cols=151 Identities=20% Similarity=0.348 Sum_probs=116.6
Q ss_pred HHHHHHHHhC----CCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCCc
Q psy6203 341 GVMLYALLCG----FLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVGQ 393 (568)
Q Consensus 341 g~~l~~~~~~----~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~~ 393 (568)
|++|.+++.. ...+++..+..++.|++.++ +++ ..+||+|||.+..... ..
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~--~~ 181 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DE 181 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC--cc
Confidence 4566666532 36899999999999999864 233 3478899997654322 22
Q ss_pred eecccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCHHHHHHHHH
Q psy6203 394 VINLLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP---PWMSPNSRQIVRS 470 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~s~~~~~li~~ 470 (568)
.....+||+.|+|||.....++.++||||+||++|+|++|+.||.+.+..+....+.......+ ..+++++.+||.+
T Consensus 182 ~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261 (285)
T ss_dssp -----CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHH
T ss_pred cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHH
Confidence 3456689999999998445688999999999999999999999999988888777766655433 3378999999999
Q ss_pred ccCCCcCCCCCHHHHhcCccccc
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
||..||++|||+.|+++||||+.
T Consensus 262 ~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 262 MLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-21 Score=202.68 Aligned_cols=152 Identities=22% Similarity=0.390 Sum_probs=115.9
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++...+++++..+..++.|++.++ +++. .+||+|||++.... ......
T Consensus 222 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~--~~~~~~ 299 (419)
T 3i6u_A 222 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 299 (419)
T ss_dssp TTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------
T ss_pred CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC--CCcccc
Confidence 3678888888888999999999999999864 3332 38889999775532 233356
Q ss_pred ccccccccccCCC----CCCCCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCC----CCCCHHHHHH
Q psy6203 397 LLRSAIVLCSAPS----SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYTEP----PWMSPNSRQI 467 (568)
Q Consensus 397 ~~~gt~~~~~pe~----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~-~~~~~~i~~~~~~~~----~~~s~~~~~l 467 (568)
+.+||+.|+|||. ....|+.++||||+||++|+|++|++||.+... ..+...+..+.+.++ ..+++.+.+|
T Consensus 300 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 379 (419)
T 3i6u_A 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 379 (419)
T ss_dssp -----CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred ccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHH
Confidence 6789999999997 246788999999999999999999999987543 345566666666543 4589999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 468 VRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 468 i~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
|.+||..||.+|||++|+++||||+.
T Consensus 380 i~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 380 VKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHccCChhHCcCHHHHhCCcccCC
Confidence 99999999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-21 Score=196.15 Aligned_cols=146 Identities=23% Similarity=0.417 Sum_probs=119.1
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|.+|.+++.....+++..+..++.|++.++ +++ +.+||+|||.+.... .+......+|
T Consensus 114 g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~~~g 191 (335)
T 3dls_A 114 GLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFCG 191 (335)
T ss_dssp SCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--TTCCBCEECS
T ss_pred CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC--CCCceeccCC
Confidence 448889999888999999999999999864 333 357889999765432 2333456789
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
|+.|+|||. +..+++.++||||+||++|+|++|.+||.... .........|..+++++.+||.+||..||.+
T Consensus 192 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 265 (335)
T 3dls_A 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSLVSGLLQPVPER 265 (335)
T ss_dssp CGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred CccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHHHHHHHccCChhh
Confidence 999999997 55556899999999999999999999997642 2334445567779999999999999999999
Q ss_pred CCCHHHHhcCcccccC
Q psy6203 479 RIKIQDLLGHNWVKMG 494 (568)
Q Consensus 479 R~t~~~~l~hp~~~~~ 494 (568)
|||++++++||||+..
T Consensus 266 Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 266 RTTLEKLVTDPWVTQP 281 (335)
T ss_dssp SCCHHHHHHCTTTTCC
T ss_pred CcCHHHHhcCccccCC
Confidence 9999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.7e-21 Score=200.25 Aligned_cols=144 Identities=16% Similarity=0.240 Sum_probs=101.1
Q ss_pred CCChhhHHHHHHHHhhcc------------Ccc------------eeEEEccccCcccccCCC--Cceeccccccccccc
Q psy6203 353 PFDSDSIDQLYDKILSHF------------MPI------------CTILISQYFPTILLPCKV--GQVINLLRSAIVLCS 406 (568)
Q Consensus 353 ~~~e~~~~~~~~qil~~~------------~~~------------~~iki~dfG~~~~~~~~~--~~~~~~~~gt~~~~~ 406 (568)
.+++..++.++.|++.++ +++ +.+||+|||++....... .......+||+.|+|
T Consensus 124 ~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a 203 (405)
T 3rgf_A 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203 (405)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccC
Confidence 599999999999999864 333 357789999776543211 123456789999999
Q ss_pred CCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH---------HHHHHHHc--CCCCCC----------------
Q psy6203 407 APS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---------QLYDKILN--GKYTEP---------------- 457 (568)
Q Consensus 407 pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~---------~~~~~i~~--~~~~~~---------------- 457 (568)
||. +...|+.++||||+||++|+|++|++||.+.+.. +.+..+.. +.+...
T Consensus 204 PE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 283 (405)
T 3rgf_A 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMK 283 (405)
T ss_dssp HHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHH
T ss_pred chhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhh
Confidence 997 4467999999999999999999999999876542 33343332 111110
Q ss_pred --------------------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 458 --------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 458 --------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
...++.+.+||.+||..||.+|||++|+++||||...+.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 284 DFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred hccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 112778999999999999999999999999999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.9e-21 Score=195.23 Aligned_cols=150 Identities=19% Similarity=0.251 Sum_probs=115.0
Q ss_pred HHHHHHHHhCCC--CCChhhHHHHHHHHhhcc------------Ccce---------------------------eEEEc
Q psy6203 341 GVMLYALLCGFL--PFDSDSIDQLYDKILSHF------------MPIC---------------------------TILIS 379 (568)
Q Consensus 341 g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~------------~~~~---------------------------~iki~ 379 (568)
|++|.+++...+ ++++..+..++.|++.++ +++. .+||+
T Consensus 100 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 179 (339)
T 1z57_A 100 GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179 (339)
T ss_dssp CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEEC
T ss_pred CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEe
Confidence 577777777544 799999999999999864 3333 36788
Q ss_pred cccCcccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-
Q psy6203 380 QYFPTILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP- 457 (568)
Q Consensus 380 dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~- 457 (568)
|||.+.... ......+||+.|+|||. .+..|+.++||||+||++|||++|.+||.+.+..+....+.....+.|
T Consensus 180 Dfg~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~ 255 (339)
T 1z57_A 180 DFGSATYDD----EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK 255 (339)
T ss_dssp CCSSCEETT----SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCH
T ss_pred eCcccccCc----cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999765422 12345689999999998 667799999999999999999999999999887665544322111111
Q ss_pred -------------------------------------------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 458 -------------------------------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 458 -------------------------------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
...++++.+||.+||..||.+|||++|+++||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 256 HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 1124678899999999999999999999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=193.31 Aligned_cols=154 Identities=17% Similarity=0.262 Sum_probs=116.4
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCc--------
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQ-------- 393 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~-------- 393 (568)
++|.+++.. +.+++..+..++.|++.++ ++ .+++||+|||++.........
T Consensus 98 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 176 (353)
T 2b9h_A 98 TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176 (353)
T ss_dssp EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-------------
T ss_pred ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccc
Confidence 456667665 5799999999999999864 33 346789999977543221110
Q ss_pred -eecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC--------------
Q psy6203 394 -VINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKY-------------- 454 (568)
Q Consensus 394 -~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~--~~~-------------- 454 (568)
.....+||+.|+|||. ....++.++||||+||++|+|++|++||.+.+..+.+..+.. +.+
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 2b9h_A 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256 (353)
T ss_dssp ---CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHH
T ss_pred cchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchh
Confidence 1234588999999997 567899999999999999999999999999887665544432 100
Q ss_pred --------C--------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 455 --------T--------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 455 --------~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
. .++.+++++.+||.+||..||++|||++|+++||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 0 11357899999999999999999999999999999986543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.7e-21 Score=194.60 Aligned_cols=152 Identities=18% Similarity=0.225 Sum_probs=114.9
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|+.+.+++.....+++..+..++.|++.++ +++ +.+||+|||.+..... .+......+|
T Consensus 108 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~ 186 (331)
T 4aaa_A 108 HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA 186 (331)
T ss_dssp EEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------CCC
T ss_pred cchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC-CccccCCCcC
Confidence 677777777778899999999999999864 333 3678899997654322 2233456689
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C-----------------CCC---
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K-----------------YTE--- 456 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~-----------------~~~--- 456 (568)
|+.|+|||. +...++.++||||+||++|+|++|++||.+.+..+.+..+... . ...
T Consensus 187 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
T 4aaa_A 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEI 266 (331)
T ss_dssp CCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCC
T ss_pred CccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccc
Confidence 999999997 4457999999999999999999999999998877665554321 0 001
Q ss_pred ---------CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 457 ---------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 457 ---------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
.+.+++.+.+||.+||..||++|||++|+++||||+.
T Consensus 267 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 267 KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 1247899999999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.82 E-value=7.2e-21 Score=188.46 Aligned_cols=151 Identities=23% Similarity=0.374 Sum_probs=123.4
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce------------eEEEccccCcccccCCCCceec
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC------------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~------------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|++|.+++....++++..+..++.|++.++ +++. .+||+|||.+.... .+....
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~--~~~~~~ 169 (283)
T 3bhy_A 92 GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEFK 169 (283)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc--CCCccc
Confidence 688888888778899999999999999864 2322 47889999665432 222334
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
...||+.|+|||. ....++.++||||+||++|+|++|..||.+.+..+....+.......+ ...++.+.+||.+|
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 249 (283)
T 3bhy_A 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRL 249 (283)
T ss_dssp --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTT
T ss_pred ccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHH
Confidence 5679999999998 667789999999999999999999999999998888888887766554 56889999999999
Q ss_pred cCCCcCCCCCHHHHhcCccccc
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
|..||.+|||+.++++||||+.
T Consensus 250 l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 250 LVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHH
T ss_pred ccCCHhHCcCHHHHHhCHHHHH
Confidence 9999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=188.15 Aligned_cols=150 Identities=15% Similarity=0.260 Sum_probs=118.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------Cc---------ceeEEEccccCcccccCCCCceecc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------MP---------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------~~---------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|++|.+++...+.+++..+..++.|++.++ ++ .+.+||+|||.+..... .....
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~---~~~~~ 189 (290)
T 1t4h_A 113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKA 189 (290)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSBEE
T ss_pred CCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc---ccccc
Confidence 678888888778899999999999988753 22 23578889996643221 22345
Q ss_pred cccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYT--EPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~-~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~~L~~ 474 (568)
..||+.|+|||.....++.++||||+||++|+|++|+.||.+. +.......+..+..+ .+...++++.+||.+||..
T Consensus 190 ~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 269 (290)
T 1t4h_A 190 VIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269 (290)
T ss_dssp SCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred ccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccC
Confidence 6899999999984456899999999999999999999999884 455555555555333 3556789999999999999
Q ss_pred CcCCCCCHHHHhcCccccc
Q psy6203 475 EPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 475 dp~~R~t~~~~l~hp~~~~ 493 (568)
||.+|||++++++||||+.
T Consensus 270 dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 270 NKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SGGGSCCHHHHHTSGGGC-
T ss_pred ChhhCCCHHHHhhCccccc
Confidence 9999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=187.94 Aligned_cols=153 Identities=21% Similarity=0.326 Sum_probs=127.0
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++.....+++..+..++.|++.++ ++ .+.+||+|||.+.... .+.......
T Consensus 107 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~--~~~~~~~~~ 184 (298)
T 1phk_A 107 KKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVC 184 (298)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC--TTCCBCCCC
T ss_pred CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC--CCccccccc
Confidence 3678888988878999999999999999864 22 3468899999765432 233345678
Q ss_pred cccccccCCC-------CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Q psy6203 400 SAIVLCSAPS-------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIV 468 (568)
Q Consensus 400 gt~~~~~pe~-------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li 468 (568)
||+.|+|||. ....++.++||||+||++|+|++|..||.+.+.......+..+.+.++ ..+++.+.+||
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 264 (298)
T 1phk_A 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264 (298)
T ss_dssp SCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHH
T ss_pred CCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHH
Confidence 9999999996 245689999999999999999999999999998888888888766543 24789999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 469 RSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 469 ~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.+||..||.+|||++++++||||+..
T Consensus 265 ~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 265 SRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHccCCcccCCCHHHHHhChHhhhc
Confidence 99999999999999999999999854
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.7e-20 Score=186.47 Aligned_cols=145 Identities=23% Similarity=0.413 Sum_probs=121.1
Q ss_pred CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccC-CCCceecccccccccccCCC
Q psy6203 351 FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPC-KVGQVINLLRSAIVLCSAPS 409 (568)
Q Consensus 351 ~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~-~~~~~~~~~~gt~~~~~pe~ 409 (568)
...+++..+..++.|++.++ +++ +.+||+|||++..... ..........||+.|+|||.
T Consensus 103 ~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 182 (305)
T 2wtk_C 103 EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182 (305)
T ss_dssp TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHH
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhh
Confidence 45799999999999998764 333 3578899997654322 12233456689999999997
Q ss_pred -C--CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHh
Q psy6203 410 -S--KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 486 (568)
Q Consensus 410 -~--~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 486 (568)
. ...++.++||||+||++|+|++|+.||.+.+..+....+..+.+..|..+++.+.+||.+||..||.+|||+++++
T Consensus 183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 262 (305)
T 2wtk_C 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIR 262 (305)
T ss_dssp HTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 3 3345789999999999999999999999999999999999998888989999999999999999999999999999
Q ss_pred cCcccccCC
Q psy6203 487 GHNWVKMGP 495 (568)
Q Consensus 487 ~hp~~~~~~ 495 (568)
+||||+...
T Consensus 263 ~~~~~~~~~ 271 (305)
T 2wtk_C 263 QHSWFRKKH 271 (305)
T ss_dssp HSHHHHSCC
T ss_pred cCcccccCC
Confidence 999998653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.3e-21 Score=194.60 Aligned_cols=143 Identities=20% Similarity=0.298 Sum_probs=112.1
Q ss_pred CCChhhHHHHHHHHhhcc------------Ccce----------eEEEccccCcccccCCC-C--ceecccccccccccC
Q psy6203 353 PFDSDSIDQLYDKILSHF------------MPIC----------TILISQYFPTILLPCKV-G--QVINLLRSAIVLCSA 407 (568)
Q Consensus 353 ~~~e~~~~~~~~qil~~~------------~~~~----------~iki~dfG~~~~~~~~~-~--~~~~~~~gt~~~~~p 407 (568)
.+++..+..++.|++.++ +++. .+||+|||.+....... + .......||+.|+||
T Consensus 164 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 164 VQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred cccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 356788888999998864 2322 58899999775432211 1 123566899999999
Q ss_pred CC---CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHccCCCcCCCC
Q psy6203 408 PS---SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSRQIVRSMLQVEPGKRI 480 (568)
Q Consensus 408 e~---~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~ 480 (568)
|. ....|+.++||||+||++|+|++|++||.+.+..+....+......++. .+++++.+||.+||..||.+||
T Consensus 244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 97 2368999999999999999999999999999988888888877655432 3799999999999999999999
Q ss_pred CHHHHhcCcccccCC
Q psy6203 481 KIQDLLGHNWVKMGP 495 (568)
Q Consensus 481 t~~~~l~hp~~~~~~ 495 (568)
|+.++++||||+...
T Consensus 324 s~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 324 DAMRALQHPWISQFS 338 (345)
T ss_dssp CHHHHHHSHHHHTTS
T ss_pred CHHHHhcChhhccCh
Confidence 999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-20 Score=186.51 Aligned_cols=154 Identities=18% Similarity=0.315 Sum_probs=118.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCC-Cceecccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKV-GQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~-~~~~~~~~ 399 (568)
|++|.+++.....+++..+..++.|++.++ ++ .+.+||+|||.+....... .......+
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 168 (276)
T 2yex_A 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168 (276)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCC
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCc
Confidence 677888888778899999999999999864 23 3467889999765432211 12234568
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCC--CCCCCHHHHHHHHHccCC
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTE--PPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~-~~~~~i~~~~~~~--~~~~s~~~~~li~~~L~~ 474 (568)
||+.|+|||. +..+++.++||||+||++|+|++|+.||.+.+.. ..+..+....... +..+++.+.+||.+||..
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 248 (276)
T 2yex_A 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 248 (276)
T ss_dssp SCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred cccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCC
Confidence 9999999998 4455688999999999999999999999876543 3334444433322 345899999999999999
Q ss_pred CcCCCCCHHHHhcCcccccC
Q psy6203 475 EPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 475 dp~~R~t~~~~l~hp~~~~~ 494 (568)
||.+|||++|+++||||+..
T Consensus 249 ~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 249 NPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp STTTSCCHHHHTTCTTTTCC
T ss_pred CchhCCCHHHHhcCccccCh
Confidence 99999999999999999854
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.8e-21 Score=192.78 Aligned_cols=153 Identities=14% Similarity=0.162 Sum_probs=115.0
Q ss_pred HHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 341 GVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 341 g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
|++|.+++... ..+++..+..++.|++.++ ++ .+++||+|||++.......+ .....
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 189 (326)
T 2x7f_A 111 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTF 189 (326)
T ss_dssp TEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------
T ss_pred CCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc-ccccc
Confidence 67888887753 5799999999999999864 23 34678899997654322211 23456
Q ss_pred ccccccccCCC-C-----CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Q psy6203 399 RSAIVLCSAPS-S-----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQIVRS 470 (568)
Q Consensus 399 ~gt~~~~~pe~-~-----~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~ 470 (568)
.||+.|+|||. . ...++.++|||||||++|+|++|.+||.+.+.......+.....+ .+..+++.+.+||.+
T Consensus 190 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 269 (326)
T 2x7f_A 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIES 269 (326)
T ss_dssp -CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHH
T ss_pred cCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHH
Confidence 89999999997 2 567899999999999999999999999998877776666555433 245689999999999
Q ss_pred ccCCCcCCCCCHHHHhcCcccccC
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
||..||.+|||++++++||||+..
T Consensus 270 ~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 270 CLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HhccChhhCCCHHHHhhChHHhhC
Confidence 999999999999999999999854
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.9e-21 Score=193.62 Aligned_cols=150 Identities=15% Similarity=0.217 Sum_probs=112.6
Q ss_pred HHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccce---------------------------eEEEc
Q psy6203 341 GVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPIC---------------------------TILIS 379 (568)
Q Consensus 341 g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~~---------------------------~iki~ 379 (568)
++.+.+++... .++++..+..++.|++.++ +++. .+||+
T Consensus 105 ~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 184 (355)
T 2eu9_A 105 GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184 (355)
T ss_dssp CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEEC
T ss_pred CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEe
Confidence 34555555433 4799999999999999864 3333 45678
Q ss_pred cccCcccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-
Q psy6203 380 QYFPTILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP- 457 (568)
Q Consensus 380 dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~- 457 (568)
|||.+.... ......+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+.+..+.....+.|
T Consensus 185 Dfg~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~ 260 (355)
T 2eu9_A 185 DFGSATFDH----EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPS 260 (355)
T ss_dssp CCTTCEETT----SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCcccccc----ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcH
Confidence 999765422 12345689999999998 667799999999999999999999999999887665444332111111
Q ss_pred -------------------------------------------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 458 -------------------------------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 458 -------------------------------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
...++++.+||.+||..||++|||++|+++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 261 HMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 0124578899999999999999999999999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=7.9e-21 Score=188.78 Aligned_cols=152 Identities=22% Similarity=0.396 Sum_probs=124.0
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCCceecc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|++|.+++.....+++..+..++.|++.++ +++ +.+||+|||.+..... ......
T Consensus 105 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~--~~~~~~ 182 (287)
T 2wei_A 105 GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKD 182 (287)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC--CSSCSC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC--CCcccc
Confidence 677777777667899999999999999864 222 2578899997654322 222345
Q ss_pred cccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHccC
Q psy6203 398 LRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 398 ~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~ 473 (568)
..||+.|+|||.....++.++||||+||++|+|++|.+||.+.+..+....+..+.+.++ ..+++++.+||.+||.
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 262 (287)
T 2wei_A 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262 (287)
T ss_dssp HHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred ccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcc
Confidence 578999999998333489999999999999999999999999998888888888766543 4589999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccC
Q psy6203 474 VEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 474 ~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.||.+|||++++++||||+..
T Consensus 263 ~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 263 FHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp SSGGGSCCHHHHHHSHHHHHH
T ss_pred cChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.8e-20 Score=188.87 Aligned_cols=153 Identities=15% Similarity=0.177 Sum_probs=118.3
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc---------eeEEEccccCcccccCCC--Cceeccc
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI---------CTILISQYFPTILLPCKV--GQVINLL 398 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~---------~~iki~dfG~~~~~~~~~--~~~~~~~ 398 (568)
++|.+++.. +++++..+..++.|++.++ +++ ..+||+|||.+....... .......
T Consensus 106 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 184 (320)
T 2i6l_A 106 TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184 (320)
T ss_dssp EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGG
T ss_pred CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccc
Confidence 467777765 6899999999999998764 222 367899999765432211 1123445
Q ss_pred ccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------------
Q psy6203 399 RSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--------------------- 455 (568)
Q Consensus 399 ~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~--------------------- 455 (568)
.+|+.|+|||. ....++.++||||+||++|+|++|++||.+.+..+.+..+......
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (320)
T 2i6l_A 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDM 264 (320)
T ss_dssp GSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHT
T ss_pred cccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccc
Confidence 77999999997 5578999999999999999999999999998877776665543211
Q ss_pred ---------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 456 ---------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 456 ---------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
.++.+++++.+||.+||..||.+|||++|+++||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 265 TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp TSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred cCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 1245899999999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=8.6e-21 Score=194.03 Aligned_cols=148 Identities=18% Similarity=0.165 Sum_probs=118.6
Q ss_pred HHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 342 VMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 342 ~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
+.+.+++. ...++++.++..++.|++.++ +++ +.+||+|||++..... ....+|
T Consensus 138 g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~~~~~g 212 (348)
T 1u5q_A 138 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVG 212 (348)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCS
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----CCcccC
Confidence 34555553 356899999999999998764 333 4678999997654321 235689
Q ss_pred ccccccCCC----CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHccCC
Q psy6203 401 AIVLCSAPS----SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 401 t~~~~~pe~----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~~L~~ 474 (568)
|+.|+|||. ....|+.++||||+||++|||++|++||.+.+.......+..+..+ .+..+++.+.+||.+||..
T Consensus 213 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 292 (348)
T 1u5q_A 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292 (348)
T ss_dssp CGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccc
Confidence 999999996 3567899999999999999999999999998877777666665433 3456899999999999999
Q ss_pred CcCCCCCHHHHhcCcccccC
Q psy6203 475 EPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 475 dp~~R~t~~~~l~hp~~~~~ 494 (568)
||++|||++++++||||...
T Consensus 293 dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 293 IPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp SGGGSCCHHHHTTCHHHHSC
T ss_pred ChhhCcCHHHHhhChhhhcc
Confidence 99999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3e-20 Score=191.74 Aligned_cols=147 Identities=18% Similarity=0.252 Sum_probs=112.9
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccccc
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSA 401 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt 401 (568)
++|.+++.. .+++..+..++.|++.++ +++ +.+||+|||++.... ......+||
T Consensus 131 ~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~----~~~~~~~~t 204 (371)
T 4exu_A 131 TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVT 204 (371)
T ss_dssp EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCC
T ss_pred ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc----cCcCCcccC
Confidence 456566643 599999999999999864 333 357889999765322 223456889
Q ss_pred cccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C---------------------C-
Q psy6203 402 IVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--Y---------------------T- 455 (568)
Q Consensus 402 ~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~--~---------------------~- 455 (568)
+.|+|||. +...++.++||||+||++|+|++|++||.+.+..+.+..+.... + .
T Consensus 205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (371)
T 4exu_A 205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 284 (371)
T ss_dssp CTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCC
T ss_pred ccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCC
Confidence 99999997 44789999999999999999999999999988777766654310 0 0
Q ss_pred -------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 456 -------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 456 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.++..++++.+||.+||+.||++|||++|+++||||+..
T Consensus 285 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 285 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 123468999999999999999999999999999999854
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.3e-20 Score=188.89 Aligned_cols=149 Identities=13% Similarity=0.139 Sum_probs=114.2
Q ss_pred HHHhCCCCCChhhHHHHHHHHhhcc--------------Cc---------ceeEEEccccCcccccCCCCceeccccccc
Q psy6203 346 ALLCGFLPFDSDSIDQLYDKILSHF--------------MP---------ICTILISQYFPTILLPCKVGQVINLLRSAI 402 (568)
Q Consensus 346 ~~~~~~~~~~e~~~~~~~~qil~~~--------------~~---------~~~iki~dfG~~~~~~~~~~~~~~~~~gt~ 402 (568)
.+......+++..+..++.|++.++ ++ .+.+||+|||++..... .......+||+
T Consensus 118 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~ 195 (360)
T 3e3p_A 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVAYICSR 195 (360)
T ss_dssp HHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCT--TSCCCSTTSCG
T ss_pred HHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCC--CCCcccccCCc
Confidence 4455667888888888888887642 22 34688999997654332 22334568899
Q ss_pred ccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------------------
Q psy6203 403 VLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-------------------------- 454 (568)
Q Consensus 403 ~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~-------------------------- 454 (568)
.|+|||. +...++.++||||+||++|+|++|++||.+.+....+..+.....
T Consensus 196 ~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
T 3e3p_A 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIP 275 (360)
T ss_dssp GGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCC
T ss_pred ceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCC
Confidence 9999997 556799999999999999999999999999988777766643110
Q ss_pred ------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 455 ------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 455 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
..+...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 276 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 276 WSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 011225678999999999999999999999999999986543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-20 Score=192.45 Aligned_cols=140 Identities=20% Similarity=0.388 Sum_probs=114.0
Q ss_pred CCCCChhhHHHHHHHHhhcc-------------Cc--------ceeEEEccccCcccccCCCCceecccccccccccCCC
Q psy6203 351 FLPFDSDSIDQLYDKILSHF-------------MP--------ICTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS 409 (568)
Q Consensus 351 ~~~~~e~~~~~~~~qil~~~-------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~ 409 (568)
..++++..+..++.|++.++ ++ .+.+||+|||.+...... ......||+.|+|||.
T Consensus 145 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~ 221 (348)
T 2pml_X 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEF 221 (348)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGG
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchh
Confidence 57899999999999888653 22 236788999976543221 3456789999999998
Q ss_pred --CCCCCCC-ccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCC-------------------CCCCHHHHH
Q psy6203 410 --SKQYYGS-ETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYTEP-------------------PWMSPNSRQ 466 (568)
Q Consensus 410 --~~~~~~~-~~DiWSlG~il~eml~g~~pf~~~~~-~~~~~~i~~~~~~~~-------------------~~~s~~~~~ 466 (568)
+...++. ++||||+||++|+|++|++||.+.+. .+....+..+....| ..+++++.+
T Consensus 222 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 301 (348)
T 2pml_X 222 FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID 301 (348)
T ss_dssp GSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHH
T ss_pred hcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHH
Confidence 3325555 99999999999999999999998776 778888888776666 568999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 467 IVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 467 li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
||.+||..||.+|||++|+++||||+.
T Consensus 302 li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 302 FLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHccCChhhCCCHHHHhcCccccC
Confidence 999999999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.9e-20 Score=185.21 Aligned_cols=153 Identities=20% Similarity=0.207 Sum_probs=125.0
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++.. +++++..+..++.|++.++ ++ .+.+||+|||.+...... ........
T Consensus 103 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 180 (303)
T 3a7i_A 103 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFV 180 (303)
T ss_dssp TTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT-BCCBCCCC
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc-ccccCccC
Confidence 36788888875 6899999999999999864 22 346788999976543322 12234568
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHccCCCcC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
||+.|+|||. ....++.++||||+||++|+|++|++||.+.+.......+..+.. ..+..+++.+.+||.+||..||.
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 260 (303)
T 3a7i_A 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 260 (303)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGG
T ss_pred CCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChh
Confidence 9999999998 667788999999999999999999999999888777777666544 35667899999999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q psy6203 478 KRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~~ 494 (568)
+|||++++++||||...
T Consensus 261 ~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 261 FRPTAKELLKHKFILRN 277 (303)
T ss_dssp GSCCHHHHTTCHHHHHH
T ss_pred hCcCHHHHhhChhhhcC
Confidence 99999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.80 E-value=6.8e-20 Score=185.30 Aligned_cols=152 Identities=14% Similarity=0.171 Sum_probs=119.0
Q ss_pred HHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 342 VMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 342 ~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
++|.+++... ..+++..+..++.|++.++ ++ .+.+||+|||.+.... .........
T Consensus 103 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~--~~~~~~~~~ 180 (326)
T 1blx_A 103 QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVV 180 (326)
T ss_dssp CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC--GGGGGCCCC
T ss_pred CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccccc--CCCCccccc
Confidence 4666776643 3599999999999999764 33 3467889999765432 222345568
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------------------
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY---------------------- 454 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~---------------------- 454 (568)
||+.|+|||. ....++.++||||+||++|+|++|++||.+.+..+.+..+... .+
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 1blx_A 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 260 (326)
T ss_dssp CCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCC
T ss_pred cccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcc
Confidence 8999999998 6667999999999999999999999999999887777666531 00
Q ss_pred ---CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 455 ---TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 455 ---~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
..+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 261 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 01245788999999999999999999999999999998543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-20 Score=190.44 Aligned_cols=145 Identities=19% Similarity=0.404 Sum_probs=119.4
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------C---------cceeEEEccccCcccccCCCCceecccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------M---------PICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~---------~~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
+++|.+++...+.+++..+..++.|++.++ + ..+.+||+|||++..... .......
T Consensus 133 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~---~~~~~~~ 209 (320)
T 3a99_A 133 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD 209 (320)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCS---SCBCCCC
T ss_pred CccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccc---ccccCCC
Confidence 377888888778999999999999999874 2 234688999997654322 1234568
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
||+.|+|||. ...+++.++|||||||++|+|++|+.||.+.+ .+..+....+..+++++.+||.+||..||.
T Consensus 210 gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 283 (320)
T 3a99_A 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPS 283 (320)
T ss_dssp SCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGG
T ss_pred CCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHHHHHHHHHccCChh
Confidence 9999999997 55667889999999999999999999997652 344566667788999999999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q psy6203 478 KRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~~ 494 (568)
+|||++++++||||+..
T Consensus 284 ~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 284 DRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp GSCCHHHHHTSGGGSSC
T ss_pred hCcCHHHHhcCHhhcCc
Confidence 99999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.5e-20 Score=185.70 Aligned_cols=155 Identities=15% Similarity=0.170 Sum_probs=122.7
Q ss_pred hHHHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++. ...++++..+..++.|++.++ ++ .+.+||+|||.+....... ......
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 185 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTV 185 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCcc
Confidence 3678888886 356899999999999999864 22 3467889999765433221 223456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHccCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~L~~ 474 (568)
.||+.|+|||. ....++.++||||+||++|+|++|+.||.+.+.......+..... ..+..+++.+.+||.+||..
T Consensus 186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 265 (314)
T 3com_A 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265 (314)
T ss_dssp CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccC
Confidence 89999999998 666789999999999999999999999998887666555544432 23556789999999999999
Q ss_pred CcCCCCCHHHHhcCcccccCC
Q psy6203 475 EPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 475 dp~~R~t~~~~l~hp~~~~~~ 495 (568)
||.+|||+.++++||||+...
T Consensus 266 dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 266 SPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CTTTSCCHHHHTTSHHHHTCC
T ss_pred ChhhCcCHHHHHhCHHHhcCC
Confidence 999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-21 Score=201.24 Aligned_cols=144 Identities=13% Similarity=0.145 Sum_probs=109.8
Q ss_pred HHHHHHHHhCCCCCCh-------hhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc
Q psy6203 341 GVMLYALLCGFLPFDS-------DSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ 393 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e-------~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~ 393 (568)
+++|.+++...+.+++ ..+..++.|++.++ +++ +.+||+|||++.. .+.
T Consensus 183 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~----~~~ 258 (377)
T 3byv_A 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR----DGA 258 (377)
T ss_dssp SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEE----TTC
T ss_pred CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhhee----cCC
Confidence 5788888887666777 77777999999864 333 4678999997653 223
Q ss_pred eecccccccccccCCC-CCC-----------CCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy6203 394 VINLLRSAIVLCSAPS-SKQ-----------YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMS 461 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~~~-----------~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s 461 (568)
.....+| +.|+|||. ... .|+.++|||||||++|||++|++||.+.+.......+.. .+..++
T Consensus 259 ~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~ 333 (377)
T 3byv_A 259 RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR----SCKNIP 333 (377)
T ss_dssp EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS----SCCCCC
T ss_pred cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh----hccCCC
Confidence 4556678 99999997 333 799999999999999999999999988765443333322 345689
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+++.+||.+||..||.+|||+.|+++||||+.
T Consensus 334 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999999999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-20 Score=186.16 Aligned_cols=148 Identities=14% Similarity=0.148 Sum_probs=110.6
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
|++|.+++.. ..++++..+..++.|++.++ +++ +++||+|||++.... ........+
T Consensus 140 ~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~--~~~~~~~~~ 217 (311)
T 3p1a_A 140 GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQE 217 (311)
T ss_dssp CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--------CCC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc--cCCCCcccC
Confidence 4556555554 45799999999999998864 333 357889999764432 222345567
Q ss_pred cccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHccCCCcC
Q psy6203 400 SAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 400 gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~~L~~dp~ 477 (568)
||+.|+|||.....++.++||||+||++|||++|..||.+... ...+..+..+ .+..+++++.+||.+||..||+
T Consensus 218 gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 294 (311)
T 3p1a_A 218 GDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294 (311)
T ss_dssp CCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred CCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChh
Confidence 9999999998334689999999999999999999777665432 3334444332 3566899999999999999999
Q ss_pred CCCCHHHHhcCccccc
Q psy6203 478 KRIKIQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~ 493 (568)
+|||++|+++||||+.
T Consensus 295 ~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 295 LRATAEALLALPVLRQ 310 (311)
T ss_dssp TSCCHHHHHTSGGGSC
T ss_pred hCcCHHHHHhCccccC
Confidence 9999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-20 Score=193.36 Aligned_cols=152 Identities=18% Similarity=0.206 Sum_probs=114.3
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc-------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF-------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~-------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++...+.+++..+..++.|++.++ +++ +++||+|||.+..... ......
T Consensus 114 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~ 190 (360)
T 3eqc_A 114 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSF 190 (360)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HC----
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc---ccccCC
Confidence 3678888888878899999999988887653 333 3578888886643211 123456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------------------------------
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYD------------------------------ 447 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~------------------------------ 447 (568)
+||+.|+|||. .+..|+.++||||+||++|+|++|+.||.+.+..+...
T Consensus 191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (360)
T 3eqc_A 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270 (360)
T ss_dssp CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence 89999999998 66789999999999999999999999998876544322
Q ss_pred ------------HHHcCCCC-C-CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 448 ------------KILNGKYT-E-PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 448 ------------~i~~~~~~-~-~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.+.....+ . +..+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 22222222 1 23478899999999999999999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-20 Score=186.13 Aligned_cols=154 Identities=17% Similarity=0.270 Sum_probs=116.0
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-------eEEEccccCcccccCCCC-ceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-------TILISQYFPTILLPCKVG-QVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-------~iki~dfG~~~~~~~~~~-~~~~~~~g 400 (568)
|++|.+++....++++..+..++.|+++++ +++. .+||+|||++........ ......+|
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~g 190 (313)
T 3cek_A 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 190 (313)
T ss_dssp SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC--------------C
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccccCCCC
Confidence 578888888888999999999999999864 3443 478999997654432221 12345689
Q ss_pred ccccccCCC-CC-----------CCCCCccceeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC--CCCCCCCCHHHH
Q psy6203 401 AIVLCSAPS-SK-----------QYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGK--YTEPPWMSPNSR 465 (568)
Q Consensus 401 t~~~~~pe~-~~-----------~~~~~~~DiWSlG~il~eml~g~~pf~~~~-~~~~~~~i~~~~--~~~~~~~s~~~~ 465 (568)
|+.|+|||. .. ..++.++||||+||++|+|++|+.||.+.. ....+..+.... ..+|...++++.
T Consensus 191 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (313)
T 3cek_A 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 270 (313)
T ss_dssp CGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHH
T ss_pred CCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHH
Confidence 999999997 22 478899999999999999999999998753 344445555443 345677889999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+||.+||..||.+|||++|+++||||+..
T Consensus 271 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 271 DVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 99999999999999999999999999854
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-20 Score=188.61 Aligned_cols=152 Identities=22% Similarity=0.399 Sum_probs=121.1
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|.+++.....+++..+..++.|++.++ +++. .+||+|||++.... ......
T Consensus 97 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~ 174 (322)
T 2ycf_A 97 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 174 (322)
T ss_dssp TTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC--CCHHHH
T ss_pred CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc--cccccc
Confidence 3678888998888999999999999999864 2332 37888999765432 222334
Q ss_pred ccccccccccCCC----CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCC----CCCCHHHHHH
Q psy6203 397 LLRSAIVLCSAPS----SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTEP----PWMSPNSRQI 467 (568)
Q Consensus 397 ~~~gt~~~~~pe~----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~-~~~~~i~~~~~~~~----~~~s~~~~~l 467 (568)
..+||+.|+|||. ....++.++||||+||++|+|++|.+||.+.... .+...+..+....+ ..+++++.+|
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (322)
T 2ycf_A 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 254 (322)
T ss_dssp HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHH
Confidence 5689999999996 4667899999999999999999999999875432 34455556655432 4589999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 468 VRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 468 i~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
|.+||..||++|||++++++||||+.
T Consensus 255 i~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 255 VKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 99999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=7.1e-21 Score=191.51 Aligned_cols=155 Identities=15% Similarity=0.161 Sum_probs=119.7
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCC--ceecc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVG--QVINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~--~~~~~ 397 (568)
.|++|.+++...+++++.++..++.|++.++ +++ +++||+|||++........ .....
T Consensus 99 ~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 178 (311)
T 3ork_A 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178 (311)
T ss_dssp CEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccc
Confidence 3788999998888999999999999999864 333 3578999997654332211 12334
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHcc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE----PPWMSPNSRQIVRSML 472 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~li~~~L 472 (568)
.+||+.|+|||. .+..++.++||||+||++|+|++|++||.+.+..+....+....... +..+++++.+||.+||
T Consensus 179 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 258 (311)
T 3ork_A 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKAL 258 (311)
T ss_dssp ---CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHT
T ss_pred cCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHH
Confidence 679999999998 66678999999999999999999999999998887776666655443 3458999999999999
Q ss_pred CCCcCCCCCHHHHhcCcccccC
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..||.+||++.+++.|+|++..
T Consensus 259 ~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 259 AKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CSSGGGSCSSHHHHHHHHHHHH
T ss_pred hcCHhhChhhHHHHHHHHHHHh
Confidence 9999999999999999999853
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=185.79 Aligned_cols=138 Identities=19% Similarity=0.266 Sum_probs=106.9
Q ss_pred CCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccccccccccCCC--C
Q psy6203 353 PFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS--S 410 (568)
Q Consensus 353 ~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~--~ 410 (568)
.+++..+..++.|++.++ ++ .+++||+|||++.... ......+||+.|+|||. +
T Consensus 122 ~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~----~~~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC----CCccccccCcCcCCHHHHhC
Confidence 589999999999998764 33 3468899999765422 12345688999999997 4
Q ss_pred CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C-----------------------------CCCCCC
Q psy6203 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K-----------------------------YTEPPW 459 (568)
Q Consensus 411 ~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~-----------------------------~~~~~~ 459 (568)
...++.++||||+||++|+|++|++||.+.+..+.+..+... . ...++.
T Consensus 198 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
T 3coi_A 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 277 (353)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTT
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCC
Confidence 478999999999999999999999999998877666555331 0 012345
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.++++.+||.+||..||++|||++++++||||+..
T Consensus 278 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 278 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 78999999999999999999999999999999854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.1e-20 Score=182.43 Aligned_cols=147 Identities=10% Similarity=0.112 Sum_probs=113.5
Q ss_pred hHHHHHHHHhCC----CCCChhhHHHHHHHHhhcc------------Ccce---------------------------eE
Q psy6203 340 MGVMLYALLCGF----LPFDSDSIDQLYDKILSHF------------MPIC---------------------------TI 376 (568)
Q Consensus 340 ~g~~l~~~~~~~----~~~~e~~~~~~~~qil~~~------------~~~~---------------------------~i 376 (568)
.|++|.+++... .++++..+..++.|++.++ +++. .+
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (289)
T 1x8b_A 94 NGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173 (289)
T ss_dssp TTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCE
T ss_pred CCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEE
Confidence 367888888753 6799999999999999864 3333 35
Q ss_pred EEccccCcccccCCCCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Q psy6203 377 LISQYFPTILLPCKVGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY 454 (568)
Q Consensus 377 ki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~ 454 (568)
||+|||.+..... .....||+.|+|||. ....++.++||||+||++|+|++|.+||.... ....+..+..
T Consensus 174 kl~Dfg~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~ 245 (289)
T 1x8b_A 174 KIGDLGHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRL 245 (289)
T ss_dssp EECCCTTCEETTC-----SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCC
T ss_pred EEcccccccccCC-----ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCC
Confidence 7778886543321 123469999999998 44467789999999999999999998886553 3344555544
Q ss_pred -CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 455 -TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 455 -~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..|..+++++.+||.+||..||.+|||+.++++||||...
T Consensus 246 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 4677899999999999999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.80 E-value=8e-20 Score=185.20 Aligned_cols=149 Identities=15% Similarity=0.182 Sum_probs=111.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce---------eEEEccccCcccccCCCCceecccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC---------TILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~---------~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
|++|.+++.. +++.++..++.|++.++ +++. .+||+|||.+.... .+......+
T Consensus 117 ~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~--~~~~~~~~~ 191 (330)
T 3nsz_A 117 NTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYNVRV 191 (330)
T ss_dssp CCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC--TTCCCCSCC
T ss_pred chhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC--CCCcccccc
Confidence 5667677653 89999999999999864 3332 68899999775432 233345678
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHH-------------HcCCCCC-------
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKI-------------LNGKYTE------- 456 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~-~~~~~~~~~i-------------~~~~~~~------- 456 (568)
||+.|+|||. ....++.++||||+||++|+|++|+.||.. .+..+.+..+ .......
T Consensus 192 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (330)
T 3nsz_A 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 271 (330)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHH
T ss_pred ccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhh
Confidence 9999999997 447899999999999999999999999954 3333322222 1111111
Q ss_pred -----------------CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 457 -----------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 457 -----------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+..+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 272 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 12278999999999999999999999999999999854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=7.9e-20 Score=181.54 Aligned_cols=145 Identities=12% Similarity=0.171 Sum_probs=103.4
Q ss_pred HHhCCCCCChhhHHHHHHHHhhcc-------------Ccc--------eeEEEccccCcccccCCCCceecccccccccc
Q psy6203 347 LLCGFLPFDSDSIDQLYDKILSHF-------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSAIVLC 405 (568)
Q Consensus 347 ~~~~~~~~~e~~~~~~~~qil~~~-------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~ 405 (568)
......++++..+..++.|++.++ +++ ..+||+|||.+..... ........||+.|+
T Consensus 99 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~ 176 (290)
T 3fme_A 99 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYM 176 (290)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------------CCCCCCS
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc--cccccccCCCcccc
Confidence 344567899999999999988753 222 4678899996654322 22234458999999
Q ss_pred cCCC-----CCCCCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHH-HcCCCCC-CCCCCHHHHHHHHHccCCCcC
Q psy6203 406 SAPS-----SKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKI-LNGKYTE-PPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 406 ~pe~-----~~~~~~~~~DiWSlG~il~eml~g~~pf~~-~~~~~~~~~i-~~~~~~~-~~~~s~~~~~li~~~L~~dp~ 477 (568)
|||. ....++.++||||+||++|+|++|++||.+ .........+ ....... +..+++++.+||.+||..||+
T Consensus 177 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 256 (290)
T 3fme_A 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSK 256 (290)
T ss_dssp CHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGG
T ss_pred ChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChh
Confidence 9996 456789999999999999999999999986 3444444444 3333433 346899999999999999999
Q ss_pred CCCCHHHHhcCccccc
Q psy6203 478 KRIKIQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~ 493 (568)
+|||++|+++||||+.
T Consensus 257 ~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 257 ERPTYPELMQHPFFTL 272 (290)
T ss_dssp GSCCHHHHTTSHHHHH
T ss_pred hCcCHHHHHhCccccc
Confidence 9999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-20 Score=191.34 Aligned_cols=151 Identities=21% Similarity=0.261 Sum_probs=109.7
Q ss_pred HHHHHHHHhC--CCCCChhhHHHHHHHHhhcc-------------Ccce--------------eEEEccccCcccccCCC
Q psy6203 341 GVMLYALLCG--FLPFDSDSIDQLYDKILSHF-------------MPIC--------------TILISQYFPTILLPCKV 391 (568)
Q Consensus 341 g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~-------------~~~~--------------~iki~dfG~~~~~~~~~ 391 (568)
|++|.+++.. ...+++..+..++.|++.++ +++. .+||+|||++.....
T Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-- 190 (373)
T 1q8y_A 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-- 190 (373)
T ss_dssp CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--
T ss_pred CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC--
Confidence 6778777764 35699999999999988753 2332 467889997654321
Q ss_pred CceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHc-------------
Q psy6203 392 GQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI------DQLYDKILN------------- 451 (568)
Q Consensus 392 ~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~------~~~~~~i~~------------- 451 (568)
.....+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+. .+.+..+..
T Consensus 191 --~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 268 (373)
T 1q8y_A 191 --HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 268 (373)
T ss_dssp --CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred --CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhcc
Confidence 2345689999999998 556689999999999999999999999987542 222222221
Q ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 452 -----------------------------GKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 452 -----------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
....++...++++.+||.+||..||++|||++|+++||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 269 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred chhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 11122333467889999999999999999999999999998653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=8.2e-20 Score=187.74 Aligned_cols=152 Identities=14% Similarity=0.162 Sum_probs=110.5
Q ss_pred HHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 342 VMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 342 ~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
+++.+++.. ..++++..+..++.|++.++ ++ .+++||+|||.+..... .......+|
T Consensus 118 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~ 195 (362)
T 3pg1_A 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA--DANKTHYVT 195 (362)
T ss_dssp EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC-----------------
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccccc--ccccceecc
Confidence 455555554 45799999999999999864 33 34678899997653222 222445689
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C----------------------C
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K----------------------Y 454 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~----------------------~ 454 (568)
|+.|+|||. +...++.++||||+||++|+|++|++||.+.+..+.+..+... . .
T Consensus 196 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (362)
T 3pg1_A 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLS 275 (362)
T ss_dssp CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCC
T ss_pred cceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcc
Confidence 999999997 4478999999999999999999999999998877766665431 0 0
Q ss_pred C--------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 455 T--------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 455 ~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
. .++..++.+.+||.+||..||.+|||++|+++||||+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 276 NVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0 1234688999999999999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-20 Score=184.82 Aligned_cols=154 Identities=16% Similarity=0.239 Sum_probs=111.8
Q ss_pred HHHHHHHHh--------CCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCC--
Q psy6203 341 GVMLYALLC--------GFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCK-- 390 (568)
Q Consensus 341 g~~l~~~~~--------~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~-- 390 (568)
|++|.+++. ..+.+++..+..++.|++.++ ++ .+.+||+|||.+......
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 176 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence 566766665 246799999999999998864 23 346788999966443221
Q ss_pred --CCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------C
Q psy6203 391 --VGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----------E 456 (568)
Q Consensus 391 --~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~----------~ 456 (568)
.........||+.|+|||. ....++.++||||+||++|+|++|+.||.+.+.............. .
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (303)
T 2vwi_A 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEM 256 (303)
T ss_dssp -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CC
T ss_pred ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchh
Confidence 1112345689999999997 3356899999999999999999999999987766555555444322 1
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 457 PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 457 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 257 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred hhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 24578899999999999999999999999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.4e-20 Score=186.67 Aligned_cols=150 Identities=11% Similarity=0.056 Sum_probs=103.8
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------Ccce--------eEEEccccCcccccC
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPIC--------TILISQYFPTILLPC 389 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~~--------~iki~dfG~~~~~~~ 389 (568)
|..|++|+++++. .+++++.+..++.|++.|+ +|+. ++||+|||+|+....
T Consensus 82 y~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 82 YHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 3448999999986 5789998888888876542 3433 679999998865543
Q ss_pred CCCc---eecccccccccccCCC-CC------CCCCCccceeehhHHHHHHHhCCCCCCCC---------------CHHH
Q psy6203 390 KVGQ---VINLLRSAIVLCSAPS-SK------QYYGSETDVWSMGVMLYALLCGFLPFDSD---------------SIDQ 444 (568)
Q Consensus 390 ~~~~---~~~~~~gt~~~~~pe~-~~------~~~~~~~DiWSlG~il~eml~g~~pf~~~---------------~~~~ 444 (568)
.... .....+||+.|||||. .+ ..|+.++||||+||++|||+||.+||... +...
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3221 2335689999999997 22 14778999999999999999998876432 2233
Q ss_pred HHHHHHcCCC--CCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 445 LYDKILNGKY--TEPPW-----MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 445 ~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+...+..... .+|.. .+..+.+||.+||..||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 4444444332 23332 22457899999999999999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-20 Score=192.84 Aligned_cols=114 Identities=19% Similarity=0.242 Sum_probs=84.4
Q ss_pred eEEEccccCcccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHH
Q psy6203 375 TILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS------IDQLYD 447 (568)
Q Consensus 375 ~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~------~~~~~~ 447 (568)
.+||+|||.+..... .....+||+.|+|||. .+..|+.++|||||||++|+|++|++||.+.+ ....+.
T Consensus 234 ~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 309 (397)
T 1wak_A 234 KVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA 309 (397)
T ss_dssp CEEECCGGGCEETTB----CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHH
T ss_pred ceEeccccccccccc----cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHH
Confidence 477888886644321 2345689999999998 55668999999999999999999999998654 222222
Q ss_pred HHHc--CCC----------------------------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHH
Q psy6203 448 KILN--GKY----------------------------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDL 485 (568)
Q Consensus 448 ~i~~--~~~----------------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~ 485 (568)
.+.. +.+ ..+...++.+.+||.+||..||++|||++|+
T Consensus 310 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 389 (397)
T 1wak_A 310 LIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389 (397)
T ss_dssp HHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH
T ss_pred HHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH
Confidence 2211 110 0112234678899999999999999999999
Q ss_pred hcCcccc
Q psy6203 486 LGHNWVK 492 (568)
Q Consensus 486 l~hp~~~ 492 (568)
++||||+
T Consensus 390 l~hp~~~ 396 (397)
T 1wak_A 390 LRHPWLN 396 (397)
T ss_dssp HTSGGGG
T ss_pred hhCcccc
Confidence 9999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-20 Score=184.69 Aligned_cols=153 Identities=18% Similarity=0.299 Sum_probs=120.8
Q ss_pred HHHHHHHHhC----CCCCChhhHHHHHHHHhhcc-----------------Ccce--------eEEEccccCcccccCCC
Q psy6203 341 GVMLYALLCG----FLPFDSDSIDQLYDKILSHF-----------------MPIC--------TILISQYFPTILLPCKV 391 (568)
Q Consensus 341 g~~l~~~~~~----~~~~~e~~~~~~~~qil~~~-----------------~~~~--------~iki~dfG~~~~~~~~~ 391 (568)
|++|.+++.. ..++++..+..++.|++.++ +++. ++||+|||.+......
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~- 169 (279)
T 2w5a_A 91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD- 169 (279)
T ss_dssp TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC----
T ss_pred CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc-
Confidence 5677777754 34599999998888877642 3333 5788888865443221
Q ss_pred CceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q psy6203 392 GQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVR 469 (568)
Q Consensus 392 ~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 469 (568)
........||+.|+|||. ....++.++||||+||++|+|++|++||.+.+..++...+..+.. ..|..+++++.+||.
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 249 (279)
T 2w5a_A 170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIIT 249 (279)
T ss_dssp CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHH
Confidence 112345678999999998 555788999999999999999999999999988888888888766 467789999999999
Q ss_pred HccCCCcCCCCCHHHHhcCcccccC
Q psy6203 470 SMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 470 ~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+||..||.+|||++|+++|+|+...
T Consensus 250 ~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 250 RMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHcCCCcccCCCHHHHHhChhhhhh
Confidence 9999999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.6e-20 Score=184.43 Aligned_cols=153 Identities=16% Similarity=0.160 Sum_probs=117.4
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
|+.|.+++.. ...+++..+..++.|++.++ +++ +++||+|||++..... .........
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 178 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-TLQKRDSFI 178 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH-HHHC-----
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc-ccccccccc
Confidence 5677776654 46799999999999998764 333 3577888885432111 111223467
Q ss_pred cccccccCCC------CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHHH
Q psy6203 400 SAIVLCSAPS------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIVRS 470 (568)
Q Consensus 400 gt~~~~~pe~------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~ 470 (568)
||+.|+|||. ....++.++||||+||++|+|++|.+||.+.+.......+.....+ .+..+++.+.+||.+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (302)
T 2j7t_A 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI 258 (302)
T ss_dssp CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred CChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHH
Confidence 9999999996 3667899999999999999999999999998888777777665443 345689999999999
Q ss_pred ccCCCcCCCCCHHHHhcCcccccC
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
||..||.+|||++++++||||...
T Consensus 259 ~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 259 ALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HcccChhhCCCHHHHhcChHHhhh
Confidence 999999999999999999999854
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-20 Score=184.79 Aligned_cols=148 Identities=20% Similarity=0.420 Sum_probs=120.1
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------C---------cceeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------M---------PICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~---------~~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++...+++++..+..++.|++.++ + ..+.+||+|||++..... ......
T Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~---~~~~~~ 198 (312)
T 2iwi_A 122 PAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDF 198 (312)
T ss_dssp SEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCS---SCBCCC
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhccc---Cccccc
Confidence 4788999998888999999999999999864 2 234688999997654332 123456
Q ss_pred ccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 399 RSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 399 ~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.||+.|+|||. ...+++.++||||+||++|+|++|+.||.+. ..+......++..+++++.+||.+||..||
T Consensus 199 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 272 (312)
T 2iwi_A 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKP 272 (312)
T ss_dssp CSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCHHHHHHHHHHTCSST
T ss_pred CCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCHHHHHHHHHHccCCh
Confidence 79999999997 4556667999999999999999999999764 234556677788899999999999999999
Q ss_pred CCCCCHHHHhcCcccccCCC
Q psy6203 477 GKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 477 ~~R~t~~~~l~hp~~~~~~~ 496 (568)
++|||++|+++||||+....
T Consensus 273 ~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 273 SSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp TTSCCHHHHHHSTTTCC---
T ss_pred hhCcCHHHHhcChhhcCchh
Confidence 99999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-20 Score=194.95 Aligned_cols=148 Identities=10% Similarity=0.133 Sum_probs=104.4
Q ss_pred HHHHHHHhCCC-CCChhhH------HHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCce
Q psy6203 342 VMLYALLCGFL-PFDSDSI------DQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 342 ~~l~~~~~~~~-~~~e~~~------~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~ 394 (568)
++|.+++...+ .+++... ..++.|+++++ +|+ +++||+|||++... +..
T Consensus 172 ~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~----~~~ 247 (371)
T 3q60_A 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV----GTR 247 (371)
T ss_dssp EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEET----TCE
T ss_pred CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeec----CCC
Confidence 56666766532 3333333 34557887753 444 35789999976543 222
Q ss_pred ecccccccccccCCC-CC--CCCCCccceeehhHHHHHHHhCCCCCCCCCHHHH--HHH-----HHcCCCCC--CCCCCH
Q psy6203 395 INLLRSAIVLCSAPS-SK--QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL--YDK-----ILNGKYTE--PPWMSP 462 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~-~~--~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~--~~~-----i~~~~~~~--~~~~s~ 462 (568)
.....+|+.|+|||. .. ..|+.++||||+||++|+|++|++||.+.+.... +.. .....+.+ +..+++
T Consensus 248 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (371)
T 3q60_A 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD 327 (371)
T ss_dssp EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCH
T ss_pred ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCH
Confidence 335567799999997 44 6799999999999999999999999988743210 000 01112222 246899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 463 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
.+.+||.+||..||++|||++++++||||+.
T Consensus 328 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 328 FVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9999999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=181.05 Aligned_cols=154 Identities=16% Similarity=0.189 Sum_probs=116.7
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|.+++...+++++.++..++.|++.++ +++ +.+||+|||++..............+
T Consensus 94 ~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 173 (294)
T 4eqm_A 94 EGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173 (294)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccc
Confidence 3788999998888999999999999999864 333 35788999977654332222344568
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHccC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-----EPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~~~li~~~L~ 473 (568)
||+.|+|||. .+..++.++||||+||++|+|++|++||.+.+.............+ .+..+++.+.++|.+||.
T Consensus 174 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 253 (294)
T 4eqm_A 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATE 253 (294)
T ss_dssp -CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSC
T ss_pred cCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhc
Confidence 9999999998 6667899999999999999999999999999887766666555433 245689999999999999
Q ss_pred CCcCCCCCHHHHhcCccccc
Q psy6203 474 VEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 474 ~dp~~R~t~~~~l~hp~~~~ 493 (568)
.||.+||+..+.+.+.|...
T Consensus 254 ~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 254 KDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp SSGGGSCSSHHHHHHHHHTS
T ss_pred CCHhHccccHHHHHHHHHHH
Confidence 99999997666666777653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=180.86 Aligned_cols=153 Identities=16% Similarity=0.141 Sum_probs=114.1
Q ss_pred hHHHHHHHHhCCCC---CChhhHHHHHHHHhhcc--------------Ccce--------eEEEccccCcccccCCCCce
Q psy6203 340 MGVMLYALLCGFLP---FDSDSIDQLYDKILSHF--------------MPIC--------TILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 340 ~g~~l~~~~~~~~~---~~e~~~~~~~~qil~~~--------------~~~~--------~iki~dfG~~~~~~~~~~~~ 394 (568)
.|++|.+++...+. +++..+..++.|++.++ +++. .+||+|||++...... ...
T Consensus 117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~ 195 (309)
T 3p86_A 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLS 195 (309)
T ss_dssp TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-ccc
Confidence 46788888887554 99999999999987753 2333 5789999976543221 122
Q ss_pred ecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHc
Q psy6203 395 INLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN--GKYTEPPWMSPNSRQIVRSM 471 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~~ 471 (568)
....+||+.|+|||. .+..++.++||||+||++|+|++|+.||.+.+..+....+.. .....|..+++++.+||.+|
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 275 (309)
T 3p86_A 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGC 275 (309)
T ss_dssp ------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHH
Confidence 345689999999998 677789999999999999999999999999988877776643 34567888999999999999
Q ss_pred cCCCcCCCCCHHHHhc--Cccccc
Q psy6203 472 LQVEPGKRIKIQDLLG--HNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~--hp~~~~ 493 (568)
|..||.+|||++++++ +++++.
T Consensus 276 l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 276 WTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999987 566653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.9e-20 Score=184.32 Aligned_cols=155 Identities=15% Similarity=0.269 Sum_probs=111.6
Q ss_pred hHHHHHHHHhCC------CCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC-
Q psy6203 340 MGVMLYALLCGF------LPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG- 392 (568)
Q Consensus 340 ~g~~l~~~~~~~------~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~- 392 (568)
.|++|.+++... ..+++..+..++.|+++++ +++. .+||+|||.+........
T Consensus 114 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~ 193 (323)
T 3qup_A 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193 (323)
T ss_dssp TTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccc
Confidence 356777776532 2699999999999999864 3433 578899997654322211
Q ss_pred ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q psy6203 393 QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVR 469 (568)
Q Consensus 393 ~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 469 (568)
.......+|+.|+|||. ....|+.++||||+||++|+|++ |++||.+.+..+....+..+. ...+..+++++.+||.
T Consensus 194 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (323)
T 3qup_A 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMY 273 (323)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHH
Confidence 11223456788999998 55678999999999999999999 999999988888888877765 4567789999999999
Q ss_pred HccCCCcCCCCC-------HHHHhcCcccccC
Q psy6203 470 SMLQVEPGKRIK-------IQDLLGHNWVKMG 494 (568)
Q Consensus 470 ~~L~~dp~~R~t-------~~~~l~hp~~~~~ 494 (568)
+||..||.+||| ++++++|||+...
T Consensus 274 ~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 274 QCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 999999999999 7788999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-19 Score=178.29 Aligned_cols=153 Identities=20% Similarity=0.303 Sum_probs=113.8
Q ss_pred HHHHHHHHhCC---CCCChhhHHHHHHHHhhcc------------Cc---------ceeEEEccccCcccccCCCCceec
Q psy6203 341 GVMLYALLCGF---LPFDSDSIDQLYDKILSHF------------MP---------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 341 g~~l~~~~~~~---~~~~e~~~~~~~~qil~~~------------~~---------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|++|.+++... ..+++..+..++.|++.++ ++ .+.+||+|||++...... .....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 181 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-NPCTE 181 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------C
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-CCccc
Confidence 57777777643 3577888888899998764 22 346788999976543221 22234
Q ss_pred ccccccccccCCC---CCCCCCCccceeehhHHHHHHHhCCCCCCCCC-HHHH-HH-HHHcCCCCCCCCCCHHHHHHHHH
Q psy6203 397 LLRSAIVLCSAPS---SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQL-YD-KILNGKYTEPPWMSPNSRQIVRS 470 (568)
Q Consensus 397 ~~~gt~~~~~pe~---~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~-~~~~-~~-~i~~~~~~~~~~~s~~~~~li~~ 470 (568)
...||+.|+|||. ....++.++||||+||++|+|++|+.||.+.. .... .. .........|..+++++.+||.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence 5689999999997 22458999999999999999999999997643 2222 22 22334455678899999999999
Q ss_pred ccCCCcCCCCCHHHHhcCcccccC
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
||..||++|||++++++||||+..
T Consensus 262 ~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 262 CFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp TTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2e-19 Score=176.78 Aligned_cols=149 Identities=19% Similarity=0.253 Sum_probs=119.3
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++ ..+||+|||.+..............
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 36788888864 45799999999999998764 333 3578889997654322222223345
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 475 (568)
.+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..+. ...|...++.+.+||.+||..|
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRER 247 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCC
Confidence 67788999998 55678999999999999999999 999999999998888888774 3456778999999999999999
Q ss_pred cCCCCCHHHHhcC
Q psy6203 476 PGKRIKIQDLLGH 488 (568)
Q Consensus 476 p~~R~t~~~~l~h 488 (568)
|.+|||+.++++|
T Consensus 248 p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 248 PEDRPAFSRLLRQ 260 (269)
T ss_dssp GGGSCCHHHHHHH
T ss_pred cccCcCHHHHHHH
Confidence 9999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-19 Score=188.39 Aligned_cols=152 Identities=15% Similarity=0.113 Sum_probs=104.6
Q ss_pred HHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Cccee-------------EEEccccCcccccCCCC--c
Q psy6203 342 VMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPICT-------------ILISQYFPTILLPCKVG--Q 393 (568)
Q Consensus 342 ~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~~~-------------iki~dfG~~~~~~~~~~--~ 393 (568)
++|.+++... ..+.+.++..++.|++.|+ +++.| +||+|||++........ .
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~ 181 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCccee
Confidence 4677777653 3567777788888888764 44444 45789997755432211 2
Q ss_pred eecccccccccccCCC-C---CCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC---CCCCCHHHH
Q psy6203 394 VINLLRSAIVLCSAPS-S---KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE---PPWMSPNSR 465 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~---~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~~~---~~~~s~~~~ 465 (568)
.....+||+.|+|||. . ...++.++||||+||++|||++ |.+||...........+....... +...++.+.
T Consensus 182 ~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (432)
T 3p23_A 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIAR 261 (432)
T ss_dssp ----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHH
T ss_pred eccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHH
Confidence 2345789999999997 2 4567889999999999999999 999997665433322222222211 222456689
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+||.+||..||.+|||++++++||||..
T Consensus 262 ~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 262 ELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 9999999999999999999999999963
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-19 Score=177.89 Aligned_cols=149 Identities=17% Similarity=0.248 Sum_probs=109.5
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++... .++++..+..++.|++.++ +++. ++||+|||.+..............
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 177 (281)
T 1mp8_A 98 TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177 (281)
T ss_dssp TTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------------
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccC
Confidence 367888888754 4799999999999998764 3433 578899997655432222223345
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 475 (568)
.+|+.|+|||. ....++.++||||+||++|+|++ |.+||.+.+..+....+..+. .+.|..+++.+.+||.+||..|
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (281)
T 1mp8_A 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYD 257 (281)
T ss_dssp -CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 67788999997 55678899999999999999996 999999988888888887764 4567789999999999999999
Q ss_pred cCCCCCHHHHhcC
Q psy6203 476 PGKRIKIQDLLGH 488 (568)
Q Consensus 476 p~~R~t~~~~l~h 488 (568)
|++|||+.+++++
T Consensus 258 p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 258 PSRRPRFTELKAQ 270 (281)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3e-19 Score=175.40 Aligned_cols=149 Identities=17% Similarity=0.231 Sum_probs=119.0
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++... ..+++..+..++.|++.++ +++ +.+||+|||.+..............
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 367788877754 3599999999999999764 333 3578899997755433322223345
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~d 475 (568)
.+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+.......+..+... .|...++.+.+||.+||..|
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 245 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHEL 245 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSS
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCC
Confidence 56778999998 55578899999999999999999 99999999988888888777544 46668999999999999999
Q ss_pred cCCCCCHHHHhcC
Q psy6203 476 PGKRIKIQDLLGH 488 (568)
Q Consensus 476 p~~R~t~~~~l~h 488 (568)
|.+|||+.+++++
T Consensus 246 p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 246 PEKRPTFQQLLSS 258 (268)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999886
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-19 Score=183.54 Aligned_cols=150 Identities=16% Similarity=0.214 Sum_probs=113.1
Q ss_pred hhHHHHHHHHhCCC---CCChhhHHHHHHHHhhcc------------Ccce------------eEEEccccCcccccCCC
Q psy6203 339 SMGVMLYALLCGFL---PFDSDSIDQLYDKILSHF------------MPIC------------TILISQYFPTILLPCKV 391 (568)
Q Consensus 339 ~~g~~l~~~~~~~~---~~~e~~~~~~~~qil~~~------------~~~~------------~iki~dfG~~~~~~~~~ 391 (568)
..|++|.+++.... .+++..+..++.|++.++ +++. .+||+|||.+.....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~-- 168 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-- 168 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT--
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC--
Confidence 34788888888643 399999999999999864 3333 367899997755432
Q ss_pred CceecccccccccccCCC-C--------CCCCCCccceeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCC---
Q psy6203 392 GQVINLLRSAIVLCSAPS-S--------KQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYT--- 455 (568)
Q Consensus 392 ~~~~~~~~gt~~~~~pe~-~--------~~~~~~~~DiWSlG~il~eml~g~~pf~~~~----~~~~~~~i~~~~~~--- 455 (568)
.......+||+.|+|||. . ...|+.++||||+||++|||++|++||.... ..+.+..+..+.+.
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (319)
T 4euu_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (319)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence 223456689999999996 1 5789999999999999999999999997432 34455555544321
Q ss_pred ----------------CC--C----CCCHHHHHHHHHccCCCcCCCCCHHHHhcCcc
Q psy6203 456 ----------------EP--P----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 490 (568)
Q Consensus 456 ----------------~~--~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 490 (568)
.| . .+++.+.+||.+||+.||++|||++|+++||=
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11 1 13457889999999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-19 Score=184.01 Aligned_cols=152 Identities=13% Similarity=0.170 Sum_probs=110.1
Q ss_pred hHHHHHHHHhCCCCC---ChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC----
Q psy6203 340 MGVMLYALLCGFLPF---DSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG---- 392 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~---~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~---- 392 (568)
.|++|.+++.....+ ++..+..++.|++.++ +++. .+||+|||++........
T Consensus 144 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 223 (332)
T 3qd2_B 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223 (332)
T ss_dssp CSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------
T ss_pred CCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc
Confidence 367888888875543 4445788889998763 3443 578889997755433211
Q ss_pred -------ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCHH
Q psy6203 393 -------QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPN 463 (568)
Q Consensus 393 -------~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~s~~ 463 (568)
......+||+.|+|||. .+..|+.++||||+||++|+|++|..|+... ......+.....+. +...+++
T Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 301 (332)
T 3qd2_B 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQ 301 (332)
T ss_dssp --------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHH
T ss_pred cccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChh
Confidence 12344679999999998 5667899999999999999999998776322 23344444443332 2346788
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 464 SRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 464 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+.+||.+||..||.+|||++|+++||||+.
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 899999999999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.5e-19 Score=176.98 Aligned_cols=150 Identities=17% Similarity=0.336 Sum_probs=108.0
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCC--------
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKV-------- 391 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~-------- 391 (568)
|++|.+++.. ...+++..+..++.|++.++ ++ .+.+||+|||.+.......
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 178 (303)
T 1zy4_A 99 NGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178 (303)
T ss_dssp SCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC----------
T ss_pred CCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccc
Confidence 6788888874 34688899999999998764 23 3357899999765432110
Q ss_pred -----CceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCC----C
Q psy6203 392 -----GQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKYTEPP----W 459 (568)
Q Consensus 392 -----~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~-~~~~~~~~~i~~~~~~~~~----~ 459 (568)
........||+.|+|||. +...++.++||||+||++|+|++ ||.. .+.......+......+|+ .
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (303)
T 1zy4_A 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDN 255 (303)
T ss_dssp ---------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTT
T ss_pred cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCcccccc
Confidence 122345679999999997 44579999999999999999998 6653 3445566666666555443 4
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
.++.+.+||.+||..||.+|||++++++||||+.
T Consensus 256 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 256 KMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp TSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred chHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 5677899999999999999999999999999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.6e-19 Score=182.14 Aligned_cols=150 Identities=13% Similarity=0.208 Sum_probs=119.7
Q ss_pred hhHHHHHHHHhCCC----------------CCChhhHHHHHHHHhhcc------------Ccc--------eeEEEcccc
Q psy6203 339 SMGVMLYALLCGFL----------------PFDSDSIDQLYDKILSHF------------MPI--------CTILISQYF 382 (568)
Q Consensus 339 ~~g~~l~~~~~~~~----------------~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG 382 (568)
..|++|.+++.... .+++.++..++.|++.++ +++ +.+||+|||
T Consensus 169 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 248 (370)
T 2psq_A 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 248 (370)
T ss_dssp CTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCS
T ss_pred CCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEcccc
Confidence 34778888887543 588999999999999864 333 467899999
Q ss_pred CcccccCCC-CceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCC
Q psy6203 383 PTILLPCKV-GQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPP 458 (568)
Q Consensus 383 ~~~~~~~~~-~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~ 458 (568)
++....... ........+|+.|+|||. ....|+.++|||||||++|||++ |.+||.+.+..+++..+..+.. ..|.
T Consensus 249 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (370)
T 2psq_A 249 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA 328 (370)
T ss_dssp SCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred CCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 775433221 112334567889999997 66679999999999999999999 9999999988888888777653 4677
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
.+++++.+||.+||..||.+|||+.|++++
T Consensus 329 ~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 329 NCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.8e-19 Score=176.07 Aligned_cols=149 Identities=13% Similarity=0.205 Sum_probs=119.3
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++ +.+||+|||.+..............
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 36788888876 56799999999999998764 333 3578889997654322211122334
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~d 475 (568)
.+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..+.. ..|...++.+.+||.+||..|
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 261 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 261 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCC
Confidence 56788999997 55568999999999999999998 9999999998888888887754 456678999999999999999
Q ss_pred cCCCCCHHHHhcC
Q psy6203 476 PGKRIKIQDLLGH 488 (568)
Q Consensus 476 p~~R~t~~~~l~h 488 (568)
|.+|||++++++|
T Consensus 262 p~~Rps~~~ll~~ 274 (283)
T 3gen_A 262 ADERPTFKILLSN 274 (283)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999999876
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=177.24 Aligned_cols=138 Identities=12% Similarity=0.221 Sum_probs=102.0
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC------------C-chH--------HHHHHHHHHHhCCCCC
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG------------E-DLP--------RVKLEINALKHISHQH 67 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~-~~~--------~~~~Ei~~l~~l~hpn 67 (568)
-|.+++.||+|++|.||+|.+. +|+.||||+++..... . ... ...+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999974 7999999998643211 0 000 1235777777775544
Q ss_pred cceeeEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC----
Q psy6203 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ---- 143 (568)
Q Consensus 68 Iv~l~~~~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---- 143 (568)
+.-..-+..... +|||||++|++|.++. ..+.+..++.||+.+|.+||+.|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~~~~--~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQSRH--TIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEETT--EEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeeccCc--eEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 432222222232 7999999998886532 2234567899999999999999999999999999998776
Q ss_pred ------CeEEEeecCccC
Q psy6203 144 ------NLKLIDFGLCAK 155 (568)
Q Consensus 144 ------~~kl~DFG~a~~ 155 (568)
.+.|+||+.+..
T Consensus 247 ~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECCCTTCEE
T ss_pred ccccccceEEEEeCCccc
Confidence 389999997654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=180.90 Aligned_cols=149 Identities=15% Similarity=0.228 Sum_probs=120.8
Q ss_pred hHHHHHHHHhCC----------------CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccC
Q psy6203 340 MGVMLYALLCGF----------------LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFP 383 (568)
Q Consensus 340 ~g~~l~~~~~~~----------------~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~ 383 (568)
.|++|.+++... ..+++..+..++.|++.++ +++ +.+||+|||+
T Consensus 158 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~ 237 (382)
T 3tt0_A 158 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237 (382)
T ss_dssp TTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSC
T ss_pred CCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCc
Confidence 367888888754 3599999999999999874 333 3578999997
Q ss_pred cccccCCC-CceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q psy6203 384 TILLPCKV-GQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPW 459 (568)
Q Consensus 384 ~~~~~~~~-~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~ 459 (568)
+....... ........+|+.|+|||. .+..++.++||||+||++|+|++ |.+||.+.+..++...+..+. ...|..
T Consensus 238 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (382)
T 3tt0_A 238 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN 317 (382)
T ss_dssp CCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSS
T ss_pred ccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 75433221 122344567889999997 66779999999999999999999 999999999888888887774 446777
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+++++.+||.+||..||++|||+.|++++
T Consensus 318 ~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 318 CTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999999886
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-19 Score=184.00 Aligned_cols=154 Identities=16% Similarity=0.168 Sum_probs=123.3
Q ss_pred hhHHHHHHHHhCC-------CCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCccccc
Q psy6203 339 SMGVMLYALLCGF-------LPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLP 388 (568)
Q Consensus 339 ~~g~~l~~~~~~~-------~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~ 388 (568)
..|++|.+++... ..+++.++..++.|++.++ +++. .+||+|||++....
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~ 235 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccc
Confidence 3478888888753 3589999999999998764 3333 37888999764321
Q ss_pred C-CCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHH
Q psy6203 389 C-KVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNS 464 (568)
Q Consensus 389 ~-~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~ 464 (568)
. ..........||+.|+|||. ....|+.++|||||||++|||++ |.+||.+.+..++...+..+.. ..|..+++.+
T Consensus 236 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 315 (367)
T 3l9p_A 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPV 315 (367)
T ss_dssp HHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 1 11122334578999999997 55679999999999999999998 9999999999999888888754 4567789999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccc
Q psy6203 465 RQIVRSMLQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 465 ~~li~~~L~~dp~~R~t~~~~l~hp~~~ 492 (568)
.+||.+||..||.+|||+.++++|.|+.
T Consensus 316 ~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 316 YRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999998775
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1e-18 Score=184.18 Aligned_cols=116 Identities=21% Similarity=0.291 Sum_probs=83.6
Q ss_pred eEEEccccCcccccCCCCc---eecccccccccccCCC-C-------CCCCCCccceeehhHHHHHHHh-CCCCCCCCCH
Q psy6203 375 TILISQYFPTILLPCKVGQ---VINLLRSAIVLCSAPS-S-------KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSI 442 (568)
Q Consensus 375 ~iki~dfG~~~~~~~~~~~---~~~~~~gt~~~~~pe~-~-------~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~ 442 (568)
.+||+|||++......... .....+||+.|+|||. . ...++.++||||+||++|||++ |++||.+...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 5778999977654322211 2345689999999997 2 2679999999999999999999 9999987653
Q ss_pred HHHHHHHHcCCCCCCC-------CCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q psy6203 443 DQLYDKILNGKYTEPP-------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 443 ~~~~~~i~~~~~~~~~-------~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~ 492 (568)
.. ..+..+....+. .+++++.+||.+||..||.+|||+.++++||||.
T Consensus 246 ~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 33 334444433221 2457899999999999999999999999999996
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-18 Score=175.04 Aligned_cols=141 Identities=20% Similarity=0.276 Sum_probs=101.5
Q ss_pred CCCCChhhHHHHHHHHhhcc-------------Cc--------ceeEEEccccCcccccCCCCceecccccccccccCCC
Q psy6203 351 FLPFDSDSIDQLYDKILSHF-------------MP--------ICTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS 409 (568)
Q Consensus 351 ~~~~~e~~~~~~~~qil~~~-------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~ 409 (568)
.+++++..+..++.|++.++ ++ .+.+||+|||.+..... ........||+.|+|||.
T Consensus 118 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~ 195 (318)
T 2dyl_A 118 QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYMAPER 195 (318)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHH
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC--CccccccCCCccccChhh
Confidence 45788888888888877653 22 23678899996644322 222345679999999997
Q ss_pred ------CCCCCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC-CC--CCCCHHHHHHHHHccCCCcCCC
Q psy6203 410 ------SKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKYT-EP--PWMSPNSRQIVRSMLQVEPGKR 479 (568)
Q Consensus 410 ------~~~~~~~~~DiWSlG~il~eml~g~~pf~~-~~~~~~~~~i~~~~~~-~~--~~~s~~~~~li~~~L~~dp~~R 479 (568)
....++.++||||+||++|+|++|+.||.. .+..+.+..+..+..+ .| ..+++++.+||.+||..||.+|
T Consensus 196 ~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 275 (318)
T 2dyl_A 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275 (318)
T ss_dssp HC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTS
T ss_pred cccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHC
Confidence 245689999999999999999999999987 4566666666665543 33 3579999999999999999999
Q ss_pred CCHHHHhcCccccc
Q psy6203 480 IKIQDLLGHNWVKM 493 (568)
Q Consensus 480 ~t~~~~l~hp~~~~ 493 (568)
||++++++||||+.
T Consensus 276 ps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 276 PKYNKLLEHSFIKR 289 (318)
T ss_dssp CCHHHHTTSHHHHH
T ss_pred cCHHHHhhCHHHHh
Confidence 99999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.1e-19 Score=176.21 Aligned_cols=147 Identities=15% Similarity=0.070 Sum_probs=111.8
Q ss_pred HHHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Cc-----------ceeEEEccccCcccccCCCC----
Q psy6203 341 GVMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MP-----------ICTILISQYFPTILLPCKVG---- 392 (568)
Q Consensus 341 g~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~-----------~~~iki~dfG~~~~~~~~~~---- 392 (568)
|++|.+++. ...++++..+..++.|++.++ ++ ...+||+|||.+........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence 678888887 456899999999999999864 23 33577889997755433221
Q ss_pred --ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC-----CCCCC
Q psy6203 393 --QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKYTE-----PPWMS 461 (568)
Q Consensus 393 --~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~---~~~~~~~i~~~~~~~-----~~~~s 461 (568)
.......||+.|+|||. .+..++.++||||+||++|+|++|+.||.+.+ ..+.+..+....... +..++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T 3uzp_A 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 247 (296)
T ss_dssp CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSC
T ss_pred ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCC
Confidence 11345689999999998 66679999999999999999999999998743 223334443333222 36689
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
+++.+||.+||..||++|||++++++
T Consensus 248 ~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 248 SEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 99999999999999999999998875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=6.3e-19 Score=176.17 Aligned_cols=149 Identities=24% Similarity=0.469 Sum_probs=98.8
Q ss_pred HHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------CcceeEEEccccC-cccccCCCCceecccccccccc
Q psy6203 341 GVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPICTILISQYFP-TILLPCKVGQVINLLRSAIVLC 405 (568)
Q Consensus 341 g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~~~iki~dfG~-~~~~~~~~~~~~~~~~gt~~~~ 405 (568)
|++|.+++... .++++..+..++.|++.++ +++.||.+.+-+. ..+..+++|..
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a----------- 167 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------- 167 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC-----------
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc-----------
Confidence 67888888764 3799999999999999874 3444433332110 01111222211
Q ss_pred cCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCC----CCCCHHHHHHHHHccCCCcC
Q psy6203 406 SAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK----ILNGKYTEP----PWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 406 ~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~----i~~~~~~~~----~~~s~~~~~li~~~L~~dp~ 477 (568)
.......|+.++||||+||++|+|++|++||.+.+....... +..+....| ..+++++.+||.+||..||.
T Consensus 168 -~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 246 (299)
T 3m2w_A 168 -KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 246 (299)
T ss_dssp -EECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred -cccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChh
Confidence 111234578899999999999999999999987764433211 122233333 46899999999999999999
Q ss_pred CCCCHHHHhcCcccccCCCCCCCC
Q psy6203 478 KRIKIQDLLGHNWVKMGPEDNPLR 501 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~~~~~~~~~ 501 (568)
+|||++|+++||||+........+
T Consensus 247 ~Rps~~e~l~hp~~~~~~~~~~~~ 270 (299)
T 3m2w_A 247 QRMTITEFMNHPWIMQSTKVPQTP 270 (299)
T ss_dssp TSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred hCCCHHHHhcChhhcccccCCCCC
Confidence 999999999999998665443333
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=173.99 Aligned_cols=147 Identities=16% Similarity=0.143 Sum_probs=105.6
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|++|.+++...+++++..+..++.|++.++ ++ .+.+||+|||++...............|
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 197 (309)
T 2h34_A 118 GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVG 197 (309)
T ss_dssp CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------C
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCC
Confidence 678888888878999999999999999864 23 3357889999765443322223345689
Q ss_pred ccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHccCCCc
Q psy6203 401 AIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 401 t~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~L~~dp 476 (568)
|+.|+|||. ....++.++||||+||++|+|++|++||.+.+...+...+..... ..++.+++++.+||.+||..||
T Consensus 198 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 277 (309)
T 2h34_A 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNP 277 (309)
T ss_dssp CGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSG
T ss_pred CcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCH
Confidence 999999998 667889999999999999999999999998876655555544332 2356789999999999999999
Q ss_pred CCCC-CHHHHhc
Q psy6203 477 GKRI-KIQDLLG 487 (568)
Q Consensus 477 ~~R~-t~~~~l~ 487 (568)
++|| +++++++
T Consensus 278 ~~Rp~s~~~l~~ 289 (309)
T 2h34_A 278 EDRYVTCGDLSA 289 (309)
T ss_dssp GGSCSSHHHHHH
T ss_pred HHHHHhHHHHHH
Confidence 9999 7777765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=6.4e-19 Score=180.73 Aligned_cols=136 Identities=17% Similarity=0.299 Sum_probs=106.2
Q ss_pred CCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCC-ceecccccccccccCCC-C
Q psy6203 353 PFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVG-QVINLLRSAIVLCSAPS-S 410 (568)
Q Consensus 353 ~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~-~~~~~~~gt~~~~~pe~-~ 410 (568)
.+++..+..++.|++.++ +++ ..+||+|||++........ .......||+.|+|||. .
T Consensus 189 ~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 268 (359)
T 3vhe_A 189 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268 (359)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhc
Confidence 399999999999999864 333 3578899997754433222 23445678999999997 5
Q ss_pred CCCCCCccceeehhHHHHHHHh-CCCCCCCCCHH-HHHHHHHcC-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 411 KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID-QLYDKILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 411 ~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
...|+.++||||+||++|+|++ |.+||.+.+.. .....+..+ ....|..+++++.+||.+||..||.+|||+.|+++
T Consensus 269 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 348 (359)
T 3vhe_A 269 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348 (359)
T ss_dssp HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5678999999999999999998 99999987643 333444444 44567789999999999999999999999999987
Q ss_pred C
Q psy6203 488 H 488 (568)
Q Consensus 488 h 488 (568)
|
T Consensus 349 ~ 349 (359)
T 3vhe_A 349 H 349 (359)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.9e-19 Score=172.08 Aligned_cols=148 Identities=20% Similarity=0.252 Sum_probs=117.1
Q ss_pred HHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 341 GVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
|++|.+++... ..+++..+..++.|++.++ ++ ...+||+|||.+...............
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 166 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 166 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence 67788888753 5799999999999998764 33 335788899966543221111223446
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHccCCCc
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dp 476 (568)
+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..+.. ..|...++.+.+||.+||..||
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p 246 (267)
T 3t9t_A 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERP 246 (267)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCCh
Confidence 7788999997 55678899999999999999999 9999999998888888887743 4566789999999999999999
Q ss_pred CCCCCHHHHhcC
Q psy6203 477 GKRIKIQDLLGH 488 (568)
Q Consensus 477 ~~R~t~~~~l~h 488 (568)
.+|||+.+++++
T Consensus 247 ~~Rps~~~ll~~ 258 (267)
T 3t9t_A 247 EDRPAFSRLLRQ 258 (267)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5.5e-19 Score=178.86 Aligned_cols=149 Identities=15% Similarity=0.211 Sum_probs=117.5
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCc-eecc
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQ-VINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~-~~~~ 397 (568)
.|++|.+++... +.+++..+..++.|++.++ ++ .+++||+|||++......... ....
T Consensus 97 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 176 (325)
T 3kex_A 97 PLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176 (325)
T ss_dssp TTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC---
T ss_pred CCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccC
Confidence 467788888764 6899999999999999864 33 346789999987654333222 2344
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 474 (568)
..||+.|+|||. ....|+.++||||+||++|+|++ |++||.+.+..+....+..+. ...|...++++.+||.+||..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 256 (325)
T 3kex_A 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMI 256 (325)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCS
T ss_pred CCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCC
Confidence 567788999997 55568999999999999999999 999999988778877777764 446777889999999999999
Q ss_pred CcCCCCCHHHHhcC
Q psy6203 475 EPGKRIKIQDLLGH 488 (568)
Q Consensus 475 dp~~R~t~~~~l~h 488 (568)
||.+|||+.++++|
T Consensus 257 dp~~Rps~~el~~~ 270 (325)
T 3kex_A 257 DENIRPTFKELANE 270 (325)
T ss_dssp CTTTSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999886
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=9.5e-19 Score=173.72 Aligned_cols=151 Identities=17% Similarity=0.178 Sum_probs=121.2
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCc--eec
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQ--VIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~--~~~ 396 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++. .+||+|||++......... ...
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 92 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp TTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 36788888864 45799999999999999864 3333 5788999977654332221 123
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
...||+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..+. ...|..+++++.+||.+||.
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~ 251 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWI 251 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcC
Confidence 3456889999998 55678899999999999999998 999999988888888887765 45677899999999999999
Q ss_pred CCcCCCCCHHHHhcCcc
Q psy6203 474 VEPGKRIKIQDLLGHNW 490 (568)
Q Consensus 474 ~dp~~R~t~~~~l~hp~ 490 (568)
.||.+|||+.++++|.+
T Consensus 252 ~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 252 YKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp SSGGGSCCHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHH
Confidence 99999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-18 Score=175.54 Aligned_cols=148 Identities=14% Similarity=0.181 Sum_probs=117.1
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc--eec
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ--VIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~--~~~ 396 (568)
.|++|.+++... +.+++..+..++.|++.++ +++ +.+||+|||++......... ...
T Consensus 133 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 212 (325)
T 3kul_A 133 ENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212 (325)
T ss_dssp TTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC
T ss_pred CCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeecc
Confidence 377898888653 6899999999999998764 333 35788999977654332221 222
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
...+|+.|+|||. ....++.++||||+||++|+|++ |..||.+.+..+....+..+. .+.|..+++.+.+||.+||.
T Consensus 213 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 292 (325)
T 3kul_A 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWH 292 (325)
T ss_dssp ---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHcc
Confidence 3456778999998 55678999999999999999999 999999999988888887763 45677899999999999999
Q ss_pred CCcCCCCCHHHHhc
Q psy6203 474 VEPGKRIKIQDLLG 487 (568)
Q Consensus 474 ~dp~~R~t~~~~l~ 487 (568)
.||.+|||+.++++
T Consensus 293 ~dp~~Rps~~eil~ 306 (325)
T 3kul_A 293 KDRAQRPRFSQIVS 306 (325)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=6.8e-19 Score=174.14 Aligned_cols=149 Identities=14% Similarity=0.156 Sum_probs=113.9
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++ +++||+|||.+..............
T Consensus 95 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 174 (281)
T 3cc6_A 95 PYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174 (281)
T ss_dssp TTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CC
T ss_pred CCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccC
Confidence 36778777765 34699999999999998764 333 3578999997654433222223445
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 475 (568)
.+|+.|+|||. ....++.++||||+||++|+|++ |++||...+..+....+..+. .+.|..+++.+.+||.+||..|
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 254 (281)
T 3cc6_A 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYD 254 (281)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 67888999997 55678899999999999999998 999998877777666666553 4567778999999999999999
Q ss_pred cCCCCCHHHHhcC
Q psy6203 476 PGKRIKIQDLLGH 488 (568)
Q Consensus 476 p~~R~t~~~~l~h 488 (568)
|++|||+.+++++
T Consensus 255 p~~Rps~~ell~~ 267 (281)
T 3cc6_A 255 PSDRPRFTELVCS 267 (281)
T ss_dssp GGGSCCHHHHHHH
T ss_pred chhCcCHHHHHHH
Confidence 9999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-18 Score=173.79 Aligned_cols=148 Identities=15% Similarity=0.104 Sum_probs=113.9
Q ss_pred HHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccce--------e-----EEEccccCcccccCCCC--
Q psy6203 341 GVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPIC--------T-----ILISQYFPTILLPCKVG-- 392 (568)
Q Consensus 341 g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~~--------~-----iki~dfG~~~~~~~~~~-- 392 (568)
|++|.+++... .++++..+..++.|++.++ +++. . +||+|||.+........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (298)
T 1csn_A 89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168 (298)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccc
Confidence 68888888854 4699999999999999874 3332 2 88999998755433221
Q ss_pred ----ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----CCCC
Q psy6203 393 ----QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYT-----EPPW 459 (568)
Q Consensus 393 ----~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~---~~~~~~~~i~~~~~~-----~~~~ 459 (568)
......+||+.|+|||. .+..++.++||||+||++|+|++|++||.+. +....+..+...... .+..
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1csn_A 169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 248 (298)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhh
Confidence 12345689999999998 6677899999999999999999999999874 344555555443221 2346
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+++++.+||.+||..||++|||++++++.
T Consensus 249 ~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 249 FPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp SCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 89999999999999999999999988753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-18 Score=172.59 Aligned_cols=148 Identities=13% Similarity=0.107 Sum_probs=119.0
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCce--ecc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQV--INL 397 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~--~~~ 397 (568)
.|++|.+++...+.+++..+..++.|++.++ +++. .+||+|||++.......... ...
T Consensus 100 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 179 (291)
T 1xbb_A 100 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179 (291)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccccccc
Confidence 3688889998888899999999999999864 3333 57899999776543332221 223
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 474 (568)
..+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..+. ...|..+++++.++|.+||..
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 259 (291)
T 1xbb_A 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 259 (291)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 456788999997 55568899999999999999999 999999999888888887765 446778999999999999999
Q ss_pred CcCCCCCHHHHhc
Q psy6203 475 EPGKRIKIQDLLG 487 (568)
Q Consensus 475 dp~~R~t~~~~l~ 487 (568)
||.+|||+.++++
T Consensus 260 dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 260 DVENRPGFAAVEL 272 (291)
T ss_dssp STTTSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.73 E-value=8.5e-19 Score=177.62 Aligned_cols=149 Identities=17% Similarity=0.227 Sum_probs=117.1
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc-eecc
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ-VINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~-~~~~ 397 (568)
.+++|.+++.. ...+++..+..++.|++.++ +++ +++||+|||++......... ....
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 178 (327)
T 3poz_A 99 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178 (327)
T ss_dssp TTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC------
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccC
Confidence 36778777765 56899999999999998864 343 36789999977554332221 2234
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 474 (568)
..||+.|+|||. .+..|+.++||||+||++|||++ |++||.+.+..++...+..+. .+.|...+.++.+||.+||..
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 258 (327)
T 3poz_A 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 258 (327)
T ss_dssp -CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred CCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 466889999997 66678999999999999999999 999999988777777776654 456777899999999999999
Q ss_pred CcCCCCCHHHHhcC
Q psy6203 475 EPGKRIKIQDLLGH 488 (568)
Q Consensus 475 dp~~R~t~~~~l~h 488 (568)
||.+|||+.+++++
T Consensus 259 ~p~~Rps~~ell~~ 272 (327)
T 3poz_A 259 DADSRPKFRELIIE 272 (327)
T ss_dssp CGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.4e-19 Score=179.90 Aligned_cols=147 Identities=15% Similarity=0.096 Sum_probs=110.9
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------e--eEEEccccCcccccCCC------C
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------C--TILISQYFPTILLPCKV------G 392 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~--~iki~dfG~~~~~~~~~------~ 392 (568)
|++|.+++...++|++.++..++.|++.++ +++ . .+||+|||++....... .
T Consensus 135 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 214 (345)
T 2v62_A 135 GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214 (345)
T ss_dssp EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchh
Confidence 789999999878999999999999999874 222 2 68899999775432211 1
Q ss_pred ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCC---------CCC
Q psy6203 393 QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILNGKYTEP---------PWM 460 (568)
Q Consensus 393 ~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~--~~~~~~~~i~~~~~~~~---------~~~ 460 (568)
.......||+.|+|||. .+..++.++||||+||++|||++|+.||.+. +...............| ..+
T Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (345)
T 2v62_A 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSS 294 (345)
T ss_dssp CGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSC
T ss_pred ccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhcccccc
Confidence 11245689999999998 5667899999999999999999999999663 33322222111111111 268
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
++++.+||.+||..||++|||++++++
T Consensus 295 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 295 CCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 899999999999999999999998876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-19 Score=189.16 Aligned_cols=144 Identities=11% Similarity=0.101 Sum_probs=108.5
Q ss_pred HHHHHHHHh-------CCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCc
Q psy6203 341 GVMLYALLC-------GFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQ 393 (568)
Q Consensus 341 g~~l~~~~~-------~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~ 393 (568)
+++|.+++. ...++++..+..++.|++.++ +|+. .+||+|||++... +.
T Consensus 188 ~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~----~~ 263 (413)
T 3dzo_A 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD----GA 263 (413)
T ss_dssp SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEET----TE
T ss_pred cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeec----CC
Confidence 355555553 134678888888889998764 4443 5788999965432 22
Q ss_pred eecccccccccccCCC-----------CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Q psy6203 394 VINLLRSAIVLCSAPS-----------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSP 462 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-----------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~ 462 (568)
.....+| +.|+|||. ....|+.++|||||||++|||++|+.||.+.+.......+.. ....+++
T Consensus 264 ~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~ 338 (413)
T 3dzo_A 264 SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQ 338 (413)
T ss_dssp EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCH
T ss_pred ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh----hcccCCH
Confidence 3456678 99999996 223477899999999999999999999988765444333332 2245789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 463 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 463 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
++.+||.+||..||++|||+.++++||||+.
T Consensus 339 ~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 339 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=9.5e-19 Score=177.11 Aligned_cols=141 Identities=19% Similarity=0.230 Sum_probs=88.5
Q ss_pred CCCCChhhHHHHHHHHhhcc-------------Ccc--------eeEEEccccCcccccCCCCceecccccccccccCCC
Q psy6203 351 FLPFDSDSIDQLYDKILSHF-------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS 409 (568)
Q Consensus 351 ~~~~~e~~~~~~~~qil~~~-------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~ 409 (568)
...+++..+..++.|++.++ +++ +.+||+|||++..... ........||+.|+|||.
T Consensus 119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~gt~~y~aPE~ 196 (327)
T 3aln_A 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPER 196 (327)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----------------------
T ss_pred cccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc--ccccccCCCCccccCcee
Confidence 46788888888888887653 333 3678999997654322 222334579999999997
Q ss_pred -----CCCCCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC-CC----CCCCHHHHHHHHHccCCCcCC
Q psy6203 410 -----SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI-DQLYDKILNGKYT-EP----PWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 410 -----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~-~~~~~~i~~~~~~-~~----~~~s~~~~~li~~~L~~dp~~ 478 (568)
....++.++||||+||++|+|++|+.||.+.+. .+.+..+..+..+ .+ ..+++.+.+||.+||..||.+
T Consensus 197 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 276 (327)
T 3aln_A 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESK 276 (327)
T ss_dssp ---------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGG
T ss_pred eccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhh
Confidence 345689999999999999999999999987542 2333333333222 22 358899999999999999999
Q ss_pred CCCHHHHhcCccccc
Q psy6203 479 RIKIQDLLGHNWVKM 493 (568)
Q Consensus 479 R~t~~~~l~hp~~~~ 493 (568)
|||+.++++||||..
T Consensus 277 Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 277 RPKYKELLKHPFILM 291 (327)
T ss_dssp SCCHHHHTTSHHHHH
T ss_pred CcCHHHHHhChHHHH
Confidence 999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.73 E-value=2.1e-18 Score=171.14 Aligned_cols=148 Identities=15% Similarity=0.234 Sum_probs=119.1
Q ss_pred hHHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 340 MGVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++ +.+||+|||.+.............
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 171 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETT
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccC
Confidence 36888888874 45699999999999998764 333 357899999776544333334445
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~ 474 (568)
..+|+.|+|||. ....++.++||||+||++|+|++ |.+||.+.+.......+... ....|..+++.+.+||.+||..
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (288)
T 3kfa_A 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251 (288)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCC
Confidence 567888999997 55568999999999999999999 99999998877777777665 3456778999999999999999
Q ss_pred CcCCCCCHHHHhc
Q psy6203 475 EPGKRIKIQDLLG 487 (568)
Q Consensus 475 dp~~R~t~~~~l~ 487 (568)
||.+|||++++++
T Consensus 252 dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 252 NPSDRPSFAEIHQ 264 (288)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-18 Score=171.48 Aligned_cols=148 Identities=14% Similarity=0.182 Sum_probs=118.2
Q ss_pred hHHHHHHHHhCCC--CCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 340 MGVMLYALLCGFL--PFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
.|++|.+++.... .+++.++..++.|++.++ +++ .++||+|||.+.............
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 3688888887643 799999999999999864 333 367889999765543322222334
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 474 (568)
..+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..+. ...|..+++++.+||.+||..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 249 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhcc
Confidence 466788999997 55668899999999999999999 999999999888888887764 345677899999999999999
Q ss_pred CcCCCCCHHHHhc
Q psy6203 475 EPGKRIKIQDLLG 487 (568)
Q Consensus 475 dp~~R~t~~~~l~ 487 (568)
||++|||++++++
T Consensus 250 ~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 250 RPEDRPTFDYLRS 262 (279)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=9.7e-19 Score=175.74 Aligned_cols=137 Identities=18% Similarity=0.239 Sum_probs=110.0
Q ss_pred CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc-eecccccccccccCCC-
Q psy6203 352 LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ-VINLLRSAIVLCSAPS- 409 (568)
Q Consensus 352 ~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~-~~~~~~gt~~~~~pe~- 409 (568)
..+++.++..++.|++.++ +++ .++||+|||++......... ......+|+.|+|||.
T Consensus 145 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 224 (314)
T 2ivs_A 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL 224 (314)
T ss_dssp CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH
T ss_pred cCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh
Confidence 3489999999999998864 333 36889999977544322221 2234567888999997
Q ss_pred CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 410 SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 410 ~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
....++.++||||+||++|+|++ |.+||.+.+...+...+..+. ...|..+++++.+||.+||..||.+|||++++++
T Consensus 225 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 225 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 55678999999999999999999 999999988888877777764 3467789999999999999999999999999987
Q ss_pred C
Q psy6203 488 H 488 (568)
Q Consensus 488 h 488 (568)
+
T Consensus 305 ~ 305 (314)
T 2ivs_A 305 D 305 (314)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-18 Score=176.36 Aligned_cols=148 Identities=18% Similarity=0.242 Sum_probs=112.6
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC-ceeccc
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG-QVINLL 398 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~-~~~~~~ 398 (568)
|++|.+++.. .+.+++..+..++.|++.++ +++. ++||+|||.+........ ......
T Consensus 100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~ 179 (327)
T 3lzb_A 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179 (327)
T ss_dssp SCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCC
Confidence 5677777764 56799999999999999864 3443 578999997755432221 122334
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 475 (568)
.+|+.|+|||. .+..|+.++||||+||++|+|++ |.+||.+.+..+....+..+. .+.|...++++.+||.+||..|
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 259 (327)
T 3lzb_A 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMID 259 (327)
T ss_dssp CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSS
T ss_pred CccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCC
Confidence 66888999997 66678999999999999999999 999999988887777776664 4567779999999999999999
Q ss_pred cCCCCCHHHHhcC
Q psy6203 476 PGKRIKIQDLLGH 488 (568)
Q Consensus 476 p~~R~t~~~~l~h 488 (568)
|.+|||+.|+++.
T Consensus 260 p~~Rps~~ell~~ 272 (327)
T 3lzb_A 260 ADSRPKFRELIIE 272 (327)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999998863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.2e-18 Score=173.26 Aligned_cols=149 Identities=17% Similarity=0.233 Sum_probs=113.0
Q ss_pred hHHHHHHHH------hCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCC-
Q psy6203 340 MGVMLYALL------CGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVG- 392 (568)
Q Consensus 340 ~g~~l~~~~------~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~- 392 (568)
.|++|.+++ .+...+++..+..++.|++.++ +++ +.+||+|||++........
T Consensus 124 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 203 (313)
T 3brb_A 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203 (313)
T ss_dssp TTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC---------
T ss_pred cCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceeccccccc
Confidence 356777777 3456799999999999999864 333 3678899997654322211
Q ss_pred ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q psy6203 393 QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVR 469 (568)
Q Consensus 393 ~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 469 (568)
.......+|+.|+|||. ....++.++||||+||++|+|++ |.+||.+.+.......+..+. ...|..+++++.+||.
T Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 283 (313)
T 3brb_A 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMY 283 (313)
T ss_dssp -------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHH
T ss_pred CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHH
Confidence 11234567888999998 66778999999999999999999 999999988888888777764 4467779999999999
Q ss_pred HccCCCcCCCCCHHHHhcC
Q psy6203 470 SMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 470 ~~L~~dp~~R~t~~~~l~h 488 (568)
+||..||.+|||+.+++++
T Consensus 284 ~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 284 SCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=2e-18 Score=175.79 Aligned_cols=137 Identities=14% Similarity=0.183 Sum_probs=109.7
Q ss_pred CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCC-CceecccccccccccCCC-
Q psy6203 352 LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKV-GQVINLLRSAIVLCSAPS- 409 (568)
Q Consensus 352 ~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~-~~~~~~~~gt~~~~~pe~- 409 (568)
.++++.++..++.|++.++ +++ +.+||+|||++....... ........||+.|+|||.
T Consensus 169 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 248 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence 6799999999999998764 333 367889999764432111 112344578899999997
Q ss_pred CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 410 SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 410 ~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
....++.++||||+||++|+|++ |..||.+.+..+....+..+.. ..|..+++++.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 249 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55568999999999999999999 9999999998888888888765 467789999999999999999999999999976
Q ss_pred C
Q psy6203 488 H 488 (568)
Q Consensus 488 h 488 (568)
+
T Consensus 329 ~ 329 (343)
T 1luf_A 329 I 329 (343)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.5e-18 Score=168.93 Aligned_cols=145 Identities=17% Similarity=0.201 Sum_probs=110.4
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc---------------Ccc----------------eeEEEccccCccccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF---------------MPI----------------CTILISQYFPTILLP 388 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~---------------~~~----------------~~iki~dfG~~~~~~ 388 (568)
.|++|.+++.+ .++++..+..++.|++.++ +++ ..+|++|||.+....
T Consensus 89 ~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 167 (271)
T 3dtc_A 89 RGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167 (271)
T ss_dssp TTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----
T ss_pred CCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccc
Confidence 36788888875 5899999999999988653 233 236788888664322
Q ss_pred CCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Q psy6203 389 CKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--TEPPWMSPNSR 465 (568)
Q Consensus 389 ~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~ 465 (568)
.. ......||+.|+|||. ....++.++||||+||++|+|++|++||.+.+.......+..... +.|..+++.+.
T Consensus 168 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (271)
T 3dtc_A 168 RT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFA 244 (271)
T ss_dssp -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cc---cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHH
Confidence 11 1235679999999997 556789999999999999999999999999888777776666543 45677899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+||.+||..||.+|||+.|+++|
T Consensus 245 ~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 245 KLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-18 Score=172.23 Aligned_cols=147 Identities=16% Similarity=0.094 Sum_probs=111.4
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCC----
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVG---- 392 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~---- 392 (568)
|++|.+++.. ..++++..+..++.|++.++ +++ +.+||+|||.+........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~ 167 (296)
T 4hgt_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence 6788888873 46899999999999999864 333 3467889997755433221
Q ss_pred --ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC-----CCCC
Q psy6203 393 --QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---DQLYDKILNGKYTEP-----PWMS 461 (568)
Q Consensus 393 --~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~---~~~~~~i~~~~~~~~-----~~~s 461 (568)
.......||+.|+|||. .+..++.++||||+||++|+|++|++||.+.+. ...+..+.......| ..++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T 4hgt_A 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 247 (296)
T ss_dssp CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSC
T ss_pred CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCC
Confidence 12345689999999998 666799999999999999999999999987432 223333333322222 5678
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
+++.+||.+||..||++|||++++++
T Consensus 248 ~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 248 SEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999999999999999999998876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-18 Score=175.17 Aligned_cols=146 Identities=17% Similarity=0.233 Sum_probs=114.0
Q ss_pred HHHHHHHHhCCC----------------CCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCc
Q psy6203 341 GVMLYALLCGFL----------------PFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPT 384 (568)
Q Consensus 341 g~~l~~~~~~~~----------------~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~ 384 (568)
|++|.+++.... ++++..+..++.|++.++ +++. .+||+|||++
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~ 189 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcC
Confidence 567777776543 799999999999998764 3333 5788888865
Q ss_pred ccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCC
Q psy6203 385 ILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMS 461 (568)
Q Consensus 385 ~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s 461 (568)
..... ........+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..+. ...|..++
T Consensus 190 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (327)
T 1fvr_A 190 RGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 267 (327)
T ss_dssp ESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBC
T ss_pred ccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCC
Confidence 43211 111234467888999997 55678899999999999999998 999999999888888877763 44667789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+++.+||.+||..||.+|||+++++++
T Consensus 268 ~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 268 DEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999886
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-18 Score=175.32 Aligned_cols=138 Identities=17% Similarity=0.274 Sum_probs=106.9
Q ss_pred CCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC-ceecccccccccccCCC-C
Q psy6203 353 PFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG-QVINLLRSAIVLCSAPS-S 410 (568)
Q Consensus 353 ~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~-~~~~~~~gt~~~~~pe~-~ 410 (568)
.+++..+..++.|++.++ +++. .+||+|||++........ .......||+.|+|||. .
T Consensus 168 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 247 (344)
T 1rjb_A 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247 (344)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence 489999999999999864 3333 578999997755433322 22345567889999997 5
Q ss_pred CCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHH-cC-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 411 KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKIL-NG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 411 ~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~-~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
...++.++|||||||++|+|++ |.+||.+.+....+..+. .+ ....|...++++.+||.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 248 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5678999999999999999998 999999876544444433 33 33457778999999999999999999999999998
Q ss_pred Ccc
Q psy6203 488 HNW 490 (568)
Q Consensus 488 hp~ 490 (568)
|-.
T Consensus 328 ~l~ 330 (344)
T 1rjb_A 328 FLG 330 (344)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-18 Score=183.58 Aligned_cols=149 Identities=13% Similarity=0.141 Sum_probs=118.0
Q ss_pred hhHHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 339 SMGVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 339 ~~g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
..|++|.+++... ..+++..+..++.|++.++ +++ ..+||+|||++............
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 3478899998853 3789999999999998864 333 36789999977654221111122
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
...+|..|+|||. ....|+.++||||+||++|||++ |++||.+.+..++...+..+. .+.|..+++++.+||.+||.
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~ 423 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWK 423 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 3456778999998 55568999999999999999999 999999999888888877663 45677899999999999999
Q ss_pred CCcCCCCCHHHHhc
Q psy6203 474 VEPGKRIKIQDLLG 487 (568)
Q Consensus 474 ~dp~~R~t~~~~l~ 487 (568)
.||++|||++++++
T Consensus 424 ~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 424 NRPEERPTFEYIQS 437 (454)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999998865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6e-18 Score=165.97 Aligned_cols=149 Identities=18% Similarity=0.203 Sum_probs=110.9
Q ss_pred hhHHHHHHHHhCCC--CCChhhHHHHHHHHhhcc--------------CcceeEEEccccCcccccCCCC--ceeccccc
Q psy6203 339 SMGVMLYALLCGFL--PFDSDSIDQLYDKILSHF--------------MPICTILISQYFPTILLPCKVG--QVINLLRS 400 (568)
Q Consensus 339 ~~g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~--------------~~~~~iki~dfG~~~~~~~~~~--~~~~~~~g 400 (568)
..|++|.+++.... ++++..+..++.|+++++ +++.||.+.+-|...+...+.+ .......|
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 170 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY 170 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCBS
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecccCccC
Confidence 34788999998755 599999999999988753 4555555444432222111111 12234578
Q ss_pred ccccccCCC-CCC---CCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHccCC
Q psy6203 401 AIVLCSAPS-SKQ---YYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 401 t~~~~~pe~-~~~---~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~ 474 (568)
|+.|+|||. .+. .++.++||||+||++|+|++|++||.+.+..+....+... .+..|..+++++.+||.+||..
T Consensus 171 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 250 (271)
T 3kmu_A 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNE 250 (271)
T ss_dssp CGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 999999997 322 3344899999999999999999999998887776666544 3446778999999999999999
Q ss_pred CcCCCCCHHHHhc
Q psy6203 475 EPGKRIKIQDLLG 487 (568)
Q Consensus 475 dp~~R~t~~~~l~ 487 (568)
||++|||++++++
T Consensus 251 ~p~~Rps~~~il~ 263 (271)
T 3kmu_A 251 DPAKRPKFDMIVP 263 (271)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.1e-18 Score=174.65 Aligned_cols=153 Identities=16% Similarity=0.173 Sum_probs=119.9
Q ss_pred hHHHHHHHHhCC-------CCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccC
Q psy6203 340 MGVMLYALLCGF-------LPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPC 389 (568)
Q Consensus 340 ~g~~l~~~~~~~-------~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~ 389 (568)
.|++|.+++... ..+++.++..++.|++.++ +++. .+||+|||++.....
T Consensus 116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~ 195 (327)
T 2yfx_A 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195 (327)
T ss_dssp TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC
T ss_pred CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccccccc
Confidence 367888888754 3488999999999998764 3333 377888886643322
Q ss_pred CC-CceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHH
Q psy6203 390 KV-GQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSR 465 (568)
Q Consensus 390 ~~-~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~ 465 (568)
.. ........||+.|+|||. ....++.++|||||||++|+|++ |.+||.+.+..+....+..+.. ..+..+++.+.
T Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 275 (327)
T 2yfx_A 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY 275 (327)
T ss_dssp ------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11 112234567889999997 55668999999999999999998 9999999998888888877644 45677899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccc
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~hp~~~ 492 (568)
+||.+||..||.+|||+.++++|.|+.
T Consensus 276 ~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 276 RIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-18 Score=173.00 Aligned_cols=149 Identities=17% Similarity=0.248 Sum_probs=115.5
Q ss_pred hHHHHHHHHhCCCC----------------CChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccC
Q psy6203 340 MGVMLYALLCGFLP----------------FDSDSIDQLYDKILSHF------------MP--------ICTILISQYFP 383 (568)
Q Consensus 340 ~g~~l~~~~~~~~~----------------~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~ 383 (568)
.|++|.+++..... +++..+..++.|++.++ ++ .+++||+|||.
T Consensus 115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 194 (316)
T 2xir_A 115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194 (316)
T ss_dssp TTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGG
T ss_pred CCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCcc
Confidence 36788888876543 89999999999998864 33 34678999997
Q ss_pred cccccCCCC-ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHH-HHHHHHHcC-CCCCCC
Q psy6203 384 TILLPCKVG-QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSID-QLYDKILNG-KYTEPP 458 (568)
Q Consensus 384 ~~~~~~~~~-~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~-~~~~~i~~~-~~~~~~ 458 (568)
+........ .......||+.|+|||. ....++.++||||+||++|+|++ |.+||.+.+.. .....+..+ ....|.
T Consensus 195 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 274 (316)
T 2xir_A 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 274 (316)
T ss_dssp GSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT
T ss_pred ccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCC
Confidence 755433322 22345678889999997 55668999999999999999998 99999886633 344444444 345677
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
..++++.++|.+||..||.+|||+.++++|
T Consensus 275 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 275 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 799999999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=3.3e-18 Score=181.17 Aligned_cols=153 Identities=16% Similarity=0.200 Sum_probs=116.4
Q ss_pred hHHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 340 MGVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++ ..+||+|||++.............
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 36788888874 35699999999999998864 333 367899999776543222222334
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 474 (568)
..+|..|+|||. ....++.++||||+||++|||++ |++||.+.+..+....+..+. .+.|..+++.+.+||.+||..
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 420 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 420 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 456788999997 55568999999999999999999 999999999888888887764 456778999999999999999
Q ss_pred CcCCCCCHHHHhcC--cccc
Q psy6203 475 EPGKRIKIQDLLGH--NWVK 492 (568)
Q Consensus 475 dp~~R~t~~~~l~h--p~~~ 492 (568)
||++|||++++++. .++.
T Consensus 421 dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 421 EPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp SGGGSCCHHHHHHHHHTTTS
T ss_pred ChhhCcCHHHHHHHHHHHhc
Confidence 99999999998763 4554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-18 Score=175.73 Aligned_cols=147 Identities=16% Similarity=0.110 Sum_probs=112.2
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccce--------e-----EEEccccCcccccCCCCc-
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPIC--------T-----ILISQYFPTILLPCKVGQ- 393 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~--------~-----iki~dfG~~~~~~~~~~~- 393 (568)
|++|.+++.. ...|++..+..++.|++.++ +++. + +||+|||++.........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~ 167 (330)
T 2izr_A 88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK 167 (330)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCc
Confidence 6778888775 46899999999999999864 3332 3 899999987654322211
Q ss_pred -----eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCC----CC
Q psy6203 394 -----VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD---SIDQLYDKILNGKYTEPP----WM 460 (568)
Q Consensus 394 -----~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~---~~~~~~~~i~~~~~~~~~----~~ 460 (568)
.....+||+.|+|||. .+..++.++|||||||++|||++|++||.+. +..+.+..+.......|. ..
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (330)
T 2izr_A 168 HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCEN 247 (330)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhcc
Confidence 1246789999999998 6677899999999999999999999999874 445556666554433331 12
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
.+++.+||..||..||.+||+++++.+
T Consensus 248 ~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 248 FPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 349999999999999999999888765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=9e-18 Score=167.30 Aligned_cols=148 Identities=16% Similarity=0.227 Sum_probs=116.7
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCC---CCcee
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCK---VGQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~---~~~~~ 395 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++ +.+||+|||.+...... .....
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 185 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccC
Confidence 36788888876 56799999999999998864 333 36889999977543221 11123
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHcc
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSML 472 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L 472 (568)
....+|+.|+|||. ....++.++||||+||++|+|++ |.+||.+.+..+....+..+. ...|..+++.+.+||.+||
T Consensus 186 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 265 (298)
T 3pls_A 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCW 265 (298)
T ss_dssp SCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHc
Confidence 44578889999998 67778999999999999999999 677777777777777777665 4467778999999999999
Q ss_pred CCCcCCCCCHHHHhc
Q psy6203 473 QVEPGKRIKIQDLLG 487 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~ 487 (568)
..||.+|||+.++++
T Consensus 266 ~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 266 EADPAVRPTFRVLVG 280 (298)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999998876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.8e-18 Score=187.83 Aligned_cols=150 Identities=13% Similarity=0.116 Sum_probs=119.5
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC--cee
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG--QVI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~--~~~ 395 (568)
|..|++|.+++...+.+++..+..++.|++.++ +++. .+||+|||++........ ...
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 334889999999888999999999999999864 4443 578999998765433222 122
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHcc
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSML 472 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L 472 (568)
....+|+.|+|||. ....|+.++||||+||++|||++ |++||.+.+..++...+..+. ...|..+++++.+||.+||
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 609 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 609 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 33456788999998 56678999999999999999998 999999999988888888775 4467789999999999999
Q ss_pred CCCcCCCCCHHHHhc
Q psy6203 473 QVEPGKRIKIQDLLG 487 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~ 487 (568)
..||++|||++++++
T Consensus 610 ~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 610 TYDVENRPGFAAVEL 624 (635)
T ss_dssp CSSTTTSCCHHHHHH
T ss_pred CCCHhHCcCHHHHHH
Confidence 999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.71 E-value=5.1e-18 Score=172.35 Aligned_cols=148 Identities=14% Similarity=0.215 Sum_probs=117.2
Q ss_pred HHHHHHHHhCCC----------------CCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCc
Q psy6203 341 GVMLYALLCGFL----------------PFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPT 384 (568)
Q Consensus 341 g~~l~~~~~~~~----------------~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~ 384 (568)
|++|.+++.... .+++.++..++.|++.++ +++ +.+||+|||++
T Consensus 125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 204 (334)
T 2pvf_A 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204 (334)
T ss_dssp TCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccccc
Confidence 567777776543 489999999999998864 333 45789999976
Q ss_pred ccccCCCC-ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCC
Q psy6203 385 ILLPCKVG-QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWM 460 (568)
Q Consensus 385 ~~~~~~~~-~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 460 (568)
........ .......+|+.|+|||. ....++.++||||+||++|+|++ |.+||.+.+..++...+..+. ...|..+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (334)
T 2pvf_A 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANC 284 (334)
T ss_dssp EECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTC
T ss_pred ccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccC
Confidence 54432221 11233467888999997 55668899999999999999999 999999999888888777764 4467778
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
++++.+||.+||..||.+|||+.+++++
T Consensus 285 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 285 TNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.1e-18 Score=173.67 Aligned_cols=147 Identities=12% Similarity=0.059 Sum_probs=111.7
Q ss_pred HHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Cc--------ce--eEEEccccCcccccCCCC----
Q psy6203 341 GVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MP--------IC--TILISQYFPTILLPCKVG---- 392 (568)
Q Consensus 341 g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~--------~~--~iki~dfG~~~~~~~~~~---- 392 (568)
|++|.+++... .++++.++..++.|++.++ ++ .. .+||+|||++........
T Consensus 141 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 220 (352)
T 2jii_A 141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220 (352)
T ss_dssp CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCC
T ss_pred CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccc
Confidence 78999999875 7899999999999999874 22 22 689999997754322111
Q ss_pred --ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC--HHHHHHHH---HcCCCCCC------C
Q psy6203 393 --QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKI---LNGKYTEP------P 458 (568)
Q Consensus 393 --~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~--~~~~~~~i---~~~~~~~~------~ 458 (568)
.......||+.|+|||. .+..++.++|||||||++|+|++|+.||.+.. ........ ......++ .
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (352)
T 2jii_A 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWI 300 (352)
T ss_dssp CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEE
T ss_pred cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccC
Confidence 11244589999999998 66689999999999999999999999998753 33333222 22222221 2
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
.+++++.+||.+||..||.+|||++++++
T Consensus 301 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 301 RPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 46899999999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=6.8e-18 Score=171.43 Aligned_cols=149 Identities=17% Similarity=0.199 Sum_probs=113.6
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc--eec
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ--VIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~--~~~ 396 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++ +.+||+|||.+......... ...
T Consensus 129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 208 (333)
T 1mqb_A 129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208 (333)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccC
Confidence 36788888875 36899999999999998764 333 36789999976554322211 122
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~ 473 (568)
...+|+.|+|||. ....++.++||||+||++|+|++ |+.||.+.+..++...+..+ ..+.+..+++.+.+||.+||.
T Consensus 209 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 288 (333)
T 1mqb_A 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQ 288 (333)
T ss_dssp --CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTC
T ss_pred CCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcC
Confidence 3356788999998 56678999999999999999998 99999999888888888776 345667789999999999999
Q ss_pred CCcCCCCCHHHHhcC
Q psy6203 474 VEPGKRIKIQDLLGH 488 (568)
Q Consensus 474 ~dp~~R~t~~~~l~h 488 (568)
.||.+||++.+++++
T Consensus 289 ~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 289 QERARRPKFADIVSI 303 (333)
T ss_dssp SSTTTSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1e-17 Score=166.18 Aligned_cols=144 Identities=18% Similarity=0.202 Sum_probs=109.6
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc--------------Cccee-------------EEEccccCcccccCCC
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF--------------MPICT-------------ILISQYFPTILLPCKV 391 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~--------------~~~~~-------------iki~dfG~~~~~~~~~ 391 (568)
.|++|.+.+.. ..++++..+..++.|++.++ +++.| +||+|||.+...
T Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~---- 179 (287)
T 4f0f_A 104 PCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS---- 179 (287)
T ss_dssp TTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC----
T ss_pred CCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc----
Confidence 35677776654 45799999999999987653 33332 788999966432
Q ss_pred CceecccccccccccCCC---CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH--HHHHHHHcC--CCCCCCCCCHHH
Q psy6203 392 GQVINLLRSAIVLCSAPS---SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID--QLYDKILNG--KYTEPPWMSPNS 464 (568)
Q Consensus 392 ~~~~~~~~gt~~~~~pe~---~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~--~~~~~i~~~--~~~~~~~~s~~~ 464 (568)
........||+.|+|||. ....++.++||||+||++|+|++|++||.+.+.. .....+... ....|..+++++
T Consensus 180 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (287)
T 4f0f_A 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259 (287)
T ss_dssp SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHH
Confidence 223455789999999997 3456889999999999999999999999876533 334444433 334677899999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhc
Q psy6203 465 RQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 465 ~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
.+||.+||..||.+|||++++++
T Consensus 260 ~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 260 RNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=4.8e-18 Score=171.43 Aligned_cols=148 Identities=18% Similarity=0.187 Sum_probs=116.0
Q ss_pred HHHHHHHHhC----------CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCC
Q psy6203 341 GVMLYALLCG----------FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCK 390 (568)
Q Consensus 341 g~~l~~~~~~----------~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~ 390 (568)
|++|.+++.. ..++++..+..++.|++.++ +++ +++||+|||.+......
T Consensus 112 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191 (322)
T ss_dssp TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred CCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccc
Confidence 5566666653 24678999999999998764 333 36788999976543222
Q ss_pred CC-ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHH
Q psy6203 391 VG-QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQ 466 (568)
Q Consensus 391 ~~-~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ 466 (568)
.. .......||+.|+|||. .+..++.++||||+||++|+|++ |.+||.+.+..+....+..+.. ..+..+++.+.+
T Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (322)
T 1p4o_A 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFE 271 (322)
T ss_dssp GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 11 11234467889999997 55668999999999999999999 8999999998888888877654 457779999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcC
Q psy6203 467 IVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 467 li~~~L~~dp~~R~t~~~~l~h 488 (568)
||.+||..||.+|||+.++++|
T Consensus 272 li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 272 LMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999886
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=4.5e-18 Score=169.01 Aligned_cols=148 Identities=17% Similarity=0.272 Sum_probs=103.2
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCC-CCceecc
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCK-VGQVINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~-~~~~~~~ 397 (568)
.|++|.+++.. ...+++..+..++.|++.++ +++. .+||+|||.+...... .......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (289)
T 3og7_A 102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181 (289)
T ss_dssp CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccc
Confidence 36788888854 46799999999999999764 3333 5788999976543221 1223445
Q ss_pred cccccccccCCC-C---CCCCCCccceeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCC-----CCCCCHHHHHH
Q psy6203 398 LRSAIVLCSAPS-S---KQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTE-----PPWMSPNSRQI 467 (568)
Q Consensus 398 ~~gt~~~~~pe~-~---~~~~~~~~DiWSlG~il~eml~g~~pf~~~~-~~~~~~~i~~~~~~~-----~~~~s~~~~~l 467 (568)
..||+.|+|||. . ...++.++||||+||++|+|++|+.||.+.+ .......+..+.... +..+++++.+|
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 261 (289)
T 3og7_A 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261 (289)
T ss_dssp --CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHH
T ss_pred cCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHH
Confidence 689999999996 2 5678889999999999999999999998855 444455555544332 34578999999
Q ss_pred HHHccCCCcCCCCCHHHHhc
Q psy6203 468 VRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 468 i~~~L~~dp~~R~t~~~~l~ 487 (568)
|.+||..||.+|||+.++++
T Consensus 262 i~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 262 MAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.7e-18 Score=171.43 Aligned_cols=136 Identities=18% Similarity=0.307 Sum_probs=105.2
Q ss_pred CCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc-eecccccccccccCCC-C
Q psy6203 353 PFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ-VINLLRSAIVLCSAPS-S 410 (568)
Q Consensus 353 ~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~-~~~~~~gt~~~~~pe~-~ 410 (568)
++++..+..++.|+++++ +++ ..+||+|||++......... ......||+.|+|||. .
T Consensus 141 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 220 (313)
T 1t46_A 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc
Confidence 599999999999999864 333 36789999977554333222 2334567888999997 5
Q ss_pred CCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHH-cC-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 411 KQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKIL-NG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 411 ~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~-~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
...++.++||||+||++|+|++ |++||.+.+.......+. .+ ....+...++++.+||.+||..||.+|||+.++++
T Consensus 221 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 221 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5678999999999999999998 999998876544433333 33 23346778999999999999999999999999987
Q ss_pred C
Q psy6203 488 H 488 (568)
Q Consensus 488 h 488 (568)
+
T Consensus 301 ~ 301 (313)
T 1t46_A 301 L 301 (313)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.1e-18 Score=170.07 Aligned_cols=148 Identities=15% Similarity=0.175 Sum_probs=114.7
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc--eecc
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ--VINL 397 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~--~~~~ 397 (568)
|++|.+++.. .+++++..+..++.|++.++ +++ +.+||+|||++......... ....
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 183 (291)
T 1u46_A 104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183 (291)
T ss_dssp TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred CCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhcc
Confidence 5777777765 35799999999999998764 333 35788999977554332221 1234
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHccC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY--TEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~~~L~ 473 (568)
..+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..... +.+..+++++.++|.+||.
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 263 (291)
T 1u46_A 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 263 (291)
T ss_dssp --CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHcc
Confidence 567888999997 55568899999999999999999 9999999998888888876543 3456789999999999999
Q ss_pred CCcCCCCCHHHHhcC
Q psy6203 474 VEPGKRIKIQDLLGH 488 (568)
Q Consensus 474 ~dp~~R~t~~~~l~h 488 (568)
.||.+|||+.+++++
T Consensus 264 ~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 264 HKPEDRPTFVALRDF 278 (291)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCcccCcCHHHHHHH
Confidence 999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.8e-18 Score=179.80 Aligned_cols=145 Identities=12% Similarity=0.233 Sum_probs=115.6
Q ss_pred hhHHHHHHHHhCCC--CCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 339 SMGVMLYALLCGFL--PFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 339 ~~g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
..|++|.+++...+ .+++..+..++.|++.++ +++ +.+||+|||++..... ...
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~~~ 344 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQD 344 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc----ccc
Confidence 34788999988644 489999999999999864 333 3578999997654321 123
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
...+|+.|+|||. ....|+.++||||+||++|||++ |++||.+.+..+....+..+. ...|..+++++.+||.+||.
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 424 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWH 424 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcC
Confidence 3467889999998 56679999999999999999998 999999988777888887764 45678899999999999999
Q ss_pred CCcCCCCCHHHHhc
Q psy6203 474 VEPGKRIKIQDLLG 487 (568)
Q Consensus 474 ~dp~~R~t~~~~l~ 487 (568)
.||.+|||+.++++
T Consensus 425 ~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 425 LDAATRPTFLQLRE 438 (450)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999998864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-17 Score=168.45 Aligned_cols=149 Identities=14% Similarity=0.215 Sum_probs=115.8
Q ss_pred hHHHHHHHHhCCC-CCChhhHHHHHHHHhhcc------------Ccc-------eeEEEccccCcccccC----CCCcee
Q psy6203 340 MGVMLYALLCGFL-PFDSDSIDQLYDKILSHF------------MPI-------CTILISQYFPTILLPC----KVGQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~~~-~~~e~~~~~~~~qil~~~------------~~~-------~~iki~dfG~~~~~~~----~~~~~~ 395 (568)
.|++|.+++...+ .+++..+..++.|++.++ +++ +++||+|||++..... ......
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 191 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKL 191 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------CCSC
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcccccccccccccccc
Confidence 3688889988754 799999999999999864 333 3578899997643321 111223
Q ss_pred cccccccccccCCC-C---------CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHH
Q psy6203 396 NLLRSAIVLCSAPS-S---------KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--PPWMSPN 463 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~---------~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~s~~ 463 (568)
....||+.|+|||. . ...++.++||||+||++|+|++|+.||.+.+.......+..+..+. +..++++
T Consensus 192 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (319)
T 2y4i_B 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE 271 (319)
T ss_dssp BCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTT
T ss_pred ccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHH
Confidence 44579999999996 2 3468999999999999999999999999999888888887765443 3357889
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 464 SRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 464 ~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+.+||.+||..||.+|||+.++++.
T Consensus 272 l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 272 ISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-18 Score=176.94 Aligned_cols=147 Identities=13% Similarity=0.087 Sum_probs=108.7
Q ss_pred HHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc----------eeEEEccccCcccccCCCC-----
Q psy6203 341 GVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI----------CTILISQYFPTILLPCKVG----- 392 (568)
Q Consensus 341 g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~----------~~iki~dfG~~~~~~~~~~----- 392 (568)
|++|.+++... ++|++..+..++.|++.++ +++ +.+||+|||++........
T Consensus 135 g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 214 (364)
T 3op5_A 135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214 (364)
T ss_dssp EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSS
T ss_pred CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccc
Confidence 78898888764 6899999999999999864 333 4577889998754322111
Q ss_pred -ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH-HHc---CC-------CCCCCC
Q psy6203 393 -QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK-ILN---GK-------YTEPPW 459 (568)
Q Consensus 393 -~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~-i~~---~~-------~~~~~~ 459 (568)
......+||+.|+|||. .+..|+.++|||||||++|||++|++||.+......... ... .. ...+..
T Consensus 215 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (364)
T 3op5_A 215 ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAAN 294 (364)
T ss_dssp CCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTC
T ss_pred cCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhccccc
Confidence 11244569999999998 666799999999999999999999999986432211111 100 00 011256
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
.++++.+||..||..||.+||+++++++
T Consensus 295 ~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 295 APGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp CCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 7899999999999999999999988865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.3e-18 Score=181.03 Aligned_cols=149 Identities=15% Similarity=0.219 Sum_probs=118.8
Q ss_pred hhHHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 339 SMGVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 339 ~~g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
..|++|.++++. ...+++..+..++.|++.++ +++ +.+||+|||++.....+......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 347899999874 45699999999999998764 333 46789999987654332222223
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
...+|..|+|||. ....|+.++|||||||++|||++ |.+||.+.+..++...+..+. ...|..+++++.+||.+||.
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 457 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 457 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 3456778999998 55668999999999999999999 999999988877777776653 44677899999999999999
Q ss_pred CCcCCCCCHHHHhc
Q psy6203 474 VEPGKRIKIQDLLG 487 (568)
Q Consensus 474 ~dp~~R~t~~~~l~ 487 (568)
.||.+|||+.++++
T Consensus 458 ~dP~~RPs~~el~~ 471 (495)
T 1opk_A 458 WNPSDRPSFAEIHQ 471 (495)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cChhHCcCHHHHHH
Confidence 99999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.7e-18 Score=176.46 Aligned_cols=148 Identities=18% Similarity=0.231 Sum_probs=115.2
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCce-ecc
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQV-INL 397 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~-~~~ 397 (568)
.|++|.++++.. ..+++..+..++.|++.++ +++ +.+||+|||++.......... ...
T Consensus 195 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~ 274 (377)
T 3cbl_A 195 QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274 (377)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCC
Confidence 367888888754 3699999999999998864 333 367899999765432111000 112
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 474 (568)
..+++.|+|||. ....|+.++||||+||++|||++ |.+||.+.+..+....+..+. .+.|..+++++.+||.+||..
T Consensus 275 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 354 (377)
T 3cbl_A 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAY 354 (377)
T ss_dssp CEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 235677999997 55568999999999999999998 999999998888877777664 456777899999999999999
Q ss_pred CcCCCCCHHHHhc
Q psy6203 475 EPGKRIKIQDLLG 487 (568)
Q Consensus 475 dp~~R~t~~~~l~ 487 (568)
||++|||++++++
T Consensus 355 dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 355 EPGQRPSFSTIYQ 367 (377)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CchhCcCHHHHHH
Confidence 9999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=4.9e-18 Score=175.20 Aligned_cols=151 Identities=13% Similarity=0.162 Sum_probs=110.5
Q ss_pred hhhHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCC---c
Q psy6203 338 WSMGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVG---Q 393 (568)
Q Consensus 338 ~~~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~---~ 393 (568)
|..|++|.+++... ..+++.++..++.|++.++ ++ ...+||+|||++........ .
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 251 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccccc
Confidence 33478999999864 4688999999999998764 33 34689999997754322111 1
Q ss_pred eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q psy6203 394 VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRS 470 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 470 (568)
......+|+.|+|||. ....|+.++||||+||++|||++ |.+||.+.+..+....+..+.. ..|..+++.+.++|.+
T Consensus 252 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~ 331 (373)
T 3c1x_A 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 331 (373)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1233467788999997 56678999999999999999999 7999998877667777777654 4567789999999999
Q ss_pred ccCCCcCCCCCHHHHhcC
Q psy6203 471 MLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~h 488 (568)
||..||++|||+.+++++
T Consensus 332 cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 332 CWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.70 E-value=9.6e-18 Score=167.25 Aligned_cols=148 Identities=14% Similarity=0.169 Sum_probs=115.4
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCC---Ccee
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKV---GQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~---~~~~ 395 (568)
.|++|.+++.. ...+++.++..++.|++.++ +++ +.+||+|||.+....... ....
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 189 (298)
T 3f66_A 110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189 (298)
T ss_dssp TTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC---
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccc
Confidence 36789999875 45689999999999998864 333 368899999765432211 1123
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHcc
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSML 472 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L 472 (568)
....||+.|+|||. ....++.++||||+||++|+|++ |.+||.+.+..+....+..+... .|..+++.+.++|.+||
T Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 269 (298)
T 3f66_A 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 269 (298)
T ss_dssp --CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHc
Confidence 34567888999997 55678999999999999999999 78899888877777777776554 46678999999999999
Q ss_pred CCCcCCCCCHHHHhc
Q psy6203 473 QVEPGKRIKIQDLLG 487 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~ 487 (568)
..||.+|||+.++++
T Consensus 270 ~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 270 HPKAEMRPSFSELVS 284 (298)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.8e-18 Score=169.32 Aligned_cols=144 Identities=13% Similarity=0.139 Sum_probs=110.1
Q ss_pred hhHHHHHHHHhCCCC-CChhhHHHHHHHHhhcc------------Cccee----------------EEEccccCcccccC
Q psy6203 339 SMGVMLYALLCGFLP-FDSDSIDQLYDKILSHF------------MPICT----------------ILISQYFPTILLPC 389 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~-~~e~~~~~~~~qil~~~------------~~~~~----------------iki~dfG~~~~~~~ 389 (568)
..|++|.+++..... +++..+..++.|+++++ +++.| +||+|||.+....
T Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~- 172 (289)
T 4fvq_A 94 VKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL- 172 (289)
T ss_dssp CTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS-
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccccccc-
Confidence 346888888876544 99999999999999864 34433 7788888543221
Q ss_pred CCCceecccccccccccCCC--CCCCCCCccceeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy6203 390 KVGQVINLLRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQ 466 (568)
Q Consensus 390 ~~~~~~~~~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 466 (568)
......||+.|+|||. ....++.++||||+||++|+|++| .+||...+..... .+.......|...++++.+
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 247 (289)
T 4fvq_A 173 ----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQLPAPKAAELAN 247 (289)
T ss_dssp ----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCCCCCSSCTTHH
T ss_pred ----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCCCCCCCCHHHHH
Confidence 1234568899999997 447899999999999999999994 5666665554443 3444556667777889999
Q ss_pred HHHHccCCCcCCCCCHHHHhcC
Q psy6203 467 IVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 467 li~~~L~~dp~~R~t~~~~l~h 488 (568)
||.+||..||.+|||++++++|
T Consensus 248 li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 248 LINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=9.7e-18 Score=185.28 Aligned_cols=150 Identities=17% Similarity=0.245 Sum_probs=117.3
Q ss_pred hhhHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 338 WSMGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|..|++|.+++... .++++..+..++.|++.++ +++ +++||+|||++............
T Consensus 471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 550 (656)
T 2j0j_A 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550 (656)
T ss_dssp CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-------
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceecc
Confidence 33478999998753 4799999999999999764 343 35789999977654332222233
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
...+|+.|+|||. ....|+.++||||+||++|||++ |.+||.+.+..+....+..+. .+.|..+++.+.+||.+||.
T Consensus 551 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~ 630 (656)
T 2j0j_A 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 630 (656)
T ss_dssp ---CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcC
Confidence 4567789999997 55678999999999999999997 999999999888888887765 45678899999999999999
Q ss_pred CCcCCCCCHHHHhc
Q psy6203 474 VEPGKRIKIQDLLG 487 (568)
Q Consensus 474 ~dp~~R~t~~~~l~ 487 (568)
.||.+|||+.++++
T Consensus 631 ~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 631 YDPSRRPRFTELKA 644 (656)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHH
Confidence 99999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=7.2e-18 Score=183.88 Aligned_cols=152 Identities=17% Similarity=0.186 Sum_probs=111.7
Q ss_pred hHHHHHHHHhCCC---CCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCc
Q psy6203 340 MGVMLYALLCGFL---PFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQ 393 (568)
Q Consensus 340 ~g~~l~~~~~~~~---~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~ 393 (568)
.|++|.+++.... .+++..+..++.|++.++ +++. .+||+|||.+.... .+.
T Consensus 101 ~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~--~~~ 178 (676)
T 3qa8_A 101 EGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGE 178 (676)
T ss_dssp SSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTT--SCC
T ss_pred CCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccc--ccc
Confidence 3788888888644 699999999999998864 3332 37889999765432 233
Q ss_pred eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH--------------HHcCCC----
Q psy6203 394 VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK--------------ILNGKY---- 454 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~--------------i~~~~~---- 454 (568)
......||+.|+|||. .+..++.++||||+||++|+|++|..||.+......+.. ...+..
T Consensus 179 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~ 258 (676)
T 3qa8_A 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSS 258 (676)
T ss_dssp CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCS
T ss_pred ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccccc
Confidence 3456789999999998 667899999999999999999999999987543221100 011111
Q ss_pred --CCCC----CCCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 455 --TEPP----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 455 --~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+.|. .+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 259 ~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 259 VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 1111 25678999999999999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-17 Score=182.99 Aligned_cols=156 Identities=16% Similarity=0.196 Sum_probs=119.6
Q ss_pred hhhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCce--
Q psy6203 338 WSMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQV-- 394 (568)
Q Consensus 338 ~~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~-- 394 (568)
|..|++|.+++.. ...+++..+..++.|++.++ +++. .+||+|||++..........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 3447899998875 45799999999999999864 3333 57899999876543222211
Q ss_pred ecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHc
Q psy6203 395 INLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 471 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~ 471 (568)
.....+|+.|+|||. ....|+.++||||+||++|||++ |+.||.+.+..++...+..+. ...|..+++++.+||.+|
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 575 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 575 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 223345678999998 55678999999999999999998 999999998888888888775 456778999999999999
Q ss_pred cCCCcCCCCCHHHH---hcCccccc
Q psy6203 472 LQVEPGKRIKIQDL---LGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~t~~~~---l~hp~~~~ 493 (568)
|..||++||++.++ |++.|+..
T Consensus 576 l~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 576 WIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999887 44556553
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=172.21 Aligned_cols=149 Identities=17% Similarity=0.183 Sum_probs=108.0
Q ss_pred hhHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCce--e
Q psy6203 339 SMGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQV--I 395 (568)
Q Consensus 339 ~~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~--~ 395 (568)
..|++|.+++... ..+++..+..++.|++.++ +++ ..+||+|||++.......... .
T Consensus 128 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 207 (373)
T 2qol_A 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207 (373)
T ss_dssp CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------
T ss_pred CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceec
Confidence 3378899998864 4799999999999998764 333 357899999776543322211 1
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHcc
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSML 472 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L 472 (568)
....+|+.|+|||. ....++.++||||+||++|||++ |+.||.+.+..+....+..+. .+.+..+++.+.+||.+||
T Consensus 208 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 287 (373)
T 2qol_A 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCW 287 (373)
T ss_dssp ------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHT
T ss_pred cCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHh
Confidence 22345678999997 55678999999999999999997 999999999888888887763 4456678899999999999
Q ss_pred CCCcCCCCCHHHHhc
Q psy6203 473 QVEPGKRIKIQDLLG 487 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~ 487 (568)
..||.+||++.++++
T Consensus 288 ~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 288 QKDRNNRPKFEQIVS 302 (373)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CcChhhCcCHHHHHH
Confidence 999999999988765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.69 E-value=9.5e-18 Score=167.08 Aligned_cols=148 Identities=20% Similarity=0.210 Sum_probs=107.6
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC--ceec
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG--QVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~--~~~~ 396 (568)
.|++|.+++... ..+++..+..++.|++.++ +++. ++||+|||.+........ ....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 175 (295)
T 3ugc_A 96 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175 (295)
T ss_dssp TTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------
T ss_pred CCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeecc
Confidence 367888888764 3599999999999998764 3433 578999997765432221 1223
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcC-CCCCCC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----------------QLYDKILNG-KYTEPP 458 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~----------------~~~~~i~~~-~~~~~~ 458 (568)
...+|+.|+|||. ....++.++||||+||++|+|++|..||...... .....+..+ ..+.|.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 3ugc_A 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 255 (295)
T ss_dssp CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCT
T ss_pred CCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCc
Confidence 4567788999987 5567899999999999999999999999754221 222333333 445677
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
.+++++.+||.+||..||++|||+.|+++
T Consensus 256 ~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 256 GCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 89999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=8.1e-18 Score=170.65 Aligned_cols=148 Identities=16% Similarity=0.251 Sum_probs=111.5
Q ss_pred HHHHHHHHhC--------------CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCccc
Q psy6203 341 GVMLYALLCG--------------FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTIL 386 (568)
Q Consensus 341 g~~l~~~~~~--------------~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~ 386 (568)
|++|.+++.. ..++++..+..++.|++.++ +++ ..+||+|||++..
T Consensus 134 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 213 (333)
T 2i1m_A 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213 (333)
T ss_dssp TEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCC
T ss_pred CCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccc
Confidence 5666666653 34689999999999998764 333 3678999997765
Q ss_pred ccCCCCc-eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC--CCCCCCCCC
Q psy6203 387 LPCKVGQ-VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG--KYTEPPWMS 461 (568)
Q Consensus 387 ~~~~~~~-~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s 461 (568)
....... ......||+.|+|||. ....++.++||||+||++|+|++ |.+||.+.........+... ....|...+
T Consensus 214 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (333)
T 2i1m_A 214 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP 293 (333)
T ss_dssp GGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCC
T ss_pred cccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCC
Confidence 4333222 2334567888999997 55568999999999999999998 99999987654444444332 234567789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+.+.+||.+||..||.+|||+.+++++
T Consensus 294 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 294 KNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 999999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=7.3e-18 Score=166.42 Aligned_cols=143 Identities=13% Similarity=0.239 Sum_probs=108.6
Q ss_pred HHHHHHHHhCCC--CCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 341 GVMLYALLCGFL--PFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 341 g~~l~~~~~~~~--~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
|++|.+++.... .+++..+..++.|++.++ +++ +.+||+|||++..... .....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----~~~~~ 174 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTG 174 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc----cccCC
Confidence 567777776543 388999999999998764 333 3578889996543221 12344
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 475 (568)
.+|+.|+|||. ....++.++||||+||++|+|++ |++||.+.+..+....+..+. ...+..+++.+.++|.+||..|
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 254 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD 254 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCC
Confidence 67888999997 55678999999999999999998 999999988777777776653 4567789999999999999999
Q ss_pred cCCCCCHHHHhc
Q psy6203 476 PGKRIKIQDLLG 487 (568)
Q Consensus 476 p~~R~t~~~~l~ 487 (568)
|.+|||+.++++
T Consensus 255 p~~Rps~~~l~~ 266 (278)
T 1byg_A 255 AAMRPSFLQLRE 266 (278)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-17 Score=181.03 Aligned_cols=154 Identities=16% Similarity=0.196 Sum_probs=120.9
Q ss_pred hhHHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 339 SMGVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 339 ~~g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
..|++|.+++.. ...+++.++..++.|++.++ +++ ..+||+|||++............
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 347899999874 25699999999999998864 333 36789999977543221111122
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
...+|..|+|||. ....|+.++|||||||++|||++ |+.||.+.+..+++..+..+. .+.|..+++++.+||.+||.
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~ 502 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 502 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 3456788999997 45568999999999999999999 999999999888888887764 45677899999999999999
Q ss_pred CCcCCCCCHHHHhcC--cccc
Q psy6203 474 VEPGKRIKIQDLLGH--NWVK 492 (568)
Q Consensus 474 ~dp~~R~t~~~~l~h--p~~~ 492 (568)
.||++|||++++++. .++.
T Consensus 503 ~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 503 KEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp SSGGGSCCHHHHHHHHHTSSC
T ss_pred CChhHCcCHHHHHHHHHHHhh
Confidence 999999999998763 4443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.8e-18 Score=168.63 Aligned_cols=147 Identities=14% Similarity=0.104 Sum_probs=109.1
Q ss_pred hhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc----
Q psy6203 339 SMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ---- 393 (568)
Q Consensus 339 ~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~---- 393 (568)
..|++|.+++.. ...+++.++..++.|++.++ +++ +++||+|||.+.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 346788888876 57899999999999999864 333 35889999977543221111
Q ss_pred ---------eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----HHHHHHcCCCCCCC
Q psy6203 394 ---------VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ-----LYDKILNGKYTEPP 458 (568)
Q Consensus 394 ---------~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~-----~~~~i~~~~~~~~~ 458 (568)
.....+||+.|+|||. .+..++.++||||+||++|+|++|..||....... ...... ....|.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 246 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DRYCPP 246 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--HHTCCT
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--cccCCC
Confidence 1125689999999998 77789999999999999999999999997632110 001111 112466
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
.+++.+.+||.+||..||++|||+.++++
T Consensus 247 ~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 78889999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-17 Score=167.89 Aligned_cols=147 Identities=8% Similarity=0.037 Sum_probs=104.8
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc----------------------Ccc--------eeEEEccccCcccccC
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF----------------------MPI--------CTILISQYFPTILLPC 389 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~----------------------~~~--------~~iki~dfG~~~~~~~ 389 (568)
.|++|.+++.. .++++..+..++.|++.++ +++ +.+||+|||.+.....
T Consensus 105 ~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~ 183 (322)
T 3soc_A 105 EKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183 (322)
T ss_dssp TTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence 36788888876 5699999999999888753 222 2588999998755432
Q ss_pred CCC-ceecccccccccccCCC-CC-----CCCCCccceeehhHHHHHHHhCCCCCCCCC----------------HHHHH
Q psy6203 390 KVG-QVINLLRSAIVLCSAPS-SK-----QYYGSETDVWSMGVMLYALLCGFLPFDSDS----------------IDQLY 446 (568)
Q Consensus 390 ~~~-~~~~~~~gt~~~~~pe~-~~-----~~~~~~~DiWSlG~il~eml~g~~pf~~~~----------------~~~~~ 446 (568)
... ......+||+.|+|||. .+ ..++.++||||+||++|||++|++||.+.. ..+..
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (322)
T 3soc_A 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263 (322)
T ss_dssp TSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred ccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence 221 12344689999999997 32 456778999999999999999999997642 22233
Q ss_pred HHHHcCCCC--CCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 447 DKILNGKYT--EPPW-----MSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 447 ~~i~~~~~~--~~~~-----~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
..+...... .+.. .++++.+||.+||..||++|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 333332221 1111 2345899999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-17 Score=164.53 Aligned_cols=147 Identities=18% Similarity=0.242 Sum_probs=103.6
Q ss_pred HHHHHHHHh----CCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceec
Q psy6203 341 GVMLYALLC----GFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 341 g~~l~~~~~----~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|++|.+++. ....+++..+..++.|++.++ ++ .+.+||+|||++...... .....
T Consensus 116 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 194 (310)
T 2wqm_A 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAH 194 (310)
T ss_dssp SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------------
T ss_pred CCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC-Ccccc
Confidence 556666664 356799999999999999864 23 346788899976543222 22234
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD--SIDQLYDKILNGKYTE--PPWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~--~~~~~~~~i~~~~~~~--~~~~s~~~~~li~~~ 471 (568)
...||+.|+|||. ....++.++||||+||++|+|++|+.||.+. +.......+..+.++. +..+++++.+||.+|
T Consensus 195 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 274 (310)
T 2wqm_A 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274 (310)
T ss_dssp ----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHH
T ss_pred ccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHH
Confidence 5678999999997 6677899999999999999999999999765 3445666666665442 356899999999999
Q ss_pred cCCCcCCCCCHHHHhcC
Q psy6203 472 LQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~h 488 (568)
|..||.+|||+.+++++
T Consensus 275 l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 275 INPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCCCHHHHHHH
Confidence 99999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-17 Score=165.95 Aligned_cols=148 Identities=18% Similarity=0.200 Sum_probs=111.2
Q ss_pred hHHHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC--ceec
Q psy6203 340 MGVMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG--QVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~--~~~~ 396 (568)
.|++|.+++. ...++++..+..++.|++.++ +++. .+||+|||.+........ ....
T Consensus 108 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 187 (302)
T 4e5w_A 108 PSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187 (302)
T ss_dssp TTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCC
T ss_pred CCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccC
Confidence 3678888884 456799999999999999864 3433 578899997765433322 1234
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCC--------------C-HHHHHHHHHcC-CCCCCCC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSD--------------S-IDQLYDKILNG-KYTEPPW 459 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~--------------~-~~~~~~~i~~~-~~~~~~~ 459 (568)
...||..|+|||. ....++.++||||+||++|+|++|..||... . .......+..+ ..+.|..
T Consensus 188 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T 4e5w_A 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPN 267 (302)
T ss_dssp CTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTT
T ss_pred CCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCC
Confidence 5678888999997 5566889999999999999999999986432 1 12233333333 3456778
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
+++++.+||.+||..||.+|||+.++++
T Consensus 268 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 268 CPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-17 Score=169.59 Aligned_cols=148 Identities=21% Similarity=0.273 Sum_probs=112.2
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCc--eecc
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQ--VINL 397 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~--~~~~ 397 (568)
|++|.+++.. ...+++..+..++.|++.++ +++. ++||+|||.+......... ....
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 189 (327)
T 3lxl_A 110 SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189 (327)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSC
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeecc
Confidence 6788888775 45799999999999998764 3433 5788999977554322221 2234
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH---------------HHHHHHHcC-CCCCCCCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---------------QLYDKILNG-KYTEPPWM 460 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~---------------~~~~~i~~~-~~~~~~~~ 460 (568)
..||+.|+|||. .+..++.++||||+||++|+|++|+.||...... .....+..+ ..+.|..+
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (327)
T 3lxl_A 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPAC 269 (327)
T ss_dssp CCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTC
T ss_pred CCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcc
Confidence 568888999997 5566899999999999999999999999764321 233333333 34467789
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
++++.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 270 PAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-17 Score=163.76 Aligned_cols=147 Identities=16% Similarity=0.177 Sum_probs=114.0
Q ss_pred HHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 341 GVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 341 g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
|++|.+++.. ...+++..+..++.|++.++ +++ +.+||+|||.+...... ......
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 181 (284)
T 2a19_B 104 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GKRTRS 181 (284)
T ss_dssp SCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC--SCCCCC
T ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc--cccccc
Confidence 5688888854 36899999999999999864 333 35789999976543322 223456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
.||+.|+|||. ....++.++||||+||++|+|++|..||... ......+..+ ..+..+++.+.+||.+||..||.
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~ 257 (284)
T 2a19_B 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPE 257 (284)
T ss_dssp CSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cccccCCHHHHHHHHHHccCChh
Confidence 79999999998 5667899999999999999999999998543 2333444443 34567899999999999999999
Q ss_pred CCCCHHHHhcCccccc
Q psy6203 478 KRIKIQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~ 493 (568)
+|||+.|+++|.|.-.
T Consensus 258 ~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 258 DRPNTSEILRTLTVWK 273 (284)
T ss_dssp GSCCHHHHHHHHHHHT
T ss_pred hCcCHHHHHHHHHHHh
Confidence 9999999999988653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-17 Score=174.07 Aligned_cols=147 Identities=15% Similarity=0.067 Sum_probs=111.7
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc-----------eeEEEccccCcccccCCCCc---
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI-----------CTILISQYFPTILLPCKVGQ--- 393 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~-----------~~iki~dfG~~~~~~~~~~~--- 393 (568)
|++|.+++.. ...|++..+..++.||+.++ +++ +.+||+|||++.........
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccc
Confidence 6788888873 56899999999999999864 333 35678999987654332211
Q ss_pred ---eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCC
Q psy6203 394 ---VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKYT-----EPPWMS 461 (568)
Q Consensus 394 ---~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~s 461 (568)
.....+||+.|++||. .+..++.++|||||||++|||++|++||.+.. ..+.+..+...... .+..++
T Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (483)
T 3sv0_A 166 PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYP 245 (483)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSC
T ss_pred ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCc
Confidence 1236789999999998 66779999999999999999999999998743 34444444333221 235678
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
+++.+||.+||..||++||+++++++
T Consensus 246 ~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 246 TEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999887654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-17 Score=166.20 Aligned_cols=147 Identities=16% Similarity=0.231 Sum_probs=90.5
Q ss_pred HHHHHHHh---CCCCCChhhHHHHHHHHhhcc--------------Ccc--------eeEEEccccCcccccCCCCc---
Q psy6203 342 VMLYALLC---GFLPFDSDSIDQLYDKILSHF--------------MPI--------CTILISQYFPTILLPCKVGQ--- 393 (568)
Q Consensus 342 ~~l~~~~~---~~~~~~e~~~~~~~~qil~~~--------------~~~--------~~iki~dfG~~~~~~~~~~~--- 393 (568)
++|.+++. ..+++++..+..++.|++.++ +++ +.+||+|||.+.........
T Consensus 118 g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 197 (337)
T 3ll6_A 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197 (337)
T ss_dssp EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----
T ss_pred CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCccccc
Confidence 45555554 356899999999999888753 222 36788999976543322111
Q ss_pred --------eecccccccccccCCC----CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy6203 394 --------VINLLRSAIVLCSAPS----SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMS 461 (568)
Q Consensus 394 --------~~~~~~gt~~~~~pe~----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s 461 (568)
.....+||+.|+|||. ....++.++|||||||++|+|++|+.||.+.......... ...+.+...+
T Consensus 198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~ 275 (337)
T 3ll6_A 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK--YSIPPHDTQY 275 (337)
T ss_dssp --------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------CCCCTTCCSS
T ss_pred ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc--ccCCcccccc
Confidence 1124579999999997 4566889999999999999999999999876544332221 1223345577
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcc
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLGHNW 490 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 490 (568)
+.+.+||.+||..||.+|||+.|+++|-+
T Consensus 276 ~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 276 TVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp GGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 88999999999999999999999999854
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-17 Score=166.81 Aligned_cols=151 Identities=18% Similarity=0.124 Sum_probs=108.2
Q ss_pred hHHHHHHHHhCCC----CCChhhHHHHHHHHhhcc---------------Ccc--------eeEEEccccCcccccCCCC
Q psy6203 340 MGVMLYALLCGFL----PFDSDSIDQLYDKILSHF---------------MPI--------CTILISQYFPTILLPCKVG 392 (568)
Q Consensus 340 ~g~~l~~~~~~~~----~~~e~~~~~~~~qil~~~---------------~~~--------~~iki~dfG~~~~~~~~~~ 392 (568)
.|++|.+++.... ++++..+..++.|++.++ +++ ..+||+|||.+........
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 189 (326)
T 3uim_A 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189 (326)
T ss_dssp TTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred cCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence 3678888887543 499999999998887653 233 2678999998766544444
Q ss_pred ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCC------------
Q psy6203 393 QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYT------------ 455 (568)
Q Consensus 393 ~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~----~~~~~~~i~~~~~~------------ 455 (568)
.......||+.|+|||. ....++.++||||+||++|+|++|++||.... ..........+...
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 3uim_A 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269 (326)
T ss_dssp CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTC
T ss_pred cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhh
Confidence 45566779999999998 55668999999999999999999999996311 00011111111100
Q ss_pred ---CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcc
Q psy6203 456 ---EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNW 490 (568)
Q Consensus 456 ---~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 490 (568)
.+...++.+.+||.+||..||.+|||+.++++|-+
T Consensus 270 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 270 QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 11113467889999999999999999999998854
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=8.5e-17 Score=161.34 Aligned_cols=145 Identities=13% Similarity=0.166 Sum_probs=103.3
Q ss_pred hHHHHHHHHhCCC---CCChhhHHHHHHHHhhc---------------cCccee---------EEEccccCcccccCCCC
Q psy6203 340 MGVMLYALLCGFL---PFDSDSIDQLYDKILSH---------------FMPICT---------ILISQYFPTILLPCKVG 392 (568)
Q Consensus 340 ~g~~l~~~~~~~~---~~~e~~~~~~~~qil~~---------------~~~~~~---------iki~dfG~~~~~~~~~~ 392 (568)
.|++|.+++.... .+++..+..++.|++++ .+++.| +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~--- 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--- 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc---
Confidence 3678888887654 36777777777766543 233332 68888886543221
Q ss_pred ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC--HHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q psy6203 393 QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS--IDQLYDKILNGK-YTEPPWMSPNSRQIV 468 (568)
Q Consensus 393 ~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~--~~~~~~~i~~~~-~~~~~~~s~~~~~li 468 (568)
......||+.|+|||. .+..++.++||||+||++|+|++|+.||.... .......+..+. ...+..+++.+.+||
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHH
Confidence 1234579999999998 66789999999999999999999999998543 334444444443 445677899999999
Q ss_pred HHccCCCcCCCCCHHHHhcC
Q psy6203 469 RSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 469 ~~~L~~dp~~R~t~~~~l~h 488 (568)
.+||..||.+|||+++++++
T Consensus 238 ~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 238 TRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=3e-17 Score=165.18 Aligned_cols=148 Identities=24% Similarity=0.207 Sum_probs=104.6
Q ss_pred HHHHHHHHhC----CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc---
Q psy6203 341 GVMLYALLCG----FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ--- 393 (568)
Q Consensus 341 g~~l~~~~~~----~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~--- 393 (568)
|++|.+++.. ..++++..+..++.|++.++ +++ +.+||+|||.+.........
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~ 193 (317)
T 2buj_A 114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193 (317)
T ss_dssp TCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHH
T ss_pred CCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccc
Confidence 5677766654 57899999999999999864 333 35677888865432211100
Q ss_pred -----eecccccccccccCCC-CCC---CCCCccceeehhHHHHHHHhCCCCCCCCCH--HHHHHHHHc-CCCCCCCCCC
Q psy6203 394 -----VINLLRSAIVLCSAPS-SKQ---YYGSETDVWSMGVMLYALLCGFLPFDSDSI--DQLYDKILN-GKYTEPPWMS 461 (568)
Q Consensus 394 -----~~~~~~gt~~~~~pe~-~~~---~~~~~~DiWSlG~il~eml~g~~pf~~~~~--~~~~~~i~~-~~~~~~~~~s 461 (568)
......||+.|+|||. ... .++.++||||+||++|+|++|+.||..... ......+.. ...+.+..++
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (317)
T 2buj_A 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS 273 (317)
T ss_dssp HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSC
T ss_pred cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCC
Confidence 0123467999999997 222 378999999999999999999999964211 112222222 2233456789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 462 PNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 462 ~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+++.+||.+||..||.+|||+++++++
T Consensus 274 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 274 SALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 999999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=5.2e-18 Score=171.25 Aligned_cols=149 Identities=13% Similarity=0.109 Sum_probs=105.6
Q ss_pred HHHHHHHHhCC----CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccC-CCCcee
Q psy6203 341 GVMLYALLCGF----LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPC-KVGQVI 395 (568)
Q Consensus 341 g~~l~~~~~~~----~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~-~~~~~~ 395 (568)
|++|.+++.+. ..+++..+..++.|++.++ ++ .+.+||+|||.+..... ......
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 56677777653 2589999999999998764 33 33678999997754322 122223
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCCC------C----C
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY-------DKILNGKYT------E----P 457 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~-------~~i~~~~~~------~----~ 457 (568)
....||+.|+|||. ....++.++||||+||++|+|++|++||.+....+.. .....+... . +
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR 278 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSC
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccC
Confidence 45578999999997 5557899999999999999999999999865432111 111111111 1 1
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCc
Q psy6203 458 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHN 489 (568)
Q Consensus 458 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 489 (568)
+..+..+.++|.+||..||++|||+.|+++|-
T Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 22456788999999999999999999999774
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.6e-17 Score=164.89 Aligned_cols=147 Identities=16% Similarity=0.183 Sum_probs=109.8
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCC--ceecc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVG--QVINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~--~~~~~ 397 (568)
.|++|.+++... .+++..+..++.|++.++ +++. .+||+|||.+........ .....
T Consensus 118 ~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 196 (318)
T 3lxp_A 118 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196 (318)
T ss_dssp TTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---
T ss_pred cCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccC
Confidence 367888888764 599999999999998864 3333 578999997755432221 12344
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH---------------HHHHHHHcC-CCCCCCCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID---------------QLYDKILNG-KYTEPPWM 460 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~---------------~~~~~i~~~-~~~~~~~~ 460 (568)
..||+.|+|||. ....++.++||||+||++|+|++|..||...... .....+..+ ..+.|..+
T Consensus 197 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (318)
T 3lxp_A 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKC 276 (318)
T ss_dssp CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccc
Confidence 578888999997 5556789999999999999999999999764321 122223333 34467779
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
++++.+||.+||..||.+|||++++++
T Consensus 277 ~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 277 PAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=5.3e-17 Score=161.98 Aligned_cols=147 Identities=14% Similarity=0.086 Sum_probs=104.5
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------Ccc--------eeEEEccccCcccccCCC
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPI--------CTILISQYFPTILLPCKV 391 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~--------~~iki~dfG~~~~~~~~~ 391 (568)
.|++|.+++.. ..+++..+..++.|++.++ +++ +.+||+|||++.......
T Consensus 89 ~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 89 EMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167 (301)
T ss_dssp TTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred cCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccc
Confidence 36889999965 5899999999999987643 222 357899999775443322
Q ss_pred Cce---ecccccccccccCCC-CCC------CCCCccceeehhHHHHHHHhC----------CCCCCCCC----HHHHHH
Q psy6203 392 GQV---INLLRSAIVLCSAPS-SKQ------YYGSETDVWSMGVMLYALLCG----------FLPFDSDS----IDQLYD 447 (568)
Q Consensus 392 ~~~---~~~~~gt~~~~~pe~-~~~------~~~~~~DiWSlG~il~eml~g----------~~pf~~~~----~~~~~~ 447 (568)
... ....+||+.|+|||. ... .++.++||||+||++|||++| .+||.... ....+.
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~ 247 (301)
T 3q4u_A 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247 (301)
T ss_dssp TEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred ccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhh
Confidence 221 234589999999997 332 345789999999999999999 99996532 222333
Q ss_pred HHHcCC---CCCCC-----CCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 448 KILNGK---YTEPP-----WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 448 ~i~~~~---~~~~~-----~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
.+.... ...|. ..++++.+||.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 333221 22222 14567899999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=9.9e-18 Score=174.45 Aligned_cols=148 Identities=16% Similarity=0.218 Sum_probs=109.7
Q ss_pred hhHHHHHHHHhCCC---CCChhhHHHHHHHHhhcc------------Ccce------------eEEEccccCcccccCCC
Q psy6203 339 SMGVMLYALLCGFL---PFDSDSIDQLYDKILSHF------------MPIC------------TILISQYFPTILLPCKV 391 (568)
Q Consensus 339 ~~g~~l~~~~~~~~---~~~e~~~~~~~~qil~~~------------~~~~------------~iki~dfG~~~~~~~~~ 391 (568)
..|++|.+++.... .+++..+..++.|++.++ +++. .+||+|||.+.... .
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~--~ 168 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--D 168 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC--C
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc--C
Confidence 34788999988643 399999999999999864 3333 36789999765432 2
Q ss_pred CceecccccccccccCCC-C--------CCCCCCccceeehhHHHHHHHhCCCCCCC----CCHHHHHHHHHcCCCC---
Q psy6203 392 GQVINLLRSAIVLCSAPS-S--------KQYYGSETDVWSMGVMLYALLCGFLPFDS----DSIDQLYDKILNGKYT--- 455 (568)
Q Consensus 392 ~~~~~~~~gt~~~~~pe~-~--------~~~~~~~~DiWSlG~il~eml~g~~pf~~----~~~~~~~~~i~~~~~~--- 455 (568)
+......+||+.|+|||. . ...|+.++||||+||++|||++|++||.+ ....+.+..+..+.+.
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (396)
T 4eut_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (396)
T ss_dssp GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence 233456789999999996 2 25688999999999999999999999964 2334556666655432
Q ss_pred ------------------CCCC----CCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 456 ------------------EPPW----MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 456 ------------------~~~~----~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
.+.. +++.+.+||.+||..||++|+|+++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1111 34567899999999999999999987553
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.5e-17 Score=164.97 Aligned_cols=149 Identities=12% Similarity=0.093 Sum_probs=107.2
Q ss_pred hHHHHHHHHhC---CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCC-cee
Q psy6203 340 MGVMLYALLCG---FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVG-QVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~---~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~-~~~ 395 (568)
.|++|.+++.. ..++++..+..++.|++.++ +++ +.+||+|||.+........ ...
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 36788887763 45799999999999998764 333 3678999997654432222 223
Q ss_pred cccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCC-----------CCCCCC
Q psy6203 396 NLLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----QLYDKILNGKY-----------TEPPWM 460 (568)
Q Consensus 396 ~~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~----~~~~~i~~~~~-----------~~~~~~ 460 (568)
....||+.|+|||.....++.++||||+||++|+|++|.+||.+.+.. .....+..... ..+...
T Consensus 193 ~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS 272 (307)
T ss_dssp SSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHH
T ss_pred cccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHH
Confidence 456899999999983345789999999999999999999999875432 22222222211 112224
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
++.+.++|.+||..||.+|||+.+++++
T Consensus 273 ~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 273 VEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5678899999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.62 E-value=2.4e-16 Score=159.89 Aligned_cols=148 Identities=14% Similarity=0.139 Sum_probs=102.4
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------------Ccc--------eeEEEccccCcccccCCC
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------------MPI--------CTILISQYFPTILLPCKV 391 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------------~~~--------~~iki~dfG~~~~~~~~~ 391 (568)
.|++|.+++.. ..+++..+..++.|++.++ +++ +.+||+|||.+.......
T Consensus 118 ~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 118 ENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196 (337)
T ss_dssp TTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecccc
Confidence 37789889876 4799999999998887643 233 257889999775433222
Q ss_pred Cc---eecccccccccccCCC-CCCCCCCc------cceeehhHHHHHHHhC----------CCCCCCCC-----HHHHH
Q psy6203 392 GQ---VINLLRSAIVLCSAPS-SKQYYGSE------TDVWSMGVMLYALLCG----------FLPFDSDS-----IDQLY 446 (568)
Q Consensus 392 ~~---~~~~~~gt~~~~~pe~-~~~~~~~~------~DiWSlG~il~eml~g----------~~pf~~~~-----~~~~~ 446 (568)
.. .....+||+.|+|||. ....++.. +||||+||++|||++| +.||.... .....
T Consensus 197 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 276 (337)
T 3mdy_A 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276 (337)
T ss_dssp ------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred ccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhH
Confidence 11 1235689999999997 44444444 9999999999999999 77776432 22222
Q ss_pred HHHHcCC--CCCCC-----CCCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 447 DKILNGK--YTEPP-----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 447 ~~i~~~~--~~~~~-----~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
..+.... ...|. .+++++.+||.+||..||.+|||+.++++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222 22332 245678999999999999999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.5e-17 Score=166.86 Aligned_cols=147 Identities=10% Similarity=0.051 Sum_probs=107.8
Q ss_pred hhHHHHHHHHh-----CCCCCChhhHHHHHHHHhhcc------------Cc-------------------ceeEEEcccc
Q psy6203 339 SMGVMLYALLC-----GFLPFDSDSIDQLYDKILSHF------------MP-------------------ICTILISQYF 382 (568)
Q Consensus 339 ~~g~~l~~~~~-----~~~~~~e~~~~~~~~qil~~~------------~~-------------------~~~iki~dfG 382 (568)
..|++|.+++. ....|++..+..++.|++.++ +| .+.+||+|||
T Consensus 149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG 228 (365)
T 3e7e_A 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228 (365)
T ss_dssp CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCT
T ss_pred cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCc
Confidence 34788998886 357899999999999999864 22 3567888999
Q ss_pred Cccccc-CCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy6203 383 PTILLP-CKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM 460 (568)
Q Consensus 383 ~~~~~~-~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 460 (568)
++.... ...+......+||+.|+|||. .+..|+.++||||+||++|||++|++||......... ....+ ...+.
T Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~-~~~~~ 304 (365)
T 3e7e_A 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEGLF-RRLPH 304 (365)
T ss_dssp TCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECSCC-TTCSS
T ss_pred hhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---echhc-cccCc
Confidence 875432 233445667789999999998 6667999999999999999999999999654321000 00011 11235
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCc
Q psy6203 461 SPNSRQIVRSMLQVEPGKRIKIQDLLGHN 489 (568)
Q Consensus 461 s~~~~~li~~~L~~dp~~R~t~~~~l~hp 489 (568)
++...+++.+||..+|.+|++..+.+.+.
T Consensus 305 ~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp HHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 67788999999999999997655555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-16 Score=161.50 Aligned_cols=148 Identities=20% Similarity=0.204 Sum_probs=109.6
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc--eec
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ--VIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~--~~~ 396 (568)
.|++|.+++... ..+++..+..++.|++.++ +++ +.+||+|||.+......... ...
T Consensus 127 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 206 (326)
T 2w1i_A 127 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 206 (326)
T ss_dssp TTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSS
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccccccccccc
Confidence 367888888754 5699999999999999764 333 35789999977654332221 123
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcC-CCCCCC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID----------------QLYDKILNG-KYTEPP 458 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~----------------~~~~~i~~~-~~~~~~ 458 (568)
...+|..|+|||. .+..++.++||||+||++|+|++|..||...... .+...+..+ ..+.|.
T Consensus 207 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (326)
T 2w1i_A 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 286 (326)
T ss_dssp CCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCT
T ss_pred CCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCC
Confidence 3467778999987 5556889999999999999999999998743110 122223332 345677
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
.+++++.+||.+||..||++|||+.++++
T Consensus 287 ~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 287 GCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-16 Score=161.99 Aligned_cols=153 Identities=11% Similarity=0.085 Sum_probs=101.7
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc---------------------Ccc--------eeEEEccccCcccccCC
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF---------------------MPI--------CTILISQYFPTILLPCK 390 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~---------------------~~~--------~~iki~dfG~~~~~~~~ 390 (568)
.|++|.+++.. ..+++..+..++.|++.++ +++ +.+||+|||++......
T Consensus 95 ~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~ 173 (336)
T 3g2f_A 95 PNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173 (336)
T ss_dssp TTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccc
Confidence 36788888876 3458888888888887643 233 36789999977543221
Q ss_pred -------CCceecccccccccccCCC-CC-------CCCCCccceeehhHHHHHHHhCCCCCC-CCCH------------
Q psy6203 391 -------VGQVINLLRSAIVLCSAPS-SK-------QYYGSETDVWSMGVMLYALLCGFLPFD-SDSI------------ 442 (568)
Q Consensus 391 -------~~~~~~~~~gt~~~~~pe~-~~-------~~~~~~~DiWSlG~il~eml~g~~pf~-~~~~------------ 442 (568)
........+||+.|+|||. .+ ..++.++||||+||++|||++|..||. +.+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3g2f_A 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253 (336)
T ss_dssp SCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHC
T ss_pred cccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccC
Confidence 1122335689999999997 33 467789999999999999999966653 3221
Q ss_pred ----HHHHHHHHcC---CCCCCCC------CCHHHHHHHHHccCCCcCCCCCHHHHhc------Cccccc
Q psy6203 443 ----DQLYDKILNG---KYTEPPW------MSPNSRQIVRSMLQVEPGKRIKIQDLLG------HNWVKM 493 (568)
Q Consensus 443 ----~~~~~~i~~~---~~~~~~~------~s~~~~~li~~~L~~dp~~R~t~~~~l~------hp~~~~ 493 (568)
.......... ...+|.. .++++.+||.+||..||++|||++|+++ ++|-+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 254 NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred CCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 1111111111 2223332 3447999999999999999999999844 677654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 568 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-82 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-20 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-07 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-80 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-16 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-05 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-79 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-19 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-07 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-20 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-06 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-77 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-18 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-06 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-76 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-16 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-05 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-76 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-17 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-06 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-75 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-18 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-07 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-74 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-19 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-08 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-74 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-20 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-08 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-74 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-18 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-06 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-73 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-19 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-07 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-11 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-71 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-18 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-06 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-16 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-06 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-70 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-05 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-17 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-05 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-68 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-17 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-06 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-12 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-06 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-66 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-13 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-04 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-66 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-16 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-06 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-15 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-04 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-65 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-14 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-06 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-12 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-05 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-63 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-11 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-04 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-62 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-13 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-06 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-62 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-04 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-11 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-04 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-11 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-05 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-11 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-05 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-11 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-04 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-60 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-12 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-11 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-59 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-12 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-05 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-58 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-06 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-10 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-04 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-11 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-05 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-11 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-09 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-09 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 0.002 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-12 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-06 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-11 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-04 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-10 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 0.003 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-56 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-11 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-56 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-14 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-56 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-11 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-05 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-11 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-04 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-11 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-04 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-54 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-10 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-04 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-53 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-11 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-06 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-12 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-05 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-07 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-52 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-06 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-08 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-04 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-08 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-09 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-07 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-04 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-04 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 0.004 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-11 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-04 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-08 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-48 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-39 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (656), Expect = 1e-82
Identities = 69/258 (26%), Positives = 141/258 (54%), Gaps = 6/258 (2%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--LPRVKLEINALKHISH 65
+ + R +G G F V LA + +A+K++ KA L + +++ E+ H+ H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+I +L+ ++ +++++EY P G + + + + E+ + + ++ +A++Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
HRD+KPEN+LL LK+ DFG S+ T CG+ +Y PE+I+G+ +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTTLCGTLDYLPPEMIEGRM-H 181
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
+ D+WS+GV+ Y L G PF++++ + Y +I ++T P +++ +R ++ +L+
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 246 EPGKRIKIQDLLGHNWVK 263
P +R ++++L H W+
Sbjct: 242 NPSQRPMLREVLEHPWIT 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.3 bits (221), Expect = 2e-20
Identities = 21/81 (25%), Positives = 49/81 (60%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471
+ + + D+WS+GV+ Y L G PF++++ + Y +I ++T P +++ +R ++ +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238
Query: 472 LQVEPGKRIKIQDLLGHNWVK 492
L+ P +R ++++L H W+
Sbjct: 239 LKHNPSQRPMLREVLEHPWIT 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (118), Expect = 4e-07
Identities = 12/45 (26%), Positives = 24/45 (53%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPI 373
+ + + D+WS+GV+ Y L G PF++++ + Y +I
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 223
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 4e-80
Identities = 87/260 (33%), Positives = 137/260 (52%), Gaps = 4/260 (1%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+ L +T+G G + +V+LA + +T E VA+KI+ + +K EI K ++H++
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
+ K + + ++ +EYC GGEL D I + E +++ FF Q+++ V YLH +G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS-CGSPNYAAPEVIKGKQYYG 186
HRD+KPEN+LLD NLK+ DFGL +L CG+ Y APE++K ++++
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTEPPW--MSPNSRQIVRSML 243
DVWS G++L A+L G LP+D S Q Y K PW + ++ +L
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244
Query: 244 QVEPGKRIKIQDLLGHNWVK 263
P RI I D+ W
Sbjct: 245 VENPSARITIPDIKKDRWYN 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.0 bits (189), Expect = 2e-16
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 3/87 (3%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYTEPPW--MSPNSR 465
++++ DVWS G++L A+L G LP+D S Q Y K PW +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVK 492
++ +L P RI I D+ W
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.1 bits (101), Expect = 4e-05
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKI 366
+ ++++ DVWS G++L A+L G LP+D S Q Y
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 6e-79
Identities = 70/271 (25%), Positives = 127/271 (46%), Gaps = 10/271 (3%)
Query: 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALK 61
+ ++ + + + +G G F KV A + T A K++ + E+L +EI+ L
Sbjct: 6 RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILA 64
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVA 120
H +I KL ++++++IE+C GG + ++E +R L E + + +Q L A+
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
YLH HRDLK N+L + ++KL DFG+ + + + G+P + APEV+
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGV-SAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 181 GKQY----YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPWMSP 233
+ Y + DVWS+G+ L + P + ++ KI + +P S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
N + ++ L+ R LL H +V +
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (216), Expect = 1e-19
Identities = 24/103 (23%), Positives = 43/103 (41%), Gaps = 4/103 (3%)
Query: 403 VLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY---TEPPW 459
V+ S + Y + DVWS+G+ L + P + ++ KI + +P
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLRE 502
S N + ++ L+ R LL H +V + + P+RE
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD-SNKPIRE 282
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (116), Expect = 6e-07
Identities = 11/52 (21%), Positives = 21/52 (40%)
Query: 321 LSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMP 372
+ + + Y + DVWS+G+ L + P + ++ KI P
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 2e-77
Identities = 72/260 (27%), Positives = 136/260 (52%), Gaps = 4/260 (1%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISHQH 67
+ + +G G F+ V LA + T + AIKI++K + +P V E + + + H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
KL+ + ++ + Y GELL +I + E +R + +I+SA+ YLH G
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLC-AKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKPEN+LL+ + ++++ DFG +++ + G+ Y +PE++ K
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 188
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVE 246
+D+W++G ++Y L+ G PF + + ++ KI+ +Y P P +R +V +L ++
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 248
Query: 247 PGKRIKIQDLLGHNWVKMGP 266
KR+ +++ G+ +K P
Sbjct: 249 ATKRLGCEEMEGYGPLKAHP 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (219), Expect = 4e-20
Identities = 21/86 (24%), Positives = 48/86 (55%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
+++ +D+W++G ++Y L+ G PF + + ++ KI+ +Y P P +R +V
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242
Query: 470 SMLQVEPGKRIKIQDLLGHNWVKMGP 495
+L ++ KR+ +++ G+ +K P
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (113), Expect = 1e-06
Identities = 10/40 (25%), Positives = 23/40 (57%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ +D+W++G ++Y L+ G PF + + ++ KI+
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 246 bits (629), Expect = 2e-77
Identities = 84/305 (27%), Positives = 141/305 (46%), Gaps = 11/305 (3%)
Query: 1 MKYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINAL 60
+K+ + + Y + +G+G F V T TG A K + D V+ EI +
Sbjct: 19 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTM 77
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAV 119
+ H + L E + + M+ E+ GGEL + + E ++ E E+ + RQ+ +
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 120 AYLHHLGYAHRDLKPENVLL--DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
++H Y H DLKPEN++ R+ LKLIDFGL A + + ++ + G+ +AAPE
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPE 195
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EPPWMSP 233
V +GK G TD+WS+GV+ Y LL G PF ++ D+ + + + +S
Sbjct: 196 VAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADH 293
+ + +R +L +P R+ I L H W+ G S P + D +
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 314
Query: 294 KQLSP 298
+ P
Sbjct: 315 PEPLP 319
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 85.1 bits (210), Expect = 1e-18
Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 4/115 (3%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EPPWMSPNSRQI 467
+ G TD+WS+GV+ Y LL G PF ++ D+ + + + +S + +
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 468 VRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPDDM 522
+R +L +P R+ I L H W+ G + + D + D
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 314
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 48.1 bits (114), Expect = 2e-06
Identities = 17/65 (26%), Positives = 28/65 (43%)
Query: 304 QLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 363
L+ T + + + G TD+WS+GV+ Y LL G PF ++ D+
Sbjct: 175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
Query: 364 DKILS 368
+ S
Sbjct: 235 RNVKS 239
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 242 bits (618), Expect = 2e-76
Identities = 78/285 (27%), Positives = 112/285 (39%), Gaps = 14/285 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKH 62
D + R +G G F V A V E VAIK M + E + E+ L+
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+ H + + ++V+EYC G V ++ L E E A L +AYL
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H HRD+K N+LL +KL DFG + + + + G+P + APEVI
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPANSFVGTPYWMAPEVILAM 186
Query: 183 QY--YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW--MSPNSRQI 238
Y + DVWS+G+ L P + + I + S R
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 239 VRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKD 283
V S LQ P R + LL H +V + P + D R KD
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVL---RERPPTVIMDLIQRTKD 288
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 76.2 bits (187), Expect = 9e-16
Identities = 21/86 (24%), Positives = 30/86 (34%), Gaps = 2/86 (2%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPW--MSPNSRQ 466
+ Y + DVWS+G+ L P + + I + S R
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVK 492
V S LQ P R + LL H +V
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.4 bits (102), Expect = 4e-05
Identities = 14/77 (18%), Positives = 27/77 (35%), Gaps = 1/77 (1%)
Query: 314 TCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH-FMP 372
T ++ + Y + DVWS+G+ L P + + I +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233
Query: 373 ICTILISQYFPTILLPC 389
+ + S+YF + C
Sbjct: 234 LQSGHWSEYFRNFVDSC 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 241 bits (616), Expect = 5e-76
Identities = 97/285 (34%), Positives = 153/285 (53%), Gaps = 13/285 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D+R+ Y +G+G F++V LA T + VAIK + K L ++ EI L I
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
H +I L + E+ H++++++ GGEL D IVE+ E+++ Q+L AV YLH
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 125 LGYAHRDLKPENVLL---DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
LG HRDLKPEN+L D + + + DFGL + G S L T+CG+P Y APEV+
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQ 183
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQ 237
K Y D WS+GV+ Y LLCG+ PF ++ +L+++IL +Y +S +++
Sbjct: 184 KP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREK 282
+R +++ +P KR + L H W+ D + + E+
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIA---GDTALDKNIHQSVSEQ 284
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 82.0 bits (202), Expect = 1e-17
Identities = 25/87 (28%), Positives = 49/87 (56%), Gaps = 4/87 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSR 465
+++ Y D WS+GV+ Y LLCG+ PF ++ +L+++IL +Y +S +++
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVK 492
+R +++ +P KR + L H W+
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.5 bits (115), Expect = 1e-06
Identities = 18/76 (23%), Positives = 36/76 (47%)
Query: 293 HKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFL 352
+S + + + C ++ + ++ Y D WS+GV+ Y LLCG+
Sbjct: 148 KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
Query: 353 PFDSDSIDQLYDKILS 368
PF ++ +L+++IL
Sbjct: 208 PFYDENDAKLFEQILK 223
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 7e-75
Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 15/266 (5%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHI 68
Y + T+G+G + + + G+ + K + ++ E + + E+N L+ + H +I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 69 CKLFQVI--ETSSHIFMVIEYCPGGELLDHIV----ERQRLGEKESRAFFRQILSAVAYL 122
+ + I T++ +++V+EYC GG+L I ERQ L E+ Q+ A+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 123 HHLGYA-----HRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
H HRDLKP NV LD QN+KL DFGL A+ S + G+P Y +PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL-ARILNHDTSFAKAFVGTPYYMSPE 184
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSR 236
+ Y ++D+WS+G +LY L PF + S +L KI GK+ P S
Sbjct: 185 QMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWV 262
+I+ ML ++ R ++++L + +
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (206), Expect = 2e-18
Identities = 23/83 (27%), Positives = 43/83 (51%), Gaps = 1/83 (1%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIV 468
++ Y ++D+WS+G +LY L PF + S +L KI GK+ P S +I+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 246
Query: 469 RSMLQVEPGKRIKIQDLLGHNWV 491
ML ++ R ++++L + +
Sbjct: 247 TRMLNLKDYHRPSVEEILENPLI 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.8 bits (121), Expect = 1e-07
Identities = 28/148 (18%), Positives = 51/148 (34%), Gaps = 17/148 (11%)
Query: 249 KRIKIQDLLGHNWV-KMGPEDNPVSFR---PDHELREKDDDVIKVMADH---KQLSPDDM 301
R+ Q L + + V R P + + +V + D + L+ D
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV--KLGDFGLARILNHDTS 169
Query: 302 WSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ 361
+++ T Y + + + Y ++D+WS+G +LY L PF + S +
Sbjct: 170 FAKAFVGTPYYMSPEQMN--------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221
Query: 362 LYDKILSHFMPICTILISQYFPTILLPC 389
L KI S I+
Sbjct: 222 LAGKIREGKFRRIPYRYSDELNEIITRM 249
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 236 bits (603), Expect = 1e-74
Identities = 90/273 (32%), Positives = 138/273 (50%), Gaps = 20/273 (7%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--------EDLPRVKLEINAL 60
Y + +G G + V+ H T ++ A+KI+ G E E++ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 61 KHIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
+ +S H +I +L ET++ F+V + GEL D++ E+ L EKE+R R +L +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
LH L HRDLKPEN+LLD + N+KL DFG + + G +L+ CG+P+Y APE+I
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEII 181
Query: 180 KG-----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EPPW 230
+ YG E D+WS GV++Y LL G PF + I++G Y E
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 231 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
S + +V L V+P KR ++ L H + +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 84.7 bits (209), Expect = 8e-19
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 402 IVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EP 457
I+ CS + YG E D+WS GV++Y LL G PF + I++G Y E
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 458 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
S + +V L V+P KR ++ L H + +
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 53.5 bits (128), Expect = 2e-08
Identities = 24/88 (27%), Positives = 33/88 (37%), Gaps = 1/88 (1%)
Query: 282 KDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMG 341
DD IK+ D D +L E ++ YG E D+WS G
Sbjct: 144 DDDMNIKL-TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202
Query: 342 VMLYALLCGFLPFDSDSIDQLYDKILSH 369
V++Y LL G PF + I+S
Sbjct: 203 VIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 1e-74
Identities = 75/291 (25%), Positives = 134/291 (46%), Gaps = 12/291 (4%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
+L +Y++ +G G F V + + K +K G D VK EI+ L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR 59
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLH 123
H++I L + E+ + M+ E+ G ++ + I L E+E ++ Q+ A+ +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 124 HLGYAHRDLKPENVLLDRNQN--LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
H D++PEN++ ++ +K+I+FG + + G + +P Y APEV +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH 177
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EPPWMSPNSRQ 237
+ TD+WS+G ++Y LL G PF +++ Q+ + I+N +YT +S +
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIK 288
V +L E R+ + L H W+K E + R +IK
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIK 287
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 2e-20
Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EPPWMSPNSR 465
+ TD+WS+G ++Y LL G PF +++ Q+ + I+N +YT +S +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496
V +L E R+ + L H W+K E
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (127), Expect = 3e-08
Identities = 16/65 (24%), Positives = 30/65 (46%)
Query: 304 QLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 363
QL T + + + TD+WS+G ++Y LL G PF +++ Q+
Sbjct: 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 364 DKILS 368
+ I++
Sbjct: 213 ENIMN 217
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 238 bits (608), Expect = 2e-74
Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 12/298 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+ Y + +GSG F V TG K + D VK EI+ + + H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPK 87
Query: 68 ICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLG 126
+ L E + +++E+ GGEL D I ++ E E + RQ + ++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 127 YAHRDLKPENVLLDRNQN--LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
H D+KPEN++ + + +K+IDFGL K ++ + + +AAPE++ +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EP 204
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVR 240
G TD+W++GV+ Y LL G PF + + + + +SP ++ ++
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSP 298
++LQ EP KR+ + D L H W+K G N S P + + + AD P
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWLK-GDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQP 321
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 85.1 bits (210), Expect = 2e-18
Identities = 29/115 (25%), Positives = 52/115 (45%), Gaps = 4/115 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSR 465
++ G TD+W++GV+ Y LL G PF + + + + +SP ++
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPD 520
++++LQ EP KR+ + D L H W+K + R K+ K+ D
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 47.7 bits (113), Expect = 2e-06
Identities = 15/65 (23%), Positives = 27/65 (41%)
Query: 304 QLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY 363
+LN T + + ++ G TD+W++GV+ Y LL G PF + +
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237
Query: 364 DKILS 368
+
Sbjct: 238 QNVKR 242
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 1e-73
Identities = 74/263 (28%), Positives = 128/263 (48%), Gaps = 7/263 (2%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D + +Y +G G V A V TG++VAI+ M + EI ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENK 75
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ +I +++V+EY GG L D + E + E + A R+ L A+ +LH
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS 134
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
HRD+K +N+LL + ++KL DFG CA+ +S+ T G+P + APEV+ K
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKA- 192
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---KYTEPPWMSPNSRQIVRS 241
YG + D+WS+G+M ++ G P+ +++ + I + P +S R +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 242 MLQVEPGKRIKIQDLLGHNWVKM 264
L ++ KR ++LL H ++K+
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKI 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (211), Expect = 6e-19
Identities = 21/96 (21%), Positives = 46/96 (47%), Gaps = 3/96 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG---KYTEPPWMSPNSRQ 466
+++ YG + D+WS+G+M ++ G P+ +++ + I + P +S R
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 467 IVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLRE 502
+ L ++ KR ++LL H ++K+ + L
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (118), Expect = 4e-07
Identities = 11/44 (25%), Positives = 25/44 (56%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMP 372
+ YG + D+WS+G+M ++ G P+ +++ + I ++ P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 4e-71
Identities = 59/306 (19%), Positives = 120/306 (39%), Gaps = 50/306 (16%)
Query: 4 IDLR-NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH 62
++L+ + + +G+G V +H +G +A K++ ++ E+ L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
+ +I + + I + +E+ GG L + + R+ E+ ++ + YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 123 HH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
HRD+KP N+L++ +KL DFG+ + +S + G+ +Y +PE ++G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 177
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPF---DSDSIDQLYDKILNGKYTEPPW-------- 230
Y ++D+WSMG+ L + G P D+ ++ ++ + G E P
Sbjct: 178 TH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 231 ---------------------------------MSPNSRQIVRSMLQVEPGKRIKIQDLL 257
S + V L P +R ++ L+
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 258 GHNWVK 263
H ++K
Sbjct: 297 VHAFIK 302
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.2 bits (148), Expect = 7e-11
Identities = 29/166 (17%), Positives = 49/166 (29%), Gaps = 43/166 (25%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILLP 388
+Y ++D+WSMG+ L + G P +L M C +
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE------LMFGCQVEGDA-------- 223
Query: 389 CKVGQVINLLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK 448
+ET G +I +L D
Sbjct: 224 ---------------------------AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY 256
Query: 449 ILNGKYTEPPW--MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
I+N + P S + V L P +R ++ L+ H ++K
Sbjct: 257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 7e-71
Identities = 80/260 (30%), Positives = 136/260 (52%), Gaps = 6/260 (2%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKH-IS 64
+IL + +G G F KV LA T + AIK +KK + +D+ +E L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
H + +F +T ++F V+EY GG+L+ HI + + + +I+ + +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
G +RDLK +N+LLD++ ++K+ DFG+C + G +++ T CG+P+Y APE++ G Q
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLG-QK 179
Query: 185 YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244
Y D WS GV+LY +L G PF ++L+ I P W+ ++ ++ +
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 245 VEPGKRIKI-QDLLGHNWVK 263
EP KR+ + D+ H +
Sbjct: 240 REPEKRLGVRGDIRQHPLFR 259
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 7e-18
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 1/84 (1%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
Q Y D WS GV+LY +L G PF ++L+ I P W+ ++ ++
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235
Query: 470 SMLQVEPGKRIKI-QDLLGHNWVK 492
+ EP KR+ + D+ H +
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (113), Expect = 2e-06
Identities = 15/45 (33%), Positives = 20/45 (44%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPI 373
Q Y D WS GV+LY +L G PF ++L+ I
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 222
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-70
Identities = 62/265 (23%), Positives = 117/265 (44%), Gaps = 16/265 (6%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHI 68
+ +G G F V T +VA ++ L + + R K E LK + H +I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 69 CKLFQVIETSS----HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ + E++ I +V E G L ++ + + K R++ RQIL + +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 125 LGYA--HRDLKPENVLL-DRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKG 181
HRDLK +N+ + ++K+ D GL S + G+P + APE+ +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE 187
Query: 182 KQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKY--TEPPWMSPNSRQI 238
K Y DV++ G+ + + P+ + + Q+Y ++ +G + P ++I
Sbjct: 188 K--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245
Query: 239 VRSMLQVEPGKRIKIQDLLGHNWVK 263
+ ++ +R I+DLL H + +
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.4 bits (185), Expect = 9e-16
Identities = 16/85 (18%), Positives = 40/85 (47%), Gaps = 3/85 (3%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKY--TEPPWMSPNSRQI 467
++ Y DV++ G+ + + P+ + + Q+Y ++ +G + P ++I
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245
Query: 468 VRSMLQVEPGKRIKIQDLLGHNWVK 492
+ ++ +R I+DLL H + +
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.8 bits (108), Expect = 7e-06
Identities = 9/46 (19%), Positives = 22/46 (47%), Gaps = 1/46 (2%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILSHFMP 372
++ Y DV++ G+ + + P+ + + Q+Y ++ S P
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 9e-70
Identities = 84/267 (31%), Positives = 139/267 (52%), Gaps = 18/267 (6%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-----EDLPRVKLEINAL 60
L +QY + +GSGGF V V VAIK ++K + + RV +E+ L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 61 KHISHQH--ICKLFQVIETSSHIFMVIEYCPGGELL-DHIVERQRLGEKESRAFFRQILS 117
K +S + +L E +++E + L D I ER L E+ +R+FF Q+L
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
AV + H+ G HRD+K EN+L+D N+ LKLIDFG A + ++ G+ Y+ P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPP 178
Query: 177 EVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSR 236
E I+ +Y+G VWS+G++LY ++CG +PF+ D ++I+ G+ +S +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQ 232
Query: 237 QIVRSMLQVEPGKRIKIQDLLGHNWVK 263
++R L + P R +++ H W++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 3e-16
Identities = 22/84 (26%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIV 468
+Y+G VWS+G++LY ++CG +PF+ D ++I+ G+ +S + ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLI 235
Query: 469 RSMLQVEPGKRIKIQDLLGHNWVK 492
R L + P R +++ H W++
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.5 bits (102), Expect = 3e-05
Identities = 17/56 (30%), Positives = 28/56 (50%), Gaps = 1/56 (1%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILSHFMPICTILISQ 380
+ +Y+G VWS+G++LY ++CG +PF+ D I + C LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 223 bits (570), Expect = 4e-69
Identities = 77/263 (29%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISH 65
+ + RT+G+G F +V L G A+K++KK + + + E L ++H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
I +++ + + IFM+++Y GGEL + + QR ++ + ++ A+ YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
+RDLKPEN+LLD+N ++K+ DFG + T CG+P+Y APEV+ K Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYTLCGTPDYIAPEVVSTKP-Y 178
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
D WS G+++Y +L G+ PF + + Y+KILN + PP+ + + + ++ ++
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR 238
Query: 246 EPGKRIK-----IQDLLGHNWVK 263
+ +R+ +D+ H W K
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.1 bits (197), Expect = 4e-17
Identities = 23/88 (26%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
S + Y D WS G+++Y +L G+ PF + + Y+KILN + PP+ + + + ++
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233
Query: 470 SMLQVEPGKRIK-----IQDLLGHNWVK 492
++ + +R+ +D+ H W K
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.5 bits (102), Expect = 4e-05
Identities = 14/40 (35%), Positives = 24/40 (60%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ Y D WS G+++Y +L G+ PF + + Y+KIL+
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 7e-68
Identities = 94/289 (32%), Positives = 147/289 (50%), Gaps = 16/289 (5%)
Query: 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-----GEDLPRVKLE 56
+ ++ + Y +GSG FA VK TG + A K +KK G ++ E
Sbjct: 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 57 INALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQIL 116
++ LK I H ++ L +V E + + +++E GGEL D + E++ L E+E+ F +QIL
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRN----QNLKLIDFGLCAKPEGGLESQLQTSCGSPN 172
+ V YLH L AH DLKPEN++L +K+IDFGL K + G ++ + G+P
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPE 181
Query: 173 YAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EP 228
+ APE++ + G E D+WS+GV+ Y LL G PF D+ + + Y
Sbjct: 182 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDH 277
S ++ +R +L +P KR+ IQD L H W+K +S H
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 1e-17
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 4/98 (4%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT----EPPWMSPNSR 465
+ + G E D+WS+GV+ Y LL G PF D+ + + Y S ++
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 466 QIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREK 503
+R +L +P KR+ IQD L H W+K L
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSA 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (106), Expect = 9e-06
Identities = 14/40 (35%), Positives = 22/40 (55%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ G E D+WS+GV+ Y LL G PF D+ + + +
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-67
Identities = 63/264 (23%), Positives = 111/264 (42%), Gaps = 15/264 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL-GEDLPRVKLEINALKHISH 65
Q + + +GSG F V VA+K++ + L K E+ L+ H
Sbjct: 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHI-VERQRLGEKESRAFFRQILSAVAYLHH 124
+I T+ + +V ++C G L H+ + + + RQ + YLH
Sbjct: 64 VNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCA-KPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRDLK N+ L + +K+ DFGL K Q + GS + APEVI+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 184 Y--YGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS------ 235
Y ++DV++ G++LY L+ G LP+ + + ++ Y P S
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 236 RQIVRSMLQVEPGKRIKIQDLLGH 259
++++ L+ + +R +L
Sbjct: 243 KRLMAECLKKKRDERPLFPQILAS 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (159), Expect = 2e-12
Identities = 17/85 (20%), Positives = 37/85 (43%), Gaps = 6/85 (7%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNS----- 464
K Y ++DV++ G++LY L+ G LP+ + + ++ Y P S
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 465 -RQIVRSMLQVEPGKRIKIQDLLGH 488
++++ L+ + +R +L
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (108), Expect = 7e-06
Identities = 12/46 (26%), Positives = 25/46 (54%)
Query: 324 KKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSH 369
+ Q K Y ++DV++ G++LY L+ G LP+ + + ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 218 bits (556), Expect = 2e-66
Identities = 62/269 (23%), Positives = 118/269 (43%), Gaps = 16/269 (5%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED-----LPRVKLEINALKH 62
N + + R +G GGF +V TG+ A+K + K + ++ ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYL 122
I + T + +++ GG+L H+ + E + R + +I+ + ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
H+ +RDLKP N+LLD + ++++ D GL + + S G+ Y APEV++
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQKG 180
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKYTEPPWMSPNSRQIV 239
Y S D +S+G ML+ LL G PF ++ L P SP R ++
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240
Query: 240 RSMLQVEPGKRIK-----IQDLLGHNWVK 263
+LQ + +R+ Q++ + +
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.0 bits (168), Expect = 3e-13
Identities = 21/91 (23%), Positives = 36/91 (39%), Gaps = 8/91 (8%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKYTEPPWMSPNSRQ 466
Y S D +S+G ML+ LL G PF ++ L P SP R
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 467 IVRSMLQVEPGKRIK-----IQDLLGHNWVK 492
++ +LQ + +R+ Q++ + +
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.4 bits (99), Expect = 1e-04
Identities = 13/47 (27%), Positives = 18/47 (38%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMP 372
Q Y S D +S+G ML+ LL G PF ++
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-66
Identities = 79/263 (30%), Positives = 144/263 (54%), Gaps = 9/263 (3%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISH 65
N + + +G G F KV L TG A+KI++K + +++ E L++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+ L +T + V+EY GGEL H+ + E+ +R + +I+SA+ YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
+RD+K EN++LD++ ++K+ DFGLC K + ++T CG+P Y APEV++ Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLC-KEGISDGATMKTFCGTPEYLAPEVLEDND-Y 182
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
G D W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++ +L+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 246 EPGKRIK-----IQDLLGHNWVK 263
+P +R+ ++++ H +
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 2e-16
Identities = 22/88 (25%), Positives = 48/88 (54%), Gaps = 5/88 (5%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVR 469
YG D W +GV++Y ++CG LPF + ++L++ IL + P +SP ++ ++
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 470 SMLQVEPGKRIK-----IQDLLGHNWVK 492
+L+ +P +R+ ++++ H +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (108), Expect = 7e-06
Identities = 28/169 (16%), Positives = 58/169 (34%), Gaps = 25/169 (14%)
Query: 205 FLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
+ + +L+ + + +IV + L+ + + +D+ N +
Sbjct: 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA-LEYLHSRDVVYRDIKLENLM-- 137
Query: 265 GPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRK 324
L + I K+ D + T Y L+ +
Sbjct: 138 --------------LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY--------LAPE 175
Query: 325 KQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPI 373
YG D W +GV++Y ++CG LPF + ++L++ IL +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-66
Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 27/304 (8%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHI 68
+ + +G G KV + T EK A+K+++ P+ + E+ S HI
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHI 67
Query: 69 CKLFQVIETSS----HIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYL 122
++ V E + +V+E GGEL I +R Q E+E+ + I A+ YL
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 123 HHLGYAHRDLKPENVLLDRNQN---LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
H + AHRD+KPEN+L + LKL DFG + + L T C +P Y APEV+
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVL 185
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEP----PWM 231
++ Y D+WS+GV++Y LLCG+ PF S+ + +I G+Y P +
Sbjct: 186 GPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 232 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMA 291
S + ++R++L+ EP +R+ I + + H W+ + L+E + V
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 304
Query: 292 DHKQ 295
+
Sbjct: 305 EMTS 308
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (181), Expect = 5e-15
Identities = 33/133 (24%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEP----PWMS 461
+ Y D+WS+GV++Y LLCG+ PF S+ + +I G+Y P +S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 462 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPDD 521
+ ++R++L+ EP +R+ I + + H W+ + V+K + + ++
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 305
Query: 522 MWSQLNEWTYNYD 534
M S L +Y+
Sbjct: 306 MTSALATMRVDYE 318
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (91), Expect = 8e-04
Identities = 15/45 (33%), Positives = 25/45 (55%)
Query: 327 GKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFM 371
G + Y D+WS+GV++Y LLCG+ PF S+ + + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 213 bits (543), Expect = 1e-65
Identities = 63/271 (23%), Positives = 116/271 (42%), Gaps = 13/271 (4%)
Query: 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHI 63
L ++Y L +G GG ++V LA + VA+K+++ R + E +
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 64 SHQHICKLFQVIETSSH----IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
+H I ++ E + ++V+EY G L D + + K + A+
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL--CAKPEGGLESQLQTSCGSPNYAAPE 177
+ H G HRD+KP N+++ +K++DFG+ G +Q G+ Y +PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSP 233
+G + +DV+S+G +LY +L G PF DS + + + P +S
Sbjct: 185 QARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264
+ +V L P R + + + V++
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 70.5 bits (172), Expect = 5e-14
Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQI 467
+ +DV+S+G +LY +L G PF DS + + + P +S + +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248
Query: 468 VRSMLQVEPGKRIKIQDLLGHNWVKM 493
V L P R + + + V++
Sbjct: 249 VLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 46.7 bits (110), Expect = 3e-06
Identities = 16/67 (23%), Positives = 28/67 (41%)
Query: 301 MWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID 360
+ N T LS ++ + +DV+S+G +LY +L G PF DS
Sbjct: 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 220
Query: 361 QLYDKIL 367
+ + +
Sbjct: 221 SVAYQHV 227
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 4e-63
Identities = 63/258 (24%), Positives = 116/258 (44%), Gaps = 15/258 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
+ L +T+G G F V L + G KVA+K +K + E + + + H
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA---EASVMTQLRHS 60
Query: 67 HICKLFQV-IETSSHIFMVIEYCPGGELLDHIVERQR--LGEKESRAFFRQILSAVAYLH 123
++ +L V +E +++V EY G L+D++ R R LG F + A+ YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 124 HLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
+ HRDL NVL+ + K+ DFGL + S T + APE ++ K+
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALREKK 176
Query: 184 YYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRS 241
+ +++DVWS G++L+ + G +P+ + + ++ G + P P +++++
Sbjct: 177 -FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235
Query: 242 MLQVEPGKRIKIQDLLGH 259
++ R L
Sbjct: 236 CWHLDAAMRPSFLQLREQ 253
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (160), Expect = 1e-12
Identities = 13/81 (16%), Positives = 37/81 (45%), Gaps = 2/81 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQI 467
++ + +++DVWS G++L+ + G +P+ + + ++ G + P P ++
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
Query: 468 VRSMLQVEPGKRIKIQDLLGH 488
+++ ++ R L
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (105), Expect = 1e-05
Identities = 17/175 (9%), Positives = 52/175 (29%), Gaps = 27/175 (15%)
Query: 216 LYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRP 275
L D + + + +++ L V + H +
Sbjct: 88 LVDYLRSRGRSVLGG-----DCLLKFSLDVCEAMEYLEGNNFVHRDLA-----------A 131
Query: 276 DHELREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSET 335
+ L +D+ + + + + + L ++ + +++
Sbjct: 132 RNVLVSEDNVAKVSDFGLTKEASSTQDTG--KLPVKWTAPEALR--------EKKFSTKS 181
Query: 336 DVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILLPC 389
DVWS G++L+ + G +P+ + + ++ + ++ C
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 236
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 7e-63
Identities = 76/328 (23%), Positives = 127/328 (38%), Gaps = 43/328 (13%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS 64
D+ +Y +G G + V A + +VAIK + R EI L
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 65 HQHICKLFQVIETSSHI----FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
H++I + +I + ++ + G +L + + Q L F QIL +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLK 123
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC--AKPEGGLESQLQTSCGSPNYAAPEV 178
Y+H HRDLKP N+LL+ +LK+ DFGL A P+ L + Y APE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 179 IKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP---------- 228
+ + Y D+WS+G +L +L F + IL +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 229 ---------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG-- 265
P + ++ ML P KRI+++ L H +++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 266 PEDNPVS---FRPDHELREKDDDVIKVM 290
P D P++ F+ D EL + + +K +
Sbjct: 304 PSDEPIAEAPFKFDMELDDLPKEKLKEL 331
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 1e-11
Identities = 23/125 (18%), Positives = 40/125 (32%), Gaps = 33/125 (26%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP------------- 457
+ Y D+WS+G +L +L F + IL +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 458 ------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG--PED 497
P + ++ ML P KRI+++ L H +++ P D
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306
Query: 498 NPLRE 502
P+ E
Sbjct: 307 EPIAE 311
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 1e-04
Identities = 10/48 (20%), Positives = 16/48 (33%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPI 373
+ Y D+WS+G +L +L F + IL
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 3e-62
Identities = 73/292 (25%), Positives = 103/292 (35%), Gaps = 33/292 (11%)
Query: 16 VGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP----RVKLEINALKHISHQHICKL 71
+G G FA V A T + VAIK +K E EI L+ +SH +I L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 72 FQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRD 131
S+I +V ++ + L +A+ L + YLH HRD
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125
Query: 132 LKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDV 191
LKP N+LLD N LKL DFG AK G + Y APE++ G + YG D+
Sbjct: 126 LKPNNLLLDENGVLKLADFG-LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 184
Query: 192 WSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----------------------- 228
W++G +L LL DS +I T
Sbjct: 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 244
Query: 229 -----PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRP 275
+ +++ + P RI L + P P P
Sbjct: 245 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (167), Expect = 2e-13
Identities = 18/116 (15%), Positives = 30/116 (25%), Gaps = 28/116 (24%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP-------------- 457
+ YG D+W++G +L LL DS +I T
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 458 --------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNP 499
+ +++ + P RI L + P P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (110), Expect = 4e-06
Identities = 14/63 (22%), Positives = 21/63 (33%)
Query: 306 NEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDK 365
Y + T G + YG D+W++G +L LL DS +
Sbjct: 153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212
Query: 366 ILS 368
I
Sbjct: 213 IFE 215
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 4e-62
Identities = 83/263 (31%), Positives = 143/263 (54%), Gaps = 12/263 (4%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVKLEINALKHISH 65
+Q+ +T+G+G F +V L H +G A+KI+ K + + + E L+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 66 QHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHL 125
+ KL + +S+++MV+EY GGE+ H+ R E +R + QI+ YLH L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 126 GYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYY 185
+RDLKPEN+L+D+ +++ DFG + +G + T CG+P APE+I + Y
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILS-KGY 215
Query: 186 GSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245
D W++GV++Y + G+ PF +D Q+Y+KI++GK P S + + ++R++LQV
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 246 EPGKRIK-----IQDLLGHNWVK 263
+ KR + D+ H W
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 72.9 bits (178), Expect = 2e-14
Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSM 471
+ Y D W++GV++Y + G+ PF +D Q+Y+KI++GK P S + + ++R++
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272
Query: 472 LQVEPGKRIK-----IQDLLGHNWVKMGPEDNPLREK 503
LQV+ KR + D+ H W + K
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRK 309
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.3 bits (96), Expect = 2e-04
Identities = 15/45 (33%), Positives = 27/45 (60%)
Query: 329 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPI 373
+ Y D W++GV++Y + G+ PF +D Q+Y+KI+S +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-62
Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 12/272 (4%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEK--VAIKIMKKATLGEDLPRVKLEINAL 60
++ N I + +G G F V+ + + ++ VAIK++K+ T D + E +
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 63
Query: 61 KHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAV 119
+ + +I +L V + + +V+E GG L +V +R+ + Q+ +
Sbjct: 64 HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC--AKPEGGLESQLQTSCGSPNYAAPE 177
YL + HRDL NVLL K+ DFGL + + + APE
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 178 VIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNS 235
I +++ +DVWS GV ++ L G P+ ++ I GK E PP P
Sbjct: 183 CINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 241
Query: 236 RQIVRSMLQVEPGKRIKIQDL---LGHNWVKM 264
++ + R + + + +
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (153), Expect = 1e-11
Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 5/89 (5%)
Query: 410 SKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQI 467
+ + + S +DVWS GV ++ L G P+ ++ I GK E PP P +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244
Query: 468 VRSMLQVEPGKRIKIQDL---LGHNWVKM 493
+ + R + + + +
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (95), Expect = 3e-04
Identities = 13/62 (20%), Positives = 23/62 (37%), Gaps = 1/62 (1%)
Query: 329 QYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILL 387
+ + S +DVWS GV ++ L G P+ ++ I C ++
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 246
Query: 388 PC 389
C
Sbjct: 247 DC 248
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-61
Identities = 62/259 (23%), Positives = 117/259 (45%), Gaps = 8/259 (3%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
ID + +G+G F VK VAIK++K+ ++ ED E + ++
Sbjct: 1 ID-PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED--EFIEEAKVMMNL 56
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAVAYL 122
SH+ + +L+ V IF++ EY G LL+++ R R ++ + + A+ YL
Sbjct: 57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
+ HRDL N L++ +K+ DFGL + S ++ PEV+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 183 QYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIVR 240
+ + S++D+W+ GV+++ + G +P++ + + + I G P S I+
Sbjct: 177 K-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 241 SMLQVEPGKRIKIQDLLGH 259
S + +R + LL +
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (153), Expect = 1e-11
Identities = 16/79 (20%), Positives = 36/79 (45%), Gaps = 2/79 (2%)
Query: 412 QYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIVR 469
+ S++D+W+ GV+++ + G +P++ + + + I G P S I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 470 SMLQVEPGKRIKIQDLLGH 488
S + +R + LL +
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (99), Expect = 6e-05
Identities = 13/62 (20%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 329 QYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILL 387
+ S++D+W+ GV+++ + G +P++ + + + I L S+ TI+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 388 PC 389
C
Sbjct: 236 SC 237
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 8e-61
Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 8/259 (3%)
Query: 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
ID ++ + +GSG F V L L +KVAIK +++ + E+ E + +
Sbjct: 2 ID-PSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEE--DFIEEAEVMMKL 57
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLG-EKESRAFFRQILSAVAYL 122
SH + +L+ V + I +V E+ G L D++ ++ L + + +AYL
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
HRDL N L+ NQ +K+ DFG+ + + +A+PEV
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 183 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIVR 240
+ Y S++DVWS GV+++ + G +P+++ S ++ + I G P S + QI+
Sbjct: 178 R-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 241 SMLQVEPGKRIKIQDLLGH 259
+ P R LL
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (151), Expect = 2e-11
Identities = 21/77 (27%), Positives = 37/77 (48%), Gaps = 2/77 (2%)
Query: 414 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQIVRSM 471
Y S++DVWS GV+++ + G +P+++ S ++ + I G P S + QI+
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 472 LQVEPGKRIKIQDLLGH 488
+ P R LL
Sbjct: 239 WKERPEDRPAFSRLLRQ 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (103), Expect = 2e-05
Identities = 17/60 (28%), Positives = 33/60 (55%), Gaps = 1/60 (1%)
Query: 331 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILLPC 389
Y S++DVWS GV+++ + G +P+++ S ++ + I + F L S + I+ C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 9e-61
Identities = 55/262 (20%), Positives = 106/262 (40%), Gaps = 9/262 (3%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVL--TGEKVAIKIMKKATLGEDLP-RVKLEINA 59
Y+D + + ++ +GSG F VK + + + VA+KI+K L + E N
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 60 LKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAV 119
++ + + +I ++ + E +V+E G L ++ + + + +K Q+ +
Sbjct: 62 MQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120
Query: 120 AYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLC--AKPEGGLESQLQTSCGSPNYAAPE 177
YL + HRDL NVLL K+ DFGL + + + APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNS 235
I + + S++DVWS GV+++ G P+ ++ + G+ P
Sbjct: 181 CINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 239
Query: 236 RQIVRSMLQVEPGKRIKIQDLL 257
++ + R +
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVE 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (149), Expect = 3e-11
Identities = 12/79 (15%), Positives = 28/79 (35%), Gaps = 2/79 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQI 467
+ + S++DVWS GV+++ G P+ ++ + G+ P +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 242
Query: 468 VRSMLQVEPGKRIKIQDLL 486
+ + R +
Sbjct: 243 MNLCWTYDVENRPGFAAVE 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (97), Expect = 1e-04
Identities = 11/62 (17%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 329 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILL 387
+ S++DVWS GV+++ G P+ ++ + C + ++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244
Query: 388 PC 389
C
Sbjct: 245 LC 246
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-60
Identities = 77/322 (23%), Positives = 133/322 (41%), Gaps = 46/322 (14%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHI 63
++R Y + VGSG + V A TG KVAIK + + E R E+ LKH+
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 64 SHQHICKLFQVIETSS------HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
H+++ L V ++V+ + G L +++ ++LGE + Q+L
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLK 132
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+ Y+H G HRDLKP N+ ++ + LK++DFGL + + S++ + Y APE
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPE 188
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM------ 231
VI Y D+WS+G ++ ++ G F +I+ T P
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 232 -------------------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM-- 264
SP + ++ ML ++ +R+ + L H + +
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 265 GPEDNPVSFRPDHELREKDDDV 286
ED P + D + D +
Sbjct: 309 DTEDEPQVQKYDDSFDDVDRTL 330
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 1e-12
Identities = 23/130 (17%), Positives = 43/130 (33%), Gaps = 33/130 (25%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM--------- 460
+ Y D+WS+G ++ ++ G F +I+ T P
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 461 ----------------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM--GPE 496
SP + ++ ML ++ +R+ + L H + + E
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 497 DNPLREKDDD 506
D P +K DD
Sbjct: 312 DEPQVQKYDD 321
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 9e-60
Identities = 62/286 (21%), Positives = 117/286 (40%), Gaps = 34/286 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-----KVAIKIMKKATLGEDLPRVKLEINALK 61
R + +GSG F KV AT + +VA+K++K+ + + E+ +
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95
Query: 62 HI-SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR------------------ 102
+ SH++I L S I+++ EYC G+LL+++ ++
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 103 -----LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-P 156
L ++ F Q+ + +L HRDL NVL+ + +K+ DFGL
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQ 215
+ + APE + Y ++DVWS G++L+ + G P+ +D
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 216 LYDKILNGKY--TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
+ K++ + +P + + I++S + KR +L
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (149), Expect = 6e-11
Identities = 17/82 (20%), Positives = 37/82 (45%), Gaps = 3/82 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKY--TEPPWMSPNSRQ 466
+ Y ++DVWS G++L+ + G P+ +D + K++ + +P + +
Sbjct: 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI 298
Query: 467 IVRSMLQVEPGKRIKIQDLLGH 488
I++S + KR +L
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTSF 320
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-59
Identities = 65/303 (21%), Positives = 116/303 (38%), Gaps = 44/303 (14%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHISHQ 66
++Y +G G F +V A H TG+KVA+K + E P EI L+ + H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 67 HICKLFQVIETSS--------HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSA 118
++ L ++ T + I++V ++C + E + + +L+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ---TSCGSPNYAA 175
+ Y+H HRD+K NVL+ R+ LKL DFGL SQ + Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM---- 231
PE++ G++ YG D+W G ++ + ++ I + P +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 232 ----------------------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
P + ++ +L ++P +RI D L H++
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
Query: 264 MGP 266
P
Sbjct: 310 SDP 312
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.1 bits (160), Expect = 2e-12
Identities = 23/196 (11%), Positives = 55/196 (28%), Gaps = 43/196 (21%)
Query: 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILLPCKVGQVINL 397
++ + + D + +L D L+ + + ++ L
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 398 LRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP 457
L ++ YG D+W G ++ + ++ I +
Sbjct: 194 L-----------GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 458 PWM--------------------------------SPNSRQIVRSMLQVEPGKRIKIQDL 485
P + P + ++ +L ++P +RI D
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 486 LGHNWVKMGPEDNPLR 501
L H++ P + L+
Sbjct: 303 LNHDFFWSDPMPSDLK 318
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (103), Expect = 3e-05
Identities = 7/42 (16%), Positives = 15/42 (35%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
G++ YG D+W G ++ + ++ I
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-58
Identities = 85/300 (28%), Positives = 152/300 (50%), Gaps = 25/300 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLGED---LPRVKLEINALK 61
+ L + +G+G + KV L + TG+ A+K++KKAT+ + + E L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 62 HISHQ-HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
HI + L +T + + ++++Y GGEL H+ +R+R E E + + +I+ A+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 121 YLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIK 180
+LH LG +RD+K EN+LLD N ++ L DFGL + + CG+ Y AP++++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 181 GKQY-YGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPPWMSPNS 235
G + D WS+GV++Y LL G PF D ++ +IL + P MS +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 236 RQIVRSMLQVEPGKRIK-----IQDLLGH------NWVKMGPEDNPVSFRPDHELREKDD 284
+ +++ +L +P KR+ ++ H NW + + P F+P +R++ D
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP--VIRDELD 321
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 9e-15
Identities = 24/104 (23%), Positives = 46/104 (44%), Gaps = 9/104 (8%)
Query: 409 SSKQYYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPPWMSPNS 464
+ D WS+GV++Y LL G PF D ++ +IL + P MS +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 465 RQIVRSMLQVEPGKRIK-----IQDLLGHNWVKMGPEDNPLREK 503
+ +++ +L +P KR+ ++ H + + D+ +K
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 307
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 2e-06
Identities = 16/72 (22%), Positives = 27/72 (37%)
Query: 301 MWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID 360
+ E Y++ + + G + D WS+GV++Y LL G PF D
Sbjct: 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238
Query: 361 QLYDKILSHFMP 372
+I +
Sbjct: 239 NSQAEISRRILK 250
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 2e-58
Identities = 58/261 (22%), Positives = 110/261 (42%), Gaps = 11/261 (4%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLGEDLPRVKLEINALKHI 63
+ +E+ +G+G F +V L G++ VAIK +K + E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYL 122
H ++ L V+ S+ + ++ E+ G L + + + + R I + + YL
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS----CGSPNYAAPEV 178
+ Y HRDL N+L++ N K+ DFGL E TS + APE
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 179 IKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSR 236
I+ +++ +DVWS G++++ ++ G P+ + + + I PP
Sbjct: 205 IQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 237 QIVRSMLQVEPGKRIKIQDLL 257
Q++ Q + R K ++
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIV 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 59.8 bits (144), Expect = 2e-10
Identities = 15/79 (18%), Positives = 33/79 (41%), Gaps = 2/79 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTEPP-WMSPNSRQI 467
+ + S +DVWS G++++ ++ G P+ + + + I PP Q+
Sbjct: 206 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQL 265
Query: 468 VRSMLQVEPGKRIKIQDLL 486
+ Q + R K ++
Sbjct: 266 MLDCWQKDRNHRPKFGQIV 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.7 bits (97), Expect = 1e-04
Identities = 11/62 (17%), Positives = 28/62 (45%), Gaps = 1/62 (1%)
Query: 329 QYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILL 387
+ + S +DVWS G++++ ++ G P+ + + + I + + ++L
Sbjct: 208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLML 267
Query: 388 PC 389
C
Sbjct: 268 DC 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-58
Identities = 71/279 (25%), Positives = 122/279 (43%), Gaps = 15/279 (5%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
R LE +G G F +V + T T VAIK +K T+ + E +K + H+
Sbjct: 16 RESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFLQEAQVMKKLRHE 72
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHH 124
+ +L+ V+ + I++V EY G LLD + + L + QI S +AY+
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
+ Y HRDL+ N+L+ N K+ DFGL E + Q + + APE +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR- 190
Query: 185 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSM 242
+ ++DVWS G++L L G +P+ ++ D++ G PP + ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250
Query: 243 LQVEPGKRIKIQDLLG--HNWVKMGPEDNPVSFRPDHEL 279
+ EP +R + L ++ ++P L
Sbjct: 251 WRKEPEERPTFEYLQAFLEDYFT----STEPQYQPGENL 285
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (152), Expect = 2e-11
Identities = 17/77 (22%), Positives = 34/77 (44%), Gaps = 2/77 (2%)
Query: 412 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVR 469
+ ++DVWS G++L L G +P+ ++ D++ G PP + ++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248
Query: 470 SMLQVEPGKRIKIQDLL 486
+ EP +R + L
Sbjct: 249 QCWRKEPEERPTFEYLQ 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (100), Expect = 5e-05
Identities = 12/62 (19%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 329 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILL 387
+ ++DVWS G++L L G +P+ ++ D++ + C + ++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248
Query: 388 PC 389
C
Sbjct: 249 QC 250
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-58
Identities = 70/259 (27%), Positives = 113/259 (43%), Gaps = 8/259 (3%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLT---GEKVAIKIMKKATLGEDLPRVKLEINALKHI 63
R + L R +G G F V ++ VAIK K T + E ++
Sbjct: 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65
Query: 64 SHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYL 122
H HI KL VI T + +++++E C GEL + R+ L + Q+ +A+AYL
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 123 HHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
+ HRD+ NVL+ N +KL DFGL E + + APE I +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 183 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVR 240
++ + +DVW GV ++ +L G PF + + +I NG+ PP P ++
Sbjct: 185 RFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 241 SMLQVEPGKRIKIQDLLGH 259
+P +R + +L
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (149), Expect = 3e-11
Identities = 19/81 (23%), Positives = 36/81 (44%), Gaps = 2/81 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQI 467
+ + + S +DVW GV ++ +L G PF + + +I NG+ PP P +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241
Query: 468 VRSMLQVEPGKRIKIQDLLGH 488
+ +P +R + +L
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (489), Expect = 1e-57
Identities = 60/255 (23%), Positives = 110/255 (43%), Gaps = 7/255 (2%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
R ++ +G G + +V VA+K +K+ T+ + E +K I H
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFLKEAAVMKEIKHP 73
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHH 124
++ +L V +++ E+ G LLD++ E RQ + QI SA+ YL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
+ HRDL N L+ N +K+ DFGL G + + + APE + +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK- 192
Query: 185 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSM 242
+ ++DVW+ GV+L+ + G P+ + Q+Y+ + + P +++R+
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252
Query: 243 LQVEPGKRIKIQDLL 257
Q P R ++
Sbjct: 253 WQWNPSDRPSFAEIH 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 56.7 bits (136), Expect = 2e-09
Identities = 15/79 (18%), Positives = 35/79 (44%), Gaps = 2/79 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQI 467
+ + ++DVW+ GV+L+ + G P+ + Q+Y+ + + P ++
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248
Query: 468 VRSMLQVEPGKRIKIQDLL 486
+R+ Q P R ++
Sbjct: 249 MRACWQWNPSDRPSFAEIH 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-57
Identities = 62/255 (24%), Positives = 113/255 (44%), Gaps = 9/255 (3%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQ 66
R L +G+G F +V + + KVA+K +K+ ++ D E N +K + HQ
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQ 68
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ--RLGEKESRAFFRQILSAVAYLHH 124
+ +L+ V+ T I+++ EY G L+D + +L + QI +A++
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQY 184
Y HRDL+ N+L+ + K+ DFGL E + + + + APE I
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT- 186
Query: 185 YGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRSM 242
+ ++DVWS G++L ++ G +P+ + ++ + G P Q++R
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 243 LQVEPGKRIKIQDLL 257
+ P R L
Sbjct: 247 WKERPEDRPTFDYLR 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (137), Expect = 1e-09
Identities = 15/77 (19%), Positives = 31/77 (40%), Gaps = 2/77 (2%)
Query: 412 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVR 469
+ ++DVWS G++L ++ G +P+ + ++ + G P Q++R
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 470 SMLQVEPGKRIKIQDLL 486
+ P R L
Sbjct: 245 LCWKERPEDRPTFDYLR 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.1 bits (88), Expect = 0.002
Identities = 9/62 (14%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 329 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILL 387
+ ++DVWS G++L ++ G +P+ + ++ + + + + ++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 388 PC 389
C
Sbjct: 245 LC 246
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-57
Identities = 74/300 (24%), Positives = 119/300 (39%), Gaps = 46/300 (15%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHIC 69
Y + +G+G F V A +GE VAIK + + D E+ ++ + H +I
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 70 KLFQVIETSS------HIFMVIEYCPGG---ELLDHIVERQRLGEKESRAFFRQILSAVA 120
+L +S ++ +V++Y P + +Q L + + Q+ ++A
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 121 YLHHLGYAHRDLKPENVLLDRNQN-LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVI 179
Y+H G HRD+KP+N+LLD + LKL DFG + G + S Y APE+I
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELI 194
Query: 180 KGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----------- 228
G Y S DVWS G +L LL G F DS +I+ T
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 229 ------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNP 270
P P + + +L+ P R+ + H++ + N
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 2e-12
Identities = 23/119 (19%), Positives = 35/119 (29%), Gaps = 29/119 (24%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP------------ 457
Y S DVWS G +L LL G F DS +I+ T
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 458 -----------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNP 499
P P + + +L+ P R+ + H++ + N
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 2e-06
Identities = 18/58 (31%), Positives = 22/58 (37%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFP 383
G Y S DVWS G +L LL G F DS +I+ I + P
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 8e-57
Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 24/274 (8%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK--VAIKIMKKATLGEDLPRVKLEINALKHIS 64
N + +G G F +V A G + AIK MK+ +D E+ L +
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 65 -HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVER----------------QRLGEKE 107
H +I L E ++++ IEY P G LLD + + L ++
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 108 SRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167
F + + YL + HRDL N+L+ N K+ DFGL E ++
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186
Query: 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYT 226
+ A E + Y + +DVWS GV+L+ ++ G P+ + +LY+K+ G
Sbjct: 187 RLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 227 E-PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
E P ++R + +P +R +L
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (152), Expect = 2e-11
Identities = 20/79 (25%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 412 QYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVR 469
Y + +DVWS GV+L+ ++ G P+ + +LY+K+ G E P ++R
Sbjct: 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMR 260
Query: 470 SMLQVEPGKRIKIQDLLGH 488
+ +P +R +L
Sbjct: 261 QCWREKPYERPSFAQILVS 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 1e-04
Identities = 14/95 (14%), Positives = 37/95 (38%), Gaps = 1/95 (1%)
Query: 296 LSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALL-CGFLPF 354
++ + + + ++ + Y + +DVWS GV+L+ ++ G P+
Sbjct: 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227
Query: 355 DSDSIDQLYDKILSHFMPICTILISQYFPTILLPC 389
+ +LY+K+ + + ++ C
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQC 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-56
Identities = 61/258 (23%), Positives = 109/258 (42%), Gaps = 8/258 (3%)
Query: 9 QYILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGEDLPRVKLEINALKHIS 64
++ + +GSG F V + GE VAIK +++AT + + E + +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 65 HQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH 124
+ H+C+L + TS+ + G L + +G + + QI + YL
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 125 LGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
HRDL NVL+ Q++K+ DFGL E + + A E I +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 184 YYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRS 241
Y ++DVWS GV ++ L+ G P+D ++ + G+ PP + + I+
Sbjct: 190 -YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 242 MLQVEPGKRIKIQDLLGH 259
++ R K ++L+
Sbjct: 249 CWMIDADSRPKFRELIIE 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 1e-10
Identities = 18/79 (22%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 412 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVR 469
+ Y ++DVWS GV ++ L+ G P+D ++ + G+ PP + + I+
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 247
Query: 470 SMLQVEPGKRIKIQDLLGH 488
++ R K ++L+
Sbjct: 248 KCWMIDADSRPKFRELIIE 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 329 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILL 387
+ Y ++DVWS GV ++ L+ G P+D ++ + + + I++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 247
Query: 388 PC 389
C
Sbjct: 248 KC 249
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 189 bits (480), Expect = 2e-56
Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 32/286 (11%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHISHQ 66
+Y +G G + V A + GE A+K ++ E +P EI+ LK + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
+I KL+ VI T + +V E+ V L +++F Q+L+ +AY H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKP+N+L++R LK+ DFGL A+ G + + Y AP+V+ G + Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGL-ARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 187 SETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP------------------ 228
+ D+WS+G + ++ G F S +I T
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 229 -----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+ + ++ ML+++P +RI + L H + K
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 63.4 bits (153), Expect = 1e-11
Identities = 18/112 (16%), Positives = 36/112 (32%), Gaps = 29/112 (25%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP------------ 457
+ Y + D+WS+G + ++ G F S +I T
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 458 -----------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
+ + ++ ML+++P +RI + L H + K
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 44.1 bits (103), Expect = 2e-05
Identities = 10/42 (23%), Positives = 18/42 (42%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
G + Y + D+WS+G + ++ G F S +I
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-56
Identities = 76/327 (23%), Positives = 132/327 (40%), Gaps = 46/327 (14%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHI 63
++ +Y VGSG + V A TG +VA+K + + R E+ LKH+
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 64 SHQHICKLFQVIETSSHI-----FMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSA 118
H+++ L V + + ++ + G L++IV+ Q+L + + QIL
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 119 VAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEV 178
+ Y+H HRDLKP N+ ++ + LK++DFGL + ++ + Y APE+
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 189
Query: 179 IKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM------- 231
+ +Y D+WS+G ++ LL G F IL T +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 232 ------------------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG-- 265
+P + ++ ML ++ KRI L H +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 266 PEDNPVS--FRPDHELREKDDDVIKVM 290
P+D PV+ + E R+ D K +
Sbjct: 310 PDDEPVADPYDQSFESRDLLIDEWKSL 336
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 6e-14
Identities = 27/157 (17%), Positives = 50/157 (31%), Gaps = 37/157 (23%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM--------- 460
+ +Y D+WS+G ++ LL G F IL T +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 461 ----------------------SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG--PE 496
+P + ++ ML ++ KRI L H + P+
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 497 DNPLREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNY 533
D P+ + D + + L D+ S + ++
Sbjct: 312 DEPVADPYDQSF----ESRDLLIDEWKSLTYDEVISF 344
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-56
Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 32/285 (11%)
Query: 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHISHQHI 68
+ +G G + V A + LTGE VA+K ++ T E +P EI+ LK ++H +I
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 69 CKLFQVIETSSHIFMVIEYCP-GGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGY 127
KL VI T + +++V E+ + + +++ Q+L +A+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 128 AHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGS 187
HRDLKP+N+L++ +KL DFGL A+ G + Y APE++ G +YY +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGL-ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 188 ETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP------------------- 228
D+WS+G + ++ F DS +I T
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 229 ----------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
P + + R ++ ML +P KRI + L H + +
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.6 bits (151), Expect = 2e-11
Identities = 21/112 (18%), Positives = 37/112 (33%), Gaps = 29/112 (25%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP------------ 457
+YY + D+WS+G + ++ F DS +I T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 458 -----------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
P + + R ++ ML +P KRI + L H + +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 3e-05
Identities = 11/42 (26%), Positives = 19/42 (45%)
Query: 326 QGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKIL 367
G +YY + D+WS+G + ++ F DS +I
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 8e-56
Identities = 61/265 (23%), Positives = 101/265 (38%), Gaps = 12/265 (4%)
Query: 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEK---VAIKIMKKATLG--EDLPRVKLEI 57
I ++ L +G G F V+ K VA+K +K L E + E+
Sbjct: 4 LIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 58 NALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQ-RLGEKESRAFFRQIL 116
NA+ + H+++ +L+ V+ T + MV E P G LLD + + Q + Q+
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGSPNYAA 175
+ YL + HRDL N+LL +K+ DFGL P+ +Q P
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT--EPPWMS 232
+ + +D W GV L+ + G P+ + Q+ KI P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 233 PNSRQIVRSMLQVEPGKRIKIQDLL 257
+ ++ +P R L
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (146), Expect = 9e-11
Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 3/78 (3%)
Query: 412 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYT--EPPWMSPNSRQIV 468
+ + +D W GV L+ + G P+ + Q+ KI P + ++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 248
Query: 469 RSMLQVEPGKRIKIQDLL 486
+P R L
Sbjct: 249 VQCWAHKPEDRPTFVALR 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (92), Expect = 5e-04
Identities = 10/42 (23%), Positives = 18/42 (42%), Gaps = 1/42 (2%)
Query: 329 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILSH 369
+ + +D W GV L+ + G P+ + Q+ KI
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (477), Expect = 9e-56
Identities = 58/283 (20%), Positives = 100/283 (35%), Gaps = 33/283 (11%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALK 61
RN R +G G F +V A VA+K++K+ + + E +
Sbjct: 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR------------------- 102
+ +I KL V + ++ EY G+L + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 103 -----LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-P 156
L E RQ+ + +AYL + HRDL N L+ N +K+ DFGL
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFL-PFDSDSIDQ 215
+ PE I + Y +E+DVW+ GV+L+ + L P+ + ++
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 216 LYDKILNGKYTE-PPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257
+ + +G P ++R P R +
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 61.4 bits (148), Expect = 7e-11
Identities = 15/79 (18%), Positives = 31/79 (39%), Gaps = 2/79 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFL-PFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQI 467
Y +E+DVW+ GV+L+ + L P+ + +++ + +G P +
Sbjct: 215 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNL 274
Query: 468 VRSMLQVEPGKRIKIQDLL 486
+R P R +
Sbjct: 275 MRLCWSKLPADRPSFCSIH 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.6 bits (94), Expect = 4e-04
Identities = 12/63 (19%), Positives = 27/63 (42%), Gaps = 1/63 (1%)
Query: 328 KQYYGSETDVWSMGVMLYALLCGFL-PFDSDSIDQLYDKILSHFMPICTILISQYFPTIL 386
Y +E+DVW+ GV+L+ + L P+ + +++ + + C ++
Sbjct: 216 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLM 275
Query: 387 LPC 389
C
Sbjct: 276 RLC 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-54
Identities = 69/287 (24%), Positives = 120/287 (41%), Gaps = 32/287 (11%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHISHQ 66
+Y +G G + V A + T E VA+K ++ E +P EI LK + H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
+I +L V+ + + +V E+C L + ++F Q+L + + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYG 186
HRDLKP+N+L++RN LKL +FGL A+ G + Y P+V+ G + Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGL-ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 187 SETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYT------------------- 226
+ D+WS G + L P F + +D +I T
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 227 ----------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
P ++ R +++++L+ P +RI ++ L H +
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (143), Expect = 2e-10
Identities = 19/113 (16%), Positives = 38/113 (33%), Gaps = 30/113 (26%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKILNGKYT------------- 455
+ Y + D+WS G + L P F + +D +I T
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 456 ----------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
P ++ R +++++L+ P +RI ++ L H +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 3e-04
Identities = 13/61 (21%), Positives = 22/61 (36%), Gaps = 1/61 (1%)
Query: 309 TYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLP-FDSDSIDQLYDKIL 367
Y+ + T G + Y + D+WS G + L P F + +D +I
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 368 S 368
Sbjct: 217 R 217
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-53
Identities = 66/294 (22%), Positives = 109/294 (37%), Gaps = 41/294 (13%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLT-GEKVAIKIMKKATLGEDLP-RVKLEINALKHIS- 64
QY +G G + KV A + G VA+K ++ T E +P E+ L+H+
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 65 --HQHICKLFQVIETSS-----HIFMVIEYCPGGEL-LDHIVERQRLGEKESRAFFRQIL 116
H ++ +LF V S + +V E+ V + + + Q+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 117 SAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAP 176
+ +LH HRDLKP+N+L+ + +KL DFGL + L + + Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAP 184
Query: 177 EVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--------- 227
EV+ Y + D+WS+G + + F S KIL+
Sbjct: 185 EVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 228 ------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
+ + ++ L P KRI L H + +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.6 bits (151), Expect = 3e-11
Identities = 17/108 (15%), Positives = 29/108 (26%), Gaps = 27/108 (25%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--------------- 456
Y + D+WS+G + + F S KIL+
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 457 ------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
+ + ++ L P KRI L H + +
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 9e-06
Identities = 12/77 (15%), Positives = 24/77 (31%)
Query: 292 DHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGF 351
+L+ + + L + + + Y + D+WS+G + +
Sbjct: 153 GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
Query: 352 LPFDSDSIDQLYDKILS 368
F S KIL
Sbjct: 213 PLFRGSSDVDQLGKILD 229
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-53
Identities = 62/278 (22%), Positives = 119/278 (42%), Gaps = 28/278 (10%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGE-------KVAIKIMKKATLGEDLPRVKLEINA 59
R++ +L + +G G F +V LA + + KVA+K++K +DL + E+
Sbjct: 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 60 LKHIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHI----------------VERQR 102
+K I H++I L +++++EY G L +++ ++
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 103 LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLE 161
L K+ + Q+ + YL HRDL NVL+ + +K+ DFGL
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKI 220
+ + APE + + Y ++DVWS GV+L+ + G P+ +++L+ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 221 LNGKYTE-PPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257
G + P + ++R P +R + L+
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.5 bits (156), Expect = 5e-12
Identities = 17/77 (22%), Positives = 36/77 (46%), Gaps = 2/77 (2%)
Query: 412 QYYGSETDVWSMGVMLYALL-CGFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVR 469
+ Y ++DVWS GV+L+ + G P+ +++L+ + G + P + ++R
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 271
Query: 470 SMLQVEPGKRIKIQDLL 486
P +R + L+
Sbjct: 272 DCWHAVPSQRPTFKQLV 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 3e-05
Identities = 16/104 (15%), Positives = 34/104 (32%), Gaps = 7/104 (6%)
Query: 287 IKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYA 346
I + + D + + L R Y ++DVWS GV+L+
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI------YTHQSDVWSFGVLLWE 229
Query: 347 LL-CGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILLPC 389
+ G P+ +++L+ + + ++ C
Sbjct: 230 IFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-52
Identities = 61/278 (21%), Positives = 110/278 (39%), Gaps = 27/278 (9%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALK 61
RN+ +T+G+G F KV AT VA+K++K + + + E+ L
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81
Query: 62 HIS-HQHICKLFQVIETSSHIFMVIEYCPGGELLDHI------------------VERQR 102
++ H +I L ++ EYC G+LL+ + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 103 LGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162
L ++ +F Q+ +A+L HRDL N+LL + K+ DFGL +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKIL 221
++ + P Y E+DVWS G+ L+ L G P+ +D + K++
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 222 NGKY--TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 257
+ P I+++ +P KR + ++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 3e-07
Identities = 18/78 (23%), Positives = 34/78 (43%), Gaps = 3/78 (3%)
Query: 412 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY--TEPPWMSPNSRQIV 468
Y E+DVWS G+ L+ L G P+ +D + K++ + P I+
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIM 281
Query: 469 RSMLQVEPGKRIKIQDLL 486
++ +P KR + ++
Sbjct: 282 KTCWDADPLKRPTFKQIV 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 180 bits (456), Expect = 2e-52
Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 51/299 (17%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-H 65
++ Y L R +G G +++V A ++ EKV +KI+K ++K EI L+++
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGG 89
Query: 66 QHICKLFQVIE--TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
+I L +++ S +V E+ + Q L + + R + +IL A+ Y H
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 124 HLGYAHRDLKPENVLLDR-NQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGK 182
+G HRD+KP NV++D ++ L+LID+GL G + S + PE++
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDY 204
Query: 183 QYYGSETDVWSMGVMLYALLCGFLPF--DSDSIDQL------------YDKILNGKYTEP 228
Q Y D+WS+G ML +++ PF D+ DQL YD I
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 229 PW------------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263
P +SP + + +L+ + R+ ++ + H +
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 47.9 bits (113), Expect = 2e-06
Identities = 23/119 (19%), Positives = 40/119 (33%), Gaps = 38/119 (31%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPF--DSDSIDQL------------YDKILNGKYTEP 457
Q Y D+WS+G ML +++ PF D+ DQL YD I
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 458 PW------------------------MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 492
P +SP + + +L+ + R+ ++ + H +
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 2e-52
Identities = 58/289 (20%), Positives = 102/289 (35%), Gaps = 27/289 (9%)
Query: 4 IDLR--NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALK 61
++LR N+Y L R +GSG F + L T + GE+VAIK+ T P++ +E K
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYK 57
Query: 62 HISHQHICKLFQVI-ETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVA 120
+ + + MV+E ++ K Q++S +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 121 YLHHLGYAHRDLKPENVL---LDRNQNLKLIDFGLCAKPEGGLESQ------LQTSCGSP 171
Y+H + HRD+KP+N L + + +IDFGL K Q + G+
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 172 NYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY------ 225
YA+ G + D+ S+G +L G LP+ K
Sbjct: 178 RYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 226 --TEPPWMSPNSRQIVRSMLQVEPGKRI---KIQDLLGHNWVKMGPEDN 269
+ + + ++ L + + + G +
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.9 bits (126), Expect = 3e-08
Identities = 10/98 (10%), Positives = 23/98 (23%), Gaps = 11/98 (11%)
Query: 412 QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY--------TEPPWMSPN 463
D+ S+G +L G LP+ K
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 464 SRQIVRSMLQVEPGKRI---KIQDLLGHNWVKMGPEDN 498
+ + + ++ L + + + G +
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.0 bits (95), Expect = 3e-04
Identities = 16/109 (14%), Positives = 27/109 (24%)
Query: 277 HELREKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETD 336
L +K + V + + D Q + N + S D
Sbjct: 136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDD 195
Query: 337 VWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTI 385
+ S+G +L G LP+ K + I
Sbjct: 196 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-52
Identities = 65/260 (25%), Positives = 112/260 (43%), Gaps = 10/260 (3%)
Query: 7 RNQYILERTVGSGGFAKVKLATHVLTGEK----VAIKIMKKATLGEDLPRVKLEINALKH 62
+ ++ +G+G F +V + K VAIK +K + E +
Sbjct: 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ 65
Query: 63 ISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR-LGEKESRAFFRQILSAVAY 121
SH +I +L VI + ++ EY G L + E+ + R I + + Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 122 LHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS--CGSPNYAAPEVI 179
L ++ Y HRDL N+L++ N K+ DFGL E E+ TS + APE I
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 180 KGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQ 237
+++ S +DVWS G++++ ++ G P+ S ++ I +G P Q
Sbjct: 186 SYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244
Query: 238 IVRSMLQVEPGKRIKIQDLL 257
++ Q E +R K D++
Sbjct: 245 LMMQCWQQERARRPKFADIV 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (127), Expect = 2e-08
Identities = 19/79 (24%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQI 467
S + + S +DVWS G++++ ++ G P+ S ++ I +G P Q+
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 468 VRSMLQVEPGKRIKIQDLL 486
+ Q E +R K D++
Sbjct: 246 MMQCWQQERARRPKFADIV 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-51
Identities = 58/290 (20%), Positives = 112/290 (38%), Gaps = 19/290 (6%)
Query: 7 RNQYILERTVGSGGFAKVKLATH-----VLTGEKVAIKIMKKATLGEDLPRVKLEINALK 61
R + + R +G G F V +VAIK + +A + E + +K
Sbjct: 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 78
Query: 62 HISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQR----------LGEKESRAF 111
+ H+ +L V+ +++E G+L ++ + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 112 FRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLESQLQTSCGS 170
+I +AYL+ + HRDL N ++ + +K+ DFG+ E +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 171 PNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGF-LPFDSDSIDQLYDKILNGKYTE-P 228
+ +PE +K + + +DVWS GV+L+ + P+ S +Q+ ++ G + P
Sbjct: 199 VRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHE 278
+++R Q P R +++ +M P VSF E
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 3e-09
Identities = 16/79 (20%), Positives = 34/79 (43%), Gaps = 2/79 (2%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGF-LPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQI 467
+ + +DVWS GV+L+ + P+ S +Q+ ++ G + P ++
Sbjct: 208 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 267
Query: 468 VRSMLQVEPGKRIKIQDLL 486
+R Q P R +++
Sbjct: 268 MRMCWQYNPKMRPSFLEII 286
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 173 bits (439), Expect = 2e-50
Identities = 48/269 (17%), Positives = 100/269 (37%), Gaps = 24/269 (8%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-Q 66
Y + R +G G F + T++L ++VAIK + + D P+++ E K ++
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCT 61
Query: 67 HICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG 126
I ++ + H +VI+ + ++ K +Q+L+ V +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 127 YAHRDLKPENVLLDR-----NQNLKLIDFGLCAKPEGGLESQ------LQTSCGSPNYAA 175
+RD+KP+N L+ R + ++DFG+ + Q + G+ Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 176 PEVIKGKQYYGSETDVWSMGVMLYALLCG---FLPFDSDSIDQLYDKILNGKYTEPPW-- 230
G+ D+ ++G + L G + + + Q Y++I K + P
Sbjct: 182 INTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 231 ---MSPNSRQIVRSMLQVEPGKRIKIQDL 256
+ + + L
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.0 bits (116), Expect = 7e-07
Identities = 10/82 (12%), Positives = 24/82 (29%), Gaps = 8/82 (9%)
Query: 412 QYYGSETDVWSMGVMLYALLCG---FLPFDSDSIDQLYDKILNGKYTEPPW-----MSPN 463
+ D+ ++G + L G + + + Q Y++I K + P
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 247
Query: 464 SRQIVRSMLQVEPGKRIKIQDL 485
+ + + L
Sbjct: 248 FYKYMHYARNLAFDATPDYDYL 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (93), Expect = 4e-04
Identities = 9/61 (14%), Positives = 20/61 (32%), Gaps = 3/61 (4%)
Query: 329 QYYGSETDVWSMGVMLYALLCG---FLPFDSDSIDQLYDKILSHFMPICTILISQYFPTI 385
+ D+ ++G + L G + + + Q Y++I + FP
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 247
Query: 386 L 386
Sbjct: 248 F 248
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-49
Identities = 53/292 (18%), Positives = 101/292 (34%), Gaps = 47/292 (16%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH 67
+L+ ++G G F +V GE+VA+KI EI + H++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREA--EIYQTVMLRHEN 58
Query: 68 ICKLFQVIE----TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLH 123
I T + +++V +Y G L D++ R + + S +A+LH
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLH 117
Query: 124 H--------LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES---QLQTSCGSPN 172
AHRDLK +N+L+ +N + D GL + + ++ G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 173 YAAPEVIKGKQY-----YGSETDVWSMGVMLYALLCGFLPFDSD---------------S 212
Y APEV+ D+++MG++ + + S
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 213 IDQLYDKILNGKYTEPPWMSPNS-------RQIVRSMLQVEPGKRIKIQDLL 257
++++ + K S +I+R R+ +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 3e-04
Identities = 9/98 (9%), Positives = 25/98 (25%), Gaps = 22/98 (22%)
Query: 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSD---------------SIDQLYDKILNGKYT 455
D+++MG++ + + S++++ + K
Sbjct: 192 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 251
Query: 456 EPPWMSPNS-------RQIVRSMLQVEPGKRIKIQDLL 486
S +I+R R+ +
Sbjct: 252 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.004
Identities = 11/99 (11%), Positives = 28/99 (28%), Gaps = 5/99 (5%)
Query: 319 LLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILSHFMPIC---- 374
+L D+++MG++ + + QL L P
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 375 -TILISQYFPTILLPCKVGQVINLLRSAIVLCSAPSSKQ 412
+ + P I + + + ++ + C +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-49
Identities = 53/258 (20%), Positives = 104/258 (40%), Gaps = 11/258 (4%)
Query: 12 LERTVGSGGFAKVKLATHVL---TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI 68
+G G F V T + A+K + + T ++ + E +K SH ++
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 69 CKLFQV-IETSSHIFMVIEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAVAYLHHLG 126
L + + + +V+ Y G+L + I E K+ F Q+ + +L
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 127 YAHRDLKPENVLLDRNQNLKLIDFGLC---AKPEGGLESQLQTSCGSPNYAAPEVIKGKQ 183
+ HRDL N +LD +K+ DFGL E + + A E ++ ++
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 184 YYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVRS 241
+ +++DVWS GV+L+ L+ G P+ + + +L G+ P + +++
Sbjct: 211 FT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269
Query: 242 MLQVEPGKRIKIQDLLGH 259
+ R +L+
Sbjct: 270 CWHPKAEMRPSFSELVSR 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (148), Expect = 6e-11
Identities = 16/79 (20%), Positives = 35/79 (44%), Gaps = 2/79 (2%)
Query: 412 QYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKYTE-PPWMSPNSRQIVR 469
Q + +++DVWS GV+L+ L+ G P+ + + +L G+ P + +++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268
Query: 470 SMLQVEPGKRIKIQDLLGH 488
+ R +L+
Sbjct: 269 KCWHPKAEMRPSFSELVSR 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 3e-04
Identities = 19/114 (16%), Positives = 40/114 (35%), Gaps = 15/114 (13%)
Query: 283 DDDVIKV--MADHKQLSPDDMWSQLNE----WTYNYDTCTYLLLLSRKKQGKQYYGSETD 336
+ +KV + + + S N+ + L Q + +++D
Sbjct: 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ--------TQKFTTKSD 216
Query: 337 VWSMGVMLYALLC-GFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILLPC 389
VWS GV+L+ L+ G P+ + + +L + ++L C
Sbjct: 217 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 7e-49
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 28/280 (10%)
Query: 7 RNQYILERTVGSGGFAKVKLAT-----HVLTGEKVAIKIMKKATLGEDLPRVKLEINALK 61
R++ L + +G G F +V A T VA+K++K+ + + E+ L
Sbjct: 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 71
Query: 62 HISHQHICKLFQ--VIETSSHIFMVIEYCPGGELLDHIVERQR----------------L 103
HI H + + +++E+C G L ++ ++ L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 104 GEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK-PEGGLES 162
+ + Q+ + +L HRDL N+LL +K+ DFGL +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGF-LPFDSDSIDQLYDKIL 221
+ + + APE I + Y ++DVWS GV+L+ + P+ ID+ + + L
Sbjct: 192 RKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 222 NG--KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259
+ P + +P Q + EP +R +L+ H
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (130), Expect = 1e-08
Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 3/82 (3%)
Query: 410 SKQYYGSETDVWSMGVMLYALLCGF-LPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQ 466
+ Y ++DVWS GV+L+ + P+ ID+ + + L + P + +P Q
Sbjct: 209 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 268
Query: 467 IVRSMLQVEPGKRIKIQDLLGH 488
+ EP +R +L+ H
Sbjct: 269 TMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-48
Identities = 70/341 (20%), Positives = 131/341 (38%), Gaps = 55/341 (16%)
Query: 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLP-RVKLEINALKHI 63
+ +Y + +GSG V A + VAIK + + + R E+ +K +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 64 SHQHICKLFQV------IETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILS 117
+H++I L V +E +++V+E + L + Q+L
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLC 130
Query: 118 AVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPE 177
+ +LH G HRDLKP N+++ + LK++DFGL + + Y APE
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 188
Query: 178 VIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM------ 231
VI G Y + D+WS+G ++ ++ + F ++K++ T P
Sbjct: 189 VILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 232 ------------------------------------SPNSRQIVRSMLQVEPGKRIKIQD 255
+ +R ++ ML ++P KRI + D
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 256 LLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQL 296
L H ++ + + V P ++ D+ + + K+L
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (135), Expect = 3e-09
Identities = 37/302 (12%), Positives = 85/302 (28%), Gaps = 58/302 (19%)
Query: 225 YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG----HNWVKMGPEDNPVSFRPDHELR 280
Y M N Q+++ L E + Q L G H+ + + P + +
Sbjct: 98 YLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157
Query: 281 EKDDDVIKVMADHKQLSPDDMWSQLNEWTYNYDTCTYLLLLSRKKQGKQYYGSETDVWSM 340
K D + + + Y D+WS+
Sbjct: 158 LKILDF-------------GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHFMPICTILISQYFPTILLPCKVGQVINLLRS 400
G ++ ++ + F ++K++ C + + PT+ N + +
Sbjct: 205 GCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR---------NYVEN 255
Query: 401 AIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWM 460
K + D +
Sbjct: 256 RPKYAGLTFPKLFP--------------------------------DSLFPADSEHNKLK 283
Query: 461 SPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPLREKDDDVIKVMADHKQLSPD 520
+ +R ++ ML ++P KRI + D L H ++ + + + + D ++ + +
Sbjct: 284 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIE 343
Query: 521 DM 522
+
Sbjct: 344 EW 345
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (362), Expect = 7e-39
Identities = 75/346 (21%), Positives = 123/346 (35%), Gaps = 71/346 (20%)
Query: 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-- 65
+YIL R +G G F+ V LA ++ VA+KI++ + + + EI L+ ++
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDAD 70
Query: 66 ---------QHICKLFQVIET----SSHIFMVIEYCPGGEL-LDHIVERQRLGEKESRAF 111
HI KL H+ MV E L L E + + +
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 112 FRQILSAVAYL-HHLGYAHRDLKPENVLLDRN-QNLKLIDFGL-CAKPEGGLESQLQTSC 168
+Q+L + Y+ G H D+KPENVL++ LI + + S
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-------IDQL----- 216
+ Y +PEV+ G +G D+WS +++ L+ G F+ D D +
Sbjct: 191 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 217 ------------------------------------YDKILNGKYTEPPWMSPNSRQIVR 240
+ +L KY + +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 241 SMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDV 286
MLQ++P KR L+ H W+K + PD EL D+
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV-PDRELYGSGSDI 354
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 61.6 bits (148), Expect = 7e-11
Identities = 48/261 (18%), Positives = 89/261 (34%), Gaps = 39/261 (14%)
Query: 249 KRIKIQDLLGHNWVKMGPEDNPVSFRPDHELREKDDDVIKVMADHKQLSPDDMWSQLNEW 308
K+I Q LLG +++ +P++ L E D ++ Q+ D+ +
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI----QIKIADLGNACWYD 183
Query: 309 TYNYDTCTYLLLLSRKKQGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILS 368
+ ++ S + +G D+WS +++ L+ G F+ D Y K
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE-GHSYTKDDD 242
Query: 369 HFMPICTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPSSKQYYGSETDVWSMGVMLY 428
H I +L P+ LL + ++ ++ S
Sbjct: 243 HIAQIIELLGE--LPSYLLR-----------------NGKYTRTFFNSR----------- 272
Query: 429 ALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488
G L S + +L KY + + MLQ++P KR L+ H
Sbjct: 273 ----GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328
Query: 489 NWVKMGPEDNPLREKDDDVIK 509
W+K +R D ++
Sbjct: 329 PWLKDTLGMEEIRVPDRELYG 349
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 4e-20
Identities = 34/203 (16%), Positives = 60/203 (29%), Gaps = 43/203 (21%)
Query: 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-----------------EDLPRVK 54
+ + +G G + V + +K K + +
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 55 LEINALKHISHQHICKLFQVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQ 114
E AL+ + + K++ +++E EL +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVR-------VENPDEVLDM 111
Query: 115 ILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTSCGSPNYA 174
IL VA +H G H DL NVL+ + + +IDF + G
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG---------EEGWREIL 161
Query: 175 APEVIKGKQY----YGSETDVWS 193
+V Y Y +E D+ S
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.95 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.95 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.94 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.94 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.94 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.94 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.94 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.94 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.94 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.94 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.94 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.94 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.93 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.93 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.93 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.93 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.93 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.91 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.91 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.91 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.91 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.9 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.9 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.9 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.89 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.89 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.89 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.88 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.88 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.88 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.88 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.88 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.87 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.87 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.87 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.87 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.87 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.87 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.86 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.86 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.86 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.85 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.84 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.84 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.83 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.83 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.82 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.82 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.81 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.8 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.8 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.8 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.79 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.78 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.72 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.56 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.98 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-62 Score=477.10 Aligned_cols=252 Identities=27% Similarity=0.605 Sum_probs=235.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|+||+||+|+++.+|+.||+|++.+... ......+.+|+.++++++|||||++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 679999999999999999999999999999999976432 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---CCE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---ccc
Confidence 99999999999999899999999999999999999999999999999999999999999999999999765542 334
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..++...+.++.+..|..+|+++++||.+||+.
T Consensus 163 ~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp ETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccC
Confidence 568999999999999876 5899999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCHHHHhcCcccc
Q psy6203 246 EPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 246 dP~~Rps~~ell~hp~~~ 263 (568)
||++|||++|+|+||||+
T Consensus 242 dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 242 NPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp SGGGSCCHHHHHTCHHHH
T ss_pred CHhHCcCHHHHHcCcCcC
Confidence 999999999999999997
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-62 Score=479.47 Aligned_cols=259 Identities=33% Similarity=0.577 Sum_probs=223.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.+.++|++++.||+|+||+||+|+++.+|+.||||++......+..+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 46689999999999999999999999999999999998765544456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-ccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQ 163 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 163 (568)
||||+||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998654322 223
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCC--CCCCChHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTE--PPWMSPNSRQIVR 240 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-~~~~~i~~~~~~~--~~~~~~~~~~li~ 240 (568)
..+.+||+.|+|||++.+..+++.++|||||||++|+|++|++||...+.. .....+....... ...+++++.+||.
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence 456689999999999998877678899999999999999999999765432 3333333333322 2457999999999
Q ss_pred HccccCcCCCCCHHHHhcCcccc
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+||+.||++|||++|+|+||||+
T Consensus 242 ~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 242 KILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTT
T ss_pred HHcCCChhHCcCHHHHhcCHhhC
Confidence 99999999999999999999997
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-61 Score=479.52 Aligned_cols=259 Identities=36% Similarity=0.679 Sum_probs=218.8
Q ss_pred ccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 3 YIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 3 ~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
..++.++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+|+.+|++++|||||++++++.+++.+|
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46889999999999999999999999999999999999987665555567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc---CCCCeEEEeecCccCCCCC
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD---RNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~ 159 (568)
||||||+||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+.....
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999999999989999999999999999999999999999999999999995 4789999999999865432
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNS 235 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~ 235 (568)
....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..++...+..+....+ +.+|+++
T Consensus 164 --~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 164 --SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -----------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred --CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 3345678999999999998876 58999999999999999999999999999999999988876543 4689999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++||.+||++||.+|||++|+++||||+.
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999999983
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-60 Score=472.62 Aligned_cols=256 Identities=28% Similarity=0.563 Sum_probs=232.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ......+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999986532 234567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-cccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~ 164 (568)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... ....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999998654322 2234
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
.+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++..++.++.+..+..+++++++||.+||+
T Consensus 168 ~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 246 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246 (288)
T ss_dssp --CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSC
T ss_pred ccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence 5568999999999998876 589999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCHHH------HhcCccccc
Q psy6203 245 VEPGKRIKIQD------LLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~~e------ll~hp~~~~ 264 (568)
.||.+|||++| +++||||+.
T Consensus 247 ~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 247 LDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp SSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999998 578999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-60 Score=471.77 Aligned_cols=257 Identities=29% Similarity=0.480 Sum_probs=228.1
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+..++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 16 ~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp SCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 3456799999999999999999999999999999999986543 345678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~ 172 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSK 172 (293)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCC
T ss_pred EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-ccc
Confidence 9999999999987755 57999999999999999999999999999999999999999999999999999876443 223
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC-C--CCCCCCCChHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-K--YTEPPWMSPNSRQIVR 240 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~-~--~~~~~~~~~~~~~li~ 240 (568)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... . +..++.+++++++||.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 45668999999999998876 589999999999999999999999988876665555443 2 3345668999999999
Q ss_pred HccccCcCCCCCHHHHhcCccccc
Q psy6203 241 SMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 241 ~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+||+.||.+|||++|+|+||||+.
T Consensus 252 ~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999984
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=474.98 Aligned_cols=255 Identities=31% Similarity=0.626 Sum_probs=237.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|+||+||+|+++.+|+.||||++++... ......+.+|+.+|++++||||+++++++++.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 679999999999999999999999999999999986532 234677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .....
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~~~ 163 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-Ccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999865432 23445
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
+.+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..++.+.+..+.+..|..+|+++++||++||++
T Consensus 164 ~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccC
Confidence 678999999999999877 5999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCC-----HHHHhcCccccc
Q psy6203 246 EPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rps-----~~ell~hp~~~~ 264 (568)
||.+|++ ++|+++||||+.
T Consensus 243 dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CchhhcccccccHHHHHcCccccc
Confidence 9999994 999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=466.01 Aligned_cols=260 Identities=35% Similarity=0.606 Sum_probs=236.5
Q ss_pred CccccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhCCCCCcceeeEEEE
Q psy6203 2 KYIDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHISHQHICKLFQVIE 76 (568)
Q Consensus 2 ~~~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 76 (568)
+-.++.++|++++.||+|+||+||+|+++.+|+.||||++++..... ..+.+.+|+.+|++++|||||++++++.
T Consensus 4 ~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34578899999999999999999999999999999999998654432 3567899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC----CeEEEeecC
Q psy6203 77 TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ----NLKLIDFGL 152 (568)
Q Consensus 77 ~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kl~DFG~ 152 (568)
+.+.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999999999999989999999999999999999999999999999999999998776 499999999
Q ss_pred ccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----
Q psy6203 153 CAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP---- 228 (568)
Q Consensus 153 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~---- 228 (568)
|...... ....+.+||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+..+....+
T Consensus 164 a~~~~~~--~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 164 AHKIDFG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp CEECTTS--CBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhcCCC--ccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 9876543 2345668999999999998766 69999999999999999999999999999999999998877654
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
+.+|+++++||++||+.||.+|||++|+|+||||+.
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 468999999999999999999999999999999984
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-60 Score=468.20 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=228.9
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.+..+.|++++.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|+++|++++|||||++++++.+.+.+|+
T Consensus 8 ~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 355678999999999999999999999999999999998653 3445678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ..
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~ 165 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQ 165 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-cc
Confidence 9999999999999775 457999999999999999999999999999999999999999999999999998754321 12
Q ss_pred ccccccCCccccccccccC----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCChHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKG----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNS 235 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~ 235 (568)
...+.+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||.+.+..+...++..+..+ .+..+|+++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 2345689999999999852 334689999999999999999999999998888888888777543 345689999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
++||.+||+.||.+|||++|+|+||||+.
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999973
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=461.01 Aligned_cols=254 Identities=30% Similarity=0.511 Sum_probs=216.5
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIET--SSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~l 83 (568)
.++|++.+.||+|+||+||+|+++.+|+.||+|++......+ ..+.+.+|+++|++++|||||++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999999999999999998765432 34568899999999999999999999864 456899
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 84 VIEYCPGGELLDHIVE----RQRLGEKESRAFFRQILSAVAYLHHLG-----YAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
|||||+||+|.+++.+ ++.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 467999999999999999999999976 9999999999999999999999999998
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCh
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSP 233 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~ 233 (568)
..... .....+.+||+.|+|||++.+.. ++.++|||||||++|+|+||..||.+.+..++...+..+.+. .+..+|+
T Consensus 163 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 240 (269)
T d2java1 163 ILNHD-TSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred ecccC-CCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 75433 22345678999999999998776 689999999999999999999999999999999999888764 5567899
Q ss_pred HHHHHHHHccccCcCCCCCHHHHhcCccc
Q psy6203 234 NSRQIVRSMLQVEPGKRIKIQDLLGHNWV 262 (568)
Q Consensus 234 ~~~~li~~~L~~dP~~Rps~~ell~hp~~ 262 (568)
++.+||.+||+.||.+|||++|+|+|||+
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-58 Score=465.21 Aligned_cols=252 Identities=31% Similarity=0.627 Sum_probs=234.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|+||+||+|+++.+|+.||||++++... ....+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 579999999999999999999999999999999976432 234677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
|||+||+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ...
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----~~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTY 159 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----ccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987543 234
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
+.+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..++..++..+....++.++++++++|.+||+.
T Consensus 160 ~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Confidence 578999999999998876 5899999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCC-----CHHHHhcCccccc
Q psy6203 246 EPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rp-----s~~ell~hp~~~~ 264 (568)
||.+|+ |++|+++||||+.
T Consensus 239 dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 239 DLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CHHhccccchhhHHHHHcCccccc
Confidence 999996 9999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-58 Score=470.36 Aligned_cols=258 Identities=30% Similarity=0.600 Sum_probs=231.8
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++-++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 455789999999999999999999999999999999976532 2356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC--CCCeEEEeecCccCCCCCCc
Q psy6203 85 IEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR--NQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~ 161 (568)
||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 999999999999954 467999999999999999999999999999999999999964 578999999999876543
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 237 (568)
....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..++...+..+.+..+ +.+|+++++
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 3345678999999999998876 58999999999999999999999999999999999988876654 348999999
Q ss_pred HHHHccccCcCCCCCHHHHhcCcccccCC
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKMGP 266 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~~~ 266 (568)
||.+||+.||.+|||++|+|+||||+...
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999998543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-59 Score=464.09 Aligned_cols=254 Identities=28% Similarity=0.349 Sum_probs=226.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
+....|++++.||+|+||+||+|++..+|+.||||++....... ..+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp CHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 34456999999999999999999999999999999998765432 2456889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+|||||++|+|..++..++++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 9999999999988888888999999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCChHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--PPWMSPNSRQI 238 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~l 238 (568)
....+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+.+..+....+..+..+. +..+|+++++|
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 2456899999999998643 346889999999999999999999999888877777776665432 34589999999
Q ss_pred HHHccccCcCCCCCHHHHhcCcccc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
|.+||+.||.+|||++|+|+||||.
T Consensus 247 i~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred HHHHCcCChhHCcCHHHHHhCHHhc
Confidence 9999999999999999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-58 Score=452.32 Aligned_cols=252 Identities=24% Similarity=0.427 Sum_probs=220.7
Q ss_pred ccCe-EEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe----CCE
Q psy6203 7 RNQY-ILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET----SSH 80 (568)
Q Consensus 7 ~~~Y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~ 80 (568)
.++| ++.++||+|+||+||+|+++.+++.||+|++...... ...+.+.+|+++|++++|||||++++++++ ...
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 3455 7888999999999999999999999999999866543 234578899999999999999999999875 456
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCceEEc-CCCCeEEEeecCccCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLG--YAHRDLKPENVLLD-RNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 157 (568)
+|+|||||+||+|.+++.+...+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 8999999999999999999899999999999999999999999998 99999999999996 57899999999997644
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCC--CCCCCChH
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYT--EPPWMSPN 234 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~-~~~~~~~~i~~~~~~--~~~~~~~~ 234 (568)
.. ...+.+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+. +..++.+.+..+..+ .+...+++
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~~--~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred CC---ccCCcccCccccCHHHhCCC--CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 32 33566899999999999763 699999999999999999999999754 566677777766543 33457899
Q ss_pred HHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 235 SRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 235 ~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+++||.+||++||++|||++|+|+||||+
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-59 Score=470.52 Aligned_cols=255 Identities=23% Similarity=0.388 Sum_probs=218.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++++.||+|+||+||+|+++.+|+.||+|+++..........+.+|+.+|++++|||||+++++|.+.+.+|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35789999999999999999999999999999999987654444567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.... ...
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HTC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---Ccc
Confidence 999999999999998999999999999999999999997 5999999999999999999999999999986432 233
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHH----------------------------
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL---------------------------- 216 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~---------------------------- 216 (568)
.+.+||+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+..+.
T Consensus 161 ~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp ---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred ccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 4668999999999999876 69999999999999999999999976542211
Q ss_pred --------------HHHHHcCCCCC-C-CCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 217 --------------YDKILNGKYTE-P-PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 217 --------------~~~i~~~~~~~-~-~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
...+.....+. + ...|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 11111111111 1 135789999999999999999999999999999983
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.1e-58 Score=451.40 Aligned_cols=256 Identities=34% Similarity=0.589 Sum_probs=231.2
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCc--------hHHHHHHHHHHHhCC-CCCcceeeEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGED--------LPRVKLEINALKHIS-HQHICKLFQVIE 76 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~Ei~~l~~l~-hpnIv~l~~~~~ 76 (568)
|.++|++.+.||+|+||+||+|+++.+|+.||||++++...... .+.+.+|+.++++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 56899999999999999999999999999999999987654321 235778999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCC
Q psy6203 77 TSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKP 156 (568)
Q Consensus 77 ~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 156 (568)
+++.+|||||||+||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccccccCCccccccccccC-----cccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKG-----KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP-- 229 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~-- 229 (568)
... ......+||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+.......+..+....+.
T Consensus 161 ~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 161 DPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred cCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 543 23345689999999999863 334688999999999999999999999999999999989888765432
Q ss_pred --CCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 230 --WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 230 --~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
.+|+++++||.+||++||.+|||++|+|+||||+
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 5899999999999999999999999999999997
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.7e-58 Score=467.23 Aligned_cols=256 Identities=28% Similarity=0.534 Sum_probs=230.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
.+-++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+|+.+|++++|||||++++++.+++.+|||
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 345789999999999999999999999999999999976542 2345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEc--CCCCeEEEeecCccCCCCCCc
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLD--RNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~~~~kl~DFG~a~~~~~~~~ 161 (568)
||||+||+|.+.+... .++++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999999999987654 4699999999999999999999999999999999999997 5689999999999876543
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 237 (568)
....+.+||+.|+|||++.+.. ++.++|||||||++|+|+||..||.+.+..++...+..+.+..+ +.+++++++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 3345678999999999998876 69999999999999999999999999999999999988876554 458999999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
||.+||++||.+|||++|+|+||||+.
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999984
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-58 Score=465.92 Aligned_cols=252 Identities=33% Similarity=0.636 Sum_probs=234.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||++++++.+.+.+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 789999999999999999999999999999999975432 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccc
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQ 165 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (568)
||+.||+|.+++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----cc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876432 34
Q ss_pred cccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHcccc
Q psy6203 166 TSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 245 (568)
Q Consensus 166 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 245 (568)
+.+||+.|+|||++.+.. ++.++|||||||++|+|+||..||.+.+...+..++..+.+..+..+++++.+||++||+.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred cccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhh
Confidence 568999999999999876 5899999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCC-----CHHHHhcCccccc
Q psy6203 246 EPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 246 dP~~Rp-----s~~ell~hp~~~~ 264 (568)
||.+|+ |++|+++||||+.
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CHHhccccccccHHHHHcCccccC
Confidence 999995 9999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-58 Score=459.87 Aligned_cols=255 Identities=31% Similarity=0.629 Sum_probs=232.9
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCc--CCchHHHHHHHHHHH-hCCCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATL--GEDLPRVKLEINALK-HISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++++.||+|+||+||+|+++.+|+.||||++++... .+....+.+|..++. .++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 689999999999999999999999999999999976432 234556677777665 68999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 85 IEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKT 160 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCB
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-cccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999865443 2334
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHHHHHHHccc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 244 (568)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..++...+..+.+..+..+|+++++||.+||+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSC
T ss_pred cccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcc
Confidence 5568999999999999877 589999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCHH-HHhcCccccc
Q psy6203 245 VEPGKRIKIQ-DLLGHNWVKM 264 (568)
Q Consensus 245 ~dP~~Rps~~-ell~hp~~~~ 264 (568)
.||.+|||+. |+++||||+.
T Consensus 240 ~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGTT
T ss_pred cCCCCCcCHHHHHHhCchhcc
Confidence 9999999995 8999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-58 Score=459.85 Aligned_cols=255 Identities=27% Similarity=0.515 Sum_probs=231.6
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV 84 (568)
++-++|++++.||+|+||+||+|.++.+|+.||+|++++.. .+...+.+|+++|++++|||||++++++++.+.+|+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 67899999999999999999999999999999999997653 2345678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC--CCeEEEeecCccCCCCCCc
Q psy6203 85 IEYCPGGELLDHIVERQ-RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN--QNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~--~~~kl~DFG~a~~~~~~~~ 161 (568)
||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 99999999999998664 79999999999999999999999999999999999999854 47999999999876443
Q ss_pred cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCChHHHH
Q psy6203 162 SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP----WMSPNSRQ 237 (568)
Q Consensus 162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~ 237 (568)
....+.+||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..++...|.++.+..+. .+|+++++
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 2345567999999999998776 589999999999999999999999999999999999998876653 68999999
Q ss_pred HHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
||.+||+.||.+|||++|+|+||||+.
T Consensus 237 li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.5e-57 Score=461.20 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=223.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC--CchHHHH---HHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG--EDLPRVK---LEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~---~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+. .|+.+++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999999999999999999754321 1222333 3577788889999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+|||||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~--- 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS---
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999865532
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCChHHHHHH
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKYTEPPWMSPNSRQIV 239 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li 239 (568)
.....+||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+ ...+...+.......+..+|+++++||
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence 34556899999999999866667999999999999999999999997654 344555555666677788999999999
Q ss_pred HHccccCcCCCCC-----HHHHhcCccccc
Q psy6203 240 RSMLQVEPGKRIK-----IQDLLGHNWVKM 264 (568)
Q Consensus 240 ~~~L~~dP~~Rps-----~~ell~hp~~~~ 264 (568)
.+||++||.+||| ++|+++||||+.
T Consensus 241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999 799999999984
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=452.97 Aligned_cols=260 Identities=27% Similarity=0.339 Sum_probs=220.2
Q ss_pred EEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC----chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 12 LERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE----DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 12 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
.+++||+|+||+||+|+++.+|+.||||+++...... ....+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999997654322 134688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccccccc
Q psy6203 88 CPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQTS 167 (568)
Q Consensus 88 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 167 (568)
|.++++......+..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .....+.
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~~~~~ 160 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQ 160 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCCCCS
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC-cccccce
Confidence 998877777666778999999999999999999999999999999999999999999999999999765443 2234456
Q ss_pred cCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC-------------------
Q psy6203 168 CGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT------------------- 226 (568)
Q Consensus 168 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~------------------- 226 (568)
+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+...++.+. ...
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence 89999999999987766899999999999999999999999998887777666431 000
Q ss_pred -------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCCCCCCCC
Q psy6203 227 -------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDNPVS 272 (568)
Q Consensus 227 -------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~~ 272 (568)
..+.+++++.+||.+||+.||++|||++|+|+||||+..+.+.|..
T Consensus 241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~ 293 (299)
T d1ua2a_ 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293 (299)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCC
Confidence 0124678999999999999999999999999999999666555443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-57 Score=445.91 Aligned_cols=249 Identities=34% Similarity=0.590 Sum_probs=222.7
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-----chHHHHHHHHHHHhCC--CCCcceeeEEEEeC
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-----DLPRVKLEINALKHIS--HQHICKLFQVIETS 78 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~ 78 (568)
+.++|++.+.||+|+||+||+|++..+|+.||||++.+....+ ....+.+|+.+|++++ |||||++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 6789999999999999999999999999999999998654432 1234678999999987 89999999999999
Q ss_pred CEEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC-CCeEEEeecCccCC
Q psy6203 79 SHIFMVIEYCPG-GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN-QNLKLIDFGLCAKP 156 (568)
Q Consensus 79 ~~~~lV~E~~~~-g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~ 156 (568)
+..|+||||+.+ +++.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 6888889888999999999999999999999999999999999999999854 78999999999765
Q ss_pred CCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCChHHH
Q psy6203 157 EGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSR 236 (568)
Q Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (568)
... ...+.+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+. ..+..+....+..+|++++
T Consensus 162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHH
T ss_pred ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHH
Confidence 432 3456789999999999988776778899999999999999999999764 2456777788889999999
Q ss_pred HHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+||++||+.||++|||++|+|+||||+
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~ 259 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQ 259 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 999999999999999999999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=440.63 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=218.1
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|++++.||+|+||+||+|+++.+|+.||||+++.....+ ....+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999997654332 35678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
|+.++ +.+++.. .+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... ....
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~~~ 159 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTY 159 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SBCT
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-cccc
Confidence 99654 4444433 457999999999999999999999999999999999999999999999999998765433 2334
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC----------------
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KYT---------------- 226 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~~---------------- 226 (568)
...+||+.|+|||++....+++.++||||+||++|+|++|+.||.+.+..+....+... ...
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 55689999999999988877789999999999999999999999988876665554321 000
Q ss_pred C-----------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccCCC
Q psy6203 227 E-----------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 267 (568)
Q Consensus 227 ~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 267 (568)
. .+.+++++++||++||++||.+|||++|+|+||||+..+.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 0 1246789999999999999999999999999999985433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-56 Score=448.42 Aligned_cols=254 Identities=33% Similarity=0.618 Sum_probs=215.3
Q ss_pred CccccccCeEEEe-eecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHh-CCCCCcceeeEEEEe--
Q psy6203 2 KYIDLRNQYILER-TVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKH-ISHQHICKLFQVIET-- 77 (568)
Q Consensus 2 ~~~~~~~~Y~i~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~-- 77 (568)
+...+-++|++.. .||+|+||+||+|+++.+|+.||||+++.. ..+.+|+.++.+ ++|||||+++++|++
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 4456778999875 699999999999999999999999998642 467889998765 589999999999976
Q ss_pred --CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---CCCeEEEee
Q psy6203 78 --SSHIFMVIEYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDF 150 (568)
Q Consensus 78 --~~~~~lV~E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DF 150 (568)
...+|+|||||+||+|.+++.++ ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 46789999999999999999864 46999999999999999999999999999999999999975 457999999
Q ss_pred cCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCC
Q psy6203 151 GLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQ----LYDKILNGKYT 226 (568)
Q Consensus 151 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~----~~~~i~~~~~~ 226 (568)
|+|+..... ......+||+.|+|||++.+.. |+.++|||||||++|+|+||.+||.+.+... +...+..+.+.
T Consensus 159 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 159 GFAKETTSH--NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp TTCEECCCC--CCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred ceeeeccCC--CccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 999865543 2345678999999999998776 6899999999999999999999997665333 33344444544
Q ss_pred CCC----CCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 EPP----WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 ~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.+. .+|+++.+||.+||+.||++|||+.|+++||||..
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 443 37899999999999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.9e-55 Score=432.33 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=217.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|+++++||+|+||+||+|+++ +|+.||||+++..... .....+.+|+.+|++++|||||++++++.+.+..|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 69999999999999999999985 8899999999765432 235678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||.|....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 159 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTH 159 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cccce
Confidence 99887777776667889999999999999999999999999999999999999999999999999987654321 22344
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------------------
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY------------------- 225 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~------------------- 225 (568)
..|++.|+|||.+.+..+++.++|||||||++|+|++|+.||.+.+..+...++... ..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 568999999999988777899999999999999999999999988877666655321 00
Q ss_pred --------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 226 --------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 226 --------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
...+.+++++.+||++||++||++|||++|+|+||||+
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 01234688999999999999999999999999999997
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-54 Score=429.39 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=220.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 468999999999999999999999999999999987543 345678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 99999999999764 5789999999999999999999999999999999999999999999999999987655433333
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhCC-CCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGF-LPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~-~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....||+.|+|||++.+.. ++.++|||||||++|||++|. +||.+.+..++.+.+..+. .+.+..+++++.+||.+|
T Consensus 174 ~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 252 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252 (287)
T ss_dssp TTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHH
Confidence 4446899999999998776 699999999999999999965 5566777777777776653 456677999999999999
Q ss_pred cccCcCCCCCHHHHhc
Q psy6203 243 LQVEPGKRIKIQDLLG 258 (568)
Q Consensus 243 L~~dP~~Rps~~ell~ 258 (568)
|+.||++|||++|+++
T Consensus 253 l~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 253 WQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCCHhHCcCHHHHHH
Confidence 9999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-54 Score=427.73 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=217.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCC---
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSS--- 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 79 (568)
.+.++|++.+.||+|+||+||+|++..+|+.||||++++....+ ....+.+|+.++++++|||||++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 57899999999999999999999999999999999998765433 2456889999999999999999999997654
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 80 -HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 80 -~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
.+|+|||||+|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 4899999999999999999999999999999999999999999999999999999999999999999999998765432
Q ss_pred CC--ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCC
Q psy6203 159 GL--ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE----PPWMS 232 (568)
Q Consensus 159 ~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~----~~~~~ 232 (568)
.. .....+.+||+.|+|||++.+.. ++.++|||||||++|+|+||.+||.+.+..+...++..+.... .+.+|
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 21 22344568999999999998776 5899999999999999999999999998888877777665443 34689
Q ss_pred hHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 233 PNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 233 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 9999999999999999999544445577765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=421.53 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=209.5
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.+.+|+.++++++|||||++++++..++..|+||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 68999999999999999999975 67789999987643 2346789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
|++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+............
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999999998754 568999999999999999999999999999999999999999999999999998765443333445
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 244 (568)
..||+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..++...+..+.. ..|...++++.+||.+||+
T Consensus 162 ~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 240 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240 (263)
T ss_dssp ---CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred eecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHcc
Confidence 67899999999998876 6899999999999999999 6788888888888888877644 4556689999999999999
Q ss_pred cCcCCCCCHHHHhcC
Q psy6203 245 VEPGKRIKIQDLLGH 259 (568)
Q Consensus 245 ~dP~~Rps~~ell~h 259 (568)
.||++|||++|+++|
T Consensus 241 ~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 241 ERPEDRPAFSRLLRQ 255 (263)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=425.37 Aligned_cols=257 Identities=23% Similarity=0.389 Sum_probs=221.4
Q ss_pred ccCeEEEee-ecccCCeEEEEEEEcCC--CcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERT-VGSGGFAKVKLATHVLT--GEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~-lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+++|.+.+. ||+|+||+||+|.++.+ +..||||+++........+.+.+|+++|++++|||||++++++.+ +.+|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 467888885 99999999999987644 457999999765443446678999999999999999999999875 45899
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 161 (568)
|||||++|+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 9999999999998765 46799999999999999999999999999999999999999999999999999986543321
Q ss_pred -cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHH
Q psy6203 162 -SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQI 238 (568)
Q Consensus 162 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l 238 (568)
......+||+.|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..++...+..+.. +.|+.+++++.+|
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 244 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 2223456899999999998776 6999999999999999998 9999998888888888888754 5677899999999
Q ss_pred HHHccccCcCCCCCHHHH---hcCcccccC
Q psy6203 239 VRSMLQVEPGKRIKIQDL---LGHNWVKMG 265 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~el---l~hp~~~~~ 265 (568)
|.+||+.||++|||+.+| |+|+|+...
T Consensus 245 i~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 999999999999999888 678988653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=424.02 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=220.9
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
..++|++.+.||+|+||+||+|+++ ++..||||+++... ...+.+.+|+.+|++++|||||++++++.+ +.+|+||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 4579999999999999999999975 67889999997543 345678999999999999999999998754 5679999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
|||++|+|.+++... .++++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999999977543 469999999999999999999999999999999999999999999999999998765443334
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 241 (568)
.....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..++...+..+. ...+..+++++.+||.+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence 44567899999999998766 5899999999999999999 566777888888888888764 44567799999999999
Q ss_pred ccccCcCCCCCHHHHhc--Ccccc
Q psy6203 242 MLQVEPGKRIKIQDLLG--HNWVK 263 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~--hp~~~ 263 (568)
||+.||++|||++|+++ |+||.
T Consensus 246 cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 246 CWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999998 78886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-54 Score=428.60 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=209.6
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCc---EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGE---KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
.++|++.+.||+|+||+||+|+++.+|+ .||||.+.........+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3689999999999999999999987765 5888888655443445678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
|||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999999999988764 57999999999999999999999999999999999999999999999999999865432211
Q ss_pred ----ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHH
Q psy6203 163 ----QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSR 236 (568)
Q Consensus 163 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 236 (568)
......||+.|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..++...+..+. .+.+..+++++.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 263 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263 (299)
T ss_dssp -----------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHH
Confidence 112235789999999998776 5899999999999999998 899999999988888888764 456667899999
Q ss_pred HHHHHccccCcCCCCCHHHHhcC
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~h 259 (568)
+||.+||+.||++|||+.|++++
T Consensus 264 ~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999998864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=430.86 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=215.9
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEe------
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIET------ 77 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 77 (568)
+-.++|+++++||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|++++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 3458999999999999999999999999999999998765443 345678899999999999999999999854
Q ss_pred --CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccC
Q psy6203 78 --SSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAK 155 (568)
Q Consensus 78 --~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 155 (568)
.+.+|+|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 346899999998776665555667899999999999999999999999999999999999999999999999999975
Q ss_pred CCCCC---ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC---
Q psy6203 156 PEGGL---ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP--- 229 (568)
Q Consensus 156 ~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~~~--- 229 (568)
..... .....+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.......++
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 44321 123344679999999999988766899999999999999999999999988877666555332111100
Q ss_pred -----------------------------CCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 230 -----------------------------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 230 -----------------------------~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
..++++.+||.+||++||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 036778899999999999999999999999999843
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-54 Score=417.31 Aligned_cols=248 Identities=24% Similarity=0.415 Sum_probs=222.7
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEec
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEY 87 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 87 (568)
++|+++++||+|+||+||+|+++ ++..||||++++... ..+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 68899999999999999999985 788999999987543 346789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 88 CPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 88 ~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
+++|+|.+++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+............
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 999999999764 4679999999999999999999999999999999999999999999999999997655443334445
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCChHHHHHHHHccc
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 244 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 244 (568)
..||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..++...+..+.. ..|...++++.+||.+||+
T Consensus 161 ~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 239 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239 (258)
T ss_dssp SCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred cCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHcc
Confidence 67899999999998776 5899999999999999998 8999999999999999988744 4566788999999999999
Q ss_pred cCcCCCCCHHHHhcC
Q psy6203 245 VEPGKRIKIQDLLGH 259 (568)
Q Consensus 245 ~dP~~Rps~~ell~h 259 (568)
.||++|||++++++|
T Consensus 240 ~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 240 EKADERPTFKILLSN 254 (258)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=435.00 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=212.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCc-----EEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGE-----KVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 80 (568)
.++|++++.||+|+||+||+|++..+++ .||+|.+...........+.+|+.+|+++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4789999999999999999999876654 69999987655555567788999999998 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCce
Q psy6203 81 IFMVIEYCPGGELLDHIVER-----------------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENV 137 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 137 (568)
+|+|||||++|+|.+++..+ ..+++..++.++.||+.||+|||++|||||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 99999999999999999754 2488999999999999999999999999999999999
Q ss_pred EEcCCCCeEEEeecCccCCCCCCcc-ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHH
Q psy6203 138 LLDRNQNLKLIDFGLCAKPEGGLES-QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQ 215 (568)
Q Consensus 138 ll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~ 215 (568)
|++.++.+||+|||+|+........ ...+.+||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999765433221 223456899999999998766 6999999999999999998 899998866544
Q ss_pred HHHHHHcC--CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 216 LYDKILNG--KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 216 ~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
....+... .++.+..+++++.+||.+||+.||++|||++||++|
T Consensus 275 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44444433 345667899999999999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=437.37 Aligned_cols=254 Identities=27% Similarity=0.469 Sum_probs=213.0
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSS---- 79 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 79 (568)
++.++|+++++||+|+||+||+|.++.+|+.||||++++....+ ..+.+.+|+.+|++++|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 57899999999999999999999999999999999997654332 2457889999999999999999999997654
Q ss_pred --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCC
Q psy6203 80 --HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPE 157 (568)
Q Consensus 80 --~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 157 (568)
.+|+||||| +++|...+ +.+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 66666655 55789999999999999999999999999999999999999999999999999998764
Q ss_pred CCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Q psy6203 158 GGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK------------- 224 (568)
Q Consensus 158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~------------- 224 (568)
. .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 173 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 S----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp S----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred C----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 3 23456799999999999887777999999999999999999999998887665544332210
Q ss_pred ------------C------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 225 ------------Y------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 225 ------------~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
. ...+.+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0 112457899999999999999999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=427.57 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=213.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCC-CcEEEEEEeecCCcCC-chHHHHHHHHHHHhC---CCCCcceeeEEEEe---
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLT-GEKVAIKIMKKATLGE-DLPRVKLEINALKHI---SHQHICKLFQVIET--- 77 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~--- 77 (568)
..++|+++++||+|+||+||+|++..+ ++.||||+++.....+ ....+.+|+.+|+.| +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 458999999999999999999999766 5679999997654332 233566788777665 79999999999853
Q ss_pred --CCEEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 78 --SSHIFMVIEYCPGGELLDHIV-ERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 78 --~~~~~lV~E~~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
...++++|||++++++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 347899999998877654443 34679999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Q psy6203 155 KPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY------- 225 (568)
Q Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~~------- 225 (568)
.... .......+||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+..+....+... ..
T Consensus 165 ~~~~--~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 165 IYSF--QMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCG--GGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhcc--cccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 6543 23445678999999999998876 699999999999999999999999998887776665431 00
Q ss_pred ------------------CCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 226 ------------------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 226 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.....+++.+++||.+||++||++|||++|+|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 112347889999999999999999999999999999983
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=420.12 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=211.7
Q ss_pred eeecccCCeEEEEEEEc--CCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEeccCC
Q psy6203 14 RTVGSGGFAKVKLATHV--LTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIEYCPG 90 (568)
Q Consensus 14 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 90 (568)
++||+|+||+||+|.+. .+++.||||+++...... ..+.+.+|+.+|++++|||||++++++.++ ..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999864 356789999997554332 245788999999999999999999999654 57899999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc--ccccccc
Q psy6203 91 GELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE--SQLQTSC 168 (568)
Q Consensus 91 g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~ 168 (568)
|+|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 99999999989999999999999999999999999999999999999999999999999999986543322 1223456
Q ss_pred CCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHccccC
Q psy6203 169 GSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVE 246 (568)
Q Consensus 169 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~d 246 (568)
||+.|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..++...+..+. ++.+..+++++.+||.+||+.|
T Consensus 172 gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 172 WPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence 899999999998766 5899999999999999998 899999999888888888765 4566779999999999999999
Q ss_pred cCCCCCHHHH---hcCcccc
Q psy6203 247 PGKRIKIQDL---LGHNWVK 263 (568)
Q Consensus 247 P~~Rps~~el---l~hp~~~ 263 (568)
|.+|||+++| |+|+|+.
T Consensus 251 p~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 251 VENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TTTSCCHHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHhhCHHhh
Confidence 9999999998 4666654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=417.65 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=206.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 85 (568)
.++|++.+.||+|+||+||+|+. +..||||+++..... ...+.+.+|+.+|++++|||||++++++. .+.+++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 57899999999999999999974 346999999765443 34567889999999999999999999864 45689999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC-ccc
Q psy6203 86 EYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL-ESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 163 (568)
|||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...... ...
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999999999754 679999999999999999999999999999999999999999999999999997654322 223
Q ss_pred cccccCCccccccccccCc--ccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCC-----CCCCCChHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGK--QYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILNGKYT-----EPPWMSPNS 235 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~~~~~~-----~~~~~~~~~ 235 (568)
..+.+||+.|+|||++.+. ..++.++|||||||++|||+||+.||.+.+ ...+...+..+... .+..+++++
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l 242 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHH
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHH
Confidence 4556799999999999653 236889999999999999999999998755 44455555554332 245688999
Q ss_pred HHHHHHccccCcCCCCCHHHHhcC
Q psy6203 236 RQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+||.+||+.||.+|||++|+++|
T Consensus 243 ~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 243 KRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-53 Score=430.46 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=214.5
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS---- 79 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 79 (568)
-++.++|++++.||+|+||+||+|.++.+|+.||||++.+.......+.+.+|+.+|++++||||+++++++....
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 3677899999999999999999999999999999999976543334567889999999999999999999996543
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 80 -HIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 80 -~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
.+|++ +|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 84 ~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 84 KDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 34555 55669999999865 5799999999999999999999999999999999999999999999999999876443
Q ss_pred CC--ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC--C----------
Q psy6203 159 GL--ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K---------- 224 (568)
Q Consensus 159 ~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--~---------- 224 (568)
.. .......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+........... .
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 21 122455679999999999977766799999999999999999999999887765444333210 0
Q ss_pred ----------C---C------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 225 ----------Y---T------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 225 ----------~---~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
. . ..+.+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0 0 123478899999999999999999999999999999843
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=416.66 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=222.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
++|+++++||+|+||+||+|+++.+|+.||||+++.....+ ....+.+|+.+|+.++||||+++++++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999999999999999997665433 35678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccccc
Q psy6203 87 YCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQLQT 166 (568)
Q Consensus 87 ~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 166 (568)
++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|....... .....
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCCCS
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-cccee
Confidence 99999999988888899999999999999999999999999999999999999999999999999998765432 23334
Q ss_pred ccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCC-CCCCHHHHHHHHHcCC---------------------
Q psy6203 167 SCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGK--------------------- 224 (568)
Q Consensus 167 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf-~~~~~~~~~~~i~~~~--------------------- 224 (568)
..+++.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+....+....
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 567899999999988777799999999999999999999885 5666666555543210
Q ss_pred --------CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccc
Q psy6203 225 --------YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVK 263 (568)
Q Consensus 225 --------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 263 (568)
....+.+++.+.+||++||++||.+|||++|+|+||||+
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~ 287 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence 011234688999999999999999999999999999997
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=419.27 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=209.5
Q ss_pred cccccCeEEEeeecccCCeEEEEEEEcCCC---cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 4 IDLRNQYILERTVGSGGFAKVKLATHVLTG---EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 4 ~~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
+-..++|++++.||+|+||+||+|.+..++ ..||||.++..........+.+|+.+|++++|||||++++++. .+.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 344689999999999999999999987554 4688888865443334567889999999999999999999985 467
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 159 (568)
+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 8999999999999998765 457999999999999999999999999999999999999999999999999999875544
Q ss_pred CccccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHH
Q psy6203 160 LESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQ 237 (568)
Q Consensus 160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 237 (568)
........+||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..++...+..+. .+.++.+++++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 333444567899999999998766 5899999999999999998 899999988888888888875 4567789999999
Q ss_pred HHHHccccCcCCCCCHHHHhcC
Q psy6203 238 IVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 238 li~~~L~~dP~~Rps~~ell~h 259 (568)
||.+||+.||++|||++||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=425.74 Aligned_cols=257 Identities=30% Similarity=0.568 Sum_probs=225.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEc---CCCcEEEEEEeecCCcC---CchHHHHHHHHHHHhCCC-CCcceeeEEEEeCCE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHV---LTGEKVAIKIMKKATLG---EDLPRVKLEINALKHISH-QHICKLFQVIETSSH 80 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~ 80 (568)
++|++++.||+|+||+||+|++. .+|+.||||++++.... ...+.+.+|+.+|++++| |||+++++++++...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999974 47899999998764321 234567889999999976 899999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGL 160 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 160 (568)
+++||||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998765444
Q ss_pred ccccccccCCccccccccccCcc-cCCcccceechhhHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCChHH
Q psy6203 161 ESQLQTSCGSPNYAAPEVIKGKQ-YYGSETDVWSMGVMLYALLCGFLPFDSDS----IDQLYDKILNGKYTEPPWMSPNS 235 (568)
Q Consensus 161 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~~lltG~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 235 (568)
.....+..|++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.+ ...+.........+.+..+++++
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 263 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHH
Confidence 44455678999999999997654 46889999999999999999999997643 44555556667777788899999
Q ss_pred HHHHHHccccCcCCCC-----CHHHHhcCccccc
Q psy6203 236 RQIVRSMLQVEPGKRI-----KIQDLLGHNWVKM 264 (568)
Q Consensus 236 ~~li~~~L~~dP~~Rp-----s~~ell~hp~~~~ 264 (568)
.+||++||++||.+|| |++|+++||||+.
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999 5899999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=427.67 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=209.6
Q ss_pred CeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe------CCEEE
Q psy6203 9 QYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET------SSHIF 82 (568)
Q Consensus 9 ~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~~~ 82 (568)
+|+.+++||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|++++||||+++++++.. ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 69999999999999999999999999999999976532 22479999999999999999999854 33589
Q ss_pred EEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCccCCCC
Q psy6203 83 MVIEYCPGGELLDH---IVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEG 158 (568)
Q Consensus 83 lV~E~~~~g~L~~~---i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~ 158 (568)
||||||+++.+... ......+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99999976533322 23456799999999999999999999999999999999999999775 899999999886544
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--------------- 223 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~--------------- 223 (568)
. ....+.+||+.|+|||.+.+...++.++||||+||++|||++|++||...+..+....+...
T Consensus 176 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 176 G--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp T--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred C--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 3 23445689999999999887766899999999999999999999999988876665554320
Q ss_pred ----CCC----------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 224 ----KYT----------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 224 ----~~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
.++ ..+..++++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 000 12347899999999999999999999999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=411.97 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=213.9
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEe
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 86 (568)
.++|++++.||+|+||+||+|+++.+ +.||||+++... ...+.+.+|+.++++++|||||++++++.+ +.+++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 46899999999999999999998654 679999997544 345679999999999999999999999854 56799999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcccc
Q psy6203 87 YCPGGELLDHIVE--RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQL 164 (568)
Q Consensus 87 ~~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (568)
||++|+|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999999988864 36799999999999999999999999999999999999999999999999999986544433344
Q ss_pred ccccCCccccccccccCcccCCcccceechhhHHHHHHhC-CCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHHHHc
Q psy6203 165 QTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 242 (568)
Q Consensus 165 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG-~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 242 (568)
....||+.|+|||++.+.. ++.++|||||||++|||++| .+|+...+..++...+..+. .+.++.+++++++||.+|
T Consensus 172 ~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250 (285)
T ss_dssp ----CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHH
Confidence 4567999999999998766 58999999999999999995 56667788888888887764 456778999999999999
Q ss_pred cccCcCCCCCHHHHhc--Cccccc
Q psy6203 243 LQVEPGKRIKIQDLLG--HNWVKM 264 (568)
Q Consensus 243 L~~dP~~Rps~~ell~--hp~~~~ 264 (568)
|+.||++|||+++|+. |+||+.
T Consensus 251 l~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 251 WRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999988 889974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=425.50 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=215.2
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-CchHHHHHHHHHHHhCCCCCcceeeEEEEeC-----
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-EDLPRVKLEINALKHISHQHICKLFQVIETS----- 78 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 78 (568)
++.++|+++++||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|++++|||||++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 4468999999999999999999999999999999999865432 2345678999999999999999999998643
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
...++||+|+.||+|.+++. .+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 172 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred CceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC-
Confidence 23456667778999999885 4679999999999999999999999999999999999999999999999999987643
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE----------- 227 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~~~~~~----------- 227 (568)
....+..||+.|+|||++.+..+++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 173 ---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 234556789999999998887777899999999999999999999999988776666554321110
Q ss_pred --------------------CCCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 228 --------------------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 228 --------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
...+++++++||++||+.||.+|||++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12478999999999999999999999999999999853
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-51 Score=417.95 Aligned_cols=249 Identities=26% Similarity=0.459 Sum_probs=209.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeC--CEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETS--SHIFM 83 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~l 83 (568)
.++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|++++ ||||+++++++... ..+++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 47899999999999999999999999999999998753 3467889999999995 99999999999744 56999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCC-CeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQ-NLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~ 162 (568)
|||||++++|.... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...... .
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~ 184 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--Q 184 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--C
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC--C
Confidence 99999999987653 5799999999999999999999999999999999999998665 6999999999865543 2
Q ss_pred ccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC-HHHHHHHHH-------------cCCCC--
Q psy6203 163 QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKIL-------------NGKYT-- 226 (568)
Q Consensus 163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~-~~~~~~~i~-------------~~~~~-- 226 (568)
.....+||+.|+|||.+.+...++.++||||+||++|+|++|..||.... .......+. .....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 34566799999999999887777999999999999999999999996543 222111111 00000
Q ss_pred ----------------------CCCCCChHHHHHHHHccccCcCCCCCHHHHhcCccccc
Q psy6203 227 ----------------------EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 264 (568)
Q Consensus 227 ----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 264 (568)
....+++++.+||++||++||.+|||++|+|+||||+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 01236889999999999999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=408.51 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=209.3
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCC----cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTG----EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
+.|++.+.||+|+||+||+|.++.++ ..||||++...........+.+|+.+|++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 57999999999999999999987655 46999999765443345568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc-
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE- 161 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 161 (568)
|||||.++++.+.+... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999999988765 6799999999999999999999999999999999999999999999999999986543221
Q ss_pred -cccccccCCccccccccccCcccCCcccceechhhHHHHHHhC-CCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHH
Q psy6203 162 -SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQI 238 (568)
Q Consensus 162 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG-~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 238 (568)
.......||+.|+|||++.+.. ++.++|||||||++|||++| .+|+...+..++...+..+. .+.+..+++.+.+|
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 245 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245 (283)
T ss_dssp -------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHH
T ss_pred ceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHH
Confidence 1223346899999999998876 58999999999999999995 56667778888888887764 34566789999999
Q ss_pred HHHccccCcCCCCCHHHHhc
Q psy6203 239 VRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 239 i~~~L~~dP~~Rps~~ell~ 258 (568)
|.+||+.||++|||+.||++
T Consensus 246 i~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 246 MMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=417.16 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=212.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCc----EEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGE----KVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 83 (568)
++|+++++||+|+||+||+|.+..+|+ +||+|.++........+.+.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 569999999999999999999988876 58888887554445567899999999999999999999999865 4678
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc
Q psy6203 84 VIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES 162 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 162 (568)
+|||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 88999999999988764 67999999999999999999999999999999999999999999999999999865443222
Q ss_pred -ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCChHHHHHH
Q psy6203 163 -QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIV 239 (568)
Q Consensus 163 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 239 (568)
......||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..++...+..+. .+.++.+++++.+||
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li 246 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 246 (317)
T ss_dssp -------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHH
T ss_pred ccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 223346899999999998776 6999999999999999998 899999988888888887765 456778999999999
Q ss_pred HHccccCcCCCCCHHHHhcCc
Q psy6203 240 RSMLQVEPGKRIKIQDLLGHN 260 (568)
Q Consensus 240 ~~~L~~dP~~Rps~~ell~hp 260 (568)
.+||+.||.+|||+.|++.|.
T Consensus 247 ~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 247 VKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhCCCChhhCcCHHHHHHHH
Confidence 999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=412.05 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=215.6
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcE--EEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEK--VAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV 84 (568)
++|++.+.||+|+||+||+|+++.+|.. ||||.+......+..+.+.+|+.+|+++ +|||||++++++.+.+.+|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6899999999999999999999988874 6777776554445566899999999999 699999999999999999999
Q ss_pred EeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEE
Q psy6203 85 IEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLI 148 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 148 (568)
||||++|+|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999999999999653 579999999999999999999999999999999999999999999999
Q ss_pred eecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhC-CCCCCCCCHHHHHHHHHcC-CCC
Q psy6203 149 DFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNG-KYT 226 (568)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG-~~pf~~~~~~~~~~~i~~~-~~~ 226 (568)
|||+|+..... ......+||+.|+|||.+.+.. ++.++|||||||++|||++| .+||.+.+..++...+..+ .++
T Consensus 170 DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~ 246 (309)
T d1fvra_ 170 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246 (309)
T ss_dssp CTTCEESSCEE--CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred ccccccccccc--ccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99998765432 2223456899999999998776 58999999999999999996 5689999999999888776 445
Q ss_pred CCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 227 EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 227 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
.+..+++++.+||.+||+.||++|||++||++|
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 667789999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=418.22 Aligned_cols=254 Identities=25% Similarity=0.449 Sum_probs=203.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCC-chHHHHHHHHHHHhCCCCCcceeeEEEEe------C
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGE-DLPRVKLEINALKHISHQHICKLFQVIET------S 78 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~ 78 (568)
+.++|+++++||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|++++|||||+++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4478999999999999999999999999999999998765432 34568899999999999999999999953 4
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 158 (568)
..+|+|||||.++ +.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 6899999999655 55544 35799999999999999999999999999999999999999999999999999876544
Q ss_pred CCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHHHc----------------
Q psy6203 159 GLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILN---------------- 222 (568)
Q Consensus 159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i~~---------------- 222 (568)
. ......+||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+.......+..
T Consensus 172 ~--~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 172 S--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp -----------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred c--cccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 2 2345567999999999998875 68999999999999999999999998876665544432
Q ss_pred ------CCCCCC--------------------CCCChHHHHHHHHccccCcCCCCCHHHHhcCcccccC
Q psy6203 223 ------GKYTEP--------------------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 265 (568)
Q Consensus 223 ------~~~~~~--------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 265 (568)
+..... ...++++.+||++||+.||++||||+|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 111000 0135678999999999999999999999999999853
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-51 Score=409.15 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=219.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSH 80 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 80 (568)
.+++|++.+.||+|+||+||+|+.+ .+++.||||+++.....+....+.+|+.+|++++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3688999999999999999999975 35678999998765433345678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCc
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ------------------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPEN 136 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~------------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 136 (568)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++|||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 999999999999999996532 37899999999999999999999999999999999
Q ss_pred eEEcCCCCeEEEeecCccCCCCCC-ccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCC-CCCCCCCHH
Q psy6203 137 VLLDRNQNLKLIDFGLCAKPEGGL-ESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGF-LPFDSDSID 214 (568)
Q Consensus 137 Ill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~-~pf~~~~~~ 214 (568)
||++.++.+||+|||+|+...... .....+.+||+.|+|||++.+.. ++.++|||||||++|||++|. +||.+.+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 999999999999999987543321 22234567899999999998776 689999999999999999985 789999999
Q ss_pred HHHHHHHcCCCC-CCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 215 QLYDKILNGKYT-EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 215 ~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
++...+..+... .+..+++++.+||.+||+.||++|||+.||++
T Consensus 250 e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999888764 46679999999999999999999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=400.24 Aligned_cols=243 Identities=26% Similarity=0.482 Sum_probs=206.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEE-eCCEEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIE-TSSHIFMVI 85 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lV~ 85 (568)
.++|++++.||+|+||.||+|++ +|+.||||++++.. ..+.+.+|++++++++||||+++++++. +.+.+|+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 35799999999999999999997 47899999997543 4467899999999999999999999885 456689999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCccc
Q psy6203 86 EYCPGGELLDHIVER--QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLESQ 163 (568)
Q Consensus 86 E~~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 163 (568)
||+++|+|.+++.++ ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----T 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC----C
Confidence 999999999999764 3589999999999999999999999999999999999999999999999999876443 2
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 241 (568)
.....+|+.|+|||++.+.. ++.++|||||||++|||+| |++||...+..++...+.++ .++.++..++++.+||.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 34456899999999998766 6999999999999999998 79999998888888888775 445677789999999999
Q ss_pred ccccCcCCCCCHHHHhcC
Q psy6203 242 MLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~h 259 (568)
||+.||.+|||+.+++++
T Consensus 236 cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHH
Confidence 999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=404.40 Aligned_cols=252 Identities=25% Similarity=0.464 Sum_probs=215.3
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCC-------cEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTG-------EKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIET 77 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 77 (568)
..++|++++.||+|+||.||+|++..++ ..||||++++.........+.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3589999999999999999999986654 379999997655434456788899999888 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC
Q psy6203 78 SSHIFMVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR 141 (568)
Q Consensus 78 ~~~~~lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 141 (568)
++.+++|||||++|+|.+++..+ ..+++.++..++.||+.||+|||++|||||||||+|||++.
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 99999999999999999999754 35899999999999999999999999999999999999999
Q ss_pred CCCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6203 142 NQNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDK 219 (568)
Q Consensus 142 ~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~ 219 (568)
++.+||+|||+++....... ......+||+.|+|||.+.+.. |+.++|||||||++|+|++ |.+||.+.+..++...
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 99999999999886543221 2234457899999999998766 6999999999999999998 7999999999998888
Q ss_pred HHcCC-CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 220 ILNGK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 220 i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+..+. +..+..+++++.+||.+||+.||++|||+.||++
T Consensus 250 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 87764 4566779999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=407.86 Aligned_cols=253 Identities=24% Similarity=0.423 Sum_probs=203.0
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeC-
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETS- 78 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~- 78 (568)
..++|++++.||+|+||+||+|++.. +++.||||+++..........+.+|..++.++ +|+||+.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 35789999999999999999999764 34689999987654434455677788888777 589999999988654
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC
Q psy6203 79 SHIFMVIEYCPGGELLDHIVER----------------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142 (568)
Q Consensus 79 ~~~~lV~E~~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 142 (568)
+.+++|||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 4689999999999999999753 248899999999999999999999999999999999999999
Q ss_pred CCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHhC-CCCCCCCCH-HHHHHH
Q psy6203 143 QNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSI-DQLYDK 219 (568)
Q Consensus 143 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG-~~pf~~~~~-~~~~~~ 219 (568)
+.+||+|||+|+....... ......+||+.|+|||++.+.. ++.++|||||||++|||+|| .+||.+.+. ..+...
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543322 2234557999999999998766 69999999999999999986 568876543 444455
Q ss_pred HHcC-CCCCCCCCChHHHHHHHHccccCcCCCCCHHHHhcC
Q psy6203 220 ILNG-KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 220 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 259 (568)
+..+ .+..+..+++++.+||.+||+.||++|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5554 345667799999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=398.89 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=204.0
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCC-C--cEEEEEEeecCCcCC--chHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLT-G--EKVAIKIMKKATLGE--DLPRVKLEINALKHISHQHICKLFQVIETSSHIF 82 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~-~--~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 82 (568)
++|++.+.||+|+||+||+|+...+ + ..||||++++....+ ..+.+.+|+.+|++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5699999999999999999986543 3 368999987654432 24678999999999999999999999965 4678
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCc
Q psy6203 83 MVIEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLE 161 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 161 (568)
+|||||++|++.+.+..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 999999999999887654 5799999999999999999999999999999999999999999999999999987544322
Q ss_pred c--ccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC--CCCCCCChHHH
Q psy6203 162 S--QLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY--TEPPWMSPNSR 236 (568)
Q Consensus 162 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 236 (568)
. ......|+..|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..+....+..... +.++.+++++.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 245 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence 1 223346788999999998766 6899999999999999998 8999999999999888876643 45567899999
Q ss_pred HHHHHccccCcCCCCCHHHHhc
Q psy6203 237 QIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 237 ~li~~~L~~dP~~Rps~~ell~ 258 (568)
+||.+||+.||++|||++||++
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=400.42 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=219.1
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcC-----CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVL-----TGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSSHI 81 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 81 (568)
.++|++.++||+|+||+||+|.++. ++..||||+++..........+.+|+.++++++|||||++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4899999999999999999998753 35789999997654333445688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeec
Q psy6203 82 FMVIEYCPGGELLDHIVER----------QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFG 151 (568)
Q Consensus 82 ~lV~E~~~~g~L~~~i~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 151 (568)
++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+|||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecc
Confidence 9999999999999998643 347899999999999999999999999999999999999999999999999
Q ss_pred CccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHhC-CCCCCCCCHHHHHHHHHcCCC-CCC
Q psy6203 152 LCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGKY-TEP 228 (568)
Q Consensus 152 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG-~~pf~~~~~~~~~~~i~~~~~-~~~ 228 (568)
+|+....... .......||+.|+|||.+.+.. ++.++|||||||++|||+|| .+||.+.+..+....+.++.. +.+
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p 257 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 9875433211 2233446899999999998776 58899999999999999998 588999999999988888765 456
Q ss_pred CCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 229 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 229 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.+++.+.++|.+||+.||++|||++||++
T Consensus 258 ~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 678999999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=398.03 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=213.4
Q ss_pred ccCeEEEeeecccCCeEEEEEEEc-----CCCcEEEEEEeecCCcCCchHHHHHHHHHHHhC-CCCCcceeeEEEEeCCE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHV-----LTGEKVAIKIMKKATLGEDLPRVKLEINALKHI-SHQHICKLFQVIETSSH 80 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 80 (568)
.++|+++++||+|+||.||+|++. .+++.||||+++..........+.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 589999999999999999999864 456789999998655434456788999999999 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCC
Q psy6203 81 IFMVIEYCPGGELLDHIVERQ------------------RLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRN 142 (568)
Q Consensus 81 ~~lV~E~~~~g~L~~~i~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 142 (568)
.|+|||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence 999999999999999997543 58999999999999999999999999999999999999999
Q ss_pred CCeEEEeecCccCCCCCCc-cccccccCCccccccccccCcccCCcccceechhhHHHHHHh-CCCCCCCCCHHHHH-HH
Q psy6203 143 QNLKLIDFGLCAKPEGGLE-SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLY-DK 219 (568)
Q Consensus 143 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~llt-G~~pf~~~~~~~~~-~~ 219 (568)
+.+||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.. +.
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987654322 2223457899999999998765 6999999999999999998 67777666554443 44
Q ss_pred HHcCC-CCCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 220 ILNGK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 220 i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+..+. ...+...++++.+||.+||+.||.+|||++||++
T Consensus 261 i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 44443 3445678999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=389.19 Aligned_cols=247 Identities=20% Similarity=0.302 Sum_probs=204.5
Q ss_pred EEeeecccCCeEEEEEEEcCCC---cEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEec
Q psy6203 12 LERTVGSGGFAKVKLATHVLTG---EKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIET-SSHIFMVIEY 87 (568)
Q Consensus 12 i~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E~ 87 (568)
+.++||+|+||+||+|++..++ ..||||++++.........+.+|+++|++++||||+++++++.. ++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 4688999999999999987653 36899999754433445779999999999999999999999765 5689999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecCccCCCCCCcc---c
Q psy6203 88 CPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGLCAKPEGGLES---Q 163 (568)
Q Consensus 88 ~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~---~ 163 (568)
|++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++........ .
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~ 190 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence 9999999988754 45778899999999999999999999999999999999999999999999999865433211 2
Q ss_pred cccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC-CCCCCCChHHHHHHHH
Q psy6203 164 LQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKY-TEPPWMSPNSRQIVRS 241 (568)
Q Consensus 164 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~-~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 241 (568)
.....||+.|+|||.+.+.. ++.++||||||+++|||+||..||.. .+..++...+..+.. ..++.+++++.+||.+
T Consensus 191 ~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~ 269 (311)
T d1r0pa_ 191 KTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269 (311)
T ss_dssp TTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHH
Confidence 22346899999999998766 59999999999999999997766644 445556666666644 4566789999999999
Q ss_pred ccccCcCCCCCHHHHhcC
Q psy6203 242 MLQVEPGKRIKIQDLLGH 259 (568)
Q Consensus 242 ~L~~dP~~Rps~~ell~h 259 (568)
||+.||++|||+.||++|
T Consensus 270 cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 270 CWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=382.04 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=203.5
Q ss_pred ccccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCC-cceeeEEEEeCCEEEE
Q psy6203 5 DLRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQH-ICKLFQVIETSSHIFM 83 (568)
Q Consensus 5 ~~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~l 83 (568)
.+.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|+| |+.+..++.+.+..++
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 356899999999999999999999999999999999876543 235778999999998766 4555666788889999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC---CCCeEEEeecCccCCCCC
Q psy6203 84 VIEYCPGGELLDHIVE-RQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR---NQNLKLIDFGLCAKPEGG 159 (568)
Q Consensus 84 V~E~~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~~~~~ 159 (568)
||||+ +++|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.....
T Consensus 81 vme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99999 5566666544 568999999999999999999999999999999999999853 457999999999865432
Q ss_pred Cc------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHHHHHHHH---HcC----C-C
Q psy6203 160 LE------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI---LNG----K-Y 225 (568)
Q Consensus 160 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~~~~~~i---~~~----~-~ 225 (568)
.. ....+.+||+.|+|||++.+.. ++.++|||||||++|||++|..||...........+ ... . .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 21 1234557999999999998876 599999999999999999999999765543322211 111 1 1
Q ss_pred CCCCCCChHHHHHHHHccccCcCCCCCHH---HHhcCccccc
Q psy6203 226 TEPPWMSPNSRQIVRSMLQVEPGKRIKIQ---DLLGHNWVKM 264 (568)
Q Consensus 226 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~---ell~hp~~~~ 264 (568)
.....+|+++.+||.+||+.||++||+++ ++|+|+|.+.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 12356889999999999999999999987 4578887764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.4e-47 Score=375.06 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=206.8
Q ss_pred cccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCC-CCcceeeEEEEeCCEEEEE
Q psy6203 6 LRNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-QHICKLFQVIETSSHIFMV 84 (568)
Q Consensus 6 ~~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV 84 (568)
+.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.++| +||+.+++++......|+|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 56899999999999999999999999999999999876432 3357789999999975 8999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcC-----CCCeEEEeecCccCCCC
Q psy6203 85 IEYCPGGELLDHIVER-QRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDR-----NQNLKLIDFGLCAKPEG 158 (568)
Q Consensus 85 ~E~~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-----~~~~kl~DFG~a~~~~~ 158 (568)
|||+ +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 78999988765 47999999999999999999999999999999999999964 57899999999976432
Q ss_pred CCc------cccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC----
Q psy6203 159 GLE------SQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKY---- 225 (568)
Q Consensus 159 ~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~---~~~~~~~i~~~~~---- 225 (568)
... ....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 211 1234557999999999998876 6999999999999999999999997542 3333333322211
Q ss_pred -CCCCCCChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 226 -TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 226 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
...+.+++++.+++..|+..+|++||+.+.+.+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123457899999999999999999999777643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=377.80 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=194.2
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCcceeeEEEEeCC----EEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHICKLFQVIETSS----HIF 82 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~ 82 (568)
..+|.+.+.||+|+||+||+|+. +|+.||||+++.... .....+.|+..+++++|||||++++++.+.+ .+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 46899999999999999999985 689999999865421 1122344565667889999999999997654 689
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 83 MVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH--------LGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 83 lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
+|||||++|+|.+++.+ ..+++.....++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999975 469999999999999999999996 599999999999999999999999999987
Q ss_pred CCCCCCc---cccccccCCccccccccccCcc-----cCCcccceechhhHHHHHHhCCCCCCC---------------C
Q psy6203 155 KPEGGLE---SQLQTSCGSPNYAAPEVIKGKQ-----YYGSETDVWSMGVMLYALLCGFLPFDS---------------D 211 (568)
Q Consensus 155 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~~lltG~~pf~~---------------~ 211 (568)
....... ......+||+.|+|||++.+.. .++.++|||||||++|||+||..||.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 6533221 1234567999999999987542 246789999999999999999887632 2
Q ss_pred CHHHHHHHHHcCCCC--CCCC-----CChHHHHHHHHccccCcCCCCCHHHHhc
Q psy6203 212 SIDQLYDKILNGKYT--EPPW-----MSPNSRQIVRSMLQVEPGKRIKIQDLLG 258 (568)
Q Consensus 212 ~~~~~~~~i~~~~~~--~~~~-----~~~~~~~li~~~L~~dP~~Rps~~ell~ 258 (568)
+.......+..+... .+.. ....+.+|+.+||+.||.+|||+.||++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 334444444443332 1111 1234889999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-44 Score=371.24 Aligned_cols=251 Identities=28% Similarity=0.492 Sum_probs=195.2
Q ss_pred cCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-----------CCCcceeeEEEE
Q psy6203 8 NQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-----------HQHICKLFQVIE 76 (568)
Q Consensus 8 ~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~~~~~ 76 (568)
++|+++++||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 479999999999999999999999999999999975432 2346778999888775 578999998875
Q ss_pred --eCCEEEEEEeccCCCChHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCceEEcCCCC------
Q psy6203 77 --TSSHIFMVIEYCPGGELLDHIV---ERQRLGEKESRAFFRQILSAVAYLHH-LGYAHRDLKPENVLLDRNQN------ 144 (568)
Q Consensus 77 --~~~~~~lV~E~~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~------ 144 (568)
.....+++|+++..+....... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 4466777777775554333322 34678999999999999999999998 89999999999999986653
Q ss_pred eEEEeecCccCCCCCCccccccccCCccccccccccCcccCCcccceechhhHHHHHHhCCCCCCCCCHH-------HHH
Q psy6203 145 LKLIDFGLCAKPEGGLESQLQTSCGSPNYAAPEVIKGKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-------QLY 217 (568)
Q Consensus 145 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~~lltG~~pf~~~~~~-------~~~ 217 (568)
++++|||.|..... .....+||+.|+|||++.+.. ++.++||||+||++++|++|+.||...+.. .+.
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccc----ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999999876443 234567999999999998776 589999999999999999999999654321 111
Q ss_pred HH--HHc---------C------------------------------CCCCCCCCChHHHHHHHHccccCcCCCCCHHHH
Q psy6203 218 DK--ILN---------G------------------------------KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDL 256 (568)
Q Consensus 218 ~~--i~~---------~------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 256 (568)
.. +.. + ........++++.+||.+||++||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 10 000 0 001111235778999999999999999999999
Q ss_pred hcCcccccC
Q psy6203 257 LGHNWVKMG 265 (568)
Q Consensus 257 l~hp~~~~~ 265 (568)
|+||||+..
T Consensus 326 L~Hp~f~~~ 334 (362)
T d1q8ya_ 326 VNHPWLKDT 334 (362)
T ss_dssp HTCGGGTTC
T ss_pred hcCcccCCC
Confidence 999999843
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.1e-30 Score=247.67 Aligned_cols=153 Identities=18% Similarity=0.405 Sum_probs=135.3
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++...++++|.+++.++.|+++|+ +|+ +++||+|||+|..... .....
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---~~~~~ 163 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTT 163 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---CCCEE
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---Ccccc
Confidence 334789999999888999999999999999874 333 4689999997754322 23456
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+++.++..+.+.+|..+|+++++||.+||+.||
T Consensus 164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp 243 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 243 (263)
T ss_dssp TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCH
Confidence 789999999998 7778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCccccc
Q psy6203 477 GKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t~~~~l~hp~~~~ 493 (568)
++|||++|+++||||+.
T Consensus 244 ~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 244 SQRPMLREVLEHPWITA 260 (263)
T ss_dssp GGSCCHHHHHTCHHHHH
T ss_pred hHCcCHHHHHcCcCcCC
Confidence 99999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.2e-29 Score=253.10 Aligned_cols=155 Identities=20% Similarity=0.377 Sum_probs=137.8
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|++++...+.|+|+.++.++.|++.|+ +| .+.+||+|||+|..... .+....+
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-~~~~~~~ 164 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT 164 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-TTCCBCC
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc-CCccccc
Confidence 344899999999989999999999999999875 33 35789999998765432 3334567
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+++..+..+.+.+|..+|+++++||++||++||
T Consensus 165 ~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP 244 (337)
T d1o6la_ 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSST
T ss_pred ceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCc
Confidence 899999999998 7778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q psy6203 477 GKRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t-----~~~~l~hp~~~~ 493 (568)
.+|++ ++|+++||||+.
T Consensus 245 ~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 245 KQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TTSTTCSTTTHHHHHTSGGGTT
T ss_pred hhhcccccccHHHHHcCccccc
Confidence 99994 899999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-29 Score=248.07 Aligned_cols=156 Identities=19% Similarity=0.334 Sum_probs=132.3
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCC-Cceecc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKV-GQVINL 397 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~-~~~~~~ 397 (568)
..|++|++++...++|++..++.++.|+++|+ +| .+++||+|||+|....... .....+
T Consensus 90 ~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 169 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169 (288)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred cCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccccc
Confidence 34789999999889999999999999999874 33 3467999999886654332 223456
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+++.+|..+.+.+|..+|+++++||++||++||
T Consensus 170 ~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 249 (288)
T d1uu3a_ 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDA 249 (288)
T ss_dssp CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSG
T ss_pred ccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCH
Confidence 789999999998 6678999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHH------HhcCcccccC
Q psy6203 477 GKRIKIQD------LLGHNWVKMG 494 (568)
Q Consensus 477 ~~R~t~~~------~l~hp~~~~~ 494 (568)
++|||++| +++||||+..
T Consensus 250 ~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 250 TKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp GGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred hHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999987 5889999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=1.6e-28 Score=243.98 Aligned_cols=153 Identities=22% Similarity=0.441 Sum_probs=121.6
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc-----------ceeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP-----------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~-----------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++...++|++.+++.++.|++.|+ +| .+.+||+|||+|... +.+....
T Consensus 90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~--~~~~~~~ 167 (307)
T d1a06a_ 90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLS 167 (307)
T ss_dssp CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------
T ss_pred CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc--cCCCeee
Confidence 4789999999889999999999999999874 33 345889999987643 3344456
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
+.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..++...|..+...++ +.+|+++++||.+|
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 247 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHH
Confidence 7899999999998 777899999999999999999999999999999999999998876543 46899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccC
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
|.+||++|||++|+++||||+..
T Consensus 248 L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 248 MEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-28 Score=241.37 Aligned_cols=155 Identities=16% Similarity=0.274 Sum_probs=128.5
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|++++.. .+|++.+++.++.|++.|+ +| .+++||+|||+|.....+ ......
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~ 175 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST 175 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCCBCC
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-cccccc
Confidence 3447889888876 5799999999999999874 33 347899999987654332 233566
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-C--CCCCCCCCHHHHHHHHHccC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-K--YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~-~--~~~~~~~s~~~~~li~~~L~ 473 (568)
.+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+.+..+... . +..|..+|+++++||.+||.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence 789999999998 7778899999999999999999999999999887776666543 3 33466799999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccC
Q psy6203 474 VEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 474 ~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.||++|||++|+++||||+..
T Consensus 256 ~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 256 MDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp SSTTTSCCHHHHTTCGGGGGC
T ss_pred CChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.9e-28 Score=244.87 Aligned_cols=155 Identities=20% Similarity=0.291 Sum_probs=136.2
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------C--------cceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------M--------PICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~--------~~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|++|.+++...+.++|.+++.++.||+.|+ + ..+++|++|||++...... ......
T Consensus 84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~~~~~ 162 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNT 162 (320)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCC
T ss_pred ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-cccccc
Confidence 334899999999889999999999999999875 2 3457899999987654332 223456
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|+|||+ .+..|+.++||||+||++|||++|++||.+.+..+++.+|..+.+.+|..+|+++.+||.+||++||
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP 242 (320)
T d1xjda_ 163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 242 (320)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred cCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCC
Confidence 799999999998 7778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHH-HHhcCccccc
Q psy6203 477 GKRIKIQ-DLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~t~~-~~l~hp~~~~ 493 (568)
++|||+. ++++||||+.
T Consensus 243 ~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 243 EKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp GGSBTTBSCGGGSGGGTT
T ss_pred CCCcCHHHHHHhCchhcc
Confidence 9999995 8999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.3e-28 Score=240.07 Aligned_cols=155 Identities=18% Similarity=0.314 Sum_probs=124.3
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCC-Cceecc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKV-GQVINL 397 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~-~~~~~~ 397 (568)
..|++|++++...++|+|.+++.++.|+++|+ +| .+++||+|||+|....... .....+
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 34788999999888999999999999999874 33 3468999999886654322 223456
Q ss_pred cccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCC--CCCCCHHHHHHHHHcc
Q psy6203 398 LRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYTE--PPWMSPNSRQIVRSML 472 (568)
Q Consensus 398 ~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~-~~~~~i~~~~~~~--~~~~s~~~~~li~~~L 472 (568)
.+||+.|+|||. +..+++.++||||+||++|||++|++||.+.+.. ..+..+....... +..+|+++.+||.+||
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 244 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHc
Confidence 799999999997 6667788999999999999999999999876543 3333444433332 3458999999999999
Q ss_pred CCCcCCCCCHHHHhcCccccc
Q psy6203 473 QVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+.||++|||++|+++||||+.
T Consensus 245 ~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 245 VENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp CSSTTTSCCHHHHTTCTTTTC
T ss_pred CCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.94 E-value=3.9e-28 Score=245.52 Aligned_cols=152 Identities=22% Similarity=0.389 Sum_probs=134.4
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecc
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~ 397 (568)
|..|+++.+++...++|++..++.++.||+.|+ +| .+++||+|||+|+.... ...+
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----~~~~ 197 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWT 197 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----CBCC
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----cccc
Confidence 334788888998888999999999999999874 33 34689999998765432 2356
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCc
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp 476 (568)
.+||+.|||||. .+..|+.++|||||||++|||++|++||.+.+...++.+|..+.+.+|..+|+++.+||++||++||
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 277 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCH
Confidence 789999999998 7778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-----CHHHHhcCccccc
Q psy6203 477 GKRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 477 ~~R~-----t~~~~l~hp~~~~ 493 (568)
.+|+ |++++++||||+.
T Consensus 278 ~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 278 TKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhccccccccHHHHHcCccccC
Confidence 9995 8999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=1.1e-27 Score=238.81 Aligned_cols=150 Identities=22% Similarity=0.421 Sum_probs=133.4
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|+++.+++.....++++.++.++.|++.|+ +| .+++||+|||+|.... ....+.+
T Consensus 87 ~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~----~~~~~~~ 162 (316)
T d1fota_ 87 EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLC 162 (316)
T ss_dssp CSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----SCBCCCC
T ss_pred CCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec----ccccccc
Confidence 3788888999889999999999999999874 33 3478999999775532 2245679
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcCC
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPGK 478 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 478 (568)
||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+++.+|..+...+|+.+|++++++|.+||++||.+
T Consensus 163 Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~ 242 (316)
T d1fota_ 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQ 242 (316)
T ss_dssp SCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred CcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHh
Confidence 9999999998 777899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CC-----CHHHHhcCccccc
Q psy6203 479 RI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 479 R~-----t~~~~l~hp~~~~ 493 (568)
|+ |++++++||||+.
T Consensus 243 R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 243 RLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CTTSSTTTTHHHHTSGGGSS
T ss_pred ccccchhhHHHHHcCccccc
Confidence 96 8999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.5e-28 Score=235.55 Aligned_cols=152 Identities=18% Similarity=0.295 Sum_probs=123.4
Q ss_pred hhHHHHHHHHhC----CCCCChhhHHHHHHHHhhcc-----------------Ccc--------eeEEEccccCcccccC
Q psy6203 339 SMGVMLYALLCG----FLPFDSDSIDQLYDKILSHF-----------------MPI--------CTILISQYFPTILLPC 389 (568)
Q Consensus 339 ~~g~~l~~~~~~----~~~~~e~~~~~~~~qil~~~-----------------~~~--------~~iki~dfG~~~~~~~ 389 (568)
..|++|.+++.. ..+|+|..+..++.|+++|+ +|| +++||+|||+|.....
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 347888888753 46899999999999887653 333 3689999998765432
Q ss_pred CCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHH
Q psy6203 390 KVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQI 467 (568)
Q Consensus 390 ~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~l 467 (568)
......+.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..++..+|..+.+. .|..+|+++.+|
T Consensus 167 -~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~l 245 (269)
T d2java1 167 -DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEI 245 (269)
T ss_dssp ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred -CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 2233566899999999998 7778999999999999999999999999999999999999888765 677899999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccc
Q psy6203 468 VRSMLQVEPGKRIKIQDLLGHNWV 491 (568)
Q Consensus 468 i~~~L~~dp~~R~t~~~~l~hp~~ 491 (568)
|.+||+.||.+|||++|+++|||+
T Consensus 246 i~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 246 ITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999995
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.3e-28 Score=243.23 Aligned_cols=155 Identities=20% Similarity=0.385 Sum_probs=124.3
Q ss_pred hhHHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccce-----------eEEEccccCcccccCCCCc
Q psy6203 339 SMGVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPIC-----------TILISQYFPTILLPCKVGQ 393 (568)
Q Consensus 339 ~~g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~~-----------~iki~dfG~~~~~~~~~~~ 393 (568)
..|++|++++... .+|+|.+++.++.|++.|+ +++. .+||+|||+|..... ..
T Consensus 91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~--~~ 168 (335)
T d2ozaa1 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HN 168 (335)
T ss_dssp CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC--CC
T ss_pred CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccC--CC
Confidence 3489999999764 4799999999999999875 3433 478999998765433 23
Q ss_pred eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCC----CCCHHH
Q psy6203 394 VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLY----DKILNGKYTEPP----WMSPNS 464 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~----~~i~~~~~~~~~----~~s~~~ 464 (568)
...+.+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..... ..+..+.+.+|. .+|+++
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 248 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHH
T ss_pred ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHH
Confidence 3566799999999998 7778999999999999999999999999887644433 344445555553 489999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 465 RQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 465 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
++||++||+.||++|||++|+++||||....
T Consensus 249 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 249 KMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 9999999999999999999999999997543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.94 E-value=1.3e-27 Score=241.41 Aligned_cols=154 Identities=19% Similarity=0.371 Sum_probs=131.6
Q ss_pred hHHHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Cc----------ceeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MP----------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~----------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++. ..++|+|++++.++.||+.|+ +| .+.+||+|||+|.... ......
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~--~~~~~~ 183 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVK 183 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC--TTSCEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc--cccccc
Confidence 4789999885 456899999999999999874 23 3458899999776543 333456
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
+.+||+.|||||. .+..|+.++||||+||++|+|++|++||.+.+..+++..|..+.+.++ ..+|+++++||.+|
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 263 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 7899999999998 667789999999999999999999999999999999999998877654 35899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccCC
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
|+.||++|||++|+++||||+...
T Consensus 264 L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 264 LLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp CCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred ccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.2e-28 Score=237.47 Aligned_cols=153 Identities=17% Similarity=0.205 Sum_probs=126.7
Q ss_pred hHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccc
Q psy6203 340 MGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 340 ~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
.|++|.+++.. .++|++.+++.++.|+++|+ +|+ +++||+|||+|..... ......+.
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~-~~~~~~~~ 170 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSF 170 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH-HHHHHTCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC-Cccccccc
Confidence 47888888654 56899999999999999874 344 3678899997644321 11234567
Q ss_pred ccccccccCCC------CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHHHHHH
Q psy6203 399 RSAIVLCSAPS------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYT---EPPWMSPNSRQIVR 469 (568)
Q Consensus 399 ~gt~~~~~pe~------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~ 469 (568)
+||+.|+|||. ....|+.++||||+||++|||++|++||.+.+..+.+.++..+.++ .|..+|+++++||.
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~ 250 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 89999999996 3567999999999999999999999999999988888888887543 35678999999999
Q ss_pred HccCCCcCCCCCHHHHhcCccccc
Q psy6203 470 SMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 470 ~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
+||+.||++|||++|+++||||+.
T Consensus 251 ~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 251 KCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.9e-27 Score=235.01 Aligned_cols=152 Identities=24% Similarity=0.381 Sum_probs=132.6
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce------------eEEEccccCcccccCCCCcee
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC------------TILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~------------~iki~dfG~~~~~~~~~~~~~ 395 (568)
.|++|.+++...+++++..++.++.|+++|+ +++. ++|++|||+|... +.+...
T Consensus 96 ~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~--~~~~~~ 173 (293)
T d1jksa_ 96 AGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEF 173 (293)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC--TTSCBC
T ss_pred CCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc--CCCccc
Confidence 3789999998888999999999999999875 3333 4789999976543 334445
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRS 470 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~ 470 (568)
.+.+||+.|+|||. ....|+.++||||+||++|||++|++||.+.+..+.+..|..+...++ +.+|+++++||++
T Consensus 174 ~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 253 (293)
T d1jksa_ 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253 (293)
T ss_dssp SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHH
Confidence 67799999999998 777899999999999999999999999999999999999999877654 5689999999999
Q ss_pred ccCCCcCCCCCHHHHhcCccccc
Q psy6203 471 MLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
||..||++|||++|+++||||+.
T Consensus 254 ~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 254 LLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.1e-27 Score=234.41 Aligned_cols=157 Identities=13% Similarity=0.123 Sum_probs=126.8
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|+.+..+....+.+++.+++.++.|+++|+ +|+ +++||+|||.|...... .....+.+|
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~~~~~~g 162 (299)
T d1ua2a_ 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVV 162 (299)
T ss_dssp EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCCCCSCC
T ss_pred chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC-cccccceec
Confidence 566767777778999999999999999874 344 46789999977554332 223456789
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC------------------C--
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK--YT------------------E-- 456 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~--~~------------------~-- 456 (568)
|+.|+|||. ...+|+.++||||+||++|||++|++||.+.+..+++.+|.... +. .
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ua2a_ 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242 (299)
T ss_dssp CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC
T ss_pred ChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCC
Confidence 999999997 66789999999999999999999999999999888887775421 00 0
Q ss_pred ------CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCCC
Q psy6203 457 ------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPEDN 498 (568)
Q Consensus 457 ------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~ 498 (568)
.+.+|+++++||++||+.||++|||++|+|+||||+..+.+.
T Consensus 243 ~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred CChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 123688999999999999999999999999999998765443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2e-27 Score=231.50 Aligned_cols=152 Identities=15% Similarity=0.255 Sum_probs=125.1
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc--------------Cc---------ceeEEEccccCcccccCCCCce
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF--------------MP---------ICTILISQYFPTILLPCKVGQV 394 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~--------------~~---------~~~iki~dfG~~~~~~~~~~~~ 394 (568)
|..|++|.+++.....+++++++.++.|+++|+ +| .+.+||+|||+|.... ...
T Consensus 93 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~---~~~ 169 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASF 169 (270)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---TTS
T ss_pred CCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc---CCc
Confidence 334789999998888999999999999999874 22 2368999999776432 223
Q ss_pred ecccccccccccCCCCCCCCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHc
Q psy6203 395 INLLRSAIVLCSAPSSKQYYGSETDVWSMGVMLYALLCGFLPFDSD-SIDQLYDKILNGKYT--EPPWMSPNSRQIVRSM 471 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~~~~~~~~~~DiWSlG~il~eml~g~~pf~~~-~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~~ 471 (568)
..+.+||+.|||||.-...|+.++||||+||++|||++|++||.+. +..+++..+..+..+ ++...++++++||.+|
T Consensus 170 ~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 249 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 249 (270)
T ss_dssp BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHH
Confidence 4567999999999984345999999999999999999999999865 456667777766543 3556899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccc
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~ 492 (568)
|..||++|||++|+++||||+
T Consensus 250 l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 250 IRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999995
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.5e-27 Score=240.93 Aligned_cols=151 Identities=19% Similarity=0.198 Sum_probs=126.8
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|++++.....+++.+++.++.||+.|+ +|| +.+||+|||+|..... + .....+
T Consensus 90 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--~-~~~~~~ 166 (364)
T d1omwa3 90 NGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--K-KPHASV 166 (364)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--S-CCCSCC
T ss_pred CCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--C-cccccc
Confidence 4789999999889999999999999999874 333 4689999998764322 1 245678
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCHHHHHHHHHccCC
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI---DQLYDKILNGKYTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 474 (568)
||+.|+|||+ .+.+|+.++||||+||++|||++|++||.+.+. ..+...+....+..|..+|+++++||.+||++
T Consensus 167 GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 246 (364)
T d1omwa3 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246 (364)
T ss_dssp SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCS
T ss_pred cccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHccc
Confidence 9999999997 567899999999999999999999999987543 34445555666777888999999999999999
Q ss_pred CcCCCCC-----HHHHhcCccccc
Q psy6203 475 EPGKRIK-----IQDLLGHNWVKM 493 (568)
Q Consensus 475 dp~~R~t-----~~~~l~hp~~~~ 493 (568)
||++||| ++|+++||||+.
T Consensus 247 dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 247 DVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp STTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CHHHhCCCcccCHHHHHcCccccC
Confidence 9999999 799999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.93 E-value=3.4e-27 Score=238.65 Aligned_cols=153 Identities=19% Similarity=0.376 Sum_probs=131.3
Q ss_pred hHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Ccc----------eeEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MPI----------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~~----------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++... .+|+|.+++.++.||+.|+ +|+ +.+||+|||+|.... .+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~--~~~~~~ 186 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVK 186 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--TTSCEE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC--CCCcee
Confidence 478898887654 4799999999999999874 333 457889999776543 333456
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
+.+||+.|+|||. .+..|+.++||||+||++|+|++|++||.+.+..+++..|..+.+.+| ..+|+++++||.+|
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 266 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 7899999999998 777899999999999999999999999999999999999998877654 45899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccC
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
|++||.+|||++|+++||||+..
T Consensus 267 L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 267 LQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp SCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999854
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.93 E-value=3.3e-27 Score=230.91 Aligned_cols=153 Identities=21% Similarity=0.332 Sum_probs=131.4
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++...+++++..++.++.||++|+ ++ ...+||+|||++.... .+......
T Consensus 92 ~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~--~~~~~~~~ 169 (277)
T d1phka_ 92 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREV 169 (277)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC--TTCCBCCC
T ss_pred CCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc--CCCceeee
Confidence 34889999999889999999999999999875 33 3468999999876543 33345667
Q ss_pred ccccccccCCC-------CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Q psy6203 399 RSAIVLCSAPS-------SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQI 467 (568)
Q Consensus 399 ~gt~~~~~pe~-------~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~l 467 (568)
+||+.|++||. ....|+.++||||+||++|+|++|++||.+.+..+.+..+..+...++ ..+|+++++|
T Consensus 170 ~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 249 (277)
T d1phka_ 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 249 (277)
T ss_dssp CSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHH
T ss_pred eccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHH
Confidence 89999999995 355689999999999999999999999999999999999998876543 2589999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 468 VRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 468 i~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
|++||+.||++|||++|+++||||+.
T Consensus 250 i~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 250 VSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHccCChhHCcCHHHHHcCHHHHH
Confidence 99999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.1e-27 Score=236.25 Aligned_cols=153 Identities=24% Similarity=0.379 Sum_probs=132.7
Q ss_pred hHHHHHHHHhCCC-CCChhhHHHHHHHHhhcc------------Ccce----------eEEEccccCcccccCCCCceec
Q psy6203 340 MGVMLYALLCGFL-PFDSDSIDQLYDKILSHF------------MPIC----------TILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 340 ~g~~l~~~~~~~~-~~~e~~~~~~~~qil~~~------------~~~~----------~iki~dfG~~~~~~~~~~~~~~ 396 (568)
.|++|++++...+ +|+|++++.++.||++|+ ++|. .|||+|||++... ..+....
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~--~~~~~~~ 161 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFR 161 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC--CTTCEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc--ccCCccc
Confidence 3789999998655 899999999999999874 3333 5788999976553 3344456
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEP----PWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~ 471 (568)
+.+||+.|+|||+ .+..|+.++||||+||++|+|++|++||.+.+..+++.+|..+.+.+| +.+|+++++||.+|
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence 7789999999998 777899999999999999999999999999999999999999887765 36899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccccC
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
|+.||++|||++|+++||||+..
T Consensus 242 L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 242 LVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=7.2e-27 Score=232.02 Aligned_cols=150 Identities=18% Similarity=0.175 Sum_probs=125.6
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|+.+..++...++|++.+++.++.|+++|+ +|+ +++||+|||+|.... .....+
T Consensus 98 ~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-----~~~~~~ 172 (309)
T d1u5ra_ 98 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFV 172 (309)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-----SBCCCC
T ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC-----CCCccc
Confidence 3677777777778999999999999999874 343 468999999775432 134568
Q ss_pred cccccccCCC----CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHccC
Q psy6203 400 SAIVLCSAPS----SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--PPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 400 gt~~~~~pe~----~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~s~~~~~li~~~L~ 473 (568)
||+.|+|||. ....|+.++||||+||++|||++|++||.+.+..+.+..+..+..+. +..+|+++++||.+||+
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 252 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTC
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCc
Confidence 9999999997 23568999999999999999999999999999888888887765543 44589999999999999
Q ss_pred CCcCCCCCHHHHhcCcccccC
Q psy6203 474 VEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 474 ~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.||++|||++|+++||||...
T Consensus 253 ~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 253 KIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp SSGGGSCCHHHHTTCHHHHSC
T ss_pred CChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.8e-27 Score=235.97 Aligned_cols=153 Identities=19% Similarity=0.240 Sum_probs=116.8
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc-------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF-------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~-------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|..|++|++++...+.|++..++.++.|+++|+ +|| +++||+|||+|..... ....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~~ 161 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMAN 161 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HTC-
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---Cccc
Confidence 334789999998888999999999999998764 333 3688999998764322 1235
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------------------------------
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQL------------------------------ 445 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~------------------------------ 445 (568)
+.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+....
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 6799999999998 667899999999999999999999999987653221
Q ss_pred ------------HHHHHcCCCC-CC-CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 446 ------------YDKILNGKYT-EP-PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 446 ------------~~~i~~~~~~-~~-~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
...+....++ .| ..+|++++|||.+||+.||.+|||++|+++||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 1111111111 11 236889999999999999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=9.3e-27 Score=227.63 Aligned_cols=144 Identities=19% Similarity=0.425 Sum_probs=122.8
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc---------eeEEEccccCcccccCCCCceecccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI---------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~---------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
++.+++++.....++|++++.++.|++.|+ +|+ ..+||+|||+|.... .....+.+
T Consensus 94 ~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~---~~~~~~~~ 170 (273)
T d1xwsa_ 94 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD 170 (273)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC---SSCBCCCC
T ss_pred cchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc---cccccccc
Confidence 467788888888999999999999999874 232 368999999775432 22346779
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccCCCcC
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPPWMSPNSRQIVRSMLQVEPG 477 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 477 (568)
||+.|+|||. ...+++.++||||+||++|||++|++||.+. ..+..+...++..+|+++++||++||..||+
T Consensus 171 GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~ 244 (273)
T d1xwsa_ 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPS 244 (273)
T ss_dssp SCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHHHHHHTCSSGG
T ss_pred cCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHHHHHHccCCHh
Confidence 9999999997 5677889999999999999999999999875 3466778888899999999999999999999
Q ss_pred CCCCHHHHhcCccccc
Q psy6203 478 KRIKIQDLLGHNWVKM 493 (568)
Q Consensus 478 ~R~t~~~~l~hp~~~~ 493 (568)
+|||++|+++||||+.
T Consensus 245 ~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 245 DRPTFEEIQNHPWMQD 260 (273)
T ss_dssp GSCCHHHHHTSGGGSS
T ss_pred HCcCHHHHhcCHhhCC
Confidence 9999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.4e-25 Score=205.53 Aligned_cols=135 Identities=21% Similarity=0.270 Sum_probs=108.0
Q ss_pred eEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcC-----C-------c-----hHHHHHHHHHHHhCCCCCcceee
Q psy6203 10 YILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLG-----E-------D-----LPRVKLEINALKHISHQHICKLF 72 (568)
Q Consensus 10 Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~-------~-----~~~~~~Ei~~l~~l~hpnIv~l~ 72 (568)
|.++++||+|+||+||+|.+. +|+.||||+++..... . . .....+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 7899999987632211 0 0 12345688899999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCceEEcCCCCeEEEeecC
Q psy6203 73 QVIETSSHIFMVIEYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHHLGYAHRDLKPENVLLDRNQNLKLIDFGL 152 (568)
Q Consensus 73 ~~~~~~~~~~lV~E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 152 (568)
++. .. +++|||+++..+. .+++..+..++.|++.||.|||++||+||||||+|||+++++ ++|+|||+
T Consensus 81 ~~~--~~--~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWE--GN--AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEE--TT--EEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred Eec--CC--EEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 663 22 7999999876543 256667788999999999999999999999999999998654 89999999
Q ss_pred ccCCC
Q psy6203 153 CAKPE 157 (568)
Q Consensus 153 a~~~~ 157 (568)
|....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 87643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.4e-25 Score=220.22 Aligned_cols=145 Identities=14% Similarity=0.166 Sum_probs=117.5
Q ss_pred HhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCceecccccccccccC
Q psy6203 348 LCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQVINLLRSAIVLCSA 407 (568)
Q Consensus 348 ~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~p 407 (568)
......++++.++.++.|+++|+ +||. ++||+|||++.... ......+.+||+.|+||
T Consensus 107 ~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~--~~~~~~~~~gT~~Y~AP 184 (305)
T d1blxa_ 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAP 184 (305)
T ss_dssp HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC--GGGGGCCCCCCCTTCCH
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhc--ccccCCCcccChhhcCc
Confidence 34456799999999999999874 4444 56888888665432 23345678999999999
Q ss_pred CC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C-------------------------CCCCCC
Q psy6203 408 PS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K-------------------------YTEPPW 459 (568)
Q Consensus 408 e~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~-------------------------~~~~~~ 459 (568)
|. .+..|+.++||||+||++|||++|++||.+.+..+.+.++... . ..++..
T Consensus 185 E~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (305)
T d1blxa_ 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264 (305)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCS
T ss_pred chhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhcccc
Confidence 98 7778999999999999999999999999999988887776531 0 012244
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
+|+.+++||.+||++||++|||++|+++||||+..
T Consensus 265 ~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 265 IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 78999999999999999999999999999999753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2e-25 Score=223.11 Aligned_cols=155 Identities=18% Similarity=0.298 Sum_probs=126.1
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
..|++|++++...+.+++..+..++.|++.|+ ++ .+.+||+|||++............+.
T Consensus 111 ~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 190 (322)
T d1vzoa_ 111 INGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190 (322)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGG
T ss_pred ccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccccccccc
Confidence 34789999999889999999999999999874 33 34689999998765544444445667
Q ss_pred ccccccccCCC---CCCCCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy6203 399 RSAIVLCSAPS---SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSI----DQLYDKILNGKYTEPPWMSPNSRQIVRSM 471 (568)
Q Consensus 399 ~gt~~~~~pe~---~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 471 (568)
.||+.|++||+ ...+|+.++||||+||+||+|++|++||.+.+. ..+........++.|...|+++.+||++|
T Consensus 191 ~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 270 (322)
T d1vzoa_ 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 270 (322)
T ss_dssp GSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHH
Confidence 89999999997 345688999999999999999999999987653 34445555667778888999999999999
Q ss_pred cCCCcCCCC-----CHHHHhcCccccc
Q psy6203 472 LQVEPGKRI-----KIQDLLGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~-----t~~~~l~hp~~~~ 493 (568)
|..||.+|+ |++|+++||||+.
T Consensus 271 l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 271 LMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999 4899999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.91 E-value=3.6e-25 Score=217.90 Aligned_cols=152 Identities=14% Similarity=0.153 Sum_probs=118.5
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|+.+..+....+.+++..++.++.|++.|+ +|+ +++|++|||.+..... ........+|
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~~~ 162 (286)
T d1ob3a_ 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV 162 (286)
T ss_dssp EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------C
T ss_pred hhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc-Cccccceecc
Confidence 677777778889999999999999999874 333 4678899997654322 2223455679
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------------------
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--KY---------------------- 454 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~~---------------------- 454 (568)
|+.|++||. ...+++.++||||+||++|||++|++||.+.+..+.+.++... .+
T Consensus 163 ~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T d1ob3a_ 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242 (286)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred cchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccccc
Confidence 999999997 6678999999999999999999999999999888777765431 00
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q psy6203 455 -----TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKM 493 (568)
Q Consensus 455 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 493 (568)
..+..+|++++|||++||++||++|||++|+++||||++
T Consensus 243 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 012346899999999999999999999999999999973
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=7.9e-25 Score=218.85 Aligned_cols=153 Identities=13% Similarity=0.186 Sum_probs=118.6
Q ss_pred HHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCC---CCceeccc
Q psy6203 342 VMLYALLCGFLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCK---VGQVINLL 398 (568)
Q Consensus 342 ~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~---~~~~~~~~ 398 (568)
+.+.........+++..++.++.|+++|+ +| .+++||+|||++...... ......+.
T Consensus 102 ~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 181 (318)
T d3blha1 102 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181 (318)
T ss_dssp EHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSC
T ss_pred CccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccce
Confidence 44445556677899999999999999874 33 346788999987544321 12234556
Q ss_pred ccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC------------------
Q psy6203 399 RSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTEPP------------------ 458 (568)
Q Consensus 399 ~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------ 458 (568)
+||+.|+|||+ ...+|+.++||||+||++|||++|++||.+.+.......+......+++
T Consensus 182 ~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T d3blha1 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261 (318)
T ss_dssp CSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CC
T ss_pred ecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccc
Confidence 89999999997 5668999999999999999999999999998887776665442111110
Q ss_pred --------------CCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 459 --------------WMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 459 --------------~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..+++++|||.+||+.||++|+|++|+++||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 037788999999999999999999999999999854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.1e-24 Score=215.64 Aligned_cols=148 Identities=16% Similarity=0.238 Sum_probs=117.8
Q ss_pred hCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCceecccccccccccCC
Q psy6203 349 CGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQVINLLRSAIVLCSAP 408 (568)
Q Consensus 349 ~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe 408 (568)
.....|++++++.++.|++.|+ +|+. ++||+|||+|..... ........+||+.|+|||
T Consensus 94 ~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-~~~~~~~~~gt~~y~apE 172 (298)
T d1gz8a_ 94 SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 172 (298)
T ss_dssp TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-CSBCTTCCBCCCTTCCHH
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC-Ccccceeecccceeeehh
Confidence 3456799999999999999874 4444 568899997765432 233455678999999999
Q ss_pred C--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------CCC-----------
Q psy6203 409 S--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY------------------TEP----------- 457 (568)
Q Consensus 409 ~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~------------------~~~----------- 457 (568)
. ...+++.++||||+||++|+|++|++||.+.+..+.+.++..... ..+
T Consensus 173 ~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T d1gz8a_ 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252 (298)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHS
T ss_pred hhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhc
Confidence 7 667789999999999999999999999999988877766643110 001
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCCC
Q psy6203 458 PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPED 497 (568)
Q Consensus 458 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 497 (568)
+.+|+++++||++||+.||++|||++|+++||||+....+
T Consensus 253 ~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 253 PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 2368899999999999999999999999999999865443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1e-24 Score=220.69 Aligned_cols=149 Identities=16% Similarity=0.210 Sum_probs=118.8
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|..+..++.. ++|++..++.++.|++.|+ +|+ +++|++|||.|.... ......+|
T Consensus 106 ~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~----~~~~~~~~ 180 (346)
T d1cm8a_ 106 GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVV 180 (346)
T ss_dssp SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC----SSCCSSCS
T ss_pred cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC----Cccccccc
Confidence 4566666654 6899999999999999874 343 467889999765432 22456789
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------------
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKY------------------------ 454 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~------------------------ 454 (568)
|+.|+|||+ +..+++.++||||+||++|+|++|++||.+.+..+.+..+.....
T Consensus 181 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (346)
T d1cm8a_ 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 260 (346)
T ss_dssp CGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCC
T ss_pred cccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCc
Confidence 999999997 677899999999999999999999999999887766554432110
Q ss_pred -------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 455 -------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 455 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
.....+|+++.+||.+||+.||++|||++|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 261 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred ccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0123478999999999999999999999999999999854
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.8e-24 Score=217.14 Aligned_cols=156 Identities=20% Similarity=0.282 Sum_probs=121.7
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCC--Cceecc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKV--GQVINL 397 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~--~~~~~~ 397 (568)
.|++|++++.. .+|++..++.++.|++.|+ +|+ +++||+|||++....... ......
T Consensus 93 ~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 171 (345)
T d1pmea_ 93 MGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171 (345)
T ss_dssp CCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred cCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecc
Confidence 47899999875 5799999999999999874 344 467899999775432221 112355
Q ss_pred cccccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------------
Q psy6203 398 LRSAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG--K-------------------- 453 (568)
Q Consensus 398 ~~gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~--~-------------------- 453 (568)
.+||+.|+|||. ...+|+.++||||+||++|+|++|++||.+.+..+........ .
T Consensus 172 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T d1pmea_ 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251 (345)
T ss_dssp CCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred ccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccccc
Confidence 689999999997 5668899999999999999999999999988866554443210 0
Q ss_pred C----C-----CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 454 Y----T-----EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 454 ~----~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
. . ..+.+|+++++||.+||+.||++|||++|+++||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp SCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred CCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 0 12357889999999999999999999999999999986543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2.1e-24 Score=218.56 Aligned_cols=152 Identities=18% Similarity=0.196 Sum_probs=120.0
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCceecccc
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
.|++|++++.. +.|++.+++.++.|++.|+ +|+. ++|++|||++... .....+.+
T Consensus 105 ~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~----~~~~~~~~ 179 (348)
T d2gfsa1 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYV 179 (348)
T ss_dssp CSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC----TGGGSSSC
T ss_pred cCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc----Cccccccc
Confidence 37899999876 5799999999999999874 4444 5677788755332 22345678
Q ss_pred cccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Q psy6203 400 SAIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE--------------------- 456 (568)
Q Consensus 400 gt~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~--------------------- 456 (568)
||+.|+|||+ +..+++.++||||+||++|+|++|++||.+.+.......+.......
T Consensus 180 g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (348)
T d2gfsa1 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259 (348)
T ss_dssp HHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSC
T ss_pred ccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcc
Confidence 9999999997 66788999999999999999999999999998877776664421111
Q ss_pred ----------CCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCCC
Q psy6203 457 ----------PPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGPE 496 (568)
Q Consensus 457 ----------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 496 (568)
...+|++++|||.+||+.||.+|||++|+|+||||+....
T Consensus 260 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1247899999999999999999999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.6e-24 Score=215.37 Aligned_cols=149 Identities=15% Similarity=0.168 Sum_probs=119.6
Q ss_pred HHHHhCCCCCChhhHHHHHHHHhhcc------------Ccc---------eeEEEccccCcccccCCCCceecccccccc
Q psy6203 345 YALLCGFLPFDSDSIDQLYDKILSHF------------MPI---------CTILISQYFPTILLPCKVGQVINLLRSAIV 403 (568)
Q Consensus 345 ~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~---------~~iki~dfG~~~~~~~~~~~~~~~~~gt~~ 403 (568)
..+.....+|++..++.++.|++.|+ +|+ ..+||+|||++.... .+....+.+||+.
T Consensus 110 ~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~--~~~~~~~~~gt~~ 187 (350)
T d1q5ka_ 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 187 (350)
T ss_dssp HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC--TTSCCCSCCSCTT
T ss_pred HhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc--CCccccccccccc
Confidence 34455677899999999999999874 332 267999999775543 2334566799999
Q ss_pred cccCCC--CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------CCC---------
Q psy6203 404 LCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNG-----------------KYT--------- 455 (568)
Q Consensus 404 ~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~-----------------~~~--------- 455 (568)
|+|||+ +..+|+.++||||+||++|||++|++||.+.+..+.+..+... ...
T Consensus 188 y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (350)
T d1q5ka_ 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW 267 (350)
T ss_dssp SCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCG
T ss_pred ccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCch
Confidence 999998 5678999999999999999999999999999887777666431 001
Q ss_pred ---CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 456 ---EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 456 ---~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
..+..++++.+||.+||++||++|||+.|+++||||+...
T Consensus 268 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 268 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1234789999999999999999999999999999998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.6e-24 Score=211.88 Aligned_cols=155 Identities=13% Similarity=0.134 Sum_probs=126.5
Q ss_pred hhhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCc--ee
Q psy6203 338 WSMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQ--VI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~--~~ 395 (568)
|..|++|.+++....++++..+..++.||+.|+ +|+. .+||+|||+++........ ..
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 334789999999889999999999999999874 4443 5789999988665433222 22
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHcc
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSML 472 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L 472 (568)
....||+.|+|||. ....|+.++||||+||++|||++ |++||.+.+..++...+..+. ++.|..+|+++.+||.+||
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence 34578999999998 56678999999999999999997 899999999989888888875 4567889999999999999
Q ss_pred CCCcCCCCCHHHH---hcCcccc
Q psy6203 473 QVEPGKRIKIQDL---LGHNWVK 492 (568)
Q Consensus 473 ~~dp~~R~t~~~~---l~hp~~~ 492 (568)
..||++|||++++ |+|+|+.
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999988 4566653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=5.6e-24 Score=212.98 Aligned_cols=137 Identities=16% Similarity=0.261 Sum_probs=110.5
Q ss_pred CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc-eecccccccccccCCC-
Q psy6203 352 LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ-VINLLRSAIVLCSAPS- 409 (568)
Q Consensus 352 ~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~-~~~~~~gt~~~~~pe~- 409 (568)
..+++.++..++.|+++|+ +|+ +++||+|||+|+........ ...+.+||+.|||||.
T Consensus 159 ~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 159 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence 4689999999999999874 343 46899999988655433322 3445678999999997
Q ss_pred CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHh
Q psy6203 410 SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG--KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLL 486 (568)
Q Consensus 410 ~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 486 (568)
....|+.++||||+||++|||++ |++||.+.+..+.+.++... .++.|..+|+++++||.+||+.||++|||++|++
T Consensus 239 ~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 66678999999999999999997 89999987766655555544 3456778999999999999999999999999998
Q ss_pred cC
Q psy6203 487 GH 488 (568)
Q Consensus 487 ~h 488 (568)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=4.5e-23 Score=203.34 Aligned_cols=153 Identities=12% Similarity=0.189 Sum_probs=116.9
Q ss_pred HHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCceeccccc
Q psy6203 341 GVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQVINLLRS 400 (568)
Q Consensus 341 g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~~~~~~~g 400 (568)
|+.+..++...+.+++..++.++.|++.|+ +|+. ++|++|||.+...... ........+
T Consensus 85 ~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~ 163 (292)
T d1unla_ 85 QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVV 163 (292)
T ss_dssp EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-CSCCCSCCS
T ss_pred ccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC-Cccceeecc
Confidence 678888888889999999999999999874 4554 5678999977654322 222333455
Q ss_pred ccccccCCC--CCCCCCCccceeehhHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCC-----------------------
Q psy6203 401 AIVLCSAPS--SKQYYGSETDVWSMGVMLYALLCGFLPF-DSDSIDQLYDKILNGKY----------------------- 454 (568)
Q Consensus 401 t~~~~~pe~--~~~~~~~~~DiWSlG~il~eml~g~~pf-~~~~~~~~~~~i~~~~~----------------------- 454 (568)
+++|++||. ...+++.++||||+||++|||++|+.|| .+.+..+.+.++.....
T Consensus 164 ~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T d1unla_ 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243 (292)
T ss_dssp CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC
T ss_pred ccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccccc
Confidence 666666665 5667899999999999999999998875 56666766666533100
Q ss_pred ------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 455 ------TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 455 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
..+..+|+.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0123468899999999999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=6.7e-24 Score=208.06 Aligned_cols=156 Identities=16% Similarity=0.204 Sum_probs=127.5
Q ss_pred hhhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCC--ce
Q psy6203 338 WSMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVG--QV 394 (568)
Q Consensus 338 ~~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~--~~ 394 (568)
|..|++|.+++.. ..++++..+..++.|+++|+ +++ ..+||+|||+|+....... ..
T Consensus 89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 3347889888764 56899999999999999874 333 3689999998866533222 12
Q ss_pred ecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHc
Q psy6203 395 INLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSM 471 (568)
Q Consensus 395 ~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~ 471 (568)
....+||+.|+|||. ....|+.++||||+||++|||+| |++||.+.+..++...|..+. ++.|+.+++++.+||.+|
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 248 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 248 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 334678999999998 55678999999999999999998 999999988888888888875 457888999999999999
Q ss_pred cCCCcCCCCCHHHH---hcCccccc
Q psy6203 472 LQVEPGKRIKIQDL---LGHNWVKM 493 (568)
Q Consensus 472 L~~dp~~R~t~~~~---l~hp~~~~ 493 (568)
|..||++|||+.++ |+|+|+..
T Consensus 249 l~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 249 WIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999998877 67888864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=6e-24 Score=207.52 Aligned_cols=148 Identities=17% Similarity=0.254 Sum_probs=112.5
Q ss_pred HHHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccc
Q psy6203 341 GVMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLR 399 (568)
Q Consensus 341 g~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~ 399 (568)
|+++.+++. ..+++++..+..++.|+++|+ +++ +++||+|||+|+.............+
T Consensus 91 ~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~ 170 (273)
T d1mp8a_ 91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170 (273)
T ss_dssp TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------
T ss_pred CCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceecccee
Confidence 677777654 456899999999999999874 333 46899999988665433333345567
Q ss_pred cccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCCc
Q psy6203 400 SAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVEP 476 (568)
Q Consensus 400 gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dp 476 (568)
||+.|+|||. ....|+.++||||+||++|||++ |.+||.+.+..+++.++..+. ++.|+.+|+++.+||.+||..||
T Consensus 171 gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp 250 (273)
T d1mp8a_ 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 250 (273)
T ss_dssp CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCH
Confidence 8999999998 66678999999999999999997 899999999999999988875 45788899999999999999999
Q ss_pred CCCCCHHHHhcC
Q psy6203 477 GKRIKIQDLLGH 488 (568)
Q Consensus 477 ~~R~t~~~~l~h 488 (568)
++|||++|+++|
T Consensus 251 ~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 251 SRRPRFTELKAQ 262 (273)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.1e-23 Score=202.33 Aligned_cols=151 Identities=19% Similarity=0.246 Sum_probs=114.2
Q ss_pred hhhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceec
Q psy6203 338 WSMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|..|++|.+++.. ...++++.+..++.|+++|+ +| ..++||+|||+++...........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 3347888888765 46789999999999999874 33 347899999987654433333334
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~ 473 (568)
...||+.|+|||. ....|+.++||||+||++|||+| |.+||.+.+..+++..+..+.. ..|...++++.+||.+||.
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 240 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHcc
Confidence 5678999999998 66779999999999999999998 6888888888888888887754 4577789999999999999
Q ss_pred CCcCCCCCHHHHhcC
Q psy6203 474 VEPGKRIKIQDLLGH 488 (568)
Q Consensus 474 ~dp~~R~t~~~~l~h 488 (568)
.||++|||++|+++|
T Consensus 241 ~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 241 ERPEDRPAFSRLLRQ 255 (263)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999999876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.87 E-value=1e-23 Score=206.29 Aligned_cols=154 Identities=16% Similarity=0.158 Sum_probs=115.8
Q ss_pred hhHHHHHHHHhCCCCCChhhHHHHHHHHhhcc------------CcceeE--------EEccccCcccccCCC--Cceec
Q psy6203 339 SMGVMLYALLCGFLPFDSDSIDQLYDKILSHF------------MPICTI--------LISQYFPTILLPCKV--GQVIN 396 (568)
Q Consensus 339 ~~g~~l~~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~~i--------ki~dfG~~~~~~~~~--~~~~~ 396 (568)
..|++|.+++...+++++++++.++.|+++|+ +||.|| +++|||.+....... .....
T Consensus 93 ~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 172 (277)
T d1o6ya_ 93 VDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172 (277)
T ss_dssp CCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------
T ss_pred CCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccc
Confidence 34788998998888999999999999999874 666665 456777654332222 22345
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHc
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGKYTE----PPWMSPNSRQIVRSM 471 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~li~~~ 471 (568)
+.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+..+.+.++....+.+ ++.+|+++.+||.+|
T Consensus 173 ~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~ 252 (277)
T d1o6ya_ 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKA 252 (277)
T ss_dssp ------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHH
T ss_pred cccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHH
Confidence 6789999999998 67789999999999999999999999999999888888877765543 356899999999999
Q ss_pred cCCCcCCCCCHHHHhcCcccc
Q psy6203 472 LQVEPGKRIKIQDLLGHNWVK 492 (568)
Q Consensus 472 L~~dp~~R~t~~~~l~hp~~~ 492 (568)
|++||++||+..+.+.|+|.+
T Consensus 253 L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 253 LAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp TCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCCHhHCHhHHHHHHHHHHH
Confidence 999999999544445577764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.6e-23 Score=204.38 Aligned_cols=151 Identities=17% Similarity=0.261 Sum_probs=114.2
Q ss_pred hhhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCC-Ccee
Q psy6203 338 WSMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKV-GQVI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~-~~~~ 395 (568)
|..|++|++++.. .+++++..+..++.|+++|+ +|+ .++||+|||+|....... ....
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 3347899999865 46799999999999999874 333 367999999886553322 2334
Q ss_pred cccccccccccCCC-C---CCCCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCC-----CCCCCCHHHH
Q psy6203 396 NLLRSAIVLCSAPS-S---KQYYGSETDVWSMGVMLYALLCGFLPFDSDSID-QLYDKILNGKYT-----EPPWMSPNSR 465 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~---~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~-~~~~~i~~~~~~-----~~~~~s~~~~ 465 (568)
.+.+||+.|||||. . ...|+.++||||+||++|||++|+.||.+.+.. .+...+..+... .+..+++++.
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 243 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHH
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHH
Confidence 56789999999997 2 345899999999999999999999999986644 444444444322 3556899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q psy6203 466 QIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 466 ~li~~~L~~dp~~R~t~~~~l~h 488 (568)
+||.+||..||++|||++|++++
T Consensus 244 ~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 244 RLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2.2e-23 Score=211.38 Aligned_cols=142 Identities=17% Similarity=0.311 Sum_probs=104.2
Q ss_pred CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceecccccccccccCCC-C
Q psy6203 352 LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS-S 410 (568)
Q Consensus 352 ~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~-~ 410 (568)
..|++++++.++.|++.|+ +|| +++|++|||.+.... .+......+||+.|+|||. .
T Consensus 114 ~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~--~~~~~~~~~~t~~y~aPE~l~ 191 (355)
T d2b1pa1 114 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 191 (355)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHT
T ss_pred cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc--cccccccccccccccChhhhc
Confidence 4699999999999999874 344 357888888654432 3334566789999999998 6
Q ss_pred CCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------------CCC------------
Q psy6203 411 KQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKILNGK----------------------YTE------------ 456 (568)
Q Consensus 411 ~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i~~~~----------------------~~~------------ 456 (568)
+..|+.++||||+||++|+|++|++||.+.+......++.... ...
T Consensus 192 ~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (355)
T d2b1pa1 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271 (355)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGG
T ss_pred CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccc
Confidence 7789999999999999999999999999988776665553211 100
Q ss_pred --C------CCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 457 --P------PWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 457 --~------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
+ ...|+++.+||++||..||++||||+|+|+||||+...
T Consensus 272 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp GSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0 01367899999999999999999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.3e-23 Score=204.84 Aligned_cols=154 Identities=14% Similarity=0.196 Sum_probs=125.4
Q ss_pred hhHHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCceec
Q psy6203 339 SMGVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 339 ~~g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
..|++|.+++... .+|++.++..++.||++|+ +|+ ..+||+|||+|+...........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 3467888776653 3699999999999999864 343 36799999988765433333345
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 473 (568)
...||+.|+|||. ....|+.++||||+||++|||+| |.+||...+..+++..+..+. +..|..+++++.+||.+||.
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 248 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK 248 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcC
Confidence 5688999999998 55568999999999999999999 577788888888888888874 44678899999999999999
Q ss_pred CCcCCCCCHHHHhc--Ccccc
Q psy6203 474 VEPGKRIKIQDLLG--HNWVK 492 (568)
Q Consensus 474 ~dp~~R~t~~~~l~--hp~~~ 492 (568)
.||++|||++++++ |+||.
T Consensus 249 ~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 249 ERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999988 78886
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=5.2e-23 Score=198.71 Aligned_cols=151 Identities=13% Similarity=0.206 Sum_probs=123.5
Q ss_pred hhhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceec
Q psy6203 338 WSMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVIN 396 (568)
Q Consensus 338 ~~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~ 396 (568)
|..++.+.+++.. ...+++..+..++.|+++|+ ++ ...+||+|||++............
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 3346777777554 56799999999999999875 22 347899999987654433333334
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHccC
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~ 473 (568)
...||+.|+|||. ....|+.++||||+||++|||+| |+.||.+.+..++..++..+.. ..|...++++.+||.+||+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 239 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHcc
Confidence 4678999999997 55668999999999999999998 8999999999999999988754 4677789999999999999
Q ss_pred CCcCCCCCHHHHhcC
Q psy6203 474 VEPGKRIKIQDLLGH 488 (568)
Q Consensus 474 ~dp~~R~t~~~~l~h 488 (568)
.||++|||++++++|
T Consensus 240 ~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 240 EKADERPTFKILLSN 254 (258)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.87 E-value=6.3e-23 Score=202.62 Aligned_cols=151 Identities=14% Similarity=0.155 Sum_probs=114.3
Q ss_pred hhhHHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCc---
Q psy6203 338 WSMGVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQ--- 393 (568)
Q Consensus 338 ~~~g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~--- 393 (568)
|..|++|.+++.. .+.+++.++..++.|+++|+ +| .+++||+|||+++........
T Consensus 108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~ 187 (299)
T d1jpaa_ 108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187 (299)
T ss_dssp CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCccee
Confidence 4447889888776 46799999999999999874 33 346899999988654332221
Q ss_pred -eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q psy6203 394 -VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVR 469 (568)
Q Consensus 394 -~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 469 (568)
......||+.|||||. ....|+.++||||+||++|||+| |++||.+.+..+++..+..+. ++.|..+++++.+||.
T Consensus 188 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 267 (299)
T d1jpaa_ 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLML 267 (299)
T ss_dssp --------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHH
Confidence 1122467899999998 56678999999999999999998 899999999999988888764 4567789999999999
Q ss_pred HccCCCcCCCCCHHHHhcC
Q psy6203 470 SMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 470 ~~L~~dp~~R~t~~~~l~h 488 (568)
+||..||++|||+.|++++
T Consensus 268 ~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 268 DCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHTCSSTTTSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=5.3e-23 Score=203.57 Aligned_cols=149 Identities=16% Similarity=0.216 Sum_probs=111.3
Q ss_pred hHHHHHHHHhCC----------------CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccC
Q psy6203 340 MGVMLYALLCGF----------------LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFP 383 (568)
Q Consensus 340 ~g~~l~~~~~~~----------------~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~ 383 (568)
.|++|.+++... ..+++.++..++.|+++|+ +|+ +++||+|||+
T Consensus 101 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGl 180 (299)
T d1ywna1 101 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 180 (299)
T ss_dssp TTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC---
T ss_pred CCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcc
Confidence 367777776532 3589999999999999874 333 4689999998
Q ss_pred cccccCCCC-ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhC-CCCCCCCCHHH-HHHHHHcC-CCCCCC
Q psy6203 384 TILLPCKVG-QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQ-LYDKILNG-KYTEPP 458 (568)
Q Consensus 384 ~~~~~~~~~-~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g-~~pf~~~~~~~-~~~~i~~~-~~~~~~ 458 (568)
|+....... ....+.+||+.|+|||. ....|+.++||||+||++|||++| .+||.+.+..+ ....+..+ .+..|.
T Consensus 181 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (299)
T d1ywna1 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 260 (299)
T ss_dssp ---CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT
T ss_pred hhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 865433322 23445789999999998 667789999999999999999986 67898766444 44445554 355678
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
.+++++.+||.+||..||++|||++|+++|
T Consensus 261 ~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 261 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 899999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.86 E-value=1.9e-22 Score=198.02 Aligned_cols=150 Identities=14% Similarity=0.197 Sum_probs=119.6
Q ss_pred hhhHHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCcee
Q psy6203 338 WSMGVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~ 395 (568)
|..|+++.+++.. ...+++..+..++.|+++|+ +| .+++||+|||+|+....+.....
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 3446788888753 46899999999999999874 33 34689999998876544444444
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHcc
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSML 472 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g-~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L 472 (568)
....||+.|+|||. ....|+.++||||+||++|||++| .+||.+.+..++...+..+. ++.|..+++++.+||.+||
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 253 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHc
Confidence 45568999999997 556789999999999999999995 55566777777777776653 4567889999999999999
Q ss_pred CCCcCCCCCHHHHhc
Q psy6203 473 QVEPGKRIKIQDLLG 487 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~ 487 (568)
..||++|||++|+++
T Consensus 254 ~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 254 QWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCCHhHCcCHHHHHH
Confidence 999999999999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.86 E-value=3.4e-22 Score=200.39 Aligned_cols=141 Identities=16% Similarity=0.211 Sum_probs=108.1
Q ss_pred CCCChhhHHHHHHHHhhcc------------Ccce---------eEEEccccCcccccCCCCceecccccccccccCCC-
Q psy6203 352 LPFDSDSIDQLYDKILSHF------------MPIC---------TILISQYFPTILLPCKVGQVINLLRSAIVLCSAPS- 409 (568)
Q Consensus 352 ~~~~e~~~~~~~~qil~~~------------~~~~---------~iki~dfG~~~~~~~~~~~~~~~~~gt~~~~~pe~- 409 (568)
+.|++.+++.++.||+.|+ +|+. .+|++|||.|... ..+......+||+.|+|||.
T Consensus 124 ~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~--~~~~~~~~~~~t~~y~aPE~~ 201 (328)
T d3bqca1 124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELL 201 (328)
T ss_dssp TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC--CTTCCCCSCCSCGGGCCHHHH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceec--cCCCcccccccCccccCcccc
Confidence 4699999999999999874 3332 4799999976543 23334567789999999997
Q ss_pred -CCCCCCCccceeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHc-------------CCCC-------------------
Q psy6203 410 -SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS-IDQLYDKILN-------------GKYT------------------- 455 (568)
Q Consensus 410 -~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~-~~~~~~~i~~-------------~~~~------------------- 455 (568)
+...|+.++||||+||++|+|++|++||.... ..+....+.. ....
T Consensus 202 ~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (328)
T d3bqca1 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281 (328)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGG
T ss_pred cCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhh
Confidence 56779999999999999999999999997653 3322222211 0000
Q ss_pred -----CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q psy6203 456 -----EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMG 494 (568)
Q Consensus 456 -----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 494 (568)
....+|++++|||++||++||.+|||++|+|+||||+..
T Consensus 282 ~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 282 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp GCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 012278999999999999999999999999999999854
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.7e-22 Score=197.78 Aligned_cols=155 Identities=15% Similarity=0.191 Sum_probs=118.4
Q ss_pred HHHHHHHHhC--CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCceeccc
Q psy6203 341 GVMLYALLCG--FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQVINLL 398 (568)
Q Consensus 341 g~~l~~~~~~--~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~~~~~~ 398 (568)
|+++..++.. ...|++.++..++.|++.|+ ++ ..++||+|||+++.............
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 174 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence 5666666553 35799999999999999874 33 34689999998765433333334456
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 475 (568)
+||+.|+|||. ....|+.++||||+||++|||++ |.+||.+.+..+++..+..+. .+.|..+++++++||.+||+.|
T Consensus 175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~d 254 (285)
T d1fmka3 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 254 (285)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccC
Confidence 89999999998 56678999999999999999999 567778888888888888764 4578889999999999999999
Q ss_pred cCCCCCHHHHhc--CcccccCC
Q psy6203 476 PGKRIKIQDLLG--HNWVKMGP 495 (568)
Q Consensus 476 p~~R~t~~~~l~--hp~~~~~~ 495 (568)
|++|||++++++ ++||....
T Consensus 255 P~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 255 PEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp GGGSCCHHHHHHHHHTTTSCSC
T ss_pred HhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999988 88997543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=3.5e-22 Score=199.10 Aligned_cols=149 Identities=17% Similarity=0.224 Sum_probs=117.8
Q ss_pred HHHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc-eeccc
Q psy6203 341 GVMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ-VINLL 398 (568)
Q Consensus 341 g~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~-~~~~~ 398 (568)
+++|.+.+. ....+++..+..++.|++.|+ +|+ +++||+|||+|......... .....
T Consensus 94 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 173 (317)
T d1xkka_ 94 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173 (317)
T ss_dssp TCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-------
T ss_pred CCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccccccccc
Confidence 455555444 467899999999999999874 333 36899999988665433322 23345
Q ss_pred ccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCCC
Q psy6203 399 RSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQVE 475 (568)
Q Consensus 399 ~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 475 (568)
.||+.|+|||. ....|+.++||||+||++|||+| |.+||.+.+..++...+..+. ++.|+.+++++.+||.+||..|
T Consensus 174 ~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d 253 (317)
T d1xkka_ 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 253 (317)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSS
T ss_pred ccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCC
Confidence 78999999997 55678999999999999999998 899999988888888887765 4577889999999999999999
Q ss_pred cCCCCCHHHHhcCc
Q psy6203 476 PGKRIKIQDLLGHN 489 (568)
Q Consensus 476 p~~R~t~~~~l~hp 489 (568)
|.+|||+.|+++|-
T Consensus 254 P~~RPs~~eil~~l 267 (317)
T d1xkka_ 254 ADSRPKFRELIIEF 267 (317)
T ss_dssp GGGSCCHHHHHHHH
T ss_pred hhhCcCHHHHHHHH
Confidence 99999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=3.5e-22 Score=198.42 Aligned_cols=149 Identities=16% Similarity=0.221 Sum_probs=119.1
Q ss_pred hhhHHHHHHHHhCC----------------CCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccc
Q psy6203 338 WSMGVMLYALLCGF----------------LPFDSDSIDQLYDKILSHF------------MPIC--------TILISQY 381 (568)
Q Consensus 338 ~~~g~~l~~~~~~~----------------~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~df 381 (568)
|..|++|.+++... ..|++..+..++.||+.|+ +++. .+||+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccc
Confidence 33478888887643 6799999999999998764 3443 5679999
Q ss_pred cCcccccCCCCceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHcC-CCCCCC
Q psy6203 382 FPTILLPCKVGQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNG-KYTEPP 458 (568)
Q Consensus 382 G~~~~~~~~~~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g-~~pf~~~~~~~~~~~i~~~-~~~~~~ 458 (568)
|++..... .......+||+.|+|||. ....|+.++||||+||++|||++| .+||.+.+..+++..+..+ .++.|.
T Consensus 172 G~a~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~ 249 (309)
T d1fvra_ 172 GLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249 (309)
T ss_dssp TCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT
T ss_pred cccccccc--cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCc
Confidence 98754322 222345678999999998 566789999999999999999996 5789999999999988876 455678
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 459 WMSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 459 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
.+++++++||.+||..||++|||++|+++|
T Consensus 250 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 250 NCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 899999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2e-21 Score=191.86 Aligned_cols=148 Identities=15% Similarity=0.228 Sum_probs=121.4
Q ss_pred hHHHHHHHHhCC----------------CCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccC
Q psy6203 340 MGVMLYALLCGF----------------LPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFP 383 (568)
Q Consensus 340 ~g~~l~~~~~~~----------------~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~ 383 (568)
.||+|++++... ..|++..+..++.|+++|+ +|+. .+||+|||+
T Consensus 102 ~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~ 181 (299)
T d1fgka_ 102 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181 (299)
T ss_dssp TTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTC
T ss_pred CCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchh
Confidence 367788887654 3589999999999999874 4443 568999998
Q ss_pred cccccCCC-CceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q psy6203 384 TILLPCKV-GQVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPW 459 (568)
Q Consensus 384 ~~~~~~~~-~~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~ 459 (568)
+....... .......+||+.|+|||. ....|+.++||||+||++|||++ |.+||.+.+..+++..+..+. +..|..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~ 261 (299)
T d1fgka_ 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN 261 (299)
T ss_dssp CCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSS
T ss_pred hccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 76553322 223445688999999997 56679999999999999999998 799999999988888887764 456888
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
+++++.+||.+||+.||++|||+.|+++
T Consensus 262 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 262 CTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9999999999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.83 E-value=1.5e-21 Score=192.99 Aligned_cols=136 Identities=13% Similarity=0.160 Sum_probs=111.0
Q ss_pred CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCC-ceecccccccccccCCC-
Q psy6203 352 LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVG-QVINLLRSAIVLCSAPS- 409 (568)
Q Consensus 352 ~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~-~~~~~~~gt~~~~~pe~- 409 (568)
..|++..+..++.|+++|+ +|+ .++||+|||+|........ ....+.+||+.|+|||.
T Consensus 135 ~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 135 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214 (301)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence 4699999999999999763 443 4689999998865433222 22345678899999997
Q ss_pred CCCCCCCccceeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 410 SKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGKYT-EPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 410 ~~~~~~~~~DiWSlG~il~eml~g-~~pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
....|+.++||||+||++|||++| .+||.+.+..++...+..+..+ .|..+++++.+||.+||..||++|||+.|+++
T Consensus 215 ~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 215 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 666799999999999999999998 5789999999999999888754 57789999999999999999999999999854
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.7e-21 Score=189.70 Aligned_cols=146 Identities=15% Similarity=0.179 Sum_probs=114.2
Q ss_pred HHHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Ccce--------eEEEccccCcccccCCCCc--eecc
Q psy6203 341 GVMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MPIC--------TILISQYFPTILLPCKVGQ--VINL 397 (568)
Q Consensus 341 g~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~~~--------~iki~dfG~~~~~~~~~~~--~~~~ 397 (568)
++.+.+++. ..++|++..+..++.|+++|+ +++. ++|++|||++......... ....
T Consensus 94 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~ 173 (273)
T d1u46a_ 94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173 (273)
T ss_dssp TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred CcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCc
Confidence 455555444 346799999999999999874 3443 5799999988765433222 2334
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHccC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGKY--TEPPWMSPNSRQIVRSMLQ 473 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~~~L~ 473 (568)
.+||..|+|||. ....|+.++||||+||++|||++ |++||.+.+..+...++..... +.|+.+|+++.+||.+||.
T Consensus 174 ~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 253 (273)
T d1u46a_ 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253 (273)
T ss_dssp --CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcC
Confidence 567778888887 66789999999999999999998 8999999999999999877643 4567789999999999999
Q ss_pred CCcCCCCCHHHHh
Q psy6203 474 VEPGKRIKIQDLL 486 (568)
Q Consensus 474 ~dp~~R~t~~~~l 486 (568)
.||++|||+++++
T Consensus 254 ~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 254 HKPEDRPTFVALR 266 (273)
T ss_dssp SSGGGSCCHHHHH
T ss_pred CChhHCcCHHHHH
Confidence 9999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=5e-21 Score=187.50 Aligned_cols=147 Identities=18% Similarity=0.196 Sum_probs=110.6
Q ss_pred HHHHHHHHh-CCCCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCc--eecc
Q psy6203 341 GVMLYALLC-GFLPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQ--VINL 397 (568)
Q Consensus 341 g~~l~~~~~-~~~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~--~~~~ 397 (568)
++.+.+++. ....+++.++..++.|+++|+ +|+ .++||+|||+++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 172 (283)
T d1mqba_ 93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172 (283)
T ss_dssp TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred cCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEecc
Confidence 566666554 456899999999999999874 333 36899999988664332211 2234
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccCC
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNGK-YTEPPWMSPNSRQIVRSMLQV 474 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 474 (568)
..||+.|+|||. ....|+.++||||+||++|||++ |.+||.+.+..+++..+..+. ++.|..+++++.+||.+||..
T Consensus 173 ~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 252 (283)
T d1mqba_ 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQ 252 (283)
T ss_dssp -CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCS
T ss_pred CCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcC
Confidence 578999999997 66688999999999999999998 566677778888888887764 456777999999999999999
Q ss_pred CcCCCCCHHHHhc
Q psy6203 475 EPGKRIKIQDLLG 487 (568)
Q Consensus 475 dp~~R~t~~~~l~ 487 (568)
||++|||+.|+++
T Consensus 253 ~p~~RPt~~eil~ 265 (283)
T d1mqba_ 253 ERARRPKFADIVS 265 (283)
T ss_dssp STTTSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.4e-21 Score=188.87 Aligned_cols=147 Identities=13% Similarity=0.257 Sum_probs=115.2
Q ss_pred hhhHHHHHHHHhCC--CCCChhhHHHHHHHHhhcc------------Ccc--------eeEEEccccCcccccCCCCcee
Q psy6203 338 WSMGVMLYALLCGF--LPFDSDSIDQLYDKILSHF------------MPI--------CTILISQYFPTILLPCKVGQVI 395 (568)
Q Consensus 338 ~~~g~~l~~~~~~~--~~~~e~~~~~~~~qil~~~------------~~~--------~~iki~dfG~~~~~~~~~~~~~ 395 (568)
|..|++|.+++... .++++..+..++.||++|+ +++ +++|++|||+++... ...
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~----~~~ 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQ 157 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC----CCC
Confidence 44578898888653 3599999999999999874 333 357899999765432 123
Q ss_pred cccccccccccCCC-CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHcc
Q psy6203 396 NLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILNG-KYTEPPWMSPNSRQIVRSML 472 (568)
Q Consensus 396 ~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L 472 (568)
....+|+.|+|||. .+..|+.++||||+||++|||++ |++||.+.+..++...|..+ .+++|..+++++.+||++||
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl 237 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 45678999999997 45578999999999999999998 79999999888888888776 45578889999999999999
Q ss_pred CCCcCCCCCHHHHhcC
Q psy6203 473 QVEPGKRIKIQDLLGH 488 (568)
Q Consensus 473 ~~dp~~R~t~~~~l~h 488 (568)
..||.+|||+.+++++
T Consensus 238 ~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 238 HLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred ccCHhHCcCHHHHHHH
Confidence 9999999999998764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.80 E-value=8e-21 Score=192.93 Aligned_cols=147 Identities=18% Similarity=0.231 Sum_probs=103.7
Q ss_pred HHHHhCCCCCChhhHHHHHHHHhhcc-------------Cccee--------------EEEccccCcccccCCCCceecc
Q psy6203 345 YALLCGFLPFDSDSIDQLYDKILSHF-------------MPICT--------------ILISQYFPTILLPCKVGQVINL 397 (568)
Q Consensus 345 ~~~~~~~~~~~e~~~~~~~~qil~~~-------------~~~~~--------------iki~dfG~~~~~~~~~~~~~~~ 397 (568)
.........+++..++.++.|+++|+ +|+.| ++++|||.+.... .....
T Consensus 113 ~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~----~~~~~ 188 (362)
T d1q8ya_ 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EHYTN 188 (362)
T ss_dssp HHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT----BCCCS
T ss_pred ccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccc----ccccc
Confidence 34455567899999999999998753 44443 6677777554322 12356
Q ss_pred cccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHH---HcC---------------
Q psy6203 398 LRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSID------QLYDKI---LNG--------------- 452 (568)
Q Consensus 398 ~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~------~~~~~i---~~~--------------- 452 (568)
.+||+.|+|||. ....|+.++||||+||++++|++|++||...+.. +.+..+ +..
T Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~ 268 (362)
T d1q8ya_ 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTF 268 (362)
T ss_dssp CCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHH
T ss_pred ccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccc
Confidence 789999999998 5567899999999999999999999999765321 111111 100
Q ss_pred ------------------------CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCC
Q psy6203 453 ------------------------KYTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLGHNWVKMGP 495 (568)
Q Consensus 453 ------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 495 (568)
....+...++++.|||.+||++||.+|||++|+|+||||++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 269 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp BCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred cccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 0001112467899999999999999999999999999998543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=9.8e-21 Score=187.66 Aligned_cols=141 Identities=17% Similarity=0.167 Sum_probs=113.9
Q ss_pred CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCc-eecccccccccccCCC-
Q psy6203 352 LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQ-VINLLRSAIVLCSAPS- 409 (568)
Q Consensus 352 ~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~-~~~~~~gt~~~~~pe~- 409 (568)
..+++..+..++.|+++|+ ++ .+++||+|||+|+........ .....+||+.|+|||.
T Consensus 128 ~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l 207 (308)
T d1p4oa_ 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHH
Confidence 3567788888888887763 33 346899999988654332222 2334578999999998
Q ss_pred CCCCCCCccceeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 410 SKQYYGSETDVWSMGVMLYALLCG-FLPFDSDSIDQLYDKILNGKY-TEPPWMSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 410 ~~~~~~~~~DiWSlG~il~eml~g-~~pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
....|+.++||||+||++|||++| .+||.+.+..+.+..+..+.. +.|..+++.+.+||.+||+.||++|||++++++
T Consensus 208 ~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 208 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 666788999999999999999998 699999999999998888764 467789999999999999999999999999987
Q ss_pred ------Ccccc
Q psy6203 488 ------HNWVK 492 (568)
Q Consensus 488 ------hp~~~ 492 (568)
+|+|+
T Consensus 288 ~L~~~~~~~~~ 298 (308)
T d1p4oa_ 288 SIKEEMEPGFR 298 (308)
T ss_dssp HHGGGSCTTHH
T ss_pred HHHHhcCCCCc
Confidence 56654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=6.9e-21 Score=189.09 Aligned_cols=137 Identities=18% Similarity=0.285 Sum_probs=108.5
Q ss_pred CCCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCCc-eecccccccccccCCC
Q psy6203 351 FLPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVGQ-VINLLRSAIVLCSAPS 409 (568)
Q Consensus 351 ~~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~~-~~~~~~gt~~~~~pe~ 409 (568)
...+++.++..++.|+++|+ +| .+++|++|||.+......... .....+||+.|+|||.
T Consensus 139 ~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 218 (311)
T d1t46a_ 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES 218 (311)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHH
Confidence 34799999999999999874 33 346799999987655433332 2344688999999998
Q ss_pred -CCCCCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHc-CC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHH
Q psy6203 410 -SKQYYGSETDVWSMGVMLYALLC-GFLPFDSDSIDQLYDKILN-GK-YTEPPWMSPNSRQIVRSMLQVEPGKRIKIQDL 485 (568)
Q Consensus 410 -~~~~~~~~~DiWSlG~il~eml~-g~~pf~~~~~~~~~~~i~~-~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~ 485 (568)
....|+.++|||||||++|||++ |.+||.+.+..+.+.++.. +. +..|...++++.+||.+||..||++|||++++
T Consensus 219 ~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 219 IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 66789999999999999999998 7888888776555554443 33 34567789999999999999999999999998
Q ss_pred hc
Q psy6203 486 LG 487 (568)
Q Consensus 486 l~ 487 (568)
++
T Consensus 299 l~ 300 (311)
T d1t46a_ 299 VQ 300 (311)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.79 E-value=2.4e-20 Score=184.20 Aligned_cols=149 Identities=12% Similarity=0.033 Sum_probs=109.5
Q ss_pred HHHhCCCCCChhhHHHHHHHHhhcc------------Cccee-----------EEEccccCcccccCCCC------ceec
Q psy6203 346 ALLCGFLPFDSDSIDQLYDKILSHF------------MPICT-----------ILISQYFPTILLPCKVG------QVIN 396 (568)
Q Consensus 346 ~~~~~~~~~~e~~~~~~~~qil~~~------------~~~~~-----------iki~dfG~~~~~~~~~~------~~~~ 396 (568)
.+....+.|++..+..++.|++.++ +||.| +|++|||+|........ ....
T Consensus 92 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 171 (299)
T d1ckia_ 92 LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171 (299)
T ss_dssp HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCC
T ss_pred hhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccC
Confidence 3344567899999999999999874 55554 78899998865432221 1234
Q ss_pred ccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH---HcCC--C---CCCCCCCHHHHHH
Q psy6203 397 LLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDSIDQLYDKI---LNGK--Y---TEPPWMSPNSRQI 467 (568)
Q Consensus 397 ~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~~~~~~~~i---~~~~--~---~~~~~~s~~~~~l 467 (568)
+.+||+.|+|||. .+..|+.++||||+||++|||++|++||.+.+.......+ .... . ..+..+|+++.+|
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~l 251 (299)
T d1ckia_ 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATY 251 (299)
T ss_dssp SCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred CcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHH
Confidence 5689999999998 7778999999999999999999999999876544332222 1111 1 1245689999999
Q ss_pred HHHccCCCcCCCCCHH---HHhcCcccccC
Q psy6203 468 VRSMLQVEPGKRIKIQ---DLLGHNWVKMG 494 (568)
Q Consensus 468 i~~~L~~dp~~R~t~~---~~l~hp~~~~~ 494 (568)
|.+||..||++||+++ ++++|+|.+..
T Consensus 252 i~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 252 LNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 9999999999999976 55778876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=5e-20 Score=182.54 Aligned_cols=151 Identities=13% Similarity=0.117 Sum_probs=112.9
Q ss_pred hhhHHHHHHHHhCC-CCCChhhHHHHHHHHhhcc------------Cc--------ceeEEEccccCcccccCCCC---c
Q psy6203 338 WSMGVMLYALLCGF-LPFDSDSIDQLYDKILSHF------------MP--------ICTILISQYFPTILLPCKVG---Q 393 (568)
Q Consensus 338 ~~~g~~l~~~~~~~-~~~~e~~~~~~~~qil~~~------------~~--------~~~iki~dfG~~~~~~~~~~---~ 393 (568)
|..|+++.+++... ..+++..+..++.|+++|+ ++ ..++||+|||+++....... .
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 33367788877753 4577788889999999874 33 34678999998765433221 1
Q ss_pred eecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q psy6203 394 VINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDS-DSIDQLYDKILNGKY-TEPPWMSPNSRQIVRS 470 (568)
Q Consensus 394 ~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~-~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 470 (568)
......||+.|+|||. ....|+.++||||+||++|||++|..||.. .+..+....+..+.. ..|..+++++.+||.+
T Consensus 190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~ 269 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHH
Confidence 2234578999999998 556789999999999999999997666654 455566777777754 4677899999999999
Q ss_pred ccCCCcCCCCCHHHHhcC
Q psy6203 471 MLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 471 ~L~~dp~~R~t~~~~l~h 488 (568)
||..||++|||+.|+++|
T Consensus 270 cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 270 CWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.72 E-value=1.7e-18 Score=170.05 Aligned_cols=147 Identities=15% Similarity=0.091 Sum_probs=110.5
Q ss_pred HHHHHHHHhC-CCCCChhhHHHHHHHHhhcc------------Ccce-------------eEEEccccCcccccCCCC--
Q psy6203 341 GVMLYALLCG-FLPFDSDSIDQLYDKILSHF------------MPIC-------------TILISQYFPTILLPCKVG-- 392 (568)
Q Consensus 341 g~~l~~~~~~-~~~~~e~~~~~~~~qil~~~------------~~~~-------------~iki~dfG~~~~~~~~~~-- 392 (568)
|++|.+++.. ...|++.++..++.|++.++ +||. .+||+|||+|.......+
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence 5677777764 34799999999999999863 4444 478999998865432211
Q ss_pred ----ceecccccccccccCCC-CCCCCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCC-----CCCC
Q psy6203 393 ----QVINLLRSAIVLCSAPS-SKQYYGSETDVWSMGVMLYALLCGFLPFDSDS---IDQLYDKILNGKYT-----EPPW 459 (568)
Q Consensus 393 ----~~~~~~~gt~~~~~pe~-~~~~~~~~~DiWSlG~il~eml~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~ 459 (568)
....+.+||+.|||||. .+..|+.++||||+||++|||++|++||.+.+ ....+.++...... .+..
T Consensus 164 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (293)
T d1csna_ 164 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243 (293)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCC
Confidence 12445789999999998 77789999999999999999999999998643 33444444332211 2356
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHhc
Q psy6203 460 MSPNSRQIVRSMLQVEPGKRIKIQDLLG 487 (568)
Q Consensus 460 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 487 (568)
+++++.+++..|+..+|++||+.+.+.+
T Consensus 244 ~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 244 FPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 8899999999999999999999766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=3.6e-18 Score=168.51 Aligned_cols=148 Identities=11% Similarity=0.040 Sum_probs=101.8
Q ss_pred hHHHHHHHHhCCCCCChhhHHHHHHHHhhc--------------------cCcce--------eEEEccccCcccccCCC
Q psy6203 340 MGVMLYALLCGFLPFDSDSIDQLYDKILSH--------------------FMPIC--------TILISQYFPTILLPCKV 391 (568)
Q Consensus 340 ~g~~l~~~~~~~~~~~e~~~~~~~~qil~~--------------------~~~~~--------~iki~dfG~~~~~~~~~ 391 (568)
.+++|.+++.. .+++++....++.|++.+ .+|+. ++||+|||++.......
T Consensus 84 ~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 84 EHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp TTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred cCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 37889999986 478888888888888753 23433 67999999876543322
Q ss_pred Cc---eecccccccccccCCC-CCC------CCCCccceeehhHHHHHHHhCCCCCCCC---------------CHHHHH
Q psy6203 392 GQ---VINLLRSAIVLCSAPS-SKQ------YYGSETDVWSMGVMLYALLCGFLPFDSD---------------SIDQLY 446 (568)
Q Consensus 392 ~~---~~~~~~gt~~~~~pe~-~~~------~~~~~~DiWSlG~il~eml~g~~pf~~~---------------~~~~~~ 446 (568)
.. .....+||+.|+|||. ... .++.++||||+||++|||++|.+||... +.....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 21 2345689999999997 221 3678899999999999999999887532 122233
Q ss_pred HHHHcCCC--CCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q psy6203 447 DKILNGKY--TEPPW-----MSPNSRQIVRSMLQVEPGKRIKIQDLLGH 488 (568)
Q Consensus 447 ~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dp~~R~t~~~~l~h 488 (568)
..+..... .+|.. ....+.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 33333222 22222 22347899999999999999999998763
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.56 E-value=1.7e-07 Score=88.50 Aligned_cols=140 Identities=15% Similarity=0.188 Sum_probs=96.8
Q ss_pred ccCeEEEeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEE
Q psy6203 7 RNQYILERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFMVI 85 (568)
Q Consensus 7 ~~~Y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 85 (568)
-..|+..+..+.++.+.||++. ..+..+++|+....... ....+.+|...+..+. +--+.+++.+..+++..++||
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 3577877776666678999886 46677889987654322 2335678888888774 434678888888899999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q psy6203 86 EYCPGGELLDHIVERQRLGEKESRAFFRQILSAVAYLHH----------------------------------------- 124 (568)
Q Consensus 86 E~~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~aL~~LH~----------------------------------------- 124 (568)
++++|.++.+.... ......++.++...+..||+
T Consensus 90 ~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 99998877554321 11122234444444444442
Q ss_pred ------------------cCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 125 ------------------LGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 125 ------------------~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 126899999999999877666799998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.08 E-value=7e-06 Score=82.02 Aligned_cols=79 Identities=16% Similarity=0.169 Sum_probs=51.5
Q ss_pred EeeecccCCeEEEEEEEcCCCcEEEEEEeecC------CcCCchHHHHHHHHHHHhCC-C--CCcceeeEEEEeCCEEEE
Q psy6203 13 ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKA------TLGEDLPRVKLEINALKHIS-H--QHICKLFQVIETSSHIFM 83 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~Ei~~l~~l~-h--pnIv~l~~~~~~~~~~~l 83 (568)
.+.||.|....||++.+..+++.++||.-... .......+...|...|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999998777889999965421 11123446677888887663 2 345666654 4445589
Q ss_pred EEeccCCCCh
Q psy6203 84 VIEYCPGGEL 93 (568)
Q Consensus 84 V~E~~~~g~L 93 (568)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=1.2e-05 Score=74.85 Aligned_cols=78 Identities=15% Similarity=0.167 Sum_probs=53.9
Q ss_pred eEEEeeecccC-CeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCC--CCcceeeEEEEeCCEEEEEEe
Q psy6203 10 YILERTVGSGG-FAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH--QHICKLFQVIETSSHIFMVIE 86 (568)
Q Consensus 10 Y~i~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~E 86 (568)
+.+. .+..|. .+.||++.. ..+..+++|...... ...+..|...++.+.. -.+.+++.+..+.+..++||+
T Consensus 13 ~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 13 YDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp CEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence 4443 444554 468998874 456678899865432 2246778888877642 336778888888889999999
Q ss_pred ccCCCCh
Q psy6203 87 YCPGGEL 93 (568)
Q Consensus 87 ~~~~g~L 93 (568)
+++|.++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9988655
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.78 E-value=0.0021 Score=63.38 Aligned_cols=75 Identities=17% Similarity=0.134 Sum_probs=51.4
Q ss_pred EEeeecccCCeEEEEEEEcC-------CCcEEEEEEeecCCcCCchHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEE
Q psy6203 12 LERTVGSGGFAKVKLATHVL-------TGEKVAIKIMKKATLGEDLPRVKLEINALKHIS-HQHICKLFQVIETSSHIFM 83 (568)
Q Consensus 12 i~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l 83 (568)
-++.|+.|-.-.+|++.... .++.|++++.-.. .......+|..+++.+. +.-..++++++. + .+
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~ 118 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 118 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ce
Confidence 35788999999999998653 2456777776532 22335667998888885 433457777763 3 68
Q ss_pred EEeccCCCCh
Q psy6203 84 VIEYCPGGEL 93 (568)
Q Consensus 84 V~E~~~~g~L 93 (568)
||||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.69 E-value=0.0036 Score=59.86 Aligned_cols=68 Identities=9% Similarity=0.111 Sum_probs=44.5
Q ss_pred CeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCCCCc--ceee-----EEEEeCCEEEEEEeccCCC
Q psy6203 21 FAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISHQHI--CKLF-----QVIETSSHIFMVIEYCPGG 91 (568)
Q Consensus 21 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI--v~l~-----~~~~~~~~~~lV~E~~~~g 91 (568)
--.||+++. .+|..|++|+...... ....+..|...+..|...+| +... ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999985 4788899999865432 34567778888877642211 1111 2235567889999999764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.98 E-value=0.019 Score=54.20 Aligned_cols=137 Identities=18% Similarity=0.147 Sum_probs=71.6
Q ss_pred EeeecccCCeEEEEEEEcCCCcEEEEEEeecCCcCCchHHHHHHHHHHHhCCC-----CCcceee---EEEEeCCEEEEE
Q psy6203 13 ERTVGSGGFAKVKLATHVLTGEKVAIKIMKKATLGEDLPRVKLEINALKHISH-----QHICKLF---QVIETSSHIFMV 84 (568)
Q Consensus 13 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~h-----pnIv~l~---~~~~~~~~~~lV 84 (568)
.+.|..|---+.|++... +..+++|++.... ....+..|++++..|.. |..+... .+.........+
T Consensus 23 ~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~---~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~ 97 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 97 (316)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eecCCCCcccCeEEEEEC--CCcEEEEEcCCCC---CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccccee
Confidence 344567777888998853 3458999986532 22355667777776642 2222210 112334556677
Q ss_pred EeccCCCChHH----H----------HHh---cC------CCCHHH------------------HHHHHHHHHHHHHHHH
Q psy6203 85 IEYCPGGELLD----H----------IVE---RQ------RLGEKE------------------SRAFFRQILSAVAYLH 123 (568)
Q Consensus 85 ~E~~~~g~L~~----~----------i~~---~~------~l~~~~------------------~~~i~~qi~~aL~~LH 123 (568)
+.+..|..... . +.. .. ...... ....+..+...+.-.+
T Consensus 98 ~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (316)
T d2ppqa1 98 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 177 (316)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred eeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccC
Confidence 77776543210 0 000 00 001110 1112222222222222
Q ss_pred ----HcCceecCCCCCceEEcCCCCeEEEeecCcc
Q psy6203 124 ----HLGYAHRDLKPENVLLDRNQNLKLIDFGLCA 154 (568)
Q Consensus 124 ----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 154 (568)
..|+||+|+.++||+++.+...-|+||+.|.
T Consensus 178 ~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 178 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2579999999999999988777899999754
|